MIM100070	C0162871	19q13	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 1; AAA1	100329167
MIM100100	C0033770	 	ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY AND CRYPTORCHIDISM	1131
MIM100200	C0271355	 	ABDUCENS PALSY	 
MIM100300	CN028867	 	ADAMS-OLIVER SYNDROME 1; AOS1	100188340, 57514
MIM100600	C0000889	 	ACANTHOSIS NIGRICANS	 
MIM100640		9q21	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A1; ALDH1A1	216
MIM100650		12q24.2	ALDEHYDE DEHYDROGENASE 2 FAMILY; ALDH2	217
MIM100660		17p11.2	ALDEHYDE DEHYDROGENASE, FAMILY 3, SUBFAMILY A, MEMBER 1; ALDH3A1	218
MIM100670		9p13	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER B1; ALDH1B1	219
MIM100675	C1863486	 	ACETAMINOPHEN METABOLISM	 
MIM100678		6q25.3-q26	ACETYL-CoA ACETYLTRANSFERASE 2; ACAT2	39
MIM100690		2q24-q32	CHOLINERGIC RECEPTOR, NICOTINIC, ALPHA POLYPEPTIDE 1; CHRNA1	1134
MIM100700	C1332135	 	ACHARD SYNDROME	 
MIM100710		17p12-p11	CHOLINERGIC RECEPTOR, NICOTINIC, BETA POLYPEPTIDE 1; CHRNB1	1140
MIM100720		2q33-q34	CHOLINERGIC RECEPTOR, NICOTINIC, DELTA POLYPEPTIDE; CHRND	1144
MIM100725		17p13-p12	CHOLINERGIC RECEPTOR, NICOTINIC, EPSILON POLYPEPTIDE; CHRNE	1145
MIM100730		2q33-q34	CHOLINERGIC RECEPTOR, NICOTINIC, GAMMA POLYPEPTIDE; CHRNG	1146
MIM100740		7q22	ACETYLCHOLINESTERASE; ACHE	43
MIM100790		12q22-q23	ACHAETE-SCUTE COMPLEX, DROSOPHILA, HOMOLOG OF, 1; ASCL1	429
MIM100800	C0001080	4p16.3	ACHONDROPLASIA; ACH	2261
MIM100820	C1863416	 	ACHOO SYNDROME	 
MIM100850		22q11.21-q13.31	ACONITASE, MITOCHONDRIAL; ACO2	50
MIM100880		9p22-p13	ACONITASE 1, SOLUBLE; ACO1	48
MIM101000	C0027832	22q12.2	NEUROFIBROMATOSIS, TYPE II; NF2	4771
MIM101120	C1275079	 	ACROCEPHALOPOLYSYNDACTYLY TYPE III	 
MIM101200	C0001193	10q26	APERT SYNDROME	2263
MIM101400	C0175699	10q26, 7p21	SAETHRE-CHOTZEN SYNDROME; SCS	2263, 7291
MIM101600	C1863356	10q26, 8p11.2-p11.1	PFEIFFER SYNDROME	2260, 2263
MIM101800	C3276228	 	ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1	5573
MIM101805	C0796243	 	ACROFACIAL DYSOSTOSIS, CATANIA TYPE	 
MIM101840	C1863343	 	ACROKERATODERMA, HEREDITARY PAPULOTRANSLUCENT	 
MIM101850	C0545044	2p25-p12	KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE III; PPKP3	 
MIM101900	C0265971	12q23-q24.1	ACROKERATOSIS VERRUCIFORMIS; AKV	488
MIM102000	C1863342	 	ACROLEUKOPATHY, SYMMETRIC	 
MIM102100	C1321495	 	ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	 
MIM102150	C0796280	 	ACROMEGALOID FACIAL APPEARANCE SYNDROME	 
MIM102200	C0346302	16p13.3, 11q13.3	PITUITARY ADENOMA, GROWTH HORMONE-SECRETING	2778, 6755, 9049
MIM102300	C1876177	12q12-q21	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1	192142
MIM102350	C1863321	 	ACROMIAL DIMPLES	 
MIM102370	C0265287	 	ACROMICRIC DYSPLASIA; ACMICD	2200
MIM102400	C0917990	 	ACROOSTEOLYSIS	 
MIM102480		22q13.3	ACROSIN; ACR	49
MIM102500	C0917715	 	HAJDU-CHENEY SYNDROME; HJCYS	4853
MIM102510	C1863307	2q36	ACROPECTOROVERTEBRAL DYSPLASIA; ACRPV	414058
MIM102520	C0796290	 	ACRORENAL SYNDROME	 
MIM102525		11p12-q13	ACROSOMAL VESICLE PROTEIN 1; ACRV1	56
MIM102530	C0403825	6q21, 3q26.3	SPERMATOGENIC FAILURE 6; SPGF6	57120, 83893
MIM102540		15q14	ACTIN, ALPHA, CARDIAC MUSCLE; ACTC1	70
MIM102545		2p13.1	ACTIN, GAMMA-2, SMOOTH MUSCLE, ENTERIC; ACTG2	72
MIM102560		17q25.3	ACTIN, GAMMA-1; ACTG1	71
MIM102565		7q32	FILAMIN C; FLNC	2318
MIM102573		1q42-q43	ACTININ, ALPHA-2; ACTN2	88
MIM102574		11q13-q14	ACTININ, ALPHA-3; ACTN3	89
MIM102575		14q22-q24	ACTININ, ALPHA-1; ACTN1	87
MIM102576		2q23-q24	ACTIVIN A RECEPTOR, TYPE I; ACVR1	90
MIM102577		3q27	REPLICATION FACTOR C, SUBUNIT 4; RFC4	5984
MIM102578		15q22	ACUTE PROMYELOCYTIC LEUKEMIA, INDUCER OF; PML	5371
MIM102579		4p14-p13	REPLICATION FACTOR C, SUBUNIT 1; RFC1	5981
MIM102581		2q22.2-q23.3	ACTIVIN A RECEPTOR, TYPE IIA; ACVR2A	92
MIM102582		17q21	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; STAT3	6774
MIM102593		7p14-p12	ACYLOXYACYL HYDROLASE; AOAH	313
MIM102595		2p16.2	ACYLPHOSPHATASE 2, MUSCLE TYPE; ACYP2	98
MIM102600		16q24.3	ADENINE PHOSPHORIBOSYLTRANSFERASE; APRT	353
MIM102610		1q42.1	ACTIN, ALPHA, SKELETAL MUSCLE 1; ACTA1	58
MIM102620		10q22-q24	ACTIN, ALPHA-2, SMOOTH MUSCLE, AORTA; ACTA2	59
MIM102630		7p22-p12	ACTIN, BETA; ACTB	60
MIM102642		1q25	STEROL O-ACYLTRANSFERASE 1; SOAT1	6646
MIM102645		3p21	ACYLPEPTIDE HYDROLASE; APH	327
MIM102650	C0220660	 	ADACTYLIA, UNILATERAL	 
MIM102660	C0334556	 	ADAMANTINOMA OF LONG BONES	 
MIM102670		19p13.3	MUCOSAL VASCULAR ADDRESSIN CELL ADHESION MOLECULE 1; MADCAM1	8174
MIM102680		4p16.3	ADDUCIN 1; ADD1	118
MIM102681		2p14-p13	ADDUCIN 2; ADD2	119
MIM102699		19q13-qter	ADENO-ASSOCIATED VIRUS INTEGRATION SITE 1; AAVS1	17
MIM102700	C1863236	20q13.11	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	100
MIM102720		2q23	DIPEPTIDYL PEPTIDASE IV; DPP4	1803
MIM102750		10q11-q24	ADENOSINE KINASE; ADK	132
MIM102770		1p21-p13	ADENOSINE MONOPHOSPHATE DEAMINASE 1; AMPD1	270
MIM102771		1p13.3	ADENOSINE MONOPHOSPHATE DEAMINASE 2; AMPD2	271
MIM102772		11pter-p13	ADENOSINE MONOPHOSPHATE DEAMINASE 3; AMPD3	272
MIM102775		1q32.1	ADENOSINE A1 RECEPTOR; ADORA1	134
MIM102776		22q11.2	ADENOSINE A2 RECEPTOR; ADORA2A	135
MIM102800	C1863225	 	ADENOSINE TRIPHOSPHATASE DEFICIENCY, ANEMIA DUE TO	 
MIM102900	C1863224	1q21	ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES	5313
MIM102910		12p13-qter	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, BETA SUBUNIT; ATP5B	506
MIM102980		18p11	ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE 1; ADCYAP1	116
MIM102981		7p14	ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE 1, RECEPTOR FOR; ADCYAP1R1	117
MIM103000		9q34.1	ADENYLATE KINASE 1; AK1	203
MIM103020		1p34	ADENYLATE KINASE 2; AK2	204
MIM103030		1p31.3	ADENYLATE KINASE 3-LIKE 1; AK3L1	205
MIM103050	C0268126	22q13.1	ADENYLOSUCCINASE DEFICIENCY	158
MIM103060		1cen-q12	ADENYLOSUCCINATE SYNTHETASE; ADSS	159
MIM103070		8q24.2	ADENYLATE CYCLASE 8; ADCY8	114
MIM103071		5p15.3	ADENYLATE CYCLASE 2; ADCY2	108
MIM103072		7p13-p12	ADENYLATE CYCLASE 1; ADCY1	107
MIM103100	C0001519	 	ADIE PUPIL	 
MIM103180		1q42	ADP-RIBOSYLATION FACTOR 1; ARF1	375
MIM103188		7q31.3	ADP-RIBOSYLATION FACTOR 5; ARF5	381
MIM103190		12q13	ADP-RIBOSYLATION FACTOR 3; ARF3	377
MIM103195		9p22.1	PERILIPIN 2; PLIN2	123
MIM103200	C0001529	 	ADIPOSIS DOLOROSA	 
MIM103220		4q35	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER 4; SLC25A4	291
MIM103230	C0271740	 	ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL	 
MIM103260		11q22	FERREDOXIN 1; FDX1	2230
MIM103270		17q24-q25	FERREDOXIN REDUCTASE; FDXR	2232
MIM103275		11p15.4	ADRENOMEDULLIN; ADM	133
MIM103280		11p15.5	H19 GENE; H19	283120
MIM103285	C1863204	3q27	ADULT SYNDROME	8626
MIM103300	C0595985	 	HYPOGLOSSIA-HYPODACTYLIA	 
MIM103320		1pter-p32	AGRIN; AGRN	375790
MIM103390		11q12-q13	AHNAK NUCLEOPROTEIN; AHNAK	79026
MIM103400	C0001860	 	AINHUM	 
MIM103420	C1863199	 	ALACRIMA, CONGENITAL	 
MIM103470	C1863198	11q14-q21, 3p14.1-p12.3	ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS	4286, 7299
MIM103500	C0391816	3p14.1-p12.3	TIETZ SYNDROME	4286
MIM103580	C0033806	20q13.2	PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A	2778
MIM103600		4q11-q13	ALBUMIN; ALB	213
MIM103700		4q22	ALCOHOL DEHYDROGENASE 1A, CLASS I, ALPHA POLYPEPTIDE; ADH1A	124
MIM103710		4q21-q25	ALCOHOL DEHYDROGENASE 5, CHI POLYPEPTIDE; ADH5	128
MIM103720		4q22	ALCOHOL DEHYDROGENASE 1B, CLASS I, BETA POLYPEPTIDE; ADH1B	125
MIM103730		4q22	ALCOHOL DEHYDROGENASE 1C, GAMMA POLYPEPTIDE; ADH1C	126
MIM103735		4q23-q24	ALCOHOL DEHYDROGENASE 6; ADH6	130
MIM103740		4q22	ALCOHOL DEHYDROGENASE 4; ADH4	127
MIM103780	C0001973	13q14-q21, 13q14, 7q31, 4q22, 4q22, 4p13-p12	ALCOHOL DEPENDENCE	125, 126, 217, 2555, 3356, 50833, 55213
MIM103830		1p33-p32	ALDO-KETO REDUCTASE FAMILY 1, MEMBER A1; AKR1A1	10327
MIM103850		16p11.2	ALDOLASE A, FRUCTOSE-BISPHOSPHATE; ALDOA	226
MIM103870		17cen-q12	ALDOLASE C, FRUCTOSE-BISPHOSPHATE; ALDOC	230
MIM103880		7q35	ALDO-KETO REDUCTASE FAMILY 1, MEMBER B1; AKR1B1	231
MIM103900	C1260386	8q21	GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM; GRA	1584
MIM103920	C0004031	 	ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS, FAMILIAL	 
MIM103950		12p13.3-p12.3	ALPHA-2-MACROGLOBULIN; A2M	2
MIM104000	C1863094	18p11.3-p11.2	ALOPECIA AREATA 1	100034700
MIM104100	C1863093	 	PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA, AUTOSOMAL DOMINANT	 
MIM104110	C1863092	 	ALOPECIA, FAMILIAL FOCAL	 
MIM104130	C1863090	 	ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY	 
MIM104145		4q11-q13	AFAMIN; AFM	173
MIM104150		4q11-q13	ALPHA-FETOPROTEIN; AFP	174
MIM104155		16q22.3-q23.1	ZINC FINGER HOMEOBOX 3; ZFHX3	463
MIM104160		11q13-qter	GLUCOSIDASE, ALPHA, NEUTRAL AB; GANAB	23193
MIM104170		22q11	N-ACETYL-ALPHA-D-GALACTOSAMINIDASE; NAGA	4668
MIM104175		9q33-q34	GLYCOPROTEIN ALPHA-GALACTOSYLTRANSFERASE 1; GGTA1	2681
MIM104180		15q15.1-q15.2	GLUCOSIDASE, ALPHA, NEUTRAL C; GANC	2595
MIM104200	C1567743	 	ALPORT SYNDROME, AUTOSOMAL DOMINANT	1285
MIM104210		10q24-q26	ALPHA-2A-ADRENERGIC RECEPTOR; ADRA2A	150
MIM104219		20p13	ALPHA-1D-ADRENERGIC RECEPTOR; ADRA1D	146
MIM104220		5q33	ALPHA-1B-ADRENERGIC RECEPTOR; ADRA1B	147
MIM104221		8p21	ALPHA-1A-ADRENERGIC RECEPTOR; ADRA1A	148
MIM104225		4p16.3	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-ASSOCIATED PROTEIN 1; LRPAP1	4043
MIM104230		11q21	FUCOSYLTRANSFERASE 4; FUT4	2526
MIM104240		Chr.11	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 4; ST3GAL4	6484
MIM104250		4p16.1	ALPHA-2C-ADRENERGIC RECEPTOR; ADRA2C	152
MIM104260		2q11.2	ALPHA-2B-ADRENERGIC RECEPTOR; ADRA2B	151
MIM104290	C3549447	1q21-q23	ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	477
MIM104300	C0002395	17q11.2, 12p11.23-q13.12, 12p13.3-p12.3, 11q23.2-q24.2, 10q24, 10q24, 7q36, 7q36, 7q36, 6p21.3, 4p14, 21q21, 20p, 19p13.2, 17q23.1, 17q23	ALZHEIMER DISEASE; AD	1636, 2, 22976, 3077, 323, 351, 4353, 4846, 5328, 642, 6653
MIM104310	C1863051	19q13.2	ALZHEIMER DISEASE 2	348
MIM104311		14q24.3	PRESENILIN 1; PSEN1	5663
MIM104350	C1863015	 	AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	 
MIM104400	C1863014	 	AMELIA AND TERMINAL TRANSVERSE HEMIMELIA	 
MIM104500	C0399368	4q21	AMELOGENESIS IMPERFECTA, TYPE IB; AI1B	10117
MIM104510	C1863012	17q21.3-q22	AMELOGENESIS IMPERFECTA, TYPE IV; AI4	1747
MIM104530	C0399367	 	AMELOGENESIS IMPERFECTA, HYPOPLASTIC TYPE	 
MIM104570	C1863006	 	AMELOONYCHOHYPOHIDROTIC SYNDROME	 
MIM104600	C0271556	 	AMENORRHEA-GALACTORRHEA SYNDROME	 
MIM104610		7q31-q32	AMILORIDE-BINDING PROTEIN 1; ABP1	26
MIM104613		 	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 6A; CCT6A	908
MIM104614		2p16.3	SOLUTE CARRIER FAMILY 3 (CYSTINE, DIBASIC, AND NEUTRAL AMINO ACID TRANSPORTER), MEMBER 1; SLC3A1	6519
MIM104615		13q12.3	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 1; SLC7A1	6541
MIM104620		3p21.1	AMINOACYLASE 1; ACY1	95
MIM104640		4q13-q21	AMPHIREGULIN; AREG	374
MIM104650		1p21	AMYLASE, PANCREATIC, A; AMY2A	279
MIM104660		1p21	AMYLASE, PANCREATIC, B; AMY2B	280
MIM104700		1p21	AMYLASE, SALIVARY, A; AMY1A	276
MIM104701		1p21	AMYLASE, SALIVARY, B; AMY1B	277
MIM104702		1p21	AMYLASE, SALIVARY, C; AMY1C	278
MIM104750		11p15.1	SERUM AMYLOID A1; SAA1	6288
MIM104751		11p15.1	SERUM AMYLOID A2; SAA2	6289
MIM104752		11p15.1	SERUM AMYLOID A4; SAA4	6291
MIM104760		21q21	AMYLOID BETA A4 PRECURSOR PROTEIN; APP	351
MIM104770		1q21-q23	AMYLOID P COMPONENT, SERUM; APCS	325
MIM104775		19q13.2	AMYLOID BETA A4 PRECURSOR-LIKE PROTEIN 1; APLP1	333
MIM104776		11q24	AMYLOID BETA A4 PRECURSOR-LIKE PROTEIN 2; APLP2	334
MIM105120	C1622345	9q34	AMYLOIDOSIS, FINNISH TYPE	2934
MIM105150	C1527338	20p11.2	CEREBRAL AMYLOID ANGIOPATHY, CST3-RELATED	1471
MIM105200	C0268389	12q15, 11q23, 4q28	AMYLOIDOSIS, FAMILIAL VISCERAL	2243, 335, 4069
MIM105210	C2751492	18q11.2-q12.1	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	7276
MIM105250	C0268398	5p13.1	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1; PLCA1	9180
MIM105300	C1862956	 	AMYOTROPHIC DYSTONIC PARAPLEGIA	 
MIM105400	C1862939	12q12-q13, 2p13, 22q12.2, 21q22.1	AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1	1639, 4744, 5630, 6647
MIM105500	C0543859	15q21	AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1	54822
MIM105550	C1862937	9q21-q22	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS; FTDALS	203228
MIM105563	C1862936	 	ANAL SPHINCTER DYSPLASIA; ASDP	100187749
MIM105565	C1862935	 	ANAL SPHINCTER MYOPATHY, INTERNAL	 
MIM105570	C1862934	 	ANDROSTENONE, ABILITY TO SMELL	 
MIM105580	C0563211	11q22-qter	ANAL CANAL CARCINOMA	8066
MIM105590		2p23	ANAPLASTIC LYMPHOMA KINASE; ALK	238
MIM105600	C0271934	15q21	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE III; CDAN3	981
MIM105650	C2676137	19q13.2	DIAMOND-BLACKFAN ANEMIA; DBA	 
MIM105800	C1862932	7q11.2	ANEURYSM, INTRACRANIAL BERRY, 1; ANIB1	116833
MIM105805	C1387721	 	ANEURYSM OF INTERVENTRICULAR SEPTUM	 
MIM105830	C0162635	15q11-q13, Xq28, Xp22	ANGELMAN SYNDROME; AS	10479, 4204, 6638, 6792, 6925, 7337
MIM105835	C1739384	 	ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA; ASPED	 
MIM105850		14q11.2	ANGIOGENIN; ANG	283
MIM106050	C1970130	 	ANGIOMA SERPIGINOSUM, AUTOSOMAL DOMINANT	 
MIM106070	C1275084	 	ANGIOMA, HEREDITARY NEUROCUTANEOUS	 
MIM106100	C2717906	11q11-q13.1	ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	710
MIM106150		1q42-q43	ANGIOTENSINOGEN; AGT	183
MIM106165		3q21-q25	ANGIOTENSIN RECEPTOR 1; AGTR1	185
MIM106180		17q23	ANGIOTENSIN I-CONVERTING ENZYME; ACE	1636
MIM106195		2q36	SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 3; SLC4A3	6508
MIM106210	C0344542	11p13	ANIRIDIA; AN	5080, 7490
MIM106220	C1862868	 	ANIRIDIA AND ABSENT PATELLA	 
MIM106230	C1862867	 	ANIRIDIA, MICROCORNEA, AND SPONTANEOUSLY REABSORBED CATARACT	 
MIM106240	C0003079	 	ANISOCORIA	 
MIM106250	C1862866	 	ANKYLOBLEPHARON FILIFORME ADNATUM AND CLEFT PALATE; AFA	170
MIM106260	C0406709	3q27	ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	8626
MIM106280	C0152415	 	ANKYLOGLOSSIA	 
MIM106300	C0038013	6p21.3	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1	3106
MIM106400	C1862851	 	ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS	 
MIM106410		4q25-q27	ANKYRIN 2; ANK2	287
MIM106490		4q21	ANNEXIN A3; ANXA3	306
MIM106491		2p13	ANNEXIN A4; ANXA4	307
MIM106500	C0234906	 	ANNULAR ERYTHEMA	 
MIM106600	C3489529	4p16.1	TOOTH AGENESIS, SELECTIVE, 1; STHAG1	4487
MIM106700	C0036400	4q12	TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1; TAPVR1	6893
MIM106750	C1862844	 	ANONYCHIA WITH FLEXURAL PIGMENTATION	 
MIM106900	C1862843	 	ANONYCHIA-ECTRODACTYLY	 
MIM106990	C1862842	 	ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY	 
MIM106995	C1862841	 	ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES	 
MIM107000	C1862840	 	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 6; NDNC6	 
MIM107100	C0266215	 	ANORECTAL ANOMALIES	 
MIM107200	C0393778	18p11.23-q12.2	ANOSMIA, ISOLATED CONGENITAL; ANIC	550625
MIM107250	C1862839	10q25, 1p32	ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS; ASMD	2301, 437, 5309
MIM107254		15q11-q22	ANTIGEN IDENTIFIED BY MONOCLONAL ANTIBODY 30.2A8; MIC12	4273
MIM107265		16p11.2	CD19 ANTIGEN; CD19	930
MIM107266		19q13.1	CD22 ANTIGEN; CD22	933
MIM107269		11pter-p13	CD44 ANTIGEN; CD44	960
MIM107270		4p15	CD38 ANTIGEN; CD38	952
MIM107271		11p13	CD59 ANTIGEN; CD59	966
MIM107272		9p	CD72 ANTIGEN; CD72	971
MIM107273		12p13-p12	CD69 ANTIGEN; CD69	969
MIM107280		14q32.1	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 3; SERPINA3	12
MIM107285		 	SECRETORY LEUKOCYTE PROTEASE INHIBITOR; SLPI	6590
MIM107300		1q23-q25	SERPIN PEPTIDASE INHIBITOR, CLADE C (ANTITHROMBIN), MEMBER 1; SERPINC1	462
MIM107310		1p36.1-p35	SOLUTE CARRIER FAMILY 9, MEMBER 1; SLC9A1	6548
MIM107320	C0085278	6p21.3	ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	100499532
MIM107323		5q31	ALDEHYDE DEHYDROGENASE 7 FAMILY, MEMBER A1; ALDH7A1	501
MIM107325		19q13.2-q13.3	CD3-EPSILON-ASSOCIATED PROTEIN; CD3EAP	10849
MIM107400		14q32.1	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 1; SERPINA1	5265
MIM107410		14q32.1	PROTEASE INHIBITOR 1-LIKE; PIL	390502
MIM107450		21q22.1	INTERFERON, ALPHA, BETA, AND OMEGA, RECEPTOR 1; IFNAR1	3454
MIM107470		6q23-q24	INTERFERON, GAMMA, RECEPTOR 1; IFNGR1	3459
MIM107480	C0265246	16q12.1	TOWNES-BROCKS SYNDROME; TBS	6299
MIM107500	C1862682	 	AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	 
MIM107550	C1862681	 	AORTIC ARCH INTERRUPTION, FACIAL PALSY, AND RETINAL COLOBOMA	 
MIM107580		6p24	TRANSCRIPTION FACTOR AP2-ALPHA; TFAP2A	7020
MIM107600	C0282160	 	APLASIA CUTIS CONGENITA, NONSYNDROMIC; ACC	 
MIM107640	C0520680	 	APNEA, CENTRAL SLEEP	 
MIM107650	C0520679	 	APNEA, OBSTRUCTIVE SLEEP	 
MIM107670		1q21-q23	APOLIPOPROTEIN A-II; APOA2	336
MIM107680		11q23	APOLIPOPROTEIN A-I; APOA1	335
MIM107690		11q23	APOLIPOPROTEIN A-IV; APOA4	337
MIM107700	C1862632	 	APPENDICITIS, PRONENESS TO	 
MIM107710		19q13.2	APOLIPOPROTEIN C-I; APOC1	341
MIM107720		11q23	APOLIPOPROTEIN C-III; APOC3	345
MIM107730		2p24	APOLIPOPROTEIN B; APOB	338
MIM107740		3q26.2-qter	APOLIPOPROTEIN D; APOD	347
MIM107741		19q13.2	APOLIPOPROTEIN E; APOE	348
MIM107748		14q12	APEX NUCLEASE 1; APEX1	328
MIM107760		 	APOLIPOPROTEIN F; APOF	319
MIM107770		12q13.1-q13.3	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1; LRP1	4035
MIM107773		15q26.1-q26.2	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 2; NR2F2	7026
MIM107776		7p14	AQUAPORIN 1; AQP1	358
MIM107777		12q13	AQUAPORIN 2; AQP2	359
MIM107800	C0003742	 	ARCUS CORNEAE	 
MIM107820		5pter-q11	ARGINYL-tRNA SYNTHETASE 1; RARS1	5917
MIM107830		14q24.1-q24.3	ARGINASE II; ARG2	384
MIM107850	C1862535	 	ARM FOLDING PREFERENCE	 
MIM107900	C1862534	 	ARMS, MALFORMATION OF	 
MIM107910		15q21.1	CYTOCHROME P450, FAMILY 19, SUBFAMILY A, POLYPEPTIDE 1; CYP19A1	1588
MIM107920		12p	AROMATIC ALPHA-KETO ACID REDUCTASE	8083
MIM107930		7p11	DOPA DECARBOXYLASE; DDC	1644
MIM107940		11q13	ARRESTIN, BETA, 1; ARRB1	408
MIM107941		17p13	ARRESTIN, BETA, 2; ARRB2	409
MIM107970	C1862511	14q24	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1; ARVD1	7043
MIM108000	C1876179	 	ARTERIES, ANOMALIES OF	 
MIM108010	C0917804	7p21	ARTERIOVENOUS MALFORMATIONS OF THE BRAIN	3569
MIM108050	C1862510	 	ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	 
MIM108100	C0748473	 	ARTHRITIS, SACROILIAC	 
MIM108110		 	ARTHROGRYPOSIS MULTIPLEX CONGENITA; AMC	 
MIM108120	C0220662	9p13.2-p13.1	ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	7169
MIM108145	C1862472	 	ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5	 
MIM108200	C1862471	 	ARTHROGRYPOSIS, DISTAL, TYPE 6; DA6	 
MIM108300	C2020284	12q13.11-q13.2	STICKLER SYNDROME, TYPE I; STL1	1280
MIM108320	C1862464	 	ARTICHOKE, MODIFICATION OF TASTE BY	 
MIM108330		15q24.1	CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 1; CYP1A1	1543
MIM108340	C1862463	 	ARYL HYDROCARBON HYDROXYLASE INDUCIBILITY	 
MIM108345		8p23.1-p21.3	N-ACETYLTRANSFERASE 1; NAT1	9
MIM108355		17q24-q25	GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2; GRB2	2885
MIM108360		17p13-p11	ASIALOGLYCOPROTEIN RECEPTOR 1; ASGR1	432
MIM108361		17p	ASIALOGLYCOPROTEIN RECEPTOR 2; ASGR2	433
MIM108370		7q21-q31	ASPARAGINE SYNTHETASE; ASNS	440
MIM108390	C1862460	 	ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	 
MIM108410		18q21.1-q21.3	ASPARAGINYL-tRNA SYNTHETASE; NARS	4677
MIM108420	C1862459	 	SPERMATOGENIC FAILURE 2; SPGF2	100653377
MIM108450	C1862458	 	ASYMMETRIC SHORT STATURE SYNDROME	 
MIM108500	C1720416	19p13	EPISODIC ATAXIA, TYPE 2; EA2	773
MIM108600	C1970107	12p13	SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	114610
MIM108650	C1862441	 	SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7	 
MIM108700	C1862440	 	ATAXIA WITH FASCICULATIONS	 
MIM108720	C0265283	3p14.3	ATELOSTEOGENESIS, TYPE I; AOI	2317
MIM108721	C3668942	3p14.3	ATELOSTEOGENESIS, TYPE III; AOIII	2317
MIM108725	C1531719	19p13.3-p13.2	ATHEROSCLEROSIS SUSCEPTIBILITY; ATHS	470
MIM108728		17q21.1	ATP CITRATE LYASE; ACLY	47
MIM108729		10p15.1	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, GAMMA SUBUNIT 1; ATP5C1	509
MIM108730		16p12	ATPase, Ca(2+)-TRANSPORTING, FAST-TWITCH 1; ATP2A1	487
MIM108731		12q21-q23	ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 1; ATP2B1	490
MIM108732		1q25-q32	ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 4; ATP2B4	493
MIM108733		3p26-p25	ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 2; ATP2B2	491
MIM108740		12q23-q24.1	ATPase, Ca(2+)-TRANSPORTING, SLOW-TWITCH; ATP2A2	488
MIM108745		16p13.3	ATPase, H+ TRANSPORTING, LYSOSOMAL, 16-KD, V0 SUBUNIT C; ATP6V0C	527
MIM108746		22q11.2	ATPase, H+ TRANSPORTING, LYSOSOMAL, 31-KD, V1 SUBUNIT E; ATP6V1E	529
MIM108760	C1862395	 	ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTIVE DEAFNESS	 
MIM108770	C1838539	 	ATRIAL STANDSTILL	 
MIM108780		1p36.2	NATRIURETIC PEPTIDE PRECURSOR A; NPPA	4878
MIM108800	C1862389	5p	ATRIAL SEPTAL DEFECT 1; ASD1	431
MIM108900	C1862388	5q34	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS; ASD7	1482
MIM108950	C1862387	 	ATRIAL TACHYARRHYTHMIA WITH SHORT PR INTERVAL	 
MIM108960		1q21-q22	NATRIURETIC PEPTIDE RECEPTOR A/GUANYLATE CYCLASE A; NPR1	4881
MIM108961		9p21-p12	NATRIURETIC PEPTIDE RECEPTOR B/GUANYLATE CYCLASE B; NPR2	4882
MIM108962		5p14-p12	NATRIURETIC PEPTIDE RECEPTOR C; NPR3	4883
MIM108985	C1862382	11p15.2	SVEINSSON CHORIORETINAL ATROPHY; SCRA	7003
MIM108990		15q11-q12	ATTACHED CELL ANTIGEN 28.3.7; MIC7	4270
MIM109000	C1862381	 	AURICULOOSTEODYSPLASIA	 
MIM109050	C1862380	 	AUROCEPHALOSYNDACTYLY	 
MIM109090		2q31.1	SJOGREN SYNDROME ANTIGEN B; SSB	6741
MIM109091		19p13.2	CALRETICULIN; CALR	811
MIM109092		11p15.5	TRIPARTITE MOTIF-CONTAINING PROTEIN 21; TRIM21	6737
MIM109100	C0004364	 	AUTOIMMUNE DISEASE	 
MIM109120	C1862373	 	AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	 
MIM109130	C1862372	 	AXIAL OSTEOMALACIA	 
MIM109135		19q13.1-q13.2	AXL RECEPTOR TYROSINE KINASE; AXL	558
MIM109150	C0024408	14q24.3-q31	MACHADO-JOSEPH DISEASE; MJD	4287
MIM109160	C1862358	 	AZOTEMIA, FAMILIAL	 
MIM109170		6p21.3-p21.1	LEUKOCYTE-SPECIFIC TRANSCRIPT 1; LST1	7940
MIM109180	C1412786	Chr.6	BABOON M7 VIRUS INTEGRATION SITE; BEVI	628
MIM109190		19q13.3	SOLUTE CARRIER FAMILY 1 (NEUTRAL AMINO ACID TRANSPORTER), MEMBER 5; SLC1A5	6510
MIM109195		20q11.23-q12	BACTERICIDAL PERMEABILITY-INCREASING PROTEIN; BPI	671
MIM109200	C0162311	3q26	ALOPECIA, ANDROGENETIC, 1; AGA1	100188784
MIM109270		17q21-q22	SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	6521
MIM109280		7q35-q36	SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 2; SLC4A2	6522
MIM109300	C1862319	 	BANKI SYNDROME	 
MIM109350	C0017168	13q14	GASTROESOPHAGEAL REFLUX; GER	59330
MIM109400	C0004779	9q22.3	BASAL CELL NEVUS SYNDROME; BCNS	5727
MIM109480		19p13.3	BASIGIN; BSG	682
MIM109500	C1862299	 	BASILAR IMPRESSION, PRIMARY	 
MIM109530		1q21.3-q22	CD48 ANTIGEN; CD48	962
MIM109535		20q12-q13.2	CD40 ANTIGEN; CD40	958
MIM109543	C1868683	13q14	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 2	8101
MIM109545		16p13.1	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 17; TNFRSF17	608
MIM109560		19q13	B-CELL LEUKEMIA/LYMPHOMA 3; BCL3	602
MIM109565		3q27	B-CELL LYMPHOMA 6; BCL6	604
MIM109580		12q22	B-CELL TRANSLOCATION GENE 1; BTG1	694
MIM109610		22q13.31	TRANSLOCATOR PROTEIN, 18-KD; TSPO	706
MIM109630		10q24-q26	BETA-1-ADRENERGIC RECEPTOR; ADRB1	153
MIM109635		11cen-q13	BETA-ADRENERGIC RECEPTOR KINASE 1; ADRBK1	156
MIM109636		22q11	BETA-ADRENERGIC RECEPTOR KINASE 2; ADRBK2	157
MIM109650	C0004943	 	BEHCET SYNDROME	 
MIM109660	C1862289	 	BETA-AMINO ACIDS, RENAL TRANSPORT OF; AABT	8212
MIM109670	C1862288	Chr.21	BETA-ADRENERGIC STIMULATION, RESPONSE TO; BAS	8213
MIM109675		3q21-q28	ST6 BETA-GALACTOSAMIDE ALPHA-2,6-SIALYLTRANSFERASE 1; ST6GAL1	6480
MIM109684		17q12-q21	17-@BETA-HYDROXYSTEROID DEHYDROGENASE I; HSD17B1	3292
MIM109685		16q24.1-q24.2	17-@BETA-HYDROXYSTEROID DEHYDROGENASE II; HSD17B2	3294
MIM109690		5q32-q34	BETA-2-ADRENERGIC RECEPTOR; ADRB2	154
MIM109691		8p12-p11.2	BETA-3-ADRENERGIC RECEPTOR; ADRB3	155
MIM109700		15q21-q22	BETA-2-MICROGLOBULIN; B2M	567
MIM109710		15q13-q15	BETA-2-MICROGLOBULIN REGULATOR; B2MR	568
MIM109715		1p13.1	3-@BETA-HYDROXYSTEROID DEHYDROGENASE 1; HSD3B1	3283
MIM109720	CN029380	3p12-q13.2	BILIARY CIRRHOSIS, PRIMARY, 1; PBC1	 
MIM109730	C1260873	9q34.3	AORTIC VALVE DISEASE 1; AOVD1	4851
MIM109740	C2751431	 	BIFID NOSE, AUTOSOMAL DOMINANT	 
MIM109750		7p14-cen	BILIVERDIN REDUCTASE A; BLVRA	644
MIM109760		5q11.2-q13	5-@HYDROXYTRYPTAMINE RECEPTOR 1A; HTR1A	3350
MIM109770		19q13.2	CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 1; CEACAM1	634
MIM109780		6q21	BKM DNA	7951
MIM109800	C0005684	13q14.1-q14.2, 12p12.1, 11p15.5, 4p16.3, 4p16.3	BLADDER CANCER	10460, 2261, 3265, 3845, 5925
MIM109820	C0156273	 	BLADDER DIVERTICULUM	 
MIM109900	C0339085	 	BLEPHAROCHALASIS AND DOUBLE LIP	 
MIM110000	C1862275	 	BLEPHAROCHALASIS, SUPERIOR	 
MIM110050	C0796197	 	BLEPHARONASOFACIAL MALFORMATION SYNDROME	 
MIM110100	C0220663	3q23	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS; BPES	668
MIM110150	C1862259	 	BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS	 
MIM110300		9q34	ABO GLYCOSYLTRANSFERASE; ABO	28
MIM110350	C1862248	 	BLOOD GROUP--AHONEN; AN	100187761
MIM110450	C1292295	7p14	BLOOD GROUP--COLTON; CO	358
MIM110500	C0011848	17q21-q22	BLOOD GROUP--DIEGO SYSTEM; DI	6521
MIM110600		12p13-p12	ADP-RIBOSYLTRANSFERASE 4; ART4	420
MIM110700	C0013278	1q23.2	BLOOD GROUP, DUFFY SYSTEM; FY	2532
MIM110720	C1862238	 	BLOOD GROUP--En	 
MIM110750		2q14-q21	BLOOD GROUP--GERBICH; Ge	2995
MIM110800	C1862229	6p24-p23	BLOOD GROUP--I SYSTEM; Ii	2651
MIM110900	C0022546	7q33	BLOOD GROUP--KELL SYSTEM; KEL	3792
MIM111000	C0022645	18q11-q12	BLOOD GROUP--KIDD SYSTEM; JK	6563
MIM111100		19p13.3	FUCOSYLTRANSFERASE 3; FUT3	2525
MIM111150	C1292231	11p, 19p13.13-p13.12	BLOOD GROUP--LUTHERAN INHIBITOR; INLU	10661
MIM111200	C0024171	19q13.2	BLOOD GROUP--LUTHERAN SYSTEM; LU	4059
MIM111250	C1292203	19p13.3	BLOOD GROUP SYSTEM, LANDSTEINER-WIENER; LW	3386
MIM111300		4q28.2-q31.1	BLOOD GROUP--MN LOCUS; MN	2993
MIM111360	C1862210	 	BLOOD GROUP--NEWFOUNDLAND; NFLD	 
MIM111380	C1862209	19p13.3	BLOOD GROUP--OK; OK	682
MIM111400	C0599990	3q25, 22q13.2	BLOOD GROUP, P SYSTEM	53947, 8706
MIM111500	C1862206	 	BLOOD GROUP--PRIVATE SYSTEMS	 
MIM111600	C3276339	 	BLOOD GROUP, LANGEREIS SYSTEM; LAN	10058
MIM111620	C1862204	1p34	RADIN BLOOD GROUP ANTIGEN; RD	114625
MIM111680		1p36.2-p34	RHESUS BLOOD GROUP, D ANTIGEN; RHD	6007
MIM111690	C1862200	 	BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE	6006
MIM111700		1p36.2-p34	RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE	6006
MIM111730		17q21.2	BETA-1,4-N-ACETYL-GALACTOSAMINYLTRANSFERASE 2; B4GALNT2	124872
MIM111740		4q28-q31	BLOOD GROUP--Ss LOCUS; Ss	2994
MIM111750	C0443842	1p34	BLOOD GROUP--SCIANNA SYSTEM; SC	114625
MIM111800	CN029280	4q28-q31	BLOOD GROUP--STOLTZFUS SYSTEM; Sf	6420
MIM112010	C1862191	17q21-q22	BLOOD GROUP--WALDNER TYPE; WD	6521
MIM112050	C1862190	17q21-q22	BLOOD GROUP--WRIGHT ANTIGEN; WR	6521
MIM112100	C0443844	7q22	YT BLOOD GROUP ANTIGEN	43
MIM112200	C0346072	 	BLUE RUBBER BLEB NEVUS	 
MIM112203		3q21	CD80 ANTIGEN; CD80	941
MIM112205		19q13.2	CD79A ANTIGEN; CD79A	973
MIM112210		11q13	MEMBRANE-SPANNING 4 DOMAINS, SUBFAMILY A, MEMBER 1; MS4A1	931
MIM112240	CN029402	 	BONE FRAGILITY WITH CRANIOSYNOSTOSIS, OCULAR PROPTOSIS, HYDROCEPHALUS, AND DISTINCTIVE FACIAL FEATURES	 
MIM112250	C1862177	9p22-p21	DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	 
MIM112260		1q25-q31	GAMMA-CARBOXYGLUTAMIC ACID PROTEIN, BONE; BGLAP	632
MIM112261		20p12	BONE MORPHOGENETIC PROTEIN 2; BMP2	650
MIM112262		14q22-q23	BONE MORPHOGENETIC PROTEIN 4; BMP4	652
MIM112263		4p14-q21	BONE MORPHOGENETIC PROTEIN 3; BMP3	651
MIM112264		8p21	BONE MORPHOGENETIC PROTEIN 1; BMP1	649
MIM112265		6p12.1	BONE MORPHOGENETIC PROTEIN 5; BMP5	653
MIM112266		6p24-p23	BONE MORPHOGENETIC PROTEIN 6; BMP6	654
MIM112267		20q13.1-q13.3	BONE MORPHOGENETIC PROTEIN 7; BMP7	655
MIM112270	C1862176	 	BONE PAIN, PERIODIC	 
MIM112300	C0457014	 	BOOK SYNDROME	 
MIM112310	C0432201	3p14.3	BOOMERANG DYSPLASIA	2317
MIM112350	C1862172	 	BOWING OF LEGS, ANTERIOR, WITH DWARFISM	 
MIM112370	C1862171	 	BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUS ADDUCTUS, AND DEVELOPMENTAL DELAY	 
MIM112410	C1862170	12p12.2-p11.2	HYPERTENSION WITH BRACHYDACTYLY	8080
MIM112430	C1862169	 	LONG-THUMB BRACHYDACTYLY SYNDROME	 
MIM112440	C1862163	 	BRACHYDACTYLY, COMBINED B AND E TYPES	 
MIM112450	C1862162	 	BRACHYDACTYLY, PREAXIAL, WITH HALLUX VARUS AND THUMB ABDUCTION	 
MIM112500	C1862151	5p13.3-p13.2, 2q33-q35	BRACHYDACTYLY, TYPE A1; BDA1	3549
MIM112600	C1832702	4q23-q24, 20q11.2	BRACHYDACTYLY, TYPE A2; BDA2	650, 658, 8200
MIM112700	C1862140	 	BRACHYDACTYLY, TYPE A3; BDA3	 
MIM112800	C1862139	 	BRACHYDACTYLY, TYPE A4; BDA4	 
MIM112900		 	BRACHYDACTYLY, TYPE A5, WITH NAIL DYSPLASIA	 
MIM112910	C1862130	 	BRACHYDACTYLY, TYPE A6; BDA6	 
MIM113000	C1862112	9q22	BRACHYDACTYLY, TYPE B1; BDB1	4920
MIM113100	C1862103	20q11.2	BRACHYDACTYLY, TYPE C; BDC	8200
MIM113200	C0220664	2q31-q32	BRACHYDACTYLY, TYPE D; BDD	3239
MIM113300	C1862102	2q31-q32	BRACHYDACTYLY, TYPE E1; BDE1	3239
MIM113301	C1862101	 	BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	 
MIM113310	C1862100	 	BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	 
MIM113400	C1862099	 	BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	 
MIM113450	C1862092	 	BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	 
MIM113470	C1862084	 	BRACHYMESOMELIA-RENAL SYNDROME	 
MIM113475	C1862083	 	BRACHYMETATARSUS IV	 
MIM113477	C1862082	 	BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	 
MIM113480	C1862081	 	BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	 
MIM113500	C0432227	12q24.1	BRACHYOLMIA TYPE 3	59341
MIM113503		14q32.1-q32.2	BRADYKININ RECEPTOR B2; BDKRB2	624
MIM113505		11p13	BRAIN-DERIVED NEUROTROPHIC FACTOR; BDNF	627
MIM113508		22q12	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, ETA ISOFORM; YWHAH	7533
MIM113520		12p12	BRANCHED-CHAIN AMINOTRANSFERASE 1; BCAT1	586
MIM113530		19q13	BRANCHED-CHAIN AMINOTRANSFERASE 2; BCAT2	587
MIM113600	C0006131	 	BRANCHIAL CLEFT ANOMALIES	 
MIM113610	C1862071	 	BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA	 
MIM113620	C0376524	6p24	BRANCHIOOCULOFACIAL SYNDROME; BOFS	7020
MIM113630		22q11.21	BREAKPOINT CLUSTER REGION-LIKE 2; BCRL2	400892
MIM113640		22q11.21	BREAKPOINT CLUSTER REGION-LIKE 3; BCRL3	644165
MIM113650	C0265234	8q13.3	BRANCHIOOTORENAL SYNDROME 1; BOR1	2138
MIM113660		22q11.21	BREAKPOINT CLUSTER REGION-LIKE 4; BCRL4	616
MIM113670	C2676048	 	HYPERTROPHY OF THE BREAST, JUVENILE; JHB	 
MIM113700	CN033494	 	BREASTS AND NIPPLES, ABSENCE OF	 
MIM113703		 	RIBOSOMAL PROTEIN L13; RPL13	6137
MIM113705		17q21	BREAST CANCER 1 GENE; BRCA1	672
MIM113710		21q22.3	TREFOIL FACTOR 1; TFF1	7031
MIM113721		17p13.3	BREAST CANCER-RELATED REGULATOR OF TP53	8142
MIM113725		4q31.2	POU DOMAIN, CLASS 4, TRANSCRIPTION FACTOR 2; POU4F2	5458
MIM113730		4q31	UNCOUPLING PROTEIN 1; UCP1	7350
MIM113750	C2676042	15q21.1	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 4; SHEP4	283652
MIM113800	C0079153	17q21-q22, 12q13	EPIDERMOLYTIC HYPERKERATOSIS; EHK	3848, 3858
MIM113810		6p12-p11	DYSTONIN; DST	667
MIM113811		10q24.3	COLLAGEN, TYPE XVII, ALPHA-1; COL17A1	1308
MIM113900	C1879286	3p21	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A	6331
MIM113950	C0340504	 	BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	 
MIM113970	C0006413	8q24.12-q24.13	BURKITT LYMPHOMA; BL	4609
MIM113995		19q13.3-q13.4	COMPLEMENT COMPONENT 5 RECEPTOR 1; C5R1	728
MIM114000	C0020497	17q21.31-q22	CAFFEY DISEASE	1277
MIM114010		2p21	CARBAMOYL PHOSPHATE SYNTHETASE/ASPARTATE TRANSCARBAMOYLASE/DIHYDROOROTASE; CAD	790
MIM114019		16q24.3	CADHERIN 15; CDH15	1013
MIM114020		18q11.2	CADHERIN 2; CDH2	1000
MIM114021		16q22.1	CADHERIN 3; CDH3	1001
MIM114025		2p12-p11.1	CATENIN, ALPHA-2; CTNNA2	1496
MIM114030	C1861975	 	CAFE-AU-LAIT SPOTS, MULTIPLE	 
MIM114050		8q21.3-q22.1	CALBINDIN 1; CALB1	793
MIM114051		16q22.1	CALBINDIN 2; CALB2	794
MIM114070		5q32-q34	ANNEXIN A6; ANXA6	309
MIM114078		5q32	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-ALPHA; CAMK2A	815
MIM114080		5q21-q23	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IV; CAMK4	814
MIM114085		1q21	S100 CALCIUM-BINDING PROTEIN A10; S100A10	6281
MIM114090		5q15-q21	CALPASTATIN; CAST	831
MIM114100	C1861967	 	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET	 
MIM114105		4q24-q25	PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, ALPHA ISOFORM; PPP3CA	5530
MIM114106		10q21-q22	PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, BETA ISOFORM; PPP3CB	5532
MIM114107		Chr.8	PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, GAMMA ISOFORM; PPP3CC	5533
MIM114110		1q21	S100 CALCIUM-BINDING PROTEIN A6; S100A6	6277
MIM114130		11p15.2-p15.1	CALCITONIN/CALCITONIN-RELATED POLYPEPTIDE, ALPHA; CALCA	796
MIM114131		7q21.3	CALCITONIN RECEPTOR; CALCR	799
MIM114140	C1861964	 	CALLOSITIES, HEREDITARY PAINFUL	 
MIM114150	C1861963	 	CAMPTOBRACHYDACTYLY	 
MIM114160		11p15.2-p15.1	CALCITONIN-RELATED POLYPEPTIDE, BETA; CALCB	797
MIM114170		19q13.12	CALPAIN, SMALL SUBUNIT 1; CAPNS1	826
MIM114180		14q24-q31	CALMODULIN 1; CALM1	801
MIM114182		2p21	CALMODULIN 2; CALM2	805
MIM114183		19q13.2-q13.3	CALMODULIN 3; CALM3	808
MIM114184		10pter-p13	CALMODULIN-LIKE 3; CALML3	810
MIM114190		2q31-q32	CALCITONIN RECEPTOR-LIKE GENE; CALCRL	10203
MIM114200	C2751430	3q11.2-q13.12	CAMPTODACTYLY 1; CAMPD1	100381210
MIM114204		7q21-q22	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 1; CACNA2D1	781
MIM114205		12p13.3	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1C SUBUNIT; CACNA1C	775
MIM114206		3p14.3	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1D SUBUNIT; CACNA1D	776
MIM114207		17q21-q22	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-1 SUBUNIT; CACNB1	782
MIM114208		1q32	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1S SUBUNIT; CACNA1S	779
MIM114209		17q24	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-1 SUBUNIT; CACNG1	786
MIM114210		1q21	S100 CALCIUM-BINDING PROTEIN A4; S100A4	6275
MIM114212		19p13.3	CALCYPHOSINE; CAPS	828
MIM114213		7q33	CALDESMON 1; CALD1	800
MIM114217		5q35	CALNEXIN; CANX	821
MIM114220		11q13	CALPAIN 1; CAPN1	823
MIM114230		1q41-q42	CALPAIN 2; CAPN2	824
MIM114240		15q15.1-q21.1	CALPAIN 3; CAPN3	825
MIM114250		1q21	CALSEQUESTRIN 1; CASQ1	844
MIM114251		1p13.3-p11	CALSEQUESTRIN 2; CASQ2	845
MIM114280		 	CAMPATH-1 ANTIGEN; CDW52	1043
MIM114290	C1861922	17q24.3-q25.1	CAMPOMELIC DYSPLASIA	6662
MIM114300	C0220666	 	ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	 
MIM114350		9q34.1	NUCLEOPORIN, 214-KD; NUP214	8021
MIM114450	C1861915	 	CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	8105
MIM114480	C0346153	17q21, 17p13.1, 16q22.1, 16p12, 15q15.1, 14q32.3, 13q12.3, 12p12.1, 11q22.3, 11p15.5, 8q11, 1p32, 6p25, 5q33.2, 3q26.3, 2q34-q35, 2q33, 22q12.1, 17q22-q23, 17q22	BREAST CANCER	11200, 207, 3161, 3845, 472, 4835, 5002, 5245, 5290, 580, 5888, 675, 7157, 7251, 7517, 79728, 83990, 841, 8438, 8493, 9821, 999
MIM114500	C0699790	17p11.2, 17p13.1, 15q15, 14q32.3, 14q24.3, 11q13, 11p11.2, 9q32-q33, 1p13.2, 8p22-p21.3, 5q21-q22, 4q32, 3q26.3, 1p35, 2p25, 22q13, 20q13.2-q13.3, 17q24	COLORECTAL CANCER; CRC	201163, 2033, 207, 2261, 25788, 27030, 324, 4893, 4953, 5157, 5290, 5320, 5782, 5795, 595, 6790, 701, 7097, 7099, 7157, 8313, 8915
MIM114550	C2239176	17p13.1, 16p13.3, 8p22-p21.3, 7q31, 5q21-q22, 3q26.3, 3p22-p21.3, 2q33	HEPATOCELLULAR CARCINOMA	1499, 324, 4233, 5157, 5290, 7157, 8312, 841
MIM114580	C2751429	2p22.3-p21	CANDIDIASIS, FAMILIAL, 1; CANDF1	117084
MIM114600	C1861899	 	CANINE TEETH, ABSENCE OF UPPER PERMANENT	 
MIM114610		6q14-q15	CANNABINOID RECEPTOR 1; CNR1	1268
MIM114620	C2676032	 	CRANIOFACIOFRONTODIGITAL SYNDROME	 
MIM114650	C1861898	 	CAR FACTOR DEFICIENCY	 
MIM114700	C1861897	 	CARABELLI ANOMALY OF MAXILLARY MOLAR TEETH	 
MIM114750		8q22	CARBONIC ANHYDRASE III; CA3	761
MIM114760		17q23	CARBONIC ANHYDRASE IV; CA4	762
MIM114761		16q24.3	CARBONIC ANHYDRASE V; CA5A	763
MIM114770		16q21-q23	CARBONIC ANHYDRASE VII; CA7	766
MIM114780		1p36.33-p36.22	CARBONIC ANHYDRASE VI; CA6	765
MIM114800		8q22	CARBONIC ANHYDRASE I; CA1	759
MIM114815		8q11-q12	CARBONIC ANHYDRASE VIII; CA8	767
MIM114830		21q22.12	CARBONYL REDUCTASE 1; CBR1	873
MIM114835		16q13-q22.1	CARBOXYLESTERASE 1; CES1	1066
MIM114840		9q34.3	CARBOXYL-ESTER LIPASE; CEL	1056
MIM114850		7q32-qter	CARBOXYPEPTIDASE A1; CPA1	1357
MIM114851		3q24	CARBOXYPEPTIDASE A3, MAST CELL; CPA3	1359
MIM114852		 	CARBOXYPEPTIDASE B1, TISSUE; CPB1	1360
MIM114855		4q32.3	CARBOXYPEPTIDASE E; CPE	1363
MIM114860		12q15	CARBOXYPEPTIDASE M; CPM	1368
MIM114890		19q13.2	CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5; CEACAM5	1048
MIM114900	C0349535	11q23	CARCINOID TUMORS, INTESTINAL	6392
MIM115000	CN029864	 	CARDIAC ARRHYTHMIA	 
MIM115080	C0264886	17p11.1	CARDIAC CONDUCTION DEFECT	11216
MIM115150	CN029449	15q21, 12p12.1, 7q34, 19p13.3	CARDIOFACIOCUTANEOUS SYNDROME	3845, 5604, 5605, 673
MIM115195	C1861864	1q32	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2; CMH2	7139
MIM115196	C1861863	15q22.1	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CMH3	7168
MIM115197	C1861862	11p11.2	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	4607
MIM115200	C1449563	1q21.2, 11p11.2	CARDIOMYOPATHY, DILATED, 1A; CMD1A	4000, 4607
MIM115210	C1861861	19q13.4	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1; RCM1	7137
MIM115250	C0406817	 	COLLAGENOMA, FAMILIAL CUTANEOUS	 
MIM115300	C2676023	16q21-q23	HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT	53630
MIM115310	C1861848	1p36.1-p35	PARAGANGLIOMAS 4; PGL4	6390
MIM115400	C1861847	 	CARPAL DISPLACEMENT	 
MIM115430	C0007286	18q11.2-q12.1	CARPAL TUNNEL SYNDROME; CTS1	7276
MIM115435		5q13-q14.1	HYALURONAN AND PROTEOGLYCAN LINK PROTEIN 1; HAPLN1	1404
MIM115437		1p35	MATRILIN 1; MATN1	4146
MIM115440		20p13	CASEIN KINASE II, ALPHA-1; CSNK2A1	1457
MIM115441		6p21.3	CASEIN KINASE II, BETA; CSNK2B	1460
MIM115442		16p13.3-p13.2	CASEIN KINASE II, ALPHA-2; CSNK2A2	1459
MIM115450		4q21.1	CASEIN, ALPHA; CSN1	1446
MIM115460		4q21.1	CASEIN, BETA; CSN2	1447
MIM115470	C0265493	22q11	CAT EYE SYNDROME; CES	1055
MIM115500		11p13	CATALASE; CAT	847
MIM115501		9p23	TYROSINASE-RELATED PROTEIN 1; TYRP1	7306
MIM115645	C1861835	 	CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	 
MIM115650	C1855179	14q24-qter	CATARACT, ANTERIOR POLAR, 1; CTAA1	1483
MIM115660	C0344523	17q24	CATARACT, CONGENITAL, CERULEAN TYPE, 1; CCA1	878
MIM115665	C1861833	1pter-p36.13	CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	7792
MIM115700	C1861832	2q33-q35	CATARACT, CRYSTALLINE ACULEIFORM	1421
MIM115800	C1861831	 	CATARACT, CRYSTALLINE CORALLIFORM	 
MIM115900	C1861830	 	CATARACT, FLORIFORM	 
MIM116100	C0524524	 	CATARACT, MEMBRANOUS	 
MIM116150		1q21.1	CATARACT-MICROCORNEA SYNDROME	2703
MIM116200	C1861828	1q21.1	CATARACT, ZONULAR PULVERULENT 1; CZP1	2703
MIM116300	C1861827	 	CATARACT, NUCLEAR DIFFUSE NONPROGRESSIVE	 
MIM116400	C1861826	 	CATARACT, NUCLEAR TOTAL	 
MIM116600	C1861825	1pter-p36.1	CATARACT, POSTERIOR POLAR, 1; CTPP1	10306, 1969
MIM116700	C3805373	 	CATARACT, TOTAL CONGENITAL; CC	1969
MIM116790		22q11.2	CATECHOL-O-METHYLTRANSFERASE; COMT	1312
MIM116800	C0266537	16q21-q22.1	CATARACT, LAMELLAR	3299
MIM116805		5q31	CATENIN, ALPHA-1; CTNNA1	1495
MIM116806		3p22-p21.3	CATENIN, BETA-1; CTNNB1	1499
MIM116810		8p22	CATHEPSIN B; CTSB	1508
MIM116820		15q24-q25	CATHEPSIN H; CTSH	1512
MIM116830		14q11.2	CATHEPSIN G; CTSG	1511
MIM116831		14q11.2	GRANZYME H; GZMH	2999
MIM116840		11p15.5	CATHEPSIN D; CTSD	1509
MIM116845		1q21	CATHEPSIN S; CTSS	1520
MIM116850	C1861799	 	CATATRICHY	 
MIM116860	C1861784	7q11.2-q21	CEREBRAL CAVERNOUS MALFORMATIONS; CCM	 
MIM116870	C1861783	 	CELIAC ARTERY STENOSIS FROM COMPRESSION BY MEDIAN ARCUATE LIGAMENT OF DIAPHRAGM	 
MIM116880		9q21-q22	CATHEPSIN L; CTSL	1514
MIM116890		1q31	CATHEPSIN E; CTSE	1510
MIM116896		7q22	CUT-LIKE 1; CUTL1	1523
MIM116897		19q13.1	CCAAT/ENHANCER-BINDING PROTEIN, ALPHA; CEBPA	1050
MIM116898		8p11.2-p11.1	CCAAT/ENHANCER-BINDING PROTEIN, DELTA; CEBPD	1052
MIM116899		6p21.2	CYCLIN-DEPENDENT KINASE INHIBITOR 1A; CDKN1A	1026
MIM116900		1q21.3	CDC28 PROTEIN KINASE 1B; CKS1B	1163
MIM116901		 	CDC2-ASSOCIATED PROTEIN CKS2; CKS2	1164
MIM116920	C1861766	21q22.3	LEUKOCYTE ADHESION DEFICIENCY, TYPE I; LAD	3689
MIM116930		11q23.1	CELL ADHESION MOLECULE, NEURAL, 1; NCAM1	4684
MIM116940		10q21.1	CYCLIN-DEPENDENT KINASE 1; CDK1	983
MIM116945		3q21	MINICHROMOSOME MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, 2; MCM2	4171
MIM116946		17q12-q23.2	CELL DIVISION CYCLE 27; CDC27	996
MIM116947		3p21	CELL DIVISION CYCLE 25A; CDC25A	993
MIM116948		19p13.3	CELL DIVISION CYCLE 34, S. CEREVISIAE, HOMOLOG OF; CDC34	997
MIM116949		20p13	CELL DIVISION CYCLE 25B; CDC25B	994
MIM116950	C1861765	 	TEMPERATURE-SENSITIVE AF8 COMPLEMENT; AF8T	169
MIM116951		1p36.3	CYCLIN-DEPENDENT KINASE 11A; CDK11A	728642
MIM116952		1p36.1	CELL DIVISION CYCLE 42; CDC42	998
MIM116953		12q13	CYCLIN-DEPENDENT KINASE 2; CDK2	1017
MIM116955		3q13.3-q24	ZINC FINGER PROTEIN 9; ZNF9	7555
MIM116957		20q11.2	RETINOBLASTOMA-LIKE 1; RBL1	5933
MIM116960		4q33-q34.1	MORTALITY FACTOR 4; MORF4	10934
MIM117000	C0751951	19q13.1	CENTRAL CORE DISEASE OF MUSCLE	6261
MIM117100	C2363129	11p13	CENTRALOPATHIC EPILEPSY	100379198
MIM117139		2p24-p21	CENTROMERIC PROTEIN A; CENPA	1058
MIM117140		20p13	CENTROMERIC PROTEIN B; CENPB	1059
MIM117141		4q12-q13.3	CENTROMERIC PROTEIN C1; CENPC1	1060
MIM117143		4q24-q25	CENTROMERIC PROTEIN E; CENPE	1062
MIM117210	C1861736	16q21	SPINOCEREBELLAR ATAXIA 31; SCA31	100312950, 146227
MIM117300	C1861735	13q14	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2	9445
MIM117340		16p13.1-p12	CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 2; CDR2	1039
MIM117360	C1861732	3p26	SPINOCEREBELLAR ATAXIA 29; SCA29	100038747
MIM117550	CN035106	5q35	SOTOS SYNDROME 1; SOTOS1	64324
MIM117600	C1861714	 	CEREBRAL SARCOMA	 
MIM117650	C0265342	 	CEREBROCOSTOMANDIBULAR SYNDROME	 
MIM117700		3q23-q24	CERULOPLASMIN; CP	1356
MIM117800	C1861696	16q12.1	APOCRINE GLAND SECRETION, VARIATION IN	85320
MIM117850	C1861695	 	CERVICAL HYPERTRICHOSIS WITH UNDERLYING KYPHOSCOLIOSIS	 
MIM117900	C0158779	 	CERVICAL RIB	 
MIM118000	C1861694	 	CERVICAL VERTEBRAL BRIDGE	 
MIM118005	C1861693	 	CERVICAL VERTEBRAL DYSPLASIA	 
MIM118100	C1861689	8q22.1	KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	392255
MIM118190		2q33.1	HEAT-SHOCK 60-KD PROTEIN 1; HSPD1	3329
MIM118200	C0270912	1q22	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	1785, 4359
MIM118210	C1861678	1p36.2	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1; CMT2A1	23095
MIM118220	C0270911	17p11.2	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A; CMT1A	5376
MIM118300	C1861669	17p11.2	CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS	5376
MIM118330	C0267034	 	CHEILITIS GLANDULARIS	 
MIM118350	C1861667	 	CHEMODECTOMA, INTRAABDOMINAL, WITH CUTANEOUS ANGIOLIPOMAS	 
MIM118400	C0008029	4p16.3	CHERUBISM	6452
MIM118420	C0750929	 	CHIARI MALFORMATION TYPE I	 
MIM118423		2q31-q32.1	CHIMERIN 1; CHN1	1123
MIM118425		7q35	CHLORIDE CHANNEL 1, SKELETAL MUSCLE; CLCN1	1180
MIM118430	C1861630	 	CHLORPROPAMIDE-ALCOHOL FLUSHING; CPAF	 
MIM118440		3pter-p21	CHOLECYSTOKININ; CCK	885
MIM118444		4p15.2-p15.1	CHOLECYSTOKININ A RECEPTOR; CCKAR	886
MIM118445		11p15.5-p15.4	CHOLECYSTOKININ B RECEPTOR; CCKBR	887
MIM118450	C1956125	20p12	ALAGILLE SYNDROME 1; ALGS1	182
MIM118455		8q11-q12	CYTOCHROME P450, SUBFAMILY VIIA, POLYPEPTIDE 1; CYP7A1	1581
MIM118470		16q21	CHOLESTERYL ESTER TRANSFER PROTEIN, PLASMA; CETP	1071
MIM118485		15q23-q24	CYTOCHROME P450, SUBFAMILY XIA, POLYPEPTIDE 1; CYP11A1	1583
MIM118490		10q11.2	CHOLINE ACETYLTRANSFERASE; CHAT	1103
MIM118491		 	CHOLINE KINASE, ALPHA; CHKA	1119
MIM118493		7q35-q36	CHOLINERGIC RECEPTOR, MUSCARINIC, 2; CHRM2	1129
MIM118494		1q41-q44	CHOLINERGIC RECEPTOR, MUSCARINIC, 3; CHRM3	1131
MIM118495		11p12-p11.2	CHOLINERGIC RECEPTOR, MUSCARINIC, 4; CHRM4	1132
MIM118496		15q26	CHOLINERGIC RECEPTOR, MUSCARINIC, 5; CHRM5	1133
MIM118502		8p21	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 2; CHRNA2	1135
MIM118503		15q25.1	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 3; CHRNA3	1136
MIM118504		20q13.2-q13.3	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 4; CHRNA4	1137
MIM118505		15q25.1	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 5; CHRNA5	1138
MIM118507		1q21	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 2; CHRNB2	1141
MIM118508		8p11.2	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 3; CHRNB3	1142
MIM118509		15q24	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 4; CHRNB4	1143
MIM118510		11q13	CHOLINERGIC RECEPTOR, MUSCARINIC, 1; CHRM1	1128
MIM118511		15q14	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 7; CHRNA7	1139
MIM118600	C0856830	5p15.2-p14.1	CHONDROCALCINOSIS 2; CCAL2	56172
MIM118610	C1861580	 	CHONDROCALCINOSIS DUE TO APATITE CRYSTAL DEPOSITION	 
MIM118650	C1442935	 	CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANT	 
MIM118651	C0432224	 	CHONDRODYSPLASIA PUNCTATA, TIBIA-METACARPAL TYPE	 
MIM118661		5q12-q14	VERSICAN; VCAN	1462
MIM118700	C0393584	14q13	CHOREA, BENIGN HEREDITARY; BHC	7080
MIM118750	C1861569	 	CHOREOATHETOSIS, FAMILIAL INVERTED	 
MIM118800	C1869117	2q35	PAROXYSMAL NONKINESIGENIC DYSKINESIA 1; PNKD1	25953
MIM118820		17q22-q24	CHORIONIC SOMATOMAMMOTROPIN HORMONE 2; CSH2	1443
MIM118825		1q43	CHM-LIKE; CHML	1122
MIM118840	C1861559	5q35	CHROMATE RESISTANCE; CHR	1125
MIM118850		6q12-q21	CHORIONIC GONADOTROPIN, ALPHA CHAIN; CGA	1081
MIM118860		19q13.32	CHORIONIC GONADOTROPIN, BETA CHAIN; CGB	1082
MIM118865	C1861558	 	CHOROIDAL OSTEOMA, BILATERAL	 
MIM118870		Chr.16	CHROMOSOMAL PROTEIN, NONHISTONE 1; NHCP1	4805
MIM118888		16q22.1	CHYMOTRYPSIN-LIKE PROTEASE; CTRL	1506
MIM118890		16q23.2-q23.3	CHYMOTRYPSINOGEN B1; CTRB1	1504
MIM118900	C1861556	 	CIRRHOSIS, FAMILIAL	 
MIM118910		14q32	CHROMOGRANIN A; CHGA	1113
MIM118920		20pter-p12	CHROMOGRANIN B; CHGB	1114
MIM118930		2q35-q36	SECRETOGRANIN II; SCG2	7857
MIM118938		14q11.2	CHYMASE 1; CMA1	1215
MIM118943		1p13.3	CHYMOSIN PSEUDOGENE; CYMP	643160
MIM118945		11q12.2	CILIARY NEUROTROPHIC FACTOR; CNTF	1270
MIM118946		9p13	CILIARY NEUROTROPHIC FACTOR RECEPTOR; CNTFR	1271
MIM118950		12q13.2-q13.3	CITRATE SYNTHASE, MITOCHONDRIAL; CS	1431
MIM118955		17q23	CLATHRIN, HEAVY POLYPEPTIDE; CLTC	1213
MIM118960		9p13.3	CLATHRIN, LIGHT POLYPEPTIDE A; CLTA	1211
MIM118970		5q32.2	CLATHRIN, LIGHT POLYPEPTIDE B; CLTB	1212
MIM118980	C0265565	 	CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	 
MIM118990		 	SPERM-SPECIFIC ANTIGEN 2; SSFA2	6744
MIM119000	C1849227	 	CLEFT CHIN	 
MIM119100	C1861553	1q42.2-q43	SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 1; SHFLD1	791121
MIM119300	C0175697	1q32-q41	VAN DER WOUDE SYNDROME 1; VWS1	3664
MIM119500	C0265259	1q32-q41	POPLITEAL PTERYGIUM SYNDROME; PPS	3664
MIM119530	C1861537	6p24.3	OROFACIAL CLEFT 1; OFC1	4963
MIM119540	C1837218	17p12-p11.1, 2q33	CLEFT PALATE, ISOLATED; CPI	23314, 7314
MIM119550	C0795898	 	SYNGNATHIA	 
MIM119570	C0432098	 	CLEFT SOFT PALATE	 
MIM119580	C1861536	 	BLEPHAROCHEILODONTIC SYNDROME	 
MIM119600	C0008928	6p21	CLEIDOCRANIAL DYSPLASIA; CCD	860
MIM119650	C1861515	 	CLEIDORHIZOMELIC SYNDROME	 
MIM119800	C0009081	5q31	CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY; CCF	5307
MIM119900	C1861514	4q34-q35	DIGITAL CLUBBING, ISOLATED CONGENITAL	3248
MIM119915	C1861513	 	CLUSTER HEADACHE, FAMILIAL	 
MIM120000	C0003492	 	COARCTATION OF AORTA	 
MIM120040	C1861512	 	COCHLEOSACCULAR DEGENERATION WITH PROGRESSIVE CATARACTS	 
MIM120050	C1861511	19pter-q13	COXSACKIEVIRUS B3 SUSCEPTIBILITY; CXB3S	1526
MIM120070		2q36-q37	COLLAGEN, TYPE IV, ALPHA-3; COL4A3	1285
MIM120080	C1861502	 	COLCHICINE RESISTANCE	5243
MIM120090		13q34	COLLAGEN, TYPE IV, ALPHA-2; COL4A2	1284
MIM120100	C0343068	1q44	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1; FCAS1	114548
MIM120105		6pter-p21.1	COLIPASE, PANCREATIC; CLPS	1208
MIM120110		6q21-q22.3	COLLAGEN, TYPE X, ALPHA-1; COL10A1	1300
MIM120120		3p21.3	COLLAGEN, TYPE VII, ALPHA-1; COL7A1	1294
MIM120130		13q34	COLLAGEN, TYPE IV, ALPHA-1; COL4A1	1282
MIM120131		2q36-q37	COLLAGEN, TYPE IV, ALPHA-4; COL4A4	1286
MIM120140		12q13.11-q13.2	COLLAGEN, TYPE II, ALPHA-1; COL2A1	1280
MIM120150		17q21.31-q22	COLLAGEN, TYPE I, ALPHA-1; COL1A1	1277
MIM120160		7q22.1	COLLAGEN, TYPE I, ALPHA-2; COL1A2	1278
MIM120165		6q12-q14	COLLAGEN, TYPE XIX, ALPHA-1; COL19A1	1310
MIM120180		2q31	COLLAGEN, TYPE III, ALPHA-1; COL3A1	1281
MIM120190		2q31	COLLAGEN, TYPE V, ALPHA-2; COL5A2	1290
MIM120200	C0009363	11p13, 7q36	COLOBOMA, OCULAR	 
MIM120210		6q13	COLLAGEN, TYPE IX, ALPHA-1; COL9A1	1297
MIM120215		9q34.2-q34.3	COLLAGEN, TYPE V, ALPHA-1; COL5A1	1289
MIM120216		19p13.2	COLLAGEN, TYPE V, ALPHA-3; COL5A3	50509
MIM120220		21q22.3	COLLAGEN, TYPE VI, ALPHA-1; COL6A1	1291
MIM120240		21q22.3	COLLAGEN, TYPE VI, ALPHA-2; COL6A2	1292
MIM120250		2q37	COLLAGEN, TYPE VI, ALPHA-3; COL6A3	1293
MIM120251		3q12-q13.1	COLLAGEN, TYPE VIII, ALPHA-1; COL8A1	1295
MIM120252		1p34.3-p32.3	COLLAGEN, TYPE VIII, ALPHA-2; COL8A2	1296
MIM120260		1p33-p32.2	COLLAGEN, TYPE IX, ALPHA-2; COL9A2	1298
MIM120270		20q13.3	COLLAGEN, TYPE IX, ALPHA-3; COL9A3	1299
MIM120280		1p21	COLLAGEN, TYPE XI, ALPHA-1; COL11A1	1301
MIM120290		6p21.3	COLLAGEN, TYPE XI, ALPHA-2; COL11A2	1302
MIM120300	C1852767	 	COLOBOMA OF MACULA	 
MIM120320		 	COLLAGEN, TYPE XII, ALPHA-1; COL12A1	1303
MIM120324		8q23	COLLAGEN, TYPE XIV, ALPHA-1; COL14A1	7373
MIM120325		9q21-q22	COLLAGEN, TYPE XV, ALPHA-1; COL15A1	1306
MIM120326		1p34	COLLAGEN, TYPE XVI, ALPHA-1; COL16A1	1307
MIM120328		21q22.3	COLLAGEN, TYPE XVIII, ALPHA-1; COL18A1	80781
MIM120330	C1852759	10q24.3-q25.1	PAPILLORENAL SYNDROME	5076
MIM120340		Chr.15	COLLAGEN, TYPE I, ALPHA, RECEPTOR; COL1AR	1279
MIM120350		10q22	COLLAGEN, TYPE XIII, ALPHA-1; COL13A1	1305
MIM120353		11q22-q23	MATRIX METALLOPROTEINASE 1; MMP1	4312
MIM120355		11q21-q22	MATRIX METALLOPROTEINASE 8; MMP8	4317
MIM120360		16q13	MATRIX METALLOPROTEINASE 2; MMP2	4313
MIM120361		20q11.2-q13.1	MATRIX METALLOPROTEINASE 9; MMP9	4318
MIM120400	C1852752	 	COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY	 
MIM120420		1p21-p13	COLONY-STIMULATING FACTOR 1; CSF1	1435
MIM120430	C0155299	11p13	COLOBOMA OF OPTIC NERVE	5080
MIM120433	C1852750	 	COLOBOMA, UVEAL, WITH CLEFT LIP AND PALATE AND MENTAL RETARDATION	 
MIM120435	C2936783	2p22-p21	LYNCH SYNDROME I	4436, 5378
MIM120436		3p21.3	MutL, E. COLI, HOMOLOG OF, 1; MLH1	4292
MIM120440	C1852721	 	COLONIC VARICES WITHOUT PORTAL HYPERTENSION	 
MIM120450	C0345424	 	COMEDONES, FAMILIAL DYSKERATOTIC	 
MIM120470		18q21.3	DELETED IN COLORECTAL CARCINOMA; DCC	1630
MIM120500	C0399605	 	COMMISSURAL LIP PITS	 
MIM120502	C1852718	1q31	BRANCHIOOTIC SYNDROME 2	64585
MIM120520		3q21-q27	MEMBRANE METALLOENDOPEPTIDASE; MME	4311
MIM120550		1p36.3-p34.1	COMPLEMENT COMPONENT 1, q SUBCOMPONENT, A CHAIN; C1QA	712
MIM120570		1p36.3-p34.1	COMPLEMENT COMPONENT 1, q SUBCOMPONENT, B CHAIN; C1QB	713
MIM120575		1p36.3-p34.1	COMPLEMENT COMPONENT 1, q SUBCOMPONENT, C CHAIN; C1QC	714
MIM120577		 	COMPLEMENT COMPONENT 1, q SUBCOMPONENT, RECEPTOR 1; C1QR1	22918
MIM120580		12p13	COMPLEMENT COMPONENT 1, s SUBCOMPONENT; C1S	716
MIM120620		1q32	COMPLEMENT COMPONENT RECEPTOR 1; CR1	1378
MIM120650		1q32	COMPLEMENT COMPONENT RECEPTOR 2; CR2	1380
MIM120700		19p13.3-p13.2	COMPLEMENT COMPONENT 3; C3	718
MIM120790	C1852700	11q11-q13.1	COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF	710
MIM120810		6p21.3	COMPLEMENT COMPONENT 4A; C4A	720
MIM120820		6p21.3	COMPLEMENT COMPONENT 4B; C4B	721
MIM120830		1q32	COMPLEMENT COMPONENT 4-BINDING PROTEIN, ALPHA; C4BPA	722
MIM120831		1q32	COMPLEMENT COMPONENT 4-BINDING PROTEIN, BETA CHAIN; C4BPB	725
MIM120900		9q34.1	COMPLEMENT COMPONENT 5; C5	727
MIM120920		1q32	CD46 ANTIGEN; CD46	4179
MIM120930		9q34.3	COMPLEMENT COMPONENT 8, GAMMA SUBUNIT; C8G	733
MIM120940		5p13	COMPLEMENT COMPONENT 9; C9	735
MIM120950		1p32	COMPLEMENT COMPONENT 8, ALPHA SUBUNIT; C8A	731
MIM120960		1p32	COMPLEMENT COMPONENT 8, BETA SUBUNIT; C8B	732
MIM120970	CN074280	19q13.3	CONE-ROD DYSTROPHY 2; CORD2	1406
MIM120980		16p11.2	INTEGRIN, ALPHA-M; ITGAM	3684
MIM121009		6q23.1	CONNECTIVE TISSUE GROWTH FACTOR; CTGF	1490
MIM121010		4q12-q13	PRO-PLATELET BASIC PROTEIN; PPBP	5473
MIM121011		13q11-q12	GAP JUNCTION PROTEIN, BETA-2; GJB2	2706
MIM121012		1p35.1	GAP JUNCTION PROTEIN, ALPHA-4; GJA4	2701
MIM121013		1q21.1	GAP JUNCTION PROTEIN, ALPHA-5; GJA5	2702
MIM121014		6q21-q23.2	GAP JUNCTION PROTEIN, ALPHA-1; GJA1	2697
MIM121015		13q11	GAP JUNCTION PROTEIN, ALPHA-3; GJA3	2700
MIM121050	C0220668	5q23-q31	ARTHROGRYPOSIS, DISTAL, TYPE 9; DA9	2201
MIM121070	C1852597	 	ARTHROGRYPOSIS, DISTAL, TYPE 2E	 
MIM121200	C1852587	20q13.3	SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1	3785
MIM121201	C1852581	8q24	SEIZURES, BENIGN FAMILIAL NEONATAL, 2; BFNS2	3786
MIM121210	C1852577	8q13-q21	FEBRILE SEIZURES, FAMILIAL, 1; FEB1	2233
MIM121270	C1852576	 	COPPER DEFICIENCY, FAMILIAL BENIGN	 
MIM121300	C0162531	3q12	COPROPORPHYRIA, HEREDITARY; HCP	1371
MIM121350	C1852561	 	CORACOCLAVICULAR JOINT, ANOMALOUS	 
MIM121360		16q22	CORE-BINDING FACTOR, BETA SUBUNIT; CBFB	865
MIM121390	C1852558	 	CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	 
MIM121400	C1852557	 	CORNEA PLANA 1; CNA1	1255
MIM121450	C1852556	 	CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS	 
MIM121700		20p11.2-q11.2	CORNEAL ENDOTHELIAL DYSTROPHY 1, AUTOSOMAL DOMINANT; CHED1	8197
MIM121800	C0271287	1p36.3	CORNEAL DYSTROPHY, CRYSTALLINE, OF SCHNYDER	29914
MIM121820	C0521723	5q31	CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE; EBMD	7045
MIM121850	C1562113	2q35	CORNEAL DYSTROPHY, FLECK	200576
MIM121900	C1641846	5q31	CORNEAL DYSTROPHY, GROENOUW TYPE I; CDGG1	7045
MIM122000	CN029625	20p11.2	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1; PPCD1	30813
MIM122100	C0339277	17q12, 12q13	CORNEAL DYSTROPHY, MEESMANN; MECD	3850, 3859
MIM122200	C1690006	5q31	CORNEAL DYSTROPHY, LATTICE TYPE I; LCD1	7045
MIM122400	C1852551	 	EPITHELIAL RECURRENT EROSION DYSTROPHY; ERED	 
MIM122430	C1852543	 	CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS, UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION	 
MIM122440	C1852542	 	CORNEODERMATOOSSEOUS SYNDROME	 
MIM122450	C1852541	 	CORNEAL HYPESTHESIA, FAMILIAL	 
MIM122455	C1852540	 	CORONARY ARTERY DISSECTION, SPONTANEOUS	 
MIM122460	C1852539	15q11-qter	HUMAN CORONAVIRUS SENSITIVITY; HCVS	3063
MIM122470	CN029798	5p13.1	CORNELIA DE LANGE SYNDROME 1; CDLS1	25836, 55869, 5885, 8243
MIM122500		14q32.1	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 6; SERPINA6	866
MIM122550		6p	CORTICOSTERONE SIDE-CHAIN ISOMERASE; CSCI	7944
MIM122559		5q11.2-q13.3	CORTICOTROPIN-RELEASING HORMONE-BINDING PROTEIN; CRHBP	1393
MIM122560		8q13	CORTICOTROPIN-RELEASING HORMONE; CRH	1392
MIM122561		17q12-q22	CORTICOTROPIN-RELEASING HORMONE RECEPTOR 1; CRHR1	1394
MIM122580	C1852523	 	COSTOCORACOID LIGAMENT, CONGENITALLY SHORT	 
MIM122600	C1852521	 	SPONDYLOCOSTAL DYSOSTOSIS 5, AUTOSOMAL DOMINANT; SCDO5	 
MIM122700	CN078029	16p11.2, 10q24, Xq27.1-q27.2, 19q13.2	COUMARIN RESISTANCE	1548, 1559, 2158, 79001
MIM122720		19q13.2	CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6	1548
MIM122750	C0239138	 	COXA VARA	 
MIM122780	C1852513	 	COXOAURICULAR SYNDROME	 
MIM122850	C1852512	 	CRANIOACROFACIAL SYNDROME	 
MIM122860	C2675746	 	CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	50964
MIM122880	C1852510	2q35	CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	5077
MIM122900	C0432263	 	CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	 
MIM123000	C1852502	5p15.2-p14.1	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CMDD	56172
MIM123050	C1852501	 	CRANIORHINY	 
MIM123100	CN029978	7p21	CRANIOSYNOSTOSIS, TYPE 1; CRS1	1403, 7291
MIM123101		5q34-q35	MUSCLE SEGMENT HOMEOBOX, DROSOPHILA, HOMOLOG OF, 2; MSX2	4488
MIM123150	C0795998	10q26, 8p11.2-p11.1	JACKSON-WEISS SYNDROME; JWS	2260, 2263
MIM123155	C1838347	 	HYDROCEPHALUS	 
MIM123260		1q21-q23	C-REACTIVE PROTEIN, PENTRAXIN-RELATED; CRP	1401
MIM123270	C1852487	14q32	CREATINE KINASE, BRAIN TYPE, ECTOPIC EXPRESSION OF; CKBE	1156
MIM123280		14q32	CREATINE KINASE, BRAIN TYPE; CKB	1152
MIM123290		15q15	CREATINE KINASE, MITOCHONDRIAL 1B; CKMT1B	1159
MIM123295		5q13.3	CREATINE KINASE, MITOCHONDRIAL 2; CKMT2	1160
MIM123310		19q13	CREATINE KINASE, MUSCLE TYPE; CKM	1158
MIM123320	C0241005	3p25	CREATINE PHOSPHOKINASE, ELEVATED SERUM	859
MIM123400	C0022336	6p21.3, 20pter-p12	CREUTZFELDT-JAKOB DISEASE; CJD	3119, 5621
MIM123450	C0010314	5p15.2	CRI-DU-CHAT SYNDROME	1501
MIM123500	C0010273	10q26	CROUZON SYNDROME	2263
MIM123540	C1852457	 	CRYOFIBRINOGENEMIA, FAMILIAL PRIMARY	 
MIM123550	C1852456	 	CRYOGLOBULINEMIA, FAMILIAL MIXED	 
MIM123557	C1852455	 	CRYPTOTIA, FAMILIAL	 
MIM123560	C1852454	 	CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME	 
MIM123570	C1852453	 	CRYPTOPHTHALMOS, UNILATERAL OR BILATERAL, ISOLATED	 
MIM123580		21q22.3	CRYSTALLIN, ALPHA-A; CRYAA	1409
MIM123590		11q22.3-q23.1	CRYSTALLIN, ALPHA-B; CRYAB	1410
MIM123610		17q11.1-q12	CRYSTALLIN, BETA-A1; CRYBA1	1411
MIM123620		22q11.2-q12.2	CRYSTALLIN, BETA-B2; CRYBB2	1415
MIM123630		22q11.2-q12.2	CRYSTALLIN, BETA-B3; CRYBB3	1417
MIM123631		22q11.2-q13.1	CRYSTALLIN, BETA-A4; CRYBA4	1413
MIM123660		2q33-q35	CRYSTALLIN, GAMMA-A; CRYGA	1418
MIM123670		2q33-q35	CRYSTALLIN, GAMMA-B; CRYGB	1419
MIM123680		2q33-q35	CRYSTALLIN, GAMMA-C; CRYGC	1420
MIM123690		2q33-q35	CRYSTALLIN, GAMMA-D; CRYGD	1421
MIM123691		1p31-p22	CRYSTALLIN, ZETA; CRYZ	1429
MIM123695		3q	PHOSPHATE CYTIDYLYLTRANSFERASE 1, CHOLINE, ALPHA ISOFORM; PCYT1A	5130
MIM123700	C0268350	14q32.1, 7q11.2	CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	10516, 2006
MIM123730		3q27	CRYSTALLIN, GAMMA-S; CRYGS	1427
MIM123740		16p13.11-p12.3	CRYSTALLIN, MU; CRYM	1428
MIM123790	C1852406	10q26	BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	2263
MIM123803		12q13	ACTIVATING TRANSCRIPTION FACTOR 1; ATF1	466
MIM123805		 	PHOSPHODIESTERASE 3A, cGMP-INHIBITED; PDE3A	5139
MIM123810		2q32.3-q34	cAMP RESPONSE ELEMENT-BINDING PROTEIN 1; CREB1	1385
MIM123811		2q32	ACTIVATING TRANSCRIPTION FACTOR 2; ATF2	1386
MIM123812		10p12.1-p11.2	cAMP RESPONSE ELEMENT MODULATOR; CREM	1390
MIM123825		4p12-cen	CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-1; CNGA1	1259
MIM123828		17q22-qter	CYCLIN-DEPENDENT KINASE 3; CDK3	1018
MIM123829		12q14	CYCLIN-DEPENDENT KINASE 4; CDK4	1019
MIM123830		17q21	CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CNP	1267
MIM123831		7q36	CYCLIN-DEPENDENT KINASE 5; CDK5	1020
MIM123832		14q22	CYCLIN-DEPENDENT KINASE INHIBITOR 3; CDKN3	1033
MIM123833		12p13	CYCLIN D2; CCND2	894
MIM123834		6p21	CYCLIN D3; CCND3	896
MIM123835		4q27	CYCLIN A2; CCNA2	890
MIM123836		5q12	CYCLIN B1; CCNB1	891
MIM123837		19q13.1	CYCLIN E1; CCNE1	898
MIM123838		6q21	CYCLIN C; CCNC	892
MIM123840		7p13	PEPTIDYL-PROLYL ISOMERASE A; PPIA	5478
MIM123841		15q21-q22	PEPTIDYL-PROLYL ISOMERASE B; PPIB	5479
MIM123842		5q23.2	PEPTIDYL-PROLYL ISOMERASE C; PPIC	5480
MIM123853	C1852396	 	CYPRUS FACIAL NEUROMUSCULOSKELETAL SYNDROME	 
MIM123855		20p11.2	CYSTATIN 1; CST1	1469
MIM123856		20p11.2	CYSTATIN 2; CST2	1470
MIM123857		20p11.2	CYSTATIN 4; CST4	1472
MIM123858		20p11.21	CYSTATIN 5; CST5	1473
MIM123859		11p15.5	CYSTEINYL-tRNA SYNTHETASE; CARS	833
MIM123860		1p34.1	CYTIDINE 5-PRIME TRIPHOSPHATE SYNTHETASE; CTPS	1503
MIM123864		16q22-qter	CYTOCHROME c OXIDASE, SUBUNIT IV, ISOFORM 1; COX4I1	1327
MIM123866		2cen-q13	CYTOCHROME c OXIDASE, SUBUNIT Vb; COX5B	1329
MIM123870		11q13	CYTOCHROME c OXIDASE, SUBUNIT VIII; COX8	1351
MIM123875		14q32.33	CYSTEINE-RICH INTESTINAL PROTEIN 1; CRIP1	1396
MIM123876		1q32	CYSTEINE- AND GLYCINE-RICH PROTEIN 1; CSRP1	1465
MIM123880	C0029438	 	CYSTIC ANGIOMATOSIS OF BONE, DIFFUSE	 
MIM123885		1q21	S100 CALCIUM-BINDING PROTEIN A8; S100A8	6279
MIM123886		1q12-q22	S100 CALCIUM-BINDING PROTEIN A9; S100A9	6280
MIM123889		21q22.1	INTERLEUKIN 10 RECEPTOR, BETA; IL10RB	3588
MIM123890		2q33	CYTOTOXIC T LYMPHOCYTE-ASSOCIATED 4; CTLA4	1493
MIM123900		6q25-q26	VILLIN 2; VIL2	7430
MIM123910		14q11.2	GRANZYME B; GZMB	3002
MIM123920		1p36.2-p35	CYTIDINE DEAMINASE; CDA	978
MIM123930		19q13.2	CYTOCHROME P450, SUBFAMILY IIB, POLYPEPTIDE 6; CYP2B6	1555
MIM123940		12q13	KERATIN 4; KRT4	3851
MIM123970		7p15.2	CYTOCHROME C, SOMATIC; CYCS	54205
MIM123980		8q24.3	CYTOCHROME C1; CYC1	1537
MIM123995		19q13.12	CYTOCHROME c OXIDASE, SUBUNIT VIIa, POLYPEPTIDE 1; COX7A1	1346
MIM123996		6q12	CYTOCHROME c OXIDASE, SUBUNIT VIIa, POLYPEPTIDE 2; COX7A2	1347
MIM123997		4q22	CYTOCHROME c OXIDASE, SUBUNIT VIIa, POLYPEPTIDE 3; COX7A3	1348
MIM124000	C1852372	8q22, 5q31.1, 2q33	MITOCHONDRIAL COMPLEX III DEFICIENCY	27089, 54902, 617, 7381
MIM124010		7q22.1	CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 4; CYP3A4	1576
MIM124015		7q11.2	CYTOCHROME P450 OXIDOREDUCTASE; POR	 
MIM124020		10q24.1-q24.3	CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19	1557
MIM124030		22q13.1	CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6	1565
MIM124040		10q24.3-qter	CYTOCHROME P450, SUBFAMILY IIE; CYP2E1	1571
MIM124050		12q24	D-AMINO ACID OXIDASE; DAO	1610
MIM124060		15q24.1	CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2; CYP1A2	1544
MIM124070		19q13.2	CYTOCHROME P450, SUBFAMILY IIF, POLYPEPTIDE 1; CYP2F1	1572
MIM124075		1p34-p12	CYTOCHROME P450, SUBFAMILY IVB, MEMBER 1; CYP4B1	1580
MIM124080		8q21	CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2; CYP11B2	1585
MIM124089		19q13.1	CYTOCHROME c OXIDASE, SUBUNIT VIb, POLYPEPTIDE 1; COX6B1	1340
MIM124090		8q22-q23	CYTOCHROME c OXIDASE, SUBUNIT VIc; COX6C	1345
MIM124092		1q31-q32	INTERLEUKIN 10; IL10	3586
MIM124095		15q23-q25	CYTOPLASMIC TYROSINE KINASE; CSK	1445
MIM124097		19q13.3	D SITE OF ALBUMIN PROMOTER-BINDING PROTEIN; DBP	1628
MIM124100	C0004698	 	DANUBIAN ENDEMIC FAMILIAL NEPHROPATHY	 
MIM124200	C0022595	12q23-q24.1	DARIER-WHITE DISEASE; DAR	488
MIM124300	C1852294	 	DARWINIAN TUBERCLE OF PINNA	 
MIM124400	C1852294	 	DARWINIAN TUBERCLE OF PINNA	 
MIM124450		 	D-ASPARTATE OXIDASE; DDO	8528
MIM124480	C2675730	 	DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT; DDOD	 
MIM124490	C1852292	 	DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY	 
MIM124500	C0265964	13q11-q12	DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OF FINGERS AND TOES	2706
MIM124700	C1852283	 	DEAFNESS, MID-TONE NEURAL	 
MIM124900	C1852282	5q31	DEAFNESS, AUTOSOMAL DOMINANT 1; DFNA1	1729
MIM125000	C2607947	 	DEAFNESS, UNILATERAL	 
MIM125050	C1852279	 	DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA	 
MIM125220		8p23.1	DEFENSIN, ALPHA, 1; DEFA1	1667
MIM125230	C1852278	 	DEAFNESS-CRANIOFACIAL SYNDROME	 
MIM125240		1q32	CD55 ANTIGEN; CD55	1604
MIM125250	C1852267	3q28-q29	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	4976
MIM125255		12q21.3	DECORIN; DCN	1634
MIM125260	C1852265	Chr.16	DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	7420
MIM125263		19q13.3	SULFOTRANSFERASE FAMILY 2A, DEHYDROEPIANDROSTERONE-PREFERRING, MEMBER 1; SULT2A1	6822
MIM125264		6p23	DEK ONCOGENE; DEK	7913
MIM125265		5q22-q23	RECEPTOR EXPRESSION-ENHANCING PROTEIN 5; REEP5	7905
MIM125270		9q34	DELTA-AMINOLEVULINATE DEHYDRATASE; ALAD	210
MIM125280	C0266034	 	DENS EVAGINATUS	 
MIM125290		3p21.1	DELTA-AMINOLEVULINATE SYNTHASE 1; ALAS1	211
MIM125300	C1852250	 	DENS IN DENTE AND PALATAL INVAGINATIONS	 
MIM125305		8p21.1	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.9; EPB49	2039
MIM125310	C1272305	19p13.2-p13.1	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CADASIL	4854
MIM125320	C1852223	 	DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES	 
MIM125350	C1852222	3p22-p21.1	FAILURE OF TOOTH ERUPTION, PRIMARY; PFE	5745
MIM125370	C0751781	12p13.31	DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA	1822
MIM125400	C0399379	 	DENTIN DYSPLASIA, TYPE I; DTDP1	64094
MIM125420	C1527284	4q21.3	DENTIN DYSPLASIA, TYPE II	1834
MIM125440	C1852201	 	DENTIN DYSPLASIA WITH SCLEROTIC BONES	 
MIM125450		4q13.3-q21.1	DEOXYCYTIDINE KINASE; DCK	1633
MIM125460	C1852200	 	DEOXYRIBOSE-5-PHOSPHATE ALDOLASE DEFICIENCY	 
MIM125480	C1852197	5p15.3, 18p	MAJOR AFFECTIVE DISORDER 1; MAFD1	4095, 6531
MIM125485		4q21.3	DENTIN SIALOPHOSPHOPROTEIN; DSPP	1834
MIM125490	C0205730	4q21.3	DENTINOGENESIS IMPERFECTA 1; DGI1	1834
MIM125500	C0399378	4q21.3	DENTINOGENESIS IMPERFECTA, SHIELDS TYPE III	1834
MIM125505		16p13.3	DEOXYRIBONUCLEASE I; DNASE1	1773
MIM125520	C0431406	22q11	CAYLER CARDIOFACIAL SYNDROME	387569
MIM125530	C1852161	 	DERMAL RIDGES, NELSON SYNDROME	 
MIM125540	C1852160	 	DERMAL RIDGES, PATTERNLESS	 
MIM125550	C1852159	 	DERMAL RIDGES-OFF-THE-END; ROES	 
MIM125570	C1852158	 	DERMATOGLYPHICS--ARCH ON ANY DIGIT	 
MIM125580	C1852157	 	DERMATOGLYPHICS--FINGER RIDGE COUNT	 
MIM125590	C1852156	 	DERMATOGLYPHICS--FINGERPRINT PATTERN	 
MIM125595	C0406778	17q12-q21	DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR	3861
MIM125597		1q12-q23	DERMATOPONTIN; DPT	1805
MIM125600	C0011645	 	DERMATOSIS PAPULOSA NIGRA	 
MIM125630	C1852146	 	DERMODISTORTIVE URTICARIA; DDU	29764
MIM125635	C1852145	 	DERMOGRAPHISM, FAMILIAL	 
MIM125640	C1852144	 	DERMOODONTODYSPLASIA	 
MIM125643		18q12.1	DESMOCOLLIN 1; DSC1	1823
MIM125645		18q12.1	DESMOCOLLIN 2; DSC2	1824
MIM125647		6p24	DESMOPLAKIN; DSP	1832
MIM125660		2q35	DESMIN; DES	1674
MIM125670		18q12.1-q12.2	DESMOGLEIN 1; DSG1	1828
MIM125671		18q12.1-q12.2	DESMOGLEIN 2; DSG2	1829
MIM125700	C0687720	20p13	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	551
MIM125800	C1563706	12q13	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	359
MIM125850	C1852093	20q12-q13.1	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1	3172
MIM125851	C1841962	7p15-p13	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MODY2	2645
MIM125852	C1852092	11p15.5	DIABETES MELLITUS, INSULIN-DEPENDENT, 2	3401, 3630
MIM125853	C0011860	17q12, 17p13, 15q21-q23, 13q34, 13q12.1, 12q24.2, 11p12-p11.2, 11p15.1, 11p15.1, 10q25.3, 8q24.11, 7q32, 7p15-p13, 7p21, 6q22-q23, 6p22.3, 5q34-q35.2, 4p16.1, 3q28, 3p25, 2q36, 2q32, 2q24.1, 20q13.1-q13.2, 217q12, 17p13, 15q21-q23, 13q34, 13q12.1, 12q24.2, 11p12-p11.2, 11p15.1, 11p15.1, 10q25.3, 8q24.11, 7q32, 7p15-p13, 7p21, 6q22-q23, 6p22.3, 5q34-q35.2, 4p16.1, 3q28, 3p25, 2q36, 2q32, 2q24.1, 20q13.1-q13.2,	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM	10644, 169026, 208, 2642, 2645, 2820, 3159, 3172, 3569, 3643, 3651, 3667, 3767, 3990, 4544, 4760, 5078, 5167, 5468, 54901, 56729, 5770, 6517, 6833, 6927, 6928, 6934, 7466, 8660, 9479
MIM125855		12q13.3	DIACYLGLYCEROL KINASE, ALPHA, 80-KD; DGKA	1606
MIM125860		16q22.1	NAD(P)H DEHYDROGENASE, QUINONE 1; NQO1	1728
MIM125890	C1852087	 	DIARRHEA, GLUCOSE-STIMULATED SECRETORY, WITH COMMON VARIABLE IMMUNODEFICIENCY	 
MIM125900	C1852086	 	DIASTEMA, DENTAL MEDIAL	 
MIM125950		2q12-q21	DIAZEPAM BINDING INHIBITOR; DBI	1622
MIM126050	C1852085	 	DIGITOTALAR DYSMORPHISM	 
MIM126060		5q11.2-q13.2	DIHYDROFOLATE REDUCTASE; DHFR	1719
MIM126063		14q24.3	DIHYDROLIPOAMIDE S-SUCCINYLTRANSFERASE; DLST	1743
MIM126064		16q22	DIHYDROOROTATE DEHYDROGENASE; DHODH	1723
MIM126065		20q13.2-q13.3	CYTOCHROME P450, FAMILY 24, SUBFAMILY A, POLYPEPTIDE 1; CYP24A1	1591
MIM126070	C1876214	 	DILUTION, PIGMENTARY	 
MIM126090		10q22	PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE 1; PCBD1	5092
MIM126100	C1852076	 	DIMPLES, FACIAL	 
MIM126110		1q21	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; ARNT	405
MIM126141		7q36.2	DIPEPTIDYL PEPTIDASE VI; DPP6	1804
MIM126150		5q23	HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; HBEGF	1839
MIM126180	C1852074	 	DISCRIMINATION, TWO-POINT, REDUCTION IN	 
MIM126190	C1852073	 	DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	 
MIM126200	CN031763	6q21, 6p21.3, 6p21.3, 2q37.3	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS	100133941, 3119, 3123, 4397, 5133
MIM126250	C1852063	 	DISTAL OSTEOSCLEROSIS	 
MIM126255		2q32	DISTAL-LESS HOMEOBOX 2; DLX2	1746
MIM126300	C0423848	 	DISTICHIASIS	 
MIM126320	C1852062	 	DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL VASCULATURE	 
MIM126330		9q12	DNA, CYTOPLASMIC-MEMBRANE; DNCM	1784
MIM126335		1p34-p12	GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GENE GADD45, ALPHA; GADD45A	1647
MIM126337		12q13.1-q13.2	DNA DAMAGE-INDUCIBLE TRANSCRIPT 3; DDIT3	1649
MIM126340		19q13.2-q13.3	EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 2; ERCC2	2068
MIM126350		19p13.2-q13.4	DEOXYRIBONUCLEASE II, LYSOSOMAL; DNASE2	1777
MIM126375		19p13.3-p13.2	DNA METHYLTRANSFERASE 1; DNMT1	1786
MIM126380		19q13.2-q13.3	EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 1; ERCC1	2067
MIM126391		19q13.2-q13.3	LIGASE I, DNA, ATP-DEPENDENT; LIG1	3978
MIM126420		20q12-q13.1	TOPOISOMERASE, DNA, I; TOP1	7150
MIM126430		17q21-q22	TOPOISOMERASE, DNA, II, ALPHA; TOP2A	7153
MIM126431		3p24	TOPOISOMERASE, DNA, II, BETA; TOP2B	7155
MIM126449		5q35.1	DOPAMINE RECEPTOR D1; DRD1	1812
MIM126450		11q23.1	DOPAMINE RECEPTOR D2; DRD2	1813
MIM126451		3q13.3	DOPAMINE RECEPTOR D3; DRD3	1814
MIM126452		11p15.5	DOPAMINE RECEPTOR D4; DRD4	1815
MIM126453		4p16.1-p15.3	DOPAMINE RECEPTOR D5; DRD5	1816
MIM126455		5p15.3	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, DOPAMINE), MEMBER 3; SLC6A3	6531
MIM126500	C1852023	 	DOUBLE NAIL FOR FIFTH TOE	 
MIM126550	C1852022	 	DOUGHNUT LESIONS OF SKULL, FAMILIAL	 
MIM126600	C1832174	2p16	DOYNE HONEYCOMB RETINAL DYSTROPHY; DHRD	2202
MIM126650		7q22-q31.1	SOLUTE CARRIER FAMILY 26, MEMBER 3; SLC26A3	1811
MIM126660		5q35.3	DREBRIN E; DBN1	1627
MIM126700	C0730295	1q32	BASAL LAMINAR DRUSEN	3075
MIM126800	CN030283	8q13	DUANE RETRACTION SYNDROME 1; DURS1	10674
MIM126840	C1852009	 	DUODENAL ULCER DUE TO ANTRAL G-CELL HYPERFUNCTION	 
MIM126850	C1852008	 	DUODENAL ULCER, HYPERPEPSINOGENEMIC I	 
MIM126900	C0013312	16q11.1-q22	DUPUYTREN CONTRACTURE	780895
MIM126950	C1851996	 	DWARFISM WITH TALL VERTEBRAE	 
MIM127000	CN031291	 	KENNY-CAFFEY SYNDROME, TYPE 2	 
MIM127100	C1851994	 	DWARFISM, LEVI TYPE	 
MIM127200	C0265349	 	DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES	 
MIM127300	C0265309	Ypter-p11.2, Xpter-p22.32	LERI-WEILL DYSCHONDROSTEOSIS; LWD	6473
MIM127350	C1851986	 	DYSCHONDROSTEOSIS AND NEPHRITIS	 
MIM127400	C0406775	1q21.3	DYSCHROMATOSIS SYMMETRICA HEREDITARIA 1	103
MIM127500	C2675711	6q24.2-q25.2	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 1; DUH1	387570
MIM127550	C1851970	14q12, 5p15.33, 3q21-q28	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1	26277, 7012, 7015
MIM127600	C0265966	4q35	DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL	80870
MIM127700	C1851967	15q21	DYSLEXIA, SUSCEPTIBILITY TO, 1; DYX1	161582, 1867
MIM127750	C0752347	5q35, 4q21	DEMENTIA, LEWY BODY; DLB	2629, 6620, 6622
MIM127800	C0432282	 	DYSPLASIA EPIPHYSEALIS HEMIMELICA	 
MIM127820	C1851956	 	DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS	 
MIM128000	C1851955	 	DYSTELEPHALANGY	 
MIM128100	C1851945	9q34	DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT; DYT1	1861
MIM128101	C1851943	 	DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	1864
MIM128200	C1868682	16p11.2-q12.1	EPISODIC KINESIGENIC DYSKINESIA 1; EKD1	112476, 50818
MIM128230	C1851920	 	DYSTONIA, DOPA-RESPONSIVE; DRD	2643
MIM128235	C1868681	19q12-q13.2	DYSTONIA 12; DYT12	478
MIM128239		3p21	DYSTROPHIN-ASSOCIATED GLYCOPROTEIN 1; DAG1	1605
MIM128240		6q24	UTROPHIN; UTRN	7402
MIM128260		1q32	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE E; SNRPE	6635
MIM128300	C0155411	 	EAR EXOSTOSES	 
MIM128400	C1851902	 	EAR FLARE	 
MIM128500	C1851901	 	EAR FOLDING	 
MIM128600	C0266589	 	EAR MALFORMATION	 
MIM128700	C0546969	8q11.1-q13.3	PREAURICULAR FISTULAE, CONGENITAL	404715
MIM128710	C1851900	 	EAR PITS, POSTERIOR HELICAL	 
MIM128800	C1851899	 	EAR WITHOUT HELIX	 
MIM128900	C1851898	 	EARLOBE ATTACHMENT, ATTACHED VS UNATTACHED	 
MIM128980	C1851896	 	EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIAL ABNORMALITIES	 
MIM128990		5q31.1	EARLY GROWTH RESPONSE 1; EGR1	1958
MIM128992		2p13	EARLY GROWTH RESPONSE 4; EGR4	1961
MIM129000	C1851895	 	EARRING HOLES, NATURAL	 
MIM129010		10q21.1-q22.1	EARLY GROWTH RESPONSE 2; EGR2	1959
MIM129100	C1851889	 	EARS, ABILITY TO MOVE	 
MIM129150	C1851888	19q13.1-qter	ECHO VIRUS 11 SENSITIVITY; E11S	1878
MIM129190		6q14-q21	ECTO-5-PRIME NUCLEOTIDASE; NT5E	4907
MIM129200	C0406707	 	ADERMATOGLYPHIA WITH CONGENITAL FACIAL MILIA AND ACRAL BLISTERS, DIGITAL CONTRACTURES, AND NAIL ABNORMALITIES	 
MIM129400	C1785148	3q27	RAPP-HODGKIN SYNDROME; RHS	8626
MIM129490	C1720965	2q11-q13, 1q42.2-q43	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL DOMINANT; HED	10913, 128178
MIM129500	C0162361	13q12	ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT	10804
MIM129510	C1851858	 	ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	 
MIM129540	C1851851	 	ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE AND PREAXIAL POLYDACTYLY OF FEET	 
MIM129550	C1851850	 	ECTODERMAL DYSPLASIA WITH ADRENAL CYST	 
MIM129600	C1851286	15q21.1	ECTOPIA LENTIS, ISOLATED, AUTOSOMAL DOMINANT; ECTOL1	2200
MIM129750	C1271219	 	ECTOPIA PUPILLAE	 
MIM129810	C1851849	 	ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE	 
MIM129830	C1851848	 	ECTRODACTYLY-CLEFT PALATE SYNDROME	 
MIM129840	C1851847	 	EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	 
MIM129850	C0795933	 	EDINBURGH MALFORMATION SYNDROME	 
MIM129900	C1851841	7q11.2-q21.3	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1; EEC1	1913
MIM130000	C0268335	9q34.2-q34.3, 2q31, 17q21.31-q22	EHLERS-DANLOS SYNDROME, TYPE I	1277, 1289, 1290
MIM130010		9q34.2-q34.3	EHLERS-DANLOS SYNDROME, TYPE II	1289, 1290
MIM130020	C0268337	6p21.3, 2q31	EHLERS-DANLOS SYNDROME, TYPE III	1281, 7148
MIM130050	C0268338	2q31	EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT	1281
MIM130060	C0268345	7q22.1, 17q21.31-q22	EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT	1277, 1278
MIM130070	C1869122	5q35.2-q35.3	EHLERS-DANLOS SYNDROME, PROGEROID FORM	11285
MIM130080	C0268347	12p13	EHLERS-DANLOS SYNDROME, TYPE VIII	791254
MIM130090	C0220679	 	EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	 
MIM130100	C0221271	 	ELASTOSIS PERFORANS SERPIGINOSA; EPS	 
MIM130120		12q13	CHYMOTRYPSIN-LIKE ELASTASE FAMILY, MEMBER 1; CELA1	1990
MIM130130		19p13.3	ELASTASE, NEUTROPHIL-EXPRESSED; ELANE	1991
MIM130135		6pter-p24	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 1; SERPINB1	1992
MIM130160		7q11.2	ELASTIN; ELN	2006
MIM130180	C1851759	20q13.2-q13.3	ELECTROENCEPHALOGRAM, LOW-VOLTAGE	1940
MIM130190	C1851758	 	ELECTROENCEPHALOGRAPHIC PATTERN, BETA FREQUENCY, QUANTITATIVE TRAIT LOCUS; EEGBQTL	 
MIM130410		19q13.3	ELECTRON TRANSFER FLAVOPROTEIN, BETA POLYPEPTIDE; ETFB	2109
MIM130500		1p36.2-p34	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1; EPB41	2035
MIM130590		6q14	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, ALPHA-1; EEF1A1	1915
MIM130592		8q24.3	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, DELTA; EEF1D	1936
MIM130593		11q12.3	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, GAMMA; EEF1G	1937
MIM130600	C1851741	1q21	ELLIPTOCYTOSIS 2; EL2	6708
MIM130610		19pter-q12	EUKARYOTIC TRANSLATION ELONGATION FACTOR 2; EEF2	1938
MIM130620		5q32	RIBOSOMAL PROTEIN S14; RPS14	6208
MIM130650	C0004903	11p15.5, 11p15.5, 11p15.5, 5q35	BECKWITH-WIEDEMANN SYNDROME; BWS	1028, 10984, 283120, 3481, 3784, 64324
MIM130660		2p23.3-p23.2	ELASTIN MICROFIBRIL INTERFACER 1; EMILIN1	11117
MIM130700	C1851718	 	EMPHYSEMA, HEREDITARY PULMONARY	 
MIM130710	C0265797	 	EMPHYSEMA, CONGENITAL LOBAR; CLE	 
MIM130900	C0399376	8q24.3	AMELOGENESIS IMPERFECTA, TYPE III; AI3	286077
MIM130950	C1851708	 	ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	 
MIM131100	C0025267	11q13	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1	4221
MIM131170		7q11.2	ENDOGENOUS RETROVIRAL SEQUENCE 3; ERV3	2086
MIM131180		 	ENDOGENOUS RETROVIRAL POL-LIKE SEQUENCE-2; ERPL2	2083
MIM131190		1pter-p36	ENDOGENOUS RETROVIRAL POL-LIKE SEQUENCE-1; ERPL1	2082
MIM131195		9q34.1	ENDOGLIN; ENG	2022
MIM131200	C1851649	10q26	ENDOMETRIOSIS, SUSCEPTIBILITY TO, 1	100188863
MIM131210		1q23-q25	SELECTIN E; SELE	6401
MIM131220		5q31	FIBROBLAST GROWTH FACTOR 1; FGF1	2246
MIM131222		22q13.32-qter	THYMIDINE PHOSPHORYLASE: TYMP	1890
MIM131230		4q26-q28	ANNEXIN A5; ANXA5	308
MIM131235		 	KDEL ENDOPLASMIC RETICULUM PROTEIN RETENTION RECEPTOR 1; KDELR1	10945
MIM131240		6p24-p23	ENDOTHELIN 1; EDN1	1906
MIM131241		1p34	ENDOTHELIN 2; EDN2	1907
MIM131242		20q13.2-q13.3	ENDOTHELIN 3; EDN3	1908
MIM131243		4q31.2	ENDOTHELIN RECEPTOR, TYPE A; EDNRA	1909
MIM131244		13q22	ENDOTHELIN RECEPTOR, TYPE B; EDNRB	1910
MIM131290		2q13-q21	ENGRAILED 1; EN1	2019
MIM131300	C0011989	19q13.1	CAMURATI-ENGELMANN DISEASE; CAEND	7040
MIM131310		7q36	ENGRAILED 2; EN2	2020
MIM131320		10p15	GATA-BINDING PROTEIN 3; GATA3	2625
MIM131330		8q23-q24	PROENKEPHALIN; PENK	5179
MIM131340		20p13	PRODYNORPHIN; PDYN	5173
MIM131360		12p13	ENOLASE 2; ENO2	2026
MIM131370		17pter-p12	ENOLASE 3; ENO3	2027
MIM131390		1q43	NIDOGEN; NID	4811
MIM131398		14q11.2	RIBONUCLEASE A FAMILY, 3; RNASE3	6037
MIM131399		17q23.1	EOSINOPHIL PEROXIDASE; EPX	8288
MIM131400	C0272192	5q31-q33	EOSINOPHILIA, FAMILIAL	7908
MIM131410		14q11.2	RIBONUCLEASE A FAMILY, 2; RNASE2	6036
MIM131430	C1851586	 	EOSINOPHILOPENIA	 
MIM131440	C1851585	5q31-q32	MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	5159
MIM131445		 	EPENDYMOMA	 
MIM131450	C1851583	 	EPIBLEPHARON OF LOWER LID	 
MIM131460	C1851582	 	EPIBLEPHARON OF UPPER LID	 
MIM131500	C0678230	 	EPICANTHUS	 
MIM131530		4q25	EPIDERMAL GROWTH FACTOR; EGF	1950
MIM131550		7p12.3-p12.1	EPIDERMAL GROWTH FACTOR RECEPTOR; EGFR	1956
MIM131560		17q11-q12	FLOTILLIN 2; FLOT2	2319
MIM131600	C0014511	 	EPIDERMOID CYSTS	 
MIM131705	C1851573	3p21.3	TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN	1294
MIM131750	C0432322	3p21.3	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB	1294
MIM131760	C0079295	17q12-q21, 12q13	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE	3852, 3861
MIM131800	C0080333	17q12-q21, 17q11-qter, 12q13	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED	3691, 3852, 3861
MIM131850	C0432321	3p21.3	EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	1294
MIM131880	C1851570	 	EPIDERMOLYSIS BULLOSA WITH DEFICIENCY OF GALACTOSYLHYDROXYLYSYL GLUCOSYLTRANSFERASE	 
MIM131900	C0079299	17q12-q21, 12q13	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED	3852, 3861
MIM131950	C0432317	8q24	EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE	5339
MIM131960	C0432316	12q13	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION; EBS-MP	3852
MIM132000	C0268371	3p21.3	EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS	1294
MIM132090	C1851549	 	EPILEPSY, BENIGN OCCIPITAL; BOE	 
MIM132100	C1868677	6p21.1	PHOTOPAROXYSMAL RESPONSE; PPR	100528023
MIM132300	C0278193	 	EPILEPSY, READING	 
MIM132350		12q24.33	SYNTAXIN 2; STX2	2054
MIM132400	C1838280	19p13.1	EPIPHYSEAL DYSPLASIA, MULTIPLE, 1; EDM1	1311
MIM132450	C1851536	12q13.11-q13.2	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS	1280
MIM132500	C0339819	 	EPISTAXIS, HEREDITARY	 
MIM132600	C0206711	1p34.3-p32.1, 3p22-p21.3	PILOMATRIXOMA	1499, 4595
MIM132700	C1851526	16q12-q13	CYLINDROMATOSIS, FAMILIAL	1540
MIM132800	C0546476	9q31	MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO; MSSE	4484, 7046
MIM132810		1q42.1	EPOXIDE HYDROLASE 1, MICROSOMAL; EPHX1	2052
MIM132811		8p21-p12	EPOXIDE HYDROLASE 2, CYTOSOLIC; EPHX2	2053
MIM132850		1p35	EPSTEIN-BARR VIRUS INSERTION SITE 1; EBVS1	1888
MIM132880		19p13.1	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 6; NR2F6	2063
MIM132890		5q14	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 1; NR2F1	7025
MIM132900	C1851504	16p13.13-p13.12	AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4	4629
MIM132990	C1851503	 	ERYTHEMA NODOSUM, FAMILIAL	 
MIM133000	C1851502	 	ERYTHEMA PALMARE HEREDITARIUM	 
MIM133020	C0014805	2q24	ERYTHERMALGIA, PRIMARY	6335
MIM133090		9q34.1	ERYTHROCYTE SURFACE PROTEIN BAND 7.2; EPB72	2040
MIM133100	C1851490	19p13.3-p13.2	ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1	10019, 2057
MIM133170		7q21	ERYTHROPOIETIN; EPO	2056
MIM133171		19p13.3-p13.2	ERYTHROPOIETIN RECEPTOR; EPOR	2057
MIM133180	C0023440	 	ERYTHROLEUKEMIA, FAMILIAL	 
MIM133190	C1851481	 	SPINOCEREBELLAR ATAXIA 34; SCA34	100750330
MIM133200	C0265961	1p35.1, 1p35.1	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA; EKVP	127534, 2707
MIM133220		11q13-q22	ESTERASE A-4; ESA4	2090
MIM133239	C0546837	16q23.3-q24.1, 13q12.11, 9q32, 8p22, 3p22-p21.3, 3p22	ESOPHAGEAL CANCER	11178, 50514, 51741, 6049, 7048, 9940
MIM133240	C0341137	 	ESOPHAGEAL RING, LOWER	 
MIM133280		13q14.11	ESTERASE D; ESD	2098
MIM133290		Chr.16	ESTERASE B3; ESB3	2097
MIM133430		6q25.1	ESTROGEN RECEPTOR 1; ESR1	2099
MIM133435		8q22	RUNT-RELATED TRANSCRIPTION FACTOR 1, TRANSLOCATED TO, 1; RUNX1T1	862
MIM133440		4q21-q25	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E; EIF4E	1977
MIM133450		22q12	EWING SARCOMA BREAKPOINT REGION 1; EWSR1	2130
MIM133500	C1851463	 	EXCHONDROSIS OF PINNA, POSTERIOR	 
MIM133510		2q21	EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 3; ERCC3	2071
MIM133520		16p13.3-p13.13	EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 4; ERCC4	2072
MIM133530		13q33	EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 5; ERCC5	2073
MIM133535		 	EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN MOUSE CELLS; ERCM1	2076
MIM133540	C0751038	10q11	COCKAYNE SYNDROME, TYPE B; CSB	2074
MIM133550		9p24	SOLUTE CARRIER FAMILY 1 (NEURONAL/EPITHELIAL HIGH AFFINITY GLUTAMATE TRANSPORTER), MEMBER 1; SLC1A1	6505
MIM133600	C0877431	 	EXOSTOSES OF HEEL	 
MIM133690	C1851428	 	EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E	 
MIM133700	C0015306	8q24.11-q24.13	EXOSTOSES, MULTIPLE, TYPE I	2131
MIM133701	C1851413	11p12-p11	EXOSTOSES, MULTIPLE, TYPE II	2132
MIM133705	C1876181	 	EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICAL TALUS	 
MIM133750	C1851412	 	EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATION AND MICROCEPHALY	 
MIM133780	C1851402	11q14-q21	EXUDATIVE VITREORETINOPATHY 1; EVR1	4041, 8322
MIM133800	C1851401	 	EYEBROW, WHORL IN	 
MIM133900	C1399354	 	HEMIFACIAL HYPERPLASIA	 
MIM134000	C1851400	 	FACIAL HYPERTRICHOSIS	 
MIM134200	C1851399	 	FACIAL PALSY, FAMILIAL RECURRENT PERIPHERAL	 
MIM134300	C0278151	 	FACIAL SPASM	 
MIM134350		19p13.3	COMPLEMENT FACTOR D; CFD	1675
MIM134370		1q32	COMPLEMENT FACTOR H; CFH	3075
MIM134371		1q31-q32.1	COMPLEMENT FACTOR H-RELATED 1; CFHR1	3078
MIM134390		1p22-p21	COAGULATION FACTOR III; F3	2152
MIM134400	C1851378	 	FACTOR V EXCESS WITH SPONTANEOUS THROMBOSIS	 
MIM134430	C1851377	 	FACTOR VII AND FACTOR VIII, COMBINED DEFICIENCY OF	 
MIM134500	CN239112	 	FACTOR VIII DEFICIENCY	 
MIM134510	C1851376	 	FACTOR VIII AND FACTOR IX, COMBINED DEFICIENCY OF; F8F9D	 
MIM134520	C1851375	 	FACTORS VIII, IX AND XI, COMBINED DEFICIENCY OF	 
MIM134540	C1851374	 	FACTOR IX AND FACTOR XI, COMBINED DEFICIENCY OF	 
MIM134570		6p25-p24	FACTOR XIII, A1 SUBUNIT; F13A1	2162
MIM134580		1q31-q32.1	FACTOR XIII, B SUBUNIT; F13B	2165
MIM134600	C0341703	15q15.3	FANCONI RENOTUBULAR SYNDROME 1; FRTS1	65211
MIM134610	C1851347	16p13	FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT	4210
MIM134629		1q24-q31	FARNESYL DIPHOSPHATE SYNTHASE; FDPS	2224
MIM134635		8p22-q11	FARNESYLTRANSFERASE, CAAX BOX, ALPHA; FNTA	2339
MIM134636		14q23-q24	FARNESYLTRANSFERASE, CAAX BOX, BETA; FNTB	2342
MIM134637		10q24.1	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 6; TNFRSF6	355
MIM134638		1q23	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 6; TNFSF6	356
MIM134640		4q28-q31	FATTY ACID-BINDING PROTEIN 2; FABP2	2169
MIM134650		2p11	FATTY ACID-BINDING PROTEIN 1; FABP1	2168
MIM134651		1p33-p31	FATTY ACID-BINDING PROTEIN 3; FABP3	2170
MIM134660		11q13	GLUTATHIONE S-TRANSFERASE, PI; GSTP1	2950
MIM134690		11q13	FAU GENE; FAU	2197
MIM134700	C1851319	 	FAVISM, SUSCEPTIBILITY TO	 
MIM134720	C1851318	4q21-q25	FECUNDITY GENE, BOOROOLA, OF SHEEP, HOMOLOG OF	7892
MIM134750	C0015773	 	FELTY SYNDROME	 
MIM134770		11q12-q13	FERRITIN HEAVY CHAIN 1; FTH1	2495
MIM134780	C0265263	 	FEMORAL-FACIAL SYNDROME; FFS	 
MIM134790		19q13.3-q13.4	FERRITIN LIGHT CHAIN; FTL	2512
MIM134795		19q13.2	FIBRILLARIN; FBL	2091
MIM134797		15q21.1	FIBRILLIN 1; FBN1	2200
MIM134820		4q28	FIBRINOGEN, A ALPHA POLYPEPTIDE; FGA	2243
MIM134830		4q28	FIBRINOGEN, B BETA POLYPEPTIDE; FGB	2244
MIM134850		4q28	FIBRINOGEN, G GAMMA POLYPEPTIDE; FGG	2266
MIM134900	C1851184	 	FIBRINOLYTIC DEFECT	 
MIM134920		4q25-q27	FIBROBLAST GROWTH FACTOR 2; FGF2	2247
MIM134921		12p13	FIBROBLAST GROWTH FACTOR 6; FGF6	2251
MIM134934		4p16.3	FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3	2261
MIM134935		5q35.1-qter	FIBROBLAST GROWTH FACTOR RECEPTOR 4; FGFR4	2264
MIM135100	C0016037	2q23-q24	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	90
MIM135150	C0346010	17p11.2	BIRT-HOGG-DUBE SYNDROME; BHD	201163
MIM135290	C1851124	5q21-q22	DESMOID DISEASE, HEREDITARY	324
MIM135300	CN030594	2p22-p21	FIBROMATOSIS, GINGIVAL, 1; GINGF1	6654
MIM135400	C1851120	17q24.2-q24.3	HYPERTRICHOSIS TERMINALIS, GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	100302716
MIM135500	CN032818	3p14.3	ZIMMERMANN-LABAND SYNDROME; ZLS	353173
MIM135550	C1851112	 	FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS	 
MIM135580	C1851111	 	FIBROMUSCULAR DYSPLASIA OF ARTERIES	 
MIM135600		2q34	FIBRONECTIN 1; FN1	2335
MIM135610		11q12.1-q13.5	FIBRONECTIN-LIKE 2; FNL2	8060
MIM135620		12q11-q13	INTEGRIN, ALPHA-5; ITGA5	3678
MIM135630		10p11.2	INTEGRIN, BETA-1; ITGB1	3688
MIM135700	C1851102	12q12	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	55605
MIM135750	C1851100	14q13, 14q13	LAURIN-SANDROW SYNDROME	145282
MIM135800	C1851099	 	FIBULA, RECURRENT DISLOCATION OF HEAD OF	 
MIM135820		22q13.3	FIBULIN 1; FBLN1	2192
MIM135821		3p25-p24	FIBULIN 2; FBLN2	2199
MIM135900	CN029606	 	COFFIN-SIRIS SYNDROME; CSS	57492
MIM135940		1q21	FILAGGRIN; FLG	2312
MIM135950	C1851081	 	FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION AND PROPORTIONATE SHORT STATURE	 
MIM136000	C1851080	 	ADERMATOGLYPHIA; ADERM	56916
MIM136100	C1851079	 	FINGERS, RELATIVE LENGTH OF	 
MIM136120	C0342895	16q22.1	FISH-EYE DISEASE; FED	3931
MIM136130		1q23-q25	FLAVIN-CONTAINING MONOOXYGENASE 1; FMO1	2326
MIM136131		1q23-q25	FLAVIN-CONTAINING MONOOXYGENASE 4; FMO4	2329
MIM136132		1q23-q25	FLAVIN-CONTAINING MONOOXYGENASE 3; FMO3	2328
MIM136140	C0729582	 	FLOATING-HARBOR SYNDROME; FLHS	10847
MIM136150	C1851056	 	FLOOD FACTOR DEFICIENCY	 
MIM136200	C1851055	 	FLUSHING OF EARS AND SOMNOLENCE	 
MIM136300	C0343108	 	FLYNN-AIRD SYNDROME	 
MIM136350		8p11.2-p11.1	FIBROBLAST GROWTH FACTOR RECEPTOR 1; FGFR1	2260
MIM136351		13q12	FMS-RELATED TYROSINE KINASE 3; FLT3	2322
MIM136352		5q35.3	FMS-LIKE TYROSINE KINASE 4; FLT4	2324
MIM136400	C1851009	 	FOCAL EPITHELIAL HYPERPLASIA OF THE ORAL MUCOSA	 
MIM136425		11q13.3-q13.5	FOLATE RECEPTOR 2, FETAL; FOLR2	2350
MIM136430		11q13.3-q13.5	FOLATE RECEPTOR 1, ADULT; FOLR1	2348
MIM136435		2p21-p16	FOLLICLE-STIMULATING HORMONE RECEPTOR; FSHR	2492
MIM136440		18q21.3	FOLLICULAR LYMPHOMA VARIANT TRANSLOCATION 1; FVT1	2531
MIM136470		5q11.2	FOLLISTATIN; FST	10468
MIM136480	C1850996	 	FOURTH CRANIAL NERVE PALSY, FAMILIAL CONGENITAL	 
MIM136500	C2936827	 	BRAUER SYNDROME	 
MIM136510		9cen-q34	FOLYLPOLYGLUTAMATE SYNTHETASE; FPGS	2356
MIM136515		11q13	FOS-LIKE ANTIGEN 1; FOSL1	8061
MIM136520	C1850992	11p13	FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROME	5080
MIM136530		11p13	FOLLICLE-STIMULATING HORMONE, BETA POLYPEPTIDE; FSHB	2488
MIM136533		13q14.1	FORKHEAD BOX O1A; FOXO1A	2308
MIM136535		15q13-q14	FORMIN 1; FMN1	342184
MIM136537		19q13.4	FORMYL PEPTIDE RECEPTOR 1; FPR1	2357
MIM136538		19q13.3-q13.4	FORMYL PEPTIDE RECEPTOR 2; FPR2	2358
MIM136539		19q13.3-q13.4	FORMYL PEPTIDE RECEPTOR 3; FPR3	2359
MIM136540	C1850987	 	FRAGILE SITE 10q23	 
MIM136550	C0730294	6q14-q16.2	MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE; MCDR1	4167
MIM136570	C3149276	 	CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KB	2460
MIM136580		 	FRAGILE SITE 16q22; FRA16A	2461
MIM136590		 	FRAGILE SITE 20p11	2471
MIM136600	C1850982	 	FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURAL DEAFNESS	 
MIM136610		 	FRAGILE SITE 2q11	2373
MIM136620	C1850980	 	FRAGILE SITE 10q25; FRA10B	2431
MIM136630	C1969893	12q13.12	MENTAL RETARDATION, FRA12A TYPE	2448, 57609
MIM136640	C1850978	 	FRAGILE SITE 9q32	2426
MIM136660	C1850977	 	FRAGILE SITE 17p12	2465
MIM136680	C0950122	11p13	FRASIER SYNDROME	7490
MIM136760	C1876203	1p21-p13	FRONTONASAL DYSPLASIA 1; FND1	257
MIM136800	C1850959	1p34.3-p32.3	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1; FECD1	1296
MIM136820		6q25-qter	FUCOSIDASE, ALPHA-L, 2; FUCA2	2519
MIM136835		19p13.3	FUCOSYLTRANSFERASE 5; FUT5	2527
MIM136836		19p13.3	FUCOSYLTRANSFERASE 6; FUT6	2528
MIM136850		1q42.1	FUMARATE HYDRATASE; FH	2271
MIM136880	C0311338	15q26, 12q13-q14, 6p21.1-cen, 3q21-q24	FUNDUS ALBIPUNCTATUS	5959, 5961, 6010, 6017
MIM136900	C1850938	22q12.1-q13.2	FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY; SFD	7078
MIM136950		15q25-q26	FURIN; FUR	5045
MIM137000	C1850937	 	FUTCHER LINE	 
MIM137010		Chr.6	F9 EMBRYONIC ANTIGEN; FEA	7959
MIM137020		8q24.3	TISSUE-SPECIFIC TRANSPLANTATION ANTIGEN 3; TSTA3	7264
MIM137025		6q21	FYN ONCOGENE RELATED TO SRC, FGR, YES; FYN	2534
MIM137026		4p16.3	G PROTEIN-COUPLED RECEPTOR KINASE 4; GRK4	2868
MIM137028		Chr.15	GALACTOKINASE 2; GALK2	2585
MIM137030		2p22-p11	GALACTOSE ENZYME ACTIVATOR; GLAT	2718
MIM137035		11q13.3-q13.5	GALANIN; GAL	51083
MIM137040	C0266251	 	GALLBLADDER, AGENESIS OF	 
MIM137050	C1850934	 	GAMMA-A-GLOBULIN, DEFECT IN ASSEMBLY OF	 
MIM137060		9p13	UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 1; B4GALT1	2683
MIM137070		16p11.2	FUSED IN SARCOMA; FUS	2521
MIM137100	C0162538	6p21.3	IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1	10986
MIM137130	C1850930	 	GASTRIC SNEEZING	 
MIM137140		4p13-p12	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-2; GABRA2	2555
MIM137141		4p14-q12	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-4; GABRA4	2557
MIM137142		15q11.2-q12	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-5; GABRA5	2558
MIM137143		5q31.1-q35	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-6; GABRA6	2559
MIM137150		16p13.3	4-@AMINOBUTYRATE AMINOTRANSFERASE; ABAT	18
MIM137160		5q34-q35	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-1; GABRA1	2554
MIM137161		6q14-q21	GAMMA-AMINOBUTYRIC ACID RECEPTOR, RHO-1; GABRR1	2569
MIM137162		6q14-q21	GAMMA-AMINOBUTYRIC ACID RECEPTOR, RHO-2; GABRR2	2570
MIM137163		1p36.3	GAMMA-AMINOBUTYRIC ACID RECEPTOR, DELTA; GABRD	2563
MIM137164		5q31.1-q33.1	GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-2; GABRG2	2566
MIM137165		3p25-p24	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 1; SLC6A1	6529
MIM137166		4p14-q21.1	GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-1; GABRG1	2565
MIM137167		2p12	GAMMA-GLUTAMYL CARBOXYLASE; GGCX	2677
MIM137168		22q11.2	GAMMA-GLUTAMYLTRANSFERASE 5; GGT5	2687
MIM137170		7p15-p14	GAMMA-GLUTAMYL CYCLOTRANSFERASE; GGCT	79017
MIM137181		22q11.1	GAMMA-GLUTAMYLTRANSFERASE 2; GGT2	728441
MIM137190		4p13-p12	GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-1; GABRB1	2560
MIM137192		15q11.2-q12	GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-3; GABRB3	2562
MIM137200	CN074193	 	NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE; NMAN	 
MIM137207		11q13.5-q14	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 32; LRRC32	2615
MIM137210	C1850902	 	GASTRIC VOLVULUS, INTRATHORACIC	 
MIM137215	C1708349	17q21.1, 16q22.1, 12p12.1, 10q26, 10p15, 5q31.1, 1p34.3-p32.1, 3q26.3, 2q33-q34, 2q14.2, 2q14	GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC	1316, 2064, 2263, 3553, 3557, 3659, 3845, 4595, 5290, 843, 999
MIM137216		19q13.1	ATPase, H+,K+ EXCHANGING, ALPHA SUBUNIT; ATP4A	495
MIM137217		13q34	ATPase, H+,K+ EXCHANGING, BETA POLYPEPTIDE; ATP4B	496
MIM137240		17q21.3-q22	GASTRIC INHIBITORY POLYPEPTIDE; GIP	2695
MIM137241		19q13.3	GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; GIPR	2696
MIM137245	C1850900	 	GASTRIC LYMPHOMA, PRIMARY	8915
MIM137250		17q21	GASTRIN; GAS	2520
MIM137260		18q21	GASTRIN-RELEASING POLYPEPTIDE; GRP	2922
MIM137270	C1850899	 	GASTROCUTANEOUS SYNDROME	 
MIM137280	C0017155	 	GASTRITIS, FAMILIAL GIANT HYPERTROPHIC	 
MIM137290		1p32	TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2; TACSTD2	4070
MIM137295		3q21	GATA-BINDING PROTEIN 2; GATA2	2624
MIM137350		9q34	GELSOLIN; GSN	2934
MIM137360	C1300229	 	GENOCHONDROMATOSIS	 
MIM137370	C1842052	 	GENU VALGUM, ST. HELENA FAMILIAL	 
MIM137400	C1842051	 	GEOGRAPHIC TONGUE AND FISSURED TONGUE	 
MIM137440	C0017495	20pter-p12	GERSTMANN-STRAUSSLER DISEASE; GSD	5621
MIM137500	C1842039	 	GIANT NEUTROPHIL LEUKOCYTES	 
MIM137550	C1842036	 	GIANT PIGMENTED HAIRY NEVUS; GPHN	 
MIM137560	C1842035	 	GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA	 
MIM137570		2q11-q14	SOLUTE CARRIER FAMILY 20 (PHOSPHATE TRANSPORTER), MEMBER 1; SLC20A1	6574
MIM137575	C0555197	 	GIGANTIFORM CEMENTOMA, FAMILIAL	 
MIM137580	C0040517	13q31, 11q23	GILLES DE LA TOURETTE SYNDROME; GTS	114798, 2973
MIM137600	C1842031	4q25-q26	IRIDOGONIODYSGENESIS, TYPE 2; IRID2	5308
MIM137700	C1842030	 	GLAUCOMA WITH ELEVATED EPISCLERAL VENOUS PRESSURE	 
MIM137750	C1842028	1q24.3-q25.2, 2p22-p21	GLAUCOMA 1, OPEN ANGLE, A; GLC1A	1545, 4653
MIM137760	C0339573	10p15-p14, 2cen-q13, 2p22-p21	GLAUCOMA, PRIMARY OPEN ANGLE; POAG	10133, 1545
MIM137763	C1842025	 	GLAUCOMA AND SLEEP APNEA	 
MIM137780		17q21	GLIAL FIBRILLARY ACIDIC PROTEIN; GFAP	2670
MIM137800	C2750850	17q21.1, 3p25	GLIOMA SUSCEPTIBILITY 1; GLM1	2064, 5468
MIM137920	C0431693	17q12	RENAL CYSTS AND DIABETES SYNDROME	6928
MIM137950	C0403557	 	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	100689213
MIM137960		2p23-p21	MPV17, MOUSE, HOMOLOG OF; MPV17	4358
MIM138000	C1841984	1p22-p21	GLOMUVENOUS MALFORMATIONS; GVM	11146
MIM138030		2q36-q37	GLUCAGON; GCG	2641
MIM138032		6p21	GLUCAGON-LIKE PEPTIDE 1 RECEPTOR; GLP1R	2740
MIM138033		17q25	GLUCAGON RECEPTOR; GCGR	2642
MIM138040		5q31	GLUCOCORTICOID RECEPTOR; GCCR	2908
MIM138060		Chr.16	GLUCOCORTICOID RECEPTOR-LIKE 1; GRLL1	2910
MIM138070	C0268536	 	GLUCOGLYCINURIA	 
MIM138079		7p15-p13	GLUCOKINASE; GCK	2645
MIM138090		1p36	HEXOSE-6-PHOSPHATE DEHYDROGENASE; H6PD	9563
MIM138110		Chr.17	GLUCOSE-6-PHOSPHATE DEHYDROGENASE-LIKE; G6PDL	2540
MIM138120		9q34	HEAT-SHOCK 70-KD PROTEIN 5; HSPA5	3309
MIM138130		10q23.3	GLUTAMATE DEHYDROGENASE 1; GLUD1	2746
MIM138140		1p35-p31.3	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 1; SLC2A1	6513
MIM138150		16q21	GLUTAMATE OXALOACETATE TRANSAMINASE, MITOCHONDRIAL; GOT2	2806
MIM138160		3q26.1-q26.3	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 2; SLC2A2	6514
MIM138170		12p13.3	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 3; SLC2A3	6515
MIM138180		10q24.1-q25.1	GLUTAMATE OXALOACETATE TRANSAMINASE, SOLUBLE; GOT1	2805
MIM138190		17p13	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 4; SLC2A4	6517
MIM138200		8q24.3	GLUTAMATE PYRUVATE TRANSAMINASE; GPT	2875
MIM138210		16q12.1	GLUTAMATE PYRUVATE TRANSAMINASE 2; GPT2	84706
MIM138230		1p36.2	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE/FRUCTOSE TRANSPORTER), MEMBER 5; SLC2A5	6518
MIM138243		1p34-p33	GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 3; GRIK3	2899
MIM138244		6q21	GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 2; GRIK2	2898
MIM138245		21q22	GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 1; GRIK1	2897
MIM138246		11q22-q23	GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 4; GRIA4	2893
MIM138247		4q32-q33	GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 2; GRIA2	2891
MIM138248		5q33	GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 1; GRIA1	2890
MIM138249		9q34.3	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 1; GRIN1	2902
MIM138250		10q24.3	ALDEHYDE DEHYDROGENASE 18 FAMILY, MEMBER A1; ALDH18A1	5832
MIM138251		8q24.3	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, ASSOCIATED PROTEIN; GRINA	2907
MIM138252		12p12	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2B; GRIN2B	2904
MIM138253		16p13	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2A; GRIN2A	2903
MIM138254		17q25	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2C; GRIN2C	2905
MIM138275		10p11.23	GLUTAMATE DECARBOXYLASE 2; GAD2	2572
MIM138280		2q32-q34	GLUTAMINASE, PHOSPHATE-ACTIVATED; GLS	2744
MIM138290		1q31	GLUTAMATE-AMMONIA LIGASE; GLUL	2752
MIM138292		2p13	GLUTAMINE:FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE 1; GFPT1	2673
MIM138295		1q41-q42	GLUTAMYL-PROLYL-tRNA SYNTHETASE; EPRS	2058
MIM138297		4q25	GLUTAMYL AMINOPEPTIDASE; ENPEP	2028
MIM138300		8p21.1	GLUTATHIONE REDUCTASE; GSR	2936
MIM138319		14q24.1	GLUTATHIONE PEROXIDASE 2; GPX2	2877
MIM138320		3p21.3	GLUTATHIONE PEROXIDASE; GPX1	2876
MIM138321		5q32-q33.1	GLUTATHIONE PEROXIDASE 3; GPX3	2878
MIM138322		19p13.3	GLUTATHIONE PEROXIDASE 4; GPX4	2879
MIM138330		Chr.12	GLUTATHIONE S-TRANSFERASE, MICROSOMAL, 1; MGST1	4257
MIM138333		1p13.3	GLUTATHIONE S-TRANSFERASE, MU-4; GSTM4	2948
MIM138350		1p13.3	GLUTATHIONE S-TRANSFERASE, MU-1; GSTM1	2944
MIM138359		6p12.2	GLUTATHIONE S-TRANSFERASE, ALPHA-1; GSTA1	2938
MIM138360		6p12.2	GLUTATHIONE S-TRANSFERASE, ALPHA-2; GSTA2	2939
MIM138380		1p13.3	GLUTATHIONE S-TRANSFERASE, MU-2; GSTM2	2946
MIM138385		1p13.3	GLUTATHIONE S-TRANSFERASE, MU-5; GSTM5	2949
MIM138390		1p13.3	GLUTATHIONE S-TRANSFERASE, MU-3; GSTM3	2947
MIM138400		12p13.31-p13.1	GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GAPDH	2597
MIM138420		12q12-q13	GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1; GPD1	2819
MIM138430		2q24.1	GLYCEROL-3-PHOSPHATE DEHYDROGENASE 2; GPD2	2820
MIM138440		21q22.1	PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE/PHOSPHORIBOSYLGLYCINAMIDE SYNTHETASE/PHOSPHORIBOSYLAMINOIMIDAZOLE SYNTHETASE; GART	2618
MIM138450		12q13	SERINE HYDROXYMETHYLTRANSFERASE, MITOCHONDRIAL; SHMT2	6472
MIM138470		6p21.3	COMPLEMENT FACTOR B; CFB	629
MIM138480		8q21.1-qter	GLYCINE AUXOTROPH B, HUMAN COMPLEMENT FOR HAMSTER; GLY B+; GLYB	2757
MIM138491		5q32	GLYCINE RECEPTOR, ALPHA-1 SUBUNIT; GLRA1	2741
MIM138492		4q31.3	GLYCINE RECEPTOR, BETA SUBUNIT; GLRB	2743
MIM138500	C0543541	5q33.1, 5p15.33, 3p21.3	HYPERGLYCINURIA	153201, 340024, 54716
MIM138550		20p11.2-p11.1	GLYCOGEN PHOSPHORYLASE, BRAIN TYPE; PYGB	5834
MIM138570		19q13.3	GLYCOGEN SYNTHASE 1; GYS1	2997
MIM138571		12p12.2	GLYCOGEN SYNTHASE 2; GYS2	2998
MIM138590		4q28-q31	GLYCOPHORIN E; GYPE	2996
MIM138600		9q34.1-q34.3	OROSOMUCOID 1; ORM1	5004
MIM138610		9q34.1-q34.3	OROSOMUCOID 2; ORM2	5005
MIM138670		19cen-q13.2	ALPHA-1-B-GLYCOPROTEIN; A1BG	1
MIM138680		3q27	ALPHA-2-HS-GLYCOPROTEIN; AHSG	197
MIM138700		17q23-qter	APOLIPOPROTEIN H; APOH	350
MIM138720		22q11.2	GLYCOPROTEIN Ib, PLATELET, BETA POLYPEPTIDE; GP1BB	2812
MIM138750		6p21.3-p21.2	GLYOXALASE I; GLO1	2739
MIM138760		16p13	HYDROXYACYL GLUTATHIONE HYDROLASE; HAGH	3029
MIM138770	C1841854	 	GMS SYNDROME	 
MIM138800	C0018022	14q	GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS; MNG1	23405, 4333
MIM138850		4q21.2	GONADOTROPIN-RELEASING HORMONE RECEPTOR; GNRHR	2798
MIM138890		14q32.1	GOOSECOID; GSC	145258
MIM138900	C1841837	4q25	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1	9429
MIM138920	C1841836	 	GRANDDAD SYNDROME	 
MIM138930	C1841835	 	GRANT SYNDROME	 
MIM138945		17q21.32	GRANULIN PRECURSOR; GRN	2896
MIM138960		5q31.1	COLONY-STIMULATING FACTOR 2; CSF2	1437
MIM138965		4q12-q13	CHEMOKINE, CXC MOTIF, LIGAND 6; CXCL6	6372
MIM138970		17q11.2-q12	COLONY-STIMULATING FACTOR 3; CSF3	1440
MIM138971		1p35-p34.3	COLONY-STIMULATING FACTOR 3 RECEPTOR, GRANULOCYTE; CSF3R	1441
MIM138972		 	CCAAT/ENHANCER-BINDING PROTEIN, GAMMA; CEBPG	1054
MIM138981		22q12.2-q13.1	GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR, BETA; CSF2RB	1439
MIM139000	C0263471	 	GRANULOSIS RUBRA NASI	 
MIM139080		10q21.3-q22.1	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, GRAVES DISEASE AUTOANTIGEN), MEMBER 16; SLC25A16	8034
MIM139090	C0272302	 	GRAY PLATELET SYNDROME; GPS	23218
MIM139100	C1841809	 	GRAYING OF HAIR, PRECOCIOUS	 
MIM139110		4q12-q13	CHEMOKINE, CXC MOTIF, LIGAND 2; CXCL2	2920
MIM139111		4q12-q13	CHEMOKINE, CXC MOTIF, LIGAND 3; CXCL3	2921
MIM139130		12p13	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-3; GNB3	2784
MIM139139		12q13	NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; NR4A1	3164
MIM139150		5q13.3	RAS p21 PROTEIN ACTIVATOR 1; RASA1	5921
MIM139160		22q11.2	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA Z POLYPEPTIDE; GNAZ	2781
MIM139180		Chr.12	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING, POLYPEPTIDE-h; GNAIH	2772
MIM139185		9q21.3-q22.1	GROWTH ARREST-SPECIFIC 1; GAS1	2619
MIM139190		20q11.2	GROWTH HORMONE-RELEASING HORMONE; GHRH	2691
MIM139191		7p15-p14	GROWTH HORMONE-RELEASING HORMONE RECEPTOR; GHRHR	2692
MIM139200		4q12	GROUP-SPECIFIC COMPONENT; GC	2638
MIM139210	C0796081	 	MYHRE SYNDROME; MYHRS	4089
MIM139240		17q22-q24	GROWTH HORMONE 2; GH2	2689
MIM139250		17q22-q24	GROWTH HORMONE 1; GH1	2688
MIM139255		16q13	METALLOTHIONEIN 3; MT3	4504
MIM139259		16p13.1	G1- TO S-PHASE TRANSITION 1; GSPT1	2935
MIM139260		 	GUANINE DEAMINASE; GDA	9615
MIM139265		6p23	GUANOSINE MONOPHOSPHATE REDUCTASE; GMPR	2766
MIM139270		1q32.1-q42	GUANYLATE KINASE 1; GUK1	2987
MIM139280		1q32.1-q42	GUANYLATE KINASE 2; GUK2	2988
MIM139300	C1841762	15q21.1	AROMATASE EXCESS SYNDROME; AEXS	1588
MIM139310		7q21	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 1; GNAI1	2770
MIM139311		16q13	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-ACTIVATING ACTIVITY POLYPEPTIDE O; GNAO1	2775
MIM139312		18p	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-ACTIVATING ACTIVITY POLYPEPTIDE, OLFACTORY TYPE; GNAL	2774
MIM139313		19p13	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-11; GNA11	2767
MIM139314		19p13	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-15; GNA15	2769
MIM139320		20q13.2	GNAS COMPLEX LOCUS; GNAS	2778
MIM139330		3p21	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE 1; GNAT1	2779
MIM139340		1p13	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE 2; GNAT2	2780
MIM139350		12q13	KERATIN 1; KRT1	3848
MIM139360		3p21	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 2; GNAI2	2771
MIM139370		1p13	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 3; GNAI3	2773
MIM139380		1pter-p31.2	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-1; GNB1	2782
MIM139390		7q21	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-2; GNB2	2783
MIM139391		17q21	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-TRANSDUCING ACTIVITY POLYPEPTIDE 2; GNGT2	2793
MIM139392		1p35-p34	GUANYLATE CYCLASE ACTIVATOR 2A; GUCA2A	2980
MIM139393	C1841700	 	GUILLAIN-BARRE SYNDROME, FAMILIAL; GBS	5376
MIM139395		 	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE 3; GNAT3	346562
MIM139396		4q32	GUANYLATE CYCLASE 1, SOLUBLE, ALPHA-3; GUCY1A3	2982
MIM139397		4q32	GUANYLATE CYCLASE 1, SOLUBLE, BETA-3; GUCY1B3	2983
MIM139400	C1841697	 	HAIR WHORL	 
MIM139450	C2697452	1q21.3	HAIR MORPHOLOGY 2; HRM2	100379199
MIM139500	C0263482	 	HAIRY EARS	 
MIM139600	C1841696	 	HAIRY ELBOWS	 
MIM139605		3q28-q29	HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 1; HES1	3280
MIM139630	C1841695	 	HAIRY NOSE TIP	 
MIM139650	C1841694	 	HAIRY PALMS AND SOLES	 
MIM139750	C1841693	 	HAND AND FOOT DEFORMITY WITH FLAT FACIES	 
MIM139800	C1841692	 	HAND CLASPING PATTERN	 
MIM139900	C1841691	2p12-q22	HAND SKILL, RELATIVE; HSR	338386
MIM140000	C1841679	7p15-p14.2	HAND-FOOT-UTERUS SYNDROME	3209
MIM140050		5q11-q12	GRANZYME A; GZMA	3001
MIM140100		16q22.1	HAPTOGLOBIN; HP	3240
MIM140210		16q22.1	HAPTOGLOBIN-RELATED PROTEIN GENE; HPR	3250
MIM140300	C0677607	8q23-q24, 2q33	HASHIMOTO THYROIDITIS	140805, 1493, 3106
MIM140350	C2931042	12q24-qter	HAWKINSINURIA	3242
MIM140400	C1841658	 	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE II; PFHB2	 
MIM140450	C1841657	 	HEART-HAND SYNDROME, SPANISH TYPE	 
MIM140500	C0018798	 	HEART, MALFORMATION OF	 
MIM140550		6p21.3	HEAT-SHOCK 70-KD PROTEIN 1A; HSPA1A	3303
MIM140555		1q	HEAT-SHOCK 70-KD PROTEIN 6; HSPA6	3310
MIM140556		1q	HEAT-SHOCK 70-KD PROTEIN 7; HSPA7	3311
MIM140559		6p21.3	HEAT-SHOCK 70-KD PROTEIN-LIKE 1; HSPA1L	3305
MIM140560		14q24.1	HEAT-SHOCK 70-KD PROTEIN 2; HSPA2	3306
MIM140571		14q32.2	HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS A, MEMBER 1; HSP90AA1	3320
MIM140572		6p21.1	HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS B, MEMBER 1; HSP90AB1	3326
MIM140575		11p14.1	HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS A, MEMBER 2; HSP90AA2	3324
MIM140580		8q24.3	HEAT-SHOCK TRANSCRIPTION FACTOR 1; HSF1	3297
MIM140581		6q22.3	HEAT-SHOCK TRANSCRIPTION FACTOR 2; HSF2	3298
MIM140600	C0409957	2q12-q13, 2p24-p23	OSTEOARTHRITIS SUSCEPTIBILITY 2; OS2	4148
MIM140700	C0700299	16pter-p13.3, 16pter-p13.3, 11p15.5	HEINZ BODY ANEMIAS	3039, 3040, 3043
MIM140750		11p15	SUPPRESSOR OF TUMORIGENICITY 5; ST5	6764
MIM140850	C0472694	 	HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE	 
MIM140900	C1841654	 	HEMANGIOMAS OF SMALL INTESTINE	 
MIM141000	C0221025	 	HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	 
MIM141180		12q13.1	HEMATOPOIETIC PROTEIN HEM-1; HEM1	3071
MIM141200	C0241908	2q36-q37	HEMATURIA, BENIGN FAMILIAL; BFH	1285, 1286
MIM141250		22q12	HEME OXYGENASE 1; HMOX1	3162
MIM141251		16p13.3	HEME OXYGENASE 2; HMOX2	3163
MIM141300	C0015458	 	HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	 
MIM141350	C1841640	 	HEMIFACIAL HYPERPLASIA WITH STRABISMUS	 
MIM141400	C0220681	 	HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	7971
MIM141405	C1841639	 	HEMIFACIAL SPASM, FAMILIAL	 
MIM141500	C1832894	19p13	MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1	773
MIM141700	C1841622	 	HEMOLYTIC POIKILOCYTIC ANEMIA DUE TO REDUCED ANKYRIN BINDING SITES	 
MIM141749	C1841621	11p15.5, 11p15.5	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HBFQTL1	3043, 3047, 3048
MIM141750	C0795917	16pter-p13.3	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	8129
MIM141800		16pter-p13.3	HEMOGLOBIN--ALPHA LOCUS 1; HBA1	3039
MIM141850		16pter-p13.3	HEMOGLOBIN--ALPHA LOCUS 2; HBA2	3040
MIM141900		11p15.5	HEMOGLOBIN--BETA LOCUS; HBB	3043
MIM142000		11p15.5	HEMOGLOBIN--DELTA LOCUS; HBD	3045
MIM142100		11p15.5	HEMOGLOBIN--EPSILON LOCUS; HBE1	3046
MIM142200		11p15.5	HEMOGLOBIN, GAMMA A; HBG1	3047
MIM142210		6p21.3	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER D; HIST1H1D	3007
MIM142220		6p21.3	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER E; HIST1H1E	3008
MIM142230		1q32	HEMATOPOIETIC PROGENITOR CELL ANTIGEN CD34; CD34	947
MIM142240		16pter-p13.3	HEMOGLOBIN--THETA-1 LOCUS; HBQ1	3049
MIM142250		11p15.5	HEMOGLOBIN, GAMMA G; HBG2	3048
MIM142290		11p15.5-p15.4	HEMOPEXIN; HPX	3263
MIM142310		16pter-p13.3	HEMOGLOBIN--ZETA LOCUS; HBZ	3050
MIM142330	C1840646	12q24.2	HEPATIC ADENOMAS, FAMILIAL	6927
MIM142335	C1969758	7q36	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 5; HBFQTL5	3247
MIM142340	C1840644	15q26.1	DIAPHRAGMATIC HERNIA, CONGENITAL	1732
MIM142350	C0860251	 	HERNIA, DOUBLE INGUINAL	 
MIM142360		22q11	HEPARIN COFACTOR II; HCF2	3053
MIM142370		20q11-q12	HEMOPOIETIC CELL KINASE; HCK	3055
MIM142385		17q22	HEPATIC LEUKEMIA FACTOR; HLF	3131
MIM142395	C1840634	 	HEPATITIS B VACCINE, RESPONSE TO	 
MIM142400	C3489393	 	HERNIA, HIATUS	 
MIM142408		3p21	MACROPHAGE STIMULATING 1; MST1	4485
MIM142409		7q21.1	HEPATOCYTE GROWTH FACTOR; HGF	3082
MIM142410		12q24.2	HNF1 HOMEOBOX A; HNF1A	6927
MIM142440		19q11-q13.2	HEPSIN; HPN	3249
MIM142445		8p22-p11	NEUREGULIN 1; NRG1	3084
MIM142460		8q22-q24	SYNDECAN 2; SDC2	6383
MIM142461		1p36.1	HEPARAN SULFATE PROTEOGLYCAN OF BASEMENT MEMBRANE; HSPG2	3339
MIM142470	C1840598	6q22.3-q23.1	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2; HBFQTL2	7954
MIM142500	C0423318	 	HETEROCHROMIA IRIDIS	 
MIM142560		6p21.3	DEAD BOX POLYPEPTIDE 39B; DDX39B	7919
MIM142570		5q35.2	HEXOKINASE 3; HK3	3101
MIM142580		6p21.3	PROLINE-RICH COILED-COIL PROTEIN 2A; PRRC2A	7916
MIM142590		6p21.3	BCL2-ASSOCIATED ATHANOGENE 6; BAG6	7917
MIM142600		10q22	HEXOKINASE 1; HK1	3098
MIM142610		6p21.3	G-PATCH DOMAIN- AND ANKYRIN REPEATS-CONTAINING PROTEIN 1; GPANK1	7918
MIM142620		6p21.3	ABHYDROLASE DOMAIN-CONTAINING 16A; ABHD16A	7920
MIM142622		1p35-p34.2	HIPPOCALCIN; HPCA	3208
MIM142623	C2931876	10q11.2, 4p12, Xq28	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	5979
MIM142625	C0795976	 	HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	 
MIM142630	C1840586	 	HISTIOCYTOSIS, PROGRESSIVE MUCINOUS	 
MIM142640		3q27	HISTIDINE-RICH GLYCOPROTEIN; HRG	3273
MIM142669	C1840572	4q35	HIP DYSPLASIA, BEUKES TYPE	50947
MIM142680	C1275126	12p13.2	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	7132
MIM142690	CN028850	1q22-q23	ACNE INVERSA, FAMILIAL, 1; ACNINV1	23385
MIM142695		2q37	HIGH DENSITY LIPOPROTEIN-BINDING PROTEIN; HDLBP	3069
MIM142700	C1306065	13q22	ACETABULAR DYSPLASIA	780896
MIM142701		4q13	HISTATIN 1; HTN1	3346
MIM142702		4q13	HISTATIN 3; HTN3	3347
MIM142703		 	HISTAMINE RECEPTOR H2; HRH2	3274
MIM142704		15q21-q22	HISTIDINE DECARBOXYLASE; HDC	3067
MIM142705		19q13.3	HISTIDINE-RICH CALCIUM-BINDING PROTEIN; HRC	3270
MIM142708		22q13.1	H1 HISTONE FAMILY, MEMBER 0; H1F0	3005
MIM142709		6p21.3	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER A; HIST1H1A	3024
MIM142710		6p21.3	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER C; HIST1H1C	3006
MIM142711		6p22-p21.3	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER B; HIST1H1B	3009
MIM142712		6p21.3	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER T; HIST1H1T	3010
MIM142720		1q21	HISTONE GENE CLUSTER 2, H2A HISTONE FAMILY, MEMBER A3; HIST2H2AA3	8337
MIM142730	C1840551	 	HISTIOCYTIC DERMATOARTHRITIS	 
MIM142750		1q21	HISTONE GENE CLUSTER 2, H4 HISTONE FAMILY, MEMBER A; HIST2H4A	8370
MIM142763		4q24	H2A HISTONE FAMILY, MEMBER Z; H2AFZ	3015
MIM142765		19p13.3-p13.2	REGULATORY FACTOR X, 2; RFX2	5990
MIM142780		1q21	HISTONE GENE CLUSTER 2, H3 HISTONE FAMILY, MEMBER C; HIST2H3C	126961
MIM142790		5q32	CD74 ANTIGEN; CD74	972
MIM142800		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, A; HLA-A	3105
MIM142810		5q31.3	HISTIDYL-tRNA SYNTHETASE; HARS	3035
MIM142830		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, B; HLA-B	3106
MIM142840		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, C; HLA-C	3107
MIM142855		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DM ALPHA; HLA-DMA	3108
MIM142856		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DM BETA; HLA-DMB	3109
MIM142857		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-1; HLA-DRB1	3123
MIM142858		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP BETA-1; HLA-DPB1	3115
MIM142860		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR ALPHA; HLA-DRA	3122
MIM142871		6p21.3	HLA-G HISTOCOMPATIBILITY ANTIGEN, CLASS I; HLA-G	3135
MIM142880		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP ALPHA-1; HLA-DPA1	3113
MIM142900	C0265264	12q24.1	HOLT-ORAM SYNDROME; HOS	6910
MIM142910		5q13.3-q14	3-@HYDROXY-3-METHYLGLUTARYL-CoA REDUCTASE; HMGCR	3156
MIM142930		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DN ALPHA; HLA-DNA	3111
MIM142940		5p14-p13	3-@HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 1; HMGCS1	3157
MIM142945	C1840529	7q36	HOLOPROSENCEPHALY 3; HPE3	6469
MIM142946	C1840528	18p11.3	HOLOPROSENCEPHALY 4; HPE4	7050
MIM142950		7p15-p14.2	HOMEOBOX A7; HOXA7	3204
MIM142951		7p15-p14.2	HOMEOBOX A6; HOXA6	3203
MIM142952		7p15-p14.2	HOMEOBOX A5; HOXA5	3202
MIM142953		7p15-p14.2	HOMEOBOX A4; HOXA4	3201
MIM142954		7p15-p14.2	HOMEOBOX A3; HOXA3	3200
MIM142955		7p15.3	HOMEOBOX A1; HOXA1	3198
MIM142956		7p15-p14.2	HOMEOBOX A9; HOXA9	3205
MIM142957		7p15-p14.2	HOMEOBOX A10; HOXA10	3206
MIM142958		7p15-p14.2	HOMEOBOX A11; HOXA11	3207
MIM142959		7p15-p14.2	HOMEOBOX A13; HOXA13	3209
MIM142960		17q21-q22	HOMEOBOX B5; HOXB5	3215
MIM142961		17q21-q22	HOMEOBOX B6; HOXB6	3216
MIM142962		17q21-q22	HOMEOBOX B7; HOXB7	3217
MIM142963		17q21-q22	HOMEOBOX B8; HOXB8	3218
MIM142964		17q21-q22	HOMEOBOX B9; HOXB9	3219
MIM142965		17q21-q22	HOMEOBOX B4; HOXB4	3214
MIM142966		17q21-q22	HOMEOBOX B3; HOXB3	3213
MIM142967		17q21-q22	HOMEOBOX B2; HOXB2	3212
MIM142968		17q21-q22	HOMEOBOX B1; HOXB1	3211
MIM142970		12q13	HOMEOBOX C8; HOXC8	3224
MIM142971		12q13	HOMEOBOX C9; HOXC9	3225
MIM142972		12q13	HOMEOBOX C6; HOXC6	3223
MIM142973		12q13	HOMEOBOX 3D; HOX3D	3222
MIM142974		12q13	HOMEOBOX C4; HOXC4	3221
MIM142975		12q13	HOMEOBOX C12; HOXC12	3228
MIM142976		12q13	HOMEOBOX C13; HOXC13	3229
MIM142980		2q31-q32	HOMEOBOX D3; HOXD3	3232
MIM142981		2q31-q32	HOMEOBOX D4; HOXD4	3233
MIM142982		2q31-q32	HOMEOBOX D9; HOXD9	3235
MIM142983		4p16.1	MUSCLE SEGMENT HOMEOBOX, DROSOPHILA, HOMOLOG OF, 1; MSX1	4487
MIM142984		2q31-q32	HOMEOBOX D10; HOXD10	3236
MIM142985		2q31-q32	HOMEOBOX D8; HOXD8	3234
MIM142986		2q31-q32	HOMEOBOX D11; HOXD11	3237
MIM142987		2q31-q32	HOMEOBOX D1; HOXD1	3231
MIM142988		2q31-q32	HOMEOBOX D12; HOXD12	3238
MIM142989		2q31-q32	HOMEOBOX D13; HOXD13	3239
MIM142991		2q31-q32	EVEN-SKIPPED HOMEOBOX 2; EVX2	344191
MIM142992		4p16.1	H6 FAMILY HOMEOBOX 1; HMX1	3166
MIM142993		14q24.3	CEH10 HOMEODOMAIN-CONTAINING HOMOLOG; CHX10	338917
MIM142994		7q36	MOTOR NEURON AND PANCREAS HOMEOBOX 1; MNX1	3110
MIM142995		1q41-q42.1	H.20-LIKE HOMEOBOX 1; HLX1	3142
MIM142996		7p15-p14	EVEN-SKIPPED HOMEOBOX 1; EVX1	2128
MIM143000	C1840475	 	HORNER SYNDROME, CONGENITAL	 
MIM143010		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, E; HLA-E	3133
MIM143023		11p15.5	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 7; RASSF7	8045
MIM143024		6p21.3	GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 1; GNL1	2794
MIM143025		1q42	HTLV-RELATED ENDOGENOUS SEQUENCE 1; HRES1	3272
MIM143030		12p13	CD9 ANTIGEN; CD9	928
MIM143050	C0431800	 	HUMERORADIAL SYNOSTOSIS	 
MIM143054		6q23-q24	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 2; HIVEP2	3097
MIM143055		12q11-q13.3	CYCLIN T1; CCNT1	904
MIM143089		2p22-p16	HUMAN T-CELL LEUKEMIA VIRUS ENHANCER FACTOR; HTLF	3344
MIM143090		17q21-q23	HUMAN T-CELL LEUKEMIA VIRUS RECEPTOR; HTLVR	3345
MIM143095	C1840471	10q22.1	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	 
MIM143100	C0020179	4p16.3	HUNTINGTON DISEASE; HD	3064
MIM143110		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, F; HLA-F	3134
MIM143170		6p23-q12	MALE-ENHANCED ANTIGEN 1; MEA1	4201
MIM143200	C0339540	5q12-q14	WAGNER SYNDROME 1; WGN1	1462
MIM143400	C1840451	6p	MULTICYSTIC RENAL DYSPLASIA, BILATERAL; MCRD	7945
MIM143450		2p23	HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, BETA SUBUNIT; HADHB	3032
MIM143460		Chr.21	5-@HYDROXYTRYPTAMINE OXYGENASE REGULATOR; HTOR	3349
MIM143465	C1263846	17p11, 16p13, 11p15.5, 6q12, 5p13, 5p15.3, 4p16.1-p15.3	ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD	1815, 1816, 6531
MIM143470	C0342883	16q21	HYPERALPHALIPOPROTEINEMIA 1; HALP1	1071
MIM143500	C0017551	2q37	GILBERT SYNDROME	54658
MIM143850	C1840438	18q	ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE	50948
MIM143860	C1840437	15q22	HYPERCHLORHIDROSIS, ISOLATED	771
MIM143870	C0342639	1q24	HYPERCALCIURIA, ABSORPTIVE, 2; HCA2	55811
MIM143880	C0268080	 	HYPERCALCEMIA, INFANTILE	1591
MIM143890	C0020445	1q21-q23, 9q22-q31, 8p21-p12, 7p15, 5p13-p12, 3p21.2-p14.1, 19p13.2	HYPERCHOLESTEROLEMIA, FAMILIAL	10842, 19, 2053, 255738, 2690, 336, 338, 3700, 3949
MIM144010	C1704417	2p24	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, TYPE B	338
MIM144050	C0272273	 	HYPERHEPARINEMIA	 
MIM144100	C0038994	 	HYPERHIDROSIS, GUSTATORY; HYPRG	 
MIM144110	C1274743	 	HYPERHIDROSIS PALMARIS ET PLANTARIS; HYPRPP	100861529
MIM144120	C1840429	14q32.33	HYPERIMMUNOGLOBULIN G1(A1) SYNDROME	 
MIM144150	C0263420	 	HYPERKERATOSIS LENTICULARIS PERSTANS; HLP	100188397
MIM144190	C1840428	 	HYPERKERATOSIS-HYPERPIGMENTATION SYNDROME	 
MIM144200	C1721006	17q12-q21, 17q12-q21, 12q13	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC; EPPK	3848, 3857, 3868
MIM144250	C0020474	8p22	HYPERLIPIDEMIA, FAMILIAL COMBINED; FCHL	4023
MIM144300	C1840425	 	HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	 
MIM144600	CN074246	 	HYPERLIPOPROTEINEMIA, TYPE IV	 
MIM144650	C0020481	11q23	HYPERLIPOPROTEINEMIA, TYPE V	116519
MIM144700	C3160732	17q12, 17p11.2, 12q24.2, 8q24.1, 3q21, 3p26-p25, 3p26.2	RENAL CELL CARCINOMA, NONPAPILLARY; RCC	11236, 201163, 4968, 6927, 6928, 7428, 84925
MIM144750	C0432273	11q13.4	HYPEROSTOSIS CORTICALIS GENERALISATA, BENIGN FORM OF WORTH, WITH TORUS PALATINUS	4041
MIM144755	C1840404	 	HYPEROSTOSIS CRANIALIS INTERNA	 
MIM144800	C0020494	 	HYPEROSTOSIS FRONTALIS INTERNA	 
MIM145000	C1840402	1q25-q31	HYPERPARATHYROIDISM 1; HRPT1	3278, 4221, 79577
MIM145001	C1704981	1q25-q31	HYPERPARATHYROIDISM 2; HRPT2	79577
MIM145100	C0155211	 	HYPERPIGMENTATION OF EYELIDS	 
MIM145200	C1840393	 	HYPERPIGMENTATION OF FULDAUER AND KUIJPERS	 
MIM145250	C1840392	12q22, 19pter-p13.1	HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 2; FPH2	4254, 780897
MIM145260	C1449844	17q21-q22, 12p13, 1q31-q42	PSEUDOHYPOALDOSTERONISM, TYPE IIA; PHA2A	65125, 65266, 7830
MIM145290	C0151889	7q	HYPERREFLEXIA; HRX	7974
MIM145295	C1840387	 	HYPERSECRETION OF ADRENAL ANDROGENS, FAMILIAL	 
MIM145300	C1840386	 	HYPERSENSITIVITY PNEUMONITIS, FAMILIAL	 
MIM145350	C1840385	 	HYPERTAURINURIC CARDIOMYOPATHY	 
MIM145400	C0020534	 	HYPERTELORISM	 
MIM145410	C1801950	22q11.2	OPITZ GBBB SYNDROME, AUTOSOMAL DOMINANT	8221
MIM145420	C1840378	 	HYPERTELORISM, TEEBI TYPE	 
MIM145500	C0085580	17q21-q22, 17q, 17cen-q11.2, 1q23-q25, 1q23, 1q22-q25, 15q, 12p12.2-p12.1, 12p13, 7q36, 7q22.1, 5p13-q12, 4p16.3, 3q21-q25, 1p36.1, 2p25-p24, 1q42-q43, 20q13.11-q13.13, 20q11-q13	HYPERTENSION, ESSENTIAL	118, 1577, 183, 185, 1889, 2784, 481, 4843, 4846, 5409, 5740, 6401, 8490
MIM145505		16p13.11	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 3; ACSM3	6296
MIM145590	C1840373	 	HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	 
MIM145600	CN031421	19q13.1	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1	6261
MIM145650	C1840364	3p24.3	THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY; PRTH	7068
MIM145680	C2750824	18q11.2-q12.1	DYSTRANSTHYRETINEMIC EUTHYROIDAL HYPERTHYROXINEMIA	7276
MIM145700	C0235864	 	HYPERTRICHOSIS UNIVERSALIS	3341
MIM145701	C1840362	8q22	HYPERTRICHOSIS UNIVERSALIS CONGENITA, AMBRAS TYPE; HTC1	100188785
MIM145750	C0020480	15q11.2-q13.1, 11q23, 8q11-q13, 21q11.2	HYPERTRIGLYCERIDEMIA, FAMILIAL	116519, 149998, 56797, 6101
MIM145800	C1840361	 	HYPERTROPHIA MUSCULORUM VERA	 
MIM145900	C0011195	17p11.2, 1q22, 10q21.1-q22.1, 19q13.1-q13.2	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	1959, 4359, 5376, 57716
MIM145980	C1809471	3q13.3-q21	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I; HHC1	846
MIM145981	C1840347	19p13.3	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2	3086
MIM146000	C0410529	4p16.3	HYPOCHONDROPLASIA; HCH	2261
MIM146110	C0271623	12q13-q21, 9q34.3, 8q12.1, 8p11.2-p11.1, 4q25, 3p21.1, 19p13.3	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7	2253, 2260, 26012, 2796, 2798, 3814, 55636, 60675, 6866, 6870, 84634
MIM146160	C1840335	 	HYPOMELIA WITH MULLERIAN DUCT ANOMALIES	 
MIM146200	C1832648	11p15.3-p15.1, 6p24.2, 3q13.3-q21	HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	5741, 846, 9247
MIM146255	C1840333	10p15	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE; HDR	2625
MIM146300	C0268413	1p36.1-p34	HYPOPHOSPHATASIA, ADULT	249
MIM146350	C1840321	 	HYPOPHOSPHATEMIC BONE DISEASE; HBD	100187828
MIM146390	C0432442	18p	CHROMOSOME 18p DELETION SYNDROME	100240747
MIM146400	C1840317	 	HYPOPLASIA OF TEETH ROOTS	 
MIM146450	C2675154	 	HYPOSPADIAS 3, AUTOSOMAL; HYSP3	100689211
MIM146500	C0037019	 	MULTIPLE SYSTEM ATROPHY; MSA	 
MIM146510	C0265220	7p13	PALLISTER-HALL SYNDROME; PHS	2737
MIM146520	C1840299	6p21.3	HYPOTRICHOSIS 2; HYPT2	1041
MIM146550	C2750815	8p21.2	HYPOTRICHOSIS 4; HYPT4	50823, 55806
MIM146590	C1840296	 	ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE; IHCM	3848
MIM146600	C0432311	 	ICHTHYOSIS HYSTRIX GRAVIOR	 
MIM146630		17q23-q25	INTERCELLULAR ADHESION MOLECULE 2; ICAM2	3384
MIM146631		19p13.3-p13.2	INTERCELLULAR ADHESION MOLECULE 3; ICAM3	3385
MIM146640		10p15	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 2; ITIH2	3698
MIM146650		3p21.2-p21.1	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 3; ITIH3	3699
MIM146660		8q12-q13	INTERLEUKIN 7; IL7	3574
MIM146661		5p13	INTERLEUKIN 7 RECEPTOR; IL7R	3575
MIM146680		10q23-q25	INSULIN-DEGRADING ENZYME; IDE	3416
MIM146690		7q31.3-q32	IMP DEHYDROGENASE 1; IMPDH1	3614
MIM146691		3p21.2	IMP DEHYDROGENASE 2; IMPDH2	3615
MIM146700	C0079584	1q21	ICHTHYOSIS VULGARIS	2312
MIM146710		22q11.2-q13	INTERLEUKIN 2 RECEPTOR, BETA; IL2RB	3560
MIM146720	C1840283	 	ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	 
MIM146730		7p14-p12	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 1; IGFBP1	3484
MIM146731		2q33-q34	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2; IGFBP2	3485
MIM146732		7p14-p12	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3; IGFBP3	3486
MIM146733		17q12-q21	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 4; IGFBP4	3487
MIM146734		2q33-q36	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 5; IGFBP5	3488
MIM146735		Chr.12	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 6; IGFBP6	3489
MIM146738		19p13.2	INSULIN-LIKE 3; INSL3	3640
MIM146740		1q23	Fc FRAGMENT OF IgG, LOW AFFINITY IIIa, RECEPTOR FOR; FCGR3A	2214
MIM146750	C0432304	 	ICHTHYOSIS, LAMELLAR, AUTOSOMAL DOMINANT	 
MIM146760		1q21.2-q21.3	Fc FRAGMENT OF IgG, HIGH AFFINITY Ia, RECEPTOR FOR; FCGR1A	2209
MIM146770		22q11.21	IMMUNOGLOBULIN LAMBDA-LIKE POLYPEPTIDE 1; IGLL1	3543
MIM146780		2p12	IMMUNOGLOBULIN KAPPA DELETING ELEMENT; IGKDEL	3515
MIM146790		1q21-q23	Fc FRAGMENT OF IgG, LOW AFFINITY IIa, RECEPTOR FOR; FCGR2A	2212
MIM146800	C0432306	12q11-q13	ICHTHYOSIS, BULLOUS TYPE	3849
MIM146820	C1840267	6p21.3	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGAT; IGAT	7927
MIM146830	C1840266	 	IMMUNE DEFICIENCY, FAMILIAL VARIABLE	 
MIM146840	C1840265	 	IMMUNODEFICIENCY WITH DEFECTIVE LEUKOCYTE AND LYMPHOCYTE FUNCTION AND WITH RESPONSE TO HISTAMINE-1 ANTAGONIST	 
MIM146850	C1840264	6p21.3	IMMUNE SUPPRESSION; IS	7928
MIM146880		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ ALPHA-1; HLA-DQA1	3117
MIM146900		14q32.33	IgA CONSTANT HEAVY CHAIN 1; IGHA1	3493
MIM146910		14q32.33	IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY GENE CLUSTER; IGHD@	50648
MIM146920		1q21.3	ADENOSINE DEAMINASE, RNA-SPECIFIC; ADAR	103
MIM146928		2q35	CHEMOKINE, CXC MOTIF, RECEPTOR 2; CXCR2	3579
MIM146929		2q35	CHEMOKINE, CXC MOTIF, RECEPTOR 1; CXCR1	3577
MIM146930		4q12-q13	INTERLEUKIN 8; IL8	3576
MIM146931		5q31.1	INTERLEUKIN 9; IL9	3578
MIM146933		11q23.3	INTERLEUKIN 10 RECEPTOR, ALPHA; IL10RA	3587
MIM146970		2p12	IMMUNOGLOBULIN KAPPA LIGHT CHAIN JOINING GENE CLUSTER; IGKJ@	7842
MIM146980		2p12	IMMUNOGLOBULIN KAPPA LIGHT CHAIN VARIABLE GENE CLUSTER; IGKV@	3519
MIM146990		15q11-q12	IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY REGION 2; IGHDY2	3496
MIM147000		14q32.33	IgA CONSTANT HEAVY CHAIN 2; IGHA2	3494
MIM147010		14q32.33	IMMUNOGLOBULIN HEAVY CHAIN JOINING GENE CLUSTER; IGHJ@	3506
MIM147020		14q32.33	IMMUNOGLOBULIN HEAVY CHAIN CONSTANT REGION MU; IGHM	3507
MIM147040		10q23.3	INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 2; IFIT2	3433
MIM147045		19q13.4	Fc FRAGMENT OF IgA, RECEPTOR FOR; FCAR	2204
MIM147050	C1840253	16p11, 1q23-q25, 16p12.1-p11.2, 13q14.1, 11q13, 6p21.2-p12, 5q33.2, 5q32	IgE RESPONSIVENESS, ATOPIC; IGER	11005, 2206, 26762, 3566, 50615, 51131, 6403, 7941
MIM147060	C0022398	17q21	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	6774
MIM147061	C1840252	5q31.1	IMMUNOGLOBULIN E CONCENTRATION, SERUM; IGES	3478
MIM147070		14q32.33	IMMUNOGLOBULIN HEAVY CHAIN VARIABLE GENE CLUSTER; IGHV@	3509
MIM147080		6p21.3	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGLPHE 1; IGLP1	7925
MIM147090		6p21.3	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGLPHE 2; IGLP2	7926
MIM147100		14q32.33	IgG HEAVY CHAIN LOCUS; IGHG1	3500
MIM147110		14q32.33	IMMUNOGLOBULIN Gm2; IGHG2	3501
MIM147120		14q32.33	IMMUNOGLOBULIN Gm3; IGHG3	3502
MIM147130		14q32.33	IMMUNOGLOBULIN Gm4; IGHG4	3503
MIM147138		11q13	MEMBRANE-SPANNING 4 DOMAINS, SUBFAMILY A, MEMBER 2; MS4A2	2206
MIM147139		1q23	Fc FRAGMENT OF IgE, HIGH AFFINITY I, RECEPTOR FOR, GAMMA SUBUNIT; FCER1G	2207
MIM147140		1q23	Fc FRAGMENT OF IgE, HIGH AFFINITY I, RECEPTOR FOR, ALPHA SUBUNIT; FCER1A	2205
MIM147141		19p13.3	TRANSCRIPTION FACTOR 3; TCF3	6929
MIM147150		21q22.3	MYXOVIRUS RESISTANCE 1, MOUSE, HOMOLOG OF; MX1	4599
MIM147170		14q32.33	IMMUNOGLOBULIN: HEAVY DELTA CHAIN; IGHD	3495
MIM147180		14q32.33	IMMUNOGLOBULIN: HEAVY EPSILON CHAIN; IGHE	3497
MIM147183		4p15.2	RECOMBINATION SIGNAL-BINDING PROTEIN FOR IMMUNOGLOBULIN KAPPA J REGION; RBPJ	3516
MIM147185		2q12-q14	IMMUNOGLOBULIN KAPPA VARIABLE 1/OR2-108; IGKV1OR2108	28862
MIM147200		2p12	IMMUNOGLOBULIN KAPPA LIGHT CHAIN CONSTANT REGION; IGKC	3514
MIM147220		22q11.2	IMMUNOGLOBULIN LAMBDA CONSTANT REGION 1; IGLC1	3537
MIM147230		22q11.2	IMMUNOGLOBULIN LAMBDA LIGHT CHAIN JOINING GENE CLUSTER; IGLJ@	8217
MIM147240		22q11.2	IMMUNOGLOBULIN LAMBDA LIGHT CHAIN VARIABLE GENE CLUSTER; IGLV@	3546
MIM147245		17q23	CD79B ANTIGEN; CD79B	974
MIM147250	C1840235	7q36	SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	6469
MIM147251	C3494175	 	INCISORS, FUSED MANDIBULAR	 
MIM147263		2q32	INOSITOL POLYPHOSPHATE-1-PHOSPHATASE; INPP1	3628
MIM147264		1p34	INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 75-KD; INPP5B	3633
MIM147265		3p26-p25	INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 1; ITPR1	3708
MIM147267		6pter-p21	INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 3; ITPR3	3710
MIM147270		3p21.2-p21.1	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 1; ITIH1	3697
MIM147280		6q26	INSULIN-LIKE GROWTH FACTOR II RECEPTOR; IGF2R	3482
MIM147290		7p15-p13	INHIBIN, BETA A; INHBA	3624
MIM147300	C1840227	 	INCISORS, LONG UPPER CENTRAL	 
MIM147310		4q21	CHEMOKINE, CXC MOTIF, LIGAND 10; CXCL10	3627
MIM147330	C1840225	 	INCISORS, LOWER CENTRAL, ABSENCE OF	 
MIM147350	C1840224	 	INCISORS, ROTATION OF UPPER CENTRAL	 
MIM147360		1q21	INVOLUCRIN; IVL	3713
MIM147370		15q25-q26	INSULIN-LIKE GROWTH FACTOR I RECEPTOR; IGF1R	3480
MIM147380		2q33-q36	INHIBIN, ALPHA; INHA	3623
MIM147390		2cen-q13	INHIBIN, BETA B; INHBB	3625
MIM147400	C1409763	 	INCISORS, SHOVEL-SHAPED	 
MIM147421	C0238190	 	INCLUSION BODY MYOSITIS	 
MIM147430	C1840219	 	INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL DOMINANT	 
MIM147435		8p12-p11	INDOLEAMINE 2,3-DIOXYGENASE; IDO1	3620
MIM147440		12q22-q24.1	INSULIN-LIKE GROWTH FACTOR I; IGF1	3479
MIM147450		21q22.1	SUPEROXIDE DISMUTASE 1; SOD1	6647
MIM147460		6q25.3	SUPEROXIDE DISMUTASE 2; SOD2	6648
MIM147470		11p15.5	INSULIN-LIKE GROWTH FACTOR II; IGF2	3481
MIM147480	C0268318	7q21.1	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY; ICP	5205, 5244
MIM147485		1p32-p22	INTRACISTERNAL A PARTICLE-PROMOTED POLYPEPTIDE; IPP	3652
MIM147510		11p15.5	INSULIN-RELATED DNA POLYMORPHISM; IRDN	 
MIM147520		20p	INOSINE TRIPHOSPHATASE; ITPA	3704
MIM147521		15q14-q21	INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE A; ITPKA	3706
MIM147522		1q41-q43	INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE B; ITPKB	3707
MIM147530	C1840172	 	INSENSITIVITY TO PAIN WITH HYPERPLASTIC MYELINOPATHY	 
MIM147540	C1840171	 	INSECT STINGS, HYPERSENSITIVITY TO	 
MIM147545		2q36	INSULIN RECEPTOR SUBSTRATE 1; IRS1	3667
MIM147553		9p21	INTERFERON, OMEGA-1; IFNW1	3467
MIM147556		2q31.1	INTEGRIN, ALPHA-6; ITGA6	3655
MIM147557		17q11-qter	INTEGRIN, BETA-4; ITGB4	3691
MIM147558		2q24.2	INTEGRIN, BETA-6; ITGB6	3694
MIM147559		12q13.13	INTEGRIN, BETA-7; ITGB7	3695
MIM147561		 	INTEGRIN, BETA-5; ITGB5	3693
MIM147562		9p22	INTERFERON, ALPHA-2; IFNA2	3440
MIM147563		4q21-q25	INTEGRIN-BINDING SIALOPROTEIN; IBSP	3381
MIM147564		9p22	INTERFERON, ALPHA-4; IFNA4	3441
MIM147565		9p22	INTERFERON, ALPHA-5; IFNA5	3442
MIM147566		9p22	INTERFERON, ALPHA-6; IFNA6	3443
MIM147567		9p22	INTERFERON, ALPHA-7; IFNA7	3444
MIM147568		9p22	INTERFERON, ALPHA-8; IFNA8	3445
MIM147569		21q22.1-q22.2	INTERFERON, GAMMA, RECEPTOR 2; IFNGR2	3460
MIM147570		12q14	INTERFERON, GAMMA; IFNG	3458
MIM147571		1p36.33	UBIQUITIN-LIKE MODIFIER ISG15; ISG15	9636
MIM147572		1p35	INTERFERON-ALPHA-INDUCIBLE PROTEIN 6; IFI6	2537
MIM147573		Chr.16	INTERFERON PRODUCTION REGULATOR; IFNR	3466
MIM147574		14q11.2	INTERFERON-STIMULATED TRANSCRIPTION FACTOR 3, GAMMA; ISGF3G	10379
MIM147575		5q31.1	INTERFERON REGULATORY FACTOR 1; IRF1	3659
MIM147576		4q35.1	INTERFERON REGULATORY FACTOR 2; IRF2	3660
MIM147577		9p22	INTERFERON, ALPHA-10; IFNA10	3446
MIM147578		9p22	INTERFERON, ALPHA-13; IFNA13	3447
MIM147579		9p22	INTERFERON, ALPHA-14; IFNA14	3448
MIM147580		9p22	INTERFERON, ALPHA-16; IFNA16	3449
MIM147582		15q25.1	IRON-RESPONSIVE ELEMENT-BINDING PROTEIN 2; IREB2	3658
MIM147583		9p22	INTERFERON, ALPHA-17; IFNA17	3451
MIM147584		9p22	INTERFERON, ALPHA-21; IFNA21	3452
MIM147586		1q22	INTERFERON-GAMMA-INDUCIBLE PROTEIN 16; IFI16	3428
MIM147610	C1840140	 	IRIS PIGMENT LAYER, CLEAVAGE OF	 
MIM147620		7p21	INTERLEUKIN 6; IL6	3569
MIM147625		7p22	ISLET CELL AUTOANTIGEN 1; ICA1	3382
MIM147630	C1578917	 	ISLET CELL ADENOMATOSIS	 
MIM147640		9p21	INTERFERON, BETA-1; IFNB1	3456
MIM147650		15q26.1	ISOCITRATE DEHYDROGENASE 2; IDH2	3418
MIM147660		9p22	INTERFERON, ALPHA-1; IFNA1	3439
MIM147670		19p13.2	INSULIN RECEPTOR; INSR	3643
MIM147671		1q21-q23	INSULIN RECEPTOR-RELATED RECEPTOR; INSRR	3645
MIM147678		11q22.2-q22.3	CASPASE 1, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP1	834
MIM147679		2q14.2	INTERLEUKIN 1 RECEPTOR ANTAGONIST; IL1RN	3557
MIM147680		4q26-q27	INTERLEUKIN 2; IL2	3558
MIM147681		19q13.3-q13.4	INTERLEUKIN 11; IL11	3589
MIM147683		5q31	INTERLEUKIN 13; IL13	3596
MIM147685		17q25	FORKHEAD BOX K2; FOXK2	3607
MIM147690		10q23.3	INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 1; IFIT1	3434
MIM147700		2q33.3	ISOCITRATE DEHYDROGENASE 1; IDH1	3417
MIM147710	C0021933	 	INTUSSUSCEPTION	 
MIM147720		2q14	INTERLEUKIN 1-BETA; IL1B	3553
MIM147730		10p15.1	INTERLEUKIN 2 RECEPTOR, ALPHA; IL2RA	3559
MIM147740		5q31.1	INTERLEUKIN 3; IL3	3562
MIM147750	C1327918	20q13.13-q13.2	IVIC SYNDROME	57167
MIM147760		2q14	INTERLEUKIN 1-ALPHA; IL1A	3552
MIM147770	C0796002	 	JOHNSON NEUROECTODERMAL SYNDROME	 
MIM147780		5q31.1	INTERLEUKIN 4; IL4	3565
MIM147781		16p12.1-p11.2	INTERLEUKIN 4 RECEPTOR; IL4R	3566
MIM147790		4q21	IMMUNOGLOBULIN J POLYPEPTIDE, LINKER PROTEIN FOR IMMUNOGLOBULIN ALPHA AND MU POLYPEPTIDES; IGJ	3512
MIM147791	C0795841	11q23	JACOBSEN SYNDROME; JBS	3719
MIM147795		1p31.3	JANUS KINASE 1; JAK1	3716
MIM147796		9p24	JANUS KINASE 2; JAK2	3717
MIM147800	C0220686	 	AASE-SMITH SYNDROME I	 
MIM147810		2q12	INTERLEUKIN 1 RECEPTOR, TYPE I; IL1R1	3554
MIM147811		2q12-q22	INTERLEUKIN 1 RECEPTOR, TYPE II; IL1R2	7850
MIM147820	C1840073	 	INTERNAL CAROTID ARTERY, SPONTANEOUS DISSECTION OF	 
MIM147830		7p12-cen	INVASION AND METASTASIS FACTORS ON CHROMOSOME 7; INM7	7271
MIM147840		19p13.3-p13.2	INTERCELLULAR ADHESION MOLECULE 1; ICAM1	3383
MIM147850		5q31.1	INTERLEUKIN 5; IL5	3567
MIM147851		3p26-p24	INTERLEUKIN 5 RECEPTOR, ALPHA; IL5RA	3568
MIM147870		7q31	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 2; WNT2	7472
MIM147880		1q21.3	INTERLEUKIN 6 RECEPTOR; IL6R	3570
MIM147890		21q22.3	MYXOVIRUS RESISTANCE 2, MOUSE, HOMOLOG OF; MX2	4600
MIM147891	C1840061	17q21-q22	SMALL PATELLA SYNDROME; SPS	9496
MIM147892		1p33-p32	DEIODINASE, IODOTHYRONINE, TYPE I; DIO1	1733
MIM147900	C0268349	 	JOINT LAXITY, FAMILIAL	 
MIM147910		19q13.4	KALLIKREIN 1; KLK1	3816
MIM147920	CN030661	12q12-q14	KABUKI SYNDROME 1; KABUK1	8085
MIM147935		14q31-q32.1	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 4; SERPINA4	5267
MIM147940		12p12.3-p12.1	ISLET AMYLOID POLYPEPTIDE; IAPP	3375
MIM147950	C1563720	8p11.2-p11.1	HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA; HH2	2260
MIM147960		19q13.4	KALLIKREIN-RELATED PEPTIDASE 2; KLK2	3817
MIM148000	C0036220	7p21	KAPOSI SARCOMA, SUSCEPTIBILITY TO	3569
MIM148020		17q21-q22	KERATIN 19; KRT19	3880
MIM148021		11q13.5	KERATIN ASSOCIATED PROTEIN 5-9; KRTAP5-9	3846
MIM148022		11p15.5	KERATIN-ASSOCIATED PROTEIN 5-1; KRTAP5-1	387264
MIM148030		17q21-q22	KERATIN 15; KRT15	3866
MIM148040		12q13	KERATIN 5; KRT5	3852
MIM148041		12q13	KERATIN 6A; KRT6A	3853
MIM148042		12q13	KERATIN 6B; KRT6B	3854
MIM148043		12q13	KERATIN 3; KRT3	3850
MIM148050	C0220687	 	KBG SYNDROME; KBGS	29123
MIM148059		12q12-q14	KERATIN 7; KRT7	3855
MIM148060		12q13	KERATIN 8; KRT8	3856
MIM148065		17q21-q22	KERATIN 13; KRT13	3860
MIM148066		17q12-q21	KERATIN 14; KRT14	3861
MIM148067		17q12-q21	KERATIN 16; KRT16	3868
MIM148069		17q12-q21	KERATIN 17; KRT17	3872
MIM148070		12q13	KERATIN 18; KRT18	3875
MIM148080		17q21-q22	KERATIN 10; KRT10	3858
MIM148100	C0022548	 	KELOID FORMATION	 
MIM148180		15q15-q21.1	FIBROBLAST GROWTH FACTOR 7; FGF7	2252
MIM148190	C1835698	11p13	KERATITIS, HEREDITARY	5080
MIM148200	C1835697	 	KERATITIS FUGAX HEREDITARIA	 
MIM148210	C1835678	13q11-q12	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT	2706
MIM148300	C1835677	20p11.2	KERATOCONUS 1; KTCN1	30813
MIM148350	C1835672	13q11-q12	KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	2706
MIM148360	C1835671	 	KERATODERMA, PALMOPLANTAR, WITH NAIL DYSTROPHY AND HEREDITARY MOTOR-SENSORY NEUROPATHY	 
MIM148370	C0406756	8p23-p22	KERATOLYTIC WINTER ERYTHEMA	3896
MIM148390	C2675099	 	KERATOSIS, FAMILIAL ACTINIC	 
MIM148500	C1835664	17q25	TYLOSIS WITH ESOPHAGEAL CANCER; TOC	7149, 79651
MIM148520	C1835663	 	KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	 
MIM148600	C1835662	15q22-q24	KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE I; PPKP1	619540
MIM148700	C1835661	18q12.1-q12.2	KERATOSIS PALMOPLANTARIS STRIATA I; PPKS1	1828
MIM148730	C1835650	 	KERATOSIS, FOCAL PALMOPLANTAR AND GINGIVAL	 
MIM148750		7q22-q32	KINASE-LIKE PROTEIN G7P1; G7P1	2546
MIM148760		10q24.1	KINESIN FAMILY MEMBER 11; KIF11	3832
MIM148800	C0432126	 	KLEEBLATTSCHAEDEL	 
MIM148820	C0342680	2q35	WAARDENBURG SYNDROME, TYPE 3; WS3	5077
MIM148840	C0206085	 	KLEINE-LEVIN HIBERNATION SYNDROME	 
MIM149000	C0022739	8q22.3	KLIPPEL-TRENAUNAY-WEBER SYNDROME	791122
MIM149100	C0264000	 	KNUCKLE PADS	 
MIM149200	C0266004	13q11-q12	KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	2706
MIM149300	C1835631	 	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 2; NDNC2	 
MIM149400	C1835614	14q24, 11p15.2-p15.1, 5q32, 4q31.3	HYPEREKPLEXIA, HEREDITARY 1; HKPX1	10243, 2741, 2743, 9152
MIM149600	C1835613	 	LABIA MINORA, INCOMPLETE ADHESION OF	 
MIM149700	C1835612	 	LACRIMAL DUCT DEFECT	 
MIM149730	C0265269	5p13-p12, 4p16.3	LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	2255, 2261, 2263
MIM149750		12q13	LACTALBUMIN, ALPHA; LALBA	3906
MIM150000		11p15.4	LACTATE DEHYDROGENASE A; LDHA	3939
MIM150100		12p12.2-p12.1	LACTATE DEHYDROGENASE B; LDHB	3945
MIM150150		11p15.5-p15.3	LACTATE DEHYDROGENASE C; LDHC	3948
MIM150170	C1835591	 	LACTIC ACIDOSIS, CHRONIC ADULT FORM	 
MIM150200		17q22-q24	CHORIONIC SOMATOMAMMOTROPIN HORMONE 1; CSH1	1442
MIM150205		17q23.1	LACTOPEROXIDASE; LPO	4025
MIM150210		3p21.31	LACTOTRANSFERRIN; LTF	4057
MIM150230	C0023003	8q24.11-q24.13	TRICHORHINOPHALANGEAL SYNDROME, TYPE II; TRPS2	 
MIM150240		7q31.1-q31.3	LAMININ, BETA-1; LAMB1	3912
MIM150250	C1835564	3p14.3	LARSEN SYNDROME; LRS	2317
MIM150260	C0396059	 	LARYNGEAL ABDUCTOR PARALYSIS	 
MIM150270	C0396060	6p21.3-p21.2	LARYNGEAL ADDUCTOR PARALYSIS; LAP	7939
MIM150280	C0264303	 	LARYNGOMALACIA	 
MIM150290		1q31	LAMININ, GAMMA-1; LAMC1	3915
MIM150292		1q25-q31	LAMININ, GAMMA-2; LAMC2	3918
MIM150300	C1835555	 	LARYNX, CONGENITAL PARTIAL ATRESIA OF	 
MIM150310		1q32	LAMININ, BETA-3; LAMB3	3914
MIM150320		18p11.31	LAMININ, ALPHA-1; LAMA1	284217
MIM150325		3p21	LAMININ, BETA-2; LAMB2	3913
MIM150330		1q21.2	LAMIN A/C; LMNA	4000
MIM150340		5q23.3-q31.1	LAMIN B1; LMNB1	4001
MIM150341		19p13.3	LAMIN B2; LMNB2	84823
MIM150360	C1835494	 	LARYNGEAL WEB, FAMILIAL	 
MIM150370		3p21.3	LAMININ RECEPTOR 1; LAMR1	3921
MIM150390		2p12-q22	LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 1; LTBP1	4052
MIM150400	C1835492	 	TOOTH AGENESIS, SELECTIVE, 4; STHAG4	80326
MIM150500	C1835491	 	LATTICE DEGENERATION OF RETINA LEADING TO RETINAL DETACHMENT	 
MIM150550	C0272174	 	LAZY LEUKOCYTE SYNDROME	 
MIM150570		22q12-q13.1	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 1; LGALS1	3956
MIM150571		22q13.1	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 2; LGALS2	3957
MIM150590	C1835489	 	LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	 
MIM150600	C0023234	 	LEGG-CALVE-PERTHES DISEASE; LCPD	1280
MIM150699	C0042133	 	LEIOMYOMA, UTERINE; UL	8091
MIM150700	C1835488	 	LEIOMYOMA OF VULVA AND ESOPHAGUS	 
MIM150800	C1708350	1q42.1	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HLRCC	 
MIM150900	C0023321	 	LENTIGINES	 
MIM151000	C1835484	 	LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	 
MIM151001	C3492944	 	LENTIGINOSIS, INHERITED PATTERNED	619539
MIM151020		Chr.14	LENTIL AGGLUTININ BINDING	8118
MIM151050	C0432269	 	LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	 
MIM151100	CN074218	12q24.1	LEOPARD SYNDROME 1	5781
MIM151200	C1835450	 	LERI PLEONOSTEOSIS	 
MIM151210	C1835437	 	PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE; PLSDT	1280
MIM151290		11q25	BETA-1,3-GLUCURONYLTRANSFERASE 1; B3GAT1	27087
MIM151300		5q14.2-q15	LEUCYL-CYSTINYL AMINOPEPTIDASE; LNPEP	4012
MIM151310		Chr.20	LEUCINE TRANSPORT, HIGH; LEUT	3343
MIM151350		5cen-q11	LEUCYL-tRNA SYNTHETASE; LARS	51520
MIM151380	C0023479	 	LEUKEMIA, ACUTE MONOCYTIC	 
MIM151385		21q22.3	RUNT-RELATED TRANSCRIPTION FACTOR 1; RUNX1	861
MIM151400	C0023434	 	LEUKEMIA, CHRONIC LYMPHOCYTIC; CLL	 
MIM151410		22q11.21	BREAKPOINT CLUSTER REGION; BCR	613
MIM151430		18q21.3	B-CELL CLL/LYMPHOMA 2; BCL2	596
MIM151440		19p13.2-p13.1	LYMPHOBLASTIC LEUKEMIA-DERIVED SEQUENCE 1; LYL1	4066
MIM151441		17q22	LEUKEMIA/LYMPHOMA, CHRONIC B-CELL, 5; BCL5	603
MIM151442		1p36.1-p35	STATHMIN 1; STMN1	3925
MIM151443		5p13.1	LEUKEMIA INHIBITORY FACTOR RECEPTOR; LIFR	3977
MIM151445		19p13.3	Fc FRAGMENT OF IgE, LOW AFFINITY II, RECEPTOR FOR; FCER2	2208
MIM151450		Chr.4	LEUKOCYTE ANTIGEN GROUP FIVE; LAG5	7895
MIM151460		1q31-q32	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, C; PTPRC	5788
MIM151500	C1835405	 	LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF	 
MIM151510		16p11.2	INTEGRIN, ALPHA-X; ITGAX	3687
MIM151520		15q15.1-q21.1	LEUKOCYTE TYROSINE KINASE; LTK	4058
MIM151523		19p13-q13.4	LEUKOCYTE SURFACE ANTIGEN CD37; CD37	951
MIM151525		1p21-p13.3	LEUKOCYTE SURFACE ANTIGEN CD53; CD53	963
MIM151530		15q25-q26	ALANYL AMINOPEPTIDASE; ANPEP	290
MIM151570		12q22	LEUKOTRIENE A4 HYDROLASE; LTA4H	4048
MIM151590	C0023652	 	LICHEN SCLEROSUS ET ATROPHICUS; LSA	 
MIM151600	C0544855	 	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3; NDNC3	5333
MIM151610	C1835403	 	LEVATOR-MEDIAL RECTUS SYNKINESIS	 
MIM151620	C1835402	 	LICHEN PLANUS, FAMILIAL	 
MIM151623	C1835398	17p13.1, 9p21	LI-FRAUMENI SYNDROME 1; LFS1	1029, 7157
MIM151625		 	LIGATIN; LGTN	100529141
MIM151626		22q11-q12	LINE RETROTRANSPOSABLE ELEMENT 1; LRE1	4029
MIM151628		1q	LINE RETROTRANSPOSABLE ELEMENT 2; LRE2	4030
MIM151630	C1835396	 	LIP, MEDIAN NODULE OF UPPER	 
MIM151640	C1835395	 	LIP, HAMARTOMATOUS	 
MIM151660	C1720860	1q21.2	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; FPLD2	4000
MIM151670		15q21-q23	LIPASE, HEPATIC; LIPC	3990
MIM151675		9q34	LIPOCALIN 1; LCN1	3933
MIM151690		9q11-q22	ANNEXIN A1; ANXA1	301
MIM151700	C1835373	 	LIPOMA OF THE CONJUNCTIVA	 
MIM151740		15q21-q22	ANNEXIN A2; ANXA2	302
MIM151750		19q13.1-q13.2	LIPASE, HORMONE-SENSITIVE; LIPE	3991
MIM151800	C0023804	 	LIPOMATOSIS, MULTIPLE SYMMETRIC; MSL	 
MIM151900	C3489413	 	LIPOMATOSIS, MULTIPLE	 
MIM151990		20q11.23-q12	LIPOPOLYSACCHARIDE-BINDING PROTEIN; LBP	3929
MIM152200		6q27	APOLIPOPROTEIN(a); LPA	4018
MIM152310		2q31-q32.1	TISSUE FACTOR PATHWAY INHIBITOR; TFPI	7035
MIM152390		10q11.2	ARACHIDONATE 5-LIPOXYGENASE; ALOX5	240
MIM152391		17p13.1	ARACHIDONATE 12-OXIDOREDUCTASE; ALOX12	239
MIM152392		17p13.3	ARACHIDONATE 15-LIPOXYGENASE; ALOX15	246
MIM152420	C1835356	 	LITHIUM TRANSPORT	 
MIM152424		11p15.5	LOCUS CONTROL REGION, BETA	387281
MIM152425		4q34-q35	ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 1; ACSL1	2180
MIM152427		12p11.1, 7q35-q36	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 2; KCNH2	3757
MIM152430	C2750617	4q25	LONGEVITY 1	140802
MIM152445		1q21	LORICRIN; LOR	4014
MIM152550	C1835320	 	LUMBAR STENOSIS, FAMILIAL	 
MIM152600	C1186306	 	LUNULAE OF FINGERNAILS	 
MIM152690		22q11-q13	X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 6; XRCC6	2547
MIM152700	C0024141	1q23, 16p13.3, 1q23, 1q22, 11q14, 1p13, 6p21.3, 4q22-q24, 4p16-p15.2, 3p21.3-p21.2	SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	11277, 1773, 2213, 2214, 26191, 356, 55024, 720
MIM152760		8p21-p11.2	GONADOTROPIN-RELEASING HORMONE 1; GNRH1	2796
MIM152780		19q13.32	LUTEINIZING HORMONE, BETA POLYPEPTIDE; LHB	3972
MIM152790		2p21	LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR; LHCGR	3973
MIM152800	C0024215	 	LYMPHANGIECTASIA, INTESTINAL	 
MIM152900	C1835272	 	LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	 
MIM152950	C1835265	 	MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	3832
MIM153100	C1704423	5q35.3	LYMPHEDEMA, HEREDITARY, IA	2324
MIM153200	C1704425	 	LYMPHEDEMA, HEREDITARY, II	 
MIM153240		1q23-q25	SELECTIN L; SELL	6402
MIM153243		1p36	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 8; TNFRSF8	943
MIM153245		4q23-q25	LYMPHOID ENHANCER-BINDING FACTOR 1; LEF1	51176
MIM153300	C0221348	 	YELLOW NAIL SYNDROME	 
MIM153310		19q13.1	CHARCOT-LEYDEN CRYSTAL PROTEIN; CLC	1178
MIM153330		13q34	LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 1; LAMP1	3916
MIM153337		12p13.32	LYMPHOCYTE ACTIVATION GENE 3; LAG3	3902
MIM153340		11q13	LYMPHOCYTE ANTIGEN CD5; CD5	921
MIM153370		16p11.2	INTEGRIN, ALPHA-L; ITGAL	3683
MIM153380		6p21.3-p21.2	LYMPHOCYTE CYTOSOL POLYPEPTIDE, 20-KD	7938
MIM153390		1p35-p34.3	LYMPHOCYTE-SPECIFIC PROTEIN-TYROSINE KINASE; LCK	3932
MIM153400	C0265345	16q24.3	LYMPHEDEMA-DISTICHIASIS SYNDROME	2303
MIM153420		1p13	CD58 MOLECULE; CD58	965
MIM153430		13q14.1-q14.3	LYMPHOCYTE CYTOSOLIC PROTEIN 1; LCP1	3936
MIM153432		11p15.5	LYMPHOCYTE-SPECIFIC PROTEIN; LSP1	4046
MIM153435		Chr.6	LYMPHOKINE-ACTIVATED KILLER CELL LIGAND; LAKL	3905
MIM153440		6p21.3	LYMPHOTOXIN-ALPHA; LTA	4049
MIM153450		12q15	LYSOZYME; LYZ	4069
MIM153454		1p36.3-p36.2	PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE; PLOD1	5351
MIM153455		5q23.3-q31.2	LYSYL OXIDASE; LOX	4015
MIM153456		15q22	LYSYL OXIDASE-LIKE 1; LOXL1	4016
MIM153470	C0220690	 	MACROCEPHALY, BENIGN FAMILIAL	 
MIM153480	C0265326	10q23.31	BANNAYAN-RILEY-RUVALCABA SYNDROME; BRRS	5728
MIM153550	C0740302	5q32	CHROMOSOME 5q DELETION SYNDROME	6208
MIM153600	C1835192	6p21.3	MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1; WM1	100188787, 4615
MIM153615		2cen-q24	CAPPING PROTEIN, GELSOLIN-LIKE; CAPG	822
MIM153618		10p13	MANNOSE RECEPTOR, C-TYPE, 1; MRC1	4360
MIM153619		14q21-q22	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 3; LGALS3	3958
MIM153620		22q11.2	MACROPHAGE MIGRATION INHIBITORY FACTOR; MIF	4282
MIM153622		8p22	MACROPHAGE SCAVENGER RECEPTOR; MSR1	4481
MIM153630	C0009677	 	MACROGLOSSIA	 
MIM153634		17p13	MACROPHAGE ANTIGEN CD68; CD68	968
MIM153640	C0403445	22q11.2	FECHTNER SYNDROME; FTNS	4627
MIM153650	C0398641	22q11.2	EPSTEIN SYNDROME	4627
MIM153670	C2750610	17pter-p12	BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	2811
MIM153700	C0339510	11q13	MACULAR DYSTROPHY, VITELLIFORM; VMD	7439
MIM153800	C3495438	1p22.1	MACULAR DEGENERATION, AGE-RELATED, 2; ARMD2	24
MIM153840	C1835178	8q24	MACULAR DYSTROPHY, ATYPICAL VITELLIFORM; VMD1	7438
MIM153870	CN220153	 	MACULAR DYSTROPHY, CONCENTRIC ANNULAR	 
MIM153880	C0024440	7p21-p15	MACULAR EDEMA, CYSTOID	1541
MIM153890	C1835173	 	MACULAR DYSTROPHY, FENESTRATED SHEEN TYPE	 
MIM154000		 	MACULES, HEREDITARY CONGENITAL HYPOPIGMENTED AND HYPERPIGMENTED	 
MIM154020	C1835171	11q23	HYPOMAGNESEMIA 2, RENAL; HOMG2	486
MIM154030		1p34	NUCLEASE-SENSITIVE ELEMENT-BINDING PROTEIN 1; NSEP1	4904
MIM154040		6p21.3	RD RNA-BINDING PROTEIN; RDBP	7936
MIM154045		19q13.4	LENS INTRINSIC MEMBRANE PROTEIN 2, 19-KD; LIM2	3982
MIM154050		12q13	MAJOR INTRINSIC PROTEIN OF LENS FIBER; MIP	4284
MIM154100		7cen-q22	MALATE DEHYDROGENASE, MITOCHONDRIAL; MDH2	4191
MIM154200		2p16	MALATE DEHYDROGENASE, SOLUBLE; MDH1	4190
MIM154230	C2752149	9p24.3	46,XY SEX REVERSAL 4; SRXY4	 
MIM154235		6q22	MALE GERM CELL-ASSOCIATED KINASE; MAK	4117
MIM154250		6q12	MALIC ENZYME 1; ME1	4199
MIM154270		18q21	MALIC ENZYME 2; ME2	4200
MIM154275	C1835161	17q11.2-q24	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	4264
MIM154276	C2930982	7q21-q22	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	7977
MIM154280		1pter-p22.1	SUPPRESSOR OF ANCHORAGE INDEPENDENCE 1; SAI1	6298
MIM154300	C1835159	 	MALOCCLUSION DUE TO PROTUBERANT UPPER FRONT TEETH	 
MIM154360		7q34	MALTASE-GLUCOAMYLASE; MGAM	8972
MIM154365		7q22.1-q22.3	PROTEASOME 26S SUBUNIT, ATPase, 2; PSMC2	5701
MIM154400	C0265245	9q32	ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	10262, 171
MIM154500	CN119605	5q32-q33.1	TREACHER COLLINS SYNDROME 1; TCS1	6949
MIM154540		12p13	MANNOSE 6-PHOSPHATE RECEPTOR, CATION-DEPENDENT; M6PR	4074
MIM154545		10q11.2-q21	LECTIN, MANNOSE-BINDING, SOLUBLE, 2; MBL2	4153
MIM154550		15q22-qter	MANNOSEPHOSPHATE ISOMERASE; MPI	4351
MIM154580		15q11-q13	MANNOSIDASE, ALPHA, CLASS 2C, MEMBER 1; MAN2C1	4123
MIM154582		5q21-q22	MANNOSIDASE, ALPHA, CLASS 2A, MEMBER 1; MAN2A1	4124
MIM154600	C0266521	 	MARCUS GUNN PHENOMENON	 
MIM154700	C0024796	15q21.1	MARFAN SYNDROME; MFS	2200
MIM154750	C0268365	 	MARFANOID HYPERMOBILITY SYNDROME	 
MIM154780	C0265235	1p21	MARSHALL SYNDROME; MRSHS	1301
MIM154790		18q21.3	PROTEASE INHIBITOR 5; PI5	5268
MIM154800	C0024899	 	MAST CELL DISEASE	3815
MIM154850	C1835093	 	MASTICATORY MUSCLES, HYPERTROPHY OF	 
MIM154870		12p13.1-p12.3	MATRIX GAMMA-CARBOXYGLUTAMIC ACID; MGP	4256
MIM154950		14q23	MAX PROTEIN; MAX	4149
MIM155000	C1835088	 	MAXILLOFACIAL DYSOSTOSIS	 
MIM155050	C0220692	 	MAXILLONASAL DYSPLASIA, BINDER TYPE	 
MIM155100	C0340978	22q11.2	MAY-HEGGLIN ANOMALY; MHA	4627
MIM155120		17q21.3	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 11; ADAM11	4185
MIM155140	C0025037	 	MECKEL DIVERTICULUM	 
MIM155145	C1835087	 	CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	 
MIM155150	C1835086	 	MEDIAN-ULNAR NERVE COMMUNICATIONS	 
MIM155200	C1835085	 	MEDIOSTERNAL DEPIGMENTATION LINE	 
MIM155240	C1833921	1q21-q22, 10q11.2	THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC	4914, 5979
MIM155255	C0025149	13q12.3, 10q24-q25, 1p32	MEDULLOBLASTOMA; MDB	51684, 675, 8643
MIM155310	C1835084	 	MEGADUODENUM AND/OR MEGACYSTIS	 
MIM155350	C2720434	 	MEGALENCEPHALY	 
MIM155500	C0265552	 	MEGALODACTYLY	 
MIM155540		20q13.2	MELANOCORTIN 3 RECEPTOR; MC3R	4159
MIM155541		18q22	MELANOCORTIN 4 RECEPTOR; MC4R	4160
MIM155550		12q13-q14	SILVER, MOUSE, HOMOLOG OF; SILV	6490
MIM155555		16q24.3	MELANOCORTIN 1 RECEPTOR; MC1R	4157
MIM155600	C1835047	1p36	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1; CMM1	1243, 5728
MIM155601	C1835044	9p21	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2; CMM2	1029
MIM155700	C1835043	 	MELANOMA, MALIGNANT FAMILIAL INTRAOCULAR	 
MIM155720	C0220633	 	MELANOMA, UVEAL	 
MIM155730		4q12-q13	CHEMOKINE, CXC MOTIF, LIGAND 1; CXCL1	2919
MIM155735		 	MELANOMA ADHESION MOLECULE; MCAM	4162
MIM155740		12q12-q13	CD63 ANTIGEN; CD63	967
MIM155750		3q29	MELANOMA-ASSOCIATED ANTIGEN p97; MFI2	4241
MIM155755	C1835042	9p21	MELANOMA-ASTROCYTOMA SYNDROME	1029
MIM155760		15q26.1	AGGRECAN; ACAN	176
MIM155800	C1835039	 	MELANOSIS, UNIVERSAL	 
MIM155900	C0025235	9p11	MELKERSSON-ROSENTHAL SYNDROME	8011
MIM155950	C0025239	12q14	MELORHEOSTOSIS, ISOLATED	23592
MIM155970		3q12-q13	MEMBRANE GLYCOPROTEIN MRC OX-2; MOX2	4345
MIM155980	C1835030	 	MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	 
MIM156000	C0025281	 	MENIERE DISEASE	 
MIM156100		22q12.3-qter	MENINGIOMA 1 GENE; MN1	4330
MIM156190	C1835028	 	MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	 
MIM156200	C1969562	2q23.1	MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1	100820633, 55777
MIM156220	C1835026	 	MERALGIA PARAESTHETICA, FAMILIAL	 
MIM156225		6q22-q23	LAMININ, ALPHA-2; LAMA2	3908
MIM156230	C1835010	 	MESOMELIC DWARFISM OF HYPOPLASTIC TIBIA AND RADIUS TYPE	 
MIM156232	C1835009	2q24-q32	MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	10305
MIM156240	C0345967	9p	MESOTHELIOMA, MALIGNANT; MESOM	338340, 7490, 8915
MIM156250	C0410530	12q24.1	METACHONDROMATOSIS; METCDS	5781
MIM156349		16q13	METALLOTHIONEIN 1B; MT1B	4490
MIM156350		16q13	METALLOTHIONEIN 1A; MT1A	4489
MIM156351		16q13	METALLOTHIONEIN 1E; MT1E	4493
MIM156352		16q13	METALLOTHIONEIN 1F; MT1F	4494
MIM156353		16q13	METALLOTHIONEIN 1G; MT1G	4495
MIM156354		16q13	METALLOTHIONEIN 1H; MT1H	4496
MIM156355		16q13	METALLOTHIONEIN 1I; MT1I	644314
MIM156356		16q13	METALLOTHIONEIN 1J; MT1J	4498
MIM156357		16q13	METALLOTHIONEIN 1K; MT1K	4499
MIM156358		16q13	METALLOTHIONEIN 1L; MT1L	4500
MIM156359		16q13	METALLOTHIONEIN 1X; MT1X	4501
MIM156360		16q13	METALLOTHIONEIN 2A; MT2A	4502
MIM156400	C0265295	3p22-p21.1	METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	5745
MIM156490		17q21.3	NONMETASTATIC CELLS 1, PROTEIN EXPRESSED IN; NME1	4830
MIM156491		17q21.3	NONMETASTATIC CELLS 2, PROTEIN EXPRESSED IN; NME2	4831
MIM156500	C0265289	 	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE; MCDS	1300
MIM156510	C1834969	 	METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	 
MIM156520	C1834968	 	METATARSUS VARUS, TYPE I	 
MIM156530	C0265281	12q24.1	METATROPIC DYSPLASIA	59341
MIM156535		18q21.1	METHYL-CpG-BINDING DOMAIN PROTEIN 1; MBD1	4152
MIM156540		9p21	METHYLTHIOADENOSINE PHOSPHORYLASE; MTAP	4507
MIM156550	C0265279	12q13.11-q13.2	KNIEST DYSPLASIA	1280
MIM156560		Chr.12	METHIONYL-tRNA SYNTHETASE; MARS	4141
MIM156565		16pter-p13.3	N-@METHYLPURINE DNA GLYCOSYLASE; MPG	4350
MIM156569		10q26	METHYLGUANINE-DNA METHYLTRANSFERASE; MGMT	4255
MIM156570		1q43	5-@METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; MTR	4548
MIM156580	C0220693	 	MICROCEPHALY, AUTOSOMAL DOMINANT	 
MIM156600	C1303009	13q31-q32	MICROCORIA, CONGENITAL	8104
MIM156610	C0473586	 	SKIN CREASES, MULTIPLE BENIGN RING-SHAPED, OF LIMBS	 
MIM156620	C0796062	 	MICROCEPHALY-DEAFNESS SYNDROME	 
MIM156700	C1834935	 	MICROCORNEA, GLAUCOMA, AND ABSENT FRONTAL SINUSES	 
MIM156790		1p36.1-p35	MICROFIBRILLAR-ASSOCIATED PROTEIN 2; MFAP2	4237
MIM156810	C1834929	 	MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	 
MIM156830	C1834928	 	MICROMELIC BONE DYSPLASIA WITH CLOVERLEAF SKULL	 
MIM156845		3p14.1-p12.3	MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MITF	4286
MIM156850	C1834919	16p13.3	MICROPHTHALMIA, ISOLATED, WITH CATARACT 1; MCOPCT1	8130
MIM156900	C1834918	 	MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA; MCOPCR	 
MIM157129		5q13	MICROTUBULE-ASSOCIATED PROTEIN 1B; MAP1B	4131
MIM157130		2q34-q35	MICROTUBULE-ASSOCIATED PROTEIN 2; MAP2	4133
MIM157132		3p21	MICROTUBULE-ASSOCIATED PROTEIN 4; MAP4	4134
MIM157140		17q21.1	MICROTUBULE-ASSOCIATED PROTEIN TAU; MAPT	4137
MIM157145		10q11.2	MICROSEMINOPROTEIN, BETA; MSMB	4477
MIM157147		4q22-q24	MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN, 88-KD; MTP	4547
MIM157150	C1834881	 	MICROSPHEROPHAKIA WITH HERNIA	 
MIM157151	C1834880	 	MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	 
MIM157170	C1834877	2p21	HOLOPROSENCEPHALY 2; HPE2	6496
MIM157200	C1834876	 	MIDPHALANGEAL HAIR	 
MIM157300	C0149931	6q25.1, 6p21.3, 4q31.2, 4q24	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	1909, 192115, 2099, 7124
MIM157400	C0343079	 	MILIA, MULTIPLE ERUPTIVE	 
MIM157560		1q23	MINISATELLITE 33.6	7824
MIM157600	C1834870	18q21.3	MIRROR MOVEMENTS 1; MRMV1	1630
MIM157640	C1834846	15q25	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 1; PEOA1	5428
MIM157655		2q33-q34	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 1; NDUFS1	4719
MIM157660		9p21-p12	MITOCHONDRIAL RNA-PROCESSING ENDORIBONUCLEASE, RNA COMPONENT OF; RMRP	6023
MIM157680		5q31	CELL DIVISION CYCLE 25C; CDC25C	995
MIM157700	CN074267	16p12.1-p11.2	MITRAL VALVE PROLAPSE, FAMILIAL; MVP	50951
MIM157800	C1834818	 	MITRAL REGURGITATION, CONDUCTIVE DEAFNESS, AND FUSION OF CERVICAL VERTEBRAE AND OF CARPAL AND TARSAL BONES	 
MIM157900	C0221060	13q12.2-q13	MOEBIUS SYNDROME; MBS	4156
MIM157950	C0155930	 	PERMANENT MOLARS, SECONDARY RETENTION OF	 
MIM157960		5p14	MOLONEY LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF; MLVI2	4309
MIM157970		16q23-q24	PROTEASOME 26S SUBUNIT, NON-ATPase, 7; PSMD7	5713
MIM157980	C1834759	 	MOMO SYNDROME	 
MIM158000	C0546966	12q13, 12q13, 12q13	MONILETHRIX	3887, 3889, 3892
MIM158050		Chr.6	MONKEY RED BLOOD CELL RECEPTOR; MRBC	7960
MIM158070		11q13	SOLUTE CARRIER FAMILY 3 (ACTIVATOR OF DIBASIC AND NEUTRAL AMINO ACID TRANSPORT), MEMBER 2; SLC3A2	6520
MIM158100	C1834753	 	MONOPHALANGY OF GREAT TOE	 
MIM158105		17q11.2-q12	CHEMOKINE, CC MOTIF, LIGAND 2; CCL2	6347
MIM158106		17q11.2-q12	CHEMOKINE, CC MOTIF, LIGAND 7; CCL7	6354
MIM158120		5q31.1	MONOCYTE DIFFERENTIATION ANTIGEN CD14; CD14	929
MIM158170	C0795830	9p	CHROMOSOME 9p DELETION SYNDROME	100240748
MIM158250	C1834741	 	NONDISJUNCTION	 
MIM158270		6p21.3	MOTILIN; MLN	4295
MIM158280	C0026603	 	MOTION SICKNESS	 
MIM158300	C0265226	17p13.1	ARTHROGRYPOSIS, DISTAL, TYPE 7; DA7	4626
MIM158310	C1274795	 	MUCOEPITHELIAL DYSPLASIA, HEREDITARY	 
MIM158320	C1321489	3p21.3, 2p22-p21	MUIR-TORRE SYNDROME; MRTES	4292, 4436
MIM158330	C2675014	1p35	MULLERIAN APLASIA AND HYPERANDROGENISM	54361
MIM158340		1q21	MUCIN 1, TRANSMEMBRANE; MUC1	4582
MIM158343		16p13.1	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 1; ABCC1	4363
MIM158345	C1834724	 	MULTIPLE EXOSTOSES WITH SPASTIC TETRAPARESIS	 
MIM158350	CN072330	10q23.31	COWDEN DISEASE; CD	5728
MIM158370		11p15.5	MUCIN 2, INTESTINAL; MUC2	4583
MIM158371		7q22	MUCIN 3A, INTESTINAL; MUC3A	4584
MIM158372		3q29	MUCIN 4, TRACHEOBRONCHIAL; MUC4	4585
MIM158373		11p15.5	MUCIN 5, SUBTYPES A AND C, TRACHEOBRONCHIAL; MUC5AC	4586
MIM158374		11p15.5-p15.4	MUCIN 6, GASTRIC; MUC6	4588
MIM158375		4q13-q21	MUCIN 7, SALIVARY; MUC7	4589
MIM158378		8p12-q12	SOLUTE CARRIER FAMILY 20 (PHOSPHATE TRANSPORTER), MEMBER 2; SLC20A2	6575
MIM158380		17q11.2	ECOTROPIC VIRAL INTEGRATION SITE 2A; EVI2A	2123
MIM158381		17q11.2	ECOTROPIC VIRAL INTEGRATION SITE 2B; EVI2B	2124
MIM158400	C1834708	 	MUSCLE CRAMPS, FAMILIAL	 
MIM158500	C0342281	 	MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	 
MIM158580	C1834703	2q14	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A	50952
MIM158590	C1834692	12q24	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A	26353
MIM158600	C1834690	14q32	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY, AUTOSOMAL DOMINANT; SMALED	100529225, 1778
MIM158650	C1834689	 	MUSCULAR ATROPHY, MALIGNANT NEUROGENIC	 
MIM158800	C1834688	 	MUSCULAR DYSTROPHY, BARNES TYPE	 
MIM158810	CN029274	2q37, 21q22.3, 21q22.3	BETHLEM MYOPATHY	1291, 1292, 1293
MIM158900	C0238288	4q35	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A; FSHMD1A	22947, 2483, 2489
MIM158901	C1834671	 	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1B; FSHMD1B	2490
MIM159000	C1834659	5q31	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1A; LGMD1A	9499
MIM159001	C1834653	1q21.2	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B; LGMD1B	4000
MIM159050	C1834652	 	MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES	 
MIM159100	C1834651	 	MUSCULAR HYPOPLASIA, CONGENITAL UNIVERSAL, OF KRABBE	 
MIM159300	C1834650	 	MUSICAL PERFECT PITCH	 
MIM159350		5q21	MUTATED IN COLORECTAL CANCERS; MCC	4163
MIM159400	C1834635	 	MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	 
MIM159405		8q22	V-MYB AVIAN MYELOBLASTOSIS VIRAL ONCOGENE HOMOLOG-LIKE 1; MYBL1	4603
MIM159410	C1834634	 	MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	 
MIM159420	C1303010	 	MYDRIASIS, CONGENITAL	 
MIM159430		18q22-qter	MYELIN BASIC PROTEIN; MBP	4155
MIM159440		1q22	MYELIN PROTEIN ZERO; MPZ	4359
MIM159460		19q13.1	MYELIN-ASSOCIATED GLYCOPROTEIN; MAG	4099
MIM159465		6p21.3	MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; MOG	4340
MIM159500	C1834600	 	MYELINATED OPTIC NERVE FIBERS	 
MIM159530		1p34	MYELOPROLIFERATIVE LEUKEMIA VIRUS ONCOGENE; MPL	4352
MIM159540		22q12.1-q12.2	LEUKEMIA-INHIBITORY FACTOR; LIF	3976
MIM159550	C1327919	 	MYELOCEREBELLAR DISORDER	 
MIM159552		1q21	MYELOID CELL LEUKEMIA SEQUENCE 1; MCL1	4170
MIM159553		1q22	MYELOID CELL NUCLEAR DIFFERENTIATION ANTIGEN; MNDA	4332
MIM159555		11q23	MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA GENE; MLL	4297
MIM159556		19p13.3	MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 1; MLLT1	4298
MIM159557		4q21	AF4/FMR2 FAMILY, MEMBER 1; AFF1	4299
MIM159558		9p22	MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 3; MLLT3	4300
MIM159559		6q27	MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 4; MLLT4	4301
MIM159580	C0030481	 	MYELOPATHY, HTLV-1-ASSOCIATED; HAM	 
MIM159590		19q13.3-q13.4	CD33 ANTIGEN; CD33	945
MIM159595	C1834582	21q11.2	MYELOPROLIFERATIVE SYNDROME, TRANSIENT	8205
MIM159600	C1834581	 	MYOCLONIC EPILEPSY, HARTUNG TYPE	 
MIM159700	C1834580	 	MYOCLONUS AND ATAXIA	 
MIM159800	C1834579	 	MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	 
MIM159900	C1834570	11q23.1, 7q21	MYOCLONIC DYSTONIA	1813, 8910
MIM159950	C1834569	 	SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY; SMAPME	427
MIM159970		11p15.4	MYOGENIC DIFFERENTIATION ANTIGEN 1; MYOD1	4654
MIM159980		1q31-q41	MYOGENIC FACTOR 4; MYOG	4656
MIM159990		12q21	MYOGENIC FACTOR 5; MYF5	4617
MIM159991		12q21	MYOGENIC FACTOR 6; MYF6	4618
MIM160000		22q11.2-q13	MYOGLOBIN; MB	4151
MIM160010	C1834567	 	MYOGLOBINURIA, AUTOSOMAL DOMINANT	 
MIM160120	C1719788	12p13	EPISODIC ATAXIA, TYPE 1; EA1	3736
MIM160150	C1834558	12q21, 3p25.3, 19p13.2	MYOPATHY, CENTRONUCLEAR, 1; CNM1	1785, 4618, 64419
MIM160300	C1834556	 	MYOPATHY, DISTAL, WITH ONSET IN INFANCY	 
MIM160500	CN074249	14q12	MYOPATHY, DISTAL, 1; MPD1	4625
MIM160565	C0410207	 	MYOPATHY, TUBULAR AGGREGATE	 
MIM160700	C1834531	18p11.31	MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	4658
MIM160710		14q12	MYOSIN, HEAVY CHAIN 6, CARDIAC MUSCLE, ALPHA; MYH6	4624
MIM160720		17p13.1	MYOSIN, HEAVY CHAIN 3, SKELETAL MUSCLE, EMBRYONIC; MYH3	4621
MIM160730		17p13.1	MYOSIN, HEAVY CHAIN 1, SKELETAL MUSCLE, ADULT; MYH1	4619
MIM160740		17p13.1	MYOSIN, HEAVY CHAIN 2, SKELETAL MUSCLE, ADULT; MYH2	4620
MIM160741		17p13.1	MYOSIN, HEAVY CHAIN 8, SKELETAL MUSCLE, PERINATAL; MYH8	4626
MIM160742		17p13.1	MYOSIN, HEAVY CHAIN 4, SKELETAL MUSCLE; MYH4	4622
MIM160745		16p13.13-p13.12	MYOSIN, HEAVY CHAIN 11, SMOOTH MUSCLE; MYH11	4629
MIM160750	C0027121	 	MYOSITIS	 
MIM160760		14q12	MYOSIN, HEAVY CHAIN 7, CARDIAC MUSCLE, BETA; MYH7	4625
MIM160770		Chr.17	MYOSIN, LIGHT CHAIN 4, ALKALI, ATRIAL, EMBRYONIC; MYL4	4635
MIM160775		22q11.2	MYOSIN, HEAVY CHAIN 9, NONMUSCLE; MYH9	4627
MIM160776		17p13	MYOSIN, HEAVY CHAIN 10, NONMUSCLE; MYH10	4628
MIM160777		15q21	MYOSIN VA; MYO5A	4644
MIM160780		2q32.1-qter	MYOSIN, LIGHT POLYPEPTIDE 1, ALKALI, SKELETAL, FAST; MYL1	4632
MIM160781		12q23-q24.3	MYOSIN, LIGHT CHAIN 2, REGULATORY, CARDIAC, SLOW; MYL2	4633
MIM160782		4p16.3	MYOSIN, LIGHT CHAIN 5, REGULATORY; MYL5	4636
MIM160790		3p	MYOSIN, LIGHT CHAIN 3, ALKALI, VENTRICULAR, SKELETAL, SLOW; MYL3	4634
MIM160793		19q13.33	MYOSIN-BINDING PROTEIN C, FAST TYPE; MYBPC2	4606
MIM160794		Chr.12	MYOSIN-BINDING PROTEIN C, SLOW TYPE; MYBPC1	4604
MIM160795		1q32.1	MYOSIN-BINDING PROTEIN H; MYBPH	4608
MIM160800	C2936781	7q35	MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	1180
MIM160900	C0027126	19q13.2-q13.3	MYOTONIC DYSTROPHY 1; DM1	1760
MIM160980	C2607929	17q23-q24	CARNEY COMPLEX, TYPE 1; CNC1	5573
MIM160990	C1834418	 	MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	 
MIM160993		17q21.31	N-MYRISTOYLTRANSFERASE 1; NMT1	4836
MIM160994		19p13.3-p13.2	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN M; HNRNPM	4670
MIM160995		5q35	ALPHA-1,3-@MANNOSYL-GLYCOPROTEIN BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE; MGAT1	4245
MIM160998		6p25	NAD(P)H DEHYDROGENASE, QUINONE 2; NQO2	4835
MIM161000	C0343111	17q12-q21	NAEGELI SYNDROME	3861
MIM161015		11q13	NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 1; NDUFV1	4723
MIM161050	C0406443	 	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1; NDNC1	 
MIM161100	C1834402	 	NAILBEDS, PIGMENTATION OF	 
MIM161200	C0027341	9q34.1	NAIL-PATELLA SYNDROME; NPS	4010
MIM161400	C1834372	17q21	NARCOLEPSY 1; NRCLP1	3060
MIM161470	C1834371	 	NASAL ALAR COLLAPSE, BILATERAL	 
MIM161480	C0339851	 	NASAL BONES, ABSENCE OF	 
MIM161500	C1834370	 	NASAL GROOVE, FAMILIAL TRANSVERSE	 
MIM161530	C1834369	 	NASAL HYPERPIGMENTATION, FAMILIAL TRANSVERSE	 
MIM161550	C2750548	6p21.3	NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 2	100312951
MIM161555		12p13.2-p12.3	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 1; KLRC1	3821
MIM161560		3p12-q13.2	INTERLEUKIN 12A; IL12A	3592
MIM161561		5q31.1-q33.1	INTERLEUKIN 12B; IL12B	3593
MIM161565		3p23-p21	NATURAL KILLER TUMOR RECOGNITION SEQUENCE; NKTR	4820
MIM161600	C1267087	 	NAVICULAR BONE, ACCESSORY	 
MIM161650		2q22	NEBULIN; NEB	4703
MIM161700	C1834340	 	NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	 
MIM161800	C1834336	1q42.1	NEMALINE MYOPATHY 3; NEM3	58
MIM161900	C0403443	1q21	RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION	59331
MIM161950	CN239918	1q23-q25, 1q23-q25, 6q22-q23, 1q31-q42	IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	5284, 60498, 6401, 6402
MIM162000	C0268113	16p12.3	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1	7369
MIM162010		17q21-q22	NERVE GROWTH FACTOR RECEPTOR; NGFR	4804
MIM162030		1p13.1	NERVE GROWTH FACTOR, BETA SUBUNIT; NGFB	4803
MIM162040	C1834334	19q13.3	NERVE GROWTH FACTOR, GAMMA SUBUNIT; NGFG	8188
MIM162060		3q13	GROWTH-ASSOCIATED PROTEIN 43; GAP43	2596
MIM162080		14q11.1-q11.2	NEURAL RETINA LEUCINE ZIPPER; NRL	4901
MIM162091	CN032485	22q12.2	SCHWANNOMATOSIS	4771
MIM162095		7q33	PLEIOTROPHIN; PTN	5764
MIM162096		11p11.2	MIDKINE; MDK	4192
MIM162100	C1834304	17q25	AMYOTROPHY, HEREDITARY NEURALGIC; HNA	10801
MIM162150		5q15-q21	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 1; PCSK1	5122
MIM162151		20p11.2	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 2; PCSK2	5126
MIM162200	C0027831	17q11.2	NEUROFIBROMATOSIS, TYPE I; NF1	4763
MIM162210	C1834235	17q11.2	NEUROFIBROMATOSIS, FAMILIAL SPINAL	4763
MIM162230		22q12.2	NEUROFILAMENT PROTEIN, HEAVY POLYPEPTIDE; NEFH	4744
MIM162240	C1834232	 	NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME	 
MIM162250		8p21	NEUROFILAMENT 3; NEF3	4741
MIM162260	C1834230	 	NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL; NF3A	 
MIM162270	C0220695	 	NEUROFIBROMATOSIS, TYPE IV, OF RICCARDI; NF4	 
MIM162280		8p21	NEUROFILAMENT PROTEIN, LIGHT POLYPEPTIDE; NEFL	4747
MIM162300	C0025269	10q11.2	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	5979
MIM162320		7q21-q22	TACHYKININ 1; TAC1	6863
MIM162321		10q11-q21	TACHYKININ RECEPTOR 2; TACR2	6865
MIM162323		2p11	TACHYKININ RECEPTOR 1; TACR1	6869
MIM162330		12q13-q21	TACHYKININ 3; TAC3	6866
MIM162332		4q25	TACHYKININ RECEPTOR 3; TACR3	6870
MIM162340		15q22-qter	NEUROMEDIN B; NMB	4828
MIM162341		6q21-qter	NEUROMEDIN B RECEPTOR; NMBR	4829
MIM162350	C1834207	 	CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	80331
MIM162360		1q22	NESCIENT HELIX LOOP HELIX 1; NHLH1	4807
MIM162361		1p12-p11	NESCIENT HELIX LOOP HELIX 2; NHLH2	4808
MIM162370	C1834206	 	NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	 
MIM162380	C1834205	 	NEUROPATHY, HEREDITARY SENSORIMOTOR, WITH UPPER MOTOR NEURON, VISUAL PATHWAY AND AUTONOMIC DISTURBANCE	 
MIM162400	C0020071	9q22.1-q22.3	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	10558
MIM162500	C0393814	17p11.2	NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP	5376
MIM162640		7p15.1	NEUROPEPTIDE Y; NPY	4852
MIM162641		4q31.3-q32	NEUROPEPTIDE Y RECEPTOR Y1; NPY1R	4886
MIM162642		4q31	NEUROPEPTIDE Y RECEPTOR Y2; NPY2R	4887
MIM162643		2q21	CHEMOKINE, CXC MOTIF, RECEPTOR 4; CXCR4	7852
MIM162650		12q21	NEUROTENSIN; NTS	4922
MIM162651		20q13	NEUROTENSIN RECEPTOR 1; NTSR1	4923
MIM162660		12p13	NEUROTROPHIN 3; NTF3	4908
MIM162662		19q13.3	NEUROTROPHIN 4; NTF4	4909
MIM162700	C2267231	 	NEUTROPENIA, CHRONIC FAMILIAL	 
MIM162800	C0221023	19p13.3	CYCLIC NEUTROPENIA	1991, 51119
MIM162815		19p13.3	NEUTROPHIL AZUROCIDIN; NAZC	566
MIM162820	C1834174	7q22-qter	NEUTROPHIL MIGRATION; NM	4827
MIM162830	C0543669	1p35-p34.3	NEUTROPHILIA, HEREDITARY	1441
MIM162860		19q13.2	NEUTROPHIL-SPECIFIC ANTIGEN 1	57126
MIM162900	C0334082	4p16.3, 3q26.3	NEVUS, EPIDERMAL	2261, 3265, 5290
MIM163000	C0340803	5q13-q22	CAPILLARY MALFORMATIONS, CONGENITAL, 1	246230
MIM163050	C0265982	 	NEVUS ANEMICUS	 
MIM163100	C2697447	 	NEVUS FLAMMEUS OF NAPE OF NECK	 
MIM163200	C0265318	 	SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	3265, 3845
MIM163260		17q21.3	NUCLEAR FACTOR ERYTHROID 2-LIKE 1; NFE2L1	4779
MIM163400	C0432231	 	NIEVERGELT SYNDROME	 
MIM163500	C1876182	4p16.3	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2	5158
MIM163600	C0269269	 	NIPPLES INVERTED	 
MIM163700	CN002323	 	NIPPLES, SUPERNUMERARY	 
MIM163729		7q36	NITRIC OXIDE SYNTHASE 3; NOS3	4846
MIM163730		17cen-q11.2	NITRIC OXIDE SYNTHASE 2A; NOS2A	4843
MIM163731		12q24.2-q24.31	NITRIC OXIDE SYNTHASE 1; NOS1	4842
MIM163800	C1834144	15q24-q25	SICK SINUS SYNDROME 2, AUTOSOMAL DOMINANT; SSS2	10021
MIM163850	C1834143	 	NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	 
MIM163890		4q21	SYNUCLEIN, ALPHA; SNCA	6622
MIM163905		13q12	HIGH MOBILITY GROUP BOX 1; HMGB1	3146
MIM163906		4q31	HIGH MOBILITY GROUP BOX 2; HMGB2	3148
MIM163910		1p36.1	HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 2; HMGN2	3151
MIM163920		21q22.3	HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 1; HMGN1	3150
MIM163950	C0041409	12q24.1	NOONAN SYNDROME 1; NS1	5781
MIM163970		16q12.2	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, NORADRENALINE), MEMBER 2; SLC6A2	6530
MIM163980		19q13.2	CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 6; CEACAM6	4680
MIM164000	C1834118	 	NOSE, ANOMALOUS SHAPE OF	 
MIM164005		19p13.3	NUCLEAR FACTOR I/X; NFIX	4784
MIM164008		14q13	NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR, ALPHA; NFKBIA	4792
MIM164009		11q13	NUCLEAR MITOTIC APPARATUS PROTEIN 1; NUMA1	4926
MIM164010		16q24.3	CHMP FAMILY, MEMBER 1A; CHMP1A	5119
MIM164011		4q23-q24	NUCLEAR FACTOR KAPPA-B, SUBUNIT 1; NFKB1	4790
MIM164012		10q24	NUCLEAR FACTOR KAPPA-B, SUBUNIT 2; NFKB2	4791
MIM164013		11q24-q25	NUCLEAR FACTOR RELATED TO KAPPA-B BINDING PROTEIN; NFRKB	4798
MIM164014		11q12-q13	V-REL AVIAN RETICULOENDOTHELIOSIS VIRAL ONCOGENE HOMOLOG A; RELA	5970
MIM164015		5q31.2	MATRIN 3; MATR3	9782
MIM164017		12q13.1	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; HNRNPA1	3178
MIM164020		 	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C; HNRNPC	3183
MIM164031		12p13	NUCLEOLAR PROTEIN 1; NOL1	4839
MIM164035		2q12-qter	NUCLEOLIN; NCL	4691
MIM164040		5q35	NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 1; NPM1	4869
MIM164050		14q13.1	PURINE NUCLEOSIDE PHOSPHORYLASE; PNP	4860
MIM164060		12q21.2	NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 1; NAP1L1	4673
MIM164100	C1834079	6p12	NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	4933
MIM164150	C1834078	 	NYSTAGMUS, HEREDITARY VERTICAL	 
MIM164160		7q31.3	LEPTIN; LEP	3952
MIM164170	C0339667	 	NYSTAGMUS, VOLUNTARY	 
MIM164175		1q22-q23	POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 1; POU2F1	5451
MIM164176		19q13.2	POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 2; POU2F2	5452
MIM164177		6p21.3	POU DOMAIN, CLASS 5, TRANSCRIPTION FACTOR 1; POU5F1	5460
MIM164180	C0796092	 	OCULOCEREBROCUTANEOUS SYNDROME	 
MIM164185	C1282359	 	OCULAR CICATRICIAL PEMPHIGOID; OCP	 
MIM164190	C0422883	 	OCULAR DOMINANCE	 
MIM164200	C0812437	6q21-q23.2	OCULODENTODIGITAL DYSPLASIA; ODDD	2697
MIM164210	C0265240	14q32	HEMIFACIAL MICROSOMIA; HFM	170474
MIM164220	C1834038	 	SCHILBACH-ROTT SYNDROME	 
MIM164230	C1834037	17q11.1-q12, 13q14-q21, 11p13	OBSESSIVE-COMPULSIVE DISORDER; OCD	3356, 627, 6532
MIM164280	C0796068	2p24.1	FEINGOLD SYNDROME 1; FGLDS1	 
MIM164300	C0270952	14q11.2-q13	OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD	8106
MIM164310	C1834014	 	OCULOPHARYNGODISTAL MYOPATHY; OPDM	 
MIM164320		9q34	ODORANT-BINDING PROTEIN 2A; OBP2A	29991
MIM164330	C1834013	 	ODONTOMA-DYSPHAGIA SYNDROME	 
MIM164340		11q13.4-q14.1	OLFACTORY MARKER PROTEIN; OMP	4975
MIM164342		17p13.3	OLFACTORY RECEPTOR, FAMILY 1, SUBFAMILY D, MEMBER 2; OR1D2	4991
MIM164343		5q34	EARLY B-CELL FACTOR 1; EBF1	1879
MIM164345		17q11.2	OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; OMG	4974
MIM164350		12q24.2	2-PRIME,5-PRIME-@OLIGOADENYLATE SYNTHETASE 1; OAS1	4938
MIM164360		18q12-q21	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, ALPHA SUBUNIT 1; ATP5A1	498
MIM164400	C0752120	6p23	SPINOCEREBELLAR ATAXIA 1; SCA1	6310
MIM164500	C0752125	3p21.1-p12	SPINOCEREBELLAR ATAXIA 7; SCA7	6314
MIM164680	C1833997	 	ONYCHOGRYPOSIS, PEDAL, WITH KERATOSIS PLANTARIS AND COARSE HAIR	 
MIM164690		1q24-q25	V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 2; ABL2	27
MIM164700	C1833995	 	OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V	 
MIM164720		11q23.3	V-ETS AVIAN ERYTHROBLASTOSIS VIRUS E26 ONCOGENE HOMOLOG 1; ETS1	2113
MIM164730		14q32.3	V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1; AKT1	207
MIM164731		19q13.1-q13.2	V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 2; AKT2	208
MIM164740		21q22.3	V-ETS AVIAN ERYTHROBLASTOSIS VIRUS E26 ONCOGENE HOMOLOG 2; ETS2	2114
MIM164745	C2750355	 	OMODYSPLASIA 2; OMOD2	 
MIM164750	C0795690	 	OMPHALOCELE, AUTOSOMAL	 
MIM164755		2q14-q21	VIRAL INTEGRATION SITE 1; VIS1	7435
MIM164757		7q34	V-RAF MURINE SARCOMA VIRAL ONCOGENE HOMOLOG B1; BRAF	673
MIM164760		3p25	V-RAF-1 MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; RAF1	5894
MIM164761		10q11.2	REARRANGED DURING TRANSFECTION PROTOONCOGENE; RET	5979
MIM164762		17p13.3	V-CRK AVIAN SARCOMA VIRUS CT10 ONCOGENE HOMOLOG; CRK	1398
MIM164765		11q13	CORTACTIN; CTTN	2017
MIM164770		5q33.2-q33.3	COLONY-STIMULATING FACTOR 1 RECEPTOR; CSF1R	1436
MIM164772		19q13.3	V-FOS FBJ MURINE OSTEOSARCOMA VIRAL ONCOGENE HOMOLOG B; FOSB	2354
MIM164780		1p36.3	V-SKI AVIAN SARCOMA VIRAL ONCOGENE HOMOLOG; SKI	6497
MIM164785		12q14.3-q15	MOUSE DOUBLE MINUTE 2 HOMOLOG; MDM2	4193
MIM164790		1p13.2	NEUROBLASTOMA RAS VIRAL ONCOGENE HOMOLOG; NRAS	4893
MIM164795		7p13-p11	ONCOMODULIN; OCM	654231
MIM164800	C1833909	 	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 5; NDNC5	 
MIM164810		14q24.3	V-FOS FBJ MURINE OSTEOSARCOMA VIRAL ONCOGENE HOMOLOG; FOS	2353
MIM164820		12q12-q13	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 1; WNT1	7471
MIM164831		10p13	LEUKEMIA VIRAL BMI-1 ONCOGENE, MOUSE, HOMOLOG OF; BMI1	648
MIM164840		2p24.1	V-MYC AVIAN MYELOCYTOMATOSIS VIRAL-RELATED ONCOGENE, NEUROBLASTOMA-DERIVED; MYCN	4613
MIM164850		1p34.3	V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG 1, LUNG CARCINOMA-DERIVED; MYCL1	4610
MIM164860		7q31	MET PROTOONCOGENE; MET	4233
MIM164865		7p15	V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG-LIKE 1; MYCLK1	4612
MIM164870		17q21.1	V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 2; ERBB2	2064
MIM164873		1q21-q23	ETS VARIANT GENE 3; ETV3	2117
MIM164874		14q13	FORKHEAD BOX G1; FOXG1	2290
MIM164875		19p13.3-p13.2	VAV1 ONCOGENE; VAV1	7409
MIM164880		18p11.3	V-YES-1 YAMAGUCHI SARCOMA VIRAL ONCOGENE; YES1	7525
MIM164900	C1833872	 	OPHTHALMOMANDIBULOMELIC DYSPLASIA	 
MIM164910		2p13-p12	V-REL AVIAN RETICULOENDOTHELIOSIS VIRAL ONCOGENE HOMOLOG; REL	5966
MIM164920		4q12	V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG; KIT	3815
MIM164940		1p36.2-p36.1	GARDNER-RASHEED FELINE SARCOMA VIRAL ONCOGENE HOMOLOG; FGR	2268
MIM164950		11q13	FIBROBLAST GROWTH FACTOR 3; FGF3	2248
MIM164951		6p21.3	NOTCH, DROSOPHILA, HOMOLOG OF, 4; NOTCH4	4855
MIM164953		19p13.2-q13.3	ONCOGENE LIPOSARCOMA; LPSA	8177
MIM164958		8q24.1	NEPHROBLASTOMA OVEREXPRESSED GENE; NOV	4856
MIM164960		6p21.2	ONCOGENE PIM 1; PIM1	5292
MIM164975		3p21-p14	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 5A; WNT5A	7474
MIM164980		11q13	FIBROBLAST GROWTH FACTOR 4; FGF4	2249
MIM165000	C1833839	 	OPHTHALMOPLEGIA, FAMILIAL STATIC	 
MIM165020		6q22	V-ROS AVIAN UR2 SARCOMA VIRUS ONCOGENE HOMOLOG 1; ROS1	6098
MIM165040		19p13.2-cen	RAS-ASSOCIATED PROTEIN RAB8A; RAB8A	4218
MIM165060		19q13.2-q13.3	TRANSFER RNA SELENOCYSTEINE 1; TRNAU1	7234
MIM165070		13q12	FMS-RELATED TYROSINE KINASE 1; FLT1	2321
MIM165080		21q22.3	V-ETS AVIAN ERYTHROBLASTOSIS VIRUS E26 ONCOGENE HOMOLOG; ERG	2078
MIM165090		19q13.3-qter	RELATED RAS VIRAL ONCOGENE HOMOLOG; RRAS	6237
MIM165095		22q12.1-q12.2	ONCOSTATIN M; OSM	5008
MIM165098	C1833836	 	OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	 
MIM165110		11q13	S13 AVIAN ERYTHROBLASTOSIS ONCOGENE HOMOLOG; SEA	6395
MIM165120		8q13-qter	V-YES-1 YAMAGUCHI SARCOMA VIRAL RELATED ONCOGENE HOMOLOG; LYN	4067
MIM165140		8q24	ONCOGENE PVT-1; PVT1	5820
MIM165150	C1833835	 	OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY	 
MIM165160		1p32-p31	V-JUN AVIAN SARCOMA VIRUS 17 ONCOGENE HOMOLOG; JUN	3725
MIM165161		19p13.2	ONCOGENE JUN-B; JUNB	3726
MIM165162		19p13.1-p12	ONCOGENE JUN-D; JUND	3727
MIM165170		11p11.2	SPLEEN FOCUS FORMING VIRUS PROVIRAL INTEGRATION ONCOGENE SPI1; SPI1	6688
MIM165180		6q24-q27	MAS1 ONCOGENE; MAS1	4142
MIM165190		4q21	FIBROBLAST GROWTH FACTOR 5; FGF5	2250
MIM165195		1p36.1-p34.3	OPIOID RECEPTOR, DELTA-1; OPRD1	4985
MIM165196		8q11.2	OPIOID RECEPTOR, KAPPA-1; OPRK1	4986
MIM165199	C1833831	 	OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMAL DOMINANT	 
MIM165215		3q26	ECOTROPIC VIRAL INTEGRATION SITE 1; EVI1	2122
MIM165220		12q13.2-q13.3	GLIOMA-ASSOCIATED ONCOGENE HOMOLOG; GLI	2735
MIM165230		2q14	GLI-KRUPPEL FAMILY MEMBER 2; GLI2	2736
MIM165240		7p13	GLI-KRUPPEL FAMILY MEMBER 3; GLI3	2737
MIM165250		19q13.12	GLI-KRUPPEL FAMILY MEMBER HKR1; HKR1	284459
MIM165260		19q13.43	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 22; ZSCAN22	342945
MIM165270		1p36.3	GLI-KRUPPEL FAMILY MEMBER HKR3; HKR3	3104
MIM165280		8q24.3	GLI-KRUPPEL FAMILY MEMBER 4; GLI4	2738
MIM165300	C1833809	19q13.2-q13.3	OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	80207
MIM165320		2q14-q21	LIVER CANCER ONCOGENE; LCO	3935
MIM165330		17q21	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3; WNT3	7473
MIM165340		 	SKI-LIKE; SKIL	6498
MIM165360		11q23.3	CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE HOMOLOG; CBL	867
MIM165370		2pter-p12	RAS HOMOLOG GENE FAMILY, MEMBER B; RHOB	388
MIM165380		1p21-p13	RAS HOMOLOG GENE FAMILY, MEMBER C; RHOC	389
MIM165390		3p21.3	RAS HOMOLOG GENE FAMILY, MEMBER A; RHOA	387
MIM165500	C0338508	3q28-q29	OPTIC ATROPHY 1; OPA1	4976
MIM165510	C1833799	 	OPTIC ATROPHY WITH NEGATIVE ELECTRORETINOGRAMS	 
MIM165550	C1833797	11p13	OPTIC NERVE HYPOPLASIA, BILATERAL	5080
MIM165590	C1833796	 	OROFACIODIGITAL SYNDROME X; OFD10	 
MIM165600	C1833795	 	ORBITAL MARGIN, HYPOPLASIA OF	 
MIM165640		2p25	ORNITHINE DECARBOXYLASE 1; ODC1	4953
MIM165660	C1833792	 	OSLAM SYNDROME	 
MIM165670	C1833791	 	OSSIFIED EAR CARTILAGES	 
MIM165680	C1833790	 	OSSICULAR MALFORMATIONS, FAMILIAL	 
MIM165700	C0264081	 	THIEMANN DISEASE	 
MIM165720	C0029408	2q31-q33	OSTEOARTHRITIS SUSCEPTIBILITY 1; OS1	2487
MIM165800	C0029421	15q26.1	OSTEOCHONDRITIS DISSECANS, SHORT STATURE, AND EARLY-ONSET OSTEOARTHRITIS; OD	176
MIM166000	C0014084	 	ENCHONDROMATOSIS, MULTIPLE, OLLIER TYPE	 
MIM166200	C0023931	17q21.31-q22	OSTEOGENESIS IMPERFECTA, TYPE I	1277
MIM166210	C0268360	7q22.1, 17q21.31-q22	OSTEOGENESIS IMPERFECTA, TYPE II	1277, 1278
MIM166220	C0268363	7q22.1, 17q21.31-q22	OSTEOGENESIS IMPERFECTA, TYPE IV	1277, 1278
MIM166230	C1833748	 	OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	 
MIM166250	C0432283	8p11.2-p11.1	OSTEOGLOPHONIC DYSPLASIA; OGD	2260
MIM166260	C1833736	11p14.3	GNATHODIAPHYSEAL DYSPLASIA; GDD	203859
MIM166300	C2674705	 	MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	9935
MIM166350	C0334041	20q13.2	OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	2778
MIM166400	C1833733	 	OSTEOMAS OF MANDIBLE	 
MIM166450	C0432264	 	OSTEOMESOPYKNOSIS	 
MIM166490		4q21-q25	SECRETED PHOSPHOPROTEIN 1; SPP1	6696
MIM166600	C1833700	16p13	OSTEOPETROSIS, AUTOSOMAL DOMINANT 2; OPTA2	1186
MIM166700	C0265514	12q14	BUSCHKE-OLLENDORFF SYNDROME; BOS	23592
MIM166705	C1833698	 	OSTEOPOIKILOSIS AND DACRYOCYSTITIS	 
MIM166710	C0029458	12q12-q14, 11q13.4, 11p12, 7q22.1, 7q21.3, 5q31.1, 20p12.3, 17q21.31-q22	OSTEOPOROSIS	1277, 1278, 4041, 7421, 799, 8572
MIM166740	C1833697	 	OSTEOSCLEROSIS WITH ICHTHYOSIS AND FRACTURES	 
MIM166750	C1833693	 	OTODENTAL DYSPLASIA	100885788
MIM166760	C1833692	10q26.3	OTITIS MEDIA, SUSCEPTIBILITY TO	619538
MIM166780	C1833691	8q13.3	OTOFACIOCERVICAL SYNDROME	2138
MIM166800	CN032031	15q26.1-qter	OTOSCLEROSIS 1; OTSC1	5012
MIM166900	C1833690	 	OVALOCYTOSIS, HEREDITARY HEMOLYTIC	 
MIM166910	C1833689	 	OVALOCYTOSIS, HEREDITARY HEMOLYTIC, WITH DEFECTIVE ERYTHROPOIESIS	 
MIM166945		17q21.1	NEIGHBOR OF BRCA1 GENE 1; NBR1	4077
MIM166950	C0280131	 	TERATOMA, OVARIAN	 
MIM166970	C0149951	 	OVARIAN FIBROMATA	 
MIM166990	C1833688	 	OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA, HYDROCEPHALUS, AND HYPERTENSION	 
MIM167000	C0919267	16q22.1, 11q25, 6q26-q27, 3p22-p21.3	OVARIAN CANCER	1499, 207, 4978, 5071, 5290, 6765, 999
MIM167040		11q12.1	OXYSTEROL-BINDING PROTEIN; OSBP	5007
MIM167050		20p13	OXYTOCIN; OXT	5020
MIM167055		3p26.2	OXYTOCIN RECEPTOR; OXTR	5021
MIM167100	C2674695	 	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT; PHOAD	 
MIM167200	C1706595	17q12-q21, 12q13	PACHYONYCHIA CONGENITA, TYPE 1; PC1	3853, 3868
MIM167210	C1721007	17q12-q21, 12q13	PACHYONYCHIA CONGENITA, TYPE 2; PC2	3854, 3872
MIM167220	C1833676	 	PACMAN DYSPLASIA	 
MIM167250	CN032130	6p21.3	PAGET DISEASE OF BONE 1; PDB1	5131
MIM167320	C1833662	9p13-p12	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA; IBMPFD	7415
MIM167400	C1833661	2q24	PAROXYSMAL EXTREME PAIN DISORDER	6335
MIM167405		15q26	PAIRED BASIC AMINO ACID CLEAVING ENZYME 4; PACE4	5046
MIM167409		10q24.3-q25.1	PAIRED BOX GENE 2; PAX2	5076
MIM167410		1p36.2-p36.12	PAIRED BOX GENE 7; PAX7	5081
MIM167411		20p11.2	PAIRED BOX GENE 1; PAX1	5075
MIM167413		7q32	PAIRED BOX GENE 4; PAX4	5078
MIM167414		9p13	PAIRED BOX GENE 5; PAX5	5079
MIM167415		2q12-q14	PAIRED BOX GENE 8; PAX8	7849
MIM167416		14q12-q13	PAIRED BOX GENE 9; PAX9	5083
MIM167420		1q24	PAIRED-RELATED HOMEOBOX GENE 1; PRRX1	5396
MIM167500	C0042454	 	PALATOPHARYNGEAL INCOMPETENCE	 
MIM167600	C1868661	 	PALMARIS LONGUS MUSCLE, ABSENCE OF	 
MIM167700	C0751470	 	PALMOMENTAL REFLEX	 
MIM167730	C1868660	 	PALPEBRAL COLOBOMA-LIPOMA SYNDROME	 
MIM167750	C0149955	 	PANCREAS, ANNULAR	 
MIM167755	C1868659	 	PANCREAS, DORSAL, AGENESIS OF	 
MIM167770		2p12	REGENERATING ISLET-DERIVED 1-ALPHA; REG1A	5967
MIM167771		2p12	REGENERATING ISLET-DERIVED 1-BETA; REG1B	5968
MIM167780		17q12-q21	PANCREATIC POLYPEPTIDE/PANCREATIC ICOSAPEPTIDE; PPY	5539
MIM167790		5q32	SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 1; SPINK1	6690
MIM167800	C0238339	1p36.21, 7q35, 7q31.2, 5q32	PANCREATITIS, HEREDITARY; PCTT	1080, 11330, 5644, 5645, 6690
MIM167805		2p12	REGENERATING ISLET-DERIVED 3-ALPHA; REG3A	5068
MIM167870	C1868649	13q22-q32, 22q11.2	PANIC DISORDER 1; PAND1	1312, 387572
MIM167900	C1868648	 	PAPILLOMATOSIS, CONFLUENT AND RETICULATED; CARP	 
MIM167950	C1868647	 	PAPILLOMATOSIS, FLORID, OF NIPPLE	 
MIM167959		8q24	HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 1; HPV18I1	3260
MIM167960		12q13	HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 2; HPV18I2	3261
MIM168000	C1868633	11q23	PARAGANGLIOMAS 1; PGL1	6392
MIM168100	C0238344	 	PARALYSIS AGITANS, JUVENILE, OF HUNT	 
MIM168200	C1868632	 	PARAMOLAR TUBERCLE OF BOLK	 
MIM168300	C1868617	17q23.1-q25.3	PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC	6329
MIM168360		1p34	EMBRYONIC LETHAL, ABNORMAL VISION, DROSOPHILA, HOMOLOG-LIKE 4; ELAVL4	1996
MIM168400	C1868616	 	PARASTREMMATIC DWARFISM	59341
MIM168440		12p13.31	PARATHYMOSIN; PTMS	5763
MIM168450		11p15.3-p15.1	PARATHYROID HORMONE; PTH	5741
MIM168461		11q13	CYCLIN D1; CCND1	595
MIM168468		3p22-p21.1	PARATHYROID HORMONE 1 RECEPTOR; PTH1R	5745
MIM168470		12p12.1-p11.2	PARATHYROID HORMONE-LIKE HORMONE; PTHLH	5744
MIM168500	C1868598	5q34-q35	PARIETAL FORAMINA; PFM	4488
MIM168550	C1868597	5q34-q35	PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA; PFMCCD	4488
MIM168600	C3160718	17q21.1, 6q27, 4q22	PARKINSON DISEASE, LATE-ONSET; PD	126, 2629, 4137, 4929, 6908, 9627
MIM168601	C1868595	4q21	PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	6622
MIM168605	C1868594	2p13	PERRY SYNDROME	1639
MIM168710		12p13.2	PAROTID PROLINE-RICH SALIVARY PROTEIN Pc	8075
MIM168730		12p13.2	PROLINE-RICH PROTEIN, HaeIII SUBFAMILY, 1; PRH1	5554
MIM168790		12p13.2	PROLINE-RICH PROTEIN, HaeIII SUBFAMILY, 2; PRH2	5555
MIM168800	C1868590	 	PAROTIDOMEGALY, HEREDITARY BILATERAL	 
MIM168810		12p13.2	PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 2; PRB2	653247
MIM168820		7q21.3	PARAOXONASE 1; PON1	5444
MIM168840		12p13.2	PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 3; PRB3	5544
MIM168850	C1868581	 	PATELLA APLASIA, COXA VARA, AND TARSAL SYNOSTOSIS	 
MIM168860	C1868577	17q21-q22	PATELLA APLASIA-HYPOPLASIA; PTLAH	8830
MIM168885	C1868576	 	PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	 
MIM168890		22q12-q13.1	PARVALBUMIN; PVALB	5816
MIM168900	C0008475	 	PATELLA, CHONDROMALACIA OF	 
MIM169000	C1868575	 	PATELLA, FAMILIAL RECURRENT DISLOCATION OF	 
MIM169100	C1868570	6p12	CHAR SYNDROME	7021
MIM169150	C1868569	6p21.1-cen	PATTERNED DYSTROPHY OF RETINAL PIGMENT EPITHELIUM	5961
MIM169170	C1868546	 	PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	 
MIM169190		1q31-q32	PCTAIRE PROTEIN KINASE 3; PCTK3	5129
MIM169200	C1868545	 	PECHET FACTOR DEFICIENCY	 
MIM169300	C0016842	 	PECTUS EXCAVATUM	 
MIM169400	C0030779	1q42.1	PELGER-HUET ANOMALY; PHA	3930
MIM169500	C1868512	5q23.3-q31.1	LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	4001
MIM169545	C1868511	 	PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	 
MIM169550	C1868508	 	PELVIS-SHOULDER DYSPLASIA	 
MIM169600	C0085106	3q21-q24	BENIGN CHRONIC PEMPHIGUS; BCPM	27032
MIM169610	C1868502	 	PEMPHIGUS VULGARIS, FAMILIAL	 
MIM169615		18q12.1-q12.2	DESMOGLEIN 3; DSG3	1830
MIM169710		11q13	PEPSINOGEN 3, GROUP I; PGA3	643834
MIM169720		11q13	PEPSINOGEN 4, GROUP I; PGA4	643847
MIM169730		11q13	PEPSINOGEN 5, GROUP I; PGA5	5222
MIM169740		6p21.3-p21.1	PEPSINOGEN C	5225
MIM169800		18q23	PEPTIDASE A; PEPA	55748
MIM169900		12q21	PEPTIDASE B; PEPB	5182
MIM170000		1q42	PEPTIDASE C; PEPC	5183
MIM170100	C0268532	19cen-q13.11	PROLIDASE DEFICIENCY	5184
MIM170200		17q23-qter	PEPTIDASE E; PEPE	5185
MIM170250		4p11-q12	LEUCINE AMINOPEPTIDASE 3; LAP3	51056
MIM170260		6p21.3	TRANSPORTER, ATP-BINDING CASSETTE, MAJOR HISTOCOMPATIBILITY COMPLEX, 1; TAP1	6890
MIM170261		6p21.3	TRANSPORTER, ATP-BINDING CASSETTE, MAJOR HISTOCOMPATIBILITY COMPLEX, 2; TAP2	6891
MIM170270		5q14-q21	PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE; PAM	5066
MIM170280		10q22	PERFORIN 1; PRF1	5551
MIM170285		17q25	NUCLEOPORIN, 85-KD; NUP85	79902
MIM170290		15q26	PERILIPIN 1; PLIN1	5346
MIM170390	C1563715	17q23.1-q24.2	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	3759
MIM170400	C3714580	1q32	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1	779
MIM170500	CN074266	 	HYPERKALEMIC PERIODIC PARALYSIS; HYPP	6329
MIM170600	C0268445	 	NORMOKALEMIC PERIODIC PARALYSIS	 
MIM170650	C0031106	11q14.1-q14.3	PERIODONTITIS, AGGRESSIVE, 1	1075
MIM170700	CN074256	 	PERIPHERAL DYSOSTOSIS	 
MIM170710		12q12-q13	PERIPHERIN; PRPH	5630
MIM170715		8q21.3-q22.1	PERIPHERAL MYELIN PROTEIN 2; PMP2	5375
MIM170900	C0002892	 	PERNICIOUS ANEMIA	 
MIM170980	C1868426	 	PERONEAL NERVE, ACCESSORY DEEP	 
MIM170993		8q21.1	PEROXISOME BIOGENESIS FACTOR 2; PEX2	5828
MIM170995		1p22-p21	ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 3; ABCD3	5825
MIM170998		22q12-q13.1	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA	5465
MIM171050		7q21.1	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 1; ABCB1	5243
MIM171060		7q21.1	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 4; ABCB4	5244
MIM171100	C1868402	 	PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	 
MIM171150		16p12.1-p11.2	SULFOTRANSFERASE FAMILY 1A, PHENOL-PREFERRING, MEMBER 1; SULT1A1	6817
MIM171190		17q21-q22	PHENYLETHANOLAMINE N-METHYLTRANSFERASE; PNMT	5409
MIM171200	C1868397	7q35-q36	THIOUREA TASTING	5726
MIM171300	C0031511	1p36.2, 11q23, 10q11.2, 5p13.1-p12, 3p26-p25, 1p36.1-p35, 2q11	PHEOCHROMOCYTOMA	23095, 2668, 4149, 55654, 5979, 6390, 6392, 7428
MIM171400	C0025268	10q11.2	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	5979
MIM171420	C1868392	 	PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	 
MIM171450	C1868391	 	PHLEBECTASIA OF LIPS	 
MIM171480	C1868390	 	PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	 
MIM171490		1q25-q31.1	PHOSDUCIN; PDC	5132
MIM171500		2p25	ACID PHOSPHATASE 1, SOLUBLE; ACP1	52
MIM171640		19p13.3-p13.1	PHOSPHATASE, ACID, TYPE 5, TARTRATE-RESISTANT; ACP5	54
MIM171650		11p12-p11	ACID PHOSPHATASE 2, LYSOSOMAL; ACP2	53
MIM171720	C1868387	9q34.13	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1	100196909
MIM171740		2q37.1	ALKALINE PHOSPHATASE, INTESTINAL; ALPI	248
MIM171760		1p36.1-p34	ALKALINE PHOSPHATASE, LIVER; ALPL	249
MIM171790		3q21-q23	PHOSPHATASE, PROSTATE-SPECIFIC ACID; ACPP	55
MIM171800		2q37	ALKALINE PHOSPHATASE, PLACENTAL; ALPP	250
MIM171810		2q37	ALKALINE PHOSPHATASE, PLACENTAL-LIKE 2; ALPPL2	251
MIM171833		5q13	PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 1; PIK3R1	5295
MIM171834		3q26.3	PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, ALPHA; PIK3CA	5290
MIM171835		1q31	6-@PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 2; PFKFB2	5208
MIM171840		10p15.3-p15.2	PHOSPHOFRUCTOKINASE, PLATELET TYPE; PFKP	5214
MIM171860		21q22.3	PHOSPHOFRUCTOKINASE, LIVER TYPE; PFKL	5211
MIM171885		8q13-q22	PHOSPHODIESTERASE 7A, cAMP-SPECIFIC, HIGH-AFFINITY; PDE7A	5150
MIM171890		2q32.1	PHOSPHODIESTERASE 1A; PDE1A	5136
MIM171891		12q13	PHOSPHODIESTERASE 1B; PDE1B	5153
MIM171900		1p31	PHOSPHOGLUCOMUTASE 1; PGM1	5236
MIM172000		4p14-q12	PHOSPHOGLUCOMUTASE 2; PGM2	55276
MIM172100		6q12	PHOSPHOGLUCOMUTASE 3; PGM3	5238
MIM172150	C1868355	 	6-@PHOSPHOGLUCONOLACTONASE DEFICIENCY	 
MIM172200		1p36.2-p36.13	6-@PHOSPHOGLUCONATE DEHYDROGENASE, ERYTHROCYTE; PGD	5226
MIM172250		10q25.3	PHOSPHOGLYCERATE MUTASE 1; PGAM1	5223
MIM172270		6p21.1-p12	PHOSPHOGLYCERATE KINASE 2; PGK2	5232
MIM172280		16p13.3	PHOSPHOGLYCOLATE PHOSPHATASE; PGP	283871
MIM172400		19q13.1	GLUCOSE-6-PHOSPHATE ISOMERASE; GPI	2821
MIM172405		6q22.1	PHOSPHOLAMBAN; PLN	5350
MIM172410		12q23-q24.1	PHOSPHOLIPASE A2, GROUP IB; PLA2G1B	5319
MIM172411		1p35	PHOSPHOLIPASE A2, GROUP IIA; PLA2G2A	5320
MIM172420		20q12-q13.1	PHOSPHOLIPASE C, GAMMA-1; PLCG1	5335
MIM172425		20q12-q13.1	PHOSPHOLIPID TRANSFER PROTEIN; PLTP	5360
MIM172430		1pter-p36.13	ENOLASE 1; ENO1	2023
MIM172439		4q12	PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASE; PAICS	10606
MIM172450		4q12	PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE; PPAT	5471
MIM172460		14q24	METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1; MTHFD1	4522
MIM172470		7p12-q21	PHOSPHORYLASE KINASE, MUSCLE, GAMMA-1; PHKG1	5260
MIM172471		16p12.1-p11.2	PHOSPHORYLASE KINASE, TESTIS/LIVER, GAMMA-2; PHKG2	5261
MIM172480		7p15.2-p15.1	PHOSPHOSERINE PHOSPHATASE; PSPH	5723
MIM172490		16q12-q13	PHOSPHORYLASE KINASE, BETA SUBUNIT; PHKB	5257
MIM172500	C1809475	 	PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRAL DYSFUNCTION	 
MIM172700	C0236642	17q21.1, 14q24.3	PICK DISEASE OF BRAIN	4137, 5663
MIM172800	C0080024	8q11	PIEBALD TRAIT; PBT	3815, 6591
MIM172850	C1868311	 	PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	 
MIM172860		17p13.3	SERPIN PEPTIDASE INHIBITOR, CLADE F, MEMBER 1; SERPINF1	5176
MIM172870	C1868310	1q31-q32.1	PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY; PPCRA	23418
MIM172880	C1868309	 	PIERRE ROBIN SYNDROME AND OLIGODACTYLY	 
MIM172900	C0263396	 	PIGMENTED PURPURIC ERUPTION	 
MIM173000	C0031925	 	PILONIDAL SINUS	 
MIM173100	C0271567	17q22-q24	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II; IGHD2	2688
MIM173110		3p11	POU DOMAIN, CLASS 1, TRANSCRIPTION FACTOR 1; POU1F1	5449
MIM173120		15q11-q15	SECRETORY GRANULE NEUROENDOCRINE PROTEIN 1; SGNE1	6447
MIM173200	C0032027	 	PITYRIASIS RUBRA PILARIS; PRP	79092
MIM173310		9q34	PROGESTAGEN-ASSOCIATED ENDOMETRIAL PROTEIN; PAEP	5047
MIM173320		11p15.5	RIBONUCLEASE/ANGIOGENIN INHIBITOR; RNH	6050
MIM173321		6p25	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 6; SERPINB6	5269
MIM173325		17q21	JUNCTION PLAKOGLOBIN; JUP	3728
MIM173335		6q22-q23	ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1; ENPP1	5167
MIM173340		2p11-q11	PLASMINOGEN-LIKE B1; PLGLB1	5343
MIM173350		6q26	PLASMINOGEN; PLG	5340
MIM173360		7q21.3-q22	SERPIN PEPTIDASE INHIBITOR, CLADE E (NEXIN, PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1), MEMBER 1; SERPINE1	5054
MIM173370		8p12	PLASMINOGEN ACTIVATOR, TISSUE; PLAT	5327
MIM173390		18q21.3	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 2; SERPINB2	5055
MIM173391		19q13	PLASMINOGEN ACTIVATOR RECEPTOR, UROKINASE-TYPE; PLAUR	5329
MIM173393		1p35-p34.3	PLATELET-ACTIVATING FACTOR RECEPTOR; PTAFR	5724
MIM173400	C1868263	 	PLATELET AGGREGATION, SPONTANEOUS	 
MIM173410		5q31-q32	PLATELET-DERIVED GROWTH FACTOR RECEPTOR, BETA; PDGFRB	5159
MIM173420	C1868258	 	PLATELET DISORDER, UNDEFINED	 
MIM173430		7p22	PLATELET-DERIVED GROWTH FACTOR, ALPHA POLYPEPTIDE; PDGFA	5154
MIM173445		17q23	PLATELET-ENDOTHELIAL CELL ADHESION MOLECULE 1; PECAM1	5175
MIM173450	C1868256	 	PLATELET FACTOR 3 DEFICIENCY	 
MIM173460		4q12-q13	PLATELET FACTOR 4; PF4	5196
MIM173461		4q12-q13	PLATELET FACTOR 4, VARIANT 1; PF4V1	5197
MIM173470		17q21.32	INTEGRIN, BETA-3; ITGB3	3690
MIM173490		4q12	PLATELET-DERIVED GROWTH FACTOR RECEPTOR, ALPHA; PDGFRA	5156
MIM173500	CN240900	 	PLATELET GROUPS--Ko SYSTEM; HPA-2	 
MIM173510		7q11.2	CD36 ANTIGEN; CD36	948
MIM173511		 	GLYCOPROTEIN V, PLATELET; GP5	2814
MIM173515		3q21	GLYCOPROTEIN IX, PLATELET; GP9	2815
MIM173560	C1868201	 	PLATELET MEMBRANE FLUIDITY; PMF	 
MIM173570		2p	PLECKSTRIN; PLEK	5341
MIM173580	C1868200	 	PLATELET RESPONSIVENESS TO ADRENALINE, DEPRESSED	 
MIM173590	C1868199	 	PLATELET SIGNAL PROCESSING DEFECT	 
MIM173600	C1868193	17p11.2	PNEUMOTHORAX, PRIMARY SPONTANEOUS	201163
MIM173610		1q23-q25	SELECTIN P; SELP	6403
MIM173650	C0406557	20p13	KINDLER SYNDROME	55612
MIM173700	C0343094	 	POIKILODERMA, HEREDITARY SCLEROSING	 
MIM173800	C0032357	 	POLAND SYNDROME	 
MIM173850		19q13.2-q13.3	POLIOVIRUS RECEPTOR; PVR	5817
MIM173865		3q22-q25	POLYADENYLATE-BINDING PROTEIN-LIKE 1; PABPL1	285314
MIM173870		1q42	POLY(ADP-RIBOSE) POLYMERASE 1; PARP1	142
MIM173880		1q31-q42	POLYMERIC IMMUNOGLOBULIN RECEPTOR; PIGR	5284
MIM173900	C0085413	16p13.3-p13.12	POLYCYSTIC KIDNEY DISEASE 1; PKD1	5310
MIM173910		4q21-q23	POLYCYSTIN 2; PKD2	5311
MIM174000	C1868139	1q21	MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	4169
MIM174050	C0158683	6q21, 19p13.2-p13.1	POLYCYSTIC LIVER DISEASE; PCLD	11231, 5589
MIM174200	C0220697	7p13	POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1	2737
MIM174300	C1868118	 	OROFACIODIGITAL SYNDROME V; OFD5	 
MIM174310	C1868117	 	POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA	 
MIM174400	C1868116	 	POLYDACTYLY, PREAXIAL I	 
MIM174500	C1868114	7q36	POLYDACTYLY, PREAXIAL II; PPD2	64327
MIM174600	C1868113	 	POLYDACTYLY, PREAXIAL III	 
MIM174700	C1868111	7p13	POLYDACTYLY, PREAXIAL IV	2737
MIM174750	CN034562	 	POLYKARYOCYTOSIS INDUCER; FUSE	2522
MIM174760		8p11.2	POLYMERASE, DNA, BETA; POLB	5423
MIM174761		19q13.3-q13.4	POLYMERASE (DNA-DIRECTED), DELTA 1, CATALYTIC SUBUNIT; POLD1	5424
MIM174762		12q24.3	POLYMERASE, DNA, EPSILON; POLE	5426
MIM174763		15q25	POLYMERASE, DNA, GAMMA; POLG	5428
MIM174770	C0406217	 	ACTINIC PRURIGO	 
MIM174800	C0242292	20q13.2	MCCUNE-ALBRIGHT SYNDROME; MAS	2778
MIM174810	C0432292	18q22.1	FAMILIAL EXPANSILE OSTEOLYSIS; FEO	8792
MIM174900	C0345893	10q22.3, 18q21.1	JUVENILE POLYPOSIS SYNDROME; JPS	4089, 657
MIM175020	C0236048	 	POLYPOSIS, GASTRIC	 
MIM175050	C1832942	18q21.1	JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	4089
MIM175100	C2713442	5q21-q22	FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	324, 4595
MIM175200	C0031269	19p13.3	PEUTZ-JEGHERS SYNDROME; PJS	6794
MIM175400	C1868006	 	POLYPOSIS, INTESTINAL, SCATTERED AND DISCRETE	 
MIM175450	C1868005	 	POLYPOSIS, INTESTINAL, WITH MULTIPLE EXOSTOSES	 
MIM175500	C0282207	 	POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES	 
MIM175505	C1868001	 	POLYPOSIS OF GASTRIC FUNDUS WITHOUT POLYPOSIS COLI	 
MIM175510	C1868000	 	POLYPS, MULTIPLE AND RECURRENT INFLAMMATORY FIBROID, GASTROINTESTINAL	 
MIM175690	C1867999	 	POLYSYNDACTYLY, CROSSED	 
MIM175700	C0265306	7p13	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS	2737
MIM175750	C0032650	 	POPLITEAL CYST	 
MIM175780	CN032791	13q34	PORENCEPHALY 1; POREN1	1282
MIM175800	C0949506	 	POROKERATOSIS OF MIBELLI	 
MIM175850	C0162838	12q24.1-q24.2	POROKERATOSIS, PALMAR, PLANTAR, AND DISSEMINATED, 1; PPPD1	100196910
MIM175860	C1867982	 	KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE II; PPKP2	 
MIM175900	C1867981	12q24.1	POROKERATOSIS, DISSEMINATED SUPERFICIAL ACTINIC, 1; DSAP1	9733
MIM176000	C0162565	11q23.3	PORPHYRIA, ACUTE INTERMITTENT	3145
MIM176090	C1867968	 	PORPHYRIA CUTANEA TARDA, TYPE I	 
MIM176100	C0268323	6p21.3, 1p34	PORPHYRIA CUTANEA TARDA	3077, 7389
MIM176200	C0162532	1q22, 6p21.3	PORPHYRIA VARIEGATA	3077, 5498
MIM176240	C1867924	 	POSTAXIAL OLIGODACTYLY, TETRAMELIC	 
MIM176250	C1867923	 	POSTERIOR COLUMN ATAXIA	 
MIM176256		Chr.12	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 2; KCNC2	3747
MIM176257		12p13	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 6; KCNA6	3742
MIM176258		11p15	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 1; KCNC1	3746
MIM176260		12p13	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 1; KCNA1	3736
MIM176261		21q22.1-q22.2	POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 1; KCNE1	3753
MIM176262		 	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 2; KCNA2	3737
MIM176263		1p21-p13.3	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 3; KCNA3	3738
MIM176264		19q13.3-q13.4	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 3; KCNC3	3748
MIM176265		1p21	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 4; KCNC4	3749
MIM176266		11q13.4-q14.1	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 4; KCNA4	3739
MIM176267		12p13	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 5; KCNA5	3741
MIM176268		19q13.3	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 7; KCNA7	3743
MIM176270	C0032897	15q12, 15q11-q13	PRADER-WILLI SYNDROME; PWS	100033413, 10108, 145624, 23742, 338433, 3653, 4692, 54551, 6638, 7681, 791114, 8924
MIM176290		14q32	DELTA, DROSOPHILA, HOMOLOG-LIKE 1; DLK1	8788
MIM176300		18q11.2-q12.1	TRANSTHYRETIN; TTR	7276
MIM176305	C1867801	7p15-p14.2	PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	3209
MIM176310		1q23	PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 1; PBX1	5087
MIM176311		6p21.3	PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 2; PBX2	5089
MIM176312		9q33-q34	PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 3; PBX3	5090
MIM176385		9q33.1	PREGNANCY-ASSOCIATED PLASMA PROTEIN A; PAPPA	5069
MIM176390		19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 1; PSG1	5669
MIM176391		19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 2; PSG2	5670
MIM176392		19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 3; PSG3	5671
MIM176393		19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 4; PSG4	5672
MIM176394		19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 5; PSG5	5673
MIM176395		19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 6; PSG6	5675
MIM176396		19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 7; PSG7	5676
MIM176397		19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 8; PSG8	440533
MIM176398		19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 9; PSG9	5678
MIM176399		19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 10; PSG10	653492
MIM176400	C0342543	19p13.3	PRECOCIOUS PUBERTY, CENTRAL	84634
MIM176401		19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 11; PSG11	5680
MIM176410	C0342549	2p21	PRECOCIOUS PUBERTY, MALE-LIMITED	3973
MIM176420		12p13-p12.2	PREGNANCY ZONE PROTEIN; PZP	5858
MIM176430	C1864389	15q15	PREMATURE CHROMATID SEPARATION TRAIT; PCS	701
MIM176450	C1531773	7q36	CURRARINO SYNDROME	3110
MIM176500	C1867773	13q14	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1	9445
MIM176590		3q25.1-q25.2	PROFILIN 2; PFN2	5217
MIM176600	C1867772	 	PRESENILE DEMENTIA, KRAEPELIN TYPE	 
MIM176610		17p13.3	PROFILIN 1; PFN1	5216
MIM176620	C1867771	 	PRIAPISM, FAMILIAL IDIOPATHIC	 
MIM176635		12q13	PRIMASE POLYPEPTIDE 1; PRIM1	5557
MIM176636		6p12-p11.1	PRIMASE POLYPEPTIDE 2A; PRIM2A	5558
MIM176640		20pter-p12	PRION PROTEIN; PRNP	5621
MIM176670	C0033300	1q21.2	HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS	4000
MIM176690	C1261128	 	PROGEROID SHORT STATURE WITH PIGMENTED NEVI	 
MIM176700	C0266075	 	PROGNATHISM, MANDIBULAR	 
MIM176705		17q21	PROHIBITIN; PHB	5245
MIM176710		10q21.3-q23.1	PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, ALPHA SUBUNIT, ISOFORM 1; P4HA1	5033
MIM176720		7q32-q36	PROLACTIN-INDUCIBLE PROTEIN; PIP	5304
MIM176730		11p15.5	INSULIN; INS	3630
MIM176740		20p12	PROLIFERATING CELL NUCLEAR ANTIGEN; PCNA	5111
MIM176741		10q25-qter	PROLIFERATION-RELATED Ki-67 ANTIGEN; MKI67	4288
MIM176760		6p22.2-p21.3	PROLACTIN; PRL	5617
MIM176761		5p13-p12	PROLACTIN RECEPTOR; PRLR	5618
MIM176763		1p34.1	PEROXIREDOXIN 1; PRDX1	5052
MIM176770	C1867728	 	PROLINE-NEGATIVE AUXOTROPH OF HAMSTER, COMPLEMENTATION OF; PROA	8039
MIM176780	C0877015	1q31	PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO	100312952
MIM176785		11q14	PROLYLCARBOXYPEPTIDASE; PRCP	5547
MIM176790		17q25	PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, BETA SUBUNIT; P4HB	5034
MIM176793		5p14	PRO-MELANIN-CONCENTRATING HORMONE-LIKE 1; PMCHL1	5369
MIM176794		5q12-q13	PRO-MELANIN-CONCENTRATING HORMONE-LIKE 2; PMCHL2	5370
MIM176795		12q23-q24	PRO-MELANIN-CONCENTRATING HORMONE; PMCH	5367
MIM176797		11q23.1	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 16; ZBTB16	7704
MIM176800	C1867726	 	PRONATION-SUPINATION OF THE FOREARM, IMPAIRMENT OF	 
MIM176801		10q22.1	PROSAPOSIN; PSAP	5660
MIM176802		19p13.1	PROSTAGLANDIN E RECEPTOR 1, EP1 SUBTYPE; PTGER1	5731
MIM176803		9q34.2-q34.3	PROSTAGLANDIN D2 SYNTHASE, BRAIN; PTGDS	5730
MIM176804		14q22	PROSTAGLANDIN E RECEPTOR 2, EP2 SUBTYPE; PTGER2	5732
MIM176805		9q32-q33.3	PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1; PTGS1	5742
MIM176806		1p31.2	PROSTAGLANDIN E RECEPTOR 3, EP3 SUBTYPE; PTGER3	5733
MIM176807	C0376358	1q25, 17p11, 16q22.3-q23.1, 16q22.1, 13q12.3, 11p11.2, 10q25, 10p15, 8p22, 7q11.23, 7p11-q21, 7p22, 3p26, Xq11-q12, 1q42.2-q43, 22q12.3, 22q12.1, 20q13, 19q	PROSTATE CANCER	11200, 1316, 3092, 367, 3732, 4481, 4601, 463, 5728, 6041, 60528, 675, 8379, 999
MIM176820		19q13.4	KALLIKREIN-RELATED PEPTIDASE 3; KLK3	354
MIM176830		2p23.3	PROOPIOMELANOCORTIN; POMC	5443
MIM176842		7p13	PROTEASOME SUBUNIT, ALPHA-TYPE, 2; PSMA2	5683
MIM176843		14q23	PROTEASOME SUBUNIT, ALPHA-TYPE, 3; PSMA3	5684
MIM176844		1p13	PROTEASOME SUBUNIT, ALPHA-TYPE, 5; PSMA5	5686
MIM176846		15q25.1	PROTEASOME SUBUNIT, ALPHA-TYPE, 4; PSMA4	5685
MIM176847		16q22.1	PROTEASOME SUBUNIT, BETA-TYPE, 10; PSMB10	5699
MIM176851		6q22.3-q24	PROTEIN CARBOXYL METHYLTRANSFERASE 1; PCMT1	5110
MIM176860	C2674321	2q13-q14	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT; THPH3	5624
MIM176870		9q32-q33	ALPHA-1 MICROGLOBULIN/BIKUNIN PRECURSOR; AMBP	259
MIM176871		2p21	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 2; EIF2AK2	5610
MIM176872		15q21	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1; MAP2K1	5604
MIM176873		1p36.3	CYCLIN-DEPENDENT KINASE 11B; CDK11B	984
MIM176875		11q13	PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, ALPHA ISOFORM; PPP1CA	5499
MIM176876		12q24.1	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 11; PTPN11	5781
MIM176877		 	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 3; PTPN3	5774
MIM176878		 	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 4; PTPN4	5775
MIM176879		11p15.2-p15.1	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 5; PTPN5	84867
MIM176880		3q11.2	PROTEIN S; PROS1	5627
MIM176882		12q15-q21	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, BETA; PTPRB	5787
MIM176883		12p13	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 6; PTPN6	5777
MIM176884		20p13	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, ALPHA; PTPRA	5786
MIM176885		20q13.1-q13.2	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 1; PTPN1	5770
MIM176886		3p14.2	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, GAMMA; PTPRG	5793
MIM176887		18p11.3-p11.2	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 2; PTPN2	5771
MIM176888		18p11.2	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, MU; PTPRM	5797
MIM176889		1q32.1	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 7; PTPN7	5778
MIM176891		7q31.3	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, ZETA-1; PTPRZ1	5803
MIM176892		1p36.1	PROTEIN KINASE, cAMP-DEPENDENT, CATALYTIC, BETA; PRKACB	5567
MIM176893		9q13	PROTEIN KINASE, cAMP-DEPENDENT, CATALYTIC, GAMMA; PRKACG	5568
MIM176894		10q11.2	PROTEIN KINASE, cGMP-DEPENDENT, REGULATORY, TYPE I; PRKG1	5592
MIM176895		 	PROTEIN Z; PROZ	8858
MIM176900	C1867621	 	PROTEOLYTIC CAPACITY OF PLASMA	 
MIM176910		3p21.3-p21.2	PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE II, ALPHA; PRKAR2A	5576
MIM176911		7pter-p22	PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE I, BETA; PRKAR1B	5575
MIM176912		7q22	PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE II, BETA; PRKAR2B	5577
MIM176914		12q24.1-q24.2	PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, GAMMA ISOFORM; PPP1CC	5501
MIM176915		5q23-q31	PROTEIN PHOSPHATASE 2, CATALYTIC SUBUNIT, ALPHA ISOFORM; PPP2CA	5515
MIM176916		8p12-p11.2	PROTEIN PHOSPHATASE 2, CATALYTIC SUBUNIT, BETA ISOFORM; PPP2CB	5516
MIM176920	C0085261	 	PROTEUS SYNDROME	207
MIM176930		11p11-q12	COAGULATION FACTOR II; F2	2147
MIM176940		1q21	S100 CALCIUM-BINDING PROTEIN A1; S100A1	6271
MIM176941		19p13.2	TYROSINE KINASE 2; TYK2	7297
MIM176942		5q21-q22	FPS/FES-RELATED TYROSINE KINASE; FER	2241
MIM176943		10q26	FIBROBLAST GROWTH FACTOR RECEPTOR 2; FGFR2	2263
MIM176945		1p36.12	EPHRIN RECEPTOR EphA8; EPHA8	2046
MIM176946		1p36.1	EPHRIN RECEPTOR EphA2; EPHA2	1969
MIM176947		2q12	ZETA-CHAIN-ASSOCIATED PROTEIN KINASE; ZAP70	7535
MIM176948		22q11.2	MITOGEN-ACTIVATED PROTEIN KINASE 1; MAPK1	5594
MIM176949		18q12-q21	MITOGEN-ACTIVATED PROTEIN KINASE 4; MAPK4	5596
MIM176960		17q22-q23.2	PROTEIN KINASE C, ALPHA; PRKCA	5578
MIM176970		16p11.2	PROTEIN KINASE C, BETA-1; PRKCB1	5579
MIM176975		2p21	PROTEIN KINASE C, EPSILON; PRKCE	5581
MIM176977		3p	PROTEIN KINASE C, DELTA; PRKCD	5580
MIM176980		19q13.4	PROTEIN KINASE C, GAMMA; PRKCG	5582
MIM176981		 	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-2-LIKE 1; GNB2L1	10399
MIM176982		1p36	PROTEIN KINASE C, ZETA FORM; PRKCZ	5590
MIM176990		21q22.2-q22.3	S100 CALCIUM-BINDING PROTEIN, BETA; S100B	6285
MIM176991		1q21	S100 CALCIUM-BINDING PROTEIN A5; S100A5	6276
MIM176992		1q21	S100 CALCIUM-BINDING PROTEIN A3; S100A3	6274
MIM176993		1q21	S100 CALCIUM-BINDING PROTEIN A2; S100A2	6273
MIM177000	C0162568	18q21.3	PROTOPORPHYRIA, ERYTHROPOIETIC; EPP	2235
MIM177010		2q33-q35	SERPIN PEPTIDASE INHIBITOR, CLADE E (NEXIN, PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1), MEMBER 2; SERPINE2	5270
MIM177015		16q22.1	PROTEIN SERINE KINASE H1; PSKH1	5681
MIM177020		19p13.3	PROTEINASE 3; PRTN3	5657
MIM177040		10q22.1	SERGLYCIN; SRGN	5552
MIM177045		6p21.3	PROTEASOME SUBUNIT, BETA-TYPE, 9; PSMB9	5698
MIM177046		6p21.3	PROTEASOME SUBUNIT, BETA-TYPE, 8; PSMB8	5696
MIM177050	C0409495	 	PROTRUSIO ACETABULI	 
MIM177060		19p13.2-p13.1	PROTEIN KINASE C SUBSTRATE, 80-KD, HEAVY CHAIN; PRKCSH	5589
MIM177061		6q22.2	MYRISTOYLATED ALANINE-RICH PROTEIN KINASE C SUBSTRATE; MARCKS	4082
MIM177070		15q15	PROTEIN 4.2, ERYTHROCYTIC; EPB42	2038
MIM177075		16q22-q23	V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE HOMOLOG; MAF	4094
MIM177100	C1867499	 	PRURITUS, HEREDITARY LOCALIZED	 
MIM177170	C0410538	19p13.1	PSEUDOACHONDROPLASIA; PSACH	1311
MIM177200	C0221043	16p13-p12, 16p13-p12	LIDDLE SYNDROME	6338, 6340
MIM177300	C1867485	 	PSEUDOARTHROGRYPOSIS	 
MIM177350	C0406561	 	PSEUDOATROPHODERMA COLLI	 
MIM177400	C1283400	3q26.1-q26.2	BUTYRYLCHOLINESTERASE; BCHE	590
MIM177500		2q33-q35	CHOLINESTERASE, SERUM, 2; CHE2	1110
MIM177650	C0206368	15q22	EXFOLIATION SYNDROME; XFS	4016
MIM177700	C1867465	 	PSEUDOGLAUCOMA	 
MIM177720		16q23-q24	PSEUDOHYPERKALEMIA, FAMILIAL, 1, DUE TO RED CELL LEAK	 
MIM177735	C1449842	4q31.1	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A	4306
MIM177750	C0432346	 	PSEUDOMONILETHRIX	 
MIM177800	C0155300	 	PSEUDOPAPILLEDEMA	 
MIM177820	C1280798	17pter-p12	PSEUDO-VON WILLEBRAND DISEASE; VWDP	2811
MIM177850	C1867450	16p13.1	PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	368
MIM177900	C1867449	1p31.3, 6p21.3	PSORIASIS SUSCEPTIBILITY 1; PSORS1	149233, 3107
MIM177980	C1867443	 	PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES	 
MIM177990	C1867442	 	PTERYGIUM COLLI, ISOLATED	 
MIM178000	C1867441	 	PTERYGIUM OF CONJUNCTIVA AND CORNEA	 
MIM178110	C1867440	 	ARTHROGRYPOSIS, DISTAL, TYPE 8; DA8	 
MIM178200	C1867439	 	PTERYGIUM, ANTECUBITAL	 
MIM178300	C1867438	8q21.12, 1p34.1-p32	PTOSIS, HEREDITARY CONGENITAL 1; PTOS1	5765, 79776
MIM178330	C1867437	 	PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	 
MIM178350	C1867436	 	PUBIC BONE DYSPLASIA	 
MIM178370	C0344976	 	PULMONARY ATRESIA WITH VENTRICULAR SEPTAL DEFECT	 
MIM178400	C0340100	 	PULMONARY EDEMA OF MOUNTAINEERS	 
MIM178500	C1800706	10q22.2-q23.1, 10q22-q23, 5p15.33, 3q21-q28	PULMONARY FIBROSIS, IDIOPATHIC; IPF	6440, 653509, 7012, 7015, 727897, 729238
MIM178550	C0020807	 	PULMONARY HEMOSIDEROSIS	 
MIM178600	C0152171	13q12-q14, 2q33	PULMONARY HYPERTENSION, PRIMARY, 1; PPH1	4093, 659
MIM178610	C1867419	 	PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	 
MIM178620		8p21	SURFACTANT, PULMONARY-ASSOCIATED PROTEIN C; SFTPC	6440
MIM178630		10q22.2-q23.1	SURFACTANT, PULMONARY-ASSOCIATED PROTEIN A1; SFTPA1	653509
MIM178635		10q23.3	SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D; SFTPD	6441
MIM178640		2p12-p11.2	SURFACTANT, PULMONARY-ASSOCIATED PROTEIN B; SFTPB	6439
MIM178642		10q22-q23	SURFACTANT, PULMONARY-ASSOCIATED PROTEIN A2; SFTPA2	729238
MIM178650	C1867407	 	PULMONIC STENOSIS, ATRIAL SEPTAL DEFECT, AND UNIQUE ELECTROCARDIOGRAPHIC ABNORMALITIES	 
MIM178651	C1867406	 	PULMONIC STENOSIS AND DEAFNESS	 
MIM178800	C1867405	 	PUPIL, EGG-SHAPED	 
MIM178900	C0271130	 	PUPILLARY MEMBRANE, PERSISTENCE OF	 
MIM178990		11q21-q22	MATRIX METALLOPROTEINASE 7; MMP7	4316
MIM178995	C0269680	 	PRURITIC URTICARIAL PAPULES AND PLAQUES OF PREGNANCY; PUPPP	 
MIM179000	C0272309	 	PURPURA SIMPLEX	 
MIM179010	C1867403	12q	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 1; IHPS1	 
MIM179020		21q22.3	PYRIDOXAL KINASE; PDXK	8566
MIM179030		10q21.3	PYROPHOSPHATASE, INORGANIC, 1; PPA1	5464
MIM179035		17q25.3	PYRROLINE-5-CARBOXYLATE REDUCTASE 1; PYCR1	5831
MIM179050		15q22	PYRUVATE KINASE, MUSCLE, 2; PKM2	5315
MIM179060		3p13-q23	PYRUVATE DEHYDROGENASE, BETA POLYPEPTIDE; PDHB	5162
MIM179061		4q22-q23	PYRUVATE DEHYDROGENASE, ALPHA-2; PDHA2	5161
MIM179080		1p31	RAB GERANYLGERANYL TRANSFERASE, BETA SUBUNIT; RABGGTB	5876
MIM179095		5q23-q31	UBIQUITIN-CONJUGATING ENZYME E2B; UBE2B	7320
MIM179200	C1867398	 	RADIAL HEADS, POSTERIOR DISLOCATION OF	 
MIM179250	C1867397	 	RADIAL HYPOPLASIA, TRIPHALANGEAL THUMBS, HYPOSPADIAS, AND MAXILLARY DIASTEMA	 
MIM179270	C0339838	 	RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	 
MIM179280	C1867396	 	RADIAL-RENAL SYNDROME	 
MIM179300	C0158761	 	RADIOULNAR SYNOSTOSIS	 
MIM179400	C1867395	 	RADIUS, APLASIA OF, WITH CLEFT LIP/PALATE	 
MIM179410		11q23	RADIXIN; RDX	5962
MIM179450	C1867394	6p21.3	RAGWEED SENSITIVITY	7937
MIM179490		19p13.1-p12	RAS-ASSOCIATED PROTEIN RAB3A; RAB3A	5864
MIM179500	C1867393	 	RAINDROP HYPOPIGMENTATION	 
MIM179502		4q21-q25	RAP1, GTPase-GDP DISSOCIATION STIMULATOR 1; RAP1GDS1	5910
MIM179503		16q22	RAS-RELATED ASSOCIATED WITH DIABETES; RRAD	6236
MIM179505		11p15.5-p15.4	RAS HOMOLOG GENE FAMILY, MEMBER G; RHOG	391
MIM179508		2p14	RAS-ASSOCIATED PROTEIN RAB1; RAB1	5861
MIM179509		8q12.1	RAS-ASSOCIATED PROTEIN RAB2; RAB2	5862
MIM179510		1p32-p31	RAS-ASSOCIATED PROTEIN RAB3B; RAB3B	5865
MIM179511		1q42-q43	RAS-ASSOCIATED PROTEIN RAB4; RAB4	5867
MIM179512		3p24-p22	RAS-ASSOCIATED PROTEIN RAB5A; RAB5A	5868
MIM179513		11q13.4	RAS-ASSOCIATED PROTEIN RAB6A; RAB6A	5870
MIM179514		12q13	RAS-ASSOCIATED PROTEIN RAB5B; RAB5B	5869
MIM179520		1p13.3	RAS-RELATED PROTEIN 1A; RAP1A	5906
MIM179530		12q14	RAS-RELATED PROTEIN RAP1B; RAP1B	5908
MIM179540		13q34	RAS-RELATED PROTEIN 2A; RAP2A	5911
MIM179541		 	RAS-RELATED PROTEIN 2B; RAP2B	5912
MIM179550		7p22-p15	V-RAL SIMIAN LEUKEMIA VIRAL ONCOGENE HOMOLOG A; RALA	5898
MIM179551		2cen-q13	V-RAL SIMIAN LEUKEMIA VIRAL ONCOGENE HOMOLOG B; RALB	5899
MIM179555		10p13	RAS SUPPRESSOR PROTEIN 1; RSU1	6251
MIM179590		1p32	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F; PTPRF	5792
MIM179600	C0034734	 	RAYNAUD DISEASE	 
MIM179605		6p21.1-cen	PERIPHERIN 2, MOUSE, HOMOLOG OF; PRPH2	5961
MIM179610		7q32-q36	EPHRIN RECEPTOR EphA1; EPHA1	2041
MIM179611		3p11.2	EPHRIN RECEPTOR EphA3; EPHA3	2042
MIM179613	C0795822	 	RECOMBINANT CHROMOSOME 8 SYNDROME	 
MIM179615		11p13	RECOMBINATION-ACTIVATING GENE 1; RAG1	5896
MIM179616		11p13	RECOMBINATION-ACTIVATING GENE 2; RAG2	5897
MIM179617		15q15.1	RAD51, S. CEREVISIAE, HOMOLOG OF; RAD51	5888
MIM179618		17p13.1	RECOVERIN; RCV1	5957
MIM179620	C1867341	11p15.5	RAPH BLOOD GROUP SYSTEM	977
MIM179650	C1867340	 	RED CELL PERMEABILITY DEFECT	 
MIM179700	C1867339	 	RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	 
MIM179710		1p36.1	REGULATOR OF CHROMOSOME CONDENSATION 1; RCC1	1104
MIM179730		9pter-q12	RELAXIN 1; RLN1	6013
MIM179740		9pter-q12	RELAXIN 2; RLN2	6019
MIM179755		1q21	PAPILLARY RENAL CELL CARCINOMA TRANSLOCATION-ASSOCIATED GENE; PRCC	5546
MIM179780		16q24.3	DIPEPTIDASE 1; DPEP1	1800
MIM179800	C0259810	17q21-q22	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	6521
MIM179820		1q32	RENIN; REN	5972
MIM179830	C0268435	 	RENAL TUBULAR ACIDOSIS, PROXIMAL	 
MIM179835		17p13.3	REPLICATION PROTEIN A1, 70-KD; RPA1	6117
MIM179836		1p35	REPLICATION PROTEIN A2, 32-KD; RPA2	6118
MIM179837		7p22	REPLICATION PROTEIN A3, 14-KD; RPA3	6119
MIM179838		12q24.31-q24.33	RESTIN; RSN	6249
MIM179840	C1867332	 	RETICULAR DYSTROPHY OF RETINAL PIGMENT EPITHELIUM	 
MIM179850	C3714534	12q13	DOWLING-DEGOS DISEASE; DDD	3852
MIM179900	C1867331	 	RETINAL APLASIA	 
MIM180000	C1867327	 	RETINAL ARTERIES, TORTUOSITY OF	 
MIM180020	C1867326	6q25-q26	RETINAL CONE DYSTROPHY 1; RCD1	5953
MIM180040		1q32.3	RETINAL DEGENERATION 3, MOUSE, HOMOLOG OF; RD3	343035
MIM180050	C0035305	 	RETINAL DETACHMENT	 
MIM180069		1p31	RETINAL PIGMENT EPITHELIUM-SPECIFIC PROTEIN, 65-KD; RPE65	6121
MIM180070		 	RETINAL NONATTACHMENT AND FALCIFORM DETACHMENT	 
MIM180071		5q31.2-q34	PHOSPHODIESTERASE 6A, cGMP-SPECIFIC, ROD, ALPHA; PDE6A	5145
MIM180072		4p16.3	PHOSPHODIESTERASE 6B, cGMP-SPECIFIC, ROD, BETA; PDE6B	5158
MIM180073		17q25	PHOSPHODIESTERASE 6G, cGMP-SPECIFIC, ROD, GAMMA; PDE6G	5148
MIM180080	C0423397	 	RETINAL VENOUS BEADING	 
MIM180090		15q26	RETINALDEHYDE-BINDING PROTEIN 1; RLBP1	6017
MIM180100	C0220701	8q11-q13	RETINITIS PIGMENTOSA 1; RP1	6101
MIM180104	C1867300	7p14.2	RETINITIS PIGMENTOSA 9; RP9	6100
MIM180105	C1867299	7q31.3-q32	RETINITIS PIGMENTOSA 10; RP10	3614
MIM180190		12q13	RETINOIC ACID RECEPTOR, GAMMA; RARG	5916
MIM180200	C0035335	13q14.1-q14.2	RETINOBLASTOMA; RB1	5925
MIM180201		14q23.1	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 4A; ARID4A	5926
MIM180202		12p11	LYSINE-SPECIFIC DEMETHYLASE 5A; KDM5A	5927
MIM180203		16q12.2	RETINOBLASTOMA-LIKE 2; RBL2	5934
MIM180210	C1867261	 	RETINOPATHY, PERICENTRAL PIGMENTARY, DOMINANT	 
MIM180220		3p24	RETINOIC ACID RECEPTOR, BETA; RARB	5915
MIM180230		15q24	RETINOIC ACID-BINDING PROTEIN, CELLULAR, TYPE I; CRABP1	1381
MIM180231		1q21.3	RETINOIC ACID-BINDING PROTEIN, CELLULAR, TYPE II; CRABP2	1382
MIM180240		17q21.1	RETINOIC ACID RECEPTOR, ALPHA; RARA	5914
MIM180245		9q34.3	RETINOID X RECEPTOR, ALPHA; RXRA	6256
MIM180246		6p21.3	RETINOID X RECEPTOR, BETA; RXRB	6257
MIM180247		1q22-q23	RETINOID X RECEPTOR, GAMMA; RXRG	6258
MIM180250		10q24	RETINOL-BINDING PROTEIN 4; RBP4	5950
MIM180260		3q21-q22	RETINOL-BINDING PROTEIN 1; RBP1	5947
MIM180270	C1867235	 	RETINOSCHISIS, AUTOSOMAL DOMINANT	 
MIM180280		3q21-qter	RETINOL-BINDING PROTEIN 2; RBP2	5948
MIM180290		10q11.2	RETINOL-BINDING PROTEIN 3; RBP3	5949
MIM180295	C1867234	 	RHABDOMYOSARCOMA, EMBRYONAL, 2; RMSE2	 
MIM180297		6p21.1-p11	RHESUS BLOOD GROUP-ASSOCIATED GLYCOPROTEIN; RHAG	6005
MIM180300	C0003873	16p13, 1q22, 1p13, 6q23, 6p21.3, 6p21.3, 5q31, 2q32.2-q32.3, 1p36.13, 1q31-q32	RHEUMATOID ARTHRITIS; RA	23569, 26191, 3123, 3586, 4261, 4795, 51744, 6583, 6775
MIM180350	C0035450	 	RHEUMATOID NODULOSIS	 
MIM180360	C1867222	 	RHINY	 
MIM180370		22q11.2-qter	THIOSULFATE SULFURTRANSFERASE; TST	7263
MIM180380		3q21-q24	RHODOPSIN; RHO	6010
MIM180381		13q34	G PROTEIN-COUPLED RECEPTOR KINASE 1; GRK1	6011
MIM180385		11p13	LIM DOMAIN ONLY 2; LMO2	4005
MIM180386		12p13	LIM DOMAIN ONLY 3; LMO3	55885
MIM180390		2p25-p24	RIBONUCLEOTIDE REDUCTASE, M2 SUBUNIT; RRM2	6241
MIM180410		11p15.5	RIBONUCLEOTIDE REDUCTASE, M1 SUBUNIT; RRM1	6240
MIM180420		1q42.11-q42.13	RNA, 5S RIBOSOMAL, GENE CLUSTER 1; RN5S1@	6025
MIM180430		2p11.2	RIBOSE 5-PHOSPHATE ISOMERASE A; RPIA	22934
MIM180435		1q25	RIBONUCLEASE L; RNASEL	6041
MIM180440		14q11.2	RIBONUCLEASE A FAMILY, 1; RNASE1	6035
MIM180450		13p12	RIBOSOMAL RNA 1; RNR1	6052
MIM180451		14p12	RIBOSOMAL RNA 2; RNR2	6053
MIM180452		15p12	RIBOSOMAL RNA 3; RNR3	6054
MIM180453		21p12	RIBOSOMAL RNA 4; RNR4	6055
MIM180454		22p12	RIBOSOMAL RNA 5; RNR5	6056
MIM180460		9p21	RIBOSOMAL PROTEIN S6; RPS6	6194
MIM180463		5q13-q23	RIBOSOMAL PROTEIN S20A; RPS20A	6225
MIM180464		5q33-qter	RIBOSOMAL PROTEIN S20B; RPS20B	6226
MIM180465		11q23.3	RIBOSOMAL PROTEIN S25; RPS25	6230
MIM180466		17q11	RIBOSOMAL PROTEIN L19; RPL19	6143
MIM180467		Chr.8	RIBOSOMAL PROTEIN L30; RPL30	6156
MIM180468		3q29-qter	RIBOSOMAL PROTEIN L35A; RPL35A	6165
MIM180469		Chr.14	RIBOSOMAL PROTEIN L36A-LIKE; RPL36AL	6166
MIM180470		3q	RIBOPHORIN I; RPN1	6184
MIM180471		19q	RIBOSOMAL PROTEIN S11; RPS11	6205
MIM180472		15q	RIBOSOMAL PROTEIN S17; RPS17	6218
MIM180473		6p21.3	RIBOSOMAL PROTEIN S18; RPS18	6222
MIM180474		1p36.31	RIBOSOMAL PROTEIN L22; RPL22	6146
MIM180475		9q33.3	RIBOSOMAL PROTEIN L12; RPL12	6136
MIM180476		11p	RIBOSOMAL PROTEIN S13; RPS13	6207
MIM180477		20q13.3	RIBOSOMAL PROTEIN S21; RPS21	6227
MIM180478		4q31.2-q31.3	RIBOSOMAL PROTEIN S3a; RPS3A	6189
MIM180479		15q	RIBOSOMAL PROTEIN L4; RPL4	6124
MIM180480		2q32-q33.3	RIBULOSE 5-PHOSPHATE 3-EPIMERASE; RPE	6120
MIM180490		20q12-q13.1	RIBOPHORIN II; RPN2	6185
MIM180500	C3714873	4q25-q26	AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	5308
MIM180510		Chr.12	RIBOSOMAL PHOSPHOPROTEIN, LARGE, P0; RPLP0	6175
MIM180520		Chr.15	RIBOSOMAL PHOSPHOPROTEIN, LARGE, P1; RPLP1	6176
MIM180530		 	RIBOSOMAL PHOSPHOPROTEIN, LARGE, P2; RPLP2	6181
MIM180535		19p	RIBOSOMAL PROTEIN S15; RPS15	6209
MIM180550	C1867155	4q25-q26	RING DERMOID OF CORNEA; RDC	5308
MIM180600	C0263489	 	RINGED HAIR	 
MIM180610		1p32	REARRANGED LMYC FUSION; RLF	6018
MIM180620		6p23-q12	TRANSFER RNA METHIONINE 2; TRNAM2	7212
MIM180621		6p23-q12	TRANSFER RNA METHIONINE 1; TRNAM1	7210
MIM180630		17q23-q25	DEAD/H BOX 5; DDX5	1655
MIM180640		1p36	TRANSFER RNA GLUTAMIC ACID; TRNAE1	7193
MIM180645		1p36.1	SMALL NUCLEOLAR RNA, H/ACA BOX, 73A; SNORA73A	6080
MIM180646		 	SMALL NUCLEOLAR RNA, H/ACA BOX, 62; SNORA62	6044
MIM180647		 	SMALL NUCLEOLAR RNA, H/ACA BOX, 63; SNORA63	6043
MIM180660		17p13.1	POLYMERASE II, RNA, SUBUNIT A; POLR2A	5430
MIM180661		4q12	POLYMERASE II, RNA, SUBUNIT B; POLR2B	5431
MIM180662		19q12	POLYMERASE II, RNA, SUBUNIT I; POLR2I	5438
MIM180663		16q13-q21	POLYMERASE II, RNA, SUBUNIT C; POLR2C	5432
MIM180664		19p13.3	POLYMERASE II, RNA, SUBUNIT E; POLR2E	5434
MIM180680		1p36.3	RNA, U1A SMALL NUCLEAR; RNU1A	6060
MIM180690		17q21-q22	RNA, U2 SMALL NUCLEAR, 1; RNU2-1	6066
MIM180691		15q22.31	RNA, U5A SMALL NUCLEAR; RNU5A	26831
MIM180692		15q23	RNA, U6 SMALL NUCLEAR, 1; RNU6-1	26827
MIM180700	C0265205	 	ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS	7474
MIM180710		17p11.2	SMALL NUCLEOLAR RNA, C/D BOX, 3A; SNORD3A	780851
MIM180721		11q13	ROD OUTER SEGMENT PROTEIN 1; ROM1	6094
MIM180730	C1867147	 	ROMBO SYNDROME	 
MIM180740		19q13.3	SMALL NUCLEAR RIBONUCLEOPROTEIN, 70-KD; SNRP70	6625
MIM180750	C1867146	 	ROBINOW-SORAUF SYNDROME	7291
MIM180800	C0205713	17p11.2, 1q22	ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	4359, 5376
MIM180849	C0035934	16p13.3	RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	1387, 2033
MIM180860	C0175693	11p15.5, 7p11.2	SILVER-RUSSELL SYNDROME; SRS	140821, 283120, 3481
MIM180870	C0265248	 	RUVALCABA SYNDROME	 
MIM180900	C0796140	 	RUTHERFURD SYNDROME	 
MIM180901		19q13.1	RYANODINE RECEPTOR 1; RYR1	6261
MIM180902		1q42.1-q43	RYANODINE RECEPTOR 2; RYR2	6262
MIM180903		15q14-q15	RYANODINE RECEPTOR 3; RYR3	6263
MIM180920	C0158667	5p13-p12	APLASIA OF LACRIMAL AND SALIVARY GLANDS; ALSG	2255
MIM180950	C1867056	 	SALIVARY SUBSTANCE, CLOSTRIDIUM BOTULINUM TYPE	 
MIM180960		20cen-q13.1	S-ADENOSYLHOMOCYSTEINE HYDROLASE; AHCY	191
MIM180980		6q21-q22	S-ADENOSYLMETHIONINE DECARBOXYLASE; AMD1	262
MIM180989		12p13.2	PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 1; PRB1	5542
MIM180990		12p13.2	PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 4; PRB4	5545
MIM181000	C2697310	6p21.3	SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	3123
MIM181010	C0036089	 	SALIVARY DUCT CALCULI	 
MIM181030	C1519176	8q12	SALIVARY GLAND ADENOMA, PLEOMORPHIC	5324
MIM181031		2q37.1	S-ANTIGEN; SAG	6295
MIM181035		12q13-q14	TETRASPANIN 31; TSPAN31	6302
MIM181180	C1867023	 	SAY SYNDROME	 
MIM181200	C1867022	 	SC(1) TRAIT OF SALIVA	 
MIM181250	C1867021	 	SCALP DEFECTS AND POSTAXIAL POLYDACTYLY	 
MIM181270	C1867020	 	SCALP-EAR-NIPPLE SYNDROME	 
MIM181300	C1867019	 	SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	 
MIM181350	C0410190	1q21.2	EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2	4000
MIM181400	C1867005	2q35	SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; SCPNK	1674
MIM181405	C0751335	12q24.1	SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	59341
MIM181430	CN074265	14q12	SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM	4625, 8090
MIM181440	CN116624	 	SCHEUERMANN DISEASE	 
MIM181450	C1866994	12q24.1	ULNAR-MAMMARY SYNDROME; UMS	6926
MIM181460	C1866993	5q31-q33	SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	7911
MIM181500	C0036341	1p36.2, 15q15, 14q32.3, 13q34, 13q32, 13q14-q21, 12q24, 11q14-q21, 11p14-p13, 10q22.3, 8p21, 6q13-q26, 1p36.3, 6p22.3, 6p23, 5q23-q35, 3q13.3, 3p25, 1q42.1, 1q42.1, 22q12.3, 22q12.3, 22q11.2, 22q11, 1q32.1, 11p36.2, 15q15, 14q32.3, 13q34, 13q32, 13q14-q21, 12q24, 11q14-q21, 11p14-p13, 10q22.3, 8p21, 6q13-q26, 1p36.3, 6p22.3, 6p23, 5q23-q35, 3q13.3, 3p25, 1q42.1, 1q42.1, 22q12.3, 22q12.3, 22q11.2, 22q11, 1q32.1,	SCHIZOPHRENIA; SCZD	1116, 1312, 1610, 1814, 207, 23780, 267012, 27184, 27185, 3356, 4524, 55366, 65078, 6854, 80832, 84062
MIM181510	C0220702	5q23-q35	SCHIZOPHRENIA 1; SCZD1	6377
MIM181515		 	SCHOLTE SYNDROME	 
MIM181590		1p32	SCL/TAL1-INTERRUPTING LOCUS; STIL	6491
MIM181600	C0406767	4q23	SCLEROTYLOSIS	7303
MIM181700	C1866984	 	SCLEROCORNEA, AUTOSOMAL DOMINANT	 
MIM181750	C1866983	 	SCLERODERMA, FAMILIAL PROGRESSIVE	 
MIM181800	C2700406	19p13.3	SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 1; IS1	260402
MIM182000	C0022603	3q26.3	KERATOSIS, SEBORRHEIC	5290
MIM182090		18q21	SIMIAN SARCOMA-ASSOCIATED VIRUS-1/GIBBON APE LEUKEMIA VIRUS; SSAV1	6739
MIM182098		2q14.1	SECRETIN RECEPTOR; SCTR	6344
MIM182099		11p15.5	SECRETIN; SCT	6343
MIM182100		19q13.3	FUCOSYLTRANSFERASE 2; FUT2	2524
MIM182115		17q25	CYTOHESIN 1; CYTH1	9267
MIM182120		5q31.3-q32	SECRETED PROTEIN, ACIDIC, CYSTEINE-RICH; SPARC	6678
MIM182125		2p14-p12	SEPIAPTERIN REDUCTASE; SPR	6697
MIM182128		 	SERINE DEHYDRATASE; SDS	10993
MIM182131		6q13	5-@HYDROXYTRYPTAMINE RECEPTOR 1B; HTR1B	3351
MIM182132		6q14-q15	5-@HYDROXYTRYPTAMINE RECEPTOR 1E; HTR1E	3354
MIM182133		1p36.3-p34.3	5-@HYDROXYTRYPTAMINE RECEPTOR 1D; HTR1D	3352
MIM182134		3p12	5-@HYDROXYTRYPTAMINE RECEPTOR 1F; HTR1F	3355
MIM182135		13q14-q21	5-@HYDROXYTRYPTAMINE RECEPTOR 2A; HTR2A	3356
MIM182137		10q21-q24	5-@HYDROXYTRYPTAMINE RECEPTOR 7; HTR7	3363
MIM182138		17q11.1-q12	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, SEROTONIN), MEMBER 4; SLC6A4	6532
MIM182139		11q23.1-q23.2	5-@HYDROXYTRYPTAMINE RECEPTOR 3A; HTR3A	3359
MIM182140		20q12-q13.1	SEMENOGELIN; SEMG	6406
MIM182141		20q12-q13.1	SEMENOGELIN II; SEMG2	6407
MIM182144		17p11.2	SERINE HYDROXYMETHYLTRANSFERASE, CYTOSOLIC; SHMT1	6470
MIM182150	C1866962	 	SIMOSA CRANIOFACIAL SYNDROME	 
MIM182160		16p11.2	SIALOPHORIN; SPN	6693
MIM182170	C2674249	 	ANEMIA, SIDEROBLASTIC, AUTOSOMAL DOMINANT	 
MIM182175		5q21-q22	SIGNAL RECOGNITION PARTICLE, 19-KD; SRP19	6728
MIM182180		11q23-q24	SIGNAL RECOGNITION PARTICLE RECEPTOR; SRPR	6734
MIM182200	C1866959	 	SELLA TURCICA, BRIDGED	 
MIM182205		17p13-p12	SEX HORMONE-BINDING GLOBULIN; SHBG	6462
MIM182210	C1866958	 	SHPRINTZEN OMPHALOCELE SYNDROME	 
MIM182212	C1321551	15q21.1	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	2200, 6497
MIM182220	C1866942	 	SISTER CHROMATID EXCHANGE, FREQUENCY OF	 
MIM182230	C0338503	3p21.2-p21.1	SEPTOOPTIC DYSPLASIA	8820
MIM182250	CN033178	 	SINGLETON-MERTEN SYNDROME	 
MIM182255	C1866939	 	SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	 
MIM182257		20q12-q13	PROTEINASE INHIBITOR 3; PI3	5266
MIM182260	C0149887	 	SLIPPED FEMORAL CAPITAL EPIPHYSES	 
MIM182265		1q21-q22	SMALL PROLINE-RICH PROTEIN 1A; SPRR1A	6698
MIM182266		1q21-q22	SMALL PROLINE-RICH PROTEIN 1B; SPRR1B	6699
MIM182267		1q21-q22	SMALL PROLINE-RICH PROTEIN 2A; SPRR2A	6700
MIM182268		1q21-q22	SMALL PROLINE-RICH PROTEIN 2B; SPRR2B	6701
MIM182269		1q21-q22	SMALL PROLINE-RICH PROTEIN 2C; SPRR2C	6702
MIM182271		1q21-q22	SMALL PROLINE-RICH PROTEIN 3; SPRR3	6707
MIM182279		15q12	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE N; SNRPN	6638
MIM182280	C0149925	3p23-p21	SMALL CELL CANCER OF THE LUNG	5925, 7864
MIM182281		Chr.17	CHEMOKINE, CC MOTIF, LIGAND 1; CCL1	6346
MIM182282		 	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDES B AND B1; SNRPB	6628
MIM182283		17q12	CHEMOKINE, CC MOTIF, LIGAND 3; CCL3	6348
MIM182284		17q12	CHEMOKINE, CC MOTIF, LIGAND 4; CCL4	6351
MIM182285		19q13.1	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE A; SNRPA	6626
MIM182290	C0795864	17p11.2	SMITH-MAGENIS SYNDROME; SMS	10743
MIM182305		2p23-p22	SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER 1; SLC8A1	6546
MIM182307		5p15.3	SOLUTE CARRIER FAMILY 9, MEMBER 3; SLC9A3	6550
MIM182308		6p23-p21.3	SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 1; SLC17A1	6568
MIM182309		5q35	SOLUTE CARRIER FAMILY 34 (SODIUM/PHOSPHATE COTRANSPORTER), MEMBER 1; SLC34A1	6569
MIM182310		1p13-p11	ATPase, Na+/K+ TRANSPORTING, ALPHA-1 POLYPEPTIDE; ATP1A1	476
MIM182330		1q22-q25	ATPase, Na+/K+ TRANSPORTING, BETA-1 POLYPEPTIDE; ATP1B1	481
MIM182331		17p	ATPase, Na+/K+ TRANSPORTING, BETA-2 POLYPEPTIDE; ATP1B2	482
MIM182340		1q21-q23	ATPase, Na+/K+ TRANSPORTING, ALPHA-2 POLYPEPTIDE; ATP1A2	477
MIM182350		19q12-q13.2	ATPase, Na+/K+ TRANSPORTING, ALPHA-3 POLYPEPTIDE; ATP1A3	478
MIM182360		13q12.1-q12.3	ATPase, H+/K+ TRANSPORTING, NONGASTRIC, ALPHA POLYPEPTIDE; ATP12A	479
MIM182380		22q13.1	SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 1; SLC5A1	6523
MIM182381		16p11.2	SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 2; SLC5A2	6524
MIM182389		2q24	SODIUM CHANNEL, NEURONAL TYPE I, ALPHA SUBUNIT; SCN1A	6323
MIM182390		2q23-q24.3	SODIUM CHANNEL, VOLTAGE-GATED, TYPE II, ALPHA SUBUNIT; SCN2A	6326
MIM182391		2q24	SODIUM CHANNEL, VOLTAGE-GATED, TYPE III, ALPHA SUBUNIT; SCN3A	6328
MIM182392		2q21-q23	SODIUM CHANNEL, VOLTAGE-GATED, TYPE VII, ALPHA SUBUNIT; SCN7A	6332
MIM182396		14q24.1	SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 1; SLC10A1	6554
MIM182410	C0282492	 	SNEDDON SYNDROME	 
MIM182450		3q28	SOMATOSTATIN; SST	6750
MIM182451		14q13	SOMATOSTATIN RECEPTOR 1; SSTR1	6751
MIM182452		17q24	SOMATOSTATIN RECEPTOR 2; SSTR2	6752
MIM182453		22q13.1	SOMATOSTATIN RECEPTOR 3; SSTR3	6753
MIM182454		20p11.2	SOMATOSTATIN RECEPTOR 4; SSTR4	6754
MIM182455		16p13.3	SOMATOSTATIN RECEPTOR 5; SSTR5	6755
MIM182465		21q22.1-q22.2	SON DNA-BINDING PROTEIN; SON	6651
MIM182500		15q15.3	SORBITOL DEHYDROGENASE; SORD	6652
MIM182520		7q21.1	SORCIN; SRI	6717
MIM182530		2p22-p21	SON OF SEVENLESS, DROSOPHILA, HOMOLOG 1; SOS1	6654
MIM182590		21q22.3	TREFOIL FACTOR 2; TFF2	7032
MIM182600	C2931355	14q11-q21	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A	51062
MIM182601	C1866855	2p22-p21	SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4	6683
MIM182610	C1866854	 	SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	 
MIM182690	C1866853	 	SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND PROGRESSIVE NEPHROPATHY	 
MIM182790		2p21	SPECTRIN, BETA, NONERYTHROCYTIC, 1; SPTBN1	6711
MIM182800	C1866852	 	SPASTIC PARAPLEGIA WITH ASSOCIATED EXTRAPYRAMIDAL SIGNS	 
MIM182810		9q33-q34	SPECTRIN, ALPHA, NONERYTHROCYTIC 1; SPTAN1	6709
MIM182815	C1866851	 	SPASTIC PARAPLEGIA WITH NEUROPATHY AND POIKILODERMA	 
MIM182820	C1866850	 	SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	 
MIM182830	C1866849	 	SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	 
MIM182860		1q21	SPECTRIN, ALPHA, ERYTHROCYTIC 1; SPTA1	6708
MIM182870		14q22-q23.2	SPECTRIN, BETA, ERYTHROCYTIC; SPTB	6710
MIM182878		8q22	OUTER DENSE FIBER OF SPERM TAILS 1; ODF1	4956
MIM182880		16p13.3	SPERM PROTAMINE P1; PRM1	5619
MIM182888		16p12	ZONA PELLUCIDA GLYCOPROTEIN 2; ZP2	7783
MIM182889		7q11.23	ZONA PELLUCIDA GLYCOPROTEIN 3; ZP3	7784
MIM182890		16p13.3	SPERM PROTAMINE P2; PRM2	5620
MIM182891		1p36-p22	SPERMIDINE SYNTHASE; SRM	6723
MIM182900	C2674218	8p11.2	SPHEROCYTOSIS, TYPE 1; SPH1	286
MIM182920	C1866785	5q31	MYOPATHY, SPHEROID BODY	9499
MIM182940	C0027794	17q11.2-q12, 1p13, 6q27	NEURAL TUBE DEFECTS	6347, 6862, 80199, 81839
MIM182950	C1710146	 	SPINAL ARACHNOIDITIS	 
MIM182970	C1866783	 	SPINAL MUSCULAR ATROPHY, FACIOSCAPULOHUMERAL TYPE	 
MIM182980	C1866777	20q13.3	SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL DOMINANT	9217
MIM182990	C0344485	 	SPINAL INTRADURAL ARACHNOID CYSTS	 
MIM183020	C1866774	 	SPINAL MUSCULAR ATROPHY, SEGMENTAL	 
MIM183050	C1866770	 	SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	 
MIM183086	C0752124	19p13	SPINOCEREBELLAR ATAXIA 6; SCA6	773
MIM183090	C0752121	12q24	SPINOCEREBELLAR ATAXIA 2; SCA2	6311
MIM183100	C1866746	 	SPINOCEREBELLAR ATROPHY WITH PUPILLARY PARALYSIS	 
MIM183300	C1866745	 	SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	 
MIM183350	C1866744	 	SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA AND REDUCED CIRCULATING T-HELPER CELLS	 
MIM183400	C1866743	 	SPLIT LOWER LIP	 
MIM183500	C1866742	 	SPLIT-HAND AND SPLIT-FOOT WITH HYPODONTIA	 
MIM183600	C2931019	7q21.2-q21.3	SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	7979
MIM183700	C1866741	 	SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	 
MIM183800	C1866740	 	SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS	 
MIM183802	C1866739	 	SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATIC DEFECTS	 
MIM183840	C1866738	9q31-q34	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2; SPDA2	791255
MIM183849	C1866728	 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH HYPOTRICHOSIS	 
MIM183850	C1866727	 	SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	 
MIM183900	C0038015	12q13.11-q13.2	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA; SEDC	1280
MIM184000	C1866719	 	SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	 
MIM184095	C3159322	 	SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE	59341
MIM184100	C1866717	 	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	 
MIM184200	C0038016	 	SPONDYLOLISTHESIS	 
MIM184250	C0700635	12q13.11-q13.2	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK	1280
MIM184252	C0265280	12q24.1	SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE; SMDK	59341
MIM184253	C1866688	 	SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	 
MIM184255	C0432221	 	SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE	 
MIM184260	C0018036	 	SPONDYLOMETAPHYSEAL DYSPLASIA WITH DENTINOGENESIS IMPERFECTA	 
MIM184300	C1384641	 	SPONDYLOSIS, CERVICAL	 
MIM184400	C0152438	 	SPRENGEL DEFORMITY	 
MIM184420		8p23.1-p22	FARNESYLDIPHOSPHATE FARNESYLTRANSFERASE 1; FDFT1	2222
MIM184429		3q26.3-q27	SRY-BOX 2; SOX2	6657
MIM184430		6p22.3	SRY-BOX 4; SOX4	6659
MIM184450	C3489627	18p11.3-p11.2	STUTTERING, FAMILIAL PERSISTENT, 1; STUT1	100049541
MIM184460	C1866656	17q22	STAPES ANKYLOSIS WITH BROAD THUMB AND TOES	9241
MIM184470		4q11-q13	STATHERIN; STATH	6779
MIM184500	C0259771	17q12-q21	STEATOCYSTOMA MULTIPLEX	3872
MIM184510	C1866650	 	STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH	 
MIM184600		3q21	CYSTATIN A; CSTA	1475
MIM184700	C0032460	5q11.2	POLYCYSTIC OVARY SYNDROME 1; PCOS1	5120
MIM184705	C1866649	 	STEINFELD SYNDROME	 
MIM184745		12q22	KIT LIGAND; KITLG	4254
MIM184753		5p15	STEROID 5-ALPHA-REDUCTASE 1; SRD5A1	6715
MIM184755		1p32	STEROL CARRIER PROTEIN 2; SCP2	6342
MIM184756		17p11.2	STEROL REGULATORY ELEMENT-BINDING TRANSCRIPTION FACTOR 1; SREBF1	6720
MIM184757		9q33	NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 1; NR5A1	2516
MIM184800	C1861485	 	STERNUM, PREMATURE OBLITERATION OF SUTURES OF	 
MIM184840	C1861481	6p21.3	STICKLER SYNDROME, TYPE III; STL3	1302
MIM184850	C0085292	 	STIFF-PERSON SYNDROME; SPS	 
MIM184900	C1861456	15q21.1	STIFF SKIN SYNDROME; SSKS	2200
MIM185000	C1861455	9q34.1	STOMATOCYTOSIS I	2040
MIM185010		 	STOMATOCYTOSIS II	 
MIM185020	C1861453	 	PSEUDOHYPERKALEMIA CARDIFF	 
MIM185050	C0543679	 	STORAGE POOL PLATELET DISEASE	 
MIM185069	C1861452	 	STORM SYNDROME	 
MIM185070	C1861451	 	STORMORKEN SYNDROME	 
MIM185100	C1861449	7p22.1	STRABISMUS, SUSCEPTIBILITY TO	100188805
MIM185120	C1861448	 	STRATTON-PARKER SYNDROME	 
MIM185200	C1861447	 	STRIAE DISTENSAE, FAMILIAL	 
MIM185250		11q23	MATRIX METALLOPROTEINASE 3; MMP3	4314
MIM185260		11q22.3-q23	MATRIX METALLOPROTEINASE 10; MMP10	4319
MIM185261		22q11.2	MATRIX METALLOPROTEINASE 11; MMP11	4320
MIM185300	C0038505	 	STURGE-WEBER SYNDROME; SWS	 
MIM185430		8p21-p12	CLUSTERIN; CLU	1191
MIM185440		11p14.3-p12	SUPPRESSOR OF TUMORIGENICITY 2; ST2	6761
MIM185460	C1861437	 	SULFHEMOGLOBINEMIA, CONGENITAL	 
MIM185470		1p36.1-p35	SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT B, IRON SULFUR PROTEIN; SDHB	6390
MIM185480	C0796204	 	SUPRABULBAR PARESIS, CONGENITAL	 
MIM185490		4p15.3-p15.1	SUPEROXIDE DISMUTASE 3; SOD3	6649
MIM185500	C0003499	7q11.2	SUPRAVALVULAR AORTIC STENOSIS; SVAS	2006
MIM185535		2p21	EPITHELIAL CELLULAR ADHESION MOLECULE; EPCAM	4072
MIM185600	C1861418	 	SYMPHALANGISM OF TOES	 
MIM185605		12cen-q21	SYNAPTOTAGMIN 1; SYT1	6857
MIM185620		9q34	SURFEIT 1; SURF1	6834
MIM185630		9q34	SURFEIT 2; SURF2	6835
MIM185640		9q34	RIBOSOMAL PROTEIN L7a; RPL7A	6130
MIM185641		9q34	MEDIATOR COMPLEX SUBUNIT 22; MED22	6837
MIM185642		9q34	SURFEIT 6; SURF6	6838
MIM185650	C1861404	 	SYMPHALANGISM, C. S. LEWIS TYPE	 
MIM185660		9q34	SURFEIT 4; SURF4	6836
MIM185700	C1861401	 	SYMPHALANGISM, DISTAL	 
MIM185750	C1861391	 	SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	 
MIM185800	C1861385	20q11.2, 17q22	SYMPHALANGISM, PROXIMAL; SYM1	8200, 9241
MIM185860		 	SYNAPTIC VESICLE GLYCOPROTEIN 2A; SV2A	9900
MIM185861		 	SYNAPTIC VESICLE GLYCOPROTEIN 2B; SV2B	9899
MIM185880		12p	VESICLE-ASSOCIATED MEMBRANE PROTEIN 1; VAMP1	6843
MIM185881		17p12	VESICLE-ASSOCIATED MEMBRANE PROTEIN 2; VAMP2	6844
MIM185900	C1861380	2q34-q36	SYNDACTYLY, TYPE I	57306
MIM186000	C1861367	2q31-q32	SYNPOLYDACTYLY 1; SPD1	3239
MIM186100	C1861366	6q21-q23.2	SYNDACTYLY, TYPE III	2697
MIM186200	C1861355	7q36	SYNDACTYLY, TYPE IV	64327
MIM186300	C1861348	2q31-q32	SYNDACTYLY, TYPE V	3239
MIM186350	C1861347	 	SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME	 
MIM186355		2p24.1	SYNDECAN 1; SDC1	6382
MIM186357		1pter-p22.3	SYNDECAN 3; SDC3	9672
MIM186360		10q21.1-q21.2	ANNEXIN A7; ANXA7	310
MIM186400	C1876184	 	SYNOSTOSES, TARSAL, CARPAL, AND DIGITAL	 
MIM186500	C0342282	17q22	MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1	9241
MIM186550	C1861313	 	SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	 
MIM186570	C1861305	17q22	TARSAL-CARPAL COALITION SYNDROME; TCC	9241
MIM186575	C1861304	 	SYNOVIAL CHONDROMATOSIS, FAMILIAL, WITH DWARFISM	 
MIM186580	C1861303	16q12	BLAU SYNDROME	64127
MIM186590		7q11.2	SYNTAXIN 1A; STX1A	6804
MIM186591		16p11.2	SYNTAXIN 4; STX4	6810
MIM186600	C1861302	 	SYRINGOMAS, MULTIPLE	 
MIM186700	C1861301	 	SYRINGOMYELIA, ISOLATED	 
MIM186710		11pter-p11.2	T-CELL ACTIVATION ANTIGEN p250; TP250	8041
MIM186711		12p13	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 7; TNFRSF7	939
MIM186720		Chr.11	CD6 ANTIGEN; CD6	923
MIM186730		2p12	CD8 ANTIGEN, BETA POLYPEPTIDE; CD8B	926
MIM186740		11q23	CD3 ANTIGEN, GAMMA SUBUNIT; CD3G	917
MIM186745		9p	TALIN 1; TLN1	7094
MIM186750	C1861296	 	TALONAVICULAR COALITION	 
MIM186760		2q33-q34	ANTIGEN CD28; CD28	940
MIM186770		10q24	T-CELL LEUKEMIA, HOMEOBOX 1; TLX1	3195
MIM186780		1q22-q23	CD247 ANTIGEN; CD247	919
MIM186790		11q23	CD3 ANTIGEN, DELTA SUBUNIT; CD3D	915
MIM186810		14q11.2	T-CELL ANTIGEN RECEPTOR, DELTA SUBUNIT; TCRD	6964
MIM186820		17q25.2-q25.3	T-CELL ANTIGEN CD7; CD7	924
MIM186830		11q23	CD3 ANTIGEN, EPSILON SUBUNIT; CD3E	916
MIM186845		11p	CD81 ANTIGEN; CD81	975
MIM186850	C1406822	 	TARSAL COALITION	 
MIM186852		11p13-p12	PROTEASOME 26S SUBUNIT, ATPase, 3; PSMC3	5702
MIM186854		3p25-q24	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, TAURINE), MEMBER 6; SLC6A6	6533
MIM186855		9q31	T-CELL ACUTE LYMPHOCYTIC LEUKEMIA 2; TAL2	6887
MIM186860		2q34	T-CELL LEUKEMIA/LYMPHOMA 4; TCL4	6946
MIM186880		14q11.2	T-CELL ANTIGEN RECEPTOR, ALPHA SUBUNIT; TCRA	6955
MIM186910		2p12	CD8 ANTIGEN, ALPHA POLYPEPTIDE; CD8A	925
MIM186921		11p15	LIM DOMAIN ONLY 1; LMO1	4004
MIM186930		7q35	T-CELL ANTIGEN RECEPTOR, BETA SUBUNIT; TCRB	6957
MIM186940		12pter-p12	CD4 ANTIGEN; CD4	920
MIM186945		20p13	FK506-BINDING PROTEIN 1A; FKBP1A	2280
MIM186946		11q13.1-q13.3	FK506-BINDING PROTEIN 2; FKBP2	2286
MIM186947		 	FK506-BINDING PROTEIN 3; FKBP3	2287
MIM186950	C1861277	 	T-CELL SUBGROUPS, NON-HLA-LINKED	 
MIM186960		14q32.1	T-CELL LEUKEMIA/LYMPHOMA 1A; TCL1A	8115
MIM186970		7p15-p14	T-CELL ANTIGEN RECEPTOR, GAMMA SUBUNIT; TCRG	6965
MIM186973		5q32	IL2-INDUCIBLE T-CELL KINASE; ITK	3702
MIM186975		6p21.3-cen	T COMPLEX-ASSOCIATED TESTIS-EXPRESSED 1; TCTE1	202500
MIM186977		6q27	T COMPLEX-ASSOCIATED TESTIS-EXPRESSED 3; TCTE3	6991
MIM186980		6q25.3-q26	T-COMPLEX 1; TCP1	6950
MIM186982		6p21.3-p21.2	T-COMPLEX HOMOLOG TCP11; TCP11	6954
MIM186990		1p13.1	T-LYMPHOCYTE SURFACE CD2 ANTIGEN; CD2	914
MIM187000	C1861274	 	TEETH, ODD SHAPES OF	 
MIM187011		17q11.2-q12	CHEMOKINE, CC MOTIF, LIGAND 5; CCL5	6352
MIM187020		6q27	T-COMPLEX 10; TCP10	6953
MIM187040		1p32	T-CELL ACUTE LYMPHOCYTIC LEUKEMIA 1; TAL1	6886
MIM187050	C0027443	 	TEETH PRESENT AT BIRTH	 
MIM187100	C0040457	 	TEETH, SUPERNUMERARY	 
MIM187260	C0406502	 	TELANGIECTASIA, HEREDITARY BENIGN	338411
MIM187270		5p15.33	TELOMERASE REVERSE TRANSCRIPTASE; TERT	7015
MIM187280	C1861253	8q21	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, tsBN51; BN51T	661
MIM187290	C1861252	Chr.9	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, H142; H142T	8023
MIM187300	C0039445	9q34.1	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER; HHT	2022, 4089, 94
MIM187310	C1861245	Chr.14	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, K12	3729
MIM187320	C1861244	Chr.4	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, ts13; TS13	7896
MIM187330	C1861243	Chr.6	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, ts546; TS546	7963
MIM187340	C1861242	 	TEMPERATURE-SENSITIVE LETHAL MUTATION	 
MIM187350	C0423113	 	TELECANTHUS	 
MIM187360	C1956391	 	TEMPORAL ARTERITIS	 
MIM187370	C1861238	 	ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10	 
MIM187380		9q33	TENASCIN C; TNC	3371
MIM187390	C1861237	 	TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF	 
MIM187395		3p23-p21	TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	6997
MIM187400	C0037856	 	TESTICULAR TORSION	 
MIM187410		10q23-q24	DEOXYNUCLEOTIDYLTRANSFERASE, TERMINAL; DNTT	1791
MIM187430		6p12	CYSTEINE-RICH SECRETORY PROTEIN 2; CRISP2	7180
MIM187500	C0039685	8q23, 5q34, 20p12, 19p12	TETRALOGY OF FALLOT; TOF	1482, 182, 23414, 2627, 2657
MIM187501	C1861234	 	TETRALOGY OF FALLOT AND GLAUCOMA	 
MIM187510	C1861233	 	TETRAMELIC MONODACTYLY	 
MIM187520		3p22-p21.3	TETRANECTIN; TNA	7123
MIM187600	C1868678	4p16.3	THANATOPHORIC DYSPLASIA, TYPE I; TD1	2261
MIM187601	C1300257	 	THANATOPHORIC DYSPLASIA, TYPE II; TD2	2261
MIM187680		6p22.3	THIOPURINE S-METHYLTRANSFERASE; TPMT	7172
MIM187700		9q31	THIOREDOXIN; TXN	7295
MIM187750	C1861204	 	THORACIC DYSOSTOSIS, ISOLATED	 
MIM187760	C1861197	 	THORACOLARYNGOPELVIC DYSPLASIA; TLPD	 
MIM187770	C1861196	 	THORACOPELVIC DYSOSTOSIS	 
MIM187790		5p13-cen	THREONYL-tRNA SYNTHETASE; TARS	6897
MIM187800	C1861195	 	GLANZMANN THROMBASTHENIA, AUTOSOMAL DOMINANT	 
MIM187900	C1861194	 	THROMBASTHENIA-THROMBOCYTOPENIA, HEREDITARY	 
MIM187930		5q13	COAGULATION FACTOR II RECEPTOR; F2R	2149
MIM187950	C0040028	9p24, 1p34, 3q26.3-q27	THROMBOCYTHEMIA 1; THCYT1	10019, 3717, 4352, 7066
MIM188000	C1861185	10p12.1	THROMBOCYTOPENIA 2; THC2	22852, 84930
MIM188020	C0272282	 	THROMBOCYTOPENIA, CYCLIC	 
MIM188025	C1861178	11q23	THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT	140892
MIM188030	C0043117	1q23	THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP	9103
MIM188035		4q12-q13	PRO-PLATELET BASIC PROTEIN-LIKE 1; PPBPL1	728045
MIM188040		20p11.2	THROMBOMODULIN; THBD	7056
MIM188050	C0398623	11p11-q12, 10q25-q26, 1p36.3	THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1	2147, 2153, 2162, 3026, 4524
MIM188055	C1861171	1q23	THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE; THPH2	2147, 2153
MIM188060		15q15	THROMBOSPONDIN I; THBS1	7057
MIM188061		6q27	THROMBOSPONDIN II; THBS2	7058
MIM188062		1q21	THROMBOSPONDIN III; THBS3	7059
MIM188070		19p13.3	THROMBOXANE A2 RECEPTOR, PLATELET; TBXA2R	6915
MIM188100	C0575897	 	THUMB DEFORMITY	 
MIM188150	C1861168	 	THUMB DEFORMITY AND ALOPECIA	 
MIM188201	C1861166	 	THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	 
MIM188230		11q23.3	THY-1 T-CELL ANTIGEN; THY1	7070
MIM188250		16q22	THYMIDINE KINASE, MITOCHONDRIAL; TK2	7084
MIM188300		17q25.2-q25.3	THYMIDINE KINASE, SOLUBLE; TK1	7083
MIM188340		1q21-q23	THYMOCYTE ANTIGEN CD1C; CD1C	911
MIM188345		 	DEOXYTHYMIDYLATE KINASE; DTYMK	1841
MIM188350		18p11.32	THYMIDYLATE SYNTHETASE; TYMS	7298
MIM188360		1q21-q23	THYMOCYTE ANTIGEN CD1B; CD1B	910
MIM188370		1q21-q23	THYMOCYTE ANTIGEN CD1A; CD1A	909
MIM188380		12q22	THYMOPOIETIN; TMPO	7112
MIM188390		2q36-q37	PROTHYMOSIN, ALPHA; PTMA	5757
MIM188399		 	THYMOSIN, BETA-10; TMSB10	9168
MIM188400	C0012236	22q11.2	DIGEORGE SYNDROME; DGS	1714, 6899
MIM188410		1q21-q23	THYMOCYTE ANTIGEN CD1D; CD1D	912
MIM188411		1q21-q23	THYMOCYTE ANTIGEN CD1E; CD1E	913
MIM188450		8q24.2-q24.3	THYROGLOBULIN; TG	7038
MIM188455	C1861114	 	THYROGLOSSAL DUCT CYST, FAMILIAL	 
MIM188470	C0206682	11p15.5, 10q23, 1p13.2	THYROID CARCINOMA, FOLLICULAR; FTC	3265, 4893, 5728, 9562
MIM188540		1p13	THYROID-STIMULATING HORMONE, BETA CHAIN; TSHB	7252
MIM188545		8q23	THYROTROPIN-RELEASING HORMONE RECEPTOR; TRHR	7201
MIM188550	C0238463	14q, 10q21, 10q11.2, 1p13, 8p22-p21.3, 7q32-q34, 17q23-q24	THYROID CARCINOMA, PAPILLARY	5108, 51592, 5573, 8030, 8031, 8805, 9950
MIM188560	C1861101	 	THYROID HORMONE PLASMA MEMBRANE TRANSPORT DEFECT	 
MIM188570	C2937288	3p24.3	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT; GRTH	7068
MIM188580	C0268446	1q32	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	779
MIM188595		22q13	THYROTROPH EMBRYONIC FACTOR; TEF	7008
MIM188700	C0175756	 	BLOUNT DISEASE, INFANTILE	 
MIM188740	C1861099	 	TIBIA, ABSENCE OF, WITH POLYDACTYLY	 
MIM188770		 	TIBIA, HYPOPLASIA OF, WITH POLYDACTYLY	 
MIM188800	C1861097	 	TIBIAL TORSION, BILATERAL MEDIAL	 
MIM188825		17q25	TISSUE INHIBITOR OF METALLOPROTEINASE 2; TIMP2	7077
MIM188826		22q12.1-q13.2	TISSUE INHIBITOR OF METALLOPROTEINASE 3; TIMP3	7078
MIM188830		17q23-q24	PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE I, ALPHA; PRKAR1A	5573
MIM188840		2q31	TITIN; TTN	7273
MIM188855		2p12-q11	GRANULYSIN; GNLY	10578
MIM188860		2cen-q13	MYELIN AND LYMPHOCYTE PROTEIN; MAL	4118
MIM188890	C1861063	9q22.1, 5p15.3, 20q13.2-q13.3, 19q13.2	TOBACCO ADDICTION, SUSCEPTIBILITY TO	1137, 1548, 6531, 9568
MIM189000	C1861062	 	TOE, FIFTH, NUMBER OF PHALANGES IN	 
MIM189100	C1861061	 	TOE, MISSHAPEN	 
MIM189150	C1861060	 	TOE, ROTATED FIFTH	 
MIM189200	C1861059	 	TOES, RELATIVE LENGTH OF FIRST AND SECOND	 
MIM189230	C1861058	 	TOES, SPACE BETWEEN FIRST AND SECOND	 
MIM189300	C1861055	 	TONGUE CURLING, FOLDING, OR ROLLING	 
MIM189490	C2752157	 	MALPOSITION OF TEETH WITH OR WITHOUT HYPODONTIA/OLIGODONTIA	 
MIM189500	C0406735	4p16.1	WITKOP SYNDROME	4487
MIM189600	C0040485	 	TORTICOLLIS	 
MIM189700	C1861044	 	TORUS PALATINUS AND TORUS MANDIBULARIS	 
MIM189800	C0032914	7q36, 2p13, 1q42.1	PREECLAMPSIA/ECLAMPSIA 1; PEE1	2052, 4846, 5177
MIM189880		1p36.1	TRANSFER RNA ASPARAGINE 1; TRNAN1	7214
MIM189889		12q13	TRANSCRIPTION FACTOR CP2; TFCP2	7024
MIM189901		2p11.2-p11.1	TRANSCRIPTION FACTOR 9; TCF9	6936
MIM189902		13q34	TRANSCRIPTION FACTOR DP1; TFDP1	7027
MIM189903		6p21.3	NUCLEAR TRANSCRIPTION FACTOR Y, ALPHA; NFYA	4800
MIM189904		12q22-q23	NUCLEAR TRANSCRIPTION FACTOR Y, BETA; NFYB	4801
MIM189905		11q11-q12	TRANSCOBALAMIN I; TCN1	6947
MIM189906		12q13.1	TRANSCRIPTION FACTOR Sp1; SP1	6667
MIM189907		17q12	HNF1 HOMEOBOX B; HNF1B	6928
MIM189908		5q31.1	TRANSCRIPTION FACTOR 7; TCF7	6932
MIM189909		10p11.2	ZINC FINGER E BOX-BINDING HOMEOBOX 1; ZEB1	6935
MIM189910		 	TRANSFER RNA SERINE 2; TRNAS2	23437
MIM189911		Chr.16	TRANSFER RNA GLYCINE 1; TRNAG1	7195
MIM189912		Chr.5	TRANSFER RNA PROLINE 3; TRNAP3	7219
MIM189913		Chr.5	TRANSFER RNA THREONINE 1; TRNAT1	7236
MIM189918		17p13.1	TRANSFER RNA LYSINE 1 (ANTICODON UUU); TRNAK1	7206
MIM189919		17p13.1	TRANSFER RNA GLUTAMINE 1; TRNAQ1	7228
MIM189920		17p13.1	TRANSFER RNA LEUCINE 2; TRNAL2	7208
MIM189921		 	TRANSFER RNA VALINE 1; TRNAV1	7239
MIM189923		 	TRANSFER RNA GLUTAMINE 2; TRNAQ2	7229
MIM189930		14q11	TRANSFER RNA PROLINE 1; TRNAP1	7217
MIM189931		14q11-q12	TRANSFER RNA PROLINE 2; TRNAP2	7218
MIM189932		14q11-q12	TRANSFER RNA LEUCINE 1; TRNAL1	7207
MIM189933		14q11-q12	TRANSFER RNA THREONINE 2; TRNAT2	7237
MIM189940		1q25	TRANSLOCATED PROMOTER REGION; TPR	7175
MIM189960	C1861028	 	TRACHEOESOPHAGEAL FISTULA WITH OR WITHOUT ESOPHAGEAL ATRESIA	 
MIM189961	C0520538	 	TRACHEOPATHIA OSTEOPLASTICA	 
MIM189962		 	GENERAL TRANSCRIPTION FACTOR IIE, POLYPEPTIDE 1; GTF2E1	2960
MIM189963		1p22-p21	GENERAL TRANSCRIPTION FACTOR IIB; GTF2B	2959
MIM189964		8p21-p12	GENERAL TRANSCRIPTION FACTOR IIE, POLYPEPTIDE 2; GTF2E2	2961
MIM189965		20q13.1	CCAAT/ENHANCER-BINDING PROTEIN, BETA; CEBPB	1051
MIM189967		11p15.2	TEA DOMAIN FAMILY MEMBER 1; TEAD1	7003
MIM189968		19p13.3	GENERAL TRANSCRIPTION FACTOR IIF, POLYPEPTIDE 1, 74-KD; GTF2F1	2962
MIM189969		 	GENERAL TRANSCRIPTION FACTOR IIF, POLYPEPTIDE 2, 30-KD; GTF2F2	2963
MIM189970		7q21.3	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-TRANSDUCING ACTIVITY POLYPEPTIDE 1; GNGT1	2792
MIM189971		20q11.2	E2F TRANSCRIPTION FACTOR 1; E2F1	1869
MIM189972		11p15.1-p14	GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 1; GTF2H1	2965
MIM189973		 	E74-LIKE FACTOR 1; ELF1	1997
MIM189980		9q34.1	ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ABL1	25
MIM189990		6q22	V-MYB AVIAN MYELOBLASTOSIS VIRAL ONCOGENE HOMOLOG; MYB	4602
MIM190000		6p21.3, 3q21	TRANSFERRIN; TF	7018
MIM190010		3q29	TRANSFERRIN RECEPTOR; TFRC	7037
MIM190020		11p15.5	V-HA-RAS HARVEY RAT SARCOMA VIRAL ONCOGENE HOMOLOG; HRAS	3265
MIM190030		15q26.1	V-FES FELINE SARCOMA VIRAL/V-FPS FUJINAMI AVIAN SARCOMA VIRAL ONCOGENE HOMOLOG; FES	2242
MIM190040		22q12.3-q13.1	PLATELET-DERIVED GROWTH FACTOR, BETA POLYPEPTIDE; PDGFB	5155
MIM190060		8q11	V-MOS MOLONEY MURINE SARCOMA VIRAL ONCOGENE HOMOLOG; MOS	4342
MIM190070		12p12.1	V-KI-RAS2 KIRSTEN RAT SARCOMA VIRAL ONCOGENE HOMOLOG; KRAS	3845
MIM190080		8q24.12-q24.13	V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG; MYC	4609
MIM190090		20q12-q13	V-SRC AVIAN SARCOMA (SCHMIDT-RUPPIN A-2) VIRAL ONCOGENE; SRC	6714
MIM190100	C1860972	9q13-q21	GENIOSPASM 1; GSM1	2933
MIM190120		17q11.2	THYROID HORMONE RECEPTOR, ALPHA-1; THRA	7067
MIM190151		12q13	V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 3; ERBB3	2065
MIM190160		3p24.3	THYROID HORMONE RECEPTOR, BETA; THRB	7068
MIM190170		2p13	TRANSFORMING GROWTH FACTOR, ALPHA; TGFA	7039
MIM190180		19q13.1	TRANSFORMING GROWTH FACTOR, BETA-1; TGFB1	7040
MIM190181		9q22	TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE I; TGFBR1	7046
MIM190182		3p22	TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE II; TGFBR2	7048
MIM190195		14q11.2	TRANSGLUTAMINASE 1; TGM1	7051
MIM190196		20q11.2-q12	TRANSGLUTAMINASE 2; TGM2	7052
MIM190197		1q32.1	CONTACTIN 2; CNTN2	6900
MIM190198		9q34.3	NOTCH, DROSOPHILA, HOMOLOG OF, 1; NOTCH1	4851
MIM190200	C1860872	 	TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	 
MIM190220		1q41	TRANSFORMING GROWTH FACTOR, BETA-2; TGFB2	7042
MIM190230		14q24	TRANSFORMING GROWTH FACTOR, BETA-3; TGFB3	7043
MIM190231		2q35-q36	TRANSITION PROTEIN 1; TNP1	7141
MIM190232		16p13.3	TRANSITION PROTEIN 2; TNP2	7142
MIM190300	C1860861	3q13.3	TREMOR, HEREDITARY ESSENTIAL, 1; ETM1	1814
MIM190310	C1860860	 	TREMOR, NYSTAGMUS, AND DUODENAL ULCER	 
MIM190315		22q11	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, CITRATE TRANSPORTER), MEMBER 1; SLC25A1	6576
MIM190320	C0265333	17q21.3-q22	TRICHODENTOOSSEOUS SYNDROME	1747
MIM190330	C0854699	 	TRICHOMEGALY	 
MIM190340	C1860850	 	DISCOID FIBROMAS, FAMILIAL MULTIPLE; FMDF	 
MIM190345	C1860849	 	TRICHOEPITHELIOMAS, MULTIPLE DESMOPLASTIC	 
MIM190350	C0432233	8q24.12	TRICHORHINOPHALANGEAL SYNDROME, TYPE I; TRPS1	7227
MIM190351	C1860823	8q24.12	TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	7227
MIM190360	C1860822	 	TRICHODYSPLASIA-XERODERMA	 
MIM190370		1q21.3	TRICHOHYALIN; TCHH	7062
MIM190400	C0040997	 	TRIGEMINAL NEURALGIA	 
MIM190410	C0410060	 	TRIGGER THUMB	 
MIM190440	C0432122	8p11.2-p11.1	TRIGONOCEPHALY 1; TRIGNO1	2260
MIM190445		 	TRIIODOTHYRONINE RECEPTOR AUXILIARY PROTEIN; TRAP	100187907
MIM190450		12p13	TRIOSEPHOSPHATE ISOMERASE 1; TPI1	7167
MIM190470		13q32-q33	TRIPEPTIDYL PEPTIDASE II; TPP2	7174
MIM190500	C1860807	 	TRIPHALANGEAL THUMB WITH DOUBLE PHALANGES	 
MIM190600	C1860806	 	TRIPHALANGEAL THUMB, NONOPPOSABLE	 
MIM190650	C1860805	 	TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	 
MIM190680	C1860804	 	TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	 
MIM190685	C0013080	1q43, Xp11.23, 21q22.3	DOWN SYNDROME	1637, 2623, 4548
MIM190700		19q13.1	ZINC FINGER PROTEIN 36, MOUSE, HOMOLOG OF; ZFP36	7538
MIM190800	C1860785	 	TRISTICHIASIS	 
MIM190900	C0155017	7q31.3-q32	TRITANOPIA	611
MIM190920		6q14-q15	TROPHOBLAST GLYCOPROTEIN; TPBG	7162
MIM190930		9q22.3	TROPOMODULIN; TMOD	7111
MIM190990		9p13.2-p13.1	TROPOMYOSIN 2; TPM2	7169
MIM191000	C1860773	 	TROCHLEA OF THE HUMERUS, APLASIA OF	 
MIM191010		15q22.1	TROPOMYOSIN 1; TPM1	7168
MIM191030		1q22-q23	TROPOMYOSIN 3; TPM3	7170
MIM191039		20q12-q13.11	TROPONIN C, FAST; TNNC2	7125
MIM191040		3p21.3-p14.3	TROPONIN C, SLOW; TNNC1	7134
MIM191041		19q13.4	TROPONIN T1, SKELETAL, SLOW; TNNT1	7138
MIM191042		1q31.3	TROPONIN I, SLOW-TWITCH SKELETAL MUSCLE ISOFORM; TNNI1	7135
MIM191043		11p15.5	TROPONIN I, FAST-TWITCH SKELETAL MUSCLE ISOFORM; TNNI2	7136
MIM191044		19q13.4	TROPONIN I, CARDIAC; TNNI3	7137
MIM191045		1q32	TROPONIN T2, CARDIAC; TNNT2	7139
MIM191050		14q32.31	TRYPTOPHANYL-tRNA SYNTHETASE; WARS	7453
MIM191060		11p15.3-p14	TRYPTOPHAN HYDROXYLASE 1; TPH1	7166
MIM191070		4q31-q32	TRYPTOPHAN 2,3-DIOXYGENASE; TDO2	6999
MIM191080		16p13.3	TRYPTASE, ALPHA/BETA-1; TPSAB1	7177
MIM191081		16p13.3	TRYPTASE, BETA-2; TPSB2	64499
MIM191092		16p13.3	TSC2 GENE; TSC2	7249
MIM191100	C1854465	16p13.3, 9q34	TUBEROUS SCLEROSIS 1; TSC1	7248, 7249
MIM191110		 	TUBULIN, ALPHA-4A; TUBA4A	7277
MIM191130		6p21.3	TUBULIN, BETA; TUBB	203068
MIM191135		17q21	TUBULIN, GAMMA-1; TUBG1	7283
MIM191150	C0398741	 	TUFTSIN DEFICIENCY	 
MIM191155		3q21-q25	TRANSMEMBRANE 4 SUPERFAMILY, MEMBER 1; TM4SF1	4071
MIM191160		6p21.3	TUMOR NECROSIS FACTOR; TNF	7124
MIM191161		17q22-q23	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 1; TNFAIP1	7126
MIM191163		6q23	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 3; TNFAIP3	7128
MIM191164		1q21-q22	EPHRIN A1; EFNA1	1942
MIM191170		17p13.1	TUMOR PROTEIN p53; TP53	7157
MIM191175		12q23.3	HEAT-SHOCK PROTEIN, 90-KD, BETA, 1; HSP90B1	7184
MIM191181	C1860658	11q13	SUPPRESSOR OF TUMORIGENICITY 3; ST3	6762
MIM191190		12p13.2	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 1A; TNFRSF1A	7132
MIM191191		1p36.3-p36.2	TUMOR NECROSIS FACTOR RECEPTOR SUBFAMILY, MEMBER 1B; TNFRSF1B	7133
MIM191195		10p11.2	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 8; MAP3K8	1326
MIM191200	C1860646	 	TUNE DEAFNESS	 
MIM191270		11p11.2	TYROSINASE-LIKE; TYRL	7300
MIM191275		13q31-q32	DOPACHROME TAUTOMERASE; DCT	1638
MIM191290		11p15.5	TYROSINE HYDROXYLASE; TH	7054
MIM191305		8p23-p22	TYROSINE KINASE, B-LYMPHOCYTE SPECIFIC; BLK	640
MIM191306		4q12	KINASE INSERT DOMAIN RECEPTOR; KDR	3791
MIM191311		1q12-qter	DISCOIDIN DOMAIN RECEPTOR FAMILY, MEMBER 2; DDR2	4921
MIM191315		1q21-q22	NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 1; NTRK1	4914
MIM191316		15q25	NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 3; NTRK3	4916
MIM191317		21q22.3	U2 SMALL NUCLEAR RNA AUXILIARY FACTOR 1; U2AF1	7307
MIM191318		 	U2 SMALL NUCLEAR RNA AUXILIARY FACTOR 2; U2AF2	11338
MIM191321		19p13.1-p12	UBIQUITIN A-52-RESIDUE RIBOSOMAL PROTEIN FUSION PRODUCT; UBA52	7311
MIM191325		3p21	UBIQUITIN-ACTIVATING ENZYME E1-LIKE; UBE1L	7318
MIM191327		19q12	UBIQUINOL-CYTOCHROME c REDUCTASE, RIESKE IRON-SULFUR; UQCRFS1	7386
MIM191328		3p21.3	UBIQUINOL-CYTOCHROME c REDUCTASE CORE PROTEIN I; UQCRC1	7384
MIM191329		16p12	UBIQUINOL-CYTOCHROME c REDUCTASE CORE PROTEIN II; UQCRC2	7385
MIM191330		8q22	UBIQUINOL-CYTOCHROME c REDUCTASE-BINDING PROTEIN; UQCRB	7381
MIM191339		17p12-p11.1	UBIQUITIN B; UBB	7314
MIM191340		12q24.3	UBIQUITIN C; UBC	7316
MIM191342		4p14	UBIQUITIN CARBOXYL-TERMINAL ESTERASE L1; UCHL1	7345
MIM191343		 	RIBOSOMAL PROTEIN S27a; RPS27A	6233
MIM191350		11q23.3	DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINE PHOSPHOTRANSFERASE; DPAGT1	1798
MIM191390	C2674051	7q22	INFLAMMATORY BOWEL DISEASE 11; IBD11	100529151
MIM191400	C1860616	 	ULNA AND FIBULA, HYPOPLASIA OF	 
MIM191420	C1860615	 	ULNA METAPHYSEAL DYSPLASIA SYNDROME	 
MIM191440	C1860614	 	ULNAR HYPOPLASIA	 
MIM191480	C0432347	 	UNCOMBABLE HAIR SYNDROME	 
MIM191482	C1860605	 	UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, AND BRACHYDACTYLY	 
MIM191500	C1860604	 	UNDRITZ ANOMALY	 
MIM191510		1p22	COLD-SHOCK DOMAIN-CONTAINING E1, RNA-BINDING; CSDE1	7812
MIM191520	C1860596	 	UPINGTON DISEASE	 
MIM191523		1q22-q23	UPSTREAM STIMULATORY FACTOR 1; USF1	7391
MIM191525		12q23-q24.1	URACIL-DNA GLYCOSYLASE; UNG	7374
MIM191540		1p22	URATE OXIDASE, PSEUDOGENE; UOX	391051
MIM191550	C1860586	 	URETER, BIFID OR DOUBLE	 
MIM191600	C0153619	 	URETER, CANCER OF	 
MIM191650	C0041960	 	URETEROCELE	 
MIM191700	C2674049	 	UROLITHIASIS, URIC ACID, AUTOSOMAL DOMINANT	 
MIM191710		1p32	CYTIDINE MONOPHOSPHATE (UMP-CMP) KINASE 1, CYTOSOLIC; CMPK1	51727
MIM191720		17q23-q25	5-PRIME,3-PRIME-@NUCLEOTIDASE, CYTOSOLIC; NT5C	30833
MIM191730		7p12.3	URIDINE PHOSPHORYLASE 1; UPP1	7378
MIM191740		2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1	54658
MIM191750		1q21-q22	URIDYL DIPHOSPHATE GLUCOSE PYROPHOSPHORYLASE 1; UGP1	7359
MIM191760		2p14-p13	URIDYL DIPHOSPHATE GLUCOSE PYROPHOSPHORYLASE 2; UGP2	7360
MIM191800	C0403645	 	URINARY BLADDER, ATONY OF	 
MIM191830	C1619700	10q11.2, 22q13.31	RENAL ADYSPLASIA	5979, 7380
MIM191840		10q24	PLASMINOGEN ACTIVATOR, URINARY; PLAU	5328
MIM191845	NULL	16p12.3	UROMODULIN; UMOD	7369
MIM191850	C0263334	 	URTICARIA, AQUAGENIC	 
MIM191900	C0268390	1q44	MUCKLE-WELLS SYNDROME; MWS	114548
MIM191950	C1860551	 	URTICARIA, FAMILIAL LOCALIZED HEAT	 
MIM192000	C0266383	 	UTERINE ANOMALIES	 
MIM192020		11q12.3-q13.1	SECRETOGLOBIN, FAMILY 1A, MEMBER 1; SCGB1A1	7356
MIM192050	C1860549	 	UTERUS BICORNIS BICOLLIS WITH PARTIAL VAGINAL SEPTUM AND UNILATERAL HEMATOCOLPOS WITH IPSILATERAL RENAL AGENESIS	 
MIM192090		16q22.1	CADHERIN 1; CDH1	999
MIM192100	C0266122	 	UVULA, BIFID	 
MIM192130		17q21	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A1; ATP6V0A1	535
MIM192132		2cen-q13	ATPase, H+ TRANSPORTING, LYSOSOMAL, 56/58-KD, V1 SUBUNIT B, ISOFORM 1; ATP6V1B1	525
MIM192150		6p21.3	VALYL-tRNA SYNTHETASE; VARS	7407
MIM192200	C0042345	 	VARICOSE VEINS	619537
MIM192225		1p32-p31	VASCULAR CELL ADHESION MOLECULE 1; VCAM1	7412
MIM192240		6p12	VASCULAR ENDOTHELIAL GROWTH FACTOR A; VEGFA	7422
MIM192300	C1860520	 	VASCULAR HELIX OF UMBILICAL CORD	 
MIM192310	C1860519	 	VASCULITIS, LYMPHOCYTIC, NODULAR	 
MIM192315	C1860518	3p21.3-p21.2	VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	11277
MIM192320		6q26-q27	VASOACTIVE INTESTINAL PEPTIDE; VIP	7432
MIM192321		3p22	VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 1; VIPR1	7433
MIM192340		20p13	ARGININE VASOPRESSIN; AVP	551
MIM192350	C0220708	2q31-q32	VATER ASSOCIATION	3239
MIM192400	C1860490	 	VEINS, PATTERN OF, ON ANTERIOR THORAX	 
MIM192430	C0220704	22q11.2	VELOCARDIOFACIAL SYNDROME	1714, 54487, 6899, 8214, 8220, 9993
MIM192445	C1860471	 	VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE	 
MIM192500	C0035828	11p15.5	LONG QT SYNDROME 1; LQT1	3784
MIM192600	C3495498	14q12, 4q35, 3p25, 20q13.3	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1	291, 4624, 4625, 85366, 859
MIM192605	C0340485	3p21	VENTRICULAR TACHYCARDIA, FAMILIAL	2771
MIM192700	C1860465	 	VENULAR INSUFFICIENCY, SYSTEMIC	 
MIM192800	C1860464	 	VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	 
MIM192900	C1860463	 	VERTEBRAL HYPOPLASIA WITH LUMBAR KYPHOSIS	 
MIM192950	C0240912	2q31-q32	VERTICAL TALUS, CONGENITAL; CVT	3236
MIM192968		5q11.2	INTEGRIN, ALPHA-1; ITGA1	3672
MIM192974		5q23-q31	INTEGRIN, ALPHA-2; ITGA2	3673
MIM192975		2q31-q32	INTEGRIN, ALPHA-4; ITGA4	3676
MIM192977		9p24	VERY LOW DENSITY LIPOPROTEIN RECEPTOR; VLDLR	7436
MIM193000	C0042580	1p13	VESICOURETERAL REFLUX 1; VUR1	54113
MIM193001		10q25	SOLUTE CARRIER FAMILY 18 (VESICULAR MONOAMINE), MEMBER 2; SLC18A2	6571
MIM193002		8p21.3	SOLUTE CARRIER FAMILY 18 (VESICULAR MONOAMINE), MEMBER 1; SLC18A1	6570
MIM193003	C1860433	13q31-q33	NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4	317685
MIM193005	C1860432	 	VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	 
MIM193007	C0155502	6q	VERTIGO, BENIGN RECURRENT; BRV	619536
MIM193040		2q35-q36	VILLIN; VIL	7429
MIM193050	C0473546	 	VIBRATORY ANGIOEDEMA	 
MIM193060		10p13	VIMENTIN; VIM	7431
MIM193065		10q22.1-q23	VINCULIN; VCL	7414
MIM193067		11q24	FRIEND LEUKEMIA VIRUS INTEGRATION 1; FLI1	2313
MIM193100	C0342642	12p13.3	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT; ADHR	8074
MIM193190		17q11	VITRONECTIN; VTN	7448
MIM193200	C0042900	6p21.3	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 6; VAMAS6	246319
MIM193210		2q31	INTEGRIN, ALPHA-V; ITGAV	3685
MIM193220	C1860406	11q13	VITREORETINOCHOROIDOPATHY; VRCP	7439
MIM193230	C1860405	2q37	VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD	3769
MIM193235	C1860404	11q13	VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY; VRNI	7445
MIM193240	C1860403	 	VOCAL CORD PARALYSIS AND PTOSIS	 
MIM193245		10q22	VOLTAGE-DEPENDENT ANION CHANNEL 2; VDAC2	7417
MIM193250	C0221210	 	VOLVULUS OF MIDGUT	 
MIM193300	C0019562	11q13, 3p26-p25	VON HIPPEL-LINDAU SYNDROME; VHL	595, 7428
MIM193400	C1264039	12p13.3	VON WILLEBRAND DISEASE, TYPE 1; VWD1	7450
MIM193450	C1860357	 	VULVOVAGINITIS, ALLERGIC SEMINAL	 
MIM193500	C1847800	2q35	WAARDENBURG SYNDROME, TYPE 1; WS1	5077
MIM193510	C1860339	3p14.1-p12.3	WAARDENBURG SYNDROME, TYPE 2A; WS2A	4286
MIM193520	C0553586	17q11.2	WATSON SYNDROME	4763
MIM193525		11p15.3-p15.1	WEE1, S. POMBE, HOMOLOG OF; WEE1	7465
MIM193530	C0457013	4p16	WEYERS ACROFACIAL DYSOSTOSIS	2121
MIM193670	C0472817	2q21	WHIM SYNDROME	7852
MIM193680		 	WHISPERING DYSPHONIA, HEREDITARY	 
MIM193700	C0265224	17p13.1	ARTHROGRYPOSIS, DISTAL, TYPE 2A; DA2A	4621
MIM193900	C1721005	17q21-q22, 12q13	WHITE SPONGE NEVUS; WSN	3851, 3860
MIM194000	C1853486	 	WIDOW'S PEAK	 
MIM194050	C0175702	7q11.23	WILLIAMS-BEUREN SYNDROME; WBS	2006, 51085
MIM194070	CN033288	13q12.3, 11p13, Xq26	WILMS TUMOR 1; WT1	2719, 283120, 5080, 675, 7490
MIM194071	C0694899	11p15.5	WILMS TUMOR 2; WT2	283120, 7491
MIM194072	C0206115	11p13	WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATION SYNDROME; WAGR	100528024, 5080, 7490
MIM194080	C0950121	11p13	DENYS-DRASH SYNDROME; DDS	7490
MIM194090	C1860265	16q	WILMS TUMOR 3; WT3	8136
MIM194190	C1956097	4p16.3	WOLF-HIRSCHHORN SYNDROME; WHS	7467, 7468
MIM194200	C0043202	7q36	WOLFF-PARKINSON-WHITE SYNDROME	51422
MIM194300	C1860238	12q13	WOOLLY HAIR, AUTOSOMAL DOMINANT; ADWH	121391
MIM194320	C1860237	 	WORONETS TRAIT	 
MIM194350	C1327917	 	WT LIMB-BLOOD SYNDROME	 
MIM194355		22q12	X BOX-BINDING PROTEIN 1; XBP1	7494
MIM194360		19q13.2	X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 1; XRCC1	7515
MIM194363		5q13-q14	X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 4; XRCC4	7518
MIM194364		2q35	X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 5; XRCC5	7520
MIM194370	C1860232	13q14	X-RAY SENSITIVITY; XRS	8102
MIM194380	C0272051	16q23-q24	DEHYDRATED HEREDITARY STOMATOCYTOSIS; DHS	10774
MIM194400	C1860231	 	XERODERMA PIGMENTOSUM, AUTOSOMAL DOMINANT, MILD	 
MIM194460		7q22.1	ALPHA-2-GLYCOPROTEIN, ZINC; AZGP1	563
MIM194470	C1860228	4q11-q13	ZINC, ELEVATED PLASMA	213
MIM194480		17pter-p12	ZINC FINGER PROTEIN 3, MOUSE, HOMOLOG OF; ZFP3	124961
MIM194500		2q11.2	ZINC FINGER PROTEIN 2; ZNF2	7549
MIM194510		7q22.1	ZINC FINGER PROTEIN 3; ZNF3	7551
MIM194521		10q11.2	ZINC FINGER PROTEIN 33A; ZNF33A	7581
MIM194522		10q11.2	ZINC FINGER PROTEIN 33B; ZNF33B	7582
MIM194524		17p13-p12	ZINC FINGER PROTEIN 18; ZNF18	7566
MIM194525		16q22	ZINC FINGER PROTEIN 19; ZNF19	7567
MIM194526		8q24.12-q24.13	ZINC FINGER PROTEIN 34; ZNF34	80778
MIM194527		16q22	ZINC FINGER PROTEIN 23; ZNF23	7571
MIM194528		10p11.2-q11.2	ZINC FINGER PROTEIN 25; ZNF25	219749
MIM194529		10q11.2	ZINC FINGER PROTEIN 22; ZNF22	7570
MIM194531		8q24	ZINC FINGER PROTEIN 7; ZNF7	7553
MIM194532		19q13.43	ZINC FINGER PROTEIN 8; ZNF8	7554
MIM194533		3p22-p21	ZINC FINGER PROTEIN 35; ZNF35	7584
MIM194534		18q12	ZINC FINGER PROTEIN 24; ZNF24	7572
MIM194535		17p13-p12	ZINC FINGER PROTEIN 29; ZNF29	7577
MIM194536		7p22-p21	ZINC FINGER PROTEIN 12; ZNF12	7559
MIM194537		12q24.33	ZINC FINGER PROTEIN 26; ZNF26	7574
MIM194538		12q13-qter	ZINC FINGER PROTEIN 10; ZNF10	7556
MIM194539		10q23-q24	ZINC FINGER PROTEIN 32; ZNF32	7580
MIM194540		6p24-p22.3	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 1; HIVEP1	3096
MIM194541		14q23-q24	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 25; ZBTB25	7597
MIM194542		19p13.2	ZINC FINGER PROTEIN 44; ZNF44	51710
MIM194543		19p13.2	ZINC FINGER PROTEIN 69; ZNF69	7620
MIM194544		22q11.2	ZINC FINGER PROTEIN 70; ZNF70	7621
MIM194545		19q13.4	ZINC FINGER PROTEIN 71; ZNF71	58491
MIM194546		22p	ZINC FINGER PROTEIN 72; ZNF72	100287084
MIM194547		22p	ZINC FINGER PROTEIN 73; ZNF73	7624
MIM194548		22q11.2	ZINC FINGER PROTEIN 74; ZNF74	7625
MIM194549		6p21.3-p21.2	ZINC FINGER PROTEIN 76; ZNF76	7629
MIM194550		19q13.2-q13.4	MYELOID ZINC FINGER GENE 1; MZF1	7593
MIM194551		19p	ZINC FINGER PROTEIN 77; ZNF77	58492
MIM194552		9q34	ZINC FINGER PROTEIN 79; ZNF79	7633
MIM194553		3p12-qter	ZINC FINGER PROTEIN 80; ZNF80	7634
MIM194554		19q13.2	ZINC FINGER PROTEIN 45; ZNF45	7596
MIM194555		19q13.2-qter	ZINC FINGER PROTEIN 224; ZNF224	7767
MIM194556		19p13.3-p13.2	ZINC FINGER PROTEIN 14; ZNF14	7561
MIM194557		19p13.3-p13.2	ZINC FINGER PROTEIN 20; ZNF20	7568
MIM194558		19q13.3-q13.4	ZINC FINGER PROTEIN 83; ZNF83	55769
MIM194624		7q11.2	ZINC FINGER PROTEIN 117; ZNF117	51351
MIM194628		19p	ZINC FINGER PROTEIN 121; ZNF121	7675
MIM194630		11q23.1-q23.2	ZINC FINGER PROTEIN 123; ZNF123	100188891
MIM194631		1q44	ZINC FINGER PROTEIN 124; ZNF124	7678
MIM194648		4p16.3	ZINC FINGER PROTEIN 141; ZNF141	7700
MIM195000		11q12.2	ZONA PELLUCIDA GLYCOPROTEIN 1; ZP1	22917
MIM200100	C0000744	4q22-q24	ABETALIPOPROTEINEMIA; ABL	4547
MIM200110	C1860224	 	ABLEPHARON-MACROSTOMIA SYNDROME	 
MIM200130	C0796125	 	ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	 
MIM200150	C0393576	9q21	CHOREOACANTHOCYTOSIS; CHAC	23230
MIM200170	C1860215	 	ACANTHOSIS NIGRICANS WITH MUSCLE CRAMPS AND ACRAL ENLARGEMENT	 
MIM200300	C1860214	 	ACETOPHENETIDIN SENSITIVITY	 
MIM200350		17q21	ACETYL-CoA CARBOXYLASE-ALPHA; ACACA	31
MIM200400	C1860213	 	ACHALASIA, FAMILIAL ESOPHAGEAL	 
MIM200450	C1860212	 	ACHALASIA-MICROCEPHALY SYNDROME	 
MIM200500	C0265559	7q36	ACHEIROPODY	64327
MIM200600	C0265273	14q31-q32	ACHONDROGENESIS, TYPE IA; ACG1A	9321
MIM200610	C0220685	12q13.11-q13.2	ACHONDROGENESIS, TYPE II; ACG2	1280
MIM200700	C0265260	20q11.2	CHONDRODYSPLASIA, GREBE TYPE	8200
MIM200900	C1860168	 	SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	 
MIM200950	C0268410	11p12-p11	ACID PHOSPHATASE DEFICIENCY	53
MIM200970	C1860167	 	ACKERMAN SYNDROME	 
MIM200980	C1860166	 	ACRORENAL-MANDIBULAR SYNDROME	 
MIM200990	C0796147	7p13	ACROCALLOSAL SYNDROME; ACLS	2737, 374654, 46
MIM200995	C1860157	 	ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	 
MIM201000	C1275078	6p11	CARPENTER SYNDROME	51715
MIM201020	C0265303	 	ACROCEPHALOPOLYSYNDACTYLY TYPE IV	 
MIM201050	C1860145	 	ACROCRANIOFACIAL DYSOSTOSIS	 
MIM201100	C0221036	8q24.3	ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE; AEZ	55630
MIM201170	C1860119	 	ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	 
MIM201180	C1860118	 	ACROFRONTOFACIONASAL DYSOSTOSIS 1	 
MIM201200	C0406584	 	ACROGERIA, GOTTRON TYPE	 
MIM201250	C2930970	20q11.2	ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	8200
MIM201300	C2752089	12p13	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA; HSAN2A	65125
MIM201310	C1860089	 	ACRORENAL SYNDROME, AUTOSOMAL RECESSIVE	 
MIM201400	C0342388	1q23-q24	ACTH DEFICIENCY, ISOLATED; IAD	9095
MIM201450	C0220710	1p31	ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF; ACADMD	34
MIM201470	C0342783	12q22-qter	ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD	35
MIM201475	C0342784	17p13	ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD	37
MIM201550	C0431886	 	ADDUCTED THUMBS SYNDROME	 
MIM201710	C0342474	15q23-q24, 8p11.2	LIPOID CONGENITAL ADRENAL HYPERPLASIA; LCAH	6770
MIM201750	C1860042	7q11.2	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	5447
MIM201810	C0342471	1p13.1	3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF	3284
MIM201910	C0852654	6p21.3	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	1589
MIM202010	C0268292	8q21	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	1584
MIM202110	C0268285	10q24.3	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	1586
MIM202150	C1859978	 	ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZING HORMONE	 
MIM202155	C1859977	 	ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	 
MIM202200	C1859974	18p11.2	GLUCOCORTICOID DEFICIENCY 1; GCCD1	4158
MIM202300	C1859972	17p13.1	ADRENOCORTICAL CARCINOMA, HEREDITARY; ADCC	7157
MIM202370	C0282525	12p13.3, 7q21-q22, 1p36.32, 2p15, 22q11.21	ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM	5189, 5192, 5194, 55670, 5830
MIM202400	CN071205	4q28, 4q28	AFIBRINOGENEMIA, CONGENITAL	2243, 2244
MIM202550	C0345240	 	AGANGLIONOSIS, TOTAL INTESTINAL	 
MIM202600	C1859969	 	AGENESIS OF CEREBRAL WHITE MATTER	 
MIM202650	C1876185	 	AGNATHIA-OTOCEPHALY COMPLEX; AGOTC	5396
MIM202660	C1859967	 	PAGOD SYNDROME	 
MIM202700	C1859966	19p13.3	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1	1991
MIM202900	C1859965	 	ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	 
MIM203000	C1859964	 	FRONTONASAL DYSPLASIA WITH ALAR CLEFTS	 
MIM203100	C0268494	11q14-q21	ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	7299
MIM203200	C0268495	16q24.3, 15q11.2-q12	ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	4157, 4948
MIM203290	C1859932	9p23	ALBINISM, OCULOCUTANEOUS, TYPE III; OCA3	7306
MIM203300	C2931875	11p15-p13, 10q24.32, 10q23.1, 6p22.3, 3q24, 22q11.2-q12.2, 19q13	HERMANSKY-PUDLAK SYNDROME 1; HPS1	3257
MIM203330	C0271870	 	PSEUDOHYPOPARATHYROIDISM, TYPE II; PHP2	 
MIM203340	C1859910	 	ALBINISM-MICROCEPHALY-DIGITAL ANOMALIES SYNDROME	 
MIM203400	CN074214	8q21	CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY	1585
MIM203450	C0270726	17q21, 11q13	ALEXANDER DISEASE	2670, 4723
MIM203500	C0002066	3q21-q23	ALKAPTONURIA	3081
MIM203550	C0795895	 	ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	 
MIM203600	C0265328	 	ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN	 
MIM203650	C1859878	3q26.3-q27.3	ALOPECIA-MENTAL RETARDATION SYNDROME 1; APMR1	780898
MIM203655	C1859877	8p21.2	ALOPECIA UNIVERSALIS CONGENITA; ALUNC	55806
MIM203700	C0205710	15q25	MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE); MTDPS4A	5428
MIM203740	C2752074	7p14-p13	ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	4967
MIM203750	C1536500	11q22.3-q23.1	ALPHA-METHYLACETOACETIC ACIDURIA	38
MIM203780	C1567744	2q36-q37, 2q36-q37	ALPORT SYNDROME, AUTOSOMAL RECESSIVE	1285, 1286
MIM203800	C0268425	2p13	ALSTROM SYNDROME; ALMS	7840
MIM204000	C2931258	17p13.1	LEBER CONGENITAL AMAUROSIS 1; LCA1	3000
MIM204100	C1859844	1p31	LEBER CONGENITAL AMAUROSIS 2; LCA2	6121
MIM204110	C1859843	 	AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	 
MIM204200	C0751383	16p12.1	CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	1201
MIM204300	C0022797	 	CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE; CLN4A	54982
MIM204500	C1876161	11p15.5	CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2	1200
MIM204650	C2673923	4q21	AMELOGENESIS IMPERFECTA, TYPE IC; AI1C	10117
MIM204690	C2931783	 	ENAMEL-RENAL SYNDROME; ERS	 
MIM204700	C2673922	19q13.4	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA1; AI2A1	9622
MIM204730	C1859818	 	AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY, OSTEOPOROSIS, AND ACIDOSIS	 
MIM204750	C1859817	 	AMINOADIPIC ACIDURIA	 
MIM204800	C1859816	 	AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	 
MIM204850	C1859815	 	AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	 
MIM204870	C0339273	1p32	CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE; GDLD	4070
MIM204900	C0268399	 	AMYLOIDOSIS, CUTANEOUS BULLOUS	 
MIM205000	C0002735	 	AMYOTONIA CONGENITA	 
MIM205100	C1859807	2q33	AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	57679
MIM205200	C1859806	 	AMYOTROPHIC LATERAL SCLEROSIS, JUVENILE, WITH DEMENTIA	 
MIM205250	C1859805	 	AMYOTROPHIC LATERAL SCLEROSIS WITH POLYGLUCOSAN BODIES	 
MIM205400	C0039292	9q22-q31	TANGIER DISEASE; TGD	19
MIM205700	C0002880	 	ANEMIA, AUTOIMMUNE HEMOLYTIC	 
MIM205950	C2673914	14q32, 3p22.1	ANEMIA, SIDEROBLASTIC, PYRIDOXINE-REFRACTORY, AUTOSOMAL RECESSIVE	51218, 54977
MIM206000	C1859787	 	ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE	 
MIM206100	C2673913	12q13	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD	4891
MIM206200	C0085576	22q12-q13	IRON-REFRACTORY IRON DEFICIENCY ANEMIA; IRIDA	164656
MIM206300	C1859786	 	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF RED CELL MEMBRANE	 
MIM206400	C1859785	 	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRIN METABOLISM	 
MIM206500	C0002902	 	ANENCEPHALY	 
MIM206550	C1859784	 	ANGIOLIPOMATOSIS, FAMILIAL	 
MIM206570	C1859783	 	ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	 
MIM206600	C0003028	 	ANHIDROSIS	 
MIM206700	C0431401	11p13	ANIRIDIA, CEREBELLAR ATAXIA, AND MENTAL RETARDATION	5080
MIM206750	C1859782	 	ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTOR RETARDATION	 
MIM206780	C1290511	 	ANODONTIA OF PERMANENT DENTITION	 
MIM206800	C0265998	20p13	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4; NDNC4	343637
MIM206900	C1859773	3q26.3-q27	MICROPHTHALMIA, SYNDROMIC 3; MCOPS3	4990, 6657
MIM206920	C0599973	 	MICROPHTHALMIA WITH LIMB ANOMALIES	64093
MIM207000	C1859762	 	ANOSMIA FOR ISOBUTYRIC ACID	 
MIM207300	C1859761	 	ANTITHROMBIN, FAMILIAL HEMORRHAGIC DIATHESIS DUE TO	 
MIM207410	C2936791	10q26	ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	2263, 5447
MIM207500	C0003466	 	ANUS, IMPERFORATE	 
MIM207600	C0039263	 	TAKAYASU ARTERITIS	 
MIM207620	C1859754	 	APHALANGY WITH HEMIVERTEBRAE	 
MIM207720	C0520680	 	APNEA, CENTRAL SLEEP	 
MIM207731	C1859753	 	APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA	 
MIM207750	C1720779	19q13.2	APOLIPOPROTEIN C-II DEFICIENCY	344
MIM207770	C0795952	 	APROSENCEPHALY SYNDROME	 
MIM207780	C0342280	 	AREDYLD	 
MIM207790	C0751615	 	ARACHNOID CYSTS, INTRACRANIAL	 
MIM207800	C0268548	6q23	ARGININEMIA	383
MIM207900	C0268547	7cen-q11.2	ARGININOSUCCINIC ACIDURIA	435
MIM207950	C0555206	 	CHIARI MALFORMATION TYPE II	 
MIM208000	C1859727	6q22-q23	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	5167
MIM208050	C1859726	20q13.1	ARTERIAL TORTUOSITY SYNDROME; ATS	81031
MIM208060	C1859725	 	ARTERIOSCLEROSIS, SEVERE JUVENILE	 
MIM208080	C1859724	 	ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION, AND FACIAL ANOMALIES	 
MIM208081	C1859723	 	ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTIC FACIES	 
MIM208085	C1859722	15q26.1	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1; ARCS1	26276
MIM208100	C1859721	5q35	ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	261
MIM208150	C1276035	11p11.2-p11.1, 4p16.2	FETAL AKINESIA DEFORMATION SEQUENCE; FADS	285489, 5913
MIM208155	C1859711	 	ILLUM SYNDROME	 
MIM208158	C1859710	 	ARTHROGRYPOSIS WITH HYPERKERATOSIS	 
MIM208200		 	ARTHROGRYPOSIS-LIKE DISORDER	 
MIM208230	C0432215	6q22-q23	ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD; PPAC	8838
MIM208250	C1859690	1q24-q25	CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME; CACP	10216
MIM208300	C0008732	 	ASCITES, CHYLOUS	 
MIM208400	C0268225	4q32-q33	ASPARTYLGLUCOSAMINURIA; AGU	175
MIM208500	CN119532	15q13	ASPHYXIATING THORACIC DYSTROPHY 1; ATD1	465
MIM208530	C0175707	 	ASPLENIA WITH CARDIOVASCULAR ANOMALIES	 
MIM208540	C2673883	3q22	RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD	27031
MIM208550	C1859648	14q22, 17q21.3	ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	30009, 5732
MIM208600	C1859647	 	ASTHMA, SHORT STATURE, AND ELEVATED IgA	 
MIM208700	C1859646	 	ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	 
MIM208750	C1859645	 	ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	 
MIM208850	C0796045	 	ATAXIA-DEAFNESS-RETARDATION SYNDROME	 
MIM208870	C0796056	 	ATAXIA-MICROCEPHALY-CATARACT SYNDROME	 
MIM208900	C0004135	11q22.3	ATAXIA-TELANGIECTASIA; AT	472
MIM208920	C1859598	9p13.3	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	54840
MIM209050	C1859595	 	ATHROMBIA, ESSENTIAL	 
MIM209100	C1859594	 	ATONIC-ASTATIC SYNDROME OF FOERSTER	 
MIM209300	C1859593	3q21	ATRANSFERRINEMIA	7018
MIM209500	C1859592	8p21.2	ATRICHIA WITH PAPULAR LESIONS; APL	55806
MIM209600	C0004331	 	ATRIOVENTRICULAR DISSOCIATION	 
MIM209700	C0263429	 	ATROPHODERMIA VERMICULATA	 
MIM209770	C1859591	 	AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	 
MIM209850	C0004352	7q22	AUTISM	100188832, 54413, 57502, 6638
MIM209880	C1275808	12q22-q23, 11p13, 10q11.2, 5p13.1-p12, 4p12, 20q13.2-q13.3	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	1908, 2668, 429, 5979, 627, 8929
MIM209885	C1319466	 	BARBER-SAY SYNDROME	 
MIM209900	C0752166	16q21, 15q22.3-q23, 14q32.1, 12q21.3, 12q21.2, 11q13, 9q31-q34.1, 8q21.13-q22.1, 7p14, 4q27, 4q27, 3p12-q13, 2q31, 2p15, 20p12, 17q23	BARDET-BIEDL SYNDROME; BBS	10806, 123016, 129880, 166379, 22954, 27241, 51057, 54903, 55212, 582, 583, 585, 79140, 79738, 80184, 8195, 84100, 91147
MIM209901		11q13	BBS1 GENE; BBS1	582
MIM209920	C0242583	16p13, 1q21.1-q21.3, 13q14, 19p12	BARE LYMPHOCYTE SYNDROME, TYPE II	4261, 5993, 5994, 8625
MIM209950	C0694566	6q23-q24, 5q31.1-q33.1, 2q32.2-q32.3, 21q22.1-q22.2, 19p13.1	ATYPICAL MYCOBACTERIOSIS, FAMILIAL	3459, 3460, 3593, 3594, 6772
MIM209970	C1859526	 	BEEMER LETHAL MALFORMATION SYNDROME	 
MIM210000	C0221061	 	BEHR SYNDROME	 
MIM210050	C1859519	 	BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	 
MIM210200	CN028786	3q25-q27	3-@METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY	56922
MIM210210	C1859499	5q12-q13	3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY	64087
MIM210250	C0342907	2p21, 2p21	SITOSTEROLEMIA	64240, 64241
MIM210350	C1859487	 	BIEMOND SYNDROME II	 
MIM210370	C1859486	4q35.1	BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY	285440
MIM210400	C0221363	 	BIFID NOSE, AUTOSOMAL RECESSIVE	 
MIM210500	C0005411	 	BILIARY ATRESIA, EXTRAHEPATIC; EHBA	 
MIM210550	C0400972	 	BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	 
MIM210600	CN033164	3q22-q24	SECKEL SYNDROME 1; SCKL1	22995, 5116, 545, 55835
MIM210700	C1859468	 	MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	 
MIM210710	C1859452	2q14.2-q14.3	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I; MOPD1	100151683
MIM210720	C0432246	21q22.3	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	5116
MIM210730	C1859439	 	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	 
MIM210740	C0342284	 	BANGSTAD SYNDROME	 
MIM210745	C1859432	 	BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	 
MIM210750	C2673866	14q32	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6; SHEP6	123041
MIM210900	C0005859	15q26.1	BLOOM SYNDROME; BLM	641
MIM211000	C0268478	 	BLUE DIAPER SYNDROME	 
MIM211100		19q13.3	FUCOSYLTRANSFERASE 1; FUT1	2523
MIM211120	C1859407	 	BONE DYSPLASIA, LETHAL, HOLMGREN TYPE	 
MIM211170	C1859406	 	BORRONE DERMATOCARDIOSKELETAL SYNDROME	 
MIM211180	C1859405	12p13, 12p13.3	BOWEN-CONRADI SYNDROME; BWCNS	10436
MIM211200	C1859404	 	BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	 
MIM211350	C0432239	 	KYPHOMELIC DYSPLASIA	 
MIM211355	C1859394	 	BOWING OF LONG BONES, ASYMMETRIC AND SYMMETRIC	 
MIM211369	C1859393	 	BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	 
MIM211370	C1859385	 	BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	 
MIM211380	C1859384	 	BRACHIOSKELETOGENITAL SYNDROME	 
MIM211390	C0796271	 	SABINAS BRITTLE HAIR SYNDROME	 
MIM211400	CN029847	16p13-p12, 7q31.2	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1	1080, 6338
MIM211410		 	CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	8105
MIM211450	C0340231	 	BRONCHOMALACIA	 
MIM211500	C0393540	20p13	FAZIO-LONDE DISEASE	113278
MIM211530	CN029849	20p13	BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	113278
MIM211600	C0268312	18q21	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1; PFIC1	5205
MIM211750	C0796095	3q13.13	C SYNDROME	10225
MIM211770	C0796282	 	CAHMR SYNDROME	 
MIM211800	C1859372	6q14-q21	CALCIFICATION OF JOINTS AND ARTERIES; CALJA	4907
MIM211890	C1859371	 	CAMPOMELIA, CUMMING TYPE	 
MIM211900	C1876187	13q12, 12p13.3, 2q24-q31	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL; HFTC	 
MIM211910	C1859359	 	CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1	 
MIM211920	C2673861	 	CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	 
MIM211930	C1859357	 	CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	 
MIM211965	C1859355	 	CAMPTODACTYLY-ICHTHYOSIS SYNDROME	 
MIM211980	C0684249	17q21.1, 12p12.1, 11q22-q24, 11p15.5, 10q11, 10p11.2, 7q34, 7p12.3-p12.1, 6q25.2-q27, 5q31.1, 3q26.3, 3p21.3, 3p22-p21.3, 2q33, 19q13.2	LUNG CANCER	11186, 1326, 1548, 1956, 2064, 2074, 356, 3659, 3845, 5002, 5071, 5290, 5519, 673, 841, 9940
MIM211990	C1859354	 	CAMPTOMELIC SYNDROME, LONG-LIMB TYPE	 
MIM212050	C1859353	9q34.3	CANDIDIASIS, FAMILIAL, 2; CANDF2	64170
MIM212060	C1859352	 	CARBIMAZOLE SENSITIVITY	 
MIM212065	C0349653	16p13.3-p13.2	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	5373
MIM212066	C0349654	14q21	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	4247
MIM212067	C0349655	 	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx	 
MIM212070	C0398782	10q24.2	CARBOXYPEPTIDASE N DEFICIENCY	1369
MIM212080	C1859332	 	CARDIAC LIPIDOSIS, FAMILIAL	 
MIM212090	C1859331	 	CARDIAC SEPTAL DEFECTS WITH COARCTATION OF THE AORTA	 
MIM212093	C1859330	 	CARDIAC VALVULAR DEFECT, DEVELOPMENTAL	 
MIM212100	C1859329	 	CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	 
MIM212112	C0796031	 	CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	4000
MIM212130	C1859328	 	CARDIOMYOPATHY ASSOCIATED WITH MYOPATHY AND SUDDEN DEATH	 
MIM212135	C1859327	 	CARDIOSKELETAL SYNDROME, KUWAITI TYPE	 
MIM212138	C0342791	3p21.31	CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	788
MIM212140	C0342788	5q31.1	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP	6584
MIM212160	C1859318	 	CARNITINE DEFICIENCY, MYOPATHIC	 
MIM212200	C3495555	18q21.3	CARNOSINEMIA	8173
MIM212350	C1859317	 	SENGERS SYNDROME	55750
MIM212360	C1859316	 	PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA, AUTOSOMAL RECESSIVE	 
MIM212400	C1859315	 	CATARACT AND CONGENITAL ICHTHYOSIS	 
MIM212500	C2931791	 	CATARACT, CONGENITAL OR JUVENILE	 
MIM212540	C1859312	 	CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME	 
MIM212550	C1859311	14q23	MICROPHTHALMIA, ISOLATED, WITH CATARACT 2; MCOPCT2	4990
MIM212710	C0796123	 	CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	 
MIM212720	C0796037	1q41	MARTSOLF SYNDROME	25782
MIM212750	C0007570	6p21.3, 6p21.3	CELIAC DISEASE; CD	3117, 3119
MIM212780	C1859309	11p12-p11.2	CENANI-LENZ SYNDACTYLY SYNDROME; CLSS	4038
MIM212790	C1859308	 	PREMATURE CENTROMERE DIVISION; PCD	 
MIM212800	C1859307	 	CEPHALIN LIPIDOSIS	 
MIM212835	C1859306	 	CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	 
MIM212840	C1859305	 	CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM	 
MIM212850	C1859304	 	CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	 
MIM212890	C1859303	 	CEREBELLAR ATAXIA, BENIGN, WITH THERMOANALGESIA	 
MIM212895	C0393520	 	CEREBELLAR ATAXIA, EARLY-ONSET, WITH RETAINED TENDON REFLEXES; EOCA	 
MIM213000	C0266470	 	CEREBELLAR HYPOPLASIA	283989, 4983, 57038, 7443, 79042, 80746, 8573
MIM213002	C1859301	 	CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	 
MIM213010	C1859300	 	CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZ SYNDROME AND MECKEL SYNDROME	 
MIM213100	C1859299	 	CEREBELLOPARENCHYMAL DISORDER II; CPD2	 
MIM213200	C1859298	9q34-qter	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	1165
MIM213300	CN119531	9q34.3, 9q34.3	JOUBERT SYNDROME; JBTS	51524, 65250, 79809, 79867, 95681
MIM213400	C0007761	 	CEREBELLOPARENCHYMAL DISORDER V; CPD5	 
MIM213500	C1859283	 	CEREBRAL ANGIOPATHY, DYSPHORIC	 
MIM213600	C0393590	14q	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	23706, 6575
MIM213700	C0238052	2q33-qter	CEREBROTENDINOUS XANTHOMATOSIS; CTX	1593
MIM213820	C1859259	 	CEREBRAL MALFORMATION, SEIZURES, HYPERTRICHOSIS, AND OVERLAPPING FINGERS	 
MIM213950	C1859257	 	CEREBROCORTICAL DEGENERATION OF INFANCY	 
MIM213980	C1859252	 	CEREBROFACIOTHORACIC DYSPLASIA	 
MIM214100	C0043459	1p36.2, 1q22, 12p13.3, 7q21-q22, 6q23-q24, 1p36.32, 2p15, 22q11.21	ZELLWEGER SYNDROME; ZS	5189, 5192, 5194, 5195, 55670, 5824, 5830, 8504
MIM214110	C1859228	 	CEREBROHEPATORENAL SYNDROME, VARIANT TYPES	 
MIM214150	C0220722	10q11	CEREBROOCULOFACIOSKELETAL SYNDROME 1; COFS1	2074
MIM214200	C0027877	 	CEROID STORAGE DISEASE	1200, 1201, 1203, 1509, 2055, 256471, 54982
MIM214290	C0432160	 	CERVICAL VERTEBRAE, AGENESIS OF	 
MIM214300	C1859209	5q11.2	KLIPPEL-FEIL SYNDROME 2, AUTOSOMAL RECESSIVE; KFS2	 
MIM214350	C0406733	 	CHANDS	 
MIM214370	C1859206	 	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION, AND ABSENT SENSORY LARGE MYELINATED FIBERS	 
MIM214400	C1859198	8q13-q21.1	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	54332
MIM214450	C1859194	15q21	GRISCELLI SYNDROME, TYPE 1; GS1	4644
MIM214500	C0007965	1q42.1-q42.2	CHEDIAK-HIGASHI SYNDROME; CHS	1130
MIM214700	C0267662	7q22-q31.1	DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1	1811
MIM214800	C0265354	8q12.1, 7q21.11	CHARGE SYNDROME	55636, 9723
MIM214900	C0268314	15q	CHOLESTASIS-LYMPHEDEMA SYNDROME	84565
MIM214950	C1858328	5p13.2-q11.1	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4; CBAS4	23600
MIM214980	C1859161	 	CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	 
MIM215030	C0549472	 	CHOLESTEROL PNEUMONIA	 
MIM215045	C1859148	3p22-p21.1	CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	5745
MIM215050	C1859147	 	CHONDRODYSPLASIA CALCIFICANS METAPHYSEALIS	 
MIM215100	C1859133	6q22-q24	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1	5191
MIM215105	C1859132	 	CHONDRODYSPLASIA PUNCTATA SYNDROME	 
MIM215140	C1300226	1q42.1	HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA	3930
MIM215150	C0432210	6p21.3	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED	1280, 1302
MIM215250	C1859104	 	CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	 
MIM215300	C0008479	8q24.11-q24.13	CHONDROSARCOMA	2131
MIM215400	C0008487	7q33	CHORDOMA, SUSCEPTIBILITY TO; CHDM	121775
MIM215450	C1859098	 	CHOREA, BENIGN FAMILIAL	 
MIM215470	C1859093	 	CHORIORETINAL DYSTROPHY, SPINOCEREBELLAR ATAXIA, AND HYPOGONADOTROPIC HYPOGONADISM	 
MIM215480	C1859092	 	CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	 
MIM215500	C0344297	17p	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 1; CACD1	772
MIM215510	C1859091	 	CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	 
MIM215518	C0340038	 	CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	 
MIM215520	C2673817	 	CILIARY DYSKINESIA WITH TRANSPOSITION OF CILIARY MICROTUBULES	 
MIM215550	C1859089	 	CIRCUMVALLATE PLACENTA SYNDROME	 
MIM215600	C1861556	12q13, 12q13	CIRRHOSIS, FAMILIAL	 
MIM215700	C0175683	9q34.1	CITRULLINEMIA, CLASSIC	445
MIM215720	C1859084	 	CITRULLINE TRANSPORT DEFECT	 
MIM215800	C1859083	 	CLEFT LARYNX, POSTERIOR	 
MIM215850	C1859082	 	CLEFT-LIMB-HEART MALFORMATION SYNDROME	 
MIM216100	C0796099	 	CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	 
MIM216300	C1859081	 	CLEFT PALATE, DEAFNESS, AND OLIGODONTIA	 
MIM216330	C1859080	 	CLEIDOCRANIAL DYSPLASIA, RECESSIVE FORM	 
MIM216340	C1857663	 	CLEIDOCRANIAL DYSPLASIA WITH MICROGNATHIA, ABSENT THUMBS, AND DISTAL APHALANGIA	 
MIM216360	C1857662	16q12.2, 8q21.13-q22.1, 4p15.3	COACH SYNDROME	23322, 57545, 91147
MIM216400	C0751039	5q12	COCKAYNE SYNDROME, TYPE A; CSA	1161
MIM216411	C0751037	 	COCKAYNE SYNDROME, TYPE III	 
MIM216550	C0265223	8q22-q23	COHEN SYNDROME; COH1	157680
MIM216700	C1857624	 	COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING; RPC	 
MIM216800	C1857619	 	COLOBOMA OF MACULA AND SKELETAL ANOMALIES	 
MIM216820	CN074221	 	COLOBOMA, OCULAR	 
MIM216900	C1857618	2q11	ACHROMATOPSIA 2; ACHM2	1261
MIM216920	C1857617	 	COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	 
MIM216950	C3150274	12p13	COMPLEMENT COMPONENT C1r/C1s DEFICIENCY	715
MIM217000	C3150275	6p21.3	COMPLEMENT COMPONENT 2 DEFICIENCY; C2D	717
MIM217030		4q25	COMPLEMENT FACTOR I; CFI	3426
MIM217050		5p13	COMPLEMENT COMPONENT 6; C6	729
MIM217070		5p13	COMPLEMENT COMPONENT 7; C7	730
MIM217080	C1857588	2q11.2	JALILI SYNDROME	26504
MIM217085	C1857587	 	CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	 
MIM217090	C1968804	6q26	PLASMINOGEN DEFICIENCY, TYPE I	5340
MIM217095	C1857586	8p21, 2q21.1, 22q11.2, 19p12	CONOTRUNCAL HEART MALFORMATIONS; CTHM	137814, 1482, 2627, 2657, 55997, 6899
MIM217100	C0220724	 	CONSTRICTING BANDS, CONGENITAL	 
MIM217150	C1857576	 	CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	 
MIM217200	C1857575	 	CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	 
MIM217300	C1857574	12q22	CORNEA PLANA 2; CNA2	11081
MIM217400	C1857572	20p13-p12, 20p13	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	83959
MIM217500	C0155120	 	CORNEAL DYSTROPHY, BAND-SHAPED	 
MIM217520	C1857571	 	CORNEAL DEGENERATION, BAND-SHAPED SPHEROID	 
MIM217600	C1622427	 	CENTRAL CLOUDY DYSTROPHY OF FRANCOIS; CCDF	 
MIM217700	C1857569	20p13-p12	CORNEAL ENDOTHELIAL DYSTROPHY 2, AUTOSOMAL RECESSIVE; CHED2	83959
MIM217800	C1636149	16q22	MACULAR DYSTROPHY, CORNEAL, 1; MCDC1	4166
MIM217980	C0796184	 	CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	 
MIM217990	C0175754	 	CORPUS CALLOSUM, AGENESIS OF	 
MIM218000	C0795950	15q13-q14	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN	9990
MIM218010	C1857568	 	CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	 
MIM218030	C2936861	16q22	APPARENT MINERALOCORTICOID EXCESS; AME	3291
MIM218040	C0587248	11p15.5	COSTELLO SYNDROME	3265
MIM218050	C1857533	 	CRAMPS, FAMILIAL ADOLESCENT	 
MIM218090	C1857532	 	CRANE-HEISE SYNDROME	 
MIM218100	C1857531	 	CRANIAL NERVES, CONGENITAL PARESIS OF	 
MIM218200	C1857530	 	CRANIAL NERVES, RECURRENT PARESIS OF	 
MIM218300	C0410539	 	CRANIODIAPHYSEAL DYSPLASIA; CDD	 
MIM218330	C0432235	3q21	CRANIOECTODERMAL DYSPLASIA 1; CED1	55764
MIM218340	C1857512	 	CRANIOFACIAL DYSMORPHISM WITH OCULAR COLOBOMA, ABSENT CORPUS CALLOSUM, AND AORTIC DILATATION	 
MIM218350	C1857511	 	CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	 
MIM218400	C1857496	6q21-q22	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	64588
MIM218450	C1857495	 	CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	 
MIM218600	C0265308	8q24.3	BALLER-GEROLD SYNDROME; BGS	9401
MIM218649	C1857473	 	CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	 
MIM218650	C1857472	 	CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	 
MIM218670	C1857471	 	CRANIOTELENCEPHALIC DYSPLASIA	 
MIM218700	C1563716	2q12-q14	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2; CHNG2	7849
MIM218800	CN119421	2q37	CRIGLER-NAJJAR SYNDROME, TYPE I	54658
MIM218900	C0795914	 	CROME SYNDROME	 
MIM219000	C0265233	13q13.3, 4q21	FRASER SYNDROME	341640, 80144
MIM219050	C0010417	13q13.1, 19p13.2	CRYPTORCHIDISM, UNILATERAL OR BILATERAL	122042, 3640
MIM219070	C1857452	 	CURVED NAIL OF FOURTH TOE	 
MIM219080	C1857451	 	ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH	2778
MIM219090	C0221406	11q13.3	PITUITARY ADENOMA, ACTH-SECRETING	9049
MIM219095	C1857449	 	CUTANEOUS PHOTOSENSITIVITY AND COLITIS, LETHAL	 
MIM219100	CN033664	14q32.1, 11q13	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A	 
MIM219150	C0268354	 	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA; ARCL3A	5832
MIM219200	C0268355	12q24.3	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	23545
MIM219250	C0345419	 	CUTIS MARMORATA TELANGIECTATICA CONGENITA; CMTC	 
MIM219300	C1857444	 	CUTIS VERTICIS GYRATA AND MENTAL RETARDATION; CVG/MR	 
MIM219500	C0220993	1p31.1	CYSTATHIONINURIA	1491
MIM219550	C1857438	 	CYSTEINE PEPTIDURIA	 
MIM219700	C0010674	7q31.2, 19q13.1	CYSTIC FIBROSIS; CF	1080, 7040, 89845
MIM219721	C3806255	 	CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND SUBNORMAL MENTALITY	 
MIM219750	C1857413	17p13	CYSTINOSIS, ADULT NONNEPHROPATHIC	1497
MIM219800	C0010690	17p13	CYSTINOSIS, NEPHROPATHIC; CTNS	1497
MIM219900	C0268626	17p13	CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE	1497
MIM220100	C0010691	2p16.3, 19q13.1	CYSTINURIA	11136, 6519
MIM220110	C0268237	2q33.3, 19q13.1	MITOCHONDRIAL COMPLEX IV DEFICIENCY	1340, 22868, 493753, 84987
MIM220111	C1857355	2p21-p16	LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	10128
MIM220120	C1291386	 	D-GLYCERIC ACIDURIA	132158
MIM220150	C0473219	11q13	HYPOURICEMIA, RENAL, 1; RHUC1	116085
MIM220200	C0010964	3q24, 3q24	DANDY-WALKER SYNDROME; DWS	1858
MIM220210	C0796137	 	DANDY-WALKER-LIKE MALFORMATION WITH ATRIOVENTRICULAR SEPTAL DEFECT	 
MIM220219	C1857352	 	DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	 
MIM220220	C1857351	 	DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	 
MIM220290	C2673759	13q12, 13q11-q12, 1p35.1	DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1A	10804, 2706, 2707
MIM220300	C1857348	 	DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	 
MIM220400	CN034131	11p15.5	JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1	3784
MIM220500	C1857345	 	DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, AND MENTAL RETARDATION SYNDROME	 
MIM220600	C1857344	7q21.2-q21.3	SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS; SHFM1D	1749
MIM220900	C1857343	 	DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	 
MIM221200	C1857342	 	DEAFNESS, COCHLEAR, WITH MYOPIA AND INTELLECTUAL IMPAIRMENT	 
MIM221300	C1857341	 	DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	 
MIM221320	C1857340	 	DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	 
MIM221350	C1857339	 	DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	 
MIM221400	C1857338	 	DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL AND PROGRESSIVE SENSORY NEUROPATHY	 
MIM221500	C1857337	 	DEAFNESS, NEURAL, CONGENITAL MODERATE	 
MIM221700	C1857334	 	DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	 
MIM221740	C1857333	 	DEAFNESS-OLIGODONTIA SYNDROME	 
MIM221750	C1857330	9q34.3	PITUITARY HORMONE DEFICIENCY, COMBINED, 3; CPHD3	8022
MIM221760	C1857329	 	DERMATOGLYPHICS--PALMAR TRIRADIUS d, ABSENCE OF	 
MIM221770	C1857316	6p21.2, 19q13.1	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	54209, 7305
MIM221780	C1857315	 	DERMATOGLYPHICS--HYPOTHENAR RADIAL ARCH	 
MIM221790	C1857314	 	DERMATOLEUKODYSTROPHY	 
MIM221800	C0432288	 	DERMOCHONDROCORNEAL DYSTROPHY	 
MIM221810	C1857301	 	DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	 
MIM221820	C1857300	17q21-q22	LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS	1436, 8156
MIM221900	C1857299	10q21	RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL; RNANC	54719
MIM221950	C1857298	 	DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	 
MIM221995	C1857297	 	DIABETES INSIPIDUS, NEPHROGENIC, WITH MENTAL RETARDATION AND INTRACEREBRAL CALCIFICATION	 
MIM222100	C0011854	12q24.2, 12q24.2, 1p13, 7p21, 6p21.3, 6pter-p21, Xp11.23-q13.3	DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	26191, 3569, 3710, 4938, 50943, 6927
MIM222300	C0043207	4p16.1	WOLFRAM SYNDROME 1; WFS1	7466
MIM222350	C1857285	 	DIAMINOPENTANURIA	 
MIM222400	C1857284	8p23.1	DIAPHRAGMATIC HERNIA 2; DIH2	780899
MIM222448	C1857277	2q24-q31	DONNAI-BARROW SYNDROME	4036
MIM222470	CN034858	 	TRICHOHEPATOENTERIC SYNDROME 1; THES1	9652
MIM222500	C0011999	 	DIASTEMATOMYELIA	 
MIM222600	C0220726	5q32-q33.1	DIASTROPHIC DYSPLASIA	1836
MIM222690	C2673736	 	DIBASIC AMINO ACIDURIA I	 
MIM222700	C0268647	14q11.2	LYSINURIC PROTEIN INTOLERANCE; LPI	9056
MIM222730	C1857253	9p24	DICARBOXYLICAMINO ACIDURIA	6505
MIM222745		8q21.3	2,4-@DIENOYL-CoA REDUCTASE 1; DECR1	1666
MIM222748	C0342803	8q22	DIHYDROPYRIMIDINASE DEFICIENCY	1807
MIM222765	C1857242	1q42	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2; RCDP2	8443
MIM222800	C1291620	7q31-q34	BISPHOSPHOGLYCERATE MUTASE DEFICIENCY	669
MIM222900	C1283620	3q25-q26	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL; CSID	6476
MIM223000	C0268179	2q21	LACTASE DEFICIENCY, CONGENITAL	3938
MIM223100	C0268181	2q21	LACTOSE INTOLERANCE, ADULT TYPE	4175
MIM223300	C1857229	 	DISSEMINATED SCLEROSIS WITH NARCOLEPSY	 
MIM223320	C1857228	 	DIVERTICULOSIS, SMALL-INTESTINAL	 
MIM223330	C1857227	 	DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	 
MIM223340	C1857226	 	DK PHOCOMELIA SYNDROME	 
MIM223350	C1857225	 	DOHLE BODIES AND LEUKEMIA	 
MIM223360	C1857209	9q34	DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL	1621
MIM223370	C0175691	 	DUBOWITZ SYNDROME	 
MIM223400	C0266174	 	DUODENAL ATRESIA	 
MIM223500	C1857197	 	DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	 
MIM223540	C0796076	 	DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY	 
MIM223550	C1857196	 	DWARFISM, PROPORTIONATE, WITH HIP DISLOCATION	 
MIM223800	C0265286	18q12-q21.1	DYGGVE-MELCHIOR-CLAUSEN DISEASE; DMC	54808
MIM223900	C0013364	9q31	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3	8518
MIM224000	C1857153	 	DYSAUTONOMIA-LIKE DISORDER	 
MIM224050	CN074243	9p24	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	7436
MIM224100	C1306589	20p11.2	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II; CDAN2	10483
MIM224120	C0271933	15q15	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE I; CDAN1	146059
MIM224230	C1857144	15q14-q15, 5q35.3	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 1; DKCB1	55505, 55651
MIM224250	C1857143	 	DYSMYELINATION WITH JAUNDICE	 
MIM224300	C0432262	 	DYSOSTEOSCLEROSIS	 
MIM224400	C0432209	 	DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	 
MIM224410	C0432208	1p36.1	DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	3339
MIM224500	C1857093	 	DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	1862
MIM224550	C1857089	 	DYSTONIA WITH RINGBINDEN	 
MIM224690	CN030358	 	MEIER-GORLIN SYNDROME 1; MGORS1	4998
MIM224700	C0013481	 	EBSTEIN ANOMALY	 
MIM224750	C1857069	2q35	SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	80326
MIM224800	C1857068	 	ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	 
MIM224900	C0406702	2q11-q13, 1q42.2-q43	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL RECESSIVE	10913, 128178
MIM225000	C0796139	 	ROSSELLI-GULIENETTI SYNDROME	 
MIM225040	C1857053	 	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESIS OF THE CORPUS CALLOSUM	 
MIM225050	C1857052	 	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARY DYSKINESIA	 
MIM225060	C2931488	11q23-q24	CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	5818
MIM225100	C2673634	1q21	ECTOPIA LENTIS, ISOLATED, AUTOSOMAL RECESSIVE; ECTOL2	54507
MIM225200	C1644196	 	ECTOPIA LENTIS ET PUPILLAE	 
MIM225250	C2673630	5q34	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	1482
MIM225280	C1857041	16q22.1	EEM SYNDROME	1001
MIM225290	C1857040	 	ECTRODACTYLY-POLYDACTYLY	 
MIM225300	C2749665	12q13	SPLIT-HAND/FOOT MALFORMATION 6; SHFM6	7480
MIM225310	C1857038	 	EHLERS-DANLOS SYNDROME WITH PLATELET DYSFUNCTION FROM FIBRONECTIN ABNORMALITY	 
MIM225320	C1857034	7q22.1	EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	1278
MIM225400	C0268342	1p36.3-p36.2	EHLERS-DANLOS SYNDROME, TYPE VI; EDS6	5351
MIM225410	C2700425	5q23	EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE	9509
MIM225450	C1857010	 	ELLIPTOCYTOSIS, ATYPICAL	 
MIM225500	C0013903	4p16, 4p16	ELLIS-VAN CREVELD SYNDROME; EVC	132884, 2121
MIM225700	C1856991	 	ENCEPHALOMALACIA, MULTILOCULAR	 
MIM225740	C1856990	 	ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	 
MIM225750	C0796126	3p21.3-p21.2	AICARDI-GOUTIERES SYNDROME 1; AGS1	11277
MIM225753	C1856974	17q25.1	PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	283989
MIM225755	C1856973	 	ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	 
MIM225790	C1856972	14q24.3	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	55640
MIM226000	C0014117	 	ENDOCARDIAL FIBROELASTOSIS; EFE	 
MIM226100	C1856971	 	ENDOCARDIAL FIBROELASTOSIS AND COARCTATION OF ABDOMINAL AORTA	 
MIM226110	C1856970	 	ENDOTHELIAL DYSTROPHY, CONGENITAL HEREDITARY, WITH NAIL HYPOPLASIA	 
MIM226150	C0014356	 	ENTEROCOLITIS	 
MIM226200	C0268416	21q21	ENTEROKINASE DEFICIENCY	5651
MIM226300	C0033680	 	ENTEROPATHY, PROTEIN-LOSING	 
MIM226350	C0264005	 	EOSINOPHILIC FASCIITIS	 
MIM226400	C0014522	17q25, 17q25	EPIDERMODYSPLASIA VERRUCIFORMIS; EV	11322, 147138
MIM226440	C1856969	 	EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTAL RETARDATION	 
MIM226500	C0268368	 	EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA	1884
MIM226600	C0079474	11q22-q23, 3p21.3	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB	1294, 4312
MIM226650	C0268374	1q25-q31, 17q11-qter, 10q24.3, 1q32, 18q11.2	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	1308, 3691, 3909, 3914, 3918
MIM226670	C2931072	8q24	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	5339
MIM226700	C0079683	1q25-q31, 1q32, 18q11.2	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	3909, 3914, 3918
MIM226730	C1856934	17q11-qter, 2q31.1	EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA	3655, 3691, 5339
MIM226735	C1856933	 	EPIDERMOLYSIS BULLOSA WITH DIAPHRAGMATIC HERNIA	 
MIM226750	C0406740	 	KOHLSCHUTTER-TONZ SYNDROME; KTZS	79641
MIM226800	C1856931	 	EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	 
MIM226810	C1856930	 	EPILEPSY WITH BILATERAL OCCIPITAL CALCIFICATIONS	 
MIM226850	C1856929	 	EPILEPSY-TELANGIECTASIA	 
MIM226900	C1847593	5q32-q33.1	EPIPHYSEAL DYSPLASIA, MULTIPLE, 4; EDM4	1836
MIM226950	C1856918	 	EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	 
MIM226960	C0796021	 	EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	 
MIM226980	C0432217	2p12	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	9451
MIM226985	C1856902	 	EPITHELIAL SQUAMOUS DYSPLASIA, KERATINIZING DESQUAMATIVE, OF URINARY TRACT	 
MIM226990	C1856901	 	EPSTEIN-BARR VIRUS, SUSCEPTIBILITY TO CHRONIC INFECTION BY	 
MIM227000	C1856900	 	ERYTHEMA OF ACRAL REGIONS	 
MIM227010	C1856899	 	ERMINE PHENOTYPE	 
MIM227050	C0238478	19q13.2	TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD; TEC	100124696
MIM227090	C1856898	 	ERYTHRODERMA, LETHAL CONGENITAL	 
MIM227150	C0268423	 	ETHANOLAMINOSIS	 
MIM227200	C1856897	8p21-p11.2	EUNUCHOIDISM, FAMILIAL HYPOGONADOTROPIC	2796
MIM227210	C1856896	 	EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	 
MIM227220	C1856895	15q13.1, 15q11.2-q12	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1	4948, 8924
MIM227240	C2673584	5p13.3	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5; SHEP5	51151
MIM227250	C1856893	 	FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	 
MIM227255	C1856892	 	FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	 
MIM227260	C1744559	 	SETLEIS SYNDROME	117581
MIM227270	C1856891	 	FACIOCARDIOMELIC DYSPLASIA, LETHAL	 
MIM227280	C0795936	 	FACIOCARDIORENAL SYNDROME	 
MIM227300	C1856883	18q21.3-q22	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1; F5F8D1	3998
MIM227320	C1856881	 	FACIOTHORACOGENITAL SYNDROME	 
MIM227330	C1856871	 	FACIODIGITOGENITAL SYNDROME, RECESSIVE	 
MIM227400	C0015499	1q23	FACTOR V DEFICIENCY	2153
MIM227500	C0015503	13q34	FACTOR VII DEFICIENCY	2155
MIM227600	C0015519	13q34	FACTOR X DEFICIENCY	2159
MIM227645	C3468041	9q22.3	FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC	2176
MIM227646	C3160738	3p25.3	FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2	2177
MIM227650	C3469521	16q24.3	FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA	2175
MIM227810	C3495427	3q26.1-q26.3	FANCONI-BICKEL SYNDROME; FBS	6514
MIM227850	C0151638	 	FANCONI-LIKE SYNDROME	 
MIM228000	C0268255	8p22-p21.3	FARBER LIPOGRANULOMATOSIS	427
MIM228020	C1302740	 	FASCIAL DYSTROPHY, CONGENITAL	 
MIM228100	C0341447	 	VISCERAL STEATOSIS, CONGENITAL	 
MIM228200	C1856790	 	FEMUR-FIBULA-ULNA SYNDROME	 
MIM228250	C1856789	 	FEMUR, UNILATERAL BIFID, WITH MONODACTYLOUS ECTRODACTYLY	 
MIM228300	C0271582	4q21.2	FERTILE EUNUCH SYNDROME	2798
MIM228355	C0342200	 	FETAL IODINE DEFICIENCY DISORDER; FIDD	 
MIM228400	C1856788	 	FEVER, FAMILIAL LIFELONG PERSISTENT	 
MIM228520	C0265282	 	FIBROCHONDROGENESIS 1; FBCG1	1301
MIM228560	C1856761	 	FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	 
MIM228600	C2745948	4q21	FIBROMATOSIS, JUVENILE HYALINE	118429
MIM228800	C0494949	 	FIBROSCLEROSIS, MULTIFOCAL	 
MIM228900	C1856738	20q11.2	FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY	8200
MIM228930	C1856728	3p25	FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	7476
MIM228940	C1856727	 	FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	 
MIM228960	C0272340	3q27	HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY	3827
MIM228980	C1856718	 	FLECK RETINA, FAMILIAL BENIGN; FRFB	5322
MIM228990	C0271257	 	FLECK RETINA OF KANDORI	 
MIM229000		4q35	KALLIKREIN B, PLASMA, 1; KLKB1	3818
MIM229045	C0206067	 	FOCAL EPITHELIAL HYPERPLASIA, ORAL	 
MIM229050	C0342705	17q11.1	FOLATE MALABSORPTION, HEREDITARY	113235
MIM229070	C1856716	11p13	FOLLICLE-STIMULATING HORMONE DEFICIENCY, ISOLATED	2488
MIM229100	C0268609	21q22.3	FORMIMINOTRANSFERASE DEFICIENCY	10841
MIM229120	C0795944	 	FOUNTAIN SYNDROME	 
MIM229200	C0268344	16q24	BRITTLE CORNEA SYNDROME 1; BCS1	84627
MIM229250	C1856707	 	FREESIA FLOWERS, INABILITY TO SMELL	 
MIM229300	C1856689	9q13	FRIEDREICH ATAXIA 1; FRDA	2395
MIM229310	C1856688	 	FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	 
MIM229400	C1856687	 	FRONTOFACIONASAL DYSPLASIA	 
MIM229500	C1856686	 	FRUCTOSE AND GALACTOSE INTOLERANCE	 
MIM229600	C0016751	9q22.3	FRUCTOSE INTOLERANCE, HEREDITARY	229
MIM229700	C0016756	9q22.2-q22.3	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	2203
MIM229800	C0268160	2p23.3-p23.2	FRUCTOSURIA, ESSENTIAL	3795
MIM229850	C0220730	 	FRYNS SYNDROME; FRNS	 
MIM230000	C0016788	1p34	FUCOSIDOSIS	2517
MIM230200	C0268155	17q24	GALACTOKINASE DEFICIENCY	2584
MIM230300	C0235660	 	GALACTORRHEA	 
MIM230350	C0751161	1p36-p35	GALACTOSE EPIMERASE DEFICIENCY	2582
MIM230400	C0268151	9p13	GALACTOSEMIA	2592
MIM230450	C1856603	6p12	GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	2729
MIM230500	C0268271	3p21.33	GM1-GANGLIOSIDOSIS, TYPE I	2720
MIM230600	C0268272	3p21.33	GM1-GANGLIOSIDOSIS, TYPE II	2720
MIM230650	C0268273	3p21.33	GM1-GANGLIOSIDOSIS, TYPE III	2720
MIM230740	C0406723	 	GAPO SYNDROME	 
MIM230750	C0265706	 	GASTROSCHISIS	 
MIM230800	C1961835	1q21	GAUCHER DISEASE, TYPE I	2629
MIM230900	C0268250	1q21	GAUCHER DISEASE, TYPE II	2629
MIM231000	C0268251	1q21	GAUCHER DISEASE, TYPE III	2629
MIM231005	C1856476	1q21	GAUCHER DISEASE, TYPE IIIC	2629
MIM231050	CN074292	9q34.2	GELEOPHYSIC DYSPLASIA 1; GPHYSD1	9719
MIM231060	C1856466	 	GENITOPALATOCARDIAC SYNDROME	 
MIM231070	C0432255	1q24.2	GERODERMA OSTEODYSPLASTICUM; GO	92344
MIM231080	C0265373	 	GERMAN SYNDROME	 
MIM231090	C2931618	19q13.4	HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	199713
MIM231095	C1856465	7q34	GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD	6916
MIM231100	C0268059	 	HEMOCHROMATOSIS, NEONATAL	 
MIM231200	C0005129	17pter-p12, 3q21, 22q11.2	BERNARD-SOULIER SYNDROME; BSS	2811, 2812, 2815
MIM231300	C0020302	2p22-p21	GLAUCOMA 3, PRIMARY CONGENITAL, A; GLC3A	1545
MIM231530	C1291230	4q22-q26	3-@HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	3033
MIM231550	C0271742	12q13	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS	8086
MIM231630	C0008127	 	GLUTAMATE MONOSODIUM SENSITIVITY	 
MIM231670	C0268595	19p13.2	GLUTARIC ACIDEMIA I	2639
MIM231675		4q32-qter	ELECTRON TRANSFER FLAVOPROTEIN DEHYDROGENASE; ETFDH	2110
MIM231680	C0268596	15q23-q25, 4q32-qter, 19q13.3	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	2108, 2109, 2110
MIM231690	C0342873	 	GLUTARIC ACIDURIA III	79783
MIM231900	C1856399	20q11.2	GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA DUE TO	2937
MIM231950	C0268524	22q11.1-q11.2	GLUTATHIONURIA	 
MIM231970	C1856398	 	GLUTEAL MUSCLES, ABSENCE OF	 
MIM232000		13q32	PROPIONYL-CoA CARBOXYLASE, ALPHA SUBUNIT; PCCA	5095
MIM232050		3q21-q22	PROPIONYL-CoA CARBOXYLASE, BETA SUBUNIT; PCCB	5096
MIM232200	CN069618	17q21	GLYCOGEN STORAGE DISEASE Ia	2538
MIM232220	C0268146	11q23	GLYCOGEN STORAGE DISEASE Ib	2542
MIM232240	C0342749	11q23, 6p21.3	GLYCOGEN STORAGE DISEASE Ic	10786, 2542
MIM232300	C0017921	17q25.2-q25.3	GLYCOGEN STORAGE DISEASE II	2548
MIM232400	C0017922	1p21	GLYCOGEN STORAGE DISEASE III	178
MIM232500	C0017923	3p12	GLYCOGEN STORAGE DISEASE IV	2632
MIM232600	C0017924	11q13	GLYCOGEN STORAGE DISEASE V	5837
MIM232700	C0017925	14q21-q22	GLYCOGEN STORAGE DISEASE VI	5836
MIM232800	C0017926	12q13.3	GLYCOGEN STORAGE DISEASE VII	5213
MIM233100	C0017980	16p11.2	RENAL GLUCOSURIA; GLYS1	2759, 6524
MIM233270	C1856274	 	GOMBO SYNDROME	 
MIM233300	C0949595	2p21-p16	OVARIAN DYSGENESIS 1; ODG1	2492
MIM233400	C0685838	 	PERRAULT SYNDROME; PRLTS	3295
MIM233420	C1856273	12q13.1	46,XY SEX REVERSAL 7; SRXY7	50846
MIM233430	C1856272	 	GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	 
MIM233450	C0403529	 	GOODPASTURE SYNDROME	 
MIM233500	C0345382	 	GORLIN-CHAUDHRY-MOSS SYNDROME	 
MIM233600	C1856263	 	GRANULOCYTOPENIA WITH IMMUNOGLOBULIN ABNORMALITY	 
MIM233650	C2673536	11p13, 11p13	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS; CCHIDG	5896, 5897
MIM233690	C1856255	16q24	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	1535
MIM233700	C1856251	7q11.23	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I	653361
MIM233710	C1856245	1q25	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	4688
MIM233800	C1856244	 	GROUPED PIGMENTATION OF THE RETINA	 
MIM233810	C1856242	 	GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	 
MIM233910	C0268467	14q22.1-q22.2	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	2643
MIM234000	C0015526	5q33-qter	FACTOR XII DEFICIENCY	2161
MIM234030	C1856241	 	HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION	 
MIM234050	C1961117	7p14	TRICHOTHIODYSTROPHY, NONPHOTOSENSITIVE 1; TTDN1	136647
MIM234100	C0018522	6q21-q23.2	HALLERMANN-STREIFF SYNDROME; HSS	2697
MIM234200	C0018523	20p13-p12.3	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	80025
MIM234250	C1856198	 	HALL-RIGGS MENTAL RETARDATION SYNDROME	 
MIM234280	C1856197	 	HALLUX VARUS AND PREAXIAL POLYSYNDACTYLY	 
MIM234300	C0474824	 	HALO NEVI	 
MIM234350	C0241913	 	HALOTHANE HEPATITIS	 
MIM234500	C0018609	5p15.33	HARTNUP DISORDER	340024
MIM234580	C1856186	 	HEARING LOSS, SENSORINEURAL, WITH ENAMEL HYPOPLASIA AND NAIL DEFECTS	 
MIM234700	C0149530	 	HEART BLOCK, CONGENITAL	 
MIM234800	C0220738	 	HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	 
MIM234810	C0340848	 	HEMANGIOMATOSIS, FAMILIAL PULMONARY CAPILLARY	 
MIM234820	C0334542	 	HEMANGIOPERICYTOMA, MALIGNANT	 
MIM235000	C1856184	11p15	HEMIHYPERPLASIA, ISOLATED; IH	100188864
MIM235200	C0392514	6p21.3, 20p12	HEMOCHROMATOSIS; HFE	3077, 650
MIM235255	C1856159	 	MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	 
MIM235370	C1856158	 	HEMOLYTIC ANEMIA WITH THERMAL SENSITIVITY OF RED CELLS	 
MIM235400	C2749604	1q32, 1q31-q32.1, 1q31-q32.1	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1	10878, 3075, 3078, 3426, 4179, 629, 7056, 718, 81494, 8862
MIM235500	C0020807	 	HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	 
MIM235510	C0340834	18q21.32	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	147372
MIM235550	C1856128	2q37.1	HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY; VODI	3431
MIM235555	C1856127	7q32-q33	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2	6718
MIM235700	C0472792	10q22	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	3098
MIM235730	C1856113	2q22	MOWAT-WILSON SYNDROME	9839
MIM235800	C0220992	12q22-q23	HISTIDINEMIA	3034
MIM235830	C0268642	 	HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	 
MIM235900	C0334125	 	HISTIOCYTOSIS, FAMILIAL LIPOCHROME	 
MIM236000	C0019829	3p21.31	LYMPHOMA, HODGKIN	200942
MIM236100	C1856096	21q22.3	HOLOPROSENCEPHALY	3244, 4838, 8928
MIM236110	C1856095	 	HOLZGREVE SYNDROME	 
MIM236130	C0268632	 	HOMOCARNOSINOSIS	 
MIM236200	C3150344	21q22.3	HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	875
MIM236250	C1856058	1p36.3	HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY	4524
MIM236270	C1856057	5p15.3-p15.2	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, cblE COMPLEMENTATION TYPE	4552
MIM236400	C0431800	 	HUMERORADIAL SYNOSTOSIS	 
MIM236410	C1968717	 	HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	 
MIM236450	C1856054	 	HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME	 
MIM236490		4q21	HYALINOSIS, INFANTILE SYSTEMIC; ISH	118429
MIM236500	C1856053	 	HYDRANENCEPHALY WITH RENAL APLASIA-DYSPLASIA	 
MIM236600	C0020255	 	HYDROCEPHALUS	 
MIM236635	CN074258	 	HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	 
MIM236640	C1856052	 	HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	 
MIM236660	C1856051	 	HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	 
MIM236670	CN033898	9q34.1	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1	10585, 2218, 29954, 79147, 9215
MIM236680	C1856016	11q24.2	HYDROLETHALUS SYNDROME 1; HLS1	219844
MIM236690	C0020258	 	HYDROCEPHALUS, NORMAL-PRESSURE	 
MIM236700	C0948368	20p12	MCKUSICK-KAUFMAN SYNDROME; MKKS	8195
MIM236730	C0403555	10q23-q24	UROFACIAL SYNDROME; UFS	60495
MIM236750	C0455988	 	HYDROPS FETALIS, NONIMMUNE; NIHF	 
MIM236792	C1855995	14q22.1	L-2-HYDROXYGLUTARIC ACIDURIA	79944
MIM236795	C0342737	 	3-@HYDROXYISOBUTYRIC ACIDURIA	 
MIM236800	C0268474	 	HYDROXYKYNURENINURIA	 
MIM236900	C1855986	 	HYDROXYLYSINURIA	 
MIM237000	C0268531	 	HYDROXYPROLINEMIA	 
MIM237100	C0152436	 	HYMEN, IMPERFORATE	 
MIM237300	C0751753	2q35	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO	1373
MIM237310	C0268543	17q21.31	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	162417
MIM237400	C0268630	 	HYPER-BETA-ALANINEMIA	 
MIM237450	C0220991	 	HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR	10599, 28234
MIM237500	C0022350	10q24	DUBIN-JOHNSON SYNDROME; DJS	1244
MIM237550	C0400964	 	HYPERBILIRUBINEMIA, CONJUGATED, TYPE III	 
MIM237800	C0221021	 	HYPERBILIRUBINEMIA, SHUNT	 
MIM237900	C0270210	2q37	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN	54658
MIM238300		9p22	GLYCINE DECARBOXYLASE; GLDC	2731
MIM238310		3p21.2-p21.1	AMINOMETHYLTRANSFERASE; AMT	275
MIM238320	C0266432	2p21	LEYDIG CELL HYPOPLASIA, TYPE I	3973
MIM238330		16q24	GLYCINE CLEAVAGE SYSTEM H PROTEIN; GCSH	2653
MIM238331		7q31-q32	DIHYDROLIPOAMIDE DEHYDROGENASE; DLD	1738
MIM238340	C0268574	 	HYPERLEUCINE-ISOLEUCINEMIA	 
MIM238350	C1855928	 	HYPERLEXIA	 
MIM238600	C0023817	8p22	HYPERLIPOPROTEINEMIA, TYPE I	344, 4023
MIM238700	C0268553	7q31.3	HYPERLYSINEMIA	10157
MIM238710	C1855927	 	HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA	 
MIM238750	C0268555	 	HYPERLYSINURIA WITH HYPERAMMONEMIA	 
MIM238800	C1855926	 	HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	 
MIM238950	C1855925	 	HYPEROPIA, HIGH	 
MIM238970	C0268540	13q14	HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	10166
MIM239000	C0268414	8q24	PAGET DISEASE, JUVENILE	4982
MIM239100	C0432272	17q12-q21	HYPEROSTOSIS CORTICALIS GENERALISATA	50964
MIM239199	C1855924	 	HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	 
MIM239200	C1832615	3q13.3-q21	HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY; NSHPT	846
MIM239300	C1855923	 	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1; HPMRS1	55650
MIM239350	C1855922	 	HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	 
MIM239400		 	HYPERPIPECOLATEMIA	 
MIM239500	C0268529	22q11.2	HYPERPROLINEMIA, TYPE I; HPI	5625
MIM239510	C2931835	1p36	HYPERPROLINEMIA, TYPE II; HPII	8659
MIM239710	C1855904	 	ACROFRONTOFACIONASAL DYSOSTOSIS 2	 
MIM239711	C1855903	 	HYPERTELORISM AND TETRALOGY OF FALLOT	 
MIM239800	C0220742	 	HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	 
MIM239840	C1855902	 	HYPERTRICHOSIS, CONGENITAL ANTERIOR CERVICAL, WITH PERIPHERAL SENSORY AND MOTOR NEUROPATHY	 
MIM239850	C0795905	 	HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	10060
MIM239900	C1855885	 	HYPERTROPHIC NEUROPATHY AND CATARACT	 
MIM240150	C1855883	 	HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	 
MIM240200	C1868690	 	HYPOADRENOCORTICISM, FAMILIAL	 
MIM240300	C0085859	21q22.3	AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I; APS1	326
MIM240400	C0036474	8p21.1	HYPOASCORBEMIA	2989
MIM240500	C3150354	17p11.2	IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	115650, 1380, 23495, 29851, 930
MIM240600	C1855861	12p12.2	GLYCOGEN STORAGE DISEASE 0, LIVER	2998
MIM240800	C0271714	11p15.1	HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	6833
MIM240900	C1855860	 	HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	208
MIM240950	C1855859	 	HYPOGONADISM-CATARACT SYNDROME	 
MIM241000	C1855858	 	HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	 
MIM241080	C0342286	2q22.3-q35	WOODHOUSE-SAKATI SYNDROME	80067
MIM241090	C2673480	 	HYPERGONADOTROPIC HYPOGONADISM AND PARTIAL ALOPECIA	 
MIM241100	C0151721	 	HYPOGONADISM, MALE	 
MIM241120	C1855856	 	HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	 
MIM241150	C0268444	 	HYPOKALEMIA, FAMILIAL	 
MIM241200	C1855849	11q24	BARTTER SYNDROME, ANTENATAL, TYPE 2	3758
MIM241310	C1855848	 	HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	 
MIM241410	C1855840	1q42-q43	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRD	6905
MIM241500	C0268412	1p36.1-p34	HYPOPHOSPHATASIA, INFANTILE	249
MIM241510	C0220743	1p36.1-p34	HYPOPHOSPHATASIA, CHILDHOOD	249
MIM241519	C1855809	 	HYPOPHOSPHATEMIA, RENAL, WITH INTRACEREBRAL CALCIFICATIONS	 
MIM241520	C0342643	4q21	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1; ARHR1	1758
MIM241530	C0342645	9q34	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY; HHRH	142680
MIM241540	C1855800	 	HYPOPITUITARISM, CONGENITAL, WITH CENTRAL DIABETES INSIPIDUS	 
MIM241550	C0152101	6q21-q23.2	HYPOPLASTIC LEFT HEART SYNDROME 1; HLHS1	2697
MIM241600	C1855796	15q21-q22	HYPOPROTEINEMIA, HYPERCATABOLIC	567
MIM241760	C0795989	 	HYPOSPADIAS-MENTAL RETARDATION SYNDROME	 
MIM241800	C0342418	7p13	HYPOTHALAMIC HAMARTOMAS	2737
MIM241850	C1855794	9q22	HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE	2304
MIM242100	C1855792	17p13.1, 17p13.1, 14q11.2	ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL, NONBULLOUS, 1; NCIE1	242, 59344, 7051
MIM242150	C1275089	 	ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	 
MIM242300	C3536797	14q11.2	ICHTHYOSIS, LAMELLAR, 1; LI1	7051
MIM242500	C0239849	2q34	ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE	26154
MIM242510	C1855788	 	ICHTHYOSIS WITH ALOPECIA, ECLABION, ECTROPION, AND MENTAL RETARDATION	 
MIM242520	C1275088	 	ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	 
MIM242530	C1855787	 	ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT	 
MIM242550	C1855786	 	ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	 
MIM242600	C0268654	5q33.1, 5p15.33, 3p21.3	IMINOGLYCINURIA	153201, 340024, 54716
MIM242670	C0340035	 	CILIARY DYSKINESIA WITH DEFECTIVE RADIAL SPOKES	 
MIM242680	C0340036	 	CILIARY DYSKINESIA WITH EXCESSIVELY LONG CILIA	 
MIM242700	C1744558	 	IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	 
MIM242840	C1855772	 	IMMUNODEFICIENCY WITH CLEFT LIP/PALATE, CATARACT, HYPOPIGMENTATION, AND ABSENT CORPUS CALLOSUM	 
MIM242850	C1855771	 	IMMUNE DEFICIENCY DISEASE	 
MIM242860	C0398788	20q11.2	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1; ICF1	1789
MIM242880	CN074232	 	IMMUNOERYTHROMYELOID HYPOPLASIA	 
MIM242890	C1855761	 	IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	 
MIM242900	C0877024	2q34-q36	IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	50485
MIM243000	C1855739	2q24	INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE	6335
MIM243050	C1855738	 	INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION	 
MIM243060	C0403812	19q13.43	SPERMATOGENIC FAILURE 5; SPGF5	6795
MIM243080	C1855737	 	INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	 
MIM243100	C1855736	 	INTERNAL CAROTID ARTERIES, HYPOPLASIA OF	 
MIM243110	C1855735	 	IMMUNODEFICIENCY WITH DEFECTIVE T-CELL RESPONSE TO INTERLEUKIN 1	 
MIM243150	C0220744	 	INTESTINAL ATRESIA, MULTIPLE	 
MIM243185	C1855732	 	INTESTINAL PSEUDOOBSTRUCTION WITH PATENT DUCTUS ARTERIOSUS AND NATAL TEETH	 
MIM243200	C0033845	 	INTRACRANIAL HYPERTENSION, IDIOPATHIC	 
MIM243300	C1855731	18q21	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1; BRIC1	5205
MIM243305		9q31	INVERSIN; INVS	27130
MIM243310	C1855722	 	BARAITSER-WINTER SYNDROME 1; BRWS1	60
MIM243320	C1855721	 	INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	 
MIM243400	C1827377	8p23.1-p21.3	ACETYLATION, SLOW	10
MIM243440	C1855715	 	ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME	 
MIM243450	C1855714	 	ISOVALERIC ACID, INABILITY TO SMELL	 
MIM243500	C0268575	15q14-q15	ISOVALERIC ACIDEMIA; IVA	3712
MIM243600	C0266175	 	JEJUNAL ATRESIA	 
MIM243605	C1855705	 	JEJUNAL ATRESIA WITH MICROCEPHALY AND OCULAR ANOMALIES	 
MIM243700	C1968689	9p24	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE	81704
MIM243800	C0175692	15q15-q21.1	JOHANSON-BLIZZARD SYNDROME; JBS	197131
MIM243910	C1855675	 	ARIMA SYNDROME	 
MIM244100	C1280764	 	JUMPING FRENCHMAN OF MAINE	 
MIM244200	C2930927	20p13	HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	128674
MIM244300	C0796005	 	KAPUR-TORIELLO SYNDROME	 
MIM244400	C0022521	9p21-p13	CILIARY DYSKINESIA, PRIMARY, 1; CILD1	27019
MIM244450	C1855663	 	KAUFMAN OCULOCEREBROFACIAL SYNDROME	 
MIM244460	C1855648	1q42-q43	KENNY-CAFFEY SYNDROME, TYPE 1; KCS1	6905
MIM244510	C1855647	 	KERATOCONUS AND CONGENITAL HIP DYSPLASIA	 
MIM244600	C1855645	 	KERATOCONUS POSTICUS CIRCUMSCRIPTUS; KPC	 
MIM244850	C1855644	 	KERATODERMA, PALMOPLANTAR, NORRBOTTEN RECESSIVE TYPE	 
MIM245000	C0030360	11q14.1-q14.3	PAPILLON-LEFEVRE SYNDROME; PALS	1075
MIM245010	C1855627	11q14.1-q14.3	HAIM-MUNK SYNDROME; HMS	1075
MIM245050	C0342792	5p13	SUCCINYL-CoA:3-OXOACID CoA TRANSFERASE DEFICIENCY	5019
MIM245100	C0796136	 	KETOACIDURIA WITH MENTAL DEFICIENCY AND OTHER FEATURES	 
MIM245130	C1855626	 	KETOADIPICACIDURIA	 
MIM245150	C1855607	12p13.1-p12.3	KEUTEL SYNDROME	4256
MIM245160	C1855606	 	KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS	 
MIM245180	C0796010	 	KIFAFA SEIZURE DISORDER	 
MIM245190	C1855605	 	KNIEST-LIKE DYSPLASIA, LETHAL	 
MIM245200	C0023521	14q31	KRABBE DISEASE	2581
MIM245300	C1855588	 	KURU, SUSCEPTIBILITY TO	5621
MIM245340	C1855577	1p13.2-p12	ERYTHROCYTE LACTATE TRANSPORTER DEFECT	6566
MIM245348	C1855565	11q23.1	PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	1737
MIM245349	C1855553	11p13	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY; PDHXD	8050
MIM245400	C3151476	2p11.2	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA); MTDPS9	8802
MIM245450	C1855552	 	LACTIC ACIDURIA DUE TO D-LACTIC ACID	 
MIM245480	C0398593	14q11.2	SPECIFIC GRANULE DEFICIENCY; SGD	1053
MIM245550	C1855551	 	LAMBERT SYNDROME	 
MIM245552	C1855550	 	LAMBOTTE SYNDROME	 
MIM245570	C1832814	 	LANDAU-KLEFFNER SYNDROME; LKS	 
MIM245590	C1855548	17q11.2	GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY	6777
MIM245600	C1855536	 	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, CRANIOFACIAL DYSMORPHISM, AND CONGENITAL HEART DEFECTS	26229, 9469
MIM245650	C1855535	 	LARSEN-LIKE SYNDROME, LETHAL TYPE	 
MIM245660	C1328355	18q11.2	LARYNGOONYCHOCUTANEOUS SYNDROME; LOCS	3909
MIM245800	C0023138	 	LAURENCE-MOON SYNDROME	 
MIM245900	C0023195	16q22.1	LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	3931
MIM246000	C1855523	 	LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	 
MIM246200	C0265344	19p13.2	DONOHUE SYNDROME	3643
MIM246300	C1968668	4q32	LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3	7097
MIM246400	C0023381	 	LETTERER-SIWE DISEASE	 
MIM246450	C0268601	1pter-p33	3-@HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	3155
MIM246470	C1855505	 	LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	 
MIM246500	C1855504	 	LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	 
MIM246530		5q35	LEUKOTRIENE C4 SYNTHASE; LTC4S	4056
MIM246550	C1855502	 	LICHTENSTEIN SYNDROME	 
MIM246555	C1855501	 	LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY	 
MIM246560	C1855500	10q24	SPLIT-HAND/FOOT MALFORMATION 3; SHFM3	100049542
MIM246570	C1855499	 	FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	 
MIM246600		10q26.1	PANCREATIC LIPASE; PNLIP	5406
MIM246650	C1855498	16p13.3	LIPASE DEFICIENCY, COMBINED	64788
MIM246700	C0795956	5q31.1	CHYLOMICRON RETENTION DISEASE; CMRD	51128
MIM247100	C0023795	1q21	LIPOID PROTEINOSIS OF URBACH AND WIETHE	1893
MIM247150	C1855497	 	LIP PRINTS	 
MIM247200	C0265219	17p13.3	MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	 
MIM247410	C1855477	 	LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	 
MIM247420	C1292230	19q13.2	LUTHERAN NULL	4059
MIM247430	C1855476	 	LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	 
MIM247440	C1855475	 	LYMPHEDEMA, CONGENITAL RECESSIVE	 
MIM247450	C1855474	 	LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	 
MIM247610	C0264511	 	LYMPHOID INTERSTITIAL PNEUMONIA; LIP	 
MIM247630	C1855473	 	LYMPHOID SYSTEM DETERIORATION, PROGRESSIVE	 
MIM247640	C1855472	9p22-p21	LYMPHOBLASTIC LEUKEMIA, ACUTE, WITH LYMPHOMATOUS FEATURES; LALL	8009
MIM247650	C1855471	 	LYMPHOKINE DEFICIENCY	 
MIM247800	C1855470	 	LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNE HEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS	 
MIM247950	C0796023	 	LYSINE MALABSORPTION SYNDROME	 
MIM247980		Chr.16	LIPASE B, LYSOSOMAL ACID; LIPB	3989
MIM247990	C0796024	 	MACDERMOT-WINTER SYNDROME	 
MIM248000	C2243051	 	MACROCEPHALY	 
MIM248010	C1855469	 	MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	 
MIM248100	C1855468	 	MACROSOMIA ADIPOSA CONGENITA	 
MIM248110	C1855467	 	MACROSOMIA WITH MICROPHTHALMIA, LETHAL	 
MIM248190	C1855466	1p34.2	HYPOMAGNESEMIA 5, RENAL, WITH OCULAR INVOLVEMENT; HOMG5	149461
MIM248200	C1855465	8q21-q22, 1p22.1	STARGARDT DISEASE 1; STGD1	24, 54714
MIM248250	C0268448	3q27	HYPOMAGNESEMIA 3, RENAL; HOMG3	10686
MIM248260	C1855464	 	MAGNESIUM, ELEVATED RED CELL	 
MIM248300	C0025221	8qter	MAL DE MELEDA	57152
MIM248310	C1855456	5q31-q33	PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL	7910
MIM248340	C0796032	 	3MC SYNDROME 3; 3MC3	 
MIM248350	C1855453	 	MALOCCLUSION AND SHORT STATURE	 
MIM248360	C0342793	16q24	MALONYL-CoA DECARBOXYLASE DEFICIENCY	23417
MIM248370	C0432291	1q21.2	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	4000
MIM248390	C1855433	6p22.3	TREACHER COLLINS SYNDROME 3; TCS3	9533
MIM248400	C1855432	 	MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL DEFICIENCY	 
MIM248450	C1855425	 	MANITOBA OCULOTRICHOANAL SYNDROME; MOTA	158326
MIM248500	C0024748	19cen-q12	MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA	4125
MIM248510	C0342849	4q22-q25	MANNOSIDOSIS, BETA A, LYSOSOMAL; MANSB	4126
MIM248600	C0024776	7q31-q32, 1p31, 6q14, 19q13.1-q13.2	MAPLE SYRUP URINE DISEASE	1629, 1738, 593, 594
MIM248610		1p31	DIHYDROLIPOAMIDE BRANCHED-CHAIN TRANSACYLASE; DBT	1629
MIM248611		6q14	BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, BETA POLYPEPTIDE; BCKDHB	594
MIM248700	C0796033	 	MARDEN-WALKER SYNDROME	 
MIM248760	C1855348	 	MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	 
MIM248770	C1855347	 	MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	 
MIM248800	C0024814	5q31	MARINESCO-SJOGREN SYNDROME; MSS	64374
MIM248900	C1855346	15q21-q22	MAST SYNDROME	51324
MIM248910	C1855345	 	CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	 
MIM248950	C0796038	 	MCDONOUGH SYNDROME	 
MIM249000	C3714506	17q23	MECKEL SYNDROME, TYPE 1; MKS1	54903
MIM249100	C0031069	16p13	FAMILIAL MEDITERRANEAN FEVER; FMF	4210
MIM249210		 	MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	 
MIM249230	C1855310	 	MEGAEPIPHYSEAL DWARFISM	 
MIM249240	C1855309	 	MEGALENCEPHALY WITH DYSMYELINATION	 
MIM249270	C0342287	1q23.3	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA	10560
MIM249300	C0344530	 	MEGALOCORNEA	 
MIM249310	C0796086	 	MEGALOCORNEA-MENTAL RETARDATION SYNDROME	 
MIM249400	C0544862	 	MELANOSIS, NEUROCUTANEOUS	 
MIM249420	C1855305	5q35.1	FRANK-TER HAAR SYNDROME; FTHS	285590
MIM249500	C1855304	4q25-q26	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1; MRT1	8492
MIM249599	C1855303	 	MENTAL RETARDATION SYNDROME, BELGIAN TYPE	 
MIM249600	C0265249	 	MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	 
MIM249620	C0796094	 	OHDO SYNDROME	 
MIM249630	C0796080	 	MENTAL RETARDATION, BUENOS AIRES TYPE	 
MIM249650	C0796055	 	MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU	 
MIM249660	C1855282	 	MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	 
MIM249670	C0796057	 	MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	 
MIM249700	C0432230	Ypter-p11.2, Xpter-p22.32	LANGER MESOMELIC DYSPLASIA; LMD	6473
MIM249710	C1855273	 	MESOMELIC LIMB SHORTENING AND BOWING	 
MIM249900	C0268262	10q22.1	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	5660
MIM250100	C0023522	22q13.31-qter	METACHROMATIC LEUKODYSTROPHY	410
MIM250215	C1855243	 	METAPHYSEAL ACROSCYPHODYSPLASIA	 
MIM250220	C1855229	 	SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	 
MIM250230	C1855217	 	METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	 
MIM250250	C0220748	9p21-p12	CARTILAGE-HAIR HYPOPLASIA; CHH	6023
MIM250300	C1855195	 	METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	 
MIM250400	C0432225	 	METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	 
MIM250410	C1855188	 	METAPHYSEAL CHONDRODYSPLASIA WITH RETINITIS PIGMENTOSA	 
MIM250420	C1855175	 	METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	 
MIM250450	C1855174	 	METAPHYSEAL DYSPLASIA, ANETODERMA, AND OPTIC ATROPHY	 
MIM250460	C1834821	9p21-p12	METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS	6023
MIM250500	C1855164	 	METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	 
MIM250620	C0342738	2q32.2	BETA-HYDROXYISOBUTYRYL CoA DEACYLASE DEFICIENCY	26275
MIM250650	C1855163	 	METHANE PRODUCTION	 
MIM250700	C0878679	 	METHEMOGLOBIN REDUCTASE DEFICIENCY	 
MIM250790	C2673427	18q23	METHEMOGLOBINEMIA TYPE IV	1528
MIM250800	C0268193	22q13.31-qter	METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	1727
MIM250850	C0268621	10q22	METHIONINE ADENOSYLTRANSFERASE DEFICIENCY	4143
MIM250900	C0268622	 	METHIONINE MALABSORPTION SYNDROME	 
MIM250940	C1855128	1q43	METHYLCOBALAMIN DEFICIENCY, cblG TYPE	4548
MIM250950	C0342727	Chr.9	3-@METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	549, 6901
MIM250951	C1855126	 	3-@METHYLGLUTACONIC ACIDURIA, TYPE IV; MGCA4	 
MIM251000	C1855114	6p21	METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY	4594
MIM251100	C1855109	4q31.1-q31.2	METHYLMALONIC ACIDURIA, cblA TYPE	166785
MIM251110	C1855102	12q24	METHYLMALONIC ACIDURIA, cblB TYPE	326625
MIM251120	C1855100	2p13.3	METHYLMALONYL-CoA EPIMERASE DEFICIENCY	84693
MIM251170		12q24	MEVALONATE KINASE; MVK	4598
MIM251190	C1855089	 	MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	 
MIM251200	C1855081	8p23	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE; MCPH1	79648
MIM251220	C1855080	 	MICROCEPHALY-CARDIOMYOPATHY	 
MIM251230	C1855079	 	MICROCEPHALY-MICROMELIA SYNDROME	 
MIM251240	C1855078	 	MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	 
MIM251250	C0796066	 	MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	 
MIM251255	C2673414	18p11.22-q11.2	JAWAD SYNDROME; JWDS	100192306, 5932
MIM251260	C0398791	8q21	NIJMEGEN BREAKAGE SYNDROME	4683
MIM251270	C1855056	 	MICROCEPHALY AND CHORIORETINOPATHY WITH OR WITHOUT MENTAL RETARDATION, AUTOSOMAL RECESSIVE	85378
MIM251280	C1855055	 	MICROCEPHALY WITH SPASTIC QUADRIPLEGIA	 
MIM251290	C3489725	5q13.1	BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA; BLCPMG	100506658
MIM251300	C0795949	 	MICROCEPHALY, HIATAL HERNIA, AND NEPHROTIC SYNDROME	 
MIM251400	C0266200	 	MICROCOLON	 
MIM251450	CN030744	17q25.3, 17q25.3	DESBUQUOIS DYSPLASIA; DBQD	124583
MIM251505	C1855053	 	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 4; MCOPCB4	 
MIM251600	C1855052	14q32	MICROPHTHALMIA, ISOLATED 1; MCOP1	8113
MIM251700	C1968637	 	MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA, AND DENTAL ANOMALIES	 
MIM251750	C1562061	 	MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	4053
MIM251800	C1855050	 	MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	 
MIM251850	C0341306	18q21	DIARRHEA 2, WITH MICROVILLUS ATROPHY; DIAR2	4645
MIM251880	C3151513	2p13	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE); MTDPS3	1716
MIM251900	C0162670	 	MITOCHONDRIAL MYOPATHY	 
MIM251950	C1855033	 	MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS	 
MIM252010	C1838979	1q23, 14q12, 11q24.2, 11q13, 6q16.1, 5q12.1, 5q11.1, 5pter-p15.33, 3p21.31, 2q33-q34, Xq24, 20p12.1, 19p13.3, 18p11.31-p11.2	MITOCHONDRIAL COMPLEX I DEFICIENCY	126328, 25915, 29078, 4694, 4709, 4719, 4720, 4723, 4724, 4726, 4729, 51103, 55572, 79133, 80224, 91942
MIM252011	C1855008	5p15, 19q12-q13.2	MITOCHONDRIAL COMPLEX II DEFICIENCY	6389, 644096
MIM252100	C0026363	 	MOHR SYNDROME	 
MIM252150	C1854988	14q24, 6p21.3, 5q11	MOLYBDENUM COFACTOR DEFICIENCY	10243, 4337, 4338
MIM252250	C1854982	 	MONOCYTE CHEMOTACTIC DISORDER	 
MIM252270	C1854978	 	MONOSOMY 7 OF BONE MARROW	100820631
MIM252300	C1854965	 	MORQUIO SYNDROME C	 
MIM252320	C1854961	 	MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA	 
MIM252350	C2931384	3p26-p24.2	MOYAMOYA DISEASE 1; MYMY1	50960
MIM252500	C2673377	12q23.3	MUCOLIPIDOSIS II ALPHA/BETA	79158
MIM252600	C0033788	12q23.3	MUCOLIPIDOSIS III ALPHA/BETA	79158
MIM252605	C1854896	16p	MUCOLIPIDOSIS III GAMMA	84572
MIM252650	C0238286	19p13.3-p13.2	MUCOLIPIDOSIS IV	57192
MIM252700	C0220752	 	MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	 
MIM252800		4p16.3	ALPHA-L-IDURONIDASE; IDUA	3425
MIM252900	C0086647	17q25.3	MUCOPOLYSACCHARIDOSIS TYPE IIIA	6448
MIM252920	C0086648	17q21	MUCOPOLYSACCHARIDOSIS TYPE IIIB	4669
MIM252930	C0086649	8p11.1	MUCOPOLYSACCHARIDOSIS TYPE IIIC	138050
MIM252940	C0086650	12q14	MUCOPOLYSACCHARIDOSIS TYPE IIID	2799
MIM253000	C0086651	16q24.3	MUCOPOLYSACCHARIDOSIS TYPE IVA	2588
MIM253010	C0086652	3p21.33	MUCOPOLYSACCHARIDOSIS TYPE IVB	2720
MIM253200	C0026709	5q11-q13	MUCOPOLYSACCHARIDOSIS TYPE VI	411
MIM253220	C0085132	7q21.11	MUCOPOLYSACCHARIDOSIS TYPE VII	2990
MIM253240	C1854729	 	MUCUS INSPISSATION OF RESPIRATORY TRACT	 
MIM253250	C0524582	17q22-q23	MULIBREY NANISM	4591
MIM253260	C0220754	3p25	BIOTINIDASE DEFICIENCY	686
MIM253270	C0268581	21q22.1	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	3141
MIM253280	C0457133	1p34-p33	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	55624
MIM253290	C1854678	2q33-q34, 2q33-q34, 2q24-q32	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS	1134, 1144, 1146
MIM253300	C0043116	5q12.2-q13.3	SPINAL MUSCULAR ATROPHY, TYPE I; SMA1	 
MIM253310	C1854664	9q34	LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1	2733
MIM253320	C1854663	 	MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPIC HYPOGONADISM	 
MIM253400	C0152109	5q12.2-q13.3, 5q12.2-q13.3	SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	6606, 6607
MIM253550	C0393538	5q12.2-q13.3	SPINAL MUSCULAR ATROPHY, TYPE II; SMA2	6606
MIM253590	C1854646	 	MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	 
MIM253600	C1869123	15q15.1-q21.1	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	825
MIM253601	C1850889	2p13.3-p13.1	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	8291
MIM253700	C0410173	13q12	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C	6445
MIM253800	C0410174	9q31	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	2218
MIM253900	C1850865	 	MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	 
MIM254000	C1850864	 	MUSCULAR DYSTROPHY, CONGENITAL, WITH INFANTILE CATARACT AND HYPOGONADISM	 
MIM254090	CN033863	2q37, 21q22.3, 21q22.3	ULLRICH CONGENITAL MUSCULAR DYSTROPHY; UCMD	1291, 1292, 1293
MIM254100	C1850840	 	MUSCULAR DYSTROPHY, CONGENITAL, WITH RAPID PROGRESSION	 
MIM254110	C0270968	9q31-q34.1	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H; LGMD2H	22954
MIM254120	C1850827	 	MUSCULAR HYPERTONIA, LETHAL	 
MIM254130	C1850808	2p13.3-p13.1	MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	8291
MIM254150	C1850807	 	MUSK, INABILITY TO SMELL	 
MIM254200	C0026896	 	MYASTHENIA GRAVIS; MG	 
MIM254210	C0393929	10q11.2	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA	1103
MIM254300	C1850792	1pter-p32, 4p16.2	MYASTHENIA, LIMB-GIRDLE, FAMILIAL	285489, 375790
MIM254400	C0026948	 	MYCOSIS FUNGOIDES	 
MIM254450	C0001815	9p24	MYELOFIBROSIS	10019, 3717, 4352
MIM254500	C0026764	13q22-q34	MYELOMA, MULTIPLE	3662, 3981
MIM254600	C0398595	17q23.1	MYELOPEROXIDASE DEFICIENCY; MPOD	4353
MIM254770	C1850778	6p12-p11	EPILEPSY, MYOCLONIC JUVENILE; EJM	114327
MIM254780	C0751783	6q24, 6p22.3	MYOCLONIC EPILEPSY OF LAFORA	378884, 7957
MIM254800	C0751785	21q22.3	MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	1476
MIM254900	C0751779	4q13-q21	EPILEPSY, PROGRESSIVE MYOCLONIC 4, WITH OR WITHOUT RENAL FAILURE; EPM4	950
MIM254940	C1850746	 	MYOPATHY, CONGENITAL NONPROGRESSIVE, WITH MOEBIUS SEQUENCE AND ROBIN SEQUENCE	 
MIM254950	C1850745	 	MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	 
MIM254960	C1850744	 	MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT	 
MIM255100	CN032199	 	MYOPATHY WITH ABNORMAL LIPID METABOLISM	 
MIM255110	C1833508	1p32	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET	1376
MIM255120	C0342789	11q13	CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	1374
MIM255125	C1850718	12q24.1	MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY; HML	23479
MIM255140	C1850717	 	MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	 
MIM255160	C1850709	3p22.2-p21.32	MYOPATHY, HYALINE BODY, AUTOSOMAL RECESSIVE	619511
MIM255200	C0410204	2q14	MYOPATHY, CENTRONUCLEAR, 2; CNM2	274
MIM255300	C0270960	 	MYOPATHY, CONGENITAL	 
MIM255310	C0546264	1q42.1	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	57190, 58, 7170
MIM255320	C1850674	19q13.1	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	6261
MIM255500	C2749509	 	MYOPIA 18, AUTOSOMAL RECESSIVE; MYP18	100359406
MIM255600	C1850671	21q22.3	MYOSCLEROSIS, AUTOSOMAL RECESSIVE	1292
MIM255700	C0751360	7q35	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	1180
MIM255710	C1850654	 	MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	 
MIM255800	C0036391	1p36.1	SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	3339
MIM255900	C0027145	 	MYXEDEMA	 
MIM255960	C1850635	17q23-q24	MYXOMA, INTRACARDIAC	5573
MIM255980	C1850627	 	NASODIGITOACOUSTIC SYNDROME	 
MIM255990	C1850626	 	NATHALIE SYNDROME	 
MIM255995	C1850625	 	NATIVE AMERICAN MYOPATHY; NAM	 
MIM256000	C0023264	11q24.2, 11q13, 11q13, 11p11.11, 10q24, 9q34, 8q22.1, 7q31-q32, 5q31.2, 5q12.1, 5q11.1, 5p15, 2q33, 19p13	LEIGH SYNDROME; LS	1355, 137682, 1738, 374291, 4695, 4704, 4705, 4722, 4723, 4724, 4728, 55572, 55967, 617, 6389, 6834, 91942
MIM256030	C1850569	2q22	NEMALINE MYOPATHY 2; NEM2	4703
MIM256040	C1850568	 	AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME; ALDD	5696
MIM256050	C1850554	5q32-q33.1	ATELOSTEOGENESIS, TYPE II; AOII	1836
MIM256100	C1855681	2q13	NEPHRONOPHTHISIS 1; NPHP1	4867
MIM256120	C1850553	 	NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	 
MIM256150	C0268232	 	NEPHROSIALIDOSIS	 
MIM256200	C1850552	 	NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	 
MIM256300	C0403399	19q13.1	NEPHROTIC SYNDROME, TYPE 1; NPHS1	4868
MIM256370	C0268747	11p13	NEPHROTIC SYNDROME, TYPE 4; NPHS4	7490
MIM256450	C1257959	11p15.1	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1	6833
MIM256500	C0265962	5q32	NETHERTON SYNDROME; NETH	11005
MIM256520	CN032230	 	NEU-LAXOVA SYNDROME; NLS	 
MIM256540	C0268233	20q13.1	GALACTOSIALIDOSIS; GSL	5476
MIM256550	C0268226	6p21.3	NEURAMINIDASE DEFICIENCY	4758
MIM256600	C0270724	22q13.1	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A	8398
MIM256690	C0796088	 	NEUROFACIODIGITORENAL SYNDROME	 
MIM256700	C0027819	1p36.2, 17q21.3	NEUROBLASTOMA, SUSCEPTIBILITY TO	23095, 4830
MIM256710	C1850466	 	ELEJALDE DISEASE	 
MIM256730	C1850451	1p32	CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1	5538
MIM256731	C1850442	13q21.1-q32	CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5	1203
MIM256800	C0020074	1q21-q22	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	4914
MIM256810	C1850406	2p23-p21	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6	4358
MIM256840	C1850395	5p15.2	NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	22948, 80208
MIM256850	C1850386	16q24.1	GIANT AXONAL NEUROPATHY 1; GAN1	8139
MIM256855	C1850385	 	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH EXCESSIVE MYELIN FOLDING COMPLEX, AUTOSOMAL RECESSIVE	 
MIM256860	C1850384	 	NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	 
MIM256870	C1850383	 	NEUROPATHY, PAINFUL	 
MIM257100	C1850381	 	NEUTROPENIA, LETHAL CONGENITAL, WITH EOSINOPHILIA	 
MIM257150	C1850380	 	NEUTROPHIL ACTIN DYSFUNCTION; NAD	 
MIM257200	C0268242	11p15.4-p15.1	NIEMANN-PICK DISEASE, TYPE A	6609
MIM257220	C3179455	18q11-q12	NIEMANN-PICK DISEASE, TYPE C1; NPC1	4864
MIM257270	C1850362	5q35	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B	2916
MIM257300	C1850343	15q15	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1	701
MIM257320	C0796089	7q22	LISSENCEPHALY 2; LIS2	5649
MIM257350	C0948242	 	NUCHAL BLEB, FAMILIAL	 
MIM257500	C0031880	 	OBESITY-HYPOVENTILATION SYNDROME	 
MIM257550	C0271270	2q13	OCULAR MOTOR APRAXIA	266710
MIM257600	C1850341	 	OCULAR MYOPATHY WITH CURARE SENSITIVITY	 
MIM257790	C1850340	 	OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	 
MIM257800	C0268496	 	OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	 
MIM257850	C2749477	6q21-q23.2	OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	2697
MIM257910	C1850338	 	OCULOPALATOCEREBRAL SYNDROME	 
MIM257920	C0796059	 	3MC SYNDROME 1; 3MC1	5648
MIM257960	C1850332	 	OCULOTRICHODYSPLASIA; OTD	 
MIM257970	C1850331	 	OCULORENOCEREBELLAR SYNDROME	 
MIM257980	C0796093	2q35	ODONTOONYCHODERMAL DYSPLASIA; OODD	80326
MIM258040	C1850321	 	OEIS COMPLEX	 
MIM258100	C1306122	2q37.1	OGUCHI DISEASE 1	6295
MIM258150	C0403810	 	SPERMATOGENIC FAILURE 1; SPGF1	 
MIM258200	C1850320	 	OLIVER SYNDROME	 
MIM258300	C1850319	 	OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	 
MIM258315	C1850318	13q32	OMODYSPLASIA 1; OMOD1	10082
MIM258320	C1850317	 	OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	 
MIM258360	C1850316	 	ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	 
MIM258400	C1850314	 	OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	 
MIM258450	C1850303	15q25	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE; PEOB	5428
MIM258470	C1850302	 	OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA	 
MIM258480	C0432219	 	OPSISMODYSPLASIA	 
MIM258500	C1850281	8q21-q22	OPTIC ATROPHY 6; OPA6	777778
MIM258501	C0574084	19q13.2-q13.3	3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3	80207
MIM258650	C1850270	 	OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE	 
MIM258660	C1847711	17pter-p12	NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO	2811
MIM258700	C0520711	 	OPTICOCOCHLEODENTATE DEGENERATION	 
MIM258800	C1850269	 	ORAL SENSIBILITY, DISTURBANCE OF	 
MIM258840	C1850268	 	ORAL AND DIGITAL ANOMALIES WITH ICHTHYOSIS	 
MIM258850	C0406726	 	OROFACIODIGITAL SYNDROME III; OFD3	 
MIM258860	C0406727	 	OROFACIODIGITAL SYNDROME IV; OFD4	26123
MIM258865	C0796102	 	OROFACIODIGITAL SYNDROME IX; OFD9	 
MIM258870	C0599035	10q26	GYRATE ATROPHY OF CHOROID AND RETINA; GACR	4942
MIM258900	C0268128	3q13	OROTIC ACIDURIA	7372
MIM259050	C0796121	 	OSSIFIED EAR CARTILAGES WITH MENTAL DEFICIENCY, MUSCLE WASTING, AND BONY CHANGES	 
MIM259100	C0029411	4q34-q35	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	3248
MIM259200	C0220757	 	BLOUNT DISEASE, ADOLESCENT	 
MIM259250	C1850186	 	OSTEODYSPLASIA, FAMILIAL, ANDERSON TYPE	 
MIM259270	C1850185	 	OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	 
MIM259410	C1850184	 	OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	 
MIM259420	C0268362	7q22.1, 17q21.31-q22	OSTEOGENESIS IMPERFECTA, TYPE III	1277, 1278
MIM259440	C1850169	15q21-q22	OSTEOGENESIS IMPERFECTA, TYPE IX	5479
MIM259450	C1850168	17p12	BRUCK SYNDROME 1; BRKS1	50963
MIM259500	C0029463	17p13.1, 13q14.1-q14.2, 22q12.1, 18q21-q22	OSTEOGENIC SARCOMA	11200, 5925, 7157
MIM259550	C0029441	 	OSTEOID OSTEOMA	 
MIM259600	C1850155	16q13	TORG-WINCHESTER SYNDROME	4313
MIM259610	C1850143	 	OSTEOLYSIS SYNDROME, RECESSIVE	 
MIM259650	C1850142	 	OSTEOMA OF MIDDLE EAR	 
MIM259660	C1850141	 	OSTEOMALACIA, SCLEROSING, WITH CEREBRAL CALCIFICATION	 
MIM259680	C0410422	 	CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS; CRMO	 
MIM259690	C1850140	 	OSTEOPENIA AND SPARSE HAIR	 
MIM259700	C1850127	11q13.4-q13.5	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	10312
MIM259710	C1850126	13q14	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2	8600
MIM259720	C1968603	6q21	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	28962
MIM259730	C0345407	8q22	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	760
MIM259750	C0264080	 	OSTEOPOROSIS, JUVENILE	 
MIM259770	C0432252	11q13.4	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; OPPG	4041
MIM259775	C1850106	7p22	RAINE SYNDROME; RNS	56975
MIM259780	C1850105	 	OTOONYCHOPERONEAL SYNDROME	 
MIM259900	C0268164	2q36-q37	HYPEROXALURIA, PRIMARY, TYPE I; HP1	189
MIM260000	C0268165	9cen	HYPEROXALURIA, PRIMARY, TYPE II	9380
MIM260005	C0268525	 	5-@OXOPROLINASE DEFICIENCY; OPLAHD	26873
MIM260130	C1850103	 	PACHYONYCHIA CONGENITA, AUTOSOMAL RECESSIVE	 
MIM260150	C1850102	 	PALANT CLEFT PALATE SYNDROME	 
MIM260200	C1850101	 	PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	 
MIM260300	C1850100	22q12-q13	PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK15	25793
MIM260350	C0235974	17p13.1, 12p12.1	PANCREATIC CANCER	3845, 7157
MIM260370	C1850096	13q12.1	PANCREATIC AGENESIS, CONGENITAL; PAGEN	3651
MIM260400	C0272170	7q11	SHWACHMAN-DIAMOND SYNDROME; SDS	51119
MIM260450	C1850081	 	PANCREATIC INSUFFICIENCY, COMBINED EXOCRINE	 
MIM260470	C0038522	 	PANENCEPHALITIS, SUBACUTE SCLEROSING	 
MIM260480	C1850080	 	PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	 
MIM260500	C0205770	17p13.1	PAPILLOMA OF CHOROID PLEXUS	7157
MIM260530	C1850079	 	PARANA HARD-SKIN SYNDROME	 
MIM260540	C1850076	17q21.1	PARKINSON-DEMENTIA SYNDROME	4137
MIM260555	C1850075	 	PARTINGTON-ANDERSON SYNDROME	 
MIM260565	C1850055	 	PEHO SYNDROME	 
MIM260570	C1850054	 	PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	 
MIM260600	C1850053	 	LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	9255
MIM260650	C1850052	 	PELLAGRA-LIKE SYNDROME	 
MIM260660	C1850040	1p13	COUSIN SYNDROME	6913
MIM260800	C0268162	17q25.3	PENTOSURIA	51181
MIM260900	C1850039	 	PERICARDIAL EFFUSION, CHRONIC	 
MIM260910	C0263506	 	PERIFOLLICULITIS CAPITIS ABSCEDENS ET SUFFODIENS, FAMILIAL	 
MIM260920	C0398691	12q24	HYPER-IgD SYNDROME; HIDS	4598
MIM260950	C0266929	 	PERIODONTITIS, CHRONIC	 
MIM260970	C1850022	 	PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND SPONGY DEGENERATION OF BRAIN	 
MIM261000	C1394891	11q13	INTRINSIC FACTOR DEFICIENCY; IFD	2694
MIM261100	C1306856	14q32, 10p12.1	MEGALOBLASTIC ANEMIA 1	8029, 81693
MIM261400	C1850001	 	PERONEUS TERTIUS MUSCLE, ABSENCE OF	 
MIM261500	C1850000	17q23.1	PEROXIDASE AND PHOSPHOLIPID DEFICIENCY IN EOSINOPHILS	8288
MIM261515	C0342870	5q2	D-BIFUNCTIONAL PROTEIN DEFICIENCY	3295
MIM261540	C0796012	13q12.3	PETERS-PLUS SYNDROME	145173
MIM261550	C1849930	12q13, 19p13.3-p13.2	PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II; PMDS	268, 269
MIM261560	C1849929	 	PFEIFFER-PALM-TELLER SYNDROME	 
MIM261575	C1849928	 	PHAVER SYNDROME	 
MIM261590	C1849927	 	PHENFORMIN 4-HYDROXYLATION	 
MIM261600	C0031485	12q24.1	PHENYLKETONURIA; PKU	5053
MIM261630	C0268465	4p15.31	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	5860
MIM261640	C0878676	11q22.3-q23.3	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	5805
MIM261650	C1849821	14q11.2-q12	PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL	5106
MIM261670	C0268149	7p13-p12.3	GLYCOGEN STORAGE DISEASE X; GSD10	5224
MIM261740	C1849813	7q36	GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	51422
MIM261750	C1849812	16q12-q13	GLYCOGEN STORAGE DISEASE IXb; GSD9B	5257
MIM261800	C0031900	17q24.3-q25.1	PIERRE ROBIN SYNDROME	100301572
MIM261900	C0263491	 	PILI TORTI, EARLY-ONSET	 
MIM261990	C1849811	 	PILI TORTI AND DEVELOPMENTAL DELAY	 
MIM262000	C0266006	2q33	BJORNSTAD SYNDROME; BJS	617
MIM262020	C1849805	 	PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	 
MIM262190	C0271695	19p13.2	PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	3643
MIM262300	C1849792	8q21-q22	ACHROMATOPSIA 3; ACHM3	54714
MIM262400	C0342573	17q22-q24	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA; IGHD1A	2688
MIM262500	C0271568	5p13-p12	LARON SYNDROME	2690
MIM262600	C0878683	5q	PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2	5626
MIM262650	C1849779	17q22-q24	KOWARSKI SYNDROME	2688
MIM262700	C2678408	1q25	PITUITARY HORMONE DEFICIENCY, COMBINED, 4; CPHD4	89884
MIM262710	C0271575	 	PITUITARY DWARFISM WITH LARGE SELLA TURCICA	 
MIM262800	C1849778	 	PLASMA CLOT RETRACTION FACTOR, DEFICIENCY OF	 
MIM262850	C2752081	17pter-p12	ALPHA-2-PLASMIN INHIBITOR DEFICIENCY	5345
MIM262890	C0796149	12q12	SCOTT SYNDROME; SCTS	196527
MIM262900	C1849773	 	PLEOCONIAL MYOPATHY WITH SALT CRAVING	 
MIM263000	C0238378	 	INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	100188011
MIM263100	C1849771	 	POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	 
MIM263200	C0085548	6p21.1-p12	POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE; ARPKD	5314
MIM263210	C1849762	 	POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY, HYPERTELORISM, AND BRACHYMELIA	 
MIM263300	C0032463	9p24	POLYCYTHEMIA VERA	3717
MIM263400	C1837915	3p26-p25	ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2	7428, 8056
MIM263450	C3550661	 	POLYDACTYLY, POSTAXIAL, TYPE A5; PAPA5	 
MIM263510		11q13.5	SHORT RIB-POLYDACTYLY SYNDROME, TYPE III	79659
MIM263520	C0024507	11q13.5	SHORT RIB-POLYDACTYLY SYNDROME, TYPE II	4750, 79659
MIM263530		 	SHORT RIB-POLYDACTYLY SYNDROME, TYPE I; SRPS1	 
MIM263540	C1849732	 	POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	 
MIM263550	C1849731	 	POLYMYOCLONUS, INFANTILE	 
MIM263570	C1849722	 	POLYGLUCOSAN BODY DISEASE, ADULT FORM; APBD	2632
MIM263610	C1849720	 	POLYHYDRAMNIOS, CHRONIC IDIOPATHIC	 
MIM263630	C1849719	 	POLYSYNDACTYLY WITH CARDIAC MALFORMATION	 
MIM263650	C1849718	 	POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE	54101
MIM263700	C0162530	10q25.2-q26.3	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	7390
MIM263750	C0265257	 	POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS	1723
MIM263800	C0268450	16q13	GITELMAN SYNDROME	6559
MIM264010	C0796189	 	PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY	 
MIM264050	C1849701	 	PRENATAL BOWING	 
MIM264060	C1828066	 	PREPAPILLARY VASCULAR LOOPS	 
MIM264070	C1849700	10q22	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D; HPABH4D	5092
MIM264080	C1849699	11q22	PROGESTERONE RESISTANCE	5241
MIM264090	C0406586	 	PROGEROID SYNDROME, NEONATAL	 
MIM264110	C0271586	 	PROLACTIN DEFICIENCY, ISOLATED	 
MIM264120	C1849698	 	PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES	 
MIM264140	C0403551	 	PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, AND DEAFNESS	 
MIM264180	C0432206	 	PSEUDODIASTROPHIC DYSPLASIA	 
MIM264270	C1849696	 	PSEUDOHERMAPHRODITISM, FEMALE, WITH SKELETAL ANOMALIES	 
MIM264300	C0268296	9q22	17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	3293
MIM264350	C1449843	16p13-p12, 16p13-p12, 12p13	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B	6337, 6338, 6340
MIM264420	C1849694	 	FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	 
MIM264470	C1849678	17q25	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY	51
MIM264475	C1849661	 	PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HAND ANOMALIES	 
MIM264480	C1849649	 	PSEUDOTRISOMY 13 SYNDROME	 
MIM264500	C1849648	 	PSEUDOURIDINURIA AND MENTAL DEFECT	 
MIM264600	C0268297	2p23	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	6716
MIM264700	C0268689	12q13.1-q13.3	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A	1594
MIM264800	C0033847	16p13.1, 16p13.1, 17q21.3-q22	PSEUDOXANTHOMA ELASTICUM; PXE	368, 64131, 64132
MIM264900		4q35	COAGULATION FACTOR XI; F11	2160
MIM265000	C0265261	2q33-q34	MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS	1146
MIM265050	C0796279	 	3MC SYNDROME 2; 3MC2	78989
MIM265100	C0155912	4p15.31-p15.2	PULMONARY ALVEOLAR MICROLITHIASIS	10568
MIM265120	C1968602	2p12-p11.2	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	6439
MIM265140	C0155675	 	PULMONARY ARTERIOVENOUS FISTULAS	 
MIM265150	C0344975	 	PULMONARY ATRESIA WITH INTACT VENTRICULAR SEPTUM	 
MIM265200	C1849566	 	PULMONARY BULLAE CAUSING PNEUMOTHORAX	 
MIM265300	C1849554	 	LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL	 
MIM265380	C0031190	16q24, 2q35	ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	1373, 2294
MIM265400	C1849552	 	PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	 
MIM265430	C0456891	 	LUNG AGENESIS	 
MIM265450	C0034091	2q33	PULMONARY VENOOCCLUSIVE DISEASE; PVOD	659
MIM265500	C1956257	 	PULMONIC STENOSIS	 
MIM265600	C0403552	 	PULMONIC STENOSIS AND CONGENITAL NEPHROSIS	 
MIM265800	C0238402	1q21	PYCNODYSOSTOSIS	1513
MIM265850	C1849524	 	PYGMY	 
MIM265880	C1849523	 	PYKNOACHONDROGENESIS	 
MIM265900	C0265294	 	PYLE DISEASE	 
MIM265950	C0266159	 	PYLORIC ATRESIA	 
MIM266100	C1849508	5q31	EPILEPSY, PYRIDOXINE-DEPENDENT; EPD	501
MIM266120	C1849507	7p15-p14	URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	51251
MIM266130	C0398746	20q11.2	GLUTATHIONE SYNTHETASE DEFICIENCY	2937
MIM266140	C0520739	1q21	PYROPOIKILOCYTOSIS, HEREDITARY; HPP	6708
MIM266150	C0034341	11q13.4-q13.5	PYRUVATE CARBOXYLASE DEFICIENCY	5091
MIM266200	C1849472	1q21	PYRUVATE KINASE DEFICIENCY OF RED CELLS	5313
MIM266250	C1849471	 	RADICULONEUROPATHY, FATAL NEONATAL	 
MIM266255	C1849470	 	RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATION AND HYPOTONIA	 
MIM266265	C0796132	11p11.2	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	55343
MIM266270	C0796133	 	RAMON SYNDROME	 
MIM266280	C1849453	8q24.3	RAPADILINO SYNDROME	9401
MIM266300	C1849452	16q24.3	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2; SHEP2	3057, 4157
MIM266350	C1849451	 	RED SKIN PIGMENT ANOMALY OF NEW GUINEA	 
MIM266400	C1849450	 	REESE RETINAL DYSPLASIA	 
MIM266500	C0034960	10pter-p11.2, 6q22-q24	REFSUM DISEASE, ADULT	5191, 5264
MIM266510	C0282527	8q21.1, 7q21-q22, 22q11.21	REFSUM DISEASE, INFANTILE	5189, 55670, 5828
MIM266600	C0678202	16q12, 7p21	INFLAMMATORY BOWEL DISEASE 1; IBD1	3569, 64127
MIM266810	C1849439	 	RENAL AND MULLERIAN DUCT HYPOPLASIA	 
MIM266900	C0403553	2q13	SENIOR-LOKEN SYNDROME 1; SLSN1	4867
MIM266910	C1849438	 	RENAL DYSPLASIA-LIMB DEFECTS SYNDROME	 
MIM266920	C1849437	 	MAINZER-SALDINO SYNDROME; MZSDS	9742
MIM267000	C0796113	 	PERLMAN SYNDROME; PRLMNS	129563
MIM267010	C2673885	3q22	MECKEL SYNDROME, TYPE 7; MKS7	27031
MIM267200	C1849435	 	RENAL TUBULAR ACIDOSIS III	 
MIM267300	C0403554	2cen-q13	RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	525
MIM267400	C1849432	 	RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	 
MIM267430	C0266313	3q21-q25, 1q42-q43, 1q32, 17q23	RENAL TUBULAR DYSGENESIS; RTD	1636, 183, 185, 5972
MIM267450	C1968593	 	RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS	 
MIM267480	C1849430	 	RESPIRATORY UNDERRESPONSIVENESS TO HYPOXIA AND HYPERCAPNIA	 
MIM267500	C0272167	1p34	RETICULAR DYSGENESIS	204
MIM267700	CN034020	9q21.3-q22	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1; FHL1	27259
MIM267730	C0024302	 	RETICULUM CELL SARCOMA	 
MIM267740	C1849416	 	RETINAL DEGENERATION AND EPILEPSY	 
MIM267750	C1849409	21q22.3	KNOBLOCH SYNDROME 1; KNO1	80781
MIM267760	C1849408	 	RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION, AND ANGLE CLOSURE GLAUCOMA	 
MIM267800	C1849407	 	RETINAL DYSTROPHY, RETICULAR PIGMENTARY, OF POSTERIOR POLE	 
MIM267900	C1849406	 	RETINAL TELANGIECTASIA AND HYPOGAMMAGLOBULINEMIA	 
MIM268000	C0035334	16q13, 14q31.3, 2q14.1, 1q41, 19q13.3	RETINITIS PIGMENTOSA; RP	1259, 1406, 157657, 23746, 5148, 55812, 5949, 6094, 7401, 84100, 9227
MIM268010	C1849405	 	RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	 
MIM268020	C1849401	 	RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	 
MIM268025	C1849400	 	RETINITIS PIGMENTOSA, LATE-ADULT ONSET	 
MIM268040	C1849399	 	RETINOHEPATOENDOCRINOLOGIC SYNDROME	 
MIM268050	C0796072	 	RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	 
MIM268060	C1849398	 	RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	 
MIM268080	C1849397	 	RETINOSCHISIS OF FOVEA	 
MIM268100	C1849394	15q23	ENHANCED S-CONE SYNDROME; ESCS	10002
MIM268130	C1327916	14q12	REVESZ SYNDROME	26277
MIM268150	C1849387	6p21.1-p11	RH-NULL, REGULATOR TYPE; RHN	6005
MIM268200	C1849386	2p21	MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE	23175
MIM268210	C1849385	11p15.5	RHABDOMYOSARCOMA 1; RMS1	5002
MIM268220	C0206655	1p36.2-p36.12, 13q14.1, 2q35	RHABDOMYOSARCOMA 2; RMS2	2308, 5077, 5081
MIM268250	C1849382	 	RHIZOMELIC SYNDROME	 
MIM268300	C0392475	8p21.1	ROBERTS SYNDROME; RBS	 
MIM268305	C1849348	 	ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	 
MIM268310	C1849334	9q22	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS	4920
MIM268315	C1849333	 	ROD-CONE DYSTROPHY, SENSORINEURAL DEAFNESS, AND FANCONI-TYPE RENAL DYSFUNCTION	 
MIM268320	C1849332	 	RODRIGUES BLINDNESS	 
MIM268400	C0032339	8q24.3	ROTHMUND-THOMSON SYNDROME; RTS	9401
MIM268500	C0268426	 	ROWLEY-ROSENBERG SYNDROME	 
MIM268650	C0406704	 	RUDIGER SYNDROME	 
MIM268700	C0268556	7q31.3	SACCHAROPINURIA	10157
MIM268800	C0036161	5q13	SANDHOFF DISEASE	3074
MIM268850	C0796142	 	SAO PAULO MCA/MR SYNDROME	 
MIM268900	C0268563	9q33-q34	SARCOSINEMIA	1757
MIM269000	C0392475	8p21.1	SC PHOCOMELIA SYNDROME	 
MIM269150	C1849294	18q21.1	SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME	26040
MIM269160	C0266484	10q26.1	SCHIZENCEPHALY	2018, 6469, 6496
MIM269200	C0085860	 	AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II; APS2	 
MIM269250	C0432194	1p32-p31	SCHNECKENBECKEN DYSPLASIA	23169
MIM269300	C0265292	 	SCHWARTZ-LELEK SYNDROME	 
MIM269400	C1853235	 	SCLEROCORNEA, AUTOSOMAL RECESSIVE	 
MIM269500	C0265301	17q12-q21	SCLEROSTEOSIS 1; SOST1	50964
MIM269600	C0036489	19q13.2	SEA-BLUE HISTIOCYTE DISEASE	348
MIM269630	C1849259	 	SECOND METATARSAL-METACARPAL SYNDROME	 
MIM269650	C0398709	 	SECRETORY COMPONENT DEFICIENCY	 
MIM269700	C1720863	11q13	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2; CGL2	26580
MIM269720	C1849250	 	SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	 
MIM269800	C1849249	 	SENILE PLAQUE FORMATION	 
MIM269840	C1849236	 	SEVERE COMBINED IMMUNODEFICIENCY, ATYPICAL	 
MIM269860	C0432198	 	SHORT RIB-POLYDACTYLY SYNDROME, TYPE IV	 
MIM269870	C1849235	 	SHORT STATURE-OBESITY SYNDROME; SSOS	 
MIM269880	C0878684	 	SHORT SYNDROME	 
MIM269920	C1096902	6q14-q15	INFANTILE SIALIC ACID STORAGE DISORDER	26503
MIM269921	C0342853	9p13.3	SIALURIA	10020
MIM270100	C3495537	10q22.1	HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5	4838, 8114
MIM270150	C1527336	 	SJOGREN SYNDROME	 
MIM270200	C0037231	17p11.2	SJOGREN-LARSSON SYNDROME; SLS	224
MIM270220	C1849195	 	SJOGREN-LARSSON-LIKE ICHTHYOSIS WITHOUT CNS OR EYE INVOLVEMENT	 
MIM270300	C1849193	 	PEELING SKIN SYNDROME	1041
MIM270350	C1849192	 	SKUNK N-BUTYLMERCAPTAN, INABILITY TO SMELL	 
MIM270400	C0175694	11q12-q13	SMITH-LEMLI-OPITZ SYNDROME; SLOS	1717
MIM270420	C0267663	19q13.1	DIARRHEA 3, SECRETORY SODIUM, CONGENITAL; DIAR3	10653
MIM270425	C1849169	 	SODIUM-POTASSIUM-ATPase ACTIVITY OF RED CELL	 
MIM270450	C1849157	15q25-q26	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO	3480
MIM270460	C0796162	 	SONODA SYNDROME	 
MIM270500	C1849156	 	ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	 
MIM270550	C1849140	13q12	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE; SACS	26278
MIM270600	C1849139	 	SPASTIC DIPLEGIA, INFANTILE TYPE	 
MIM270685	CN074197	11q13	SPASTIC PARAPLEGIA 17; SPG17	26580
MIM270700	C1849128	14q24.1	SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15	23503
MIM270710	C0795942	 	FITZSIMMONS-GUILBERT SYNDROME	 
MIM270750	C0796019	 	SPASTIC PARAPLEGIA 23; SPG23	353293
MIM270800	C1849115	8q21.3	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	9420
MIM270805	C1849114	 	SPASTIC PARAPLEGIA WITH MYOCLONIC EPILEPSY	 
MIM270850	C1849113	 	SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION	 
MIM270900	C0599464	 	SPASTIC PSEUDOSCLEROSIS	 
MIM270950	C1849112	 	SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	 
MIM270960	C0232981	12q23	SPERMATOGENIC FAILURE 4; SPGF4	50511
MIM270970	C2678338	1q21	SPHEROCYTOSIS, TYPE 3; SPH3	6708
MIM271109	C1849109	 	SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	 
MIM271110	C1849108	 	SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	 
MIM271150	C1838230	5q12.2-q13.3	SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4	6606
MIM271200	C1849102	 	SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE	 
MIM271220	CN074295	 	SPINAL MUSCULAR ATROPHY, SCAPULOPERONEAL	 
MIM271225	C1849101	 	SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	 
MIM271245	C1849096	10q24	MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE); MTDPS7	56652
MIM271250	C1849094	6p23-p21	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3; SCAR3	85502
MIM271270	C1849088	 	SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	 
MIM271310	C1849087	 	SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	 
MIM271320	C1849085	 	SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITAL CATARACTS, AND MYOPIA	 
MIM271322	C2931904	 	SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	 
MIM271400	C1849084	 	SPLENIC HYPOPLASIA	 
MIM271500	C0340826	 	SPLENOPORTAL VASCULAR ANOMALIES	 
MIM271510	C1300260	 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE	 
MIM271520	C1849069	 	SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	 
MIM271530	C1849055	 	BRACHYOLMIA TYPE 1, HOBAEK TYPE	 
MIM271550		 	SPONDYLOENCHONDRODYSPLASIA; SPENCD	 
MIM271600	C1849054	 	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE	 
MIM271620	C1849053	 	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH MENTAL RETARDATION	 
MIM271630	C1849048	 	BRACHYOLMIA TYPE 1, TOLEDO TYPE	 
MIM271640	C0432243	 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1; SEMDJL1	 
MIM271650	C0432213	 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE; SEMDIT	 
MIM271665	C1849011	1q12-qter	SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	4921
MIM271700	C0796173	12q13.11-q13.2	SPONDYLOPERIPHERAL DYSPLASIA	1280
MIM271900	C0206307	17pter-p13	CANAVAN DISEASE	443
MIM271930	C0795996	19q13.33	STRIATONIGRAL DEGENERATION, INFANTILE; SNDI	23636
MIM271950	C1848979	 	SUBAORTIC STENOSIS, MEMBRANOUS	 
MIM271960	C0795947	 	SUBAORTIC STENOSIS--SHORT STATURE SYNDROME	 
MIM271980	C0268631	6p22	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	7915
MIM272000	C1848963	 	SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	 
MIM272100	C0007795	 	SUDANOPHILIC CEREBRAL SCLEROSIS	 
MIM272120	C0038644	3p21	SUDDEN INFANT DEATH SYNDROME	6331
MIM272150	C1848962	 	SUGARMAN BRACHYDACTYLY	 
MIM272200	C0268263	3p26	MULTIPLE SULFATASE DEFICIENCY; MSD	285362
MIM272300	C0268624	Chr.12	SULFOCYSTEINURIA	6821
MIM272350	C1802405	 	SUMMITT SYNDROME	 
MIM272370	C1848953	6p21.3	SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS; EC1	4819
MIM272430	C1848947	19p12	COLD-INDUCED SWEATING SYNDROME 1; CISS1	9244
MIM272440	C0795940	 	SYNDACTYLY, TYPE I, WITH MICROCEPHALY AND MENTAL RETARDATION	 
MIM272450	C1848946	 	SYNDESMODYSPLASIC DWARFISM	 
MIM272460	C1848934	3p14.3	SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	2317
MIM272600	C1848932	 	TAPETORETINAL DEGENERATION WITH ATAXIA	 
MIM272620	C0686347	 	TARDIVE DYSKINESIA	 
MIM272650	C1848931	 	TATSUMI FACTOR DEFICIENCY	 
MIM272700	C0266039	 	TAURODONTISM	 
MIM272750	C0268275	5q31.3-q33.1	GM2-GANGLIOSIDOSIS, AB VARIANT	2760
MIM272800	C0039373	15q23-q24	TAY-SACHS DISEASE; TSD	3073
MIM272950	C1848912	 	TEEBI-SHALTOUT SYNDROME	 
MIM272980	C1848909	 	TEETH, CONGENITAL ABSENCE OF, WITH TAURODONTIA AND SPARSE HAIR	 
MIM273000	C0016873	 	TEETH, FUSED	 
MIM273050	C1848903	 	TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM	 
MIM273120	C1848902	 	TERATOMA, PINEAL	 
MIM273150	C1848901	 	TESTES, RUDIMENTARY	 
MIM273250	C0266427	 	TESTICULAR REGRESSION SYNDROME; TRS	 
MIM273300	C0153594	12q22, 4q12, 19p13.3	TESTICULAR GERM CELL TUMOR; TGCT	2261, 3815, 6794, 8093, 8915
MIM273390	C2749282	 	TETRAAMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	 
MIM273395	C2749279	17q21	TETRAAMELIA, AUTOSOMAL RECESSIVE	7473
MIM273400	CN074199	 	TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, AND OTHER ABNORMALITIES	 
MIM273490	C1848867	 	THALAMIC DEGENERATION, SYMMETRIC INFANTILE	 
MIM273600	C1848866	 	THALIDOMIDE SUSCEPTIBILITY	 
MIM273680	C1848865	 	THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	 
MIM273730	C1848864	 	THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	 
MIM273740	C1848863	 	THORACOMELIC DYSPLASIA	 
MIM273750	C1848862	6p21.1	THREE M SYNDROME 1; 3M1	9820
MIM273770	C1848861	 	THREONINEMIA	 
MIM273800	C0040015	17q21.32	GLANZMANN THROMBASTHENIA; GT	3674, 3690
MIM273900	C2678311	 	THROMBOCYTOPENIA 3; THC3	 
MIM274000	C0175703	1q21.1	THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR	100034701, 9939
MIM274150	C1268935	9q34	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP	11093
MIM274180		7q34	THROMBOXANE A SYNTHASE 1; TBXAS1	6916
MIM274190	C1848818	 	THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	 
MIM274200	C1848817	 	THUMB, DISTAL HYPEREXTENSIBILITY OF	 
MIM274205	C1848816	 	THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX, AND DEAFNESS	 
MIM274210	C1848815	 	THYMIC APLASIA WITH FETAL DEATH	 
MIM274230	C1848814	 	THYMOMA, FAMILIAL	7063
MIM274240	C1848813	 	THYROCEREBRORETINAL SYNDROME	 
MIM274265	C1848812	 	THYMIC-RENAL-ANAL-LUNG DYSPLASIA	 
MIM274270	C2720286	1p22	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	1806
MIM274300	C3489796	3p24.3	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE; GRTH	7068
MIM274400	C1848805	19p13.2-p12	THYROID DYSHORMONOGENESIS 1; TDH1	6528
MIM274500	C1291299	2p25	THYROID DYSHORMONOGENESIS 2A; TDH2A	7173
MIM274600	C0271829	7q31	PENDRED SYNDROME; PDS	2299, 3766, 5172
MIM274700	C0342194	8q24.2-q24.3	THYROID DYSHORMONOGENESIS 3; TDH3	7038
MIM274800	C0342195	6q24-q25	THYROID DYSHORMONOGENESIS 4; TDH4	389434
MIM274900	C0342196	15q15	THYROID DYSHORMONOGENESIS 5; TDH5	405753
MIM275000	C0018213	14q31	GRAVES DISEASE	100312954
MIM275100	C0271789	1p13	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4; CHNG4	7252
MIM275120	C0220998	3q13.3-q21	THYROTROPIN-RELEASING HORMONE DEFICIENCY	7200
MIM275190	C1848793	 	TIGLIC ACIDEMIA	 
MIM275200	C3493776	14q31	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1; CHNG1	 
MIM275210	C0406585	1p34	RESTRICTIVE DERMOPATHY, LETHAL	10269, 4000
MIM275220	C0265633	8q24.1	TIBIAL HEMIMELIA	117193
MIM275230	C1848758	 	TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	 
MIM275240	C0276742	 	TINEA IMBRICATA, SUSCEPTIBILITY TO	 
MIM275250	C1848756	 	TONGUE, PIGMENTED FUNGIFORM PAPILLAE OF	 
MIM275300	C0040587	 	TRACHEOBRONCHOMEGALY	 
MIM275350	C0342701	22q11.2-qter	TRANSCOBALAMIN II DEFICIENCY	6948
MIM275355	C1168401	13q34, 8p22-p21	SQUAMOUS CELL CARCINOMA, HEAD AND NECK; HNSCC	3621, 5728, 8795
MIM275360		11q23	TREHALASE; TREH	11181
MIM275370	C1848746	 	TRICARBOXYLIC ACID CYCLE, DEFECT OF	 
MIM275400	C1848745	 	TRICHOMEGALY WITH MENTAL RETARDATION, DWARFISM, AND PIGMENTARY DEGENERATION OF RETINA	 
MIM275450	C1848744	 	TRICHOODONTOONYCHIAL DYSPLASIA WITH BONE DEFICIENCY	 
MIM275550	C1313961	 	TRICHORRHEXIS NODOSA SYNDROME	 
MIM275595	C1848743	 	TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIES OF THE HANDS AND FEET	 
MIM275630	C0268238	3p21	CHANARIN-DORFMAN SYNDROME; CDS	51099
MIM275900	C0393559	13q12.3	SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20	23111
MIM276000		7q35	PROTEASE, SERINE, 1; PRSS1	5644
MIM276100	C0268473	 	TRYPTOPHANURIA WITH DWARFISM	 
MIM276200	C1848724	 	T-SUBSTANCE ANOMALY	 
MIM276300	C0265325	7p22, 3p21.3, 2p16, 2p22-p21	MISMATCH REPAIR CANCER SYNDROME	2956, 4292, 4436, 5395
MIM276600	C0268487	 	TYROSINEMIA, TYPE II	6898
MIM276700	C0268490	15q23-q25	TYROSINEMIA, TYPE I	2184
MIM276710	C0268623	12q24-qter	TYROSINEMIA, TYPE III	3242
MIM276800	C0268484	 	TYROSINOSIS	 
MIM276820	C1848651	3p25	ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY	7476
MIM276821	C1848650	 	ULNAR HYPOPLASIA WITH MENTAL RETARDATION	 
MIM276822	C1848649	 	ULNAR AGENESIS AND ENDOCARDIAL FIBROELASTOSIS	 
MIM276880	C0268514	3q21.3	UROCANASE DEFICIENCY	131669
MIM276900	C1568247	11q13.5	USHER SYNDROME, TYPE I; USH1	10083, 4647, 7393
MIM276901	C1848634	1q41	USHER SYNDROME, TYPE IIA; USH2A	7399, 79955
MIM276902	C1568248	3q21-q25	USHER SYNDROME, TYPE IIIA; USH3A	7401
MIM276903		11q13.5	MYOSIN VIIA; MYO7A	4647
MIM276904	C1848604	11p15.1	USHER SYNDROME, TYPE IC; USH1C	10083
MIM276950	C1848599	10q23.31	VACTERL ASSOCIATION WITH HYDROCEPHALUS	5728
MIM277000	C1698581	 	MAYER-ROKITANSKY-KUSTER-HAUSER SYNDROME	 
MIM277100	C0268573	 	VALINEMIA	 
MIM277150	C1848598	 	VAN BOGAERT-HOZAY SYNDROME	 
MIM277170	C2745997	 	OROFACIODIGITAL SYNDROME VI; OFD6	 
MIM277175	C1848590	 	VASCULAR HYALINOSIS	 
MIM277180	C0403814	7q31.2	VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD	1080
MIM277200	C1848587	 	RIGHT VENTRICULAR HYPOPLASIA, ISOLATED	 
MIM277300	CN032975	19q13	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE; SCDO1	10683, 145873
MIM277320	C1848586	 	VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	 
MIM277350	C2678266	 	HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL RECESSIVE	 
MIM277380	C1848578	6q13	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE	55788
MIM277400	C1848561	1p34.1	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE	25974
MIM277410	C1848552	2q23.2	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE	27249
MIM277440	C0268690	12q12-q14	VITAMIN D-DEPENDENT RICKETS, TYPE 2A; VDDR2A	7421
MIM277450	C1848534	2p12	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1	2677
MIM277460	C1848533	8q13.1-q13.3	VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF; VED	7274
MIM277465	C1848532	 	VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	 
MIM277470	C1848526	17q25.1	PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	283989
MIM277480	C1848525	12p13.3	VON WILLEBRAND DISEASE, TYPE 3; VWD3	7450
MIM277580	C1848519	13q22	WAARDENBURG SYNDROME, TYPE 4A; WS4A	1910
MIM277590	C0265210	5q35	WEAVER SYNDROME 1; WVS1	2146, 64324
MIM277600	C1869114	19p13.3-p13.2	WEILL-MARCHESANI SYNDROME 1; WMS1	81794
MIM277610	C1848488	6p21.3	WEISSENBACHER-ZWEYMULLER SYNDROME; WZS	1302
MIM277700	C0043119	8p12-p11.2	WERNER SYNDROME; WRN	7486
MIM277720	C1848470	 	WHISTLING FACE SYNDROME, RECESSIVE FORM	 
MIM277730	C0349464	 	WERNICKE-KORSAKOFF SYNDROME	 
MIM277740	C1848463	 	WHITE FORELOCK WITH MALFORMATIONS	 
MIM277900	C0019202	13q14.3-q21.1	WILSON DISEASE	540
MIM277970	C0043194	 	WISKOTT-ALDRICH SYNDROME	 
MIM277990	C1848439	 	WOLFF MENTAL RETARDATION SYNDROME	 
MIM278000	C0043208	10q23.31	LYSOSOMAL ACID LIPASE DEFICIENCY	3988
MIM278150	C1848435	13q14.12-q14.2	HYPOTRICHOSIS 8; HYPT8	 
MIM278200	C0406718	 	WOOLLY HAIR, HYPOTRICHOSIS, EVERTED LOWER LIP, AND OUTSTANDING EARS	 
MIM278250	C0406587	12q24.3	WRINKLY SKIN SYNDROME; WSS	23545
MIM278300	C0268118	2p23-p22	XANTHINURIA, TYPE I	7498
MIM278700	C0268135	9q22.3	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	7507
MIM278720	C2752147	3p25	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC	7508
MIM278730	C0268138	19q13.2-q13.3	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	2068
MIM278740	C1848411	11p12-p11	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	1643
MIM278750	C1848410	6p21.1-p12	XERODERMA PIGMENTOSUM, VARIANT TYPE; XPV	5429
MIM278760	C0268140	16p13.3-p13.13	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	2072
MIM278780	C0268141	13q33	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	2073
MIM278800	C0265201	10q11	DE SANCTIS-CACCHIONE SYNDROME	2074
MIM278850	C2749215	 	46,XX SEX REVERSAL 2; SRXX2	100653378, 6736
MIM278900	C1848407	 	XYLOSIDASE DEFICIENCY	 
MIM279000	C0340037	 	YOUNG SYNDROME	 
MIM280000	C1848392	 	COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, MENTAL RETARDATION, AND EAR ANOMALIES SYNDROME; CHIME	9487
MIM300000	C0175696	Xp22	OPITZ GBBB SYNDROME, X-LINKED	4281
MIM300001	C1848387	 	ICHTHYOSIS, X-LINKED, WITHOUT STEROID SULFATASE DEFICIENCY	 
MIM300002		Xp22.3	ARYLSULFATASE D; ARSD	414
MIM300003		Xp22.3	ARYLSULFATASE F; ARSF	416
MIM300004	C0796124	Xp22.13	CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA	170302
MIM300005		Xq28	METHYL-CpG-BINDING PROTEIN 2; MECP2	4204
MIM300006		Xq28	CENTRIN, EF-HAND PROTEIN, 2; CETN2	1069
MIM300007		Xq28	INTERLEUKIN 9 RECEPTOR; IL9R	3581
MIM300008		Xp11.22	CHLORIDE CHANNEL 5; CLCN5	1184
MIM300009	C1848336	Xp11.22	DENT DISEASE 1	1184
MIM300010		Xq	A-11 GENE; A11	8248
MIM300011		Xq12-q13	ATPase, Cu(2+)-TRANSPORTING, ALPHA POLYPEPTIDE; ATP7A	538
MIM300012		Xq26.1	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 1; SMARCA1	6594
MIM300013		Xq28	N-ALPHA-ACETYLTRANSFERASE 10, NatA CATALYTIC SUBUNIT; NAA10	8260
MIM300014		Xq28	ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 3; ATP2B3	492
MIM300015		Xpter-p22.32	ACETYLSEROTONIN METHYLTRANSFERASE, X-CHROMOSOMAL; ASMT	438
MIM300016		Xq28	MELANOMA ANTIGEN, FAMILY A, 1; MAGEA1	4100
MIM300017		Xq28	FILAMIN A; FLNA	2316
MIM300018	C1848296	Xp21.3-p21.2	46,XY SEX REVERSAL 2; SRXY2	190
MIM300019		Xq28	HOST CELL FACTOR C1; HCFC1	3054
MIM300022		Xq28	PLEXIN A3; PLXNA3	55558
MIM300023		Xq28	RHO GTPase-ACTIVATING PROTEIN 4; ARHGAP4	393
MIM300024		Xp11.2	ZINC FINGER PROTEIN 157; ZNF157	7712
MIM300025		Xq13.2	CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 4; CDX4	1046
MIM300026		 	NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 2; NAP1L2	4674
MIM300027		Xp11.23	RNA-BINDING MOTIF PROTEIN 3; RBM3	5935
MIM300028		Xp22.1	ZINC FINGER-, CCCH DOMAIN-, AND RNA-BINDING MOTIF-CONTAINING SERINE/ARGININE-RICH PROTEIN 2; ZRSR2	8233
MIM300029	C1848295	Xp11.4	RETINITIS PIGMENTOSA 3; RP3	6103
MIM300030	C1848294	Xp21.2	DEAFNESS, X-LINKED 3; DFNX3	1680
MIM300031		Xq28	FAMILY WITH SEQUENCE SIMILARITY 11, MEMBER A; FAM11A	84548
MIM300032		Xq13	ATR-X GENE; ATRX	546
MIM300033		Xq13.1	MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 7; MLLT7	4303
MIM300034		Xq22-q23	ANGIOTENSIN II RECEPTOR, TYPE 2; AGTR2	186
MIM300035		Xq12	EPHRIN B1; EFNB1	1947
MIM300036		Xq28	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, CREATINE), MEMBER 8; SLC6A8	6535
MIM300037		Xq26	GLYPICAN 3; GPC3	2719
MIM300038		Xq13	PYRIMIDINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 4; P2RY4	5030
MIM300039		Xq21.1	POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 4; POU3F4	5456
MIM300040		Xp11.22-p11.21	STRUCTURAL MAINTENANCE OF CHROMOSOMES 1A; SMC1A	8243
MIM300041		Xq22	GUANYLATE CYCLASE 2F, RETINAL; GUCY2F	2986
MIM300042	C0265992	 	ALOPECIA, CONGENITAL	 
MIM300044		Xq28	TRANSKETOLASE-LIKE 1; TKTL1	8277
MIM300046	C0796229	Xq23-q24	MENTAL RETARDATION, X-LINKED 23; MRX23	4387
MIM300047	C0796226	Xp11-q21	MENTAL RETARDATION, X-LINKED 20; MRX20	4384
MIM300048	C1848221	Xq28, Xq28	INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	2316, 8268
MIM300049	C1848213	Xq28	HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT	2316
MIM300050		Xp21.2-p11.2	UBIQUITIN-SPECIFIC PROTEASE 11; USP11	8237
MIM300051		Xp22.2	GLYCOPROTEIN M6B; GPM6B	2824
MIM300052		Xq22	DYSTROPHIN-RELATED PROTEIN 2; DRP2	1821
MIM300053		Xq28	VESICLE-ASSOCIATED MEMBRANE PROTEIN 7: VAMP7	6845
MIM300054		 	BODY LENGTH, MOUSE, HUMAN HOMOLOG	100913186
MIM300055	C1968550	Xq28	MENTAL RETARDATION, X-LINKED, SYNDROMIC 13; MRXS13	4204
MIM300056		Xp22	HOLOCYTOCHROME C SYNTHASE; HCCS	3052
MIM300059		Xq28	TRANSMEMBRANE PROTEIN 187; TMEM187	8269
MIM300060		Xq28	L ANTIGEN FAMILY, MEMBER 3; LAGE3	8270
MIM300061		Xq13.1	ZINC FINGER, MYM-TYPE 3; ZMYM3	9203
MIM300062	C0796220	Xp11.3-q13.3	MENTAL RETARDATION, X-LINKED 14; MRX14	4378
MIM300064	C1848205	 	MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM	 
MIM300065		Xq22	CENTROMERIC PROTEIN I; CENPI	2491
MIM300066	C1848204	Xp22	DEAFNESS, X-LINKED 4; DFNX4	1682, 23676
MIM300067	C1848199	Xq22.3-q23	LISSENCEPHALY, X-LINKED, 1; LISX1	1641
MIM300068	C0039585	Xq11-q12	ANDROGEN INSENSITIVITY SYNDROME; AIS	367
MIM300070		Xq26.3	FIBROBLAST GROWTH FACTOR 13; FGF13	2258
MIM300071	C1848172	Xp11.23	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A	778
MIM300072		Xp11.4	UBIQUITIN-SPECIFIC PROTEASE 9, X CHROMOSOME; USP9X	8239
MIM300073	C1848171	 	FETAL AKINESIA SYNDROME, X-LINKED	 
MIM300074		 	X CHROMOSOME-CONTROLLING ELEMENT; XCE	7497
MIM300075		Xp22.2-p22.1	RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 3; RPS6KA3	6197
MIM300076	C1848144	Xq26-qter	IMMUNONEUROLOGIC DISORDER, X-LINKED	8259
MIM300078		Xq24	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 1; NDUFA1	4694
MIM300079		Xq25	INHIBITOR OF APOPTOSIS, X-LINKED; XIAP	331
MIM300080		Xp11.23	RNA-BINDING MOTIF PROTEIN 10; RBM10	8241
MIM300081		Xq28	DEOXYRIBONUCLEASE I-LIKE 1; DNASE1L1	1774
MIM300082	C1848140	Xq	COGNITIVE FUNCTION 1, SOCIAL; CGF1	1083
MIM300083		Xp22.3	PROTEIN KINASE, X-LINKED; PRKX	5613
MIM300084		Xq13.1	NON-POU DOMAIN-CONTAINING OCTAMER-BINDING PROTEIN; NONO	4841
MIM300085	C1848139	Xq27	CONE-ROD DYSTROPHY, X-LINKED, 2; CORDX2	1275
MIM300086		Xq13-q21.1	LYSOPHOSPHATIDIC ACID RECEPTOR 4; LPAR4	2846
MIM300087	C1848138	Xq13.2	X INACTIVATION, FAMILIAL SKEWED, 1; SXI1	7503
MIM300088	C1848137	Xq22	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	57526
MIM300089		Xq28	ISOCITRATE DEHYDROGENASE 3, GAMMA SUBUNIT; IDH3G	3421
MIM300090		Xq28	SIGNAL SEQUENCE RECEPTOR, DELTA; SSR4	6748
MIM300091		Xp22.31	FOS-INDUCED GROWTH FACTOR; FIGF	2277
MIM300092		Xq28	TESTIS-EXPRESSED GENE 28; TEX28	1527
MIM300093		Xq28	GAMMA-AMINOBUTYRIC ACID RECEPTOR, EPSILON; GABRE	2564
MIM300095		Xq13.2	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 2; SLC16A2	6567
MIM300096		Xq11	TETRASPANIN 7; TSPAN7	7102
MIM300097		Xp21.3	MELANOMA ANTIGEN, FAMILY B, 1; MAGEB1	4112
MIM300098		Xp21.3	MELANOMA ANTIGEN, FAMILY B, 2; MAGEB2	4113
MIM300100	C0162309	Xq28	ADRENOLEUKODYSTROPHY; ALD	215
MIM300101		Xp22.2	BONE MARROW KINASE, X-LINKED; BMX	660
MIM300102		Xp22.3	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 4; PNPLA4	8228
MIM300103		Xp22.3	SHROOM FAMILY MEMBER 2; SHROOM2	357
MIM300104		Xq28	GDP DISSOCIATION INHIBITOR 1; GDI1	2664
MIM300105		Xp22.1	SPERMINE SYNTHASE; SMS	6611
MIM300106	C1848097	 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED	 
MIM300107		Xq26-q28	BOMBESIN-LIKE RECEPTOR 3; BRS3	680
MIM300108		Xq22	DIAPHANOUS, DROSOPHILA, HOMOLOG OF, 2; DIAPH2	1730
MIM300109		Xp22.2-p22.1	PROTEIN PHOSPHATASE, EF-HAND CALCIUM-BINDING DOMAIN 1; PPEF1	5475
MIM300110		Xp11.23	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-1F SUBUNIT; CACNA1F	778
MIM300111		Xp11.23-p11.22	LIM DOMAIN ONLY 6; LMO6	4007
MIM300112		Xp11.23-p11.22	PROTEOLIPID PROTEIN 2; PLP2	5355
MIM300114	CN031541	Xp22.3	MENTAL RETARDATION, X-LINKED 49; MRX49	4412
MIM300115	C1848087	Xp11.3-p11.21	MENTAL RETARDATION, X-LINKED 50; MRX50	4413
MIM300116		Xq28	MATURE T-CELL PROLIFERATION 1; MTCP1	4515
MIM300117		Xq21.3-q22	NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 3; NAP1L3	4675
MIM300118		Xp22.3	RHO GTPase-ACTIVATING PROTEIN 6; ARHGAP6	395
MIM300119		Chr.X	INTERLEUKIN 13 RECEPTOR, ALPHA-1; IL13RA1	3597
MIM300120		Xq28	MASTERMIND-LIKE DOMAIN-CONTAINING PROTEIN 1; MAMLD1	10046
MIM300121		Xq22.3-q23	DOUBLECORTIN; DCX	1641
MIM300123	C2678223	Xq26.3	MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISM	6658
MIM300124		Xp22.33	GTP-BINDING PROTEIN 6; GTPBP6	8225
MIM300125	C1848066	Xq	MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	8249
MIM300126		Xq28	DYSKERIN; DKC1	1736
MIM300127		Xq12	OLIGOPHRENIN 1; OPHN1	4983
MIM300128		Xp11.2	LYSINE-SPECIFIC DEMETHYLASE 6A; KDM6A	7403
MIM300129	C1848046	 	HEMATOPOIETIC STEM CELL KINETICS, CONTROL OF	 
MIM300130		Xq24	INTERLEUKIN 13 RECEPTOR, ALPHA-2; IL13RA2	3598
MIM300131		Chr.X	PLASTIN 3; PLS3	5358
MIM300132		Xp11.22-p11.21	TROPHININ; TRO	7216
MIM300133		Xq28	VON HIPPEL-LINDAU BINDING PROTEIN 1; VBP1	7411
MIM300134		 	DUAL-SPECIFICITY PHOSPHATASE 9; DUSP9	1852
MIM300135		Xq13.1-q13.3	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 7; ABCB7	22
MIM300136	C1848042	Xp11	DIABETES MELLITUS, INSULIN-DEPENDENT, X-LINKED, SUSCEPTIBILITY TO	8245
MIM300137		Xq25	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 1; IGSF1	3547
MIM300138		 	CHLORIDE INTRACELLULAR CHANNEL 2; CLIC2	1193
MIM300139		Xq13.1-q13.3	IMMUNOGLOBULIN-BINDING PROTEIN 1; IGBP1	3476
MIM300142		Xq21.3-q24	p21 PROTEIN-ACTIVATED KINASE 3; PAK3	5063
MIM300143	C0796227	Xp22.1-p21.3	MENTAL RETARDATION, X-LINKED 21; MRX21	11141
MIM300144		Xq25	GLUTAMATE DEHYDROGENASE 2; GLUD2	2747
MIM300145		Xq25	X-PROLYL AMINOPEPTIDASE 2; XPNPEP2	7512
MIM300146		 	CALPAIN 6; CAPN6	827
MIM300147	C1846279	Xq27-q28	PROSTATE CANCER, HEREDITARY, X-LINKED 1; HPCX1	9566
MIM300148	C1846278	Xp22.13-p21.1	MENTAL RETARDATION, EPILEPTIC SEIZURES, HYPOGONADISM AND HYPOGENITALISM, MICROCEPHALY, AND OBESITY; MEHMO	8422
MIM300149		Xq13.1	CBP/p300-INTERACTING TRANSACTIVATOR WITH GLU/ASP-RICH C-TERMINAL DOMAIN, 1; CITED1	4435
MIM300150		Xq24-q26	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER A5; SLC25A5	292
MIM300151		Xp22.32	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER A6; SLC25A6	293
MIM300152		Xp21.3	MELANOMA ANTIGEN, FAMILY B, 3; MAGEB3	4114
MIM300153		Xp21.3	MELANOMA ANTIGEN, FAMILY B, 4; MAGEB4	4115
MIM300154		Xq22.1-q22.3	ESX1-LIKE PROTEIN; ESX1L	80712
MIM300155	C1846277	Xq26-q27	RETINITIS PIGMENTOSA 24; RP24	6116
MIM300156		Xq28	CANCER/TESTIS ANTIGEN 1B; CTAG1B	1485
MIM300157		Xq22.3	ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 4; ACSL4	2182
MIM300158	C1846273	 	ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX	619510
MIM300159		Xq21.3-q22	THYMOSIN, BETA-4, X CHROMOSOME; TMSB4X	7114
MIM300160		Xp11.3-p11.23	DEAD/H BOX 3, X-LINKED; DDX3X	1654
MIM300161		Xp22.2-p22.1	EUKARYOTIC TRANSLATION INITIATION FACTOR 2, SUBUNIT 3; EIF2S3	1968
MIM300162		Xpter-p22.32	ACETYLSEROTONIN METHYLTRANSFERASE-LIKE; ASMTL	8623
MIM300163		Xq27.2	FOUR-AND-A-HALF LIM DOMAINS 1; FHL1	2273
MIM300164		 	INACTIVATION ESCAPE 1; INE1	8552
MIM300165		 	INACTIVATION ESCAPE 2; INE2	8551
MIM300166	C1846265	Xp11.4	MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	54880
MIM300167		Xq11-q12	HEPHAESTIN; HEPH	9843
MIM300168		Xq26	GLYPICAN 4; GPC4	2239
MIM300169		Xq25-q26	APOPTOSIS-INDUCING FACTOR, MITOCHONDRION-ASSOCIATED, 1; AIFM1	9131
MIM300170		Xp22.3-p22.2	OFD1 GENE; OFD1	8481
MIM300171		Xq28	MYOTUBULARIN-RELATED PROTEIN 1; MTMR1	8776
MIM300172		Xp11.4	CALCIUM/CALMODULIN-DEPENDENT SERINE PROTEIN KINASE; CASK	8573
MIM300173		Xq28	MELANOMA ANTIGEN, FAMILY A, 2; MAGEA2	4101
MIM300174		Xq28	MELANOMA ANTIGEN, FAMILY A, 3; MAGEA3	4102
MIM300175		Xq28	MELANOMA ANTIGEN, FAMILY A, 4; MAGEA4	4103
MIM300176		Xq28	MELANOMA ANTIGEN, FAMILY A, 6; MAGEA6	4105
MIM300177		Xq28	MELANOMA ANTIGEN, FAMILY A, 12; MAGEA12	4111
MIM300178		Xp22.33	ZING FINGER BED DOMAIN-CONTAINING PROTEIN 1; ZBED1	9189
MIM300179	C1846257	Xq25-q26	X INACTIVATION, FAMILIAL SKEWED, 2; SXI2	117237
MIM300180		Xp22.3	ARYLSULFATASE E; ARSE	415
MIM300181		Xq13.2	X INACTIVATION-SPECIFIC TRANSCRIPT-ANTISENSE; TSIX	9383
MIM300182		Xp11.4-p11.2	MEDIATOR COMPLEX SUBUNIT 14; MED14	9282
MIM300184	C1970936	 	HYPOTONIA, CONGENITAL NYSTAGMUS, ATAXIA, AND ABNORMAL AUDITORY BRAINSTEM RESPONSES	 
MIM300185		Xp11.2	A-KINASE ANCHOR PROTEIN 4; AKAP4	8852
MIM300186		Chr.X	EUKARYOTIC TRANSLATION INITIATION FACTOR 1A, X-LINKED; EIF1AX	1964
MIM300187		Xp21.1	SUSHI REPEAT-CONTAINING PROTEIN, X-LINKED; SRPX	8406
MIM300188		Xq13	MEDIATOR COMPLEX SUBUNIT 12; MED12	9968
MIM300189		Xq13.1	DISCS LARGE, DROSOPHILA, HOMOLOG OF, 3; DLG3	1741
MIM300190		Xq13.3	SH3-BINDING DOMAIN AND GLUTAMIC ACID-RICH PROTEIN-LIKE PROTEIN; SH3BGRL	6451
MIM300191		Xq22	TETRASPANIN 6; TSPAN6	7105
MIM300192		Xp11.2	SARCOMA, SYNOVIAL, X BREAKPOINT 2; SSX2	6757
MIM300193		Xq28	HIGH MOBILITY GROUP BOX 3; HMGB3	3149
MIM300194	C1846242	Xq22.3	AMME COMPLEX	100499260
MIM300195		Xq22.3	AMME CHROMOSOME REGION GENE 1; AMMECR1	9949
MIM300196		Xp22.3	TRANSDUCIN-BETA-LIKE 1, X-LINKED; TBL1X	6907
MIM300197		Xq28	ATPase, H+ TRANSPORTING, LYSOSOMAL, ACCESSORY PROTEIN 1; ATP6AP1	537
MIM300198		Xp22.3	GLYCOGENIN 2; GYG2	8908
MIM300199		Xq26	RNA-BINDING MOTIF PROTEIN, X CHROMOSOME; RBMX	27316
MIM300200	C0342482	Xp21.3-p21.2	ADRENAL HYPOPLASIA, CONGENITAL; AHC	190
MIM300201		Xq13-q21	CYSTEINYL LEUKOTRIENE RECEPTOR 1; CYSLTR1	10800
MIM300202		Xp22.2-p22.1	TRACKING PROTEIN PARTICLE COMPLEX, SUBUNIT 2; TRAPPC2	6399
MIM300203		Xp22	CYCLIN-DEPENDENT KINASE-LIKE 5; CDKL5	6792
MIM300204		Xq22	MIDLINE 2; MID2	11043
MIM300205		Xp11.23-p11.22	EMOPAMIL-BINDING PROTEIN; EBP	10682
MIM300206		Xp22.1-p21.3	INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN-LIKE 1; IL1RAPL1	11141
MIM300207		Xq28	G PROTEIN-COUPLED RECEPTOR 50; GPR50	9248
MIM300208		Xp22	SEX COMB ON MIDLEG, DROSOPHILA, HOMOLOG-LIKE 2; SCML2	10389
MIM300209	C1846175	Xp22, Xp22.3-p22.2	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2	8481
MIM300210	C1846174	Xq11	MENTAL RETARDATION, X-LINKED 58; MRX58	7102
MIM300211	C1846173	Xp22.3	EPISODIC MUSCLE WEAKNESS, X-LINKED; EMWX	10118
MIM300212		Xp11.2-q11.2	REGUCALCIN; RGN	9104
MIM300213		Xq26	CAAX BOX PROTEIN 1; CXX1	8933
MIM300214		Xq28	PLEXIN B3; PLXNB3	5365
MIM300215	C1846171	Xp22.13	LISSENCEPHALY, X-LINKED, 2; LISX2	170302
MIM300216	C0154832	 	COATS DISEASE	1283
MIM300217		Xp22	RETINOIC ACID-INDUCED 2; RAI2	10742
MIM300218	C1846170	Xp11.3-q22	MENTAL RETARDATION, X-LINKED, SYNDROMIC 7; MRXS7	4429
MIM300219	C1846169	 	MYOTUBULAR MYOPATHY WITH ABNORMAL GENITAL DEVELOPMENT	 
MIM300220	C1846168	Xp11.2, Xp11.2	MENTAL RETARDATION, X-LINKED, SYNDROMIC 10; MRXS10	3028
MIM300221	C1846167	Xpter-p22.32	HODGKIN DISEASE, X-LINKED PSEUDOAUTOSOMAL	50829
MIM300222		Xq13.3-q21.2	INTEGRAL MEMBRANE PROTEIN 2A; ITM2A	9452
MIM300223		Xq26	MELANOMA ANTIGEN, FAMILY C, 1; MAGEC1	9947
MIM300224		Xp11.23	MELANOMA ANTIGEN, FAMILY D, 1; MAGED1	9500
MIM300225		Xq22	NADPH OXIDASE 1; NOX1	27035
MIM300226		Xp22.1	SMALL MUSCLE PROTEIN, X-LINKED; SMPX	23676
MIM300227		Xp22.2-p22.1	SEX COMB ON MIDLEG, DROSOPHILA, HOMOLOG-LIKE 1; SCML1	6322
MIM300228	C1846164	Xq27	TESTICULAR GERM CELL TUMOR 1; TGCT1	50830
MIM300229		Xp22.3	VARIABLY CHARGED, X CHROMOSOME; VCX	26609
MIM300230		Xp22.1	CARBONIC ANHYDRASE VB, MITOCHONDRIAL; CA5B	11238
MIM300231		Xq26.3	SOLUTE CARRIER FAMILY 9, MEMBER 6; SLC9A6	10479
MIM300232	C1846148	 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION	 
MIM300233	C1846147	 	RADIOULNAR SYNOSTOSIS, RADIAL RAY ABNORMALITIES, AND SEVERE MALFORMATIONS IN THE MALE	 
MIM300234		 	UBIQUITOUSLY EXPRESSED TRANSCRIPT; UXT	8409
MIM300235		Xp11.21	ZINC FINGER-ENCODING GENE, X-LINKED, DUPLICATED, A; ZXDA	7789
MIM300236		Xp11.21	ZINC FINGER-ENCODING GENE, X-LINKED, DUPLICATED, B; ZXDB	158586
MIM300237		Xq22.1	TRANSCRIPTION ELONGATION FACTOR A-LIKE 1; TCEAL1	9338
MIM300238	C1846145	Xq26-q27	MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	50644
MIM300239		Xp22	EPIDERMAL GROWTH FACTOR-LIKE 6; EGFL6	25975
MIM300240		Xq28	HOYERAAL-HREIDARSSON SYNDROME; HHS	1736
MIM300241		Xp11.4	G PROTEIN-COUPLED RECEPTOR 34; GPR34	2857
MIM300242		Xq24	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, BRAIN), MEMBER 14; SLC25A14	9016
MIM300243	C2678194	Xq26.3, Xq24-q27.3	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE; MRXSCH	10479
MIM300244	C1846129	Xq27.3-q28	TERMINAL OSSEOUS DYSPLASIA; TOD	2316, 54114
MIM300245	C1846128	Xq24-q27.1	PTOSIS, HEREDITARY CONGENITAL 2	54115
MIM300246		Xq21.3	PROTOCADHERIN 11, X-LINKED; PCDH11X	27328
MIM300247		Xp11.2	BONE MORPHOGENETIC PROTEIN 15; BMP15	9210
MIM300248		Xq28	INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE OF, GAMMA; IKBKG	8517
MIM300249		Xp11.2	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 17, YEAST, HOMOLOG OF, B; TIMM17B	10245
MIM300252		Xq13	PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, NIMA-INTERACTING, 4; PIN4	5303
MIM300253		Xp11	SUPERCONSERVED RECEPTOR EXPRESSED IN BRAIN 3; SREB3	54328
MIM300254		Xp11.23	SUPPRESSOR OF VARIEGATION 3-9, DROSOPHILA, HOMOLOG OF, 1; SUV39H1	6839
MIM300255		Xq13	O-LINKED N-ACETYLGLUCOSAMINE TRANSFERASE; OGT	8473
MIM300256		Xp11.2	17-@BETA-HYDROXYSTEROID DEHYDROGENASE X; HSD17B10	3028
MIM300257	C0878677	Xq24	DANON DISEASE	3920
MIM300258		Chr.X	ROIFMAN SYNDROME	57788
MIM300259	C1866629	 	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, X-LINKED	57789
MIM300260	C1846058	Xq28, Xq28	LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	4204, 57790
MIM300261	C1846057	Xq28	ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA	57791
MIM300262	C1846056	Xq13.2	ABIDI X-LINKED MENTAL RETARDATION SYNDROME; MRXSAB	57792
MIM300263	C1846055	Xp11.2	SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	23133
MIM300264		Xp11.23-p11.1	UBIQUILIN 2; UBQLN2	29978
MIM300265		Xq26.2	ZINC FINGER PROTEIN OF CEREBELLUM 3; ZIC3	7547
MIM300266	C1846046	Xq11.2	SPASTIC PARAPLEGIA 16, X-LINKED; SPG16	57760
MIM300267		Xq26	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; ARHGEF6	9459
MIM300269		Xq13	HISTONE DEACETYLASE 8; HDAC8	55869
MIM300270	C1846044	 	ADRENOMYODYSTROPHY	 
MIM300271	C1846038	Xq28	MENTAL RETARDATION, X-LINKED 72; MRX72	116442, 23695
MIM300272		Xp11.23	HISTONE DEACETYLASE 6; HDAC6	10013
MIM300273	C1846033	Xp22	GOITER, MULTINODULAR 2; MNG2	59081
MIM300274	C1846032	 	ANDROGEN INSENSITIVITY SYNDROME DUE TO COACTIVATOR DEFICIENCY	 
MIM300275		Xq28	NAD(P)H STEROID DEHYDROGENASE-LIKE PROTEIN; NSDHL	50814
MIM300276		Xq12	ECTODYSPLASIN A2 RECEPTOR; EDA2R	60401
MIM300277		Xq22	INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN-LIKE 2; IL1RAPL2	26280
MIM300278		Xp11.4	NYCTALOPIN; NYX	60506
MIM300280	C1846010	 	URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME	 
MIM300281		 	POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 1; KCND1	3750
MIM300282		Xq25-q26.2	ECTO-NOX DISULFIDE-THIOL EXCHANGER 2; ENOX2	10495
MIM300283		Xq28	INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 1; IRAK1	3654
MIM300284		Xp22.2	RAS-ASSOCIATED PROTEIN RAB9; RAB9	9367
MIM300285		Xq22.1-q22.3	RAS-ASSOCIATED PROTEIN 9B; RAB9B	51209
MIM300286		Chr.X	KRUPPEL-LIKE FACTOR 8; KLF8	11279
MIM300287		Xp11.23	P ANTIGEN FAMILY, MEMBER 4; PAGE4	9506
MIM300288		Xp11.23	P ANTIGEN FAMILY, MEMBER 1; PAGE1	8712
MIM300289		Chr.X	X ANTIGEN FAMILY, MEMBER 1D; XAGE1D	9503
MIM300291	C1846006	Xq28	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY	8517
MIM300292		Xp11.23-q13.3	FORKHEAD BOX P3; FOXP3	50943
MIM300294		Xp22.12-p22.11	MEMBRANE-BOUND TRANSCRIPTION FACTOR PROTEASE, SITE 2; MBTPS2	51360
MIM300295		Chr.X	ONCOGENE PIM2; PIM2	11040
MIM300296		Xq26	PLACENTA-SPECIFIC GENE 1; PLAC1	10761
MIM300297		Xq25-q26.3	APELIN; APLN	8862
MIM300298		Xq25-q26	UPF3, YEAST, HOMOLOG OF, B; UPF3B	65109
MIM300299	C1845987	Xp11.23-p11.22	NEUTROPENIA, SEVERE CONGENITAL, X-LINKED; SCNX	7454
MIM300300		Xq21.3-q22	BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE; BTK	695
MIM300301	C1845919	Xq28	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNODEFICIENCY, OSTEOPETROSIS, AND LYMPHEDEMA; OLEDAID	8517
MIM300302		Xp21	DYNEIN, LIGHT CHAIN, TCTEX TYPE, 3; DYNLT3	6990
MIM300303		Xq21	RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 6; RPS6KA6	27330
MIM300304		Xq23	CULLIN 4B; CUL4B	8450
MIM300305		Xq27.1	SPERM PROTEIN ASSOCIATED WITH THE NUCLEUS, X CHROMOSOME, FAMILY MEMBER A1; SPANXA1	30014
MIM300306	C2678155	Xq23-q24	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 11; BMIQ11	11254
MIM300307		Xq12-q21	T-BOX 22; TBX22	50945
MIM300308		Chr.X	FERRITIN HEAVY POLYPEPTIDE-LIKE 17; FTHL17	53940
MIM300309		Xq26.2	UBIQUITIN-SPECIFIC PROTEASE 26; USP26	83844
MIM300310	C1845903	Xp22	AGAMMAGLOBULINEMIA, X-LINKED, TYPE 2; AGMX2	179
MIM300311		Chr.X	TESTIS-EXPRESSED GENE 11; TEX11	56159
MIM300312		Chr.X	TESTIS-EXPRESSED GENE 13A; TEX13A	56157
MIM300313		Chr.X	TESTIS-EXPRESSED GENE 13B; TEX13B	56156
MIM300314		Chr.X	TAF7-LIKE RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 50-KD; TAF7L	54457
MIM300315		Chr.X	NUCLEAR RNA EXPORT FACTOR 2; NXF2	56001
MIM300316		Xq21.3-q22.3	NUCLEAR RNA EXPORT FACTOR 3; NXF3	56000
MIM300317		Chr.X	RALBP1-ASSOCIATED EPS DOMAIN-CONTAINING PROTEIN 2; REPS2	9185
MIM300318		Xq22.1-q22.3	NUCLEAR RNA EXPORT FACTOR 4; NXF4	55999
MIM300319		Chr.X	NUCLEAR RNA EXPORT FACTOR 5; NXF5	55998
MIM300320		Xq23	NTF2-LIKE EXPORT FACTOR 2; NXT2	55916
MIM300321	C1845902	Xq28, Xq28	FG SYNDROME 2; FGS2	2270, 2316
MIM300322	C0023374	Xq26-q27.2	LESCH-NYHAN SYNDROME; LNS	3251
MIM300323	C0268117	Xq26-q27.2	KELLEY-SEEGMILLER SYNDROME	3251
MIM300324	C1845889	Xq22.2-q26	MENTAL RETARDATION, X-LINKED 53; MRX53	4416
MIM300325		Xp11.4-p11.1	SYNOVIAL SARCOMA, X BREAKPOINT 3; SSX3	10214
MIM300326		Xp11.2	SYNOVIAL SARCOMA, X BREAKPOINT 4; SSX4	6759
MIM300327		 	SYNOVIAL SARCOMA, X BREAKPOINT 5; SSX5	6758
MIM300328		Xq22.3	POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED FAMILY, MEMBER 1-LIKE; KCNE1L	23630
MIM300329		Xq23	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 33; ZBTB33	10009
MIM300330		Xq26.3-q27.1	SPANX FAMILY, MEMBER C; SPANXC	64663
MIM300331	C1845888	Chr.X	THROMBOCYTHEMIA, X-LINKED; THCYTX	84434
MIM300332		Xq12-q13	INTEGRIN, BETA-1, BINDING PROTEIN OF, 2; ITGB1BP2	26548
MIM300333		Chr.X	RAS-ASSOCIATED PROTEIN RAB33A; RAB33A	9363
MIM300334		Xq23	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 5; TRPC5	7224
MIM300335		Xp22	ANGIOTENSIN I-CONVERTING ENZYME 2; ACE2	59272
MIM300336		Xq13	NEUROLIGIN 3; NLGN3	54413
MIM300337	C0022283	 	HYPOMELANOSIS OF ITO; HMI	3160
MIM300338		Xq27	CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-2; CNGA2	1260
MIM300339		 	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B-DOUBLE PRIME, BETA; PPP2R3B	28227
MIM300340		Xq28	MELANOMA ANTIGEN, FAMILY A, 5; MAGEA5	4104
MIM300341		Xq28	MELANOMA ANTIGEN, FAMILY A, 8; MAGEA8	4107
MIM300342		Xq28	MELANOMA ANTIGEN, FAMILY A, 9; MAGEA9	4108
MIM300343		Xq28	MELANOMA ANTIGEN, FAMILY A, 10; MAGEA10	4109
MIM300344		Xq28	MELANOMA ANTIGEN, FAMILY A, 11; MAGEA11	4110
MIM300345	C1845877	Chr.X	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 1; MCOPCB1	85503
MIM300346		 	HIV-1 TAT STIMULATORY FACTOR 1; HTATSF1	27336
MIM300347		Xq21-q22	EARLY LYMPHOID ACTIVATION GENE	10824
MIM300348		 	KELCH-LIKE 4; KLHL4	56062
MIM300349		Xq28	GAMMA-AMINOBUTYRIC ACID RECEPTOR, THETA; GABRQ	55879
MIM300350		Xq22.1-q23	CHORDIN-LIKE 1; CHRDL1	91851
MIM300351	C2678151	Xp11	GRAVES DISEASE, SUSCEPTIBILITY TO, X-LINKED 1	117189
MIM300352	C1845862	Xq28	CREATINE DEFICIENCY SYNDROME, X-LINKED	6535
MIM300353		Xq12	V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 4; VSIG4	11326
MIM300354	C1845861	Xq23	MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE, HYPOGONADISM, AND ABNORMAL GAIT	8450
MIM300355	C1845860	 	MENTAL RETARDATION, X-LINKED 73; MRX73	23694
MIM300356		Xq22	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 8, YEAST, HOMOLOG OF, A; TIMM8A	1678
MIM300357		Xp22.3	CYTOKINE RECEPTOR-LIKE FACTOR 2; CRLF2	64109
MIM300358		Xp11.2	PROTEIN KINASE, LYSINE-DEFICIENT 3; WNK3	65267
MIM300359		Xq28	SARCOMA ANTIGEN 1; SAGE1	55511
MIM300360		Xq24	MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE	114890
MIM300361		Xq22.1-q23	NERVE GROWTH FACTOR RECEPTOR-ASSOCIATED PROTEIN 1; NGFRAP1	27018
MIM300362		Xq21.33-q22.2	ARMADILLO REPEAT CONTAINING, X-LINKED 1; ARMCX3	51309
MIM300363		Xq21.33-q22.2	ARMADILLO REPEAT CONTAINING, X-LINKED 2; ARMCX2	9823
MIM300364		Xq21.33-q22.2	ARMADILLO REPEAT CONTAINING, X-LINKED 3; ARMCX3	51566
MIM300365		Xp22.3-p22.2	TOLL-LIKE RECEPTOR 7; TLR7	51284
MIM300366		Xp22.3-p22.2	TOLL-LIKE RECEPTOR 8; TLR8	51311
MIM300367	C1845837	Xp11.23	THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA; XLTDA	2623
MIM300368		Xp11.3	SOLUTE CARRIER FAMILY 9, MEMBER 7; SLC9A7	84679
MIM300369		Xq13.1	ACIDIC REPEAT-CONTAINING GENE; ACRC	93953
MIM300370		Xq28	3-PRIME @REPAIR EXONUCLEASE 2; TREX2	11219
MIM300371		Xq28	ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 1; ABCD1	215
MIM300372	C1845810	Xq26	MENTAL RETARDATION, X-LINKED 42; MRX42	4406
MIM300373	C0432268	Xq11.1	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS; OSCS	139285
MIM300374		Xp22.1-p21.3	SH3-DOMAIN KINASE-BINDING PROTEIN 1; SH3KBP1	30011
MIM300375		Xp11.3	CARBOHYDRATE SULFOTRANSFERASE 7; CHST7	56548
MIM300376	C0917713	12q21, Xp21.2	MUSCULAR DYSTROPHY, BECKER TYPE; BMD	1756, 4618
MIM300377		Xp21.2	DYSTROPHIN; DMD	1756
MIM300378	C1845717	Xq24-q25	RADIAL RAY DEFICIENCY, X-LINKED	266719
MIM300379		Xq13-q21	RING FINGER PROTEIN 12; RNF12	51132
MIM300380		Xp22	CYTIDINE 5-PRIME TRIPHOSPHATE SYNTHETASE 2; CTPS2	56474
MIM300381		Xq28	ZINC FINGER PROTEIN 185; ZNF185	7739
MIM300382		Xp22.13	ARISTALESS-RELATED HOMEOBOX, X-LINKED; ARX	170302
MIM300383		Xp11.4-p11.23	COMPLEMENT FACTOR PROPERDIN; CFP	5199
MIM300384		Xq28	EMERIN; EMD	2010
MIM300385		Xq13	NUCLEOSOMAL BINDING PROTEIN 1; NSBP1	79366
MIM300386		Xq26	CD40 LIGAND; CD40LG	959
MIM300387	C1845672	Xq22.3	MENTAL RETARDATION, X-LINKED 63; MRX63	2182
MIM300388	C1845668	Xq27.2-q28	POLYMICROGYRIA, BILATERAL PERISYLVIAN; BPP	 
MIM300390		Xq21.2	CHM GENE; CHM	1121
MIM300391		Xp22.3-p22.1	AMELOGENIN; AMELX	265
MIM300392		Xp11.23-p11.22	WAS GENE; WAS	7454
MIM300393		Chr.X	G PROTEIN-COUPLED RECEPTOR 101; GPR101	83550
MIM300394		Xq28	TAFAZZIN; TAZ	6901
MIM300395		Chr.X	THO COMPLEX, SUBUNIT 2; THOC2	57187
MIM300396		 	CANCER/TESTIS ANTIGEN 2; CTAG2	30848
MIM300398		Xq28	B-CELL RECEPTOR-ASSOCIATED PROTEIN 31; BCAP31	10134
MIM300399		Xp11.3	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 1, INHIBITOR OF: PCSK1N	27344
MIM300400	C1279481	Xq13	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED; SCIDX1	3561
MIM300401		Xq22	PROTEOLIPID PROTEIN 1; PLP1	5354
MIM300402		Xq27	LEUCINE ZIPPER, DOWNREGULATED IN CANCER 1; LDOC1	23641
MIM300403		Xp11.3	NADH DEHYDROGENASE 1 BETA SUBCOMPLEX, 11; NDUFB11	54539
MIM300405		Xq22.2	RAS-ASSOCIATED PROTEIN RAB40A-LIKE; RAB40AL	282808
MIM300406	C1845567	Xp22.3	FG SYNDROME 3; FGS3	93985
MIM300407		Xq21.3	POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 5; PABPC5	140886
MIM300408		Chr.X	GRIP1-ASSOCIATED PROTEIN 1; GRIPAP1	56850
MIM300409		Xq22	MORTALITY FACTOR 4-LIKE PROTEIN 2; MORF4L2	9643
MIM300410		Chr.X	ANGIOMOTIN; AMOT	154796
MIM300411		Xp21.3	TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR 2-LIKE, X-LINKED; TGIF2LX	90316
MIM300413		Xq26	MUSCLEBLIND-LIKE PROTEIN 3; MBNL3	55796
MIM300414		Xq26.3	PHD FINGER PROTEIN 6; PHF6	84295
MIM300415		Xq28	MYOTUBULARIN; MTM1	4534
MIM300416		 	X ANTIGEN FAMILY, MEMBER 2; XAGE2	9502
MIM300417		Xq22	G PROTEIN-COUPLED RECEPTOR-ASSOCIATED SORTING PROTEIN 1; GPRASP1	9737
MIM300418		Xp11.23-p11.21	G1- TO S-PHASE TRANSITION 2; GSPT2	23708
MIM300419	C0796244	Xp22.13	MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED; MRXARX	170302
MIM300420		 	PRAJA 1; PJA1	64219
MIM300421	C0796202	 	WITTWER SYNDROME	619509
MIM300422	C1845546	Xp11.4	FG SYNDROME 4; FGS4	8573
MIM300423	C1845543	Xp11.4	MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	10159
MIM300424	C1845542	Xp22	RETINITIS PIGMENTOSA 23; RP23	6115
MIM300425	C1845540	Xq13	AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	54413
MIM300427		Xp22.33	NEUROLIGIN 4; NLGN4	57502
MIM300428	C0796207	Xp22.3	MENTAL RETARDATION, X-LINKED 2; MRX2	4367
MIM300429		Xq22.1	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 9; ARHGEF9	23229
MIM300431	C0796206	 	ATKIN-FLAITZ SYNDROME	 
MIM300433	C1845531	Xp11.2-q12	MENTAL RETARDATION, X-LINKED 81; MRX81	266678
MIM300434	C1845530	Xp11.2	STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME	57477
MIM300435		Xq22-q24	PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1; PGRMC1	10857
MIM300436	C1845526	Xq26	MENTAL RETARDATION, X-LINKED 46; MRX46	9459
MIM300437		Xp11.2	EMBRYONIC STEM CELL-EXPRESSED RAS; ERAS	3266
MIM300438	C1845517	Xp11.2	17-@BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY	3028
MIM300439		Chr.X	RING FINGER PROTEIN 128; RNF128	79589
MIM300440		Xq24	NFKB-REPRESSING FACTOR; NKRF	55922
MIM300441		 	SH3 PROTEIN EXPRESSED IN LYMPHOCYTES	54440
MIM300443		 	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 3; SLC7A3	84889
MIM300444		Xq23-q24	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 14; SLC6A14	11254
MIM300445		 	H2A HISTONE FAMILY, MEMBER B; H2AFB	83740
MIM300446		Xq24	RHOX HOMEOBOX FAMILY, MEMBER 1; RHOXF1	158800
MIM300447		Xq24	RHOX HOMEOBOX FAMILY, MEMBER 2; RHOXF2	84528
MIM300448	C0585216	Xq13	ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME; ATMDS	546
MIM300450		 	FETAL AND ADULT TESTIS-EXPRESSED GENE 1; FATE1	89885
MIM300451		Xq12-q13.1	ECTODYSPLASIN A; EDA	1896
MIM300452		Xq12	INHIBITOR OF GROWTH, X-LINKED; INGX	27160
MIM300453		 	FAMILY WITH SEQUENCE SIMILARITY 50, MEMBER A; FAM50A	9130
MIM300454	C1845499	Xq12-q21.3	MENTAL RETARDATION, X-LINKED 77; MRX77	93991
MIM300455	C2749137	Xp11.4	RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITH OR WITHOUT DEAFNESS	6103
MIM300456		Xp11.22	CYCLIN B3; CCNB3	85417
MIM300457		Xp22.13	NHS GENE; NHS	4810
MIM300459		Xq22	TENOMODULIN; TNMD	64102
MIM300460		Xq22	PROTOCADHERIN 19; PCDH19	57526
MIM300461		Xp21.1	ORNITHINE CARBAMOYLTRANSFERASE; OTC	5009
MIM300462		Xq24	A-KINASE ANCHOR PROTEIN 14; AKAP14	158798
MIM300463		Xp11.23	POLYGLUTAMINE-BINDING PROTEIN 1; PQBP1	10084
MIM300464	C1845454	Xq23-q26	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 3	387573
MIM300466		Xp22	MELANOMA ANTIGEN, FAMILY B, 5; MAGEB5	347541
MIM300467		Xp22	MELANOMA ANTIGEN, FAMILY B, 6; MAGEB6	158809
MIM300468		Xq27	MELANOMA ANTIGEN, FAMILY C, 2; MAGEC2	51438
MIM300469		Xq27	MELANOMA ANTIGEN, FAMILY C, 3; MAGEC3	139081
MIM300470		Xp11.2	MELANOMA ANTIGEN, FAMILY D, 2; MAGED2	10916
MIM300471	C1845450	Chr.X	CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	494028
MIM300472	C1845446	Xq13.1-q13.3	CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA, AND MICROGNATHIA	3476
MIM300473		Xp21.3-p21.2	NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 1; NR0B1	190
MIM300474		Xp21.3-p21.2	GLYCEROL KINASE; GK	2710
MIM300475	C1845408	Xq28	CHROMOSOME Xq28 DELETION SYNDROME	100302680
MIM300476	C1845407	Xp11.23, Xp11.4-q13.1	CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3	778
MIM300477		Xp22.33-p22.32	FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER A; FAM9A	171482
MIM300478		Xp22.32	FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER B; FAM9B	171483
MIM300479		Xp22.31	FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER C; FAM9C	171484
MIM300480		 	TAK1-BINDING PROTEIN 3; TAB3	257397
MIM300481		Xp21.1	CYTOCHROME b(-245), BETA SUBUNIT; CYBB	1536
MIM300482		 	GRB2-ASSOCIATED BINDING PROTEIN 3; GAB3	139716
MIM300484	C0796101	 	OROFACIODIGITAL SYNDROME VIII; OFD8	 
MIM300485		Xp11.4	BCL6 COREPRESSOR; BCOR	54880
MIM300486	C1845366	Xq12	MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	4983
MIM300487		Xq25	ACTIN-RELATED PROTEIN T1; ACTRT1	139741
MIM300488	C1970897	Xp21.3	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1; MENOQ1	494029
MIM300489	C1845359	Xq13.1-q21, Xq12-q13	SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3; SMAX3	538
MIM300490		Xq25	SH2 DOMAIN PROTEIN 1A; SH2D1A	4068
MIM300491	C1845343	Xp11.4-p11.2	EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR DISORDERS	6853
MIM300492		 	FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER A; FAM3A	60343
MIM300493		Xq27.2	SPERM PROTEIN ASSOCIATED WITH THE NUCLEUS, X CHROMOSOME, FAMILY MEMBER A2; SPANXA2	728712
MIM300494	C1845341	Xq13	ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	54413
MIM300495	C1845539	Xp22.33	AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	57502
MIM300496	C1845336	Xq28	AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	4204
MIM300497	C1845334	Xp22.33	ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	57502
MIM300498	C1845333	Xp22.1-p11	MENTAL RETARDATION, X-LINKED 45; MRX45	347344
MIM300499		Xp11.23	FTSJ HOMOLOG 1; FTSJ1	24140
MIM300500	C0342684	Xp22.3	ALBINISM, OCULAR, TYPE I; OA1	4935
MIM300502		Xp22.2-p22.1	PYRUVATE DEHYDROGENASE, ALPHA-1; PDHA1	5160
MIM300504	C1845298	Xp11.21-q22.3	MENTAL RETARDATION, X-LINKED 52; MRX52	4415
MIM300505	C1845297	Xp11.3-q22.3	MENTAL RETARDATION, X-LINKED 84; MRX84	378882
MIM300506		Xq22.2	TSC22 DOMAIN FAMILY, MEMBER 3; TSC22D3	1831
MIM300507		 	H2B HISTONE FAMILY, MEMBER W, TESTIS-SPECIFIC; H2BFWT	158983
MIM300508		 	UTP14, S. CEREVISIAE, HOMOLOG OF, A; UTP14A	10813
MIM300509	C1845296	Xq27.3	DYSLEXIA, SUSCEPTIBILITY TO, 9; DYX9	474159
MIM300510	C1845294	Xp11.2	OVARIAN DYSGENESIS 2; ODG2	9210
MIM300511	C1845293	Xq22	PREMATURE OVARIAN FAILURE 2A; POF2A	1730
MIM300512		Xp11.23	WD REPEAT-CONTAINING PROTEIN 13; WDR13	64743
MIM300513		 	G PROTEIN-COUPLED RECEPTOR 119; GPR119	139760
MIM300514	C1845292	Xp22.31	FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	2187
MIM300515		Xp22.31	FANCB GENE; FANCB	2187
MIM300516		 	ATPase, CLASS VI, TYPE 11C; ATP11C	286410
MIM300517		 	SPINDLIN FAMILY, MEMBER 2	474343
MIM300518	C1845286	Xq24-q25	MENTAL RETARDATION, X-LINKED 82; MRX82	378484
MIM300519	C1845285	Xq11-q21	MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE; MRXSMP	282808, 574047
MIM300520		 	CLAUDIN 2; CLDN2	9075
MIM300521		Xq13.1	KINESIN FAMILY MEMBER 4A; KIF4A	24137
MIM300522		Xp11.22	IQ MOTIF- AND SEC7 DOMAIN-CONTAINING PROTEIN 2; IQSEC2	23096
MIM300523	C0795889	Xq13.2	ALLAN-HERNDON-DUDLEY SYNDROME; AHDS	6567
MIM300524		 	KIAA2022	340533
MIM300525		 	PYRIMIDINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 8; P2RY8	286530
MIM300526		 	WD REPEAT-CONTAINING PROTEIN 45; WDR45	11152
MIM300527		Xp11.23	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 10; NUDT10	170685
MIM300528		Xp11.23	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 11; NUDT11	55190
MIM300529		 	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 10; P2RY10	27334
MIM300531		Xq28	SPROUTY, DROSOPHILA, HOMOLOG OF, 3; SPRY3	10251
MIM300532		Xp22.3	VARIABLY CHARGED, X CHROMOSOME, 2; VCX2	51480
MIM300533		Xp22.3	VARIABLY CHARGED, X CHROMOSOME, 3A; VCX3A	51481
MIM300534	C1845243	Xp11.22-p11.21	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ	8242
MIM300535		Xq26.1	OCRL GENE; OCRL	4952
MIM300536	C1845236	Xq27	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 4; BMND4	554316
MIM300537	C1848213	Xq28	HETEROTOPIA, PERIVENTRICULAR, EHLERS-DANLOS VARIANT	2316
MIM300538		Xq28	ARGININE VASOPRESSIN RECEPTOR 2; AVPR2	554
MIM300539	C1845202	Xq28	NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	554
MIM300540		Xq28	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 7; HAUS7	55559
MIM300541		 	SARCOMA, SYNOVIAL, X BREAKPOINT 6; SSX6	280657
MIM300542		 	SARCOMA, SYNOVIAL, X BREAKPOINT 7; SSX7	280658
MIM300543		 	SARCOMA, SYNOVIAL, X BREAKPOINT 8; SSX8	280659
MIM300544		 	SARCOMA, SYNOVIAL, X BREAKPOINT 9; SSX9	280660
MIM300545		Xq26.2	HEPARAN SULFATE 6-O-SULFOTRANSFERASE 2; HS6ST2	90161
MIM300546		Xp11.21	FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 1; FGD1	2245
MIM300547		 	MST3- AND SOK1-RELATED KINASE	51765
MIM300548		 	MELANOMA ANTIGEN, FAMILY H, 1; MAGEH1	28986
MIM300549		 	MELANOMA ANTIGEN, FAMILY A, 2B; MAGEA2B	266740
MIM300550		Xp22.2-p22.1	PHOSPHATE-REGULATING ENDOPEPTIDASE HOMOLOG, X-LINKED; PHEX	5251
MIM300551	C2931498	Xp11.4-p11.23	MENTAL RETARDATION, X-LINKED 78; MRX78	170530
MIM300552		Xp22	MIDLINE 1; MID1	4281
MIM300553		Xq13	BROMODOMAIN- AND WD REPEAT-CONTAINING PROTEIN 3; BRWD3	254065
MIM300554	C1845168	Xp11.22	HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	1184
MIM300555	C1845167	Xq26.1	DENT DISEASE 2	4952
MIM300556		Xp11.4	ATPase, H+ TRANSPORTING, LYSOSOMAL, ACCESSORY PROTEIN 2; ATP6AP2	10159
MIM300557	C1845165	Xq21-q25	PARKINSON DISEASE 12; PARK12	677662
MIM300558	C0796237	Xq21.3-q24	MENTAL RETARDATION, X-LINKED 30; MRX30	5063
MIM300559	C1845151	Xq13	GLYCOGEN STORAGE DISEASE, TYPE IXd; GSD9D	5255
MIM300560		Xp11.2	PHD FINGER PROTEIN 8; PHF8	23133
MIM300561		Xq27	SLIT- AND NTRK-LIKE FAMILY, MEMBER 2; SLITRK2	84631
MIM300562		Xq27	SLIT- AND NTRK-LIKE FAMILY, MEMBER 4; SLITRK4	139065
MIM300564		Xp11.2	TSPY-LIKE 2; TSPYL2	64061
MIM300565		Xq27	CHROMOSOME X OPEN READING FRAME 1; CXORF1	9142
MIM300566		Xq23	LHFP-LIKE PROTEIN 1; LHFPL1	340596
MIM300567		Xq13.3	PHOSPHOGLYCERATE MUTASE FAMILY MEMBER 4; PGAM4	441531
MIM300568		Xp11.3	MICRO RNA 221; MIR221	407006
MIM300569		Xp11.3	MICRO RNA 222; MIR222	407007
MIM300570		 	TRANSCRIPTION FACTOR YY2; YY2	404281
MIM300572		Xp21.3	G PROTEIN-COUPLED RECEPTOR 64; GPR64	10149
MIM300573		Xp11	ZINC FINGER PROTEIN 674; ZNF674	641339
MIM300574		Xq13	CHEMOKINE, CXC MOTIF, RECEPTOR 3; CXCR3	2833
MIM300575		Xq22.3	RIPPLY1, ZEBRAFISH, HOMOLOG OF; RIPPLY1	92129
MIM300576		Xq13.3	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 15; ZDHHC15	158866
MIM300577	C1845142	Xq13.3	MENTAL RETARDATION, X-LINKED 91; MRX91	158866
MIM300578	C1845136	Xp11.3	CHROMOSOME Xp11.3 DELETION SYNDROME	100271686
MIM300579		Xp11.2	SHROOM FAMILY MEMBER 4; SHROOM4	57477
MIM300580	C2749128	Xq13.1-q22.1	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	100188765
MIM300581	C1845119	Xq22.3	FG SYNDROME 5; FGS5	780900
MIM300582	C1845118	Ypter-p11.2, Xpter-p22.32	SHORT STATURE, IDIOPATHIC, X-LINKED; ISS	6473
MIM300583		Xq26.1-q27.2	VESTIGIAL-LIKE 1; VGLL1	51442
MIM300584	C1845117	Xq28	IMMUNODEFICIENCY WITHOUT ANHIDROTIC ECTODERMAL DYSPLASIA	8517
MIM300585		Xp11.3	ZINC FINGER PROTEIN 673; ZNF673	55634
MIM300586		Xp22.3	ARYLSULFATASE H; ARSH	347527
MIM300587		Xq22-q24	MALIGNANT T-CELL AMPLIFIED SEQUENCE 1; MCTS1	28985
MIM300588		 	ODZ, DROSOPHILA, HOMOLOG OF, 1; ODZ1	10178
MIM300589	C1845116	Xp11.4	NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	780901
MIM300590	C1802395	Xp11.22-p11.21	CORNELIA DE LANGE SYNDROME 2; CDLS2	8243
MIM300591	C1845115	Xq24-q25	STATURE QUANTITATIVE TRAIT LOCUS 6; STQTL6	100037264
MIM300592		Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A11; CT47A11	255313
MIM300593		Xp11.23	SPERM ACROSOME-ASSOCIATED PROTEIN 5; SPACA5	389852
MIM300594		Xp11.23	G ANTIGEN 1; GAGE1	2543
MIM300595		Xp11.23	G ANTIGEN 2C; GAGE2C	2574
MIM300596		 	G ANTIGEN 3; GAGE3	2575
MIM300597		 	G ANTIGEN 4; GAGE4	2576
MIM300598		 	G ANTIGEN 5; GAGE5	2577
MIM300599		 	G ANTIGEN 6; GAGE6	2578
MIM300600	C0268505	Xp11.23	ALAND ISLAND EYE DISEASE; AIED	778
MIM300601		Xp11.23	G ANTIGEN 7; GAGE7	2579
MIM300603		Xq21	ACTIN-BINDING PROTEIN, 34-KD	79983
MIM300604	C1845105	Xq21	PREMATURE OVARIAN FAILURE 2B; POF2B	79983
MIM300605	C1845104	Xq28	RETINITIS PIGMENTOSA 34; RP34	777642
MIM300607	C1845102	Xq22.1	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8	23229
MIM300608		 	DACHSHUND, DROSOPHILA, HOMOLOG OF, 2; DACH2	117154
MIM300609		Xp22.3	MALE-SPECIFIC LETHAL 3, DROSOPHILA, HOMOLOG OF; MSL3	10943
MIM300610		Xq22	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H2; HNRNPH2	3188
MIM300611		Xq23	C1GALT1-SPECIFIC CHAPERONE 1; C1GALT1C1	29071
MIM300613	C1845096	Xq23-q27.2	MYOPIA 13, X-LINKED; MYP13	677764
MIM300614	C1845095	Xq23-q27.3	DEAFNESS, X-LINKED 5; DFNX5	751798
MIM300615	C0796275	Xp11.23	BRUNNER SYNDROME	4128
MIM300616		 	LEUCINE ZIPPER PROTEIN 4; LUZP4	51213
MIM300617		 	BRCA1/BRCA2-CONTAINING COMPLEX, SUBUNIT 3; BRCC3	79184
MIM300618		 	PHD FINGER PROTEIN 16; PHF16	9767
MIM300620		 	V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 1; VSIG1	340547
MIM300621		 	DXF34 GENE	54466
MIM300622	C0272137	Xq23	TN SYNDROME	29071
MIM300623	C1839780	Xq27.3	FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	2332
MIM300624	C0016667	Xq27.3	FRAGILE X MENTAL RETARDATION SYNDROME	2332
MIM300625		Xq22	KITA-KYUSHU LUNG CANCER ANTIGEN 1	203413
MIM300626		Xp22.31	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 11; ASB11	140456
MIM300627		Xq26.3	ZINC FINGER PROTEIN 449; ZNF449	203523
MIM300628		Xq26.2	FERM DOMAIN-CONTAINING PROTEIN 7; FRMD7	90167
MIM300629		Xp22	ADAPTOR-RELATED PROTEIN COMPLEX 1, SIGMA-2 SUBUNIT; AP1S2	8905
MIM300630		Xp22	MENTAL RETARDATION, X-LINKED, SYNDROMIC, FRIED TYPE; MRXSF	8905
MIM300631		Xp22	TRANSMEMBRANE PROTEIN 27; TMEM27	57393
MIM300632		Xq13.1	PDZ DOMAIN-CONTAINING 11; PDZD11	51248
MIM300633	C2678098	Xq11-q12	HYPOSPADIAS 1, X-LINKED; HYSP1	367
MIM300634		Xq28	PDZ DOMAIN-CONTAINING 4; PDZD4	57595
MIM300635	C1845076	Xq25	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	331
MIM300636	C1970879	Xq28	ATYPICAL MYCOBACTERIOSIS, FAMILIAL, X-LINKED 1; AMCBX1	8517
MIM300637		Xp11.23	G ANTIGEN 12I; GAGE12I	26748
MIM300638		Xp11.4-p11.2	G ANTIGEN 8; GAGE8	100101629
MIM300640	C1845073	 	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 2; IPD2	8517
MIM300641		Xq24	SOLUTE CARRIER FAMILY 25, MEMBER 43; SLC25A43	203427
MIM300642		Xq21.33-q23	SUSHI REPEAT-CONTAINING PROTEIN, X-LINKED, 2; SRPX2	27286
MIM300643	C1845070	Xq21.33-q23	ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED; RESDX	27286
MIM300644		Xq22	GALACTOSIDASE, ALPHA; GLA	2717
MIM300645	C1970859	Xp21.2-q26.3	ATYPICAL MYCOBACTERIOSIS, FAMILIAL, X-LINKED 2; AMCBX2	1536
MIM300646		Xq26.1	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 9; ZDHHC9	51114
MIM300647		Xq11.1	FAMILY WITH SEQUENCE SIMILARITY 123, MEMBER B; FAM123B	139285
MIM300648		Xq26.3	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A1; CT45A1	541466
MIM300649		Xp11.23	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 5; SLC38A5	92745
MIM300650	C1845069	Xp22.3	ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS; OASD	4941
MIM300651		Xp11.23	PORCUPINE, DROSOPHILA, HOMOLOG OF; PORCN	64840
MIM300652	C0263637	Xp11.3-q12	ANGIOMA SERPIGINOSUM, X-LINKED	100188767
MIM300653	C1970848	Xq13	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	5230
MIM300654		Xp11	FATTY ACID AMIDE HYDROLASE 2; FAAH2	158584
MIM300655		 	KELCH-LIKE 13; KLHL13	90293
MIM300656		 	URACIL PHOSPHORIBOSYLTRANSFERASE, S. CEREVISIAE, HOMOLOG OF; UPRT	139596
MIM300657		 	CANCER/TESTIS ANTIGEN 1A; CTAG1A	246100
MIM300658		Xp11.4	NDP GENE; NDP	4693
MIM300659	C1970841	Xq13	MENTAL RETARDATION, X-LINKED 93; MRX93	254065
MIM300660	C1970840	Xq25-q27	LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	100302058
MIM300661	C1970827	Xq22-q24	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	5631
MIM300662		 	SMALL NUCLEOLAR RNA, H/ACA BOX, 11; SNORA11	677799
MIM300663		 	AUTOPHAGY 4, S. CEREVISIAE, HOMOLOG OF, A; ATG4A	115201
MIM300664		 	SPANX FAMILY, MEMBER N1; SPANXN1	494118
MIM300665		 	SPANX FAMILY, MEMBER N2; SPANXN2	494119
MIM300666		 	SPANX FAMILY, MEMBER N3; SPANXN3	139067
MIM300667		 	SPANX FAMILY, MEMBER N4; SPANXN4	441525
MIM300668		 	SPANX FAMILY, MEMBER N5; SPANXN5	494197
MIM300669		 	SPANX FAMILY, MEMBER B1; SPANXB1	728695
MIM300670		 	SPANX FAMILY, MEMBER D; SPANXD	64648
MIM300671		 	SPANX FAMILY, MEMBER E; SPANXE	171489
MIM300672	C1839333	Xp22	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2	6792
MIM300673	C1968556	Xq28	ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	4204
MIM300674		 	MOTILE SPERM DOMAIN-CONTAINING PROTEIN 1; MOSPD1	56180
MIM300675		 	PARANEOPLASTIC ANTIGEN MA3; PNMA3	29944
MIM300676	C1970822	Xq25-q26	MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	65109
MIM300677		 	CHROMOSOME X OPEN READING FRAME 15; CXORF15	55787
MIM300678		 	DUAL-SPECIFICITY PHOSPHATASE 21; DUSP21	63904
MIM300679	C0795887	Xp21	CHROMOSOME Xp21 DELETION SYNDROME	100505389
MIM300680		Xq28	PREGNANCY-UPREGULATED, NONUBIQUITOUS, CAM KINASE; PNCK	139728
MIM300681		 	DEDICATOR OF CYTOKINESIS 11; DOCK11	139818
MIM300682		Xq26.3	MICRO RNA 424; MIRN424	494336
MIM300683		Xq24	SEPTIN 6; SEPT6	23157
MIM300684		Xq22.1	X KELL BLOOD GROUP PRECURSOR-RELATED, X-LINKED; XKRX	402415
MIM300685		Xq28	PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 3; PRRG3	79057
MIM300686		Xq23	MICRO RNA 448; MIRN448	554212
MIM300687		Xq13.1	ERCC6-LIKE; ERCC6L	54821
MIM300688		Xq25-q26.1	BCL6 COREPRESSOR-LIKE 1; BCORL1	63035
MIM300689		Xq13.1	START DOMAIN-CONTAINING PROTEIN 8; STARD8	9754
MIM300690		Xq22.1-q22.2	BRAIN-EXPRESSED X-LINKED GENE 1; BEX1	55859
MIM300691		Xq22	BRAIN-EXPRESSED X-LINKED GENE 2; BEX2	84707
MIM300692		Xq22.2	BEX FAMILY MEMBER 4; BEX4	56271
MIM300693		Xq22.1	BEX FAMILY MEMBER 5; BEX5	340542
MIM300694		Xq12	MICRO RNA 223; MIR223	407008
MIM300695	C2678061	Xq27.2	SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM	2273
MIM300696	C2678055	Xq27.2	MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY; XMPMA	2273
MIM300697		Xp11.2	HECT, UBA, AND WWE DOMAINS-CONTAINING PROTEIN 1; HUWE1	10075
MIM300698		Xp11.4	TRANSMEMBRANE PROTEIN 47; TMEM47	83604
MIM300699	C2678051	Xq25-q26	MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	2892
MIM300700	C1845068	Xq26.3-q27.1	ALBINISM-DEAFNESS SYNDROME; ADFN	122
MIM300701		Xq24	ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 12; ZCCHC12	170261
MIM300702		Xp11	MELANOMA ANTIGEN, FAMILY D, 4; MAGED4	728239
MIM300703	C2678048	Xq25-q27.1	SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	100188768
MIM300704	C2678047	Xp11.22	PROSTATE CANCER, HEREDITARY, X-LINKED 2; HPCX2	100188769
MIM300705	C0796223	Xp11.2	MENTAL RETARDATION, X-LINKED 17; MRX17	3028
MIM300706	C2678046	Xp11.2	MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	10075
MIM300707	C2678045	Xq28	TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	92002
MIM300708		Xq28	FAMILY WITH SEQUENCE SIMILARITY 58, MEMBER A; FAM58A	92002
MIM300710	C2678038	Xq11-q12	ALOPECIA, ANDROGENETIC, 2; AGA2	100188771
MIM300711	C2678037	Xq23	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 4; IHPS4	100188772
MIM300712	C2678036	Xq26-q27	CRANIOFACIOSKELETAL SYNDROME	100188773
MIM300713		Xp11.23	OTU DOMAIN-CONTAINING PROTEIN 5; OTUD5	55593
MIM300714		Xq13.1	OTU DOMAIN-CONTAINING PROTEIN 6A; OTUD6A	139562
MIM300715		Xq13.1-q13.2	MAGNESIUM TRANSPORTER 1; MAGT1	84061
MIM300716	C2678034	Xq13.1-q13.2	MENTAL RETARDATION, X-LINKED 95; MRX95	84061
MIM300717	C2678027	Xq27.2	MYOPATHY, REDUCING BODY, X-LINKED, EARLY-ONSET, SEVERE	2273
MIM300718	C2678015	Xq27.2	MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET	2273
MIM300719	C2678011	Chr.X	DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	100188774
MIM300720		Xp11.23	G ANTIGEN 2A; GAGE2A	729447
MIM300721		Xp11.22	MICRO RNA LET7F2; MIRNLET7F2	406889
MIM300722		Xq26.2	MICRO RNA 19B2; MIR19B2	406981
MIM300723		Xq21.33	SYNAPTOTAGMIN-LIKE 4; SYTL4	94121
MIM300724		Xp22.12	CONNECTOR ENHANCER OF KSR 2; CNKSR2	22866
MIM300725		Xp11.21	RAS-RELATED GTP-BINDING PROTEIN B; RRAGB	10325
MIM300726		Xp11.23	G ANTIGEN 2B; GAGE2B	645037
MIM300727		Xp11.23	G ANTIGEN 12C; GAGE12C	729422
MIM300728		Xp11.23	G ANTIGEN 12D; GAGE12D	100132399
MIM300729		Xp11.23	G ANTIGEN 12E; GAGE12E	729431
MIM300730		Xp11.23	G ANTIGEN 12F; GAGE12F	100008586
MIM300731		Xp11.23	G ANTIGEN 12G; GAGE12G	645073
MIM300732		Xp11.23	G ANTIGEN 12H; GAGE12H	729442
MIM300733		Xp11.23	G ANTIGEN 12J; GAGE12J	729396
MIM300734		Xp11.23	G ANTIGEN 13; GAGE13	645051
MIM300735		Xp11.23	G ANTIGEN 2D; GAGE2D	729408
MIM300736		Xp11.23	G ANTIGEN 2E; GAGE2E	26749
MIM300737		Xp11.23	G ANTIGEN 10; GAGE10	643832
MIM300738		Xp11.21	P ANTIGEN FAMILY, MEMBER 2; PAGE2	203569
MIM300739		Xp11.21	P ANTIGEN FAMILY, MEMBER 3; PAGE3	139793
MIM300740		Xp11.22	X ANTIGEN FAMILY, MEMBER 3; XAGE3	170626
MIM300741		Xp11.2	FAMILY WITH SEQUENCE SIMILARITY 120, MEMBER C; FAM120C	54954
MIM300742		Xp11.22	X ANTIGEN FAMILY, MEMBER 1A; XAGE1A	653219
MIM300743		Xp11.22	X ANTIGEN FAMILY, MEMBER 1B; XAGE1B	653220
MIM300744		Xp11.22	X ANTIGEN FAMILY, MEMBER 1C; XAGE1C	653048
MIM300745		Xp11.22	X ANTIGEN FAMILY, MEMBER 1E; XAGE1E	653067
MIM300746		Xq27.1-q27.2	COAGULATION FACTOR IX; F9	2158
MIM300747		Xp22.32	STEROID SULFATASE; STS	412
MIM300748		Xp11.4	G PROTEIN-COUPLED RECEPTOR 82; GPR82	27197
MIM300749	C2677903	Xp11.4	MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	8573
MIM300750	C2677897	Xq24-q25	SPASTIC PARAPLEGIA 34, X-LINKED; SPG34	724110
MIM300751	C0221018	Xp11.21	ANEMIA, SIDEROBLASTIC, X-LINKED; XLSA	212
MIM300752	C2677889	Xp11.21	PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED; XLEPP	212
MIM300753		Xp22.1	APOLIPOPROTEIN O; APOO	79135
MIM300754		Xq13.1-q22.1	TAF9B RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 31-KD; TAF9B	51616
MIM300755	C0221026	Xq21.3-q22	AGAMMAGLOBULINEMIA, X-LINKED; XLA	695
MIM300756	C2677888	Xq21.3	ALZHEIMER DISEASE 16; AD16	100271718
MIM300757		Xp11.23	RP2 GENE; RP2	6102
MIM300758	C2677879	Xq28	HYPOSPADIAS 2, X-LINKED; HYSP2	10046
MIM300759		Xq13.1	MELANOMA ANTIGEN, FAMILY E, 1; MAGEE1	57692
MIM300760		Xq13.1	MELANOMA ANTIGEN, FAMILY E, 2; MAGEE2	139599
MIM300761		Xp21.3	MELANOMA ANTIGEN, FAMILY B, 10; MAGEB10	139422
MIM300762		Xp21.3	MELANOMA ANTIGEN, FAMILY B, 16; MAGEB16	139604
MIM300763		Xp21.3	MELANOMA ANTIGEN, FAMILY B, 17; MAGEB17	645864
MIM300764		Xq28	MELANOMA ANTIGEN, FAMILY A, 9B; MAGEA9B	728269
MIM300765		Xp11	MELANOMA ANTIGEN, FAMILY D, 4B; MAGED4B	81557
MIM300766		Xq24	NFKB-ACTIVATING PROTEIN; NKAP	79576
MIM300767		Xq21.33	REPLICATION PROTEIN A4; RPA4	29935
MIM300768		Xq21.1	CYLICIN 1; CYLC1	1538
MIM300769		Xq28	MICRO RNA 224; MIR224	407009
MIM300770	C2677877	Xp22.32	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP4	1438
MIM300771		Xq22.1-q22.3	TRANSCRIPTION ELONGATION FACTOR A-LIKE 7; TCEAL7	56849
MIM300772		Xq26.2	TRANSCRIPTION FACTOR DP FAMILY, MEMBER 3; TFDP3	51270
MIM300773		Xp11.21	APEX NUCLEASE (APURINIC/APYRIMIDINIC ENDONUCLEASE) 2; APEX2	27301
MIM300774		Xq28	RAS-ASSOCIATED PROTEIN RAB39B; RAB39B	116442
MIM300775		Xq26	E74-LIKE FACTOR 4; ELF4	2000
MIM300776		Xq23	ALG13, S. CEREVISIAE, HOMOLOG OF; ALG13	79868
MIM300777		Xq28	EPSILON-TRIMETHYLLYSINE HYDROXYLASE; TMLHE	55217
MIM300778	C2749050	Xp22.3	CORNEAL DYSTROPHY, LISCH EPITHELIAL; LECD	100302509
MIM300779	C2749049	Xq25	CORNEAL DYSTROPHY, ENDOTHELIAL, X-LINKED; XECD	100302510
MIM300780		Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A1; CT47A1	728096
MIM300781		Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A2; CT47A2	728090
MIM300782		Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A3; CT47A3	728082
MIM300783		Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A4; CT47A4	728075
MIM300784		Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A5; CT47A5	728072
MIM300785		Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A6; CT47A6	728062
MIM300786		Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A7; CT47A7	653282
MIM300787		Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A8; CT47A8	728049
MIM300788		Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A9; CT47A9	728042
MIM300789		Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A10; CT47A10	728036
MIM300790		Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER B1; CT47B1	643311
MIM300791		Xq22.3	NIK-RELATED KINASE; NRK	203447
MIM300792		Xq26.2	MICRO RNA 106A; MIR106A	406899
MIM300793		Xq26.3	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A2; CT45A2	728911
MIM300794		Xq26.3	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A3; CT45A3	441519
MIM300795		Xq26.3	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A4; CT45A4	441520
MIM300796		Xq26.3	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A5; CT45A5	441521
MIM300797		Xq26.3	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A6; CT45A6	541465
MIM300798		Xp22.2-p22.1	PHOSPHORYLASE KINASE, LIVER, ALPHA-2 SUBUNIT; PHKA2	5256
MIM300799	C2749033	Xq26.1	MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR	51114
MIM300801	C2749022	Xp11.23-p11.22	CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	100310754
MIM300802	C2749021	Xp11.23-p11.22	MENTAL RETARDATION, X-LINKED 96; MRX96	6855
MIM300803	C2749020	 	MENTAL RETARDATION, X-LINKED 97; MRX97	7552
MIM300804	C2749019	Xp22.3-p22.2	JOUBERT SYNDROME 10; JBTS10	8481
MIM300805		Xq27	FMR1 ANTISENSE RNA 1; FMR1AS1	100126270
MIM300806		Xq28	AF4/FMR2 FAMILY, MEMBER 2; AFF2	2334
MIM300807	C2749016	Xq27.1-q27.2	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; THPH8	2158
MIM300808		Xp22.3	G PROTEIN-COUPLED RECEPTOR 143; GPR143	4935
MIM300809	C2749008	Xq28	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 15; SLEB15	100379200
MIM300810		Xp11.22	MICRO RNA 98; MIR98	407054
MIM300811		Xq28	MICRO RNA 105-1; MIR105-1	406897
MIM300812		Xq28	MICRO RNA 105-2; MIR105-2	406898
MIM300814	C3151752	Xp22.3	NYSTAGMUS 6, CONGENITAL, X-LINKED; NYS6	4935
MIM300815	C2749007	Xq28	CHROMOSOME Xq28 DUPLICATION SYNDROME	100415893
MIM300816	C3151753	Xq25-q26	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	9131
MIM300817		Xp11.3	EF-HAND DOMAIN (C-TERMINAL)-CONTAINING PROTEIN 2; EFHC2	80258
MIM300818	C3806670	Xp22.1	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PNH	5277
MIM300819		Xp11.23	ZINC FINGER PROTEIN 630; ZNF630	57232
MIM300820		Xp22.12	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 15; MAP3K15	389840
MIM300821		Xq28	OPSIN 1, MEDIUM-WAVE-SENSITIVE; OPN1MW	2652
MIM300822		Xq28	OPSIN 1, LONG-WAVE-SENSITIVE; OPN1LW	5956
MIM300823		Xq28	IDURONATE 2-SULFATASE; IDS	3423
MIM300824		Xq28	OPN1LW AND OPN1MW GENES, CONTROLLER OF	100534624
MIM300825		Xp22.2	RETINOBLASTOMA-BINDING PROTEIN 7; RBBP7	5931
MIM300826		Xq25	STROMAL ANTIGEN 2; STAG2	10735
MIM300827		Xq21.1	FIBROBLAST GROWTH FACTOR 16; FGF16	8823
MIM300828		Xp22.11	PATCHED DOMAIN-CONTAINING PROTEIN 1; PTCHD1	139411
MIM300830	C0795888	Xp22.11	CHROMOSOME Xp22 DELETION SYNDROME	100529118
MIM300831	C3151781	Xq28	CK SYNDROME	50814
MIM300832		Xq13.2	JUST PROXIMAL TO XIST; JPX	554203
MIM300833	C3151782	 	46,XX SEX REVERSAL 3; SRXX3	100653372
MIM300834	C3151784	 	MACULAR DEGENERATION, X-LINKED ATROPHIC	6103
MIM300835	C3151785	 	ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES; XLANP	2623
MIM300836		 	KAL1 GENE; KAL1	3730
MIM300837		 	DIACYLGLYCEROL KINASE, KAPPA, 142-KD; DGKK	139189
MIM300838		 	FERM AND PDZ DOMAINS-CONTAINING PROTEIN 4; FRMPD4	9758
MIM300839		 	RETINOSCHISIN; RS1	6247
MIM300840		 	PRA1 DOMAIN FAMILY, MEMBER 2; PRAF2	11230
MIM300841		 	COAGULATION FACTOR VIII; F8	2157
MIM300842	C0398568	 	MCLEOD SYNDROME; MCLDS	7504
MIM300843	C3159311	 	BORNHOLM EYE DISEASE; BED	100653365
MIM300844	C0796225	 	MENTAL RETARDATION, X-LINKED 19; MRX19	6197
MIM300845	C3151857	 	MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM, AND FACIAL DYSMORPHISM; MYMY4	100653379
MIM300846		 	CD99 ANTIGEN-LIKE 2; CD99L2	83692
MIM300847	C3275438	 	AUTISM, SUSCEPTIBILITY TO, X-LINKED 5; AUTSX5	6134
MIM300848	C1839082	 	MENTAL RETARDATION, X-LINKED 89; MRX89	7592
MIM300849	CN069590	 	MENTAL RETARDATION, X-LINKED 41; MRX41	2664
MIM300850	C3275443	 	MENTAL RETARDATION, X-LINKED 90; MRX90	1741
MIM300851	C1845144	 	MENTAL RETARDATION, X-LINKED 92; MRX92	641339
MIM300852	C3275444	 	MENTAL RETARDATION, X-LINKED 88; MRX88	186
MIM300853	C3275445	 	IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN	84061
MIM300854	C3275446	 	RENAL CELL CARCINOMA, Xp11-ASSOCIATED; RCCX1	7030
MIM300855	C3275447	 	OGDEN SYNDROME; OGDNS	8260
MIM300856	C3275458	 	HYPOSPADIAS 4, X-LINKED, SUSCEPTIBILITY TO; HYSP4	100689214
MIM300857	C3275459	 	AMYOTROPHIC LATERAL SCLEROSIS 15, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	29978
MIM300858	C3275460	 	MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17	100739996
MIM300859		 	COILED-COIL DOMAIN-CONTAINING PROTEIN 22; CCDC22	28952
MIM300860	C3275464	 	MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN	7319
MIM300861	C3275471	 	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS	100820761
MIM300862		 	ACYL-CoA THIOESTERASE 9; ACOT9	23597
MIM300863	C3275476	 	CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	100820762
MIM300864	C3275487	 	CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	100820758
MIM300865		 	MICRO RNA 503; MIR503	574506
MIM300866		 	MICRO RNA 510; MIR510	574515
MIM300867	C3275495	 	KABUKI SYNDROME 2; KABUK2	7403
MIM300868	C3275508	 	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	5277
MIM300869	C3275521	 	CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	100874533
MIM300871		 	FUN14 DOMAIN-CONTAINING PROTEIN 1; FUNDC1	139341
MIM300872	C3550875	 	EPSILON-TRIMETHYLLYSINE HYDROXYLASE DEFICIENCY; TMLHED	55217
MIM300873		 	GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 3-LIKE PROTEIN; GNL3L	54552
MIM300874		 	MICRO RNA 508; MIR508	574513
MIM300875		 	MICRO RNA 509-1; MIR509-1	574514
MIM300876		 	MICRO RNA 509-3; MIR509-3	100126337
MIM300877		 	MICRO RNA 506; MIR506	574511
MIM300878		 	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR C1; DMRTC1	63947
MIM300879		 	XG GLYCOPROTEIN; XG	7499
MIM300882	C3550903	 	CORNELIA DE LANGE SYNDROME 5; CDLS5	55869
MIM300883		 	SORTING NEXIN 12; SNX12	29934
MIM300885		 	CYTOCHROME c OXIDASE, SUBUNIT VIIb; COX7B	1349
MIM301000	C0043194	Xp11.23-p11.22	WISKOTT-ALDRICH SYNDROME; WAS	7454
MIM301040	C1845055	Xq13	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	546
MIM301050	C1567742	Xq22.3	ALPORT SYNDROME, X-LINKED; ATS	1287
MIM301200	C1845052	Xp22.3-p22.1	AMELOGENESIS IMPERFECTA, TYPE IE; AI1E	265
MIM301201	C1845051	Xq22-q28	AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 2	201
MIM301220	C1845050	Xp22-p21	PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS; PDR	5171
MIM301300		Xp11.21	DELTA-AMINOLEVULINATE SYNTHASE 2; ALAS2	212
MIM301310	C1845028	Xq13.1-q13.3	ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA; ASAT	22
MIM301410	C2931178	 	NEURAL TUBE DEFECTS, X-LINKED	 
MIM301500	C0002986	Xq22	FABRY DISEASE	2717
MIM301590	C1844948	Xq27-q28	MICROPHTHALMIA, SYNDROMIC 4; MCOPS4	289
MIM301700	CN000428	 	ANOSMIA	 
MIM301770		Xcen-q21	ARRESTIN 3, RETINAL; ARR3	407
MIM301780		Xpter-p22.32	ARYLSULFATASE C, ISOZYME F; ARSC2	413
MIM301790	C1844936	 	SPINOCEREBELLAR ATAXIA, X-LINKED 3	727715
MIM301800		 	ANUS, IMPERFORATE	 
MIM301815	C1844935	 	ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	 
MIM301830	C1844934	Xp11.23	SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2	7317
MIM301835	C0796028	Xq22-q24, Xq21.2-q24	ARTS SYNDROME; ARTS	5631
MIM301840	C1844933	 	SPINOCEREBELLAR ATAXIA, X-LINKED 4	727716
MIM301845	C0346104	Xq24-q27	BAZEX SYNDROME; BZX	8255
MIM301870		Xq28	BIGLYCAN; BGN	633
MIM301900	C0265339	Xq26.3	BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	84295
MIM301940	C1844919	 	BRACHYDACTYLY, MONONEN TYPE	 
MIM301950	C1844918	 	BRANCHIAL ARCH SYNDROME, X-LINKED	 
MIM302000	C0795974	Xq27.3-qter	BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	1881
MIM302020		Xp	CALBINDIN 3; CALB3	795
MIM302030	C1863351	 	CALVARIAL HYPEROSTOSIS	 
MIM302045	C3668940	Xp21.2	CARDIOMYOPATHY, DILATED, 3B; CMD3B	1756
MIM302060	C0574083	Xq28	BARTH SYNDROME; BTHS	6901
MIM302200	C2752078	Xp22.13	CATARACT, CONGENITAL, X-LINKED; CXN	4810, 907
MIM302300		 	MICROPHTHALMIA, ISOLATED, WITH CATARACT 3; MCOPCT3	 
MIM302350	C0796085	Xp22.13	NANCE-HORAN SYNDROME; NHS	4810
MIM302380		 	CATEL-MANZKE SYNDROME	100862706
MIM302400	C1844886	 	CENTRAL INCISORS, ABSENCE OF	 
MIM302500	C0796205	Xp11.21-q21.3	SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	1166
MIM302600	C1844885	 	SPINOCEREBELLAR ATAXIA, X-LINKED 2	727714
MIM302650		Xq27.1-q27.2	CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 1; CDR1	1038
MIM302700	C1844884	 	CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	 
MIM302800	C0393808	Xq13.1	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1	2705
MIM302801	C1844873	Xp22.2	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2; CMTX2	1253
MIM302802	C1844865	Xq26	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	1254
MIM302803	C1844864	 	CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED, WITH APLASIA CUTIS CONGENITA	 
MIM302900	C1844863	 	CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA, COMBINED	 
MIM302905	C1844862	 	CHARGE-LIKE SYNDROME, X-LINKED	 
MIM302910		Xp22.3	CHLORIDE CHANNEL 4; CLCN4	1183
MIM302950	C1844853	Xp22.3	CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1	415
MIM302960	C0282102	Xp11.23-p11.22	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	10682
MIM303100	C0008525	Xq21.2	CHOROIDEREMIA; CHM	1121
MIM303110	C1844836	 	CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION	100887743
MIM303350	C0795953	Xq28	MASA SYNDROME	3897
MIM303400	C1844830	Xq12-q21	CLEFT PALATE, X-LINKED; CPX	50945
MIM303600	C0265252	Xp22.2-p22.1	COFFIN-LOWRY SYNDROME; CLS	6197
MIM303630		Xq22.3	COLLAGEN, TYPE IV, ALPHA-5; COL4A5	1287
MIM303631		Xq22.3	COLLAGEN, TYPE IV, ALPHA-6; COL4A6	1288
MIM303650	C0266190	 	COLONIC ATRESIA	 
MIM303700	C0339537	Xq28, Xq28	BLUE CONE MONOCHROMACY; BCM	2652, 5956
MIM303800	C0155016	Xq28	COLORBLINDNESS, PARTIAL, DEUTAN SERIES; CBD	2652
MIM303900	C0155015	Xq28	COLORBLINDNESS, PARTIAL, PROTAN SERIES; CBP	5956
MIM304020	C1844776	Xp11.4	CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	6103
MIM304030	C1844775	 	CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	 
MIM304040		Xq13.1	GAP JUNCTION PROTEIN, BETA-1; GJB1	2705
MIM304050	C0175713	Xp22	AICARDI SYNDROME; AIC	192
MIM304100	C1839909	Xq28	CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	3897
MIM304110	C0220767	Xq12	CRANIOFRONTONASAL SYNDROME; CFNS	1947
MIM304120	C1844696	Xq28	OTOPALATODIGITAL SYNDROME, TYPE II; OPD2	2316
MIM304150	C0268353	Xq12-q13	OCCIPITAL HORN SYNDROME; OHS	538
MIM304200	C1844682	 	CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	 
MIM304300	C1844681	 	CYANIDE, INABILITY TO SMELL	 
MIM304340	C0796254	Xq25-q27	DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, BASAL GANGLIA DISEASE, AND SEIZURES	5242
MIM304350	C1844680	 	DEAFNESS-HYPOGONADISM SYNDROME; DHS	 
MIM304400	C1844678	Xq21.1	DEAFNESS, X-LINKED 2; DFNX2	10804, 2706, 5456
MIM304500	C1844677	Xq22-q24	DEAFNESS, X-LINKED 1; DFNX1	5631
MIM304590	C1844677	 	DEAFNESS, HIGH-FREQUENCY SENSORINEURAL, X-LINKED	 
MIM304700	C0796074	Xq22	MOHR-TRANEBJAERG SYNDROME; MTS	1678
MIM304730	C1844671	Xq24-qter	DERMOIDS OF CORNEA; CND	8231
MIM304790	C0342288	Xp11.23-q13.3	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	50943
MIM304800	C1563705	Xq28	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	554
MIM304900	CN074293	 	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	 
MIM304950	C1844654	 	DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	 
MIM305000	C1148551	Xq28	DYSKERATOSIS CONGENITA, X-LINKED; DKCX	1736
MIM305100	C0162359	Xq12-q13.1	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, X-LINKED; XHED	1896
MIM305200	C0268341	 	EHLERS-DANLOS SYNDROME, TYPE V	 
MIM305350	C1844589	 	EPIDERMODYSPLASIA VERRUCIFORMIS, X-LINKED; EDVX; EDV2	 
MIM305360		Xq28	MEMBRANE PROTEIN, PALMITOYLATED 1; MPP1	4354
MIM305370		Xp11.3-p11.23	TISSUE INHIBITOR OF METALLOPROTEINASE 1; TIMP1	7076
MIM305371		Xp11.23	GATA-BINDING PROTEIN 1; GATA1	2623
MIM305390	C1844579	Xp11.4	EXUDATIVE VITREORETINOPATHY 2, X-LINKED; EVR2	4693
MIM305400	C0175701	Xp11.21	AARSKOG-SCOTT SYNDROME; AAS	2245
MIM305423		Xq28	FACTOR VIII-ASSOCIATED GENE 1; F8A	8263
MIM305435	C1844568	Xp22.2	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HBFQTL3	2221
MIM305450	C0220769	Xq13	OPITZ-KAVEGGIA SYNDROME; OKS	9968
MIM305550	C1844560	 	FINGERPRINT BODY MYOPATHY	 
MIM305600	C0016395	Xp11.23	FOCAL DERMAL HYPOPLASIA; FDH	64840
MIM305620	C0265293	Xq28	FRONTOMETAPHYSEAL DYSPLASIA; FMD	2316
MIM305660		Xq28	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-3; GABRA3	2556
MIM305670		Xp22.3-p21.2	GASTRIN-RELEASING PEPTIDE RECEPTOR; GRPR	2925
MIM305690	C1844502	 	GENITOURINARY TRACT ANOMALIES	 
MIM305700	C1384583	 	SPERMATOGENIC FAILURE, X-LINKED, 1; SPGFX1	 
MIM305800	C1844501	 	MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	 
MIM305900		Xq28	GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD	2539
MIM305915		Xq25-q26	GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 3; GRIA3	2892
MIM305990		Xp22.1-p21.2	GLYCINE RECEPTOR, ALPHA-2 SUBUNIT; GLRA2	2742
MIM306000	C0017927	Xp22.2-p22.1	GLYCOGEN STORAGE DISEASE IXa1; GSD9A1	5256
MIM306250		Xp22.32	COLONY-STIMULATING FACTOR 2 RECEPTOR, ALPHA; CSF2RA	1438
MIM306300	C1844406	 	GRANULOMAS, CONGENITAL CEREBRAL	 
MIM306400	C1844376	Xp21.1	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CGD	1536
MIM306480		Xp22.32	HALOACID DEHALOGENASE-LIKE HYDROLASE DOMAIN-CONTAINING 1A; HDHD1A	8226
MIM306500	C1844375	 	GYNECOMASTIA, FAMILIAL	 
MIM306700	C0019069	Xq28	HEMOPHILIA A; HEMA	 
MIM306800	C1844137	 	HEMOPHILIA A WITH VASCULAR ABNORMALITY	 
MIM306900	C0008533	Xq27.1-q27.2	HEMOPHILIA B; HEMB	2158
MIM306930	C1844026	 	HEMOPOIETIC PROLIFERATION	 
MIM306950	C1844025	 	HERNIA, ANTERIOR DIAPHRAGMATIC	 
MIM306955	C1844020	Xq26.2	HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	7547
MIM306960	C1844019	 	HHHH SYNDROME	 
MIM306995	C1415621	Xq28	HOMOSEXUALITY 1; HMS1	 
MIM307000	C0265216	Xq28	HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS; HSAS	3897
MIM307010	C1844005	 	HYDROCEPHALUS WITH CEREBELLAR AGENESIS	 
MIM307030	C0268418	Xp21.3-p21.2	HYPERGLYCEROLEMIA	2710
MIM307150	C1855900	Xq24-q27.1	HYPERTRICHOSIS, CONGENITAL GENERALIZED; HTC2	3342
MIM307200	C0472813	Xq21.3-q22	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3	695
MIM307300	C0151721	 	HYPOGONADISM, MALE	 
MIM307500	C1843994	 	HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	 
MIM307700	C0342344	Xq26-q27	HYPOPARATHYROIDISM, X-LINKED; HYPX	3258
MIM307800	C0733682	Xp22.2-p22.1	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR	5251
MIM307830	C1843972	 	HYPOURICEMIA, FAMILIAL RENAL, DUE TO TUBULAR HYPERSECRETION	 
MIM308000		Xq26-q27.2	HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1; HPRT1	3251
MIM308050	C0265267	Xq28	CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	50814
MIM308100	C0079588	Xp22.32	ICHTHYOSIS, X-LINKED; XLI	412
MIM308200	C1839989	 	ICHTHYOSIS AND MALE HYPOGONADISM	 
MIM308205	C1839988	Xp22.12-p22.11	IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	51360
MIM308220	C1839982	 	IMMUNODEFICIENCY, X-LINKED, WITH DEFICIENCY OF 115,000 DALTON SURFACE GLYCOPROTEIN	 
MIM308230	C0398689	Xq26	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1; HIGM1	959
MIM308240	C1868674	Xq25	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	331, 4068
MIM308250	C1839966	 	IMMUNOGLOBULIN M, LEVEL OF	 
MIM308280	C1839965	 	IMPACTED TEETH, MULTIPLE	 
MIM308300	C0021171	Xq28	INCONTINENTIA PIGMENTI; IP	8517, 8518
MIM308350	C3463992	Xp22.13	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	170302
MIM308380		Xq13	INTERLEUKIN 2 RECEPTOR, GAMMA; IL2RG	3561
MIM308385		Xp22.3	INTERLEUKIN 3 RECEPTOR, ALPHA; IL3RA	3563
MIM308500	C1839928	 	IRIS HYPOPLASIA WITH GLAUCOMA; IHG	2296, 3548
MIM308600	C1839927	 	JAUNDICE, FAMILIAL OBSTRUCTIVE, OF INFANCY	182, 5205, 5244, 5265, 8647
MIM308700	C1563719	Xp22.3	HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	3730
MIM308750	C1839911	 	KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	 
MIM308800	C0343057	Xp22.1	KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	51360, 6303
MIM308830	C1839910	 	KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	 
MIM308840		Xq28	L1 CELL ADHESION MOLECULE; L1CAM	3897
MIM308850	C0396059	 	LARYNGEAL ABDUCTOR PARALYSIS	 
MIM308905	C1839891	Xp11	LEBER OPTIC ATROPHY, SUSCEPTIBILITY TO	100188775
MIM308930		Xp22.2-p22.1	LEIGH SYNDROME, X-LINKED	5160
MIM308940	C1839884	Xq22.3	LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS	1288
MIM308950	C1839883	 	LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	 
MIM308960	C1839882	 	LEUKEMIA, ACUTE, ?X-LINKED	 
MIM308990	C1839874	Xp11.22	PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	1184
MIM309000	C0028860	Xq26.1	LOWE OCULOCEREBRORENAL SYNDROME; OCRL	4952
MIM309050		Xp21.2-q21.1	LUTHERAN SUPPRESSOR, X-LINKED; XS	7523
MIM309060		Xq24	LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 2; LAMP2	3920
MIM309100	C1839842	 	MACULAR DYSTROPHY, X-LINKED	 
MIM309120	C1839841	 	SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	100820759
MIM309200	C1839839	Xq28	MAJOR AFFECTIVE DISORDER 2; MAFD2	4096
MIM309300	C0344530	Xq21.3-q22	MEGALOCORNEA; MGC1	4251
MIM309350	C0025237	Xq28	MELNICK-NEEDLES SYNDROME; MNS	2316
MIM309400	C0022716	Xq12-q13	MENKES DISEASE	538
MIM309480	C1839801	 	MENTAL RETARDATION AND PSORIASIS	 
MIM309500	C0796135	Xp11.23	RENPENNING SYNDROME 1; RENS1	10084
MIM309510	C0796250	Xp22.13	PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS	170302
MIM309520	C0796022	Xq13	LUJAN-FRYNS SYNDROME	9968
MIM309530	C2931498	Xp11.22, Xp11.3-q21.1	MENTAL RETARDATION, X-LINKED 1; MRX1	23096, 4365
MIM309541	C0796208	Xq28	MENTAL RETARDATION, X-LINKED 3; MRX3	2664
MIM309545	C1839792	Xp11	MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	8246
MIM309548	C0751157	Xq28	MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE	2334
MIM309549	C0796215	Xp11.23	MENTAL RETARDATION, X-LINKED 9; MRX9	24140
MIM309550		Xq27.3	FMR1 GENE; FMR1	2332
MIM309555	C0795965	Xq26	MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	8258
MIM309560	C2745996	 	MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	 
MIM309580	C0796003	Xq13	MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	546
MIM309583	C0796160	Xp22.1	MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE; MRXSSR	6611
MIM309585	C1839736	Xp21.1-q22	WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	55869, 7492
MIM309605	C1839735	Xq13-q22	MILES-CARPENTER X-LINKED MENTAL RETARDATION SYNDROME; MCS	4183
MIM309610	C1839730	Xp11-q21	PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	5640
MIM309620	C1839729	Xq28	MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD	4364
MIM309630	C1839728	 	METACARPAL 4-5 FUSION; MF4	4235
MIM309640	C1839727	 	MENTAL RETARDATION WITH SPASTIC PARAPLEGIA	 
MIM309800	C0796016	Xq27-q28	MICROPHTHALMIA, SYNDROMIC 1; MCOPS1	4080, 54880
MIM309801	C0796070	Xp22	MICROPHTHALMIA, SYNDROMIC 7; MCOPS7	3052
MIM309840	C1839708	 	MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	 
MIM309845		Xq11.2-q12	MOESIN; MSN	4478
MIM309850		Xp11.23	MONOAMINE OXIDASE A; MAOA	4128
MIM309860		Xp11.23	MONOAMINE OXIDASE B; MAOB	4129
MIM309900	C0026705	Xq28	MUCOPOLYSACCHARIDOSIS TYPE II	3423
MIM309930	C1442927	 	MUSCULAR DYSTROPHY, CARDIAC TYPE	 
MIM309950	C1839671	 	MUSCULAR DYSTROPHY, HEMIZYGOUS LETHAL TYPE	 
MIM310000	C1839670	 	MUSCULAR DYSTROPHY, MABRY TYPE	 
MIM310095	C1839669	 	MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL	 
MIM310200	C0013264	Xp21.2	MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	1756
MIM310300	C0751337	Xq28	EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	2010
MIM310310		Xq22-q23	MYCL-RELATED PROCESSED GENE; MYCL2	4611
MIM310350	C1839650	 	MYELOLYMPHATIC INSUFFICIENCY	 
MIM310370	C0751778	 	MYOCLONIC EPILEPSY, PROGRESSIVE	 
MIM310400	C0410203	Xq28	MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	4534
MIM310440	C1839615	Xq28	MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX	203547
MIM310460	C1839612	Xq28	MYOPIA 1, X-LINKED; MYP1	4657
MIM310465	C2936859	Xp22.3-p21.1	N SYNDROME; NSX	4906, 5422
MIM310468	C0403720	Xp11.22	NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE; XRN	1184
MIM310470	C1839602	 	NEUROPATHY, HEREDITARY SENSORY, X-LINKED	 
MIM310490	C0795910	Xq24-q26.1	COWCHOCK SYNDROME	4672
MIM310500	C1839601	Xp11.4	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A	60506
MIM310600	C0266526	Xp11.4	NORRIE DISEASE; ND	4693
MIM310700	C1839580	Xq26.2	NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1	90167
MIM310800	C1839579	 	NYSTAGMUS, MYOCLONIC	 
MIM310900	C1839578	 	OCCIPITAL HAIR, WHITE LOCK OF	 
MIM310980		 	OMPHALOCELE, X-LINKED	 
MIM311000	C1839577	 	OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA; OPEM	4981
MIM311010		Xp11.4-p11.2	V-RAF MURINE SARCOMA 3611 VIRAL ONCOGENE HOMOLOG 1; ARAF1	369
MIM311030		Xq27	MCF.2 CELL LINE-DERIVED TRANSFORMING SEQUENCE; MCF2	4168
MIM311040		Xp11.2	ELK1, MEMBER OF ETS ONCOGENE FAMILY; ELK1	2002
MIM311050	C1839576	Xp11.4-p11.21	OPTIC ATROPHY 2; OPA2	4977
MIM311070	C1839566	Xq22-q24	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5; CMTX5	5631
MIM311100	C1839565	 	OPTIC ATROPHY--SPASTIC PARAPLEGIA SYNDROME	 
MIM311150	C1839564	Xq22	OPTICOACOUSTIC NERVE ATROPHY WITH DEMENTIA	1678
MIM311200	C1510460	Xp22.3-p22.2	OROFACIODIGITAL SYNDROME I; OFD1	8481
MIM311240		Xp11.3-p11.23	TBC1 DOMAIN FAMILY, MEMBER 25; TBC1D25	4943
MIM311250	C0268542	Xp21.1	ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO	5009
MIM311300	C0265251	Xq28	OTOPALATODIGITAL SYNDROME, TYPE I; OPD1	2316
MIM311350	C1839502	 	OUABAIN RESISTANCE; OUBR	 
MIM311360	C2749126	Xq26-q28	PREMATURE OVARIAN FAILURE 1; POF1	2332
MIM311400	C1412041	 	PAINE SYNDROME	4434
MIM311450	C0796110	 	PALLISTER W SYNDROME	 
MIM311510	C0796195	Xq28	PARKINSONISM, EARLY-ONSET, WITH MENTAL RETARDATION	7489
MIM311550		Xp11.3-p11.23	PCTAIRE PROTEIN KINASE 1; PCTK1	5127
MIM311770		Xp22.1	PHOSPHATIDYLINOSITOL GLYCAN, CLASS A; PIGA	5277
MIM311790		Xp11.21	6-@PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 1; PFKFB1	5207
MIM311800		Xq13	PHOSPHOGLYCERATE KINASE 1; PGK1	5230
MIM311850		Xq22-q24	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE I; PRPS1	5631
MIM311860		Xp22.3-p22.2	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE II; PRPS2	5634
MIM311870		Xq13	PHOSPHORYLASE KINASE, MUSCLE, ALPHA-1 SUBUNIT; PHKA1	5255
MIM311895	C1839464	 	PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	 
MIM311900	C1839463	Xp11.23-q13.3, Xp11.23	TARP SYNDROME; TARPS	8241
MIM312000	C0342376	Xq27.2-q27.3, Xq26.3	PANHYPOPITUITARISM, X-LINKED; PHPX	6658
MIM312040		Xp22.3-p21.1	POLYMERASE, DNA, ALPHA-1; POLA1	5422
MIM312060	C1839454	Xp11.4-p11.23	PROPERDIN DEFICIENCY, X-LINKED; CFPD	5199
MIM312070		Xq28	UBIQUITIN-LIKE 4A; UBL4A	8266
MIM312080	C0205711	Xq22	PELIZAEUS-MERZBACHER DISEASE; PMD	5354
MIM312090		Xq28	SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY) MEMBER 3; SLC10A3	8273
MIM312095		Xp22.32	SPLICING FACTOR, ARGININE/SERINE-RICH, 17A; SFRS17A	8227
MIM312100	C1839441	 	PSEUDOHERMAPHRODITISM, INCOMPLETE MALE, TYPE I	 
MIM312150	C1839440	 	MULTIPLE PTERYGIUM SYNDROME, X-LINKED	 
MIM312170	C1839414	Xp22.2-p22.1	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	5160
MIM312173		Xq28	RIBOSOMAL PROTEIN L10; RPL10	6134
MIM312180		Xq24-q25	UBIQUITIN-CONJUGATING ENZYME E2A; UBE2A	7319
MIM312190	C1839410	 	RADIAL APLASIA, X-LINKED	 
MIM312200	C1839409	 	RADIAL LOOP, PLAIN, ON RIGHT INDEX FINGER	 
MIM312210	C1839408	 	RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	 
MIM312300	C0268301	Xq11-q12	ANDROGEN INSENSITIVITY, PARTIAL; PAIS	367
MIM312420		Xq28	RENIN-BINDING PROTEIN; RENBP	5973
MIM312500	C0035288	 	RETICULOENDOTHELIOSIS, X-LINKED	 
MIM312530		 	RETINAL DETACHMENT	 
MIM312550	C1418874	 	RETINAL DYSPLASIA, PRIMARY; PRD	5548
MIM312600	C2681923	Xp11.23	RETINITIS PIGMENTOSA 2; RP2	6102
MIM312610		Xp11.4	RETINITIS PIGMENTOSA GTPase REGULATOR; RPGR	6103
MIM312612	C1839368	Xp21.3-p21.2	RETINITIS PIGMENTOSA 6; RP6	6104
MIM312700	C0271091	Xp22.2-p22.1	RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	6247
MIM312750	C0035372	Xq28	RETT SYNDROME; RTT	2290, 4204, 4208, 6792
MIM312760		Xq13.1	RIBOSOMAL PROTEIN S4, X-LINKED; RPS4X	6191
MIM312780	C0220775	 	RUSSELL-SILVER SYNDROME, X-LINKED	 
MIM312820		Xp11.2	SARCOMA, SYNOVIAL, X BREAKPOINT 1; SSX1	6756
MIM312830	C1839321	 	SCARF SYNDROME	 
MIM312840	C1839320	 	SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	 
MIM312860		 	SCOTT CRANIODIGITAL SYNDROME WITH MENTAL RETARDATION	 
MIM312861		Xq24	5-@HYDROXYTRYPTAMINE RECEPTOR 2C; HTR2C	3358
MIM312863	C1706416	Xq13	COMBINED IMMUNODEFICIENCY, X-LINKED; CIDX	3561
MIM312865		Xpter-p22.32	SHORT STATURE HOMEOBOX; SHOX	6473
MIM312870	C0796154	Xq26	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1; SGBS1	2239, 2719
MIM312910	C1839267	 	SPASTIC PARAPARESIS AND DEAFNESS	 
MIM312920	C1839264	Xq22	SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	5354
MIM313000	C1839262	Xp22.33	SPATIAL VISUALIZATION, APTITUDE FOR	59332
MIM313020		Xp22.1	SPERMIDINE/SPERMINE N(1)-ACETYLTRANSFERASE 1; SAT1	6303
MIM313200	C1839259	Xq11-q12	SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1; SMAX1	367
MIM313350	C1839258	Xq26	SPLIT-HAND/FOOT MALFORMATION 2; SHFM2	6463
MIM313400	C0220776	Xp22.2-p22.1	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT	6399
MIM313420	C0796172	 	SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	 
MIM313430		Xq26.3	SRY-BOX 3; SOX3	6658
MIM313440		Xp11.4-p11.2	SYNAPSIN I; SYN1	6853
MIM313470		Xpter-p22.32	CD99 ANTIGEN, X CHROMOSOME; CD99	4267
MIM313475		Xp11.23-p11.22	SYNAPTOPHYSIN; SYP	6855
MIM313490	C1839235	 	TAURODONTISM, MICRODONTIA, AND DENS INVAGINATUS	 
MIM313500	C1970757	Xq12-q13.1	TOOTH AGENESIS, SELECTIVE, X-LINKED, 1; STHAGX1	1896
MIM313650		Xq13	TAF1 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 250-KD; TAF1	6872
MIM313700		Xq11-q12	ANDROGEN RECEPTOR; AR	367
MIM313850	C1839172	Xq25-q26.1	THORACOABDOMINAL SYNDROME; THAS	7055
MIM313900	C1839163	Xp11.23-p11.22	THROMBOCYTOPENIA 1; THC1	7454
MIM314050	C1839161	Xp11.23	THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT	2623
MIM314100	CN074234	 	THUMBS, CONGENITAL CLASPED	 
MIM314200		Xq22.2	THYROXINE-BINDING GLOBULIN OF SERUM; TBG	6906
MIM314240	C1839140	 	TOOTH SIZE	 
MIM314250	C1839130	Xq13	DYSTONIA 3, TORSION, X-LINKED; DYT3	6872
MIM314300	C1839129	Xq28	TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	7085
MIM314310		Xp11.22	TRANSCRIPTION FACTOR FOR IMMUNOGLOBULIN HEAVY-CHAIN ENHANCER 3; TFE3	7030
MIM314320	C1839125	 	TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	 
MIM314360	C1839123	 	ULNAR HYPOPLASIA WITH LOBSTER-CLAW DEFORMITY OF FEET	 
MIM314370		Xp11.23	UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 1; UBA1	7317
MIM314375		Xp11.23-p11.22	SOLUTE CARRIER FAMILY 35 (UDP-GALACTOSE TRANSPORTER), MEMBER 2; SLC35A2	7355
MIM314380	C1839116	 	UNIQUE GREEN PHENOMENON	 
MIM314390	C1839115	 	VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	2187, 7547
MIM314400	C0262436	Xq28	CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	2316
MIM314500	C0796192	 	VAN DEN BOSCH SYNDROME	 
MIM314550	C1839114	 	VESICOURETERAL REFLUX, X-LINKED; VURX	 
MIM314570	C1839112	 	WIDOW'S PEAK SYNDROME	 
MIM314580	C0796200	Xq13-q21	WIEACKER SYNDROME	7493
MIM314600	C0265239	 	WILDERVANCK SYNDROME	 
MIM314670		Xq13.2	X INACTIVATION-SPECIFIC TRANSCRIPT; XIST	7503
MIM314690		Xp11.22-p11.21	LYSINE-SPECIFIC DEMETHYLASE 5C; KDM5C	8242
MIM314700	CN143716	Xpter-p22.32	BLOOD GROUP, XG SYSTEM; XG	 
MIM314705	C1839098	Xp22.32	XG REGULATOR; XGR	7501
MIM314850		Xp21.2-p21.1	KELL BLOOD GROUP PROTEIN, MCLEOD SYNDROME-ASSOCIATED; XK	7504
MIM314980		Xp22.2-p21.3	ZINC FINGER PROTEIN, X-LINKED; ZFX	7543
MIM314990		Xq21.1-q21.3	ZINC FINGER PROTEIN 711; ZNF711	7552
MIM314993		Xp11.3	ZINC FINGER PROTEIN 21; ZNF21	7569
MIM314995		Xp22.1-cen	ZINC FINGER PROTEIN 41; ZNF41	7592
MIM314997		Xq26	ZINC FINGER PROTEIN 75D; ZNF75D	7626
MIM314998		Xp22.1-p11	ZINC FINGER PROTEIN 81; ZNF81	347344
MIM315000		 	ZONULAR CATARACT AND NYSTAGMUS	 
MIM400003		Yq11	DELETED IN AZOOSPERMIA; DAZ	1617
MIM400004	C1839079	Chr.Y	RETINITIS PIGMENTOSA, Y-LINKED; RPY	79051
MIM400005		Yq11.2	UBIQUITIN-SPECIFIC PROTEASE 9, Y CHROMOSOME; USP9Y	8287
MIM400006		Yq11	RNA-BINDING MOTIF PROTEIN, Y CHROMOSOME, FAMILY 1, MEMBER A1; RBMY1A1	5940
MIM400008		Yp11.2	PROTEIN KINASE, Y-LINKED; PRKY	5616
MIM400009		Yq11	UBIQUITOUSLY TRANSCRIBED TETRATRICOPEPTIDE REPEAT GENE ON Y CHROMOSOME; UTY	7404
MIM400010		Yq11	DEAD/H BOX 3, Y-LINKED; DDX3Y	8653
MIM400011		Ypter-p11.2	ACETYLSEROTONIN METHYLTRANSFERASE-LIKE, Y-LINKED	8623
MIM400012		Yq11.221	VARIABLY CHARGED, Y CHROMOSOME; VCY	9084
MIM400013		Yq	BASIC PROTEIN, Y CHROMOSOME, 2; BPY2	9083
MIM400014		Yq11.223	EUKARYOTIC TRANSLATION INITIATION FACTOR 1A, Y-LINKED; EIF1AY	9086
MIM400015		Yq11.222	XK-RELATED PROTEIN ON Y CHROMOSOME	9082
MIM400016		Yq11.23	CHROMODOMAIN PROTEIN, Y CHROMOSOME, 1; CDY1	9085
MIM400017		Yq11.221	THYMOSIN, BETA-4, Y CHROMOSOME; TMSB4Y	9087
MIM400018		Yq11.221	CHROMODOMAIN PROTEIN, Y CHROMOSOME, 2; CDY2	9426
MIM400019		Yq11.223	PTPBL-RELATED GENE ON Y; PRY	9081
MIM400020		Ypter-p11.2	SHORT STATURE HOMEOBOX, Y-LINKED; SHOXY	6473
MIM400022		Yp11.2	PROTOCADHERIN 11, Y-LINKED; PCDH11Y	83259
MIM400023		Yp11.3	CYTOKINE RECEPTOR-LIKE FACTOR 2, Y-LINKED; CRLF2Y	64109
MIM400025		Yp11.2	TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR 2-LIKE, Y-LINKED; TGIF2LY	90655
MIM400026		Yq11.2	DELETED IN AZOOSPERMIA 2; DAZ2	57055
MIM400027		Yq11.2	DELETED IN AZOOSPERMIA 3; DAZ3	57054
MIM400028		Yq11.2	NEUROLIGIN 4, Y-LINKED; NLGN4Y	22829
MIM400029		Yq11.2	HEAT-SHOCK TRANSCRIPTION FACTOR, Y-LINKED; HSFY	86614
MIM400030		Yq11.2	RIBOSOMAL PROTEIN S4, Y-LINKED, 2; RPS4Y2	140032
MIM400031		Yq11.2	CHROMOSOME Y OPEN READING FRAME 15A; CYORF15A	246126
MIM400033		Yp11.2	TRANSDUCIN-BETA-LIKE 1, Y-LINKED; TBL1Y	90665
MIM400034		 	CHONDROITIN SULFATE PROTEOGLYCAN 4-LIKE, Y-LINKED; CSPG4LY	114758
MIM400035		 	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 2-LIKE, Y-LINKED; GOLGA2LY	84559
MIM400036		 	TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 3; TTTY3	114760
MIM400037		 	TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 4; TTTY4	114761
MIM400038		 	TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 5; TTTY5	83863
MIM400039		 	TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 6; TTTY6	84672
MIM400040		 	TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 17; TTTY17	252949
MIM400041		Yq11.2	PTPBL-RELATED GENE ON Y, 2; PRY2	442862
MIM400042	C1839073	3q21	SPERMATOGENIC FAILURE, Y-LINKED, 1; SPGFY1	619469, 7707
MIM400043	C1824927	Chr.Y	DEAFNESS, Y-LINKED 1; DFNY1	724074
MIM400044	C2748896	Yp11.3	46,XY SEX REVERSAL 1; SRXY1	6736
MIM400045	C2748895	Yp11.3	46,XX SEX REVERSAL 1; SRXX1	6736
MIM402500		Ypter-p11.2	ACETYLSEROTONIN METHYLTRANSFERASE, Y-CHROMOSOMAL; ASMT	438
MIM403000		Yp	ADENINE NUCLEOTIDE TRANSLOCATOR 3, Y-CHROMOSOMAL; ANT3Y	293
MIM410000		Yp11	AMELOGENIN, Y-CHROMOSOMAL; AMELY	266
MIM415000	C1839071	Yq11.2	SPERMATOGENIC FAILURE, Y-LINKED, 2; SPGFY2	140032, 1617, 442862, 560, 57054, 57055, 5940, 8284, 8287, 8653, 86614, 9081, 9082, 9083, 9084, 9085, 9426
MIM424500	C0206661	 	GONADOBLASTOMA; GBY	 
MIM425000		Yp11	GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR, ALPHA SUBUNIT, Y-CHROMOSOMAL; CSF2RY	1438
MIM425500	C1839070	Yq	HAIRY EARS, Y-LINKED	100188776
MIM426000		Yq11	LYSINE-SPECIFIC DEMETHYLASE 5D; KDM5D	8284
MIM430000		Yp11.3	INTERLEUKIN 3 RECEPTOR, Y-CHROMOSOMAL; IL3RA	3563
MIM450000		Ypter-p11.2	CD99 ANTIGEN, Y CHROMOSOME	4267
MIM465000		Ypter-p11.2	SPLICING FACTOR, ARGININE/SERINE RICH, 17A; SFRS17A	8227
MIM470000		Yp11.3	RIBOSOMAL PROTEIN S4, Y-LINKED, 1; RPS4Y1	6192
MIM475000	C1868676	Yq12	GROWTH CONTROL, Y-CHROMOSOME INFLUENCED; GCY	2656
MIM480000		Yp11.3	SEX-DETERMINING REGION Y; SRY	6736
MIM480100		Ypter-p11.2	TESTIS-SPECIFIC PROTEIN, Y-LINKED, 1; TSPY1	7258
MIM489500		Yp11	XG REGULATOR; XGR	7501
MIM490000		Yp11.3	ZINC FINGER PROTEIN, Y-LINKED; ZFY	7544
MIM500000	C1708371	 	CARDIOMYOPATHY, INFANTILE HISTIOCYTOID	 
MIM500001	C1839040	 	LEBER OPTIC ATROPHY AND DYSTONIA	 
MIM500002	C1839028	 	MITOCHONDRIAL MYOPATHY WITH DIABETES	 
MIM500003	C1839022	 	STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	 
MIM500004	C0271097	 	RETINITIS PIGMENTOSA-DEAFNESS SYNDROME	 
MIM502000	C0001811	 	AGING	 
MIM515000	C1838989	 	CHLORAMPHENICOL TOXICITY	 
MIM520000	C0342289	 	DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED	 
MIM520100	C1838912	 	DIARRHEA, CHRONIC, WITH VILLOUS ATROPHY	 
MIM530000	C0022541	 	KEARNS-SAYRE SYNDROME; KSS	 
MIM535000	C0917796	 	LEBER OPTIC ATROPHY	 
MIM540000	C0162671	 	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	 
MIM545000	C0162672	 	MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS; MERRF	 
MIM550500	C1838877	 	MYOGLOBINURIA, RECURRENT	 
MIM551000	C1838876	 	MITOCHONDRIAL MYOPATHY, LETHAL, INFANTILE; LIMM	 
MIM551200	C1838875	 	NEPHROPATHY, CHRONIC TUBULOINTERSTITIAL	 
MIM551500	C1838914	 	NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	 
MIM553000	C1510502	 	ONCOCYTOMA	 
MIM556500	C1838867	 	PARKINSON DISEASE, MITOCHONDRIAL	 
MIM557000	C0342773	 	PEARSON MARROW-PANCREAS SYNDROME	 
MIM560000	C3151959	 	RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	 
MIM580000	C1838854	22q13	DEAFNESS, AMINOGLYCOSIDE-INDUCED	55687
MIM598500	C1838782	 	WOLFRAM SYNDROME, MITOCHONDRIAL FORM	 
MIM600000	C1838781	 	SPONDYLOCAMPTODACTYLY	 
MIM600001	C1838780	 	PANCREATIC AGENESIS AND CONGENITAL HEART DEFECTS; PACHD	2627
MIM600002	C1838779	3p22-p21.1	EIKEN SKELETAL DYSPLASIA	5745
MIM600003		10p12	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-2 SUBUNIT; CACNB2	783
MIM600004		4q13	EPHRIN RECEPTOR EphA5; EPHA5	2044
MIM600005		16p13	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, TRANSACTIVATOR; MHC2TA	4261
MIM600006		19p13.1	REGULATORY FACTOR X, 1; RFX1	5989
MIM600007		 	FMS-RELATED TYROSINE KINASE 3 LIGAND; FLT3LG	2323
MIM600008		11q23.1	NICOTINAMIDE N-METHYLTRANSFERASE; NNMT	4837
MIM600009		14q32	INTERFERON-ALPHA-INDUCIBLE PROTEIN 27; IFI27	3429
MIM600010		20p11.2	INSULINOMA-ASSOCIATED 1; INSM1	3642
MIM600011		7q22	EPHRIN RECEPTOR EphB4; EPHB4	2050
MIM600012		14q24.3	UBIQUITIN-CONJUGATING ENZYME E2L 1; UBE2L1	283556
MIM600013		14q	TRANSCRIPTION FACTOR YY1; YY1	7528
MIM600014		9p24-p23	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 2; SMARCA2	6595
MIM600016		12q11-q12	CONTACTIN 1; CNTN1	1272
MIM600017		20q12-q13	SYNDECAN 4; SDC4	6385
MIM600018		6q24-q25	OPIOID RECEPTOR, MU-1; OPRM1	4988
MIM600019		17q11-qter	CYTOCHROME b561; CYB561	1534
MIM600020		10q25	MAX-INTERACTING PROTEIN 1; MXI1	4601
MIM600021		2p13	MAX DIMERIZATION PROTEIN 1; MXD1	4084
MIM600022		19q13.3	PROSTAGLANDIN I2 RECEPTOR; PTGIR	5739
MIM600023		16q21-q22.1	CADHERIN 11; CDH11	1009
MIM600024		1q42.1	LAMIN B RECEPTOR; LBR	3930
MIM600025		14q32.3	KINESIN LIGHT CHAIN 1; KLC1	3831
MIM600026		8q23-q24	SYNTROPHIN, BETA-1; SNTB1	6641
MIM600027		16q22-q23	SYNTROPHIN, BETA-2; SNTB2	6645
MIM600028		7q22	DISTAL-LESS HOMEOBOX 5; DLX5	1749
MIM600029		2q32	DISTAL-LESS HOMEOBOX 1; DLX1	1745
MIM600030		7q22	DISTAL-LESS HOMEOBOX 6; DLX6	1750
MIM600031		1q31-q32	CHITINASE 1; CHIT1	1118
MIM600033		7q22	TISSUE FACTOR PATHWAY INHIBITOR 2; TFPI2	7980
MIM600034		2p14-p13	EMPTY SPIRACLES, DROSOPHILA, HOMOLOG OF, 1; EMX1	2016
MIM600035		10q26.1	EMPTY SPIRACLES, DROSOPHILA, 2, HOMOLOG OF; EMX2	2018
MIM600036		2p13	ORTHODENTICLE, DROSOPHILA, HOMOLOG OF, 1; OTX1	5013
MIM600037		14q21-q22	ORTHODENTICLE, DROSOPHILA, HOMOLOG OF, 2; OTX2	5015
MIM600038		19p13.3	MEGAKARYOCTYE-ASSOCIATED TYROSINE KINASE; MATK	4145
MIM600039		20q11.21	BCL2-LIKE 1; BCL2L1	598
MIM600040		19q13.3-q13.4	BCL2-ASSOCIATED X PROTEIN; BAX	581
MIM600041		11q13.5	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 2; P2RY2	5029
MIM600042		18p11.2	MELANOCORTIN 5 RECEPTOR; MC5R	4161
MIM600043		4q13.1	SULFOTRANSFERASE, ESTROGEN-PREFERRING; STE	6783
MIM600044		3q26.3-q27	THROMBOPOIETIN; THPO	7066
MIM600045		11q12-q13	DNA DAMAGE-BINDING PROTEIN 1; DDB1	1642
MIM600046		9q22-q31	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 1; ABCA1	19
MIM600047		9q34	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 2; ABCA2	20
MIM600048	C1332441	11q23	BREAST CANCER, 11-22 TRANSLOCATION-ASSOCIATED; BRCATA	8068
MIM600049		3q26	MDS1 GENE; MDS1	 
MIM600050		11q13.1-q13.3	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 11; MAP3K11	4296
MIM600051		1p32	EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 15; EPS15	2060
MIM600052		11q12	ANGIOTENSIN RECEPTOR-LIKE 1; AGTRL1	187
MIM600053		2q11	CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-3; CNGA3	1261
MIM600057	C1838703	 	EXSTROPHY OF BLADDER	 
MIM600058		4p12	PROTEIN TYROSINE KINASE TXK; TXK	7294
MIM600059	C1838702	17p13.3	RETINITIS PIGMENTOSA 13; RP13	10594
MIM600060	C1838701	11q13.5	DEAFNESS, AUTOSOMAL RECESSIVE 2; DFNB2	4647
MIM600061		19p13.2	RAD23, YEAST, HOMOLOG OF, A; RAD23A	5886
MIM600062		Chr.9	RAD23, YEAST, HOMOLOG OF, B; RAD23B	5887
MIM600063		1q31	TROVE DOMAIN FAMILY, MEMBER 2; TROVE2	6738
MIM600064		21q22.11	KERATIN-ASSOCIATED PROTEIN 11-1; KRTAP11-1	337880
MIM600065		21q22.3	INTEGRIN, BETA-2; ITGB2	3689
MIM600066		 	EPHRIN RECEPTOR EphA6; EPHA6	285220
MIM600067		4q13	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B4; UGT2B4	7363
MIM600068		4q13	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B7; UGT2B7	7364
MIM600069		4q13	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B15; UGT2B15	7366
MIM600070		 	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B10; UGT2B10	7365
MIM600072	C0206042	20pter-p12	FATAL FAMILIAL INSOMNIA; FFI	5621
MIM600073		2q24-q31	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 2; LRP2	4036
MIM600074		6q21	CD24 ANTIGEN; CD24	100133941
MIM600075		6q27	TATA BOX-BINDING PROTEIN; TBP	6908
MIM600076		2q35-q36	TENSIN 1; TNS1	7145
MIM600079		7q11.23	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 12; PTPN12	5782
MIM600080	C1838670	 	MYELOCYTIC LEUKEMIA-LIKE SYNDROME, FAMILIAL, CHRONIC	 
MIM600081	C1838657	11p15.2	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B; VDDR1B	120227
MIM600082	C1704272	 	PROSTATIC HYPERPLASIA, BENIGN; BPH	 
MIM600084	C1838656	 	MACROCYTOSIS, FAMILIAL	 
MIM600085		9q22	PROTEIN-TYROSINE KINASE SYK; SYK	6850
MIM600086		4q23-q24	ALCOHOL DEHYDROGENASE 7; ADH7	131
MIM600087		1q21	TUFTELIN; TUFT1	7286
MIM600089	C1838655	6p21.3	PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	7962
MIM600092	C1838654	 	CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	 
MIM600093	C1838653	 	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	 
MIM600096	C1838651	 	PUERTO RICAN INFANT HYPOTONIA SYNDROME	 
MIM600098		11pter-p15.5	RELATED RAS VIRAL ONCOGENE HOMOLOG 2; RRAS2	22800
MIM600101	C2677637	1p34	DEAFNESS, AUTOSOMAL DOMINANT 2A; DFNA2A	9132
MIM600103		18q12.3	SYNAPTOTAGMIN 4; SYT4	6860
MIM600104		1q	SYNAPTOTAGMIN 2; SYT2	127833
MIM600105	C1838647	1q31-q32.1	RETINITIS PIGMENTOSA 12; RP12	23418
MIM600106		10q26.3	INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 40-KD; INPP5A	3632
MIM600108		11q22.3	MATRIX METALLOPROTEINASE 13; MMP13	4322
MIM600110	C1838644	6q14	STARGARDT DISEASE 3; STGD3	6785
MIM600111		5p13	SOLUTE CARRIER FAMILY 1 (GLIAL HIGH AFFINITY GLUTAMATE TRANSPORTER), MEMBER 3; SLC1A3	6507
MIM600112		14q32	DYNEIN, CYTOPLASMIC 1, HEAVY CHAIN 1; DYNC1H1	1778
MIM600114		1q23	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 3; CCT3	7203
MIM600116	C1868675	6q25.2-q27	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2	5071
MIM600117	C1838630	 	DYSPHASIA, FAMILIAL DEVELOPMENTAL	 
MIM600118	C1838625	2q21.3	WARBURG MICRO SYNDROME 1; WARBM1	22930, 22931, 25782
MIM600119		17q12-q21.33	SARCOGLYCAN, ALPHA; SGCA	6442
MIM600121	C1838612	2q31	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3; RCDP3	8540
MIM600122	C1838611	 	MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	 
MIM600123	C1838606	 	ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL AND RADIAL DEFECTS	 
MIM600124		7p15	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2/B1; HNRNPA2B1	3181
MIM600126		19p13.2	PHOSPHODIESTERASE 4A, cAMP-SPECIFIC; PDE4A	5141
MIM600127		1p31	PHOSPHODIESTERASE 4B, cAMP-SPECIFIC; PDE4B	5142
MIM600128		19p13.1	PHOSPHODIESTERASE 4C, cAMP-SPECIFIC; PDE4C	5143
MIM600129		5q12	PHOSPHODIESTERASE 4D, cAMP-SPECIFIC; PDE4D	5144
MIM600130		12p13.1	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE 1; APOBEC1	339
MIM600131	C1838604	8q24	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	50966
MIM600132	C1838603	6p21.3	RETINITIS PIGMENTOSA 14; RP14	7287
MIM600133		6q21	LAMININ, ALPHA-4; LAMA4	3910
MIM600135		19p13.2	CORTEXIN 1; CTXN1	404217
MIM600136		14q24.3-q31	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9; MAP3K9	4293
MIM600137		19q13.1-q13.2	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 10; MAP3K10	4294
MIM600138	C1838601	19q13.4	RETINITIS PIGMENTOSA 11; RP11	26121
MIM600139		 	SUBEPENDYMOMA	 
MIM600140		16p13.3	CREB-BINDING PROTEIN; CREBBP	1387
MIM600141		2q33.1	HEAT-SHOCK 10-KD PROTEIN; HSPE1	3336
MIM600142	C1838577	 	CEREBRAL AUTOSOMAL RECESSIVE ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	5654
MIM600143	C1838570	8p23	CEROID LIPOFUSCINOSIS, NEURONAL, 8; CLN8	2055
MIM600144		12p11	INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 2; ITPR2	3709
MIM600145	C1838568	1p13	SACRAL DEFECT WITH ANTERIOR MENINGOCELE	81839
MIM600146	C1838566	 	SPASTIC PARAPLEGIA 5B, AUTOSOMAL RECESSIVE; SPG5B	6685
MIM600147		17q21	MESENCHYME HOMEOBOX 1; MEOX1	4222
MIM600148		 	GLYCEROL KINASE, TESTICULAR, TYPE A	2712
MIM600149		 	GLYCEROL KINASE, TESTICULAR, TYPE B	2713
MIM600150		10q22.3	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, ALPHA MEMBER 1; KCNMA1	3778
MIM600152		3p25-p24	SEC13-LIKE PROTEIN 1; SEC13L1	6396
MIM600153		2p21-p16	PHOSPHATIDYLINOSITOL GLYCAN, CLASS F; PIGF	5281
MIM600154		14q11-q24	PHOSPHATIDYLINOSITOL GLYCAN, CLASS H; PIGH	5283
MIM600155	C1838564	13q22	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2; HSCR2	1910
MIM600156	C1970723	9q31	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 5; HSCR5	404720
MIM600157		22q12	ADAPTOR-RELATED PROTEIN COMPLEX 1, BETA-1 SUBUNIT; AP1B1	162
MIM600159	C1838562	 	PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	 
MIM600160		9p21	CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A	1029
MIM600161		15q11-q13	PRADER-WILLI/ANGELMAN REGION TRANSCRIPT 1	145624
MIM600162		15q11-q13	PRADER-WILLI/ANGELMAN REGION TRANSCRIPT 5	8123
MIM600163		3p21	SODIUM CHANNEL, VOLTAGE-GATED, TYPE V, ALPHA SUBUNIT; SCN5A	6331
MIM600164		8q13-q21	GTP-BINDING MITOGEN-INDUCED T-CELL PROTEIN; GEM	2669
MIM600165	C1838502	11p	NANOPHTHALMOS 1; NNO1	23691
MIM600166	C1838501	 	HYPERPARATHYROIDISM, PRIMARY, CAUSED BY WATER CLEAR CELL HYPERPLASIA	 
MIM600167		3p21-p14	HISTAMINE RECEPTOR H1; HRH1	3269
MIM600168		3p21.3	MACROPHAGE STIMULATING 1 RECEPTOR; MST1R	4486
MIM600169		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN-RELATED GENE A; MICA	100507436
MIM600170		9p13	AQUAPORIN 3; AQP3	360
MIM600171	C0949331	 	GONADAL AGENESIS	 
MIM600172		1p33	METAL-REGULATORY TRANSCRIPTION FACTOR 1; MTF1	4520
MIM600173		19p13.1	JANUS KINASE 3; JAK3	3718
MIM600174		17p13.3	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, ALPHA; PITPNA	5306
MIM600175	C1838492	12q23-q24	SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE	59341, 8094
MIM600176	C1838491	19q13.12	PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS	 
MIM600178		15q13-qter	MICROTUBULE-ASSOCIATED PROTEIN 1A; MAP1A	4130
MIM600179		17p13.1	GUANYLATE CYCLASE 2D, MEMBRANE; GUCY2D	3000
MIM600181		9q34	LIPOCALIN 2; LCN2	3934
MIM600182		16q24.3	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 5; SLC7A5	8140
MIM600183		17q21	DUAL-SPECIFICITY PHOSPHATASE 3; DUSP3	1845
MIM600184		9q34.1	CARNITINE ACETYLTRANSFERASE; CRAT	1384
MIM600185		13q12.3	BRCA2 GENE; BRCA2	675
MIM600187		17p13-p12	EUKARYOTIC TRANSLATION INITIATION FACTOR 5A; EIF5A	1984
MIM600188		19p13.3	AMINO-TERMINAL ENHANCER OF SPLIT; AES	166
MIM600189		9q21.3	TRANSDUCIN-LIKE ENHANCER OF SPLIT 1; TLE1	7088
MIM600190		15q22	TRANSDUCIN-LIKE ENHANCER OF SPLIT 3; TLE3	7090
MIM600192		18q11.2	SYNOVIAL SARCOMA TRANSLOCATION, CHROMOSOME 18; SS18	6760
MIM600193	C1838447	1p21-p13.3	WAARDENBURG SYNDROME, TYPE 2B; WS2B	7488
MIM600194		12q11-q13	KERATIN 2; KRT2	3849
MIM600195	C1838437	9p21	VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL; VMCM	7010
MIM600197		7p22	V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE FAMILY, PROTEIN K; MAFK	7975
MIM600201		20q11.2	AGOUTI SIGNALING PROTEIN; ASIP	434
MIM600202	C1838436	6p22.2	DYSLEXIA, SUSCEPTIBILITY TO, 2; DYX2	9856
MIM600204	C1838429	1p33-p32.2	EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2	1298
MIM600206		12p12.3	EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 8; EPS8	2059
MIM600207		2p25.1	HIPPOCALCIN-LIKE 1; HPCAL1	3241
MIM600208	C1834478	22q11.2	MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	4627
MIM600209	C1838420	19p	EXOSTOSES, MULTIPLE, TYPE III; EXT3	2133
MIM600210		1p36	RUNT-RELATED TRANSCRIPTION FACTOR 3; RUNX3	864
MIM600211		6p21	RUNT-RELATED TRANSCRIPTION FACTOR 2; RUNX2	860
MIM600212		17q25	FATTY ACID SYNTHASE; FASN	2194
MIM600214		6p21.3	ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; AGER	177
MIM600215		15q15-q12	MICROFIBRILLAR-ASSOCIATED PROTEIN 1; MFAP1	4236
MIM600220		16q24.1	PHOSPHOLIPASE C, GAMMA-2; PLCG2	5336
MIM600221		9p21	TEK TYROSINE KINASE, ENDOTHELIAL; TEK	7010
MIM600222		1p34-p33	TYROSINE KINASE WITH IMMUNOGLOBULIN AND EGF FACTOR HOMOLOGY DOMAINS 1; TIE1	7075
MIM600223	C0752122	16q22.1	SPINOCEREBELLAR ATAXIA 4; SCA4	 
MIM600224	C0752123	11q13	SPINOCEREBELLAR ATAXIA 5; SCA5	6712
MIM600225		14q22.1-q22.2	GTP CYCLOHYDROLASE I; GCH1	2643
MIM600227		16p13.3	CYCLIN F; CCNF	899
MIM600228		12p13	SODIUM CHANNEL, NONVOLTAGE-GATED 1, ALPHA SUBUNIT; SCNN1A	6337
MIM600229		2p14	SOLUTE CARRIER FAMILY 1 (GLUTAMATE/NEUTRAL AMINO ACID TRANSPORTER), MEMBER 4; SLC1A4	6509
MIM600230		11q13	PHOSPHOLIPASE C, BETA-3; PLCB3	5331
MIM600231	C1838359	12q11-q13	PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE; PPKB	8084
MIM600232		5q34-q35	GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-2; GABRB2	2561
MIM600233		15q11.2-q12	GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-3; GABRG3	2567
MIM600234		1p13-p12	3-@HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 2; HMGCS2	3158
MIM600235		19q13.1	SODIUM CHANNEL, VOLTAGE-GATED, TYPE I, BETA SUBUNIT; SCN1B	6324
MIM600236		1q32-q41	CENTROMERIC PROTEIN F; CENPF	1063
MIM600237		22q11	HISTONE CELL CYCLE REGULATION DEFECTIVE, S. CEREVISIAE, HOMOLOG OF, A; HIRA	7290
MIM600238		20q12	TRANSGLUTAMINASE 3; TGM3	7053
MIM600239		2q33.3	G PROTEIN-COUPLED RECEPTOR 1; GPR1	2825
MIM600240		17q21.1-q21.3	G PROTEIN-COUPLED RECEPTOR 2; GPR2	2826
MIM600241		1p36.1-p34.3	G PROTEIN-COUPLED RECEPTOR 3; GPR3	2827
MIM600242		17q12-q21.2	CHEMOKINE, CC MOTIF, RECEPTOR 7; CCR7	1236
MIM600243		14q11-q12	DEFENDER AGAINST CELL DEATH 1; DAD1	1603
MIM600244		2q37.3	PROGRAMMED CELL DEATH 1; PDCD1	5133
MIM600245		1q32.1	FIBROMODULIN; FMOD	2331
MIM600246		1q32	ELK4, ETS-DOMAIN PROTEIN; ELK4	2005
MIM600247		12q23	ELK3, ETS-DOMAIN PROTEIN; ELK3	2004
MIM600249		3q21.3	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER L1; ALDH1L1	10840
MIM600250		1q23	CHEMOKINE, C MOTIF, LIGAND 1; XCL1	6375
MIM600251	C1838348	 	FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	23384
MIM600252	C0796020	 	LOWRY-MACLEAN SYNDROME	 
MIM600253		7p15	ARYL HYDROCARBON RECEPTOR; AHR	196
MIM600256		 	HYDROCEPHALUS, AUTOSOMAL DOMINANT	 
MIM600257	C1838346	 	CHROMOSOME 8q12.1-q21.2 DELETION SYNDROME	100885787
MIM600258		2q31-q33	POSTMEIOTIC SEGREGATION INCREASED, S. CEREVISIAE, 1; PMS1	5378
MIM600259		7p22	POSTMEIOTIC SEGREGATION INCREASED, S. CEREVISIAE, 2; PMS2	5395
MIM600262		1q25.2-q25.3	PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2; PTGS2	5743
MIM600263	C1838332	7q31.3, 6q23-q24	HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO	3459, 5803
MIM600264		1q32	ARGININE VASOPRESSIN RECEPTOR 1B; AVPR1B	553
MIM600266		2q35	SOLUTE CARRIER FAMILY 11 (PROTON-COUPLED DIVALENT METAL ION TRANSPORTER), MEMBER 1; SLC11A1	6556
MIM600267		4q21.3	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 13; PTPN13	5783
MIM600268	C1838329	 	APLASIA CUTIS CONGENITA WITH EPIBULBAR DERMOIDS	 
MIM600269	C1838328	 	SHORT TARSUS WITH ABSENCE OF LOWER EYELASHES; STALE	 
MIM600270		7q21.3-q22	PROCOLLAGEN C-ENDOPEPTIDASE ENHANCER; PCOLCE	5118
MIM600271		18q12.1	DESMOCOLLIN 3; DSC3	1825
MIM600272		17q22-q23	COILIN; COIL	8161
MIM600273	C1838327	16p13.3	POLYCYSTIC KIDNEY DISEASE, INFANTILE SEVERE, WITH TUBEROUS SCLEROSIS; PKDTS	8132
MIM600274	C0338451	17q21.1, 14q24.3	FRONTOTEMPORAL DEMENTIA; FTD	4137, 5663
MIM600275		1p13-p11	NOTCH, DROSOPHILA, HOMOLOG OF, 2; NOTCH2	4853
MIM600276		19p13.2-p13.1	NOTCH, DROSOPHILA, HOMOLOG OF, 3; NOTCH3	4854
MIM600277		1p36.13-p36.12	INHIBITOR OF DNA BINDING 3; ID3	3399
MIM600278		1p36.1-p35	RAP1, GTPase-ACTIVATING PROTEIN 1; RAP1GA1	5909
MIM600279		1q22	PEROXISOME BIOGENESIS FACTOR 19; PEX19	5824
MIM600280		16p13.1	NUCLEOTIDE-BINDING PROTEIN 1; NUBP1	4682
MIM600281		20q12-q13.1	HEPATOCYTE NUCLEAR FACTOR 4-ALPHA; HNF4A	3172
MIM600282		11q22.3	GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 4; GRIK4	2900
MIM600283		19q13.2	GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 5; GRIK5	2901
MIM600284		19p13.1	ELONGATION FACTOR RNA POLYMERASE II; ELL	8178
MIM600285		5q31.1	EUKARYOTIC TRANSLATION TERMINATION FACTOR 1; ETF1	2107
MIM600286		22q11.21	PHOSPHATIDYLINOSITOL 4-KINASE, CATALYTIC, ALPHA; PI4KA	5297
MIM600287		7p15	GLYCYL-tRNA SYNTHETASE; GARS	2617
MIM600288		20p11	FORKHEAD BOX A2; FOXA2	3170
MIM600289		6p21.3-p21.2	MITOGEN-ACTIVATED PROTEIN KINASE 14; MAPK14	1432
MIM600291		2p24-p22	ADENYLATE CYCLASE 3; ADCY3	109
MIM600292		14q11.2	ADENYLATE CYCLASE 4; ADCY4	196883
MIM600293		3q13.2-q21	ADENYLATE CYCLASE 5; ADCY5	111
MIM600294		12q12-q13	ADENYLATE CYCLASE 6; ADCY6	112
MIM600295		1p36.2	NATRIURETIC PEPTIDE PRECURSOR B; NPPB	4879
MIM600296		2q24-qter	NATRIURETIC PEPTIDE PRECURSOR C; NPPC	4880
MIM600297		13q12.3	CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 2; CDX2	1045
MIM600298		1q22-q23	LIM HOMEOBOX TRANSCRIPTION FACTOR 1, ALPHA; LMX1A	4009
MIM600299		8p22-p21.3	PERICENTRIOLAR MATERIAL 1; PCM1	5108
MIM600300		11p13-p12	SOLUTE CARRIER FAMILY 1 (GLIAL HIGH AFFINITY GLUTAMATE TRANSPORTER), MEMBER 2; SLC1A2	6506
MIM600301		10q25-q26	ACYL-CoA DEHYDROGENASE, SHORT/BRANCHED CHAIN; ACADSB	36
MIM600302	C1838281	 	FRYNS MACROCEPHALY	 
MIM600303		9q34.3	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; RAPGEF1	2889
MIM600305		16p13.3	DODECENOYL-CoA DELTA ISOMERASE; DCI	1632
MIM600306		14q11.2	PROTEASOME SUBUNIT, BETA-TYPE, 5; PSMB5	5693
MIM600307		 	PROTEASOME SUBUNIT, BETA-TYPE, 6; PSMB6	5694
MIM600308		18q11.2-q12.1	AQUAPORIN 4; AQP4	361
MIM600309	C0344783	1p31-p21, 6q21-q23.2	ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	2697
MIM600310		19p13.1	CARTILAGE OLIGOMERIC MATRIX PROTEIN; COMP	1311
MIM600311		19p13.3	GRANZYME M; GZMM	3004
MIM600312		7p22	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 1; NUDT1	4521
MIM600314		9p12-p11	SHB ADAPTOR PROTEIN; SHB	6461
MIM600315		1p36	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 4; TNFRSF4	7293
MIM600316	C1838263	17p11.2	DEAFNESS, AUTOSOMAL RECESSIVE 3; DFNB3	51168
MIM600317		19p13.1	TROPOMYOSIN 4; TPM4	7171
MIM600318	C1838262	15q26	DIABETES MELLITUS, INSULIN-DEPENDENT, 3; IDDM3	3402
MIM600319	C1838261	11q13	DIABETES MELLITUS, INSULIN-DEPENDENT, 4; IDDM4	3403
MIM600320	C1838260	6q25	DIABETES MELLITUS, INSULIN-DEPENDENT, 5; IDDM5	387082
MIM600321	C1838259	2q31	DIABETES MELLITUS, INSULIN-DEPENDENT, 7; IDDM7	3406
MIM600322		20p11.2	SYNAPTOSOMAL-ASSOCIATED PROTEIN, 25-KD; SNAP25	6616
MIM600323		1q31	REGULATOR OF G PROTEIN SIGNALING 1; RGS1	5996
MIM600324		4q12-q13	CHEMOKINE, CXC MOTIF, LIGAND 5; CXCL5	6374
MIM600325	C0795939	 	AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA	 
MIM600326		11q23.3	DEAD/H BOX 6; DDX6	1656
MIM600327		19q	SYNAPTOTAGMIN 3; SYT3	84258
MIM600328		17q21	MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 6; MLLT6	4302
MIM600329	C1838258	 	OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	 
MIM600331	C1838256	 	PARC SYNDROME	 
MIM600332	C1838254	1q41	RIPPLING MUSCLE DISEASE 1; RMD1	6022
MIM600334	C1838244	2q31	TIBIAL MUSCULAR DYSTROPHY, TARDIVE	7273
MIM600335	C1838243	 	SUCCINIC ACIDEMIA	 
MIM600336		10q11.2	SOLUTE CARRIER FAMILY 18 (VESICULAR ACETYLCHOLINE), MEMBER 3; SLC18A3	6572
MIM600337		14q32.1-q32.2	BRADYKININ RECEPTOR B1; BDKRB1	623
MIM600338		3q21.3-q25.2	ARYLACETAMIDE DEACETYLASE; AADAC	13
MIM600339		1q21	HEPATOMA-DERIVED GROWTH FACTOR; HDGF	3068
MIM600340		16q13	PLASMA MEMBRANE PROTEOLIPID; PLLP	51090
MIM600341		15q15.1-q21.1	TYRO3 PROTEIN TYROSINE KINASE; TYRO3	7301
MIM600342		10q23	G PROTEIN-COUPLED RECEPTOR, RETINAL; RGR	5995
MIM600345		4q13-q21	BETACELLULIN; BTC	685
MIM600346		17q12	POLYCOMB GROUP RING FINGER PROTEIN 2; PCGF2	7703
MIM600347		 	BREVICAN	63827
MIM600348	C1838239	 	BAND HETEROTOPIA OF BRAIN	 
MIM600349		20q11	INHIBITOR OF DNA BINDING 1; ID1	3397
MIM600351	C1838238	 	ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	 
MIM600353		1q21	S100 CALCIUM-BINDING PROTEIN A7; S100A7	6278
MIM600354		5q12.2-q13.3	SURVIVAL OF MOTOR NEURON 1; SMN1	6606
MIM600355		5q12.2-q13.3	NEURONAL APOPTOSIS INHIBITORY PROTEIN; NAIP	4671
MIM600356	C1838218	 	PACHYDERMODACTYLY, FAMILIAL	 
MIM600357		1p34.1-p32	RIBOSOMAL PROTEIN S8; RPS8	6202
MIM600358		3q24	GUANINE MONOPHOSPHATE SYNTHETASE; GMPS	8833
MIM600359		11q24	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 1; KCNJ1	3758
MIM600360	C1838206	 	APLASIA CUTIS CONGENITA OF LIMBS, AUTOSOMAL RECESSIVE	 
MIM600361	CN074211	 	HEREDITARY MOTOR AND SENSORY NEUROPATHY V	101059903
MIM600362		17p11.2	FLIGHTLESS I, DROSOPHILA, HOMOLOG OF; FLII	2314
MIM600363	C1838192	15q11.1	SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT; SPG6	123606
MIM600364		6p21.1	GUANYLATE CYCLASE ACTIVATOR 1A; GUCA1A	2978
MIM600365		17p13.3	ACTIVE BCR-RELATED GENE; ABR	29
MIM600366		5q	ISL LIM HOMEOBOX 1; ISL1	3670
MIM600367		 	CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 3, 77-KD; CSTF3	1479
MIM600368		 	CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 2, 64-KD; CSTF2	1478
MIM600369		 	CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 1, 50-KD; CSTF1	1477
MIM600370		12q23	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 3; SLC25A3	5250
MIM600372		12q22	NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 1; NEDD1	121441
MIM600373	C1838180	 	CODAS SYNDROME	 
MIM600374		15q22.3-q23	BBS4 GENE; BBS4	585
MIM600375		7q36.1	X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 2; XRCC2	7516
MIM600376	C1838163	12q11-q14	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	94
MIM600377		18q23	GALANIN RECEPTOR 1; GALR1	2587
MIM600378		2p11.2	INNER MEMBRANE PROTEIN, MITOCHONDRIAL; IMMT	10989
MIM600379		20q13.3	MYELIN TRANSCRIPTION FACTOR 1; MYT1	4661
MIM600380		19q13.3	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2; NR1H2	7376
MIM600381		14q22	KINECTIN; KTN1	3895
MIM600382		 	MYC PROMOTER-BINDING PROTEIN	10260
MIM600383	C1838162	8q13	MESOMELIA-SYNOSTOSES SYNDROME	100526741
MIM600384	C1838161	 	APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSAL IV	 
MIM600385		16q12-q13	ADENYLATE CYCLASE 7; ADCY7	113
MIM600386		2p25	INHIBITOR OF DNA BINDING 2; ID2	3398
MIM600387		4p15.32	BONE MARROW STROMAL CELL ANTIGEN 1; BST1	683
MIM600388		6p21.2-p21.1	MEPRIN, ALPHA SUBUNIT; MEP1A	4224
MIM600389		18q12.2-q12.3	MEPRIN, BETA SUBUNIT; MEP1B	4225
MIM600390		19q13	UPSTREAM STIMULATORY FACTOR 2; USF2	7392
MIM600391		9q13	GLUCOSAMINYL (N-ACETYL) TRANSFERASE 1, CORE 2; GCNT1	2650
MIM600392		12p13-p12.2	RAD52, YEAST, HOMOLOG OF; RAD52	5893
MIM600393		11q12	FLAP STRUCTURE-SPECIFIC ENDONUCLEASE 1; FEN1	2237
MIM600395		2q35-q37	GLYPICAN 1; GPC1	2817
MIM600396		17q21.31	DEAH BOX POLYPEPTIDE 8; DHX8	1659
MIM600397		20q13.2	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAB-RELATED SUBFAMILY, MEMBER 1; KCNB1	3745
MIM600398		19q13.3-q13.4	ZINC FINGER PROTEIN 160; ZNF160	90338
MIM600399	C1838160	 	PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	 
MIM600400		6q22	PROLYL ENDOPEPTIDASE; PREP	5550
MIM600403		2q23	FIBROBLAST ACTIVATION PROTEIN, ALPHA; FAP	2191
MIM600404		7q11.23	REPLICATION FACTOR C, SUBUNIT 2; RFC2	5982
MIM600405		13q12.3-q13	REPLICATION FACTOR C, SUBUNIT 3; RFC3	5983
MIM600407		12q24.2-q24.3	REPLICATION FACTOR C, SUBUNIT 5; RFC5	5985
MIM600408		6p21.3	DISCOIDIN DOMAIN RECEPTOR FAMILY, MEMBER 1; DDR1	780
MIM600409		6p21.2-p21.1	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA; PPARD	5467
MIM600410		2q23.3	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 6; TNFAIP6	7130
MIM600411		1p22.2	GUANYLATE-BINDING PROTEIN 1, INTERFERON-INDUCIBLE, 67-KD; GBP1	2633
MIM600412		1p22.2	GUANYLATE-BINDING PROTEIN 2, INTERFERON-INDUCIBLE; GBP2	2634
MIM600413		1p22.2	GUANYLATE-BINDING PROTEIN 3; GBP3	2635
MIM600414		12p13.3	PEROXISOME BIOGENESIS FACTOR 5; PEX5	5830
MIM600415		8q13.1-q13.3	TOCOPHEROL TRANSFER PROTEIN, ALPHA; TTPA	7274
MIM600416	C0410192	 	MUSCULAR DYSTROPHY, SCAPULOHUMERAL	 
MIM600417		10q24.3	5-PRIME-@NUCLEOTIDASE, CYTOSOLIC II; NT5C2	22978
MIM600418		7p14-p13	AMPHIPHYSIN; AMPH	273
MIM600419	C1838141	 	ANGIOKERATOMA CORPORIS DIFFUSUM WITH ARTERIOVENOUS FISTULAS	 
MIM600421		4q33-q34	GLYCINE RECEPTOR, ALPHA-3 SUBUNIT; GLRA3	8001
MIM600422		5q23-q35	FATTY ACID-BINDING PROTEIN 6; FABP6	2172
MIM600423		1p36.1	ENDOTHELIN-CONVERTING ENZYME 1; ECE1	1889
MIM600424		21q22.3	SOLUTE CARRIER FAMILY 19 (FOLATE TRANSPORTER), MEMBER 1; SLC19A1	6573
MIM600426		1p36	E2F TRANSCRIPTION FACTOR 2; E2F2	1870
MIM600427		6p22	E2F TRANSCRIPTION FACTOR 3; E2F3	1871
MIM600428		9q34	VAV2 ONCOGENE; VAV2	7410
MIM600429		6p24-p23	GLUCOSAMINYL (N-ACETYL) TRANSFERASE 2, I-BRANCHING ENZYME; GCNT2	2651
MIM600430	C1838126	2q37.2	BRACHYDACTYLY-MENTAL RETARDATION SYNDROME; BDMR	626, 9759
MIM600431		9p21	CYCLIN-DEPENDENT KINASE INHIBITOR 2B; CDKN2B	1030
MIM600432		16q12.1	PRECEREBELLIN 1; CBLN1	869
MIM600433		18q23	PRECEREBELLIN 2; CBLN2	147381
MIM600434		8q21	FATTY ACID-BINDING PROTEIN 4; FABP4	2167
MIM600435		16p11.2-p11.1	CARDIOTROPHIN 1; CTF1	1489
MIM600436		22q11.2	GLUTATHIONE S-TRANSFERASE, THETA-1; GSTT1	2952
MIM600437		22q11.2	GLUTATHIONE S-TRANSFERASE, THETA-2; GSTT2	2953
MIM600438		10q21	TRANSCRIPTION FACTOR A, MITOCHONDRIAL; TFAM	7019
MIM600439		7q34	SINGLE-STRANDED DNA-BINDING PROTEIN 1; SSBP1	6742
MIM600440		9q34.1	ENDONUCLEASE G, MITOCHONDRIAL; ENDOG	2021
MIM600441		13q34	GROWTH ARREST-SPECIFIC 6; GAS6	2621
MIM600442		12q13	AQUAPORIN 5; AQP5	362
MIM600443		5q14	GLUTAREDOXIN; GLRX	2745
MIM600444		21q22	SOLUTE CARRIER FAMILY 5 (INOSITOL TRANSPORTER), MEMBER 3; SLC5A3	6526
MIM600445		1p21-p13	ADENOSINE A3 RECEPTOR; ADORA3	140
MIM600446		17p12-p11.2	ADENOSINE A2B RECEPTOR; ADORA2B	136
MIM600447		12q13	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 12; MAP3K12	7786
MIM600448		10p15	PROTEIN KINASE C, THETA; PRKCQ	5588
MIM600449		10p15-p14	ALDO-KETO REDUCTASE FAMILY 1, MEMBER 1; AKR1C1	1645
MIM600450		10p15-p14	ALDO-KETO REDUCTASE FAMILY 1, MEMBER C2; AKR1C2	1646
MIM600451		10p15-p14	ALDO-KETO REDUCTASE FAMILY 1, MEMBER C4; AKR1C4	1109
MIM600453		17q23.1	TRIPARTITE MOTIF-CONTAINING PROTEIN 25; TRIM25	7706
MIM600454		11q13.3-q13.5	RIBOSOMAL PROTEIN S3; RPS3	6188
MIM600455		11q13.3-q13.5	RNA, U15A SMALL NUCLEOLAR; RNU15A	6079
MIM600456		9q22.1	NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 2; NTRK2	4915
MIM600457	C1838123	 	HYPERTRICHOSIS, ANTERIOR CERVICAL	 
MIM600458	C0341858	 	ADENOMYOSIS	 
MIM600459	C1838122	 	ARTERIAL DISSECTION WITH LENTIGINOSIS	 
MIM600460	C1838121	 	CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY	 
MIM600461	C1838120	 	HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	 
MIM600462	C1838103	12q24.33	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	80324
MIM600463		15q26	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A3; ALDH1A3	220
MIM600464		 	ADP-RIBOSYLATION FACTOR 6; ARF6	382
MIM600465		10q21	ANKYRIN 3; ANK3	288
MIM600466		Chr.11	ALDEHYDE DEHYDROGENASE 3 FAMILY, MEMBER B1; ALDH3B1	221
MIM600467	C1838102	3q13.1	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	4265
MIM600469		9q22.3-q31	NUCLEAR CAP-BINDING PROTEIN 1; NCBP1	4686
MIM600470		3q24	ZINC FINGER PROTEIN OF CEREBELLUM 1; ZIC1	7545
MIM600471		8p23.1	DEFENSIN, ALPHA, 6; DEFA6	1671
MIM600472		8p23.1	DEFENSIN, ALPHA, 5; DEFA5	1670
MIM600473		5q31	PURINE-RICH ELEMENT-BINDING PROTEIN A; PURA	5813
MIM600474		3p21.3	CATHELICIDIN ANTIMICROBIAL PEPTIDE; CAMP	820
MIM600475		11p15.3	TAF10 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 30-KD; TAF10	6881
MIM600477		16q22.1	SOLUTE CARRIER FAMILY 9, MEMBER 5; SLC9A5	6553
MIM600478		6p21	SUPERKILLER VIRALICIDIC ACTIVITY 2, S. CEREVISIAE, HOMOLOG-LIKE; SKIV2L	6499
MIM600480		15q21	TRANSCRIPTION FACTOR 12; TCF12	6938
MIM600481		22q13	STEROL REGULATORY ELEMENT-BINDING TRANSCRIPTION FACTOR 2; SREBF2	6721
MIM600483		10q24	FIBROBLAST GROWTH FACTOR 8; FGF8	2253
MIM600487		19p13.3	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 4; PCSK4	54760
MIM600488		9q21.3	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 5; PCSK5	5125
MIM600489		18q23	NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 1; NFATC1	4772
MIM600490		20q13.2-q13.3	NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 2; NFATC2	4773
MIM600491		5q32-q33.3	MICROFIBRILLAR-ASSOCIATED PROTEIN 3; MFAP3	4238
MIM600492		2q31	NUCLEAR FACTOR ERYTHROID 2-LIKE 2; NFE2L2	4780
MIM600493		19p13.3	EGF-LIKE MODULE-CONTAINING, MUCIN-LIKE HORMONE RECEPTOR 1; EMR1	2015
MIM600494		6q16	POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 2; POU3F2	5454
MIM600495		3q27	EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 1; EIF4G1	1981
MIM600496	C1838100	12q24.2	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3	6927
MIM600497		1p31	PROTEIN KINASE, AMP-ACTIVATED, CATALYTIC, ALPHA-2; PRKAA2	5563
MIM600501	C1838099	13q22	ABCD SYNDROME; ABCDS	1910
MIM600502		11q13.2-q13.4	IMMUNOGLOBULIN MU-BINDING PROTEIN 2; IGHMBP2	3508
MIM600503		 	SUB1, S. CEREVISIAE, HOMOLOG OF; SUB1	10923
MIM600504		22q13.1	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 4; KCNJ4	3761
MIM600505		5q32	CASEIN KINASE I, ALPHA-1; CSNK1A1	1452
MIM600508		3q21	NCK ADAPTOR PROTEIN 1; NCK1	4690
MIM600509		11p15.1	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 8; ABCC8	6833
MIM600510	C1271398	7q35-q36	GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1	7986
MIM600511	C1838069	6p23	SCHIZOPHRENIA 3; SCZD3	6365
MIM600512	C1838062	10q24	EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1	9211
MIM600513	C1838049	20q13.2-q13.3	EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	1137
MIM600514		7q22	REELIN; RELN	5649
MIM600515		3q24-q25	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 12; P2RY12	64805
MIM600516		6p21.3-p21.2	BCL2 ANTAGONIST KILLER 1; BAK1	578
MIM600517		18q21.3	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 3; SERPINB3	6317
MIM600518		18q21.3	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 4; SERPINB4	6318
MIM600519		 	GENERAL TRANSCRIPTION FACTOR IIA, GAMMA SUBUNIT; GTF2A2	2958
MIM600520		 	GENERAL TRANSCRIPTION FACTOR IIA, ALPHA/BETA SUBUNITS; GTF2A1	2957
MIM600521		3q27-q28	MANNAN-BINDING LECTIN SERINE PROTEASE 1; MASP1	5648
MIM600522		1q25	PHOSPHOLIPASE A2, GROUP IVA; PLA2G4A	5321
MIM600523		12q13	SOLUTE CARRIER FAMILY 11 (PROTON-COUPLED DIVALENT METAL ION TRANSPORTER), MEMBER 2; SLC11A2	4891
MIM600524		 	RYK RECEPTOR-LIKE TYROSINE KINASE; RYK	6259
MIM600525		17q21.3-q22	DISTAL-LESS HOMEOBOX 3; DLX3	1747
MIM600526		11q12-q13	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 2; MARK2	2011
MIM600527		13q33	EPHRIN B2; EFNB2	1948
MIM600528		11q13	CARNITINE PALMITOYLTRANSFERASE I, LIVER; CPT1A	1374
MIM600529		Chr.9	AU-SPECIFIC RNA-BINDING PROTEIN; AUH	549
MIM600530		2q11.2	SOLUTE CARRIER FAMILY 9, MEMBER 2; SLC9A2	6549
MIM600531		2q12.1	SOLUTE CARRIER FAMILY 9, MEMBER 4; SLC9A4	389015
MIM600532		18p11.31-p11.2	NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 2; NDUFV2	4729
MIM600533		1q21-q23	VANG-LIKE 2; VANGL2	57216
MIM600534		19p13.2	BONE MARROW STROMAL CELL ANTIGEN 2; BST2	684
MIM600535		7p22.1-p21.3	MESENCHYME HOMEOBOX 2; MEOX2	4223
MIM600536		12q13	INTEGRIN, ALPHA-7; ITGA7	3679
MIM600537		12p12-p11	RECQ PROTEIN-LIKE; RECQL	5965
MIM600538		 	PEROXIREDOXIN 2; PRDX2	7001
MIM600539		3p25-q27	PROTEIN KINASE C, IOTA FORM; PRKCI	5584
MIM600540		7p15	TRANSCRIPTION FACTOR Sp4; SP4	6671
MIM600541		7p22	ETS VARIANT GENE 1; ETV1	2115
MIM600542		9q22	NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 3; NR4A3	8013
MIM600543		2q33.3-q34	V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 4; ERBB4	2066
MIM600544		13q33-q34	SOLUTE CARRIER FAMILY 15 (OLIGOPEPTIDE TRANSPORTER), MEMBER 1; SLC15A1	6564
MIM600547		9q34.11	CYSTEINE CONJUGATE BETA-LYASE 1; CCBL1	883
MIM600548		5q31.1	HEAT-SHOCK 70-KD PROTEIN 9; HSPA9	3313
MIM600549		5q22-q23	IK CYTOKINE, DOWNREGULATOR OF HLA II; IK	3550
MIM600550		 	CATHEPSIN O; CTSO	1519
MIM600551		19q13.2-q13.3	G PROTEIN-COUPLED RECEPTOR 4; GPR4	2828
MIM600552		3p21.3-p21.1	CHEMOKINE, C MOTIF, RECEPTOR 1; XCR1	2829
MIM600553		6q21-q22.1	G PROTEIN-COUPLED RECEPTOR 6; GPR6	2830
MIM600554		4q31	INTERLEUKIN 15; IL15	3600
MIM600555		2q32.2-q32.3	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1; STAT1	6772
MIM600556		12q13.2	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 2; STAT2	6773
MIM600558		2q32.2-q32.3	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 4; STAT4	6775
MIM600559	C1833607	 	HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS	 
MIM600560		1q21	SHC TRANSFORMING PROTEIN; SHC1	6464
MIM600561	C1833603	 	SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	 
MIM600562		5p14-p13	CADHERIN 12; CDH12	1010
MIM600563		1p31.1	PROSTAGLANDIN F RECEPTOR; PTGFR	5737
MIM600564		3p21.2-p14.1	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 4; ITIH4	3700
MIM600565		2p16.3	NEUREXIN I; NRXN1	9378
MIM600566		11q13	NEUREXIN II; NRXN2	9379
MIM600567		14q24.3-q31.1	NEUREXIN III; NRXN3	9369
MIM600568		3q26.3	NEUROLIGIN 1; NLGN1	22871
MIM600570		3q26	CHLORIDE CHANNEL 2; CLCN2	1181
MIM600571		4q12	RE1-SILENCING TRANSCRIPTION FACTOR; REST	5978
MIM600572		2p22-p21	SPLICING FACTOR, SERINE/ARGININE-RICH, 7; SRSF7	6432
MIM600573		5q31	TAF7 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 55-KD; TAF7	6879
MIM600574		22q11.1-q11.2	LEUCINE ZIPPER-LIKE TRANSCRIPTIONAL REGULATOR 1; LZTR1	8216
MIM600575		2q21.1	TRANSLIN; TSN	7247
MIM600576		8p23.1-p22	GATA-BINDING PROTEIN 4; GATA4	2626
MIM600577		9q34.3	LIM HOMEOBOX GENE 3; LHX3	8022
MIM600578		6p21.3	OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY H, MEMBER 3; OR2H3	7932
MIM600579		12p13-p12	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, O; PTPRO	5800
MIM600580		4q33	CHLORIDE CHANNEL 3; CLCN3	1182
MIM600581		6p22-p21.3	INHIBITOR OF DNA BINDING 4; ID4	3400
MIM600582		8q12.1	ASPARTATE BETA-HYDROXYLASE; ASPH	444
MIM600583		4p12	TEC PROTEIN TYROSINE KINASE; TEC	7006
MIM600584		5q34	NK2 HOMEOBOX 5; NKX2-5	1482
MIM600585		3p22-p21.33	TRANSGLUTAMINASE 4; TGM4	7047
MIM600586		3q26.1-q26.2	EPITHELIAL CELL TRANSFORMING SEQUENCE 2 ONCOGENE; ECT2	1894
MIM600587		7q11.2	POM121/ZP3 FUSION PROTEIN; POMZP3	22932
MIM600589		 	SERUM RESPONSE FACTOR; SRF	6722
MIM600590		2p23	PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, BETA ISOFORM; PPP1CB	5500
MIM600591		 	SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 1; SNAPC1	6617
MIM600592		7q21.3-q22.1	MINICHROMOSOME MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, 7; MCM7	4176
MIM600593	C1833578	4p16	CRANIOSYNOSTOSIS, ADELAIDE TYPE; CRSA	7885
MIM600594		22q11.2	DIGEORGE SYNDROME CRITICAL REGION GENE 2; DGCR2	9993
MIM600595		13q12.1	INTRAFLAGELLAR TRANSPORT 88, CHLAMYDOMONAS, HOMOLOG OF; IFT88	8100
MIM600596		17p11.2	MICROFIBRILLAR-ASSOCIATED PROTEIN 4; MFAP4	4239
MIM600597		2q33	PHOSPHOLIPASE C-LIKE 1; PLCL1	5334
MIM600598	C1833577	 	SETTING-SUN PHENOMENON, FAMILIAL BENIGN	 
MIM600599		19p13.13-p13.12	KRUPPEL-LIKE FACTOR 1; KLF1	10661
MIM600600		3q21-q23	EPHRIN RECEPTOR EphB1; EPHB1	2047
MIM600605		1q21	METAXIN 1; MTX1	4580
MIM600607		1q21	VACUOLAR PROTEIN SORTING 72, YEAST, HOMOLOG OF; VPS72	6944
MIM600608		5q31	PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, ALPHA SUBUNIT, ISOFORM 2; P4HA2	8974
MIM600609		21q21-q22.1	GA-BINDING PROTEIN TRANSCRIPTION FACTOR, ALPHA SUBUNIT; GABPA	2551
MIM600610		15q21.2	GA-BINDING PROTEIN TRANSCRIPTION FACTOR, BETA SUBUNIT; GABPB	2553
MIM600611		 	FK506-BINDING PROTEIN 4; FKBP4	2288
MIM600613		1p36.13-p36.11	NEUROBLASTOMA CANDIDATE REGION, SUPPRESSION OF TUMORIGENICITY 1; NBL1	4681
MIM600614		4p16	S100 CALCIUM-BINDING PROTEIN P; S100P	6286
MIM600615		19q13.2	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 7; LGALS7	3963
MIM600616		12q21.3-q22	LUMICAN; LUM	4060
MIM600617		8p11.2	STEROIDOGENIC ACUTE REGULATORY PROTEIN; STAR	6770
MIM600618		12p13	ETS VARIANT GENE 6; ETV6	2120
MIM600620		2p23.3	FK506-BINDING PROTEIN 1B; FKBP1B	2281
MIM600621		Chr.8	STATHMIN-LIKE 2; STMN2	11075
MIM600623		11p11.2	CD82 ANTIGEN; CD82	3732
MIM600624	C1833564	18q21.1-q21.3	CONE-ROD DYSTROPHY 1; CORD1	1319
MIM600625	C2677434	14q22-q23	OROFACIAL CLEFT 11; OFC11	652
MIM600626		17q25	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 3 BINDING PROTEIN; LGALS3BP	3959
MIM600627	C1833562	 	HYPERTRYPTOPHANEMIA, FAMILIAL	 
MIM600628	C0406468	 	LOOSE ANAGEN HAIR SYNDROME	 
MIM600629		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DO BETA; HLA-DOB	3112
MIM600630	C1833561	10q11	UV-SENSITIVE SYNDROME 1; UVSS1	2074
MIM600631	C0270327	13q13-q14.3	ENURESIS, NOCTURNAL, 1; ENUR1	2031
MIM600632		11q25	OPIOID-BINDING PROTEIN/CELL ADHESION MOLECULE-LIKE; OPCML	4978
MIM600633		21q22.3	TREFOIL FACTOR 3; TFF3	7033
MIM600634	C0033375	11q13.3	PITUITARY ADENOMA, PROLACTIN-SECRETING	9049
MIM600635		14q13	NK2 HOMEOBOX 1; NKX2-1	7080
MIM600636		4q35	CASPASE 3, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP3	836
MIM600637		 	SOLUTE CARRIER FAMILY 1 (HIGH AFFINITY ASPARTATE/GLUTAMATE TRANSPORTER), MEMBER 6; SLC1A6	6511
MIM600638	C2748801	16q24.3, 16q24.2-q24.3	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT; CFEOM3A	10381
MIM600639		7q35	CASPASE 2, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP2	835
MIM600641		16p11.2	SULFOTRANSFERASE FAMILY 1A, PHENOL-PREFERRING, MEMBER 3; SULT1A3	6818
MIM600642		6p21.3	MINOR HISTOCOMPATIBILITY ANTIGEN HA-2	7921
MIM600644		11q23-q24	POLIOVIRUS RECEPTOR-LIKE 1; PVRL1	5818
MIM600646		20q11.2	PROTEIN C RECEPTOR; PROCR	10544
MIM600647		10q25.2-q26.3	H6 FAMILY HOMEOBOX 2; HMX2	3167
MIM600649	C1833511	1p32	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	1376
MIM600650		1p32	CARNITINE PALMITOYLTRANSFERASE II; CPT2	1376
MIM600651	C1833506	 	FRAGILE SITE 11B; FRA11B	 
MIM600652	C1833503	19q13.33	DEAFNESS, AUTOSOMAL DOMINANT 4A; DFNA4A	79784
MIM600654		14q11.2	PROTEASOME ACTIVATOR SUBUNIT 1; PSME1	5720
MIM600655		2q33-q34	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, BETA-2; EEF1B2	1933
MIM600658		19q13.3	PROTEIN PHOSPHATASE 5, CATALYTIC SUBUNIT; PPP5C	5536
MIM600659		16q22.1	E2F TRANSCRIPTION FACTOR 4; E2F4	1874
MIM600660		15q26	MADS BOX TRANSCRIPTION ENHANCER FACTOR 2, POLYPEPTIDE A; MEF2A	4205
MIM600661		19p12	MADS BOX TRANSCRIPTION ENHANCER FACTOR 2, POLYPEPTIDE B; MEF2B	100271849
MIM600662		5q14	MADS BOX TRANSCRIPTION ENHANCER FACTOR 2, POLYPEPTIDE C; MEF2C	4208
MIM600663		1q12-q23	MADS BOX TRANSCRIPTION ENHANCER FACTOR 2, POLYPEPTIDE D; MEF2D	4209
MIM600664		10q24	CONSERVED HELIX-LOOP-HELIX UBIQUITOUS KINASE; CHUK	1147
MIM600665		4q35.1	MELATONIN RECEPTOR 1A; MTNR1A	4543
MIM600666	C1418603	 	POLYCYSTIC KIDNEY DISEASE 3, AUTOSOMAL DOMINANT; PKD3	5312
MIM600667		17q21.1	FRIZZLED, DROSOPHILA, HOMOLOG OF, 2; FZD2	2535
MIM600668	C1833499	8q	CHONDROCALCINOSIS 1; CCAL1	882
MIM600669	C0270850	8q24, 18q21	EPILEPSY, IDIOPATHIC GENERALIZED; EIG	1957, 4200
MIM600670	C1833487	 	VARICELLA, SEVERE RECURRENT	 
MIM600673		17q21.3	UPSTREAM BINDING TRANSCRIPTION FACTOR (RNA POLYMERASE I); UBTF	7343
MIM600674	C1833486	 	MICROTIA-ANOTIA	 
MIM600675		14q32.3	X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 3; XRCC3	7517
MIM600676		7q32	CATR TUMORIGENIC CONVERSION 1; CATR1	856
MIM600678		2p16	MutS, E. COLI, HOMOLOG OF, 6; MSH6	2956
MIM600679	C1833473	 	DERMOID CYSTS, FAMILIAL FRONTONASAL	 
MIM600681		17q23.1-q24.2	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 2; KCNJ2	3759
MIM600682		1p13.2-p12	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 1; SLC16A1	6566
MIM600684		1q21.3-q22	T-LYMPHOCYTE SURFACE ANTIGEN LY-9; LY9	4063
MIM600685		17q23-q24	KARYOPHERIN ALPHA-2; KPNA2	3838
MIM600686		3q21	KARYOPHERIN ALPHA-1; KPNA1	3836
MIM600687		21q22.1	T-CELL LYMPHOMA INVASION AND METASTASIS 1; TIAM1	7074
MIM600688		7q32	CARBOXYPEPTIDASE A2, PANCREATIC; CPA2	1358
MIM600690		3p21	T-CELL LEUKEMIA TRANSLOCATION-ASSOCIATED GENE; TCTA	6988
MIM600691		19p13.1	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 1; SLC27A1	376497
MIM600692		11p15.5	TROPONIN T3, FAST SKELETAL; TNNT3	7140
MIM600693		19p13.3	POLYPYRIMIDINE TRACT-BINDING PROTEIN 1; PTBP1	5725
MIM600694		5q11	INTERLEUKIN 6 SIGNAL TRANSDUCER; IL6ST	3572
MIM600696		19q13	ENOYL-CoA HYDRATASE, PEROXISOMAL; ECH1	1891
MIM600697		1q32	RETINOBLASTOMA-BINDING PROTEIN 5; RBBP5	5929
MIM600698		12q14.3	HIGH MOBILITY GROUP AT-HOOK 2; HMGA2	8091
MIM600700		3q28	LIM DOMAIN-CONTAINING PREFERRED TRANSLOCATION PARTNER IN LIPOMA; LPP	4026
MIM600701		6p21	HIGH MOBILITY GROUP AT-HOOK 1; HMGA1	3159
MIM600702		12q13	SODIUM CHANNEL, VOLTAGE-GATED, TYPE VIII, ALPHA SUBUNIT; SCN8A	6334
MIM600705	C1833454	 	SATOYOSHI SYNDROME	 
MIM600706	C1833453	 	PROXIMAL MYOPATHY WITH FOCAL DEPLETION OF MITOCHONDRIA	 
MIM600707		 	SIGNAL RECOGNITION PARTICLE, 9-KD; SRP9	6726
MIM600708		15q22	SIGNAL RECOGNITION PARTICLE, 14-KD; SRP14	6727
MIM600709		9q21	ISOLEUCYL-tRNA SYNTHETASE; IARS	3376
MIM600711		17q21	ETS VARIANT GENE 4; ETV4	2118
MIM600712		9q21.32-q21.33	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; HNRNPK	3190
MIM600713		1q32-q41	11-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE I; HSD11B1	3290
MIM600714		5q34	DUAL-SPECIFICITY PHOSPHATASE 1; DUSP1	1843
MIM600715		 	THROMBOSPONDIN IV; THBS4	7060
MIM600716		1p13	PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 22; PTPN22	26191
MIM600719		17p13.1-q25	NITRIC OXIDE SYNTHASE 2B; NOS2B	201288
MIM600720		17p13.1-q25	NITRIC OXIDE SYNTHASE 2C; NOS2C	645740
MIM600721	C3152055	2q37.3	D-2-@HYDROXYGLUTARIC ACIDURIA 1	728294
MIM600722		1p32	PALMITOYL-PROTEIN THIOESTERASE 1; PPT1	5538
MIM600723		17q12-q21	MEMBRANE PROTEIN, PALMITOYLATED 2; MPP2	4355
MIM600724		16q13	CYCLIC NUCLEOTIDE-GATED CHANNEL, BETA-1; CNGB1	1258
MIM600725		7q36	SONIC HEDGEHOG; SHH	6469
MIM600726		2q33-q35	INDIAN HEDGEHOG; IHH	3549
MIM600727		1p31.3-p31.2	NUCLEAR FACTOR I/A; NFIA	4774
MIM600728		9p24.1	NUCLEAR FACTOR I/B; NFIB	4781
MIM600729		19p13.3	NUCLEAR FACTOR I/C; NFIC	4782
MIM600730		8q11.23	NEUROPEPTIDES B AND W RECEPTOR 1; NPBWR1	2831
MIM600731		20q13.3	G PROTEIN-COUPLED RECEPTOR 8; GPR8	2832
MIM600732		17q12-q21	ADP-RIBOSYLATION FACTOR-LIKE 4D; ARL4D	379
MIM600733		13q12.1	PANCREAS/DUODENUM HOMEOBOX PROTEIN 1; PDX1	3651
MIM600734		11q24	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 5; KCNJ5	3762
MIM600735		17q21	INTERFERON-INDUCED PROTEIN 35; IFI35	3430
MIM600736	C1833380	 	VELOFACIOSKELETAL SYNDROME	 
MIM600737	C1833373	9p13.3	INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE; IBM2	10020
MIM600738		12q24	SELECTIN P LIGAND; SELPLG	6404
MIM600739		17q21-q22	SHC-LIKE PROTEIN; SHCL1	6466
MIM600740	C1833372	19q13	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III; HHC3	9151
MIM600742		1p33-p32	TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE III; TGFBR3	7049
MIM600743		16p13	TRANSCRIPTION FACTOR AP4; TFAP4	7023
MIM600744		6p21	T-CELL TRANSCRIPTION FACTOR EB; TFEB	7942
MIM600745		19q13.2	APOLIPOPROTEIN C-IV; APOC4	346
MIM600746		5q31-q33	CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 1; CDX1	1044
MIM600747		17q23	T-BOX 2; TBX2	6909
MIM600748		12q12-q13	TESTIS-ENHANCED GENE TRANSCRIPT; TEGT	7009
MIM600749		14q11.2	CCAAT/ENHANCER-BINDING PROTEIN, EPSILON; CEBPE	1053
MIM600750		7q21.3-q22.1	PENTRAXIN II, NEURONAL; NPTX2	4885
MIM600751		20p13	SIALOADHESIN; SN	6614
MIM600752		13q12	G PROTEIN-COUPLED RECEPTOR 12; GPR12	2835
MIM600753		16q22-q23	GOLGI APPARATUS PROTEIN 1; GLG1	2734
MIM600754		14q11-q12	MATRIX METALLOPROTEINASE 14; MMP14	4323
MIM600755		3p25	SYNAPSIN II; SYN2	6854
MIM600756		9q34	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B-PRIME; PPP2R4	5524
MIM600757	C1833369	19q13	OROFACIAL CLEFT 3; OFC3	4965
MIM600758		8q24-qter	PROTEIN-TYROSINE KINASE, CYTOPLASMIC; PTK2	5747
MIM600759		1q31-q42	PRESENILIN 2; PSEN2	5664
MIM600760		16p13-p12	SODIUM CHANNEL, NONVOLTAGE-GATED 1, BETA SUBUNIT; SCNN1B	6338
MIM600761		16p13-p12	SODIUM CHANNEL, NONVOLTAGE-GATED 1, GAMMA SUBUNIT; SCNN1G	6340
MIM600762		7p14-p13	HUMAN PAPILLOMAVIRUS E5 CENTRAL SEQUENCE-LIKE 1; HPVC1	3262
MIM600763		13q12-q14	TUMOR PROTEIN, TRANSLATIONALLY-CONTROLLED 1; TPT1	7178
MIM600764		1q25.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I-RELATED; MR1	3140
MIM600767		10p15	GDP-DISSOCIATION INHIBITOR 2; GDI2	2665
MIM600768		 	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 9; PTPN9	5780
MIM600769		12q14.1-q21.1	TETRASPANIN 8; TSPAN8	7103
MIM600770		11p15	MUCIN 5, SUBTYPE B, TRACHEOBRONCHIAL; MUC5B	727897
MIM600771	C1833341	 	DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	 
MIM600772		6p21.31	TAF11 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 28-KD; TAF11	6882
MIM600773		1p35.3	TAF12 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 20-KD; TAF12	6883
MIM600774		 	TAF13 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 18-KD; TAF13	6884
MIM600775	C1833340	 	LAMBDOID SYNOSTOSIS	 
MIM600776	C1833339	 	FRYNS MICROPHTHALMIA SYNDROME	 
MIM600777		 	TRANSCRIPTION TERMINATION FACTOR, RNA POLYMERASE I; TTF1	7270
MIM600778		12p13	CYCLIN-DEPENDENT KINASE INHIBITOR 1B; CDKN1B	1027
MIM600781		17q21	PEPTIDE YY; PYY	5697
MIM600782		19q13.42	SYNAPTOTAGMIN 5; SYT5	6861
MIM600783		5q31.3	HISTIDYL-tRNA SYNTHETASE 2; HARS2	23438
MIM600784		 	GRANZYME K; GZMK	3003
MIM600786		1p36.1	TRANSCRIPTION ELONGATION FACTOR B, POLYPEPTIDE 3; TCEB3	6924
MIM600787		 	TRANSCRIPTION ELONGATION FACTOR B, POLYPEPTIDE 2; TCEB2	6923
MIM600788		Chr.8	TRANSCRIPTION ELONGATION FACTOR B, POLYPEPTIDE 1; TCEB1	6921
MIM600789		11p15.5	RIBOSOMAL PROTEIN L23-LIKE; RPL23L	6150
MIM600790	C1833321	6q14-q16.2	CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	7948
MIM600791	C1863752	7q31, 5q34	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4	2299, 3766, 5172
MIM600792	C1833319	14q12	DEAFNESS, AUTOSOMAL RECESSIVE 5; DFNB5	1697
MIM600794	C1833308	11q13, 7p15	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A	2617, 26580
MIM600795	C1833296	3p11.2	FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	25978
MIM600796		19p13.3-p13.2	SPLICING FACTOR 3A, SUBUNIT 2; SF3A2	8175
MIM600797		13q34	INSULIN RECEPTOR SUBSTRATE 2; IRS2	8660
MIM600798		19q13.2	POLIOVIRUS RECEPTOR-LIKE 2; PVRL2	5819
MIM600799		2q33	BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE II; BMPR2	659
MIM600800		2q32.3-q33	NGFIA-BINDING PROTEIN; NAB1	4664
MIM600801	C1833276	 	ISOPROTERENOL-MEDIATED VASODILATATION	 
MIM600802	C1833275	 	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	3718
MIM600803	C0008325	7q21.1	GALLBLADDER DISEASE 1; GBD1	5244
MIM600804		11q21-q22	MELATONIN RECEPTOR 1B; MTNR1B	4544
MIM600805		18q11.2	LAMININ, ALPHA-3; LAMA3	3909
MIM600806		19p13.2	CALPONIN 1; CNN1	1264
MIM600807	C1869116	17q21.1-q21.2, 13q14.1, 11q12.3-q13.1, 10q11.2, 6p21.2-p12, 6p21.3, 6p21.3, 5q32-q34, 5q31.1-q33.1, 5q31-q34, 5q31, 4q13-q21, 2q22	ASTHMA, SUSCEPTIBILITY TO	117156, 154, 240, 3135, 3176, 3593, 3596, 4589, 51131, 6356, 7124, 7356, 7941
MIM600808	C1833268	12q13-q21	ENURESIS, NOCTURNAL, 2; ENUR2	2032
MIM600810		20p12	PHOSPHOLIPASE C, BETA-4; PLCB4	5332
MIM600811		11p12-p11	DNA DAMAGE-BINDING PROTEIN 2; DDB2	1643
MIM600812		17q21.3-q22	SPLICING FACTOR, SERINE/ARGININE-RICH, 1; SRSF1	6426
MIM600813		17q25	SPLICING FACTOR, SERINE/ARGININE-RICH, 2; SRSF2	6427
MIM600814		11q21	MEIOTIC RECOMBINATION 11, S. CEREVISIAE, HOMOLOG OF, A; MRE11A	4361
MIM600815		7p13	POLYMERASE (DNA-DIRECTED), DELTA 2, REGULATORY SUBUNIT; POLD2	5425
MIM600816		11q23.3-q25	HEAT-SHOCK 70-KD PROTEIN 8; HSPA8	3312
MIM600817		2p	VISININ-LIKE 1; VSNL1	7447
MIM600818		11q23.2	TRANSGELIN; TAGLN	6876
MIM600819		3q28	FRAGILE X MENTAL RETARDATION, AUTOSOMAL HOMOLOG 1; FXR1	8087
MIM600820		11q23.3	ARCHAIN 1; ARCN1	372
MIM600821		12q14-q15	ARGININE VASOPRESSIN RECEPTOR 1A; AVPR1A	552
MIM600822		5q11.2-q13.1	TAF9 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 32-KD; TAF9	6880
MIM600823		16p11.2	PROTEASE, SERINE, 8; PRSS8	5652
MIM600824		11p15.1	CYSTEINE- AND GLYCINE-RICH PROTEIN 3; CSRP3	8048
MIM600825		15q21-q22	RAR-RELATED ORPHAN RECEPTOR A; RORA	6095
MIM600826		19p12	CHONDROITIN SULFATE PROTEOGLYCAN 3; CSPG3	1463
MIM600827		10q24	PHOSPHODIESTERASE 6C, cGMP-SPECIFIC, CONE, ALPHA-PRIME; PDE6C	5146
MIM600828		21q22.1-q22.2	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, O SUBUNIT; ATP5O	539
MIM600829		11q23	INOSITOL POLYPHOSPHATE PHOSPHATASE-LIKE 1; INPPL1	3636
MIM600830		6p21.3	TRIPARTITE MOTIF-CONTAINING PROTEIN 26; TRIM26	7726
MIM600831		9q34.1	DEATH-ASSOCIATED PROTEIN KINASE 1; DAPK1	1612
MIM600832		15q22.3-q23	ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER A; ANP32A	8125
MIM600833		7q31.1	SUPPRESSOR OF TUMORIGENICITY 7; ST7	7982
MIM600834		6p21.3	ZINC FINGER PROTEIN 165; ZNF165	7718
MIM600835		10q11.1	CHEMOKINE, CXC MOTIF, LIGAND 12; CXCL12	6387
MIM600836		2q34-q36	CRYSTALLIN, BETA-A2; CRYBA2	1412
MIM600837		5p13.1-p12	GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GDNF	2668
MIM600838		17q11-q12	FORKHEAD BOX N1; FOXN1	8456
MIM600839		15q15-q21.1	SOLUTE CARRIER FAMILY 12 (SODIUM/POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 1; SLC12A1	6557
MIM600840		5q23.3	SOLUTE CARRIER FAMILY 12 (SODIUM/POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 2; SLC12A2	6558
MIM600842		2p23.3-p23.2	GLUCOKINASE REGULATORY PROTEIN; GCKR	2646
MIM600843		11q12	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 3; P2RX3	5024
MIM600844		 	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 2; P2RX2	22953
MIM600845		17p13.3	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 1; P2RX1	5023
MIM600846		12q24.32	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 4; P2RX4	5025
MIM600848		12q24	NUCLEAR RECEPTOR COREPRESSOR 2; NCOR2	9612
MIM600849		 	NUCLEAR RECEPTOR COREPRESSOR 1; NCOR1	9611
MIM600850	C1833247	22q11.2	SCHIZOPHRENIA 4; SCZD4	5625
MIM600852	C1833245	17q23	RETINITIS PIGMENTOSA 17; RP17	762
MIM600853		5q32-q33.3	N-DEACETYLASE/N-SULFOTRANSFERASE 1; NDST1	3340
MIM600855		21q22.1	DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1A; DYRK1A	1859
MIM600856		11p15.5	CYCLIN-DEPENDENT KINASE INHIBITOR 1C; CDKN1C	1028
MIM600857		5p15	SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT A, FLAVOPROTEIN; SDHA	6389
MIM600858	C1833236	7q36	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6; CMH6	51422
MIM600859		7p22	JTV1 GENE	7965
MIM600860		13q12.3-q13.1	GENERAL TRANSCRIPTION FACTOR IIIA; GTF3A	2971
MIM600861		1q31	REGULATOR OF G PROTEIN SIGNALING 2; RGS2	5997
MIM600862		2q36	HIV-1 REV-BINDING PROTEIN; HRB	3267
MIM600863		22q12-q13	CASEIN KINASE I, EPSILON; CSNK1E	1454
MIM600864		17q25	CASEIN KINASE I, DELTA; CSNK1D	1453
MIM600865		14q21-q22	RETICULON 1; RTN1	6252
MIM600866		6q27	PROGRAMMED CELL DEATH 2; PDCD2	5134
MIM600867		1q21-q23	SIGNAL SEQUENCE RECEPTOR, BETA; SSR2	6746
MIM600868		 	SIGNAL SEQUENCE RECEPTOR, ALPHA; SSR1	6745
MIM600869		5q35	G PROTEIN-COUPLED RECEPTOR KINASE 6; GRK6	2870
MIM600870		10q24-qter	G PROTEIN-COUPLED RECEPTOR KINASE 5; GRK5	2869
MIM600871		1p22	GROWTH FACTOR-INDEPENDENT 1; GFI1	2672
MIM600873		1p22	CHITOBIASE, DI-N-ACETYL-; CTBS	1486
MIM600874		1p22	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-5; GNG5	2787
MIM600875		14q24.3	ACYLPHOSPHATASE, ERYTHROCYTE; ACYP1	97
MIM600876		11q12.1	SYNTAXIN 3; STX3	6809
MIM600877		21q22.1	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 6; KCNJ6	3763
MIM600879		7q32	NUCLEAR RESPIRATORY FACTOR 1; NRF1	4899
MIM600880	C0856761	1q23, 9p24	BUDD-CHIARI SYNDROME; BDCHS	2153, 3717
MIM600881	C1833229	17q11.1-q12	CATARACT, CONGENITAL ZONULAR, WITH SUTURAL OPACITIES; CCZS	1411
MIM600882	C1833219	3q21	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	7879
MIM600883	C1833218	6q25-q27	DIABETES MELLITUS, INSULIN-DEPENDENT, 8; IDDM8	3407
MIM600884	C1868673	9q13	CARDIOMYOPATHY, DILATED, 1B; CMD1B	1218
MIM600886	C1833213	19q13.3-q13.4	HYPERFERRITINEMIA-CATARACT SYNDROME	2512
MIM600887		5q11-q12	MutS, E. COLI, HOMOLOG OF, 3; MSH3	4437
MIM600888		7q33-q35	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 5; ARHGEF5	7984
MIM600889		1q31-q32.1	COMPLEMENT FACTOR H-RELATED 2; CFHR2	3080
MIM600890		2p23	HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, ALPHA SUBUNIT; HADHA	3030
MIM600892		21q22.2	SINGLE-MINDED, DROSOPHILA, HOMOLOG OF, 2; SIM2	6493
MIM600895		10q25.3-q26	PROLACTIN-RELEASING HORMONE RECEPTOR; PRLHR	2834
MIM600896		17q25.3	G PROTEIN-COUPLED RECEPTOR 14; GPR14	2837
MIM600897		1q21.1	GAP JUNCTION PROTEIN, ALPHA-8; GJA8	2703
MIM600898		2p25	SRY-BOX 11; SOX11	6664
MIM600899		8q11	PROTEIN KINASE, DNA-ACTIVATED, CATALYTIC SUBUNIT; PRKDC	5591
MIM600900		4q12	SARCOGLYCAN, BETA; SGCB	6443
MIM600901	C3160739	6p22-p21	FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	2178
MIM600902		 	SELENOPHOSPHATE SYNTHETASE 1; SEPHS1	22929
MIM600903	C1833170	 	WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	 
MIM600904		1q25	ASTROTACTIN 1; ASTN1	460
MIM600906	C1833169	 	ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	 
MIM600907	C1833163	 	ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	 
MIM600908	C1833162	 	AGONADISM, 46,XY, WITH MENTAL RETARDATION, SHORT STATURE, RETARDED BONE AGE, AND MULTIPLE EXTRAGENITAL MALFORMATIONS	 
MIM600909		21q22.3	LANOSTEROL SYNTHASE; LSS	4047
MIM600910		9p24	INSULIN-LIKE 4; INSL4	3641
MIM600911		11p14-p13	METALLOPHOSPHOESTERASE DOMAIN-CONTAINING PROTEIN 2; MPPED2	744
MIM600912		6p21.3	TRANSCRIPTION FACTOR 19; TCF19	6941
MIM600914		 	SPLICING FACTOR, SERINE/ARGININE-RICH, 5; SRSF5	6430
MIM600915		 	NESTIN; NES	10763
MIM600916		2q11.2	INOSITOL POLYPHOSPHATE-4-PHOSPHATASE, TYPE I, 107-KD; INPP4A	3631
MIM600917		7q11.23-q21.11	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3A; PPP1R3A	5506
MIM600919	C1970119	4q25-q27	CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED	287
MIM600920	C1833136	 	VAN DEN ENDE-GUPTA SYNDROME; VDEGS	91179
MIM600921		13q11-q12	FIBROBLAST GROWTH FACTOR 9; FGF9	2254
MIM600922		3q21	MYOSIN LIGHT CHAIN KINASE; MYLK	4638
MIM600923		1q22	PROTOPORPHYRINOGEN OXIDASE; PPOX	5498
MIM600924		16p13.3-p13.12	GROWTH FACTOR, ERV1-LIKE; GFER	2671
MIM600925		11p11.2	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, J; PTPRJ	5795
MIM600926		10q26	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, EPSILON; PTPRE	5791
MIM600927		19p13	CYCLIN-DEPENDENT KINASE INHIBITOR 2D; CDKN2D	1032
MIM600928		16p13.3	CONSERVED GENE TELOMERIC TO ALPHA GLOBIN CLUSTER	8131
MIM600929		22q11.2-q12.1	CRYSTALLIN, BETA-B1; CRYBB1	1414
MIM600930		7q31	SPERM ADHESION MOLECULE 1; SPAM1	6677
MIM600932		1q21-q23	G PROTEIN-COUPLED INWARD RECTIFIER POTASSIUM CHANNEL	3765
MIM600933		5q13	COAGULATION FACTOR II RECEPTOR-LIKE 1; F2RL1	2150
MIM600934		11p11.2	FOLATE HYDROLASE 1; FOLH1	2346
MIM600935		12p11.23	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 8; KCNJ8	3764
MIM600936		5q33.2	HYALURONAN-MEDIATED MOTILITY RECEPTOR; HMMR	3161
MIM600937		11p15.1	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 11; KCNJ11	3767
MIM600938		16p12-p11.2	RETINOBLASTOMA-BINDING PROTEIN 6; RBBP6	5930
MIM600939		9p13	INTERLEUKIN 11 RECEPTOR, ALPHA; IL11RA	3590
MIM600940		17q11.2-q12	LIGASE III, DNA, ATP-DEPENDENT; LIG3	3980
MIM600941		19q13.13-q13.2	BILIVERDIN REDUCTASE B; BLVRB	645
MIM600943		11q13.5	SERPIN PEPTIDASE INHIBITOR, CLADE H, MEMBER 1; SERPINH1	871
MIM600944		19p13.12-p13.11	DEOXYHYPUSINE SYNTHASE; DHPS	1725
MIM600945		2p23-p21	UROCORTIN; UCN	7349
MIM600946		5p13-p12	GROWTH HORMONE RECEPTOR; GHR	2690
MIM600947		17q21.2-q21.3	HUNTINGTIN-ASSOCIATED PROTEIN 1; HAP1	9001
MIM600948		3p22-p21	MYELIN-ASSOCIATED OLIGODENDROCYTE BASIC PROTEIN; MOBP	4336
MIM600950		17q25	ARYLALKYLAMINE N-ACETYLTRANSFERASE; AANAT	15
MIM600951		8q13	TELOMERIC REPEAT-BINDING FACTOR 1; TERF1	7013
MIM600952	C1833064	 	TRANSSEXUALITY	 
MIM600953		11q22.2-q22.3	INTERLEUKIN 18; IL18	3606
MIM600954		5p15.2	DEATH-ASSOCIATED PROTEIN; DAP	1611
MIM600955	C1833053	5q15-q21	PROPROTEIN CONVERTASE 1/3 DEFICIENCY	5122
MIM600956		12q13	ANTI-MULLERIAN HORMONE TYPE II RECEPTOR; AMHR2	269
MIM600957		19p13.3-p13.2	ANTI-MULLERIAN HORMONE; AMH	268
MIM600958		11p11.2	MYOSIN-BINDING PROTEIN C, CARDIAC; MYBPC3	4607
MIM600959		11p15.2	COATOMER PROTEIN COMPLEX, SUBUNIT BETA; COPB	1315
MIM600960		9q34	SET TRANSLOCATION, MYELOID LEUKEMIA-ASSOCIATED; SET	6418
MIM600962	C1833030	17q12-q21, 12q13	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC; NEPPK	3848, 3868
MIM600963		19q13.3	SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 5; SIX5	147912
MIM600964		10pter-p11.2	REFSUM DISEASE WITH INCREASED PIPECOLIC ACIDEMIA; RDPA	8024
MIM600965	C1833021	4p16.1	DEAFNESS, AUTOSOMAL DOMINANT 6; DFNA6	7466
MIM600966		17p12-p11.2	LETHAL GIANT LARVAE, DROSOPHILA, HOMOLOG OF, 1; LLGL1	3996
MIM600967		 	E2F TRANSCRIPTION FACTOR 5; E2F5	1875
MIM600968		16q13	SOLUTE CARRIER FAMILY 12 (SODIUM/CHLORIDE TRANSPORTER), MEMBER 3; SLC12A3	6559
MIM600969	C1832998	20q13.3	EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3	1299
MIM600970		6q13	MYOSIN VI; MYO6	4646
MIM600971	C1832992	3p21	DEAFNESS, AUTOSOMAL RECESSIVE 6; DFNB6	259236
MIM600972	C0265274	5q32-q33.1	ACHONDROGENESIS, TYPE IB; ACG1B	1836
MIM600974	C1832978	9q13-q21	DEAFNESS, AUTOSOMAL RECESSIVE 7; DFNB7	117531
MIM600975	C1832977	1p36.2-p36.1	GLAUCOMA 3, PRIMARY INFANTILE, B; GLC3B	2728
MIM600976		4q34-q35	FAT TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 1; FAT1	2195
MIM600977	C1832976	17p13.1	CONE-ROD DYSTROPHY 5; CORD5	83394
MIM600978		6p21.3	LYMPHOTOXIN-BETA; LTB	4050
MIM600979		12p13	LYMPHOTOXIN B RECEPTOR; LTBR	4055
MIM600980		4q21	DENTIN MATRIX ACIDIC PHOSPHOPROTEIN 1; DMP1	1758
MIM600981		9p12-q12	PHOSPHOGLUCOMUTASE 5; PGM5	5239
MIM600982		5q11.2	MITOGEN-ACTIVATED KINASE KINASE KINASE 1; MAP3K1	4214
MIM600983		4q31.1	NUCLEAR RECEPTOR SUBFAMILY 3, GROUP C, MEMBER 2; NR3C2	4306
MIM600984		6p21.3	ACTIVATING TRANSCRIPTION FACTOR 6, BETA; ATF6B	1388
MIM600985		6p21.3	TENASCIN XB; TNXB	7148
MIM600986		1q21	TRIPARTITE MOTIF-CONTAINING PROTEIN 46; TRIM46	80128
MIM600987	C1832950	 	CARDIAC MALFORMATION, CLEFT LIP-PALATE, MICROCEPHALY AND DIGITAL ANOMALIES	 
MIM600988		15q25	MANNOSIDASE, ALPHA, CLASS 2A, MEMBER 2; MAN2A2	4122
MIM600989	C1832949	 	INFUNDIBULOPELVIC DYSGENESIS	 
MIM600991	C1832948	 	HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	 
MIM600993		18q21.1	MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 4; SMAD4	4089
MIM600994	C1832932	7p15	DEAFNESS, AUTOSOMAL DOMINANT 5; DFNA5	1687
MIM600995	C1868672	1q25-q31	NEPHROTIC SYNDROME, TYPE 2; NPHS2	7827
MIM600996	C1832931	1q42.1-q43	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2; ARVD2	6262
MIM600997		1p36.1-p35	EPHRIN RECEPTOR EphB2; EPHB2	2048
MIM600998		9q21	GUANINE NUCLEOTIDE-BINDING PROTEIN, Q POLYPEPTIDE; GNAQ	2776
MIM600999		16p11.2	MYC-ASSOCIATED ZINC FINGER PROTEIN; MAZ	4150
MIM601001	C1832926	17q12-q21	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE	3861
MIM601002		20q11.2	GLUTATHIONE SYNTHETASE; GSS	2937
MIM601003	C1832918	16p12	BRODY MYOPATHY	487
MIM601004	C1832917	 	PORTAL VEIN, CAVERNOUS TRANSFORMATION OF	 
MIM601005	C1832916	12p13.3	TIMOTHY SYNDROME; TS	775
MIM601007		1p31	LEPTIN RECEPTOR; LEPR	3953
MIM601009		15q13	TIGHT JUNCTION PROTEIN 1; TJP1	7082
MIM601010		20p13	TRANSCRIPTION FACTOR 15; TCF15	6939
MIM601011		19p13	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, P/Q TYPE, ALPHA-1A SUBUNIT; CACNA1A	773
MIM601012		9q34	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, N TYPE, ALPHA-1B SUBUNIT; CACNA1B	774
MIM601013		1q25-q31	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-1E SUBUNIT; CACNA1E	777
MIM601014		3q29	DISCS LARGE, DROSOPHILA, HOMOLOG OF, 1; DLG1	1739
MIM601015		14q24.3	NPC2 GENE; NPC2	10577
MIM601016	C1832874	 	MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM	 
MIM601017		20q11.2	SYNTROPHIN, ALPHA-1; SNTA1	6640
MIM601019		1p33	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GLYCINE), MEMBER 9; SLC6A9	6536
MIM601020		3q21	CD86 ANTIGEN; CD86	942
MIM601021		11p15	NUCLEOPORIN, 98-KD; NUP98	4928
MIM601022		6p21.3	NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR-LIKE 1; NFKBIL1	4795
MIM601023		9p13-p12	VALOSIN-CONTAINING PROTEIN; VCP	7415
MIM601024		3q28	ADAPTOR-RELATED PROTEIN COMPLEX 2, MU-1 SUBUNIT; AP2M1	1173
MIM601025		17q11.2-q12	ADAPTOR-RELATED PROTEIN COMPLEX 2, BETA-1 SUBUNIT; AP2B1	163
MIM601026		19q13.3	ADAPTOR-RELATED PROTEIN COMPLEX 2, ALPHA-1 SUBUNIT; AP2A1	160
MIM601027	C1832859	 	TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	 
MIM601028		3q13.1-q13.2	CD47 ANTIGEN; CD47	961
MIM601029		7q32	MESODERM-SPECIFIC TRANSCRIPT, MOUSE, HOMOLOG OF; MEST	4232
MIM601030		14q11.2	RIBONUCLEASE A FAMILY, 4; RNASE4	6038
MIM601031		 	RHOPHILIN 1; RHPN1	114822
MIM601032		19p12	PROTEIN KINASE N1; PKN1	5585
MIM601033		20q13.2-q13.3	LAMININ, ALPHA-5; LAMA5	3911
MIM601035		5q35.3	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H1; HNRNPH1	3187
MIM601037		10q11.21-q11.22	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F; HNRNPF	3185
MIM601038		14q32	DEIODINASE, IODOTHYRONINE, TYPE III; DIO3	1735
MIM601039	C1832858	 	ICHTHYOSIS-MENTAL RETARDATION SYNDROME WITH LARGE KERATOHYALIN GRANULES IN THE SKIN	 
MIM601040		12q24.31	SCAVENGER RECEPTOR CLASS B, MEMBER 1; SCARB1	949
MIM601041		19p13.3	TRANSDUCIN-LIKE ENHANCER OF SPLIT 2; TLE2	7089
MIM601042	C1832855	1p	DYSTONIA 9; DYT9	1433
MIM601045		11q11	CATENIN, DELTA-1; CTNND1	1500
MIM601046		11q22.2-q22.3	MATRIX METALLOPROTEINASE 12; MMP12	4321
MIM601047		7q31.1	CAVEOLIN 1; CAV1	857
MIM601048		7q31.1	CAVEOLIN 2; CAV2	858
MIM601051		Chr.16	MESOTHELIN; MSLN	10232
MIM601052		19p13	PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, NIMA-INTERACTING, 1; PIN1	5300
MIM601053		3pter-p14	PLEXIN B1; PLXNB1	5364
MIM601054		1q32.2	PLEXIN A2; PLXNA2	5362
MIM601055		3q21-qter	PLEXIN A1; PLXNA1	5361
MIM601056		15q24.3	BCL2-RELATED PROTEIN A1; BCL2A1	597
MIM601057		 	PROGRAMMED CELL DEATH 6; PDCD6	10016
MIM601058		17q25	H3 HISTONE, FAMILY 3B; H3F3B	3021
MIM601060		8q24.1	ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 2; ENPP2	5168
MIM601061		 	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE D2; SNRPD2	6633
MIM601062		 	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE D3; SNRPD3	6634
MIM601063		 	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE D1; SNRPD1	6632
MIM601064		14q22-q24	ZINC FINGER PROTEIN 36-LIKE 1; ZFP36L1	677
MIM601065		16q22	ALANYL-tRNA SYNTHETASE; AARS	16
MIM601066		14q11.2	OXIDASE, CYTOCHROME c, ASSEMBLY 1-LIKE; OXA1L	5018
MIM601067	C1832845	10q21-q22, 10q21-q22	USHER SYNDROME, TYPE ID; USH1D	64072, 65217
MIM601068	C1832841	8q24	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	50968
MIM601069		10q11.2	ZINC FINGER PROTEIN 239; ZNF239	8187
MIM601070		10p15-p14	INTERLEUKIN 15 RECEPTOR, ALPHA; IL15RA	3601
MIM601071	C1832828	2p23-p22	DEAFNESS, AUTOSOMAL RECESSIVE 9; DFNB9	9381
MIM601072	C1832827	21q22.3	DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8; DFNB8	64699
MIM601074		11p11	CUG TRIPLET REPEAT, RNA-BINDING PROTEIN 1; CUGBP1	10658
MIM601075	C1832826	 	APLASIA CUTIS CONGENITA, HIGH MYOPIA, AND CONE-ROD DYSFUNCTION	 
MIM601076	C1832817	 	MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACIC SOMITE ANOMALIES; MURCS	 
MIM601077		17q12-q21	KERATIN 31; KRT31	3881
MIM601078		 	KERATIN 82; KRT82	3888
MIM601079		5q22	ZINC FINGER-, CCCH DOMAIN-, AND RNA-BINDING MOTIF-CONTAINING SERINE/ARGININE-RICH PROTEIN 1; ZRSR1	7310
MIM601080		19p13.2	U2 SMALL NUCLEAR RIBONUCLEOPROTEIN AUXILIARY FACTOR, SMALL SUBUNIT 3; U2AF1RS3	199746
MIM601081		12q11-q12	ATP-BINDING CASSETTE, SUBFAMILY 3, MEMBER 2; ABCD2	225
MIM601082		7q32	UBIQUITIN-CONJUGATING ENZYME E2H; UBE2H	7328
MIM601083	C1832816	 	CD4/CD8 T-CELL RATIO	 
MIM601085		 	ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT; RESDAD	 
MIM601086	C1832813	6p21	LATERALITY DEFECTS, AUTOSOMAL DOMINANT	207115
MIM601088	C1832812	 	CATARACTS, CONGENITAL, WITH SENSORINEURAL DEAFNESS, DOWN SYNDROME-LIKE FACIAL APPEARANCE, SHORT STATURE, AND MENTAL RETARDATION	 
MIM601089		16q24	FORKHEAD BOX F1; FOXF1	2294
MIM601090		6p25	FORKHEAD BOX C1; FOXC1	2296
MIM601091		5q12-q13	FORKHEAD BOX D1; FOXD1	2297
MIM601092		9p1-q1	FORKHEAD BOX D4; FOXD4	2298
MIM601093		5q34	FORKHEAD BOX I1; FOXI1	2299
MIM601094		1p32	FORKHEAD BOX E3; FOXE3	2301
MIM601095	C0795970	 	HARROD SYNDROME	 
MIM601096	C1832800	 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	 
MIM601097		17p11.2	PERIPHERAL MYELIN PROTEIN 22; PMP22	5376
MIM601098	C0270913	16p13.3-p12	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C	9516
MIM601099		8q24.2-q24.3	SRC-LIKE ADAPTOR; SLA	6503
MIM601100		21q11.1	HEAT SHOCK 70-KD PROTEIN 13; HSPA13	6782
MIM601101	C1832774	5q31.3-q32	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 3; HHT3	780903
MIM601102		3q28	EUKARYOTIC TRANSLATION INITIATION FACTOR 4A, ISOFORM 2; EIF4A2	1974
MIM601103		12p13.1-p12.3	MICROFIBRILLAR-ASSOCIATED PROTEIN 5; MFAP5	8076
MIM601104	C0038868	17q21.1	SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	4137
MIM601105		1q21	CATHEPSIN K; CTSK	1513
MIM601107		10q24	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 2; ABCC2	1244
MIM601109		1p36-p35	5-@HYDROXYTRYPTAMINE RECEPTOR 6; HTR6	3362
MIM601110	C1832736	3q27	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	10195
MIM601112		12q23-q24.1	THIOREDOXIN REDUCTASE 1; TXNRD1	7296
MIM601113		5q31.1-q31.2	HEAT-SHOCK 70-KD PROTEIN 4; HSPA4	3308
MIM601114		17q12-q21	MEMBRANE PROTEIN, PALMITOYLATED 3; MPP3	4356
MIM601115		7q21.1-q21.2	GLUTAMATE RECEPTOR, METABOTROPIC, 3; GRM3	2913
MIM601116		7q31.3-q32.1	GLUTAMATE RECEPTOR, METABOTROPIC, 8; GRM8	2918
MIM601117		19p13.3	THIMET OLIGOPEPTIDASE 1; THOP1	7064
MIM601118		5q23	CALCIUM-MODULATING CYCLOPHILIN LIGAND; CAMLG	819
MIM601119		19p13.3	CLpP, E. COLI, HOMOLOG OF; CLPP	8192
MIM601120		16q22.1	CADHERIN 5; CDH5	1003
MIM601121		14q24-q31	PLACENTAL GROWTH FACTOR; PGF	5228
MIM601122		2q36.3-q37.1	5-@HYDROXYTRYPTAMINE RECEPTOR 2B; HTR2B	3357
MIM601123		12p12.1-p11.2	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 1; ST8SIA1	6489
MIM601124		3p21.3	SEMAPHORIN 3F; SEMA3F	6405
MIM601125		2p12	HEXOKINASE 2; HK2	3099
MIM601126		3p21-p12	TATA ELEMENT MODULATORY FACTOR 1; TMF1	7110
MIM601127	C1832735	 	FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	 
MIM601128		1q41	H3 HISTONE, FAMILY 3A; H3F3A	3020
MIM601129		10q23.3	CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 8; CYP2C8	1558
MIM601130		10q24	CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9	1559
MIM601131		 	CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 18; CYP2C18	1562
MIM601132		17q11.2	KINASE SUPPRESSOR OF RAS 1; KSR1	8844
MIM601133		 	CYTOCHROME P450, SUBFAMILY IIG, POLYPEPTIDE 1; CYP2G1	22952
MIM601134		11q23.3	INTEGRAL MEMBRANE PROTEIN 1; ITM1	3703
MIM601135		2q36-q37	GASTRULATION BRAIN HOMEOBOX 2; GBX2	2637
MIM601136		Chr.2	TRANSSUPPRESSOR OF EXPRESSION 2	57324
MIM601138		 	GUANYLATE CYCLASE 2E; GUCY2E	390226
MIM601139		19q13.4	ZINC FINGER PROTEIN 175; ZNF175	7728
MIM601140		11q13	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14B; PPP1R14B	26472
MIM601141		3q26.1	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 1; KCNAB1	7881
MIM601142		1p36.3	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 2; KCNAB2	8514
MIM601143		2p13	DYNACTIN 1; DCTN1	1639
MIM601144	CN029323	3p21	BRUGADA SYNDROME 1; BRGDA1	6331
MIM601145		21q22.3	CYSTATIN B; CSTB	1476
MIM601146		20q11.2	GROWTH/DIFFERENTIATION FACTOR 5; GDF5	8200
MIM601147		8q22.1	GROWTH/DIFFERENTIATION FACTOR 6; GDF6	392255
MIM601148		1q21	SPERM MITOCHONDRIA-ASSOCIATED CYSTEINE-RICH PROTEIN; SMCP	4184
MIM601149		15q25.1-q25.2	ISOCITRATE DEHYDROGENASE 3, ALPHA SUBUNIT; IDH3A	3419
MIM601150		12p11	DEAD/H BOX 11; DDX11	1663
MIM601151		12p13	DEAD/H BOX 12; DDX12	440081
MIM601152	C0393807	1p36.2	HEREDITARY MOTOR AND SENSORY NEUROPATHY VI	9927
MIM601153		3p14.2	FRAGILE HISTIDINE TRIAD GENE; FHIT	2272
MIM601154	C1832680	3p21	CARDIOMYOPATHY, DILATED, 1E; CMD1E	6331
MIM601155		19p13.3	MINOR HISTOCOMPATIBILITY ANTIGEN HA-1; HMHA1	23526
MIM601156		17q21.1-q21.2	CHEMOKINE, CC MOTIF, LIGAND 11; CCL11	6356
MIM601157		8p23	DEFENSIN, ALPHA, 4; DEFA4	1669
MIM601158		10q11.2	MITOGEN-ACTIVATED PROTEIN KINASE 8; MAPK8	5599
MIM601159		3p21	CHEMOKINE, CC MOTIF, RECEPTOR 1; CCR1	1230
MIM601160	C1832678	 	LISSENCEPHALY TYPE III AND BONE DYSPLASIA	 
MIM601161	C1832677	 	TRISOMY 18-LIKE SYNDROME	 
MIM601162	C1832669	10q23.3-q24.1	SPASTIC PARAPLEGIA 9, AUTOSOMAL DOMINANT; SPG9	9193
MIM601163	C1832668	 	DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	 
MIM601166		3q11.2-q13.1	G PROTEIN-COUPLED RECEPTOR 15; GPR15	2838
MIM601167		3q25	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 1; P2RY1	5028
MIM601168		5q32	DIHYDROPYRIMIDINASE-LIKE 3; DPYSL3	1809
MIM601170	C1832665	 	MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	 
MIM601172		Chr.15	CHONDROITIN SULFATE PROTEOGLYCAN 4; CSPG4	1464
MIM601175		11q13	ADP-RIBOSYLATION FACTOR-LIKE 2; ARL2	402
MIM601176		1p22.1	GLUTAMATE-CYSTEINE LIGASE, MODIFIER SUBUNIT; GCLM	2730
MIM601177		3p14.1	ADP-RIBOSYLATION FACTOR 4; ARF4	378
MIM601178		11p13	GPI-ANCHORED MEMBRANE PROTEIN 1; GPIAP1	4076
MIM601179		12q24.3	RAS-RELATED NUCLEAR PROTEIN; RAN	5901
MIM601180		 	RAN-BINDING PROTEIN 1; RANBP1	5902
MIM601181		2q11-q13	RAN-BINDING PROTEIN 2; RANBP2	5903
MIM601182		2q33	ORIGIN RECOGNITION COMPLEX, SUBUNIT 2, S. CEREVISIAE, HOMOLOG OF; ORC2	4999
MIM601183		14q32.3	CYSTEINE-RICH INTESTINAL PROTEIN 2; CRIP2	1397
MIM601184		13q32	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 3; DNAJC3	5611
MIM601185		8p21-p11.2	STANNIOCALCIN 1; STC1	6781
MIM601186	C1832661	15q24.1	MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	64220
MIM601187	C0796046	 	GURRIERI SYNDROME	 
MIM601189		11p15	POLYMERASE II, RNA, SUBUNIT L; POLR2L	5441
MIM601190		12p13	PHOSPHODIESTERASE 6H, cGMP-SPECIFIC, CONE, GAMMA; PDE6H	5149
MIM601191		14q24.1	ENHANCER OF RUDIMENTARY, DROSOPHILA, HOMOLOG OF; ERH	2079
MIM601192		1p36-p34	PHOSPHOLIPASE A2, GROUP V; PLA2G5	5322
MIM601193		6p21.2-p21.1	CYSTEINE-RICH SECRETORY PROTEIN 1; CRISP1	167
MIM601194		4p14	TOLL-LIKE RECEPTOR 1; TLR1	7096
MIM601195	C0268063	 	IRON OVERLOAD IN AFRICA	 
MIM601196		1p36	PR DOMAIN-CONTAINING PROTEIN 2; PRDM2	7799
MIM601197		 	TUBBY, MOUSE, HOMOLOG OF; TUB	7275
MIM601199		3q13.3-q21	CALCIUM-SENSING RECEPTOR; CASR	846
MIM601200	CN072455	14q31	PLEUROPULMONARY BLASTOMA; PPB	23405
MIM601201		1p36.1-p35	METHYLATION MODIFIER FOR CLASS I HLA	7795
MIM601202	C1832609	17p13	CATARACT, ANTERIOR POLAR, 2; CTAA2	1484
MIM601203		2q11.2	INTERLEUKIN 1 RECEPTOR-LIKE 1; IL1RL1	9173
MIM601204		1p13.1-q21.3	PROSTAGLANDIN F2 RECEPTOR NEGATIVE REGULATOR; PTGFRN	5738
MIM601205		14q23	SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 1; SIX1	6495
MIM601206		11q23.1	POU DOMAIN, CLASS 2, ASSOCIATING FACTOR 1; POU2AF1	5450
MIM601207		4p16.3	DIACYLGLYCEROL KINASE, THETA, 110-KD; DGKQ	1609
MIM601208	C1832605	14q24.3-q31	DIABETES MELLITUS, INSULIN-DEPENDENT, 11; IDDM11	3410
MIM601209		2p13-p12	POLY(rC)-BINDING PROTEIN 1; PCBP1	5093
MIM601210		12q13.12-q13.13	POLY(rC)-BINDING PROTEIN 2; PCBP2	5094
MIM601211		19p13.2-p13.12	CD97 ANTIGEN; CD97	976
MIM601212		8p22-p11.2	PROTEIN-TYROSINE KINASE 2, BETA; PTK2B	2185
MIM601213		4q31	RIBONUCLEASE 4 INHIBITOR; RNS4I	6059
MIM601214	C1832600	17q21	NAXOS DISEASE	3728
MIM601215		3q22-q24	ATR GENE; ATR	545
MIM601216	C1832594	 	PLATYSPONDYLY WITH AMELOGENESIS IMPERFECTA	 
MIM601217	C1832593	 	ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPIC HYPOGONADISM	 
MIM601218		21q22.3	ADENOSINE DEAMINASE, RNA-SPECIFIC, B1; ADARB1	104
MIM601220	C1832592	 	OSTEOPOROSIS AND OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME; OOCH	 
MIM601222		 	CRANIOSYNOSTOSIS, PHILADELPHIA TYPE	 
MIM601223	C1832589	 	NEURONAL INTESTINAL DYSPLASIA, TYPE B	 
MIM601224	C1832588	11p11.2	POTOCKI-SHAFFER SYNDROME	780904
MIM601225		22q11	DISHEVELLED 1-LIKE 1; DVL1L1	8215
MIM601228	C1832587	15q15.3-q22.1	POLYPOSIS SYNDROME, HEREDITARY MIXED, 1; HMPS1	338377
MIM601230	C1832586	 	DERMATITIS HERPETIFORMIS, FAMILIAL	 
MIM601231		1p36.2	FKBP12-RAPAMYCIN COMPLEX-ASSOCIATED PROTEIN 1; FRAP1	2475
MIM601232		7q22	PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, GAMMA; PIK3CG	5294
MIM601233		12q13.1	INHIBIN, BETA C; INHBC	3626
MIM601234		12q23-q24.1	NASCENT POLYPEPTIDE-ASSOCIATED COMPLEX, ALPHA POLYPEPTIDE; NACA	4666
MIM601235		11q22-q23	DEAD/H BOX 10; DDX10	1662
MIM601236		5p13	DISABLED, DROSOPHILA, HOMOLOG OF, 2; DAB2	1601
MIM601237		17p11.2	ZINC FINGER PROTEIN 179; ZNF179	7732
MIM601238	C1832585	19p13.3	CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	85300
MIM601239		18q12.1-q12.2	DYSTROBREVIN, ALPHA; DTNA	1837
MIM601240		19p13.3	GUANIDINOACETATE METHYLTRANSFERASE; GAMT	2593
MIM601241		1p34.1	HISTONE DEACETYLASE 1; HDAC1	3065
MIM601242		20cen-q13	MICROTUBULE-ASSOCIATED PROTEIN 1, LIGHT CHAIN 3, ALPHA; MAP1LC3A	84557
MIM601243		17p12-p11.2	TOPOISOMERASE, DNA, III, ALPHA; TOP3A	7156
MIM601244		11q21-q22	GUANYLATE CYCLASE 1, SOLUBLE, ALPHA-2; GUCY1A2	2977
MIM601245		21q22.2	CHROMATIN ASSEMBLY FACTOR I, SUBUNIT B; CHAF1B	8208
MIM601246		 	CHROMATIN ASSEMBLY FACTOR I, SUBUNIT A; CHAF1A	10036
MIM601247		14q21	SON OF SEVENLESS, DROSOPHILA, HOMOLOG 2; SOS2	6655
MIM601248		2q14	BRIDGING INTEGRATOR 1; BIN1	274
MIM601249		17q24-q25	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE-ASSOCIATED PROTEIN 1; PRPSAP1	5635
MIM601250		 	PEPTIDE METHIONINE SULFOXIDE REDUCTASE; MSRA	4482
MIM601252		9q34	FICOLIN 1; FCN1	2219
MIM601253		3p25	CAVEOLIN 3; CAV3	859
MIM601254		17q24.3	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 6; MAP2K6	5608
MIM601255		2q37	KINESIN FAMILY MEMBER 1A; KIF1A	547
MIM601257		2p24	DEAD/H BOX 1; DDX1	1653
MIM601258		1p31.3-p31.2	CYTOCHROME P450, SUBFAMILY IIJ, POLYPEPTIDE 2; CYP2J2	1573
MIM601259		4q21	AMELOBLASTIN ENAMEL MATRIX PROTEIN; AMBN	258
MIM601260		7q21-q22	ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 1; ZKSCAN1	7586
MIM601261		7q21-q22	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 21; ZSCAN21	7589
MIM601262		8q24	ZINC FINGER PROTEIN 16; ZNF16	7564
MIM601263		19p13.3	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2; MAP2K2	5605
MIM601265		10q22.1	NODAL, MOUSE, HOMOLOG OF; NODAL	4838
MIM601266		15q15-q21.1	dUTP PYROPHOSPHATASE; DUT	1854
MIM601267		3p21	CHEMOKINE, CC MOTIF, RECEPTOR 2; CCR2	729230
MIM601268		3p21.3	CHEMOKINE, CC MOTIF, RECEPTOR 3; CCR3	1232
MIM601269		17p13.3	COMPLEMENT COMPONENT C1q-BINDING PROTEIN; C1QBP	708
MIM601270		19p13.2	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 3; CYP4F3	4051
MIM601271		1p34-p33	GUANYLATE CYCLASE ACTIVATOR 2B; GUCA2B	2981
MIM601272		15q22.3	SORTING NEXIN 1; SNX1	6642
MIM601273		22q11.2	CLATHRIN, HEAVY POLYPEPTIDE-LIKE 1; CLTCL1	8218
MIM601274		 	LEUKOTRIENE B4 12-HYDROXYDEHYDROGENASE; LTB4DH	22949
MIM601275		4q34	GLYCOPROTEIN M6A; GPM6A	2823
MIM601276		19p13	ZINC FINGER PROTEIN 177; ZNF177	7730
MIM601277	C1832550	2q34	ICHTHYOSIS, LAMELLAR, 2; LI2	26154
MIM601278		4q35	FSHD REGION GENE 1; FRG1	2483
MIM601279		22q11	DIGEORGE SYNDROME CRITICAL REGION GENE 6; DGCR6	8214
MIM601280		13q13	MAB21, C. ELEGANS, HOMOLOG-LIKE 1; MAB21L1	4081
MIM601281		3p21.3	SEMAPHORIN 3B; SEMA3B	7869
MIM601282		8q24	PLECTIN 1; PLEC1	5339
MIM601283	C1832544	2q37.3	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 1; NIDDM1	11132, 4812
MIM601284		12q11-q14	ACTIVIN A RECEPTOR, TYPE II-LIKE 1; ACVRL1	94
MIM601285		7q21.3-q22.1	DELETED IN SPLIT-HAND/SPLIT-FOOT 1 REGION	 
MIM601286		2q33-q35	CATARACT, NONNUCLEAR POLYMORPHIC CONGENITAL, AUTOSOMAL DOMINANT	1421
MIM601287	C1832525	5q33	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F; LGMD2F	6444
MIM601288		8q22.3	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, ZETA ISOFORM; YWHAZ	7534
MIM601289		20q13.1	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, BETA ISOFORM; YWHAB	7529
MIM601290		 	STRATIFIN; SFN	2810
MIM601291		4q26	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 8; UGT8	7368
MIM601292		16p12.1-p11.2	SULFOTRANSFERASE FAMILY 1A, PHENOL-PREFERRING, MEMBER 2; SULT1A2	6799
MIM601293		7q36	RAS HOMOLOG ENRICHED IN BRAIN; RHEB	6009
MIM601295		13q33	SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2; SLC10A2	6555
MIM601296		9q31.3-q32	MUSCLE, SKELETAL, RECEPTOR TYROSINE KINASE; MUSK	4593
MIM601297		17p13	SRY-BOX 15; SOX15	6665
MIM601299		10q22.3	BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE IA; BMPR1A	657
MIM601300		12q13	ACTIVIN A RECEPTOR, TYPE IB; ACVR1B	91
MIM601301		6p21.1	PEPTIDYL-PROLYL ISOMERASE-LIKE 1; PPIL1	51645
MIM601302		2p16-p15	PROTEIN PHOSPHATASE 3, REGULATORY SUBUNIT B, ALPHA; PPP3R1	5534
MIM601303		19q13.11-q13.12	CYTOSKELETON-ASSOCIATED PROTEIN 1; CKAP1	1155
MIM601304		22q13.2	NON-HISTONE CHROMOSOME PROTEIN 2, S. CEREVISIAE, HOMOLOG-LIKE 1; NHP2L1	4809
MIM601305		7q36.1	5-@HYDROXYTRYPTAMINE RECEPTOR 5A; HTR5A	3361
MIM601306		3q13	HEMATOPOIETIC CELL-SPECIFIC LYN SUBSTRATE 1; HCLS1	3059
MIM601308	C1832510	20q11.2-q12	MYELOID TUMOR SUPPRESSOR	8201
MIM601309		9q22.3	PATCHED, DROSOPHILA, HOMOLOG OF, 1; PTCH1	5727
MIM601310		1p33	CYTOCHROME P450, SUBFAMILY IVA, POLYPEPTIDE 11; CYP4A11	1579
MIM601311		12q13	STEROL O-ACYLTRANSFERASE 2; SOAT2	8435
MIM601313		16p13.3-p13.12	POLYCYSTIN 1; PKD1	5310
MIM601314		5q31.2	HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1; HINT1	3094
MIM601316	C1832476	6q23	DEAFNESS, AUTOSOMAL DOMINANT 10; DFNA10	2070
MIM601317	C1832475	11q13.5	DEAFNESS, AUTOSOMAL DOMINANT 11; DFNA11	4647
MIM601318	C1832474	2q34	DIABETES MELLITUS, INSULIN-DEPENDENT, 13; IDDM13	3412
MIM601319	C1832473	 	ODONTOMICRONYCHIAL DYSPLASIA	 
MIM601321	C2931482	17q11.2	NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	4763
MIM601322	C1832472	 	PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	 
MIM601323		19q13.2-q13.4	NUCLEOBINDIN 1; NUCB1	4924
MIM601324		4q21.1-q21.2	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HNRNPD	3184
MIM601325		3p26	CONTACTIN 3; CNTN3	5067
MIM601326		3q26.2-q26.3	CLAUDIN 11; CLDN11	5010
MIM601327		11q23	SODIUM CHANNEL, VOLTAGE-GATED, TYPE II, BETA SUBUNIT; SCN2B	6327
MIM601328		1p36.3-p36.2	SODIUM CHANNEL, NONVOLTAGE-GATED 1, DELTA SUBUNIT; SCNN1D	6339
MIM601329		7q11.23	LIM DOMAIN KINASE 1; LIMK1	3984
MIM601330		12p12	GUANYLATE CYCLASE 2C; GUCY2C	2984
MIM601331	C1832471	 	RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO; CYSRD	80114
MIM601332		10p12.1	MOHAWK HOMEOBOX; MKX	283078
MIM601333		17q11.2	SUPPRESSOR OF TY 6, S. CEREVISIAE, HOMOLOG OF; SUPT6H	6830
MIM601334		19q13.2-q13.3	KINESIN LIGHT CHAIN 3; KLC3	147700
MIM601335		17p11.2	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4; MAP2K4	6416
MIM601336		2p13-p12	GLUCOSIDASE I; GCS1	7841
MIM601337		 	REGULATORY FACTOR X, 3; RFX3	5991
MIM601338	C1832466	 	CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS	 
MIM601340		19q13.32-q13.33	MELANOMA INHIBITORY ACTIVITY PROTEIN; MIA	8190
MIM601341	C1832465	 	ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL; AMVC	 
MIM601342		20q13	CHROMOSOME SEGREGATION 1-LIKE; CSE1L	1434
MIM601344	C1832464	 	SPINAL DYSPLASIA, ANHALT TYPE	 
MIM601345	C1832444	 	ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	 
MIM601346	C1832443	 	PANCREATIC HYPOPLASIA, INTESTINAL ATRESIA, AND GALLBLADDER APLASIA OR HYPOPLASIA, WITH OR WITHOUT TRACHEOESOPHAGEAL FISTULA	222546
MIM601347	C1832442	 	MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE, AND PSYCHOMOTOR DELAY	 
MIM601348	C1832441	 	ECTRODACTYLY OF LOWER LIMBS, CONGENITAL HEART DEFECT, AND MICROGNATHIA	 
MIM601349	C1832440	6q21	MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	 
MIM601350	C1832439	 	SHORT STATURE SYNDROME, BRUSSELS TYPE	 
MIM601351	C1832438	 	GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	 
MIM601352	C1832437	 	MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	 
MIM601353	C0795941	 	BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	 
MIM601356	C1832435	 	LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE	 
MIM601357	C1832434	 	BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	 
MIM601358	C1303073	 	NICOLAIDES-BARAITSER SYNDROME; NCBRS	6595
MIM601360	C1832432	 	AMELIA, AUTOSOMAL RECESSIVE	 
MIM601361		 	GROWTH/DIFFERENTIATION FACTOR 10; GDF10	2662
MIM601362	C1832431	10p14-p13	DIGEORGE SYNDROME/VELOCARDIOFACIAL SYNDROME COMPLEX 2	8026
MIM601363	C1832426	17q12-q21	WILMS TUMOR 4	8151
MIM601364		16q24.2-q24.3	CADHERIN 13; CDH13	1012
MIM601365		1p36	DISHEVELLED 1; DVL1	1855
MIM601366		18q21	MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 2; SMAD2	4087
MIM601367	C0948008	1q23, 14q22-q23, 13q12, 11p11-q12, 7q36	STROKE, ISCHEMIC	2147, 2153, 241, 4846, 5583
MIM601368		3q27	DISHEVELLED 3; DVL3	1857
MIM601369	C1832425	14q12-q13	DEAFNESS, AUTOSOMAL DOMINANT 9; DFNA9	1690
MIM601370	C1832424	 	HOLOPROSENCEPHALY, SEMILOBAR, WITH CRANIOSYNOSTOSIS	 
MIM601371	C1832423	 	CATARACT, AGE-RELATED NUCLEAR	 
MIM601372	C1832422	 	CHOREA, REMITTING, WITH NYSTAGMUS AND CATARACT	 
MIM601373		3p21	CHEMOKINE, CC MOTIF, RECEPTOR 5; CCR5	1234
MIM601374	C1832412	 	APROSENCEPHALY AND CEREBELLAR DYSGENESIS	 
MIM601375	C1832411	 	ECTODERMAL DYSPLASIA, HIDROTIC, CHRISTIANSON-FOURIE TYPE	 
MIM601376	C1832410	 	CHONDRODYSPLASIA, LETHAL, WITH LONG BONE ANGULATION AND MIXED BONE DENSITY	 
MIM601378		19p12	CRISPONI SYNDROME	9244
MIM601379	C1832408	 	HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	 
MIM601380		1q21-q22	EPHRIN A4; EFNA4	1945
MIM601381		1q21-q22	EPHRIN A3; EFNA3	1944
MIM601382	C1832399	11q22	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	8898
MIM601383		12q13	AQUAPORIN 6; AQP6	363
MIM601384		8q24.3	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS E; LY6E	4061
MIM601385		8p22	TUMOR SUPPRESSOR CANDIDATE 3; TUSC3	7991
MIM601386	C1832394	10q21-q22, 3p26-p25	DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	491, 64072
MIM601387		11p15.2-p15.1	TUMOR SUSCEPTIBILITY GENE 101; TSG101	7251
MIM601388	C1832392	2q33	DIABETES MELLITUS, INSULIN-DEPENDENT, 12; IDDM12	1493
MIM601389	C1832391	 	CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	 
MIM601390	C1832390	 	CEREBROFACIOARTICULAR SYNDROME	 
MIM601391		17q11.2	CHEMOKINE, CC MOTIF, LIGAND 13; CCL13	6357
MIM601392		17q11.2	CHEMOKINE, CC MOTIF, LIGAND 14; CCL14	6358
MIM601393		17q11.2	CHEMOKINE, CC MOTIF, LIGAND 15; CCL15	6359
MIM601394		17q11.2	CHEMOKINE, CC MOTIF, LIGAND 16; CCL16	6360
MIM601395		17q11.2	CHEMOKINE, CC MOTIF, LIGAND 3-LIKE 1; CCL3L1	6349
MIM601396		10q24	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 8B; WNT8B	7479
MIM601397		6q27	T BRACHYURY, MOUSE, HOMOLOG OF; T	6862
MIM601398		11q13	VASCULAR ENDOTHELIAL GROWTH FACTOR B; VEGFB	7423
MIM601399	C1832388	21q22.3	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	861
MIM601401		12p13	MYELOID LEUKEMIA FACTOR 2; MLF2	8079
MIM601402		3q25.1	MYELOID LEUKEMIA FACTOR 1; MLF1	4291
MIM601403		10q26.13-q26.3	DEDICATOR OF CYTOKINESIS 1; DOCK1	1793
MIM601404		14q31	G PROTEIN-COUPLED RECEPTOR 68; GPR68	8111
MIM601405		1p36.21	CHYMOTRYPSIN C; CTRC	11330
MIM601406		12q24.1	B-CELL CLL/LYMPHOMA 7A; BCL7A	605
MIM601407	C1832387	12q24.2	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2; NIDDM2	4813
MIM601408		8p11	HISTONE ACETYLTRANSFERASE MYST3; MYST3	7994
MIM601409		11q13	K(LYSINE) ACETYLTRANSFERASE 5; KAT5	10524
MIM601410	C1832386	6q24, 6p22.1	DIABETES MELLITUS, TRANSIENT NEONATAL, 1	346171, 5325, 57061, 7952
MIM601411		5q33	SARCOGLYCAN, DELTA; SGCD	6444
MIM601412	C1832379	1q21-q23	DEAFNESS, AUTOSOMAL DOMINANT 7; DFNA7	1689
MIM601413		14q24.3	DEIODINASE, IODOTHYRONINE, TYPE II; DIO2	1734
MIM601414	C1832378	1q21.2	RETINITIS PIGMENTOSA 18; RP18	9129
MIM601415		20q13.1	V-MYB AVIAN MYELOBLASTOSIS VIRAL ONCOGENE HOMOLOG-LIKE 2; MYBL2	4605
MIM601416		6p21.3	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 7; SLC39A7	7922
MIM601417		6p21.3	17-@BETA-HYDROXYSTEROID DEHYDROGENASE VIII; HSD17B8	7923
MIM601418		20p12-p11.2	RIBOSOME BINDING PROTEIN 1; RRBP1	6238
MIM601419	C1832370	2q35	MYOPATHY, MYOFIBRILLAR, 1; MFM1	1674
MIM601420	C1832369	 	MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	 
MIM601421		16q22.2-q22.3	LYSYL-tRNA SYNTHETASE; KARS	3735
MIM601422		1p36	LEUCINE ZIPPER PROTEIN 1; LUZP1	7798
MIM601423		12q24.1	THYMINE-DNA GLYCOSYLASE; TDG	6996
MIM601424		5p13	3-@OXOACID CoA TRANSFERASE 1; OXCT1	5019
MIM601425		8q11.23	TRANSCRIPTION ELONGATION FACTOR A, 1; TCEA1	6917
MIM601426		3p25	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 2; NR2C2	7182
MIM601427	C1832362	 	ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	 
MIM601428		 	RNA, U4ATAC SMALL NUCLEAR; RNU4ATAC	100151683
MIM601429		 	RNA, U6ATAC SMALL NUCLEAR; RNU6ATAC	100151684
MIM601430		19p13.2-p13.11	UPF1, YEAST, HOMOLOG OF; UPF1	5976
MIM601431		6p22.3-p21.1	TRANSFER RNA ALANINE 1; TRNAA1	7154
MIM601432		6p22.3-p21.1	TRANSFER RNA ARGININE 3; TRNAR3	7232
MIM601434		5q31	S-PHASE KINASE-ASSOCIATED PROTEIN 1A; SKP1A	6500
MIM601435		12p12	S-PHASE KINASE-ASSOCIATED PROTEIN 1B; SKP1B	728622
MIM601436		5p13	S-PHASE KINASE-ASSOCIATED PROTEIN 2; SKP2	6502
MIM601437		19q13.3	Fc FRAGMENT OF IgG, RECEPTOR TRANSPORTER, ALPHA; FCGRT	2217
MIM601438	C1832359	 	RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	 
MIM601439		12p12.1	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 9; ABCC9	10060
MIM601440		17q22	DIACYLGLYCEROL KINASE, EPSILON, 64-KD; DGKE	8526
MIM601441		 	DIACYLGLYCEROL KINASE, ZETA, 104-KD: DGKZ	8525
MIM601442		11q13	COFILIN 1; CFL1	1072
MIM601443		14q12	COFILIN 2; CFL2	1073
MIM601444		12q13-q14	BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 1; BLOC1S1	2647
MIM601445		8q13.3	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 9; NDUFB9	4715
MIM601447		12p13	UBIQUITIN-SPECIFIC PROTEASE 5; USP5	8078
MIM601448		11q22.3	NUCLEAR PROTEIN, ATAXIA-TELANGIECTASIA LOCUS; NPAT	4863
MIM601449	C1832354	 	DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION	 
MIM601450	C1832353	 	DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERS AND FACIAL DYSMORPHISM	 
MIM601451		1p36.3-p36.2	NEVO SYNDROME	5351
MIM601452	C1832352	 	OCULOAURICULOFRONTONASAL SYNDROME; OAFNS	 
MIM601453	C0406724	 	TRICHODENTAL DYSPLASIA	 
MIM601454	C1832345	4q	PSORIASIS SUSCEPTIBILITY 3; PSORS3	7889
MIM601455	C1832334	8q24.3	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D	10397
MIM601456		 	MULTIMERIN 1; MMRN1	22915
MIM601457	C1832322	11p13, 11p13	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	5896, 5897
MIM601458	C1832321	12p13.2-q24.1	INFLAMMATORY BOWEL DISEASE 2; IBD2	3378
MIM601459		8p21	PREPRONOCICEPTIN; PNOC	5368
MIM601460		3q21	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 2A1; SLCO2A1	6578
MIM601461		4q22	ATONAL, DROSOPHILA, HOMOLOG OF, 1; ATOH1	474
MIM601462	C0751885	17p12-p11, 17p13-p12, 2q33-q34, 2q24-q32	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL; SCCMS	1134, 1140, 1144, 1145
MIM601463		19q13.3-q13.4	HYALURONAN SYNTHASE 1; HAS1	3036
MIM601464		2q11.2-q12	AF4/FMR2 FAMILY, MEMBER 3; AFF3	3899
MIM601465		2p13	DEOXYGUANOSINE KINASE; DGUOK	1716
MIM601466	C0344688	 	PATENT DUCTUS VENOSUS; PDV	 
MIM601467		4q27	MITOTIC ARREST-DEFICIENT 2, S. CEREVISIAE, HOMOLOG-LIKE 1; MAD2L1	4085
MIM601468		2p11.2	METHIONINE ADENOSYLTRANSFERASE II, ALPHA; MAT2A	4144
MIM601469		2q33	PARATHYROID HORMONE RECEPTOR 2; PTHR2	5746
MIM601470		3pter-p21	CHEMOKINE, CX3C MOTIF, RECEPTOR 1; CX3CR1	1524
MIM601471	C1832284	3q21-q22	FACIAL PARESIS, HEREDITARY CONGENITAL, 1; HCFP1	7880
MIM601472	C1832274	7p15	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	2617
MIM601473		16pter-p11	ZINC FINGER PROTEIN 75A; ZNF75A	7627
MIM601475		21q22.3	PERIODIC TRYPTOPHAN PROTEIN 2, YEAST, HOMOLOG OF; PWP2H	5822
MIM601476		1p34	LYSOSOME-ASSOCIATED PROTEIN, TRANSMEMBRANE 5; LAPTM5	7805
MIM601478		12q13-q15	MYOSIN IA; MYO1A	4640
MIM601479		15q21-q22	MYOSIN IE; MYO1E	4643
MIM601480		19p13.3-p13.2	MYOSIN IF; MYO1F	4542
MIM601481		5p15.1-p14.3	MYOSIN X; MYO10	4651
MIM601482		1p22.1	DOWNREGULATOR OF TRANSCRIPTION 1, TBP-BINDING; DR1	1810
MIM601483		19q13.4	PATERNALLY EXPRESSED GENE 3; PEG3	5178
MIM601484		5p11	SELENOPROTEIN P, PLASMA, 1; SEPP1	6414
MIM601485		16p11.2	SYNTAXIN 1B; STX1B	112755
MIM601486		3p24	DELETED IN AZOOSPERMIA-LIKE; DAZL	1618
MIM601487		3p25	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA; PPARG	5468
MIM601488		22q13.1	NEUTROPHIL CYTOSOLIC FACTOR 4; NCF4	4689
MIM601489		16p13.3	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN, ACID-LABILE SUBUNIT; IGFALS	3483
MIM601490		12q13	NUCLEAR FACTOR ERYTHROID 2, p45 SUBUNIT; NFE2	4778
MIM601491		15q11-q13	IMPRINTED IN PRADER-WILLI SYNDROME; IPW	3653
MIM601492	C1291490	3p21.3-p21.2	MUCOPOLYSACCHARIDOSIS TYPE IX	3373
MIM601493	C1832244	10q22.2-q23.3	CARDIOMYOPATHY, DILATED, 1C; CMD1C	11155, 1219
MIM601494	C1832243	1q32	CARDIOMYOPATHY, DILATED, 1D; CMD1D	7139
MIM601495	C1832241	14q32.33	AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE; AGM1	3507
MIM601496		10q26	GDNF FAMILY RECEPTOR ALPHA-1; GFRA1	2674
MIM601497		9p12	BCL2-ASSOCIATED ATHANOGENE 1; BAG1	573
MIM601498		6p21.1	PEROXISOME BIOGENESIS FACTOR 6; PEX6	5190
MIM601499	C1832229	13q14	AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2	6012
MIM601500		7q31-q32	SMOOTHENED, DROSOPHILA, HOMOLOG OF; SMOH	6608
MIM601501		16q12	VACUOLAR PROTEIN SORTING 35, YEAST, HOMOLOG OF; VPS35	55737
MIM601502		1p12	Fc FRAGMENT OF IgG, HIGH AFFINITY Ib, RECEPTOR FOR; FCGR1B	2210
MIM601503		1q21	Fc FRAGMENT OF IgG, HIGH AFFINITY Ic, RECEPTOR FOR; FCGR1C	100132417
MIM601504		17q25.1-q25.2	SEC14-LIKE 1; SEC14L1	6397
MIM601505		19q13.1	ZINC FINGER PROTEIN 146; ZNF146	7705
MIM601506		2q37	SEPTIN 2; SEPT2	4735
MIM601507		5q23.1	ADAPTOR-RELATED PROTEIN COMPLEX 3, SIGMA-1 SUBUNIT; AP3S1	1176
MIM601509		8q12.3	GAMMA-GLUTAMYL HYDROLASE; GGH	8836
MIM601510		3p21.31	SREBP CLEAVAGE-ACTIVATING PROTEIN; SCAP	22937
MIM601511		 	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5A; STAT5A	6776
MIM601512		12q13	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6; STAT6	6778
MIM601513		3q28	FIBROBLAST GROWTH FACTOR 12; FGF12	2257
MIM601514		17q21	FIBROBLAST GROWTH FACTOR 11; FGF11	2256
MIM601515		13q34	FIBROBLAST GROWTH FACTOR 14; FGF14	2259
MIM601516		11q13	SPLICING FACTOR 1; SF1	7536
MIM601517		12q24	ATAXIN 2; ATXN2	6311
MIM601518	C2931456	1q25	PROSTATE CANCER, HEREDITARY, 1; HPC1	6041
MIM601519		 	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT E; ATP5I	521
MIM601520		16q13	CHEMOKINE, CC MOTIF, LIGAND 17; CCL17	6361
MIM601521		 	ENDOTHELIAL CELL-SPECIFIC MOLECULE 1; ESM1	11082
MIM601522		17q21-q22	GROWTH FACTOR RECEPTOR-BOUND PROTEIN 7; GRB7	2886
MIM601523		7p12-p11.2	GROWTH FACTOR RECEPTOR-BOUND PROTEIN 10; GRB10	2887
MIM601524		2q22-q24	GROWTH FACTOR RECEPTOR-BOUND PROTEIN 14; GRB14	2888
MIM601525		1q32.1	CHITINASE 3-LIKE 1; CHI3L1	1116
MIM601526		 	CHITINASE 3-LIKE 2; CHI3L2	1117
MIM601527		12q21.3-q22	ARISTALESS-LIKE HOMEOBOX 1; ALX1	8092
MIM601528		 	VASCULAR ENDOTHELIAL GROWTH FACTOR C; VEGFC	7424
MIM601529		 	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 1; NR2C1	7181
MIM601530		5q35	SEQUESTOSOME 1; SQSTM1	8878
MIM601531		14q11.2-q12	LEUKOTRIENE B4 RECEPTOR; LTB4R	1241
MIM601532		4q25-q25	CASPASE 6, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP6	839
MIM601533		8p11.2	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 2; ADAM2	2515
MIM601534		2q24.1	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 3; KCNJ3	3760
MIM601535		 	EPHRIN A5; EFNA5	1946
MIM601536	C1832215	7p15.3	ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS	3198
MIM601537	C1832214	 	MICROCEPHALY, RETINITIS PIGMENTOSA, AND SUTURAL CATARACT	 
MIM601538		5q	PROPHET OF PIT1, PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR; PROP1	5626
MIM601539	CN168921	 	PEROXISOME BIOGENESIS DISORDERS; PBD	5189, 5190, 5192, 5193, 55670, 5828, 9409
MIM601540		6p21.3	BROMODOMAIN-CONTAINING PROTEIN 2; BRD2	6046
MIM601541		9q34	BROMODOMAIN-CONTAINING PROTEIN 3; BRD3	8019
MIM601542		4q25-q26	PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 2; PITX2	5308
MIM601543	C1832187	11q22-q24	DEAFNESS, AUTOSOMAL DOMINANT 12; DFNA12	7007
MIM601544	C2675750	13q11-q12	DEAFNESS, AUTOSOMAL DOMINANT 3A; DFNA3A	2706
MIM601545		17p13.3	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, ALPHA SUBUNIT; PAFAH1B1	5048
MIM601546		1q32.2-q32.3	PROSPERO-RELATED HOMEOBOX 1; PROX1	5629
MIM601547	C1832175	22q11.2-q12.2	CATARACT, CONGENITAL, CERULEAN TYPE, 2; CCA2	1415
MIM601548		2p16	EGF-CONTAINING FIBULIN-LIKE EXTRACELLULAR MATRIX PROTEIN 1; EFEMP1	2202
MIM601549	C0344505	 	ALACRIMA, CONGENITAL	 
MIM601550	C1832169	 	BLOOD GROUP--SWANN SYSTEM; SW	6521
MIM601551	C1832168	17q21-q22	BLOOD GROUP--FROESE	6521
MIM601552	C1832167	 	ECTOPIA LENTIS, SPONTANEOUS FILTERING BLEBS, AND CRANIOFACIAL DYSMORPHISM	 
MIM601553	C1832162	16q22.1	HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY; HJMD	1001
MIM601554		6q25.2-q25.3	DYNEIN, LIGHT CHAIN, TCTEX TYPE, 1; DYNLT1	6993
MIM601555		17q21	RHO FAMILY GTPase 2; RND2	8153
MIM601556		6p23	ATAXIN 1; ATXN1	6310
MIM601557		12q24.1	ACETYL-CoA CARBOXYLASE-BETA; ACACB	32
MIM601558		8p12-p11	RNA-BINDING PROTEIN GENE WITH MULTIPLE SPLICING; RBPMS	11030
MIM601559	C0796176	5p13.1	STUVE-WIEDEMANN SYNDROME	3977
MIM601560	C1832112	 	MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	 
MIM601561	C1832111	 	DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	 
MIM601562		12q24.2	DYNEIN, LIGHT CHAIN, LC8 TYPE, 1; DYNLL1	8655
MIM601564		7q35	PROTEASE, SERINE, 2; PRSS2	5645
MIM601565		 	INTERFERON REGULATORY FACTOR 8; IRF8	3394
MIM601566		13q34	INHIBITOR OF GROWTH 1; ING1	3621
MIM601567		18q21.3-q22	LECTIN, MANNOSE-BINDING, 1; LMAN1	3998
MIM601568		10q24.2-q24.3	ADDUCIN 3; ADD3	120
MIM601569		Chr.17	UBIQUITIN-CONJUGATING ENZYME E2G 1; UBE2G1	7326
MIM601570		3p25	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 7A; WNT7A	7476
MIM601571		7q31.2-q31.3	CAPPING PROTEIN, ALPHA-2; CAPZA2	830
MIM601572		1p36.1	CAPPING PROTEIN, BETA; CAPZB	832
MIM601573		7q35	ENHANCER OF ZESTE, DROSOPHILA, HOMOLOG 2; EZH2	2146
MIM601574		17q11.1-q11.2	TAF15 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 68-KD; TAF15	8148
MIM601575		2p23-p22	FOS-LIKE ANTIGEN 2; FOSL2	2355
MIM601576		19p13.3	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, SIGMA; PTPRS	5802
MIM601577		11q13.3	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, C POLYPEPTIDE-ASSOCIATED PROTEIN; PTPRCAP	5790
MIM601578		5q32-q34	CYCLIN G1; CCNG1	900
MIM601579		19p13.3	ORNITHINE DECARBOXYLASE ANTIZYME 1; OAZ1	4946
MIM601580		1p13.2	CAPPING PROTEIN, ALPHA-1; CAPZA1	829
MIM601581		7q31.1-q31.2	NEURONAL CELL ADHESION MOLECULE; NRCAM	4897
MIM601582		2q36-q37	INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 145-KD; INPP5D	3635
MIM601583	C1832099	7p14-p13	WILMS TUMOR 5; WT5	11281
MIM601584		1p35	PROTEIN-TYROSINE PHOSPHATASE, TYPE 4A, 2; PTP4A2	8073
MIM601585		6q12	PROTEIN-TYROSINE PHOSPHATASE, TYPE 4A, 1; PTP4A1	7803
MIM601586		5p13.1	PROSTAGLANDIN E RECEPTOR 4, EP4 SUBTYPE; PTGER4	5734
MIM601587		 	THYMOSIN, BETA-15; TMSB15A	11013
MIM601589		3q22-q23	RAS p21 PROTEIN ACTIVATOR 2; RASA2	5922
MIM601590		17q25	ENVOPLAKIN; EVPL	2125
MIM601591		4q13.1-q21.1	PROTEIN KINASE, cGMP-DEPENDENT, TYPE II; PRKG2	5593
MIM601592		11p11.2-p11.1	RECEPTOR-ASSOCIATED PROTEIN OF THE SYNAPSE, 43-KD; RAPSN	5913
MIM601593		2q34-q35	BRCA1-ASSOCIATED RING DOMAIN 1; BARD1	580
MIM601594		6p24-p23	JUMONJI, AT-RICH INTERACTIVE DOMAIN 2; JARID2	3720
MIM601595		4q28	MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 1; SMAD1	4086
MIM601596	C1866636	5q32	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	79628
MIM601597		1q32	B-CELL TRANSLOCATION GENE 2; BTG2	7832
MIM601598		9p24.3-p23	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, DELTA; PTPRD	5789
MIM601599		12p11.2	SARCOSPAN; SSPN	8082
MIM601600		3q28	ETS VARIANT GENE 5; ETV5	2119
MIM601601		6p12	TRANSCRIPTION FACTOR AP2-BETA; TFAP2B	7021
MIM601602		20q13.2	TRANSCRIPTION FACTOR AP2-GAMMA; TFAP2C	7022
MIM601603		5q33.1-qter	LYMPHOCYTE CYTOSOLIC PROTEIN 2; LCP2	3937
MIM601604		19p13.1	INTERLEUKIN 12 RECEPTOR, BETA-1; IL12RB1	3594
MIM601606	C1275122	16q12-q13	TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1	1540
MIM601607		22q11	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY B, MEMBER 1; SMARCB1	6598
MIM601608	C1866619	 	SPASTIC PARAPLEGIA AND EVANS SYNDROME	 
MIM601609		4q22-q26	3-@HYDROXYACYL-CoA DEHYDROGENASE; HADH	3033
MIM601610		6p22.1	BUTYROPHILIN, SUBFAMILY 1, MEMBER A1; BTN1A1	696
MIM601611		18q12.1-q21.1	SOLUTE CARRIER FAMILY 14 (UREA TRANSPORTER), MEMBER 2; SLC14A2	8170
MIM601612	C0265780	 	LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME; LACHT	 
MIM601613		11q23.3	CHEMOKINE, CXC MOTIF, RECEPTOR 5; CXCR5	643
MIM601614		 	NETRIN 1, MOUSE, HOMOLOG OF; NTN1	9423
MIM601615		16p13.3	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 3; ABCA3	21
MIM601616	C1866608	 	IRIS PIGMENT EPITHELIUM ANOMALIES	 
MIM601617		12q13-q14	RETINOL DEHYDROGENASE 5; RDH5	5959
MIM601618		20q13.33	SRY-BOX 18; SOX18	54345
MIM601619		9q34	RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR; RALGDS	5900
MIM601620		12q24.1	T-BOX 5; TBX5	6910
MIM601621		12q24.1	T-BOX 3; TBX3	6926
MIM601622		7p21	TWIST, DROSOPHILA, HOMOLOG OF, 1; TWIST1	7291
MIM601623		15q11-q13	UBIQUITIN-PROTEIN LIGASE E3A; UBE3A	7337
MIM601624		9q34	FICOLIN 2; FCN2	2220
MIM601625		11p15	ADP-RIBOSYLTRANSFERASE 1; ART1	417
MIM601626	C0023467	16q22, 13q12, 12p13, 11q23.3, 11q14, 10p12, 9q34.1, 9p24, 8p12, 5q35, 5q35, 4q12, 4q11-q12, 3q28, 3q25.1, 3q24, 21q22.3, 19q13.1, 19p13.3	LEUKEMIA, ACUTE MYELOID; AML	1050, 2120, 2322, 23365, 2624, 26511, 3717, 3815, 4026, 4291, 4869, 54904, 64324, 6455, 7015, 8021, 8028, 8301, 861, 865, 8833, 9163
MIM601627		5q12.2-q13.3	SURVIVAL OF MOTOR NEURON 2; SMN2	6607
MIM601629		21q22.3	PURKINJE CELL PROTEIN 4; PCP4	5121
MIM601631	C1866560	6p25	IRIDOGONIODYSGENESIS, TYPE 1; IRID1	2296
MIM601632		13q21.1-q22	POU DOMAIN, CLASS 4, TRANSCRIPTION FACTOR 1; POU4F1	5457
MIM601633		17q21-q22	N-ETHYLMALEIMIDE-SENSITIVE FACTOR; NSF	4905
MIM601634	C1866558	14q24, 1p36.3, 5p15.3-p15.2, 1q43	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	4522, 4524, 4548, 4552
MIM601636		8q24.12	HYALURONAN SYNTHASE 2; HAS2	3037
MIM601637		7q21.2-q21.3	CYTOCHROME P450, FAMILY 51, SUBFAMILY A, POLYPEPTIDE 1; CYP51A1	1595
MIM601638		 	ADP-RIBOSYLATION FACTOR-INTERACTING PROTEIN 2; ARFIP2	23647
MIM601639		19p13.1	PROTEIN KINASE, cAMP-DEPENDENT, CATALYTIC, ALPHA; PRKACA	5566
MIM601641		3p14.3	ACYL-CoA OXIDASE 2, BRANCHED-CHAIN; ACOX2	8309
MIM601642		1p31.2	INTERLEUKIN 12 RECEPTOR, BETA-2; IL12RB2	3595
MIM601643		1q41	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), ALPHA; PPP2R5A	5525
MIM601644		11q13	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), BETA; PPP2R5B	5526
MIM601645		14q32.31	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), GAMMA; PPP2R5C	5527
MIM601646		6p21.1	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), DELTA; PPP2R5D	5528
MIM601647		14q23.1	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), EPSILON; PPP2R5E	5529
MIM601648		 	PROTEASOME 26S SUBUNIT, NON-ATPase, 4; PSMD4	5710
MIM601650	C1866552	11q13.1	PARAGANGLIOMAS 2; PGL2	54949
MIM601651		11p15.5	NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 4; NAP1L4	4676
MIM601652		1q24.3-q25.2	MYOCILIN; MYOC	4653
MIM601653		8q13.3	EYES ABSENT 1; EYA1	2138
MIM601654		20q13.1	EYES ABSENT 2; EYA2	2139
MIM601655		1p36	EYES ABSENT 3; EYA3	2140
MIM601656		18q11.1-q11.2	GATA-BINDING PROTEIN 6; GATA6	2627
MIM601657		12q21	DERMATAN SULFATE PROTEOGLYCAN 3; DSPG3	1833
MIM601658		8q24	OTOCONIN 90; OC90	729330
MIM601659		21q22.3	ES1, ZEBRAFISH, HOMOLOG OF; ES1	8209
MIM601661		16p13.3	UBIQUITIN-CONJUGATING ENZYME E2I; UBE2I	7329
MIM601662		3q13.1-q13.2	ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALCAM	214
MIM601663		14q	ESTROGEN RECEPTOR 2; ESR2	2100
MIM601664		2q11.2	SMALL NUCLEAR RIBONUCLEOPROTEIN, 200-KD; SNRNP200	23020
MIM601665	C0028754	17q21, 16q22, 1pter-p22.3, 11q13, 8p12-p11.2, 6q22-q23, 6q16.3-q21, 5q33, 5q32-q34, 5q13.2, 4q31, 3p25, 3p26-p25, 1p36.1, 2p23.3, 18q22	OBESITY	133522, 154, 155, 181, 4160, 5167, 51738, 5443, 5468, 5697, 6492, 7350, 7352, 8431, 9607, 9672
MIM601666	C1866519	6q21	DIABETES MELLITUS, INSULIN-DEPENDENT, 15; IDDM15	3414
MIM601667		8q22	ANGIOPOIETIN 1; ANGPT1	284
MIM601668	C1866507	 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	 
MIM601670		19q13.13-q13.2	D4, ZINC, AND DOUBLE PHD FINGERS FAMILY, MEMBER 1; DPF1	8193
MIM601671		11q13	D4, ZINC, AND DOUBLE PHD FINGERS FAMILY, MEMBER 2; DPF2	5977
MIM601672		14q24.3-q31.1	D4, ZINC, AND DOUBLE PHD FINGERS FAMILY, MEMBER 3; DPF3	8110
MIM601673		9p21	EMBRYONIC LETHAL, ABNORMAL VISION, DROSOPHILA, HOMOLOG-LIKE 2; ELAVL2	1993
MIM601674		17q21.1-q21.3	ENHANCER OF ZESTE, DROSOPHILA, HOMOLOG 1; EZH1	2145
MIM601675	C1866504	6q25.3, 2q21, 19q13.2-q13.3	TRICHOTHIODYSTROPHY, PHOTOSENSITIVE; TTDP	2068, 2071, 404672
MIM601676	C1866503	1p31	ACUTE INSULIN RESPONSE	7808
MIM601677		7q32	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 5; NDUFA5	4698
MIM601678	C1866495	15q15-q21.1	BARTTER SYNDROME, ANTENATAL, TYPE 1	6557
MIM601679		7q11.23	GENERAL TRANSCRIPTION FACTOR II-I; GTF2I	2969
MIM601680	C1834523	17p13.1, 11p15.5, 11p15.5, 9p13.2-p13.1	ARTHROGRYPOSIS, DISTAL, TYPE 2B; DA2B	4621, 7136, 7140, 7169
MIM601681		17q24-q25	PROTEASOME 26S SUBUNIT, ATPase, 5; PSMC5	5705
MIM601682	C1866483	3q21-q24	GLAUCOMA 1, OPEN ANGLE, C; GLC1C	2723
MIM601683		16p13.1-p12	COQ7, S. CEREVISIAE, HOMOLOG OF; COQ7	10229
MIM601684		1p36.1	RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 1; RPS6KA1	6195
MIM601685		6q27	RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 2; RPS6KA2	6196
MIM601686		14q11.2	TELOMERASE-ASSOCIATED PROTEIN 1; TEP1	7011
MIM601687		17q12	KERATIN 12; KRT12	3859
MIM601688		4q34-q35	15-@HYDROXYPROSTAGLANDIN DEHYDROGENASE; HPGD	3248
MIM601689		18q11.2	TAF4B RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 105-KD; TAF4B	6875
MIM601690		6p21.2-p12	PHOSPHOLIPASE A2, GROUP VII; PLA2G7	7941
MIM601691		1p22.1	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 4; ABCA4	24
MIM601692		5q31	TRANSFORMING GROWTH FACTOR, BETA-INDUCED, 68-KD; TGFBI	7045
MIM601693		11q13	UNCOUPLING PROTEIN 2; UCP2	7351
MIM601694	C1866431	2p21	LEPTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; LEPQTL1	7839
MIM601695		4q13-q21	CASEIN, KAPPA; CSN10	1448
MIM601696	C1866430	11p15.5	NOVELTY SEEKING PERSONALITY TRAIT	1815
MIM601697		18q21.3	PROTEASE INHIBITOR 8; PI8	5271
MIM601698		7q36	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, N, POLYPEPTIDE 2; PTPRN2	5799
MIM601699		20q13.11-q13.13	PROSTAGLANDIN I2 SYNTHASE; PTGIS	5740
MIM601700	C1866428	 	SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	 
MIM601701	C1866427	 	ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	 
MIM601702		18q11.1	RHO-ASSOCIATED COILED-COIL-CONTAINING PROTEIN KINASE 1; ROCK1	6093
MIM601703		19q13.2-q13.3	VASODILATOR-STIMULATED PHOSPHOPROTEIN; VASP	7408
MIM601704		4q21	CHEMOKINE, CXC MOTIF, LIGAND 9; CXCL9	4283
MIM601705	C1866426	17q11-q12	T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY	8456
MIM601706	C1866425	 	YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	 
MIM601707	C0795915	 	CRANIOFACIAL MALFORMATIONS, ASYMMETRIC, WITH POLYSYNDACTYLY AND ABNORMAL SKIN AND GUT DEVELOPMENT	 
MIM601708	C1866424	 	SUPERIOR TRANSVERSE SCAPULAR LIGAMENT, CALCIFICATION OF, FAMILIAL	 
MIM601709	C1866423	 	QUEBEC PLATELET DISORDER; QPD	5328
MIM601710		14q32.3	EUKARYOTIC TRANSLATION INITIATION FACTOR 5; EIF5	1983
MIM601711		9q33-q34	TNF RECEPTOR-ASSOCIATED FACTOR 1; TRAF1	7185
MIM601712		11q22-q23	BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2; BIRC2	329
MIM601713		 	GLIA MATURATION FACTOR, BETA; GMFB	2764
MIM601714		12p13.3-p13.2	TEA DOMAIN FAMILY MEMBER 4; TEAD4	7004
MIM601716		20q13.1	STAUFEN, DROSOPHILA, HOMOLOG OF, 1; STAU1	6780
MIM601717		19p13.3-p13.2	SYNTAXIN-BINDING PROTEIN 2; STXBP2	6813
MIM601718	C1866422	1p22.1	RETINITIS PIGMENTOSA 19; RP19	24
MIM601719		17q21-q22	T-BOX 4; TBX4	9496
MIM601720		10p15-p14	ANTIGENIC DETERMINANT OF RECOMBINATION PROTEIN A, MOUSE, HOMOLOG OF; KIN	22944
MIM601721		11q22-q23	BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 3; BIRC3	330
MIM601723		2q33-q34	FRIZZLED, DROSOPHILA, HOMOLOG OF, 5; FZD5	7855
MIM601724		2q32	NEUROGENIC DIFFERENTIATION 1; NEUROD1	4760
MIM601725		17q12	NEUROGENIC DIFFERENTIATION 2; NEUROD2	4761
MIM601726		5q23-q31	NEUROGENIN 1; NEUROG1	4762
MIM601728	C1959582	10q23.31	PHOSPHATASE AND TENSIN HOMOLOG; PTEN	5728
MIM601729		19q13.3	TEA DOMAIN FAMILY MEMBER 2; TEAD2	8463
MIM601730		1q23-q25	PHOSPHATIDYLINOSITOL GLYCAN, CLASS C; PIGC	5279
MIM601731		2q35	5-@AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOTIDE FORMYLTRANSFERASE/IMP CYCLOHYDROLASE; ATIC	471
MIM601732		3p23-p21	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY C, MEMBER 1; SMARCC1	6599
MIM601733		4q28-q31	GLUTATHIONE S-TRANSFERASE, MICROSOMAL, 2; MGST2	4258
MIM601734		12q13-q14	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY C, MEMBER 2; SMARCC2	6601
MIM601735		12q13-q14	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY D, MEMBER 1; SMARCD1	6602
MIM601736		17q23-q24	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY D, MEMBER 2; SMARCD2	6603
MIM601737		7q35-q36	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY D, MEMBER 3; SMARCD3	6604
MIM601738		1p36.1	EXOSTOSIN-LIKE 1; EXTL1	2134
MIM601739		2p14-p13	MEIS1, MOUSE, HOMOLOG OF, 1; MEIS1	4211
MIM601740		15q14-q25	MEIS1, MOUSE, HOMOLOG OF, 2; MEIS2	4212
MIM601741		11q22-q23	CULLIN 5; CUL5	8065
MIM601742		 	TRIPARTITE MOTIF-CONTAINING PROTEIN 28; TRIM28	10155
MIM601743		5p13.1	ONCOSTATIN M RECEPTOR; OSMR	9180
MIM601744	C1866373	1q41-q42	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 1; SLEB1	7100, 7833
MIM601745		1q42-q43	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 1; KCNK1	3775
MIM601746		Chr.11	HYPOXIA UP-REGULATED 1; HYOU1	10525
MIM601747		 	TRIPARTITE MOTIF-CONTAINING PROTEIN 23; TRIM23	373
MIM601748		5q12.2-q13.3	GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 2; GTF2H2	2966
MIM601749		1p22-p21	GLOMULIN; GLMN	11146
MIM601750		 	GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 3; GTF2H3	2967
MIM601751		22q13.3	MELANIN-CONCENTRATING HORMONE RECEPTOR 1; MCHR1	2847
MIM601752		10q24	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; ENTPD1	953
MIM601753		4q31.3	PEPTIDYL-PROLYL ISOMERASE D; PPID	5481
MIM601754		22q11.2	UBIQUITIN FUSION DEGRADATION 1-LIKE; UFD1L	7353
MIM601755		22q11.2	DIGEORGE SYNDROME CRITICAL REGION GENE 14; DGCR14	8220
MIM601756		2q24-q31	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3; GALNT3	2591
MIM601757		6q22-q24	PEROXISOME BIOGENESIS FACTOR 7; PEX7	5191
MIM601758		Chr.17	PEROXISOME BIOGENESIS FACTOR 12; PEX12	5193
MIM601759	C1866339	 	PREAXIAL HALLUCAL POLYDACTYLY	 
MIM601760		6p21.3	GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 4; GTF2H4	2968
MIM601761		10q25.1-q25.2	CASPASE 7, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP7	840
MIM601762		2q33-q34	CASPASE 10, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP10	843
MIM601763		2q33	CASPASE 8, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP8	841
MIM601764	C1866328	19q	SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	8181
MIM601766		7q11.23	FRIZZLED, DROSOPHILA, HOMOLOG OF, 9; FZD9	8326
MIM601767		7q11.23	HUNTINGTIN-INTERACTING PROTEIN 1; HIP1	3092
MIM601768		19p13.3	SH3 DOMAIN, GRB2-LIKE, 1; SH3GL1	6455
MIM601769		12q12-q14	VITAMIN D RECEPTOR; VDR	7421
MIM601770		5q31	NEUROPEPTIDE Y RECEPTOR Y6; NPY6R	4888
MIM601771		2p22-p21	CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 1; CYP1B1	1545
MIM601772		11q23.2-q23.3	H2A HISTONE FAMILY, MEMBER X; H2AFX	3014
MIM601773		2q35-q36.1	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, N; PTPRN	5798
MIM601774		2q21	ALPHA-1,6-@MANNOSYL-GLYCOPROTEIN BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; MGAT5	4249
MIM601775	C1866295	 	FOLATE LEVEL IN ERYTHROCYTES	 
MIM601776	C1866294	15q14	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE	113189
MIM601777	C1866293	17p13.1	CONE-ROD DYSTROPHY 6; CORD6	3000
MIM601778		19p13.3	POLYMERASE, RNA, MITOCHONDRIAL; POLRMT	5442
MIM601780	C1866282	15q21-q23	CEROID LIPOFUSCINOSIS, NEURONAL, 6; CLN6	54982
MIM601782		9p13	TESTIS-SPECIFIC PROTEIN KINASE 1; TESK1	7016
MIM601783		 	MICROTUBULE-ASSOCIATED PROTEIN 6; MAP6	4135
MIM601784		17q11.2-q12	CATION CHANNEL, AMILORIDE-SENSITIVE, NEURONAL, 1; ACCN1	40
MIM601785		16p13.3-p13.2	PHOSPHOMANNOMUTASE 2; PMM2	5373
MIM601786		22q13.1	PHOSPHOMANNOMUTASE 1; PMM1	5372
MIM601787		10q24-q25.2	TAF5 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 100-KD; TAF5	6877
MIM601788		2q32.2	MYOSTATIN; MSTN	2660
MIM601789		2p15	PEROXISOME BIOGENESIS FACTOR 13; PEX13	5194
MIM601790		10q11.2-q21.2	PANCREATIC POLYPEPTIDE RECEPTOR 1; PPYR1	5540
MIM601791		1p36.2	PEROXISOME BIOGENESIS FACTOR 14; PEX14	5195
MIM601792		3q29	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 2; PPP1R2	5504
MIM601794	C1866256	 	COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	 
MIM601795		16p11.2	MITOGEN-ACTIVATED PROTEIN KINASE 3; MAPK3	5595
MIM601796		20q13.33	TAF4 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 135-KD; TAF4	6874
MIM601797		6q21	ABSENT IN MELANOMA 1; AIM1	202
MIM601798		5q31	GLUCOSAMINE-6-PHOSPHATE DEAMINASE 1; GNPDA1	10007
MIM601799		6p25	PROTEASE INHIBITOR 9, OVALBUMIN TYPE; PI9	5272
MIM601800	C2677190	11q14-q21	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 3; SHEP3	7299
MIM601801		 	TRANSCRIPTION FACTOR Sp2; SP2	6668
MIM601802		3p21.2-p21.1	HOMEOBOX GENE EXPRESSED IN ES CELLS; HESX1	8820
MIM601803	C0265449	 	PALLISTER-KILLIAN SYNDROME; PKS	 
MIM601804		2q31	TRANSCRIPTION FACTOR Sp3; SP3	6670
MIM601805		7p22	G PROTEIN-COUPLED ESTROGEN RECEPTOR; GPER	2852
MIM601806		2q21	MINICHROMOSOME MAINTENANCE, S. POMBE, HOMOLOG OF, 6; MCM6	4175
MIM601807		12q14	MATRIX METALLOPROTEINASE 19; MMP19	4327
MIM601808	C0432443	18q	CHROMOSOME 18q DELETION SYNDROME	100216483
MIM601809	C1866184	 	SPONDYLOSPINAL THORACIC DYSOSTOSIS	 
MIM601810		10q21.3-q22.1	DNA REPLICATION HELICASE 2, YEAST, HOMOLOG OF; DNA2	1763
MIM601811	C1866183	 	PREMATURE AGING SYNDROME, OKAMOTO TYPE	 
MIM601812	C1866182	 	PREMATURE AGING SYNDROME, PENTTINEN TYPE	 
MIM601813	C1866176	11q13.4	EXUDATIVE VITREORETINOPATHY 4; EVR4	4041
MIM601814		11q23	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 2; FXYD2	486
MIM601815	C1866174	1q12	PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	26227
MIM601816	C1866173	2q37	BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1	54658
MIM601817		16q13	NONMETASTATIC CELLS 3, PROTEIN EXPRESSED IN; NME3	4832
MIM601818		16p13.3	NONMETASTATIC CELLS 4, PROTEIN EXPRESSED IN; NME4	4833
MIM601819		17q24	FETAL ALZHEIMER ANTIGEN; FALZ	2186
MIM601820	C0027773	11p15.1	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	3767
MIM601821		7q36	RNA, Y1 SMALL CYTOPLASMIC; RNY1	6084
MIM601822		7q36	RNA, Y3 SMALL CYTOPLASMIC; RNY3	6085
MIM601823		7q36	RNA, Y4 SMALL CYTOPLASMIC; RNY4	6086
MIM601824		7q36	RNA, Y5 SMALL CYTOPLASMIC; RNY5	6090
MIM601825		19p13	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 7; NDUFS7	374291
MIM601826		2q37.1	DIACYLGLYCEROL KINASE, DELTA, 130-KD; DGKD	8527
MIM601828		2q22-q23	NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; NR4A2	4929
MIM601829	C1866168	 	ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	 
MIM601831		1q21-q23	HISTONE GENE CLUSTER 2, H2B HISTONE FAMILY, MEMBER E; HIST2H2BE	8349
MIM601832		3q29-qter	RIBOSOMAL PROTEIN L29; RPL29	6159
MIM601833		6p21.3	ALLOGRAFT INFLAMMATORY FACTOR 1; AIF1	199
MIM601834		3p22	CHEMOKINE, CC MOTIF, RECEPTOR 8; CCR8	1237
MIM601835		6q27	CHEMOKINE, CC MOTIF, RECEPTOR 6; CCR6	1235
MIM601836		1q24.2	KINESIN-ASSOCIATED PROTEIN 3; KIFAP3	22920
MIM601837		13q22-q34	LIGASE IV, DNA, ATP-DEPENDENT; LIG4	3981
MIM601838		 	INOSITOL 1,3,4-TRISPHOSPHATE 5/6-KINASE; ITPK1	3705
MIM601839		3q21-qter	EPHRIN RECEPTOR EphB3; EPHB3	2049
MIM601841		14q32.1	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 5; SERPINA5	5104
MIM601843		19p13.2-p12	SOLUTE CARRIER FAMILY 5 (SODIUM IODIDE SYMPORTER), MEMBER 5; SLC5A5	6528
MIM601844		17q21-q22	PROTEIN KINASE, LYSINE-DEFICIENT 4; WNK4	65266
MIM601845		22q11.2	GOOSECOID-LIKE; GSCL	2928
MIM601846	C1866139	19p13.3	VACUOLAR NEUROMYOPATHY	4195
MIM601847	C1866138	2q24	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2; PFIC2	8647
MIM601848		 	MAS20P, S. CEREVISIAE, HOMOLOG OF	9804
MIM601851		4q12	CIRCADIAN LOCOMOTOR OUTPUT CYCLES KAPUT; CLOCK	9575
MIM601852		19p13.2	INTERCELLULAR ADHESION MOLECULE 5; ICAM5	7087
MIM601853	C0795959	 	CEREBELLOTRIGEMINAL DERMAL DYSPLASIA	 
MIM601854		3q27-q28	DIACYLGLYCEROL KINASE, GAMMA, 90-KD; DGKG	1608
MIM601855		19q13.13	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; ARHGEF1	9138
MIM601856		19q13.4	ZINC FINGER PROTEIN 211; ZNF211	10520
MIM601858		 	CALMEGIN; CLGN	1047
MIM601859	C1328840	10q24.1	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; ALPS	355
MIM601860		5q2	17-@BETA-HYDROXYSTEROID DEHYDROGENASE IV; HSD17B4	3295
MIM601861		13q14	REGULATORY FACTOR X-ASSOCIATED PROTEIN; RFXAP	5994
MIM601863		1q21.1-q21.3	REGULATORY FACTOR X, 5; RFX5	5993
MIM601865		3q23-q24	PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE 2; PLOD2	5352
MIM601866		 	SEMAPHORIN 4D; SEMA4D	10507
MIM601867		3q22-q23	ATPase, Na+/K+ TRANSPORTING, BETA-3 POLYPEPTIDE; ATP1B3	483
MIM601868	C1866095	6p21.3	DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13	1302
MIM601869	C1866094	3q	DEAFNESS, AUTOSOMAL RECESSIVE 15; DFNB15	126326
MIM601870		 	METHIONINE AMINOPEPTIDASE 2; METAP2	10988
MIM601871		12q21.1	CYSTEINE- AND GLYCINE-RICH PROTEIN 2; CSRP2	1466
MIM601872		8p22	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 2; SLC7A2	6542
MIM601873		12q13.3	BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE 1; B4GALNT1	2583
MIM601874		5q15	ELONGATION FACTOR, RNA POLYMERASE II, 2; ELL2	22936
MIM601877		1q42.1	LEFT-RIGHT DETERMINATION FACTOR 2; LEFTY2	7044
MIM601878		 	KRUPPEL-LIKE FACTOR 10; KLF10	7071
MIM601879		17q11.2	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 9; LGALS9	3965
MIM601880		16q	CHEMOKINE, CX3C MOTIF, LIGAND 1; CX3CL1	6376
MIM601881		18q21.3	RETINA AND ANTERIOR NEURAL FOLD HOMEOBOX GENE; RAX	30062
MIM601882		1p36.3-p36.2	DNA FRAGMENTATION FACTOR, 45-KD, ALPHA SUBUNIT; DFFA	1676
MIM601883		1p36.3	DNA FRAGMENTATION FACTOR, 40-KD, BETA SUBUNIT; DFFB	1677
MIM601884	C1866079	11q13.4	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1; BMND1	4041
MIM601885	C1866078	13q11	CATARACT, ZONULAR PULVERULENT 3; CZP3	2700
MIM601886		11p15.5	ACHAETE-SCUTE COMPLEX, DROSOPHILA, HOMOLOG OF, 2; ASCL2	430
MIM601887	C2930984	1q32	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	779
MIM601888	C1866076	5p	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 6	4266
MIM601889		15q11-q13	B-CELL CLL/LYMPHOMA 8; BCL8	606
MIM601890		6p21.1-p12.2	PROTEIN-TYROSINE KINASE PTK7; PTK7	5754
MIM601891		11q13	CYSTATIN 6; CST6	1474
MIM601892		13q14.3	KARYOPHERIN ALPHA-3; KPNA3	3839
MIM601893		5p15.1-p14	TRIPLE FUNCTIONAL DOMAIN; TRIO	7204
MIM601894	C1866075	2q34, 1q32	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2	2335
MIM601895		 	TNF RECEPTOR-ASSOCIATED FACTOR 2; TRAF2	7186
MIM601896		 	TNF RECEPTOR-ASSOCIATED FACTOR 3; TRAF3	7187
MIM601897		3q21	ZINC FINGER PROTEIN 148; ZNF148	7707
MIM601898		3q26.3	GROWTH HORMONE SECRETAGOGUE RECEPTOR; GHSR	2693
MIM601899		10p14-p13	SIGNAL-TRANSDUCING ADAPTOR MOLECULE 1; STAM	8027
MIM601900		6p25-p23	INTERFERON REGULATORY FACTOR 4; IRF4	3662
MIM601901		19q13.3	SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER 2; SLC8A2	6543
MIM601902		1p32	ORIGIN RECOGNITION COMPLEX, SUBUNIT 1, S. CEREVISIAE, HOMOLOG OF; ORC1	4998
MIM601903		4q13	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B17; UGT2B17	7367
MIM601904		 	RIBOSOMAL PROTEIN L39; RPL39	6170
MIM601905		14q11.2	RAB GERANYLGERANYL TRANSFERASE, ALPHA SUBUNIT; RABGGTA	5875
MIM601906		12q13	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 10B; WNT10B	7480
MIM601907		15q22.3-q23	NEOGENIN; NEO1	4756
MIM601908		8q24.2-q24.3	G PROTEIN-COUPLED RECEPTOR 20; GPR20	2843
MIM601909		9q33	G PROTEIN-COUPLED RECEPTOR 21; GPR21	2844
MIM601910		7q22-q31.1	G PROTEIN-COUPLED RECEPTOR 22; GPR22	2845
MIM601911		17q21.3-q22	DISTAL-LESS HOMEOBOX 4; DLX4	1748
MIM601912		2q32.2-q33	SMALL UBIQUITIN-LIKE MODIFIER 1; SUMO1	7341
MIM601913		19q13.3	arsA ARSENITE TRANSPORTER, ATP-BINDING, E. COLI, HOMOLOG OF, 1; ASNA1	439
MIM601914		1q32	PROLINE ARGININE-RICH END LEUCINE-RICH REPEAT PROTEIN; PRELP	5549
MIM601915		3p25	TISSUE INHIBITOR OF METALLOPROTEINASE 4; TIMP4	7079
MIM601916		3p21.1	ARGININE-RICH PROTEIN MUTATED IN EARLY STAGE TUMORS; ARMET	7873
MIM601917		Chr.11	ALDEHYDE DEHYDROGENASE 3 FAMILY, MEMBER B2; ALDH3B2	222
MIM601918		 	GROWTH/DIFFERENTIATION FACTOR 9; GDF9	2661
MIM601919		5q13	COAGULATION FACTOR II RECEPTOR-LIKE 2; F2RL2	2151
MIM601920		20p12	JAGGED 1; JAG1	182
MIM601922		8p23	ANGIOPOIETIN 2; ANGPT2	285
MIM601924		1q23-q25	COATOMER PROTEIN COMPLEX, SUBUNIT ALPHA; COPA	1314
MIM601925		17q25.3	RHO GDP-DISSOCIATION INHIBITOR ALPHA; ARHGDIA	396
MIM601926		11q13.5	THYROID HORMONE-RESPONSIVE SPOT14, RAT, HOMOLOG OF; THRSP	7069
MIM601927	C2677167	 	LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES	 
MIM601928		12q13	KERATIN 86; KRT86	3892
MIM601929		17p13.3	ATPase, Ca(2+)-TRANSPORTING, UBIQUITOUS; ATP2A3	489
MIM601930		15q25.1	BASONUCLIN 1; BNC1	646
MIM601931		14q11.2-q12	BCL2-LIKE 2; BCL2L2	599
MIM601932		12q24.3	MUCIN 8, TRACHEOBRONCHIAL; MUC8	4590
MIM601933		12q23-q24.1	CRYPTOCHROME 1; CRY1	1407
MIM601934		17q25.3	G PROTEIN PATHWAY SUPPRESSOR 1; GPS1	2873
MIM601935		 	G PROTEIN PATHWAY SUPPRESSOR 2; GPS2	2874
MIM601936		12q21	PRKC, APOPTOSIS, WT1, REGULATOR; PAWR	5074
MIM601937		20q12	NUCLEAR RECEPTOR COACTIVATOR 3; NCOA3	8202
MIM601939		 	PROTEIN KINASE, SERINE/ARGININE-SPECIFIC, 1; SRPK1	6732
MIM601940		 	SPLICING FACTOR, SERINE/ARGININE-RICH, 4; SRSF4	6429
MIM601941	C1866041	18q21	DIABETES MELLITUS, INSULIN-DEPENDENT, 6; IDDM6	3405
MIM601942	C1866040	10p15.1	DIABETES MELLITUS, INSULIN-DEPENDENT, 10; IDDM10	3409, 3559
MIM601943		 	SPLICING FACTOR, SERINE/ARGININE-RICH, 9; SRSF9	8683
MIM601944		 	SPLICING FACTOR, SERINE/ARGININE-RICH, 6; SRSF6	6431
MIM601945		 	SPLICING FACTOR, ARGININE/SERINE-RICH, 8; SFRS8	6433
MIM601947		20p13	SRY-BOX 12; SOX12	6666
MIM601949		2q22-q23	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-4 SUBUNIT; CACNB4	785
MIM601950		16q24.3	ZINC FINGER PROTEIN, MULTITYPE 1; ZFPM1	161882
MIM601951		2q33	CDC-LIKE KINASE 1; CLK1	1195
MIM601952	C1866029	13q12.3	KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA	51371
MIM601953		5q13.3-q14	CYCLIN H; CCNH	902
MIM601954	C1866008	17q12	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G; LGMD2G	8557
MIM601955		5q13.2	CYCLIN-DEPENDENT KINASE 7; CDK7	1022
MIM601956		8p21	GDNF FAMILY RECEPTOR ALPHA-2; GFRA2	2675
MIM601957	C1865998	 	ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME	 
MIM601958		12q13	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-3 SUBUNIT; CACNB3	784
MIM601959		3p21.1	NEVER IN MITOSIS GENE A-RELATED KINASE 4; NEK4	6787
MIM601960		2q33-q37	CHEMOKINE, CC MOTIF, LIGAND 20; CCL20	6364
MIM601961		21q22.3	PROTEIN ARGININE N-METHYLTRANSFERASE 2; PRMT2	3275
MIM601962		6p21.3	TAP-BINDING PROTEIN; TAPBP	6892
MIM601963		5q32-q33.2	TETRATRICOPEPTIDE REPEAT DOMAIN 1; TTC1	7265
MIM601964		17q11-q23	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 7; DNAJC7	7266
MIM601965		9q22.1-q22.2	SPHINGOSINE 1-PHOSPHATE RECEPTOR 3; S1PR3	1903
MIM601966		1p36.1	REGULATORY SOLUTE CARRIER PROTEIN, FAMILY 1, MEMBER 1; RSC1A1	6248
MIM601967		22q13	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 7B; WNT7B	7477
MIM601968		1p13	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 2B; WNT2B	7482
MIM601969		10q25.3-q26.1	DELETED IN MALIGNANT BRAIN TUMORS 1; DMBT1	1755
MIM601970		7q36.3	VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 2; VIPR2	7434
MIM601972		9q22	RAR-RELATED ORPHAN RECEPTOR B; RORB	6096
MIM601973		7q36.1	RETINOIC ACID RECEPTOR RESPONDER 2; RARRES2	5919
MIM601974		1p21	SPHINGOSINE 1-PHOSPHATE RECEPTOR 1; S1PR1	1901
MIM601975		1q32	PLAKOPHILIN 1; PKP1	5317
MIM601976	C1865988	 	OTOFACIOOSSEOUS-GONADAL SYNDROME	 
MIM601977	C1865987	 	THROMBOCYTHEMIA 2; THCYT2	4352
MIM601978		9p13	SIGMA NONOPIOID INTRACELLULAR RECEPTOR 1; SIGMAR1	10280
MIM601979	C1865986	 	HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	 
MIM601980		 	LIPASE, GASTRIC; LIPF	8513
MIM601981		14q11.2	RIBONUCLEASE A FAMILY, 6; RNASE6	6039
MIM601982		3p26.2	8-@OXOGUANINE DNA GLYCOSYLASE; OGG1	4968
MIM601983		19q13.1-q13.4	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 1; MAP4K1	11184
MIM601984		10q11.2	NUCLEAR RECEPTOR COACTIVATOR 4; NCOA4	8031
MIM601985		10q21	COILED-COIL DOMAIN-CONTAINING PROTEIN 6; CCDC6	8030
MIM601987		22q13	CARNITINE PALMITOYLTRANSFERASE I, MUSCLE; CPT1B	1375
MIM601988		 	LIM DOMAIN KINASE 2; LIMK2	3985
MIM601989		1q21	S100 CALCIUM-BINDING PROTEIN A13; S100A13	6284
MIM601990		1p36	TUMOR PROTEIN p73; TP73	7161
MIM601991		19q13.3	NEUROONCOLOGIC VENTRAL ANTIGEN 2; NOVA2	4858
MIM601992	C1865981	9p23-p11	FRIEDREICH ATAXIA 2	2420
MIM601993		8q13.2-q13.3	NUCLEAR RECEPTOR COACTIVATOR 2; NCOA2	10499
MIM601994		3p21.3	TRANSFER RNA ARGININE	7870
MIM601995		1q24	TENASCIN R; TNR	7143
MIM601997		22q11.2	BH3-INTERACTING DOMAIN DEATH AGONIST; BID	637
MIM601998		11q12	ESTROGEN-RELATED RECEPTOR, ALPHA; ESRRA	2101
MIM601999		17q12	LIM HOMEOBOX GENE 1; LHX1	3975
MIM602000		 	POLYMERASE I, RNA, SUBUNIT B; POLR1B	84172
MIM602001		4q31-q32	NEUROPEPTIDE Y RECEPTOR Y5; NPY5R	4889
MIM602002		7q34-q35	ZYXIN; ZYX	7791
MIM602003		 	LYMPHOID-RESTRICTED MEMBRANE PROTEIN; LRMP	4033
MIM602004		 	PROTEIN-TYROSINE KINASE 6; PTK6	5753
MIM602005		11q23.2-q24.2	SORTILIN-RELATED RECEPTOR; SORL1	6653
MIM602006		 	MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 2; MAPKAPK2	9261
MIM602007		22q11	V-CRK AVIAN SARCOMA VIRUS CT10 ONCOGENE HOMOLOG-LIKE; CRKL	1399
MIM602008		 	RAN-BINDING PROTEIN 5; RANBP5	3843
MIM602009		 	CYTOCHROME c OXIDASE, SUBUNIT VIa, POLYPEPTIDE 2; COX6A2	1339
MIM602010		 	SPLICING FACTOR, SERINE/ARGININE-RICH, 11; SRSF11	9295
MIM602011		3p25	SUPPRESSOR OF TUMORIGENICITY 11; ST11	8466
MIM602012		9q34	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 2; ENTPD2	954
MIM602013		11q13.1	POLYMERASE II, RNA, SUBUNIT G; POLR2G	5436
MIM602014	C1865974	9q22	HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	140803
MIM602015		9q34	OUTER DENSE FIBER OF SPERM TAILS 2; ODF2	4957
MIM602016		19p13.1	KRUPPEL-LIKE FACTOR 2; KLF2	10365
MIM602017		6q27	PROTEASOME SUBUNIT, BETA-TYPE, 1; PSMB1	5689
MIM602018		19p13.3	NEURTURIN; NRTN	4902
MIM602019		8q24.1	SQUALENE EPOXIDASE; SQLE	6713
MIM602020		17q25	V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE FAMILY, PROTEIN G; MAFG	4097
MIM602021		12q15-q21.2	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 12A; PPP1R12A	4659
MIM602022		2q13	MAL-LIKE; MALL	7851
MIM602023		1p36	CHLORIDE CHANNEL, KIDNEY, B; CLCNKB	1188
MIM602024		1p36	CHLORIDE CHANNEL, KIDNEY, A; CLCNKA	1187
MIM602025	C2677162	20q13.2, 20q13.11-q13.2	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9; BMIQ9	4159
MIM602026		10pter-p11.2	PHYTANOYL-CoA HYDROXYLASE; PHYH	5264
MIM602027		16q22.1	TELOMERIC REPEAT-BINDING FACTOR 2; TERF2	7014
MIM602030		Chr.9	FUCOSYLTRANSFERASE 7; FUT7	2529
MIM602031		 	PROTEIN GERANYLGERANYLTRANSFERASE TYPE I, BETA SUBUNIT; PGGT1B	5229
MIM602032	C1865951	12q13	ECTODERMAL DYSPLASIA, 'PURE' HAIR-NAIL TYPE	3891
MIM602033		14q32	ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 1; EML1	2009
MIM602034		7p21-p15	CORTICOTROPIN-RELEASING HORMONE RECEPTOR 2; CRHR2	1395
MIM602035		16p12-p11	PROTEIN PHOSPHATASE 4, CATALYTIC SUBUNIT; PPP4C	5531
MIM602037		4p13	RAS HOMOLOG GENE FAMILY, MEMBER H; RHOH	399
MIM602038		11p15.5	DUAL-SPECIFICITY PHOSPHATASE 8; DUSP8	1850
MIM602039		10q26	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT A; EIF3A	8661
MIM602040		21q21	CELL ADHESION MOLECULE, NEURAL, 2; NCAM2	4685
MIM602041		8p21	NK3 HOMEOBOX 1; NKX3-1	4824
MIM602042		13q32	G PROTEIN-COUPLED RECEPTOR 18; GPR18	2841
MIM602043		6q27	G PROTEIN-COUPLED RECEPTOR 31; GPR31	2853
MIM602044		11q13	UNCOUPLING PROTEIN 3; UCP3	7352
MIM602045		6p21.3	RING FINGER PROTEIN 1; RING1	6015
MIM602046		15q15	PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 3; PDIA3	2923
MIM602047		11p15	PHOSPHODIESTERASE 3B, cGMP-INHIBITED; PDE3B	5140
MIM602048		 	RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1; RAC1	5879
MIM602049		22q12.3-q13.2	RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 2; RAC2	5880
MIM602050		17q25.3	RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 3; RAC3	5881
MIM602051		1p31	PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, NIMA-INTERACTING, 1-LIKE; PIN1L	5301
MIM602052		4p16	CYCLIN G-ASSOCIATED KINASE; GAK	2580
MIM602053		10p15	KRUPPEL-LIKE FACTOR 6; KLF6	1316
MIM602054		22q11.2	T-BOX 1; TBX1	6899
MIM602055		7q36	INSULIN-INDUCED GENE 1; INSIG1	3638
MIM602056		8p23.1	DEFENSIN, BETA, 1; DEFB1	1672
MIM602058		18q21.3	PROTEASE INHIBITOR 10; PI10	5273
MIM602059		15q23-q24	IMMUNOGLOBULIN SUPERFAMILY CONTAINING LEUCINE-RICH REPEAT; ISLR	3671
MIM602060		21q22.3	TRANSMEMBRANE PROTEASE, SERINE 2; TMPRSS2	7113
MIM602061		 	EPIREGULIN; EREG	2069
MIM602062		9q22	NERVE INJURY-INDUCED PROTEIN 1; NINJ1	4814
MIM602063		11p15.5-p15.4	TRANSALDOLASE 1; TALDO1	6888
MIM602064		8q21.13-q21.3	MYO-INOSITOL MONOPHOSPHATASE 1; IMPA1	3612
MIM602065		10p15	ADENOSINE DEAMINASE, RNA-SPECIFIC, B2; ADARB2	105
MIM602066	C1865926	16p12-q12	CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS; ICCA	3387
MIM602068	CN006488	 	LEISHMANIASIS, TEGUMENTARY, SUSCEPTIBILITY TO	 
MIM602069		10p12	NEUROPILIN 1; NRP1	8829
MIM602070		2q34	NEUROPILIN 2; NRP2	8828
MIM602071	C1865923	 	BROAD TERMINAL PHALANGES, FAMILIAL	 
MIM602072		12q24.2	CYTOCHROME c OXIDASE, SUBUNIT VIa, POLYPEPTIDE 1; COX6A1	1337
MIM602074		1q21	DEATH-ASSOCIATED PROTEIN 3; DAP3	7818
MIM602075		3p23	SPECIAL AT-RICH SEQUENCE-BINDING PROTEIN 1; SATB1	6304
MIM602076		17p13	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 1; TRPV1	7442
MIM602078	C1865915	11q13.3-q13.4	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	401
MIM602079	C0342739	1q23-q25	TRIMETHYLAMINURIA; TMAU	2328
MIM602080	C4016837	5q35, 5q31, 18q22.1	PAGET DISEASE OF BONE; PDB	8792, 8878
MIM602081	C0750927	7q31	SPEECH-LANGUAGE DISORDER 1; SPCH1	93986
MIM602082	C1562894	10q24, 5q31	CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE II; CDB2	7045, 982
MIM602083	C1865885	10q21-q22	USHER SYNDROME, TYPE IF; USH1F	65217
MIM602085	C1865883	13q21-q32	POLYDACTYLY, POSTAXIAL, TYPE A2; PAPA2	8103
MIM602086	C1865882	14q12-q22	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 3; ARVD3	424
MIM602087	C1865881	2q32.1-q32.3	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 4; ARVD4	425
MIM602088	C1865872	9q31	NEPHRONOPHTHISIS 2; NPHP2	27130
MIM602089	C1865871	5q35.3, 5q31-q33, 4q12, 2p13.1	HEMANGIOMA, CAPILLARY INFANTILE	2324, 3791, 7909, 84168
MIM602090		11q12	LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 3; LTBP3	4054
MIM602091		14q24	LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 2; LTBP2	4053
MIM602092	C1865870	11p15.1	DEAFNESS, AUTOSOMAL RECESSIVE 18; DFNB18	10083
MIM602093	C1865869	6p21.1	CONE DYSTROPHY 3; COD3	2978
MIM602095		15q21.1	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 4; SLC30A4	7782
MIM602096	C1865868	12p11.23-q13.12	ALZHEIMER DISEASE 5	8081
MIM602097	C1865865	21q21	USHER SYNDROME, TYPE IE; USH1E	7396
MIM602098		 	POLO-LIKE KINASE 1; PLK1	5347
MIM602099	C1865864	15q15.1-q21.1	AMYOTROPHIC LATERAL SCLEROSIS 5; ALS5	255
MIM602100		21q22.3	PBX/KNOTTED 1 HOMEOBOX 1; PKNOX1	5316
MIM602101		22q11.2	CLAUDIN 5; CLDN5	7122
MIM602102		19q13.1-q13.2	SUPPRESSOR OF TY 5, S. CEREVISIAE, HOMOLOG OF; SUPT5H	6829
MIM602103		21q22.3	TRANSMEMBRANE PROTEIN 1; TMEM1	7109
MIM602104		4p16.3	SH3 DOMAIN-BINDING PROTEIN 2; SH3BP2	6452
MIM602105		1p31	MutS, E. COLI, HOMOLOG OF, 4; MSH4	4438
MIM602106		21q22.2	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 15; KCNJ15	3772
MIM602107	C1865856	 	NEUROPATHY, HEREDITARY THERMOSENSITIVE	 
MIM602108		8q22	MATRILIN 2; MATN2	4147
MIM602109		2p24-p23	MATRILIN 3; MATN3	4148
MIM602110		11q13	SOLUTE CARRIER FAMILY 29 (NUCLEOSIDE TRANSPORTER), MEMBER 2; SLC29A2	3177
MIM602111	C1865832	11q22.3	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE	4322
MIM602112		22q13.31	METALLOPHOSPHOESTERASE DOMAIN-CONTAINING PROTEIN 1; MPPED1	758
MIM602113		12q12-q14	MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA 2; MLL2	8085
MIM602115		5p13-p12	FIBROBLAST GROWTH FACTOR 10; FGF10	2255
MIM602116		12q13-q15	YEATS DOMAIN-CONTAINING PROTEIN 4; YEATS4	8089
MIM602117		15q11-q13	NECDIN; NDN	4692
MIM602118		5q15-q21	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 1; CHD1	1105
MIM602119		15q26	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 2; CHD2	1106
MIM602120		17p13	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 3; CHD3	1107
MIM602121		5q31	DIAPHANOUS, DROSOPHILA, HOMOLOG OF, 1; DIAPH1	1729
MIM602122		4q11	SIGNAL RECOGNITION PARTICLE, 72-KD; SRP72	6731
MIM602123		10q22	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-GAMMA; CAMK2G	818
MIM602124	C1865818	18p	DYSTONIA 7, TORSION; DYT7	1866
MIM602125		17p12-p11.2	CYTOCHROME c OXIDASE ASSEMBLY PROTEIN COX10; COX10	1352
MIM602126		18p11.21	ZINC FINGER PROTEIN 161, MOUSE, HOMOLOG OF; ZFP161	7541
MIM602127		22q12.3	SMOOTHELIN; SMTN	6525
MIM602128		22q12	GROWTH ARREST-SPECIFIC 2-LIKE 1; GAS2L1	10634
MIM602129		19p13.1	MYOSIN IXB; MYO9B	4650
MIM602130		3p21.3	MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3; MAPKAPK3	7867
MIM602131		11p15.5	PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY A, MEMBER 2; PHLDA2	7262
MIM602132		14q	CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 5; CTAGE5	4253
MIM602133		Chr.17	PHOSPHORIBOSYLFORMYLGLYCINAMIDINE SYNTHASE; PFAS	5198
MIM602134	C1865810	2p25-p22	TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	2112
MIM602135		1p35.1	DYNEIN, AXONEMAL, LIGHT INTERMEDIATE POLYPEPTIDE 1; DNALI1	7802
MIM602136		7q21-q22	PEROXISOME BIOGENESIS FACTOR 1; PEX1	5189
MIM602137		5q31.2	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 2; NDUFA2	4695
MIM602138		22q13.1	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 6; NDUFA6	4700
MIM602139		19p13.2	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 7; NDUFA7	4701
MIM602140		10q23.2-q23.33	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 8; NDUFB8	4714
MIM602141		11q13	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 8; NDUFS8	4728
MIM602142		3p22-p21.3	PHOSPHOLIPASE C, DELTA-1; PLCD1	5333
MIM602143		1q42.1	TUMOR PROTEIN p53-BINDING PROTEIN 2; TP53BP2	7159
MIM602144		1p	BROMODOMAIN, TESTIS-SPECIFIC; BRDT	676
MIM602145		12q13	PROLIFERATION-ASSOCIATED 2G4, 38-KD; PA2G4	5036
MIM602146		1q25	LIM HOMEOBOX GENE 4; LHX4	89884
MIM602148		13q34	SRY-BOX 1; SOX1	6656
MIM602149		5q31	PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 1; PITX1	5307
MIM602150		8q11	SNAIL, DROSOPHILA, HOMOLOG OF, 2; SNAI2	6591
MIM602151		 	DISHEVELLED 2; DVL2	1856
MIM602152	C1865794	 	RHYNS SYNDROME	 
MIM602153		12q13	KERATIN 81; KRT81	3887
MIM602154		6q23-q24	NONCODING TRANSCRIPT IN T CELLS	7956
MIM602155		8p12-p11.2	UBX DOMAIN PROTEIN 8; UBXN8	7993
MIM602157		14q	NEUROONCOLOGIC VENTRAL ANTIGEN 1; NOVA1	4857
MIM602158		11q13.5-q14.1	CHLORIDE CHANNEL, NUCLEOTIDE SENSITIVE, 1A; CLNS1A	1207
MIM602159		9q22.3	CORONIN 2A; CORO2A	7464
MIM602160		3q23	TRANSCRIPTION FACTOR DP2; TFDP2	7029
MIM602161		14q11.2	PROTEASOME ACTIVATOR SUBUNIT 2; PSME2	5721
MIM602162		1p13	SYNAPTONEMAL COMPLEX PROTEIN 1; SYCP1	6847
MIM602163		3p24.2	UBIQUITIN-CONJUGATING ENZYME E2E 2; UBE2E2	7325
MIM602164		5q31-q33	5-@HYDROXYTRYPTAMINE RECEPTOR 4; HTR4	3360
MIM602165		6p22	TRIPARTITE MOTIF-CONTAINING PROTEIN 27; TRIM27	5987
MIM602166		15q	ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-2 SUBUNIT; AP3B2	8120
MIM602167		14q24.3	ESTROGEN-RELATED RECEPTOR, BETA; ESRRB	2103
MIM602168		14q32	VACCINIA-RELATED KINASE 1; VRK1	7443
MIM602169		2p16-p15	VACCINIA-RELATED KINASE 2; VRK2	7444
MIM602170		3p22-p21.3	MYELOID DIFFERENTIATION PRIMARY RESPONSE GENE 88; MYD88	4615
MIM602171		 	GLYCOPROTEIN A33; GPA33	10223
MIM602172		3p22-p21.3	CYTOCHROME P450, SUBFAMILY VIIIB, POLYPEPTIDE 1; CYP8B1	1582
MIM602173		3q26.2	SEC62, S. CEREVISIAE, HOMOLOG OF; SEC62	7095
MIM602174		1q32.1	G PROTEIN-COUPLED RECEPTOR 25; GPR25	2848
MIM602175		1p34.2	PROTEASOME SUBUNIT, BETA-TYPE, 2; PSMB2	5690
MIM602176		17q12	PROTEASOME SUBUNIT, BETA-TYPE, 3; PSMB3	5691
MIM602177		1q21	PROTEASOME SUBUNIT, BETA-TYPE, 4; PSMB4	5692
MIM602178		17q21.33	CHONDROADHERIN; CHAD	1101
MIM602179		11q22-q23	HEAT-SHOCK 27-KD PROTEIN 2; HSPB2	3316
MIM602180		11q13.3	SIGNAL-INDUCED PROLIFERATION-ASSOCIATED GENE 1; SIPA1	6494
MIM602181		7q31.3	EBNA2 COACTIVATOR p100	27044
MIM602182		6q22	ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 3; ENPP3	5169
MIM602183		4p16.1	NK3 HOMEOBOX 2; NKX3-2	579
MIM602184		21q22.3	NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 3; NDUFV3	4731
MIM602186		7q22	VGF, NERVE GROWTH FACTOR-INDUCIBLE; VGF	7425
MIM602187		11p15.5	ZINC FINGER PROTEIN 195; ZNF195	7748
MIM602188		 	EPHRIN RECEPTOR EphA4; EPHA4	2043
MIM602189		9q31-q33	REGULATOR OF G PROTEIN SIGNALING 3; RGS3	5998
MIM602190		 	EPHRIN RECEPTOR EphA7; EPHA7	2045
MIM602191		1q32	E74-LIKE FACTOR 3; ELF3	1999
MIM602192		15q21.3-q23	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 10; ADAM10	102
MIM602193		6p21.2-p21.1	SOLUTE CARRIER FAMILY 29 (NUCLEOSIDE TRANSPORTER), MEMBER 1; SLC29A1	2030
MIM602194		10q25.3-q26.2	HTRA SERINE PEPTIDASE 1; HTRA1	5654
MIM602195		7q11.23	HEAT-SHOCK 27-KD PROTEIN 1; HSPB1	3315
MIM602196	C1865783	 	PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	 
MIM602197		17q25	CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 3	8163
MIM602198		12q24.31	CDK2-ASSOCIATED PROTEIN 1; CDK2AP1	8099
MIM602199	C1865781	 	MEDIUM CHAIN 3-KETOACYL-CoA THIOLASE DEFICIENCY	 
MIM602200	C1865780	 	VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY	 
MIM602201		1q21	EXTRACELLULAR MATRIX PROTEIN 1; ECM1	1893
MIM602202		1p36.1	DOLICHYL-DIPHOSPHOOLIGOSACCHARIDE-PROTEIN GLYCOSYLTRANSFERASE; DDOST	1650
MIM602203		11q22-q23	SARCOLIPIN; SLN	6588
MIM602204		12p11.2-p11.1	BICAUDAL D, DROSOPHILA, HOMOLOG OF, 1; BICD1	636
MIM602206		2q37.3	RAS-ASSOCIATED PROTEIN RAB17; RAB17	64284
MIM602207		10p12.1	RAS-ASSOCIATED PROTEIN RAB18; RAB18	22931
MIM602208		1q23.2	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 10; KCNJ10	3766
MIM602209		6p25	RAS-RESPONSIVE ELEMENT BINDING PROTEIN 1; RREB1	6239
MIM602210		8q22-q23	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT E; EIF3E	3646
MIM602211		1p34-p32	FORKHEAD, DROSOPHILA, HOMOLOG-LIKE 17; FKHL17	2306
MIM602212		16q12	SEVEN IN ABSENTIA, DROSOPHILA, HOMOLOG OF, 1; SIAH1	6477
MIM602213		3q25	SEVEN IN ABSENTIA, DROSOPHILA, HOMOLOG OF, 2; SIAH2	6478
MIM602214		19p13.3	CASEIN KINASE I, GAMMA-2; CSNK1G2	1455
MIM602215		8p23.1	DEFENSIN, BETA, 4A; DEFB4A	1673
MIM602216		19p13.3	SERINE/THREONINE PROTEIN KINASE 11; STK11	6794
MIM602217		 	SYNDECAN-BINDING PROTEIN; SDCBP	6386
MIM602218		16q12.1	SAL-LIKE 1; SALL1	6299
MIM602219		14q11.1-q12	SAL-LIKE 2; SALL2	6297
MIM602220		22q12	RAS-LIKE, FAMILY 10, MEMBER A; RASL10A	10633
MIM602221		13q11-q12	ZINC FINGER, MYM-TYPE 2; ZMYM2	7750
MIM602223		8p12	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 1; EIF4EBP1	1978
MIM602224		10q21-q22	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 2; EIF4EBP2	1979
MIM602225		19q13.3	CONE-ROD HOMEOBOX-CONTAINING GENE; CRX	1406
MIM602226		5q12	LYMPHOCYTE ANTIGEN 64, RADIOPROTECTIVE, 105-KD; LY64	4064
MIM602227		9p13	CHEMOKINE, CC MOTIF, LIGAND 19; CCL19	6363
MIM602228		10q25.3	TRANSCRIPTION FACTOR 7-LIKE 2; TCF7L2	6934
MIM602229		22q13	SRY-BOX 10; SOX10	6663
MIM602230		21q22.3	SH3-BINDING DOMAIN AND GLUTAMIC ACID-RICH PROTEIN; SH3BGR	6450
MIM602231		21q22.3	SMALL UBIQUITIN-LIKE MODIFIER 3; SUMO3	6612
MIM602232		8q24	POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 3; KCNQ3	3786
MIM602233		12q23	APOPTOTIC PROTEASE ACTIVATING FACTOR 1; APAF1	317
MIM602234		1p36.3-p36.1	CASPASE 9, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP9	842
MIM602235		20q13.3	POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 2; KCNQ2	3785
MIM602238		 	EXOSOME COMPONENT 2; EXOSC2	23404
MIM602239		10q23-q24	CYTOCHROME P450, SUBFAMILY XXVIA, POLYPEPTIDE 1; CYP26A1	1592
MIM602240		6p21.3	ZINC FINGER PROTEIN 192; ZNF192	7745
MIM602241		13q12	MITOCHONDRIAL INTERMEDIATE PEPTIDASE; MIPEP	4285
MIM602242		19q13.2-q13.3	ADAPTOR-RELATED PROTEIN COMPLEX 2, SIGMA-1 SUBUNIT; AP2S1	1175
MIM602243		11p15.5	CD151 ANTIGEN; CD151	977
MIM602244		3p21.1-p14.3	DEOXYRIBONUCLEASE I-LIKE 3; DNASE1L3	1776
MIM602245		22q12-q13.1	GTP-BINDING PROTEIN 1; GTPBP1	9567
MIM602246		6p21.3	ZINC FINGER PROTEIN 193; ZNF193	7746
MIM602247	C1865704	 	XANTHOMATOSIS, SUSCEPTIBILITY TO	 
MIM602248	C0221011	 	MALIGNANT ATROPHIC PAPULOSIS	 
MIM602249	C1865699	 	PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	 
MIM602250		1p36	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 9; TNFRSF9	3604
MIM602251		11q12.1-q12.3	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 10, YEAST, HOMOLOG OF; TIMM10	26519
MIM602253		9q31	KRUPPEL-LIKE FACTOR 4; KLF4	9314
MIM602254		22q12.1	SRR1 DOMAIN-CONTAINING PROTEIN; SRRD	402055
MIM602255		 	SERINE/THREONINE PROTEIN KINASE 25; STK25	10494
MIM602256		4q21.1	PROTEIN PHOSPHATASE, EF-HAND CALCIUM-BINDING DOMAIN 2; PPEF2	5470
MIM602257		4q13-q21	SCAVENGER RECEPTOR CLASS B, MEMBER 2; SCARB2	950
MIM602259		21q22.2	TETRATRICOPEPTIDE REPEAT DOMAIN 3; TTC3	7267
MIM602260		17p12	PERIOD, DROSOPHILA, HOMOLOG OF; PER1	5187
MIM602261		16q13-q21	MATRIX METALLOPROTEINASE 15; MMP15	4324
MIM602262		8q21	MATRIX METALLOPROTEINASE 16; MMP16	4325
MIM602264		5q31	SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN; SPOCK	6695
MIM602265		6p25-p24	NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 9; NEDD9	4739
MIM602267		10q26.3	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 8; ADAM8	101
MIM602268		17q21	AMINE OXIDASE, COPPER-CONTAINING, 2; AOC2	314
MIM602269		22q11	ARMADILLO REPEAT GENE DELETED IN VCFS; ARVCF	421
MIM602270		5q32	ANTIOXIDANT PROTEIN 1; ATOX1	475
MIM602271	C1865695	 	SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL	 
MIM602272		18q21.2	TRANSCRIPTION FACTOR 4; TCF4	6925
MIM602273		18q12.1	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 1; GALNT1	2589
MIM602274		1q41-q42	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 2; GALNT2	2590
MIM602275		6p21.1	GUANYLATE CYCLASE ACTIVATOR 1B; GUCA1B	2979
MIM602276		17q12-q21	TRANSCRIPTIONAL ADAPTOR 2A; TADA2A	6871
MIM602277		6p21.3	ZINC FINGER PROTEIN 184; ZNF184	7738
MIM602278		15q	NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 4; NEDD4	4734
MIM602279		14q11.2-q13	POLYADENYLATE-BINDING PROTEIN, NUCLEAR, 1; PABPN1	8106
MIM602280		6p21.3	TUBBY-LIKE PROTEIN 1; TULP1	7287
MIM602281		15q25	MILK FAT GLOBULE-EGF FACTOR 8; MFGE8	4240
MIM602282		9q31.3	LYSOPHOSPHATIDIC ACID RECEPTOR 1; LPAR1	1902
MIM602283		17q11.2	CHEMOKINE, CC MOTIF, LIGAND 8; CCL8	6355
MIM602284		1p35-p32	BONE MORPHOGENETIC PROTEIN 8; BMP8B	656
MIM602285		12q24.33	MATRIX METALLOPROTEINASE 17; MMP17	4326
MIM602286		11q23.3	STEROL C5-DESATURASE-LIKE; SC5DL	6309
MIM602287		Chr.12	ENDOPLASMIC RETICULUM PROTEIN, 29-KD; ERP29	10961
MIM602288		2p13	RHOTEKIN; RTKN	6242
MIM602289		 	DR1-ASSOCIATED PROTEIN 1; DRAP1	10589
MIM602290		9q31-q34.1	TRIPARTITE MOTIF-CONTAINING PROTEIN 32; TRIM32	22954
MIM602291		17q22-q25	FORKHEAD BOX J1; FOXJ1	2302
MIM602292		10q26.2-q26.3	ENOYL-CoA HYDRATASE, SHORT-CHAIN, 1, MITOCHONDRIAL; ECHS1	1892
MIM602293		15q25.3-q26.1	CALCIUM- AND INTEGRIN-BINDING PROTEIN 1; CIB1	10519
MIM602294		14q13	FORKHEAD BOX A1; FOXA1	3169
MIM602295		19q13.2-q13.4	FORKHEAD BOX A3; FOXA3	3171
MIM602296		7q22.1	ADAPTOR-RELATED PROTEIN COMPLEX 4, MU-1 SUBUNIT; AP4M1	9179
MIM602297		17p13.1-p11.2	EPHRIN B3; EFNB3	1949
MIM602298		3q21	RAS-ASSOCIATED PROTEIN RAB7; RAB7	7879
MIM602300		22q12.2	GALACTOSE-3-O-SULFOTRANSFERASE 1; GAL3ST1	9514
MIM602301		17q21	K(LYSINE) ACETYLTRANSFERASE 2A; KAT2A	2648
MIM602302		8p21.2	HAIRLESS, MOUSE, HOMOLOG OF; HR	55806
MIM602303		3p24	K(LYSINE) ACETYLTRANSFERASE 2B; KAT2B	8850
MIM602304		 	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP D, MEMBER 2; NR1D2	9975
MIM602306		6p21.3	RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 2; RGL2	5863
MIM602307		8q21	WW DOMAIN-CONTAINING PROTEIN 1; WWP1	11059
MIM602308		16q21	WW DOMAIN-CONTAINING PROTEIN 2; WWP2	11060
MIM602309		19q13.1	TUBBY-LIKE PROTEIN 2; TULP2	7288
MIM602310		 	RNA-BINDING MOTIF PROTEIN, SINGLE STRAND-INTERACTING, 1; RBMS1	5937
MIM602311		16q22	AGOUTI-RELATED PROTEIN, MOUSE, HOMOLOG OF; AGRP	181
MIM602313		11q13	OVO, DROSOPHILA, HOMOLOG-LIKE, 1; OVOL1	5017
MIM602314		1q25.1-q32.3	LADININ 1; LAD1	3898
MIM602315		17q11.2	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 3; MAP2K3	5606
MIM602316		1q25.1	PEROXIREDOXIN 6; PRDX6	9588
MIM602317		3p24-p22	SRC HOMOLOGY 3 AND CYSTEINE-RICH DOMAIN; STAC	6769
MIM602318		7q21-q22	TRANSCRIPTION TERMINATION FACTOR, MITOCHONDRIAL; MTERF	7978
MIM602319		11p15.2-p15.1	NEL-LIKE 1; NELL1	4745
MIM602320		12q13.11-q13.12	NEL-LIKE 2; NELL2	4753
MIM602321		 	GLUTATHIONE S-TRANSFERASE, KAPPA-1; GSTK1	373156
MIM602322		3q21-q28	TELOMERASE RNA COMPONENT; TERC	7012
MIM602323		17p11.2-p11.1	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 12; KCNJ12	3768
MIM602324		10q22	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H3; HNRNPH3	3189
MIM602325		11p15	EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 2; EIF4G2	1982
MIM602326		17q11	RIBOSOMAL PROTEIN L23A; RPL23A	6147
MIM602327		10q24	PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN; PSD	5662
MIM602329		14q31	SUPPRESSOR OF LIN12-LIKE; SEL1L	6400
MIM602330		10q25	ACTIN-BINDING LIM PROTEIN FAMILY, MEMBER 1; ABLIM1	3983
MIM602331		7q22.1	ORIGIN RECOGNITION COMPLEX, SUBUNIT 5, S. CEREVISIAE, HOMOLOG OF; ORC5	5001
MIM602332		2q11.2	NON-SMC CONDENSIN I COMPLEX SUBUNIT H; NCAPH	23397
MIM602333		12p12.3	EPITHELIAL MEMBRANE PROTEIN 1; EMP1	2012
MIM602334		16p13.2	EPITHELIAL MEMBRANE PROTEIN 2; EMP2	2013
MIM602335		19q13.3	EPITHELIAL MEMBRANE PROTEIN 3; EMP3	2014
MIM602336		1p32-p31	RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTOR 1; ROR1	4919
MIM602337		9q22	RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTOR 2; ROR2	4920
MIM602338		6p25.2	PRECURSOR mRNA-PROCESSING FACTOR 4, S. POMBE, HOMOLOG OF, B; PRPF4B	8899
MIM602339		 	SOLUTE CARRIER FAMILY 15 (H+/PEPTIDE TRANSPORTER), MEMBER 2; SLC15A2	6565
MIM602340	C1865645	 	SENSORINEURAL HEARING LOSS, RETINAL PIGMENT EPITHELIUM LESIONS, DISCOLORED TEETH	 
MIM602341		12p13	FORKHEAD BOX M1; FOXM1	2305
MIM602342	C1865644	 	PLANTAR LIPOMATOSIS, UNUSUAL FACIES, AND DEVELOPMENTAL DELAY	 
MIM602343		3q22-q24	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 1; TRPC1	7220
MIM602344		 	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE 2; PAFAH2	5051
MIM602345		 	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 3; TRPC3	7222
MIM602346		17q21	CONTACTIN-ASSOCIATED PROTEIN 1; CNTNAP1	8506
MIM602347	C1865643	7q21.1	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	5244
MIM602348		 	SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 3; SNAPC3	6619
MIM602349		16p13.3	NETRIN 2, CHICKEN, HOMOLOG-LIKE; NTN2L	4917
MIM602350		11q24	NEUROGRANIN; NRGN	4900
MIM602351		12q24.1	CHEMOKINE-LIKE RECEPTOR 1; CMKLR1	1240
MIM602352		20p13	GONADOTROPIN-RELEASING HORMONE 2; GNRH2	2797
MIM602353		16p11.2	TRANSFORMING GROWTH FACTOR, BETA-1-INDUCED 1; TGFB1I1	7041
MIM602354		16p11.2	LINKER FOR ACTIVATION OF T CELLS; LAT	27040
MIM602355		11p12	TNF RECEPTOR-ASSOCIATED FACTOR 6; TRAF6	7189
MIM602356		1q32	TNF RECEPTOR-ASSOCIATED FACTOR 5; TRAF5	7188
MIM602357		 	WAS/WASL-INTERACTING PROTEIN FAMILY, MEMBER 1; WIPF1	7456
MIM602358		17q21	HYPOCRETIN; HCRT	3060
MIM602359		19q13.1	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 1; FXYD1	5348
MIM602360		15q15.3	L-ARGININE:GLYCINE AMIDINOTRANSFERASE; GATM	2628
MIM602361	C1865639	 	GRACILE BONE DYSPLASIA	 
MIM602362		 	GTPase-ACTIVATING PROTEIN, RAN, 1; RANGAP1	5905
MIM602364		11q13.1	CATHEPSIN W; CTSW	1521
MIM602365		11q14.1-q14.3	CATHEPSIN C; CTSC	1075
MIM602366		11p15.5-p15.4	INTEGRIN-LINKED KINASE; ILK	3611
MIM602367		17q25.1-q25.2	PENTRAXIN I, NEURONAL; NPTX1	4884
MIM602368		4q22	GLUTAMATE RECEPTOR, IONOTROPIC, DELTA 2; GRID2	2895
MIM602369		1p22.3	CYSTEINE-RICH, ANGIOGENIC INDUCER, 61; CYR61	3491
MIM602370		8q24.3	GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED MOLECULE-LIKE PROTEIN; GML	2765
MIM602371		2q34-q35	ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 3; ACSL3	2181
MIM602372		7q22	ZONADHESIN; ZAN	7455
MIM602373		19p13.3	CALPONIN 2; CNN2	1265
MIM602374		1p22-p21	CALPONIN 3; CNN3	1266
MIM602375		17q25-qter	MITOCHONDRIAL RIBOSOMAL PROTEIN L12; MRPL12	6182
MIM602376		21q22.1	INTERFERON, ALPHA, BETA, AND OMEGA, RECEPTOR 2; IFNAR2	3455
MIM602377		9q34	DYNAMIN 1; DNM1	1759
MIM602378		19p13.2	DYNAMIN 2; DNM2	1785
MIM602380		3q13.3-q21	UROPLAKIN 1B; UPK1B	7348
MIM602381		12q13.3-q14.1	NGFIA-BINDING PROTEIN 2; NAB2	4665
MIM602382		3q26	PHOSPHOLIPASE D1, PHOSPHATIDYLCHOLINE-SPECIFIC; PLD1	5337
MIM602383		9q22.3	OSTEOGLYCIN; OGN	4969
MIM602384		17p13.1	PHOSPHOLIPASE D2; PLD2	5338
MIM602385		2q11.1-q11.2	SULFOTRANSFERASE FAMILY 1C, MEMBER 1; SULT1C1	6819
MIM602386		7q36.1	ZINC FINGER PROTEIN 212; ZNF212	7988
MIM602387		 	RNA-BINDING MOTIF PROTEIN, SINGLE STRAND-INTERACTING, 2; RBMS2	5939
MIM602388		19q13.3	SYMPLEKIN	8189
MIM602389		16p11.2	Tu TRANSLATION ELONGATION FACTOR, MITOCHONDRIAL; TUFM	7284
MIM602390	C1865614	1q21	HEMOCHROMATOSIS, TYPE 2A; HFE2A	148738
MIM602391		 	PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; PEMT	10400
MIM602392		 	HYPOCRETIN RECEPTOR 1; HCRTR1	3061
MIM602393		 	HYPOCRETIN RECEPTOR 2; HCRTR2	3062
MIM602394		 	NUCLEOLAR AND COILED-BODY PHOSPHOPROTEIN 1; NOLC1	9221
MIM602395		10q24-q26	GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE, MITOCHONDRIAL; GPAM	57678
MIM602396		10q11.2	ANNEXIN A8; ANXA8	653145
MIM602397		18q21	ATPase, CLASS I, TYPE 8B, MEMBER 1; ATP8B1	5205
MIM602398	C1865596	1p33-p31.1	DESMOSTEROLOSIS	1718
MIM602399		22q13.3	MITOGEN-ACTIVATED PROTEIN KINASE 12; MAPK12	6300
MIM602400	C1865595	 	ICHTHYOSIS, FOLLICULAR ATROPHODERMA, HYPOTRICHOSIS, AND HYPOHIDROSIS	 
MIM602401	C1865594	 	ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL RECESSIVE	 
MIM602402		16q24.3	FORKHEAD BOX C2; FOXC2	2303
MIM602403		17q11.2	BLEOMYCIN HYDROLASE; BLMH	642
MIM602404	C1865581	2p13	PARKINSON DISEASE 3, AUTOSOMAL DOMINANT; PARK3	5072
MIM602406		 	HEART- AND NEURAL CREST DERIVATIVES-EXPRESSED 1; HAND1	9421
MIM602407		4q33	HEART- AND NEURAL CREST DERIVATIVES-EXPRESSED 2; HAND2	9464
MIM602408		17q11.2	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP D, MEMBER 1; NR1D1	9572
MIM602409		10p12	MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 10; MLLT10	8028
MIM602410		3p26-p25	BROMODOMAIN AND PHD FINGER-CONTAINING PROTEIN; BRPF1	7862
MIM602411		1p12-p11	EXOSTOSIN-LIKE 2; EXTL2	2135
MIM602412		10q22-q23	RIBOSOMAL PROTEIN S24; RPS24	6229
MIM602413		1q21	SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT C, INTEGRAL MEMBRANE PROTEIN, 15-KD; SDHC	6391
MIM602414		9q21.11-q21.12	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 1; APBA1	320
MIM602415		2p23-p22	DYSTROBREVIN, BETA; DTNB	1838
MIM602416		 	ADAPTOR-RELATED PROTEIN COMPLEX 3, SIGMA-2 SUBUNIT; AP3S2	10239
MIM602418	C1865566	 	WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	 
MIM602419		8p23-p21	EARLY GROWTH RESPONSE 3; EGR3	1960
MIM602420		1p13.1	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 10; KCNA10	3744
MIM602421		7q31.2	CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR	1080
MIM602422		4p16.3	STEM-LOOP BINDING PROTEIN; SLBP	7884
MIM602423		 	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 3; NR1H3	10062
MIM602424		9p24.3	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR 1; DMRT1	1761
MIM602425		6q26	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 4; MAP3K4	4216
MIM602426		1q41-q42.2	NUCLEAR VALOSIN-CONTAINING PROTEIN-LIKE; NVL	4931
MIM602427		16p11.2	T-BOX 6; TBX6	6911
MIM602428		16q22.1	HYALURONAN SYNTHASE 3; HAS3	3038
MIM602429	C1865427	8q23	GLAUCOMA 1, OPEN ANGLE, D; GLC1D	2724
MIM602430		3p12	ROUNDABOUT, DROSOPHILA, HOMOLOG OF, 1; ROBO1	6091
MIM602431		3p12.3	ROUNDABOUT, DROSOPHILA, HOMOLOG OF, 2; ROBO2	6092
MIM602432		10p15-p14	OPTINEURIN; OPTN	10133
MIM602433	C1865409	9q34	AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4	23064
MIM602434		2p13	ANCIENT UBIQUITOUS PROTEIN 1; AUP1	550
MIM602435		 	PEPTIDYL-PROLYL ISOMERASE E; PPIE	10450
MIM602436		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN-RELATED GENE B; MICB	4277
MIM602437		 	GTP CYCLOHYDROLASE I FEEDBACK REGULATORY PROTEIN; GCHFR	2644
MIM602438		16q21-q22.1	HEAT-SHOCK TRANSCRIPTION FACTOR 4; HSF4	3299
MIM602439		16q22	ACUTE MYELOGENOUS LEUKEMIA	9163
MIM602440	C1865384	 	AMYOTROPHY, MONOMELIC	 
MIM602441		3p21.3	CYTOKINE-INDUCIBLE SH2-CONTAINING PROTEIN; CISH	1154
MIM602442		21q22.1-q22.2	INTERSECTIN 1; ITSN1	6453
MIM602443		10q25.3	X-PROLYL AMINOPEPTIDASE 1; XPNPEP1	7511
MIM602444		5q35.3	TRANSCRIPTION FACTOR 17; TCF17	6940
MIM602445		3q26	SERINE PROTEASE INHIBITOR, CLADE I, MEMBER 1; SERPINI1	5274
MIM602446		13q32	GLYPICAN 5; GPC5	2262
MIM602447		7q21.3	PARAOXONASE 2; PON2	5445
MIM602448		6q22.33	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5; MAP3K5	4217
MIM602449		Chr.17	A-KINASE ANCHOR PROTEIN 1; AKAP1	8165
MIM602450	C1865370	10p	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	3981, 64421
MIM602451		11q13.5	PYRIMIDINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 6; P2RY6	5031
MIM602452		2q14	BUDDING UNINHIBITED BY BENZIMIDAZOLES 1, S. CEREVISIAE, HOMOLOG OF; BUB1	699
MIM602453		16p11.2	INTEGRIN, ALPHA-D; ITGAD	3681
MIM602454		1p35.3	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, U; PTPRU	10076
MIM602457		11q13.3	FAS-ASSOCIATED VIA DEATH DOMAIN; FADD	8772
MIM602458		1p21.3-p13.1	SORTILIN; SORT1	6272
MIM602459	C1865366	5q31	DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15	5459
MIM602460		5q31	POU DOMAIN, CLASS 4, TRANSCRIPTION FACTOR 3; POU4F3	5459
MIM602461		20p13	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR TYPE, SUBSTRATE 1; PTPNS1	140885
MIM602462		4p16.1-p15	COLLAPSIN RESPONSE MEDIATOR PROTEIN 1; CRMP1	1400
MIM602463		8p21	DIHYDROPYRIMIDINASE-LIKE 2; DPYSL2	1808
MIM602464		 	TNF RECEPTOR-ASSOCIATED FACTOR 4; TRAF4	9618
MIM602465		4q28.1	SPROUTY, DROSOPHILA, HOMOLOG OF, 1; SPRY1	10252
MIM602466		13q31.1	SPROUTY, DROSOPHILA, HOMOLOG OF, 2; SPRY2	10253
MIM602468		7q21.3	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 9A; PPP1R9A	55607
MIM602469		 	FOLATE RECEPTOR 3; FOLR3	2352
MIM602470		8q24.2	PROSTATE STEM CELL ANTIGEN; PSCA	8000
MIM602471	C1865361	 	SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, SKELETAL ABNORMALITIES	 
MIM602473	C1865349	19q13.32	ENCEPHALOPATHY, ETHYLMALONIC; EE	23474
MIM602474		 	PROTEIN KINASE, MEMBRANE-ASSOCIATED TYROSINE/THREONINE, 1; PKMYT1	9088
MIM602475	C1865343	6q22-q23, 21q22.3	OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	1291, 5167, 7933
MIM602477	C1865342	19p13.3	FEBRILE SEIZURES, FAMILIAL, 2; FEB2	2234
MIM602478		10p15.1	tRNA ASPARTIC ACID METHYLTRANSFERASE 1; TRDMT1	1787
MIM602479		1p34.1	POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 1; POU3F1	5453
MIM602480		2q12.1	POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 3; POU3F3	5455
MIM602481	C1865322	1q21-q23	MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	477
MIM602482	C2678503	6p25	AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3	2296
MIM602483	C1865295	1p21.1-q23.3	AURICULOCONDYLAR SYNDROME 1; ARCND1	100381211, 2773
MIM602484	C1865294	 	PELVIC HYPOPLASIA WITH LOWER-LIMB ARTHROGRYPOSIS	 
MIM602485	C1865290	7p15-p13	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	2645
MIM602486		 	PROCESSING OF PRECURSOR 1, S. CEREVISIAE, HOMOLOG OF; POP1	10940
MIM602487		8q22	HEAT-RESPONSIVE PROTEIN 12; HRSP12	10247
MIM602488		19q13	CYTOHESIN 2; CYTH2	9266
MIM602489		 	KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 1; KHDRBS1	10657
MIM602490		21q11	NUCLEAR RECEPTOR-INTERACTING PROTEIN 1; NRIP1	8204
MIM602491	C1865289	1q22-q23	HYPERLIPIDEMIA, COMBINED, 1	7391
MIM602492		3q25	PENTRAXIN 3, LONG; PTX3	5806
MIM602493		11q13	UV RADIATION RESISTANCE-ASSOCIATED GENE; UVRAG	7405
MIM602494		17q21.1-q21.2	CHEMOKINE, CC MOTIF, LIGAND 23; CCL23	6368
MIM602495		7q11.23	CHEMOKINE, CC MOTIF, LIGAND 24; CCL24	6369
MIM602496		22q11.2-qter	MERCAPTOPYRUVATE SULFURTRANSFERASE; MPST	4357
MIM602497	C1865288	 	CHONDRODYSPLASIA PUNCTATA, BRACHYTELEPHALANGIC, AUTOSOMAL	 
MIM602498		3q11-q12	TRK-FUSED GENE; TFG	10342
MIM602499	C1865286	 	MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	791229
MIM602500		3q13	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY B, 1; GOLGB1	2804
MIM602501	C1865285	 	MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME; MCAP	 
MIM602502		 	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 1; GOLGA1	2800
MIM602503		 	FREQUENTLY REARRANGED IN ADVANCED T-CELL LYMPHOMAS; FRAT1	10023
MIM602504		3q25-q26	SHORT STATURE HOMEOBOX 2; SHOX2	6474
MIM602505		12q24	PAXILLIN; PXN	5829
MIM602507		2p11.2	ZINC FINGER PROTEIN 103, MOUSE, HOMOLOG OF; ZFP103	7844
MIM602508		11q23	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, BETA SUBUNIT; PAFAH1B2	5049
MIM602509		3p22-p21.3	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 4; GOLGA4	2803
MIM602510		19q13.4	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, H; PTPRH	5794
MIM602511	C1865284	 	PSEUDOACROMEGALY WITH SEVERE INSULIN RESISTANCE	 
MIM602512		 	REGULATOR OF G PROTEIN SIGNALING 12; RGS12	6002
MIM602513		5q35.3	REGULATOR OF G PROTEIN SIGNALING 14; RGS14	10636
MIM602514		1q25-q31	REGULATOR OF G PROTEIN SIGNALING 16; RGS16	6004
MIM602515		6p22.1	PHOSPHOLIPASE D1, GLYCOSYLPHOSPHATIDYLINOSITOL-SPECIFIC; GPLD1	2822
MIM602516		1q23.3	REGULATOR OF G PROTEIN SIGNALING 4; RGS4	5999
MIM602517		 	REGULATOR OF G PROTEIN SIGNALING 7; RGS7	6000
MIM602518		19q13.2	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 4; LGALS4	3960
MIM602519		16p13.3	UBIQUITIN-SPECIFIC PROTEASE 7; USP7	7874
MIM602520		15q23	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 5; MAP2K5	5607
MIM602521		17p11.2	MITOGEN-ACTIVATED PROTEIN KINASE 7; MAPK7	5598
MIM602522	C1865270	1p31, 1p36	BARTTER SYNDROME, TYPE 4A	1188, 7809
MIM602523		21q22.2-q22.3	DOWN SYNDROME CELL ADHESION MOLECULE; DSCAM	1826
MIM602524		 	PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 1; PDK1	5163
MIM602525		 	PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 2; PDK2	5164
MIM602526		 	PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 3; PDK3	5165
MIM602527		7q21.3-q22.1	PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 4; PDK4	5166
MIM602528		13q11	TUBULIN, ALPHA-3C; TUBA3C	7278
MIM602529		12q12-q14	TUBULIN, ALPHA-1A; TUBA1A	7846
MIM602530		 	TUBULIN, ALPHA-1B; TUBA1B	10376
MIM602532		6q23	SIX-TWELVE LEUKEMIA GENE	7955
MIM602533		1p36	ONCOGENE DJ1; DJ1	11315
MIM602534		15q21-q22	SYNAPTOSOMAL-ASSOCIATED PROTEIN, 23-KD; SNAP23	8773
MIM602535	C0265211	 	MARSHALL-SMITH SYNDROME; MRSHSS	4784
MIM602536		2q21.3	RAB3 GTPase-ACTIVATING PROTEIN, CATALYTIC SUBUNIT; RAB3GAP1	22930
MIM602537		11q14	CALPAIN 5; CAPN5	726
MIM602538		10p13	CUG TRIPLET REPEAT, RNA-BINDING PROTEIN 2; CUGBP2	10659
MIM602539		 	MITOGEN-ACTIVATED KINASE KINASE KINASE 3; MAP3K3	4215
MIM602540	C1865234	13q11-q12	ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS	2706
MIM602541	C1865233	 	MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC	1120
MIM602542		 	BASIC TRANSCRIPTION FACTOR 3; BTF3	689
MIM602543		13q22	BASIC TRANSCRIPTION FACTOR 3-LIKE 1; BTF3L1	690
MIM602544		6q25.2-q27	PARKIN; PARK2	5071
MIM602545		6q22.2-q22.3	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, KAPPA; PTPRK	5796
MIM602546		15q26	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 2; ST8SIA2	8128
MIM602547		5q21	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 4; ST8SIA4	7903
MIM602548		 	OPIOID RECEPTOR-LIKE 1; OPRL1	4987
MIM602549		1p22.2	PROTEIN KINASE N2; PKN2	5586
MIM602550		11p15	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR-LIKE PROTEIN; ARNTL	406
MIM602551	C1865209	 	JEJUNAL ATRESIA WITH RENAL ADYSPLASIA	 
MIM602552		17p13	NUCLEOPORIN, 88-KD; NUP88	4927
MIM602553	C1865208	 	ANAL ATRESIA, HYPOSPADIAS, AND PENOSCROTAL INVERSION	 
MIM602554	C1865205	 	TORSION DYSTONIA WITH ONSET IN INFANCY	 
MIM602555	C1865204	 	MICROCEPHALY, MACROTIA, AND MENTAL RETARDATION	 
MIM602556	C1865203	 	FACIAL DYSMORPHISM, CLEFT PALATE, HEARING LOSS, AND CAMPTODACTYLY	 
MIM602557	C1865185	 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	 
MIM602558	C1865184	 	CRANIOMICROMELIC SYNDROME	 
MIM602559		2p16	EXPORTIN 1; XPO1	7514
MIM602561	C1865182	 	BRACHYDACTYLY, INTRAVENTRICULAR SEPTAL DEFECT, AND DEAFNESS	 
MIM602562	C1865181	 	MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	 
MIM602563		4q21.2-q22	NK6, DROSOPHILA, HOMOLOG OF, 1; NKX6-1	4825
MIM602564	C1865180	 	EMPHYSEMA, CONGENITAL, WITH DEAFNESS, PENOSCROTAL WEB, AND MENTAL RETARDATION	 
MIM602565		19p13.2	CHEMOKINE, CC MOTIF, LIGAND 25; CCL25	6370
MIM602566		12q24	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 7; P2RX7	5027
MIM602567		 	LIM AND SENESCENT CELL ANTIGEN-LIKE DOMAINS 1; LIMS1	3987
MIM602568		5p15.3-p15.2	METHIONINE SYNTHASE REDUCTASE; MTRR	4552
MIM602569		5q35	SYNUCLEIN, BETA; SNCB	6620
MIM602570		14q32	JAGGED 2; JAG2	3714
MIM602571		11q13	RNA-BINDING MOTIF PROTEIN 4; RBM4	5936
MIM602572		10q22.3-q23.1	ANNEXIN A11; ANXA11	311
MIM602573		8q24.1-q24.2	ANNEXIN A13; ANXA13	312
MIM602574		11q22-q24	TECTORIN, ALPHA; TECTA	7007
MIM602575		9q34.1	LIM HOMEOBOX TRANSCRIPTION FACTOR 1, BETA; LMX1B	4010
MIM602576		7p22	LUNATIC FRINGE; LFNG	3955
MIM602577		22q12	MANIC FRINGE; MFNG	4242
MIM602578		17q25	RADICAL FRINGE; RFNG	5986
MIM602579	C1865145	15q22-qter	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	4351
MIM602580		 	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 2; GOLGA2	2801
MIM602581		Chr.12	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 3; GOLGA3	2802
MIM602582		12q24	DELTEX, DROSOPHILA, HOMOLOG OF, 1; DTX1	1840
MIM602583		7q31	G PROTEIN-COUPLED RECEPTOR 37; GPR37	2861
MIM602584		15q23	RETICULOCALBIN 2; RCN2	5955
MIM602587		1p36	ACYL-CoA THIOESTERASE 7; ACOT7	11332
MIM602588	C1865143	 	BRANCHIOOTIC SYNDROME 1; BOS1	2138
MIM602589		14q23	FUCOSYLTRANSFERASE 8; FUT8	2530
MIM602590		11q13-q14	p21 PROTEIN-ACTIVATED KINASE 1; PAK1	5058
MIM602591		5q12-q13	KINESIN HEAVY CHAIN MEMBER 2A; KIF2A	3796
MIM602592		1q21-q23	LYMPHOCYTE ANTIGEN CD5-LIKE; CD5L	922
MIM602593		6p21.3	CORNEODESMOSIN; CDSN	1041
MIM602594	C1865140	16p12.3-p12.1	RETINITIS PIGMENTOSA 22; RP22	6114
MIM602595		14q13-q21	SMN-INTERACTING PROTEIN 1; SIP1	8487
MIM602596	C1865139	 	PANCREATIC LYMPHOMA, FAMILIAL	 
MIM602597		1q21	B-CELL CLL/LYMPHOMA 9; BCL9	607
MIM602598		4q21-q22	PROSTAGLANDIN D2 SYNTHASE, HEMATOPOIETIC; HPGDS	27306
MIM602600		1p34	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 8; LRP8	7804
MIM602601		12p13-p12	LOW DENSITY LIPOPROTEIN, OXIDIZED, RECEPTOR 1; OLR1	4973
MIM602602		17q25.2-q25.3	SECRETED AND TRANSMEMBRANE 1; SECTM1	6398
MIM602603		1p34-p33	MAGO NASHI, DROSOPHILA, HOMOLOG OF; MAGOH	4116
MIM602606		5q13.2	COCAINE- AND AMPHETAMINE-REGULATED TRANSCRIPT	9607
MIM602607		6q26	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 1; SLC22A1	6580
MIM602608		6q26	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 2; SLC22A2	6582
MIM602609		 	PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 3; PIK3C3	5289
MIM602610		 	PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 4; PIK3R4	30849
MIM602611	C1865134	 	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CORONAL CRANIOSYNOSTOSIS, CATARACTS, CLEFT PALATE, AND MENTAL RETARDATION	 
MIM602612	C1865133	 	CAMPTODACTYLY, MYOPIA, AND FIBROSIS OF THE MEDIAL RECTUS MUSCLE OF EYE	 
MIM602613	C1865117	 	SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	 
MIM602614		6q14-q21	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7; MAP3K7	6885
MIM602615		22q13.1	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7-INTERACTING PROTEIN 1; MAP3K7IP1	10454
MIM602616		14q21	ALPHA-1,6-@MANNOSYL-GLYCOPROTEIN BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE; MGAT2	4247
MIM602617		9q22	FORKHEAD BOX E1; FOXE1	2304
MIM602618		4p16	C-TERMINAL-BINDING PROTEIN 1; CTBP1	1487
MIM602619		10q26.13	C-TERMINAL-BINDING PROTEIN 2; CTBP2	1488
MIM602620		14q32.1	LEGUMAIN; LGMN	5641
MIM602621		21q11.2	COXSACKIEVIRUS AND ADENOVIRUS RECEPTOR; CXADR	1525
MIM602622		 	DEOXYRIBONUCLEASE I-LIKE 2; DNASE1L2	1775
MIM602623		6p21.3-p21.2	FK506-BINDING PROTEIN 5; FKBP5	2289
MIM602625		3p14.1	MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAINS-CONTAINING, 1; MAGI1	9223
MIM602626		3q28	INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; IL1RAP	3556
MIM602627		17q21.3	CELL DIVISION CYCLE 6, S. CEREVISIAE, HOMOLOG OF; CDC6	990
MIM602628		14q24.3-q31	FORKHEAD BOX N3; FOXN3	1112
MIM602629	C1414216	8p11.21	DYSTONIA 6, TORSION; DYT6	55145
MIM602630		18p11.3	TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR; TGIF	7050
MIM602631		11p15.5	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 18; SLC22A18	5002
MIM602632		7q32-q33	PODOCALYXIN-LIKE; PODXL	5420
MIM602633		2q12-q14	FOUR-AND-A-HALF LIM DOMAINS 2; FHL2	2274
MIM602634		7q31.1	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 9; DNAJB9	4189
MIM602635		 	DEAF1, DROSOPHILA, HOMOLOG OF; DEAF1	10522
MIM602636		1p35	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 8; PPP1R8	5511
MIM602637		2q37-qter	SECRETED PHOSPHOPROTEIN 2; SPP2	6694
MIM602638		8q11.2	MINICHROMOSOME MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, 4; MCM4	4173
MIM602639	C1865092	16q12.1	TOOTH AGENESIS, SELECTIVE, 2; STHAG2	8137
MIM602640		11q12	N-ACETYLATED ALPHA-LINKED ACIDIC DIPEPTIDASE-LIKE 1; NAALADL1	10004
MIM602641		17p13	EUKARYOTIC TRANSLATION INITIATION FACTOR 4A, ISOFORM 1; EIF4A1	1973
MIM602642		13q14	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 11; TNFSF11	8600
MIM602643		8q24	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 11B; TNFRSF11B	4982
MIM602644		11p15.5	TETRASPANIN 4; TSPAN4	7106
MIM602645		 	SEMAPHORIN 3C; SEMA3C	10512
MIM602646		2q37.3	G PROTEIN-COUPLED RECEPTOR 35; GPR35	2859
MIM602647		11q12-q13	NUCLEAR RNA EXPORT FACTOR 1; NXF1	10482
MIM602648		3p21.3	CHEMOKINE-BINDING PROTEIN 2; CCBP2	1238
MIM602649		19p13.3	COLD-INDUCIBLE RNA-BINDING PROTEIN; CIRBP	1153
MIM602650		 	SPECKLE-TYPE POZ PROTEIN; SPOP	8405
MIM602651		1p32.2	NARDILYSIN; NRD1	4898
MIM602652		19q13.4	KALLIKREIN-RELATED PEPTIDASE 6; KLK6	5653
MIM602653		 	TECTORIN, BETA; TECTB	6975
MIM602654		 	FERM, ARHGEF, AND PLECKSTRIN DOMAIN-CONTAINING PROTEIN 1; FARP1	10160
MIM602655		2p23.3-p23.2	SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1, ADAPTOR PROTEIN; SLC4A1AP	22950
MIM602656		16p13.3-p13.2	ENDONUCLEASE III-LIKE 1; NTHL1	4913
MIM602658		 	PHOSPHODIESTERASE 2A, cGMP-STIMULATED; PDE2A	5138
MIM602659		14q23	MENAGE A TROIS 1; MNAT1	4331
MIM602660		 	TUBULIN, BETA-2C; TUBB2C	10383
MIM602661		16q24.3	TUBULIN, BETA-3; TUBB3	10381
MIM602662		 	TUBULIN, BETA-4; TUBB4	10382
MIM602663		 	PROLACTIN-RELEASING HORMONE; PRLH	51052
MIM602664		11q22.2-q22.3	CASPASE 4, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP4	837
MIM602665		11q22.2-q22.3	CASPASE 5, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP5	838
MIM602666		17p11.2	MYOSIN XVA; MYO15A	51168
MIM602667		8q21	NIBRIN; NBN	4683
MIM602668	C0752354	3q13.3-q24	MYOTONIC DYSTROPHY 2; DM2	7555
MIM602669		10q25	PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 3; PITX3	5309
MIM602670		14q13-q21	POLYMERASE, DNA, EPSILON-2; POLE2	5427
MIM602671		11q23	SOLUTE CARRIER FAMILY 37 (GLUCOSE-6-PHOSPHATE TRANSPORTER), MEMBER 4; SLC37A4	2542
MIM602672		1q21.3	RAS-ASSOCIATED PROTEIN RAB13; RAB13	5872
MIM602673		19q13.4	KALLIKREIN-RELATED PEPTIDASE 10; KLK10	5655
MIM602675		1q32.1-q32.2	ARGINYL AMINOPEPTIDASE; RNPEP	6051
MIM602676		2q36-q37	PHOSPHODIESTERASE 6D, cGMP-SPECIFIC, ROD, DELTA; PDE6D	5147
MIM602677		6p21.3	RING FINGER PROTEIN 5; RNF5	6048
MIM602678		14q32.3	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 3; MARK3	4140
MIM602679		 	PHOSPHATE CYTIDYLYLTRANSFERASE 2, ETHANOLAMINE; PCYT2	5833
MIM602680		14q12	RHO GTPase-ACTIVATING PROTEIN 5; ARHGAP5	394
MIM602681		6q21	FORKHEAD BOX O3A; FOXO3A	2309
MIM602682		8q24	BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR 1; BAI1	575
MIM602683		1p35	BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR 2; BAI2	576
MIM602684		6q12	BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR 3; BAI3	577
MIM602685	C1864549	15q24	MENTAL RETARDATION, SEVERE, WITH SPASTICITY AND PIGMENTARY TAPETORETINAL DEGENERATION	8126
MIM602686		7p22	MITOTIC ARREST-DEFICIENT 1, YEAST, HOMOLOG-LIKE 1; MAD1L1	8379
MIM602688		 	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A/B; HNRNPAB	3182
MIM602689		7p22	FASCIN, SEA URCHIN, HOMOLOG OF, 1; FSCN1	6624
MIM602690		11q23	SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT D, INTEGRAL MEMBRANE PROTEIN; SDHD	6392
MIM602691		2p23	NUCLEAR RECEPTOR COACTIVATOR 1; NCOA1	8648
MIM602692		12q21	GLIOMA PATHOGENESIS-RELATED PROTEIN 1; GLIPR1	11010
MIM602693		6p12	MINICHROMOSOME MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, 3; MCM3	4172
MIM602694		5q11.1	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 4; NDUFS4	4724
MIM602695		17p13.3	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 12; TNFSF12	8742
MIM602696		22q13.1	MINICHROMOSOME MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, 5; MCM5	4174
MIM602697		19p13	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 11; P2RY11	5032
MIM602698		Chr.16	NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 3; NFATC3	4775
MIM602699		Chr.14	NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 4; NFATC4	4776
MIM602700		22q13	E1A-BINDING PROTEIN, 300-KD; EP300	2033
MIM602701		3p21.2-p14.3	SARCOLEMMAL-ASSOCIATED PROTEIN; SLMAP	7871
MIM602702		19p13.3	PERILIPIN 3; PLIN3	10226
MIM602703		 	KATANIN, p80 SUBUNIT, B1; KATNB1	10300
MIM602704		1q32	MOUSE DOUBLE MINUTE 4 HOMOLOG; MDM4	4194
MIM602705		22q12.3	SYNAPSIN III; SYN3	8224
MIM602706		14q32.11	PROTEASOME 26S SUBUNIT, ATPase, 1; PSMC1	5700
MIM602707		19q13.11-q13.13	PROTEASOME 26S SUBUNIT, ATPase, 4; PSMC4	5704
MIM602708		14q22.1	PROTEASOME 26S SUBUNIT, ATPase, 6; PSMC6	5706
MIM602709		11p15	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY B, MEMBER 1; APBB1	322
MIM602710		4p14	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY B, MEMBER 2; APBB2	323
MIM602711		5q31	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY B, MEMBER 3; APBB3	10307
MIM602712		15q	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 2; APBA2	321
MIM602713		8p11.23	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 9; ADAM9	8754
MIM602714		10q26.3	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 12; ADAM12	8038
MIM602715		 	LEIOMODIN 1; LMOD1	25802
MIM602716		19q13.1	NEPHRIN; NPHS1	4868
MIM602717		19q13.1-qter	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2D; GRIN2D	2906
MIM602718		 	TRANSFORMER 2, DROSOPHILA, HOMOLOG OF, ALPHA	29896
MIM602719		3q26.2-q27	SPLICING FACTOR, ARGININE/SERINE-RICH, 10; SFRS10	6434
MIM602720		7q21.3	PARAOXONASE 3; PON3	5446
MIM602721		 	DISRUPTED MEIOTIC cDNA 1, YEAST, HOMOLOG OF; DMC1	11144
MIM602722	C1864498	7q33-q34	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR	50617
MIM602723	C1864497	17q25	PSORIASIS SUSCEPTIBILITY 2; PSORS2	5722, 79092
MIM602724		22q11.2	SEPTIN 5; SEPT5	5413
MIM602725		3p21.3	INTERFERON-RELATED DEVELOPMENTAL REGULATOR 2; IFRD2	7866
MIM602726		1p36	CHLORIDE CHANNEL 6; CLCN6	1185
MIM602727		16p13	CHLORIDE CHANNEL 7; CLCN7	1186
MIM602728		8p21	SCAVENGER RECEPTOR CLASS A, MEMBER 3; SCARA3	51435
MIM602729		5q32-q33	GAMMA-AMINOBUTYRIC ACID RECEPTOR, PI; GABRP	2568
MIM602730		3p22-p21.3	ACTIVIN A RECEPTOR, TYPE IIB; ACVR2B	93
MIM602731		 	FYN-BINDING PROTEIN; FYB	2533
MIM602732		11p12-q12	RHO GTPase-ACTIVATING PROTEIN 1; ARHGAP1	392
MIM602733		1q22-q23	ALDEHYDE DEHYDROGENASE, FAMILY 9, SUBFAMILY A, MEMBER 1; ALDH9A1	223
MIM602734		3q23	PLASTIN 1; PLS1	5357
MIM602735		11p13	RETICULOCALBIN 1; RCN1	5954
MIM602736		2q31.1	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT C, ISOFORM 3; ATP5G3	518
MIM602737		9p13	CHEMOKINE, CC MOTIF, LIGAND 21; CCL21	6366
MIM602738		17q21	KARYOPHERIN BETA-1; KPNB1	3837
MIM602739		5p12	PROTEIN KINASE, AMP-ACTIVATED, CATALYTIC, ALPHA-1; PRKAA1	5562
MIM602740		12q24.1	PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, BETA-1; PRKAB1	5564
MIM602741		 	PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, BETA-2; PRKAB2	5565
MIM602742		12q13.1	PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-1; PRKAG1	5571
MIM602743		7q36	PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-2; PRKAG2	51422
MIM602744		1q42	GLYCERONEPHOSPHATE O-ACYLTRANSFERASE; GNPAT	8443
MIM602745		9q13	PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, BETA; PIP5K1B	8395
MIM602746		1p36.3-p36.2	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 14; TNFRSF14	8764
MIM602747		8p12-p11	DUAL-SPECIFICITY PHOSPHATASE 4; DUSP4	1846
MIM602748		12q22-q23	DUAL-SPECIFICITY PHOSPHATASE 6; DUSP6	1848
MIM602749		3p21	DUAL-SPECIFICITY PHOSPHATASE 7; DUSP7	1849
MIM602750		22q11.2	D-DOPACHROME TAUTOMERASE; DDT	1652
MIM602751		21q22.1	BTB AND CNC HOMOLOGY 1; BACH1	571
MIM602752		2q12.3-q13	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 8; RGPD8	727851
MIM602753		11q13.3-q13.4	ARISTALESS HOMEOBOX, DROSOPHILA, HOMOLOG OF; ARIX	401
MIM602754		19q13.2	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 4; KCNN4	3783
MIM602755		 	CYCLIN B2; CCNB2	9133
MIM602756		19p13.3	EPHRIN A2; EFNA2	1943
MIM602757		7q33-q35	EPHRIN RECEPTOR EphB6; EPHB6	2051
MIM602758		1q21.1-q21.3	PHOSPHATIDYLINOSITOL 4-KINASE, CATALYTIC, BETA; PIK4CB	5298
MIM602759	C1864472	1q42.2-q43	PROSTATE CANCER, HEREDITARY, 8	7834
MIM602760		17q12-q21	KERATIN 32; KRT32	3882
MIM602761		17q12-q21	KERATIN 33A; KRT33A	3883
MIM602762		17q12-q21	KERATIN 33B; KRT33B	3884
MIM602763		17q12-q21	KERATIN 34; KRT34	3885
MIM602764		17q12-q21	KERATIN 35; KRT35	3886
MIM602765		12q13	KERATIN 83; KRT83	3889
MIM602766		 	KERATIN 84; KRT84	3890
MIM602767		12q13	KERATIN 85; KRT85	3891
MIM602768		19q13	DELTA-LIKE 3; DLL3	10683
MIM602769		2p23	DNA METHYLTRANSFERASE 3A; DNMT3A	1788
MIM602770		17q25	CHROMOBOX HOMOLOG 2, DROSOPHILA POLYCOMB CLASS; CBX2	84733
MIM602771	C0410180	1p36-p35	RIGID SPINE MUSCULAR DYSTROPHY 1; RSMD1	57190
MIM602772	C1864446	6q12	RETINITIS PIGMENTOSA 25; RP25	346007
MIM602773		3q21	DISRUPTED IN RENAL CARCINOMA 2; DIRC2	84925
MIM602774		17q22	RAD51, S. CEREVISIAE, HOMOLOG OF, C; RAD51C	5889
MIM602775		10q25	SUPPRESSOR OF CLEAR, C. ELEGANS, HOMOLOG OF; SHOC2	8036
MIM602776		6q21	REV3, S. CEREVISIAE, HOMOLOG OF; REV3L	5980
MIM602777		 	SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 4; SNAPC4	6621
MIM602778		9q33-q34.1	NUCLEAR RECEPTOR SUBFAMILY 6, GROUP A, MEMBER 1; NR6A1	2649
MIM602779		19p12	COAGULATION FACTOR II RECEPTOR-LIKE 3; F2RL3	9002
MIM602780		 	HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 1; HCN1	348980
MIM602781		19p13.3	HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 2; HCN2	610
MIM602782	C1864445	11q25	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	55315
MIM602783		16q24.3	SPG7 GENE; SPG7	6687
MIM602784		1p36	CORTISTATIN; CORT	1325
MIM602785		 	H1 HISTONE FAMILY, MEMBER X; H1FX	8971
MIM602786		6p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER E; HIST1H2AE	3012
MIM602787		6p22-p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER I; HIST1H2AI	8329
MIM602788		6p22-p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER K; HIST1H2AK	8330
MIM602790		1p34	FOUR-AND-A-HALF LIM DOMAINS 3; FHL3	2275
MIM602791		6p22-p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER J; HIST1H2AJ	8331
MIM602792		6p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER D; HIST1H2AD	3013
MIM602793		6p22-p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER L; HIST1H2AL	8332
MIM602794		6p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER C; HIST1H2AC	8334
MIM602795		6p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER B; HIST1H2AB	8335
MIM602796		6p22-p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER M; HIST1H2AM	8336
MIM602797		1q21-q23	HISTONE GENE CLUSTER 2, H2A HISTONE FAMILY, MEMBER C; HIST2H2AC	8338
MIM602798		6p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER G; HIST1H2BG	8339
MIM602799		6p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER D; HIST1H2BD	3017
MIM602800		6p22-p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER L; HIST1H2BL	8340
MIM602801		6p22-p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER N; HIST1H2BN	8341
MIM602802		6p22-p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER M; HIST1H2BM	8342
MIM602803		6p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER B; HIST1H2BB	3018
MIM602804		6p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER F; HIST1H2BF	8343
MIM602805		6p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER E; HIST1H2BE	8344
MIM602806		6p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER H; HIST1H2BH	8345
MIM602807		6p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER I; HIST1H2BI	8346
MIM602808		6p22-p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER O; HIST1H2BO	8348
MIM602809		10p12-cen	KINESIN FAMILY MEMBER 5B; KIF5B	3799
MIM602810		6p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER A; HIST1H3A	8350
MIM602811		6p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER D; HIST1H3D	8351
MIM602812		6p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER C; HIST1H3C	8352
MIM602813		6p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER E; HIST1H3E	8353
MIM602814		6p22-p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER I; HIST1H3I	8354
MIM602815		6p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER G; HIST1H3G	8355
MIM602816		6p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER F; HIST1H3F	8968
MIM602817		6p22-p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER J; HIST1H3J	8356
MIM602818		6p22-p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER H; HIST1H3H	8357
MIM602819		6p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER B; HIST1H3B	8358
MIM602820		1q42	HISTONE GENE CLUSTER 3, H3 HISTONE; HIST3H3	8290
MIM602821		12q13	KINESIN FAMILY MEMBER 5A; KIF5A	3798
MIM602822		6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER A; HIST1H4A	8359
MIM602823		6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER D; HIST1H4D	8360
MIM602824		6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER F; HIST1H4F	8361
MIM602825		6p22-p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER K; HIST1H4K	8362
MIM602826		6p22-p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER J; HIST1H4J	8363
MIM602827		6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER C; HIST1H4C	8364
MIM602828		6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER H; HIST1H4H	8365
MIM602829		6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER B; HIST1H4B	8366
MIM602830		6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER E; HIST1H4E	8367
MIM602831		6p22-p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER L; HIST1H4L	8368
MIM602832		6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER G; HIST1H4G	8369
MIM602833		6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER I; HIST1H4I	8294
MIM602835		11p15.2-p14.3	GROWTH ARREST-SPECIFIC 2; GAS2	2620
MIM602836		 	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 5; P2RX5	5026
MIM602837		 	DNAJ/HSP40 HOMOLOG, SUBFAMILY A, MEMBER 1; DNAJA1	3301
MIM602838		1q32	PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 2, BETA; PIK3C2B	5287
MIM602839		1p36.2	PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, DELTA; PIK3CD	5293
MIM602840		19p13	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 7; TNFSF7	970
MIM602841		2q33	ALDEHYDE OXIDASE 1; AOX1	316
MIM602842		 	GEMININ; GMNN	51053
MIM602843		12p12.3	RHO GDP-DISSOCIATION INHIBITOR BETA; ARHGDIB	397
MIM602844		 	RHO GDP-DISSOCIATION INHIBITOR GAMMA; ARHGDIG	398
MIM602845		2p23	KINESIN FAMILY MEMBER 3C; KIF3C	3797
MIM602846		4p14	HUNTINGTIN-INTERACTING PROTEIN 2; HIP2	3093
MIM602847		6p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER C; HIST1H2BC	8347
MIM602848		 	BROMODOMAIN-CONTAINING PROTEIN 8; BRD8	10902
MIM602849	C1864436	4p16.3	MUENKE SYNDROME; MNKES	2261
MIM602850		4p16.3	RING FINGER PROTEIN 4; RNF4	6047
MIM602851		5q14.3	G PROTEIN-COUPLED RECEPTOR 98; GPR98	84059
MIM602852		9p13	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 2; NUDT2	318
MIM602853		 	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, R; PTPRR	5801
MIM602854		11p15.1	PROTEASOME SUBUNIT, ALPHA-TYPE, 1; PSMA1	5682
MIM602855		14q13	PROTEASOME SUBUNIT, ALPHA-TYPE, 6; PSMA6	5687
MIM602856		 	REGULATOR OF G PROTEIN SIGNALING 10; RGS10	6001
MIM602857		7p15.3	CHIMERIN 2; CHN2	1124
MIM602858		11q12-q13	7-@DEHYDROCHOLESTEROL REDUCTASE; DHCR7	1717
MIM602859		1p36.32	PEROXISOME BIOGENESIS FACTOR 10; PEX10	5192
MIM602860		15q15	BUDDING UNINHIBITED BY BENZIMIDAZOLES 1, S. CEREVISIAE, HOMOLOG OF, BETA; BUB1B	701
MIM602861		12p11	PLAKOPHILIN 2; PKP2	5318
MIM602862		 	UDP-N-ACETYLGLUCOSAMINE PYROPHOSPHORYLASE 1; UAP1	6675
MIM602863		1q42	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 9A; WNT9A	7483
MIM602864		17q21	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 9B; WNT9B	7484
MIM602865		9q32-q33	DELETED IN BLADDER CANCER 1; DBC1	1620
MIM602866		12q12	CATION CHANNEL, AMILORIDE-SENSITIVE, NEURONAL, 2; ACCN2	41
MIM602867		4q12	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 7; IGFBP7	3490
MIM602868		6p21	CELL DIVISION CYCLE 5, S. POMBE, HOMOLOG OF; CDC5L	988
MIM602869		 	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U; HNRNPU	3192
MIM602870		6q13-q15	INTERPHOTORECEPTOR MATRIX PROTEOGLYCAN 1; IMPG1	3617
MIM602871		16p13	PERIPLAKIN; PPL	5493
MIM602872		 	CHLORIDE INTRACELLULAR CHANNEL 1; CLIC1	1192
MIM602873		10q24-q26	NEBULIN-RELATED ANCHORING PROTEIN; NRAP	4892
MIM602874		9q31	UDP-GLUCOSE CERAMIDE GLUCOSYLTRANSFERASE; UGCG	7357
MIM602875	C1864356	9p21-p12	ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDM	4882
MIM602876		5q13.1	OCCLUDIN; OCLN	100506658
MIM602877		2q37.3	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 7; PPP1R7	5510
MIM602878		2p23.3	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 3; SLC30A3	7781
MIM602879		 	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 1; EPB41L1	2036
MIM602880		19p12	GROWTH/DIFFERENTIATION FACTOR 1; GDF1	2657
MIM602881		6p21.3	PHD FINGER PROTEIN 1; PHF1	5252
MIM602882		5q31.1-q32	LEUKOCYTE CELL-DERIVED CHEMOTAXIN 2; LECT2	3950
MIM602883		12p12	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1A2; SLCO1A2	6579
MIM602884		6p25	GDP-MANNOSE 4,6-DEHYDRATASE; GMDS	2762
MIM602885		13q14-q21	MOTILIN RECEPTOR; MLNR	2862
MIM602886		2q21-q22	G PROTEIN-COUPLED RECEPTOR 39; GPR39	2863
MIM602887		17p13.1	DISCS LARGE, DROSOPHILA, HOMOLOG OF, 4; DLG4	1742
MIM602888		5q13.1-q13.2	BETAINE-HOMOCYSTEINE METHYLTRANSFERASE; BHMT	635
MIM602890		12p13-p12	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 1; KLRB1	3820
MIM602891		12p13.2-p12.3	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 2; KLRC2	3822
MIM602892		12p13.2-p12.3	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 3; KLRC3	3823
MIM602893		12p13.2-p12.3	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 4; KLRC4	8302
MIM602894		12p13.2-p12.3	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY D, MEMBER 1; KLRD1	3824
MIM602895		19p13.3-p13.2	SCAFFOLD ATTACHMENT FACTOR B; SAFB	6294
MIM602896		5q35	MITOGEN-ACTIVATED PROTEIN KINASE 9; MAPK9	5601
MIM602897		4q21.3	MITOGEN-ACTIVATED PROTEIN KINASE 10; MAPK10	5602
MIM602898		 	MITOGEN-ACTIVATED PROTEIN KINASE 11; MAPK11	5600
MIM602899		 	MITOGEN-ACTIVATED PROTEIN KINASE 13; MAPK13	5603
MIM602900		20q11.2	DNA METHYLTRANSFERASE 3B; DNMT3B	1789
MIM602901		5q13.2	TRANSPORTIN 1; TNPO1	3842
MIM602902		9q13	KRUPPEL-LIKE FACTOR 9; KLF9	687
MIM602903		 	KRUPPEL-LIKE FACTOR 5; KLF5	688
MIM602904		 	MITOGEN-ACTIVATED PROTEIN KINASE 6; MAPK6	5597
MIM602905		 	POTASSIUM CHANNEL, VOLTAGE-GATED, DELAYED-RECTIFIER, SUBFAMILY S, MEMBER 1; KCNS1	3787
MIM602906		8q22	POTASSIUM CHANNEL, VOLTAGE-GATED, DELAYED-RECTIFIER, SUBFAMILY S, MEMBER 2; KCNS2	3788
MIM602907		 	CENTRIN 3; CETN3	1070
MIM602908		20p11.2	RETINOBLASTOMA-BINDING PROTEIN 9; RBBP9	10741
MIM602909		7q11.23	CLAUDIN 4; CLDN4	1364
MIM602910		7q11	CLAUDIN 3; CLDN3	1365
MIM602911		22q13.1	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-2 SUBUNIT; CACNG2	10369
MIM602912		20q11.2	EUKARYOTIC TRANSLATION INITIATION FACTOR 6; EIF6	3692
MIM602913		1p34.1	POLO-LIKE KINASE 3; PLK3	1263
MIM602914		15q22	AQUAPORIN 9; AQP9	366
MIM602915		21q22.3	TRYPTOPHAN-RICH BASIC PROTEIN; WRB	7485
MIM602916		 	UBIQUITIN-CONJUGATING ENZYME E2E 1; UBE2E1	7324
MIM602917		21q22.1-q22.2	REGULATOR OF CALCINEURIN 1; RCAN1	1827
MIM602918		 	PHENYLALANINE-tRNA SYNTHETASE, ALPHA SUBUNIT; FARSA	2193
MIM602919		2p13	DOCKING PROTEIN 1; DOK1	1796
MIM602920		17q21	LIM AND SH3 PROTEIN 1; LASP1	3927
MIM602921		19p13.3	PERSEPHIN; PSPN	5623
MIM602923		 	RETINOBLASTOMA-BINDING PROTEIN 4; RBBP4	5928
MIM602924		 	RHO FAMILY GTPase 3; RND3	390
MIM602925		3q22.3	PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, BETA; PIK3CB	5291
MIM602926		9q34.1	SYNTAXIN-BINDING PROTEIN 1; STXBP1	6812
MIM602927		12p13.2-p12.3	G PROTEIN-COUPLED RECEPTOR 19; GPR19	2842
MIM602928		15q21.1-q21.2	TROPOMODULIN 2; TMOD2	29767
MIM602929		11q23	VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 5A; VWA5A	4013
MIM602930		9q34	RNA EXONUCLEASE 4, S. CEREVISIAE, HOMOLOG OF; REXO4	57109
MIM602931		15q21-q22	MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 6; SMAD6	4091
MIM602932		18q21.1	MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 7; SMAD7	4092
MIM602933		7q22	THYROID HORMONE RECEPTOR INTERACTOR 6; TRIP6	7205
MIM602934		17q11.2	STROMAL CELL-DERIVED FACTOR 2; SDF2	6388
MIM602935		1p35-p34	FATTY ACID AMIDE HYDROLASE; FAAH	2166
MIM602937		6q23.3	CBP/p300-INTERACTING TRANSACTIVATOR, WITH GLU/ASP-RICH C-TERMINAL DOMAIN, 2; CITED2	10370
MIM602938		9q22.3	BILE ACID CoA:AMINO ACID N-ACYLTRANSFERASE; BAAT	570
MIM602939		 	FORKHEAD BOX S1; FOXS1	2307
MIM602940		1p34	MARCKS-LIKE PROTEIN 1; MARCKSL1	65108
MIM602941		16q23.1	BREAST CANCER ANTIESTROGEN RESISTANCE 1; BCAR1	9564
MIM602942		1p22	ECOTROPIC VIRAL INTEGRATION SITE 5; EVI5	7813
MIM602943		1q21	RAR-RELATED ORPHAN RECEPTOR C; RORC	6097
MIM602944		 	E2F TRANSCRIPTION FACTOR 6; E2F6	1876
MIM602945		3p25.3	TRANSCRIPTIONAL ADAPTOR 3; TADA3	10474
MIM602946		 	TAF6-LIKE RNA POLYMERASE II; TAF6L	10629
MIM602947		 	SUPPRESSOR OF TY 3, S. CEREVISIAE, HOMOLOG OF; SUPT3H	8464
MIM602948		14q23.3-q24	RAD51, S. CEREVISIAE, HOMOLOG OF, B; RAD51L1	5890
MIM602949		 	SIN3-ASSOCIATED POLYPEPTIDE, 18-KD; SAP18	10284
MIM602950		19q13	PROTEIN ARGININE N-METHYLTRANSFERASE 1; PRMT1	3276
MIM602951		9q32	ZINC FINGER PROTEIN 37, MOUSE, HOMOLOG OF; ZFP37	7539
MIM602952		4p16.3	WHS CANDIDATE 1 GENE; WHSC1	7468
MIM602953		 	HAIRY/ENHANCER OF SPLIT-RELATED WITH YRPW MOTIF 1; HEY1	23462
MIM602954		17q11	RAD51, S. CEREVISIAE, HOMOLOG OF, D; RAD51D	5892
MIM602955		7q22.1	TAF6 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 80-KD; TAF6	6878
MIM602956		9p13	FANCG GENE; FANCG	2189
MIM602957		16q13	CHEMOKINE, CC MOTIF, LIGAND 22; CCL22	6367
MIM602958		6q23	SERUM/GLUCOCORTICOID-REGULATED KINASE 1; SGK1	6446
MIM602959		20q13	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, ALPHA-2; EEF1A2	1917
MIM602961		10q11.2-q21	UBIQUITIN-CONJUGATING ENZYME E2D 1; UBE2D1	7321
MIM602962		 	UBIQUITIN-CONJUGATING ENZYME E2D 2; UBE2D2	7322
MIM602963		 	UBIQUITIN-CONJUGATING ENZYME E2D 3; UBE2D3	7323
MIM602964		1q41	TRANSLIN-ASSOCIATED FACTOR X; TSNAX	7257
MIM602965		6q22-q23	FATTY ACID-BINDING PROTEIN 7; FABP7	2173
MIM602966	C1864323	2p13	OROFACIAL CLEFT 2; OFC2	4964
MIM602967		20q13.2	ZINC FINGER PROTEIN 217; ZNF217	7764
MIM602968		20q13.2	BREAST CARCINOMA AMPLIFIED SEQUENCE 1; BCAS1	8537
MIM602969		1q41	ESTROGEN-RELATED RECEPTOR, GAMMA; ESRRG	2104
MIM602970		3q26.1	KARYOPHERIN ALPHA-4; KPNA4	3840
MIM602971		 	TUBULIN-SPECIFIC CHAPERONE C; TBCC	6903
MIM602972		15q25.3-q26.1	PHOSPHODIESTERASE 8A; PDE8A	5151
MIM602973		21q22.3	PHOSPHODIESTERASE 9A; PDE9A	5152
MIM602974		9p13	AQUAPORIN 7; AQP7	364
MIM602976		17q21.1	MAX-LIKE PROTEIN X; MLX	6945
MIM602977		16p12.3	GLYCOPROTEIN 2, ZYMOGEN GRANULE MEMBRANE; GP2	2813
MIM602978		 	POLYHOMEOTIC-LIKE 1; PHC1	1911
MIM602979		 	POLYHOMEOTIC-LIKE 2; PHC2	1912
MIM602980		 	PROTEIN KINASE, SERINE/ARGININE-SPECIFIC, 2; SRPK2	6733
MIM602981		 	AE-BINDING PROTEIN 1; AEBP1	165
MIM602982		 	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 1; KCNN1	3780
MIM602983		1q21.3	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 3; KCNN3	3782
MIM602984		 	MEDIATOR COMPLEX SUBUNIT 6; MED6	10001
MIM602985		1q23	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 2; NDUFS2	4720
MIM602986		17p11.2	DEVELOPMENTALLY REGULATED GTP-BINDING PROTEIN 2; DRG2	1819
MIM602987		7p14.3	PHOSPHODIESTERASE 1C; PDE1C	5137
MIM602988		4p15	PROTOCADHERIN 7; PCDH7	5099
MIM602989		1p31	CDC-LIKE KINASE 2; CLK2	1196
MIM602990		15q24	CDC-LIKE KINASE 3; CLK3	1198
MIM602991		17q22	NOGGIN, MOUSE, HOMOLOG OF; NOG	9241
MIM602992		19q13.4	LEUKOCYTE-ASSOCIATED IMMUNOGLOBULIN-LIKE RECEPTOR 1; LAIR1	3903
MIM602993		 	LEUKOCYTE-ASSOCIATED IMMUNOGLOBULIN-LIKE RECEPTOR 2; LAIR2	3904
MIM602995		20q13.2	UBIQUITIN-CONJUGATING ENZYME E2 VARIANT 1; UBE2V1	7335
MIM602996		6p21.3	IMMEDIATE-EARLY RESPONSE 3; IER3	8870
MIM602997		10p12.1	CUBILIN; CUBN	8029
MIM602998		10q23.2-q23.3	SYNUCLEIN, GAMMA; SNCG	6623
MIM602999		10q23-q24	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3C; PPP1R3C	5507
MIM603000		 	IMMATURE COLON CARCINOMA TRANSCRIPT 1; ICT1	3396
MIM603001		 	UBIQUITIN-CONJUGATING ENZYME E2 VARIANT 2; UBE2V2	7336
MIM603002		19p13.13	TRANSPORTIN 2; TNPO2	30000
MIM603003	C1257797	 	BILE DUCT CYSTS	 
MIM603004		7p12	GLIOBLASTOMA AMPLIFIED SEQUENCE; GBAS	2631
MIM603005		10q22-q24	3-PRIME-@PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 2; PAPSS2	9060
MIM603006		20q13.3	CADHERIN 4; CDH4	1002
MIM603007		5p15.1-p14	CADHERIN 6; CDH6	1004
MIM603008		16q21-q22.1	CADHERIN 8; CDH8	1006
MIM603009		2p13.3-p13.1	DYSFERLIN; DYSF	8291
MIM603010	C1864276	7q31	DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	1709
MIM603011		5q12.2-q13.3	SMALL EDRK-RICH FACTOR 1A; SERF1A	8293
MIM603012		6p21.3	HEAT-SHOCK 70-KD PROTEIN 1B; HSPA1B	3304
MIM603013	C1864275	8p21, 8p22-p11	SCHIZOPHRENIA 6; SCZD6	3084, 8400
MIM603014		 	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7; MAP2K7	5609
MIM603015		7q21.2-q22.1	TRANSFORMATION/TRANSCRIPTION DOMAIN-ASSOCIATED PROTEIN; TRRAP	8295
MIM603016		18q22-q23	CADHERIN 19; CDH19	28513
MIM603017		8q22.1	CADHERIN 17; CDH17	1015
MIM603018		1q31	UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE, POLYPEPTIDE 2; B3GALT2	8707
MIM603019		5p15.2-p15.1	CADHERIN 18; CDH18	1016
MIM603020		16q24	ATPase FAMILY GENE 3-LIKE 1; AFG3L1	172
MIM603021		19q13.1	MITOCHONDRIAL RIBOSOMAL PROTEIN S12; MRPS12	6183
MIM603022		16p13.3	E4F TRANSCRIPTION FACTOR 1; E4F1	1877
MIM603023		7p12	IKAROS FAMILY ZINC FINGER 1; IKZF1	10320
MIM603024		1p36.1-p35	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 1A; ARID1A	8289
MIM603025		11q14	PHOSPHATIDYLINOSITOL-BINDING CLATHRIN ASSEMBLY PROTEIN; PICALM	8301
MIM603026		8q12	PLEOMORPHIC ADENOMA GENE 1; PLAG1	5324
MIM603027		Chr.9	FRUCTOSE-1,6-BISPHOSPHATASE 2; FBP2	8789
MIM603028		4q32	TOLL-LIKE RECEPTOR 2; TLR2	7097
MIM603029		4q35	TOLL-LIKE RECEPTOR 3; TLR3	7098
MIM603030		9q32-q33	TOLL-LIKE RECEPTOR 4; TLR4	7099
MIM603031		1q41-q42	TOLL-LIKE RECEPTOR 5; TLR5	7100
MIM603032		16p13	STANNIN; SNN	8303
MIM603033		3p25	COLLAGENIC TAIL OF ENDPLATE ACETYLCHOLINESTERASE; COLQ	8292
MIM603034	C1864233	3p25	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY; EAD	8292
MIM603035		15q26.1	INTERLEUKIN 16; IL16	3603
MIM603037		1q42.1	LEFT-RIGHT DETERMINATION FACTOR 1; LEFTY1	10637
MIM603038		20q11.2	SPERM-ASSOCIATED ANTIGEN 4; SPAG4	6676
MIM603039		17p13.3	MAX-BINDING PROTEIN; MNT	4335
MIM603040	C1864232	11q23	TUMOR SUPPRESSOR GENE ON CHROMOSOME 11	50970
MIM603041	C0872218	22q13.32-qter	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	1890
MIM603042		 	SMALL UBIQUITIN-LIKE MODIFIER 2; SUMO2	6613
MIM603043		8q12-q13	NEUTRAL SPHINGOMYELINASE ACTIVATION-ASSOCIATED FACTOR; NSMAF	8439
MIM603044		6q24	PLEOMORPHIC ADENOMA GENE-LIKE 1; PLAGL1	5325
MIM603046		8q24.1	RING FINGER PROTEIN 139; RNF139	11236
MIM603047	C0004106	 	ASTIGMATISM	 
MIM603048		8q24	GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR ATTACHMENT PROTEIN 1; GPAA1	8733
MIM603049		 	THIOREDOXIN-LIKE 1; TXNL1	9352
MIM603050		10p11.2	ABL INTERACTOR 1; ABI1	10006
MIM603051		2q31	ALKYLGLYCERONE-PHOSPHATE SYNTHASE; AGPS	8540
MIM603052		7q21-q22	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 4; CPSF4	10898
MIM603053		2q31.2-q33.1	HISTONE ACETYLTRANSFERASE 1; HAT1	8520
MIM603054		15q13-q15	GREMLIN 1 HOMOLOG, CYSTINE KNOT SUPERFAMILY; GREM1	26585
MIM603055		 	SKI-INTERACTING PROTEIN; SKIIP	22938
MIM603056		2q22-q23	ORIGIN RECOGNITION COMPLEX, SUBUNIT 4, S. CEREVISIAE, HOMOLOG OF; ORC4	5000
MIM603057		 	DACHSOUS, DROSOPHILA, HOMOLOG OF, 1; DCHS1	8642
MIM603058		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 4; PCDHGB4	8641
MIM603059		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 12; PCDHGA12	26025
MIM603060		 	KINESIN FAMILY MEMBER 1C; KIF1C	10749
MIM603061		1q21.2	ENDOSULFINE, ALPHA; ENSA	2029
MIM603062		2p11.2	TRANS-GOLGI NETWORK PROTEIN 2; TGOLN2	10618
MIM603063		 	3-@HYDROXYBUTYRATE DEHYDROGENASE 1; BDH1	622
MIM603064		 	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B11; UGT2B11	10720
MIM603065		3q13-q21	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP I, MEMBER 2; NR1I2	8856
MIM603066		7q22	PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE 3; PLOD3	8985
MIM603068		2q11	DUAL-SPECIFICITY PHOSPHATASE 2; DUSP2	1844
MIM603069		10q25	DUAL-SPECIFICITY PHOSPHATASE 5; DUSP5	1847
MIM603070		12p13.2-p13.1	RAD51-ASSOCIATED PROTEIN 1; RAD51AP1	10635
MIM603071		2q21	G PROTEIN-COUPLED RECEPTOR 17; GPR17	2840
MIM603072		20q13.2-q13.3	AURORA KINASE A; AURKA	6790
MIM603073		13q32	ZINC FINGER PROTEIN OF CEREBELLUM 2; ZIC2	7546
MIM603074		19q13.1	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, GAMMA SUBUNIT; PAFAH1B3	5050
MIM603075	C1864205	1q24-q25, 10q25.3-q26.2, 6p21.3, 6p21.3, 3pter-p21, 19q13.2, 1q31-q32.1, 1q31-q32.1	MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	10878, 3078, 348, 59338, 629, 717, 83872
MIM603076		21q22.3	ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 1; ABCG1	9619
MIM603078		11q22-q23	CHECKPOINT, S. POMBE, HOMOLOG OF, 1; CHEK1	1111
MIM603079		 	CHROMOBOX HOMOLOG 4, DROSOPHILA POLYCOMB CLASS; CBX4	8535
MIM603080		12p13	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, BETAINE/GABA), MEMBER 12; SLC6A12	6539
MIM603081		 	ADP-RIBOSYLARGININE HYDROLASE; ADPRH	141
MIM603083		 	HETEROGENEOUS NUCLEAR RIBOPROTEIN L; HNRNPL	3191
MIM603084		 	ASPARTYL-tRNA SYNTHETASE; DARS	1615
MIM603085		9q31-q32	SOLUTE CARRIER FAMILY 31 (COPPER TRANSPORTER), MEMBER 1; SLC31A1	1317
MIM603086		4p15.1-p14	ADP-RIBOSYLTRANSFERASE 3; ART3	419
MIM603088		9q31-q32	SOLUTE CARRIER FAMILY 31 (COPPER TRANSPORTER), MEMBER 2; SLC31A2	1318
MIM603089		3p21.3	BRCA1-ASSOCIATED PROTEIN 1; BAP1	8314
MIM603090		13q22	UBIQUITIN CARBOXYL-TERMINAL ESTERASE L3; UCHL3	7347
MIM603091		5q34	UBIQUITIN-SPECIFIC PROTEASE 12; USP12	9959
MIM603092		2p13.1	DUAL-SPECIFICITY PHOSPHATASE 11; DUSP11	8446
MIM603093		 	UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE, POLYPEPTIDE 1; B3GALT1	8708
MIM603094		3q25	BETA-1,3-N-ACETYLGALACTOSAMINYLTRANSFERASE 1; B3GALNT1	8706
MIM603095		6p21.3	UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE, POLYPEPTIDE 4; B3GALT4	8705
MIM603097		8q22.3	ATPase, H+ TRANSPORTING, LYSOSOMAL, 42-KD, V1 SUBUNIT C, ISOFORM 1; ATP6V1C1	528
MIM603098	C1864199	7q34-q36	DEAFNESS, AUTOSOMAL RECESSIVE 13; DFNB13	1705
MIM603099		6p21.3	1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 1; AGPAT1	10554
MIM603100		9q34.3	1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 2; AGPAT2	10555
MIM603101		13q14.11	CARBOXYPEPTIDASE B2, PLASMA; CPB2	1361
MIM603102		17p11.1-q11.1	CARBOXYPEPTIDASE D; CPD	1362
MIM603103		10q24.2	CARBOXYPEPTIDASE N, POLYPEPTIDE 1, 50-KD; CPN1	1369
MIM603104		3q29	CARBOXYPEPTIDASE N, POLYPEPTIDE 2, 83-KD; CPN2	1370
MIM603105		 	CARBOXYPEPTIDASE Z; CPZ	8532
MIM603106		20q11.2-q12	NEURONATIN; NNAT	4826
MIM603107		22q13.3	TRANSCRIPTION FACTOR 20; TCF20	6942
MIM603108		20q11.1-q11.23	MICROTUBULE-ASSOCIATED PROTEIN, RP/EB FAMILY, MEMBER 1; MAPRE1	22919
MIM603109		15q21-q22	MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 3; SMAD3	4088
MIM603110		5q31	MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 5; SMAD5	4090
MIM603111		 	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY E, MEMBER 1; SMARCE1	6605
MIM603112		1q21	S100 CALCIUM-BINDING PROTEIN A12; S100A12	6283
MIM603113		11q22-q24	PROTEIN PHOSPHATASE 2, STRUCTURAL/REGULATORY SUBUNIT A, BETA; PPP2R1B	5519
MIM603114		1q21	S100 CALCIUM-BINDING PROTEIN A11; S100A11	6282
MIM603115		1q25	DEAH BOX POLYPEPTIDE 9; DHX9	1660
MIM603116	C1864186	22q12-q13	CDAGS SYNDROME	574043
MIM603117	C1864185	 	SPASTIC PARAPLEGIA, OPTIC ATROPHY, MICROCEPHALY, AND XY SEX REVERSAL	 
MIM603118		16q22.1	CADHERIN 16; CDH16	1014
MIM603119	C1864184	 	APRAXIA OF EYELID OPENING	 
MIM603120		 	QUIESCIN Q6 SULFHYDRYL OXIDASE 1; QSOX1	5768
MIM603122		5q35.1	DEDICATOR OF CYTOKINESIS 2; DOCK2	1794
MIM603123		3p14	DEDICATOR OF CYTOKINESIS 3; DOCK3	1795
MIM603124		21q22.3	UBIQUITIN-CONJUGATING ENZYME E2G 2; UBE2G2	7327
MIM603125		7q11.21	TYROSYLPROTEIN SULFOTRANSFERASE 1; TPST1	8460
MIM603126		22q12.1	TYROSYLPROTEIN SULFOTRANSFERASE 2; TPST2	8459
MIM603127		17p	GROWTH ARREST-SPECIFIC 7; GAS7	8522
MIM603128		6q16.3-q21	SINGLE-MINDED, DROSOPHILA, HOMOLOG OF, 1; SIM1	6492
MIM603129		1p22.3	LIM DOMAIN ONLY 4; LMO4	8543
MIM603130		20p13	ATTRACTIN; ATRN	8455
MIM603131		7q22-q31.1	PEPTIDASE, MITOCHONDRIAL PROCESSING, BETA; PMPCB	9512
MIM603132		9q22-q31	ZINC FINGER PROTEIN 189; ZNF189	7743
MIM603133	C1864183	 	DISLOCATED ELBOWS, BOWED TIBIAS, SCOLIOSIS, DEAFNESS, CATARACT, MICROCEPHALY, AND MENTAL RETARDATION	 
MIM603134		 	CULLIN 1; CUL1	8454
MIM603135		10p11.2-p11.1	CULLIN 2; CUL2	8453
MIM603136		2q36	CULLIN 3; CUL3	8452
MIM603137		13q34	CULLIN 4A; CUL4A	8451
MIM603139		5q13	RAD17, S. POMBE, HOMOLOG OF; RAD17	5884
MIM603140		10p12.2	PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE II, ALPHA; PIP5K2A	5305
MIM603141		 	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN-BINDING PROTEIN 1; PPFIBP1	8496
MIM603142		 	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN-BINDING PROTEIN 2; PPFIBP2	8495
MIM603143		 	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN ALPHA-2; PPFIA2	8499
MIM603144		19q13.33	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN ALPHA 3; PPFIA3	8541
MIM603145		 	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN ALPHA 4; PPFIA4	8497
MIM603146		12q24.2-q24.3	PROTEASOME 26S SUBUNIT, NON-ATPase, 9; PSMD9	5715
MIM603147	C1864178	1p22.3	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	29929
MIM603148		1q32.3	ACTIVATING TRANSCRIPTION FACTOR 3; ATF3	467
MIM603149		6p12.2	INTERLEUKIN 17A; IL17A	3605
MIM603150		 	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, DELTA SUBUNIT; ATP5D	513
MIM603151		7p14	SEPTIN 7; SEPT7	989
MIM603152		21q21.3	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT F6; ATP5J	522
MIM603153		5p13.3-p13.2	RAD1, S. POMBE, HOMOLOG OF; RAD1	5810
MIM603154		Chr.14	PININ; PNN	5411
MIM603155		1q32	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 14; PTPN14	5784
MIM603156		6p25	BIPHENYL HYDROLASE-LIKE; BPHL	670
MIM603157		19q13.2-q13.4	PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 2; PIK3R2	5296
MIM603158		 	UBIQUITIN-SPECIFIC PROTEASE 8; USP8	9101
MIM603159		19q12-q13.2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 3; LRP3	4037
MIM603160		20q11.2	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 6; ENTPD6	955
MIM603161		3p21.3	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 3; ENTPD3	956
MIM603162		14q24	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 5; ENTPD5	957
MIM603163		 	SCRAPIE-RESPONSIVE GENE 1	11341
MIM603164		6q23-q24	PEROXISOME BIOGENESIS FACTOR 3; PEX3	8504
MIM603165	C0011615	3q21	DERMATITIS, ATOPIC	64069
MIM603166		11q13	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 2; MAP4K2	5871
MIM603167		11q13.1	BCL2 ANTAGONIST OF CELL DEATH; BAD	572
MIM603168		12q24.3	UNC51-LIKE KINASE 1; ULK1	8408
MIM603169		20q13	CATHEPSIN Z; CTSZ	1522
MIM603170		6p21.3	TEA DOMAIN FAMILY MEMBER 3; TEAD3	7005
MIM603171		 	NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 8; NEDD8	4738
MIM603172		 	UBIQUITIN-ACTIVATING ENZYME E1C; UBE1C	9039
MIM603173		 	UBIQUITIN-CONJUGATING ENZYME E2M; UBE2M	9040
MIM603174	C0598608	 	HOMOCYSTEINEMIA	 
MIM603175	C1864153	6q13-q26	SCHIZOPHRENIA 5; SCZD5	 
MIM603176	C1864152	13q32	SCHIZOPHRENIA 7; SCZD7	8401
MIM603177		2p12-p11.2	VESICLE-ASSOCIATED MEMBRANE PROTEIN 8; VAMP8	8673
MIM603178		14q24.3	METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE; MMSDH	4329
MIM603179		9p13.3	CARBONIC ANHYDRASE IX; CA9	768
MIM603180		 	EXPORTIN, tRNA; XPOT	11260
MIM603181		 	INTERLEUKIN ENHANCER-BINDING FACTOR 2; ILF2	3608
MIM603182		19p13	INTERLEUKIN ENHANCER-BINDING FACTOR 3; ILF3	3609
MIM603183		19q13.3	RETICULON 2; RTN2	6253
MIM603184		13q12	CYCLIN-DEPENDENT KINASE 8; CDK8	1024
MIM603185		 	NUCLEAR AUTOANTIGENIC SPERM PROTEIN; NASP	4678
MIM603186		6p21.3	DEATH-ASSOCIATED PROTEIN 6; DAXX	1616
MIM603187		18p11.32	CENTRIN 1; CETN1	1068
MIM603188	C2676933	10p	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 8; BMIQ8	56694
MIM603189		11q12.3	SYNTAXIN 5; STX5	6811
MIM603190		 	PROTEIN ARGININE N-METHYLTRANSFERASE 3; PRMT3	10196
MIM603191		21q22.3	CHROMOSOME 21 OPEN READING FRAME 2; C21ORF2	755
MIM603192		Chr.17	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT C, ISOFORM 1; ATP5G1	516
MIM603193		Chr.12	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT C, ISOFORM 2; ATP5G2	517
MIM603194	C1864148	11q13	MECKEL SYNDROME, TYPE 2; MKS2	51259
MIM603195		19q13.3	G PROTEIN-COUPLED RECEPTOR 32; GPR32	2854
MIM603196		14q12-q13	COCHLIN; COCH	1690
MIM603197		19p13.3	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 6; PNPLA6	10908
MIM603198		17q21	RNA POLYMERASE I AND TRANSCRIPT RELEASE FACTOR; PTRF	284119
MIM603199		1p31.3	INAD-LIKE; INADL	10207
MIM603200		19p12	REGULATORY FACTOR X, ANKYRIN REPEAT-CONTAINING; RFXANK	8625
MIM603201		2q24	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 11; ABCB11	8647
MIM603202		2q21	LACTASE; LCT	3938
MIM603203		 	CYCLIN G2; CCNG2	901
MIM603204	C1864125	15q24	EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 2	50971
MIM603205		3q13	MORC FAMILY CW-TYPE ZINC FINGER 1; MORC1	27136
MIM603206	C1864124	18p	SCHIZOPHRENIA 8; SCZD8	8806
MIM603207		 	VTI1, S. CEREVISIAE, HOMOLOG OF, B; VTI1B	10490
MIM603208		2q37	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 13; KCNJ13	3769
MIM603209		6p22.3-p22.2	CYTIDINE MONOPHOSPHO-N-ACETYLNEURAMINIC ACID HYDROXYLASE, PSEUDOGENE; CMAH	8418
MIM603210		8q24	JERKY, MOUSE, HOMOLOG OF; JRK	8629
MIM603211		11q21	JERKY, MOUSE, HOMOLOG-LIKE; JRKL	8690
MIM603212		3q21-q25	BEADED FILAMENT STRUCTURAL PROTEIN 2; BFSP2	8419
MIM603213		16p11.2	KINESIN FAMILY MEMBER 22; KIF22	3835
MIM603214		14q24.3	ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 4; ABCD4	5826
MIM603215		19q13.3	N-ETHYLMALEIMIDE-SENSITIVE FACTOR ATTACHMENT PROTEIN, ALPHA; NAPA	8775
MIM603216		 	SOLUBLE NSF-ATTACHMENT PROTEIN, GAMMA; NAPG	8774
MIM603217		6q23.2	SYNTAXIN 7; STX7	8417
MIM603218	C1864112	20pter-p12	HUNTINGTON DISEASE-LIKE 1; HDL1	5621
MIM603219		1q41	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 2; KCNK2	3776
MIM603220		2p23	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 3; KCNK3	3777
MIM603221	C1864111	12q21-q23	MYOPIA 3, AUTOSOMAL DOMINANT; MYP3	8782
MIM603222		11q13	U22 HOST GENE	23642
MIM603223		 	RNA, U22 SMALL NUCLEOLAR; RNU22	9304
MIM603224		 	RNA, U25 SMALL NUCLEOLAR; RNU25	9303
MIM603225		 	RNA, U26 SMALL NUCLEOLAR; RNU26	9302
MIM603226		 	RNA, U27 SMALL NUCLEOLAR; RNU27	9301
MIM603227		 	RNA, U28 SMALL NUCLEOLAR; RNU28	9300
MIM603228		 	RNA, U29 SMALL NUCLEOLAR; RNU29	9297
MIM603229		 	RNA, U30 SMALL NUCLEOLAR; RNU30	9299
MIM603230		 	RNA, U31 SMALL NUCLEOLAR; RNU31	9298
MIM603231		16p13	ZINC FINGER PROTEIN 200; ZNF200	7752
MIM603232		16p13	OLFACTORY RECEPTOR, FAMILY 1, SUBFAMILY F, MEMBER 1; OR1F1	4992
MIM603233	C1864100	20q13.32, 20q13.2, 20q13.2	PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B	149775, 2778, 8675
MIM603234		16p13.1	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 6; ABCC6	368
MIM603235		19q13.3	SELENOPROTEIN W, 1; SEPW1	6415
MIM603236		 	MEVALONATE PYROPHOSPHATE DECARBOXYLASE; MVD	4597
MIM603237		6q22-q23	ERYTHROCYTE MEMBRANE PROTEIN 4.1-LIKE 2; EPB41L2	2037
MIM603238		1p36.1	RNA, U17D SMALL NUCLEOLAR; RNU17D	8420
MIM603239		1p36.1	SMALL NUCLEOLAR RNA, H/ACA BOX, 73B; SNORA73B	6081
MIM603240		11p15.5	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 18, ANTISENSE; SLC22A18AS	5003
MIM603241		3q13.2-q21	LIMBIC SYSTEM-ASSOCIATED MEMBRANE PROTEIN; LSAMP	4045
MIM603242		12p13-p12	C-TYPE LECTIN DOMAIN FAMILY 2, MEMBER B; CLEC2B	9976
MIM603243		16q21	AUTOCRINE MOTILITY FACTOR RECEPTOR; AMFR	267
MIM603244		 	HEPARAN SULFATE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE 1; HS3ST1	9957
MIM603245		14q12-q13	NK2 HOMEOBOX 8; NKX2-8	26257
MIM603246		 	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 1; GTF3C1	2975
MIM603247		15q21.2	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 2; SLC27A2	11001
MIM603248		4q23-q24	BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE IB; BMPR1B	658
MIM603249		22q12	NIPSNAP, C. ELEGANS, HOMOLOG OF, 1; NIPSNAP1	8508
MIM603250		6p25.3	FORKHEAD BOX F2; FOXF2	2295
MIM603251		9q34.1	CYCLIN-DEPENDENT KINASE 9; CDK9	1025
MIM603252		16q24.1	FORKHEAD BOX L1; FOXL1	2300
MIM603253		 	CYSTATIN 7; CST7	8530
MIM603254		19p13.2	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 4; SMARCA4	6597
MIM603255		 	NUCLEAR TRANSCRIPTION FACTOR, X BOX-BINDING, 1; NFX1	4799
MIM603256		 	LEUCINE-RICH REPEAT IN FLII-INTERACTING PROTEIN 1; LRRFIP1	9208
MIM603257		3q25.1-q26.1	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 3; SMARCA3	6596
MIM603258		8p11.2	INHIBITOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS, KINASE OF, BETA; IKBKB	3551
MIM603260		9q12	BarH-LIKE HOMEOBOX GENE 1; BARX1	56033
MIM603261		 	PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE II, BETA; PIP5K2B	8396
MIM603262		4q24	3-PRIME-@PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 1; PAPSS1	9061
MIM603263		15q22	CARBONIC ANHYDRASE XII; CA12	771
MIM603264		16p13.3	RHOMBOID-LIKE 1; RHBDL1	9028
MIM603265		19p13.3	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 3A; ARID3A	1820
MIM603266	C1864068	10q25	DIABETES MELLITUS, INSULIN-DEPENDENT, 17; IDDM17	8691
MIM603267		16p13.3	SMALL OPTIC LOBES, DROSOPHILA, HOMOLOG OF; SOLH	6650
MIM603268		10q22	N-DEACETYLASE/N-SULFOTRANSFERASE 2; NDST2	8509
MIM603269		11q22	SPLICING FACTOR, SERINE/ARGININE-RICH, 8; SRSF8	10929
MIM603270		 	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT B, ISOFORM 1; ATP5F1	515
MIM603271		 	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 21; PTPN21	11099
MIM603272		 	CONNECTOR ENHANCER OF KSR 1; CNKSR1	10256
MIM603273		3q27	TUMOR PROTEIN p63; TP63	8626
MIM603275		1q22-q24	PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, ALPHA; PIP5K1A	8394
MIM603276		1q23	REGULATOR OF G PROTEIN SIGNALING 5; RGS5	8490
MIM603277		12p13	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 4; CHD4	1108
MIM603278	C0017668	19q13	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1; FSGS1	81
MIM603279		17q21.3	EXPANDED REPEAT DOMAIN, CAG/CTG, 1; ERDA1	9030
MIM603281		12q24.2	2-PRIME,5-PRIME-@OLIGOADENYLATE SYNTHETASE-LIKE; OASL	8638
MIM603282		6p21.3	ZINC FINGER PROTEIN 204; ZNF204	7754
MIM603283		6q22-q23	TRIADIN; TRDN	10345
MIM603284	C1864041	7p13	CEREBRAL CAVERNOUS MALFORMATIONS 2; CCM2	83605
MIM603285	C1864040	3q26.1	CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	11235
MIM603286		1q32	KISS1 METASTASIS SUPPRESSOR; KISS1	3814
MIM603287		17q21.32	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE; PNPO	55163
MIM603288		12q22	KERATOCAN; KERA	11081
MIM603289		19q13.3	DEATH-ASSOCIATED PROTEIN KINASE 3; DAPK3	1613
MIM603290		11q13.3-q13.4	SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 2; SHANK2	22941
MIM603291		 	BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 1; BNIP1	662
MIM603292		 	BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 2; BNIP2	663
MIM603293		 	BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 3; BNIP3	664
MIM603294		21q22.3	MINICHROMOSOME MAINTENANCE 3-ASSOCIATED PROTEIN; MCM3AP	8888
MIM603295		13q12-q14	MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 9; SMAD9	4093
MIM603296		 	LATE ENDOSOMAL/LYSOSOMAL ADAPTOR, MITOGEN-ACTIVATED PROTEIN KINASE AND MAMMALIAN TARGET OF RAPAMYCIN ACTIVATOR 3; LAMTOR3	8649
MIM603297		11q13.5	DYNEIN, CYTOPLASMIC 2, HEAVY CHAIN 1; DYNC2H1	79659
MIM603298		6p21.3	PALMITOYL-PROTEIN THIOESTERASE 2; PPT2	9374
MIM603300		14q32	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 2; TNFAIP2	7127
MIM603301		2p25	KRUPPEL-LIKE FACTOR 11; KLF11	8462
MIM603302		16p13.3	ADENYLATE CYCLASE 9; ADCY9	115
MIM603303		Chr.8	TRF1-INTERACTING, ANKYRIN-RELATED ADP-RIBOSE POLYMERASE; TNKS	8658
MIM603304		3p25.3	INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 2; IRAK2	3656
MIM603305		1q32-q41	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 1; KCNH1	3756
MIM603306		6q23-q24	TRANSCRIPTION FACTOR 21; TCF21	6943
MIM603307		20p12.1-p11.23	BEADED FILAMENT STRUCTURAL PROTEIN 1; BFSP1	631
MIM603308		9q22.2	CATHEPSIN L2; CTSL2	1515
MIM603309		 	CYCLIN-DEPENDENT KINASE 13; CDK13	8621
MIM603310		4q26	PHOSPHODIESTERASE 5A; PDE5A	8654
MIM603311		1p22	CELL DIVISION CYCLE 7, S. CEREVISIAE, HOMOLOG-LIKE 1; CDC7L1	8317
MIM603312		Chr.11	BUTYROBETAINE-GAMMA,2-OXOGLUTARATE DIOXYGENASE 1; BBOX1	8424
MIM603313		12p11.1	ALG10, S. CEREVISIAE, HOMOLOG OF; ALG10	84920
MIM603314		19q13.43	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 5; SLC27A5	10998
MIM603315		9q34	FREQUENIN, DROSOPHILA, HOMOLOG OF; FREQ	23413
MIM603316		12p12.1	CYTIDINE 5-PRIME-MONOPHOSPHATE N-ACETYLNEURAMINIC ACID SYNTHETASE; CMAS	55907
MIM603317		12q21.2	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, Q; PTPRQ	374462
MIM603319		1q21	ANNEXIN A9; ANXA9	8416
MIM603320		1p36.3	MATRIX METALLOPROTEINASE 23A; MMP23A	8511
MIM603321		1p36.3	MATRIX METALLOPROTEINASE 23B; MMP23B	8510
MIM603322		 	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 6; NDUFB6	4712
MIM603323	C1864028	 	MUSCULAR DYSTROPHY, CONGENITAL, WITH CEREBELLAR ATROPHY	 
MIM603324		1p35.1	GAP JUNCTION PROTEIN, BETA-3; GJB3	2707
MIM603325		 	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 9B; PPP1R9B	84687
MIM603326		20q13.3	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3D; PPP1R3D	5509
MIM603327		19p13.3	RAN-BINDING PROTEIN 3; RANBP3	8498
MIM603328		12q24.1-q24.31	MUSASHI, DROSOPHILA, HOMOLOG OF, 1; MSI1	4440
MIM603329		 	PIRIN; PIR	8544
MIM603330		17p12	DYNEIN, AXONEMAL, HEAVY CHAIN 9; DNAH9	1770
MIM603331		2q31.1	DYNEIN, CYTOPLASMIC 1, INTERMEDIATE CHAIN 2; DYNC1I2	1781
MIM603332		3p21.3	DYNEIN, AXONEMAL, HEAVY CHAIN 1; DNAH1	25981
MIM603333		17p13	DYNEIN, AXONEMAL, HEAVY CHAIN 2; DNAH2	146754
MIM603334		16p12	DYNEIN, AXONEMAL, HEAVY CHAIN 3; DNAH3	55567
MIM603335		5p15-p14	DYNEIN, AXONEMAL, HEAVY CHAIN 5; DNAH5	1767
MIM603336		2p11.2	DYNEIN, AXONEMAL, HEAVY CHAIN 6; DNAH6	1768
MIM603337		6p21	DYNEIN, AXONEMAL, HEAVY CHAIN 8; DNAH8	1769
MIM603339		7p21	DYNEIN, AXONEMAL, HEAVY CHAIN 11; DNAH11	8701
MIM603340		3p21.1	DYNEIN, AXONEMAL, HEAVY CHAIN 12; DNAH12	201625
MIM603341		1q42	DYNEIN, AXONEMAL, HEAVY CHAIN 14; DNAH14	127602
MIM603342	C1864010	11q14-q21	SCHIZOPHRENIA 2; SCZD2	6378
MIM603343		 	RNA EXPORT 1, S. POMBE, HOMOLOG OF; RAE1	8480
MIM603344		 	USO1 VESICLE DOCKING PROTEIN, S. CEREVISIAE, HOMOLOG OF; USO1	8615
MIM603345		4q21	SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 4; SLC4A4	8671
MIM603346		19q13.2-q13.3	NEURONAL PAS DOMAIN PROTEIN 1; NPAS1	4861
MIM603347		2q13	NEURONAL PAS DOMAIN PROTEIN 2; NPAS2	4862
MIM603348		14q21-q24	HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; HIF1A	3091
MIM603349		2p21-p16	ENDOTHELIAL PAS DOMAIN PROTEIN 1; EPAS1	2034
MIM603350		12q24.2	2-PRIME,5-PRIME-@OLIGOADENYLATE SYNTHETASE 2; OAS2	4939
MIM603351		12q24.2	2-PRIME,5-PRIME-@OLIGOADENYLATE SYNTHETASE 3; OAS3	4940
MIM603352		17q25	BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 5; BIRC5	332
MIM603353		3p22	SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 7; SLC4A7	9497
MIM603354		7q36	GASTRULATION BRAIN HOMEOBOX 1; GBX1	2636
MIM603355		16q24	MEMBRANE-BOUND TRANSCRIPTION FACTOR PROTEASE, SITE 1; MBTPS1	8720
MIM603356		6q21	CD164 ANTIGEN; CD164	8763
MIM603357		19q21.3	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 7; SERPINB7	8710
MIM603358	C1864002	2q33	GRACILE SYNDROME	617
MIM603359		9q33.2-q34.11	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 8; NDUFA8	4702
MIM603360		11p12-p11.2	PEROXISOME BIOGENESIS FACTOR 16; PEX16	9409
MIM603361		20q13	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 6B; TNFRSF6B	8771
MIM603362		15q24	SH3 DOMAIN, GRB2-LIKE, 3; SH3GL3	6457
MIM603363		3p12-p11.1	CGG-BINDING PROTEIN 1; CGGBP1	8545
MIM603364		6p21	SPLICING FACTOR, SERINE/ARGININE-RICH, 3; SRSF3	6428
MIM603365		 	HIRA-INTERACTING PROTEIN 3; HIRIP3	8479
MIM603366		1p36.3	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 25; TNFRSF25	8718
MIM603368		7q21-q22	CYCLIN-DEPENDENT KINASE 6; CDK6	1021
MIM603369		1p32	CYCLIN-DEPENDENT KINASE INHIBITOR 2C; CDKN2C	1031
MIM603370		4p15.1	UDP-GLUCOSE DEHYDROGENASE; UGDH	7358
MIM603371		9q34	GLE1, S. CEREVISIAE, HOMOLOG-LIKE; GLE1L	2733
MIM603372		14q31	THYROID-STIMULATING HORMONE RECEPTOR; TSHR	7253
MIM603373	C1863959	14q31	HYPERTHYROIDISM, FAMILIAL GESTATIONAL	7253
MIM603375		4q31.1-q31.2	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 5; SMARCA5	8467
MIM603376	C1863958	 	LONG CHAIN FATTY ACIDS, DEFECT IN TRANSPORT OF	 
MIM603377		5q31.1	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 5; SLC22A5	6584
MIM603378		 	SIN3-ASSOCIATED POLYPEPTIDE, 30-KD; SAP30	8819
MIM603379		15q26	IQ MOTIF-CONTAINING GTPase-ACTIVATING PROTEIN 1; IQGAP1	8826
MIM603380		 	LIN7, C. ELEGANS, HOMOLOG OF, A; LIN7A	8825
MIM603381		3p14.3	FILAMIN B; FLNB	2317
MIM603382		 	MutS, E. COLI, HOMOLOG OF, 5; MSH5	4439
MIM603383	C1863926	7q35-q36	GLAUCOMA 1, OPEN ANGLE, F; GLC1F	2726
MIM603384		6p21.3	SYNAPTIC RAS-GTPase-ACTIVATING PROTEIN 1; SYNGAP1	8831
MIM603385		16q22	NEDD8-ACTIVATING ENZYME E1, SUBUNIT 1; NAE1	8883
MIM603386	C1863925	19p13.2	THYROID CARCINOMA, NONMEDULLARY, WITH OR WITHOUT CELL OXYPHILIA	50975
MIM603387	C1863924	 	MEGALENCEPHALY POLYMICROGYRIA-POLYDACTYLY HYDROCEPHALUS SYNDROME; MPPH	 
MIM603388	C1863923	20q13.11	GRAVES DISEASE, SUSCEPTIBILITY TO, 2	50976
MIM603389	C1863922	 	OSEBOLD SKELETAL DYSPLASIA/OSTEOLYSIS SYNDROME	 
MIM603390		5q13	PHOSPHODIESTERASE 8B; PDE8B	8622
MIM603392		22q13.3	BCL2-INTERACTING KILLER; BIK	638
MIM603393	C1863920	 	OSTEOSCLEROTIC CHONDRODYSPLASIA, LETHAL, WITH INTRACELLULAR INCLUSIONS	 
MIM603394	C1863919	 	MICROCEPHALY, SEVERE, WITH SKELETAL ANOMALIES INCLUDING POSTERIOR RIB-GAP DEFECTS	 
MIM603395		8q22	SPERM-ASSOCIATED ANTIGEN 1; SPAG1	6674
MIM603396	C1863918	 	TONOKI SYNDROME	 
MIM603397		 	ZINC FINGER PROTEIN 282; ZNF282	8427
MIM603398		8q24.1-q24.3	WNT1-INDUCIBLE SIGNALING PATHWAY PROTEIN 1; WISP1	8840
MIM603399		20q12-q13	WNT1-INDUCIBLE SIGNALING PATHWAY PROTEIN 2; WISP2	8839
MIM603400		6q22-q23	WNT1-INDUCIBLE SIGNALING PATHWAY PROTEIN 3; WISP3	8838
MIM603401		5q14.1	ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-1 SUBUNIT; AP3B1	8546
MIM603402		4p15.3	ACYL-CoA OXIDASE 3, PRISTANOYL; ACOX3	8310
MIM603403		4p15.3	DEAH BOX POLYPEPTIDE 15; DHX15	1665
MIM603404		9q22.3	ZINC FINGER PROTEIN 169; ZNF169	169841
MIM603405		6p21.3	DEAH BOX POLYPEPTIDE 16; DHX16	8449
MIM603406		7q32-q34	TRIPARTITE MOTIF-CONTAINING PROTEIN 24; TRIM24	8805
MIM603407		1p36-p32	POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 4; PABPC4	8761
MIM603408		7q21	FRIZZLED, DROSOPHILA, HOMOLOG OF, 1; FZD1	8321
MIM603409		8q22.3-q23.1	FRIZZLED, DROSOPHILA, HOMOLOG OF, 6; FZD6	8323
MIM603410		2q33	FRIZZLED, DROSOPHILA, HOMOLOG OF, 7; FZD7	8324
MIM603412		1q41-q42	CDC42-BINDING PROTEIN KINASE, ALPHA; CDC42BPA	8476
MIM603413		10q	TIA1 CYTOTOXIC GRANULE-ASSOCIATED RNA-BINDING PROTEIN-LIKE 1; TIAL1	7073
MIM603414		11q13	TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 2; TM7SF2	7108
MIM603415		2q24	SODIUM CHANNEL, VOLTAGE-GATED, TYPE IX, ALPHA SUBUNIT; SCN9A	6335
MIM603417		1q32-q41	RAB-INTERACTING FACTOR; RABIF	5877
MIM603418		 	ALDO-KETO REDUCTASE FAMILY 7, MEMBER A2; AKR7A2	8574
MIM603419		19p13	SMALL GLUTAMINE-RICH TETRATRICOPEPTIDE REPEAT-CONTAINING PROTEIN, ALPHA; SGTA	6449
MIM603420		7q32	CALUMENIN; CALU	813
MIM603421		9q31	TRANSMEMBRANE PROTEIN WITH EGF-LIKE AND 2 FOLLISTATIN-LIKE DOMAINS 1; TMEFF1	8577
MIM603422		5q31.1	PDZ AND LIM DOMAIN PROTEIN 4; PDLIM4	8572
MIM603423		6q21-q22.1	PR DOMAIN-CONTAINING PROTEIN 1; PRDM1	639
MIM603424		2q31.3	PROTEIN KINASE, INTERFERON-INDUCIBLE DOUBLE-STRANDED RNA-DEPENDENT ACTIVATOR; PRKRA	8575
MIM603425		 	ADP-RIBOSYLATION FACTOR-LIKE 1; ARL1	400
MIM603426		2q37.3	PERIOD, DROSOPHILA, HOMOLOG OF, 2; PER2	8864
MIM603427		 	PERIOD, DROSOPHILA, HOMOLOG OF, 3; PER3	8863
MIM603428		17q11.2	ZINC FINGER PROTEIN 207; ZNF207	7756
MIM603429		6p21.33	ATP-BINDING CASSETTE, SUBFAMILY F, MEMBER 1; ABCF1	23
MIM603430		11q23.3	ZINC FINGER PROTEIN 202; ZNF202	7753
MIM603431		7q11.23	EUKARYOTIC TRANSLATION INITIATION FACTOR 4H; EIF4H	7458
MIM603432		7q11.23	CAP-GLY DOMAIN-CONTAINING LINKER PROTEIN 2; CLIP2	7461
MIM603433		11p15.4-p15.3	ZINC FINGER PROTEIN 143; ZNF143	7702
MIM603434		1q21.1	PHOSPHOPROTEIN ENRICHED IN ASTROCYTES, 15-KD; PEA15	8682
MIM603435		 	GLUTATHIONE PEROXIDASE 5; GPX5	2880
MIM603436		16p13.3	ZINC FINGER PROTEIN 205; ZNF205	7755
MIM603437		12p13.1	COLD-SHOCK DOMAIN PROTEIN A; CSDA	8531
MIM603438	C1863881	 	RADIOULNAR SYNOSTOSIS WITH MICROCEPHALY, SHORT STATURE, SCOLIOSIS, AND MENTAL RETARDATION	 
MIM603439	C1863880	 	EXPANSILE BONE LESIONS	 
MIM603440		 	PCTAIRE PROTEIN KINASE 2; PCTK2	5128
MIM603441		 	CYCLIN-DEPENDENT KINASE-LIKE 1; CDKL1	8814
MIM603442		 	CYCLIN-DEPENDENT KINASE-LIKE 2; CDKL2	8999
MIM603443		6p21.3	SUPPRESSOR OF ACTIN MUTATIONS 2, S. CEREVISIAE, HOMOLOG-LIKE; SACM2L	6293
MIM603444		1p31.1	FAR UPSTREAM ELEMENT-BINDING PROTEIN 1; FUBP1	8880
MIM603445		19p13.3	KH-TYPE SPLICING REGULATORY PROTEIN; KHSRP	8570
MIM603446	C1863879	 	OROACRAL SYNDROME, VERLOES-KOULISCHER TYPE	 
MIM603447		 	HARAKIRI; HRK	8739
MIM603448		1p32-p31	DISABLED, DROSOPHILA, HOMOLOG OF, 1; DAB1	1600
MIM603449		3q21	RUVB, E. COLI, HOMOLOG-LIKE 1; RUVBL1	8607
MIM603450		4p15	LIM DOMAIN-BINDING 2; LDB2	9079
MIM603451		10q24-q25	LIM DOMAIN-BINDING 1; LDB1	8861
MIM603453		 	RECEPTOR-INTERACTING SERINE/THREONINE KINASE 1; RIPK1	8737
MIM603454		12q21.33-q23.1	CASP2 AND RIPK1 DOMAIN-CONTAINING ADAPTOR WITH DEATH DOMAIN; CRADD	8738
MIM603455		 	RECEPTOR-INTERACTING SERINE/THREONINE KINASE 2; RIPK2	8767
MIM603456		1p34	DPH2, S. CEREVISIAE, HOMOLOG OF; DPH2	1802
MIM603457	C1863878	 	ARHINIA, CHOANAL ATRESIA, AND MICROPHTHALMIA	 
MIM603458		19p13.2	EMBRYONIC LETHAL, ABNORMAL VISION, DROSOPHILA, HOMOLOG-LIKE 3; ELAVL3	1995
MIM603460		 	CYCLIN-DEPENDENT KINASE 5, REGULATORY SUBUNIT 1; CDK5R1	8851
MIM603461		 	CELL DIVISION CYCLE 16, S. CEREVISIAE, HOMOLOG OF; CDC16	8881
MIM603462		5q31.1	CELL DIVISION CYCLE 23; CDC23	8697
MIM603463	C1863870	 	HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARING LOSS	 
MIM603464		16q24	CYCLIN-DEPENDENT KINASE 10; CDK10	8558
MIM603465		22q11.2	CELL DIVISION CYCLE 45, S. CEREVISIAE, HOMOLOG-LIKE; CDC45L	8318
MIM603466		19p13.2	EMBRYONIC LETHAL, ABNORMAL VISION, DROSOPHILA, HOMOLOG-LIKE 1; ELAVL1	1994
MIM603467	CN068975	11p15	FANCONI ANEMIA, COMPLEMENTATION GROUP F; FANCF	2188
MIM603470		9q34.1	ARGININOSUCCINATE SYNTHETASE 1; ASS1	445
MIM603471	C1863844	7q21.3	CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2	10165
MIM603473		 	LARGE TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 1; LATS1	9113
MIM603474		19q13.2	RIBOSOMAL PROTEIN S19; RPS19	6223
MIM603475		3q27	CHORDIN; CHRD	8646
MIM603476		12p13	cAMP RESPONSE ELEMENT-BINDING PROTEIN-LIKE 2; CREBL2	1389
MIM603477		 	G10 MATERNAL TRANSCRIPT, XENOPUS, HOMOLOG OF	8896
MIM603478		1p32.1-p31.3	UBIQUITIN-SPECIFIC PROTEASE 1; USP1	7398
MIM603479		9q22.3	EXTRACELLULAR MATRIX PROTEIN 2; ECM2	1842
MIM603481		 	PROTEASOME 26S SUBUNIT, NON-ATPase, 13; PSMD13	5719
MIM603482		10q24-q25	BETA-TRANSDUCIN REPEAT-CONTAINING PROTEIN; BTRC	8945
MIM603483		 	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 3; EIF4EBP3	8637
MIM603484		15q26.1	PROTEIN REGULATING CYTOKINESIS 1; PRC1	9055
MIM603485		20pter-p12.3	NITROGEN FIXATION GENE 1; NFS1	9054
MIM603486		3p21.31	UBIQUITIN-SPECIFIC PROTEASE 4; USP4	7375
MIM603487		17p13.1-p12	MYOSIN, SKELETAL MUSCLE, HEAVY CHAIN 13; MYH13	8735
MIM603488		 	ANGIO-ASSOCIATED MIGRATORY CELL PROTEIN; AAMP	14
MIM603489		15q22	CARTILAGE INTERMEDIATE LAYER PROTEIN; CILP	8483
MIM603490		1p35	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 4; WNT4	54361
MIM603491		1p13	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 3; IGSF3	3321
MIM603492		1q22-q23	SLAM FAMILY, MEMBER 1; SLAMF1	6504
MIM603493		6p21	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 5; KCNK5	8645
MIM603494		19q12	NNX3 PROTEIN	8725
MIM603495		19q13.43	AURORA KINASE C; AURKC	6795
MIM603496		12q14	DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 2; DYRK2	8445
MIM603497		1q32.2	DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 3; DYRK3	8444
MIM603498		 	SPHINGOMYELIN PHOSPHODIESTERASE 2, NEUTRAL MEMBRANE; SMPD2	6610
MIM603499		18q22.1	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 11A; TNFRSF11A	8792
MIM603500		16q22	TUMOR NECROSIS FACTOR RECEPTOR 1-ASSOCIATED DEATH DOMAIN PROTEIN; TRADD	8717
MIM603501		10q11.23	POLY(ADP-RIBOSE) GLYCOHYDROLASE; PARG	8505
MIM603502		7q22-q31	INTERFERON-RELATED DEVELOPMENTAL REGULATOR 1; IFRD1	3475
MIM603503		20q13.13	DOLICHYL-PHOSPHATE MANNOSYLTRANSFERASE 1, CATALYTIC SUBUNIT; DPM1	8813
MIM603504		1p21	CELL DIVISION CYCLE 14, S. CEREVISIAE, HOMOLOG A; CDC14A	8556
MIM603505		Chr.9	CELL DIVISION CYCLE 14, S. CEREVISIAE, HOMOLOG B; CDC14B	8555
MIM603506		11q13.4	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 5; LRP5	4041
MIM603507		12p13.3-p11.2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6; LRP6	4040
MIM603508		 	MYOMESIN 1; MYOM1	8736
MIM603509		8p23.3	MYOMESIN 2; MYOM2	9172
MIM603510		 	INSULIN RECEPTOR SUBSTRATE 4; IRS4	8471
MIM603511	C3148763	7q	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E; LGMD1E	10049, 9186
MIM603512		6q16	RNA GUANYLYLTRANSFERASE AND 5-PRIME-PHOSPHATASE; RNGTT	8732
MIM603513	C2751938	2q31	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 1; CPSQ1	2571
MIM603514		18p11.23-p11.22	RNA GUANINE-7-METHYLTRANSFERASE; RNMT	8731
MIM603515		17q22-q24	CHORIONIC SOMATOMAMMOTROPIN HORMONE-LIKE 1; CSHL1	1444
MIM603516	C1963674	22q13	SPINOCEREBELLAR ATAXIA 10; SCA10	25814
MIM603517		1p22	B-CELL CLL/LYMPHOMA 10; BCL10	8915
MIM603518		2p13	TIA1 CYTOTOXIC GRANULE-ASSOCIATED RNA-BINDING PROTEIN; TIA1	7072
MIM603519		10q23	SURVIVAL OF MOTOR NEURON-RELATED PROTEIN	10285
MIM603520		 	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE B-DOUBLE PRIME; SNRPB2	6629
MIM603521		15q26.3	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE A-PRIME; SNRPA1	6627
MIM603522		6p21.31	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE C; SNRPC	6631
MIM603523	C0340014	 	CHYLOTHORAX, CONGENITAL	 
MIM603524		13q14.3	RCC1 DOMAIN- AND BTB DOMAIN-CONTAINING PROTEIN 2; RCBTB2	1102
MIM603525		2q23.3	NMYC INTERACTOR; NMI	9111
MIM603526		14q32.3	METASTASIS-ASSOCIATED GENE 1; MTA1	9112
MIM603527		17p13.3	DPH1, S. CEREVISIAE, HOMOLOG OF; DPH1	1801
MIM603528		16q23-q24	DEHYDRATED HEREDITARY STOMATOCYTOSIS, PSEUDOHYPERKALEMIA, AND PERINATAL EDEMA	 
MIM603529	C1863768	 	DYSERYTHROPOIESIS, CONGENITAL, WITH INTERNUCLEAR CHROMATIN BRIDGES AND ULTRASTRUCTURALLY NORMAL ERYTHROBLAST HETEROCHROMATIN	 
MIM603530	C1863767	 	LIGHT FIXATION SEIZURE SYNDROME	 
MIM603531		7q22.1	ADAPTOR-RELATED PROTEIN COMPLEX 1, SIGMA-1 SUBUNIT; AP1S1	1174
MIM603533		16q23	ADAPTOR-RELATED PROTEIN COMPLEX 1, GAMMA-1 SUBUNIT; AP1G1	164
MIM603534		 	ADAPTOR-RELATED PROTEIN COMPLEX 1, GAMMA-2 SUBUNIT; AP1G2	8906
MIM603535		19p13.12	ADAPTOR-RELATED PROTEIN COMPLEX 1, MU-1 SUBUNIT; AP1M1	8907
MIM603536		 	FAR UPSTREAM ELEMENT-BINDING PROTEIN 3; FUBP3	8939
MIM603537		1p34	POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 4; KCNQ4	9132
MIM603538		1q43	KYNURENINE 3-MONOOXYGENASE; KMO	8564
MIM603539		11q13.1	CATHEPSIN F; CTSF	8722
MIM603540		 	GAMMA-AMINOBUTYRIC ACID B RECEPTOR 1; GABBR1	2550
MIM603541		 	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE F; SNRPF	6636
MIM603542		 	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE G; SNRPG	6637
MIM603543	C1863753	3q27	LIMB-MAMMARY SYNDROME; LMS	8626
MIM603544		14q32	CYCLIN K; CCNK	8812
MIM603546	C1863732	 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY TYPE 2; SEMDJL2	3835
MIM603547		18q21	METHYL-CpG-BINDING DOMAIN PROTEIN 2; MBD2	8932
MIM603548		4q21	CDP-DIACYLGLYCEROL SYNTHASE 1; CDS1	1040
MIM603549		20p13	CDP-DIACYLGLYCEROL SYNTHASE 2; CDS2	8760
MIM603550		6q23	EYES ABSENT 4; EYA4	2070
MIM603551		3p21.3	HYALURONOGLUCOSAMINIDASE 2; HYAL2	8692
MIM603552	C1863728	6q24	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4; FHL4	8676
MIM603553	C1863727	10q22	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2; FHL2	5551
MIM603554	C1801959	11p13, 11p13, 10p	OMENN SYNDROME	5896, 5897, 64421
MIM603555		 	SUPPRESSOR OF TY 4, S. CEREVISIAE, HOMOLOG OF, 1; SUPT4H1	6827
MIM603557		11q22	MYOTUBULARIN-RELATED PROTEIN 2; MTMR2	8898
MIM603558		22q12	MYOTUBULARIN-RELATED PROTEIN 3; MTMR3	8897
MIM603559		Chr.17	MYOTUBULARIN-RELATED PROTEIN 4; MTMR4	9110
MIM603560		22qter	SET-BINDING FACTOR 1; SBF1	6305
MIM603561		13q12	MYOTUBULARIN-RELATED PROTEIN 6; MTMR6	9107
MIM603562		8p22	MYOTUBULARIN-RELATED PROTEIN 7; MTMR7	9108
MIM603563	C1863704	8q24.13	SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT; SPG8	9897
MIM603564		 	DOLICHYL-PHOSPHATE MANNOSYLTRANSFERASE 2, REGULATORY SUBUNIT; DPM2	8818
MIM603565		12q21.3-q22	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 4; GALNT4	8693
MIM603566		15q22	PROTEIN INHIBITOR OF ACTIVATED STAT1; PIAS1	8554
MIM603567		 	PROTEIN INHIBITOR OF ACTIVATED STAT2; PIAS2	9063
MIM603568		 	RNA, U73 SMALL NUCLEOLAR; RNU73	8944
MIM603569	C1863703	 	TRACHEOBRONCHIAL STENOSIS, CONGENITAL	 
MIM603570		6q23-q24	VANIN 1; VNN1	8876
MIM603571		6q23-q24	VANIN 2; VNN2	8875
MIM603572	C1863702	 	MICROCEPHALY, FACIAL ABNORMALITIES, MICROMELIA, AND MENTAL RETARDATION	 
MIM603573		19p13.3	METHYL-CpG-BINDING DOMAIN PROTEIN 3; MBD3	53615
MIM603574		3q21-q22	METHYL-CpG-BINDING DOMAIN PROTEIN 4; MBD4	8930
MIM603575		5q23-q31	NONMETASTATIC CELLS 5, PROTEIN EXPRESSED IN; NME5	8382
MIM603576		15q13-q14	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 1; TRPM1	4308
MIM603577		 	NUCLEOLAR PROTEIN 4; NOL4	8715
MIM603578		 	OVIDUCTAL GLYCOPROTEIN 1; OVGP1	5016
MIM603579		18q11.2	SUDD, ASPERGILLUS NIDULANS, HOMOLOG OF; SUDD	8780
MIM603580		13q14.3	PROTOCADHERIN 8; PCDH8	5100
MIM603581		13q21.1	PROTOCADHERIN 9; PCDH9	5101
MIM603582		22q11	TOPOISOMERASE, DNA, III, BETA; TOP3B	8940
MIM603583		11q21	DISCS LARGE, DROSOPHILA, HOMOLOG OF, 2; DLG2	1740
MIM603584		11p11.2	MAP KINASE-ACTIVATING DEATH DOMAIN; MADD	8567
MIM603585	C1970344	6q15	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	10559
MIM603587	C1863692	 	FOLLICULAR ATROPHODERMA, PERIORAL PIGMENTED, WITH MILIA AND EPIDERMOID CYSTS	 
MIM603588	C1863691	 	PAROTITIS, JUVENILE RECURRENT	 
MIM603589	C1970343	 	FACIAL DYSMORPHISM, SELECTIVE TOOTH AGENESIS, AND CHOROID CALCIFICATION	 
MIM603590		22q12.3-q13.1	ACETYLGLUCOSAMINYLTRANSFERASE-LIKE PROTEIN; LARGE	9215
MIM603591		3q26.2-q26.3	UBIQUITIN-SPECIFIC PROTEASE 13; USP13	8975
MIM603593		14q11.2	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 7; SLC7A7	9056
MIM603594		1q25	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 4; TNFSF4	7292
MIM603595	C1863678	 	CRANIOSYNOSTOSIS WITH ECTOPIA LENTIS	 
MIM603596	C0152427	 	POLYDACTYLY	 
MIM603597		16p13.2	SUPPRESSOR OF CYTOKINE SIGNALING 1; SOCS1	8651
MIM603598		3q26	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 10; TNFSF10	8743
MIM603599		2q33	CASP8- AND FADD-LIKE APOPTOSIS REGULATOR; CFLAR	8837
MIM603600	C1863677	 	OSTEOMA OF CRANIAL VAULT, FAMILIAL	 
MIM603601		 	PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 2, ALPHA; PIK3C2A	5286
MIM603602		19q13.3	PHOSPHOLIPASE A2, GROUP IVC; PLA2G4C	8605
MIM603603		16p13.1-p12	PHOSPHOLIPASE A2, GROUP X; PLA2G10	8399
MIM603604		22q13.1	PHOSPHOLIPASE A2, GROUP VI; PLA2G6	8398
MIM603605		4q24	AMINOACYL-tRNA SYNTHETASE COMPLEX-INTERACTING MULTIFUNCTIONAL PROTEIN 1; AIMP1	9255
MIM603606		 	RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 4; RPS6KA4	8986
MIM603607		14q31-q32	RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 5; RPS6KA5	9252
MIM603608		21q22.2	CARBONYL REDUCTASE 3; CBR3	874
MIM603609		 	FUCOSE-1-PHOSPHATE GUANYLYLTRANSFERASE; FPGT	8790
MIM603610		4q21-q23	UNC5, C. ELEGANS, HOMOLOG OF, C; UNC5C	8633
MIM603611		8p21	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10A; TNFRSF10A	8797
MIM603612		8p22-p21	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10B; TNFRSF10B	8795
MIM603613		8p22-p21	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10C; TNFRSF10C	8794
MIM603614		8p21	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10D; TNFRSF10D	8793
MIM603615		1p32	RAD54, S. CEREVISIAE, HOMOLOG-LIKE; RAD54L	8438
MIM603616		17p13	RAB GTPase-BINDING EFFECTOR PROTEIN 1; RABEP1	9135
MIM603617		15q22	SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 1; SLC24A1	9187
MIM603618		1p34.2-p33	CELL DIVISION CYCLE 20, S. CEREVISIAE, HOMOLOG OF; CDC20	991
MIM603619		19p13.3	FIZZY-RELATED PROTEIN, DROSOPHILA, HOMOLOG OF, 1; FZR1	51343
MIM603620		9p22.2	PC4- AND SFRS1-INTERACTING PROTEIN 1; PSIP1	11168
MIM603621		8q24.3	FORKHEAD BOX H1; FOXH1	8928
MIM603622	C1863659	22q11.2	DEAFNESS, AUTOSOMAL DOMINANT 17; DFNA17	4627
MIM603623		1p35	TYROSYL-tRNA SYNTHETASE; YARS	8565
MIM603624		16p13.3	RIBOSOMAL PROTEIN S2; RPS2	6187
MIM603625		8q24.3	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS H; LY6H	4062
MIM603626		5q32-q33	PROTOCADHERIN 1; PCDH1	5097
MIM603627		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY C, MEMBER 3; PCDHGC3	5098
MIM603628		 	MUSCULIN; MSC	9242
MIM603629	C1863655	11q22-q24	DEAFNESS, AUTOSOMAL RECESSIVE 21; DFNB21	7007
MIM603630		19q13.4	RIBOSOMAL PROTEIN S5; RPS5	6193
MIM603631		19q13.4	RIBOSOMAL PROTEIN S9; RPS9	6203
MIM603632		6p	RIBOSOMAL PROTEIN S10; RPS10	6204
MIM603633		14q	RIBOSOMAL PROTEIN S29; RPS29	6235
MIM603634		1p22.1	RIBOSOMAL PROTEIN L5; RPL5	6125
MIM603635		 	RNA, U21 SMALL NUCLEOLAR; RNU21	6083
MIM603636		13q	RIBOSOMAL PROTEIN L21; RPL21	6144
MIM603637		11p15	RIBOSOMAL PROTEIN L27a; RPL27A	6157
MIM603638		19q13.4	RIBOSOMAL PROTEIN L28; RPL28	6158
MIM603639		2p25	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 17; ADAM17	6868
MIM603640		5q32-q33	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 19; ADAM19	8728
MIM603641	C1863649	 	NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	 
MIM603642	C1863648	 	ATRIAL SEPTAL DEFECT, SECUNDUM, WITH VARIOUS CARDIAC AND NONCARDIAC DEFECTS	 
MIM603643	C1863647	 	SITUS INVERSUS TOTALIS WITH CYSTIC DYSPLASIA OF KIDNEYS AND PANCREAS	 
MIM603644	CN068958	17p13-p12	SCO1, S. CEREVISIAE, HOMOLOG OF; SCO1	6341
MIM603645		4q27-q28	PET112, S. CEREVISIAE, HOMOLOG-LIKE; PET112L	5188
MIM603646		10q24	CYTOCHROME c OXIDASE ASSEMBLY PROTEIN COX15; COX15	1355
MIM603647		2q33	BCS1, S. CEREVISIAE, HOMOLOG-LIKE; BCS1L	617
MIM603648		17q22	CYTOCHROME c OXIDASE ASSEMBLY PROTEIN COX11; COX11	1353
MIM603649	C1863634	6q12-q13	CONE-ROD DYSTROPHY 7; CORD7	22999
MIM603650		2q31	BBS5 GENE; BBS5	129880
MIM603651		13q13.1-q13.2	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 4; TRPC4	7223
MIM603652		11q21-q22	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 6; TRPC6	7225
MIM603654		12q13	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 7; SLC16A7	9194
MIM603656	C1863622	 	EXOSTOSIS, DUPUYTREN SUBUNGUAL	 
MIM603657		1p36	VESICLE-ASSOCIATED MEMBRANE PROTEIN 3; VAMP3	9341
MIM603658		2p25	RIBOSOMAL PROTEIN S7; RPS7	6201
MIM603659		17p13.3	GLUCAGON-LIKE PEPTIDE 2 RECEPTOR; GLP2R	9340
MIM603660		6q	RIBOSOMAL PROTEIN S12; RPS12	6206
MIM603661		18q	RIBOSOMAL PROTEIN L17; RPL17	6139
MIM603662		17q	RIBOSOMAL PROTEIN L23; RPL23	9349
MIM603663	C1863621	4p	MENTAL HEALTH WELLNESS 1	10386
MIM603664	C1863620	4q	MENTAL HEALTH WELLNESS 2	50979
MIM603665		 	STANNIOCALCIN 2; STC2	8614
MIM603666		20q13.32	SYNTAXIN 16; STX16	8675
MIM603667		2q24	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ARALAR), MEMBER 12; SLC25A12	8604
MIM603668		12q12-q13.11	SR-RELATED C-TERMINAL DOMAIN-ASSOCIATED FACTOR 11; SCAF11	9169
MIM603669	C1863618	 	ECCRINE SYRINGOFIBROADENOMATOSIS WITH EYELID ABNORMALITIES	 
MIM603670	C1863617	 	BLUE NEVI, FAMILIAL MULTIPLE	 
MIM603671	C1863616	 	ACROMELIC FRONTONASAL DYSOSTOSIS	 
MIM603672		20q11.2	CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2, TRANSLOCATED TO, 2; CBFA2T2	9139
MIM603673		1p32	PATCHED, DROSOPHILA, HOMOLOG OF, 2; PTCH2	8643
MIM603674		16p	RIBOSOMAL PROTEIN S15a; RPS15A	6210
MIM603675		19q	RIBOSOMAL PROTEIN S16; RPS16	6217
MIM603678	C1863613	7q31	DEAFNESS, AUTOSOMAL RECESSIVE 14; DFNB14	1706
MIM603679		 	UBIQUITIN-CONJUGATING ENZYME E2N; UBE2N	7334
MIM603680		13q21	ATAXIN 8 OPPOSITE STRAND; ATXN8OS	6315
MIM603681		2p23-p22	OTOFERLIN; OTOF	9381
MIM603682		8q	RIBOSOMAL PROTEIN S20; RPS20	6224
MIM603683		5q	RIBOSOMAL PROTEIN S23; RPS23	6228
MIM603684		18q21.1	LIPASE, ENDOTHELIAL; LIPG	9388
MIM603685		19p13.2	RIBOSOMAL PROTEIN S28; RPS28	6234
MIM603686		4p13	RIBOSOMAL PROTEIN L9; RPL9	6133
MIM603687		Chr.15	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A2; ALDH1A2	8854
MIM603688	C1863600	1p36.1-p35	PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY	2048
MIM603689	C1863599	2q31	HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE; HMERF	7273
MIM603690		3q25.31	SOLUTE CARRIER FAMILY 33 (ACETYL-CoA TRANSPORTER), MEMBER 1; SLC33A1	9197
MIM603691		17q25.3	GALANIN RECEPTOR 2; GALR2	8811
MIM603692		22q12.2-q13.1	GALANIN RECEPTOR 3; GALR3	8484
MIM603693		8q23	ZINC FINGER PROTEIN, MULTITYPE 2; ZFPM2	23414
MIM603694	C1863594	20q12-q13.1	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 3	50982
MIM603695		13q14.3	GUANYLATE CYCLASE 1, SOLUBLE, BETA-2; GUCY1B2	2974
MIM603696		17q23	SEPTIN 4; SEPT4	5414
MIM603697		 	ARACHIDONATE 15-LIPOXYGENASE, SECOND TYPE; ALOX15B	247
MIM603698		10q24	GOLGI-SPECIFIC BREFELDIN-A RESISTANCE FACTOR 1; GBF1	8729
MIM603699		11q13.5	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 11; WNT11	7481
MIM603700		13q12	ARACHIDONATE 5-LIPOXYGENASE-ACTIVATING PROTEIN; ALOX5AP	241
MIM603701		12q	RIBOSOMAL PROTEIN S26; RPS26	6231
MIM603702		1q21	RIBOSOMAL PROTEIN S27; RPS27	6232
MIM603703		12q	RIBOSOMAL PROTEIN L6; RPL6	6128
MIM603704		17p	RIBOSOMAL PROTEIN L26; RPL26	6154
MIM603705		20p13	ANGIOPOIETIN 4; ANGPT4	51378
MIM603706		2p13	SEMAPHORIN 4F; SEMA4F	10505
MIM603707		6p21.3	MOLYBDENUM COFACTOR SYNTHESIS GENE 1; MOCS1	4337
MIM603708		5q11	MOLYBDENUM COFACTOR SYNTHESIS GENE 2; MOCS2	4338
MIM603709		7q21	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 22; ADAM22	53616
MIM603710		2q33	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 23; ADAM23	8745
MIM603711		8q21.3	CYTOCHROME P450, FAMILY 7, SUBFAMILY B, POLYPEPTIDE 1; CYP7B1	9420
MIM603712		14q24.1	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 20; ADAM20	8748
MIM603713		14q24.1	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 21; ADAM21	8747
MIM603714		2p21	SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 3; SIX3	6496
MIM603715		 	GLIAL CELLS MISSING, DROSOPHILA, HOMOLOG OF, 1; GCM1	8521
MIM603716		6p24.2	GLIAL CELLS MISSING, DROSOPHILA, HOMOLOG OF, 2; GCM2	9247
MIM603717		1p32.3	ATPase, H+ TRANSPORTING, LYSOSOMAL, 21-KD, V0 SUBUNIT C-PRIME, PRIME; ATP6V0B	533
MIM603718		3q28-q29	CLAUDIN 1; CLDN1	9076
MIM603719		10q24-q26	BUDDING UNINHIBITED BY BENZIMIDAZOLES 3, S. CEREVISIAE, HOMOLOG OF; BUB3	9184
MIM603720	C1863561	15q15	DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	161497
MIM603721		22q11.2-q13.1	UBIQUITIN-CONJUGATING ENZYME E2L 3; UBE2L3	7332
MIM603722		9q31	INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE COMPLEX-ASSOCIATED PROTEIN; IKBKAP	8518
MIM603725		 	FIBROBLAST GROWTH FACTOR 17; FGF17	8822
MIM603726		5q34	FIBROBLAST GROWTH FACTOR 18; FGF18	8817
MIM603727		3p21	GLUTAMINYL-tRNA SYNTHETASE; QARS	5859
MIM603728		14q24.3	NUMB, DROSOPHILA, HOMOLOG OF; NUMB	8650
MIM603729		10q21	SPHINGOSINE-1-PHOSPHATE LYASE 1; SGPL1	8879
MIM603730		17q25.2	SPHINGOSINE KINASE 1; SPHK1	8877
MIM603731		5q31-q33	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 8; CNOT8	9337
MIM603732		Chr.11	CRYPTOCHROME 2; CRY2	1408
MIM603733		11p11.2-p11.1	SOLUTE CARRIER FAMILY 43 (L-TYPE AMINO ACID TRANSPORTER), MEMBER 1; SLC43A1	8501
MIM603734		19q13.3-q13.4	INTERFERON REGULATORY FACTOR 3; IRF3	3661
MIM603735		17q21	AMINE OXIDASE, COPPER-CONTAINING, 3; AOC3	8639
MIM603736	C1863557	 	OHDO SYNDROME, SBBYS VARIANT; SBBYSS	23522
MIM603737	C0346180	 	OVARIAN GERM CELL CANCER	 
MIM603738		 	BASIC TRANSCRIPTION FACTOR 3-LIKE 2; BTF3L2	652963
MIM603739		 	BASIC TRANSCRIPTION FACTOR 3-LIKE 3; BTF3L3	132556
MIM603740	C1863556	 	ACRODYSPLASIA WITH OSSIFICATION ABNORMALITIES, SHORT STATURE, AND FIBULAR HYPOPLASIA	 
MIM603741		17p13.1	ARACHIDONATE 12-LIPOXYGENASE, R TYPE; ALOX12B	242
MIM603742		 	SLIT, DROSOPHILA, HOMOLOG OF, 1; SLIT1	6585
MIM603743		22q12.3	APOLIPOPROTEIN L-I; APOL1	8542
MIM603744	C1709457	 	PAPILLARY THYROID MICROCARCINOMA	 
MIM603745		5q35	SLIT, DROSOPHILA, HOMOLOG OF, 3; SLIT3	6586
MIM603746		4p15.2	SLIT, DROSOPHILA, HOMOLOG OF, 2; SLIT2	9353
MIM603747		20q13.2-q13.3	TUMOR PROTEIN D52-LIKE 2; TPD52L2	7165
MIM603749		21q22.3	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 2; TRPM2	7226
MIM603750		16p12-p11.2	AQUAPORIN 8; AQP8	343
MIM603751		19p13.3	SPHINGOSINE 1-PHOSPHATE RECEPTOR 4; S1PR4	8698
MIM603752		22q11.2	SOLUTE CARRIER FAMILY 7 (CARIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 4; SLC7A4	6545
MIM603753		Chr.11	UBIQUITINATION FACTOR E4A; UBE4A	9354
MIM603754		20q11.21	KINESIN FAMILY MEMBER 3B; KIF3B	9371
MIM603755		 	MADH-INTERACTING PROTEIN; MADHIP	9372
MIM603756		4q22	ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 2; ABCG2	9429
MIM603757		17q11.2	CHEMOKINE, CC MOTIF, LIGAND 18; CCL18	6362
MIM603758		14q24.3	GLUTATHIONE S-TRANSFERASE, ZETA-1; GSTZ1	2954
MIM603759		9q33-q34.1	LIM HOMEOBOX GENE 2; LHX2	9355
MIM603760		7p13-p12	HYDROXYUREA-SENSITIVE 1, S. POMBE, HOMOLOG OF; HUS1	3364
MIM603761		11q13.1-q13.2	RAD9, S. POMBE, HOMOLOG OF, A; RAD9A	5883
MIM603762		17p12-p11.2	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE-ASSOCIATED PROTEIN 2; PRPSAP2	5636
MIM603763		6p21.3	KINESIN FAMILY MEMBER C1; KIFC1	3833
MIM603764		2q35	CYCLIN-DEPENDENT KINASE 5, REGULATORY SUBUNIT 2; CDK5R2	8941
MIM603765		 	SYNTAXIN 10; STX10	8677
MIM603766		2p16-p14	MITOCHONDRIAL TRANSLATIONAL INITIATION FACTOR 2; MTIF2	4528
MIM603767		19q13.4	KALLIKREIN-RELATED PEPTIDASE 4; KLK4	9622
MIM603768		1q32.1	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 12B; PPP1R12B	4660
MIM603769		14q32.1	T-CELL LYMPHOMA/LEUKEMIA 1B; TCL1B	9623
MIM603770		2p21	PROTEIN PHOSPHATASE, MAGNESIUM-DEPENDENT, 1B; PPM1B	5495
MIM603771		 	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 10; PPP1R10	5514
MIM603772		7q21.3-q22.1	DYNEIN, CYTOPLASMIC 1, INTERMEDIATE CHAIN 1; DYNC1I1	1780
MIM603773		15q25	CYTOCHROME c OXIDASE, SUBUNIT Va; COX5A	9377
MIM603774		5q14	CYTOCHROME c OXIDASE, SUBUNIT VIIc; COX7C	1350
MIM603775		 	CYCLIN E2; CCNE2	9134
MIM603776	C1863551	1p34.1-p32	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3; HCHOLA3	255738
MIM603777		9p22	CERBERUS 1 HOMOLOG, CYSTINE KNOT SUPERFAMILY; CER1	9350
MIM603778		6p25.1	CHROMODOMAIN PROTEIN ON Y CHROMOSOME-LIKE; CDYL	9425
MIM603779		5q23.1-q23.3	SYNUCLEIN-ALPHA-INTERACTING PROTEIN; SNCAIP	9627
MIM603780		8q24.3	RECQ PROTEIN-LIKE 4; RECQL4	9401
MIM603781		17q25	RECQ PROTEIN-LIKE 5; RECQL5	9400
MIM603782		17q12	CHEMOKINE, CC MOTIF, LIGAND 4-LIKE 1; CCL4L1	9560
MIM603783	C1863535	4p16-q34	INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1	100462721
MIM603784		21q22.3	PITUITARY TUMOR-TRANSFORMING GENE 1 PROTEIN-INTERACTING PROTEIN; PTTG1IP	754
MIM603785		9p24-p22	MULTIPLE PDZ DOMAIN PROTEIN; MPDZ	8777
MIM603786	C1863534	4p, 4p15.3	STARGARDT DISEASE 4; STGD4	8842
MIM603787		2p25	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY F, MEMBER 1; KCNF1	3754
MIM603788		20q13	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 1; KCNG1	3755
MIM603790		5q31.2-q31.3	SOLUTE CARRIER FAMILY 23 (NUCLEOBASE TRANSPORTER), MEMBER 1; SLC23A1	9963
MIM603791		20p13-p12	SOLUTE CARRIER FAMILY 23 (NUCLEOBASE TRANSPORTER), MEMBER 2; SLC23A2	9962
MIM603794	C1863533	 	HYDROA VACCINIFORME, FAMILIAL	 
MIM603795		16p13.3-p12	LIPOPOLYSACCHARIDE-INDUCED TUMOR NECROSIS FACTOR-ALPHA FACTOR; LITAF	9516
MIM603796		21q22.1	POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 2; KCNE2	9992
MIM603797		11p11.2-p11.1	CARBOHYDRATE SULFOTRANSFERASE 1; CHST1	8534
MIM603798		3q24	CARBOHYDRATE SULFOTRANSFERASE 2; CHST2	9435
MIM603799		10q22.1	CARBOHYDRATE SULFOTRANSFERASE 3; CHST3	9469
MIM603800		12p11.23	MEDIATOR COMPLEX SUBUNIT 21; MED21	9412
MIM603801		10p13	N-MYRISTOYLTRANSFERASE 2; NMT2	9397
MIM603802	C1863516	 	MICROCEPHALY WITH SIMPLIFIED GYRAL PATTERN	 
MIM603803		13q22	DACHSHUND, DROSOPHILA, HOMOLOG OF, 1; DACH1	1602
MIM603804		10q25.1	NEURALIZED, DROSOPHILA, HOMOLOG-LIKE; NEURL	9148
MIM603805		15q15.2	TRANSGLUTAMINASE 5; TGM5	9333
MIM603806	C1863514	 	URINARY TRACT INFECTIONS, RECURRENT, SUSCEPTIBILITY TO	 
MIM603808		17q22-q23	MEDIATOR COMPLEX SUBUNIT 13; MED13	9969
MIM603809		 	THYROID HORMONE RECEPTOR-ASSOCIATED PROTEIN 3; THRAP3	9967
MIM603810		11q21	MEDIATOR COMPLEX SUBUNIT 17; MED17	9440
MIM603811		Chr.11	BARRIER-TO-AUTOINTEGRATION FACTOR 1; BANF1	8815
MIM603812		14q24.1-q24.2	DDB1- AND CUL4-ASSOCIATED FACTOR 5; DCAF5	8816
MIM603813	C1863512	1p36-p35	HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH	26119
MIM603814		 	RING-BOX 1; RBX1	9978
MIM603815		6q27	KINESIN FAMILY MEMBER 25; KIF25	3834
MIM603816		16p13.3	AXIS INHIBITOR 1; AXIN1	8312
MIM603817		2p24	DEVELOPMENT- AND DIFFERENTIATION-ENHANCING FACTOR 2; DDEF2	8853
MIM603818		5q23-q33	NEUREGULIN 2; NRG2	9542
MIM603819		5q31.3	STEROID RECEPTOR RNA ACTIVATOR 1; SRA1	10011
MIM603820		19q13.1	G PROTEIN-COUPLED RECEPTOR 40; GPR40	2864
MIM603821		19q13.1	G PROTEIN-COUPLED RECEPTOR 41; GPR41	2865
MIM603822		19q13.1	G PROTEIN-COUPLED RECEPTOR 42; GPR42	2866
MIM603823		19q13.1	G PROTEIN-COUPLED RECEPTOR 43; GPR43	2867
MIM603824		9p13.3	UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE	10020
MIM603825		17p13.3	HYPERMETHYLATED IN CANCER 1; HIC1	3090
MIM603826		12q	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 4; NR1H4	9971
MIM603827		2q12-q13	BCL2-LIKE 11; BCL2L11	10018
MIM603828	C1859069	 	BRITTLE BONE DISORDER	 
MIM603829	C2751898	3p21	VENTRICULAR FIBRILLATION DURING MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO	6331
MIM603830	C1859062	3p21	LONG QT SYNDROME 3; LQT3	6331
MIM603831		1q21	PDZ DOMAIN-CONTAINING 1; PDZK1	5174
MIM603832		 	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 3; NDUFA3	4696
MIM603833		 	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 4; NDUFA4	4697
MIM603834		12p	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 9; NDUFA9	4704
MIM603835		2q37.3	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 10; NDUFA10	4705
MIM603836		16p12.3-p12.1	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA/BETA SUBCOMPLEX, 1; NDUFAB1	4706
MIM603837		 	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 1; NDUFB1	4707
MIM603838		 	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 2; NDUFB2	4708
MIM603839		2q31.3	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 3; NDUFB3	4709
MIM603840		 	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 4; NDUFB4	4710
MIM603841		 	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 5; NDUFB5	4711
MIM603842		19p13.12-p13.11	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 7; NDUFB7	4713
MIM603843		16p13.3	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 10; NDUFB10	4716
MIM603844		4q28.2-q31.1	NADH-UBIQUINONE OXIDOREDUCTASE 1, SUBUNIT C1; NDUFC1	4717
MIM603845		 	NADH-UBIQUINONE OXIDOREDUCTASE 1, SUBUNIT C2; NDUFC2	4718
MIM603846		11p11.11	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 3; NDUFS3	4722
MIM603847		1p34.2-p33	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 5; NDUFS5	4725
MIM603848		5pter-p15.33	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 6; NDUFS6	4726
MIM603849		6q21	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP E, MEMBER 1; NR2E1	7101
MIM603850		12p11.21	DYNAMIN 1-LIKE; DNM1L	10059
MIM603851		4p12	PAIRED-LIKE HOMEOBOX 2B; PHOX2B	8929
MIM603852		11p15.5	TUMOR-SUPPRESSING SUBCHROMOSOMAL TRANSFERABLE FRAGMENT CANDIDATE GENE 4; TSSC4	10078
MIM603853		11p15.5	TETRASPANIN 32; TSPAN32	10077
MIM603854		6p23	RAN-BINDING PROTEIN 9; RANBP9	10048
MIM603855		19q13.2-q13.4	CYSTIC FIBROSIS, MODIFIER OF, 1; CFM1	10167
MIM603856		15q11-q13	MAKORIN 3; MKRN3	7681
MIM603857		15q11-q13	MKRN3 ANTISENSE RNA; MKRN3AS	10108
MIM603859		7q21.3	SOLUTE CARRIER FAMILY 25 (CITRIN), MEMBER 13; SLC25A13	10165
MIM603860	C1859040	16p12.3	MEDULLARY CYSTIC KIDNEY DISEASE 2; MCKD2	7369
MIM603861		13q14	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ORNITHINE TRANSPORTER), MEMBER 15; SLC25A15	10166
MIM603862		2p14-q21.3	CYCLIN T2; CCNT2	905
MIM603863		3q22-q24	RING FINGER PROTEIN 7; RNF7	9616
MIM603864		11q13	COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE; CCS	9973
MIM603865		5q34-q35	GLUTAMINE:FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE 2; GFPT2	9945
MIM603866		Chr.15	PEROXISOME BIOGENESIS FACTOR 11A; PEX11A	8800
MIM603867		 	PEROXISOME BIOGENESIS FACTOR 11B; PEX11B	8799
MIM603868		15q21	RAS-ASSOCIATED PROTEIN RAB27A; RAB27A	5873
MIM603869		 	RAS-ASSOCIATED PROTEIN RAB27B; RAB27B	5874
MIM603870		16q24	CORE-BINDING FACTOR, ALPHA SUBUNIT 2, TRANSLOCATED TO, 3; CBFA2T3	863
MIM603871		6p21.1	BY THE RIBOSOMAL PROTEIN S6 GENE, DROSOPHILA, HOMOLOG-LIKE; BYSL	705
MIM603872		 	TROPHININ-ASSOCIATED PROTEIN; TROAP	10024
MIM603873		 	PHOSPHOLIPASE A2-ACTIVATING PROTEIN; PLAA	9373
MIM603874		 	ANGIOPOIETIN-LIKE 1; ANGPTL1	9068
MIM603875		9q33	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 8; TNFSF8	944
MIM603876		1q21-q23	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 4; ADAMTS4	9507
MIM603877		 	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 3; SLC16A3	9123
MIM603878		 	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 4; SLC16A4	9122
MIM603879		 	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 5; SLC16A5	9121
MIM603880		 	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 6; SLC16A6	9120
MIM603881		 	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP I, MEMBER 3; NR1I3	9970
MIM603882		 	BCL2-ASSOCIATED ATHANOGENE 2; BAG2	9532
MIM603883		10q25.2-q26.2	BCL2-ASSOCIATED ATHANOGENE 3; BAG3	9531
MIM603884		 	BCL2-ASSOCIATED ATHANOGENE 4; BAG4	9530
MIM603885		 	BCL2-ASSOCIATED ATHANOGENE 5; BAG5	9529
MIM603886		 	ARTEMIN; ARTN	9048
MIM603887		12q12-q13	TIMELESS, DROSOPHILA, HOMOLOG OF; TIMELESS	8914
MIM603888		2p24	POTASSIUM CHANNEL, VOLTAGE-GATED, DELAYED-RECTIFIER, SUBFAMILY S, MEMBER 3; KCNS3	3790
MIM603889		 	SIGNAL REGULATORY PROTEIN, BETA-1; SIRPB1	10326
MIM603890		11q12	UBIQUITIN-CONJUGATING ENZYME E2L 6; UBE2L6	9246
MIM603891		11q13.1	FIBROBLAST GROWTH FACTOR 19; FGF19	9965
MIM603892		17q21.31	ELONGATION FACTOR Tu GTP-BINDING DOMAIN-CONTAINING 2; EFTUD2	9343
MIM603893		 	TRAF FAMILY MEMBER-ASSOCIATED NF-KAPPA-B ACTIVATOR; TANK	10010
MIM603894		14q24.3	REGULATOR OF G PROTEIN SIGNALING 6; RGS6	9628
MIM603895		16p13.3	REGULATOR OF G PROTEIN SIGNALING 11; RGS11	8786
MIM603896	C1858991	14q24, Chr.12, 1p34.1, 3q27, 2p23.3	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	1967, 8890, 8891, 8892, 8893
MIM603897		20q13.1-q13.2	MATRILIN 4; MATN4	8785
MIM603898		1q23	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 18; TNFSF18	8995
MIM603899		19p13.1-p12	ZINC FINGER PROTEIN 85; ZNF85	7639
MIM603900		16p13.3	ZINC FINGER PROTEIN 174; ZNF174	7727
MIM603901		 	ZINC FINGER PROTEIN 259; ZNF259	8882
MIM603902	C1858990	11p15.5	BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE	3043
MIM603903	C0002895	11p15.5	SICKLE CELL ANEMIA	3043
MIM603904		13q14	INTEGRAL MEMBRANE PROTEIN 2B; ITM2B	9445
MIM603905		1p36.3	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 18; TNFRSF18	8784
MIM603906		1p31-p22	CHLORIDE CHANNEL, CALCIUM-ACTIVATED, 1; CLCA1	1179
MIM603907		 	EUKARYOTIC TRANSLATION INITIATION FACTOR 2, SUBUNIT 1; EIF2S1	1965
MIM603908		 	EUKARYOTIC TRANSLATION INITIATION FACTOR 2, SUBUNIT 2; EIF2S2	8894
MIM603909	C1858968	2q33-q34	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA; ALPS2A	843
MIM603910		15q15.3	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT J; EIF3J	8669
MIM603911		1p34.1	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT I; EIF3I	8668
MIM603912		8q24.11	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT H; EIF3H	8667
MIM603913		19p13.2	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT G; EIF3G	8666
MIM603914		11p15.4	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT F; EIF3F	8665
MIM603915		22q13.1	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT D; EIF3D	8664
MIM603916		16p11.2	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT C; EIF3C	8663
MIM603917		7p22.2	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT B; EIF3B	8662
MIM603918	C1858967	17q	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 1	117191
MIM603919		5q35.1	SERINE/THREONINE PROTEIN KINASE 10; STK10	6793
MIM603920		21q22.1	CRYSTALLIN, ZETA-LIKE 1; CRYZL1	9946
MIM603921		13q12.2-q13	SUCCINATE-CoA LIGASE, ADP-FORMING, BETA SUBUNIT; SUCLA2	8803
MIM603922		 	SUCCINATE-CoA LIGASE, GDP-FORMING, BETA SUBUNIT; SUCLG2	8801
MIM603924		10q25-q26	HYALURONAN-BINDING PROTEIN 2; HABP2	3026
MIM603925		22q13	SYNAPTOGYRIN 1; SYNGR1	9145
MIM603926		17q25	SYNAPTOGYRIN 2; SYNGR2	9144
MIM603927		16pter	SYNAPTOGYRIN 3; SYNGR3	9143
MIM603928		 	EUKARYOTIC TRANSLATION INITIATION FACTOR 4B; EIF4B	1975
MIM603929		 	EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 3; EIF4G3	8672
MIM603930		14q24	GEPHYRIN; GPHN	10243
MIM603931		5q35.2	ATPase, H+ TRANSPORTING, LYSOSOMAL, 9-KD, V0 SUBUNIT E1; ATP6V0E1	8992
MIM603932	C0158252	15q22, 9q21.3-q22, 1p21, 6q27, 1p33-p32.2, 20q13.3	INTERVERTEBRAL DISC DISEASE; IDD	1298, 1299, 1301, 54829, 7058, 8483
MIM603933	C2676832	6p12	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1; MVCD1	23771, 7422
MIM603934		 	COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1; CARM1	10498
MIM603935	C1858958	1q21	PSORIASIS SUSCEPTIBILITY 4; PSORS4	10547
MIM603936		12q13.13	GROWTH/DIFFERENTIATION FACTOR 11; GDF11	10220
MIM603937		8q11-q13	RP1 GENE; RP1	6101
MIM603939		19q13.1	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 6; KCNK6	9424
MIM603940		11q13	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 7; KCNK7	10089
MIM603941		1q23.3	SOLUTE CARRIER FAMILY 19 (THIAMINE TRANSPORTER), MEMBER 2; SLC19A2	10560
MIM603942		3q24-q25.1	GLYCOGENIN 1; GYG1	2992
MIM603943		5q22-q23	CYSTEINE DIOXYGENASE; CDO	1036
MIM603944		 	SYNTAXIN 6; STX6	10228
MIM603945		3q27	EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 5; EIF2B5	8893
MIM603946		10q23.3-q24.2	HELICASE, LYMPHOID-SPECIFIC; HELLS	3070
MIM603947		11q12-q13.1	METASTASIS-ASSOCIATED 1-LIKE 1; MTA1L1	9219
MIM603948		6p22.3	NUCLEOPORIN, 153-KD; NUP153	9972
MIM603949		1q32	RAB7-LIKE 1; RAB7L1	8934
MIM603950		 	N-DEACETYLASE/N-SULFOTRANSFERASE 3; NDST3	9348
MIM603951		5q34	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 1; KCNMB1	3779
MIM603952		 	DEVELOPMENTALLY REGULATED GTP-BINDING PROTEIN 1; DRG1	4733
MIM603953		 	POTASSIUM INWARDLY-RECTIFYING CHANNEL, SUBFAMILY J, MEMBER 14; KCNJ14	3770
MIM603954		Chr.11	ZESTE-WHITE 10, DROSOPHILA, HOMOLOG OF; ZW10	9183
MIM603955		1q23-q25	FLAVIN-CONTAINING MONOOXYGENASE 2; FMO2	2327
MIM603956	C0302592	4p16.3	CERVICAL CANCER	2261
MIM603957		1q21.1	FLAVIN-CONTAINING MONOOXYGENASE 5; FMO5	2330
MIM603958		 	REGULATORY FACTOR X, 4; RFX4	5992
MIM603959		3q27	CLAUDIN 16; CLDN16	10686
MIM603960		 	CALICIN; CCIN	881
MIM603961		 	SEMAPHORIN 3A; SEMA3A	10371
MIM603962		15q15	RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 1; RASGRP1	10125
MIM603963		3p21.3	INTEGRIN, ALPHA-9; ITGA9	3680
MIM603964	C1858916	2q23-q24.3	DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16	1694
MIM603965	C1858915	11q21-q22	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	7225
MIM603966		10p15-p14	ALDO-KETO REDUCTASE FAMILY 1, MEMBER C3; AKR1C3	8644
MIM603967		17q23.1-q25.3	SODIUM CHANNEL, VOLTAGE-GATED, TYPE IV, ALPHA SUBUNIT; SCN4A	6329
MIM603968		6p21.1-p12	POLYMERASE, DNA, ETA; POLH	5429
MIM603969		13q32-q34	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 13B; TNFSF13B	10673
MIM603970		 	PARANEOPLASTIC ANTIGEN MA2; PNMA2	10687
MIM603971		19p13.1-p12	ZINC FINGER PROTEIN 91; ZNF91	7644
MIM603972		19p13.1-p12	ZINC FINGER PROTEIN 43; ZNF43	7594
MIM603973		19p13.1-p12	ZINC FINGER PROTEIN 90; ZNF90	7643
MIM603974		7q11.21	ZINC FINGER PROTEIN 92; ZNF92	168374
MIM603975		19p13.1-p12	ZINC FINGER PROTEIN 93; ZNF93	81931
MIM603977		19p13.1-p12	ZINC FINGER PROTEIN 208; ZNF208	7757
MIM603978		6p22.2-p21.3	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 12; ZSCAN12	9753
MIM603980		19p12	ZINC FINGER PROTEIN 98; ZNF98	148198
MIM603981		19p12	ZINC FINGER PROTEIN 99; ZNF99	7652
MIM603982		19p13.1-p12	ZINC FINGER PROTEIN 100; ZNF100	163227
MIM603983		19p13.1-p12	ZINC FINGER PROTEIN 101; ZNF101	94039
MIM603984		19p13.1-p12	ZINC FINGER PROTEIN 737; ZNF737	100129842
MIM603989		7q11.2	ZINC FINGER PROTEIN 107; ZNF107	51427
MIM603996		19q13.33	ZINC FINGER PROTEIN 114; ZNF114	163071
MIM604001		7q21-q22	A-KINASE ANCHOR PROTEIN 9; AKAP9	10142
MIM604002		2p24	RHO-ASSOCIATED COILED-COIL-CONTAINING PROTEIN KINASE 2; ROCK2	9475
MIM604003		1p31-p22	CHLORIDE CHANNEL, CALCIUM-ACTIVATED, 2; CLCA2	9635
MIM604004	C1858854	22q13.33	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1	220296, 23209
MIM604008		1p36.3	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, ZETA-2; PTPRZ2	5804
MIM604009		16p13.3	BAI1-ASSOCIATED PROTEIN 3; BAIAP3	8938
MIM604010		 	PARANEOPLASTIC ANTIGEN MA1; PNMA1	9240
MIM604011		17q11.2	UNC119, C. ELEGANS, HOMOLOG OF; UNC119	9094
MIM604012		 	RNA, U20 SMALL NUCLEOLAR; RNU20	6082
MIM604013		1p33-p32	UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 2; B4GALT2	8704
MIM604014		1q23	UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 3; B4GALT3	8703
MIM604015		3q13.3	UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 4; B4GALT4	8702
MIM604016		20q13.1-q13.2	UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 5; B4GALT5	9334
MIM604017		18q11	UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 6; B4GALT6	9331
MIM604018		19q13.13-q13.2	NUMB, DROSOPHILA, HOMOLOG-LIKE; NUMBL	9253
MIM604019		7q22.1	HIV-1 REV-BINDING PROTEIN-LIKE; HRBL	3268
MIM604020		3p21.31	BASSOON, MOUSE, HOMOLOG OF; BSN	8927
MIM604024		 	SOLUTE CARRIER FAMILY 5 (SODIUM-DEPENDENT VITAMIN TRANSPORTER), MEMBER 6; SLC5A6	8884
MIM604025		17q24	AXIS INHIBITOR 2; AXIN2	8313
MIM604026		17q11	GOLGI SNAP RECEPTOR COMPLEX MEMBER 1; GOSR1	9527
MIM604027		17q21	GOLGI SNAP RECEPTOR COMPLEX MEMBER 2; GOSR2	9570
MIM604028		 	SECRETION DEFICIENT 22, S. CEREVISIAE, HOMOLOG OF, C; SEC22C	9117
MIM604029		1q21.2-q21.3	SECRETION DEFICIENT 22, S. CEREVISIAE, HOMOLOG-LIKE 1; SEC22L1	9554
MIM604030		9q34.11-q34.12	PROTEASOME SUBUNIT, BETA-TYPE, 7; PSMB7	5695
MIM604031		10q24.31	STEAROYL-CoA DESATURASE; SCD	6319
MIM604032		2p12	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3; EIF2AK3	9451
MIM604033		 	ENDOPLASMIC RETICULUM-TO-NUCLEUS SIGNALING 1; ERN1	2081
MIM604034		Chr.16	ENDOPLASMIC RETICULUM-TO-NUCLEUS SIGNALING 2; ERN2	10595
MIM604035		9q31.1	CYLICIN 2; CYLC2	1539
MIM604036		13q12.3-q13	CYCLIN A1; CCNA1	8900
MIM604037		17q21.2	RAS-ASSOCIATED PROTEIN RAB5C; RAB5C	5878
MIM604038		3p21.3	HYALURONOGLUCOSAMINIDASE 3; HYAL3	8372
MIM604039		10q24.1-q24.3	MENINGIOMA-EXPRESSED ANTIGEN 5; MGEA5	10724
MIM604040		5q31	RAD50, S. CEREVISIAE, HOMOLOG OF; RAD50	10111
MIM604041		17p13.1-p12	MANNOSE-P-DOLICHOL UTILIZATION DEFECT 1; MPDU1	9526
MIM604042		 	INTEGRIN, ALPHA-10; ITGA10	8515
MIM604043		1q32.2-q41	NEVER IN MITOSIS GENE A-RELATED KINASE 2; NEK2	4751
MIM604044		13q14.2	NEVER IN MITOSIS GENE A-RELATED KINASE 3; NEK3	4752
MIM604045		 	PROTEIN ARGININE N-METHYLTRANSFERASE 5; PRMT5	10419
MIM604046		3p22-p21.3	OXIDATIVE STRESS-RESPONSIVE 1; OXSR1	9943
MIM604047		 	ORGANIC-CATION TRANSPORTER-LIKE 3; ORCTL3	9390
MIM604048		 	ORGANIC-CATION TRANSPORTER-LIKE 4; ORCTL4	9389
MIM604049		3p22-p21.3	XYLULOKINASE, H. INFLUENZAE, HOMOLOG OF; XYLB	9942
MIM604050		3p22-p21.3	DELETED IN LUNG AND ESOPHAGEAL CANCER 1; DLEC1	9940
MIM604051		3p22-p21.3	ENDO/EXONUCLEASE, ENDOG-LIKE; EXOG	9941
MIM604052		9q32	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 15; TNFSF15	9966
MIM604053		 	3-PRIME(2-PRIME),5-PRIME-@BISPHOSPHATE NUCLEOTIDASE 1; BPNT1	10380
MIM604054		3p23-p22	ACETYL-CoA ACYLTRANSFERASE 1; ACAA1	30
MIM604055		 	ISOPENTENYL-DIPHOSPHATE DELTA-ISOMERASE; IDI1	3422
MIM604056		16p12	HEPARAN SULFATE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE 2; HS3ST2	9956
MIM604057		17p12-p11.2	HEPARAN SULFATE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE 3A1; HS3ST3A1	9955
MIM604058		17p12-p11.2	HEPARAN SULFATE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE 3B1; HS3ST3B1	9953
MIM604059		16p11.2	HEPARAN SULFATE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE 4; HS3ST4	9951
MIM604060	C1858840	11q25-qter	DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	1713
MIM604061		17q25	SEPTIN 9; SEPT9	10801
MIM604062		 	MEDIATOR COMPLEX SUBUNIT 16; MED16	10025
MIM604063		 	INTEGRIN, ALPHA-8; ITGA8	8516
MIM604064		22q13.1	ACTIVATING TRANSCRIPTION FACTOR 4; ATF4	468
MIM604065		17q22	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1G SUBUNIT; CACNA1G	8913
MIM604066		21q22.3	UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE, POLYPEPTIDE 5; B3GALT5	10317
MIM604067		17q23-q24	REGULATOR OF G PROTEIN SIGNALING 9; RGS9	8787
MIM604068		 	TUMOR PROTEIN D52; TPD52	7163
MIM604069		 	TUMOR PROTEIN D52-LIKE 1; TPD52L1	7164
MIM604070		7p21.2	DIACYLGLYCEROL KINASE, BETA, 90-KD; DGKB	1607
MIM604071		 	DIACYLGLYCEROL KINASE, ETA, 130-KD; DGKH	160851
MIM604072		7q32.3-q33	DIACYLGLYCEROL KINASE, IOTA, 130-KD; DGKI	9162
MIM604073		5p12-p11	ZINC FINGER PROTEIN 131; ZNF131	7690
MIM604074		19q13.4	ZINC FINGER PROTEIN 132; ZNF132	7691
MIM604075		20p11.2	ZINC FINGER PROTEIN 133; ZNF133	7692
MIM604076		19q13.4	ZINC FINGER PROTEIN 134; ZNF134	7693
MIM604077		19q13.4	ZINC FINGER PROTEIN 135; ZNF135	7694
MIM604078		19p13.2-p13.12	ZINC FINGER PROTEIN 136; ZNF136	7695
MIM604079		19q13.3-q13.4	ZINC FINGER PROTEIN 137; ZNF137	7696
MIM604080		7q11.21-q11.23	ZINC FINGER PROTEIN 138; ZNF138	7697
MIM604082		12q24.32-q24.33	ZINC FINGER PROTEIN 140; ZNF140	7699
MIM604083		2q34-q35	ZINC FINGER PROTEIN 142; ZNF142	7701
MIM604084		1p36.2-p36.1	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 17; ZBTB17	7709
MIM604085		19q13.4	ZINC FINGER PROTEIN 154; ZNF154	7710
MIM604086		19q13.2-q13.32	ZINC FINGER PROTEIN 155; ZNF155	7711
MIM604087		14q32.1	CYTOCHROME P450, FAMILY 46, SUBFAMILY A, POLYPEPTIDE 1; CYP46A1	10858
MIM604088		7p15	G-SUBSTRATE	10842
MIM604089		19q13.1	HEMATOPOIETIC CELL SIGNAL TRANSDUCER; HCST	10870
MIM604090		10q23	DISCS LARGE, DROSOPHILA, HOMOLOG OF, 5; DLG5	9231
MIM604091	C1704429	11q23, 9q22-q31	HYPOALPHALIPOPROTEINEMIA, PRIMARY	19, 335
MIM604092		6q13-q21	TTK PROTEIN KINASE; TTK	7272
MIM604093	C0263383	 	KERATOSIS PILARIS	 
MIM604094		1p36	MITOTIC ARREST-DEFICIENT 2, S. CEREVISIAE, HOMOLOG-LIKE 2; MAD2L2	10459
MIM604095		2q11-q13	ECTODYSPLASIN A RECEPTOR; EDAR	10913
MIM604096		5q35	GLUTAMATE RECEPTOR, METABOTROPIC, 6; GRM6	2916
MIM604097		 	UROTENSIN II; UTS2	10911
MIM604098		 	SUPPRESSOR OF G2 ALLELE OF SKP1, S. CEREVISIAE, HOMOLOG OF; SUGT1	10910
MIM604099		3p21.2-p21.1	GLUTAMATE RECEPTOR, METABOTROPIC, 2; GRM2	2912
MIM604100		6p21.3	GLUTAMATE RECEPTOR, METABOTROPIC, 4; GRM4	2914
MIM604101		3p26.1-p25.2	GLUTAMATE RECEPTOR, METABOTROPIC, 7; GRM7	2917
MIM604102		 	GLUTAMATE RECEPTOR, METABOTROPIC, 5; GRM5	2915
MIM604103		5q31	TITIN IMMUNOGLOBULIN DOMAIN PROTEIN; TTID	9499
MIM604104		19q13.2	GLIA MATURATION FACTOR, GAMMA; GMFG	9535
MIM604105		20q13.33	SYNAPTONEMAL COMPLEX PROTEIN 2; SYCP2	10388
MIM604106		1q24	G PROTEIN-COUPLED RECEPTOR 52; GPR52	9293
MIM604107		2q37	G PROTEIN-COUPLED RECEPTOR 55; GPR55	9290
MIM604108		6q22-q25	MICROTUBULE-ASSOCIATED PROTEIN 7; MAP7	9053
MIM604109		8q24	HUMAN ENDOGENOUS RETROVIRUS-H LONG TERMINAL REPEAT-ASSOCIATING 1; HHLA1	10086
MIM604110		16q13	G PROTEIN-COUPLED RECEPTOR 56; GPR56	9289
MIM604111		17p13.1	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 3; KCNAB3	9196
MIM604112		13q22	SCIELLIN; SCEL	8796
MIM604113		 	INTERLEUKIN 18-BINDING PROTEIN; IL18BP	10068
MIM604114		15q15	PHOSPHOLIPASE C, BETA-2; PLCB2	5330
MIM604115		11p15.5	KCNQ1-OVERLAPPING TRANSCRIPT 1; KCNQ1OT1	10984
MIM604116	C1858806	1p22.1	CONE-ROD DYSTROPHY 3; CORD3	24
MIM604117	C1858805	1q21	VOHWINKEL SYNDROME, VARIANT FORM	4014
MIM604118		12q23-q24	RAS PROTEIN ACTIVATOR-LIKE 1; RASAL1	8437
MIM604119		16q22.1	SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 4; SLC12A4	6560
MIM604121	C1858804	 	CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY	 
MIM604122		15q21-q22	PHOSPHATIDYLINOSITOL GLYCAN, CLASS B; PIGB	9488
MIM604123		2p25	RIBONUCLEASE H1; RNASEH1	246243
MIM604124		18q11.2	RETINOBLASTOMA-BINDING PROTEIN 8; RBBP8	5932
MIM604125		19q13.3	SULFOTRANSFERASE FAMILY 2B, MEMBER 1; SULT2B1	6820
MIM604126		10p11.2	SUPERVILLIN; SVIL	6840
MIM604127		1p13	T-BOX 15; TBX15	6913
MIM604128		 	TRANSCRIPTION ELONGATION FACTOR A, 3; TCEA3	6920
MIM604129	C1275114	3p21.3	EPIDERMOLYSIS BULLOSA PRURIGINOSA	1294
MIM604130		10q26	UNDIFFERENTIATED EMBRYONIC CELL TRANSCRIPTION FACTOR 1; UTF1	8433
MIM604131	C0002312	16pter-p13.3, 16pter-p13.3, 11p15.5, 11p15.5	ALPHA-THALASSEMIA	3039, 3040, 387281
MIM604134		9q34	A DISINTEGRIN-LIKE AND METALLOPROTEASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 13; ADAMTS13	11093
MIM604135		7p15-p14	NUCLEAR FACTOR ERYTHROID 2-LIKE 3; NFE2L3	9603
MIM604136		1q32	INTERLEUKIN 24; IL24	11009
MIM604138		12p13-p12.3	G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER A; GPRC5A	9052
MIM604139		2q32-34	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 2; DNAJB2	3300
MIM604140		20q13.33	DEATH INDUCER-OBLITERATOR 1; DIDO1	11083
MIM604141		8q13	ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; ARFGEF1	10565
MIM604142		19q13.1	TYRO PROTEIN TYROSINE KINASE-BINDING PROTEIN; TYROBP	7305
MIM604143		12q13	EXTRA SPINDLE POLES-LIKE 1; ESPL1	9700
MIM604144		19q13.1	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 9; SLC7A9	11136
MIM604145	C1858763	2q31	CARDIOMYOPATHY, DILATED, 1G; CMD1G	7273
MIM604146		11q13	SYNAPTOTAGMIN 7; SYT7	9066
MIM604147		5q33	PITUITARY TUMOR-TRANSFORMING GENE 1; PTTG1	9232
MIM604148		17p11.1-q11.1	SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER), MEMBER 2; SLC13A2	9058
MIM604149		7q21	SARCOGLYCAN, EPSILON; SGCE	8910
MIM604150		7q22-q31.1	POLYMERASE II, RNA, SUBUNIT J; POLR2J	5439
MIM604151		2q32.1	UBIQUITIN-CONJUGATING ENZYME E2E 3; UBE2E3	10477
MIM604152		 	ORNITHINE DECARBOXYLASE ANTIZYME 2; OAZ2	4947
MIM604153		2q37.1	NEUROMEDIN U RECEPTOR 1; NMUR1	10316
MIM604155		2q34	LanC-LIKE 1; LANCL1	10314
MIM604156		8p12-p11.1	SECRETED FRIZZLED-RELATED PROTEIN 1; SFRP1	6422
MIM604157		4q31.3	SECRETED FRIZZLED-RELATED PROTEIN 2; SFRP2	6423
MIM604158		10q24.1	SECRETED FRIZZLED-RELATED PROTEIN 5; SFRP5	6425
MIM604159		11p15.2-p15.1	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GLYCINE), MEMBER 5; SLC6A5	9152
MIM604160		 	INTEGRIN, BETA-8; ITGB8	3696
MIM604161		19p13.3	KISS1 RECEPTOR; KISS1R	84634
MIM604163		22q	RIBOSOMAL PROTEIN L3; RPL3	6122
MIM604164		15q21.1-q21.2	ONE CUT HOMEOBOX 1; ONECUT1	3175
MIM604165		17p13.3	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, OXOGLUTARATE CARRIER), MEMBER 11; SLC25A11	8402
MIM604166		8q	RIBOSOMAL PROTEIN L7; RPL7	6129
MIM604167		16q22.1	CCCTC-BINDING FACTOR; CTCF	10664
MIM604168	C1858726	18q23	CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY	9150
MIM604169	C1858725	18q12.1-q12.2	LEFT VENTRICULAR NONCOMPACTION 1; LVNC1	1837
MIM604170		3q23	PHOSPHOLIPID SCRAMBLASE 1; PLSCR1	5359
MIM604171		17q25.3	THO COMPLEX, SUBUNIT 4; THOC4	10189
MIM604173	C1858723	16q13	POIKILODERMA WITH NEUTROPENIA; PN	79650
MIM604174		3p	RIBOSOMAL PROTEIN L15; RPL15	6138
MIM604175		1p36.1-p35	RIBOSOMAL PROTEIN L11; RPL11	6135
MIM604176		17q25.3	SUPPRESSOR OF CYTOKINE SIGNALING 3; SOCS3	9021
MIM604177		8q	RIBOSOMAL PROTEIN L8; RPL8	6132
MIM604178		19p	RIBOSOMAL PROTEIN L18A; RPL18A	6142
MIM604179		19q	RIBOSOMAL PROTEIN L18; RPL18	6141
MIM604180		3q	RIBOSOMAL PROTEIN L24; RPL24	6152
MIM604181		5p	RIBOSOMAL PROTEIN L37; RPL37	6167
MIM604182		17q	RIBOSOMAL PROTEIN L38; RPL38	6169
MIM604183	C0395886	 	CHOLESTEATOMA, CONGENITAL	 
MIM604184		15q22.3-q23	PUTATIVE NEURONAL CELL ADHESION MOLECULE; PUNC	9543
MIM604185	C1858717	10q21.3-q22.1	FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	22811
MIM604186		5q31	CHEMOKINE, CXC MOTIF, LIGAND 14; CXCL14	9547
MIM604187	C1858712	12q13	SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10	3798
MIM604188		1q21-q22	SELENIUM-BINDING PROTEIN 1; SELENBP1	8991
MIM604189		11q13	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 4; DNAJC4	3338
MIM604190		5q31	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 4; SLC22A4	6583
MIM604191		 	ZINC FINGER PROTEIN 263; ZNF263	10127
MIM604193		1q21.3	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 3; SLC27A3	11000
MIM604194		9q34	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 4; SLC27A4	10999
MIM604196		 	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 6; SLC27A6	28965
MIM604197		 	5,10-@METHENYLTETRAHYDROFOLATE SYNTHETASE; MTHFS	10588
MIM604198		 	RAS-ASSOCIATED PROTEIN RAB11B; RAB11B	9230
MIM604199		 	RAS-ASSOCIATED PROTEIN RAB35; RAB35	11021
MIM604200		19q13.3	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 5; SIGLEC5	8778
MIM604201	C1858709	6q22-q23	HEPATIC FIBROSIS, SEVERE, SUSCEPTIBILITY TO, DUE TO SCHISTOSOMA MANSONI INFECTION	53366
MIM604202		22q11.2	SYNAPTOSOMAL-ASSOCIATED PROTEIN, 29-KD; SNAP29	9342
MIM604203		17p12	SYNTAXIN 8; STX8	9482
MIM604204		9q31	SYNTAXIN 17; STX17	55014
MIM604205		 	COPINE I; CPNE1	8904
MIM604206		 	COPINE II; CPNE2	221184
MIM604207		8q21.3	COPINE III; CPNE3	8895
MIM604208		 	COPINE IV; CPNE4	131034
MIM604209		6p21	COPINE V; CPNE5	57699
MIM604210		1q31-q32.1	CRUMBS, DROSOPHILA, HOMOLOG OF, 1; CRB1	23418
MIM604212		16p13.12	POLYADENYLATE-SPECIFIC RIBONUCLEASE; PARN	5073
MIM604213	C1858695	 	CHUDLEY-MCCULLOUGH SYNDROME; CMCS	29899
MIM604214		7q11.2-q21	KREV INTERACTION TRAPPED 1; KRIT1	889
MIM604215		4q35.1	INHIBITOR OF GROWTH 2; ING2	3622
MIM604216		6p22-p21.3	SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 4; SLC17A4	10050
MIM604217		4p15.31-p15.2	SOLUTE CARRIER FAMILY 34 (SODIUM/PHOSPHATE COTRANSPORTER), MEMBER 2; SLC34A2	10568
MIM604218	C1858680	3q26	ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	5274
MIM604219	C1858679	12q13, 11p13, 3q21-q25	CATARACT, AUTOSOMAL DOMINANT	4284, 5080, 8419
MIM604220		7q21-q22	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 1A; ARPC1A	10552
MIM604221		 	ACTIN-RELATED PROTEIN 2; ACTR2	10097
MIM604222		2q14.1	ACTIN-RELATED PROTEIN 3; ACTR3	10096
MIM604223		7q21-q22	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 1B; ARPC1B	10095
MIM604224		2q35	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 2; ARPC2	10109
MIM604225		 	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 3; ARPC3	10094
MIM604226		 	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 4; ARPC4	10093
MIM604227		 	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 5; ARPC5	10092
MIM604229	C0344559	11p13, 4q25-q26, 2p22-p21	PETERS ANOMALY	1545, 5080, 5308
MIM604230		16q22.2-q22.3	ADENOSINE DEAMINASE, tRNA-SPECIFIC, 1; ADAT1	23536
MIM604231		4p12	PITUITARY TUMOR-TRANSFORMING GENE 2; PTTG2	10744
MIM604232	C1858677	14q31.3	LEBER CONGENITAL AMAUROSIS 3; LCA3	55812
MIM604233	C1858672	5q31.1-q33.1, 1p36.3, 2q24, 19q13.1	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1	6324
MIM604234		13q33	INTEGRIN, BETA-LIKE 1; ITGBL1	9358
MIM604235		14q11.2	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 8; SLC7A8	23428
MIM604237		19p12	CYTOKINE RECEPTOR-LIKE FACTOR 1; CRLF1	9244
MIM604238		20q13.1	SNAIL, DROSOPHILA, HOMOLOG OF, 1; SNAI1	6615
MIM604239		7q11.2	PHOSPHOSERINE PHOSPHATASE-LIKE; PSPHL	8781
MIM604240		2p13.1-p12	T-CELL LEUKEMIA, HOMEOBOX 2; TLX2	3196
MIM604241		6p12	CD2-ASSOCIATED PROTEIN; CD2AP	23607
MIM604242		13q12.11	RING FINGER PROTEIN 6; RNF6	6049
MIM604249		11q13	RETICULON 3; RTN3	10313
MIM604250	C1858664	7q22	HEMOCHROMATOSIS, TYPE 3; HFE3	7036
MIM604251		22q11.2	CALCINEURIN-BINDING PROTEIN 1	23523
MIM604252		11q23.3	BETA-SITE AMYLOID BETA A4 PRECURSOR PROTEIN-CLEAVING ENZYME 1; BACE1	23621
MIM604253		5q23	CASEIN KINASE I, GAMMA-3; CSNK1G3	1456
MIM604254	C1858662	2p16-p15	DYSLEXIA, SUSCEPTIBILITY TO, 3; DYX3	11192
MIM604255		10q24	LADY BIRD LATE, DROSOPHILA, HOMOLOG OF, 1	10660
MIM604256		3p26	BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E40; BHLHE40	8553
MIM604257	C1858661	 	CAMERA-MARUGO-COHEN SYNDROME	 
MIM604258		8p22-p21.3	DELETED IN LIVER CANCER 1; DLC1	10395
MIM604259		Chr.12	PLEXIN C1; PLXNC1	10154
MIM604260		17q11.2	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5B; STAT5B	6777
MIM604261		6q21	AUTOPHAGY 5, S. CEREVISIAE, HOMOLOG OF; ATG5	9474
MIM604262		 	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 3; APBA3	9546
MIM604263		20pter-p12	PRION GENE COMPLEX, DOWNSTREAM; PRND	23627
MIM604264		3p24.1-p21.2	CADHERIN EGF LAG SEVEN-PASS G-TYPE RECEPTOR 3; CELSR3	1951
MIM604265		1p21	CADHERIN EGF LAG SEVEN-PASS G-TYPE RECEPTOR 2; CELSR2	1952
MIM604266		1p36.3	MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 6; MEGF6	1953
MIM604267		19q12	MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 8; MEGF8	1954
MIM604268		9q32-q33.3	MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 9; MEGF9	1955
MIM604269		5q32-q33	FAT TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 2; FAT2	2196
MIM604270		11p12-p11.2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 4; LRP4	4038
MIM604271	C1858656	5p13-p12, 3q26.3	SHORT STATURE, IDIOPATHIC, AUTOSOMAL	2690, 2693
MIM604272		22q13	SCO2, S. CEREVISIAE, HOMOLOG OF; SCO2	9997
MIM604273	C2700431	17p11.2, 8q21.11	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	91647
MIM604274		12p13-p12	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 1; KLRA1	10748
MIM604275		5p15.2	CATENIN, DELTA-2; CTNND2	1501
MIM604276		2q23-q31	PLAKOPHILIN 4; PKP4	8502
MIM604277		2p22-p21	SPASTIN; SPAST	6683
MIM604278	C1970309	4q21	RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL RETARDATION	8671
MIM604279		5q13.2	JUNCTION-MEDIATING AND REGULATORY PROTEIN	133746
MIM604280		7q32.3	PLEXIN A4; PLXNA4	91584
MIM604281		7q21.3	DBF4, S. CEREVISIAE, HOMOLOG OF; DBF4	10926
MIM604282		3q22	PLEXIN D1; PLXND1	23129
MIM604283		1q24-q25	PROTEOGLYCAN 4; PRG4	10216
MIM604285		2q36-q37	ALANINE-GLYOXYLATE AMINOTRANSFERASE; AGXT	189
MIM604286	C1858593	4q12	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E; LGMD2E	6443
MIM604287	C1858592	 	CARNEY TRIAD	 
MIM604288	C1858591	2q14-q22	CARDIOMYOPATHY, DILATED, 1H; CMD1H	23459
MIM604289		8q21.3-q22	RAD54, S. CEREVISIAE, HOMOLOG OF, B	25788
MIM604290	C0878682	3q23-q24	ACERULOPLASMINEMIA	1356
MIM604291	C1858580	 	ASCARIS LUMBRICOIDES INFECTION, SUSCEPTIBILITY TO	 
MIM604292	C1858562	3q27	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	8626
MIM604293		22q13.31-q13.33	PLEXIN B2; PLXNB2	23654
MIM604294		10q26.1	VENTRAL ANTERIOR HOMEOBOX 1; VAX1	11023
MIM604295		2p13	VENTRAL ANTERIOR HOMEOBOX 2; VAX2	25806
MIM604296		9cen	GLYOXYLATE REDUCTASE/HYDROXYPYRUVATE REDUCTASE; GRHPR	9380
MIM604297		21q22.2	SYNAPTOJANIN 1; SYNJ1	8867
MIM604298		 	SIGNAL TRANSDUCING ADAPTOR FAMILY MEMBER 1; STAP1	26228
MIM604299		3p21.1-p14.3	ADAPTOR PROTEIN, PHOSPHOTYROSINE INTERACTION, PH DOMAIN, AND LEUCINE ZIPPER-CONTAINING PROTEIN 1; APPL1	26060
MIM604300		 	2-@HYDROXYACYL-CoA LYASE 1; HACL1	26061
MIM604301		 	OCULOMEDIN; OCLM	10896
MIM604302	C1858558	7p21, 22q11.2	RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE	3569, 4282
MIM604303		9q31	ACTIN-LIKE 7A; ACTL7A	10881
MIM604304		9q31	ACTIN-LIKE 7B; ACTL7B	10880
MIM604305		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ BETA-1; HLA-DQB1	3119
MIM604306		12q13	FAS APOPTOTIC INHIBITORY MOLECULE 2; FAIM2	23017
MIM604307	C1852438	2q33-q35, 22q11.2-q12.2	CATARACT, COPPOCK-LIKE; CCL	1415, 1420
MIM604308	C1858556	15q21.1	MASS SYNDROME	2200
MIM604309		7q33	SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER), MEMBER 4; SLC13A4	26266
MIM604310		15q15	PALLIDIN; PLDN	26258
MIM604311		17q12	MEDIATOR COMPLEX SUBUNIT 1; MED1	5469
MIM604312		20p11.2	CYSTATIN 3; CST3	1471
MIM604313		17q24	GALACTOKINASE 1; GALK1	2584
MIM604314	C1858538	 	BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	 
MIM604315	C1858537	 	ANEMIA, CONGENITAL HYPOPLASTIC, WITH MULTIPLE CONGENITAL ANOMALIES/MENTAL RETARDATION SYNDROME	 
MIM604316	C1858536	3q21	PSORIASIS SUSCEPTIBILITY 5; PSORS5	63870
MIM604317	C1858535	19q13.1-q13.2	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS; MCPH2	284403
MIM604318		7q11.23	GTF2I REPEAT DOMAIN-CONTAINING PROTEIN 1; GTF2IRD1	9569
MIM604319		14q12	TRF1-INTERACTING NUCLEAR FACTOR 2; TINF2	26277
MIM604320	C1858517	11q13.2-q13.4	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	 
MIM604321	C1858516	15q21.1	MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	22995
MIM604322		6q14-q15	SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 5; SLC17A5	26503
MIM604323		17q22	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 3; ABCC3	8714
MIM604324	C1858506	 	ACNE, ADULT	 
MIM604325		5q31-q33	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, BETA; PPP2R2B	5521
MIM604326	C1858501	5q31-q33	SPINOCEREBELLAR ATAXIA 12; SCA12	5521
MIM604327		5q35.2-q35.3	XYLOSYLPROTEIN 4-BETA-GALACTOSYLTRANSFERASE, POLYPEPTIDE 7; B4GALT7	11285
MIM604328		11q12	STRUCTURE-SPECIFIC RECOGNITION PROTEIN 1; SSRP1	6749
MIM604329	C1858497	15q	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 2	50986
MIM604330		 	GRB2-RELATED ADAPTOR PROTEIN; GRAP	10750
MIM604331		13q14.12-q14.2	INTEGRATOR COMPLEX SUBUNIT 6; INTS6	26512
MIM604332		4q11-q12	CYSTEINE-RICH HYDROPHOBIC DOMAIN 2; CHIC2	26511
MIM604333		2q11.2	WD40 REPEAT-CONTAINING PROTEIN CIAO1; CIAO1	9391
MIM604334		17p13	UBIQUITIN-SPECIFIC PROTEASE 6; USP6	9098
MIM604335	C0034931	 	REFLEX SYMPATHETIC DYSTROPHY	 
MIM604336		21p	TRANSMEMBRANE PHOSPHATASE WITH TENSIN HOMOLOGY; TPTE	7179
MIM604337		1p31-p22	CHLORIDE CHANNEL, CALCIUM-ACTIVATED, 3; CLCA3	9629
MIM604344		6q22	MANNOSIDASE, ALPHA, CLASS 1A, MEMBER 1; MAN1A1	4121
MIM604345		1p13	MANNOSIDASE, ALPHA, CLASS 1A, MEMBER 2; MAN1A2	10905
MIM604346		 	MANNOSIDASE, ALPHA, CLASS 1B, MEMBER 1; MAN1B1	11253
MIM604347		1p22.1-p21.3	ZINC FINGER PROTEIN 265; ZNF265	9406
MIM604348	CN028819	2q37.3	ADVANCED SLEEP-PHASE SYNDROME, FAMILIAL	8864
MIM604349		9q33-q34	LAMININ, GAMMA-3; LAMC3	10319
MIM604350		19p13.2	RAS-ASSOCIATED PROTEIN RAB3D; RAB3D	9545
MIM604351		9q22	PHD FINGER PROTEIN 2; PHF2	5253
MIM604352	C1858493	5q14.3	FEBRILE SEIZURES, FAMILIAL, 4; FEB4	84059
MIM604353		 	CYSTEINE- AND HISTIDINE-RICH DOMAIN-CONTAINING PROTEIN 1; CHORDC1	26973
MIM604354		13q14	NUCLEAR FRAGILE X MENTAL RETARDATION PROTEIN-INTERACTING PROTEIN 1; NUFIP1	26747
MIM604355		7q32	COATOMER PROTEIN COMPLEX, SUBUNIT GAMMA-2; COPG2	26958
MIM604356	C0751083	2q31-q32.1	DUANE RETRACTION SYNDROME 2; DURS2	1123
MIM604357		 	MAB21, C. ELEGANS, HOMOLOG-LIKE 2; MAB21L2	10586
MIM604358		 	STROMAL ANTIGEN 1; STAG1	10274
MIM604360	C1858479	15q21.1	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11	80208
MIM604362		13q21-q22	LIM DOMAIN ONLY 7; LMO7	4008
MIM604363	C1858478	 	MYOCLONIC EPILEPSY, CONGENITAL DEAFNESS, MACULAR DYSTROPHY, AND PSYCHIATRIC DISORDERS	 
MIM604364	C1858477	22q11-q12	EPILEPSY, PARTIAL, WITH VARIABLE FOCI	50987
MIM604365		4p15.3	PROMININ 1; PROM1	8842
MIM604366		9p21-p13	DYNEIN, AXONEMAL, INTERMEDIATE CHAIN 1; DNAI1	27019
MIM604367	C1720861	7q11.23-q21.11, 3p25	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3	5468, 5506
MIM604368		 	GLYCOPROTEIN NMB; GPNMB	10457
MIM604369	C1096903	6q14-q15	SIALURIA, FINNISH TYPE	26503
MIM604370	C2676676	17q21, 14q32.3, 6q25.2-q27, 3q26.3	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1	672
MIM604371		 	HUMAN ENDOGENOUS RETROVIRUS-H LONG TERMINAL REPEAT-ASSOCIATING 2; HHLA2	11148
MIM604372		 	HUMAN ENDOGENOUS RETROVIRUS-H LONG TERMINAL REPEAT-ASSOCIATING 3; HHLA3	11147
MIM604373		22q12.1	CHECKPOINT KINASE 2, S. POMBE, HOMOLOG OF; CHEK2	11200
MIM604374		11q13.2-q13.3	METALLOTHIONEIN-LIKE 5, TESTIS-SPECIFIC; MTL5	9633
MIM604375		17q25	HUMAN GROWTH FACTOR-REGULATED TYROSINE KINASE SUBSTRATE; HGS	9146
MIM604376		 	MYELIN PROTEIN ZERO-LIKE 1; MPZL1	9019
MIM604377	C1858424	22q13	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY	9997
MIM604378		17q21	BECLIN 1; BECN1	8678
MIM604379	C1836672	3q27-q28	HYPOTRICHOSIS 7; HYPT7	200879
MIM604380	C1858422	 	ULNAR RAY DYSGENESIS WITH POSTAXIAL POLYDACTYLY AND RENAL CYSTIC DYSPLASIA	 
MIM604381	C1858420	 	PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	 
MIM604382	C1858419	 	LISSENCEPHALY, FAMILIAL, WITH CLEFT PALATE AND CEREBELLAR HYPOPLASIA	 
MIM604383		9q34.13	GROWTH FACTOR-INDEPENDENT 1B; GFI1B	8328
MIM604384		3q21-q24	ATPase, Ca(2+)-TRANSPORTING, TYPE 2C, MEMBER 1; ATP2C1	27032
MIM604385		3p24-p21	SODIUM CHANNEL, VOLTAGE-GATED, TYPE XI, ALPHA SUBUNIT; SCN11A	11280
MIM604386		8q24.12	ZINC FINGER TRANSCRIPTION FACTOR TRPS1; TRPS1	7227
MIM604387	C1858392	3q22	NEPHRONOPHTHISIS 3; NPHP3	27031
MIM604388		 	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-4; GNG4	2786
MIM604389		 	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-10; GNG10	2790
MIM604390		 	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-11; GNG11	2791
MIM604391	C1858391	11q21	ATAXIA-TELANGIECTASIA-LIKE DISORDER; ATLD	4361
MIM604392		17p13.1	ARYLHYDROCARBON-INTERACTING RECEPTOR PROTEIN-LIKE 1; AIPL1	23746
MIM604393	C1858386	17p13.1	LEBER CONGENITAL AMAUROSIS 4; LCA4	23746
MIM604394		7p22.2	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-12; GNA12	2768
MIM604395		14q24.3	MutL, E. COLI, HOMOLOG OF, 3; MLH3	27030
MIM604396		1q21	SET DOMAIN PROTEIN, BIFURCATED, 1; SETDB1	9869
MIM604397		9q21	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-14; GNA14	9630
MIM604398		11q13	MAMMAGLOBIN 2; MGB2	4246
MIM604399		 	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 1B; PPP1R1B	84152
MIM604400	C1858379	3p21.3, 3p25	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5	3921, 79188
MIM604401	C1858378	10p14-p12	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 6; ARVD6	27038
MIM604402		2p11.2	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 5; ST3GAL5	8869
MIM604403	C1858673	2q24, 2q24	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2	6323, 6335
MIM604404		13q32	GLYPICAN 6; GPC6	10082
MIM604405		19q13.3	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 6; SIGLEC6	946
MIM604406		17q24.3	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-13; GNA13	10672
MIM604407		4p16.3	LEUCINE ZIPPER/EF-HAND-CONTAINING TRANSMEMBRANE PROTEIN 1; LETM1	3954
MIM604409		1p35.3	GLUCOCORTICOID MODULATORY ELEMENT-BINDING PROTEIN 1; GMEB1	10691
MIM604410		19q13.3	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 7; SIGLEC7	27036
MIM604411		 	INNER CENTROMERE PROTEIN; INCENP	3619
MIM604412		14q32.1	T-CELL LEUKEMIA/LYMPHOMA 6; TCL6	27004
MIM604414		22q13.1	POLYMERASE II, RNA, SUBUNIT F; POLR2F	5435
MIM604415		7q21	SIX-TRANSMEMBRANE EPITHELIAL ANTIGEN OF PROSTATE; STEAP	26872
MIM604416	C1858361	15q24-q25.1	PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE	9051
MIM604417		5q31	AF4/FMR2 FAMILY, MEMBER 4; AFF4	27125
MIM604418		13q12	GAP JUNCTION PROTEIN, BETA-6; GJB6	10804
MIM604419		3q13.3	POLYMERASE, DNA, THETA; POLQ	10721
MIM604420		10q24	HEMATOPOIETICALLY EXPRESSED HOMEOBOX; HHEX	3087
MIM604421		Chr.9	PHOSDUCIN-LIKE; PDCL	5082
MIM604422		 	PANCREATIC LIPASE-RELATED PROTEIN 1; PNLIPRP1	5407
MIM604423		10q25.3	PANCREATIC LIPASE-RELATED PROTEIN 2; PNLIPRP2	5408
MIM604424		11p13	HOMEODOMAIN-INTERACTING PROTEIN KINASE 3; HIPK3	10114
MIM604425		1p31.1	LIM HOMEOBOX GENE 8; LHX8	431707
MIM604426		 	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 2; CYP4F2	8529
MIM604427		3p24.2-p22	SODIUM CHANNEL, VOLTAGE-GATED, TYPE X, ALPHA SUBUNIT; SCN10A	6336
MIM604428		 	PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 1; PRRG1	5638
MIM604429		 	PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 2; PRRG2	5639
MIM604430		 	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-7; GNG7	2788
MIM604431	C1858353	 	POLYNEUROPATHY, LETHAL NEONATAL, AXONAL SENSORIMOTOR, AUTOSOMAL RECESSIVE	 
MIM604432	C1858351	15q15.2	SPINOCEREBELLAR ATAXIA 11; SCA11	146057
MIM604433		11q13-q14	POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 3; KCNE3	10008
MIM604434		19q13.4	KALLIKREIN-RELATED PEPTIDASE 11; KLK11	11012
MIM604436		8p11.2	PROLINE SYNTHETASE COTRANSCRIBED, BACTERIA, HOMOLOG OF; PROSC	11212
MIM604437		3p21.3	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 3; SLC38A3	10991
MIM604438		 	KALLIKREIN-RELATED PEPTIDASE 7; KLK7	5650
MIM604439		4q13.1	GRB2-ASSOCIATED BINDING PROTEIN 1; GAB1	2549
MIM604440		 	CELL DEATH-INDUCING DFFA-LIKE EFFECTOR A; CIDEA	1149
MIM604441		 	CELL DEATH-INDUCING DFFA-LIKE EFFECTOR B; CIDEB	27141
MIM604443		5q31	ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 6; ACSL6	23305
MIM604444		10p12.3-p11.2	BMP AND ACTIVIN MEMBRANE-BOUND INHIBITOR, XENOPUS, HOMOLOG OF; BAMBI	25805
MIM604445		18q21.3	PROTEASE INHIBITOR 13; PI13	5275
MIM604446		10p12	PHOSPHOTRIESTERASE-RELATED PROTEIN; PTER	9317
MIM604447		Chr.15	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-5; GNB5	10681
MIM604448		2q11.2	CYTOHESIN 1-INTERACTING PROTEIN; CYTIP	9595
MIM604449		 	PROTEASOME 26S SUBUNIT, NON-ATPase, 11; PSMD11	5717
MIM604450		 	PROTEASOME 26S SUBUNIT, NON-ATPase, 12; PSMD12	5718
MIM604451	C1304297	 	BASAL CELL CARCINOMA, INFUNDIBULOCYSTIC	 
MIM604452		Chr.9	PROTEASOME 26S SUBUNIT, NON-ATPase, 5; PSMD5	5711
MIM604453		1q32.1	NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 2; NR5A2	2494
MIM604454	C0221054	2p13	WELANDER DISTAL MYOPATHY; WDM	50988
MIM604455		9q33-q34	SARCOSINE DEHYDROGENASE; SARDH	1757
MIM604456		Chr.11	INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 1; IFITM1	8519
MIM604457		2q37.1	NUCLEAR BODY PROTEIN SP110; SP110	3431
MIM604459		12q14.3	INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 3; IRAK3	11213
MIM604460		 	FAS-ASSOCIATED FACTOR 1; FAF1	11124
MIM604461		14q13.3-q21.1	HUMAN PAPILLOMAVIRUS TYPE 6A INTEGRATION SITE 1; HPV6AI1	3259
MIM604462		 	SEMAPHORIN 4C; SEMA4C	54910
MIM604463		 	CD160 ANTIGEN; CD160	11126
MIM604464		2p25	INTERSECTIN 2; ITSN2	50618
MIM604465		9p22	SH3 DOMAIN, GRB2-LIKE, 2; SH3GL2	6456
MIM604466		12q13	METHYLTRANSFERASE-LIKE 1; METTL1	4234
MIM604467		 	MONOCYTE-TO-MACROPHAGE DIFFERENTIATION-ASSOCIATED PROTEIN; MMD	23531
MIM604468		 	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 6; MAP3K6	9064
MIM604469		 	EXOCYST COMPLEX COMPONENT 5; EXOC5	10640
MIM604470		 	CD2 ANTIGEN-BINDING PROTEIN 2; CD2BP2	10421
MIM604471		 	SOLUTE CARRIER FAMILY 1 (GLUTAMATE TRANSPORTER), MEMBER 7; SLC1A7	6512
MIM604472		 	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 13; TNFSF13	8741
MIM604473		6q24	GLUTAMATE RECEPTOR, METABOTROPIC, 1; GRM1	2911
MIM604474	C1858340	 	HUMAN HERPESVIRUS TYPE 6, INTEGRATED	 
MIM604475		2p14-p13	RETICULON 4; RTN4	57142
MIM604477		 	CHROMOBOX HOMOLOG 3; CBX3	11335
MIM604478		 	CHROMOBOX HOMOLOG 5; CBX5	23468
MIM604479		10q21.3	SIRTUIN 1; SIRT1	23411
MIM604480		19q	SIRTUIN 2; SIRT2	22933
MIM604481		11p15.5	SIRTUIN 3; SIRT3	23410
MIM604482		12q	SIRTUIN 4; SIRT4	23409
MIM604483		6p23	SIRTUIN 5; SIRT5	23408
MIM604484	C1858338	3q13.1	HEREDITARY MOTOR AND SENSORY NEUROPATHY, PROXIMAL TYPE; HMSNP	10342, 50989
MIM604485		15q23	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP E, MEMBER 3; NR2E3	10002
MIM604486		10q22-q23	PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, MITOCHONDRIAL; PPIF	10105
MIM604487		11p14.3	OTOGELIN; OTOG	340990
MIM604488		17q12	TITIN-CAP; TCAP	8557
MIM604489		5p13.2-q11.1	ALPHA-METHYLACYL-CoA RACEMASE; AMACR	23600
MIM604490		13q12	SACSIN; SACS	26278
MIM604491		3q	CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE B; CBLB	868
MIM604492		5q31	VOLTAGE-DEPENDENT ANION CHANNEL 1; VDAC1	7416
MIM604493		1p35.1	GAP JUNCTION PROTEIN, BETA-5; GJB5	2709
MIM604494		2q12	INTERLEUKIN 18 RECEPTOR 1; IL18R1	8809
MIM604495		19q13.1	NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR, BETA; NFKBIB	4793
MIM604496		 	NFKB INHIBITOR-INTERACTING RAS-LIKE PROTEIN 1; NKIRAS1	28512
MIM604497		 	NFKB INHIBITOR-INTERACTING RAS-LIKE PROTEIN 2; NKIRAS2	28511
MIM604498	C1327915	1p34	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL; CAMT	4352
MIM604499	C1858308	11p	HYPERLIPIDEMIA, COMBINED, 2	28515
MIM604500		17q12	ZINC FINGER HIT DOMAIN-CONTAINING PROTEIN 3; ZNHIT3	9326
MIM604501		 	THYROID HORMONE RECEPTOR INTERACTOR 4; TRIP4	9325
MIM604502		6q14.1	HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 3; HMGN3	9324
MIM604503		 	JUMONJI DOMAIN-CONTAINING PROTEIN 1C; JMJD1C	221037
MIM604504		 	THYROID HORMONE RECEPTOR INTERACTOR 10; TRIP10	9322
MIM604505		14q31-q32	THYROID HORMONE RECEPTOR INTERACTOR 11; TRIP11	9321
MIM604506		2q36.3	THYROID HORMONE RECEPTOR INTERACTOR 12; TRIP12	9320
MIM604507		 	THYROID HORMONE RECEPTOR INTERACTOR 13; TRIP13	9319
MIM604508		15q21.2	COP9, SUBUNIT 2; COPS2	9318
MIM604509		2q12	INTERLEUKIN 18 RECEPTOR ACCESSORY PROTEIN; IL18RAP	8807
MIM604510		7q31	HYALURONOGLUCOSAMINIDASE 4; HYAL4	23553
MIM604511		 	CHROMOBOX HOMOLOG 1; CBX1	10951
MIM604512		2q12	INTERLEUKIN 1 RECEPTOR-LIKE 2; IL1RL2	8808
MIM604513		 	CD84 ANTIGEN; CD84	8832
MIM604514		1q21	SH2 DOMAIN PROTEIN 2A; SH2D2A	9047
MIM604515		10q23.2	B-CELL LINKER PROTEIN; BLNK	29760
MIM604516		 	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 2; IGSF2	9398
MIM604517		4p15.1	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR 1, ALPHA; PPARGC1A	10891
MIM604518		22q12-qter	GRB2-RELATED ADAPTOR PROTEIN 2; GRAP2	9402
MIM604519	C1858303	6p21.3	INFLAMMATORY BOWEL DISEASE 3; IBD3	30829
MIM604520		19p13.3	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 14; TNFSF14	8740
MIM604521		 	3-@HYDROXYANTHRANILATE 3,4-DIOXYGENASE; HAAO	23498
MIM604522		 	DEFENSIN, ALPHA, 3; DEFA3	1668
MIM604523		22q13.3	CADHERIN EGF LAG SEVEN-PASS G-TYPE RECEPTOR 1; CELSR1	9620
MIM604524		 	LYMPHOCYTE ANTIGEN 75; LY75	4065
MIM604525		 	HISTAMINE RECEPTOR H3; HRH3	11255
MIM604526		20p13	ISOCITRATE DEHYDROGENASE 3, BETA SUBUNIT; IDH3B	3420
MIM604527		12q13	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 3; KCNH3	23416
MIM604528		 	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 4; KCNH4	23415
MIM604529		5q13.3	ORTHOPEDIA, DROSOPHILA, HOMOLOG OF; OTP	23440
MIM604530		19q13.42	NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NCR1	9437
MIM604531		6p21.1	NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NCR2	9436
MIM604532		10q24-q25	POLYCYSTIN 2-LIKE 1; PKD2L1	9033
MIM604533		15q26	INTERFERON-STIMULATED GENE, 20-KD; ISG20	3669
MIM604534		6p23	CD83 ANTIGEN; CD83	9308
MIM604535		16q13-q21	KINESIN FAMILY MEMBER C3; KIFC3	3801
MIM604536	C1858302	1q32	ECTODERMAL DYSPLASIA/SKIN FRAGILITY SYNDROME	5317
MIM604537	C1858301	6q14.1	LEBER CONGENITAL AMAUROSIS 5; LCA5	167691
MIM604538		1p34.1	KINESIN FAMILY MEMBER 2C; KIF2C	11004
MIM604539		5q23	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 2; ADAMTS2	9509
MIM604540		17q12-q21	KERATIN 36; KRT36	8689
MIM604541		17q12-q21	KERATIN 37; KRT37	8688
MIM604542		17q12-q21	KERATIN 38; KRT38	8687
MIM604543		3p21.3	LIM DOMAIN-CONTAINING PROTEIN 1; LIMD1	8994
MIM604544		3p21.3	LEUCYL-tRNA SYNTHETASE 2; LARS2	23395
MIM604545		 	KARYOPHERIN ALPHA-5; KPNA5	3841
MIM604546		8q24.3	NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR-LIKE 2; NFKBIL2	4796
MIM604547	C1858298	17p11.2-p11.2	VAN DER WOUDE SYNDROME 1, MODIFIER OF	100917
MIM604548		 	NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR, EPSILON; NFKBIE	4794
MIM604550		 	DENSITY-REGULATED PROTEIN; DENR	8562
MIM604551		10q23	CHOLESTEROL 25-HYDROXYLASE; CH25H	9023
MIM604552		4p16	HEPATOCYTE GROWTH FACTOR ACTIVATOR; HGFAC	3083
MIM604553		 	HEAT-SHOCK FACTOR-BINDING PROTEIN 1; HSBP1	3281
MIM604554		21q22.3	HEAT-SHOCK TRANSCRIPTION FACTOR 2-BINDING PROTEIN; HSF2BP	11077
MIM604555		5p14-p13	CADHERIN 10; CDH10	1008
MIM604556		19q12-q13.11	DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1B; DYRK1B	9149
MIM604557		16q12	ZINC FINGER PROTEIN 423; ZNF423	23090
MIM604558		2q33	INDUCIBLE T-CELL COSTIMULATOR; ICOS	29851
MIM604559	C1970298	19q13.32	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB; PFHB1B	54795, 8184
MIM604561		5q35	ALPHA-1,3-@MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE, ISOZYME B; MGAT4B	11282
MIM604562		Chr.14	ACINUS	22985
MIM604563	C1858278	11p15	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	81846
MIM604564		1q23	GLUTATHIONE S-TRANSFERASE, MICROSOMAL, 3; MGST3	4259
MIM604565		 	ALG5, S. CEREVISIAE, HOMOLOG OF; ALG5	29880
MIM604566		1p22.3	ALG6, S. CEREVISIAE, HOMOLOG OF; ALG6	29929
MIM604567		16p11.2	DOUBLE C2-LIKE DOMAIN-CONTAINING PROTEIN, ALPHA; DOC2A	8448
MIM604568		17p13.3	DOUBLE C2-LIKE DOMAIN-CONTAINING PROTEIN, BETA; DOC2B	8447
MIM604569		7q35-q36	CONTACTIN-ASSOCIATED PROTEIN-LIKE 2; CNTNAP2	26047
MIM604570		4q21.1	SHROOM FAMILY MEMBER 3; SHROOM3	57619
MIM604571	C1858266	6p21.3, 6p21.3, 6p21.3	BARE LYMPHOCYTE SYNDROME, TYPE I	6890, 6891, 6892
MIM604572		19p13.2	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 1; DNAJB1	3337
MIM604573		14q32.33	CHROMOSOME 14 OPEN READING FRAME 2; C14ORF2	9556
MIM604574		9q31-q33	CHROMOSOME 9 OPEN READING FRAME 4; C9ORF4	23732
MIM604575		11q13	ZINC FINGER HIT DOMAIN-CONTAINING PROTEIN 2; ZNHIT2	741
MIM604576		14q24	CHROMOSOME 14 OPEN READING FRAME 1; C14ORF1	11161
MIM604577		6q21	BLOOD VESSEL EPICARDIAL SUBSTANCE; BVES	11149
MIM604578		1q22	ABSENT IN MELANOMA 2; AIM2	9447
MIM604579		11q14-q21	FRIZZLED, DROSOPHILA, HOMOLOG OF, 4; FZD4	8322
MIM604580		14q32.1	FIBULIN 5; FBLN5	10516
MIM604581		18p11	ATPase FAMILY GENE 3-LIKE 2; AFG3L2	10939
MIM604582		9q31-q33	A-KINASE ANCHOR PROTEIN 2; AKAP2	11217
MIM604583		 	PROGRAMMED CELL DEATH 5; PDCD5	9141
MIM604584		8p22-p21.3	PLATELET-DERIVED GROWTH FACTOR RECEPTOR-LIKE; PDGFRL	5157
MIM604585		2q37.1	NUCLEAR BODY PROTEIN SP100; SP100	6672
MIM604586		6q24.3	SYNTAXIN-BINDING PROTEIN 5; STXBP5	134957
MIM604587		 	CALCIUM BINDING AND COILED-COIL DOMAIN PROTEIN 2; CALCOCO2	10241
MIM604588		4q33	NEVER IN MITOSIS GENE A-RELATED KINASE 1; NEK1	4750
MIM604589		22q13	BROMODOMAIN-CONTAINING PROTEIN 1; BRD1	23774
MIM604590		1q22	Fc FRAGMENT OF IgG, LOW AFFINITY IIb, RECEPTOR FOR; FCGR2B	2213
MIM604591		12q24.23	PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN 1; PEBP1	5037
MIM604592		11q13.4-q13.5	T CELL IMMUNE REGULATOR 1; TCIRG1	10312
MIM604593		2q23.1	KINESIN FAMILY MEMBER 5C; KIF5C	3800
MIM604594		 	CYSTEINE-RICH INTERACTOR OF PDZ3	9419
MIM604595	C1858233	13q	CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1	54501
MIM604596		 	CMT1A DUPLICATED REGION TRANSCRIPT 1; CDRT1	374286
MIM604597		12q14.3	GLUTAMATE RECEPTOR-INTERACTING PROTEIN 1; GRIP1	23426
MIM604598		8q21	CHROMOSOME 8 OPEN READING FRAME 1; C8ORF1	734
MIM604599		 	EUCHROMATIC HISTONE-LYSINE N-METHYLTRANSFERASE 2; EHMT2	10919
MIM604600		11p15.5	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 5; TRPM5	29850
MIM604601		13q14.1-q14.3	TRANSLATIONAL RELEASE FACTOR, MITOCHONDRIAL, 1; MTRF1	9617
MIM604602		9q32-q34.1	RIBOSOME-RECYCLING FACTOR, MITOCHONDRIAL; MRRF	92399
MIM604603		 	FER-1, C. ELEGANS, HOMOLOG-LIKE 3; FER1L3	26509
MIM604604		4p13-p12	CHROMOSOME 4 OPEN READING FRAME 1; C4ORF1	10463
MIM604605		 	KALIRIN; KALRN	8997
MIM604606		9q34	ODORANT-BINDING PROTEIN 2B; OBP2B	29989
MIM604607		17q21.2	HOMEOBOX B13; HOXB13	10481
MIM604609		7q22	MUCIN 12; MUC12	10071
MIM604610		15q26.1	RECQ PROTEIN-LIKE 3; RECQL3	641
MIM604611		8p12-p11.2	RECQ PROTEIN-LIKE 2; RECQL2	7486
MIM604612		20p11	NK2 HOMEOBOX 2; NKX2-2	4821
MIM604613		 	T-BOX 18; TBX18	9096
MIM604614		1q23-q24	T-BOX 19; TBX19	9095
MIM604615		3p21.3-p21.2	EOMESODERMIN, XENOPUS, HOMOLOG OF; EOMES	8320
MIM604616		2q23-q37	T-BOX, BRAIN, 1; TBR1	10716
MIM604617		11q13.5	NEURAMINIDASE 3; NEU3	10825
MIM604618		1q21-q22	NITRILASE 1; NIT1	4817
MIM604619		10q24	LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 1; LGI1	9211
MIM604620		14q31-q32.1	G PROTEIN-COUPLED RECEPTOR 65; GPR65	8477
MIM604621		22q13.1	BETA-1,4-@MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE; MGAT3	4248
MIM604622	C1847874	 	AORTIC ANEURYSM, GIANT CONGENITAL	 
MIM604623		2q12	ALPHA-1,3-@MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE, ISOZYME A; MGAT4A	11320
MIM604624		5q11.2	HEAT-SHOCK 27-KD PROTEIN 3; HSPB3	8988
MIM604625	C1970291	14q12-q13	TOOTH AGENESIS, SELECTIVE, 3; STHAG3	5083
MIM604626		11cen-q22.3	MALIC ENZYME 3; ME3	10873
MIM604627		5q32-q34	INTERLEUKIN 17B; IL17B	27190
MIM604628		16q24	INTERLEUKIN 17C; IL17C	27189
MIM604629		11q22.3-q23	MATRIX METALLOPROTEINASE 20; MMP20	9313
MIM604630		1p36.1	NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 2; NR0B2	8431
MIM604631		17q21	VESICLE AMINE TRANSPORT PROTEIN 1	10493
MIM604632		16q22.1	VAC14, S. CEREVISIAE, HOMOLOG OF; VAC14	55697
MIM604633		11q13	EGF-CONTAINING FIBULIN-LIKE EXTRACELLULAR MATRIX PROTEIN 2; EFEMP2	30008
MIM604634		1q21-q25	TRANSGELIN 2; TAGLN2	8407
MIM604635		 	NEUREXOPHILIN 2; NXPH2	11249
MIM604636		 	NEUREXOPHILIN 3; NXPH3	11248
MIM604637		 	NEUREXOPHILIN 4; NXPH4	11247
MIM604638		19q13	ACTININ, ALPHA-4; ACTN4	81
MIM604639		 	NEUREXOPHILIN 1; NXPH1	30010
MIM604640		5q35.1	T-CELL LEUKEMIA HOMEOBOX 3; TLX3	30012
MIM604641		11p12-p11.2	MITOGEN-ACTIVATED PROTEIN KINASE 8-INTERACTING PROTEIN 1; MAPK8IP1	9479
MIM604642		Chr.17	CARBONIC ANHYDRASE X; CA10	56934
MIM604643		 	NEUROPEPTIDE FF-AMIDE PEPTIDE; NPFF	8620
MIM604644		19q13.2-q13.3	CARBONIC ANHYDRASE XI; CA11	770
MIM604645		 	PHOSPHODIESTERASE 7B, cAMP-SPECIFIC, HIGH-AFFINITY; PDE7B	27115
MIM604646		22q13.3	NUCLEOPORIN, 50-KD; NUP50	10762
MIM604647		 	DOPAMINE RECEPTOR D1-INTERACTING PROTEIN; DRD1IP	50632
MIM604648		11q13.1-q13.2	T-BOX 10; TBX10	347853
MIM604649		17q25	TUBULIN-SPECIFIC CHAPERONE D; TBCD	6904
MIM604650		10q23.3	INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 4; IFIT4	3437
MIM604651		2p24-p23	GROWTH/DIFFERENTIATION FACTOR 7; GDF7	151449
MIM604652		 	TRANSCRIPTION FACTOR 7-LIKE 1; TCF7L1	83439
MIM604653		2q32	SOLUTE CARRIER FAMILY 40 (IRON-REGULATED TRANSPORTER), MEMBER 1; SLC40A1	30061
MIM604654		11q23.1	5-@HYDROXYTRYPTAMINE RECEPTOR 3B; HTR3B	9177
MIM604655		17q21	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14; MAP3K14	9020
MIM604656		17q21	FORMIN-LIKE; FMNL	752
MIM604657		17p13.3	TRANSMEMBRANE 4 SUPERFAMILY, MEMBER 5; TM4SF5	9032
MIM604658		1q42-q43	TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 1; TM7SF1	7107
MIM604659		7q21-q22	ENDOGENOUS RETROVIRAL FAMILY W, ENV-C7, MEMBER 1; ERVWE1	30816
MIM604660		 	POTASSIUM CHANNEL-INTERACTING PROTEIN 1; KCNIP1	30820
MIM604661		 	POTASSIUM CHANNEL-INTERACTING PROTEIN 2; KCNIP2	30819
MIM604662		2q11.1	POTASSIUM CHANNEL-INTERACTING PROTEIN 3; KCNIP3	30818
MIM604663		2q35	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 6; WNT6	7475
MIM604664		19p13.11	INTERFERON-GAMMA-INDUCIBLE PROTEIN 30; IFI30	10437
MIM604665		17p11.2	COP9, SUBUNIT 3; COPS3	8533
MIM604666		 	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4; MAP4K4	9448
MIM604667		3p21.1	CALCIUM-DEPENDENT ACTIVATOR PROTEIN FOR SECRETION; CADPS	8618
MIM604668		19q13.4	ZINC FINGER PROTEIN 264; ZNF264	9422
MIM604669		5q31	POLYCYSTIN 2-LIKE 2; PKD2L2	27039
MIM604670		22q13.3	POLYCYSTIN AND SEA URCHIN REJ HOMOLOG-LIKE; PKDREJ	10343
MIM604671		1q21	JUMPING TRANSLOCATION BREAKPOINT; JTB	10899
MIM604672		19p13.3	CD209 ANTIGEN; CD209	30835
MIM604673		 	MURINE RETROVIRUS INTEGRATION SITE 1, HOMOLOG OF; MRVI1	10335
MIM604674		6q21	HAIRY/ENHANCER OF SPLIT-RELATED WITH YRPW MOTIF 2; HEY2	23493
MIM604675		9q34.1	PAIRED-RELATED HOMEOBOX GENE 2; PRRX2	51450
MIM604676		6p21.3	HLA COMPLEX P5 GENE; HCP5	10866
MIM604677		 	COLLAGEN, TYPE IV, ALPHA-3 BINDING PROTEIN; COL4A3BP	10087
MIM604678		 	TRANSMEMBRANE 9 SUPERFAMILY, MEMBER 2; TM9SF2	9375
MIM604679		8q22	POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 1; PABPC1	26986
MIM604680		13q11-q12	POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 3; PABPC3	5042
MIM604681		12q13-q14	POLYADENYLATE-BINDING PROTEIN-LIKE 2; PABPL2	341315
MIM604682		 	INTEGRIN, ALPHA-E; ITGAE	3682
MIM604683		5q31	KINESIN FAMILY MEMBER 3A; KIF3A	11127
MIM604684		1q21	MYELOID/LYMPHOID OR MIXED-LINEAGE LEUKEMIA, TRANSLOCATED TO, 11; MLLT11	10962
MIM604685		7p15-p14	HOMEOBOX A2; HOXA2	3199
MIM604686		15q24-q25	A-KINASE ANCHOR PROTEIN 13; AKAP13	11214
MIM604687		14q22.1	PROSTAGLANDIN D2 RECEPTOR; PTGDR	5729
MIM604688		 	A-KINASE ANCHOR PROTEIN 5; AKAP5	9495
MIM604689		 	A-KINASE ANCHOR PROTEIN 3; AKAP3	10566
MIM604690	C1858182	 	GROWTH AND DEVELOPMENTAL RETARDATION, OCULAR PTOSIS, CARDIAC DEFECT, AND ANAL ATRESIA	 
MIM604691		14q	A-KINASE ANCHOR PROTEIN 6; AKAP6	9472
MIM604692		 	A-KINASE ANCHOR PROTEIN 8; AKAP8	10270
MIM604693		 	A-KINASE ANCHOR PROTEIN 7; AKAP7	9465
MIM604694		17p11.1	A-KINASE ANCHOR PROTEIN 10; AKAP10	11216
MIM604695		10q23.3	ADP-RIBOSYLATION FACTOR-LIKE 3; ARL3	403
MIM604696		 	A-KINASE ANCHOR PROTEIN 11; AKAP11	11215
MIM604697		7q11.2	CHEMOKINE, CC MOTIF, LIGAND 26; CCL26	10344
MIM604698		 	A-KINASE ANCHOR PROTEIN 12; AKAP12	9590
MIM604699		 	ADP-RIBOSYLATION FACTOR-RELATED PROTEIN 1; ARFRP1	10139
MIM604700		 	TARGET OF MYB1, CHICKEN, HOMOLOG OF; TOM1	10043
MIM604701		 	TOM1-LIKE 1; TOM1L1	10040
MIM604702		22q13.1	HMG BOX DOMAIN-CONTAINING 4; HMGXB4	10042
MIM604704		 	BREAST CANCER ANTIESTROGEN RESISTANCE 3; BCAR3	8412
MIM604705		2q14.1	MER TYROSINE KINASE PROTOONCOGENE; MERTK	10461
MIM604707		 	ALDO-KETO REDUCTASE FAMILY 1, MEMBER B10; AKR1B10	57016
MIM604708		 	NUCLEAR FACTOR OF ACTIVATED T CELLS 5; NFAT5	10725
MIM604709		 	T-CELL LYMPHOMA INVASION AND METASTASIS 2; TIAM2	26230
MIM604710		19q13.1-q13.2	LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 4; LTBP4	8425
MIM604711		13q12-q13	UBIQUITIN-LIKE 3; UBL3	5412
MIM604712		8q23.1	RIBONUCLEOTIDE REDUCTASE, M2 B; RRM2B	50484
MIM604713		 	C-TYPE LECTIN DOMAIN FAMILY 11, MEMBER A; CLEC11A	6320
MIM604714		6q22-q23	TSPY-LIKE 1; TSPYL1	7259
MIM604715	C0026267	16q12.2	ORTHOSTATIC INTOLERANCE	6530
MIM604716		4q13	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER A1; UGT2A1	10941
MIM604717	C1858172	17q25.3	DEAFNESS, AUTOSOMAL DOMINANT 20; DFNA20	71
MIM604718		 	TRANSCRIPTION TERMINATION FACTOR, RNA POLYMERASE II; TTF2	8458
MIM604719		 	SERINE/THREONINE PROTEIN KINASE 16; STK16	8576
MIM604720		7q22	TRANSFERRIN RECEPTOR 2; TFR2	7036
MIM604721		 	SH2 DOMAIN-CONTAINING PROTEIN 3A; SH2D3A	10045
MIM604722		 	SH2 DOMAIN-CONTAINING PROTEIN 3C; SH2D3C	10044
MIM604723		12q13-q14	Ts TRANSLATION ELONGATION FACTOR, MITOCHONDRIAL; TSFM	10102
MIM604724		4q21.3	HEPARANASE; HPSE	10855
MIM604725		 	UBIQUITIN-SPECIFIC PROTEASE 2; USP2	9099
MIM604726		 	SERINE/THREONINE PROTEIN KINASE 17A; STK17A	9263
MIM604727		 	SERINE/THREONINE PROTEIN KINASE 17B; STK17B	9262
MIM604728		15q22.3	UBIQUITIN-SPECIFIC PROTEASE 3; USP3	9960
MIM604729		1q22	UBIQUITIN-SPECIFIC PROTEASE 21; USP21	27005
MIM604730		12p13	TUBBY-LIKE PROTEIN 3; TULP3	7289
MIM604731		 	UBIQUITIN-SPECIFIC PROTEASE 15; USP15	9958
MIM604732		 	TRANSCRIPTION FACTOR EC; TFEC	22797
MIM604733		1p13.3-p13.1	TRYPTOPHANYL-tRNA SYNTHETASE 2; WARS2	10352
MIM604734		4p	WD REPEAT-CONTAINING PROTEIN 1; WDR1	9948
MIM604735		 	UBIQUITIN-SPECIFIC PROTEASE 16; USP16	10600
MIM604736		 	UBIQUITIN-SPECIFIC PROTEASE 25; USP25	29761
MIM604737		1p13-p12	WD REPEAT-CONTAINING PROTEIN 3; WDR3	10885
MIM604738		3p21.3	CHEMOKINE, CC MOTIF, RECEPTOR 9; CCR9	10803
MIM604739		 	RNA BINDING MOTIF PROTEIN 39; RBM39	9584
MIM604740		1q21	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 1; SLC39A1	27173
MIM604741		7q32-q33	ALDO-KETO REDUCTASE FAMILY 1, MEMBER D1; AKR1D1	6718
MIM604742		13q13	DOUBLECORTIN-LIKE KINASE 1; DCLK1	9201
MIM604743		1p22	DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1; DDAH1	23576
MIM604744		6p21.3	DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 2; DDAH2	23564
MIM604745		 	TRANSCRIPTION FACTOR-LIKE 5; TCFL5	10732
MIM604746		 	TESTIS-SPECIFIC PROTEIN KINASE 2; TESK2	10420
MIM604747		3q23	SRY-BOX 14; SOX14	8403
MIM604748		1q32	SRY-BOX 13; SOX13	9580
MIM604749		19q13.2	ZINC FINGER PROTEIN 93, MOUSE, HOMOLOG OF; ZFP93	9310
MIM604750		 	ZINC FINGER PROTEIN 234; ZNF234	10780
MIM604751		19p13.2	ZINC FINGER PROTEIN 266; ZNF266	10781
MIM604752		Chr.16	ZINC FINGER PROTEIN 267; ZNF267	10308
MIM604753		12q24.3	ZINC FINGER PROTEIN 268; ZNF268	10795
MIM604754		18q12	ZINC FINGER PROTEIN 271; ZNF271	10778
MIM604755		19q13.4	ZINC FINGER PROTEIN 272; ZNF272	10794
MIM604756		 	ZINC FINGER PROTEIN 273; ZNF273	10793
MIM604757	C1858160	5q34-q35	CRANIOSYNOSTOSIS, TYPE 2; CRS2	4488
MIM604758		19q13.32	V-REL AVIAN RETICULOENDOTHELIOSIS VIRAL ONCOGENE HOMOLOG B; RELB	5971
MIM604759		12q23	SYNAPTONEMAL COMPLEX PROTEIN 3; SYCP3	50511
MIM604760		18q22-q23	ZINC FINGER PROTEIN 236; ZNF236	7776
MIM604761		9q13-q21	ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 5; ZFAND5	7763
MIM604762		11p15	SWITCH-ASSOCIATED PROTEIN 70	23075
MIM604763		11q23.3	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 12; ARHGEF12	23365
MIM604764		8q	ZINC FINGER AND HOMEODOMAIN PROTEIN 1; ZHX1	11244
MIM604765	C1858154	2q35	CARDIOMYOPATHY, DILATED, 1I; CMD1I	1674
MIM604766		1q25-q31	PODOCIN; NPHS2	7827
MIM604767		9q32	DELETED IN ESOPHAGEAL CANCER 1; DEC1	50514
MIM604768		19p13.12-p13.11	ZINC FINGER PROTEIN 254; ZNF254	9534
MIM604769		10q25-q26	PEROXIREDOXIN 3; PRDX3	10935
MIM604770		 	ACETYL-CoA ACYLTRANSFERASE 2; ACAA2	10449
MIM604772	CN033270	1q42.1-q43	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	10345, 6262, 845
MIM604773		11q25	ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 8; ACAD8	27034
MIM604774		1p31	ANGIOPOIETIN-LIKE 3; ANGPTL3	27329
MIM604775		8q13	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY A, MEMBER 1; TRPA1	8989
MIM604776		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-5; HLA-DRB5	3127
MIM604777	C1858142	19p13.12	ICHTHYOSIS, LAMELLAR, 3; LI3	126410
MIM604778		4q34	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 29; ADAM29	11086
MIM604779		1p13-p11	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 30; ADAM30	11085
MIM604780		3p21	ABHYDROLASE DOMAIN-CONTAINING 5; ABHD5	51099
MIM604781	C1858142	19p13.2-p13.1	ICHTHYOSIS, NONLAMELLAR AND NONERYTHRODERMIC, CONGENITAL, AUTOSOMAL RECESSIVE; NNCI	50992
MIM604782		8p11.2	ASH2-LIKE; ASH2L	9070
MIM604783		 	CLEFT LIP- AND PALATE-ASSOCIATED TRANSMEMBRANE PROTEIN 1; CLPTM1	1209
MIM604784		 	TRANSCRIPTION ELONGATION FACTOR A, 2; TCEA2	6919
MIM604785		9q31.2	CATENIN, ALPHA-LIKE, 1; CTNNAL1	8727
MIM604786		7q	ADP-RIBOSYLATION FACTOR-LIKE 4A; ARL4A	10124
MIM604787		 	ADP-RIBOSYLATION FACTOR-LIKE 4C; ARL4C	10123
MIM604788		19q13.3	RUVB, E. COLI, HOMOLOG-LIKE 2; RUVBL2	10856
MIM604789		15q23	INTEGRIN, ALPHA-11; ITGA11	22801
MIM604790		12p13	TASTE RECEPTOR, TYPE 2, MEMBER 14; TAS2R14	50840
MIM604791		12p13	TASTE RECEPTOR, TYPE 2, MEMBER 10; TAS2R10	50839
MIM604792		12p13	TASTE RECEPTOR, TYPE 2, MEMBER 13; TAS2R13	50838
MIM604793		12p13	TASTE RECEPTOR, TYPE 2, MEMBER 7; TAS2R7	50837
MIM604794		12p13	TASTE RECEPTOR, TYPE 2, MEMBER 8; TAS2R8	50836
MIM604795		12p13	TASTE RECEPTOR, TYPE 2, MEMBER 9; TAS2R9	50835
MIM604796		5p15	TASTE RECEPTOR, TYPE 2, MEMBER 1; TAS2R1	50834
MIM604797		6p21	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 2; APOBEC2	10930
MIM604798		5q14.2	HOMER, DROSOPHILA, HOMOLOG OF, 1; HOMER1	9456
MIM604799		15q24.3	HOMER, DROSOPHILA, HOMOLOG OF, 2; HOMER2	9455
MIM604800		19p13.11	HOMER, DROSOPHILA, HOMOLOG OF, 3; HOMER3	9454
MIM604801	C1858118	1q42	MUSCULAR DYSTROPHY, CONGENITAL, 1B; MDC1B	53368
MIM604802	C1858114	4p15.3	HUNTINGTON DISEASE-LIKE 3; HDL3	53369
MIM604803		21q22.2	DOPEY FAMILY MEMBER 2; DOPEY2	9980
MIM604804	C1858108	9q33.3	MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	55755
MIM604805	C1858106	19q13	SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT; SPG12	6253
MIM604806		11q12-q13	FIBRONECTIN-LIKE DOMAIN-CONTAINING LEUCINE-RICH TRANSMEMBRANE PROTEIN 1; FLRT1	23769
MIM604807		14q24-q32	FIBRONECTIN-LIKE DOMAIN-CONTAINING LEUCINE-RICH TRANSMEMBRANE PROTEIN 2; FLRT2	23768
MIM604808		20p11	FIBRONECTIN-LIKE DOMAIN-CONTAINING LEUCINE-RICH TRANSMEMBRANE PROTEIN 3; FLRT3	23767
MIM604809	C0878555	6p21.3	PANBRONCHIOLITIS, DIFFUSE	 
MIM604810		19q13.2	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 1; LILRA1	11024
MIM604811		19q13.4	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 1; LILRB1	10859
MIM604812		19q13.4	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 2; LILRA2	11027
MIM604813		3q	CYTOCHROME c OXIDASE ASSEMBLY PROTEIN COX17; COX17	10063
MIM604814		19q13.2	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 5; LILRB5	10990
MIM604815		19q13.4	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 2; LILRB2	10288
MIM604817		16q22	CARBOHYDRATE SULFOTRANSFERASE 5; CHST5	23563
MIM604818		19q13.4	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 3; LILRA3	11026
MIM604819		 	POLY-U-BINDING SPLICING FACTOR, 60-KD; PUF60	22827
MIM604820		19q13.4	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 3; LILRB3	11025
MIM604821		19q13.4	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 4; LILRB4	11006
MIM604822		6p12	CALPAIN 11; CAPN11	11131
MIM604823		11q25	BarH-LIKE HOMEOBOX GENE 2; BARX2	8538
MIM604824		13q12	KLOTHO; KL	9365
MIM604825		Chr.11	FASCICULATION AND ELONGATION PROTEIN ZETA 1; FEZ1	9638
MIM604826		 	FASCICULATION AND ELONGATION PROTEIN ZETA 2; FEZ2	9637
MIM604827	C2751729	15q14	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 7; EIG7	50715
MIM604828		1q23	CHEMOKINE, C MOTIF, LIGAND 2; XCL2	6846
MIM604829		21q22.2	DOWN SYNDROME CRITICAL REGION GENE 4; DSCR4	10281
MIM604830	C1858101	 	MANDIBULOFACIAL DYSOSTOSIS SYNDROME, BAURU TYPE	 
MIM604831		4p16	EVC GENE; EVC	2121
MIM604832		1q21	CARBONIC ANHYDRASE XIV; CA14	23632
MIM604833		9p13	CHEMOKINE, CC MOTIF, LIGAND 27; CCL27	10850
MIM604834		 	TANK-BINDING KINASE 1; TBK1	29110
MIM604835		1q21-q22	DUAL-SPECIFICITY PHOSPHATASE 12; DUSP12	11266
MIM604836		3p24	CHEMOKINE, CC MOTIF, RECEPTOR 4; CCR4	1233
MIM604837		11q12-q13.3	G PROTEIN-COUPLED RECEPTOR 44; GPR44	11251
MIM604838		2q11.2-q12	G PROTEIN-COUPLED RECEPTOR 45; GPR45	11250
MIM604839		7q11.23	FK506-BINDING PROTEIN 6; FKBP6	8468
MIM604840		19p12	FK506-BINDING PROTEIN 8; FKBP8	23770
MIM604841	C1858084	1p21	STICKLER SYNDROME, TYPE II; STL2	1301
MIM604842		6q27	SOLUTE CARRIER FAMILY 22 (EXTRANEURONAL MONOAMINE TRANSPORTER), MEMBER 3; SLC22A3	6581
MIM604843		12p12	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1B1; SLCO1B1	10599
MIM604844		1p22	HEPARAN SULFATE 2-O-SULFOTRANSFERASE 1; HS2ST1	9653
MIM604845		9q21-q22	PROSTATE CANCER ANTIGEN 3; PCA3	50652
MIM604846		2q21	HEPARAN SULFATE 6-O-SULFOTRANSFERASE 1; HS6ST1	9394
MIM604847		10q26.2-q26.3	G PROTEIN-COUPLED RECEPTOR 26; GPR26	2849
MIM604849		6q24	TRACE AMINE-ASSOCIATED RECEPTOR 2; TAAR2	9287
MIM604850		 	COP9, SUBUNIT 5; COPS5	10987
MIM604851		4q13	G-RICH RNA SEQUENCE-BINDING FACTOR 1; GRSF1	2926
MIM604852		4q21.2	CHEMOKINE, CXC MOTIF, LIGAND 11; CXCL11	6373
MIM604853		16p13.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L28; MRPL28	10573
MIM604854		7p15.3-p15.2	INDOLETHYLAMINE N-METHYLTRANSFERASE; INMT	11185
MIM604855	C1858083	 	HYALURONAN METABOLISM, DEFECT IN	 
MIM604856	C0019621	 	LANGERHANS CELL HISTIOCYTOSIS	 
MIM604857		14q13.2	SIGNAL RECOGNITION PARTICLE, 54-KD; SRP54	6729
MIM604858		17q25.1	SIGNAL RECOGNITION PARTICLE, 68-KD; SRP68	6730
MIM604859		3p26-p24	LIM AND CYSTEINE-RICH DOMAINS 1; LMCD1	29995
MIM604860		18q21	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION GENE 1; MALT1	10892
MIM604861		13q11-q12	LARGE TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 2; LATS2	26524
MIM604862		2p13	CD207 ANTIGEN; CD207	50489
MIM604863		4q31	LECITHIN RETINOL ACYLTRANSFERASE; LRAT	9227
MIM604864	C1858079	12q13.11-q13.2	OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA	1280
MIM604865		2q32	KRUPPEL-LIKE FACTOR 7; KLF7	8609
MIM604866		 	PLEOMORPHIC ADENOMA GENE-LIKE 2; PLAGL2	5326
MIM604867		7q31	TASTE RECEPTOR, TYPE 2, MEMBER 16; TAS2R16	50833
MIM604868		7q31.3-q32	TASTE RECEPTOR, TYPE 2, MEMBER 3; TAS2R3	50831
MIM604869		7q31.3-q32	TASTE RECEPTOR, TYPE 2, MEMBER 4; TAS2R4	50832
MIM604870		2q12-q13	MACROPHAGE RECEPTOR WITH COLLAGENOUS STRUCTURE; MARCO	8685
MIM604871		20q11.2	MATRIX METALLOPROTEINASE 24; MMP24	10893
MIM604872		 	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 7; PCSK7	9159
MIM604873		11q24	MYELIN PROTEIN ZERO-LIKE 2; MPZL2	10205
MIM604874		12p13-p12	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY G, MEMBER 1; KLRG1	10219
MIM604875		15q22-q23	MYOSIN IXA; MYO9A	4649
MIM604876		6p12.3	REGULATOR OF CALCINEURIN 2; RCAN2	10231
MIM604877		22q12.2-q13.2	V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE FAMILY, PROTEIN F; MAFF	23764
MIM604878		15q13-q14	SOLUTE CARRIER FAMILY 12 (SODIUM/CHLORIDE TRANSPORTER), MEMBER 6; SLC12A6	9990
MIM604879		5p15.3	SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 7; SLC12A7	10723
MIM604881		17p13.3	RABPHILIN 3A-LIKE; RPH3AL	9501
MIM604882		10q21.3	NEUROGENIN 3; NEUROG3	50674
MIM604883		 	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 2; GTF3C2	2976
MIM604884		9q33.3-q34.11	NEVER IN MITOSIS GENE A-RELATED KINASE 6; NEK6	10783
MIM604885		17p13.3	MYB-BINDING PROTEIN 1A; MYBBP1A	10514
MIM604886		16q22-qter	COX4, NEIGHBOR OF; NOC4	10328
MIM604887		 	METHYLENETETRAHYDROFOLATE DEHYDROGENASE 2; MTHFD2	10797
MIM604888		 	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 3; GTF3C3	9330
MIM604889		13q13.2	NEUROBEACHIN; NBEA	26960
MIM604890		 	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 5; GTF3C5	9328
MIM604891		2q32.1-q32.2	NCK-ASSOCIATED PROTEIN 1; NCKAP1	10787
MIM604892		 	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 4; GTF3C4	9329
MIM604893		6q26	ANTISENSE IGF2R RNA, NONCODING; AIRN	100271873
MIM604894		18q21.1-q21.2	ONE CUT HOMEOBOX 2; ONECUT2	9480
MIM604895		17q21.3	T-BOX 21; TBX21	30009
MIM604896		20p12	MKKS GENE; MKKS	8195
MIM604897		5q31	PREFOLDIN 1; PFDN1	5201
MIM604898		20q13.2	PREFOLDIN 4; PFDN4	5203
MIM604899		12q12	PREFOLDIN 5; PFDN5	5204
MIM604900		8qter	DIACYLGLYCEROL O-ACYLTRANSFERASE 1; DGAT1	8694
MIM604901	C1858051	16q22	NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS; NAIC	84916
MIM604902		14q	BRF1, S. CEREVISIAE, HOMOLOG OF; BRF1	2972
MIM604903		1q42	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1A; TAF1A	9015
MIM604904		2p25	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1B; TAF1B	9014
MIM604905		16q24	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1C; TAF1C	9013
MIM604906	C1858050	1q42.1	SCHIZOPHRENIA 9; SCZD9	27185
MIM604907		17p11.2	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 13B; TNFRSF13B	23495
MIM604908		18p11.22	PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 1; PPP4R1	9989
MIM604909		12q15	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 2; CNOT2	4848
MIM604910		19q13.4	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 3; CNOT3	4849
MIM604911		7q22-qter	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 4; CNOT4	4850
MIM604912		 	TAF2 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 150-KD; TAF2	6873
MIM604913		8p22-p21.3	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 7; CNOT7	29883
MIM604914		17q25	JUMONJI DOMAIN-CONTAINING PROTEIN 6; JMJD6	23210
MIM604915		3q27	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 13; MAP3K13	9175
MIM604916	C1858043	 	HYDRONEPHROSIS, CONGENITAL, WITH CLEFT PALATE, CHARACTERISTIC FACIES, HYPOTONIA, AND MENTAL RETARDATION	 
MIM604917		16q21	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 1; CNOT1	23019
MIM604918		7q11.23-q21.1	PICCOLO, MOUSE, HOMOLOG OF; PCLO	27445
MIM604919	C1858042	 	BECKER NEVUS SYNDROME	 
MIM604921		 	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 3; MAP4K3	8491
MIM604922	C1858032	 	CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	 
MIM604923		Chr.14	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 5; MAP4K5	11183
MIM604924		 	RNA, U SMALL NUCLEAR, EXPORT ADAPTOR; RNUXA	51808
MIM604925		19q13.2	RAB ACCEPTOR 1; RABAC1	10567
MIM604926		 	PHOSPHATE CYTIDYLYLTRANSFERASE 1, CHOLINE, BETA ISOFORM; PCYT1B	9468
MIM604927		18q23	C-TERMINAL DOMAIN OF RNA POLYMERASE II SUBUNIT A, PHOSPHATASE OF, SUBUNIT 1; CTDP1	9150
MIM604928	C1858028	4q22-q24	WOLFRAM SYNDROME 2; WFS2	493856
MIM604930		2q12	NCK ADAPTOR PROTEIN 2; NCK2	8440
MIM604931	C3551716	1p36, 1q32-q41	CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1	3290, 9563
MIM604932		20q	PROTEIN KINASE, cAMP-DEPENDENT CATALYTIC, INHIBITOR GAMMA; PKIG	11142
MIM604933		1p34.3-p32.1	MutY, E. COLI, HOMOLOG OF; MUTYH	4595
MIM604934		1q42-q43	TUBULIN-SPECIFIC CHAPERONE E; TBCE	6905
MIM604935		9p24.3	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR 2; DMRT2	10655
MIM604936		19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 1; KIR2DL1	3802
MIM604937		19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 2; KIR2DL2	3803
MIM604938		19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 3; KIR2DL3	3804
MIM604939		2q23-q24	PHOSPHOLIPASE A2 RECEPTOR 1; PLA2R1	22925
MIM604941		 	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, ALPHA; PPP2R2A	5520
MIM604942		20p13	SYNTAPHILIN; SNPH	9751
MIM604943		7q22.1	SOLUTE CARRIER FAMILY 26, MEMBER 5; SLC26A5	375611
MIM604944		 	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B-DOUBLE PRIME, ALPHA; PPP2R3A	5523
MIM604945		19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 4; KIR2DL4	3805
MIM604946		19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, LONG CYTOPLASMIC TAIL, 1; KIR3DL1	3811
MIM604947		19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, LONG CYTOPLASMIC TAIL, 2; KIR3DL2	3812
MIM604948		19p13.3	GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GENE GADD45, BETA; GADD45B	4616
MIM604949		9q22.1-q22.2	GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GENE GADD45, GAMMA; GADD45G	10912
MIM604950		1p13	PUTATIVE HOMEODOMAIN TRANSCRIPTION FACTOR 1; PHTF1	10745
MIM604951		19p13.2	6-@PHOSPHOGLUCONOLACTONASE; PGLS	25796
MIM604952		19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 1; KIR2DS1	3806
MIM604953		19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 2; KIR2DS2	100132285
MIM604954		19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 3; KIR2DS3	3808
MIM604955		19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 4; KIR2DS4	3809
MIM604956		 	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 5; KIR2DS5	3810
MIM604958		3q26.3	ACTIN-LIKE 6A; ACTL6A	86
MIM604959		 	PHORBOL-12-MYRISTATE-13-ACETATE-INDUCED PROTEIN 1; PMAIP1	5366
MIM604960		 	PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 2; PACSIN2	11252
MIM604961		2q31.2	PHOSPHODIESTERASE 11A; PDE11A	50940
MIM604962		3q13	T-CELL RECEPTOR-ASSOCIATED TRANSMEMBRANE ADAPTOR 1; TRAT1	50852
MIM604963		19q13	PEPTIDOGLYCAN RECOGNITION PROTEIN 1; PGLYRP1	8993
MIM604964		9p13-p12	SHP2-INTERACTING TRANSMEMBRANE ADAPTOR PROTEIN 1; SIT1	27240
MIM604965		20q11.2-q13.2	SERINE/THREONINE PROTEIN KINASE 4; STK4	6789
MIM604966		5q31	PROTOCADHERIN-ALPHA GENE CLUSTER; PCDHA@	56117
MIM604967		5q31	PROTOCADHERIN-BETA GENE CLUSTER; PCDHB@	56116
MIM604968		5q31	PROTOCADHERIN-GAMMA GENE CLUSTER; PCDHG@	56115
MIM604969		Chr.17	SRC KINASE-ASSOCIATED PHOSPHOPROTEIN 1; SKAP1	8631
MIM604970		17p13.1	AURORA KINASE B; AURKB	9212
MIM604971		6p21	MYOD FAMILY INHIBITOR; MDFI	4188
MIM604972		6q15	ORIGIN RECOGNITION COMPLEX, SUBUNIT 3, S. CEREVISIAE, HOMOLOG OF; ORC3	23595
MIM604973		1p36.11	FICOLIN 3; FCN3	8547
MIM604974		13q31-q32	SRY-BOX 21; SOX21	11166
MIM604975		12p12.1	SRY-BOX 5; SOX5	6660
MIM604976		2q35	PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-3; PRKAG3	53632
MIM604977		6p21.3	SERINE/THREONINE PROTEIN KINASE 19; STK19	8859
MIM604978		Chr.16	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 5; CPSF5	11051
MIM604979		Chr.12	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 6; CPSF6	11052
MIM604980		 	GTPase-ACTIVATING PROTEIN, RAC, 1; RACGAP1	29127
MIM604981		 	WW DOMAIN-CONTAINING BINDING PROTEIN 4; WBP4	11193
MIM604982		10q23.1	HPS1 GENE; HPS1	3257
MIM604983		17q23-q24	POLYMERASE, DNA, GAMMA-2; POLG2	11232
MIM604984		13q31.2-q32.3	SERINE/THREONINE PROTEIN KINASE 24; STK24	8428
MIM604985		11q13	SPECTRIN, BETA, NONERYTHROCYTIC, 2; SPTBN2	6712
MIM604986		12q24	BRCA1-ASSOCIATED PROTEIN; BRAP	8315
MIM604987		7q33	C-TYPE LECTIN DOMAIN FAMILY 5, MEMBER A; CLEC5A	23601
MIM604988		Chr.11	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 2B1; SLCO2B1	11309
MIM604989		Chr.11	SPONDIN 1; SPON1	10418
MIM604990		17q25.1	SOLUTE CARRIER FAMILY 9, MEMBER 3, REGULATOR 1; SLC9A3R1	9368
MIM604991		5q12	PROSTATE ANDROGEN-REGULATED TRANSCRIPT 1; PART1	25859
MIM604992		16p13.3	SARCALUMENIN; SRL	6345
MIM604993		10p13	PRECURSOR mRNA-PROCESSING FACTOR 18, S. CEREVISIAE, HOMOLOG OF; PRPF18	8559
MIM604994		2p16-p15	SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 2; SIX2	10736
MIM604995		6p21.2-p21.1	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION TRANSPORTER), MEMBER 7; SLC22A7	10864
MIM604996		19q13.12	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 3; FXYD3	5349
MIM604997		8p21.3	DOCKING PROTEIN 2; DOK2	9046
MIM604998		3p25.3	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I; CAMK1	8536
MIM604999		 	SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 1; SHANK1	50944
MIM605000		16p11.2	CORONIN 1A; CORO1A	11151
MIM605001		 	ANGIOPOIETIN-LIKE 2; ANGPTL2	23452
MIM605002		15q23	CORONIN 2B; CORO2B	10391
MIM605003		6q13	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 6; SENP6	26054
MIM605004		3q13.3	GLYCOGEN SYNTHASE KINASE 3-BETA; GSK3B	2932
MIM605005		4q31.1	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 7; GALNT7	51809
MIM605006		10q24.1	FREQUENTLY REARRANGED IN ADVANCED T-CELL LYMPHOMAS 2; FRAT2	23401
MIM605007		21q21-q22	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 5; ADAMTS5	11096
MIM605008		5q12	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 6; ADAMTS6	11174
MIM605009		Chr.15	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 7; ADAMTS7	11173
MIM605010		5q32	SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 5; SPINK5	11005
MIM605011		4q21	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 3; ADAMTS3	9508
MIM605012		 	SUPPRESSOR OF TY 16, S. CEREVISIAE, HOMOLOG OF; SUPT16H	11198
MIM605013	C1857977	16p13.3-p12.1	MICROHYDRANENCEPHALY; MHAC	53341
MIM605014		6q24	SYNTAXIN 11; STX11	8676
MIM605015		11p15.4	ZINC FINGER PROTEIN 214; ZNF214	7761
MIM605016		11p15.4	ZINC FINGER PROTEIN 215; ZNF215	7762
MIM605017		22q11	PRE-B-LYMPHOCYTE GENE 3; VPREB3	29802
MIM605018		16q12-q13	CYLD GENE; CYLD	1540
MIM605019	C1857970	1p31	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2; FHBL2	27329
MIM605020		20p11.2	VISUAL SYSTEM HOMEOBOX GENE 1, ZEBRAFISH, HOMOLOG OF; VSX1	30813
MIM605021	C0917800	16p13.3	MYOCLONIC EPILEPSY, FAMILIAL INFANTILE; FIME	54119, 57465
MIM605022		3q29	p21 PROTEIN-ACTIVATED KINASE 2; PAK2	5062
MIM605023		20p12	HYDROXYACID OXIDASE 1; HAO1	54363
MIM605024		Chr.12	SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 8; SLC4A8	9498
MIM605025		Chr.17	INTEGRIN, ALPHA-3; ITGA3	3675
MIM605026	C1857958	 	DIABETES MELLITUS, CONGENITAL AUTOIMMUNE	 
MIM605027	C0024305	10q22, 1p32, 2q33-q34	LYMPHOMA, NON-HODGKIN, FAMILIAL	5551, 843, 8438
MIM605029		12p13.2-p12.3	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY F, MEMBER 1; KLRF1	51348
MIM605030		 	SERINE/THREONINE PROTEIN KINASE 3; STK3	6788
MIM605031		4q27-q28	POLO-LIKE KINASE 4; PLK4	10733
MIM605032		4p16.3	COMPLEXIN 1; CPLX1	10815
MIM605033		5q35.2	COMPLEXIN 2; CPLX2	10814
MIM605034		10q11.21-q11.23	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 23, YEAST, HOMOLOG OF; TIMM23	100287932
MIM605035		6q21-q22	WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY, MEMBER 1; WASF1	8936
MIM605036		14q11	ZINC FINGER PROTEIN 219; ZNF219	51222
MIM605037		 	KINESIN FAMILY MEMBER 17; KIF17	57576
MIM605038		 	POSTMEIOTIC SEGREGATION INCREASED 2-LIKE 1; PMS2L1	5379
MIM605039	C0796232	3q13.13	BOHRING-OPITZ SYNDROME; BOPS	10225, 171023
MIM605040	C1857942	 	CLAVICULAR HYPOPLASIA, ZYGOMATIC ARCH HYPOPLASIA, AND MICROGNATHIA	 
MIM605041	C1857941	16q12-q13, 16q12-q13	BROOKE-SPIEGLER SYNDROME; BRSS	1540
MIM605042		 	MEDIATOR COMPLEX SUBUNIT 23; MED23	9439
MIM605043		19p13.11	MEDIATOR COMPLEX SUBUNIT 26; MED26	9441
MIM605044		9q34	MEDIATOR COMPLEX SUBUNIT 27; MED27	9442
MIM605045		5q33.3	MEDIATOR COMPLEX SUBUNIT 7; MED7	9443
MIM605046		9q21.2-q21.3	UBIQUILIN 1; UBQLN1	29979
MIM605047		 	INTERFERON REGULATORY FACTOR 7; IRF7	3665
MIM605048		1q32.1	INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE OF, EPSILON; IKBKE	9641
MIM605049		18p11.3-p11.2	TWISTED GASTRULATION HOMOLOG 1; TWSG1	57045
MIM605051		1p36	CANNABINOID RECEPTOR 2; CNR2	1269
MIM605052		1q42.3	TAR RNA-BINDING PROTEIN 1; TARBP1	6894
MIM605053		12p12.1-q13.1	TAR RNA-BINDING PROTEIN 2; TARBP2	6895
MIM605054		 	SMALL EDRK-RICH FACTOR 2; SERF2	10169
MIM605055	C1857933	 	ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	 
MIM605056		 	WISKOTT-ALDRICH SYNDROME GENE-LIKE; WASL	8976
MIM605057		1q32	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 17, YEAST, HOMOLOG OF, A; TIMM17A	10440
MIM605058		19p13.3-p13.2	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 44, YEAST, HOMOLOG OF; TIMM44	10469
MIM605060		17p13	SEDOHEPTULOKINASE; SHPK	23729
MIM605061		16q23.1	TERF2-INTERACTING PROTEIN; TERF2IP	54386
MIM605062		7q31.3-q32	TASTE RECEPTOR, TYPE 2, MEMBER 5; TAS2R5	54429
MIM605063		11q13	STRESS-INDUCED PHOSPHOPROTEIN 1; STIP1	10963
MIM605064		15q23	KINESIN FAMILY MEMBER 23; KIF23	9493
MIM605065		 	CELL DIVISION CYCLE 37, S. CEREVISIAE, HOMOLOG OF; CDC37	11140
MIM605066		17p13.3	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, EPSILON ISOFORM; YWHAE	7531
MIM605067	C0243002	 	TRICUSPID ATRESIA	 
MIM605068		13q12	WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY, MEMBER 3; WASF3	10810
MIM605069		19p13.3	MITOGEN-ACTIVATED PROTEIN KINASE-INTERACTING SERINE/THREONINE KINASE 2; MKNK2	2872
MIM605070		 	EARLY ENDOSOME ANTIGEN 1; EEA1	8411
MIM605071		 	REGULATOR OF G PROTEIN SIGNALING 19; RGS19	10287
MIM605072		19p13.1	GIPC PDZ DOMAIN-CONTAINING FAMILY, MEMBER 1; GIPC1	10755
MIM605073		17q22-q23	TRIPARTITE MOTIF-CONTAINING PROTEIN 37; TRIM37	4591
MIM605074	C0007134	1q21, 7q31, Xp11.22	RENAL CELL CARCINOMA, PAPILLARY, 1; RCCP1	4233, 5546, 7030
MIM605076		 	SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 2; SNAPC2	6618
MIM605077		 	DNMT1-ASSOCIATED PROTEIN 1; DNMAP1	55929
MIM605078		1p36.2	TAR DNA-BINDING PROTEIN; TARDBP	23435
MIM605079		18q23	SAL-LIKE 3; SALL3	27164
MIM605080		8q21-q22	CYCLIC NUCLEOTIDE-GATED CHANNEL, BETA-3; CNGB3	54714
MIM605081		7p22.1	CYTOHESIN 3; CYTH3	9265
MIM605082		3p21.3	RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1; RASSF1	11186
MIM605083		2q31-q33	FRIZZLED-RELATED PROTEIN; FRZB	2487
MIM605084		 	CALCIUM-BINDING ATOPY-RELATED AUTOANTIGEN 1; CBARA1	10367
MIM605085		6p21.1	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TREM1	54210
MIM605086		6p21.2	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; TREM2	54209
MIM605087		1p31.1	PHOSPHATIDYLINOSITOL GLYCAN, CLASS K; PIGK	10026
MIM605088		16p13.1-p11.2	MAJOR VAULT PROTEIN, RAT, HOMOLOG OF; MVP	9961
MIM605089		22q11	MITOCHONDRIAL RIBOSOMAL PROTEIN L40; MRPL40	64976
MIM605090		3q25.3	RETINOIC ACID RECEPTOR RESPONDER 1; RARRES1	5918
MIM605091		 	FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 2; FGD2	221472
MIM605092		11q23	RETINOIC ACID RECEPTOR RESPONDER 3; RARRES3	5920
MIM605093		12q24	SH2B ADAPTOR PROTEIN 3; SH2B3	10019
MIM605094		7q21	SIX-TRANSMEMBRANE EPITHELIAL ANTIGEN OF PROSTATE 2; STEAP2	261729
MIM605096		2q37.3	ANOCTAMIN 7; ANO7	50636
MIM605097		1q32.1	SOLUTE CARRIER FAMILY 45, MEMBER 3; SLC45A3	85414
MIM605100		17q22-q23	PROTEIN PHOSPHATASE, MAGNESIUM-DEPENDENT, 1D; PPM1D	8493
MIM605101		6q25	TAK1-BINDING PROTEIN 2; TAB2	23118
MIM605102		1p36.3-p36.2	MANNAN-BINDING LECTIN SERINE PROTEASE 2; MASP2	10747
MIM605103		 	NEUROMEDIN U; NMU	10874
MIM605104		16p13	RNA-BINDING PROTEIN FOX1, C. ELEGANS, HOMOLOG OF, 1; RBFOX1	54715
MIM605106		1p31.1-p22.3	LYSOPHOSPHATIDIC ACID RECEPTOR 3; LPAR3	23566
MIM605107		 	ENDOTHELIAL DIFFERENTIATION-RELATED FACTOR 1; EDF1	8721
MIM605108		5q33.1	NEUROMEDIN U RECEPTOR 2; NMUR2	56923
MIM605109		 	HECT DOMAIN AND RCC1-LIKE DOMAIN 1; HERC1	8925
MIM605110		19p12	LYSOPHOSPHATIDIC ACID RECEPTOR 2; LPAR2	9170
MIM605111		19p13.2	SPHINGOSINE 1-PHOSPHATE RECEPTOR 2; S1PR2	9294
MIM605112		15q21.1-q21.2	TROPOMODULIN 3; TMOD3	29766
MIM605113		7q31.3	ALPHA-AMINOADIPIC SEMIALDEHYDE SYNTHASE; AASS	10157
MIM605114		20q13.2-q13.3	SPO11, S. CEREVISIAE, HOMOLOG OF; SPO11	23626
MIM605115	C1854631	4q31.1	HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATION IN PREGNANCY	4306
MIM605116		4p15.1-p14	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 9; CHRNA9	55584
MIM605117		 	SUPPRESSOR OF CYTOKINE SIGNALING 2; SOCS2	8835
MIM605118		18q21.1	SUPPRESSOR OF CYTOKINE SIGNALING 4; SOCS4	9306
MIM605119		 	PROTEIN PHOSPHATASE, MAGNESIUM-DEPENDENT, 1G; PPM1G	5496
MIM605120		10q11.22	GROWTH/DIFFERENTIATION FACTOR 2; GDF2	2658
MIM605121		16p12	RRN3, S. CEREVISIAE, HOMOLOG OF; RRN3	54700
MIM605122		10q22.1	SUV3-LIKE 1; SUPV3L1	6832
MIM605123		 	SERINE PROTEASE INHIBITOR, KUNITZ-TYPE, 1; SPINT1	6692
MIM605124		19q13.1	SERINE PROTEASE INHIBITOR, KUNITZ-TYPE, 2; SPINT2	10653
MIM605125		17p13.1	GABA-A RECEPTOR-ASSOCIATED PROTEIN; GABARAP	11337
MIM605126		6q16.1-q16.3	FOUR-AND-A-HALF LIM DOMAINS 5; FHL5	9457
MIM605127		 	OPTICIN; OPTC	26254
MIM605128		3q13.1	GUANYLATE CYCLASE ACTIVATOR 1C; GUCA1C	9626
MIM605129		17q12-q21	PROTEASOME ACTIVATOR SUBUNIT 3; PSME3	10197
MIM605130	C1854630	 	HAIRY ELBOWS, SHORT STATURE, FACIAL DYSMORPHISM, AND DEVELOPMENTAL DELAY	4297
MIM605131		16q23.3-q24.1	WW DOMAIN-CONTAINING OXIDOREDUCTASE; WWOX	51741
MIM605132		 	TRANSDUCIN-LIKE ENHANCER OF SPLIT 4; TLE4	7091
MIM605133		 	NUCLEAR CAP-BINDING PROTEIN 2; NCBP2	22916
MIM605134		 	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, CYTOPLASMIC, 1; PITPNC1	26207
MIM605138		 	ORNITHINE DECARBOXYLASE ANTIZYME 3; OAZ3	51686
MIM605139		Chr.12	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 2; CCT2	10576
MIM605140		 	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 7; CCT7	10574
MIM605141		22q11.2	PRE-B-LYMPHOCYTE GENE 1; VPREB1	7441
MIM605142		2p15	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 4; CCT4	10575
MIM605143		 	ACTIN-RELATED PROTEIN 1A; ACTR1A	10121
MIM605144		2q11.1-q11.2	ACTIN-RELATED PROTEIN 1B; ACTR1B	10120
MIM605145		5p15.2-p14.1	ANK, MOUSE, HOMOLOG OF; ANKH	56172
MIM605146		19p13.2	SPHINGOSINE 1-PHOSPHATE RECEPTOR 5; S1PR5	53637
MIM605147		13q14-q21	LEUKOCYTE CELL-DERIVED CHEMOTAXIN 1; LECT1	11061
MIM605148		12q13	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 6; GALNT6	11226
MIM605149		4q21	CHEMOKINE, CXC MOTIF, LIGAND 13; CXCL13	10563
MIM605152		1q22-q24	COILED-COIL DOMAIN-CONTAINING PROTEIN 19; CCDC19	25790
MIM605153		2q36-q37.1	RECEPTOR ACTIVITY-MODIFYING PROTEIN 1; RAMP1	10267
MIM605154		17q12-q21.1	RECEPTOR ACTIVITY-MODIFYING PROTEIN 2; RAMP2	10266
MIM605155		7p13-p12	RECEPTOR ACTIVITY-MODIFYING PROTEIN 3; RAMP3	10268
MIM605157		 	p53-RESPONSIVE GENE 1	23574
MIM605158		2p25.3	PEROXIDASIN, DROSOPHILA, HOMOLOG OF; PXDN	7837
MIM605159		 	APOPTOSIS-INDUCING FACTOR, MITOCHONDRION-ASSOCIATED, 2; AIFM2	84883
MIM605160		 	p53-RESPONSIVE GENE 4	23572
MIM605161		20q12-q13.2	WAP 4-DISULFIDE CORE DOMAIN 5; WFDC5	149708
MIM605162		19p13.13	GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GADD45G-INTERACTING PROTEIN; GADD45GIP1	90480
MIM605163		3p21	CHEMOKINE, CXC MOTIF, RECEPTOR 6; CXCR6	10663
MIM605164		6q21	HISTONE DEACETYLASE 2; HDAC2	3066
MIM605165		22q12	ZINC FINGER PROTEIN 278; ZNF278	23598
MIM605166		5q31	HISTONE DEACETYLASE 3; HDAC3	8841
MIM605167		 	B MELANOMA ANTIGEN; BAGE	574
MIM605168		8q21.13	FATTY ACID-BINDING PROTEIN 5; FABP5	2171
MIM605169		11p15-p13	E74-LIKE FACTOR 5; ELF5	2001
MIM605170		11q23	ETOPOSIDE-INDUCED 1.4 mRNA; EI24	9538
MIM605171		2p	TUMOR PROTEIN p53-INDUCIBLE PROTEIN 3; TP53I3	9540
MIM605172		9q34.3	PROSTAGLANDIN E SYNTHASE; PTGES	9536
MIM605173		5q13	ECTODERMAL-NEURAL CORTEX 1; ENC1	8507
MIM605174		21q21.2	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 1; ADAMTS1	9510
MIM605175		11q25	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 8; ADAMTS8	11095
MIM605176		1p13	HYDROXYACID OXIDASE 2; HAO2	51179
MIM605178		16q24.3	GROWTH ARREST-SPECIFIC 8; GAS8	2622
MIM605179		16q24.3	CHROMOSOME 16 OPEN READING FRAME 3; C16ORF3	750
MIM605180		Chr.12	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 2; SLC38A2	54407
MIM605181		12q11-q12	TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 3; TM7SF3	51768
MIM605182		13q34	RAS p21 PROTEIN ACTIVATOR 3; RASA3	22821
MIM605183		 	CALMODULIN-LIKE 5; CALML5	51806
MIM605184		5p12	POLYADENYLATE-BINDING PROTEIN-INTERACTING PROTEIN 1; PAIP1	10605
MIM605185		15q21.1	DELTA-LIKE 4; DLL4	54567
MIM605186		Chr.12	WNT INHIBITORY FACTOR 1; WIF1	11197
MIM605187		3p21-p14	G PROTEIN-COUPLED RECEPTOR 27; GPR27	2850
MIM605188		7q31	G PROTEIN-COUPLED RECEPTOR 85; GPR85	54329
MIM605189		10q11.2	DICKKOPF, XENOPUS, HOMOLOG OF, 1; DKK1	22943
MIM605190		Chr.8	TRANSLOCATION-ASSOCIATING MEMBRANE PROTEIN 1; TRAM1	23471
MIM605191		10q22-q23	BTAF1 RNA POLYMERASE II, B-TFIID TRANSCRIPTION FACTOR-ASSOCIATED, 170-KD; BTAF1	9044
MIM605192	C1854594	14q23	DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	6495
MIM605193		1p31	DIRAS FAMILY, GTP-BINDING RAS-LIKE PROTEIN 3; DIRAS3	9077
MIM605194		2q21.1	CRYPTIC PROTEIN; CFC1	55997
MIM605195		15q26.1	MESODERM POSTERIOR 2; MESP2	145873
MIM605196		 	COQ3, S. CEREVISIAE, HOMOLOG OF; COQ3	51805
MIM605197		 	KYNURENINASE; KYNU	8942
MIM605198		5p15	POLY(A) POLYMERASE-ASSOCIATED DOMAIN-CONTAINING PROTEIN 7; PAPD7	11044
MIM605199		1p34	SPLICING FACTOR, PROLINE- AND GLUTAMINE-RICH; SFPQ	6421
MIM605200		 	HECT DOMAIN AND RCC1-LIKE DOMAIN 3; HERC3	8916
MIM605201	C1854587	11q23.3	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 14; HDLCQ14	56801
MIM605202		Chr.9	N-ACETYLNEURAMINIC ACID PHOSPHATE SYNTHASE; NANS	54187
MIM605204		9q34	TORSIN 1A; TOR1A	1861
MIM605205		1q24	ADENYLYL CYCLASE, SOLUBLE	55811
MIM605206		15q24-q25	HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 4; HCN4	10021
MIM605207		 	CYTOCHROME P450, SUBFAMILY XXVIB, POLYPEPTIDE 1; CYP26B1	56603
MIM605208		19q13	SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 7; SLC17A7	57030
MIM605209		12q24.33	CHECKPOINT PROTEIN WITH FHA AND RING FINGER DOMAINS; CHFR	55743
MIM605210		1q42.1	DISRUPTED IN SCHIZOPHRENIA 1; DISC1	27185
MIM605211		9q34	BARH-LIKE 1; BARHL1	56751
MIM605212		 	BARH-LIKE 2; BARHL2	343472
MIM605213		16p13.3	3-@PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1; PDPK1	5170
MIM605214		 	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 2; KCNMB2	10242
MIM605215		7p21-p15	SKAP55-RELATED PROTEIN	8935
MIM605216		2q22	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 4; ARHGEF4	50649
MIM605217		 	SHC TRANSFORMING PROTEIN 2; SHC2	25759
MIM605218	C1854577	2q37.3	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 2; SLEB2	5133, 56179
MIM605219		Chr.12	DIRECT IAP-BINDING PROTEIN WITH LOW pI; DIABLO	56616
MIM605220		16p11.2	APOLIPOPROTEIN B48 RECEPTOR	55911
MIM605221		1p36.1	SPLICING FACTOR, SERINE/ARGININE-RICH, 10; SRSF10	10772
MIM605222		3q26.3-q27.1	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 3; KCNMB3	27094
MIM605223		12q14.1-q15	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 4; KCNMB4	27345
MIM605224		4q	RHODOPSIN HOMOLOG, RETINAL PIGMENT EPITHELIUM-DERIVED; RRH	10692
MIM605225	C1854573	1p36	INFLAMMATORY BOWEL DISEASE 7; IBD7	57042
MIM605226		1p36.2-p36.1	RE REPEATS-ENCODING GENE; RERE	473
MIM605227		9p13-p12	REVERSION-INDUCING CYSTEINE-RICH PROTEIN WITH KAZAL MOTIFS; RECK	8434
MIM605228		 	COREPRESSOR INTERACTING WITH RBPJ, 1; CIR1	9541
MIM605229	C1854568	3q27-q28	SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE; SPG14	57309
MIM605230		15q15-q21	TUMOR PROTEIN p53-BINDING PROTEIN 1; TP53BP1	7158
MIM605232		12p13	PROTEIN KINASE, LYSINE-DEFICIENT 1; WNK1	65125
MIM605233	C1854565	 	DIANZANI AUTOIMMUNE LYMPHOPROLIFERATIVE DISEASE	 
MIM605234		19q13.4	VOMERONASAL 1 RECEPTOR 1; VN1R1	57191
MIM605235		16q21-q23	NUCLEOLAR PROTEIN 3; NOL3	8996
MIM605236		4p13-p12	CORIN, SERINE PEPTIDASE; CORIN	10699
MIM605237		1q25.1	XENOTROPIC AND POLYTROPIC RETROVIRUS RECEPTOR; XPR1	9213
MIM605238		2q22	HISTAMINE N-METHYLTRANSFERASE; HNMT	3176
MIM605239		7q33-q34	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 4; ATP6V0A4	50617
MIM605240		5p12	CHEMOKINE, CC MOTIF, LIGAND 28; CCL28	56477
MIM605241		 	LYMPHOCYTE ANTIGEN 86; LY86	9450
MIM605242		11p15.1	USH1C GENE; USH1C	10083
MIM605243		 	LYMPHOCYTE ANTIGEN 96; LY96	23643
MIM605244	C1854540	2p16	CARNEY COMPLEX, TYPE 2; CNC2	1257
MIM605245		Chr.9	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 8; SLC2A8	29988
MIM605246		 	COMPLEMENT COMPONENT 3a RECEPTOR 1; C3AR1	719
MIM605247		 	LEUCINE-RICH REPEATS- AND DEATH DOMAIN-CONTAINING PROTEIN; LRDD	55367
MIM605248		19p13.3-p13.2	MUCOLIPIN 1; MCOLN1	57192
MIM605249	C1854520	22q11.2	SEBASTIAN SYNDROME; SBS	4627
MIM605250		13q32	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 4; ABCC4	10257
MIM605251		3q27	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 5; ABCC5	10057
MIM605252		18q21.1	POLYMERASE, DNA, IOTA; POLI	11201
MIM605253	C0393818	1q22, 10q21.1-q22.1	NEUROPATHY, CONGENITAL HYPOMYELINATING	1959, 4359
MIM605254		1q22-q23	NICASTRIN; NCSTN	23385
MIM605255		6p21	ETS VARIANT GENE 7; ETV7	51513
MIM605256		3p25-p24	RAD18, S. CEREVISIAE, HOMOLOG OF; RAD18	56852
MIM605257		12p13	ACTIVATION-INDUCED CYTIDINE DEAMINASE; AICDA	57379
MIM605258	C1720956	12p13	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2; HIGM2	57379
MIM605259	C1854488	19q13.3-q13.4	SPINOCEREBELLAR ATAXIA 13; SCA13	3748
MIM605261		11q14.2-q21	NADPH OXIDASE 4; NOX4	50507
MIM605262		8q24.3	NMYC DOWNSTREAM-REGULATED GENE 1; NDRG1	10397
MIM605263		 	SHC TRANSFORMING PROTEIN 3; SHC3	53358
MIM605264		10q23.3-q24.1	SORBIN AND SH3-DOMAINS CONTAINING 1; SORBS1	10580
MIM605265		Chr.15	CELL DEATH REGULATOR AVEN	57099
MIM605266		8q21	JUNCTOPHILIN 1; JPH1	56704
MIM605267		20q12	JUNCTOPHILIN 2; JPH2	57158
MIM605268		16q24.3	JUNCTOPHILIN 3; JPH3	57338
MIM605269		12q24.1	CORONIN 1C; CORO1C	23603
MIM605270		17q25.3	N-SULFOGLUCOSAMINE SULFOHYDROLASE; SGSH	6448
MIM605271		14q32.1	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 10; SERPINA10	51156
MIM605272		14q11.2	NMYC DOWNSTREAM-REGULATED GENE 2; NDRG2	57447
MIM605273		20q11.21-q11.23	NMYC DOWNSTREAM-REGULATED GENE 3; NDRG3	57446
MIM605274	C1854470	 	MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	 
MIM605275	C1854469	 	NOONAN SYNDROME 2; NS2	57762
MIM605276		17q25.3	APOPTOSIS-ASSOCIATED TYROSINE KINASE; AATK	9625
MIM605277		19q13.2-q13.4	GLUCOCORTICOID RECEPTOR DNA-BINDING FACTOR 1; GRLF1	2909
MIM605278		 	CARBOXYLESTERASE 2; CES2	8824
MIM605279		16q21	CARBOXYLESTERASE 3; CES3	23491
MIM605280	C1854467	2q33.1	SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT; SPG13	3329
MIM605281		5q11.2-q12	DEAD/H BOX 4; DDX4	54514
MIM605282	C1854466	 	TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME; TPBS	22856
MIM605283		15q11-q13	MAGE-LIKE 2; MAGEL2	54551
MIM605284		9q34	TSC1 GENE; TSC1	7248
MIM605285	C1854449	10q23.2	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE	59333
MIM605286		2q37.3	CALPAIN 10; CAPN10	11132
MIM605287		2q37.3	ARGINYL AMINOPEPTIDASE-LIKE 1; RNPEPL1	57140
MIM605289	C1854442	3q27	SPLIT-HAND/FOOT MALFORMATION 4; SHFM4	8626
MIM605290		3q28-q29	OPA1 GENE; OPA1	4976
MIM605292		17p11.2	5-PRIME-@NUCLEOTIDASE, MITOCHONDRIAL; NT5M	56953
MIM605293	C1854430	18q12.2-q12.3	OPTIC ATROPHY 4; OPA4	58156
MIM605294		16q22	CARBOHYDRATE SULFOTRANSFERASE 6; CHST6	4166
MIM605295		 	FIDGETIN; FIGN	55137
MIM605296		21q22.3	PROTEASOME-ASSEMBLING CHAPERONE 1; PSMG1	8624
MIM605297		20q13	TH1-LIKE; TH1L	51497
MIM605298		21q22.2	DOWN SYNDROME CRITICAL REGION GENE 3; DSCR3	10311
MIM605299		20q11	NUCLEAR RECEPTOR COACTIVATOR 6; NCOA6	23054
MIM605300		7q22	SH2B ADAPTOR PROTEIN 2; SH2B2	10603
MIM605301		8p11	TRANSFORMING, ACIDIC, COILED-COIL-CONTAINING PROTEIN 1; TACC1	6867
MIM605302		10q26	TRANSFORMING, ACIDIC, COILED-COIL-CONTAINING PROTEIN 2; TACC2	10579
MIM605303		4p16.3	TRANSFORMING, ACIDIC, COILED-COIL-CONTAINING PROTEIN 3; TACC3	10460
MIM605304		14q24	NEUROGLOBIN; NGB	58157
MIM605305		19p13.3	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 5; KIR2DL5	57292
MIM605306		12p13	C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER A; CLEC4A	50856
MIM605307		 	ADRENOMEDULLIN RECEPTOR; ADMR	11318
MIM605308		 	ZINC FINGER PROTEIN 346; ZNF346	23567
MIM605309	C1854416	10q23.31	MACROCEPHALY/AUTISM SYNDROME	5728
MIM605310		6p21.3	COILED-COIL ALPHA-HELICAL ROD PROTEIN 1; CCHCR1	54535
MIM605312		19p13.2-p13.1	GROWTH/DIFFERENTIATION FACTOR 15; GDF15	9518
MIM605313		1q12	RNA-BINDING MOTIF PROTEIN 8A; RBM8A	9939
MIM605314		2q37.2	HISTONE DEACETYLASE 4; HDAC4	9759
MIM605315		Chr.17	HISTONE DEACETYLASE 5; HDAC5	10014
MIM605316	C1832827	21q22.3	DEAFNESS, AUTOSOMAL RECESSIVE 10; DFNB10	64699
MIM605317		7q31	FORKHEAD BOX P2; FOXP2	93986
MIM605319		10p15-p14	6-@PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3; PFKFB3	5209
MIM605320		3p22-p21	6-@PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 4; PFKFB4	5210
MIM605321	C1854405	 	FRONTOOCULAR SYNDROME	 
MIM605322		16q24.3	WAP 4-DISULFIDE CORE DOMAIN 1; WFDC1	58189
MIM605323		2q34	C-TERMINAL DOMAIN OF RNA POLYMERASE II POLYPEPTIDE A, SMALL PHOSPHATASE OF, 1; CTDSP1	58190
MIM605324		17q22-q23	AMYLOID BETA PRECURSOR PROTEIN-BINDING PROTEIN 2; APPBP2	10513
MIM605325		7q22.1	CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 5; CYP3A5	1577
MIM605326		7p15	TAX1-BINDING PROTEIN 1; TAX1BP1	8887
MIM605327		9q22.1-q22.3	NUCLEAR FACTOR, INTERLEUKIN 3-REGULATED; NFIL3	4783
MIM605328		15q12	KRUPPEL-LIKE FACTOR 13; KLF13	51621
MIM605330		12q15	INTERLEUKIN 22; IL22	50616
MIM605331		18p11.3	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 3; EPB41L3	23136
MIM605332		13q21	KELCH-LIKE 1; KLHL1	57626
MIM605333		13q12.3	PDS5, REGULATOR OF COHESION MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, B; PDS5B	23047
MIM605335		12q15-q21.2	PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY A, MEMBER 1; PHLDA1	22822
MIM605336		1q31-q32.1	COMPLEMENT FACTOR H-RELATED 3; CFHR3	10878
MIM605337		1q31-q32.1	COMPLEMENT FACTOR H-RELATED 4; CFHR4	10877
MIM605338		 	INTERNEXIN, ALPHA; INA	9118
MIM605339		17p13.1	FRAGILE X MENTAL RETARDATION, AUTOSOMAL HOMOLOG 2; FXR2	9513
MIM605340		7q22.1	CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 7; CYP3A7	1551
MIM605341		7q22	PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR, ALPHA; PILRA	29992
MIM605342		7q22	PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR, BETA; PILRB	29990
MIM605343		19p13	FOLLISTATIN-LIKE 3; FSTL3	10272
MIM605344		1p32	NUCLEAR TRANSCRIPTION FACTOR Y, GAMMA; NFYC	4802
MIM605345		14q24	AlkB, E. COLI, HOMOLOG OF, 1; ALKBH1	8846
MIM605347		1p36.13	PEPTIDYLARGININE DEIMINASE, TYPE IV; PADI4	23569
MIM605348		1p36.2-p34	SMALL MEMBRANE PROTEIN 1	23585
MIM605349		 	NUCLEAR PRELAMIN A RECOGNITION FACTOR; NARF	26502
MIM605350		19p13.11	INTERLEUKIN 27 RECEPTOR, ALPHA; IL27RA	9466
MIM605351		7q11.2	FIBRINOGEN-LIKE 2; FGL2	10875
MIM605352		8p23.1	MALIGNANT FIBROUS HISTIOCYTOMA-AMPLIFIED SEQUENCE 1; MFHAS1	9258
MIM605353		3p26-p25	GHRELIN; GHRL	51738
MIM605354		11q21-q22	CASPASE 1 INHIBITOR	59082
MIM605355	C1854380	19q13.4	NEMALINE MYOPATHY 5; NEM5	7138
MIM605356		7q11.23	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, GAMMA ISOFORM; YWHAG	7532
MIM605357		 	STONIN 1; STON1	11037
MIM605358		2p16.3	GENERAL TRANSCRIPTION FACTOR IIA, 1-LIKE; GTF2A1L	11036
MIM605359		Chr.12	PROLINE-RICH 4; PROL4	11272
MIM605360		Chr.11	DELTA ANTIGEN-INTERACTING PROTEIN A	11007
MIM605361	C1854369	19q13.4	SPINOCEREBELLAR ATAXIA 14; SCA14	5582
MIM605362	C1854368	6q23	CARDIOMYOPATHY, DILATED, 1J; CMD1J	2070
MIM605363		2q31	GLUTAMATE DECARBOXYLASE 1; GAD1	2571
MIM605364	C1854366	19p13	PSORIASIS SUSCEPTIBILITY 6; PSORS6	63869
MIM605365	C1854365	13q21	BREAST CANCER 3; BRCA3	60500
MIM605366		Chr.9	OLFACTOMEDIN 1; OLFM1	10439
MIM605367		17p11	ELAC, E. COLI, HOMOLOG OF, 2; ELAC2	60528
MIM605368		8p21	BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 3-LIKE; BNIP3L	665
MIM605369		 	TRANSMEMBRANE PROTEASE, SERINE 11D; TMPRSS11D	9407
MIM605370		5q31	RHO GTPase-ACTIVATING PROTEIN 26; ARHGAP26	23092
MIM605371		20q13.13	ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; ARFGEF2	10564
MIM605372		2q31.2	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A3; HNRNPA3	220988
MIM605373	C1854336	1q21	PARAGANGLIOMAS 3; PGL3	6391
MIM605374		2p24.1	MYCN, OPPOSITE STRAND; MYCNOS	10408
MIM605375	C1854335	1q21	EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 3	1141
MIM605376	C1854334	2q21.1	HETEROTAXY, VISCERAL, 2, AUTOSOMAL; HTX2	55997
MIM605377		19q13.2-q13.3	DYSTROPHIA MYOTONICA PROTEIN KINASE; DMPK	1760
MIM605378		12q13	AAAS GENE; AAAS	8086
MIM605379		16q24.1	GAN GENE; GAN	8139
MIM605380		12p13.3	FIBROBLAST GROWTH FACTOR 23; FGF23	8074
MIM605381		15q25	RHESUS BLOOD GROUP, C GLYCOPROTEIN; RHCG	51458
MIM605383		16p11	INTERLEUKIN 21 RECEPTOR; IL21R	50615
MIM605384		4q26-q27	INTERLEUKIN 21; IL21	59067
MIM605385		Chr.11	PRENYL PROTEIN PROTEASE RCE1; RCE1	9986
MIM605386		9q22.32	MICRO RNA LET7A1; MIRNLET7A1	406881
MIM605387	C1854311	20q11.21	CATARACT, POSTERIOR POLAR, 3; CTPP3	128866
MIM605388	C0394005	9p12-q12	CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	60502
MIM605389	C1854310	18p11.32-p11.23	HYPOTRICHOSIS 1; HYPT1	147495
MIM605390		Chr.11	LEUPAXIN; LPXN	9404
MIM605391		10q23	MULTIPLE INOSITOL POLYPHOSPHATE PHOSPHATASE 1; MINPP1	9562
MIM605392		6q27	FIBROBLAST GROWTH FACTOR RECEPTOR 1 ONCOGENE PARTNER; FGFR1OP	11116
MIM605393		1q32	LYSINE-SPECIFIC DEMETHYLASE 5B; KDM5B	10765
MIM605394		6q15	BTB AND CNC HOMOLOGY 2; BACH2	60468
MIM605395		19p13.2	TRANSMEMBRANE EMP24 TRANSPORT DOMAIN-CONTAINING PROTEIN 1; TMED1	11018
MIM605397		18q22.3	CD226 ANTIGEN; CD226	10666
MIM605398		17p13	CHEMOKINE, CXC MOTIF, LIGAND 16; CXCL16	58191
MIM605399		Chr.14	NIDOGEN 2; NID2	22795
MIM605400	C1854306	 	FIBROMATOSIS, GINGIVAL, WITH HYPERTRICHOSIS AND MENTAL RETARDATION	 
MIM605401		5q11-q13	IQ MOTIF-CONTAINING GTPase-ACTIVATING PROTEIN 2; IQGAP2	10788
MIM605402		9p24	PROGRAMMED CELL DEATH 1 LIGAND 1; PDCD1LG1	29126
MIM605403		4p14	TOLL-LIKE RECEPTOR 6; TLR6	10333
MIM605404		 	BCL2-RELATED OVARIAN KILLER; BOK	666
MIM605405		10p13	USP6 N-TERMINAL-LIKE; USP6NL	9712
MIM605406		14q24.3	TRANSMEMBRANE EMP24 TRANSPORT DOMAIN-CONTAINING PROTEIN 10; TMED10	10972
MIM605407	C1854299	11p15.5	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	7054
MIM605409		5q31	TRANSCRIPTION ELONGATION REGULATOR 1; TCERG1	10915
MIM605410		7q31	POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 2; KCND2	3751
MIM605411		1p13.3-p13.2	POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 3; KCND3	3752
MIM605412		2q13	RAB-LIKE 2A; RABL2A	11159
MIM605413		22q13.3	RAB-LIKE 2B; RABL2B	11158
MIM605414		19p13.3	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 7; ABCA7	10347
MIM605415		 	DICKKOPF, XENOPUS, HOMOLOG OF, 2; DKK2	27123
MIM605416		 	DICKKOPF, XENOPUS, HOMOLOG OF, 3; DKK3	27122
MIM605417		8p11.2-p11.1	DICKKOPF, XENOPUS, HOMOLOG OF, 4; DKK4	27121
MIM605418		19q13.33	DICKKOPF-LIKE 1; DKKL1	27120
MIM605419	C0543918	15q15	SCHIZOPHRENIA 10; SCZD10	63944
MIM605420		11p11.2	ARISTALESS-LIKE 4, MOUSE, HOMOLOG OF; ALX4	60529
MIM605421		3p14.3-p14.2	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 9; ADAMTS9	56999
MIM605422		 	ZINC FINGER PROTEIN 350; ZNF350	59348
MIM605423		12q13.1	DESERT HEDGEHOG; DHH	50846
MIM605424		5q35	MASTERMIND-LIKE 1; MAML1	9794
MIM605425		1p35.1	GAP JUNCTION PROTEIN, BETA-4; GJB4	127534
MIM605426		11q24	p53-REGULATED APOPTOSIS-INDUCING PROTEIN 1	63970
MIM605427		12q24.1	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 4; TRPV4	59341
MIM605428	C1854275	4q31	DEAFNESS, AUTOSOMAL RECESSIVE 26; DFNB26	23714
MIM605429	C1854274	1q24	DEAFNESS, NONSYNDROMIC, MODIFIER 1; DFNM1	54362
MIM605430		17q21.33	SPERM-ASSOCIATED ANTIGEN 9; SPAG9	9043
MIM605431		 	MITOGEN-ACTIVATED PROTEIN KINASE 8-INTERACTING PROTEIN 3; MAPK8IP3	23162
MIM605432	C1854273	7p15-p14.2	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	3207
MIM605433		6p23	KINESIN FAMILY MEMBER 13A; KIF13A	63971
MIM605434		1p34.3-p34.1	CLASPIN, XENOPUS, HOMOLOG OF; CLSPN	63967
MIM605435		14q12	PROTEIN KINASE D1; PRKD1	5587
MIM605436		15q11.2	SMALL NUCLEOLAR RNA, C/D BOX, 116-1; SNORD116-1	100033413
MIM605437		14q22-q23	PROTEIN KINASE C, ETA; PRKCH	5583
MIM605438		8p	DISCS LARGE-ASSOCIATED PROTEIN 2; DLGAP2	9228
MIM605439		11p12	ETS HOMOLOGOUS FACTOR; EHF	26298
MIM605440		1q21	UBIQUILIN 4; UBQLN4	56893
MIM605441		3q27	ADIPOCYTE-, C1q-, AND COLLAGEN DOMAIN-CONTAINING; ADIPOQ	9370
MIM605442		6q25-q27	WILMS TUMOR 1-ASSOCIATING PROTEIN; WTAP	9589
MIM605443		2q32	PROSTATE-SPECIFIC GENE PCGEM1; PCGEM1	64002
MIM605444		11p15	RNA-BINDING MOTIF PROTEIN, X CHROMOSOME, LIKE 2; RBMXL2	27288
MIM605445		 	DISCS LARGE-ASSOCIATED PROTEIN 1; DLGAP1	9229
MIM605446		14q11	RETINITIS PIGMENTOSA GTPase REGULATOR-INTERACTING PROTEIN; RPGRIP1	57096
MIM605447		6p21.3	G8 PROTEIN	50854
MIM605448		17q21.3	RUN DOMAIN-CONTAINING 3A; RUNDC3A	10900
MIM605449		6p12.2	GLUTATHIONE S-TRANSFERASE, ALPHA-3; GSTA3	2940
MIM605450		6p12.2	GLUTATHIONE S-TRANSFERASE, ALPHA-4; GSTA4	2941
MIM605451		19q13.2	p21 PROTEIN-ACTIVATED KINASE 4; PAK4	10298
MIM605452		2q36	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 6; ABCB6	10058
MIM605453		12q24	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 9; ABCB9	23457
MIM605454		1q42	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 10; ABCB10	23456
MIM605455		16p13.3	RAS-ASSOCIATED PROTEIN RAB26; RAB26	25837
MIM605456		 	BET1, S. CEREVISIAE, HOMOLOG OF	10282
MIM605457		 	INTERLEUKIN 22 RECEPTOR, ALPHA-1; IL22RA1	58985
MIM605458		3p21.1	INTERLEUKIN 17 RECEPTOR B; IL17RB	55540
MIM605459		2p21	ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 5; ABCG5	64240
MIM605460		2p21	ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 8; ABCG8	64241
MIM605461		22q11.22-q11.23	INTERLEUKIN 17 RECEPTOR A; IL17RA	23765
MIM605462	C1854245	9q22.3, 1p32, 5q13.3, 1p36	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1	100307118, 5727, 5921, 8643
MIM605463	C1854244	14q11.2	RADIATION SENSITIVITY/CHROMOSOME INSTABILITY SYNDROME, AUTOSOMAL DOMINANT	64239
MIM605464		7q35-q36	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 8; ABCB8	11194
MIM605465		7q31.1	ZINC FINGER PROTEIN 277; ZNF277	11179
MIM605466		20p13	SIGNAL REGULATORY PROTEIN, GAMMA; SIRPG	55423
MIM605467		19q13.4	ZINC FINGER PROTEIN 274; ZNF274	10782
MIM605468		17q24-q25	CDC42 EFFECTOR PROTEIN 4; CDC42EP4	23580
MIM605469		9p24.1	LYSINE-SPECIFIC DEMETHYLASE 4C; KDM4C	23081
MIM605470		11p15	MATRIX METALLOPROTEINASE 26; MMP26	56547
MIM605471		14q22-q24	ZINC FINGER PROTEIN, SUBFAMILY 2A, MEMBER 1; ZNFN2A1	53349
MIM605472	C1854237	5q14.3	USHER SYNDROME, TYPE IIC; USH2C	79955, 84059
MIM605473		11p15	UBIQUILIN 3; UBQLN3	50613
MIM605474		3p21.3	TOLL-LIKE RECEPTOR 9; TLR9	54106
MIM605475		17q25	BAI1-ASSOCIATED PROTEIN 2; BAIAP2	10458
MIM605476		Chr.12	CENTAURIN, GAMMA-1; CENTG1	116986
MIM605477		13q34	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 7; ARHGEF7	8874
MIM605478		11p15.5	SINGLE IMMUNOGLOBULIN DOMAIN-CONTAINING IL1R-RELATED PROTEIN; SIGIRR	59307
MIM605479	C2608083	2q24	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2	8647
MIM605480	C1854235	4p16-p15.2	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 3; SLEB3	64695
MIM605481		1q31	ABNORMAL SPINDLE-LIKE, MICROCEPHALY-ASSOCIATED; ASPM	259266
MIM605482		10q24-q25	GLUTATHIONE S-TRANSFERASE, OMEGA-1; GSTO1	9446
MIM605483		17q25	DYNEIN, AXONEMAL, INTERMEDIATE CHAIN 2; DNAI2	64446
MIM605484		1q32.3	Fc FRAGMENT OF IgA AND IgM, RECEPTOR FOR; FCAMR	83953
MIM605485		7p14.1	VACUOLAR PROTEIN SORTING 41, YEAST, HOMOLOG OF; VPS41	27072
MIM605487		Chr.15	CYCLIC AMP-REGULATED PHOSPHOPROTEIN, 19-KD; ARPP19	10776
MIM605488		 	CYCLIC AMP-REGULATED PHOSPHOPROTEIN, 21-KD; ARPP21	10777
MIM605489		12q24	CARNITINE DEFICIENCY-ASSOCIATED GENE EXPRESSED IN VENTRICLE 1; CDV1	28981
MIM605490		19p13.2	PROTEASE, SERINE, 15; PRSS15	9361
MIM605491		10p13-p12	NEBULETTE; NEBL	10529
MIM605492		1q32.1	LEUCINE-RICH REPEAT PROTEIN, NEURONAL, 5; LRRN5	10446
MIM605493		Chr.11	TRIPARTITE MOTIF-CONTAINING 3; TRIM3	10612
MIM605494		1p31.3	INTEGRIN, BETA-3, BINDING PROTEIN OF; ITGB3BP	23421
MIM605495		 	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1B3; SLCO1B3	28234
MIM605496		9q33	CENTROSOMAL PROTEIN 1; CEP1	11064
MIM605497		3p22	CARTILAGE-ASSOCIATED PROTEIN; CRTAP	10491
MIM605498		10q22-q24	M-PHASE PHOSPHOPROTEIN 1; MPHOSPH1	9585
MIM605500		Chr.16	M-PHASE PHOSPHOPROTEIN 6; MPHOSPH6	10200
MIM605501		Chr.12	M-PHASE PHOSPHOPROTEIN 9; MPHOSPH9	10198
MIM605502		7q22	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 2; DNAJC2	27000
MIM605503		 	M-PHASE PHOSPHOPROTEIN 10; MPHOSPH10	10199
MIM605504		19q13.4	KALLIKREIN-RELATED PEPTIDASE 9; KLK9	284366
MIM605505		19q13.4	KALLIKREIN-RELATED PEPTIDASE 13; KLK13	26085
MIM605506		10q21.1	VACUOLAR PROTEIN SORTING 26, YEAST, HOMOLOG OF, A; VPS26A	9559
MIM605507		2q12.1	INTERLEUKIN 36 RECEPTOR ANTAGONIST; IL36RN	26525
MIM605508		2q	INTERLEUKIN 36, BETA; IL36B	27177
MIM605509		2q	INTERLEUKIN 36, ALPHA; IL36A	27179
MIM605510		2q12.1	INTERLEUKIN 37; IL37	27178
MIM605511		21q22.3	TRANSMEMBRANE PROTEASE, SERINE 3; TMPRSS3	64699
MIM605512		6q14	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 4; ELOVL4	6785
MIM605513		Chr.9	MELAN A; MLANA	2315
MIM605514		10q21-q22	PROTOCADHERIN 15; PCDH15	65217
MIM605515		3p14.1	FORKHEAD BOX P1; FOXP1	27086
MIM605516		10q21-q22	CADHERIN 23; CDH23	64072
MIM605517		Chr.11	I-BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE	11041
MIM605518		2p21	LIPIN 1; LPIN1	23175
MIM605519		18p	LIPIN 2; LPIN2	9663
MIM605520		20q	LIPIN 3	64900
MIM605521		 	TATA BOX-BINDING PROTEIN-LIKE PROTEIN 1; TBPL1	9519
MIM605522		7q36	LIMB REGION 1, MOUSE, HOMOLOG OF; LMBR1	64327
MIM605523		17q21	TRANSDUCER OF ERBB2, 1; TOB1	10140
MIM605525		 	CHROMATIN LICENSING AND DNA REPLICATION FACTOR 1; CDT1	81620
MIM605526	C1854187	10q24	ALZHEIMER DISEASE 6	64851
MIM605527		 	METHIONINE ADENOSYLTRANSFERASE II, BETA; MAT2B	27430
MIM605528		2q37	NEURAMINIDASE 2; NEU2	4759
MIM605529		10p15-p13	UPF2, YEAST, HOMOLOG OF; UPF2	26019
MIM605530		13q34	UPF3, YEAST, HOMOLOG OF, A; UPF3A	65110
MIM605532		 	SMAD-SPECIFIC E3 UBIQUITIN PROTEIN LIGASE 2; SMURF2	64750
MIM605533		10q22	NEUREGULIN 3; NRG3	10718
MIM605534		15q24	HIGH MOBILITY GROUP PROTEIN 20A; HMG20A	10363
MIM605535		19p13.3	HIGH MOBILITY GROUP PROTEIN 20B; HMG20B	10362
MIM605536		2p13-p12	RAB11 FAMILY-INTERACTING PROTEIN 5; RAB11FIP5	26056
MIM605537		1q22-q23	ACTIVATING TRANSCRIPTION FACTOR 6; ATF6	22926
MIM605538		 	NEUROTENSIN RECEPTOR 2; NTSR2	23620
MIM605539		19q13.4	KALLIKREIN-RELATED PEPTIDASE 12; KLK12	43849
MIM605540		 	POLY(A) POLYMERASE-ASSOCIATED DOMAIN-CONTAINING PROTEIN 5; PAPD5	64282
MIM605541		1p13.3	VAV3 ONCOGENE; VAV3	10451
MIM605542		2q12.1	INTERLEUKIN 36, GAMMA; IL36G	56300
MIM605543	C1854182	4q21	PARKINSON DISEASE 4, AUTOSOMAL DOMINANT; PARK4	60454, 6622
MIM605544	C1854181	5q13-q22	FIBROMATOSIS, GINGIVAL, 2; GINGF2	64644
MIM605545		12p13.3	CD163 ANTIGEN; CD163	9332
MIM605546		19q13.4	GLYCOPROTEIN VI, PLATELET; GP6	51206
MIM605547		3q13.3	FOLLISTATIN-LIKE 1; FSTL1	11167
MIM605548		1q21.3	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 15; ADAM15	8751
MIM605549	C1854180	1q12-q24	CONE-ROD DYSTROPHY 8; CORD8	54109
MIM605550		17p11.2	RAS PROTEIN, DEXAMETHASONE-INDUCED, 1; RASD1	51655
MIM605551		1q23.3	NITRIC OXIDE SYNTHASE 1 (NEURONAL) ADAPTOR PROTEIN; NOS1AP	9722
MIM605552	C0524620	4q22-q24, 3q27	ABDOMINAL OBESITY-METABOLIC SYNDROME	4547, 65076
MIM605553		14q32.1-q32.2	POLY(A) POLYMERASE, ALPHA; PAPOLA	10914
MIM605554		1q22	CD244 ANTIGEN; CD244	51744
MIM605555		11q13.3	ARYL HYDROCARBON RECEPTOR-INTERACTING PROTEIN; AIP	9049
MIM605556		2q23-q24	SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE TRANSPORTER-LIKE), MEMBER 10; SLC4A10	57282
MIM605557		1p36.3	PR DOMAIN-CONTAINING PROTEIN 16; PRDM16	63976
MIM605558		8p22-p21.3	FIBROBLAST GROWTH FACTOR 20; FGF20	26281
MIM605559		Chr.12	HOMEOBOX C11; HOXC11	3227
MIM605560		Chr.12	HOMEOBOX C10; HOXC10	3226
MIM605561		11p15	PLAKOPHILIN 3; PKP3	11187
MIM605562		11q12.3-q13.1	SECRETOGLOBIN, FAMILY 2A, MEMBER 2; SCGB2A2	4250
MIM605563		 	CALCIUM-BINDING PROTEIN 1; CABP1	9478
MIM605564		15q24	CALCIUM- AND INTEGRIN-BINDING PROTEIN 2; CIB2	10518
MIM605565		19p13.2	RESISTIN; RETN	56729
MIM605566		22q11	RETICULON 4 RECEPTOR; RTN4R	65078
MIM605567		 	SIVA APOPTOSIS-INDUCING FACTOR 1; SIVA1	10572
MIM605568		7q21.1-q31.1	SMAD-SPECIFIC E3 UBIQUITIN PROTEIN LIGASE 1; SMURF1	57154
MIM605569		11q21	G PROTEIN-COUPLED RECEPTOR 83; GPR83	10888
MIM605570		15q21.3-q22.31	RAS-ASSOCIATED PROTEIN RAB11A; RAB11A	8766
MIM605571		Chr.12	PIWI-LIKE 1; PIWIL1	9271
MIM605572	C1854170	17p12	ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	65077
MIM605573		9q22	17-@BETA HYDROXYSTEROID DEHYDROGENASE III; HSD17B3	3293
MIM605574		20q13.12	UBIQUITIN-CONJUGATING ENZYME E2C; UBE2C	11065
MIM605575		3q26.1	STRUCTURAL MAINTENANCE OF CHROMOSOMES 4; SMC4	10051
MIM605576		Chr.9	STRUCTURAL MAINTENANCE OF CHROMOSOMES 2; SMC2	10592
MIM605577		11q13	RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 2; RASGRP2	10235
MIM605578		Chr.11	INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 2; IFITM2	10581
MIM605579		Chr.11	INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 3; IFITM3	10410
MIM605580		12q13.2	INTERLEUKIN 23-ALPHA; IL23A	51561
MIM605581		 	BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE; B3GNT1	10678
MIM605582	C1854159	6q12-q16	CARDIOMYOPATHY, DILATED, 1K; CMD1K	65014
MIM605583	C1854158	12q23	DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25	246213
MIM605584		16q21-q22	DEAH BOX POLYPEPTIDE 38; DHX38	9785
MIM605585		6q22.1	CELL DIVISION CYCLE 40, S. CEREVISIAE, HOMOLOG OF; CDC40	51362
MIM605586		Chr.11	IMPORTIN 7; IPO7	10527
MIM605587		3q26.1-q26.2	PROTEASE INHIBITOR 14; PI14	5276
MIM605588	C1854154	1q21.2	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	4000
MIM605589	C1854150	19q13.3	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2; CMT2B2	81857
MIM605590		2q33.1	SPLICING FACTOR 3B, SUBUNIT 1; SF3B1	23451
MIM605591		Chr.11	SPLICING FACTOR 3B, SUBUNIT 2; SF3B2	10992
MIM605592		Chr.16	SPLICING FACTOR 3B, SUBUNIT 3; SF3B3	23450
MIM605593		1q12-q21	SPLICING FACTOR 3B, SUBUNIT 4; SF3B4	10262
MIM605594	C1854146	4q21.3	DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	1834
MIM605595		22q12.2	SPLICING FACTOR 3A, SUBUNIT 1; SF3A1	10291
MIM605596		 	SPLICING FACTOR 3A, SUBUNIT 3; SF3A3	10946
MIM605597		3q23	FORKHEAD TRANSCRIPTION FACTOR FOXL2; FOXL2	668
MIM605598	C1854125	5q31.1-q33.1	DIABETES MELLITUS, INSULIN-DEPENDENT, 18; IDDM18	57044
MIM605599		Chr.8	LYSOPHOSPHOLIPASE I; LYPLA1	10434
MIM605600		12p11.2	IMPORTIN 8; IPO8	10526
MIM605601		11cen-q12	PROTEOGLYCAN 2; PRG2	5553
MIM605602		4q26-q27	MYOZENIN 2; MYOZ2	51778
MIM605603		10q22.1	MYOZENIN 1; MYOZ1	58529
MIM605604		5q31.2	POLYADENYLATE-BINDING PROTEIN-INTERACTING PROTEIN 2; PAIP2	51247
MIM605606	C1854124	1p	PSORIASIS SUSCEPTIBILITY 7; PSORS7	149233, 65245
MIM605607		 	CENTROMERIC PROTEIN H; CENPH	64946
MIM605608		21q22.3	CLAUDIN 14; CLDN14	23562
MIM605609		8q23	OXIDATION RESISTANCE 1; OXR1	55074
MIM605610		19q13.4	POLYNUCLEOTIDE KINASE 3-PRIME PHOSPHATASE; PNKP	11284
MIM605611		2q37.1-q37.2	SH3 DOMAIN-BINDING PROTEIN 4; SH3BP4	23677
MIM605612		3p25.1	SH3 DOMAIN-BINDING PROTEIN 5; SH3BP5	9467
MIM605613		12q24.2-q24.3	HUNTINGTIN-INTERACTING PROTEIN 1-RELATED PROTEIN; HIP1R	9026
MIM605614		12q24.2	GENERAL CONTROL OF AMINO ACID SYNTHESIS 1, YEAST, HOMOLOG-LIKE 1; GCN1L1	10985
MIM605615		3p21	ARIADNE, DROSOPHILA, HOMOLOG OF, 2; ARIH2	10425
MIM605616		3p21.3	SOLUTE CARRIER FAMILY 6 (PROLINE IMINO TRANSPORTER), MEMBER 20; SLC6A20	54716
MIM605618	C1854119	 	TETRALOGY OF FALLOT SYNDROME, AUTOSOMAL RECESSIVE	 
MIM605619		1q32	INTERLEUKIN 20; IL20	50604
MIM605620		6q23	INTERLEUKIN 20 RECEPTOR, ALPHA; IL20RA	53832
MIM605621		 	INTERLEUKIN 20 RECEPTOR, BETA; IL20RB	53833
MIM605622		5q31	PROTOCADHERIN 12; PCDH12	51294
MIM605623		7q32	MUSKELIN 1; MKLN1	4289
MIM605624		15q24	ARIADNE, DROSOPHILA, HOMOLOG OF, 1; ARIH1	25820
MIM605625		11q13.1	MYELOMA OVEREXPRESSED GENE; MYEOV	26579
MIM605626		7p22	ENDOGENOUS RETROVIRUS GROUP K, MEMBER 6; ERVK-6	64006
MIM605627	C1854108	 	CEREBROOCULONASAL SYNDROME	 
MIM605628		11p15.1	HIV-1 TAT-INTERACTING PROTEIN 2, 30-KD; HTATIP2	10553
MIM605629		12q24.1-q24.3	SERINE/THREONINE PROTEIN KINASE 21	11113
MIM605630		1p36.12	PHOSPHOLIPASE A2, GROUP IID; PLA2G2D	26279
MIM605631		19q13.33	NAPSIN A	9476
MIM605632		1p21	SOLUTE CARRIER FAMILY 35 (UDP-N-ACETYLGLUCOSAMINE TRANSPORTER), MEMBER 3; SLC35A3	23443
MIM605633		7q22	MUCIN 3B, INTESTINAL; MUC3B	57876
MIM605634		6q15	SOLUTE CARRIER FAMILY 35 (CMP-SIALIC ACID TRANSPORTER), MEMBER 1; SLC35A1	10559
MIM605635	C1854107	7p22	HYPERALDOSTERONISM, FAMILIAL, TYPE II	79179
MIM605636		14q32.3	MATERNALLY EXPRESSED GENE 3; MEG3	55384
MIM605637	C1854106	17p13.1	INCLUSION BODY MYOPATHY 3, AUTOSOMAL DOMINANT; IBM3	4620
MIM605638		2p22-p21	BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 6; BIRC6	57448
MIM605639		19q13.33-q13.41	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 8; SIGLEC8	27181
MIM605640		19q13.4	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 9; SIGLEC9	27180
MIM605641		Chr.16	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 6; SLC7A6	9057
MIM605642	C1854104	1q21	THYROID CARCINOMA, PAPILLARY, WITH PAPILLARY RENAL NEOPLASIA	79052
MIM605643		19q13.4	KALLIKREIN-RELATED PEPTIDASE 5; KLK5	25818
MIM605644		19q13.4	KALLIKREIN-RELATED PEPTIDASE 8; KLK8	11202
MIM605645		 	RESISTIN-LIKE PROTEIN, BETA; RETNLB	84666
MIM605646		7q31	SOLUTE CARRIER FAMILY 26, MEMBER 4; SLC26A4	5172
MIM605647		1p36.23	F-BOX ONLY PROTEIN 6; FBXO6	26270
MIM605648		22q12-q13	F-BOX ONLY PROTEIN 7; FBXO7	25793
MIM605649		4q34.1	F-BOX ONLY PROTEIN 8; FBXO8	26269
MIM605650		5q13.1	POLYMERASE, DNA, KAPPA; POLK	51426
MIM605651		5q35.1	F-BOX AND WD40 DOMAIN PROTEIN 11; FBXW11	23291
MIM605652		3p22.3	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 2; FBXL2	25827
MIM605653		13q22	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 3; FBXL3	26224
MIM605654		6q16.1-q16.3	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 4; FBXL4	26235
MIM605655		4p15.33	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 5; FBXL5	26234
MIM605656		5p15.1	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 7; FBXL7	23194
MIM605657		Chr.11	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 11; FBXL11	22992
MIM605658		14q11.2	INTERLEUKIN 25; IL25	64806
MIM605659		12p13	C-TYPE LECTIN DOMAIN FAMILY 2, MEMBER D; CLEC2D	29121
MIM605660		 	PREFOLDIN 6; PFDN6	10471
MIM605661		13q14.3	TRIPARTITE MOTIF-CONTAINING PROTEIN 13; TRIM13	10206
MIM605662		22q11.2	RAS-ASSOCIATED PROTEIN RAB36; RAB36	9609
MIM605663		22q11.2	RHABDOID TUMOR DELETION REGION GENE 1; RTDR1	27156
MIM605664		5q31	KINESIN FAMILY MEMBER 20A; KIF20A	10112
MIM605666		13q14	CYSTEINYL LEUKOTRIENE RECEPTOR 2; CYSLTR2	57105
MIM605667		1q25.3	RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 1; RGL1	23179
MIM605668		21q22.3	BETA-SITE AMYLOID BETA A4 PRECURSOR PROTEIN-CLEAVING ENZYME 2; BACE2	25825
MIM605669		6q23-q24	PROSTATE AND BREAST CANCER OVEREXPRESSED 1; PBOV1	59351
MIM605670	C1854065	11q23.3	LATE-ONSET RETINAL DEGENERATION; LORD	114902
MIM605671		5q21-q22	DMX-LIKE 1; DMXL1	1657
MIM605672	C1854064	 	CEREBELLAR ATAXIA AND HYPERGONADOTROPIC HYPOGONADISM	 
MIM605673		11q23	B-CELL TRANSLOCATION GENE 4; BTG4	54766
MIM605674		21q11.2-q21.1	B-CELL TRANSLOCATION GENE 3; BTG3	10950
MIM605675		5q23.3-q31.1	RING FINGER PROTEIN 14; RNF14	9604
MIM605676	C1854063	6p24	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA	1832
MIM605677		10q25.1-q25.2	ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 5; ACSL5	51703
MIM605678		7q11.23	MLX-INTERACTING PROTEIN-LIKE; MLXIPL	51085
MIM605679		12q15	INTERLEUKIN 26; IL26	55801
MIM605680		14q12-q13	BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 1A; BAZ1A	11177
MIM605681		7q11-q21	BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 1B; BAZ1B	9031
MIM605682		12q24.3-qter	BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 2A; BAZ2A	11176
MIM605683		2q23-q24	BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 2B; BAZ2B	29994
MIM605684		11p15.4-p15.3	TRIPARTITE MOTIF-CONTAINING PROTEIN 34; TRIM34	53840
MIM605685		 	CUTIS VERTICIS GYRATA, RETINITIS PIGMENTOSA, AND SENSORINEURAL DEAFNESS	 
MIM605686		11q23.2	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 4; IGSF4	23705
MIM605687		1q32	INTERLEUKIN 19; IL19	29949
MIM605688		14q11.2	COPINE VI; CPNE6	9362
MIM605689		16q24.3	COPINE VII; CPNE7	27132
MIM605690		19q13.3	GLIOMA TUMOR SUPPRESSOR CANDIDATE REGION GENE 1; GLTSCR1	29998
MIM605691		19q13.3	GLIOMA TUMOR SUPPRESSOR CANDIDATE REGION GENE 2; GLTSCR2	29997
MIM605692		15q21	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 7; TRPM7	54822
MIM605693		11q12-q14	RAS-ASSOCIATED PROTEIN RAB30; RAB30	27314
MIM605694		18p11.3	RAS-ASSOCIATED PROTEIN RAB31; RAB31	11031
MIM605695		4p16.1	CAPPUCCINO, MOUSE, HOMOLOG OF; CNO	55330
MIM605696		 	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 2; KCNG2	26251
MIM605697		6q25	UL16-BINDING PROTEIN 1; ULBP1	80329
MIM605698		6q25	UL16-BINDING PROTEIN 2; ULBP2	80328
MIM605699		6q25	UL16-BINDING PROTEIN 3; ULBP3	79465
MIM605700		6p22.1-p21.3	TRIPARTITE MOTIF-CONTAINING PROTEIN 39; TRIM39	56658
MIM605701		6p21.3	TRIPARTITE MOTIF-CONTAINING PROTEIN 10; TRIM10	10107
MIM605702		Chr.11	LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1	10894
MIM605703		18p11.22	VESICLE-ASSOCIATED MEMBRANE PROTEIN-ASSOCIATED PROTEIN A; VAPA	9218
MIM605704		20q13.3	VESICLE-ASSOCIATED MEMBRANE PROTEIN-ASSOCIATED PROTEIN B; VAPB	9217
MIM605705		21q22.3	SALT-INDUCIBLE KINASE 1; SIK1	150094
MIM605706		21q22.3	RECEPTOR-INTERACTING SERINE-THREONINE KINASE 4; RIPK4	54101
MIM605708		 	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 11; ARHGEF11	9826
MIM605709		3p14	ADP-RIBOSYLATION-LIKE FACTOR 6-INTERACTING PROTEIN 5; ARL6IP5	10550
MIM605710		5q31	GDNF FAMILY RECEPTOR ALPHA-3; GFRA3	2676
MIM605711	C1854052	2p14-p13	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	27247, 80767
MIM605712		9q22.1-q22.3	SERINE PALMITOYLTRANSFERASE, LONG-CHAIN BASE SUBUNIT 1; SPTLC1	10558
MIM605713		14q24.3-q31	SERINE PALMITOYLTRANSFERASE, LONG-CHAIN BASE SUBUNIT 2; SPTLC2	9517
MIM605714	C2751536	21q21	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED	351
MIM605715		15q23-q24	CD276 ANTIGEN; CD276	80381
MIM605716		Chr.14	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 5; KCNH5	27133
MIM605717		21q22.3	INDUCIBLE T-CELL COSTIMULATOR LIGAND; ICOSLG	23308
MIM605718		13q14.2	MEDIATOR COMPLEX SUBUNIT 4; MED4	29079
MIM605719		7q11.23	LINKER FOR ACTIVATION OF T CELLS FAMILY, MEMBER 2; LAT2	7462
MIM605720		11q13	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 4; KCNK4	50801
MIM605721		1q21.2-q21.3	JUNCTION ADHESION MOLECULE 1; JAM1	50848
MIM605722		17q25	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 16; KCNJ16	3773
MIM605723		9p24.2	PROGRAMMED CELL DEATH 1 LIGAND 2; PDCD1LG2	80380
MIM605724	C1838457	13q12.3	FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1	675
MIM605725		19q13.1-q13.2	PERIAXIN; PRX	57716
MIM605726	C1854023	9p21.1-p12	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 2; DSMA2	80768
MIM605727	C1854022	7q34-q36	OTOSCLEROSIS 2; OTSC2	93999
MIM605728	C1854021	15q21-q22	CATARACT, CENTRAL SACCULAR, WITH SUTURAL OPACITIES	80770
MIM605729		 	AT-HOOK TRANSCRIPTION FACTOR AKNA	80709
MIM605730		10p12-p11.2	SPERM-ASSOCIATED ANTIGEN 6; SPAG6	9576
MIM605731		9p13-p12	SPERM-ASSOCIATED ANTIGEN 8; SPAG8	26206
MIM605732		 	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 21; TNFRSF21	27242
MIM605733		5q35.3	PRELI DOMAIN-CONTAINING PROTEIN 1; PRELID1	27166
MIM605734		2q32-q33	TRANSMEMBRANE PROTEIN WITH EGF-LIKE AND 2 FOLLISTATIN-LIKE DOMAINS 2; TMEFF2	23671
MIM605735	C2751535	 	BLEEDING DISORDER, PLATELET-TYPE, 12; BDPLT12	 
MIM605736		21q22.3	UBIQUITIN-ASSOCIATED AND SH3 DOMAIN-CONTAINING PROTEIN A; UBASH3A	53347
MIM605737		20q13.3	BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7; BIRC7	79444
MIM605738	C1854018	15q12-q15	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 2; MCOPCB2	80771
MIM605739		3q21	KYPHOSCOLIOSIS PEPTIDASE; KY	339855
MIM605740		17q12-q21	SCLEROSTIN; SOST	50964
MIM605741		13q32.3	G PROTEIN-COUPLED RECEPTOR 183; GPR183	1880
MIM605742	NULL	22q11	TUBULIN, ALPHA-8; TUBA8	51807
MIM605743		1q32	HEDGEHOG ACYLTRANSFERASE; HHAT	55733
MIM605744		8p21	EXOSTOSIN-LIKE 3; EXTL3	2137
MIM605745		 	CYTOCHROME b REDUCTASE 1; CYBRD1	79901
MIM605746	C1854013	16q13-q21	ANISOMASTIA	80871
MIM605747		1p36-p35	LOW DENSITY LIPOPROTEIN RECEPTOR ADAPTOR PROTEIN 1; LDLRAP1	26119
MIM605748		16q21-q23	BETA-CAROTENE 15,15-PRIME-MONOOXYGENASE 1; BCMO1	53630
MIM605749	C1854003	9q13-q22	CATARACT, AUTOSOMAL RECESSIVE, EARLY-ONSET, PULVERULENT	81863
MIM605750	C1854002	11p13-p12	EXUDATIVE VITREORETINOPATHY 3; EVR3	81864
MIM605751	C1853995	16p12-q12	SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2	81865
MIM605752		17q25.1	CHROMOSOME 17 OPEN READING FRAME 28; C7ORF28	283987
MIM605753		4p	SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 2; SPINK2	6691
MIM605754		 	PHOSPHATIDYLINOSITOL GLYCAN, CLASS Q; PIGQ	9091
MIM605755		6p22.1	DOUBLECORTIN DOMAIN-CONTAINING PROTEIN 2; DCDC2	51473
MIM605756	C3148970	 	OVARIAN DYSGENESIS, HYPERGONADOTROPIC, WITH SHORT STATURE AND RECURRENT METABOLIC ACIDOSIS	 
MIM605757		5q11.2	PELOTA, DROSOPHILA, HOMOLOG OF; PELO	53918
MIM605758		2q37	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 1; ASB1	51665
MIM605759		Chr.14	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 2; ASB2	51676
MIM605760		2p16-p14	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 3; ASB3	51130
MIM605761		7q21-q22	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 4; ASB4	51666
MIM605762		14q32	RENAL TUMOR ANTIGEN; RAGE	5891
MIM605763		1p36.2-p36.1	SOLUTE CARRIER FAMILY 45, MEMBER 1; SLC45A1	50651
MIM605764		6p22.3-p22.1	TRAF- AND TNF RECEPTOR-ASSOCIATED PROTEIN; TTRAP	51567
MIM605765		13q14	DELETED IN LYMPHOCYTIC LEUKEMIA, 1; DLEU1	10301
MIM605766		13q14	DELETED IN LYMPHOCYTIC LEUKEMIA, 2; DLEU2	8847
MIM605767		Chr.8	PHOSPHOPROTEIN ASSOCIATED WITH GLYCOSPHINGOLIPID-ENRICHED MICRODOMAINS 1; PAG1	55824
MIM605768		4q25-q27	DUAL ADAPTOR OF PHOSPHOTYROSINE AND 3-PHOSPHOINOSITIDES 1	27071
MIM605769		1p13	TRIPARTITE MOTIF-CONTAINING PROTEIN 33; TRIM33	51592
MIM605770		19p13.1	ILVB-LIKE; ILVBL	10994
MIM605771		2p21	CYTOCHROME C OXIDASE SUBUNIT VIIA, POLYPEPTIDE 2-LIKE; COX7A2L	9167
MIM605772		8q23	ESTROGEN RECEPTOR-BINDING SITE-ASSOCIATED ANTIGEN, 9; EBAG9	9166
MIM605773		14q11.2-q12	LEUKOTRIENE B4 RECEPTOR 2; LTB4R2	56413
MIM605774		4q21.2	KELCH-LIKE 2; KLHL2	11275
MIM605775		5q31	KELCH-LIKE 3; KLHL3	26249
MIM605776		8p22	FIBRINOGEN-LIKE 1; FGL1	2267
MIM605777		 	SPHINGOMYELIN PHOSPHODIESTERASE 3, NEUTRAL MEMBRANE; SMPD3	55512
MIM605778		2q33	NIF3-LIKE 1; NIF3L1	60491
MIM605779	C1853984	17p13	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 7; NDNC7	81866
MIM605780		12q23-q24.1	PR DOMAIN-CONTAINING PROTEIN 4; PRDM4	11108
MIM605781		11q14.3	RAS HOMOLOG GENE FAMILY, MEMBER D; RHOD	29984
MIM605782		3q25-q27	EUKARYOTIC TRANSLATION INITIATION FACTOR 5A2; EIF5A2	56648
MIM605783		1p21-p13.3	BREAST CARCINOMA AMPLIFIED SEQUENCE 2; BCAS2	10286
MIM605784		19q13.4	TWEETY, DROSOPHILA, HOMOLOG OF, 1; TTYH1	57348
MIM605785		17q21	TUBULIN, GAMMA-2; TUBG2	27175
MIM605786		3p24-p23	RNA-BINDING MOTIF PROTEIN, SINGLE STRAND-INTERACTING, 3; RBMS3	27303
MIM605787		5q12-q13	ANKYRIN REPEAT-CONTAINING PROTEIN, FAMILY A, MEMBER 2; ANKRA2	57763
MIM605788		2p23.3-p23.1	MICROTUBULE-ASSOCIATED PROTEIN, RP/EB FAMILY, MEMBER 3; MAPRE3	22924
MIM605789		18q12-q21	MICROTUBULE-ASSOCIATED PROTEIN, RP/EB FAMILY, MEMBER 2; MAPRE2	10982
MIM605790		7p15.3	SERINE/THREONINE KINASE 31; STK31	56164
MIM605791		Chr.11	TESTIS-EXPRESSED GENE 12; TEX12	56158
MIM605792		Chr.17	TESTIS-EXPRESSED GENE 14; TEX14	56155
MIM605793		13q12.1	RING FINGER PROTEIN 17; RNF17	56163
MIM605794		22q13.33	MOV10-LIKE 1; MOV10L1	54456
MIM605795		Chr.8	TESTIS-EXPRESSED GENE 15; TEX15	56154
MIM605796		10q25.3	TUDOR DOMAIN-CONTAINING PROTEIN 1; TDRD1	56165
MIM605797		7q31.3	ANKYRIN REPEAT, SAM, AND BASIC LEUCINE ZIPPER DOMAIN-CONTAINING 1; ASZ1	136991
MIM605798		Chr.9	NEURAL PROLIFERATION, DIFFERENTIATION, AND CONTROL PROTEIN 1; NPDC1	56654
MIM605799		14q32	AMNIONLESS, MOUSE, HOMOLOG OF; AMN	81693
MIM605800		19q13.2	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U-LIKE 1; HNRNPUL1	11100
MIM605801		18p11	RALA-BINDING PROTEIN 1; RALBP1	10928
MIM605802		2q22	ZINC FINGER E BOX-BINDING HOMEOBOX 2; ZEB2	9839
MIM605803	C1853965	1q21	DERMATITIS, ATOPIC, 2; ATOD2	2312
MIM605804	C1853964	20p	DERMATITIS, ATOPIC, 3; ATOD3	117187
MIM605805	C1853963	17q25.3	DERMATITIS, ATOPIC, 4; ATOD4	 
MIM605806		18q22-q23	CADHERIN 7; CDH7	1005
MIM605807		18q22-q23	CADHERIN 20; CDH20	28316
MIM605808	C1853959	 	BIRDSHOT CHORIORETINOPATHY	 
MIM605809	C1853949	17p13	MYASTHENIA, FAMILIAL INFANTILE, 1	8144
MIM605810		3q23	MITOCHONDRIAL RIBOSOMAL PROTEIN S22; MRPS22	56945
MIM605811		20p12-p11.2	NTF2-LIKE EXPORT FACTOR 1; NXT1	29107
MIM605812		Chr.16	DEAD/H BOX 19; DDX19	11269
MIM605813		 	NUCLEAR TRANSPORT FACTOR 2	10204
MIM605814	C1853942	7q21.3	CITRULLINEMIA, TYPE II, NEONATAL-ONSET	10165
MIM605815		19q13.33	NUCLEOPORIN, 62-KD; NUP62	23636
MIM605816		19p13.3	EPSTEIN-BARR VIRUS-INDUCED GENE 3; EBI3	10148
MIM605817		14q11.2	RECEPTOR-INTERACTING SERINE/THREONINE KINASE 3; RIPK3	11035
MIM605818	C1853941	2q23-q31	DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	23713
MIM605819		22q12.1	PESCADILLO, ZEBRAFISH, HOMOLOG OF, 1; PES1	23481
MIM605820	C1853926	9p13.3	NONAKA MYOPATHY; NM	10020
MIM605821		16p11.2	ERYTHROID-ASSOCIATED FACTOR; ERAF	51327
MIM605822	C1853925	 	SPONDYLOOCULAR SYNDROME, AUTOSOMAL RECESSIVE	 
MIM605823		3q13.3	POPEYE DOMAIN-CONTAINING PROTEIN 2; POPDC2	64091
MIM605824		6q21	POPEYE DOMAIN-CONTAINING PROTEIN 3; POPDC3	64208
MIM605825		6q24	HEME-BINDING PROTEIN 2; HEBP2	23593
MIM605826		Chr.12	HEME-BINDING PROTEIN 1; HEBP1	50865
MIM605828		17q25	TRANSMEMBRANE CHANNEL-LIKE PROTEIN 6; TMC6	11322
MIM605829		17q25	TRANSMEMBRANE CHANNEL-LIKE PROTEIN 8; TMC8	147138
MIM605830		4p16	FIBROBLAST GROWTH FACTOR RECEPTOR-LIKE 1; FGFRL1	53834
MIM605831		19p13.3	FIBROBLAST GROWTH FACTOR 22; FGF22	27006
MIM605832		20q11.22	ACETYL-CoA SYNTHETASE SHORT CHAIN FAMILY, MEMBER 2; ACSS2	55902
MIM605833	C1853912	1q21-q23	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 2; BMND2	338027
MIM605834		1q12	TROPOMODULIN 4; TMOD4	29765
MIM605835		9q13-q21	TRANSMEMBRANE PROTEIN 2; TMEM2	23670
MIM605836		Chr.9	UNC13, C. ELEGANS, HOMOLOG OF, B; UNC13B	10497
MIM605837		15q13.1	HECT DOMAIN AND RCC1-LIKE DOMAIN 2; HERC2	8924
MIM605838	C1853911	 	BABY RATTLE PELVIS DYSPLASIA	 
MIM605840		 	RING FINGER PROTEIN 111; RNF111	54778
MIM605841	C1853901	4p13-q21	NARCOLEPSY 2, SUSCEPTIBILITY TO; NRCLP2	100918
MIM605842		7q11.23	TRANSDUCIN-BETA-LIKE 2; TBL2	26608
MIM605843		2q35	PEROXISOMAL TRANS-2-ENOYL-CoA REDUCTASE; PECR	55825
MIM605844	C1853900	13q12-q14	DERMATITIS, ATOPIC, 5; ATOD5	117188
MIM605845	C1853899	5q31-q33	DERMATITIS, ATOPIC, 6; ATOD6	114477
MIM605846		7q11.23	B-CELL CLL/LYMPHOMA 7B; BCL7B	9275
MIM605847		16p11	B-CELL CLL/LYMPHOMA 7C; BCL7C	9274
MIM605848		19p13.1	CASPASE 14, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP14	23581
MIM605849		5q12.2-q12.3	DIMETHYLGLYCINE DEHYDROGENASE; DMGDH	29958
MIM605850	C1853892	5q12.2-q12.3	DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY; DMGDHD	29958
MIM605851		1p36	ISOPRENYLCYSTEINE CARBOXYLMETHYLTRANSFERASE; ICMT	23463
MIM605852		2q14	CYTOPLASMIC LINKER-ASSOCIATED PROTEIN 1; CLASP1	23332
MIM605853		3p22.3	CYTOPLASMIC LINKER-ASSOCIATED PROTEIN 2; CLASP2	23122
MIM605854		19q	BCL2-BINDING COMPONENT 3; BBC3	27113
MIM605855		15q11-q13	ATPase, CLASS V, TYPE 10A; ATP10A	57194
MIM605856	C1970039	 	SHORT STATURE, MENTAL RETARDATION, CALLOSAL AGENESIS, HEMINASAL HYPOPLASIA, MICROPHTHALMIA, AND ATYPICAL CLEFTING	 
MIM605857		2p21	RAS HOMOLOG GENE FAMILY, MEMBER Q; RHOQ	23433
MIM605858		Chr.8	SCRATCH, MOUSE, HOMOLOG OF; SCRT1	83482
MIM605859		19q13.1	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 32; ZBTB32	27033
MIM605860		1p35.2-p33	RCAN FAMILY MEMBER 3; RCAN3	11123
MIM605861		12q15	CANOPY 2, ZEBRAFISH, HOMOLOG OF; CNPY2	10330
MIM605862		12q14.2	TRANSMEMBRANE PROTEIN 5; TMEM5	10329
MIM605863		19p	BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 3; B3GNT3	10331
MIM605864		12q24.31	BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 4; B3GNT4	79369
MIM605865		1p36.33	TASTE RECEPTOR TYPE 1, MEMBER 3; TAS1R3	83756
MIM605866		19p13.3	ATPase, CLASS I, TYPE 8B, MEMBER 3; ATP8B3	148229
MIM605867		1q21.3	ATPase, CLASS I, TYPE 8B, MEMBER 2; ATP8B2	57198
MIM605868		13q34	ATPase, CLASS VI, TYPE 11A; ATP11A	23250
MIM605869		3q27	ATPase, CLASS VI, TYPE 11B; ATP11B	23200
MIM605870		13q12	ATPase, CLASS I, TYPE 8A, MEMBER 2; ATP8A2	51761
MIM605872		19p13.3	C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER M; CLEC4M	10332
MIM605873		14q31	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 10; KCNK10	54207
MIM605874		8q24.1-q24.3	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 9; KCNK9	51305
MIM605875		1p36.11-p34.3	WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY, MEMBER 2; WASF2	10163
MIM605876		1q21	Fc RECEPTOR-LIKE PROTEIN 4; FCRL4	83417
MIM605877		1q21	Fc RECEPTOR-LIKE PROTEIN 5; FCRL5	83416
MIM605878		19p13.3	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 7; ZBTB7	51341
MIM605879		5q21.2-q22.1	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 2; KCNN2	3781
MIM605880		10q22	LYSINE ACETYLTRANSFERASE 6B; KAT6B	23522
MIM605881		11p11.2	SOLUTE CARRIER FAMILY 35, MEMBER C1; SLC35C1	55343
MIM605882		17q22	BRCA1-INTERACTING PROTEIN 1; BRIP1	83990
MIM605883		3q26.3-q27	LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 3; LAMP3	27074
MIM605884		12q24.31	DYNEIN, AXONEMAL, HEAVY CHAIN 10; DNAH10	196385
MIM605885		 	SEMAPHORIN 6A; SEMA6A	57556
MIM605886		1q32	COMPLEMENT COMPONENT RECEPTOR 1-LIKE; CR1L	1379
MIM605888		11q13	EH DOMAIN-CONTAINING 1; EHD1	10938
MIM605889		4q35	PDZ AND LIM DOMAIN PROTEIN 3; PDLIM3	27295
MIM605890		19q13.3	EH DOMAIN-CONTAINING 2; EHD2	30846
MIM605891		2p21	EH DOMAIN-CONTAINING 3; EHD3	30845
MIM605892		15q11.1	EH DOMAIN-CONTAINING 4; EHD4	30844
MIM605893		 	CDP-DIACYLGLYCEROL-INOSITOL 3-PHOSPHATIDYLTRANSFERASE; CDIPT	10423
MIM605894		15q21.1-q21.2	CREBBP/EP300 INHIBITORY PROTEIN 1; CRI1	23741
MIM605895		2q37.1	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E FAMILY, MEMBER 2; EIF4E2	9470
MIM605896		2q36-q37	ENDOTHELIN-CONVERTING ENZYME-LIKE 1; ECEL1	9427
MIM605897		2q14.3	UDP-GLUCOSE:GLYCOPROTEIN GLUCOSYLTRANSFERASE 1; UGGT1	56886
MIM605898		13q32.1	UDP-GLUCOSE:GLYCOPROTEIN GLUCOSYLTRANSFERASE 2; UGGT2	55757
MIM605899	C0751748	16q24, 9p22, 3p21.2-p21.1	GLYCINE ENCEPHALOPATHY; GCE	2653, 2731, 275
MIM605900		10q26	PDZ AND LIM DOMAIN PROTEIN 1; PDLIM1	9124
MIM605901		 	UROCORTIN III; UCN3	114131
MIM605902		3p21.3	UROCORTIN II; UCN2	90226
MIM605903		5q35.3	PDZ AND LIM DOMAIN PROTEIN 7; PDLIM7	9260
MIM605904		4q22	PDZ AND LIM DOMAIN PROTEIN 5; PDLIM5	10611
MIM605905		3q26.3	DCN1 DOMAIN-CONTAINING PROTEIN 1; DCUN1D1	54165
MIM605906		10q22.2-q23.3	LIM DOMAIN-BINDING 3; LDB3	11155
MIM605907		16p13.3	ALG1, YEAST, HOMOLOG OF; ALG1	56052
MIM605908		22q13.33	MLC1 GENE; MLC1	23209
MIM605909	C1853833	1p36	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK6	65018
MIM605910		19p13.3	ANGIOPOIETIN-LIKE 4; ANGPTL4	51129
MIM605911	C2751532	1p13-p12	3-@HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 2 DEFICIENCY	3158
MIM605912		4q21.1	MATRIX, EXTRACELLULAR, PHOSPHOGLYCOPROTEIN; MEPE	56955
MIM605913	C1853831	1q23	BLEEDING DISORDER, EAST TEXAS TYPE	85504
MIM605914		16p13.3	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 12A; TNFRSF12A	51330
MIM605915		16p13.3	TRANSDUCIN-BETA-LIKE 3; TBL3	10607
MIM605916		15q21	SPECTRIN, BETA, NONERYTHROCYTIC, 5; SPTBN5	51332
MIM605917		20q11.2	CHROMOSOME 20 OPEN READING FRAME 1; C20ORF1	22974
MIM605918		4p16.3	SPONDIN 2; SPON2	10417
MIM605920		8q13-q21.1	STAUFEN, DROSOPHILA, HOMOLOG OF, 2; STAU2	27067
MIM605921		11p15.5	STROMAL INTERACTION MOLECULE 1; STIM1	6786
MIM605922		18p11.2	MYO-INOSITOL MONOPHOSPHATASE 2; IMPA2	3613
MIM605923		16p13.3	SRY-BOX 8; SOX8	30812
MIM605924		21q22.3	WD REPEAT-CONTAINING PROTEIN 4; WDR4	10785
MIM605925		21q22.3	PERICENTRIN; PCNT	5116
MIM605926		22q12.3-q13.2	PROTEIN INTERACTING WITH C KINASE 1; PICK1	9463
MIM605927		8q24.1-q24.3	MOUSE DOUBLE MINUTE 2 HOMOLOG, BINDING PROTEIN OF; MTBP	27085
MIM605928		 	ADP-RIBOSYLATION FACTOR-INTERACTING PROTEIN 1; ARFIP1	27236
MIM605929		5q23	SORTING NEXIN 2; SNX2	6643
MIM605930		6q21	SORTING NEXIN 3; SNX3	8724
MIM605931		3q21.2	SORTING NEXIN 4; SNX4	8723
MIM605932		5q13.1-q13.2	BETAINE-HOMOCYSTEINE METHYLTRANSFERASE 2; BHMT2	23743
MIM605933		8q22	TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 4; TM7SF4	81501
MIM605934	C1853830	2q37.1-q37.3	HOLOPROSENCEPHALY 6; HPE6	117190
MIM605935	C1853829	 	ARTHROPATHY, EROSIVE	 
MIM605936		12q13.13	BRIDGING INTEGRATOR 2; BIN2	51411
MIM605937		20p11	SORTING NEXIN 5; SNX5	27131
MIM605938		21q22.1-q22.2	PHOSPHATIDYLINOSITOL GLYCAN, CLASS P; PIGP	51227
MIM605939		 	PHOSPHOLIPASE C, DELTA-4; PLCD4	84812
MIM605940		5p15.1-p14	BRAIN-ABUNDANT SIGNAL PROTEIN, MEMBRANE-ATTACHED, 1; BASP1	10409
MIM605941		Chr.11	SQUAMOUS CELL CARCINOMA ANTIGEN RECOGNIZED BY T CELLS 1; SART1	9092
MIM605942		6q22	DERMATAN SULFATE EPIMERASE; DSE	29940
MIM605943		16p12-p11.2	GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE 1; GDE1	51573
MIM605945	C1853826	 	CRUMPLED HELICES AND SMALL MOUTH	 
MIM605946	C1853825	 	METAPHYSEAL DYSPLASIA, BRAUN-TINSCHERT TYPE	 
MIM605947		17p12-p11.2	PHOSPHATIDYLINOSITOL GLYCAN, CLASS L; PIGL	9487
MIM605948		16p12.3-p12.1	G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER B; GPRC5B	51704
MIM605949		17q25.1-q25.3	G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER C; GPRC5C	55890
MIM605950		 	RAS-ASSOCIATED PROTEIN RAB33B; RAB33B	83452
MIM605951		1q12-q21	DOLICHYL-PHOSPHATE MANNOSYLTRANSFERASE 3; DPM3	54344
MIM605952		6q26.3	SORTING NEXIN 9; SNX9	51429
MIM605953		8q24.1-q24.2	DEVELOPMENT- AND DIFFERENTIATION-ENHANCING FACTOR 1; DDEF1	50807
MIM605954		3q27	FETUIN B; FETUB	26998
MIM605955		10q26	NK6, DROSOPHILA, HOMOLOG OF, 2; NKX6-2	84504
MIM605956		16q12	NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN PROTEIN 2; NOD2	64127
MIM605958		3p21.31	TRAF-INTERACTING PROTEIN; TRAIP	10293
MIM605959		 	HR44 ANTIGEN	27251
MIM605960		1p36.22	EXOSOME COMPONENT 10; EXOSC10	5394
MIM605961		4q31.2-q32.1	PLEIOTROPIC REGULATOR 1; PLRG1	5356
MIM605962		 	RAB9 EFFECTOR PROTEIN WITH KELCH MOTIFS; RABEPK	10244
MIM605963		2p23-p22	SORTING NEXIN 17; SNX17	9784
MIM605964		11q13	SORTING NEXIN 15; SNX15	29907
MIM605965		 	RAS AND RAB INTERACTOR 1; RIN1	9610
MIM605966		8q21	HEPATOCYTE NUCLEAR FACTOR 4-GAMMA; HNF4G	3174
MIM605967	C1853812	7q36	ACROPECTORAL SYNDROME; ACRPS	85505
MIM605968		22q12-q13	RET FINGER PROTEIN-LIKE 1; RFPL1	5988
MIM605969		22q12-q13	RET FINGER PROTEIN-LIKE 2; RFPL2	10739
MIM605970		22q12-q13	RET FINGER PROTEIN-LIKE 3; RFPL3	10738
MIM605971		22q12-q13	RET FINGER PROTEIN-LIKE 3, ANTISENSE; RFPL3S	10737
MIM605972		22q12-q13	RET FINGER PROTEIN-LIKE 1, ANTISENSE; RFPL1S	10740
MIM605973		 	DDB1- AND CUL4-ASSOCIATED FACTOR 7; DCAF7	10238
MIM605974		 	SLU7 SPLICING FACTOR, S. CEREVISIAE, HOMOLOG OF; SLU7	10569
MIM605975		1p36.11	SERINE/ARGININE REPETITIVE MATRIX PROTEIN 1; SRRM1	10250
MIM605976		 	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 6; ZBTB6	10773
MIM605977		7q31	INNER MITOCHONDRIAL MEMBRANE PEPTIDASE, SUBUNIT 2, S. CEREVISIAE, HOMOLOG OF; IMMP2L	83943
MIM605978		9q21	VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, A; VPS13A	23230
MIM605979		 	SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 5; SNAPC5	10302
MIM605980		7p15-p14	NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN PROTEIN 1; NOD1	10392
MIM605981		15q15-q21.1	UBIQUITIN-PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 1; UBR1	197131
MIM605983		19q13.4	PROTEIN PHOSPHATASE 2, STRUCTURAL/REGULATORY SUBUNIT A, ALPHA; PPP2R1A	5518
MIM605984		11q14.2-q22.3	EMBRYONIC ECTODERM DEVELOPMENT PROTEIN, MOUSE, HOMOLOG OF; EED	8726
MIM605986		12p12.3	SERINE/THREONINE KINASE RECEPTOR-ASSOCIATED PROTEIN; STRAP	11171
MIM605987		1q21	PROTEIN INHIBITOR OF ACTIVATED STAT3	10401
MIM605988		10p	DNA CROSS-LINK REPAIR PROTEIN 1C; DCLRE1C	64421
MIM605989		 	PROTEIN INHIBITOR OF ACTIVATED STAT4; PIAS4	51588
MIM605990	C2700426	10q21.2	NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO	22891
MIM605991		2q37	NEURONAL GUANINE NUCLEOTIDE EXCHANGE FACTOR; NGEF	25791
MIM605992		12q24.31-q24.32	LIM HOMEOBOX PROTEIN 5; LHX5	64211
MIM605993		8q22.1	PYRUVATE DEHYDROGENASE PHOSPHATASE CATALYTIC SUBUNIT 1; PDP1	54704
MIM605994		6p21.1-p11.2	CYTOCHROME P450, FAMILY 39, SUBFAMILY A, POLYPEPTIDE 1; CYP39A1	51302
MIM605995		1p36.2	KINESIN FAMILY MEMBER 1B; KIF1B	23095
MIM605996		6p21.3	DOM3, C. ELEGANS, HOMOLOG OF, Z; DOM3Z	1797
MIM605997		4p16	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, GAMMA ISOFORM; PPP2R2C	5522
MIM605998		1q21.3	HCLS1-ASSOCIATED PROTEIN X1; HAX1	10456
MIM605999		17p13.1	C-TYPE LECTIN DOMAIN FAMILY 10, MEMBER A; CLEC10A	10462
MIM606000		6p21.3	BUTYROPHILIN-LIKE PROTEIN 2; BTNL2	56244
MIM606001		16p13.3	INTERLEUKIN 32; IL32	9235
MIM606002	C1853761	9q34	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	23064
MIM606003	C1291329	11p15.5-p15.4	TRANSALDOLASE DEFICIENCY	6888
MIM606004		22q13.31	GOLGI-ASSOCIATED, GAMMA-ADAPTIN EAR-CONTAINING, ARF-BINDING PROTEIN 1; GGA1	26088
MIM606005		 	GOLGI-ASSOCIATED, GAMMA-ADAPTIN EAR-CONTAINING, ARF-BINDING PROTEIN 2; GGA2	23062
MIM606006		Chr.17	GOLGI-ASSOCIATED, GAMMA-ADAPTIN EAR-CONTAINING, ARF-BINDING PROTEIN 3; GGA3	23163
MIM606007		 	POLYMERASE III, RNA, SUBUNIT K; POLR3K	51728
MIM606008		 	NATURAL KILLER CELL GROUP 7 SEQUENCE; NKG7	4818
MIM606009		4q35	DOUBLE HOMEOBOX PROTEIN 4; DUX4	22947
MIM606010		2p23	NUCLEAR RECEPTOR-BINDING PROTEIN 1; NRBP1	29959
MIM606011		 	V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 2; VSIG2	23584
MIM606012	C1853760	3q22	DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18	85507
MIM606013		6q25-q26	F-BOX ONLY PROTEIN 5; FBXO5	26271
MIM606014		1p21-p13	ARISTALESS-LIKE HOMEOBOX 3; ALX3	257
MIM606015		1q32.2	FAS APOPTOTIC INHIBITORY MOLECULE 3; FAIM3	9214
MIM606016		19p13.2	KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; KEAP1	9817
MIM606017		 	POLYMERASE II, RNA, SUBUNIT D; POLR2D	5433
MIM606018		 	EGF-LIKE REPEATS- AND DISCOIDIN I-LIKE DOMAINS-CONTAINING PROTEIN 3; EDIL3	10085
MIM606019		13q13.1	EXOSOME COMPONENT 8; EXOSC8	11340
MIM606020		 	OPA-INTERACTING PROTEIN 5; OIP5	11339
MIM606021		22q11.22	PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA; PRAME	23532
MIM606022		 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 9; NUDT9	53343
MIM606023		3q28	POLYMERASE II, RNA, SUBUNIT H; POLR2H	5437
MIM606025		3q13.2	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 20; ZBTB20	26137
MIM606026		4p16.3	WHS CANDIDATE 2 GENE; WHSC2	7469
MIM606027		 	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 1; CPSF1	29894
MIM606028		 	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 2; CPSF2	53981
MIM606029		 	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 3; CPSF3	51692
MIM606030		 	ENHANCER OF mRNA DECAPPING 4; EDC4	23644
MIM606031		3p21.31	WD REPEAT-CONTAINING PROTEIN 6; WDR6	11180
MIM606032		Chr.16	SERINE/ARGININE REPETITIVE MATRIX PROTEIN 2; SRRM2	23524
MIM606033		8p22	POLYMERASE II, RNA, SUBUNIT K; POLR2K	5440
MIM606034		19p13.13	RIBONUCLEASE H2, SUBUNIT A; RNASEH2A	10535
MIM606035	C2676369	6q22-q24	FASTING INSULIN LEVEL QUANTITATIVE TRAIT LOCUS 1; FIQTL1	619503
MIM606036		15q24	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR 2; ARNT2	9915
MIM606037		3q13.13	CD96 ANTIGEN; CD96	10225
MIM606038		6p21.3	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G6D; LY6G6D	58530
MIM606039		12q24.31	G PROTEIN-COUPLED RECEPTOR 109B; GPR109B	8843
MIM606040		1p36.3	WD REPEAT-CONTAINING PROTEIN 8; WDR8	49856
MIM606041		 	SPARC-LIKE PROTEIN 1; SPARCL1	8404
MIM606042		 	MYONEURIN; MYNN	55892
MIM606043		19q13.3-q13.4	ZINC FINGER PROTEIN 331; ZNF331	55422
MIM606044		 	SJOGREN SYNDROME/SCLERODERMA AUTOANTIGEN 1; SSSCA1	10534
MIM606045		3q21	INTRAFLAGELLAR TRANSPORT 122, CHLAMYDOMONAS, HOMOLOG OF; IFT122	55764
MIM606046		 	SYNTAXIN 18; STX18	53407
MIM606047		19q13.4	IMMUNOGLOBULIN-LIKE TRANSCRIPT 11	353514
MIM606048		19q13.4	LEUKOCYTE RECEPTOR CLUSTER GENE 4; LENG4	79143
MIM606049	C1853757	Chr.11	ACROMEGALOID FEATURES, OVERGROWTH, CLEFT PALATE, AND HERNIA	93956
MIM606050		6p21.3	UBIQUITIN D; UBD	10537
MIM606051		11p14	DEAFNESS LOCUS-ASSOCIATED PUTATIVE GUANINE NUCLEOTIDE EXCHANGE FACTOR	26297
MIM606053	C1853755	2q	AUTISM, SUSCEPTIBILITY TO, 5; AUTS5	94313
MIM606054	C0268579	13q32, 3q21-q22	PROPIONIC ACIDEMIA	5095, 5096
MIM606055		17q21-q22	PHOSPHATIDYLCHOLINE TRANSFER PROTEIN; PCTP	58488
MIM606056	C1853736	2p13-p12	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb; CDG2B	7841
MIM606057		Chr.12	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3; RAPGEF3	10411
MIM606058		 	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAPGEF4	11069
MIM606059		Chr.8	PROTEIN KINASE, cAMP-DEPENDENT CATALYTIC, INHIBITOR ALPHA; PKIA	5569
MIM606060		10q21.1	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 12; DNAJC12	56521
MIM606061		7p15-p14	T-BOX 20; TBX20	57057
MIM606062		10q25	STRUCTURAL MAINTENANCE OF CHROMOSOMES 3; SMC3	9126
MIM606063		1q42-q43	EXONUCLEASE 1, S. CEREVISIAE, HOMOLOG OF; EXO1	9156
MIM606064		11q13	CD248 ANTIGEN; CD248	57124
MIM606065		3q22	CHEMOKINE, CC MOTIF, RECEPTOR-LIKE PROTEIN 1; CCRL1	51554
MIM606066		1q31-q32	LIM HOMEOBOX GENE 9; LHX9	56956
MIM606067		20p11	OTORAPLIN; OTOR	56914
MIM606068	C1853734	2p15-p11, 2p15	RETINITIS PIGMENTOSA 28; RP28	84140
MIM606069	C1853733	2q32	HEMOCHROMATOSIS, TYPE 4; HFE4	30061
MIM606070	C1853723	5q31.2, 5q	MYOPATHY, DISTAL, 2; MPD2	9782
MIM606071	C2079540	12q24.1	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	59341
MIM606072	C1853698	3p25, 1q41	RIPPLING MUSCLE DISEASE; RMD	859
MIM606073		9q34.3	NADPH-DEPENDENT DIFLAVIN OXIDOREDUCTASE 1; NDOR1	27158
MIM606074		9q34	GLOBOSIDE ALPHA-1,3-N-ACETYLGALACTOSAMINYLTRANSFERASE; GBGT1	26301
MIM606075		10q24	CHROMOSOME 10 OPEN READING FRAME 2; C10ORF2	56652
MIM606076		1p34.2	PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 3; PIK3R3	8503
MIM606077		1p13	RNA-BINDING MOTIF PROTEIN 15; RBM15	64783
MIM606078		22q13	MEGAKARYOBLASTIC LEUKEMIA 1 GENE; MKL1	57591
MIM606079		12p13.3	CD163 ANTIGEN-LIKE 1; CD163L1	283316
MIM606080		1p21.3-p13.1	CHITINASE, ACIDIC; CHIA	27159
MIM606081		 	TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 70, YEAST, HOMOLOG OF, A; TOMM70A	9868
MIM606082	C1853686	3q26.1-q26.3	GOITER, MULTINODULAR 3; MNG3	94337
MIM606083		3p21	POLYBROMO 1, CHICKEN, HOMOLOG OF; PBRM1	55193
MIM606084		22q13.1	CDC42 EFFECTOR PROTEIN 1; CDC42EP1	11135
MIM606085		7q31.2	TESTIS-DERIVED TRANSCRIPT; TES	26136
MIM606086		 	EUKARYOTIC TRANSLATION INITIATION FACTOR 5B; EIF5B	9669
MIM606087		Chr.15	DESMUSLIN; DMN	23336
MIM606088		Chr.15	PHOSPHOLIPASE A2, GROUP IVB; PLA2G4B	100137049
MIM606089		 	BRAIN CYTOPLASMIC RNA 1; BCYRN1	618
MIM606090		7q21.1	CARNITINE OCTANOYLTRANSFERASE; CROT	54677
MIM606091		19q13.4	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 10; SIGLEC10	89790
MIM606092		12q13.1-q13.2	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 14; DNAJC14	85406
MIM606093		2q31.1	PEPTIDYL-PROLYL ISOMERASE G; PPIG	9360
MIM606094		19q13.4	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 12; SIGLEC12	89858
MIM606095		1p34.1	PEPTIDYL-PROLYL ISOMERASE H; PPIH	10465
MIM606096		11q13	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 12	85329
MIM606097		18q21.2	PHOSPHATIDYLINOSITOL GLYCAN, CLASS N; PIGN	23556
MIM606098		Chr.14	SORTING NEXIN 6; SNX6	58533
MIM606099		1q42-q43	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 8; LGALS8	3964
MIM606100		 	EGF-LIKE MODULE-CONTAINING, MUCIN-LIKE HORMONE RECEPTOR 2; EMR2	30817
MIM606101		 	EGF-LIKE MODULE-CONTAINING, MUCIN-LIKE HORMONE RECEPTOR 3; EMR3	84658
MIM606102		19p13.3	PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, GAMMA; PIP5K1C	23396
MIM606103		6q21	SESTRIN 1; SESN1	27244
MIM606105		9q31.2	SOLUTE CARRIER FAMILY 44, MEMBER 1; SLC44A1	23446
MIM606106		19p13.1	SOLUTE CARRIER FAMILY 44, MEMBER 2; SLC44A2	57153
MIM606107		6p21.3	SOLUTE CARRIER FAMILY 44, MEMBER 4; SLC44A4	80736
MIM606108		 	PROTEIN PHOSPHATASE, MAGNESIUM-DEPENDENT, 1A; PPM1A	5494
MIM606109		8q23	NUDC DOMAIN-CONTAINING PROTEIN 1; NUDCD1	84955
MIM606110		Chr.8	LY6/NEUROTOXIN 1; LYNX1	66004
MIM606111		6q16.2-q21	MELANIN-CONCENTRATING HORMONE RECEPTOR 2; MCHR2	84539
MIM606112		 	RIBONUCLEASE P, 14-KD SUBUNIT; RPP14	11102
MIM606113		7q22	PROCESSING OF PRECURSOR 7, S. CEREVISIAE, HOMOLOG OF; POP7	10248
MIM606114		19q12	PROCESSING OF PRECURSOR 4, S. CEREVISIAE, HOMOLOG OF; POP4	10775
MIM606115		10q23.31	RIBONUCLEASE P/MRP, 30-KD SUBUNIT; RPP30	10556
MIM606116		10p13	RIBONUCLEASE P/MRP, 38-KD SUBUNIT; RPP38	10557
MIM606117		6p25.1	RIBONUCLEASE P, 40-KD SUBUNIT; RPP40	10799
MIM606118		3q24	HPS3 GENE; HPS3	84343
MIM606119		8qter	SECRETED LY6/PLAUR DOMAIN-CONTAINING PROTEIN 1; SLURP1	57152
MIM606121		7q21.3-q22	CALCITONIN GENE-RELATED PEPTIDE RECEPTOR COMPONENT PROTEIN	27297
MIM606122		13q12.11-q12.3	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 19; TNFRSF19	55504
MIM606123		1q42	RING FINGER PROTEIN 16; RNF16	51127
MIM606124		11p11.12-q12	RING FINGER PROTEIN 18; RNF18	57093
MIM606125		10q24.3	TRIPARTITE MOTIF-CONTAINING PROTEIN 8; TRIM8	81603
MIM606126		12p12	APOPTOSIS REGULATOR BCLG	79370
MIM606127		17p11.2	MYOCARDIN; MYOCD	93649
MIM606129	C1853666	8p23.3-p22	DIAMOND-BLACKFAN ANEMIA 2; DBA2	114086
MIM606130		11q23	RING FINGER PROTEIN 26; RNF26	79102
MIM606131		1p34-p33	RING FINGER PROTEIN 28; RNF28	84676
MIM606132		11q12-q13	CDC42 EFFECTOR PROTEIN 2; CDC42EP2	10435
MIM606133		2p21	CDC42 EFFECTOR PROTEIN 3; CDC42EP3	10602
MIM606134		 	REV1, S. CEREVISIAE, HOMOLOG OF; REV1L	51455
MIM606135		19q13.4	KALLIKREIN-RELATED PEPTIDASE 14; KLK14	43847
MIM606136		 	RAS PROTEIN ACTIVATOR-LIKE 2; RASAL2	9462
MIM606137		 	CELL GROWTH REGULATOR WITH EF-HAND DOMAIN 1; CGREF1	10669
MIM606138		14q22.1	CELL GROWTH REGULATOR WITH RING FINGER DOMAIN 1; CGRRF1	10668
MIM606139		 	KRUPPEL-LIKE FACTOR 16; KLF16	83855
MIM606140		Chr.8	EXPORTIN 7; XPO7	23039
MIM606141		5q34	RAN-BINDING PROTEIN 17; RANBP17	64901
MIM606142		4p16-p15.3	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 9; SLC2A9	56606
MIM606143		8p21	FRIZZLED, DROSOPHILA, HOMOLOG OF, 3; FZD3	7976
MIM606144		6p11	RAS-ASSOCIATED PROTEIN RAB23; RAB23	51715
MIM606145		20q13.1	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 10; SLC2A10	81031
MIM606146		10p11.2	FRIZZLED, DROSOPHILA, HOMOLOG OF, 8; FZD8	8325
MIM606147		12q24.33	FRIZZLED, DROSOPHILA, HOMOLOG OF, 10; FZD10	11211
MIM606148		11q12-q13.1	FATTY ACID DESATURASE 1; FADS1	3992
MIM606149		11q12-q13.1	FATTY ACID DESATURASE 2; FADS2	9415
MIM606150		11q12-q13.1	FATTY ACID DESATURASE 3; FADS3	3995
MIM606151		16q21	BBS2 GENE; BBS2	583
MIM606152		2q36.3	SOLUTE CARRIER FAMILY 19 (THIAMINE TRANSPORTER), MEMBER 3; SLC19A3	80704
MIM606153		20q13.3	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, EPSILON SUBUNIT; ATP5E	514
MIM606154		 	MUCIN 16; MUC16	94025
MIM606155	C1853623	 	FRYNS-AFTIMOS SYNDROME	 
MIM606156	C1853616	 	SENER SYNDROME	 
MIM606157		20p13-p12.3	PANTOTHENATE KINASE 2; PANK2	80025
MIM606158		11q13	BSCL2 GENE; BSCL2	26580
MIM606159	C1853578	19q13.3-q13.4	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	2512
MIM606160		10q23	PANTOTHENATE KINASE 1; PANK1	53354
MIM606161		5q35	PANTOTHENATE KINASE 3; PANK3	79646
MIM606162		1p36	PANTOTHENATE KINASE 4; PANK4	55229
MIM606164	C1853576	 	DIAMOND-BLACKFAN ANEMIA WITH MICROTIA AND CLEFT PALATE	 
MIM606165		2q33	BOL-LIKE; BOLL	66037
MIM606167		14q32.3	G PROTEIN-COUPLED RECEPTOR 132; GPR132	29933
MIM606168		1p21.1-p13.2	DEAD/H BOX 20; DDX20	11218
MIM606170	C1853566	 	GENITOPATELLAR SYNDROME; GTPTS	23522
MIM606171		 	TRANSFER RNA SERINE 1; TRNAS1	94017
MIM606172		 	TRANSFER RNA SERINE 3; TRNAS3	23540
MIM606173		4p16	GrpE, E. COLI, HOMOLOG OF, 1; GRPEL1	80273
MIM606174	C1853565	 	BACULUM, CONGENITAL ABSENCE OF	 
MIM606175	C1443228	 	CARNITINE ACETYLTRANSFERASE DEFICIENCY	 
MIM606176	C1833104	11p15.1, 11p15.1, 11p15.5, 7p15-p13	DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	2645, 3630, 3651, 3767, 6833
MIM606177	C0030593	 	PARS PLANITIS	 
MIM606178		4q28-q32	HEDGEHOG-INTERACTING PROTEIN; HHIP	64399
MIM606179	C0152244	16q22	ANEURYSMAL BONE CYSTS	114293
MIM606180		4q27	EXOSOME COMPONENT 9; EXOSC9	5393
MIM606181		14q32	DEAD/H BOX 24; DDX24	57062
MIM606182		19p13.3	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 9; TNFSF9	8744
MIM606183	C1853556	 	LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	 
MIM606184		5q35	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 12; ADAMTS12	81792
MIM606185		8q22	TUMOR PROTEIN p53-INDUCIBLE NUCLEAR PROTEIN 1; TP53INP1	94241
MIM606186		1q24-q25	CALCYCLIN-BINDING PROTEIN; CACYBP	27101
MIM606187	C1853555	10p13	ALZHEIMER DISEASE 7	114475
MIM606188		8p12	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 28; ADAM28	10863
MIM606189		2p22-p21	CYSTEINE-RICH MOTOR NEURON PROTEIN 1; CRIM1	51232
MIM606190	C1853554	1p11	MENINGIOMA, RADIATION-INDUCED	117192
MIM606191		9q34	FORMIN-BINDING PROTEIN 1; FNBP1	23048
MIM606192		5q35	BUTYROPHILIN-LIKE PROTEIN 3; BTNL3	10917
MIM606193		7q31-q32	SOLUTE CARRIER FAMILY 13 (SODIUM/SULFATE SYMPORTER), MEMBER 1; SLC13A1	6561
MIM606194		 	KERATIN 23; KRT23	25984
MIM606195		16q11.2-q13	IROQUOIS HOMEOBOX PROTEIN 5; IRX5	10265
MIM606196		16q11.2-q13	IROQUOIS HOMEOBOX PROTEIN 6; IRX6	79190
MIM606197		5p15.3	IROQUOIS HOMEOBOX PROTEIN 1; IRX1	79192
MIM606198		5p15.3	IROQUOIS HOMEOBOX PROTEIN 2; IRX2	153572
MIM606199		5p15.3	IROQUOIS HOMEOBOX PROTEIN 4; IRX4	50805
MIM606200		12p12.1-p11.23	BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E41; BHLHE41	79365
MIM606201		4p16.1	WFS1 GENE; WFS1	7466
MIM606202		5p13.3	SOLUTE CARRIER FAMILY 45, MEMBER 2; SLC45A2	51151
MIM606203		11q13.4-q13.5	GRB2-ASSOCIATED BINDING PROTEIN 2; GAB2	9846
MIM606204		8q24-qter	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS D; LY6D	8581
MIM606205		5q31-q32	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, L-PROLINE), MEMBER 7; SLC6A7	6534
MIM606206		Chr.16	METALLOTHIONEIN 4; MT4	84560
MIM606207		15q25-q26	SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER), MEMBER 1; SLC28A1	9154
MIM606208		15q15	SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER), MEMBER 2; SLC28A2	9153
MIM606209		 	YKT6, S. CEREVISIAE, HOMOLOG OF; YKT6	10652
MIM606210		1p36-p35	SELENOPROTEIN N, 1; SEPN1	57190
MIM606211		19p13.3	SIRTUIN 6; SIRT6	51548
MIM606213		 	SIGNAL SEQUENCE RECEPTOR, GAMMA; SSR3	6747
MIM606214	NULL	19q13.13	SPECTRIN, BETA, NONERYTHROCYTIC, 4; SPTBN4	57731
MIM606215	C1853513	1p31-p21	ATRIOVENTRICULAR SEPTAL DEFECT; AVSD	7446
MIM606216		16p13.3	SELENOPROTEIN X, 1; SEPX1	51734
MIM606217	C1853508	3p25.3	ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2; AVSD2	78987
MIM606218		16p11.2	SELENOPHOSPHATE SYNTHETASE 2; SEPHS2	22928
MIM606219		16p13.3	TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PROTEIN 1; TRAP1	10131
MIM606220	C1853507	 	MENTAL RETARDATION, SHORT STATURE, FACIAL ANOMALIES, AND JOINT DISLOCATIONS	 
MIM606221		17q21	IKAROS FAMILY ZINC FINGER 3; IKZF3	22806
MIM606222		16p13	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 6; IGSF6	10261
MIM606223		3q27.1	PROTEASOME 26S SUBUNIT, NON-ATPASE, 2; PSMD2	5708
MIM606224		7p15-p14	5-PRIME-@NUCLEOTIDASE, CYTOSOLIC III; NT5C3	51251
MIM606225		1p36	TASTE RECEPTOR TYPE 1, MEMBER 1; TAS1R1	80835
MIM606226		1p36	TASTE RECEPTOR TYPE 1, MEMBER 2; TAS1R2	80834
MIM606227		11q23	MEMBRANE-TYPE FRIZZLED-RELATED PROTEIN; MFRP	83552
MIM606228		1p35-p34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2C, SUBUNIT 1; EIF2C1	26523
MIM606229		8q24	EUKARYOTIC TRANSLATION INITIATION FACTOR 2C, SUBUNIT 2; EIF2C2	27161
MIM606230		22q13.3	SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 3; SHANK3	85358
MIM606231		12q24.1	ADAPTOR PROTEIN, PHOSPHOTYROSINE INTERACTION, PH DOMAIN, AND LEUCINE ZIPPER-CONTAINING PROTEIN 2; APPL2	55198
MIM606232	C1853490	22q13.3	CHROMOSOME 22q13.3 DELETION SYNDROME	85358
MIM606233		1p21	PROKINETICIN 1; PROK1	84432
MIM606234		 	IKAROS FAMILY ZINC FINGER 2; IKZF2	22807
MIM606235		3q21	THIOREDOXIN REDUCTASE 3; TXNRD3	114112
MIM606236		17q25	ALVEOLAR SOFT PART SARCOMA CHROMOSOME REGION, CANDIDATE 1; ASPSCR1	79058
MIM606237		2q12.1	TRANSFORMING GROWTH FACTOR-BETA RECEPTOR-ASSOCIATED PROTEIN 1; TGFBRAP1	9392
MIM606238		 	IKAROS FAMILY ZINC FINGER 5; IKZF5	64376
MIM606239		12q13	IKAROS FAMILY ZINC FINGER 4; IKZF4	64375
MIM606240	C1853488	2q21	THYROID CARCINOMA, NONMEDULLARY, SUSCEPTIBILITY TO, 1	114568
MIM606241		14q31	DICER, DROSOPHILA, HOMOLOG OF, 1; DICER1	23405
MIM606242	C1853480	 	MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES, AND FACIAL DYSMORPHISM	100653373
MIM606243	C0206657	17q25	ALVEOLAR SOFT PART SARCOMA; ASPS	79058
MIM606244		2q23.3	SIGNAL-TRANSDUCING ADAPTOR MOLECULE 2; STAM2	10254
MIM606245		17q11.2	SUPPRESSOR OF ZESTE 12, DROSOPHILA, HOMOLOG OF; SUZ12	23512
MIM606246		7p15	JUXTAPOSED WITH ANOTHER ZINC FINGER GENE 1; JAZF1	221895
MIM606247		2p13-p12	STAM-BINDING PROTEIN; STAMBP	10617
MIM606248		16p11.2	QUINOLINATE PHOSPHORIBOSYLTRANSFERASE; QPRT	23475
MIM606249		9q22.3	PROTEIN KINASE, LYSINE-DEFICIENT 2; WNK2	65268
MIM606250		12p13.3	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 8; GALNT8	26290
MIM606251		 	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 9; GALNT9	50614
MIM606252		11q23-q24	TIR DOMAIN-CONTAINING ADAPTOR PROTEIN; TIRAP	114609
MIM606254		1p31	SELENOPROTEIN, 15-KD	9403
MIM606255	C1853477	6q24-q25	STATURE AS A QUANTITATIVE TRAIT	 
MIM606256	C1853476	7q31.3	STATURE QUANTITATIVE TRAIT LOCUS 2; STQTL2	192143
MIM606257	C1853475	12p11.2-q14	STATURE QUANTITATIVE TRAIT LOCUS 3; STQTL3	282549
MIM606258	C1853474	13q32-q33	STATURE QUANTITATIVE TRAIT LOCUS 4; STQTL4	282550
MIM606259		11q13.1-q13.2	BREAST CANCER METASTASIS SUPPRESSOR 1; BRMS1	25855
MIM606260		8p23-p22	MYOTUBULARIN-RELATED PROTEIN 9; MTMR9	66036
MIM606261		 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 6; NUDT6	11162
MIM606263	C1853473	5q31	PAGET DISEASE OF BONE 4; PDB4	94003
MIM606264		12p13.2-p12.3	C-TYPE LECTIN DOMAIN FAMILY 7, MEMBER A; CLEC7A	64581
MIM606265		12q24.33	E1A-BINDING PROTEIN, 400-KD; EP400	57634
MIM606266		15q14	BCL2-MODIFYING FACTOR; BMF	90427
MIM606267		 	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 16; WNT16	51384
MIM606268		2q35	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 10A; WNT10A	80326
MIM606269		22q13.1-q13.31	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 13C; TNFRSF13C	115650
MIM606270		 	TOLL-LIKE RECEPTOR 10; TLR10	81793
MIM606271		1q42.1	DISRUPTED IN SCHIZOPHRENIA 2; DISC2	27184
MIM606272		17p13	CYSTINOSIN; CTNS	1497
MIM606273		1p34.1	EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 3; EIF2B3	8891
MIM606274		15q22.1-q22.31	CASEIN KINASE I, GAMMA-1; CSNK1G1	53944
MIM606276		 	CARTILAGE ACIDIC PROTEIN 1; CRTAC1	55118
MIM606277		11p15.5	TOLL-INTERACTING PROTEIN; TOLLIP	54472
MIM606278		4q31.3	F-BOX AND WD40 DOMAIN PROTEIN 7; FBXW7	55294
MIM606279		3q12	TARGET OF NESH-SH3	25890
MIM606280		4p15.3	NON-SMC CONDENSIN I COMPLEX SUBUNIT G; NCAPG	64151
MIM606281		11q13.5-q22.3	RAS-ASSOCIATED PROTEIN RAB38; RAB38	23682
MIM606282	C1853451	4q35-qter	DEAFNESS, AUTOSOMAL DOMINANT 24; DFNA24	23723
MIM606283		10q23.3	SORCS RECEPTOR 1; SORCS1	114815
MIM606284		4p16.1	SORCS RECEPTOR 2; SORCS2	57537
MIM606285		10q23.3	SORCS RECEPTOR 3; SORCS3	22986
MIM606286		6q12-q13	DEAD/H BOX 43; DDX43	55510
MIM606288		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 1; PCDHGA1	56114
MIM606289		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 2; PCDHGA2	56113
MIM606290		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 3; PCDHGA3	56112
MIM606291		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 4; PCDHGA4	56111
MIM606292		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 5; PCDHGA5	56110
MIM606293		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 6; PCDHGA6	56109
MIM606294		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 7; PCDHGA7	56108
MIM606295		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 8; PCDHGA8	9708
MIM606296		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 9; PCDHGA9	56107
MIM606297		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 10; PCDHGA10	56106
MIM606298		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 11; PCDHGA11	56105
MIM606299		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 1; PCDHGB1	56104
MIM606300		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 2; PCDHGB2	56103
MIM606301		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 3; PCDHGB3	56102
MIM606302		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 5; PCDHGB5	56101
MIM606303		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 6; PCDHGB6	56100
MIM606304		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 7; PCDHGB7	56099
MIM606305		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY C, MEMBER 4; PCDHGC4	56098
MIM606306		5q31	PROTOCADHERIN-GAMMA, SUBFAMILY C, MEMBER 5; PCDHGC5	56097
MIM606307		5q31	PROTOCADHERIN-ALPHA 1; PCDHA1	56147
MIM606308		5q31	PROTOCADHERIN-ALPHA 2; PCDHA2	56146
MIM606309		5q31	PROTOCADHERIN-ALPHA 3; PCDHA3	56145
MIM606310		5q31	PROTOCADHERIN-ALPHA 4; PCDHA4	56144
MIM606311		5q31	PROTOCADHERIN-ALPHA 5; PCDHA5	56143
MIM606312		5q31	PROTOCADHERIN-ALPHA 6; PCDHA6	56142
MIM606313		5q31	PROTOCADHERIN-ALPHA 7; PCDHA7	56141
MIM606314		5q31	PROTOCADHERIN-ALPHA 8; PCDHA8	56140
MIM606315		5q31	PROTOCADHERIN-ALPHA 9; PCDHA9	9752
MIM606316		5q31	PROTOCADHERIN-ALPHA 10; PCDHA10	56139
MIM606317		5q31	PROTOCADHERIN-ALPHA 11; PCDHA11	56138
MIM606318		5q31	PROTOCADHERIN-ALPHA 12; PCDHA12	56137
MIM606319		5q31	PROTOCADHERIN-ALPHA 13; PCDHA13	56136
MIM606320		5q31	PROTOCADHERIN-ALPHA, SUBFAMILY C, MEMBER 1; PCDHAC1	56135
MIM606321		5q31	PROTOCADHERIN-ALPHA, SUBFAMILY C, MEMBER 2; PCDHAC2	56134
MIM606322		15q11	CYTOPLASMIC FMRP-INTERACTING PROTEIN 1; CYFIP1	23191
MIM606323		5q33.3	CYTOPLASMIC FMRP-INTERACTING PROTEIN 2; CYFIP2	26999
MIM606324	C1853445	1p36	PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK7	11315
MIM606325	C1853444	6q21	HETEROTAXY, VISCERAL, 3, AUTOSOMAL; HTX3	116629
MIM606326		14q23	SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 6; SIX6	4990
MIM606327		5q31	PROTOCADHERIN-BETA 1; PCDHB1	29930
MIM606328		5q31	PROTOCADHERIN-BETA 2; PCDHB2	56133
MIM606329		5q31	PROTOCADHERIN-BETA 3; PCDHB3	56132
MIM606330		5q31	PROTOCADHERIN-BETA 4; PCDHB4	56131
MIM606331		5q31	PROTOCADHERIN-BETA 5; PCDHB5	26167
MIM606332		5q31	PROTOCADHERIN-BETA 6; PCDHB6	56130
MIM606333		5q31	PROTOCADHERIN-BETA 7; PCDHB7	56129
MIM606334		5q31	PROTOCADHERIN-BETA 8; PCDHB8	56128
MIM606335		5q31	PROTOCADHERIN-BETA 9; PCDHB9	56127
MIM606336		5q31	PROTOCADHERIN-BETA 10; PCDHB10	56126
MIM606337		5q31	PROTOCADHERIN-BETA 11; PCDHB11	56125
MIM606338		5q31	PROTOCADHERIN-BETA 12; PCDHB12	56124
MIM606339		5q31	PROTOCADHERIN-BETA 13; PCDHB13	56123
MIM606340		5q31	PROTOCADHERIN-BETA 14; PCDHB14	56122
MIM606341		5q31	PROTOCADHERIN-BETA 15; PCDHB15	56121
MIM606342		14q23	SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 4; SIX4	51804
MIM606343		10q23	POLYMERASE, DNA, LAMBDA; POLL	27343
MIM606344		 	POLYMERASE, DNA, MU; POLM	27434
MIM606345		5q31	PROTOCADHERIN-BETA 16; PCDHB16	57717
MIM606346	C1853441	6q13	DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22	4646
MIM606347		15q24-q25.1	PROLINE/SERINE/THREONINE PHOSPHATASE-INTERACTING PROTEIN 1; PSTPIP1	9051
MIM606348	C1853438	5q31	INFLAMMATORY BOWEL DISEASE 5; IBD5	50941
MIM606349	C0030662	 	GAMBLING, PATHOLOGIC	 
MIM606350		9p13.3	APRATAXIN; APTX	54840
MIM606351		1p36.3-p36.1	ESPIN, MOUSE, HOMOLOG OF; ESPN	83715
MIM606352		2q33	ALSIN	57679
MIM606353	C1853396	2q33	PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	57679
MIM606355		2q14.1	DEAD/H BOX 18; DDX18	8886
MIM606356		11q22.1	TRANSMEMBRANE PROTEIN 123; TMEM123	114908
MIM606357		10q21	DEAD/H BOX 21; DDX21	9188
MIM606358		7p21.3	ANTERIOR GRADIENT 2, XENOPUS, HOMOLOG OF; AGR2	10551
MIM606359		1q42	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3A; WNT3A	89780
MIM606360		 	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 8A; WNT8A	7478
MIM606361		12p13.3	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 5B; WNT5B	81029
MIM606362		19q13	ACID PHOSPHATASE, TESTICULAR; ACPT	93650
MIM606363		17q21.3	NESH PROTEIN	51225
MIM606365		12q13	GLUTAMINASE, LIVER; GLS2	27165
MIM606366		1q42	RAS HOMOLOG GENE FAMILY, MEMBER U; RHOU	58480
MIM606367	C1853392	10p15.1	INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF	3559
MIM606368		11q23	APOLIPOPROTEIN A-V; APOA5	116519
MIM606369	C1853372	4q21.3	EPILEPTIC ENCEPHALOPATHY, LENNOX-GASTAUT TYPE	5602
MIM606370		7q34	THIAMINE PYROPHOSPHOKINASE; TPK1	27010
MIM606371		Chr.12	ACTIVATING TRANSCRIPTION FACTOR 7; ATF7	11016
MIM606372		11p15.5	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 10; CHRNA10	57053
MIM606373		1q23-q32	FORMIN 2; FMN2	56776
MIM606374		11q12-q13	BETA-1,3-GLUCURONYLTRANSFERASE 3; B3GAT3	26229
MIM606376		2q11.2	CARBOHYDRATE SULFOTRANSFERASE 10; CHST10	9486
MIM606377		 	DIMERIC DIHYDRODIOL DEHYDROGENASE; DHDH	27294
MIM606378		9q31	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 4; ST6GALNAC4	27090
MIM606379		3q24	G PROTEIN-COUPLED RECEPTOR 87; GPR87	53836
MIM606380		3q24	G PROTEIN-COUPLED RECEPTOR 86; GPR86	53829
MIM606381		3q24-q25.1	G PROTEIN-COUPLED RECEPTOR 91; GPR91	56670
MIM606382		7q21	MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAINS-CONTAINING, 2; MAGI2	9863
MIM606383		12q13.13	G PROTEIN-COUPLED RECEPTOR 84; GPR84	53831
MIM606384		18q21	UBIQUITIN PROTEIN LIGASE NEDD4-LIKE; NEDD4L	23327
MIM606385		 	OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 1; OLIG1	116448
MIM606386		21q22.11	OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 2; OLIG2	10215
MIM606387		8q24.3	TOPOISOMERASE I, MITOCHONDRIAL; TOP1MT	116447
MIM606388		1q21	C-TERMINAL MODULATOR PROTEIN	117145
MIM606389		11q13.1	CATION CHANNEL, SPERM-ASSOCIATED, 1; CATSPER1	117144
MIM606391	C0342276	 	MATURITY-ONSET DIABETES OF THE YOUNG; MODY	 
MIM606392	C1833382	13q12.1	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 4; MODY4	3651
MIM606393		8p12	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN-LIKE PROTEIN DECYSIN 1; ADAMDEC1	27299
MIM606394	C1853371	2q32	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 6; MODY6	4760
MIM606395		2p23	PROLACTIN REGULATORY ELEMENT-BINDING PROTEIN; PREB	10113
MIM606396		8p21.3	BRIDGING INTEGRATOR 3; BIN3	55909
MIM606397		3q21-q25	CLARIN 1; CLRN1	7401
MIM606398		19q13.3	ACTIVATING TRANSCRIPTION FACTOR 5; ATF5	22809
MIM606399		3p21.1	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 3; CACNA2D3	55799
MIM606400		3p24	CALPAIN 7; CAPN7	23473
MIM606401		1q42	CALPAIN 9; CAPN9	10753
MIM606402		2p13.3	GASTROKINE 1; GKN1	56287
MIM606403		16p13.1-p12	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-3 SUBUNIT; CACNG3	10368
MIM606404		 	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-4 SUBUNIT; CACNG4	27092
MIM606405		17q24	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-5 SUBUNIT; CACNG5	27091
MIM606406		16p13.1	NUCLEAR PORE COMPLEX-INTERACTING PROTEIN; NPIP	9284
MIM606407	C1848030	2p21	HYPOTONIA-CYSTINURIA SYNDROME	100415942
MIM606408	C1848029	6p21.3	EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY	7148
MIM606409		20q11.22-q11.23	ITCHY E3 UBIQUITIN PROTEIN LIGASE, MOUSE, HOMOLOG OF; ITCH	83737
MIM606410		2p13.1	ANTHRAX TOXIN RECEPTOR 1; ANTXR1	84168
MIM606411		20q12-q13.1	SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER), MEMBER 3; SLC13A3	64849
MIM606412		1p31	BSND GENE	7809
MIM606413		1p31.1-p22.3	INSULIN-LIKE 5; INSL5	10022
MIM606414		9p24	INSULIN-LIKE 6; INSL6	11172
MIM606416		1q44	NLR FAMILY, PYRIN DOMAIN-CONTAINING 3; NLRP3	114548
MIM606417		10q26	WD REPEAT-CONTAINING PROTEIN 11; WDR11	55717
MIM606418		1p33-p31.1	24-@DEHYDROCHOLESTEROL REDUCTASE; DHCR24	1718
MIM606419		19q13.4	PRECURSOR mRNA-PROCESSING FACTOR 31, S. CEREVISIAE, HOMOLOG OF; PRPF31	26121
MIM606420		7p14	ENGULFMENT AND CELL MOTILITY GENE 1; ELMO1	9844
MIM606421		20q13	ENGULFMENT AND CELL MOTILITY GENE 2; ELMO2	63916
MIM606422		Chr.16	ENGULFMENT AND CELL MOTILITY GENE 3; ELMO3	79767
MIM606423		2q33	DISRUPTED IN RENAL CARCINOMA 1; DIRC1	116093
MIM606424		19q13.2	EGL9, C. ELEGANS, HOMOLOG OF, 2; EGLN2	112398
MIM606425		1q42-q43	EGL9, C. ELEGANS, HOMOLOG OF, 1; EGLN1	54583
MIM606426		Chr.14	EGL9, C. ELEGANS, HOMOLOG OF, 3; EGLN3	112399
MIM606427		19q13.3-q13.4	ZINC FINGER PROTEIN 320; ZNF320	162967
MIM606428		2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A3; UGT1A3	54659
MIM606429		2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A4; UGT1A4	54657
MIM606430		2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A5; UGT1A5	54579
MIM606431		2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A6; UGT1A6	54578
MIM606432		2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A7; UGT1A7	54577
MIM606433		2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A8; UGT1A8	54576
MIM606434		2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A9; UGT1A9	54600
MIM606435		2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A10; UGT1A10	54575
MIM606436		11q13.2	SYNAPTOTAGMIN 12; SYT12	91683
MIM606438	C1847987	16q24.3	HUNTINGTON DISEASE-LIKE 2; HDL2	57338
MIM606439		14q11-q21	ATLASTIN GTPase 1; ATL1	51062
MIM606440		15q15	STEREOCILIN; STRC	161497
MIM606441		2p12	HTRA SERINE PEPTIDASE 2; HTRA2	27429
MIM606442		 	ABL INTERACTOR 2	10152
MIM606443		Chr.9	cAMP RESPONSE ELEMENT-BINDING PROTEIN 3; CREB3	10488
MIM606444		 	ZHANGFEI PROTEIN	58487
MIM606445	C1847973	 	PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS	 
MIM606446		1q23.1	SLAM FAMILY, MEMBER 6; SLAMF6	114836
MIM606447		 	RNA-BINDING PROTEIN S1; RNPS1	10921
MIM606448		22q11.2	THIOREDOXIN REDUCTASE 2; TXNRD2	10587
MIM606449		8q24.3	PROTEIN-TYROSINE PHOSPHATASE, TYPE 4A, 3; PTP4A3	11156
MIM606450		 	NEUROEPITHELIAL CELL TRANSFORMING GENE 1; NET1	10276
MIM606451	C1847972	15q25-q26	DEAFNESS, AUTOSOMAL DOMINANT 30; DFNA30	23719
MIM606452		3q26.3-q27	WILDTYPE p53-INDUCED GENE	64393
MIM606453		 	LIPOPOLYSACCHARIDE-RESPONSIVE, BEIGE-LIKE ANCHOR PROTEIN; LRBA	987
MIM606454		14q24	EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 2; EIF2B2	8892
MIM606455		 	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 13B; PPP1R13B	23368
MIM606456		10q24-q26	NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 3; NPM3	10360
MIM606457		6q13-q14	INHIBITOR OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE; IBTK	25998
MIM606458		3p22	AXIN1 UPREGULATED; AXUD1	64651
MIM606459		 	OPIOID GROWTH FACTOR RECEPTOR; OGFR	11054
MIM606460	C2751375	6q21	LONGEVITY 2	100329168
MIM606461		8q11	TRIMETHYLGUANOSINE SYNTHASE, S. CEREVISIAE, HOMOLOG OF; TGS1	96764
MIM606462		8q24	RAD21, S. POMBE, HOMOLOG OF; RAD21	5885
MIM606463		1q21	GLUCOSIDASE, BETA, ACID; GBA	2629
MIM606464		19q13	HEPCIDIN ANTIMICROBIAL PEPTIDE; HAMP	57817
MIM606465		3q21-q22	KRUPPEL-LIKE FACTOR 15; KLF15	28999
MIM606466		 	PML-RARA TARGET GENE ENCODING AN ADAPTOR MOLECULE 1; PRAM1	84106
MIM606467		6q23.2	ALDEHYDE DEHYDROGENASE 8 FAMILY, MEMBER A1; ALDH8A1	64577
MIM606468		4q25	NUCLEOLAR PROTEIN FAMILY A, MEMBER 1; NOLA1	54433
MIM606469		 	RING FINGER PROTEIN 29; RNF29	84675
MIM606470		5q35.3	NUCLEOLAR PROTEIN FAMILY A, MEMBER 2; NOLA2	55651
MIM606471		15q14-q15	NUCLEOLAR PROTEIN FAMILY A, MEMBER 3; NOLA3	55505
MIM606472		20q13.3	SS18-LIKE GENE 1; SS18L1	26039
MIM606473		3p21	SS18-LIKE GENE 2; SS18L2	51188
MIM606474		 	RING FINGER PROTEIN 30; RNF30	57159
MIM606475		19p13.2	CD320 ANTIGEN; CD320	51293
MIM606476		19q13.2	INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE C; ITPKC	80271
MIM606477		17p13.3	SERINE RACEMASE; SRR	63826
MIM606478		 	PROTECTION OF TELOMERES 1; POT1	25913
MIM606479		Chr.17	NEUROLIGIN 2; NLGN2	57555
MIM606480		1p34	ZINC METALLOPROTEINASE STE24; ZMPSTE24	10269
MIM606481		22q11.2-q13.2	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 5-PHOSPHATASE, A; PIB5PA	27124
MIM606482	C1847902	19p13.2	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB	1785
MIM606483	C1847896	10q24.1-q25.1	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA	387574
MIM606484		7q33-q35	MYOTROPHIN; MTPN	136319
MIM606485		15q22.1	POLYMERASE II, RNA, SUBUNIT M; POLR2M	81488
MIM606486		18p11	CHMP FAMILY, MEMBER 1B; CHMP1B	57132
MIM606487		3q28-q29	HRAS-LIKE SUPPRESSOR; HRASLS	57110
MIM606488		 	EXOSOME COMPONENT 7; EXOSC7	23016
MIM606489		 	EXOSOME COMPONENT 3; EXOSC3	51010
MIM606490		 	EXOSOME COMPONENT 6; EXOSC6	118460
MIM606491		 	EXOSOME COMPONENT 4; EXOSC4	54512
MIM606492		 	EXOSOME COMPONENT 5; EXOSC5	56915
MIM606493		 	EXOSOME COMPONENT 1; EXOSC1	51013
MIM606494		1p34.1	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 3; ST3GAL3	6487
MIM606495		19q13.2	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 4; MARK4	57787
MIM606496		6p12	INTERLEUKIN 17F; IL17F	112744
MIM606497		4q13.2	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B28; UGT2B28	54490
MIM606498		11q12-q13	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 3; MS4A3	932
MIM606499		11q12-q13	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 5; MS4A5	64232
MIM606500		5q35	SECRETOGLOBIN, FAMILY 3A, MEMBER 1; SCGB3A1	92304
MIM606501		5p13.3	MYOTUBULARIN-RELATED PROTEIN 12; MTMR12	54545
MIM606502		11q12-q13	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 7; MS4A7	58475
MIM606503		10p13	SUPPRESSOR OF VARIEGATION 3-9, DROSOPHILA, HOMOLOG OF, 2; SUV39H2	79723
MIM606504		17q12-q21.3	CANCER SUSCEPTIBILITY CANDIDATE 3; CASC3	22794
MIM606505		8p23	PIN2-INTERACTING PROTEIN 1	54984
MIM606506		 	PEROXIREDOXIN 4; PRDX4	10549
MIM606508		1q21.2-q22	Fc RECEPTOR-LIKE PROTEIN 1; FCRL1	115350
MIM606509		1q21.2-q22	Fc RECEPTOR-LIKE PROTEIN 2; FCRL2	79368
MIM606510		1q21.2-q22	Fc RECEPTOR-LIKE PROTEIN 3; FCRL3	115352
MIM606511		1q41	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 1; MARK1	4139
MIM606512		6p21	PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 1; PACSIN1	29993
MIM606513		11p11	PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 3; PACSIN3	29763
MIM606514		22q12.3-q13.1	CYTOHESIN 4; CYTH4	27128
MIM606515		6p12.1	RNA, 7SK, SMALL NUCLEAR; RN7SK	125050
MIM606516		3q25	MUSCLEBLIND-LIKE PROTEIN 1; MBNL1	4154
MIM606517		5p15.3	ARYLHYDROCARBON RECEPTOR REPRESSOR; AHRR	57491
MIM606518		5q33.2	HEPATITIS A VIRUS CELLULAR RECEPTOR 1; HAVCR1	26762
MIM606519		 	PHACE ASSOCIATION	 
MIM606520		 	G6B PROTEIN	80739
MIM606521		17q25.3	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL THIAMINE PYROPHOSPHATE CARRIER), MEMBER 19; SLC25A19	60386
MIM606522		12p13.1	GROWTH/DIFFERENTIATION FACTOR 3; GDF3	9573
MIM606523		Chr.12	SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 1; SRGAP1	57522
MIM606524		1q32.1	SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2; SRGAP2	23380
MIM606525		3p25	SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 3; SRGAP3	9901
MIM606526		2q37	MELANOPHILIN; MLPH	79083
MIM606527	C1847871	 	MEGARBANE SYNDROME	 
MIM606528	C1847866	11p15-p14	HOMOZYGOUS 11p15-p14 DELETION SYNDROME	100240736
MIM606529	C1847865	 	CRANIOSYNOSTOSIS SYNDROME, AUTOSOMAL RECESSIVE	 
MIM606530		2q33-qter	CYTOCHROME P450, SUBFAMILY XXVIIA, POLYPEPTIDE 1; CYP27A1	1593
MIM606531		5q31-q34	SECRETOGLOBIN, FAMILY 3A, MEMBER 2; SCGB3A2	117156
MIM606532		21q22	HORMONALLY UPREGULATED NEU-ASSOCIATED KINASE; HUNK	30811
MIM606533		Chr.9	CHLORIDE INTRACELLULAR CHANNEL 3; CLIC3	9022
MIM606534		7q22.1	CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 43; CYP3A43	64816
MIM606535		1p33-p32.2	MYC-BINDING PROTEIN; MYCBP	26292
MIM606536		 	CHLORIDE INTRACELLULAR CHANNEL 4; CLIC4	25932
MIM606537		2q32	MYOSIN IB; MYO1B	4430
MIM606538		17p13	MYOSIN IC; MYO1C	4641
MIM606539		17q11-q12	MYOSIN ID; MYO1D	4642
MIM606540		18q21	MYOSIN VB; MYO5B	4645
MIM606541		2q21.1	MYOSIN VIIB; MYO7B	4648
MIM606542		Chr.12	HISTONE DEACETYLASE 7A; HDAC7A	51564
MIM606543		7p21-p15	HISTONE DEACETYLASE 9; HDAC9	9734
MIM606544		5q13	MITOCHONDRIAL ELONGATION FACTOR G2; GFM2	84340
MIM606545	C1847849	17p13.2-p13.1	ICHTHYOSIS, LAMELLAR, 5; LI5	140560
MIM606546		6q24	HYDATIDIFORM MOLE-ASSOCIATED AND IMPRINTED TRANSCRIPT; HYMAI	57061
MIM606547		11q12-q13	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 4A; MS4A4A	51338
MIM606548		11q12-q13	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 6A; MS4A6A	64231
MIM606549		11q12-q13	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 8B; MS4A8B	83661
MIM606550		11q12-q13	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 12	54860
MIM606551		8p22	LEUCINE ZIPPER, PUTATIVE TUMOR SUPPRESSOR 1; LZTS1	11178
MIM606552	C1847843	 	EPISODIC ATAXIA, TYPE 4; EA4	 
MIM606553		16p13.3	SOLUTE CARRIER FAMILY 9, MEMBER 3, REGULATOR 2; SLC9A3R2	9351
MIM606554	C1847839	1q42	EPISODIC ATAXIA, TYPE 3; EA3	780905
MIM606555		14q21-q24	TRIPARTITE MOTIF-CONTAINING PROTEIN 9; TRIM9	114088
MIM606556		9q22-q31	TRIPARTITE MOTIF-CONTAINING PROTEIN 14; TRIM14	9830
MIM606557		2p16.1	B-CELL CLL/LYMPHOMA 11A; BCL11A	53335
MIM606558		14q32.1	B-CELL CLL/LYMPHOMA 11B; BCL11B	64919
MIM606559		11p15	TRIPARTITE MOTIF-CONTAINING PROTEIN 22; TRIM22	10346
MIM606560		8p23-p22	SPERM-ASSOCIATED ANTIGEN 11; SPAG11	10407
MIM606561		5q31-q33	SOLUTE CARRIER FAMILY 36 (PROTON/AMINO ACID SYMPORTER), MEMBER 1; SLC36A1	206358
MIM606562		15q24-q26	TRANSMEMBRANE 6 SUPERFAMILY, MEMBER 1; TM6SF1	53346
MIM606563		19p12	TRANSMEMBRANE 6 SUPERFAMILY, MEMBER 2; TM6SF2	53345
MIM606564		20q13	TRANSMEMBRANE PROSTATE ANDROGEN-INDUCED RNA; TMEPAI	56937
MIM606565		11q23.3	TRANSMEMBRANE PROTEASE, SERINE 4; TMPRSS4	56649
MIM606566		20q13.3	MYOSIN LIGHT CHAIN KINASE 2; MYLK2	85366
MIM606567		3q25	TRANSMEMBRANE 4 SUPERFAMILY, MEMBER 4; TM4SF4	7104
MIM606568		3p21.3	LEUCINE ZIPPER TRANSCRIPTION FACTOR-LIKE 1; LZTFL1	54585
MIM606569		3p21.3	SUPPRESSOR OF ACTIN MUTATIONS 1-LIKE; SACM1L	22908
MIM606570		7p14-p13	SECRETED FRIZZLED-RELATED PROTEIN 4; SFRP4	6424
MIM606571		18p11.2	CHROMOSOME 18 OPEN READING FRAME 1; C18ORF1	753
MIM606572		Chr.15	NADPH OXIDASE 5; NOX5	79400
MIM606573		6q21-q22.3	FYN-RELATED KINASE; FRK	2444
MIM606574	C1847836	5p13.3	ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4	51151
MIM606575		2q31	MEMBRANE PROTEIN, PALMITOYLATED 4; MPP4	58538
MIM606576		10p15.1	TAF3 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 140-KD; TAF3	83860
MIM606577		20q11.23	SRC-LIKE ADAPTOR 2; SLA2	84174
MIM606578		 	AQUAPORIN 10; AQP10	89872
MIM606579	C1847835	17p13	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1; VAMAS1	22861
MIM606580		19q13.2-q13.3	OPA3 GENE; OPA3	80207
MIM606581	C1847831	 	POLYSUBSTANCE ABUSE, SUSCEPTIBILITY TO	 
MIM606582		 	DELTA-LIKE 1; DLL1	28514
MIM606583		11q13	PEROXIREDOXIN 5; PRDX5	25824
MIM606584		3p21.3	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 23; PTPN23	25930
MIM606585		4q21	ENAMELIN; ENAM	10117
MIM606586		5p13.3-p13.2	RETINOIC ACID-INDUCED 14; RAI14	26064
MIM606587		2q21.1	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 18; PTPN18	26469
MIM606588		21q22.3	DNA METHYLTRANSFERASE 3-LIKE PROTEIN; DNMT3L	29947
MIM606589		7p21.1	SORTING NEXIN 13; SNX13	23161
MIM606590		17qter	NUCLEAR PROTEIN LOCALIZATION 4, S. CEREVISIAE, HOMOLOG OF; NPLOC4	55666
MIM606591		11q13	MUS81, S. CEREVISIAE, HOMOLOG OF; MUS81	80198
MIM606592		6q23-q24	VANIN 3; VNN3	55350
MIM606593	C1847827	13q22-q34	LIG4 SYNDROME	3981
MIM606594		4q28	SET DOMAIN-CONTAINING PROTEIN 7; SETD7	80854
MIM606595	C1847823	7q11.23	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	3315
MIM606596		19q13.3	FUKUTIN-RELATED PROTEIN; FKRP	79147
MIM606597		2q35	PAIRED BOX GENE 3; PAX3	5077
MIM606598		8q13-q21.1	GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 1; GDAP1	54332
MIM606599		1q21	THIOREDOXIN-INTERACTING PROTEIN; TXNIP	10628
MIM606600		 	RAS PROTEIN-SPECIFIC GUANINE NUCLEOTIDE-RELEASING FACTOR 1; RASGRF1	5923
MIM606601		17q11	ENDOGENOUS RETROVIRAL SEQUENCE E, 1; ERVE1	85314
MIM606602		8q22.3	BRAIN AND ACUTE LEUKEMIA GENE, CYTOPLASMIC; BAALC	79870
MIM606603		1q42.2-q43	EDAR-ASSOCIATED DEATH DOMAIN; EDARADD	128178
MIM606604		8q24.13	F-BOX ONLY PROTEIN 32; FBXO32	114907
MIM606605		3p21.3-p21.2	ATR-INTERACTING PROTEIN; ATRIP	84126
MIM606607		20q13.33	PROTEASOME SUBUNIT, ALPHA-TYPE, 7; PSMA7	5688
MIM606608		11q13	YES-ASSOCIATED PROTEIN 1, 65-KD; YAP1	10413
MIM606609		3p21.3-p21.2	3-PRIME @REPAIR EXONUCLEASE 1; TREX1	11277
MIM606610		20p	NSFL1 COFACTOR; NSFL1C	55968
MIM606611		8p23.1	DEFENSIN, BETA, 103A; DEFB103A	55894
MIM606612	C1847759	19q13.3	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT MENTAL RETARDATION), TYPE B, 5; MDDGB5	79147
MIM606613	C1847758	9p	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1; HDLCQ1	192144
MIM606614		5q13	RAS PROTEIN-SPECIFIC GUANINE NUCLEOTIDE-RELEASING FACTOR 2; RASGRF2	5924
MIM606615		10q24	HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR; HIF1AN	55662
MIM606616	C1847757	18p11.2	DYSLEXIA, SUSCEPTIBILITY TO, 6; DYX6	266691
MIM606618		Chr.17	DUAL-SPECIFICITY PHOSPHATASE 14; DUSP14	11072
MIM606619		4p15.31	GLUCOSIDASE, BETA, ACID 3; GBA3	57733
MIM606620		1q21	SLAM FAMILY, MEMBER 8; SLAMF8	56833
MIM606621		3p12-q13	INTRAFLAGELLAR TRANSPORT 57, CHLAMYDOMONAS, HOMOLOG OF: IFT57	55081
MIM606622		2q34-q36	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A-LIKE PROTEIN 1; SMARCAL1	50485
MIM606623		12q13	17-@BETA-HYDROXYSTEROID DEHYDROGENASE VI; HSD17B6	8630
MIM606624		 	NEUROGENIN 2; NEUROG2	63973
MIM606625		1q23-q24	SLAM FAMILY, MEMBER 7; SLAMF7	57823
MIM606626		Chr.14	DISHEVELLED-ASSOCIATED ACTIVATOR OF MORPHOGENESIS 1; DAAM1	23002
MIM606627		6p21.2	DISHEVELLED-ASSOCIATED ACTIVATOR OF MORPHOGENESIS 2; DAAM2	23500
MIM606628		6p12	GLYCINE N-METHYLTRANSFERASE; GNMT	27232
MIM606629		6q12-q13	PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 1; RIMS1	22999
MIM606630		Chr.8	PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 2; RIMS2	9699
MIM606632	C1847745	 	ODOR, MALE, WOMEN'S CHOICE OF	 
MIM606633		 	TRANSCRIPTION FACTOR Sp7; SP7	121340
MIM606634		12q13.1	DERMCIDIN; DCD	117159
MIM606635		21q21	PROTEASE, SERINE, 7; PRSS7	5651
MIM606636		17p13	NLR FAMILY, PYRIN DOMAIN-CONTAINING 1; NLRP1	22861
MIM606637		17q11	PEPTIDE YY, 2; PYY2	23615
MIM606638		17q11	PANCREATIC POLYPEPTIDE 2; PPY2	23614
MIM606639		3q25.1-q26.2	MITOCHONDRIAL ELONGATION FACTOR G1; GFM1	85476
MIM606640	C1847735	18q21	AMYOTROPHIC LATERAL SCLEROSIS 3; ALS3	253
MIM606641	C2240399	7q32.3	BODY MASS INDEX; BMI	170815
MIM606643	C1847733	13q14	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 2; BMIQ2	192149
MIM606644		1q23.1	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 8; IGSF8	93185
MIM606645		4p14	CENTAURIN, DELTA-1; CENTD1	116984
MIM606646		Chr.11	CENTAURIN, DELTA-2; CENTD2	116985
MIM606647		 	CENTAURIN, DELTA-3; CENTD3	64411
MIM606648		6q24.1-q24.2	INTERLEUKIN 22 RECEPTOR, ALPHA-2; IL22RA2	116379
MIM606649		1p34	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 3; HIVEP3	59269
MIM606650		9q31.1	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3A; GRIN3A	116443
MIM606651		 	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3B; GRIN3B	116444
MIM606652		5q33.2	HEPATITIS A VIRUS CELLULAR RECEPTOR 2; HAVCR2	84868
MIM606653		1q32	LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 6; LGR6	59352
MIM606654		4q32	LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 7	59350
MIM606655		13q13.1	RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 2; RXFP2	122042
MIM606656	C1847731	 	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 2; IBGC2	100874532
MIM606657	C1847730	10p15-p14, 3q28-q29	GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO	10133, 4976
MIM606658	C1847725	3p26-p25	SPINOCEREBELLAR ATAXIA 15; SCA15	3708
MIM606659		 	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 8, YEAST, HOMOLOG OF, B; TIMM8B	26521
MIM606660	C1847724	3q24-q26	MELANOMA, UVEAL, SUSCEPTIBILITY TO, 1	170592
MIM606661	C1847723	3p25.2-p25.1	MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2	170593
MIM606662	C1847722	8p23	WAARDENBURG SYNDROME, TYPE 2C; WS2C	170594
MIM606663		8p21.3-p21.2	LYSYL OXIDASE-LIKE 2; LOXL2	4017
MIM606664	C1847720	6p12	GLYCINE N-METHYLTRANSFERASE DEFICIENCY	27232
MIM606665		 	OPSIN 4; OPN4	94233
MIM606666		11p14-p13	G PROTEIN-COUPLED RECEPTOR 48; GPR48	55366
MIM606667		12q15-q23	LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 5; LGR5	8549
MIM606668	C1847719	16p	INFLAMMATORY BOWEL DISEASE 8; IBD8	170595
MIM606669		19q13.12	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 5; FXYD5	53827
MIM606670		6p21.3	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 11; PPP1R11	6992
MIM606671		3p21	NCK-INTERACTING PROTEIN WITH SH3 DOMAIN; NCKIPSD	51517
MIM606672		17pter-p12	GLYCOPROTEIN Ib, PLATELET, ALPHA POLYPEPTIDE; GP1BA	2811
MIM606673		22q11.2	BETA-UREIDOPROPIONASE; UPB1	51733
MIM606674	C1847692	19p13	INFLAMMATORY BOWEL DISEASE 6; IBD6	50942
MIM606675	C1847691	14q11-q12	INFLAMMATORY BOWEL DISEASE 4; IBD4	50608
MIM606676		Chr.17	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 2; TRPV2	51393
MIM606677		12p13.2-p12.3	C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER C; CLEC4C	170482
MIM606678		2q37	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 8; TRPM8	79054
MIM606679		7q35	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 5; TRPV5	56302
MIM606680		7q33-q34	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 6; TRPV6	55503
MIM606681		5q35	NUCLEAR RECEPTOR-BINDING Su-var, ENHANCER OF ZESTE, AND TRITHORAX DOMAIN PROTEIN 1; NSD1	64324
MIM606682		22q11.2-q12.2	HPS4 GENE; HPS4	89781
MIM606683		Chr.11	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 6; FXYD6	53826
MIM606684		19q13.12	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 7; FXYD7	53822
MIM606685	C1847667	5q33	CARDIOMYOPATHY, DILATED, 1L; CMD1L	6444
MIM606686		Chr.12	EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 1; EIF2B1	1967
MIM606687		2p23.3	EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 4; EIF2B4	8890
MIM606688	C1847650	20pter-p12	SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES	5621
MIM606689	C1847649	2cen-q13	GLAUCOMA 1, OPEN ANGLE, B; GLC1B	2722
MIM606690	C0751674	16p13.3, 9q34	LYMPHANGIOLEIOMYOMATOSIS; LAM	7248, 7249
MIM606691		 	CARCINOEMBRYONIC ANTIGEN-LIKE 1; CEAL1	56971
MIM606692		16p13.3	TNF RECEPTOR-ASSOCIATED FACTOR 7; TRAF7	84231
MIM606693	C1847640	1p36	KUFOR-RAKEB SYNDROME; KRS	23400
MIM606694		5p13	NUCLEOPORIN, 155-KD; NUP155	9631
MIM606695		1q43	OPSIN 3; OPN3	23596
MIM606696		6q25.1	KATANIN, p60 SUBUNIT, A1; KATNA1	11104
MIM606697		19p13.2	ZINC FINGER PROTEIN ZK1	10224
MIM606698		 	SRY-BOX 30	11063
MIM606699		Chr.17	HELICASE WITH ZINC FINGER DOMAIN; HELZ	9931
MIM606700		19p13.3	MIDNOLIN, MOUSE, HOMOLOG OF; MIDN	90007
MIM606701		10q11.23	DORSAL ROOT GANGLIA HOMEOBOX; DRGX	644168
MIM606702		6p21.1-p12	PKHD1 GENE; PKHD1	5314
MIM606703	C1847627	 	DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM	111
MIM606704		2p16	G PROTEIN-COUPLED RECEPTOR 75; GPR75	10936
MIM606705	C1847626	9q13-q21	DEAFNESS, AUTOSOMAL DOMINANT 36; DFNA36	117531
MIM606706		9q13-q21	TRANSMEMBRANE CHANNEL-LIKE PROTEIN 1; TMC1	117531
MIM606707		20p13	TRANSMEMBRANE CHANNEL-LIKE PROTEIN 2; TMC2	117532
MIM606708	C1847622	2q31	SPLIT-HAND/FOOT MALFORMATION 5; SHFM5	171157
MIM606709		4q25-q26	PROTEASE, SERINE, 12; PRSS12	8492
MIM606710		13q12	LIPOMA HMGIC FUSION PARTNER; LHFP	10186
MIM606711	C1847614	16q	SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	171013
MIM606712	C1847605	19q	SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	171014
MIM606713	C1847604	1p34	VAN DER WOUDE SYNDROME 2; VWS2	149465
MIM606714		6q15	PROLINE-RICH NUCLEAR RECEPTOR COACTIVATOR 1; PNRC1	10957
MIM606715		2q35-q36	CATION CHANNEL, AMILORIDE-SENSITIVE, NEURONAL, 4; ACCN4	55515
MIM606716		2p13.1-p12	N-ACETYLTRANSFERASE 8; NAT8	9027
MIM606717		17p13.2	XIAP-ASSOCIATED FACTOR 1	54739
MIM606718		5q32-q33.1	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 2; SLC26A2	1836
MIM606719	C1838547	9p21	MELANOMA-PANCREATIC CANCER SYNDROME	1029
MIM606720		 	PLACENTAL PROTEIN 11	8909
MIM606721	C1847582	 	LIPODYSTROPHY WITH CONGENITAL CATARACTS AND NEURODEGENERATION	 
MIM606722		8q22.2	NEUROCALCIN, DELTA; NCALD	83988
MIM606723		12q24.12-q24.13	MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 5; MAPKAPK5	8550
MIM606724		1p33	MITOGEN-ACTIVATED PROTEIN KINASE-INTERACTING SERINE/THREONINE KINASE 1; MKNK1	8569
MIM606725		15q21-q23	CLN6 GENE; CLN6	54982
MIM606726		20q12-q13.1	SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 5; SLC12A5	57468
MIM606727		10q24.2	NK2 HOMEOBOX 3; NKX2-3	159296
MIM606728		2q32-q33	SERUM DEPRIVATION RESPONSE PHOSPHATIDYLSERINE-BINDING PROTEIN; SDPR	8436
MIM606729		22q12	OXYSTEROL-BINDING PROTEIN 2; OSBP2	23762
MIM606730		18q11-q12	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 1A; OSBPL1A	114876
MIM606731		20q	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 2; OSBPL2	9885
MIM606732		7p15	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 3; OSBPL3	26031
MIM606733		11p15.4	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 5; OSBPL5	114879
MIM606734		2q32.1	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 6; OSBPL6	114880
MIM606735		17q21.2	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 7; OSBPL7	114881
MIM606736		12p	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 8; OSBPL8	114882
MIM606737		1p34.2-p32.2	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 9; OSBPL9	114883
MIM606738		3p25.3-p22	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 10; OSBPL10	114884
MIM606739		3q21.1	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 11; OSBPL11	114885
MIM606740		19q13.2	ZINC FINGER PROTEIN 180; ZNF180	7733
MIM606741		19q13.2	ZINC FINGER PROTEIN 181; ZNF181	339318
MIM606742		4q32-q33	TOLLOID-LIKE 1; TLL1	7092
MIM606743		10q23-q24	TOLLOID-LIKE 2; TLL2	7093
MIM606744	C1847572	18p11.31-q11.2	SECKEL SYNDROME 2; SCKL2	347729, 5932
MIM606745		10p11.21	PARTITIONING-DEFECTIVE PROTEIN 3, C. ELEGANS, HOMOLOG OF; PARD3	56288
MIM606746		19p13.3	CHROMOSOME 19 OPEN READING FRAME 10; C19ORF10	56005
MIM606747		17q22	VASCULAR ENDOTHELIAL ZINC FINGER 1; VEZF1	7716
MIM606748		16q24.1	COACTOSIN-LIKE PROTEIN 1; COTL1	23406
MIM606749		6p12-p11.2	TUBULOINTERSTITIAL NEPHRITIS ANTIGEN; TINAG	27283
MIM606750		20q13.31	Z-DNA BINDING PROTEIN 1; ZBP1	81030
MIM606751		11q23.3	TRANSMEMBRANE PROTEASE, SERINE 5; TMPRSS5	80975
MIM606752	C0014077	 	ACUTE HEMORRHAGIC LEUKOENCEPHALITIS	 
MIM606753		1p31.3	TETRATRICOPEPTIDE REPEAT DOMAIN 4; TTC4	7268
MIM606754		20q11.2	SAM DOMAIN- AND HD DOMAIN-CONTAINING PROTEIN 1; SAMHD1	25939
MIM606755		1p36.13	PEPTIDYLARGININE DEIMINASE, TYPE III; PADI3	51702
MIM606756		1q23.3	17-@BETA-HYDROXYSTEROID DEHYDROGENASE VII; HSD17B7	51478
MIM606757		2p13	SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 5; SLC4A5	57835
MIM606758		15q15.3	DUAL OXIDASE 1; DUOX1	53905
MIM606759		15q15.3	DUAL OXIDASE 2; DUOX2	50506
MIM606761		16q24	MALONYL-CoA DECARBOXYLASE; MLYCD	23417
MIM606762	C1847555	10q23.3	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	2746
MIM606763	C1847554	19q13.3-qter	CILIARY DYSKINESIA, PRIMARY, 2; CILD2	352909, 56162
MIM606764	C0238198	4q12, 4q12	GASTROINTESTINAL STROMAL TUMOR; GIST	3815, 5156, 6390, 6391
MIM606765		2p25	THYROID PEROXIDASE; TPO	7173
MIM606766	C1847540	6p21.3	SPERMATOGENIC FAILURE 3; SPGF3	338331
MIM606767		2p21	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 3; KCNG3	170850
MIM606768	C1847532	2p13.3-p13.1	MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT	8291
MIM606769		4q21	HELICASE, POLQ-LIKE; HELQ	113510
MIM606770	C1847530	5p15.2-p14	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2; ADIPQTL2	171511
MIM606771	C1847529	14p11.2-q13	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 3; ADIPQTL3	171512
MIM606772	C1847522	 	MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKIN ANOMALIES	 
MIM606773	C1847521	 	HEMIFACIAL MYOHYPERPLASIA; HMH	 
MIM606774		 	ALDEHYDE REDUCTASE-LIKE 6; ALDRL6	55586
MIM606775		 	CHONDROITIN SULFATE PROTEOGLYCAN 5; CSPG5	10675
MIM606776		15q15.2	TRANSGLUTAMINASE 7; TGM7	116179
MIM606777	CN030711	1p35-p31.3	GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1	6513
MIM606778		Chr.12	SLINGSHOT, DROSOPHILA, HOMOLOG OF, 1; SSH1	54434
MIM606779		Chr.17	SLINGSHOT, DROSOPHILA, HOMOLOG OF, 2; SSH2	85464
MIM606780		Chr.11	SLINGSHOT, DROSOPHILA, HOMOLOG OF, 3; SSH3	54961
MIM606781		3p14.3	TRANSKETOLASE; TKT	7086
MIM606782		12p13	C-TYPE LECTIN DOMAIN FAMILY 1, MEMBER A; CLEC1A	51267
MIM606783		12p13	C-TYPE LECTIN DOMAIN FAMILY 1, MEMBER B; CLEC1B	51266
MIM606784		 	GLYCOGEN SYNTHASE KINASE 3-ALPHA; GSK3A	2931
MIM606785	C2931132	2q37	CRIGLER-NAJJAR SYNDROME, TYPE II	54658
MIM606786		17q22-q24	CD300C ANTIGEN; CD300C	10871
MIM606787	C1847493	1p31	PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1	171513
MIM606788	C1847492	13q14-q21, 11p13, 1p	ANOREXIA NERVOSA, SUSCEPTIBILITY TO, 1; ANON1	171514, 3356, 627
MIM606789	C1969842	8q	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 4; HBFQTL4	171515
MIM606790		17q24	CD300A ANTIGEN; CD300A	11314
MIM606791		 	TPTE AND PTEN HOMOLOGOUS INOSITOL LIPID PHOSPHATASE; TPIP	93492
MIM606792		18q11.2	HISTAMINE RECEPTOR H4; HRH4	59340
MIM606793		17q21	AMINOPEPTIDASE, PUROMYCIN-SENSITIVE; NPEPPS	9520
MIM606794		17q25.3	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 10; SLC25A10	1468
MIM606795		22q13	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 17; SLC25A17	10478
MIM606796		22q13	SUPPRESSION OF TUMORIGENICITY 13; ST13	6767
MIM606797		11q24-q25	SUPPRESSION OF TUMORIGENICITY 14; ST14	6768
MIM606798	C2930898	4p16.1-p15.3	BLEPHAROSPASM, BENIGN ESSENTIAL	1816
MIM606799	C1847482	5q12	STROKE, SUSCEPTIBILITY TO, 1	5144
MIM606800		17q25.2-q25.3	GLUCOSIDASE, ALPHA, ACID; GAA	2548
MIM606801		4p16.3	MACROPHAGE ERYTHROBLAST ATTACHER; MAEA	10296
MIM606802		19q13.3-q13.4	SPIB TRANSCRIPTION FACTOR; SPIB	6689
MIM606803		1p32.3	ACYL-CoA THIOESTERASE 11; ACOT11	26027
MIM606804		9q21.33	GOLGI PHOSPHOPROTEIN 2; GOLPH2	51280
MIM606805		3q26.2	GOLGI INTEGRAL MEMBRANE PROTEIN 4; GOLIM4	27333
MIM606806		21q22.3	FORMIMINOTRANSFERASE CYCLODEAMINASE; FTCD	10841
MIM606807		3p14.3-p14.2	INTERLEUKIN 17 RECEPTOR D; IL17RD	54756
MIM606808		10p11.1	MYOSIN IIIA; MYO3A	53904
MIM606809		1q42.1	ACYL-CoA-BINDING DOMAIN-CONTAINING PROTEIN 3; ACBD3	64746
MIM606810		22q11.2	PROLINE DEHYDROGENASE; PRODH	5625
MIM606811		1p36	ALDEHYDE DEHYDROGENASE, FAMILY 4, SUBFAMILY A, MEMBER 1; ALDH4A1	8659
MIM606812	C0342770	1q42.1	FUMARASE DEFICIENCY	2271
MIM606813		9q34	SOLUTE CARRIER FAMILY 2i (FACILITATED GLUCOSE TRANSPORTER), MEMBER 6; SLC2A6	11182
MIM606814		11cen-q12	PROTEOGLYCAN 3; PRG3	10394
MIM606815		1p35-p34	CBP/P300-INTERACTING TRANSACTIVATOR, WITH GLU/ASP-RICH CARBOXY TERMINAL DOMAIN, 4; CITED4	163732
MIM606816		 	SID1 TRANSMEMBRANE FAMILY, MEMBER 1; SIDT1	54847
MIM606817		6p21.3	PRE-T-CELL RECEPTOR, ALPHA-CHAIN PRECURSOR; PTCRA	171558
MIM606818		11q12-q13.1	DIPEPTIDYL PEPTIDASE III; DPP3	10072
MIM606819		15q22	DIPEPTIDYL PEPTIDASE VIII; DPP8	54878
MIM606820		1q31.2-q31.3	GLUTAREDOXIN 2; GLRX2	51022
MIM606821		7q31	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 5; COG5	10466
MIM606822		1p34-p33	PROTEIN O-MANNOSE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE; POMGNT1	55624
MIM606823		8p12	G PROTEIN-COUPLED RECEPTOR 124; GPR124	25960
MIM606824	C0268186	22q13.1	GLUCOSE/GALACTOSE MALABSORPTION; GGM	6523
MIM606825		7p12.3	TENSIN 3; TNS3	64759
MIM606826		17q21.1	PLEXIN DOMAIN-CONTAINING PROTEIN 1; PLXDC1	57125
MIM606827		10p12.3	PLEXIN DOMAIN-CONTAINING PROTEIN 2; PLXDC2	84898
MIM606828		2p13.3	N-ACETYLGLUCOSAMINE KINASE; NAGK	55577
MIM606829		9q13	FRATAXIN; FXN	2395
MIM606830		Chr.9	ATP/GTP-BINDING PROTEIN 1; AGTPBP1	23287
MIM606831		2p22-p21	NLR FAMILY, CASPASE RECRUITMENT DOMAIN-CONTAINING 4; NLRC4	58484
MIM606832		5q15	ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; ERAP1	51752
MIM606833		7q36	MYELOID/LYMPHOID OR MIXED-LINEAGE LEUKEMIA 3; MLL3	58508
MIM606834		19q13.1	MYELOID/LYMPHOID OR MIXED-LINEAGE LEUKEMIA 4	9757
MIM606835	C1847406	 	DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL; FDAB	59341
MIM606836		15q21.3	GLUCOSAMINYL (N-ACETYL) TRANSFERASE 3, MUCIN-TYPE; GCNT3	9245
MIM606837		8q11	RB1-INDUCIBLE COILED-COIL 1; RB1CC1	9821
MIM606838		16p12-p11.2	PYD AND CARD DOMAIN-CONTAINING PROTEIN; PYCARD	29108
MIM606839		11p15.5	CADHERIN-RELATED FAMILY, MEMBER 5; CDHR5	53841
MIM606840	C1847399	 	PARASOMNIA, SLEEP BRUXISM TYPE; PSMNSB	 
MIM606841		1q23.3	DEATH EFFECTOR DOMAIN-CONTAINING PROTEIN; DEDD	9191
MIM606842	C1847387	 	CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS	 
MIM606843	C1720957	20q12-q13.2	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3; HIGM3	958
MIM606844		2p13	ALMS1 GENE; ALMS1	7840
MIM606845		6q21	GOLGI-ASSOCIATED PDZ AND COILED-COIL DOMAINS-CONTAINING PROTEIN; GOPC	57120
MIM606846		 	SET AND MYND DOMAIN-CONTAINING PROTEIN 1; SMYD1	150572
MIM606847		5q32-q33.1	TCOF1 GENE; TCOF1	6949
MIM606848		1q31.3	NEVER IN MITOSIS GENE A-RELATED KINASE 7; NEK7	140609
MIM606849		19p13.2	UBIQUITIN-LIKE 5; UBL5	59286
MIM606850		14q13	MIRROR-IMAGE POLYDACTYLY GENE 1; MIPOL1	145282
MIM606851	C1847361	 	CREE MENTAL RETARDATION SYNDROME	 
MIM606852	C1847360	1p32	PARKINSON DISEASE 10; PARK10	170534
MIM606853		6p21.3	ATPase, H+ TRANSPORTING, LYSOSOMAL, 13-KD, V1 SUBUNIT G, ISOFORM 2; ATP6V1G2	534
MIM606854	C1847352	16q13	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	100506658, 10381, 26128, 347733, 51807, 9289
MIM606855		19p13.3	RELAXIN 3; RLN3	117579
MIM606856	C1847351	4q32.3	PANCREATIC CANCER, SUSCEPTIBILITY TO, 1	23022
MIM606857		6p12	GLUTAMATE-CYSTEINE LIGASE, CATALYTIC SUBUNIT; GCLC	2729
MIM606860		11q11-q13.1	COMPLEMENT COMPONENT 1 INHIBITOR; C1NH	710
MIM606861		11q24	PROSTATE- AND TESTIS-EXPRESSED GENE	160065
MIM606862		19q13.4	OSTEOCLAST-ASSOCIATED RECEPTOR	126014
MIM606863		Chr.8	THYMOCYTE SELECTION-ASSOCIATED HIGH MOBILITY GROUP BOX; TOX	9760
MIM606864	C1847319	1q21, 11q23, 1p36.1-p35	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	6390, 6391, 6392
MIM606865		6q16	FUCOSYLTRANSFERASE 9; FUT9	10690
MIM606866		11q13	MITOCHONDRIAL RIBOSOMAL PROTEIN L49; MRPL49	740
MIM606867		3p21.3	GOLGI REASSEMBLY STACKING PROTEIN 1; GORASP1	64689
MIM606868		7q33-q34	HOMEODOMAIN-INTERACTING PROTEIN KINASE 2; HIPK2	28996
MIM606869		15q23-q24	HEXOSAMINIDASE A; HEXA	3073
MIM606870		21q21.2	JUNCTIONAL ADHESION MOLECULE 2; JAM2	58494
MIM606871		11q25	JUNCTIONAL ADHESION MOLECULE 3; JAM3	83700
MIM606872		7q22.3	CAS-BR-M MURINE ECTOPIC RETROVIRAL TRANSFORMING SEQUENCE LIKE-1; CBLL1	79872
MIM606873		5q13	HEXOSAMINIDASE B; HEXB	3074
MIM606874	C1969837	3p21	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 6; HSCR6	246321
MIM606875	C1969836	19q12	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 7; HSCR7	246322
MIM606876		22q12.1	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, BETA; PITPNB	23760
MIM606877		4q32.3	ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER C; ANP32C	23520
MIM606878		Chr.12	ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER D; ANP32D	23519
MIM606879		1q12	PHOSPHOGLYCERATE DEHYDROGENASE; PHGDH	26227
MIM606880		6q15	CASPASE 8-ASSOCIATED PROTEIN 2; CASP8AP2	9994
MIM606881		16q22	FORMIN HOMOLOGY-2 DOMAIN-CONTAINING PROTEIN 1; FHOD1	29109
MIM606882		13q14.3-q21.1	ATPase, Cu(2+)-TRANSPORTING, BETA POLYPEPTIDE; ATP7B	540
MIM606883		12q12	INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 4; IRAK4	51135
MIM606884		3p21.3	RNA-BINDING MOTIF PROTEIN 5; RBM5	10181
MIM606885		12q22-qter	ACYL-CoA DEHYDROGENASE, SHORT-CHAIN; ACADS	35
MIM606886		3p21.3	RNA-BINDING MOTIF PROTEIN 6; RBM6	10180
MIM606887		Chr.12	SULFITE OXIDASE; SUOX	6821
MIM606888		8p11.21	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 6; CHRNA6	8973
MIM606889	C1847200	1q31-q42	ALZHEIMER DISEASE 4	348, 5664
MIM606890		14q31	GALACTOSYLCERAMIDASE; GALC	2581
MIM606891		1q23	Fc RECEPTOR-LIKE PROTEIN A; FCRLA	84824
MIM606892		 	SYNTAXIN 12; STX12	23673
MIM606893	C1847197	 	VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	 
MIM606894	C1847196	 	DUODENOJEJUNAL ATRESIA WITH VOLVULUS, ABSENT DORSAL MESENTERY, AND ABSENT SUPERIOR MESENTERIC ARTERY	 
MIM606895	C1847185	 	SYMPHALANGISM, DISTAL, WITH MICRODONTIA, DENTAL PULP STONES, AND NARROWED ZYGOMATIC ARCH	 
MIM606896	C1847184	3p12-q13	DYSLEXIA, SUSCEPTIBILITY TO, 5; DYX5	171089
MIM606897		1q42.1-q42.2	LYSOSOMAL TRAFFICKING REGULATOR; LYST	1130
MIM606898		19q13.4	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-6 SUBUNIT; CACNG6	59285
MIM606899		19q13.4	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-7 SUBUNIT; CACNG7	59284
MIM606900		19q13.4	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-8 SUBUNIT; CACNG8	59283
MIM606902		 	PYGOPUS, DROSOPHILA, HOMOLOG OF, 1	26108
MIM606903		1q21.3	PYGOPUS, DROSOPHILA, HOMOLOG OF, 2	90780
MIM606905		20q13.13	PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE-DEPENDENT RAC EXCHANGER 1; PREX1	57580
MIM606906		7p22	FTSJ, E. COLI, HOMOLOG OF, 2; FTSJ2	29960
MIM606907		 	APOLIPOPROTEIN M; APOM	55937
MIM606908		11p11.2-p11.12	ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 2; ARFGAP2	84364
MIM606909		1q24-q25	VESICLE-ASSOCIATED MEMBRANE PROTEIN 4; VAMP4	8674
MIM606910		15q21	BCL2-LIKE 10; BCL2L10	10017
MIM606911		5q13.3-q14.1	SECRETORY CARRIER MEMBRANE PROTEIN 1; SCAMP1	9522
MIM606912		Chr.15	SECRETORY CARRIER MEMBRANE PROTEIN 2; SCAMP2	10066
MIM606913		1q21	SECRETORY CARRIER MEMBRANE PROTEIN 3; SCAMP3	10067
MIM606914		6q22.31	PROTEIN KINASE, cAMP-DEPENDENT CATALYTIC, INHIBITOR BETA; PKIB	5570
MIM606915		6q16.1-q16.3	G PROTEIN-COUPLED RECEPTOR 63; GPR63	81491
MIM606916		1p13.3	G PROTEIN-COUPLED RECEPTOR 61; GPR61	83873
MIM606917		3p21.1	G PROTEIN-COUPLED RECEPTOR 62; GPR62	118442
MIM606918		14q	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 5; GOLGA5	9950
MIM606919		19p12	CERAMIDE SYNTHASE 1; CERS1	10715
MIM606920		1q11	CERAMIDE SYNTHASE 2; CERS2	29956
MIM606921		4p16.1	G PROTEIN-COUPLED RECEPTOR 78; GPR78	27201
MIM606922		13q32.1	G PROTEIN-COUPLED RECEPTOR 80; GPR80	27199
MIM606923		12q24.31	G PROTEIN-COUPLED RECEPTOR 81; GPR81	27198
MIM606925		 	G PROTEIN-COUPLED RECEPTOR 103; GPR103	84109
MIM606926		12p13	LYSOPHOSPHATIDIC ACID RECEPTOR 5; LPAR5	57121
MIM606927		6q23.2	TRACE AMINE-ASSOCIATED RECEPTOR 8; TAAR8	83551
MIM606928	C1847161	1p36	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 3; BMND3	246259
MIM606929		5q35.2	THO COMPLEX, SUBUNIT 3; THOC3	84321
MIM606930		18p11.32	THO COMPLEX, SUBUNIT 1; THOC1	9984
MIM606932		 	VACUOLAR PROTEIN SORTING 29, YEAST, HOMOLOG OF; VPS29	51699
MIM606933		11q14-q21	TYROSINASE; TYR	7299
MIM606934		15q13.3	NADH DEHYDROGENASE 1 ALPHA SUBCOMPLEX, ASSEMBLY FACTOR 1; NDUFAF1	51103
MIM606935		10p15.1	RNA-BINDING MOTIF PROTEIN 17; RBM17	84991
MIM606936		19q13.32	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 4; TRPM4	54795
MIM606937		15q25.3	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 5; SCAR5	9640
MIM606938		10q25.2-q26.3	UROPORPHYRINOGEN III SYNTHASE; UROS	7390
MIM606939		8p21.3	ATPasE, H+ TRANSPORTING, LYSOSOMAL, 56/58-KD, V1 SUBUNIT B, ISOFORM 2; ATP6V1B2	526
MIM606940		8q21.12	ZINC FINGER HOMEOBOX 4; ZFHX4	79776
MIM606941		11q23	ALG9, S. CEREVISIAE, HOMOLOG OF; ALG9	79796
MIM606942		19p13.11	COATOMER PROTEIN COMPLEX, SUBUNIT EPSILON; COPE	11316
MIM606943	C1847089	17q24-q25	USHER SYNDROME, TYPE IG; USH1G	124590
MIM606944		5q12	ERBB2 INTERACTING PROTEIN; ERBB2IP	55914
MIM606945		19p13.2	LOW DENSITY LIPOPROTEIN RECEPTOR; LDLR	3949
MIM606946		Chr.9	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 2; ANAPC2	29882
MIM606947		4p15.2	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 4; ANAPC4	29945
MIM606948		Chr.12	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 5; ANAPC5	51433
MIM606949		 	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 7; ANAPC7	51434
MIM606950		12q15-q21	THYROTROPIN-RELEASING HORMONE-DEGRADING ECTOENZYME; TRHDE	29953
MIM606951		2q24	INTERFERON-INDUCED HELICASE C DOMAIN-CONTAINING PROTEIN 1; IFIH1	64135
MIM606952	C1847024	11q14-q21	ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B	7299
MIM606953		1p36-p35	UDP-GALACTOSE-4-EPIMERASE; GALE	2582
MIM606954		19p13	ZINC FINGER PROTEIN 253; ZNF253	56242
MIM606956		19q13	ZINC FINGER PROTEIN 256; ZNF256	10172
MIM606957		19q13	ZINC FINGER PROTEIN 257; ZNF257	113835
MIM606958		Chr.14	MEMBRANE PROTEIN, PALMITOYLATED 5; MPP5	64398
MIM606959		7p21-p15	MEMBRANE PROTEIN, PALMITOYLATED 6; MPP6	51678
MIM606960		22q12.1-q12.2	INSULINOMA TUMOR SUPPRESSOR GENE LOCUS	282551
MIM606961		2p12	WW DOMAIN-BINDING PROTEIN 1; WBP1	23559
MIM606962		17q25	WW DOMAIN-BINDING PROTEIN 2; WBP2	23558
MIM606963	C0024117	14q32.1, 11q22-q23, 2q, 22q12	PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; COPD	260431, 3162, 4312, 5265
MIM606964		6p21	SERINE/THREONINE PROTEIN KINASE 38; STK38	11329
MIM606965		7q35	FAS-ACTIVATED SERINE/THREONINE KINASE; FASTK	10922
MIM606966	C1847013	1p36	NEPHRONOPHTHISIS 4; NPHP4	261734
MIM606967		16q22.1	LECITHIN:CHOLESTEROL ACYLTRANSFERASE; LCAT	3931
MIM606968		Chr.16	EUKARYOTIC ELONGATION FACTOR 2 KINASE; EEF2K	29904
MIM606969		 	GEM-ASSOCIATED PROTEIN 4; GEMIN4	50628
MIM606972	C1846992	14q23	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 2; EIG2	353124
MIM606973		17q25.1	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 1; COG1	9382
MIM606974		1q42.2	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 2; COG2	22796
MIM606975		13q14.12	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 3; COG3	83548
MIM606976		16q22.1	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 4; COG4	25839
MIM606977		13q13.3	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 6; COG6	57511
MIM606978		16p	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 7; COG7	91949
MIM606979		16q22.1	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 8; COG8	84342
MIM606980		1q42.2	AARF DOMAIN-CONTAINING KINASE 3; ADCK3	56997
MIM606981		14q21	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-2; GNG2	54331
MIM606982		1q43	GERANYLGERANYL DIPHOSPHATE SYNTHASE 1; GGPS1	9453
MIM606983		Chr.11	DIACYLGLYCEROL O-ACYLTRANSFERASE 2; DGAT2	84649
MIM606984	C1846990	 	HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 2	 
MIM606985		11p13	ELONGATION PROTEIN 4, S. CEREVISIAE, HOMOLOG OF; ELP4	26610
MIM606987		3q21-q23	G PROTEIN-COUPLED RECEPTOR KINASE 7; GRK7	131890
MIM606988		Chr.15	CALCINEURIN B HOMOLOGOUS PROTEIN	11261
MIM606989		17q23.1	MYELOPEROXIDASE; MPO	4353
MIM606990		3q23	COATOMER PROTEIN COMPLEX, SUBUNIT BETA-2; COPB2	9276
MIM606991		3p21.31	INOSITOL HEXAPHOSPHATE KINASE 1; IHPK1	9807
MIM606992		3p21	INOSITOL HEXAPHOSPHATE KINASE 2; IHPK2	51447
MIM606993		6p21	INOSITOL HEXAPHOSPHATE KINASE 3; IHPK3	117283
MIM606994		3q29	TYROSINE KINASE, NONRECEPTOR, 2; TNK2	10188
MIM606995	C1846980	3q22	SENIOR-LOKEN SYNDROME 3; SLSN3	260432
MIM606996	C1846979	1p36	SENIOR-LOKEN SYNDROME 4; SLSN4	261734
MIM606997		2p13-p12	NUCLEAR DNA-BINDING PROTEIN C1D	10438
MIM606998		6p21.3	FLOTILLIN 1; FLOT1	10211
MIM606999		9p13	GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; GALT	2592
MIM607000		17q21.1	MEDIATOR COMPLEX SUBUNIT 24; MED24	9862
MIM607001		9q34.3	EUCHROMATIC HISTONE METHYLTRANSFERASE 1; EHMT1	79813
MIM607002		3p21.1	PROKINETICIN 2; PROK2	60675
MIM607003		5q22.1	THYMIC STROMAL LYMPHOPOIETIN; TSLP	85480
MIM607004	C1846949	5p13.3-p13.2	BRACHYDACTYLY, TYPE A1, B	246260
MIM607005		5q33.2	GEM-ASSOCIATED PROTEIN 5	25929
MIM607006		 	GEM-ASSOCIATED PROTEIN 6; GEMIN6	79833
MIM607007		1q22	SNARE-ASSOCIATED PROTEIN SNAPIN; SNAPAP	23557
MIM607008		1p31	ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN; ACADM	34
MIM607009		9q22	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 6; TRPM6	140803
MIM607010		3p21.1	DECAPPING ENZYME 1, S. CEREVISIAE, HOMOLOG OF, A; DCP1A	55802
MIM607011		4p16.1	UBIQUITIN-SPECIFIC PROTEASE 17; USP17	391627
MIM607012		5q13	B-DOUBLE PRIME 1, SUBUNIT OF RNA POLYMERASE III TRANSCRIPTION INITIATION FACTOR IIIB; BDP1	55814
MIM607013		8p11.23	BRF2 SUBUNIT OF RNA POLYMERASE III TRANSCRIPTION INITIATION FACTOR; BRF2	55290
MIM607014	C0086795	4p16.3	HURLER SYNDROME	3425
MIM607015	C0086431	4p16.3	HURLER-SCHEIE SYNDROME	3425
MIM607016	C0026708	4p16.3	SCHEIE SYNDROME	3425
MIM607017	C1846922	6p21.3	DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	192644
MIM607018		1p31.1	LATROPHILIN HOMOLOG 1; LPHH1	23266
MIM607019		12q14.1	RAS ASSOCIATION DOMAIN FAMILY PROTEIN 3; RASSF3	283349
MIM607020		1q32.1	RAS ASSOCIATION DOMAIN FAMILY PROTEIN 5; RASSF5	83593
MIM607021		22q12.1	SEIZURE-RELATED 6-LIKE; SEZ6L	23544
MIM607022		20q13.2	CCCTC-BINDING FACTOR-LIKE PROTEIN; CTCFL	140690
MIM607023		5q12-q13	POLO-LIKE KINASE 2; PLK2	10769
MIM607024		 	DEBRANCHING ENZYME 1, S. CEREVISIAE, HOMOLOG OF; DBR1	51163
MIM607025		Chr.9	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE; MELK	9833
MIM607026		11p15.1	NEURON NAVIGATOR 2; NAV2	89797
MIM607027		3p13	ATPase, H+ TRANSPORTING, LYSOSOMAL ALPHA POLYPEPTIDE, 70-KD, ISOFORM 1; ATP6V1A1	523
MIM607028		16q22	ATPase, H+ TRANSPORTING, LYSOSOMAL, 38-KD, V0 SUBUNIT D, ISOFORM 1; ATP6V0D1	9114
MIM607029		2p11.2	VESICLE-ASSOCIATED MEMBRANE PROTEIN 5; VAMP5	10791
MIM607030		2q24.2	GRANCALCIN; GCA	25801
MIM607031		4p14	LIPOIC ACID SYNTHASE; LIAS	11019
MIM607032		16p12	SMG1, C. ELEGANS, HOMOLOG OF	23049
MIM607033		6q25	TRANSCRIPTION FACTOR B1, MITOCHONDRIAL; TFB1M	51106
MIM607035		10q24-q25	SUPPRESSOR OF FUSED, DROSOPHILA, HOMOLOG OF; SUFU	51684
MIM607036		15q14-q15	ISOVALERYL-CoA DEHYDROGENASE; IVD	3712
MIM607037		3q27	ENOYL-CoA HYDRATASE/3-HYDROXYACYL CoA DEHYDROGENASE; EHHADH	1962
MIM607038		16p12.2	OTOANCORIN; OTOA	146183
MIM607039	C1846896	16p12.2	DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22	146183
MIM607040		16q12.1	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 11; ABCC11	85320
MIM607041		16q12.1	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 12; ABCC12	94160
MIM607042		16p12.1	CLN3 GENE; CLN3	1201
MIM607043		6q21	TRAF3-INTERACTING PROTEIN 2; TRAF3IP2	10758
MIM607045		12q21	RHABDOMYOSARCOMA 2-ASSOCIATED TRANSCRIPT; RMST	196475
MIM607046		22q12-q13	TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 22, YEAST, HOMOLOG OF; TOMM22	56993
MIM607047		14q24.3-q31	ATAXIN 3; ATXN3	4287
MIM607048		17q11-q21	START DOMAIN-CONTAINING PROTEIN 3; STARD3	10948
MIM607049		5q22	START DOMAIN-CONTAINING PROTEIN 4; STARD4	134429
MIM607050		15q26	START DOMAIN-CONTAINING PROTEIN 5; STARD5	80765
MIM607051		18q21	START DOMAIN-CONTAINING PROTEIN 6; STARD6	147323
MIM607052		3p21.3	TUMOR SUPPRESSOR CANDIDATE 2; TUSC2	11334
MIM607053	C1846886	8q23	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2; HDLCQ2	353127
MIM607054		1q31	PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY A, MEMBER 3; PHLDA3	23612
MIM607055		 	TRANSCRIPTION FACTOR B2, MITOCHONDRIAL; TFB2M	64216
MIM607056		3q11.2	INTERPHOTORECEPTOR MATRIX PROTEOGLYCAN 2; IMPG2	50939
MIM607057		22q11.2	UBIQUITIN-SPECIFIC PROTEASE 18; USP18	11274
MIM607058		15q14	GAP JUNCTION PROTEIN, DELTA-2; GJD2	57369
MIM607059		8q24.3	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 4; SLC39A4	55630
MIM607060	C1846862	12q12	PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	120892
MIM607061		Chr.12	PROSTAGLANDIN E SYNTHASE 3; PTGES3	10728
MIM607062		 	FK506-BINDING PROTEIN 7; FKBP7	51661
MIM607063		17q21.2	FK506-BINDING PROTEIN 10; FKBP10	60681
MIM607064		3q21-q24	PROCOLLAGEN C-ENDOPEPTIDASE ENHANCER 2; PCOLCE2	26577
MIM607065		2p22.2	GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE; QPCT	25797
MIM607066		17p13	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 3; TRPV3	162514
MIM607067		17q21.1	SAITOHIN	246744
MIM607068		3p21.3	CYTOCHROME b561 DOMAIN-CONTAINING PROTEIN 2; CYB561D2	11068
MIM607069		 	PL6 GENE	11070
MIM607070		3p21.3	ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 10; ZMYND10	51364
MIM607071		3p21.3-p21.2	HYALURONOGLUCOSAMINIDASE 1; HYAL1	3373
MIM607072		3p21.3	TUMOR SUPPRESSOR CANDIDATE 4; TUSC4	10641
MIM607073		3p21.3	FUS2 GENE	24142
MIM607074		19q13.3	PROTEIN KINASE D2; PRKD2	25865
MIM607075		7q22.1	PDGFA-ASSOCIATED PROTEIN 1; PDAP1	11333
MIM607076		 	PROTEASE INHIBITOR 15; PI15	51050
MIM607077		2p21	PROTEIN KINASE C, NU; PRKCN	23683
MIM607078	C1846843	2p24-p23	EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5	4148
MIM607079		1q21.3	RHESUS BLOOD GROUP, B GLYCOPROTEIN; RHBG	57127
MIM607080	C2751325	12q13.1	46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY	50846
MIM607081		12p13.3	TAP-BINDING PROTEIN-LIKE; TAPBPL	55080
MIM607082		3p21.3	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 2; CACNA2D2	9254
MIM607083		8p12	WOLF-HIRSCHHORN SYNDROME CANDIDATE 1-LIKE 1; WHSC1L1	54904
MIM607084	C1846839	9q32-q34	DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31	25861
MIM607085	C1846838	6p21.3	MYASTHENIA GRAVIS WITH THYMUS HYPERPLASIA	246750
MIM607086	C0345050	11q23.3-q24	AORTIC ANEURYSM, FAMILIAL THORACIC 1; AAT1	252842
MIM607087	C1846837	5q13-q14	AORTIC ANEURYSM, FAMILIAL THORACIC 2; AAT2	252843
MIM607088	C1846823	11q13	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 3; DSMA3	246751
MIM607089		Chr.15	CYCLIN D-TYPE-BINDING PROTEIN 1; CCNDBP1	23582
MIM607090		1p36.11	SYF2, S. CEREVISIAE, HOMOLOG OF; SYF2	25949
MIM607091	C1846816	9p13	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId; CDG2D	2683
MIM607092		19q13.2	SPHINGOSINE KINASE 2; SPHK2	56848
MIM607093		1p36.3	5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR	4524
MIM607094		2p21	SUPPRESSOR OF CYTOKINE SIGNALING 5	9655
MIM607095	C1846796	9p21-p12	ANAUXETIC DYSPLASIA	6023
MIM607096		11q13	SOLUTE CARRIER FAMILY 22 (URATE TRANSPORTER), MEMBER 12; SLC22A12	116085
MIM607097		11q13	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/CATION TRANSPORTER), MEMBER 11	55867
MIM607099		Chr.11	MBD2-INTERACTING ZINC FINGER PROTEIN; MIZF	25988
MIM607100		2q13	NEPHROCYSTIN 1; NPHP1	4867
MIM607101	C1846784	10p11.1	DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30	53904
MIM607102		11p13	WT1 GENE; WT1	7490
MIM607103		 	ARGINYLTRANSFERASE 1; ATE1	11101
MIM607104		11q12	TANKYRASE 1-BINDING PROTEIN 1; TNKS1BP1	85456
MIM607105		6q25.1	NADPH OXIDASE 3; NOX3	50508
MIM607106		20q11.21	MINOR HISTOCOMPATIBILITY 13; HM13	81502
MIM607107	C2931822	17p13.1, 4p15.1-q12	NASOPHARYNGEAL CARCINOMA	257641, 7157
MIM607108		11p13	PAIRED BOX GENE 6; PAX6	5080
MIM607109		22q13	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3A; APOBEC3A	200315
MIM607110		22q13	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3B; APOBEC3B	9582
MIM607111		13q12.3	SPG20 GENE; SPG20	23111
MIM607112		1p36	F-BOX ONLY PROTEIN 2; FBXO2	26232
MIM607113		22q12-q13.2	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3G; APOBEC3G	60489
MIM607114		20p13	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 33; ADAM33	80332
MIM607115	C0409818	1q44	CINCA SYNDROME; CINCA	114548
MIM607116	C1846735	20p	ALZHEIMER DISEASE 8	353128
MIM607117		8p23	MCPH1 GENE; MCPH1	79648
MIM607118		 	MITOCHONDRIAL RIBOSOMAL PROTEIN L3; MRPL3	11222
MIM607119		 	DOUBLE RING FINGER PROTEIN	25897
MIM607120		20p12	PHOSPHOLIPASE C, BETA-1; PLCB1	23236
MIM607122		 	PROKINETICIN RECEPTOR 1; PROKR1	10887
MIM607123		20p13	PROKINETICIN RECEPTOR 2; PROKR2	128674
MIM607124		 	PHOSPHATIDIC ACID PHOSPHATASE TYPE 2A; PPAP2A	8611
MIM607125		 	PHOSPHATIDIC ACID PHOSPHATASE TYPE 2B; PPAP2B	8613
MIM607126		 	PHOSPHATIDIC ACID PHOSPHATASE TYPE 2C; PPAP2C	8612
MIM607127		 	RAB6-INTERACTING PROTEIN 2; RAB6IP2	23085
MIM607128		 	TRF1-INTERACTING ANKYRIN-RELATED ADP-RIBOSE POLYMERASE 2; TNKS2	80351
MIM607129		6q16.1	MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 1; MICAL1	64780
MIM607130		17q25.3	REGULATORY ASSOCIATED PROTEIN OF MTOR; RPTOR	57521
MIM607131	C1846722	15q26.1	MACROCEPHALY WITH MULTIPLE EPIPHYSEAL DYSPLASIA AND DISTINCTIVE FACIES	260403
MIM607132	C1846721	 	LARYNGEAL ATRESIA, ENCEPHALOCELE, AND LIMB DEFORMITIES	 
MIM607133		22q11.2-q12.2	CATARACT, SUTURAL, WITH PUNCTATE AND CERULEAN OPACITIES	1415
MIM607134	C1846719	13q21	SPECIFIC LANGUAGE IMPAIRMENT 3; SLI3	780906
MIM607135	C1846718	3p	CREATININE CLEARANCE QUANTITATIVE TRAIT LOCUS	261727
MIM607136	C1846707	6q27	SPINOCEREBELLAR ATAXIA 17; SCA17	6908
MIM607137		4q13-q21	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D-LIKE PROTEIN; HNRNPDL	9987
MIM607138		1q21.3	cAMP RESPONSE ELEMENT-BINDING PROTEIN 3-LIKE 4; CREB3L4	148327
MIM607139		16q24.3	FANCA GENE; FANCA	2175
MIM607140	C0002982	 	ANGIOID STREAKS	 
MIM607141		9p13-p12	CHROMOSOME 9 OPEN READING FRAME 19; C9ORF19	152007
MIM607143	C1846695	22q13.33	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	79087
MIM607144		22q13.33	ALG12, S. CEREVISIAE, HOMOLOG OF; ALG12	79087
MIM607145		6p22.3	DYSTROBREVIN-BINDING PROTEIN 1; DTNBP1	84062
MIM607146		11q23	PDZ DOMAIN-CONTAINING 3; PDZD3	79849
MIM607147		3q13	POLIOVIRUS RECEPTOR-LIKE 3; PVRL3	25945
MIM607149		11q23.1-q23.2	RNA EXONUCLEASE 2, S. CEREVISIAE, HOMOLOG OF; REXO2	25996
MIM607150		2q36	FIFTH EWING SARCOMA VARIANT; FEV	54738
MIM607151	C1846689	17q25	MOYAMOYA DISEASE 2; MYMY2	57674
MIM607152	C1846685	9q	SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT; SPG19	140907
MIM607153		2p25.2	INTEGRIN, BETA-1, BINDING PROTEIN OF, 1; ITGB1BP1	9270
MIM607154	C2607914	5q31	ALLERGIC RHINITIS	260328, 3596
MIM607155	C1846672	19q13.3	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	79147
MIM607156		3q12.1	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 6; ST3GAL6	10402
MIM607157		19q13.3-q13.4	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 11; SIGLEC11	114132
MIM607158		10q26.3	VENT-LIKE HOMEOBOX 2; VENTX2	27287
MIM607159		10q22.1-q22.3	ZINC FINGER MIZ-DOMAIN CONTAINING 1; ZMIZ1	57178
MIM607160		 	ATPase, H+ TRANSPORTING, LYSOSOMAL, 14-KD, V1 SUBUNIT F; ATP6V1F	9296
MIM607161	C1846671	 	MULTIPLE CONGENITAL ANOMALIES SYNDROME WITH CLOVERLEAF SKULL	 
MIM607162		18q21.1	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 5; ST8SIA5	29906
MIM607163		2p13.3	LYSYL OXIDASE-LIKE 3; LOXL3	84695
MIM607164		2p13	LADY BIRD-LIKE HOMEOBOX 2; LBX2	85474
MIM607165		20q13.1-q13.3	SERINE INCORPORATOR 3; SERINC3	10955
MIM607166		2q11.2	TESTIS-SPECIFIC PROTEIN 10; TSGA10	80705
MIM607167		20q12-q13.11	DYNEIN, LIGHT CHAIN, ROADBLOCK TYPE, 1; DYNLRB1	83658
MIM607168		16q23.3	DYNEIN, LIGHT CHAIN, ROADBLOCK TYPE, 2; DYNLRB2	83657
MIM607169		6p22-p21.3	PROTEASE, SERINE, 16; PRSS16	10279
MIM607170		3p25.3	CYSTEINE-RICH PROTEIN WITH EGF-LIKE DOMAINS 1; CRELD1	78987
MIM607171		 	CYSTEINE-RICH PROTEIN WITH EGF-LIKE DOMAINS 2	79174
MIM607172		2q36	SERINE/THREONINE KINASE 11-INTERACTING PROTEIN; STK11IP	114790
MIM607173		2q24.2	PROTEASOME 26S SUBUNIT, NON-ATPase, 14; PSMD14	10213
MIM607174	C1333989	10q23.31, 22q12.3-qter, 22q12.2	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO	4330, 4771, 51684, 5728
MIM607175		 	DUAL-SPECIFICITY PHOSPHATASE 16; DUSP16	80824
MIM607176		 	CALNEURON 1; CALN1	83698
MIM607177		1q25.3	IMMEDIATE-EARLY RESPONSE GENE 5; IER5	51278
MIM607178		1p33	MEMBRANE-ASSOCIATED PROTEIN 17	10158
MIM607179		 	RNA-BINDING MOTIF PROTEIN 12; RBM12	10137
MIM607180		3p21.3	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 2; LRRC2	79442
MIM607181		3p21.3	RECEPTOR-TRANSPORTING PROTEIN 3; RTP3	83597
MIM607182		 	FYVE AND COILED-COIL DOMAIN CONTAINING 1; FYCO1	79443
MIM607183		 	SEC24-RELATED GENE FAMILY, MEMBER A; SEC24A	10802
MIM607184		 	SEC24-RELATED GENE FAMILY, MEMBER B; SEC24B	10427
MIM607185		 	SEC24-RELATED GENE FAMILY, MEMBER C; SEC24C	9632
MIM607186		 	SEC24-RELATED GENE FAMILY, MEMBER D; SEC24D	9871
MIM607187		 	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 1; ST3GAL1	6482
MIM607188		 	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 2; ST3GAL2	6483
MIM607189		 	REGULATOR OF G PROTEIN SIGNALING 8; RGS8	85397
MIM607190		 	REGULATOR OF G PROTEIN SIGNALING 13; RGS13	6003
MIM607191		 	REGULATOR OF G PROTEIN SIGNALING 17; RGS17	26575
MIM607192		 	REGULATOR OF G PROTEIN SIGNALING 18; RGS18	64407
MIM607193		 	REGULATOR OF G PROTEIN SIGNALING 20; RGS20	8601
MIM607194		10p12.3	PANCREAS TRANSCRIPTION FACTOR 1, ALPHA SUBUNIT; PTF1A	256297
MIM607196	C1846648	17q25.3	MICROCEPHALY, AMISH TYPE; MCPHA	60386
MIM607197	C1846647	 	DEAFNESS, AUTOSOMAL RECESSIVE	 
MIM607198		14q31-q32	TYROSYL-DNA PHOSPHODIESTERASE 1; TDP1	55775
MIM607199		1q32-q41	INTERFERON REGULATORY FACTOR 6; IRF6	3664
MIM607200	C1846632	15q15.3	THYROID DYSHORMONOGENESIS 6; TDH6	50506
MIM607201		1p36.11	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN R; HNRNPR	10236
MIM607202	C1846631	15q11-q13	CELIAC DISEASE, SUSCEPTIBILITY TO, 5; CELIAC5	338332
MIM607203		14q13-q23	SALVADOR, DROSOPHILA, HOMOLOG OF; SAV1	60485
MIM607204		1p35.2	PUMILIO, DROSOPHILA, HOMOLOG OF, 1; PUM1	9698
MIM607205		2p22-p21	PUMILIO, DROSOPHILA, HOMOLOG OF, 2; PUM2	23369
MIM607206		17p13.1	ARACHIDONATE LIPOXYGENASE 3; ALOXE3	59344
MIM607207		16p13.3	STIP1 HOMOLOGOUS AND U BOX-CONTAINING PROTEIN 1; STUB1	10273
MIM607208	C0751122	5q31.1-q33.1, 2q24	DRAVET SYNDROME	2566, 6323, 6335
MIM607209		22q13.1	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 10; CARD10	29775
MIM607210		7p22	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 11; CARD11	84433
MIM607211		 	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 14; CARD14	79092
MIM607212		9q34.3	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 9; CARD9	64170
MIM607213		16q12	ORIGIN RECOGNITION COMPLEX, SUBUNIT 6, S. CEREVISIAE, HOMOLOG OF; ORC6	23594
MIM607214	C1846617	 	ANONYCHIA, TOTAL, WITH MICROCEPHALY	 
MIM607215		1p36	NEPHROCYSTIN 4; NPHP4	261734
MIM607216		 	SIDEKICK, DROSOPHILA, HOMOLOG OF, 1; SDK1	221935
MIM607217		 	SIDEKICK, DROSOPHILA, HOMOLOG OF, 2; SDK2	54549
MIM607218		7q32	INTERFERON REGULATORY FACTOR 5; IRF5	3663
MIM607219		11q21-q22.2	CONTACTIN 5; CNTN5	53942
MIM607220		3p26-p25	CONTACTIN 6; CNTN6	27255
MIM607221	C1846609	4p15	EPILEPSY, PARTIAL, WITH PERICENTRAL SPIKES; PEPS	266789
MIM607222		10p15.1	F-BOX ONLY PROTEIN 18; FBXO18	84893
MIM607223		6q72	SPARC-RELATED MODULAR CALCIUM-BINDING PROTEIN 2; SMOC2	64094
MIM607224		11q13	ORAL CANCER OVEREXPRESSED GENE 1; ORAOV1	220064
MIM607225	C1846588	2q33	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	57679
MIM607226		 	HISTONE DEACETYLASE 11; HDAC11	79885
MIM607227		11p15.1	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X1; MRGPRX1	259249
MIM607228		11p15.1	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X2; MRGPRX2	117194
MIM607229		11p15.1	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X3; MRGPRX3	117195
MIM607230		11p15.1	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X4; MRGPRX4	117196
MIM607231		11q13.2	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER D; MRGPRD	116512
MIM607232		11p15.4	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER E; MRGPRE	116534
MIM607233		11q13.2	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER F; MRGPRF	116535
MIM607234		11p15.5	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER G; MRGPRG	386746
MIM607235		6p21	MAS1 ONCOGENE-LIKE; MAS1L	116511
MIM607236	C1846582	20p13-p12.3	HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA, AND PALLIDAL DEGENERATION	80025
MIM607237		3p21	TRANSMEMBRANE INNER EAR-EXPRESSED GENE; TMIE	259236
MIM607238		2p16-p13	COMM DOMAIN-CONTAINING PROTEIN 1; COMMD1	150684
MIM607239	C1846576	10p11.23-q21.1	DEAFNESS, AUTOSOMAL RECESSIVE 33; DFNB33	170508
MIM607240		 	SET DOMAIN-CONTAINING PROTEIN 8; SETD8	387893
MIM607241		 	CHROMOSOME 4 OPEN READING FRAME 7; C4ORF7	260436
MIM607242		11p15.5	ADAPTOR-RELATED PROTEIN COMPLEX 2, ALPHA-2 SUBUNIT; AP2A2	161
MIM607243		14q12	ADAPTOR-RELATED PROTEIN COMPLEX 4, SIGMA-1 SUBUNIT; AP4S1	11154
MIM607244		15q21.2	ADAPTOR-RELATED PROTEIN COMPLEX 4, EPSILON-1 SUBUNIT; AP4E1	23431
MIM607245		1p13.2	ADAPTOR-RELATED PROTEIN COMPLEX 4, BETA-1 SUBUNIT; AP4B1	10717
MIM607246		 	ADAPTOR-RELATED PROTEIN COMPLEX 3, DELTA-1 SUBUNIT; AP3D1	8943
MIM607247		 	CHONDROLECTIN; CHODL	140578
MIM607248	C2750944	15q23-q26.3	GLIOMA SUSCEPTIBILITY 4; GLM4	338030
MIM607249		 	CATION CHANNEL, SPERM-ASSOCIATED, 2; CATSPER2	117155
MIM607250	C1846574	14q31-q32	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY; SCAN1	55775
MIM607251		Chr.17	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 22, YEAST, HOMOLOG OF; TIMM22	29928
MIM607252		22q12.3	APOLIPOPROTEIN L-II; APOL2	23780
MIM607253		22q12.3	APOLIPOPROTEIN L-III; APOL3	80833
MIM607254		22q12.3	APOLIPOPROTEIN L-IV; APOL4	80832
MIM607255		22q12.3	APOLIPOPROTEIN L-V; APOL5	80831
MIM607256		22q12.3	APOLIPOPROTEIN L-VI; APOL6	80830
MIM607257		11p15.3-p15.2	SRY-BOX 6; SOX6	55553
MIM607258	C1846573	4q33-qter	HYPERCALCIURIA, ABSORPTIVE, 1	266790
MIM607259	C1846564	16q24.3	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	6687
MIM607260		19q13.2	PLACENTAL PROTEIN 13-LIKE PROTEIN	56891
MIM607261		4p16	EVC2 GENE; EVC2	132884
MIM607262		19q13	EPSIN 1; EPN1	29924
MIM607263		Chr.17	EPSIN 2; EPN2	22905
MIM607264		Chr.17	EPSIN 3; EPN3	55040
MIM607265		5q33.3	CLATHRIN INTERACTOR 1; CLINT1	9685
MIM607267		9q33	POLYMERASE, DNA, EPSILON-3; POLE3	54107
MIM607268		8q11-q12	CHROMATIN ACCESSIBILITY COMPLEX, SUBUNIT 1; CHRAC1	54108
MIM607269		2p12	POLYMERASE, DNA, EPSILON-4; POLE4	56655
MIM607270		7q11.2	KIAA0442 GENE; KIAA0442	26053
MIM607271	C1846545	2q33	CASPASE 8 DEFICIENCY	841
MIM607272		 	NDC80, S. CEREVISIAE, HOMOLOG OF; NDC80	10403
MIM607273		17p11.2	FOLLICULIN; FLCN	201163
MIM607274		18p	UBIQUITIN-SPECIFIC PROTEASE 14; USP14	9097
MIM607275		4q11-q12	HOP HOMEOBOX; HOPX	84525
MIM607276	C1821417	10q24-q26	RESTING HEART RATE, VARIATION IN	153
MIM607277	C1846534	14q22.1	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1	5729
MIM607278	C1709353	 	OSTEOFIBROUS DYSPLASIA	 
MIM607279	C1846533	11q14	SYSTEMIC LUPUS ERYTHEMATOSUS WITH HEMOLYTIC ANEMIA, SUSCEPTIBILITY TO, 1; SLEH1	170682
MIM607280		3p26-p25	CONTACTIN 4; CNTN4	152330
MIM607281		Chr.8	LSM1 PROTEIN; LSM1	27257
MIM607282		6p21.3	LSM2 PROTEIN; LSM2	57819
MIM607283		3p25.1	LSM3 PROTEIN; LSM3	27258
MIM607284		19p13.11	LSM4 PROTEIN; LSM4	25804
MIM607285		7p14.3	LSM5 PROTEIN; LSM5	23658
MIM607286		4q31.2	LSM6 PROTEIN; LSM6	11157
MIM607287		19p13.3	LSM7 PROTEIN; LSM7	51690
MIM607288		 	LSM8 PROTEIN; LSM8	51691
MIM607289		6p24.3	MUTED, MOUSE, HOMOLOG OF; MUTED	63915
MIM607290		3p21.3	SHISA, XENOPUS, HOMOLOG OF, 5; SHISA5	51246
MIM607291		Chr.17	ADAPTOR-RELATED PROTEIN COMPLEX 1 GAMMA SUBUNIT-BINDING PROTEIN 1; AP1GBP1	11276
MIM607292		1q22	SEMAPHORIN 4A; SEMA4A	64218
MIM607293		6p21.1-p12.1	CHLORIDE INTRACELLULAR CHANNEL 5; CLIC5	53405
MIM607294		20q11.2-q12	TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR 2; TGIF2	60436
MIM607295		22q12.1	MYOSIN XVIIIB; MYO18B	84700
MIM607296		Chr.9	ATPase, H+ TRANSPORTING, LYSOSOMAL, 13-KD, V1 SUBUNIT G, ISOFORM 1; ATP6V1G1	9550
MIM607297		12p13	NERVE INJURY-INDUCED PROTEIN 2; NINJ2	4815
MIM607298		16p13.3	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-13; GNG13	51764
MIM607299		2q37	DELTA- AND NOTCH-LIKE EPIDERMAL GROWTH FACTOR-RELATED RECEPTOR	92737
MIM607300		17p13.3	PRECURSOR mRNA-PROCESSING FACTOR 8, S. CEREVISIAE, HOMOLOG OF; PRPF8	10594
MIM607301		1q21.2	PRECURSOR mRNA-PROCESSING FACTOR 3, S. CEREVISIAE, HOMOLOG OF; PRPF3	9129
MIM607303		15q24	MORTALITY FACTOR 4-LIKE PROTEIN 1; MORF4L1	10933
MIM607304	C1846520	2p12	CATARACT, NUCLEAR PROGRESSIVE	266979
MIM607305		1p36.1	MDS2 GENE	259283
MIM607306		2p23	STEROID 5-ALPHA-REDUCTASE 2; SRD5A2	6716
MIM607307		6q14.1	FILAMIN A-INTERACTING PROTEIN 1; FILIP1	27145
MIM607308	C1268717	 	MAMMOGRAPHIC DENSITY	 
MIM607309		19p13.2	ADAPTOR-RELATED PROTEIN COMPLEX 1, MU-2 SUBUNIT; AP1M2	10053
MIM607310		8p12	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 7; ADAM7	8756
MIM607311		11q22	PROGESTERONE RECEPTOR; PGR	5241
MIM607312		7q34	ZINC FINGER CCCH DOMAIN-CONTAINING ANTIVIRAL PROTEIN 1; ZC3HAV1	56829
MIM607313	C1846496	11q23-q25	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS; HGPPS	64221
MIM607314		11q13.1	CALCIUM-BINDING PROTEIN 2; CABP2	51475
MIM607315		19q13.33	CALCIUM-BINDING PROTEIN 5; CABP5	56344
MIM607317	C1846492	1p36	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	260415
MIM607318		10q24	LYSYL OXIDASE-LIKE 4; LOXL4	84171
MIM607319		 	RENAL UBIQUITOUS PROTEIN 1	51460
MIM607320		19q13.1	RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 4; RASGRP4	115727
MIM607321		1q21-q32	ATPase, Na+/K+ TRANSPORTING, ALPHA-4 POLYPEPTIDE; ATP1A4	480
MIM607323	C1623209	20q13.13-q13.2	DUANE-RADIAL RAY SYNDROME; DRRS	57167
MIM607324	C1846452	19p13.2-p13.1	POLYDACTYLY, POSTAXIAL, TYPE A3	338333
MIM607325		13q32.3	DEDICATOR OF CYTOKINESIS 9; DOCK9	23348
MIM607326	C1846431	18q12-q21.1	SMITH-MCCORT DYSPLASIA; SMC	54808
MIM607327		 	MUSCLEBLIND-LIKE PROTEIN 2; MBNL2	10150
MIM607328		Chr.17	HEXAMETHYLENE BIS ACETAMIDE-INDUCIBLE PROTEIN 1; HEXIM1	10614
MIM607329	C1846430	2p25-p24	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 3	387575
MIM607330	C1846421	11q23.3	LATHOSTEROLOSIS	6309
MIM607331		7p14.2	RP9 GENE; RP9	6100
MIM607332		5q22.1	CHROMOSOME 5 OPEN READING FRAME 13; C5ORF13	9315
MIM607333		2q33-q34	STE20-RELATED KINASE ADAPTOR BETA; STRADB	55437
MIM607334		2q33-q34	TRAFFICKING PROTEIN, KINESIN-BINDING 2; TRAK2	66008
MIM607335		19p13.2-p13.12	BESTROPHIN 2; BEST2	54831
MIM607336		1p33-p32.3	BESTROPHIN 4; BEST4	266675
MIM607337		12q14.2-q15	BESTROPHIN 3; BEST3	144453
MIM607338		8p21.2-p21.1	LEPTIN RECEPTOR OVERLAPPING TRANSCRIPT-LIKE 1; LEPROTL1	23484
MIM607339	C1846418	16pter-p13, 3pter-p21	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 1	1524, 338334
MIM607340		9q22.1	GAMMA-AMINOBUTYRIC ACID B RECEPTOR 2; GABBR2	9568
MIM607341	C1846385	9q34	FOCAL CORTICAL DYSPLASIA OF TAYLOR; FCDT	7248
MIM607342		 	CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 1; CPEB1	64506
MIM607343		20q13.13-q13.2	SAL-LIKE 4; SALL4	57167
MIM607344		Chr.17	TUBULIN, DELTA-1; TUBD1	51174
MIM607345		6q21	TUBULIN, EPSILON-1; TUBE1	51175
MIM607346	C1846367	1p21-q21	SPINOCEREBELLAR ATAXIA 19; SCA19	140452
MIM607347		4q25	ALPHA-KINASE 1; ALPK1	80216
MIM607348		1p36.31	HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 5; HES5	388585
MIM607349		15q15-q21	TALIN 2; TLN2	83660
MIM607350		Chr.8	KINESIN FAMILY MEMBER 13B; KIF13B	23303
MIM607351		10q21.1	RHO-RELATED BTB DOMAIN-CONTAINING PROTEIN 1; RHOBTB1	9886
MIM607352		8p21.2	RHO-RELATED BTB DOMAIN-CONTAINING PROTEIN 2; RHOBTB2	23221
MIM607353		5q14.3	RHO-RELATED BTB DOMAIN-CONTAINING PROTEIN 3; RHOBTB3	22836
MIM607354	C1846366	17p11.2	SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 2; IS2	282552
MIM607355		1p35-p34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2C, SUBUNIT 3; EIF2C3	192669
MIM607356		1p35-p34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2C, SUBUNIT 4; EIF2C4	192670
MIM607357		6q14	POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 5; KCNQ5	56479
MIM607358		21q22.3	AUTOIMMUNE REGULATOR; AIRE	326
MIM607359		8p21	KIAA1967 GENE; KIAA1967	57805
MIM607360		12q13	LACRITIN; LACRT	90070
MIM607361	C1846357	8q21.13-q22.1	MECKEL SYNDROME, TYPE 3; MKS3	91147
MIM607362		15q26.1	RGM DOMAIN FAMILY, MEMBER A; RGMA	56963
MIM607363		12q24.31	KINETOCHORE-ASSOCIATED PROTEIN 1; KNTC1	9735
MIM607364	C1846343	1p36	BARTTER SYNDROME, TYPE 3	1188
MIM607365		3q27-q28	LIPASE H; LIPH	200879
MIM607366		2p22-p21	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 12; KCNK12	56660
MIM607367		14q24.1-q24.3	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 13; KCNK13	56659
MIM607368		20q12-q13	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 15; KCNK15	60598
MIM607369		6p21.2-p21.1	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 16; KCNK16	83795
MIM607370		6p21.2-p21.1	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 17; KCNK17	89822
MIM607371	C1846331	7p22-p12	DYSTONIA, JUVENILE-ONSET	60
MIM607372		22q11.2	MEDIATOR COMPLEX SUBUNIT 15; MED15	51586
MIM607373	C1969710	3q25-q27	AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	282553
MIM607374		 	PRKR INHIBITOR, REPRESSOR OF; PRKRIR	5612
MIM607375		19p13.3	DOT1-LIKE; DOT1L	84444
MIM607376		Chr.12	DYNACTIN 2; DCTN2	10540
MIM607377		1q22	LENS EPITHELIAL PROTEIN; LENEP	55891
MIM607378		 	SERPINE1 mRNA-BINDING PROTEIN 1; SERBP1	26135
MIM607379		22q12.2	NEUROFIBROMIN 2; NF2	4771
MIM607380		2q37.3	TRAF3-INTERACTING PROTEIN 1; TRAF3IP1	26146
MIM607381		 	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 50, YEAST, HOMOLOG OF; TIMM50	92609
MIM607382		19q13	CYTOPLASMIC LINKER PROTEIN 170-RELATED PROTEIN, 59-KD	25999
MIM607383		19p13.3	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 13, YEAST, HOMOLOG OF; TIMM13	26517
MIM607384		14q21	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 9, YEAST, HOMOLOG OF; TIMM9	26520
MIM607385		12q21	UDP-N-ACETYLGLUCOSAMINE:ALPHA-1,3-D-MANNOSIDE BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE IV	25834
MIM607386		2p23.3	INTRAFLAGELLAR TRANSPORT 172, CHLAMYDOMONAS, HOMOLOG OF; IFT172	26160
MIM607387		9p13	DYNACTIN 3; DCTN3	11258
MIM607388		11p15.5-p15.2	FRACTURE CALLUS 1, RAT, HOMOLOG OF; FXC1	26515
MIM607389		5q13.3	SINGLE-STRANDED DNA-BINDING PROTEIN 2; SSBP2	23635
MIM607390		1p31.3	SINGLE-STRANDED DNA-BINDING PROTEIN 3; SSBP3	23648
MIM607391		19p13.1	SINGLE-STRANDED DNA-BINDING PROTEIN 4; SSBP4	170463
MIM607392		3q24	WW DOMAIN-CONTAINING TRANSCRIPTION REGULATOR 1; WWTR1	25937
MIM607393		1q25-q31	CELL DIVISION CYCLE PROTEIN 73, S. CEREVISIAE, HOMOLOG OF; CDC73	79577
MIM607394		11q23.3	POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 3; POU2F3	25833
MIM607395	C1846298	 	STREPTOCOCCUS, GROUP A, SEVERITY OF INFECTION BY	 
MIM607396		22q13.1-q13.31	TRANSDUCER OF ERBB2, 2; TOB2	10766
MIM607397		18p11.2	MELANOCORTIN 2 RECEPTOR; MC2R	4158
MIM607398	C1846284	21q22.1	GLUCOCORTICOID DEFICIENCY 2; GCCD2	282631, 56246
MIM607399		1p22	MUCOLIPIN 2; MCOLN2	255231
MIM607400		1p22.3	MUCOLIPIN 3; MCOLN3	55283
MIM607401		19q13.13	INTERLEUKIN 28A; IL28A	282616
MIM607402		19q13.13	INTERLEUKIN 28B; IL28B	282617
MIM607403		19q13.13	INTERLEUKIN 29; IL29	282618
MIM607404		1p36.11	INTERLEUKIN 28 RECEPTOR, ALPHA; IL28RA	163702
MIM607405		6q23.2	TRACE AMINE-ASSOCIATED RECEPTOR 5; TAAR5	9038
MIM607406		4q25-q34	STARCH-BINDING DOMAIN-CONTAINING PROTEIN 1; STBD1	8987
MIM607407		10q26.3	EARLY B-CELL FACTOR 3; EBF3	253738
MIM607408		13q34	D-AMINO ACID OXIDASE ACTIVATOR; DAOA	267012
MIM607409		6p25.1	NEURITIN 1; NRN1	51299
MIM607410		 	DIENCEPHALON/MESENCEPHALON HOMEOBOX 1; DMBX1	127343
MIM607411	CN032556	 	PATENT DUCTUS ARTERIOSUS	100996949
MIM607412		20q11	BPI FOLD-CONTAINING PROTEIN, FAMILY A, MEMBER 1; BPIFA1	51297
MIM607414		3p14.2	FEZ FAMILY ZINC FINGER PROTEIN 2; FEZF2	55079
MIM607415		13q34	DAOA ANTISENSE RNA; DAOAAS	282706
MIM607416		3p26.1	CHL1, MOUSE, HOMOLOG OF; CHL1	10752
MIM607417	C1843942	3p26.2	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	51185
MIM607418		7q32.1	GRIP AND COILED-COIL DOMAINS-CONTAINING PROTEIN 1; GCC1	79571
MIM607419		19q13.32	GEM-ASSOCIATED PROTEIN 7; GEMIN7	79760
MIM607420		12p12.3	GABA-A RECEPTOR-ASSOCIATED PROTEIN-LIKE PROTEIN 1; GABARAPL1	23710
MIM607421		7p14-p13	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 3; TXNDC3	51314
MIM607422		22q12-q13	GLYCINE C-ACETYLTRANSFERASE; GCAT	23464
MIM607423		9q34.1	PROTEIN O-MANNOSYLTRANSFERASE 1; POMT1	10585
MIM607424		Chr.11	GLYCINE N-ACYLTRANSFERASE; GLYAT	10249
MIM607425		17q21.1	GAP JUNCTION PROTEIN, DELTA-3; GJD3	125111
MIM607426	C1843920	16q13, 10p12.1, 9p13.3, 6q21, 4q21-q22, 1q42.2	COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	23590, 27235, 54840, 56997, 57017, 57107
MIM607427		18p11.32	ENOLASE SUPERFAMILY MEMBER 1; ENOSF1	55556
MIM607428		 	KIN OF IRRE-LIKE; KIRREL	55243
MIM607429		10p12.1	PRENYL DIPHOSPHATE SYNTHASE, SUBUNIT 1; PDSS1	23590
MIM607430		 	DAZ-ASSOCIATED PROTEIN 1; DAZAP1	26528
MIM607431		 	DAZ-ASSOCIATED PROTEIN 2; DAZAP2	9802
MIM607432	C1843916	17p13.3	LISSENCEPHALY 1; LIS1	5048
MIM607433		3p21.1	TWINFILIN, DROSOPHILA, HOMOLOG OF, 2; TWF2	11344
MIM607434		6p21.2-p21.1	GTP-BINDING PROTEIN 2; GTPBP2	54676
MIM607435		 	ERA G-PROTEIN-LIKE 1; ERAL1	26284
MIM607436		7p22.1	POLY(A) POLYMERASE, BETA; PAPOLB	56903
MIM607437		12p13.3	G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER D; GPRC5D	55507
MIM607439		14q24.3	PROTEIN O-MANNOSYLTRANSFERASE 2; POMT2	29954
MIM607440		9q31	FUKUTIN; FKTN	2218
MIM607441		13q13.3	EPITHELIAL STROMAL INTERACTION 1; EPSTI1	94240
MIM607442		2p22-p21	ECHINODERM MICROTUBULE ASSOCIATED PROTEIN LIKE-4; EML4	27436
MIM607443		 	EPIDIDYMAL SPERM BINDING PROTEIN 1; ELSPBP1	64100
MIM607444		7q11	SBDS GENE; SBDS	51119
MIM607445		22q11.2	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E NUCLEAR IMPORT FACTOR 1; EIF4ENIF1	56478
MIM607446	C1843899	6q23-q25	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 3; BMIQ3	337895
MIM607447	C1843898	11q13	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4; BMIQ4	338026, 7351
MIM607448		10q21	G PROTEIN-COUPLED RECEPTOR 147; GPR147	64106
MIM607449		4q13.2-q13.3	G PROTEIN-COUPLED RECEPTOR 74; GPR74	10886
MIM607450	C1843896	6p24	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8	1832
MIM607451		20q13.33	GLUCOCORTICOID MODULATORY ELEMENT-BINDING PROTEIN 2; GMEB2	26205
MIM607452		16q22.3-q24.1	GABA-A RECEPTOR-ASSOCIATED PROTEIN-LIKE PROTEIN 2; GABARAPL2	11345
MIM607453	C1843895	3q28	DEAFNESS, AUTOSOMAL DOMINANT 44; DFNA44	152137
MIM607454	C1843891	7p21.3-p15.1	SPINOCEREBELLAR ATAXIA 21; SCA21	170545
MIM607455		6pter-p22.3	ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 3; ZFAND3	60685
MIM607456		16q22	CIRHIN; CIRH1A	84916
MIM607457	C1843889	9p13	GIL BLOOD GROUP	360
MIM607458	C1843884	7q22-q32	SPINOCEREBELLAR ATAXIA 18; SCA18	94008
MIM607459	C1843851	 	SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	5428, 56652
MIM607460		3q13.2-q13.3	PHOSPHATIDYLSERINE-SPECIFIC PHOSPHOLIPASE A1-ALPHA; PLA1A	51365
MIM607461		18q12-q21.1	DYMECLIN; DYM	54808
MIM607462		12p13.31	ATROPHIN 1; ATN1	1822
MIM607463		 	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 13-LIKE; PPP1R13L	10848
MIM607464	C0749424	19p13.2-p13.1	THYROID CARCINOMA, HURTHLE CELL	51079, 619501
MIM607465		15q15	CODANIN 1; CDAN1	146059
MIM607466		14q11.1-q11.2	RAS-ASSOCIATED PROTEIN RAB2B; RAB2B	84932
MIM607467		 	DENDRITIC CELL-ASSOCIATED LECTIN 1	160365
MIM607468		 	G PROTEIN-COUPLED RECEPTOR 88; GPR88	54112
MIM607469		 	N-ACYLSPHINGOSINE AMIDOHYDROLASE-LIKE PROTEIN; ASAHL	27163
MIM607470		 	BREAST CARCINOMA AMPLIFIED SEQUENCE 3; BCAS3	54828
MIM607471		20q13.13	BREAST CARCINOMA AMPLIFIED SEQUENCE 4; BCAS4	55653
MIM607472		10p14	MITOCHONDRIAL ESCAPE 1-LIKE 1; YME1L1	10730
MIM607473	C1843832	16p11.2	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2; VKCFD2	79001
MIM607474		3q21-q23	HOMOGENTISATE 1,2-DIOXYGENASE; HGD	3081
MIM607475	C1843816	15q26	BOTHNIA RETINAL DYSTROPHY	6017
MIM607476	C1843815	15q26	NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD	6017
MIM607477		 	G2- AND S-PHASE EXPRESSED GENE 1; GTSE1	51512
MIM607478		12q21.1	TRYPTOPHAN HYDROXYLASE 2; TPH2	121278
MIM607479		18p11	APC, DOWNREGULATED BY, 1; APCDD1	147495
MIM607481		4q31.1-q31.2	MMAA GENE; MMAA	166785
MIM607482	C1843808	11p15.1	CARDIOMYOPATHY, DILATED, 1M; CMD1M	8048
MIM607483	C1843807	2q36.3	THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	80704
MIM607484		 	PARTITIONING-DEFECTIVE PROTEIN 6, C. ELEGANS, HOMOLOG OF, ALPHA; PARD6A	50855
MIM607485	C1843792	17q21.32	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	2896
MIM607486	CN031306	1q32	KNOPS BLOOD GROUP SYSTEM; KN	1378
MIM607487	C1843791	17q12	CARDIOMYOPATHY, DILATED, 1N; CMD1N	8557
MIM607488	C1843786	18p11	DYSTONIA 15, MYOCLONIC; DYT15	317714
MIM607489		 	CULLIN 9; CUL9	23113
MIM607490		Chr.16	LACTATE DEHYDROGENASE D; LDHD	197257
MIM607491		 	PROTEIN O-FUCOSYLTRANSFERASE 1; POFUT1	23509
MIM607492		 	PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 1; PACS1	55690
MIM607493		7q31	INHIBITOR OF GROWTH 3; ING3	54556
MIM607494		 	INOSITOL POLYPHOSPHATE-4-PHOSPHATASE, TYPE II, 105-KD; INPP4B	8821
MIM607496		2q31.1	NITRIC OXIDE SYNTHASE TRAFFICKER; NOSTRIN	115677
MIM607497		6q13	BETA-1,3-GLUCURONYLTRANSFERASE 2; B3GAT2	135152
MIM607498	C1843782	6p21.1-p12.2	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	337892
MIM607499	C1843776	11p13, 10p	BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1; BULN1	337893, 627
MIM607501	C1843773	14q21.2-q22.3	MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	338342
MIM607502		1q42	DISPATCHED, DROSOPHILA, HOMOLOG OF, 1; DISP1	84976
MIM607503		Chr.15	DISPATCHED, DROSOPHILA, HOMOLOG OF, 2; DISP2	85455
MIM607504	C0393754	 	HEADACHE ASSOCIATED WITH SEXUAL ACTIVITY; HSA	 
MIM607505		2q37.3	PAS DOMAIN-CONTAINING SERINE/THREONINE KINASE; PASK	23178
MIM607506		 	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 14; ADAMTS14	140766
MIM607507	C1835223	16q12, 6p21.3	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO	4049, 64127
MIM607508	C1843771	19p13	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	387576
MIM607509		 	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 15; ADAMTS15	170689
MIM607510		5p15	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 16; ADAMTS16	170690
MIM607511		15q24	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 17; ADAMTS17	170691
MIM607512		16q23	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 18; ADAMTS18	170692
MIM607513		 	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 19; ADAMTS19	171019
MIM607514	C2675659	10q	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10; BMIQ10	338557, 353126
MIM607515		 	PLACENTA-SPECIFIC GENE 8; PLAC8	51316
MIM607516	C1843765	1q31	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	317773
MIM607517		 	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 4	23547
MIM607518		19p13.2-p12	MONOCYTE AND PLASMACYTOID ACTIVATED MOLECULE	126364
MIM607519		13q11	POLY(ADP-RIBOSE) POLYMERASE 4; PARP4	143
MIM607520		4p11	ZYGOTE ARREST 1; ZAR1	326340
MIM607521		11p15-p13	HPS5 GENE; HPS5	11234
MIM607522		10q24.32	HPS6 GENE; HPS6	79803
MIM607523	C1843761	3p21.3	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8	1294
MIM607524		6p21.3	RING FINGER PROTEIN 39; RNF39	80352
MIM607525		 	ZINC RIBBON DOMAIN-CONTAINING PROTEIN 1; ZNRD1	30834
MIM607526		17q21.1-q21.2	RIBOSOMAL PROTEIN L27; RPL27	6155
MIM607527		Chr.9	REGULATOR OF DIFFERENTIATION 1; ROD1	9991
MIM607528		11q24.2	ROUNDABOUT, DROSOPHILA, HOMOLOG OF, 4; ROBO4	54538
MIM607529		1p13	SERYL-tRNA SYNTHETASE; SARS	6301
MIM607530		7p15-p14.2	HOMEOBOX A11, ANTISENSE	221883
MIM607531		13q22	KRUPPEL-LIKE FACTOR 12; KLF12	11278
MIM607532		13q21-q22	PROGESTERONE-INDUCED BLOCKING FACTOR 1	10464
MIM607533		13q21-q22	DIS3 MITOTIC CONTROL, S. CEREVISIAE, HOMOLOG OF; DIS3	22894
MIM607534		 	YY1-ASSOCIATED FACTOR 2; YAF2	10138
MIM607535		3p13	RING1- AND YY1-BINDING PROTEIN; RYBP	23429
MIM607536		19p13	CREB-REGULATED TRANSCRIPTION COACTIVATOR 1; CRTC1	23373
MIM607537		11q21	MASTERMIND-LIKE 2; MAML2	84441
MIM607538		Chr.17	NDE1-LIKE 1; NDEL1	81565
MIM607539	C1843758	 	CAMPTOSYNPOLYDACTYLY, COMPLEX	 
MIM607540	C1843757	 	SECRETORY DIARRHEA, MYOPATHY, AND DEAFNESS	 
MIM607541	C1275685	5q31	CORNEAL DYSTROPHY, AVELLINO TYPE; CDA	7045
MIM607542		11p15.5	POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 1; KCNQ1	3784
MIM607543	C1843706	 	SPONDYLOMETAPHYSEAL DYSPLASIA WITH BOWED FOREARMS AND FACIAL DYSMORPHISM	 
MIM607544		2p21-p16	LEUCINE-RICH PPR MOTIF-CONTAINING PROTEIN; LRPPRC	10128
MIM607545		4q32-q34	STEROL C4-METHYLOXIDASE-LIKE; SC4MOL	6307
MIM607546		3q13.1	CD200 RECEPTOR 1; CD200R1	131450
MIM607547		3q27	RIBOSOMAL PROTEIN L39-LIKE; RPL39L	116832
MIM607548		19q13.3	RADIAL SPOKEHEAD-LIKE 1; RSHL1	81492
MIM607549		21q11.2	POTE ANKYRIN DOMAIN FAMILY, MEMBER D; POTED	317754
MIM607550		6q21-q22	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 10; SLC16A10	117247
MIM607551		22q11.2	STROMAL CELL-DERIVED FACTOR 2-LIKE 1; SDF2L1	23753
MIM607552	C1843691	 	MINICORE MYOPATHY, ANTENATAL ONSET, WITH ARTHROGRYPOSIS	 
MIM607553		 	EPIPLAKIN 1; EPPK1	83481
MIM607554	C1837014	11p15.5	ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	3784
MIM607555		1q25-q31	TORSIN 3A; TOR3A	64222
MIM607556		2q37.3	TWIST, DROSOPHILA, HOMOLOG OF, 2; TWIST2	117581
MIM607557		12q23	SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 8; SLC17A8	246213
MIM607558		22q12.1-qter	SEC14-LIKE 2; SEC14L2	23541
MIM607559		16p13.3	MAHOGUNIN, RING FINGER 1; MGRN1	23295
MIM607560		1q21-q22	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; ARHGEF2	9181
MIM607562		1p31.3	INTERLEUKIN 23 RECEPTOR; IL23R	149233
MIM607563		11p14.3	SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 6; SLC17A6	57084
MIM607564		11p15	TRIPARTITE MOTIF-CONTAINING PROTEIN 6; TRIM6	117854
MIM607565	C1843661	 	SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	 
MIM607566		6q24	EPM2A GENE; EPM2A	7957
MIM607567		 	OLFACTOMEDIN 3; OLFM3	118427
MIM607568		12q24	MMAB GENE; MMAB	326625
MIM607569	C1843633	 	MYOPATHY, DISTAL, WITH EARLY RESPIRATORY FAILURE, AUTOSOMAL DOMINANT	 
MIM607570		17q23.3	DEAH BOX POLYPEPTIDE 40; DHX40	79665
MIM607571		14q11.2	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL OXODICARBOXYLATE CARRIER), MEMBER 21; SLC25A21	89874
MIM607572	C1843632	6q25.2-q27	LEPROSY, SUSCEPTIBILITY TO, 2; LPRS2	5071
MIM607573		19p13.11	BPY2-INTERACTING PROTEIN 1; BPY2IP1	55201
MIM607574		22q13.31-qter	ARYLSULFATASE A; ARSA	410
MIM607575		22q11.2	CAT EYE SYNDROME CHROMOSOME REGION, CANDIDATE 1; CECR1	51816
MIM607576		22q11.2	CAT EYE SYNDROME CHROMOSOME REGION, CANDIDATE 2; CECR2	27443
MIM607577		Chr.8	LYSOSOMAL APYRASE-LIKE PROTEIN 1; LYSAL1	9583
MIM607578	C0476287	 	BREATH-HOLDING SPELLS	 
MIM607579		 	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/CATION TRANSPORTER), MEMBER 9; SLC22A9	114571
MIM607580		 	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/CATION TRANSPORTER), MEMBER 10; SLC22A10	387775
MIM607581		Chr.11	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION TRANSPORTER), MEMBER 8; SLC22A8	9376
MIM607582		11q13.1-q13.2	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION TRANSPORTER), MEMBER 6; SLC22A6	9356
MIM607583		19p13.3	PEROXISOME BIOGENESIS FACTOR 11G; PEX11G	92960
MIM607584	C1843569	13q14	SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE; SPG24	338090
MIM607585		11q22.3	ATAXIA-TELANGIECTASIA MUTATED GENE; ATM	472
MIM607586		2q33	ALS2 CHROMOSOME REGION GENE 8; ALS2CR8	79800
MIM607587		13p11	INTERLEUKIN 17D; IL17D	53342
MIM607588		22q11.21	PEPTIDYL-PROLYL ISOMERASE-LIKE 2; PPIL2	23759
MIM607589		20q13.2	SERUM/GLUCOCORTICOID-REGULATED KINASE 2; SGK2	10110
MIM607590		4q27	BBS7 GENE; BBS7	55212
MIM607591		8q12.3-q13.1	SERUM/GLUCOCORTICOID-REGULATED KINASE-LIKE PROTEIN; SGKL	23678
MIM607592	C1843533	19q	PROSTATE CANCER AGGRESSIVENESS QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 19	347747
MIM607593		6pter-p21.3	MEDIATOR OF DNA DAMAGE CHECKPOINT PROTEIN 1; MDC1	9656
MIM607594	C3149378	2q33	IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1	29851
MIM607595	C1843512	13q34	BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE	1282
MIM607596	C1843504	14q32	PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	7443
MIM607597	C1843492	 	MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	 
MIM607598	C1843478	12q13	LETHAL CONGENITAL CONTRACTURE SYNDROME 2; LCCS2	2065
MIM607599		Chr.8	RETINOL DEHYDROGENASE 10; RDH10	157506
MIM607600	C1843477	 	EPIDERMOLYSIS BULLOSA SIMPLEX SUPERFICIALIS; EBSS	 
MIM607601		19p13.3	TIR DOMAIN-CONTAINING ADAPTOR MOLECULE 1; TICAM1	148022
MIM607602	C1843463	17q21-q22, 12q13	ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS	3848, 3858
MIM607603		16q24.1	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 4; KCNG4	93107
MIM607604		9p24.2	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY V, MEMBER 2; KCNV2	169522
MIM607605		6p12.2	GLUTATHIONE S-TRANSFERASE, ALPHA-5; GSTA5	221357
MIM607606		17q12-q21	KERATIN 9; KRT9	3857
MIM607607		4q21.1	NUCLEOPORIN, 54-KD; NUP54	53371
MIM607608		11p15.4-p15.1	SPHINGOMYELIN PHOSPHODIESTERASE 1, ACID LYSOSOMAL; SMPD1	6609
MIM607609		6q24-q25	PEPTIDYL-PROLYL ISOMERASE-LIKE 4; PPIL4	85313
MIM607610		3q23	PHOSPHOLIPID SCRAMBLASE 2; PLSCR2	57047
MIM607611		17p13.1	PHOSPHOLIPID SCRAMBLASE 3; PLSCR3	57048
MIM607612		3q23	PHOSPHOLIPID SCRAMBLASE 4; PLSCR4	57088
MIM607613		1q42.13	NUCLEOPORIN, 133-KD; NUP133	55746
MIM607614		Chr.11	NUCLEOPORIN, 160-KD; NUP160	23279
MIM607615		13q12.1	NUCLEOPORIN-LIKE 1; NUPL1	9818
MIM607616	C0268243	11p15.4-p15.1	NIEMANN-PICK DISEASE, TYPE B	6609
MIM607617		Chr.12	NUCLEOPORIN, 107-KD; NUP107	57122
MIM607618		16q22.1	DEAD/H BOX 28; DDX28	55794
MIM607619		9q21-q22	FERM DOMAIN-CONTAINING PROTEIN 3; FRMD3	257019
MIM607620		8q23-q24.1	COLLECTIN 10; COLEC10	10584
MIM607621		18p11.32	COLLECTIN 12; COLEC12	81035
MIM607622		1p13-q23	PHOSPHOMEVALONATE KINASE; PMVK	10654
MIM607623		18q11-q12	NPC1 GENE; NPC1	4864
MIM607624	C1868679	15q21	GRISCELLI SYNDROME, TYPE 2; GS2	5873
MIM607625	C1843366	14q24.3	NIEMANN-PICK DISEASE, TYPE C2	10577
MIM607626	C1843355	3q28-q29	ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS	9076
MIM607627		20q11.21	BREAST CANCER- AND SALIVARY GLAND-EXPRESSED GENE	317716
MIM607628	C0393697	3q26	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11; EIG11	1181
MIM607629		1p36.13-q31.3	ANTERIOR PHARYNX DEFECTIVE 1, C. ELEGANS, HOMOLOG OF, A; APH1A	51107
MIM607630		15q22.2	ANTERIOR PHARYNX DEFECTIVE 1, C. ELEGANS, HOMOLOG OF, B; APH1B	83464
MIM607631	C0014553	6p12-p11	EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1; EJA1	114327
MIM607632		19q13.1	PRESENILIN ENHANCER 2, C. ELEGANS, HOMOLOG OF; PSENEN	55851
MIM607633		2p23-p22	XANTHINE DEHYDROGENASE; XDH	7498
MIM607634	C1843330	11q13.4	OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	4041
MIM607635		7q32	CARBOXYPEPTIDASE A4; CPA4	51200
MIM607636	C1843323	11q13.4	VAN BUCHEM DISEASE, TYPE 2	4041
MIM607637		10q26	EMX2 OPPOSITE STRAND; EMX2OS	196047
MIM607638		4q35	DEOXYCYTIDYLATE DEAMINASE; DCTD	1635
MIM607639		7q11.23	PROTEIN WITH 4 GROUP B SCAVENGER RECEPTOR CYSTEINE-RICH DOMAINS; SRCRB4D	136853
MIM607640		3p21.1-p12	ATAXIN 7; ATXN7	6314
MIM607641	C1843315	2p13	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB; HMN7B	1639
MIM607642		17p11.2	RETINOIC ACID-INDUCED GENE 1; RAI1	10743
MIM607643		17q25	FASCIN, SEA URCHIN, HOMOLOG OF, 2; FSCN2	25794
MIM607644	C1843306	11p13-q12	CANDIDIASIS, FAMILIAL, 3; CANDF3	338434
MIM607645		4p16.3	D4S234E GENE; D4S234E	27065
MIM607646		 	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 7B; ZBTB7B	51043
MIM607647		19p13.2	PLASMALEMMA VESICLE-ASSOCIATED PROTEIN; PLVAP	83483
MIM607648		2q24.3	SERINE/THREONINE PROTEIN KINASE 39; STK39	27347
MIM607649		6q21	OSTEOPETROSIS-ASSOCIATED TRANSMEMBRANE PROTEIN 1; OSTM1	28962
MIM607650		20q11	DEFENSIN, BETA, 118; DEFB118	117285
MIM607651		11q13-q14.1	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY B, MEMBER 1; PLEKHB1	58473
MIM607652		2q35	SERINE/THREONINE PROTEIN KINASE 36; STK36	27148
MIM607653		Chr.14	RAS HOMOLOG GENE FAMILY, MEMBER J; RHOJ	57381
MIM607654	C1843302	12q13	KERATOSIS PALMOPLANTARIS STRIATA III; PPKS3	3848
MIM607655	C1843292	6p24	SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	1832
MIM607656	C1843291	 	CURLY HAIR-ACRAL KERATODERMA-CARIES SYNDROME	 
MIM607657		1p31.1	CYSTATHIONINE GAMMA-LYASE; CTH	1491
MIM607658	C1843285	 	HYPOTRICHOSIS-OSTEOLYSIS-PERIODONTITIS-PALMOPLANTAR KERATODERMA SYNDROME	 
MIM607659		 	ELL-ASSOCIATED FACTOR 2; EAF2	55840
MIM607660		1p35-p34	TESTIS-SPECIFIC SERINE/THREONINE KINASE 3; TSSK3	81629
MIM607662		20q13.1-q13.2	SPERMATOGENESIS-ASSOCIATED PROTEIN 2; SPATA2	9825
MIM607663		11q24	DEAD BOX POLYPEPTIDE 25; DDX25	29118
MIM607664		12q14	N-ACETYLGLUCOSAMINE-6-SULFATASE; GNS	2799
MIM607665	C1843273	 	TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	 
MIM607666		11q22	ANGIOPOIETIN-LIKE 5; ANGPTL5	253935
MIM607667		10q21	CATENIN, ALPHA-3; CTNNA3	29119
MIM607668		Chr.12	ADP-RIBOSYLATION-LIKE FACTOR 6-INTERACTING PROTEIN 4; ARL6IP4	51329
MIM607669		16p12-p11.2	ADP-RIBOSYLATION-LIKE FACTOR 6-INTERACTING PROTEIN 1; ARL6IP1	23204
MIM607670		11p15.3	SERINE/THREONINE PROTEIN KINASE 33; STK33	65975
MIM607671	C1843264	1p36.32-p36.13	DYSTONIA 13, TORSION; DYT13	93983
MIM607672		11q13.3	CARDIOTROPHIN-LIKE CYTOKINE FACTOR 1; CLCF1	23529
MIM607673		3p26.1	ENDOPLASMIC RETICULUM DEGRADATION-ENHANCING ALPHA-MANNOSIDASE-LIKE PROTEIN 1; EDEM1	9695
MIM607674	C1843257	 	CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	 
MIM607675		Chr.14	REST COREPRESSOR; RCOR	23186
MIM607676	C1843256	12q12	IRAK4 DEFICIENCY	51135
MIM607677	C1843251	1q22	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I; CMT2I	4359
MIM607678	C1843247	10q21.1-q22.1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D	1959
MIM607679		7q31	DEDICATOR OF CYTOKINESIS 4; DOCK4	9732
MIM607680		 	ZINC FINGER PROTEIN 363; ZNF363	25898
MIM607681	C1843244	5q31.1-q33.1	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2; ECA2	2566
MIM607682	C2750887	2q22-q23	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9	785
MIM607683	C1843232	4q28	DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52	170507
MIM607684	C1843225	8p21	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	4747
MIM607685	C0206141	4q12	HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC; HES	5156
MIM607686		4q12	FIP1-LIKE 1; FIP1L1	81608
MIM607687	C1843212	16q24.1	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 3	353125
MIM607688	C1843211	2q37.1	PARKINSON DISEASE 11, AUTOSOMAL DOMINANT; PARK11	26058
MIM607690		5q31.1	SAR1, S. CEREVISIAE, HOMOLOG B; SAR1B	51128
MIM607691		10q22.1	SAR1, S. CEREVISIAE, HOMOLOG OF, A; SAR1A	56681
MIM607693		9q22.2	SELENOCYSTEINE INSERTION SEQUENCE-BINDING PROTEIN 2; SECISBP2	79048
MIM607694	C1843200	 	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD7	11128, 55703
MIM607695		 	EUKARYOTIC ELONGATION FACTOR, SELENOCYSTEINE-tRNA-SPECIFIC; EEFSEC	60678
MIM607696		17q24-q25	USH1G GENE; USH1G	124590
MIM607697		11p15	SET-BINDING FACTOR 2; SBF2	81846
MIM607698		10q24.1	LIGAND-DEPENDENT NUCLEAR RECEPTOR COREPRESSOR; LCOR	84458
MIM607699		 	RING FINGER PROTEIN 20; RNF20	56254
MIM607700		 	RING FINGER PROTEIN 40; RNF40	9810
MIM607701		2q31.1	KELCH REPEAT AND BTB/POZ DOMAINS-CONTAINING PROTEIN 10; KBTBD10	10324
MIM607702		8p11.2	CHROMOSOME 8 OPEN READING FRAME 4; C8ORF4	56892
MIM607703		3p25.1	NUCLEOPORIN, 210-KD; NUP210	23225
MIM607704		9p24.3	KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 1; KANK1	23189
MIM607705		2p16.2	PROTEASOME ACTIVATOR SUBUNIT 4; PSME4	23198
MIM607706	C1843183	8q13-q21.1	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE	54332
MIM607707		7p14	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-BETA; CAMK2B	816
MIM607708		4q26	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-DELTA; CAMK2D	817
MIM607709		9q12-q13	TIGHT JUNCTION PROTEIN 2; TJP2	9414
MIM607710		9q13-q21	FAMILY WITH SEQUENCE SIMILARITY 189, MEMBER A2; FAM189A2	9413
MIM607711		21q22.3	DISCO-INTERACTING PROTEIN 2, DROSOPHILA, HOMOLOG OF, A; DIP2A	23181
MIM607712		22q11.2	HYPERMETHYLATED IN CANCER 2; HIC2	23119
MIM607713		4p16	KILLER-SPECIFIC SECRETORY PROTEIN, 37-KD	83888
MIM607714		5q32-q33.1	TNFAIP3-INTERACTING PROTEIN 1; TNIP1	10318
MIM607715		13q14	TSC22 DOMAIN FAMILY, MEMBER 1; TSC22D1	8848
MIM607716		Chr.11	SYNAPTOTAGMIN 13; SYT13	57586
MIM607717		Chr.12	TENSIN-LIKE C1 DOMAIN-CONTAINING PHOSPHATASE; TENC1	23371
MIM607718		1p13.2	SYNAPTOTAGMIN 6; SYT6	148281
MIM607719		 	SYNAPTOTAGMIN 8; SYT8	90019
MIM607720		 	TRANSLIN-ASSOCIATED FACTOR X-INTERACTING PROTEIN 1; TSNAXIP1	55815
MIM607721	C1843181	10q25	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR; NSLH	8036
MIM607722		Chr.8	KIAA0103 GENE; KIAA0103	9694
MIM607723		7p22.3	SAD1 AND UNC84 DOMAIN-CONTAINING PROTEIN 1; SUN1	23353
MIM607724		12q15	CALCYPHOSINE 2; CAPS2	84698
MIM607725		14q11.2	POLY(ADP-RIBOSE) POLYMERASE 2; PARP2	10038
MIM607726		3p21.3-p21.1	POLY(ADP-RIBOSE) POLYMERASE 3; PARP3	10039
MIM607727		 	CULLIN-ASSOCIATED NEDDYLATION-DISSOCIATED PROTEIN 1; CAND1	55832
MIM607728	C1843180	15q25.1-q26.1	POROKERATOSIS, DISSEMINATED SUPERFICIAL ACTINIC, 2	353147
MIM607729		10q24.33	DNA DAMAGE-INDUCIBLE TRANSCRIPT 4; DDIT4	54541
MIM607730		4q24-q25	DNA DAMAGE-INDUCIBLE TRANSCRIPT 4-LIKE; DDIT4L	115265
MIM607731	C1843173	 	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H	619496
MIM607732		17q11	STERILE ALPHA AND TIR MOTIFS-CONTAINING PROTEIN 1; SARM1	23098
MIM607733		Chr.8	SCRIBBLE, DROSOPHILA, HOMOLOG OF; SCRIB	23513
MIM607734	C1843164	8p21	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	4747
MIM607735		4q26	PROGESTERONE RECEPTOR MEMBRANE COMPONENT 2; PGRMC2	10424
MIM607736	C1843153	1q22	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J; CMT2J	4359
MIM607737		4p15.3	FIBROBLAST GROWTH FACTOR-BINDING PROTEIN 1; FGFBP1	9982
MIM607738		Chr.8	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAB-RELATED SUBFAMILY, MEMBER 2; KCNB2	9312
MIM607740		17q22	UBIQUITIN-SPECIFIC PROTEASE 32; USP32	84669
MIM607741		17q12	TBC1 DOMAIN FAMILY, MEMBER 3; TBC1D3	729873
MIM607742		17q11.2	KERATIN 24; KRT24	192666
MIM607743		 	FIBROBLAST GROWTH FACTOR RECEPTOR SUBSTRATE 2; FRS2	10818
MIM607744		 	FIBROBLAST GROWTH FACTOR RECEPTOR SUBSTRATE 3	10817
MIM607745	C1843140	2q23-q24.3	SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	6326
MIM607746		14q22.1	FERMITIN FAMILY (DROSOPHILA) HOMOLOG 2; FERMT2	10979
MIM607747		1p36.13	FILAMIN-BINDING LIM PROTEIN 1; FBLP1	54751
MIM607748	C1843139	9q22.3, 9q12-q13, 1q42.1	HYPERCHOLANEMIA, FAMILIAL; FHCA	2052, 570, 9414
MIM607749		 	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 3; CDCA3	83461
MIM607750		22q13	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3C; APOBEC3C	27350
MIM607751		7q35-q36	TASTE RECEPTOR, TYPE 2, MEMBER 38; TAS2R38	5726
MIM607752		5p15.2-p13.1	CYCLIN O; CCNO	10309
MIM607753		12q	SINGLE-STRAND-SELECTIVE MONOFUNCTIONAL URACIL-DNA GLYCOSYLASE 1	23583
MIM607754		 	MAKORIN 1; MKRN1	23608
MIM607755		22q13	MITOGEN-ACTIVATED PROTEIN KINASE 8-INTERACTING PROTEIN 2; MAPK8IP2	23542
MIM607756		 	ALPHA-AMINOADIPATE SEMIALDEHYDE DEHYDROGENASE-PHOSPHOPANTETHEINYL TRANSFERASE; AASDHPPT	60496
MIM607757		22q12-q13	CHIBBY; CBY	25776
MIM607758		1p36.22	CATENIN, BETA-INTERACTING PROTEIN 1; CTNNBIP1	56998
MIM607759		17q21.32	INTEGRIN, ALPHA-2B; ITGA2B	3674
MIM607760		3q22.1	DNA TOPOISOMERASE II-BINDING PROTEIN 1; TOPBP1	11073
MIM607761		11q24.2	KIN OF IRRE-LIKE 3; KIRREL3	84623
MIM607762		19q13.1	KIN OF IRRE-LIKE 2; KIRREL2	84063
MIM607763		Chr.17	CENTAURIN, BETA-1; CENTB1	9744
MIM607764		16p12-p11.2	3-@BETA-HYDROXY-DELTA-5-C27-STEROID OXIDOREDUCTASE; HSD3B7	80270
MIM607765	C1843116	16p12-p11.2	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	80270
MIM607766		3q29	CENTAURIN, BETA-2; CENTB2	23527
MIM607767		1p35.3	SESTRIN 2; SESN2	83667
MIM607768		11q21	SESTRIN 3; SESN3	143686
MIM607769		19q13.33	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 4; PLEKHA4	57664
MIM607770		12p12	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 5; PLEKHA5	54477
MIM607771		1q32.1	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 6; PLEKHA6	22874
MIM607772		10q25.3-q26.2	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 1; PLEKHA1	59338
MIM607773		Chr.8	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 2; PLEKHA2	59339
MIM607774		2q31.2	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 3; PLEKHA3	65977
MIM607775		2q35-q36	POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 4; KCNE4	23704
MIM607776		15q24	SIN3, YEAST, HOMOLOG OF, A; SIN3A	25942
MIM607777		19p13.11	SIN3, YEAST, HOMOLOG OF, B; SIN3B	23309
MIM607778	C1843096	2q33-q35	ACROCAPITOFEMORAL DYSPLASIA; ACFD	3549
MIM607779		1p36.11	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 7; PAQR7	164091
MIM607780		6p12	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 8; PAQR8	85315
MIM607781		Chr.15	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 5; PAQR5	54852
MIM607782		16p13.3	LUC7, S. CEREVISIAE, HOMOLOG OF; LUC7L	55692
MIM607783		Chr.15	MESODERM DEVELOPMENT CANDIDATE GENE 2; MESDC2	23184
MIM607784		11q23.3	ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 4; ABCG4	64137
MIM607785	C0349639	17q11.2, 12q24.1, 5q31	JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML	23092, 4763, 5781
MIM607786		1p34.1-p32	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 9; PCSK9	255738
MIM607787		13q31	INTIMAL THICKNESS-RELATED RECEPTOR	160897
MIM607788		2p21-p16.3	MULTIPLE COAGULATION FACTOR DEFICIENCY PROTEIN 2; MCFD2	90411
MIM607789		6q12	PHD FINGER PROTEIN 3; PHF3	23469
MIM607790		10q22	TET ONCOGENE FAMILY, MEMBER 1; TET1	80312
MIM607791	C1843075	1q22	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D; CMTDID	4359
MIM607792		3q13	GERMINAL CENTER-EXPRESSED TRANSCRIPT 2; GCET2	257144
MIM607793		19p13	PETER PAN, DROSOPHILA, HOMOLOG OF; PPAN	56342
MIM607794		 	MEST INTRONIC TRANSCRIPT 1; MESTIT1	317751
MIM607795		9q31-q33	PRECURSOR mRNA-PROCESSING FACTOR 4, S. CEREVISIAE, HOMOLOG OF; PRPF4	9128
MIM607796		13q14.1	PHD FINGER PROTEIN 11; PHF11	51131
MIM607797		1p35.2	SMALL NUCLEAR RIBONUCLEOPROTEIN, 40-KD; SNRNP40	9410
MIM607798		 	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1-LIKE; TAF1L	138474
MIM607799		12q14-q15	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 17; ZDHHC17	23390
MIM607800		2q34	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 12; ABCA12	26154
MIM607801	C1832567	3p25	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C; LGMD1C	859
MIM607802		10q23-q24	CYCLIN M1; CNNM1	26507
MIM607803		10q24.33	CYCLIN M2; CNNM2	54805
MIM607804		2q11.2	CYCLIN M3; CNNM3	26505
MIM607805		2q11.2	CYCLIN M4; CNNM4	26504
MIM607806		 	OTOPETRIN 1	133060
MIM607807		7p12.3	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 13; ABCA13	154664
MIM607808		20p11	NK2 HOMEOBOX 4; NKX2-4	644524
MIM607809		11q22.3-q23.1	ACETYL-CoA ACETYLTRANSFERASE 1; ACAT1	38
MIM607810		2p25.2	RADICAL S-ADENOSYL METHIONINE DOMAIN-CONTAINING PROTEIN 2; RSAD2	91543
MIM607811		6p24.2	p21-ACTIVATED KINASE- AND PHOSPHOLIPASE C-INTERACTING PROTEIN 1; PAK1IP1	55003
MIM607812	C1843042	14q21.1	CRANIOLENTICULOSUTURAL DYSPLASIA; CLSD	10484
MIM607813		1p21.3	PLASTICITY-RELATED GENE 1	9890
MIM607814		19q13.11	REGULATOR OF G PROTEIN SIGNALING 9-BINDING PROTEIN; RGS9BP	388531
MIM607815		12q23.1	ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 1B; ANKS1B	56899
MIM607816		10q24.33	POLYCOMB GROUP RING FINGER PROTEIN 6; PCGF6	84108
MIM607817		8q22-q23	VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, B; VPS13B	157680
MIM607818		10q21.2	ZINC FINGER PROTEIN 365; ZNF365	22891
MIM607819		5q11.2	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 5; SLC30A5	64924
MIM607820		1p32.1	HOOK, DROSOPHILA, HOMOLOG OF, 1; HOOK1	51361
MIM607821	C1843028	6q13	DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	4646
MIM607822	C1843013	14q24.3	ALZHEIMER DISEASE 3	5663
MIM607823	C1843004	20q13.33	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	54345
MIM607824		19p13.13	HOOK, DROSOPHILA, HOMOLOG OF, 2; HOOK2	29911
MIM607825		8p11.21	HOOK, DROSOPHILA, HOMOLOG OF, 3; HOOK3	84376
MIM607826		 	S-ADENOSYLHOMOCYSTEINE HYDROLASE-LIKE 1; AHCYL1	10768
MIM607827		 	OTOPETRIN 2	92736
MIM607828		 	OTOPETRIN 3	347741
MIM607829	C1843003	11p15.4	MITRAL VALVE PROLAPSE, MYXOMATOUS 2; MMVP2	352956
MIM607830		4q21	FRAS1 GENE; FRAS1	80144
MIM607831	C1842983	8q13-q21.1	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	54332
MIM607832	C1842982	6p12	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3	23607
MIM607833		 	TACHYKININ 4; TAC4	255061
MIM607834	C1842981	17q11.1-q12	ANXIETY	6532
MIM607835		 	SPLICING FACTOR 3B, 14-KD SUBUNIT	51639
MIM607836	C1842979	1p31	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1; AIS1	27022, 373071
MIM607837		8p23	CLN8 GENE; CLN8	2055
MIM607838		16p	N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE, GAMMA SUBUNIT; GNPTG	84572
MIM607839		3p12	GLYCOGEN BRANCHING ENZYME; GBE1	2632
MIM607840		12q23.3	N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE, ALPHA/BETA SUBUNITS; GNPTAB	79158
MIM607841	C1842939	12q13-q15	DEAFNESS, AUTOSOMAL DOMINANT 48; DFNA48	4640
MIM607842	C1842937	18q22.3-q23	AURAL ATRESIA, CONGENITAL; CAA	10194
MIM607843		8q23	PKHD1-LIKE 1; PKHD1L1	93035
MIM607844		12q14	LEM DOMAIN-CONTAINING PROTEIN 3; LEMD3	23592
MIM607845		6p21.1	EXPORTIN 5; XPO5	57510
MIM607846		 	METHYLTRANSFERASE-LIKE 2; METTL2	55798
MIM607847	C1842930	1p22	NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS	2672
MIM607848		 	RAB-INTERACTING LYSOSOMAL PROTEIN	83547
MIM607849		14q23.3	RETINOL DEHYDROGENASE 11; RDH11	51109
MIM607850	C2675609	9q21.3-q22	OSTEOARTHRITIS SUSCEPTIBILITY 3; OS3	54829
MIM607851		 	NAKED CUTICLE, DROSOPHILA, HOMOLOG OF, 1; NKD1	85407
MIM607852		 	NAKED CUTICLE, DROSOPHILA, HOMOLOG OF, 2; NKD2	85409
MIM607853	C1842922	9q31	PANIC DISORDER 2	619493
MIM607854		11q13	BESTROPHIN 1; BEST1	7439
MIM607855	C1263858	6q22-q23	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	3908
MIM607856		15q21.2-q21.3	CINGULIN-LIKE 1; CGNL1	84952
MIM607857	C1842897	4q31-q34	PSORIASIS SUSCEPTIBILITY 9; PSORS9	359825
MIM607858		3q27	PRESENILIN-ASSOCIATED RHOMBOID-LIKE PROTEIN; PARL	55486
MIM607859	C0346073	 	ANGIOMA, TUFTED	 
MIM607860		 	YY1 ASSOCIATED PROTEIN 1; YY1AP1	55249
MIM607861		14q22.3	DAPPER, ANTAGONIST OF BETA-CATENIN, 1; DACT1	51339
MIM607862		 	DIRAS FAMILY, GTP-BINDING RAS-LIKE PROTEIN 1; DIRAS1	148252
MIM607863		 	DIRAS FAMILY, GTP-BINDING RAS-LIKE PROTEIN 2; DIRAS2	54769
MIM607864	C1842884	16p13.3	CAUDAL DUPLICATION ANOMALY	8312
MIM607865		13q14	SET DOMAIN PROTEIN, BIFURCATED, 2; SETDB2	83852
MIM607866		13q14	CHROMOSOME 13 OPEN READING FRAME 1; C13ORF1	57213
MIM607867		13q14	RCC1 DOMAIN- AND BTB DOMAIN-CONTAINING PROTEIN 1; RCBTB1	55213
MIM607868		 	TRIPARTITE MOTIF-CONTAINING PROTEIN 11; TRIM11	81559
MIM607869		5q35.2	UNC5, C. ELEGANS, HOMOLOG OF, A; UNC5A	90249
MIM607870		10q21-q22	UNC5, C. ELEGANS, HOMOLOG OF, B; UNC5B	219699
MIM607871		2p21	F-BOX ONLY PROTEIN 11; FBXO11	80204
MIM607872	C1842870	1p36	CHROMOSOME 1p36 DELETION SYNDROME	100240737
MIM607873		17p13.3	SCAVENGER RECEPTOR CLASS F, MEMBER 1; SCARF1	8578
MIM607874		19q13.43	ZINC FINGER PROTEIN 444; ZNF444	55311
MIM607875		Chr.17	SKELETAL MUSCLE- AND KIDNEY-ENRICHED INOSITOL PHOSPHATASE	51763
MIM607876	C1842852	2p11.1-q12.2	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2	554188
MIM607877		2q37.3	OTOSPIRALIN	150677
MIM607878		5p13.1-cen	NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; NNT	23530
MIM607879		4q12	EXOCYST COMPLEX COMPONENT 1; EXOC1	55763
MIM607880		2p13.2	EXOCYST COMPLEX COMPONENT 6B; EXOC6B	23233
MIM607881		 	SIGNAL-TRANSDUCING ADAPTOR PROTEIN 2	55620
MIM607882		8q24.3	SOLUTE CARRIER FAMILY 52 (RIBOFLAVIN TRANSPORTER), MEMBER 2; SLC52A2	79581
MIM607883		17p13.2	SOLUTE CARRIER FAMILY 52 (RIBOFLAVIN TRANSPORTER), MEMBER 1; SLC52A1	55065
MIM607884		 	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 1; CMTM1	113540
MIM607885		 	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 2; CMTM2	146225
MIM607886		 	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 3; CMTM3	123920
MIM607887		 	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 4; CMTM4	146223
MIM607888		 	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 5; CMTM5	116173
MIM607889		 	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 6; CMTM6	54918
MIM607890		 	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 7; CMTM7	112616
MIM607891		 	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 8; CMTM8	152189
MIM607892		18q12	DESMOGLEIN 4; DSG4	147409
MIM607893	C2675601	3p25-p22	OVARIAN CANCER, SUSCEPTIBILITY TO, 1; OVCAS1	574048
MIM607894		 	POLYCYSTIN 1-LIKE 2; PKD1L2	114780
MIM607895		16q22	POLYCYSTIN 1-LIKE 3; PKD1L3	342372
MIM607896		 	OVARIAN CANCER-ASSOCIATED GENE 2	124641
MIM607897		 	MUSASHI, DROSOPHILA, HOMOLOG OF, 2; MSI2	124540
MIM607898		 	TRIBBLES, DROSOPHILA, HOMOLOG OF, 3; TRIB3	57761
MIM607899		 	WIT1 GENE	51352
MIM607900		20p13	FERMITIN FAMILY (DROSOPHILA) HOMOLOG 1; FERMT1	55612
MIM607901		11q12	FERMITIN FAMILY (DROSOPHILA) HOMOLOG 3; FERMT3	83706
MIM607902		 	RNA, U TRANSPORTER 1; RNUT1	10073
MIM607903	C1842839	18q12	HYPOTRICHOSIS 6; HYPT6	147409
MIM607904		16p13.3	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1H SUBUNIT; CACNA1H	8912
MIM607905		9q22	ALG2, S. CEREVISIAE, HOMOLOG OF	85365
MIM607906	C1842836	9q22	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	85365
MIM607907	C0392784	 	DERMATOFIBROSARCOMA PROTUBERANS; DFSP	 
MIM607908		 	LIM AND SENESCENT CELL ANTIGEN-LIKE DOMAINS 2; LIMS2	55679
MIM607909		8q22.3	ANTIZYME INHIBITOR 1; AZIN1	51582
MIM607910		 	KINESIN FAMILY MEMBER 9; KIF9	64147
MIM607911		 	EPM2A-INTERACTING PROTEIN 1; EPM2AIP1	9852
MIM607912		 	SELENOPROTEIN T	51714
MIM607913		 	GLUTATHIONE PEROXIDASE 6; GPX6	257202
MIM607914		 	SELENOPROTEIN H	280636
MIM607915		 	SELENOPROTEIN I	85465
MIM607916		 	SELENOPROTEIN K	58515
MIM607917		 	SELENOPROTEIN O	83642
MIM607918		15q26.3	SELENOPROTEIN S; SEPS1	55829
MIM607919		 	SELENOPROTEIN V	348303
MIM607921	C1842816	17q25	RETINITIS PIGMENTOSA 30; RP30	25794
MIM607922		22q13.2	ALPHA-1,4-GALACTOSYLTRANSFERASE; A4GALT	53947
MIM607923		 	SYNAPTOSOMAL-ASSOCIATED PROTEIN, 91-KD; SNAP91	9892
MIM607924		11q13.1	METASTASIS-ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; MALAT1	378938
MIM607925		 	B- AND T-LYMPHOCYTE ATTENUATOR; BTLA	151888
MIM607926		12q23.3	HOST CELL FACTOR C2; HCFC2	29915
MIM607927		 	ANKYRIN REPEATS- AND FYVE DOMAIN-CONTAINING PROTEIN 1; ANKFY1	51479
MIM607928		9q32-q34	WHIRLIN; WHRN	25861
MIM607929		7p13	CCM2 GENE; CCM2	83605
MIM607930		 	CYTOKINE-LIKE PROTEIN 1; CYTL1	54360
MIM607931		16p11	ATAXIN 2-LIKE; ATXN2L	11273
MIM607932	C1864689	14q22-q23	MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	652
MIM607933		 	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 11; SLC7A11	23657
MIM607934		1p36.13	PEPTIDYLARGININE DEIMINASE, TYPE I; PADI1	29943
MIM607935		1p36.13	PEPTIDYLARGININE DEIMINASE, TYPE II; PADI2	11240
MIM607936	C1842797	12q13	EXFOLIATIVE ICHTHYOSIS, AUTOSOMAL RECESSIVE, ICHTHYOSIS BULLOSA OF SIEMENS-LIKE	1475
MIM607937		 	HOMEOBOX TRANSCRIPTION FACTOR NANOG; NANOG	79923
MIM607938		11q25	NEUROTRIMIN	50863
MIM607939		3p26	SULFATASE-MODIFYING FACTOR 1; SUMF1	285362
MIM607940		 	SULFATASE-MODIFYING FACTOR 2	25870
MIM607941	C1842778	8p23.1-p22	ATRIAL SEPTAL DEFECT 2; ASD2	2626
MIM607942		 	PHOSPHOINOSITIDE 3-KINASE ADAPTOR PROTEIN 1	118788
MIM607943		7q22	RAS p21 PROTEIN ACTIVATOR 4; RASA4	10156
MIM607944	C1842763	 	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	54
MIM607945		1p36.13-q41	ADIPONECTIN RECEPTOR 1; ADIPOR1	51094
MIM607946		 	ADIPONECTIN RECEPTOR 2; ADIPOR2	79602
MIM607947		 	POTASSIUM CHANNEL REGULATOR; KCNRG	283518
MIM607948	C1834752	17q11.2-q12, 12q14, 11q23-q24, 6q23-q24, 5q33.1, 3p21.3, 2q37.1, 2q35, 20q13.2, 19p13.3	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	114609, 1154, 30835, 3431, 345611, 3458, 3459, 4159, 6347, 6556
MIM607949	C1842762	2q35	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 1	404716
MIM607950		 	TESTIS-SPECIFIC PROTEASE 50	29122
MIM607951		 	CENTROSOMAL PROTEIN, 57-KD; CEP57	9702
MIM607952		3p25.3	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 11; SLC6A11	6538
MIM607953		 	NEURONAL PROTEIN, 25-KD, RAT, HOMOLOG OF	29114
MIM607954		 	RAN GUANINE NUCLEOTIDE RELEASE FACTOR	29098
MIM607955		6q24.3	STERILE ALPHA MOTIFS- AND SH3 DOMAIN-CONTAINING PROTEIN 1; SASH1	23328
MIM607956		 	MEDIATOR COMPLEX SUBUNIT 8; MED8	112950
MIM607957		 	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I-DELTA; CAMK1D	57118
MIM607958		 	SYNTAXIN-BINDING PROTEIN 6; STXBP6	29091
MIM607959		 	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 10; SLC7A10	56301
MIM607960		10q26	DEAH BOX POLYPEPTIDE 32; DHX32	55760
MIM607961		15q22.2-q23	SEMAPHORIN 7A; SEMA7A	8482
MIM607962		19p13.13	MICRO RNA 23A; MIR23A	407010
MIM607963		 	METHYL-CpG BINDING DOMAIN PROTEIN 3-LIKE 1; MBD3L1	85509
MIM607964		 	METHYL-CpG BINDING DOMAIN PROTEIN 3-LIKE 2; MBD3L2	125997
MIM607965	C1842757	10q22.3	SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 1; SLEN1	192677
MIM607966	C1842756	2q34-q35	SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 2; SLEN2	192679
MIM607967	C1842755	11p15.5	SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 3; SLEN3	282849
MIM607968		7p14	PARATHYROID HORMONE-RESPONSIVE B1 GENE	27241
MIM607969		 	CDC-LIKE KINASE 4; CLK4	57396
MIM607970		 	G PROTEIN-COUPLED RECEPTOR 135; GPR135	64582
MIM607971		 	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 15; SLC6A15	55117
MIM607972		 	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 16; SLC6A16	28968
MIM607973		18q22-q23	NEUROPILIN- AND TOLLOID-LIKE 1; NETO1	81832
MIM607974		16q11	NEUROPILIN- AND TOLLOID-LIKE 2; NETO2	81831
MIM607975		 	PREGNANCY-INDUCED GROWTH INHIBITOR OKL38	29948
MIM607976		20q11.21	CYTOCHROME c OXIDASE, SUBUNIT IV, ISOFORM 2; COX4I2	84701
MIM607977		 	HEADCASE, DROSOPHILA, HOMOLOG OF; HECA	51696
MIM607978		21q11.2	SAM DOMAIN, SH3 DOMAIN, AND NUCLEAR LOCALIZATION SIGNALS 1; SAMSN1	64092
MIM607979		 	SERINE HYDROLASE-LIKE; SERHL	94009
MIM607980		 	TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 7, YEAST, HOMOLOG OF	54543
MIM607981		 	NEGATIVE REGULATOR OF UBIQUITIN-LIKE PROTEINS 1; NUB1	51667
MIM607982		11q13	SCY1-LIKE 1; SCYL1	57410
MIM607983		1q24.2	GOLGIN, RAB6-INTERACTING; GORAB	92344
MIM607984		5q31.3	SPROUTY, DROSOPHILA, HOMOLOG OF, 4; SPRY4	81848
MIM607985		16p13.3	N-ACETYLGLUCOSAMINE-1-PHOSPHODIESTER ALPHA-N-ACETYLGLUCOSAMINIDASE; NAGPA	51172
MIM607986		1q21	S100 CALCIUM-BINDING PROTEIN A14; S100A14	57402
MIM607987		2p23.1-p22.1	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 10; DNAJC10	54431
MIM607988		10q21-q23	SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN 2; SPOCK2	9806
MIM607989		4q32.3	SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN 3; SPOCK3	50859
MIM607990		19p13.3	UBIQUITIN-LIKE PROTEIN CONTAINING PHD AND RING FINGER DOMAINS 1; UHRF1	29128
MIM607991		 	SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER 3; SLC8A3	6547
MIM607992		19p13.11	SPLICING FACTOR 4; SF4	57794
MIM607993		19p13.11	SPLICING FACTOR, ARGININE/SERINE-RICH, 14; SFRS14	10147
MIM607994		3q25-q26.1	5-PRIME,3-PRIME-@EXORIBONUCLEASE 1; XRN1	54464
MIM607995		6q27	UNC93, C. ELEGANS, HOMOLOG OF, A; UNC93A	54346
MIM607996		 	PREPRONEUROPEPTIDE B	256933
MIM607997		 	PREPRONEUROPEPTIDE W	283869
MIM607998		11p15.5	TRIPEPTIDYL PEPTIDASE I; TPP1	1200
MIM607999		 	ASH1, DROSOPHILA, HOMOLOG OF	55870
MIM608000		 	N-ALPHA-ACETYLTRANSFERASE 15, NatA AUXILIARY SUBUNIT; NAA15	80155
MIM608001		 	MELANOMA INHIBITORY ACTIVITY PROTEIN 2; MIA2	117153
MIM608002		3q22	NEPHROCYSTIN 3; NPHP3	27031
MIM608003		 	HOMEODOMAIN-INTERACTING PROTEIN KINASE 1; HIPK1	204851
MIM608004		3q13.11	NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR, ZETA; NFKBIZ	64332
MIM608005		5q31	SIL1, S. CEREVISIAE, HOMOLOG OF; SIL1	64374
MIM608006		 	LEIOMODIN 2; LMOD2	442721
MIM608007		 	PLECKSTRIN 2; PLEK2	26499
MIM608008		4q33	ANNEXIN A10; ANXA10	11199
MIM608009		1p31	ADENYLATE KINASE 5; AK5	26289
MIM608010		7p13	NPC1-LIKE 1; NPC1L1	29881
MIM608011		3p21.1	GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 3; GNL3	26354
MIM608012		16p13.3	PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 2; PDIA2	64714
MIM608013	C1842704	1q21	GAUCHER DISEASE, PERINATAL LETHAL	2629
MIM608014		12q24	HEAT-SHOCK 22-KD PROTEIN 8; HSPB8	26353
MIM608015		11q13.5	TSUKUSHIN; TSKU	25987
MIM608016		11q13.4	COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 8; CHCHD8	51287
MIM608017		3q21.1	CHROMOSOME 3 OPEN READING FRAME 28; C3ORF28	26355
MIM608018		 	PANCREASIN	83886
MIM608019		 	TNFAIP3-INTERACTING PROTEIN 3; TNIP3	79931
MIM608020		11p15-p14	NUCLEOBINDIN 2; NUCB2	4925
MIM608021		16p13.3	WAP, FOLLISTATIN, IMMUNOGLOBULIN, KUNITZ, AND NTR DOMAINS-CONTAINING PROTEIN 1; WFIKKN1	117166
MIM608022	C1842691	 	DIAPHANOSPONDYLODYSOSTOSIS	168667
MIM608023		 	DEAD/H BOX 56; DDX56	54606
MIM608024		 	PEROXISOMAL D3,D2-ENOYL-CoA ISOMERASE; PECI	10455
MIM608025		2p24-p23	NEUROBLASTOMA-AMPLIFIED SEQUENCE; NBAS	51594
MIM608026	C0848548	9q31-q32	HYPERTENSIVE NEPHROPATHY; HNP1	574045
MIM608027	C1842687	7q11-q21	PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3	373073
MIM608028	C1842679	 	THAI SYMPHALANGISM SYNDROME	 
MIM608029	C1842676	20q11-q13	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6; SCAR6	1167
MIM608030	C1842675	16p11.2	AMYOTROPHIC LATERAL SCLEROSIS 6, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS6	2521
MIM608031	C1842674	20p13	AMYOTROPHIC LATERAL SCLEROSIS 7; ALS7	406238
MIM608033	C2675556	2q11-q13	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3	5903
MIM608034		17pter-p13	ASPARTOACYLASE; ASPA	443
MIM608035	C1842643	1p22	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 4; CMM4	474388
MIM608036	C1842642	5q34-q35.2	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 4	100188782
MIM608037		7q36.1	CHONDROITIN POLYMERIZING FACTOR 2; CHPF2	54480
MIM608038		 	p21 PROTEIN-ACTIVATED KINASE 7; PAK7	57144
MIM608039		 	NYD-SP16	83890
MIM608040		9q	INTRAFLAGELLAR TRANSPORT 74, CHLAMYDOMONAS, HOMOLOG OF; IFT74	80173
MIM608041		4q21	ANTHRAX TOXIN RECEPTOR 2; ANTXR2	118429
MIM608042		1p36.11	SYNAPTOTAGMIN-LIKE 1; SYTL1	84958
MIM608043		5q33.2	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 10; GALNT10	55568
MIM608044		12q22-q23	SOLUTE CARRIER FAMILY 5 (IODIDE TRANSPORTER), MEMBER 8; SLC5A8	160728
MIM608045	C1842633	 	REPRESSOR OF TELOMERASE EXPRESSION 1	404685
MIM608046		11q13	SYNOVIAL APOPTOSIS INHIBITOR 1; SYVN1	84447
MIM608047		 	UBIQUITIN-PROTEIN LIGASE E3B; UBE3B	89910
MIM608048		 	SNF2, LINKER HISTONE, PHD FINGER, RING FINGER, AND HELICASE DOMAINS-CONTAINING PROTEIN; SHPRH	257218
MIM608049	C1842632	13q14.2-q14.1	AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	387577
MIM608050		9q34	TORSIN 1B; TOR1B	27348
MIM608051	C0339512	4p15.3	MACULAR DYSTROPHY, RETINAL, 2; MCDR2	8842
MIM608052		 	TORSIN 2A; TOR2A	27433
MIM608053		15q23-q25	ELECTRON TRANSFER FLAVOPROTEIN, ALPHA POLYPEPTIDE; ETFA	2108
MIM608054		19q13.2	CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 7; CYP2A7	1549
MIM608055		19q13.2	CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 13; CYP2A13	1553
MIM608057		1p22.3	DEOXYRIBONUCLEASE II BETA; DNASE2B	58511
MIM608058		2q24-q32	GLUCOSE-6-PHOSPHATASE, CATALYTIC, 2; G6PC2	57818
MIM608059		17p13.2	HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 7; HES7	84667
MIM608060		1p36.31	HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 4	57801
MIM608061		19q13.2	TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 40, YEAST, HOMOLOG OF; TOMM40	10452
MIM608062		11p13	DOUBLECORTIN DOMAIN-CONTAINING PROTEIN 1; DCDC1	341019
MIM608063	C1842614	 	BILE AND PANCREATIC DUCTS, COMPLETE ABSENCE OF	 
MIM608064		4p15.1-p13	KELCH-LIKE 5; KLHL5	51088
MIM608065		12q13	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 4; SLC38A4	55089
MIM608066		19p13.3	SCAFFOLD ATTACHMENT FACTOR B2; SAFB2	9667
MIM608067		1q24.1	RING FINGER AND WD REPEAT DOMAINS-CONTAINING PROTEIN 2; RFWD2	64326
MIM608068	C0085077	 	NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE	 
MIM608069		1p36	ERBB RECEPTOR FEEDBACK INHIBITOR 1; ERRFI1	54206
MIM608070		16q12.2-q13	HOMOCYSTEINE- AND ENDOPLASMIC RETICULUM STRESS-INDUCIBLE PROTEIN, UBIQUITIN-LIKE DOMAIN-CONTAINING, 1; HERPUD1	9709
MIM608071		10q24	F-BOX AND WD40 DOMAIN PROTEIN 4; FBXW4	6468
MIM608072		6p22.3	NHL REPEAT-CONTAINING 1 GENE; NHLRC1	378884
MIM608073		8p21.3	NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 2; NPM2	10361
MIM608074		3p22.3	PROGRAMMED CELL DEATH 6-INTERACTING PROTEIN; PDCD6IP	10015
MIM608075		12p12.3	PHOSPHOLIPASE C, ZETA-1; PLCZ1	89869
MIM608076		17p13.1	TYROSINE KINASE, NONRECEPTOR, 1; TNK1	8711
MIM608077		22q11	PURINERGIC RECEPTOR P2X-LIKE 1; P2RXL1	9127
MIM608078	C1842605	10q22.3	SCHIZOPHRENIA 11	404686
MIM608079		18q21	ELAC, E. COLI, HOMOLOG OF, 1; ELAC1	55520
MIM608080		18q21	MAESTRO; MRO	83876
MIM608081		10q11.1	SYNAPTOTAGMIN 15; SYT15	83849
MIM608082		22q11.2	YIPPEE-LIKE 1; YPEL1	29799
MIM608083		19q13.2	APOLIPOPROTEIN C-II; APOC2	344
MIM608084		7q36.1	GTPase, IMAP FAMILY, MEMBER 1; GIMAP1	170575
MIM608085		7q36.1	GTPase, IMAP FAMILY, MEMBER 2; GIMAP2	26157
MIM608086		7q36.1	GTPase, IMAP FAMILY, MEMBER 5; GIMAP5	55340
MIM608087		7q36.1	GTPase, IMAP FAMILY, MEMBER 4; GIMAP4	55303
MIM608088	C1842586	3p24-p22	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	378888
MIM608089	C0476089	16q22.1, 14q24.3, 2p16	ENDOMETRIAL CANCER	27030, 2956, 5728, 999
MIM608090		12q21.31	MLX-INTERACTING PROTEIN; MLXIP	22877
MIM608091	C1842577	11q13, 11p12-q13.3	JOUBERT SYNDROME 2; JBTS2	51259
MIM608092		4q32.3	PALLADIN, MOUSE, HOMOLOG OF; PALLD	23022
MIM608093	C1842572	11q23.3	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	1798
MIM608094		21q22.3	SOLUTE CARRIER FAMILY 37 (GLYCEROL-3-PHOSPHATE TRANSPORTER), MEMBER 1; SLC37A1	54020
MIM608095		1q21.3	SODIUM CHANNEL MODIFIER 1; SCNM1	79005
MIM608096	C1842564	12q22-q23.3	EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	619399
MIM608097	C1842563	20q13.13	HETEROTOPIA, PERIVENTRICULAR, AUTOSOMAL RECESSIVE	10564
MIM608098	C1842562	5p15.1	HETEROTOPIA, PERIVENTRICULAR, ASSOCIATED WITH CHROMOSOME 5p ANOMALIES	100302681
MIM608099	C1842550	17q12-q21.33	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D; LGMD2D	6442
MIM608100		2p15-p13	NFU1, S. CEREVISIAE, HOMOLOG OF; NFU1	27247
MIM608101		17q21.33	SPERMATID-SPECIFIC LINKER HISTONE H1-LIKE PROTEIN	373861
MIM608102		13q21.1-q32	CLN5 GENE; CLN5	1203
MIM608103		11pter-p15.5	ALG8, S. CEREVISIAE, HOMOLOG OF	79053
MIM608104	C1842539	11pter-p15.5	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	79053
MIM608105	C1842531	16p12-p11.2	EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	574044
MIM608106	C1720958	12q23-q24.1	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5; HIGM5	7374
MIM608107		16p13	FAMILIAL MEDITERRANEAN FEVER GENE; MEFV	4210
MIM608108		16q22.2-q22.3	CRANIOFACIAL DEVELOPMENT PROTEIN 1; CFDP1	10428
MIM608109		12q24.33	PSEUDOURIDINE SYNTHASE 1; PUS1	80324
MIM608110		15q14	p21 PROTEIN-ACTIVATED KINASE 6; PAK6	56924
MIM608111		2p16.1	FANCL GENE; FANCL	55120
MIM608112		3p25.3-p24.1	TRAFFICKING PROTEIN, KINESIN-BINDING 1; TRAK1	22906
MIM608113		 	SARCOGLYCAN, ZETA; SGCZ	137868
MIM608114		7p22.3	CENTAURIN, ALPHA-1; CENTA1	11033
MIM608115	C0085083	2p21-p16	OVARIAN HYPERSTIMULATION SYNDROME	2492
MIM608116		 	CHROMOSOME 3 OPEN READING FRAME 3	57467
MIM608117		 	PHOSPHODIESTERASE 4D-INTERACTING PROTEIN; PDE4DIP	9659
MIM608118	C1842486	 	ZINC IN BREAST MILK, REDUCED	 
MIM608119		 	HOMEODOMAIN LEUCINE ZIPPER-CONTAINING FACTOR	57594
MIM608120		11p15	PARVIN, ALPHA; PARVA	55742
MIM608121		22q13.31	PARVIN, BETA; PARVB	29780
MIM608122		22q13.31	PARVIN, GAMMA; PARVG	64098
MIM608123		20q13.1	ACYL-CoA THIOESTERASE 8; ACOT8	10005
MIM608124		16p13.1	XYLOSYLTRANSFERASE 1; XYLT1	64131
MIM608125		17q21.3-q22	XYLOSYLTRANSFERASE 2; XYLT2	64132
MIM608126		 	ACIDIC NUCLEOPLASMIC DNA-BINDING PROTEIN 1, XENOPUS, HOMOLOG OF	11169
MIM608127		 	PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 4; PBX4	80714
MIM608129		9q34.3	UBIQUITIN-ASSOCIATED DOMAIN-CONTAINING PROTEIN 1; UBAC1	10422
MIM608130		 	NUAK FAMILY, SNF1-LIKE KINASE, 1; NUAK1	9891
MIM608131		 	NUAK FAMILY, SNF1-LIKE KINASE, 2; NUAK2	81788
MIM608132		14q32.1	TETRATRICOPEPTIDE REPEAT DOMAIN 8; TTC8	123016
MIM608133	C1842475	6p21.1-cen	RETINITIS PIGMENTOSA 7; RP7	5961
MIM608134		 	PARALEMMIN; PALM	5064
MIM608135		9q21.3-q22	ASPORIN; ASPN	54829
MIM608136		8p23	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 10; ARHGEF10	9639
MIM608137		9q34.3	NASAL EMBRYONIC LHRH FACTOR; NELF	26012
MIM608138		15q22.31	PROGRAMMED CELL DEATH 7; PDCD7	10081
MIM608139		17p11.2	CENTROMERE PROTEIN V; CENPV	201161
MIM608140		2q32.1	NUCLEOPORIN, 35-KD; NUP35	129401
MIM608141		6q24.3	NUCLEOPORIN, 43-KD; NUP43	348995
MIM608142		22q11-q12	HSC20, E. COLI, HOMOLOG OF	150274
MIM608143		8p11.21	1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 6; AGPAT6	137964
MIM608144		6p21.3	SAM POINTED DOMAIN-CONTAINING ETS TRANSCRIPTION FACTOR; SPDEF	25803
MIM608145		15q11.1	NONIMPRINTED GENE IN PRADER-WILLI SYNDROME/ANGELMAN SYNDROME CHROMOSOME REGION 1; NIPA1	123606
MIM608146		15q11.2	NONIMPRINTED GENE IN PRADER-WILLI SYNDROME/ANGELMAN SYNDROME CHROMOSOME REGION 2; NIPA2	81614
MIM608147		15q11.2	TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 5; TUBGCP5	114791
MIM608148		2q33	SPECIAL AT-RICH SEQUENCE-BINDING PROTEIN 2; SATB2	23314
MIM608150		12q12	PERIPHILIN 1; PPHLN1	51535
MIM608151		4p14-p11	WD REPEAT-CONTAINING PROTEIN 19; WDR19	57728
MIM608152		9q34.13	PROSTAGLANDIN E SYNTHASE 2; PTGES2	80142
MIM608153		19q13.1	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14A; PPP1R14A	94274
MIM608154	C1842465	 	LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	 
MIM608155		5q33.1	SYNAPTOPODIN; SYNPO	11346
MIM608156	C1842464	 	NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	100885786
MIM608157		5q31	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ORNITHINE TRANSPORTER), MEMBER 2; SLC25A2	83884
MIM608158	C1842463	 	CoQ-RESPONSIVE OXPHOS DEFICIENCY	 
MIM608159		16p13.3	PROTEASE, SERINE, 21; PRSS21	10942
MIM608160		17q24.3-q25.1	SRY-BOX 9; SOX9	6662
MIM608161	C1842914	11q13, 6p21.1-cen	MACULAR DYSTROPHY, VITELLIFORM, ADULT-ONSET	5961, 7439
MIM608162		1p13.1	V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1; VTCN1	79679
MIM608163		17q25.1	EXOCYST COMPLEX COMPONENT 7; EXOC7	23265
MIM608164		8q22.3-q24.1	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY V, MEMBER 1; KCNV1	27012
MIM608165		2q32.2-q33	PTB DOMAIN-CONTAINING ENGULFMENT ADAPTOR PROTEIN 1; GULP1	51454
MIM608166		7q21.11	SEMAPHORIN 3E; SEMA3E	9723
MIM608167		9q34.3	POTASSIUM CHANNEL, SUBFAMILY T, MEMBER 1; KCNT1	57582
MIM608168		 	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 6; KCNH6	81033
MIM608169		2q24.2	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 7; KCNH7	90134
MIM608170		5q35.3	DEAD/H BOX 41; DDX41	51428
MIM608171		12p13.3	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 4; CACNA2D4	93589
MIM608172		1p35	DEHYDRODOLICHYL DIPHOSPHATE SYNTHASE; DHDDS	79947
MIM608173	C1842446	6p11	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 1	387578
MIM608174	C1842445	5q31-q33	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 2	387579
MIM608175	C1842444	8q24.2-q24.3, 8q23-q24	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3	57623, 7038
MIM608176	C1842443	10q	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 4	387581
MIM608177		8q24.11-q24.13	EXOSTOSIN 1; EXT1	2131
MIM608178		11p14-p13	LEUCINE ZIPPER PROTEIN 2; LUZP2	338645
MIM608179		19p13.3	CAYTAXIN	85300
MIM608180	C1842422	22q13.3	SYNPOLYDACTYLY 2; SPD2	2192
MIM608181		15q21-q22	ACIDIC CLUSTER PROTEIN, 33-KD	51324
MIM608182		4p15.3	POTASSIUM CHANNEL-INTERACTING PROTEIN 4	80333
MIM608183		15q26.3	CHONDROITIN SULFATE SYNTHASE 1; CHSY1	22856
MIM608184	C1842413	 	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 4; HIGM4	 
MIM608185		7q31	EXOCYST COMPLEX COMPONENT 4; EXOC4	60412
MIM608186		 	EXOCYST COMPLEX COMPONENT 3; EXOC3	11336
MIM608187		20p13-p12.3	MINICHROMOSOME MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, 8; MCM8	84515
MIM608188		20p13-p12.3	CARDIOLIPIN SYNTHASE 1; CRLS1	54675
MIM608189	C1842402	5q32	TROPICAL CALCIFIC PANCREATITIS	6690
MIM608190		 	N-ACETYLTRANSFERASE 8B; NAT8B	51471
MIM608191		 	RB-ASSOCIATED KRAB REPRESSOR	57786
MIM608192		1q23.3	PROTEIN ASSOCIATED WITH THE C-TERMINAL DOMAIN OF EZRIN	57147
MIM608193		14q11.2-q12	REC8, S. POMBE, HOMOLOG OF; REC8L1	9985
MIM608194	C2750720	14q11	CONE-ROD DYSTROPHY 13; CORD13	57096
MIM608195		6p12.3-p12.2	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 1; LRRC1	55227
MIM608196		6p25.2	WERNER HELICASE-INTERACTING PROTEIN 1; WRNIP1	56897
MIM608197		1q21	PEPTIDOGLYCAN RECOGNITION PROTEIN 3; PGLYRP3	114771
MIM608198		1q21	PEPTIDOGLYCAN RECOGNITION PROTEIN 4; PGLYRP4	57115
MIM608199		19p13.12	PEPTIDOGLYCAN RECOGNITION PROTEIN 2; PGLYRP2	114770
MIM608200		20q11.2	CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1; CDK5RAP1	51654
MIM608201		9q33.3	CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 2; CDK5RAP2	55755
MIM608202		17q21.31	CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 3; CDK5RAP3	80279
MIM608203	C1842398	22q12.3-q13.2	NEUTROPHIL IMMUNODEFICIENCY SYNDROME	5880
MIM608204		11q13	UNC93, C. ELEGANS, HOMOLOG OF, B1; UNC93B1	81622
MIM608205		1p36.1-p22.3	MITOCHONDRIAL TRANS-2-ENOYL-CoA REDUCTASE; MECR	51102
MIM608206		5q32	SH3 DOMAIN AND TETRATRICOPEPTIDE REPEAT DOMAIN 2; SH3TC2	79628
MIM608207	C1969520	22q12	KALA-AZAR, SUSCEPTIBILITY TO, 1; KAZA1	387582
MIM608208		2q35	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 4; MARCH4	57574
MIM608209		2q12.3-q14.2	DIPEPTIDYL PEPTIDASE X; DPP10	57628
MIM608210		11p12-p11	EXOSTOSIN 2; EXT2	2132
MIM608211		6p22.1	KIDNEY-ASSOCIATED ANTIGEN 1; KAAG1	353219
MIM608212		5q33.1	IMMUNITY-RELATED GTPase FAMILY, M; IRGM	345611
MIM608213		11p15.5	CELL CYCLE EXIT AND NEURONAL DIFFERENTIATION 1; CEND1	51286
MIM608214		11q23.3	SODIUM CHANNEL, VOLTAGE-GATED, TYPE III, BETA SUBUNIT; SCN3B	55800
MIM608215		 	LIM HOMEOBOX GENE 6; LHX6	26468
MIM608216		8q24.3	COMM DOMAIN-CONTAINING PROTEIN 5; COMMD5	28991
MIM608217	C1842382	 	SEIZURES, BENIGN FAMILIAL NEONATAL, 3; BFNS3	 
MIM608218		17q12-q21	KERATIN 20; KRT20	54474
MIM608219	C1842381	6q26-q27	DEAFNESS, AUTOSOMAL RECESSIVE 38; DFNB38	337991
MIM608220	C2936860	6q23-q24.1	SPASTIC PARAPLEGIA 25, AUTOSOMAL RECESSIVE; SPG25	387583
MIM608221		10p12.1	MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE-LIKE; MASTL	84930
MIM608222		22q13.1	ADENYLOSUCCINATE LYASE; ADSL	158
MIM608223	C1842372	 	ASPIRIN RESISTANCE	 
MIM608224	C1842371	12q24.32-qter	DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	94142
MIM608225		2p23.2	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 14; GALNT14	79623
MIM608226		10q26.11	NANOS, DROSOPHILA, HOMOLOG OF, 1; NANOS1	340719
MIM608227	C1842363	 	CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRAL NEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	 
MIM608228		 	NANOS, DROSOPHILA, HOMOLOG OF, 2	339345
MIM608229		 	NANOS, DROSOPHILA, HOMOLOG OF, 3	342977
MIM608230		22q13.1	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1I SUBUNIT; CACNA1I	8911
MIM608231		 	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 8; RASSF8	11228
MIM608232	C0023473	22q11.21	LEUKEMIA, CHRONIC MYELOID; CML	613
MIM608233	C1842362	5q14.1	HERMANSKY-PUDLAK SYNDROME 2; HPS2	8546
MIM608234		11q13	GALACTOSE-3-O-SULFOTRANSFERASE 3; GAL3ST3	89792
MIM608235		7q22	GALACTOSE-3-O-SULFOTRANSFERASE 4; GAL3ST4	79690
MIM608236	C1842357	8p23	SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT	9639
MIM608237		2q37.3	GALACTOSE-3-O-SULFOTRANSFERASE 2; GAL3ST2	64090
MIM608238		15q15.3	SIGNAL PEPTIDE PEPTIDASE-LIKE 2A	84888
MIM608239		19p13.3	SIGNAL PEPTIDE PEPTIDASE-LIKE 2B	56928
MIM608240		12q24.31	SIGNAL PEPTIDE PEPTIDASE-LIKE 3	121665
MIM608241		1p32.3-p32.2	SMAD NUCLEAR INTERACTING PROTEIN 1; SNIP1	79753
MIM608242		4q22.2-q22.3	HECT DOMAIN AND RCC1-LIKE DOMAIN 5; HERC5	51191
MIM608243		15q13.1	NECDIN-LIKE GENE 2; NDNL2	56160
MIM608244	C1842353	6p22.3-p21.3	OTOSCLEROSIS 3; OTSC3	170532
MIM608245		12q13	KERATIN 71; KRT71	112802
MIM608246		12q13	KERATIN 72; KRT72	140807
MIM608247		12q13	KERATIN 73; KRT73	319101
MIM608248		12q13	KERATIN 74; KRT74	121391
MIM608249		14q11.1	CYCLIN B1 INTERACTING PROTEIN 1; CCNB1IP1	57820
MIM608250		 	SDS3, YEAST, HOMOLOG OF	64426
MIM608251	C0236801	Chr.14	PHOBIA, SPECIFIC	404684
MIM608252		 	ACTIN FILAMENT-ASSOCIATED PROTEIN 1; AFAP1	60312
MIM608253		 	TESTIS-SPECIFIC KINASE SUBSTRATE	60385
MIM608254		7q36	PAX TRANSCRIPTION ACTIVATION DOMAIN-INTERACTING PROTEIN 1; PAXIP1	22976
MIM608255		 	TRAF3-INTERACTING PROTEIN 3; TRAF3IP3	80342
MIM608256		11q23	SODIUM CHANNEL, VOLTAGE-GATED, TYPE IV, BETA SUBUNIT; SCN4B	6330
MIM608257	C1842349	 	MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	 
MIM608258		 	DIPEPTIDYL PEPTIDASE IX; DPP9	91039
MIM608259		7p15	INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 3; IGF2BP3	10643
MIM608260		 	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 8; KCNH8	131096
MIM608261		3q27	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 2; SENP2	59343
MIM608262		 	DISRUPTED IN RENAL CARCINOMA 3; DIRC3	729582
MIM608263		 	HEAT-SHOCK 27-KD PROTEIN-ASSOCIATED PROTEIN 1; HSPBAP1	79663
MIM608264	C1842345	22q11.21-q12.1	DEAFNESS, AUTOSOMAL RECESSIVE 40; DFNB40	379003
MIM608265	C1842342	7q21.1	DEAFNESS, AUTOSOMAL RECESSIVE 39; DFNB39	3082
MIM608266	C0687150	1q25-q31	PARATHYROID CARCINOMA	79577
MIM608267		1p34	RAS-RELATED GTP-BINDING PROTEIN C; RRAGC	64121
MIM608268		6q15-q16	RAS-RELATED GTP-BINDING PROTEIN D; RRAGD	58528
MIM608269		9q22.2	SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER), MEMBER 3; SLC28A3	64078
MIM608270		20p12.1	THREONINE ASPARTASE 1; TASP1	55617
MIM608271		1p32-p31	MICROTUBULE-ACTIN CROSS-LINKING FACTOR 1; MACF1	23499
MIM608272		6p21.3	NEURAMINIDASE 1; NEU1	4758
MIM608273		16p11	INTERLEUKIN 27; IL27	246778
MIM608274		1p13.3	PROTEIN ARGININE N-METHYLTRANSFERASE 6; PRMT6	55170
MIM608275		1p13.1	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 15; SLC22A15	55356
MIM608276		6q21	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 16; SLC22A16	85413
MIM608277		10q26	CARBOHYDRATE SULFOTRANSFERASE 15; CHST15	51363
MIM608278	C1842321	 	GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGE JOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLAR ATROPHY	 
MIM608279	C1842316	 	CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	 
MIM608280		1q23.3	GROWTH ARREST-SPECIFIC 5; GAS5	60674
MIM608281	C1842315	 	SCIMITAR ANOMALY, MULTIPLE CARDIAC MALFORMATIONS, AND CRANIOFACIAL AND CENTRAL NERVOUS SYSTEM ABNORMALITIES	 
MIM608282		6q23.2	TRACE AMINE-ASSOCIATED RECEPTOR 9; TAAR9	134860
MIM608283		12q12	KINESIN FAMILY MEMBER 21A; KIF21A	55605
MIM608284		17q21.31	INTRAMEMBRANE PROTEASE 5	162540
MIM608285		11q13.2	NAD SYNTHETASE 1; NADSYN1	55191
MIM608286		4q28.3	PROTOCADHERIN 10; PCDH10	57575
MIM608287		4q31	PROTOCADHERIN 18; PCDH18	54510
MIM608288		17q21.3	INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 1; IGF2BP1	10642
MIM608289		3q28	INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 2; IGF2BP2	10644
MIM608290	C1842307	 	LELIS SYNDROME	 
MIM608291		2q13	TUBULIN-TYROSINE LIGASE; TTL	150465
MIM608292		9p13.1	STOMATIN-LIKE PROTEIN 2; STOML2	30968
MIM608293		16p12.2	RHO GTPase-ACTIVATING PROTEIN 17; ARHGAP17	55114
MIM608294		3p21.3	NONMETASTATIC CELLS 6, PROTEIN EXPRESSED IN; NME6	10201
MIM608295		3p21.1	FAMILY WITH SEQUENCE SIMILARITY 107, MEMBER A; FAM107A	11170
MIM608296		11q13.1	FIBROBLAST GROWTH FACTOR, ACIDIC, INTRACELLULAR BINDING PROTEIN; FIBP	9158
MIM608298		3q13.2	URB, MOUSE, HOMOLOG OF	151887
MIM608299		12q23-q24.1	RING FINGER PROTEIN 34; RNF34	80196
MIM608300		17q21.31	N-ACETYLGLUTAMATE SYNTHASE; NAGS	162417
MIM608301		4p15.2	LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 2; LGI2	55203
MIM608302		8p21.3	LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 3; LGI3	203190
MIM608303		19q13.11	LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 4; LGI4	163175
MIM608304		6p25.3-p24.1	CANCER/TESTIS ANTIGEN 3; CTAG3	285782
MIM608305		17p13-p12	SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT CITRATE TRANSPORTER), MEMBER 5; SLC13A5	284111
MIM608306		7p21	TRANSCRIPTION FACTOR Sp8; SP8	221833
MIM608307		2q35	CARBAMOYL PHOSPHATE SYNTHETASE I; CPS1	1373
MIM608308		3q21	ANKYRIN REPEAT AND BTB/POZ DOMAIN CONTAINING 1; ABTB1	80325
MIM608309		1p36	PTEN-INDUCED PUTATIVE KINASE 1; PINK1	65018
MIM608310		7cen-q11.2	ARGININOSUCCINATE LYASE; ASL	435
MIM608311		4q12	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL D-ASPARTATE-LIKE 1B; GRINL1B	339970
MIM608312		7p21	TWIST NEIGHBOR; TWISTNB	221830
MIM608313		6q23	ARGINASE, LIVER; ARG1	383
MIM608314		22q13.2	SEPTIN 3; SEPT3	55964
MIM608315		3p25.1	ELL-ASSOCIATED FACTOR 1; EAF1	85403
MIM608316	C1842260	2q21.1-q22	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 2	387584
MIM608317		1p36.11	GRAINYHEAD-LIKE 3; GRHL3	57822
MIM608318	C1842258	14q32	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 4	387585
MIM608320	C1842247	15q26	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	4205
MIM608321		5q23.1	TIR DOMAIN-CONTAINING ADAPTOR MOLECULE 2; TICAM2	353376
MIM608322		1q31-q32	KINESIN FAMILY MEMBER 21B; KIF21B	23046
MIM608323	C1842237	1p35	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	8565
MIM608324		5q32	NGF-INDUCED DIFFERENTIATION CLONE 67	85027
MIM608325		11p11.2	PHD FINGER PROTEIN 21A; PHF21A	51317
MIM608326		15q22	STOMATIN-LIKE PROTEIN 1; STOML1	9399
MIM608327		13q13	STOMATIN-LIKE PROTEIN 3; STOML3	161003
MIM608328	C1869115	15q21.1	WEILL-MARCHESANI SYNDROME 2; WMS2	2200
MIM608329		11q12-q13.1	CHROMOSOME 11 OPEN READING FRAME 9; C11ORF9	745
MIM608330		11q12.2	PRECURSOR mRNA-PROCESSING FACTOR 19, S. CEREVISIAE, HOMOLOG OF; PRPF19	27339
MIM608331		5q33.1	SOLUTE CARRIER FAMILY 36 (PROTON/AMINO ACID SYMPORTER), MEMBER 2; SLC36A2	153201
MIM608332		 	SOLUTE CARRIER FAMILY 36 (PROTON/AMINO ACID SYMPORTER), MEMBER 3; SLC36A3	285641
MIM608333		16q13	DOCKING PROTEIN 4; DOK4	55715
MIM608334		20q13.2	DOCKING PROTEIN 5; DOK5	55816
MIM608335		 	CASEIN KINASE II-INTERACTING PROTEIN 1	51177
MIM608336		 	TRANSMEMBRANE DOMAIN PROTEIN REGULATED IN ADIPOCYTES, 40-KD	131601
MIM608337		11q13.1	OTU DOMAIN-CONTAINING UBIQUITIN ALDEHYDE-BINDING PROTEIN 1; OTUB1	55611
MIM608338		14q32.12	OTU DOMAIN-CONTAINING UBIQUITIN ALDEHYDE-BINDING PROTEIN 2; OTUB2	78990
MIM608339		 	SYNTAXIN-BINDING PROTEIN 3; STXBP3	6814
MIM608340	C1842197	8q13-q21.1	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA	54332
MIM608341		1q32	CYTOCHROME b5 REDUCTASE 1; CYB5R1	51706
MIM608342		11p15.4	CYTOCHROME b5 REDUCTASE 2; CYB5R2	51700
MIM608343		6q14-q15	CYTOCHROME b5 REDUCTASE 4; CYB5R4	51167
MIM608344		 	HEAT-SHOCK 27-KD PROTEIN 9	94086
MIM608345	C1842186	7p11.2	NYSTAGMUS 3, CONGENITAL, AUTOSOMAL DOMINANT; NYS3	4934
MIM608347		17q25.3	DICARBONYL/L-XYLULOSE REDUCTASE; DCXR	51181
MIM608348		19q13.1-q13.2	BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, ALPHA POLYPEPTIDE; BCKDHA	593
MIM608349		 	HEMATOPOIETIC SH2 DOMAIN-CONTAINING PROTEIN	84941
MIM608350		 	ENDOMUCIN; EMCN	51705
MIM608351		 	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 11; IGSF11	152404
MIM608352		 	ACROSIN-BINDING PROTEIN; ACRBP	84519
MIM608353		 	ANTIZYME INHIBITOR 2	113451
MIM608354	C1842180	5q13.3	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION	5921
MIM608355	CN074207	5q13.3	PARKES WEBER SYNDROME	5921
MIM608356		11p15.5	OUTER DENSE FIBER OF SPERM TAILS 3; ODF3	113746
MIM608357		2q11.2	SULFOTRANSFERASE FAMILY 1C, MEMBER 2; SULT1C2	27233
MIM608358	C1842160	14q12	MYOPATHY, MYOSIN STORAGE	4625
MIM608359		22q13.2-q13.31	SULFOTRANSFERASE FAMILY 4A, MEMBER 1; SULT4A1	25830
MIM608360		9q34.13	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8A; LRRC8A	56262
MIM608361	C1842149	15q26.1	SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE	176
MIM608362		20q13.3	STATHMIN-LIKE 3; STMN3	50861
MIM608363	C2675369	22q11.2	CHROMOSOME 22q11.2 DUPLICATION SYNDROME	100240738
MIM608364		12q13	LIM DOMAIN AND ACTIN-BINDING PROTEIN 1; LIMA1	51474
MIM608365		21q22.1	T-COMPLEX PROTEIN 10-LIKE; TCP10L	140290
MIM608366		15q24	KIAA1199 GENE	57214
MIM608367	CN031794	7p15	MYOPIA 17, AUTOSOMAL DOMINANT; MYP17	100359401
MIM608368		12q24	RAD9, S. POMBE, HOMOLOG OF, B; RAD9B	144715
MIM608369		2q24.1	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 13; GALNT13	114805
MIM608370		4q21.1	STEAROYL-CoA DESATURASE 5; SCD5	79966
MIM608371	C1842143	4q21-q31	OROFACIAL CLEFT 4; OFC4	474387
MIM608372	C1842136	1q21-q23	DEAFNESS, AUTOSOMAL DOMINANT 49; DFNA49	317664
MIM608373		19q13.3	SYNAPTOGYRIN 4; SYNGR4	23546
MIM608374		1q21	HEMOJUVELIN	148738
MIM608375		1p32.1-p31.3	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 6; DNAJC6	9829
MIM608376		10q22.2	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 12; DNAJB12	54788
MIM608377		20q13.33	ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 1; ARFGAP1	55738
MIM608378		14q22	SEROLOGICALLY DEFINED COLON CANCER ANTIGEN 1; SDCCAG1	9147
MIM608379		3p21	CHEMOKINE, CC MOTIF, RECEPTOR-LIKE PROTEIN 2; CCRL2	9034
MIM608380	C1842127	2q31.2-q32.3	RETINITIS PIGMENTOSA 26; RP26	375298
MIM608381		2q31.2-q32.3	CERAMIDE KINASE-LIKE; CERKL	375298
MIM608382		16p13.3	DNAJ/HSP40 HOMOLOG, SUBFAMILY A, MEMBER 3; DNAJA3	9093
MIM608383		2p23.3	DIHYDROPYRIMIDINASE-LIKE 5; DPYSL5	56896
MIM608384		8q24.1-q24.2	GASDERMIN C; GSDMC	56169
MIM608385		17q12-q21	TENSIN 4; TNS4	84951
MIM608386		19q13.33	TUBEROINFUNDIBULAR PEPTIDE OF 39 AMINO ACIDS	113091
MIM608387		16p13.3	ZINC FINGER PROTEIN 213; ZNF213	7760
MIM608388		19p13.2	EVOLUTIONARILY-CONSERVED SIGNALING INTERMEDIATE IN TOLL PATHWAY; ECSIT	51295
MIM608389	C1842124	14q23	BRANCHIOOTIC SYNDROME 3; BOS3	6495
MIM608390	C0752355	17q23.1-q25.3	MYOTONIA, POTASSIUM-AGGRAVATED	6329
MIM608391	C1842113	Chr.7	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 2; AIS2	378426
MIM608392	C1842112	Chr.8	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 3; AIS3	378427
MIM608393	C1842109	13q12.2	MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE; MCPH6	55835
MIM608394	C1842108	2p12	DEAFNESS, AUTOSOMAL DOMINANT 43; DFNA43	192676
MIM608396		3q24	SOLUTE CARRIER FAMILY 9 (SODIUM/HYDROGEN EXCHANGER), MEMBER 9; SLC9A9	285195
MIM608397		8p23	CUB AND SUSHI MULTIPLE DOMAINS 1; CSMD1	64478
MIM608398		1p35.3	CUB AND SUSHI MULTIPLE DOMAINS 2; CSMD2	114784
MIM608399		8q23.3	CUB AND SUSHI MULTIPLE DOMAINS 3; CSMD3	114788
MIM608400		1q41	USH2A GENE; USH2A	7399
MIM608401		11q12-q13.1	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 4E; MS4A4E	643680
MIM608402		11q12-q13.1	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 6E; MS4A6E	245802
MIM608403		11q12-q13.1	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 10; MS4A10	341116
MIM608404	C1842090	7q11.2	PLATELET GLYCOPROTEIN IV DEFICIENCY	948
MIM608405		11p11	1-@AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE; ACCS	84680
MIM608406	C1842082	 	VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	 
MIM608407		10q25.2-q26	DIHYDROPYRIMIDINASE-LIKE 4; DPYSL4	10570
MIM608408		12p13.31	DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 3; DPPA3	359787
MIM608409		15q21.1	NORMAL MUCOSA OF ESOPHAGUS-SPECIFIC GENE 1	84419
MIM608410	C2675358	4p15-p14	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 7; BMIQ7	404683
MIM608411		16p12.1	EXPORTIN 6; XPO6	23214
MIM608412		5q11.2	GC-RICH PROMOTER-BINDING PROTEIN 1; GPBP1	65056
MIM608413		8q22.3	E3 UBIQUITIN PROTEIN LIGASE, HECT DOMAIN-CONTAINING, 1; EDD1	51366
MIM608414		10q23	PHOSPHOLIPASE C, EPSILON-1; PLCE1	51196
MIM608415	C1842073	19q13.11, 17q23-q24	PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION; PERRS	388531, 8787
MIM608416		 	MATRIX METALLOPROTEINASE 21; MMP21	118856
MIM608417		 	MATRIX METALLOPROTEINASE 28; MMP28	79148
MIM608418		5q31-q33	SEPTIN 8; SEPT8	23176
MIM608419		2p13.3	METHYLMALONYL-CoA EPIMERASE; MCEE	84693
MIM608420		 	PANNEXIN 1; PANX1	24145
MIM608421		 	PANNEXIN 2; PANX2	56666
MIM608422		 	PANNEXIN 3; PANX3	116337
MIM608423	C1842062	7q32.1-q32.2	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1F; LGMD1F	404679
MIM608424		7q22	MUCIN 17; MUC17	140453
MIM608425		 	FRUCTOSAMINE 3-KINASE	64122
MIM608426		3p25	MAKORIN 2; MKRN2	23609
MIM608427		6q25-q27	PARKIN COREGULATED GENE; PACRG	135138
MIM608428		10q23.3	CYTOCHROME P450, SUBFAMILY XXVIC, POLYPEPTIDE 1; CYP26C1	340665
MIM608429		15q14	CARBOHYDRATE SULFOTRANSFERASE 14; CHST14	113189
MIM608430		20q11.23	TRPC4-ASSOCIATED PROTEIN; TRPC4AP	26133
MIM608431		5q33.1	GTPase-ACTIVATING PROTEIN SH3 DOMAIN-BINDING PROTEIN 1; G3BP1	10146
MIM608432	C1842058	 	CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	 
MIM608433		1q44	ZINC FINGER PROTEIN 238; ZNF238	10472
MIM608434		17p11.2	G PROTEIN-COUPLED RECEPTOR KINASE-INTERACTING PROTEIN 1; GIT1	28964
MIM608435		3q22.3	MUSCLE RAS VIRAL ONCOGENE HOMOLOG; MRAS	22808
MIM608436		 	SULFOTRANSFERASE FAMILY 1B, MEMBER 1; SULT1B1	27284
MIM608437	C1842057	12q24	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 4; SLEB4	404714
MIM608438		 	TOUSLED-LIKE KINASE 1; TLK1	9874
MIM608439		 	TOUSLED-LIKE KINASE 2; TLK2	11011
MIM608440		15q22.1	LACTAMASE, BETA; LACTB	114294
MIM608441		6q25	SYNAPTIC NUCLEAR ENVELOPE PROTEIN 1; SYNE1	23345
MIM608442		14q23	SYNAPTIC NUCLEAR ENVELOPE PROTEIN 2; SYNE2	23224
MIM608443	C1838023	19p13.12	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	54862
MIM608444		7q22	MYELOID/LYMPHOID OR MIXED-LINEAGE LEUKEMIA 5; MLL5	55904
MIM608445	C1838022	3p12-q13	SPEECH-SOUND DISORDER	404713
MIM608446	C1838021	1q25, 6q25.1, 6p12, 1p34	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO	2099, 2155, 2162, 2729, 2730, 3690, 3957, 4049, 440823, 4973, 5687, 7056, 7292, 7804
MIM608447	C1838020	12q24	CAROTID INTIMAL MEDIAL THICKNESS 2	404677
MIM608448	C1838019	3p26	INFLAMMATORY BOWEL DISEASE 9; IBD9	317669
MIM608449		1p21	POLYPYRIMIDINE TRACT-BINDING PROTEIN 2; PTBP2	58155
MIM608450		7q36	B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA-EXPRESSED GENE; BLACE	338436
MIM608451		19q13.32	ETHE1 GENE; ETHE1	23474
MIM608452		4q32	PLATELET-DERIVED GROWTH FACTOR C; PDGFC	56034
MIM608453		19q13.2	CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE C; CBLC	23624
MIM608454		 	KNOBLOCH SYNDROME 2; KNO2	170692
MIM608455		11q13	GLYCOGEN PHOSPHORYLASE, MUSCLE; PYGM	5837
MIM608456	C1837991	1p34.3-p32.1	FAMILIAL ADENOMATOUS POLYPOSIS, 2; FAP2	4595
MIM608457		22q13.1	CHROMOBOX HOMOLOG 7; CBX7	23492
MIM608458		1p34.3	NEUROCHONDRIN; NCDN	23154
MIM608459		5q31	CYCLIN-DEPENDENT KINASE-LIKE 3; CDKL3	51265
MIM608460		16q24.3	ZINC FINGER PROTEIN 276; ZFP276	92822
MIM608461		9q32	COLLAGEN, TYPE XXVII, ALPHA-1; COL27A1	85301
MIM608462	C1969482	16q23	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 8; HSCR8	404719
MIM608463		17q11.2-q12	APOPTOSIS-ANTAGONIZING TRANSCRIPTION FACTOR; AATF	26574
MIM608464		5q13.3	ANGIOGENIC FACTOR WITH G-PATCH AND FHA DOMAINS 1; AGGF1	55109
MIM608465		9q34	SENATAXIN; SETX	23064
MIM608466		 	ACTIVATOR OF HEAT-SHOCK 90-KD PROTEIN ATPase 1; AHSA1	10598
MIM608467		 	STONIN 2; STON2	85439
MIM608468		4q31.1	CARBON CATABOLITE REPRESSION 4-LIKE; CCRN4L	25819
MIM608469		22q13.1	DEAD/H BOX 17; DDX17	10521
MIM608470	C0339278	5q31	CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE I; CDB1	7045
MIM608471	C1837974	5q31	CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A	7045
MIM608472		2q11.2-q12.1	ST6 BETA-GALACTOSAMIDE ALPHA-2,6-SIALYLTRANSFERASE 2; ST6GAL2	84620
MIM608473		 	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 1; ANAPC1	64682
MIM608474	C1837972	17q21-q22	MYOPIA 5, AUTOSOMAL DOMINANT; MYP5	404682
MIM608475		 	3-@HYDROXYISOBUTYRATE DEHYDROGENASE; HIBADH	11112
MIM608476		 	TBK1-BINDING PROTEIN 1; TBKBP1	9755
MIM608477		 	ALDO-KETO REDUCTASE FAMILY 7, MEMBER A3; AKR7A3	22977
MIM608478		 	ALDO-KETO REDUCTASE FAMILY 7, MEMBER A4	246181
MIM608479		 	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 7; SLC26A7	115111
MIM608480		 	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 8; SLC26A8	116369
MIM608481		 	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 9; SLC26A9	115019
MIM608482		 	MATRIX METALLOPROTEINASE 25; MMP25	64386
MIM608483		16q12.2	AKT-INTERACTING PROTEIN; AKTIP	64400
MIM608484	C1837970	 	CONGENITAL CORNEAL OPACITIES, CORNEA GUTTATA, AND CORECTOPIA	 
MIM608485		 	TRANSLOCATION-ASSOCIATED MEMBRANE PROTEIN 2; TRAM2	9697
MIM608486		8q24.1	METASTASIS SUPPRESSOR 1; MTSS1	9788
MIM608487		11p15	TRIPARTITE MOTIF-CONTAINING PROTEIN 5; TRIM5	85363
MIM608488		14q24.1	SPARC-RELATED MODULAR CALCIUM-BINDING 1; SMOC1	64093
MIM608489		7q22	STROMALIN 3; STAG3	10734
MIM608490		12q13.11	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 1; SLC38A1	81539
MIM608491		 	CYCLIN D-BINDING MYB-LIKE TRANSCRIPTION FACTOR 1; DMTF1	9988
MIM608492		 	OLFACTORY RECEPTOR, FAMILY 5, SUBFAMILY F, MEMBER 1; OR5F1	338674
MIM608493		 	OLFACTORY RECEPTOR, FAMILY 10, SUBFAMILY A, MEMBER 1; OR10A1	144124
MIM608494		 	OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY D, MEMBER 2; OR2D2	120776
MIM608495		 	OLFACTORY RECEPTOR, FAMILY 6, SUBFAMILY A, MEMBER 1; OR6A1	8590
MIM608496		 	OLFACTORY RECEPTOR, FAMILY 5, SUBFAMILY I, MEMBER 1; OR5I1	10798
MIM608497		 	OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY F, MEMBER 1; OR2F1	26211
MIM608498		 	ZONA PELLUCIDA-BINDING PROTEIN; ZPBP	11055
MIM608499		17q12-q21	ZONA PELLUCIDA-BINDING PROTEIN 2; ZPBP2	124626
MIM608500		12q12	PRICKLE-LIKE 1; PRICKLE1	144165
MIM608501		 	PRICKLE-LIKE 2; PRICKLE2	166336
MIM608502		21q22.3	POLY(rC)-BINDING PROTEIN 3; PCBP3	54039
MIM608503		 	POLY(rC)-BINDING PROTEIN 4; PCBP4	57060
MIM608504		17p13.1	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 15; ARHGEF15	22899
MIM608506		 	MITOFUSIN 1; MFN1	55669
MIM608507		1p36.2	MITOFUSIN 2; MFN2	9927
MIM608508		16q24	CYTOCHROME b(-245), ALPHA SUBUNIT; CYBA	1535
MIM608509	C1837946	 	ALOPECIA UNIVERSALIS CONGENITA, XY GONADAL DYSGENESIS, AND LARYNGOMALACIA	 
MIM608510		1q22	SH2 DOMAIN-CONTAINING 1B; SH2D1B	117157
MIM608511		 	PHYTANOYL-CoA HYDROXYLASE-INTERACTING PROTEIN; PHYHIP	9796
MIM608512		7q11.23	NEUTROPHIL CYTOSOLIC FACTOR 1; NCF1	653361
MIM608513		 	RIBONUCLEASE P, RNA COMPONENT H1; RPPH1	85495
MIM608514		 	ANDROGEN-INDUCED GENE 1; AIG1	51390
MIM608515		1q25	NEUTROPHIL CYTOSOLIC FACTOR 2; NCF2	4688
MIM608516	C1269683	15q25.3-q26.2, 13q14-q21, 12q22-q23.2, 12q21.1, 8p21.1, 6p21.3-p21.2	MAJOR DEPRESSIVE DISORDER; MDD	121278, 2289, 3356
MIM608517		 	MYOPALLADIN; MYPN	84665
MIM608518	C0796100	 	OROFACIODIGITAL SYNDROME VII; OFD7	 
MIM608519		 	F-BOX ONLY PROTEIN 16; FBXO16	157574
MIM608520	C1837929	12q22-q23.2	MAJOR DEPRESSIVE DISORDER 1	431708
MIM608521		1p13.2	HEPATITIS B VIRUS X PROTEIN-INTERACTING PROTEIN; HBXIP	10542
MIM608522		11q13	HEPATITIS B VIRUS X-ASSOCIATED PROTEIN; HBXAP	51773
MIM608523		14q32	DIO3, OPPOSITE STRAND; DIO3OS	64150
MIM608524		12p13.31	INHIBITOR OF GROWTH 4; ING4	51147
MIM608525		2q37.3	INHIBITOR OF GROWTH 5; ING5	84289
MIM608526	C1969478	1q25	PERIODONTITIS, AGGRESSIVE, 2	406237
MIM608527		 	NEURAMINIDASE 4; NEU4	129807
MIM608528		20q11.22	CELL DIVISION CYCLE 91, S. CEREVISIAE, HOMOLOG-LIKE 1; CDC91L1	128869
MIM608529		 	FIBRILLIN 3; FBN3	84467
MIM608530		 	BTB/POZ DOMAIN-CONTAINING PROTEIN 1; BTBD1	53339
MIM608531		 	BTB/POZ DOMAIN-CONTAINING PROTEIN 2; BTBD2	55643
MIM608532		 	NON-SMC CONDENSIN II COMPLEX SUBUNIT G2; NCAPG2	54892
MIM608533		5q33.1	F-BOX ONLY PROTEIN 38; FBXO38	81545
MIM608534		 	ACTIN-RELATED PROTEIN M1	84517
MIM608535		1p36.32	ACTIN-RELATED PROTEIN T2; ACTRT2	140625
MIM608536		 	GTP-BINDING PROTEIN 3; GTPBP3	84705
MIM608537		3p26-p25	VHL GENE; VHL	7428
MIM608538		10q21.2	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 5B; ARID5B	84159
MIM608539		16p13.3	GLIS FAMILY ZINC FINGER PROTEIN 2; GLIS2	84662
MIM608540	C1837896	16p13.3	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	56052
MIM608541		 	RHO GTPase INVOLVED IN BETA-CATENIN, N-CADHERIN, AND NMDA RECEPTOR SIGNALING	9743
MIM608542	C1837894	19q13	ANEURYSM, INTRACRANIAL BERRY, 2; ANIB2	449013
MIM608543	C1837893	1p36.2	SCHIZOPHRENIA 12	619488
MIM608544		 	HISTONE DEACETYLASE 10; HDAC10	83933
MIM608545	C1837884	6p25	LARSEN-LIKE SYNDROME	406214
MIM608546		 	DEAD/H BOX 48; DDX48	9775
MIM608547		16p11.2	VITAMIN K EPOXIDE REDUCTASE COMPLEX, SUBUNIT 1; VKORC1	79001
MIM608548		1q24-q25	HEMICENTIN; HMCN1	83872
MIM608549		 	VACUOLAR PROTEIN SORTING 11, YEAST, HOMOLOG OF; VPS11	55823
MIM608550		 	VACUOLAR PROTEIN SORTING 16, YEAST, HOMOLOG OF; VPS16	64601
MIM608551		 	VACUOLAR PROTEIN SORTING 18, YEAST, HOMOLOG OF; VPS18	57617
MIM608552		15q26.1	VACUOLAR PROTEIN SORTING 33, YEAST, HOMOLOG OF, B; VPS33B	26276
MIM608553	C1837873	1p36	LEBER CONGENITAL AMAUROSIS 9; LCA9	619483, 64802
MIM608554		11q13	NEURONAL PAS DOMAIN PROTEIN 4; NPAS4	266743
MIM608555		 	METAXIN 2; MTX2	10651
MIM608556	C1837872	1q41-q42	LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO	7100
MIM608557	C1837871	13q12	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 2	100233226
MIM608558	C1837870	16p13	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 5; BMIQ5	449016
MIM608559	C1837869	20pter-p11.2	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 6; BMIQ6	449017
MIM608560		 	STABILIN 1; STAB1	23166
MIM608561		 	STABILIN 2; STAB2	55576
MIM608562	C1837868	7q22	POLYDACTYLY, POSTAXIAL, TYPE A4	450096
MIM608564		 	G PROTEIN-COUPLED RECEPTOR KINASE-INTERACTING PROTEIN 2; GIT2	9815
MIM608565	C1837857	14q24.3	DEAFNESS, AUTOSOMAL RECESSIVE 35; DFNB35	2103
MIM608566		 	MUCIN 15, TRANSMEMBRANE; MUC15	143662
MIM608567	C1837845	3p21	SICK SINUS SYNDROME 1, AUTOSOMAL RECESSIVE; SSS1	6331
MIM608568		19q13.33	MYOSIN, HEAVY CHAIN 14, NONMUSCLE; MYH14	79784
MIM608569	C1837839	12p12.1	CARDIOMYOPATHY, DILATED, 1O; CMD1O	10060
MIM608570		 	AHNAK NUCLEOPROTEIN 2	113146
MIM608571	C1837830	 	ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	 
MIM608572	C1837822	 	BURN-MCKEOWN SYNDROME	 
MIM608574		11q13.4-q13.5	EMSY GENE	56946
MIM608575		19p13	RETINOL DEHYDROGENASE 8; RDH8	50700
MIM608576		8q22	GRAINYHEAD-LIKE 2; GRHL2	79977
MIM608577		 	CHURCHILL DOMAIN-CONTAINING 1; CHURC1	91612
MIM608578	C1855722	 	CEREBROFRONTOFACIAL SYNDROME	 
MIM608579	C1840548	6p21.3, 6p21.3	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO	3105, 3106
MIM608580		7q22	MYOSIN, HEAVY CHAIN 16, SKELETAL MUSCLE, PSEUDOGENE; MYH16	84176
MIM608581		8p23	RP1-LIKE PROTEIN 1; RP1L1	94137
MIM608582		9q34.3	EPIDERMAL GROWTH FACTOR-LIKE 7; EGFL7	51162
MIM608583	C1843687	1q21.1, 10q22-q24	ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	2702, 406216
MIM608584	C1837811	7p15-p14	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2	387129
MIM608585	C1837810	 	BRACHIAL PALSY, FAMILIAL CONGENITAL	 
MIM608586	C1837809	3p14-q13	KERATOCONUS 3; KTCN3	406215
MIM608587		 	LGP1, MOUSE, HOMOLOG OF	84514
MIM608588		17q21.2	DEXH BOX POLYPEPTIDE 58; DHX58	79132
MIM608589		 	SLAM FAMILY, MEMBER 9; SLAMF9	89886
MIM608591		12q12-q13.3	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2G; CMT2G	431712
MIM608592		 	CTD SMALL PHOSPHATASE-LIKE; CTDSPL	10217
MIM608593		1q32	COMPLEMENT FACTOR H-RELATED 5; CFHR5	81494
MIM608594	C1720862	9q34.3	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1; CGL1	10555
MIM608595		7p15-p14	NEUROPEPTIDE S RECEPTOR 1; NPSR1	387129
MIM608596		7p15-p14	ASTHMA-ASSOCIATED ALTERNATIVELY SPLICED GENE 1	404744
MIM608597		 	NEURALIZED-LIKE 2; NEURL2	140825
MIM608598		10q26	CANCER SUSCEPTIBILITY CANDIDATE 2; CASC2	255082
MIM608599		10q26	RAB11 FAMILY-INTERACTING PROTEIN 2; RAB11FIP2	22841
MIM608600	C1720859	 	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1; FPLD1	 
MIM608601		 	FIBROSIN 1; FBS1	64319
MIM608602		 	NUCLEAR BODY PROTEIN SP140; SP140	11262
MIM608603		15q21.2	GLIOMEDIN; GLDN	342035
MIM608604		 	RETINOL-BINDING PROTEIN 7; RBP7	116362
MIM608605		 	SOURCE OF IMMUNODOMINANT MAJOR HISTOCOMPATIBILITY COMPLEX-ASSOCIATED PEPTIDES	201595
MIM608606		 	BASIC HELIX-LOOP-HELIX PROTEIN MIST1	168620
MIM608607		 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 12; NBPF12	149013
MIM608608		 	PEPTIDYLPROLYL ISOMERASE A-LIKE PROTEIN 4E; PPIAL4E	730262
MIM608609		 	CHROMOSOME 1 OPEN READING FRAME 152; C1ORF152	767846
MIM608610		10q24	PROGRAMMED CELL DEATH 4; PDCD4	27250
MIM608611	C1291609	2p11.2	RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY	22934
MIM608612	C1837756	1p34	MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	10269
MIM608613		 	TRANSCRIPTION FACTOR Sp6; SP6	80320
MIM608614		4q35.1	CYTOCHROME P450, FAMILY 4, SUBFAMILY V, POLYPEPTIDE 2	285440
MIM608615	C1837750	17q24	OLIGODONTIA-COLORECTAL CANCER SYNDROME	8313
MIM608616		 	OBSCURIN; OBSCN	84033
MIM608617		 	FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER B; FAM3B	54097
MIM608618		 	FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER C; FAM3C	10447
MIM608619		 	FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER D; FAM3D	131177
MIM608621		 	SPERM AUTOANTIGENIC PROTEIN 17; SPA17	53340
MIM608622	C1837739	5q34	HYPERTENSION, DIASTOLIC, RESISTANCE TO	3779
MIM608624	C1837730	 	MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	 
MIM608625		17q23.1	PEPTIDYL-tRNA HYDROLASE 2; PTRH2	51651
MIM608626		17q23.3	STE20-RELATED KINASE ADAPTOR ALPHA; STRADA	92335
MIM608627	C1837728	20q13.3	AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8	9217
MIM608628		 	TRANSDUCIN-BETA-LIKE 1 RECEPTOR 1; TBL1XR1	79718
MIM608629	C1837713	6q23.3	JOUBERT SYNDROME 3; JBTS3	54806
MIM608630		11q23-q25	ROUNDABOUT, DROSOPHILA, HOMOLOG OF, 3; ROBO3	64221
MIM608631	C1837697	17p13	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2	431711
MIM608632		17q21-q22	MICRO RNA 196A1; MIRN196A1	406972
MIM608633		11q22.3	CASPASE 12, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP12	100506742
MIM608634	C2608087	7q11.23	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	3315
MIM608635		17q11.2	CENTAURIN, ALPHA-2; CENTA2	55803
MIM608636	C2675336	15q11	CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	 
MIM608638	C1837646	3q25-q27	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1	431710
MIM608639		7p21-p11.2	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 8; PLEKHA8	84725
MIM608640		19q13.4	ZINC FINGER PROTEIN 461; ZNF461	92283
MIM608641	C1837640	8q22	DEAFNESS, AUTOSOMAL DOMINANT 28; DFNA28	79977
MIM608642		14q24	ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 1; ZADH1	145482
MIM608643	C1291564	7p11	AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	1644
MIM608644	C1837618	5p15-p14	CILIARY DYSKINESIA, PRIMARY, 3; CILD3	1767
MIM608645	C1837617	6p21.3	DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31	347737
MIM608646	C1837616	15q13.1-q15.1	CILIARY DYSKINESIA, PRIMARY, 4; CILD4	408257
MIM608647	C1837615	16p12.2-p12.1	CILIARY DYSKINESIA, PRIMARY, 5; CILD5	408258
MIM608648		6q21	SEC63, S. CEREVISIAE, HOMOLOG OF; SEC63	11231
MIM608649	C1837610	9q34	ICHTHYOSIS PREMATURITY SYNDROME; IPS	10999
MIM608650		 	UNC51-LIKE KINASE 2; ULK2	9706
MIM608651		 	CENTAURIN, GAMMA-2; CENTG2	116987
MIM608652	C1837609	9p22-p21	DEAFNESS, AUTOSOMAL DOMINANT 47; DFNA47	246289
MIM608653	C1837608	 	DEAFNESS, AUTOSOMAL RECESSIVE 32; DFNB32	113877
MIM608654	C0020075	1p13.1	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V; HSAN5	4803
MIM608655		 	GAP JUNCTION PROTEIN, GAMMA-1; GJC1	10052
MIM608656	C1837595	20q13	PROSTATE CANCER, HEREDITARY, 3	408259
MIM608657		 	JUN DIMERIZATION PROTEIN 2; JDP2	122953
MIM608658	C1837593	7p11-q21	PROSTATE CANCER, HEREDITARY, 4	408260
MIM608659		 	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 8; SENP8	123228
MIM608660		2q14.1	INSULIN-INDUCED GENE 2; INSIG2	51141
MIM608661		1p32.3	PODOCAN; PODN	127435
MIM608662		11p14.3	ANOCTAMIN 5; ANO5	203859
MIM608663		12q12	ANOCTAMIN 6; ANO6	196527
MIM608664		14q21-q22	SECKEL SYNDROME 3; SCKL3	386616
MIM608665		 	PSMC3-INTERACTING PROTEIN; PSMC3IP	29893
MIM608666		22q11.21	PEROXISOME BIOGENESIS FACTOR 26; PEX26	55670
MIM608667		5p13.1	NIPPED-B-LIKE; NIPBL	25836
MIM608668		 	ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 11; ZMYND11	10771
MIM608669		9p22.1	BASONUCLIN 2; BNC2	54796
MIM608670	C1837564	 	ROBIN SEQUENCE WITH DISTINCTIVE FACIAL APPEARANCE AND BRACHYDACTYLY	 
MIM608671		 	DAZ-INTERACTING PROTEIN 1; DZIP1	22873
MIM608672		 	DAZ-INTERACTING PROTEIN 3	9666
MIM608673	C1837552	12q24	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	26353
MIM608674		4q31.3	SH3 DOMAIN PROTEIN 19	152503
MIM608675		 	FUCOKINASE; FUK	197258
MIM608676		 	TAXILIN, ALPHA; TXLNA	200081
MIM608677		 	MINDBOMB, DROSOPHILA, HOMOLOG OF, 1; MIB1	57534
MIM608678		9p24.1	INTERLEUKIN 33; IL33	90865
MIM608679		 	TP53-REGULATING KINASE; TP53RK	112858
MIM608680		 	PRPK-BINDING PROTEIN	51002
MIM608681	C1837549	15q26.1	SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	145873
MIM608682		 	ADRENOMEDULLIN 2; ADM2	79924
MIM608683		 	CYSTATIN 8; CST8	10047
MIM608684		 	NINEIN; NIN	51199
MIM608685		 	STRUCTURAL MAINTENANCE OF CHROMOSOMES 1B; SMC1B	27127
MIM608686		 	RAB3A-INTERACTING PROTEIN; RAB3IP	117177
MIM608687	C1837541	11p13-q11	SPINOCEREBELLAR ATAXIA 20; SCA20	407973
MIM608688	C1837530	2q35	AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	471
MIM608689		 	MESODERM POSTERIOR 1	55897
MIM608690		 	SSX2-INTERACTING PROTEIN; SSX2IP	117178
MIM608691	C1837529	15q25.3-q26.2	MAJOR DEPRESSIVE DISORDER 2	431709
MIM608692		 	BASIC LEUCINE ZIPPER NUCLEAR FACTOR 1; BLZF1	8548
MIM608693		 	GOLGI REASSEMBLY STACKING PROTEIN 2; GORASP2	26003
MIM608694		 	ZINC FINGER PROTEIN 622; ZNF622	90441
MIM608695	C1837528	9q22	GLAUCOMA 1, OPEN ANGLE, J; GLC1J	574078
MIM608696	C1837527	20p12	GLAUCOMA 1, OPEN ANGLE, K; GLC1K	574077
MIM608697		2p12	FACTOR IN GERMLINE ALPHA, MOUSE, HOMOLOG OF; FIGLA	344018
MIM608698		 	DISCOIDIN, CUB, AND LCCL DOMAIN-CONTAINING PROTEIN 2; DCBLD2	131566
MIM608699		 	BONE MORPHOGENETIC PROTEIN-BINDING ENDOTHELIAL REGULATOR PROTEIN; BMPER	168667
MIM608700		 	NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 1; NMNAT1	64802
MIM608701		 	NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 2; NMNAT2	23057
MIM608702		3q23	NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 3; NMNAT3	349565
MIM608703	C1837518	2p21-p13	SPINOCEREBELLAR ATAXIA 25; SCA25	338435
MIM608704		 	NICOTINAMIDE RIBOSIDE KINASE 1	54981
MIM608705		 	INTEGRIN, BETA-1, BINDING PROTEIN OF, 3; ITGB1BP3	27231
MIM608706		15q21	DYSLEXIA SUSCEPTIBILITY 1 CANDIDATE 1; DYX1C1	161582
MIM608707		 	CELL ADHESION MOLECULE-RELATED/DOWNREGULATED BY ONCOGENES; CDON	50937
MIM608708		 	BROTHER OF CDON; BOC	91653
MIM608709	C0220989	19p13.3	LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD	84823
MIM608710	C0043092	6p21.3	WEGENER GRANULOMATOSIS	474168
MIM608711		 	CTD SMALL PHOSPHATASE 2; CTDSP2	10106
MIM608712		 	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, T; PTPRT	11122
MIM608713		11p15.2	CYTOCHROME P450, SUBFAMILY IIR, POLYPEPTIDE 1; CYP2R1	120227
MIM608714		8q11	SYNTROPHIN, GAMMA-1; SNTG1	54212
MIM608715		 	SYNTROPHIN, GAMMA-2; SNTG2	54221
MIM608716	C1837501	1q31	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE; MCPH5	259266
MIM608717		19q13.1	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 13; LGALS13	29124
MIM608718		 	KERATIN-ASSOCIATED PROTEIN 13-1; KRTAP13-1	140258
MIM608719		 	TR4-ASSOCIATED PROTEIN, 16-KD	126382
MIM608720	C1837492	 	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, ADULT-ONSET, WITH ANOSMIA	 
MIM608721		3q27.1	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II INHIBITOR 2; CAMK2N2	94032
MIM608722		12p12	CAPPING PROTEIN, ALPHA-3; CAPZA3	93661
MIM608723		 	PHOSPHATASE AND ACTIN REGULATOR 1; PHACTR1	221692
MIM608724		 	PHOSPHATASE AND ACTIN REGULATOR 2; PHACTR2	9749
MIM608725		 	PHOSPHATASE AND ACTIN REGULATOR 3; PHACTR3	116154
MIM608726		 	PHOSPHATASE AND ACTIN REGULATOR 4; PHACTR4	65979
MIM608727		 	DE-ETIOLATED 1, ARABIDOPSIS, HOMOLOG OF; DET1	55070
MIM608728	C1837481	2p24-p23	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 RELATED	4148
MIM608729		 	ANGIOTENSIN II RECEPTOR-ASSOCIATED PROTEIN; AGTRAP	57085
MIM608730		 	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 5; SLC39A5	283375
MIM608731		 	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 6; SLC39A6	25800
MIM608732		 	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 8; SLC39A8	64116
MIM608733		 	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 10; SLC39A10	57181
MIM608734		 	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 12; SLC39A12	221074
MIM608735		11p11.2	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 13; SLC39A13	91252
MIM608736		 	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 14; SLC39A14	23516
MIM608737		8p11.22	RAB11 FAMILY-INTERACTING PROTEIN 1; RAB11FIP1	80223
MIM608738		16p13.3	RAB11 FAMILY-INTERACTING PROTEIN 3; RAB11FIP3	9727
MIM608739		 	EXORIBONUCLEASE 1; ERI1	90459
MIM608740		22q13.2	NFAT ACTIVATING PROTEIN WITH ITAM MOTIF 1; NFAM1	150372
MIM608741		 	SYNAPTOTAGMIN 11; SYT11	23208
MIM608742	C1837479	12p12.2-p12.1	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 4	444980
MIM608743		 	JP45, MOUSE, HOMOLOG OF	126306
MIM608744		 	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 24; SLC25A24	29957
MIM608745		 	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 25; SLC25A25	114789
MIM608746		 	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 23; SLC25A23	79085
MIM608747	C1837475	12q22-q24.1	INSULIN-LIKE GROWTH FACTOR I DEFICIENCY	3479
MIM608748		 	BONE MORPHOGENETIC PROTEIN 10; BMP10	27302
MIM608749		19p13.1	BROMODOMAIN-CONTAINING PROTEIN 4; BRD4	23476
MIM608750		3q27	ALG3, S. CEREVISIAE, HOMOLOG OF; ALG3	10195
MIM608751	C1837471	3p	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8; CMH8	4634
MIM608752		11q23.3	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 5; C1QTNF5	114902
MIM608753		3p25.1	tRNA SPLICING ENDONUCLEASE 2, S. CEREVISIAE, HOMOLOG OF; TSEN2	80746
MIM608754		19q13.4	tRNA SPLICING ENDONUCLEASE 34, S. CEREVISIAE, HOMOLOG OF; TSEN34	79042
MIM608755		17q25.1	tRNA SPLICING ENDONUCLEASE 54, S. CEREVISIAE, HOMOLOG OF; TSEN54	283989
MIM608756		 	tRNA SPLICING ENDONUCLEASE 15, S. CEREVISIAE, HOMOLOG OF; TSEN15	116461
MIM608757		 	CLP1, YEAST, HOMOLOG OF; CLP1	10978
MIM608758	C1834460	12q23-q24.3	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10	4633
MIM608759		17q25	CYTOGLOBIN; CYGB	114757
MIM608760		 	AUTOPHAGY 7, S. CEREVISIAE, HOMOLOG OF; ATG7	10533
MIM608761		 	SOLUTE CARRIER FAMILY 5 (CHOLINE TRANSPORTER), MEMBER 7; SLC5A7	60482
MIM608762	C1837468	9q32-q33	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	432400
MIM608763	C1837462	 	EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	 
MIM608764		7q22.2	NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NAMPT	10135
MIM608765	C1837461	8q12.1	SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 3; IS3	55636
MIM608766		 	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1B; LRP1B	53353
MIM608767		 	FEM1, C. ELEGANS, HOMOLOG OF, C; FEM1C	56929
MIM608768	C1837454	13q21, 13q21	SPINOCEREBELLAR ATAXIA 8; SCA8	6315, 724066
MIM608769		11p13	PYRUVATE DEHYDROGENASE COMPLEX, COMPONENT X; PDHX	8050
MIM608770		11q23.1	DIHYDROLIPOAMIDE S-ACETYLTRANSFERASE; DLAT	1737
MIM608771		12q24	MEDIATOR COMPLEX SUBUNIT 13-LIKE; MED13L	23389
MIM608772		 	INVASION INHIBITORY PROTEIN, 45-KD	60672
MIM608773		5p15.3	TUBULIN POLYMERIZATION-PROMOTING PROTEIN; TPPP	11076
MIM608774		11q23.2	ANKYRIN REPEAT AND KINASE DOMAIN CONTAINING 1; ANKK1	255239
MIM608775		18q21.1	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 1; HAUS1	115106
MIM608776	C1837438	11q23	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	79796
MIM608777		13q13.3	PERIOSTIN; POSTN	10631
MIM608778		 	KELCH-LIKE 10; KLHL10	317719
MIM608779	C1837437	16p	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	91949
MIM608780		6q25.3	GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 5; GTF2H5	404672
MIM608781	C1837434	1q21-q22	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 3	449015
MIM608782	C1837429	8q22.1	PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY; PDHPD	54704
MIM608783		 	SET AND MYND DOMAIN-CONTAINING PROTEIN 3; SMYD3	64754
MIM608784		22q11.21	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 8; ZDHHC8	29801
MIM608785		4p16.1	HTRA SERINE PEPTIDASE 3; HTRA3	94031
MIM608786		11q13.4-q13.5	PYRUVATE CARBOXYLASE; PC	5091
MIM608787	C1837422	3q22-q24	OTOSCLEROSIS 5; OTSC5	317682
MIM608788		 	SUPPRESSOR OF CYTOKINE SIGNALING 7; SOCS7	30837
MIM608789		 	NCK-ASSOCIATED PROTEIN 5	344148
MIM608790		4p16.1	TRANSCRIPTIONAL ADAPTOR 2B; TADA2B	93624
MIM608791		 	NUCLEOREDOXIN-LIKE PROTEIN 1; NXNL1	115861
MIM608792		 	GIPC PDZ DOMAIN-CONTAINING FAMILY, MEMBER 3; GIPC3	126326
MIM608793		 	SPERM ANTIGEN WITH CALPONIN HOMOLOGY AND COILED-COIL DOMAINS 1; SPECC1	92521
MIM608794		 	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED, 1; PITPNM1	9600
MIM608795		 	PHOSPHOLIPASE C, DELTA-3; PLCD3	113026
MIM608796	C1837418	8q23	MOYAMOYA DISEASE 3; MYMY3	493818
MIM608797		 	MEI1, MOUSE, HOMOLOG OF	150365
MIM608798		7p15	DFNA5 GENE; DFNA5	1687
MIM608799	C1837396	20q13.13	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie; CDG1E	8813
MIM608800	C1837371	6q22-q23	SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME; SIDDT	7259
MIM608801		19p13.2	GLUTARYL-CoA DEHYDROGENASE; GCDH	2639
MIM608802		20q12	L3MBT-LIKE; L3MBTL	26013
MIM608803		1q41-q42	GAP JUNCTION PROTEIN, GAMMA-2; GJC2	57165
MIM608804	C1837355	1q41-q42	LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2	57165
MIM608805	C0410480	 	AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY	1280
MIM608806		3q26.3	N-ACETYLATED ALPHA-LINKED ACIDIC DIPEPTIDASE-LIKE 2	254827
MIM608807	C1837342	2q31	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J; LGMD2J	7273
MIM608808	C1837341	12q24	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 1; DTGA1	23389
MIM608809	C1837329	 	LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA; LACH	 
MIM608810	C1837317	11q22.3-q23.1	MYOPATHY, MYOFIBRILLAR, 2, MFM2	1410
MIM608811	C1837316	 	METAPHYSEAL UNDERMODELING, SPONDYLAR DYSPLASIA, AND OVERGROWTH	 
MIM608812	C1837315	9q22	COLORECTAL CANCER, SUSCEPTIBILITY TO, 1; CRCS1	79695
MIM608813		 	DER1-LIKE DOMAIN FAMILY, MEMBER 1; DERL1	79139
MIM608814	C1837314	 	LATERAL SEMICIRCULAR CANAL MALFORMATION, FAMILIAL, WITH EXTERNAL AND MIDDLE EAR ABNORMALITIES	 
MIM608815		6p12-p11	EF-HAND DOMAIN (C-TERMINAL)-CONTAINING PROTEIN 1; EFHC1	114327
MIM608816	C1837308	6p21	MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 3; EJM3	449018
MIM608817		11p12	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 4C; LRRC4C	57689
MIM608818		1p13.3	NETRIN G1; NTNG1	22854
MIM608819		17q12-q21	KERATIN-ASSOCIATED PROTEIN 1-1; KRTAP1-1	81851
MIM608820		17q12-q21	KERATIN-ASSOCIATED PROTEIN 1-3; KRTAP1-3	81850
MIM608821		17q12-q21	KERATIN-ASSOCIATED PROTEIN 1-4; KRTAP1-4	728255
MIM608822		17q12-q21	KERATIN-ASSOCIATED PROTEIN 1-5; KRTAP1-5	83895
MIM608823		 	CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 1; CGB1	114335
MIM608824		 	CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 2; CGB2	114336
MIM608825		 	CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 5; CGB5	93659
MIM608826		 	CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 7; CGB7	94027
MIM608827		 	CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 8; CGB8	94115
MIM608828		5p14-p13	RIBONUCLEASE III, NUCLEAR; RNASEN	29102
MIM608829		6q25	SMALL UBIQUITIN-LIKE MODIFIER 4; SUMO4	387082
MIM608830		14q23.3	RETINOL DEHYDROGENASE 12; RDH12	145226
MIM608831	C1837285	14q13-q21	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 2; RLS2	450097
MIM608832		1q43	GREMLIN 2 HOMOLOG, CYSTINE KNOT SUPERFAMILY; GREM2	64388
MIM608833		20q13.3	REGULATOR OF TELOMERE ELONGATION HELICASE 1; RTEL1	51750
MIM608834		 	cAMP RESPONSE ELEMENT-BINDING PROTEIN 3-LIKE 2; CREB3L2	64764
MIM608835		 	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 13; ABCC13	150000
MIM608836	C1833518	1p32	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL	1376
MIM608837	C1837245	17p13.1	CARNEY COMPLEX VARIANT	4626
MIM608838		 	VITAMIN K EPOXIDE REDUCTASE COMPLEX, SUBUNIT 1-LIKE 1; VKORC1L1	154807
MIM608839		19q13	CALPAIN 12; CAPN12	147968
MIM608840	C1837229	22q12.3-q13.1	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6; MDDGB6	9215
MIM608841		 	COMPLEMENT COMPONENT 3- AND PREGNANCY ZONE PROTEIN-LIKE ALPHA-2-MACROGLOBULIN DOMAIN-CONTAINING PROTEIN 8; CPAMD8	27151
MIM608842		 	COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 1; CHCHD1	118487
MIM608843		16p13.3	VASORIN	114990
MIM608844		 	ENDONUCLEASE VIII-LIKE 1; NEIL1	79661
MIM608845		3p12-q13	ADP-RIBOSYLATION FACTOR-LIKE 6; ARL6	84100
MIM608846		19q13.33	CARNITINE PALMITOYLTRANSFERASE IC; CPT1C	126129
MIM608847		5q21.3	FERRITIN, MITOCHONDRIAL; FTMT	94033
MIM608848		 	TRANSDUCER OF CDC42-DEPENDENT ACTIN ASSEMBLY 1	54874
MIM608849		1q23.1	U2AF HOMOLOGY MOTIF KINASE 1; UHMK1	127933
MIM608850	C1426774	5p15.33-p13.1	MACULAR DYSTROPHY, RETINAL, 3	317668
MIM608851		20p11.2-p11.1	5-PRIME,3-PRIME-@EXORIBONUCLEASE 2; XRN2	22803
MIM608852	C3160731	6q21-q22	PULMONARY FUNCTION	450095
MIM608853		11q24.1	BH3-LIKE MOTIF-CONTAINING CELL DEATH INDUCER; BLID	414899
MIM608854		1p34.2	OXIDORED-NITRO DOMAIN-CONTAINING PROTEIN 1	127700
MIM608855		 	TWEETY, DROSOPHILA, HOMOLOG OF, 2; TTYH2	94015
MIM608856		 	CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 1; CTAGE1	64693
MIM608857		 	CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 3; CTAGE3	220112
MIM608858		 	FIBROBLAST GROWTH FACTOR RECEPTOR 1 ONCOGENE PARTNER 2; FGFR1OP2	26127
MIM608859		6q13	CD109 ANTIGEN; CD109	135228
MIM608860		 	ASTACIN-LIKE METALLOENDOPEPTIDASE; ASTL	431705
MIM608861		 	ATPase, H+ TRANSPORTING, LYSOSOMAL, 50/57-KD, V1 SUBUNIT H; ATP6V1H	51606
MIM608862		 	APOLIPOPROTEIN A-I-BINDING PROTEIN; APOA1BP	128240
MIM608863		 	PODOPLANIN; PDPN	10630
MIM608864	C1837213	1q32-q41	OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6	3664
MIM608865		 	NPA1, YEAST, HOMOLOG OF	9875
MIM608866		10q23.33	FRAGILE SITE, FOLIC ACID-TYPE, RARE, FRA(10)(q23.3), CANDIDATE GENE 1	118924
MIM608867		 	DUAL-SPECIFICITY PHOSPHATASE 10; DUSP10	11221
MIM608868		3p14	LEUCINE-RICH REPEATS- AND IMMUNOGLOBULIN-LIKE DOMAINS-CONTAINING PROTEIN 1; LRIG1	26018
MIM608869		1p13	LEUCINE-RICH REPEATS- AND IMMUNOGLOBULIN-LIKE DOMAINS-CONTAINING PROTEIN 2; LRIG2	9860
MIM608870		12q13.2	LEUCINE-RICH REPEATS- AND IMMUNOGLOBULIN-LIKE DOMAINS-CONTAINING PROTEIN 3; LRIG3	121227
MIM608871		 	NIPSNAP, C. ELEGANS, HOMOLOG OF, 3A; NIPSNAP3A	25934
MIM608872		 	NIPSNAP, C. ELEGANS, HOMOLOG OF, 3B; NIPSNAP3B	55335
MIM608873		 	SEMAPHORIN 6B; SEMA6B	10501
MIM608874	C1837210	4p16.1	OROFACIAL CLEFT 5; OFC5	4487
MIM608875	C1837209	14q32	GENE EXPRESSION, VARIATION IN, QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 14	474334
MIM608876		 	PCF11, YEAST, HOMOLOG OF	51585
MIM608877		 	VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, D; VPS13D	55187
MIM608878	C1837208	20q13	GENE EXPRESSION, VARIATION IN, QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 20	474333
MIM608879		 	VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, C; VPS13C	54832
MIM608880		 	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 16; ZFYVE16	9765
MIM608881		11p15.3	MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 2; MICAL2	9645
MIM608882		22q11.21	MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 3; MICAL3	57553
MIM608883		 	GALACTOSE MUTAROTASE; GALM	130589
MIM608884		14q13.2	GTPase-ACTIVATING RAP/RAN-GAP DOMAIN-LIKE 1; GARNL1	253959
MIM608885	C1837206	 	CRYOHYDROCYTOSIS, STOMATIN-DEFICIENT, WITH MENTAL RETARDATION, SEIZURES, CATARACTS, AND MASSIVE HEPATOSPLENOMEGALY	 
MIM608886		5q33	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR 1, BETA; PPARGC1B	133522
MIM608887		 	PURINE-RICH ELEMENT-BINDING PROTEIN B; PURB	5814
MIM608888		 	DEVELOPMENTALLY REGULATED RNA-BINDING PROTEIN 1	129831
MIM608889		 	AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE; ACMSD	130013
MIM608890	C1837203	8q11	WAARDENBURG SYNDROME, TYPE 2D; WS2D	6591
MIM608891		2p24	ODD-SKIPPED-RELATED 1; OSR1	130497
MIM608892		8q12.1	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 7; CHD7	55636
MIM608893		5p15.33	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 19; SLC6A19	340024
MIM608894		6q23.3	ABELSON HELPER INTEGRATION SITE 1; AHI1	54806
MIM608895	C1837187	14q32.1	MACULAR DEGENERATION, AGE-RELATED, 3; ARMD3	10516
MIM608896		13q12	SARCOGLYCAN, GAMMA; SGCG	6445
MIM608897		17q25.1	UNC13, C. ELEGANS, HOMOLOG OF, D; UNC13D	201294
MIM608898	C1837174	17q25.1	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3	201294
MIM608899		 	GTF2I REPEAT DOMAIN-CONTAINING PROTEIN 2, ALPHA	84163
MIM608900		 	GTF2I REPEAT DOMAIN-CONTAINING PROTEIN 2, BETA	389524
MIM608901	C1837173	3q13	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 5	8997
MIM608902	C1827409	22q13.1	DRUG METABOLISM, POOR, CYP2D6-RELATED	1565
MIM608903	C1837153	16p13	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 1	450087
MIM608904	C1837152	17p11	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 2	450088
MIM608905	C1837151	6q12	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 3	450089
MIM608906	C1837150	5p13	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 4	450090
MIM608907	C1837149	19p13.2	ALZHEIMER DISEASE 9	450086
MIM608908	C1837148	22q12	MYOPIA 6; MYP6	450094
MIM608909		 	ADP-RIBOSYLATION FACTOR-LIKE 5B; ARL5B	221079
MIM608910		 	CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 4; CTAGE4	100128553
MIM608911	C0220723	 	CHOANAL ATRESIA, POSTERIOR; PCA	 
MIM608912		 	POTE ANKYRIN DOMAIN FAMILY, MEMBER B; POTEB	339010
MIM608913		22q11.1	POTE ANKYRIN DOMAIN FAMILY, MEMBER H; POTEH	23784
MIM608914		2q21.1	POTE ANKYRIN DOMAIN FAMILY, MEMBER E; POTEE	445582
MIM608915		 	POTE ANKYRIN DOMAIN FAMILY, MEMBER A; POTEA	340441
MIM608916		 	POTE ANKYRIN DOMAIN FAMILY, MEMBER G; POTEG	404785
MIM608917		 	ATP SYNTHASE, MITOCHONDRIAL F1 COMPLEX, ASSEMBLY FACTOR 1; ATPAF1	64756
MIM608918		17p11.2	ATP SYNTHASE, MITOCHONDRIAL F1 COMPLEX, ASSEMBLY FACTOR 2; ATPAF2	91647
MIM608919		 	TWEETY, DROSOPHILA, HOMOLOG OF, 3; TTYH3	80727
MIM608920		 	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED, 2; PITPNM2	57605
MIM608921		17p13.1	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED, 3; PITPNM3	83394
MIM608922		3q11.2	ADP-RIBOSYLATION FACTOR-LIKE 13B; ARL13B	200894
MIM608923		6q23.2	TRACE AMINE-ASSOCIATED RECEPTOR 6; TAAR6	319100
MIM608924		6p21.1	FORKHEAD BOX P4; FOXP4	116113
MIM608925		 	MULTIMERIN 2; MMRN2	79812
MIM608926		 	EMI DOMAIN-CONTAINING PROTEIN 1; EMID1	129080
MIM608927		7q22.1	EMI DOMAIN-CONTAINING PROTEIN 2; EMID2	136227
MIM608928		 	ELASTIN MICROFIBRIL INTERFACER 2; EMILIN2	84034
MIM608929		 	ELASTIN MICROFIBRIL INTERFACER 3; EMILIN3	90187
MIM608930	C1837122	17p13-p12, 2q33-q34, 2q24-q32	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	1134, 1144, 1145
MIM608931	C1837091	17p12-p11, 17p13-p12, 11p11.2-p11.1, 9q31.3-q32	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	1140, 1145, 2673, 4593, 5913
MIM608932	C1837090	16q22.3-q23.1	KERATOCONUS 2; KTCN2	450092
MIM608933		 	ENDONUCLEASE VIII-LIKE 2; NEIL2	252969
MIM608934		 	ENDONUCLEASE VIII-LIKE 3; NEIL3	55247
MIM608935	C1837089	6q23-q25	LUNG CANCER SUSCEPTIBILITY 1; LNCR1	450093
MIM608936		 	PROLINE-RICH 1; PROL1	58503
MIM608937		 	SH2B ADAPTOR PROTEIN 1; SH2B1	25970
MIM608938		17q23.1	RIBOSOMAL PROTEIN S6 KINASE, 70-KD, 1; RPS6KB1	6198
MIM608939		 	RIBOSOMAL PROTEIN S6 KINASE, 70-KD, 2; RPS6KB2	6199
MIM608940	C1837073	 	SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY	 
MIM608941		 	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-3; GNG3	2785
MIM608942		17q23.2	DYNEIN, LIGHT CHAIN, LC8 TYPE, 2; DYNLL2	140735
MIM608943		 	CYTOKINE-INDUCED APOPTOSIS INHIBITOR 1; CIAPIN1	57019
MIM608944		9p22.3	FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 1; FREM1	158326
MIM608945		13q13.3	FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 2; FREM2	341640
MIM608946		4q31.2	FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 3	166752
MIM608947		16p11.2	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 13; KCTD13	253980
MIM608948		3q24	ZINC FINGER PROTEIN OF CEREBELLUM 4; ZIC4	84107
MIM608949		 	GLYCOLIPID TRANSFER PROTEIN	51228
MIM608950		7q21	MAGI2 INTRONIC TRANSCRIPT; MAGI2IT	266671
MIM608951		5q35.3	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 6; CNOT6	57472
MIM608952		 	RAP1-INTERACTING FACTOR 1, YEAST, HOMOLOG OF	55183
MIM608953		 	TEKTIN 2; TEKT2	27285
MIM608954		16q23.1	MON1, S. CEREVISIAE, HOMOLOG OF, B; MON1B	22879
MIM608955		22q13.1	TUBULIN TYROSINE LIGASE-LIKE FAMILY, MEMBER 1; TTLL1	25809
MIM608956		9q31-q34	SOLUTE CARRIER FAMILY 46, MEMBER 2; SLC46A2	57864
MIM608957	C1837065	2p12	CD8 DEFICIENCY, FAMILIAL	925
MIM608958		20q13.11	ADENOSINE DEAMINASE; ADA	100
MIM608959		3p24.3	DPH3, S. CEREVISIAE, HOMOLOG OF; DPH3	285381
MIM608960		2q23-q24.1	ADP-RIBOSYLATION FACTOR-LIKE 5A; ARL5A	26225
MIM608961		9q21.12	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 3; TRPM3	80036
MIM608962		 	RHOMBOID-LIKE 2; RHBDL2	54933
MIM608963		 	NUCLEAR PROTEIN IN TESTIS	256646
MIM608964		 	TATA BOX-BINDING PROTEIN-LIKE PROTEIN 2; TBPL2	387332
MIM608965		11q13.1	CALCIUM-BINDING PROTEIN 4; CABP4	57010
MIM608966		6q27	DAPPER, ANTAGONIST OF BETA-CATENIN, 2; DACT2	168002
MIM608967		9q22	LOEYS-DIETZ SYNDROME, TYPE 2A; LDS2A	7046
MIM608968		20q11.2-q13.1	V-MAF MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE FAMILY, PROTEIN B; MAFB	9935
MIM608969		 	UTP14, S. CEREVISIAE, HOMOLOG OF, B	9724
MIM608970	C1837029	 	MACULAR DYSTROPHY, BUTTERFLY-SHAPED PIGMENTARY, 2	619480
MIM608971	C1837028	11q23, 11q23, 5p13, 1q31-q32	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	3575, 5788, 915, 916
MIM608972		1q21.3	CREB-REGULATED TRANSCRIPTION COACTIVATOR 2; CRTC2	200186
MIM608973		11q23.1	SALT-INDUCIBLE KINASE 2; SIK2	23235
MIM608974		12p13.31	COMPLEMENT COMPONENT C1r-LIKE PROTEIN; C1RL	51279
MIM608975		20q13.13	PARTITIONING-DEFECTIVE PROTEIN 6, C. ELEGANS, HOMOLOG OF, BETA; PARD6B	84612
MIM608976		18q23	PARTITIONING-DEFECTIVE PROTEIN 6, C. ELEGANS, HOMOLOG OF, GAMMA; PARD6G	84552
MIM608977		3q26.3	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 19; DNAJC19	131118
MIM608978	C1837026	11p13	MEACHAM SYNDROME	7490
MIM608979		3p21.2	PROTEIN PHOSPHATASE, MAGNESIUM-DEPENDENT, 1M; PPM1M	132160
MIM608980	C2750433	9p22.3	BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR	158326
MIM608981		2q24.1	ACTIVIN A RECEPTOR, TYPE IC; ACVR1C	130399
MIM608982	C1837024	3p26	STATURE QUANTITATIVE TRAIT LOCUS 5; STQTL5	619479
MIM608983		2q33-q35	CATARACT, CONGENITAL, CERULEAN TYPE, 3; CCA3	1421
MIM608984	C1837015	8p12-q12.1	ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT; SNAX1	474386, 81790
MIM608985		1q25.3	RING FINGER PROTEIN 2; RNF2	6045
MIM608986		15q26.1	CREB-REGULATED TRANSCRIPTION COACTIVATOR 3; CRTC3	64784
MIM608987		11q12	PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, ALPHA SUBUNIT, ISOFORM 3; P4HA3	283208
MIM608988	C1837812	6q14-q16	ATRIAL FIBRILLATION, FAMILIAL, 2; ATFB2	619478
MIM608989		8q12.1	RETINAL DEHYDROGENASE, EPIDERMAL, 2	195814
MIM608990		19p13.3-p13.2	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 10; ADAMTS10	81794
MIM608991		4q28.3	MASTERMIND-LIKE 3; MAML3	55534
MIM608992		17p13.1	B-CELL LYMPHOMA 6B; BCL6B	255877
MIM608993		22q12-q13.2	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3F; APOBEC3F	200316
MIM608994		6p21.3	ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 1A; ANKS1A	23294
MIM608995	C1837009	1p36-p34	DYSLEXIA, SUSCEPTIBILITY TO, 8; DYX8	406874
MIM608996	C1837008	3q23	PREMATURE OVARIAN FAILURE 3; POF3	668
MIM608998		2p25.2	TUMOR-SUPPRESSING SUBTRANSFERABLE FRAGMENT CANDIDATE GENE 1; TSSC1	7260
MIM608999		11p15.5	TUMOR-SUPPRESSING SUBTRANSFERABLE FRAGMENT CANDIDATE GENE 2; TSSC2	7261
MIM609000		6q23.1-q23.3	MONOOXYGENASE, DBH-LIKE, 1; MOXD1	26002
MIM609001		12p12	PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 2, GAMMA; PIK3C2G	5288
MIM609002		17p13.1	TEKTIN 1; TEKT1	83659
MIM609003		7q22.1	TETRATRICOPEPTIDE REPEAT DOMAIN 11; TTC11	51024
MIM609004		11q23.3	B-CELL CLL/LYMPHOMA 9-LIKE; BCL9L	283149
MIM609005		4q34	WD REPEAT-CONTAINING PROTEIN 17; WDR17	116966
MIM609006	C1837007	1p36.3-p36.1	DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT; DFNB36	83715
MIM609007		12q12	LEUCINE-RICH REPEAT KINASE 2; LRRK2	120892
MIM609008	C1836994	 	MARFANOID HABITUS WITH SITUS INVERSUS	 
MIM609009		 	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, THETA ISOFORM; YWHAQ	10971
MIM609010		3q25-q27	3-@METHYLCROTONYL-CoA CARBOXYLASE 1; MCCC1	56922
MIM609011		 	VASOHIBIN 1; VASH1	22846
MIM609012		 	WD REPEAT-CONTAINING PROTEIN 5; WDR5	11091
MIM609013		 	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 4C1; SLCO4C1	353189
MIM609014		5q12-q13	3-@METHYLCROTONYL-CoA CARBOXYLASE 2; MCCC2	64087
MIM609015	C0342786	2p23, 2p23	TRIFUNCTIONAL PROTEIN DEFICIENCY	3030, 3032, 3033
MIM609016	CN074230	2p23	LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	3030
MIM609017		1p34	ERYTHROBLAST MEMBRANE-ASSOCIATED PROTEIN; ERMAP	114625
MIM609018		21q22.1	HOLOCARBOXYLASE SYNTHETASE; HLCS	3141
MIM609019		3p25	BIOTINIDASE; BTD	686
MIM609020		11p13-p11.1	FOLATE HYDROLASE 1B; FOLH1B	219595
MIM609021	C1836946	 	PERIPHERAL CONE DYSTROPHY	 
MIM609022		 	RAPAMYCIN-INSENSITIVE COMPANION OF MTOR; RICTOR	253260
MIM609023		2q35	MYOFIBRILLOGENESIS REGULATOR 1	25953
MIM609024		 	KDEL ENDOPLASMIC RETICULUM PROTEIN RETENTION RECEPTOR 2; KDELR2	11014
MIM609025		12q13	KERATIN 75; KRT75	9119
MIM609026	C1836942	6p12-q12	CATARACT, AGE-RELATED CORTICAL, 1; ARCC1	493862
MIM609027	CN030626	 	INDIAN BLOOD GROUP SYSTEM; IN	960
MIM609028		 	TRAF-INTERACTING PROTEIN WITH FORKHEAD-ASSOCIATED DOMAIN; TIFA	92610
MIM609029	C1836929	22q11.2	EMANUEL SYNDROME	100529146
MIM609030		22q11.2	DIGEORGE SYNDROME CRITICAL REGION GENE 8; DGCR8	54487
MIM609031		 	SERINE PROTEASE INHIBITOR-LIKE PROTEIN WITH KUNITZ AND WAP DOMAINS 1; SPINLW1	57119
MIM609032		4q35	FSHD REGION GENE 2; FRG2	448831
MIM609033	C1836916	1q31.3	POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	28982
MIM609034		 	HAIRY/ENHANCER OF SPLIT-RELATED WITH YRPW MOTIF-LIKE PROTEIN; HEYL	26508
MIM609035		 	RAS ASSOCIATION AND PLECKSTRIN HOMOLOGY DOMAINS-CONTAINING PROTEIN 1; RAPH1	65059
MIM609036		 	APBB1-INTERACTING PROTEIN; APBB1IP	54518
MIM609038		 	RHO FAMILY GTPase 1; RND1	27289
MIM609039	C1836907	21q11.2	NARCOLEPSY 3; NRCLP3	494446
MIM609040	C1836906	12p11	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9; ARVD9	5318
MIM609041	C1836899	10q22.1-q24.1	SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE; SPG27	414886
MIM609042		 	OPSIN 5; OPN5	221391
MIM609043		 	RELAXIN 3 RECEPTOR 2; RLN3R2	339403
MIM609044		 	G PROTEIN-COUPLED RECEPTOR 120; GPR120	338557
MIM609045		 	G PROTEIN-COUPLED RECEPTOR 141; GPR141	353345
MIM609046		 	G PROTEIN-COUPLED RECEPTOR 142; GPR142	350383
MIM609048	C1836892	12q14	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3; CMM3	1019
MIM609049	C1836876	3p21	PIERSON SYNDROME	3913
MIM609050		 	METASTASIS-ASSOCIATED GENE 3; MTA3	57504
MIM609051		19q13.3	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 8; CARD8	22900
MIM609053	C1836861	15q25-q26	FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	55215
MIM609054	C1836860	17q22	FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	83990
MIM609055	C1836841	 	CEROID LIPOFUSCINOSIS, NEURONAL, 9; CLN9	497231
MIM609056	C1836824	2p11.2	AMISH INFANTILE EPILEPSY SYNDROME	8869
MIM609057	C1836823	11p15.5	NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS	977
MIM609058		6p21	METHYLMALONYL-CoA MUTASE; MUT	4594
MIM609059		11p15.5	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 2; PNPLA2	57104
MIM609060	C1836797	3q25.1-q26.2	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1	85476
MIM609061		 	ENABLED, DROSOPHILA, HOMOLOG OF; ENAH	55740
MIM609062		7p14-p13	POU DOMAIN, CLASS 6, TRANSCRIPTION FACTOR 2; POU6F2	11281
MIM609063		 	THIOREDOXIN 2; TXN2	25828
MIM609064		18q22.3	CARNOSINE DIPEPTIDASE 1; CNDP1	84735
MIM609066		 	AJUBA, MOUSE, HOMOLOG OF; JUB	84962
MIM609067		8q24.3	SCLERAXIS, MOUSE, HOMOLOG OF, A; SCXA	100129885
MIM609068		 	DAN DOMAIN FAMILY, MEMBER 5; DAND5	199699
MIM609069	C1836780	10p12.3	PANCREATIC AND CEREBELLAR AGENESIS; PACA	256297
MIM609071		 	F-BOX AND WD40 DOMAIN PROTEIN 2; FBXW2	26190
MIM609072		 	F-BOX AND WD40 DOMAIN PROTEIN 5; FBXW5	54461
MIM609073		12q24.23	F-BOX AND WD40 DOMAIN PROTEIN 8; FBXW8	26259
MIM609074		 	F-BOX AND WD40 DOMAIN PROTEIN 9; FBXW9	84261
MIM609075		3p21	F-BOX AND WD40 DOMAIN PROTEIN 12; FBXW12	285231
MIM609076		 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 6; FBXL6	26233
MIM609077		 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 8; FBXL8	55336
MIM609078		 	LYSINE-SPECIFIC DEMETHYLASE 2B; KDM2B	84678
MIM609079		 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 12; FBXL12	54850
MIM609080		 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 13; FBXL13	222235
MIM609081		 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 14; FBXL14	144699
MIM609082		 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 16; FBXL16	146330
MIM609083		5q21.3	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 17; FBXL17	64839
MIM609084		 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 18; FBXL18	80028
MIM609085		 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 19; FBXL19	54620
MIM609086		 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 20; FBXL20	84961
MIM609087		 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 21; FBXL21	26223
MIM609088		 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 22; FBXL22	283807
MIM609089		11p13	F-BOX ONLY PROTEIN 3; FBXO3	26273
MIM609090		5p12	F-BOX ONLY PROTEIN 4; FBXO4	26272
MIM609091		6p12.3-p11.2	F-BOX ONLY PROTEIN 9; FBXO9	26268
MIM609092		9p13.1	F-BOX ONLY PROTEIN 10; FBXO10	26267
MIM609093		18q22.3	F-BOX ONLY PROTEIN 15; FBXO15	201456
MIM609094		19q13.2	F-BOX ONLY PROTEIN 17; FBXO17	115290
MIM609095		12q24.23	F-BOX ONLY PROTEIN 21; FBXO21	23014
MIM609096		15q23	F-BOX ONLY PROTEIN 22; FBXO22	26263
MIM609097		7q22	F-BOX ONLY PROTEIN 24; FBXO24	26261
MIM609098		8p23.3	F-BOX ONLY PROTEIN 25; FBXO25	26260
MIM609099		19q13.2	F-BOX ONLY PROTEIN 27; FBXO27	126433
MIM609100		1q42.12	F-BOX ONLY PROTEIN 28; FBXO28	23219
MIM609101		6q24	F-BOX ONLY PROTEIN 30; FBXO30	84085
MIM609102		16q24.3	F-BOX ONLY PROTEIN 31; FBXO31	79791
MIM609103		14q13.3	F-BOX ONLY PROTEIN 33; FBXO33	254170
MIM609104		14q22.2	F-BOX ONLY PROTEIN 34; FBXO34	55030
MIM609105		2q37.1	F-BOX ONLY PROTEIN 36; FBXO36	130888
MIM609106		17p13.2	F-BOX ONLY PROTEIN 39; FBXO39	162517
MIM609107		3q21.1	F-BOX ONLY PROTEIN 40; FBXO40	51725
MIM609108		2p13.2	F-BOX ONLY PROTEIN 41; FBXO41	150726
MIM609109		1p36.23-p36.11	F-BOX ONLY PROTEIN 42; FBXO42	54455
MIM609110		8q22.3	F-BOX ONLY PROTEIN 43; FBXO43	286151
MIM609111		1p36.21	F-BOX ONLY PROTEIN 44; FBXO44	93611
MIM609112		3q29	F-BOX ONLY PROTEIN 45; FBXO45	200933
MIM609113	C1836777	14q23.2	TELOMERE LENGTH, MEAN LEUKOCYTE	550641
MIM609114		20p12.1	DESTRIN; DSTN	11034
MIM609115	C1836765	4q21	LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	553991
MIM609116	C1836764	10q26	RESPIRATORY RHYTHMICITY IN SLEEP	497662
MIM609117		19q13.3	F-BOX ONLY PROTEIN 46; FBXO46	23403
MIM609118		3q26.1	PROGRAMMED CELL DEATH 10; PDCD10	11235
MIM609119		 	THAP DOMAIN-CONTAINING PROTEIN 11; THAP11	57215
MIM609120		 	CATION CHANNEL, SPERM-ASSOCIATED, 3; CATSPER3	347732
MIM609121		 	CATION CHANNEL, SPERM-ASSOCIATED, 4; CATSPER4	378807
MIM609122	C1836757	1p36.13-p34.3	ANEURYSM, INTRACRANIAL BERRY, 3; ANIB3	497657
MIM609123		 	ATPase, CLASS I, TYPE 8B, MEMBER 4; ATP8B4	79895
MIM609124		12q13.13	ZINC FINGER PROTEIN 385A; ZNF385A	25946
MIM609125		 	MOTILE SPERM DOMAIN-CONTAINING PROTEIN 3; MOSPD3	64598
MIM609126		 	ATPase, CLASS II, TYPE 9A; ATP9A	10079
MIM609128	C1836756	 	ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	100188695
MIM609129	C1836743	13q14-q21	AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1; AUNA1	81624
MIM609130		1p36.22	APOPTOSIS-INDUCING, TAF9-LIKE DOMAIN 1; APITD1	378708
MIM609131		 	CLAUDIN 7; CLDN7	1366
MIM609132		1p36.12	LYSINE-SPECIFIC DEMETHYLASE 1A; KDM1A	23028
MIM609133		 	FLT3-INTERACTING ZINC FINGER PROTEIN 1; FIZ1	84922
MIM609134		6p21.1	UBIQUITIN-PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 2; UBR2	23304
MIM609135	C0002874	12q14, 5p15.33, 3q21-q28	APLASTIC ANEMIA	3458, 7012, 7015
MIM609136	C1836727	22q13	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	6663
MIM609137		 	RECEPTOR-TRANSPORTING PROTEIN 1; RTP1	132112
MIM609138		 	RECEPTOR-TRANSPORTING PROTEIN 2; RTP2	344892
MIM609139		2p11.2	RECEPTOR EXPRESSION-ENHANCING PROTEIN 1; REEP1	65055
MIM609140	C1852795	1p34.3-p32.3	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 2; PPCD2	1296
MIM609141	C1836724	10p11.2	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3; PPCD3	6935
MIM609142		 	CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 3; CEACAM3	1084
MIM609144		1q31.3	FELINE LEUKEMIA VIRUS SUBGROUP C RECEPTOR 1; FLVCR1	28982
MIM609145		 	NEUROFASCIN	23114
MIM609146		 	RIC8, C. ELEGANS, HOMOLOG OF, A; RIC8A	60626
MIM609147		 	RIC8, C. ELEGANS, HOMOLOG OF, B	55188
MIM609148	C1836721	6p21.3, 6p21.3	MALARIA, MILD, SUSCEPTIBILITY TO	259197
MIM609149		 	SOLUTE CARRIER FAMILY 29 (MONOAMINE TRANSPORTER), MEMBER 4; SLC29A4	222962
MIM609150		 	CXXC FINGER PROTEIN 1; CXXC1	30827
MIM609151		 	SOCIUS	91544
MIM609152	C1836706	14q31	HYPERTHYROIDISM, NONAUTOIMMUNE	7253
MIM609153	C1836705	2q35-q36	PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	541461
MIM609154		 	ACHAETE-SCUTE COMPLEX, DROSOPHILA, HOMOLOG OF, 3; ASCL3	56676
MIM609155		 	ACHAETE-SCUTE COMPLEX, DROSOPHILA, HOMOLOG OF, 4; ASCL4	121549
MIM609156		 	NICALIN, ZEBRAFISH, HOMOLOG OF; NCLN	56926
MIM609157		 	NODAL MODULATOR 1; NOMO1	23420
MIM609158		 	NODAL MODULATOR 2; NOMO2	283820
MIM609159		 	NODAL MODULATOR 3; NOMO3	408050
MIM609161	C1836694	5q13	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT; ADSD	8622
MIM609162	C1836683	 	CZECH DYSPLASIA	1280
MIM609163		12q24.31	G PROTEIN-COUPLED RECEPTOR 109A; GPR109A	338442
MIM609165	C1836681	17q21-q22	ERYTHRODERMA, ICHTHYOSIFORM, CONGENITAL RETICULAR; CRIE	3858
MIM609168		3p24.3	SHUGOSHIN-LIKE 1; SGOL1	151648
MIM609169		19q13.1	GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE, SPERMATOGENIC; GAPDHS	26330
MIM609170		 	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 4; TXNDC4	23071
MIM609171		 	CDC42 EFFECTOR PROTEIN 5; CDC42EP5	148170
MIM609172		 	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 16A; PPP1R16A	84988
MIM609173		 	CANCER SUSCEPTIBILITY CANDIDATE 5; CASC5	57082
MIM609174		 	CHROMOSOME 1 OPEN READING FRAME 48; C1ORF48	25936
MIM609175		 	CHROMOSOME 20 OPEN READING FRAME 172; C20ORF172	79980
MIM609176		 	POLYAMINE-MODULATED FACTOR 1; PMF1	11243
MIM609177		 	ZW10 INTERACTOR; ZWINT	11130
MIM609178		 	MIS12, S. POMBE, HOMOLOG OF; MIS12	79003
MIM609179	C1836670	15q11.2-q12	MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 7	553992
MIM609180	C1836669	17p13.1-p12	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If; CDG1F	9526
MIM609181		12pter-p13.31	DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 4; DYRK4	8798
MIM609182		9q22.3	SOLUTE CARRIER FAMILY 35, MEMBER D2; SLC35D2	11046
MIM609183		1p36.3	AURORA KINASE A-INTERACTING PROTEIN	54998
MIM609184		5q33.1	KINESIN FAMILY MEMBER 4B; KIF4B	285643
MIM609185		 	ZINC FINGER AND HOMEODOMAIN PROTEIN 2; ZHX2	22882
MIM609186		2q37.3	D-2-@HYDROXYGLUTARATE DEHYDROGENASE; D2HGDH	728294
MIM609187		7p14	CHROMOSOME 7 OPEN READING FRAME 10; C7ORF10	79783
MIM609188		7p14	CHROMOSOME 7 OPEN READING FRAME 11; C7ORF11	136647
MIM609189		6q22.31	ANTI-SILENCING FUNCTION 1, S. CEREVISIAE, HOMOLOG OF, A; ASF1A	25842
MIM609190		19p13.13	ANTI-SILENCING FUNCTION 1, S. CEREVISIAE, HOMOLOG OF, B; ASF1B	55723
MIM609191		11p15.3	PROTEIN KINASE A-INTERACTING PROTEIN 1; AKIP1	56672
MIM609192	C2697933	9q22	LOEYS-DIETZ SYNDROME, TYPE 1A; LDS1A	7046
MIM609193		 	PEPTIDYL-PROLYL ISOMERASE-LIKE 5; PPIL5	122769
MIM609194		 	CDK5 AND ABL ENZYME SUBSTRATE 1; CABLES1	91768
MIM609195	C1836632	12p11.1-q14	SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	550623
MIM609196		21q22.1	MELANOCORTIN 2 RECEPTOR ACCESSORY PROTEIN; MRAP	56246
MIM609197	C1836621	8q11.2-q13.2	GLUCOCORTICOID DEFICIENCY 3; GCCD3	619477
MIM609198		9p22.1-p21.2	ADAMTS-LIKE PROTEIN 1; ADAMTSL1	92949
MIM609199		15q25.2	ADAMTS-LIKE PROTEIN 3; ADAMTSL3	57188
MIM609200	C1836607	5q31	MYOPATHY, MYOFIBRILLAR, 3; MFM3	9499
MIM609201		11q24.1	UBIQUITIN-ASSOCIATED AND SH3 DOMAIN-CONTAINING PROTEIN B; UBASH3B	84959
MIM609202		 	SECRETAGOGIN; SCGN	10590
MIM609203		 	CLAUDIN 23; CLDN23	137075
MIM609204		10q22.1	MITOCHONDRIAL RIBOSOMAL PROTEIN S16: MRPS16	51021
MIM609205		9q33	DAB2-INTERACTING PROTEIN; DAB2IP	153090
MIM609206		6p25.1-p23	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, EPSILON-1; EEF1E1	9521
MIM609207		2q35	MELANOREGULIN; MREG	55686
MIM609208		 	KAZAL-TYPE PROTEASE INHIBITOR DOMAIN-CONTAINING PROTEIN 1; KAZALD1	81621
MIM609209		 	INFLUENZA VIRUS NS1A PROTEIN-BINDING PROTEIN; IVNS1ABP	10625
MIM609210		 	CLAUDIN 18; CLDN18	51208
MIM609211		18p11.31	MYOSIN, LIGHT CHAIN 12B, REGULATORY; MYL12B	103910
MIM609212		 	ASPARAGINASE-LIKE PROTEIN 1; ASRGL1	80150
MIM609213		 	SEC61 COMPLEX, ALPHA-1 SUBUNIT; SEC61A1	29927
MIM609214		 	SEC61 COMPLEX, BETA SUBUNIT; SEC61B	10952
MIM609215		 	SEC61 COMPLEX, GAMMA SUBUNIT; SEC61G	23480
MIM609216		 	SPIRE, DROSOPHILA, HOMOLOG OF, 1; SPIRE1	56907
MIM609217		 	SPIRE, DROSOPHILA, HOMOLOG OF, 2; SPIRE2	84501
MIM609218	C1836603	16q23.2-q24.2	FOVEAL HYPOPLASIA AND ANTERIOR SEGMENT DYSGENESIS; FHASD	550626
MIM609219		 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 14; NUDT14	256281
MIM609220	C1836602	3q23-q24	BRUCK SYNDROME 2; BRKS2	5352
MIM609221		 	N-ACETYLTRANSFERASE 10; NAT10	55226
MIM609224		 	WD40 REPEAT PROTEIN INTERACTING WITH PHOSPHOINOSITIDES 1; WIPI1	55062
MIM609225		 	WD40 REPEAT PROTEIN INTERACTING WITH PHOSPHOINOSITIDES 2	26100
MIM609226		 	WD REPEAT-CONTAINING PROTEIN 45-LIKE; WDR45L	56270
MIM609227	C1836573	2q37	GRISCELLI SYNDROME, TYPE 3; GS3	79083
MIM609228		 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 3; NUDT3	11165
MIM609229		 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 4; NUDT4	11163
MIM609230		 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 5; NUDT5	11164
MIM609231		 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 7; NUDT7	283927
MIM609232		 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 12; NUDT12	83594
MIM609233		 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 13; NUDT13	25961
MIM609234		3q25.1	EUKARYOTIC TRANSLATION INITIATION FACTOR 2A; EIF2A	83939
MIM609235		19q13.4	BR SERINE/THREONINE KINASE 1; BRSK1	84446
MIM609236		 	BR SERINE/THREONINE KINASE 2; BRSK2	9024
MIM609237		3q21.1	IQ MOTIF-CONTAINING PROTEIN B1; IQCB1	9657
MIM609238		 	RAB GTPase-ACTIVATING PROTEIN 1-LIKE; RABGAP1L	9910
MIM609239		13q14.12-q14.2	LYSOPHOSPHATIDIC ACID RECEPTOR 6; LPAR6	10161
MIM609240		 	GERM CELL-SPECIFIC GENE 2; GSG2	83903
MIM609241	C1836544	22q11	SCHINDLER DISEASE, TYPE I	4668
MIM609242	C1836522	22q11	KANZAKI DISEASE	4668
MIM609243		 	RETINOIC ACID EARLY TRANSCRIPT 1E; RAET1E	135250
MIM609244		 	RETINOIC ACID EARLY TRANSCRIPT 1G; RAET1G	353091
MIM609245		1p13.1	G PROTEIN SIGNALING MODULATOR 2; GPSM2	29899
MIM609246		 	PYRIDOXAL PHOSPHATASE; PDXP	57026
MIM609247		 	RING FINGER PROTEIN 13; RNF13	11342
MIM609248		 	HECT DOMAIN AND RCC1-LIKE DOMAIN 4; HERC4	26091
MIM609249		 	HECT DOMAIN AND RCC1-LIKE DOMAIN 6; HERC6	55008
MIM609251		 	Fc RECEPTOR-LIKE PROTEIN B; FCRLB	127943
MIM609252		21q11.2	LIPASE I; LIPI	149998
MIM609253	C1836518	18p11.2	FEBRILE SEIZURES, FAMILIAL, 6; FEB6	619397
MIM609254	C1836517	3q21.1	SENIOR-LOKEN SYNDROME 5; SLSN5	9657
MIM609255	C1836507	6q22-q24	FEBRILE SEIZURES, FAMILIAL, 5; FEB5	619398
MIM609256	C1836506	11p13	MYOPIA 7; MYP7	553190
MIM609257	C1836505	3q26	MYOPIA 8; MYP8	553192
MIM609258	C1836504	4q12	MYOPIA 9; MYP9	553194
MIM609259	C1836503	8p23	MYOPIA 10; MYP10	553195
MIM609260	C1836485	1p36.2	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	9927
MIM609261	C1836484	12q24.1	STUTTERING, FAMILIAL PERSISTENT, 2; STUT2	100049543
MIM609262		3p26.2	CEREBLON; CRBN	51185
MIM609263		18p11.21	SEH1-LIKE PROTEIN; SEH1L	81929
MIM609264		12q23.2	NUCLEOPORIN, 37-KD; NUP37	79023
MIM609265	C1836482	22q12.1	LI-FRAUMENI SYNDROME 2; LFS2	11200
MIM609266	C1836481	1q23	LI-FRAUMENI SYNDROME 3; LFS3	553989
MIM609267		3q13	MELANOMA ANTIGEN, FAMILY F, 1; MAGEF1	64110
MIM609268		5q11.2-q12.1	SPLICING FACTOR, ARGININE/SERINE-RICH, 12; SFRS12	140890
MIM609269		6p22.2	KIAA0319 GENE; KIAA0319	9856
MIM609270	C1836474	11p15	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7	727719
MIM609271	C1836473	2p24	KERATOCONUS 4; KTCN4	550624
MIM609272		16p13.3	TRYPTASE, DELTA-1; TPSD1	23430
MIM609273	C1836472	15q22.31, 15q15-q25	NEMALINE MYOPATHY 6; NEM6	390594
MIM609274		 	NASCENT POLYPEPTIDE-ASSOCIATED COMPLEX, ALPHA POLYPEPTIDE, 2	342538
MIM609275		1q41	RAB3 GTPase-ACTIVATING PROTEIN, NONCATALYTIC SUBUNIT; RAB3GAP2	25782
MIM609276		11q25	NON-SMC CONDENSIN II COMPLEX SUBUNIT D3; NCAPD3	23310
MIM609277		 	MOLYBDENUM COFACTOR SYNTHESIS 3; MOCS3	27304
MIM609278		 	IZUMO SPERM-EGG FUSION PROTEIN 1; IZUMO1	284359
MIM609279		13q12.2	CENTROMERIC PROTEIN J; CENPJ	55835
MIM609280		 	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 4; EIF2AK4	440275
MIM609281		 	MOB1-LIKE PROTEIN 1B; MOBKL1B	55233
MIM609282		 	MOB1-LIKE PROTEIN 1A; MOBKL1A	92597
MIM609283	C1836460	4q35	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 2; PEOA2	291
MIM609284	C1836448	1q22-q23	NEMALINE MYOPATHY 1; NEM1	7170
MIM609285	C1836447	9p13.2-p13.1	NEMALINE MYOPATHY 4; NEM4	7169
MIM609286	C1836439	10q24	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 3; PEOA3	56652
MIM609287		 	SH3 DOMAIN, GRB2-LIKE, ENDOPHILIN B1; SH3GLB1	51100
MIM609288		 	SH3 DOMAIN, GRB2-LIKE, ENDOPHILIN B2; SH3GLB2	56904
MIM609290		 	ADENYLATE KINASE 3; AK3	50808
MIM609291		15q13.2	SPROUTY-RELATED EVH1 DOMAIN-CONTAINING PROTEIN 1; SPRED1	161742
MIM609292		2p14	SPROUTY-RELATED EVH1 DOMAIN-CONTAINING PROTEIN 2; SPRED2	200734
MIM609293		19q13.13	SPROUTY-RELATED EVH1 DOMAIN-CONTAINING PROTEIN 3; SPRED3	399473
MIM609294		 	SEMAPHORIN 6C; SEMA6C	10500
MIM609295		 	SEMAPHORIN 6D; SEMA6D	80031
MIM609297		5p15.2	SEMAPHORIN 5A; SEMA5A	9037
MIM609298		 	SEMAPHORIN 5B; SEMA5B	54437
MIM609299	C1836436	3p26	PROSTATE CANCER, HEREDITARY, 5	619402
MIM609300		10q24.3	CYTOCHROME P450, FAMILY 17, SUBFAMILY A, POLYPEPTIDE 1; CYP17A1	1586
MIM609301		 	p53 EFFECTOR RELATED TO PMP22; PERP	64065
MIM609302		11p15.5	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, GLUTAMATE), MEMBER 22; SLC25A22	79751
MIM609303		22q11.2	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, GLUTAMATE), MEMBER 18; SLC25A18	83733
MIM609304	C0270855	11p15.5	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	79751
MIM609305		3q25.3	LATEXIN; LXN	56925
MIM609306	C1836395	19p13.3	SPINOCEREBELLAR ATAXIA 26; SCA26	408221
MIM609307	C1836383	13q34	SPINOCEREBELLAR ATAXIA 27; SCA27	2259
MIM609308	C1836373	9q34.1	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1	10585
MIM609309		2p22-p21	MutS, E. COLI, HOMOLOG OF, 2; MSH2	4436
MIM609310	C1333991	3p21.3	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2; HNPCC2	4292
MIM609311	C1836336	12p11.2	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	121512
MIM609312		9q34	DOPAMINE BETA-HYDROXYLASE, PLASMA; DBH	1621
MIM609313	C1836330	7q22	ERYTHROKERATODERMIA VARIABILIS 3	574017
MIM609314		21q22.3	TESTIS-SPECIFIC PROTEIN 2; TSGA2	89765
MIM609315		5q35.3	TRIPARTITE MOTIF-CONTAINING PROTEIN 7; TRIM7	81786
MIM609316		6p23-p21	TRIPARTITE MOTIF-CONTAINING PROTEIN 31; TRIM31	11074
MIM609317		5q22.3	TRIPARTITE MOTIF-CONTAINING PROTEIN 36; TRIM36	55521
MIM609318		1p22	TRIPARTITE MOTIF-CONTAINING PROTEIN 45; TRIM45	80263
MIM609319	C1969258	6q23	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HCHGQ1	100381204
MIM609320	C1969257	9q	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2; HCHGQ2	100381205
MIM609321		1p21.2	SAS6, C. ELEGANS, HOMOLOG OF; SASS6	163786
MIM609322	C1836327	22q11	RHABDOID TUMOR PREDISPOSITION SYNDROME 1; RTPS1	6598
MIM609323		6q23.3	OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 3; OLIG3	167826
MIM609326		 	MICRO RNA 1-1; MIRN1-1	406904
MIM609327		8p23.1	MICRO RNA 124-1; MIR124-1	406907
MIM609328		9q34.2	URIDINE/CYTIDINE KINASE 1; UCK1	83549
MIM609329		1q22-q23.2	URIDINE/CYTIDINE KINASE 2; UCK2	7371
MIM609330		10q21.3	ONCOPROTEIN-INDUCED TRANSCRIPT 3, MOUSE, HOMOLOG OF; OIT3	170392
MIM609331		20q13	BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E23; BHLHE23	128408
MIM609332		2p21	TETRATRICOPEPTIDE REPEAT DOMAIN 7A; TTC7A	57217
MIM609333		6q23.1	TRACE AMINE-ASSOCIATED RECEPTOR 1; TAAR1	134864
MIM609334	C1836305	18q22	CHROMOSOME 18 PERICENTRIC INVERSION	100240739
MIM609335		 	CHROMOSOME 1 OPEN READING FRAME 27; C1ORF27	54953
MIM609336		19p13.2	ANGIOPOIETIN-LIKE 6; ANGPTL6	83854
MIM609337		21q21.3	MICRO RNA 155; MIRN155	406947
MIM609338	C1836302	3p25	CAROTID INTIMAL MEDIAL THICKNESS 1	5468
MIM609340	C1836295	14q21.3-q22.3	SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE; SPG28	548316
MIM609341		16p13.3	TRYPTASE, GAMMA-1; TPSG1	25823
MIM609342		11q13	GASTRIC INTRINSIC FACTOR; GIF	2694
MIM609343		16p13.3	PROTEASE, SERINE, 22; PRSS22	64063
MIM609344		7q32.3	KIELIN/CHORDIN-LIKE PROTEIN	375616
MIM609346		19p13.3	RECEPTOR EXPRESSION-ENHANCING PROTEIN 6; REEP6	92840
MIM609347		5q31	RECEPTOR EXPRESSION-ENHANCING PROTEIN 2; REEP2	51308
MIM609348		10q21.3	RECEPTOR EXPRESSION-ENHANCING PROTEIN 3; REEP3	221035
MIM609349		8p21.3	RECEPTOR EXPRESSION-ENHANCING PROTEIN 4; REEP4	80346
MIM609350		3q27	RECEPTOR-TRANSPORTING PROTEIN 4; RTP4	64108
MIM609351		13q14.3	ADP-RIBOSYLATION FACTOR-LIKE 11; ARL11	115761
MIM609352	C1836284	12q13	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MIGRATORY CIRCINATE ERYTHEMA	3852
MIM609353		8p21.1	ESTABLISHMENT OF COHESION 1, S. CEREVISIAE, HOMOLOG OF, 2; ESCO2	157570
MIM609354	C1836276	11q23	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 5; BMND5	554315
MIM609355		9q31.3	MICRO RNA 32; MIRN32	407036
MIM609356		17q11.2	NUCLEAR FRAGILE X MENTAL RETARDATION PROTEIN-INTERACTING PROTEIN 2; NUFIP2	57532
MIM609357		10p13	MINICHROMOSOME MAINTENANCE 10, S. CEREVISIAE, HOMOLOG OF; MCM10	55388
MIM609358		19q13.1	ETS VARIANT GENE 2; ETV2	2116
MIM609359		2p24.1	HS1-BINDING PROTEIN 3; HS1BP3	64342
MIM609360		10q23.33	RENALASE; RNLS	55328
MIM609361		2q33.1	MOB1-LIKE PROTEIN 3; MOBKL3	25843
MIM609362		16q22.1	LYSOPHOSPHOLIPASE 3; LYPLA3	23659
MIM609364		19q13.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 2; NLRP2	55655
MIM609365		1p34.3	GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 2; GNL2	29889
MIM609366		11p15.3	SH2 DOMAIN-BINDING PROTEIN 1; SH2BP1	9646
MIM609367		10q22.1	KIAA1279 GENE; KIAA1279	26128
MIM609368		2p22.3	ATLASTIN GTPase 2; ATL2	64225
MIM609369		11q13.1	ATLASTIN GTPase 3; ATL3	25923
MIM609370		20p13	SERINE/THREONINE KINASE 35; STK35	140901
MIM609371		 	CHROMOSOME 5 OPEN READING FRAME 5; C5ORF5	51306
MIM609372		 	FAMILY WITH SEQUENCE SIMILARITY 53, MEMBER C; FAM53C	51307
MIM609373		 	LYSINE-SPECIFIC DEMETHYLASE 3B; KDM3B	51780
MIM609374		11q12.1	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 5; CDCA5	113130
MIM609375		 	LIN9, C. ELEGANS, HOMOLOG OF; LIN9	286826
MIM609376	C1836272	19q13	CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 1; CATCN1	619404
MIM609377		16q22.1	ACD, MOUSE, HOMOLOG OF; ACD	65057
MIM609378	C1836271	17q11	AUTISM, SUSCEPTIBILITY TO, 6; AUTS6	554314
MIM609379		9q34	LIPOCALIN 6; LCN6	158062
MIM609380		 	LEISHMANOLYSIN-LIKE; LMLN	89782
MIM609381		3q13.3	SYNTAXIN-BINDING PROTEIN 5-LIKE; STXBP5L	9515
MIM609382		 	IMMEDIATE-EARLY RESPONSE 3-INTERACTING PROTEIN 1; IER3IP1	51124
MIM609383		5q33	NIPA-LIKE DOMAIN-CONTAINING 4; NIPAL4	348938
MIM609385		5q31.3	DEAD END, ZEBRAFISH, HOMOLOG OF, 1; DND1	373863
MIM609386		9q21.11	STRUCTURAL MAINTENANCE OF CHROMOSOMES 5; SMC5	23137
MIM609387		2p24.2	STRUCTURAL MAINTENANCE OF CHROMOSOMES 6; SMC6	79677
MIM609388		 	DORA REVERSE STRAND	51108
MIM609389		 	INOSITOL POLYPHOSPHATE 5-PHOSPHATASE F; INPP5F	22876
MIM609390		6q21	FIG4, S. CEREVISIAE, HOMOLOG OF; FIG4	9896
MIM609391		 	TRANSCRIPTION FACTOR Sp5; SP5	389058
MIM609392		 	KRUPPEL-LIKE FACTOR 3; KLF3	51274
MIM609393		 	KRUPPEL-LIKE FACTOR 14; KLF14	136259
MIM609394		 	SPINDLE POLE BODY COMPONENT 24, S. CEREVISIAE, HOMOLOG OF; SPBC24	147841
MIM609395		 	SPINDLE POLE BODY COMPONENT 25, S. CEREVISIAE, HOMOLOG OF; SPBC25	57405
MIM609396		 	PH DOMAIN AND LEUCINE-RICH REPEAT PROTEIN PHOSPHATASE; PHLPP	23239
MIM609397		10q22.1	STORKHEAD BOX 1; STOX1	219736
MIM609398		 	ATPase, H+ TRANSPORTING, LYSOSOMAL, 34-KD, V1 SUBUNIT D; ATP6V1D	51382
MIM609399		15q22	SPERM EQUATORIAL SEGMENT PROTEIN 1; SPESP1	246777
MIM609400	C1836258	4q13-q21	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 4; AIS4	619405
MIM609401		13q32-q33	HEPARAN SULFATE 6-O-SULFOTRANSFERASE 3; HS6ST3	266722
MIM609402	C1836257	2p25	PREECLAMPSIA/ECLAMPSIA 2; PEE2	780908
MIM609403	C1836256	9p13	PREECLAMPSIA/ECLAMPSIA 3; PEE3	780909
MIM609404	C1836255	 	PREECLAMPSIA/ECLAMPSIA 4; PEE4	219736
MIM609405		22q13.31	RHO GTPase-ACTIVATING PROTEIN 8; ARHGAP8	23779
MIM609406		22q13.31	PROLINE-RICH PROTEIN 5; PRR5	55615
MIM609407		6q22.31	HEPARAN SULFATE 3-O-SULFOTRANSFERASE 5; HS3ST5	222537
MIM609408	C1836254	14q13	HOLOPROSENCEPHALY 8; HPE8	619406
MIM609409		5q31	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A0; HNRNPA0	10949
MIM609410		6q25.3	SYNAPTOJANIN 2; SYNJ2	8871
MIM609411		14q24.2	SYNAPTOJANIN 2-BINDING PROTEIN; SYNJ2BP	55333
MIM609412		5q12	EXCISION-REPAIR CROSS-COMPLEMENTING, GROUP 8; ERCC8	1161
MIM609413		10q11	EXCISION-REPAIR CROSS-COMPLEMENTING, GROUP 6; ERCC6	2074
MIM609414		2q35	PHOSPHOINOSITIDE KINASE, FYVE FINGER-CONTAINING; PIKFYVE	200576
MIM609415		13q31.3	MICRO RNA 17 HOST GENE; MIR17HG	407975
MIM609416		13q31.3	MICRO RNA 17; MIR17	406952
MIM609417		13q31.3	MICRO RNA 18A; MIRN18A	406953
MIM609418		13q31.3	MICRO RNA 19A; MIRN19A	406979
MIM609419		13q31.3	MICRO RNA 19B1; MIR19B1	406980
MIM609420		13q31.3	MICRO RNA 20A; MIR20A	406982
MIM609422		13q31.3	MICRO RNA 92A1; MIR92A1	407048
MIM609423	C1836230	17q21.1-q21.2, 17q12, 17q11.2-q12, 17q11.2, 16p12.1-p11.2, 12q14, 10q11.1, 6p21.3, 3pter-p21, 2q35, 19q13.4, 19p13.3	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO	1234, 1524, 30835, 3107, 3458, 3566, 3577, 3586, 3811, 6347, 6348, 6349, 6356, 6387
MIM609424		1q25.1	RING FINGER AND CCCH-TYPE ZINC FINGER DOMAINS-CONTAINING 1; RC3H1	149041
MIM609425	C2674949	3q29	CHROMOSOME 3q29 DELETION SYNDROME	100188788
MIM609426		17p13.1	MISSHAPEN/NIK-RELATED KINASE 1; MINK1	50488
MIM609427		6p21.3	LHFP-LIKE PROTEIN 5; LHFPL5	222662
MIM609428	C1836217	21q22	TUKEL SYNDROME	574049
MIM609429		12q24.1	FORKHEAD BOX N4; FOXN4	121643
MIM609430		14q13	NEURONAL PAS DOMAIN PROTEIN 3; NPAS3	64067
MIM609431		14q13.3	MAP3K12-BINDING INHIBITORY PROTEIN; MBIP	51562
MIM609432	C1836206	 	SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION; MSSD	619407
MIM609433		5q35	UBIQUITIN INTERACTION MOTIF-CONTAINING PROTEIN 1; UIMC1	51720
MIM609434		17q21.3	LUC7, S. CEREVISIAE, HOMOLOG OF, 3; LUC7L3	51747
MIM609435		19p13.2-p13.1	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 13; NDUFA13	51079
MIM609436		19q13	FIBROBLAST GROWTH FACTOR 21; FGF21	26291
MIM609437		1p34.3	SERINE/THREONINE PROTEIN KINASE 40; STK40	83931
MIM609439	C1836199	 	DEAFNESS, AUTOSOMAL RECESSIVE 48; DFNB48	10518, 404086
MIM609440		1p34.3	UTP11-LIKE PROTEIN; UTP11L	51118
MIM609441	C1836182	4q23-q24	CHONDRODYSPLASIA, ACROMESOMELIC, WITH GENITAL ANOMALIES	658
MIM609443		1p36.2	CHYMOTRYPSIN-LIKE ELASTASE FAMILY, MEMBER 2A; CELA2A	63036
MIM609444		1p36.2	CHYMOTRYPSIN-LIKE ELASTASE FAMILY, MEMBER 2B; CELA2B	51032
MIM609445		5p15.1-p14	RELAXIN 3 RECEPTOR 1; RLN3R1	51289
MIM609446	C1836173	10q22.3	GENERALIZED EPILEPSY AND PAROXYSMAL DYSKINESIA; GEPD	3778
MIM609447		5q31.2	PROAPOPTOTIC CASPASE ADAPTOR PROTEIN	51237
MIM609448		1p32.3	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 12; TXNDC12	51060
MIM609449		16p13.1	NUDE, A. NIDULANS, HOMOLOG OF, 1; NDE1	54820
MIM609450		5q35.3	MAX DIMERIZATION PROTEIN 3; MXD3	83463
MIM609451		16q22.1	ZINC FINGER PROTEIN 90, MOUSE, HOMOLOG OF; ZFP90	146198
MIM609452	C1836155	10q22.2-q23.3	MYOPATHY, MYOFIBRILLAR, 4; MFM4	11155
MIM609453		 	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 7; GOLGA7	51125
MIM609454	C1836148	1q31.1	SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	619408
MIM609455		 	PROLINE-, GLUTAMIC ACID-, AND LEUCINE-RICH PROTEIN 1	27043
MIM609456	C1836133	 	MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	619409
MIM609457		12q22-q23	HISTIDINE AMMONIA-LYASE; HAL	3034
MIM609458		19cen-q12	MANNOSIDASE, ALPHA, CLASS 2B, MEMBER 1; MAN2B1	4125
MIM609459		22q11	DIGEORGE SYNDROME CRITICAL REGION GENE 6-LIKE; DGCR6L	85359
MIM609460	C1836123	10q22.1	GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	26128
MIM609461		 	TRIBBLES, DROSOPHILA, HOMOLOG OF, 1; TRIB1	10221
MIM609462		 	TRIBBLES, DROSOPHILA, HOMOLOG OF, 2; TRIB2	28951
MIM609463		 	MKL1/MYOCARDIN-LIKE 2; MKL2	57496
MIM609464	C1836122	16q12	SARCOIDOSIS, EARLY-ONSET	64127
MIM609467		 	CHEMOKINE, CC MOTIF, LIGAND 3-LIKE 2; CCL3L2	390788
MIM609468		 	CHEMOKINE, CC MOTIF, LIGAND 3-LIKE 3; CCL3L3	414062
MIM609469	C1836119	11q24	NEPHROPATHY, PROGRESSIVE, WITH DEAFNESS	619410
MIM609470	C1836118	11p15	LEFT VENTRICULAR NONCOMPACTION 2; LVNC2	619411
MIM609471		 	GLUCOSIDASE, BETA, ACID 2; GBA2	57704
MIM609472		 	CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-4; CNGA4	1262
MIM609473		 	CINGULIN, XENOPUS, HOMOLOG OF; CGN	57530
MIM609474		 	NEURONAL PENTRAXIN RECEPTOR; NPTXR	23467
MIM609475		 	A-KINASE ANCHOR PROTEIN 8-LIKE PROTEIN; AKAP8L	26993
MIM609476		 	NEMO-LIKE KINASE; NLK	51701
MIM609477		 	CHROMOSOME 11 OPEN READING FRAME 75; C11ORF75	56935
MIM609478		 	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 3; ST8SIA3	51046
MIM609479		2q24.2	LEUCINE ZIPPER- AND STERILE ALPHA MOTIF-CONTAINING KINASE	51776
MIM609481		 	ISL2 TRANSCRIPTION FACTOR, LIM/HOMEODOMAIN; ISL2	64843
MIM609482		7p21.3	ANTERIOR GRADIENT 3, XENOPUS, HOMOLOG OF; AGR3	155465
MIM609483		8q24.21	FAMILY WITH SEQUENCE SIMILARITY 84, MEMBER B; FAM84B	157638
MIM609484		19q13.1-q13.2	LY6/PLAUR DOMAIN-CONTAINING PROTEIN 3; LYPD3	27076
MIM609485		 	MODULATOR OF APOPTOSIS 1; MOAP1	64112
MIM609486		 	E2F-ASSOCIATED PHOSPHOPROTEIN	55837
MIM609487		 	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 2; MAP3K2	10746
MIM609488		4q35.1	CANCER/TESTIS ANTIGEN KM-HN-1	256309
MIM609489		4q22-q25	MANNOSIDASE, BETA A, LYSOSOMAL; MANBA	4126
MIM609490		11q22	INHIBITORY CASPASE RECRUITMENT DOMAIN PROTEIN	440068
MIM609491		 	G PROTEIN SIGNALING MODULATOR 1; GPSM1	26086
MIM609492		 	RAS ASSOCIATION DOMAIN FAMILY PROTEIN 2; RASSF2	9770
MIM609493		 	SLC2A4 REGULATOR; SLC2A4RG	56731
MIM609494		 	ZINC FINGER PROTEIN 395; ZNF395	55893
MIM609495		 	GAMETOGENETIN-BINDING PROTEIN 1; GGNBP1	449520
MIM609497		5q15	LEUKOCYTE-DERIVED ARGININE AMINOPEPTIDASE	64167
MIM609498		17q12	F-BOX ONLY PROTEIN 47	494188
MIM609499		 	MCF2-LIKE PROTEIN; MCF2L	23263
MIM609501		 	TUDOR AND KH DOMAINS-CONTAINING PROTEIN; TDRKH	11022
MIM609502		10q23.1	CADHERIN-RELATED FAMILY, MEMBER 1; CDHR1	92211
MIM609503		 	TESTICULAR HAPLOID EXPRESSED GENE, MOUSE, HOMOLOG OF; THEG	51298
MIM609504		 	MICROSPHERULE PROTEIN 1; MCRS1	10445
MIM609505		 	TRIPARTITE MOTIF-CONTAINING PROTEIN 16; TRIM16	10626
MIM609506		12q13.1-q13.3	CYTOCHROME P450, SUBFAMILY XXVIIB, POLYPEPTIDE 1; CYP27B1	1594
MIM609507		9p21	TOPOISOMERASE I-BINDING ARGININE/SERINE-RICH PROTEIN; TOPORS	10210
MIM609508	C1836080	 	STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR	1280
MIM609509		 	INTERLEUKIN 31; IL31	386653
MIM609510		5q11.2	INTERLEUKIN 31 RECEPTOR A; IL31RA	133396
MIM609511		 	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 20; ZFYVE20	64145
MIM609512		3p11.2	CHMP FAMILY, MEMBER 2B; CHMP2B	25978
MIM609513		10q26.2	NEUROPEPTIDE S	594857
MIM609514		 	TAUBE NUSS, MOUSE, HOMOLOG OF; TBN	129685
MIM609516		 	ZINC FINGER PROTEIN 382; ZNF382	84911
MIM609517		17q11.2	TGFB1-INDUCED ANTIAPOPTOTIC FACTOR 1; TIAF1	9220
MIM609518		 	THAP DOMAIN-CONTAINING PROTEIN 7; THAP7	80764
MIM609519		 	TCF3 FUSION PARTNER; TFPT	29844
MIM609520		8p11.21	THAP DOMAIN-CONTAINING PROTEIN 1; THAP1	55145
MIM609521		1q32.3	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 1; SLC30A1	7779
MIM609522		 	TRANSCRIPTION ELONGATION FACTOR B, POLYPEPTIDE 3B; TCEB3B	51224
MIM609523		17p11.2	ALDEHYDE DEHYDROGENASE, FAMILY 3, SUBFAMILY A, MEMBER 2; ALDH3A2	224
MIM609524	C1836050	7q32	MYOPATHY, MYOFIBRILLAR, 5; MFM5	2318
MIM609525		 	TENSION-INDUCED/INHIBITED PROTEIN	79828
MIM609526		16q22.1	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY G, MEMBER 4; PLEKHG4	25894
MIM609527		 	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 5; RAPGEF5	9771
MIM609528	C1836033	22q11.2	CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME	9342
MIM609529	C1836032	17p11.2	IMMUNOGLOBULIN A DEFICIENCY 2; IGAD2	23495
MIM609530		 	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; RAPGEF2	9693
MIM609531		 	RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 3; RASGRP3	25780
MIM609532	C1835407	12q14, 3p21, 19q13.13, 1q31-q32	HEPATITIS C VIRUS, SUSCEPTIBILITY TO	1234, 282617, 3458, 5788
MIM609533	C1836027	10q21-q22	DEAFNESS, AUTOSOMAL RECESSIVE 23; DFNB23	65217
MIM609534		 	CHROMOSOME 17 OPEN READING FRAME 41; C17ORF41	79915
MIM609535	C1836023	10q24.1-q24.3	DRUG METABOLISM, POOR, CYP2C19-RELATED	1557
MIM609536	C0343047	9q34.1	COMPLEMENT COMPONENT 5 DEFICIENCY; C5D	727
MIM609538		 	PROTEIN-TYROSINE PHOSPHATASE, MITOCHONDRIAL, 1; PTPMT1	114971
MIM609539		 	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 2; ARID2	196528
MIM609540		 	WD REPEAT-CONTAINING PROTEIN 61; WDR61	80349
MIM609541	C1836010	11q13	SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	619394
MIM609542		 	ATPase, CLASS I, TYPE 8A, MEMBER 1; ATP8A1	10396
MIM609543		 	BEYLA GENE	497634
MIM609544		16p12.3	CENTROSOMAL PROTEIN, 110-KD	9738
MIM609546		 	UBIQUITIN-SPECIFIC PROTEASE 29; USP29	57663
MIM609548		 	LMAN1-LIKE PROTEIN; LMAN1L	79748
MIM609549	C1836006	 	NANOPHTHALMOS 2; NNO2	83552
MIM609550		4q31.1-q31.2	ZINC FINGER PROTEIN 330; ZNF330	27309
MIM609551		 	LECTIN, MANNOSE-BINDING, 2; LMAN2	10960
MIM609552		 	LMAN2-LIKE PROTEIN; LMAN2L	81562
MIM609553		19p13	RETBINDIN	83546
MIM609554		2q37	INTEGRAL MEMBRANE PROTEIN 2C; ITM2C	81618
MIM609555		 	CARBOXYPEPTIDASE X, M14 FAMILY; CPXM	56265
MIM609556		 	ATPase, TYPE 13A4; ATP13A4	84239
MIM609557		2p21	PROLYL ENDOPEPTIDASE-LIKE; PREPL	9581
MIM609558	C1836005	22q12.3	PROSTATE CANCER, HEREDITARY, 6	100188789
MIM609559		 	CHROMOSOME 2 OPEN READING FRAME 34; C2ORF34	79823
MIM609560	C3149750	16q22	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE); MTDPS2	7084
MIM609561		 	CARBOXYPEPTIDASE A5; CPA5	93979
MIM609562		 	CARBOXYPEPTIDASE A6; CPA6	57094
MIM609563		 	CARBOXYPEPTIDASE O; CPO	130749
MIM609564		 	POLY(ADP-RIBOSE) POLYMERASE 10; PARP10	84875
MIM609565		 	MAST CELL-EXPRESSED MEMBRANE PROTEIN 1	199675
MIM609566	C1835980	 	PARIETAL FORAMINA 3; PFM3	619475
MIM609567		22q13	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 3; PNPLA3	80339
MIM609568		 	RHO GTPase-ACTIVATING PROTEIN 20; ARHGAP20	57569
MIM609570	C1835968	5q21	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 8	100188790
MIM609571		 	ZINC FINGER PROTEIN 699; ZNF699	374879
MIM609572	C1835967	13q31.3	PHOTOPAROXYSMAL RESPONSE 2; PPR2	780910
MIM609573	C1835966	7q32	PHOTOPAROXYSMAL RESPONSE 3; PPR3	619471
MIM609574		 	17-@BETA-HYDROXYSTEROID DEHYDROGENASE XII; HSD17B12	51144
MIM609575		17p13	ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN; ACADVL	37
MIM609576		2q34-q35	ACYL-CoA DEHYDROGENASE, LONG-CHAIN; ACADL	33
MIM609577		6p21.1	CULLIN 7; CUL7	9820
MIM609578	C1865071	10q23.3	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 2; RCM2	619468
MIM609579	C1865070	 	SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION	2263
MIM609580		 	NINEIN-LIKE PROTEIN; NINL	22981
MIM609582		18q21	MICRO RNA 122A; MIRN122A	406906
MIM609583	C1846790	2q13	JOUBERT SYNDROME 4; JBTS4	4867
MIM609584		14q22.1	L-2-HYDROXYGLUTARATE DEHYDROGENASE; L2HGDH	79944
MIM609585		 	COMPLEXIN 3; CPLX3	594855
MIM609586		 	COMPLEXIN 4; CPLX4	339302
MIM609587		 	REGULATOR OF CHROMOSOME CONDENSATION 2; RCC2	55920
MIM609588		14q32	GLUTAREDOXIN 5; GLRX5	51218
MIM609589		 	MITOCHONDRIAL TUMOR SUPPRESSOR GENE 1; MTUS1	57509
MIM609590		 	QUAKING, MOUSE, HOMOLOG OF; QKI	9444
MIM609591		 	RIC-LIKE PROTEIN WITHOUT CAAX MOTIF 1; RIT1	6016
MIM609592		 	RIC-LIKE PROTEIN WITHOUT CAAX MOTIF 2; RIT2	6014
MIM609593		6p22.2	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 16A; LRRC16A	55604
MIM609594		3q24-q25	VENTRICULAR ZONE-EXPRESSED PH DOMAIN-CONTAINING PROTEIN, ZEBRAFISH, HOMOLOG OF, 1; VEPH1	79674
MIM609595		1p34.3	R-SPONDIN FAMILY, MEMBER 1; RSPO1	284654
MIM609596		19q13.2	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT K; EIF3K	27335
MIM609597	C1865044	11p11.2	PARIETAL FORAMINA 2; PFM2	60529
MIM609598		20q12	ZINC FINGER AND HOMEODOMAIN PROTEIN 3; ZHX3	23051
MIM609599		 	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 1; ANKRD1	27063
MIM609600		18q12	ZINC FINGER PROTEIN 396; ZNF396	252884
MIM609601		18q12	ZINC FINGER PROTEIN 397; ZNF397	84307
MIM609602		1p34.1	ZINC FINGER PROTEIN 393; ZNF393	128209
MIM609603		 	CRYSTALLIN, GAMMA-N; CRYGN	155051
MIM609604		 	MICROTUBULE-ASSOCIATED PROTEIN 1, LIGHT CHAIN 3, BETA; MAP1LC3B	81631
MIM609605		 	MICROTUBULE-ASSOCIATED PROTEIN 1, LIGHT CHAIN 3, GAMMA; MAP1LC3C	440738
MIM609606		 	AUTOPHAGY 3, S. CEREVISIAE, HOMOLOG OF; ATG3	64422
MIM609607		1q23.3	POLIOVIRUS RECEPTOR-LIKE 4; PVRL4	81607
MIM609608		 	AUTOPHAGY 12, S. CEREVISIAE, HOMOLOG OF; ATG12	9140
MIM609610		15q15	TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 4; TUBGCP4	27229
MIM609611		1q22	ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER E; ANP32E	81611
MIM609613		 	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY M, MEMBER 2; PLEKHM2	23207
MIM609614		19p13.3	RNA EXONUCLEASE 1, S. CEREVISIAE, HOMOLOG OF; REXO1	57455
MIM609615		19p13.2	QUEUINE tRNA-RIBOSYLTRANSFERASE 1; QTRT1	81890
MIM609617		1p36.11	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 2; SLC30A2	7780
MIM609618		 	NONCODING REPRESSOR OF NFAT; NRON	641373
MIM609619		15q14	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 8B; GOLGA8B	440270
MIM609620	C1865020	7q35-q36	SHORT QT SYNDROME 1; SQT1	3757
MIM609621	C1865019	11p15.5	SHORT QT SYNDROME 2; SQT2	3784
MIM609622	C1865018	17q23.1-q24.2	SHORT QT SYNDROME 3; SQT3	3759
MIM609623		19q13.33	RAS-INTERACTING PROTEIN 1; RASIP1	54922
MIM609624		6p21.3	MITOCHONDRIAL COILED-COIL DOMAIN 1; MCCD1	401250
MIM609625	C2674937	10q26	CHROMOSOME 10q26 DELETION SYNDROME	780911
MIM609626		6p21	MAM DOMAIN-CONTAINING GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR 1; MDGA1	266727
MIM609627		12p13.2	TASTE RECEPTOR, TYPE 2, MEMBER 50; TAS2R50	259296
MIM609628	C1864997	18p	MAJEED SYNDROME	9663
MIM609630	C1864995	11q13.3	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 1	100188791
MIM609631		 	DEAD BOX POLYPEPTIDE 58; DDX58	23586
MIM609632		11q13.4-q13.5	GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE DOMAIN-CONTAINING PROTEIN 5; GDPD5	81544
MIM609633	C1864994	21q22.13	MAJOR AFFECTIVE DISORDER 3; MAFD3	100188792
MIM609634	C1864987	2q24	MIGRAINE, FAMILIAL HEMIPLEGIC, 3; FHM3	6323
MIM609635		2p24-p23	TRANSCRIPTION FACTOR 23; TCF23	150921
MIM609636	C1864828	7q36	ALZHEIMER DISEASE 10	780912
MIM609637	C1864827	13q32	HOLOPROSENCEPHALY 5; HPE5	7546
MIM609638	C1864826	6p24	EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC	1832
MIM609639		16p13.3	HEMOGLOBIN MU	3042
MIM609641		11p13	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT M; EIF3M	10480
MIM609642		 	T-CELL ANTIGEN RECEPTOR, GAMMA SUBUNIT, ALTERNATE READING FRAME PROTEIN	445347
MIM609644		14q21.3	FANCM GENE; FANCM	57697
MIM609645		19q13.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 4; NLRP4	147945
MIM609646	C1864818	 	DEAFNESS, AUTOSOMAL RECESSIVE 42; DFNB42	286676
MIM609647	C1864815	18p11.32-p11.31	DEAFNESS, AUTOSOMAL RECESSIVE 46; DFNB46	449488
MIM609648		19q13.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 12; NLRP12	91662
MIM609649	C1864801	3p24-p21.2	TRICHILEMMAL CYST 1; TRICY1	94014
MIM609650		11p15.5	NLR FAMILY, PYRIN DOMAIN-CONTAINING 6; NLRP6	171389
MIM609651		 	GLYCOPROTEIN HORMONE, ALPHA-2; GPHA2	170589
MIM609652		 	GLYCOPROTEIN HORMONE, BETA-5; GPHB5	122876
MIM609653		5q12.1	NADH DEHYDROGENASE 1 ALPHA SUBCOMPLEX, ASSEMBLY FACTOR 2; NDUFAF2	91942
MIM609656	C1864783	17q23	BONE SIZE QUANTITATIVE TRAIT LOCUS 1	100188793
MIM609657	C1864782	5q	BONE SIZE QUANTITATIVE TRAIT LOCUS 2	100188794
MIM609658		19q13	NLR FAMILY, PYRIN DOMAIN-CONTAINING 5; NLRP5	126206
MIM609659		19q13.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 8; NLRP8	126205
MIM609660		19q13.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 13; NLRP13	126204
MIM609661		19q13.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 7; NLRP7	199713
MIM609662		11p15	NLR FAMILY, PYRIN DOMAIN-CONTAINING 10; NLRP10	338322
MIM609663		19q13.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 9; NLRP9	338321
MIM609664		19q13.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 11; NLRP11	204801
MIM609665		11p15.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 14; NLRP14	338323
MIM609666		12q24.1	TWO-PORE SEGMENT CHANNEL 1; TPCN1	53373
MIM609667		6q25.3	T-CELL ACTIVATION GTPase-ACTIVATING PROTEIN; TAGAP	117289
MIM609668		12q24.1	PTC7 PROTEIN PHOSPHATASE, S. CEREVISIAE, HOMOLOG OF; PPTC7	160760
MIM609669		5q21.3-q22.1	WD REPEAT-CONTAINING PROTEIN 36; WDR36	134430
MIM609670	C1864772	11q24	MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 9	100415943
MIM609671		2q14.2	SIX-TRANSMEMBRANE EPITHELIAL ANTIGEN OF PROSTATE 3; STEAP3	55240
MIM609672		10q23.33	EXOCYST COMPLEX COMPONENT 6; EXOC6	54536
MIM609673		11q22.3	PLATELET-DERIVED GROWTH FACTOR D; PDGFD	80310
MIM609674		18q11.2	ESTABLISHMENT OF COHESION 1, S. CEREVISIAE, HOMOLOG OF, 1; ESCO1	114799
MIM609675		7p21.2	SCLEROSTIN DOMAIN-CONTAINING PROTEIN 1; SOSTDC1	25928
MIM609676		20p13	MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; MAVS	57506
MIM609677		12q13	AMPLIFIED IN OSTEOSARCOMA 9	10956
MIM609678		13q31	SLIT- AND NTRK-LIKE FAMILY, MEMBER 1; SLITRK1	114798
MIM609679		3q26	SLIT- AND NTRK-LIKE FAMILY, MEMBER 3; SLITRK3	22865
MIM609680		13q31	SLIT- AND NTRK-LIKE FAMILY, MEMBER 5; SLITRK5	26050
MIM609681		13q31	SLIT- AND NTRK-LIKE FAMILY, MEMBER 6; SLITRK6	84189
MIM609682		10q25.1	DNA CROSS-LINK REPAIR PROTEIN 1A; DCLRE1A	9937
MIM609683		1p13.3-p13.1	DNA CROSS-LINK REPAIR PROTEIN 1B; DCLRE1B	64858
MIM609684		 	MAL PROTEOLIPID PROTEIN 2; MAL2	114569
MIM609685		7p15	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 7-LIKE; CDCA7L	55536
MIM609686		13q32	CITRATE LYASE BETA-LIKE; CLYBL	171425
MIM609687		12q13	MICRO RNA 196A2; MIRN196A2	406973
MIM609688		7p15-p14.2	MICRO RNA 196B; MIRN196B	442920
MIM609689		20q11.2	CENTROSOMAL PROTEIN 2; CEP2	11190
MIM609690		2q36	PHENYLALANINE-tRNA SYNTHETASE, BETA SUBUNIT; FARSB	10056
MIM609691		18q12.2	FORMIN HOMOLOGY-2 DOMAIN-CONTAINING PROTEIN 3; FHOD3	80206
MIM609692		17q21.2	WAS/WASL-INTERACTING PROTEIN FAMILY, MEMBER 2; WIPF2	147179
MIM609693		6p21.33	VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 7; VWA7	80737
MIM609694		19p12-p11	GEM-INTERACTING PROTEIN; GMIP	51291
MIM609695		12q24-qter	4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE; HPD	3242
MIM609696		1q42.1-q43	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 4B; ARID4B	51742
MIM609697		2q14.3	SIN3A-ASSOCIATED PROTEIN, 130-KD	79595
MIM609698	C1864761	9q22.2	THYROID HORMONE METABOLISM, ABNORMAL	79048
MIM609699		3p21.3	MONOGLYCERIDE LIPASE; MGLL	11343
MIM609700		7q11.21	RAB GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; RABGEF1	27342
MIM609701		17q21	N-ACETYLGLUCOSAMINIDASE, ALPHA-; NAGLU	4669
MIM609702		18p11.21	PROTEASOME-ASSEMBLING CHAPERONE 2; PSMG2	56984
MIM609703		13q14.3	MICRO RNA 15A; MIR15A	406948
MIM609704		13q14.3	MICRO RNA 16-1; MIR16-1	406950
MIM609705		9q22.32	MICRO RNA 24-1; MIRN24-1	407012
MIM609706	C1864746	6p21.3	DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53	1302
MIM609707		16q22.1	DIHYDROURIDINE SYNTHASE 2-LIKE; DUS2L	54920
MIM609708		8p22	LIPOPROTEIN LIPASE; LPL	4023
MIM609709		11p11.2	GLYCOSYLTRANSFERASE-LIKE 1B; GYLTL1B	120071
MIM609710		5q31.1	DENDRITIC CELL NUCLEAR PROTEIN 1	140947
MIM609711		19p13.3	UBIQUINOL-CYTOCHROME c REDUCTASE, 6.4-KD SUBUNIT; UQCR	10975
MIM609712		1q21	PYRUVATE KINASE, LIVER AND RED BLOOD CELL; PKLR	5313
MIM609713		6p25.3-p25.1	HYDROXYUREA-SENSITIVE 1, S. POMBE, HOMOLOG OF, B; HUS1B	135458
MIM609714		6p21.1	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 1; TREML1	340205
MIM609715		6p21.1	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 2; TREML2	79865
MIM609716		6p21.1	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 3; TREML3	340206
MIM609717		4q21.1	GENE DIFFERENTIALLY EXPRESSED IN PROSTATE	118425
MIM609718		5q14.1	LHFP-LIKE PROTEIN 2; LHFPL2	10184
MIM609719		7q22.1	LHFP-LIKE PROTEIN 3; LHFPL3	375612
MIM609720		9q33.3	CRUMBS, DROSOPHILA, HOMOLOG OF, 2; CRB2	286204
MIM609721		7p13-p12	POLYCYSTIN 1-LIKE 1; PKD1L1	168507
MIM609722		8p21.2	PDZ AND LIM DOMAIN PROTEIN 2; PDLIM2	64236
MIM609723		17q23.2	YIPPEE-LIKE 2; YPEL2	388403
MIM609724		16p11.2	YIPPEE-LIKE 3; YPEL3	83719
MIM609725		11q12.1	YIPPEE-LIKE 4; YPEL4	219539
MIM609726		2p23.1	YIPPEE-LIKE 5; YPEL5	51646
MIM609727	C1857855	1p31.1-p21.1	SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT; SPG29	619379
MIM609728		2q33.1	METHIONYL-tRNA SYNTHETASE 2; MARS2	92935
MIM609729		3p13	PDZ DOMAIN-CONTAINING RING FINGER PROTEIN 3; PDZRN3	23024
MIM609730		12q12	PDZ DOMAIN-CONTAINING RING FINGER PROTEIN 4; PDZRN4	29951
MIM609731		20p11.21	CYSTATIN 11; CST11	140880
MIM609732		4q12	LIGAND OF NUMB PROTEIN X1; LNX1	84708
MIM609733		13q12.2	LIGAND OF NUMB PROTEIN X2; LNX2	222484
MIM609734	C1857854	2p23.3	PROOPIOMELANOCORTIN DEFICIENCY	5443
MIM609735		17q12	RING FINGER AND FYVE-LIKE DOMAIN CONTAINING 1; RFFL	117584
MIM609736		2p16.1	COILED-COIL DOMAIN-CONTAINING PROTEIN 88A; CCDC88A	55704
MIM609737		19p13.3	CRUMBS, DROSOPHILA, HOMOLOG OF, 3; CRB3	92359
MIM609738		1q22-q23	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 9; IGSF9	57549
MIM609739		3q21.1	IMMUNOGLOBULIN-LIKE DOMAIN-CONTAINING RECEPTOR 1; ILDR1	286676
MIM609740		9q33.3	PHD FINGER PROTEIN 19; PHF19	26147
MIM609741	C1857853	22q11.2-q12.2	CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 2; CATCN2	1417
MIM609742		19q13.3-q13.4	INTERLEUKIN 4-INDUCED GENE 1; IL4I1	259307
MIM609743		1q21.2-q22	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 4B; IGSF4B	57863
MIM609744		19q13.2	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 4C; IGSF4C	199731
MIM609745	C1857852	15q11-q13	GLAUCOMA 1, OPEN ANGLE, I; GLC1I	497188
MIM609746		4q31.2	RHO GTPase-ACTIVATING PROTEIN 10; ARHGAP10	79658
MIM609747		8q23	ACTIN-BINDING RHO-ACTIVATING PROTEIN; ABRA	137735
MIM609748		15q22.3-q23	UBIQUITIN-LIKE 7; UBL7	84993
MIM609749		2q12	UDP-GLUCURONATE DECARBOXYLASE 1; UXS1	80146
MIM609750	C1857851	10q25-q26	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 4; EIG4	780913
MIM609751		17q25	ACYL-CoA OXIDASE 1, PALMITOYL; ACOX1	51
MIM609752		6q22.33	NUCLEAR RECEPTOR COACTIVATOR 7; NCOA7	135112
MIM609753	C1857847	19p13.1	CELIAC DISEASE, SUSCEPTIBILITY TO, 4; CELIAC4	4650
MIM609754	C1857846	5q31-q33	CELIAC DISEASE, SUSCEPTIBILITY TO, 2; CELIAC2	317782
MIM609755	C1857845	2q33	CELIAC DISEASE, SUSCEPTIBILITY TO, 3; CELIAC3	1493
MIM609756		 	CHRNA7/FAM7A FUSION GENE; CHRFAM7A	89832
MIM609757	C1857844	7q11.23	WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	100240730
MIM609758		6q21	Na+/K+ TRANSPORTING ATPase-INTERACTING 2; NKAIN2	154215
MIM609759		 	PR DOMAIN-CONTAINING PROTEIN 7; PRDM7	11105
MIM609760		5p14.2	PR DOMAIN-CONTAINING PROTEIN 9; PRDM9	56979
MIM609761		22q13.1	TRIO- AND F-ACTIN-BINDING PROTEIN; TRIOBP	11078
MIM609762		19q13	BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 3; BLOC1S3	388552
MIM609763		10q24	PHOSPHATIDYLINOSITOL 4-KINASE, TYPE 2, ALPHA; PI4K2A	55361
MIM609764		1p34.1	LYSINE-SPECIFIC DEMETHYLASE 4A; KDM4A	9682
MIM609765		19p13.3	LYSINE-SPECIFIC DEMETHYLASE 4B; KDM4B	23030
MIM609766		11q21	JUMONJI DOMAIN-CONTAINING PROTEIN 2D; JMJD2D	55693
MIM609767		10q24	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 28; SLC25A28	81894
MIM609768		10q24.31	BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 2; BLOC1S2	282991
MIM609769		12q13.3	ORPHAN SHORT-CHAIN DEHYDROGENASE/REDUCTASE	121214
MIM609770		11q23	ADHESION MOLECULE, INTERACTS WITH CXADR ANTIGEN 1; AMICA1	120425
MIM609771		16p13.3	UBINUCLEIN 1; UBN1	29855
MIM609772		7q31	CORTACTIN-BINDING PROTEIN 2; CTTNBP2	83992
MIM609773		19q13.2	CREBBP/EP300 INHIBITORY PROTEIN 2; CRI2	163126
MIM609774		11p12	APOPTOSIS INHIBITOR 5; API5	8539
MIM609775		6p21.2-p21.1	YIP1 DOMAIN FAMILY, MEMBER 3; YIPF3	25844
MIM609776		10q26.3	PROLINE-RICH ACIDIC PROTEIN 1; PRAP1	118471
MIM609777		3p22.2	CARDIOMYOPATHY-ASSOCIATED PROTEIN 1; CMYA1	165904
MIM609778		2q24.3	CARDIOMYOPATHY-ASSOCIATED PROTEIN 3; CMYA3	129446
MIM609779		3q21-q22	NEVER IN MITOSIS GENE A-RELATED KINASE 11; NEK11	79858
MIM609780		7p15-p14	CARBOXYPEPTIDASE, VITELLOGENIC-LIKE; CPVL	54504
MIM609782	C1853364	4q31	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 2; AAA2	100505390
MIM609783		10p15	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 5; ITIH5	80760
MIM609784		3p23	UPSTREAM BINDING PROTEIN 1; UBP1	7342
MIM609785		2q14	TRANSCRIPTION FACTOR CP2-LIKE 1; TFCP2L1	29842
MIM609786		2p25.1	GRAINYHEAD-LIKE 1; GRHL1	29841
MIM609787		9p22-p21	UBIQUITIN-ASSOCIATED PROTEIN 1; UBAP1	51271
MIM609788		11q13.3	X-RAY RADIATION RESISTANCE-ASSOCIATED 1; XRRA1	143570
MIM609789		2q34-q37	AQUAPORIN 12A; AQP12A	375318
MIM609790	C1853360	9p22.1	ALZHEIMER DISEASE 11	100188795
MIM609791		15q24	LEUCINE-RICH REPEAT PROTEIN, NEURONAL, 6A; LRRN6A	84894
MIM609792		19p13.3	LEUCINE-RICH REPEAT PROTEIN, NEURONAL, 6B; LRRN6B	645191
MIM609793		9p21.2-p21.1	LEUCINE-RICH REPEAT PROTEIN, NEURONAL, 6C; LRRN6C	158038
MIM609794		 	LEUCINE-RICH REPEAT PROTEIN, NEURONAL, 6D; LRRN6D	339398
MIM609795		 	PYROGLUTAMYLATED RF-AMIDE PEPTIDE PRECURSOR PROTEIN; QRFP	347148
MIM609796	C1853354	15q15.2	PEELING SKIN SYNDROME, ACRAL TYPE	9333
MIM609797		9q22.3	BICAUDAL D, DROSOPHILA, HOMOLOG OF, 2; BICD2	23299
MIM609798		14q24.3	NEVER IN MITOSIS GENE A-RELATED KINASE 9; NEK9	91754
MIM609799		17q11.1	NEVER IN MITOSIS GENE A-RELATED KINASE 8; NEK8	284086
MIM609800	C1853345	2p24	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	100188796
MIM609801		17q25.1	CD300 ANTIGEN-LIKE FAMILY, MEMBER E; CD300LE	342510
MIM609802		15q21.1	SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 5; SLC24A5	283652
MIM609803		2q32.2	ANKYRIN AND ARMADILLO REPEATS-CONTAINING PROTEIN; ANKAR	150709
MIM609804		17p13.1	WD REPEAT-CONTAINING PROTEIN 16; WDR16	146845
MIM609805		11q25	SPERMATOGENESIS-ASSOCIATED PROTEIN 19; SPATA19	219938
MIM609806		11q23.3	HYDROXYMETHYLBILANE SYNTHASE; HMBS	3145
MIM609807		17q25.1	CD300 ANTIGEN-LIKE FAMILY, MEMBER F; CD300LF	146722
MIM609809		20q13.3	LCK-INTERACTING TRANSMEMBRANE ADAPTOR 1; LIME1	54923
MIM609810		7q21	PATERNALLY EXPRESSED GENE 10; PEG10	23089
MIM609811		4p12	CYTOCHROME C OXIDASE SUBUNIT VIIb2; COX7B2	170712
MIM609812	C1853297	9q34.3	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8	1056
MIM609813	C1853296	7p22	SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	3955
MIM609814	C0398777	1q32	COMPLEMENT FACTOR H DEFICIENCY; CFHD	3075
MIM609815	C1853294	3p21.31	ZYGODACTYLY 1	780914
MIM609816		2q33-q34	NEUROBEACHIN-LIKE 1; NBEAL1	65065
MIM609818		16q24.1	UBIQUITIN-SPECIFIC PROTEIN 10; USP10	9100
MIM609819		17q21.3	PROSTATE, RECTUM, AND COLON GENE; PRAC	84366
MIM609820	C1853286	1q42-q43	ERYTHROCYTOSIS, FAMILIAL, 3; ECYT3	54583
MIM609821	C1853278	3q24-q25	BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8	64805
MIM609822	C1853277	1p21	STATURE QUANTITATIVE TRAIT LOCUS 7; STQTL7	100037265
MIM609823	C1853276	22q13.1	DEAFNESS, AUTOSOMAL RECESSIVE 28; DFNB28	11078
MIM609824		1q21.3	HORMA DOMAIN-CONTAINING 1; HORMAD1	84072
MIM609825		4q21-q22	COQ2, S. CEREVISIAE, HOMOLOG OF; COQ2	27235
MIM609826		9q34	SOLUTE CARRIER FAMILY 34 (SODIUM/PHOSPHATE COTRANSPORTER), MEMBER 3; SLC34A3	142680
MIM609827		 	PELLINO, DROSOPHILA, HOMOLOG OF, 3; PELI3	246330
MIM609828		19p13.3	FIBRONECTIN TYPE III AND SPRY DOMAINS-CONTAINING PROTEIN 1; FSD1	79187
MIM609829		9q31	FSD1 N-TERMINUS-LIKE PROTEIN; FSD1NL	83856
MIM609831		1p34.1	MMACHC GENE; MMACHC	25974
MIM609832		17p11.2	SOLUTE CARRIER FAMILY 47, MEMBER 1; SLC47A1	55244
MIM609833		17p11.2	SOLUTE CARRIER FAMILY 47, MEMBER 2; SLC47A2	146802
MIM609834		3p26	SET AND MARINER TRANSPOSASE DOMAINS-CONTAINING PROTEIN; SETMAR	6419
MIM609835		17q21	MYCBP-ASSOCIATED PROTEIN; MYCBPAP	84073
MIM609836		5q31.2	PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE 2; PCBD2	84105
MIM609837		15q11.2	SMALL NUCLEOLAR RNA, C/D BOX, 115-1; SNORD115-1	338433
MIM609838		9p22	SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 2; SLC24A2	25769
MIM609839		20p13	SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 3; SLC24A3	57419
MIM609840		14q32	SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 4; SLC24A4	123041
MIM609841		12q24	SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 6; SLC24A6	80024
MIM609842		 	ENHANCER OF mRNA DECAPPING 3, S. CEREVISIAE, HOMOLOG OF; EDC3	80153
MIM609843		12p13.33	DECAPPING ENZYME 1, S. CEREVISIAE, HOMOLOG OF, B; DCP1B	196513
MIM609844		5q21-q22	DECAPPING ENZYME 2, S. CEREVISIAE, HOMOLOG OF; DCP2	167227
MIM609845		3q25-q26	SUCRASE-ISOMALTASE; SI	6476
MIM609846		1p13.1-p12	REGENERATING ISLET-DERIVED FAMILY, MEMBER 4; REG4	83998
MIM609847		17q25.3	NOTUM, DROSOPHILA, HOMOLOG OF; NOTUM	147111
MIM609848		17p13.2	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 11; KCTD11	147040
MIM609849		11q13.2	CORONIN 1B; CORO1B	57175
MIM609850		4p15.1-q21	TBC1 DOMAIN FAMILY, MEMBER 1; TBC1D1	23216
MIM609851		10q21	INOSITOL POLYPHOSPHATE MULTIKINASE; IPMK	253430
MIM609852		1q42.1	MIX1 HOMEOBOX-LIKE PROTEIN 1; MIXL1	83881
MIM609853		1p13.1-p12	PHOSPHOPANTOTHENOYLCYSTEINE SYNTHETASE; PPCS	79717
MIM609854		15q24.2	PHOSPHOPANTOTHENOYLCYSTEINE DECARBOXYLASE; PPCDC	60490
MIM609855		17q12-q21	COENZYME A SYNTHASE; COASY	80347
MIM609856		3q26.3	SPERMATOGENESIS-ASSOCIATED PROTEIN 16; SPATA16	83893
MIM609857		19q13.3	DYSTROPHIA MYOTONICA WD REPEAT-CONTAINING PROTEIN; DMWD	1762
MIM609858		12p12.1-p11.2	ETHANOLAMINE KINASE 1; ETNK1	55500
MIM609859		1q32.1	ETHANOLAMINE KINASE 2; ETNK2	55224
MIM609860		12p12.1-p11.2	DAD1-RELATED GENE	56286
MIM609861		12q23	I-KAPPA-B KINASE-INTERACTING PROTEIN; IKBIP	121457
MIM609862		22q12-q13	TRANSMEMBRANE PROTEASE, SERINE 6; TMPRSS6	164656
MIM609863		12q24.1	TECTONIC FAMILY, MEMBER 1; TCTN1	79600
MIM609864		8q21.2	TRANSMEMBRANE PROTEIN 55A; TMEM55A	55529
MIM609865		 	TRANSMEMBRANE PROTEIN 55B; TMEM55B	90809
MIM609866		13q12.3	START DOMAIN-CONTAINING PROTEIN 13; STARD13	90627
MIM609867		5q33.3	UBIQUITIN-LIKE DOMAIN-CONTAINING CTD PHOSPHATASE 1; UBLCP1	134510
MIM609868		14q31.3	SPERMATOGENESIS-ASSOCIATED PROTEIN 7; SPATA7	55812
MIM609869		3p21.2-p21.1	SPERMATOGENESIS-ASSOCIATED PROTEIN 12; SPATA12	353324
MIM609870		10p12.3	RHO GTPase-ACTIVATING PROTEIN 21; ARHGAP21	57584
MIM609871		9q22.3	TBC1 DOMAIN FAMILY, MEMBER 2; TBC1D2	55357
MIM609872		20q12-q13.1	WAP 4-DISULFIDE CORE DOMAIN 12; WFDC12	128488
MIM609873		1q21.3-q22	INTELECTIN 1; ITLN1	55600
MIM609874		1q21.3-q22	INTELECTIN 2; ITLN2	142683
MIM609875		10q21.3-q22.1	ATONAL, DROSOPHILA, HOMOLOG OF, 7; ATOH7	220202
MIM609876	C1835949	21q22.13-qter	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 6; BMND6	100188797
MIM609877		13q12.11	CRYSTALLIN, LAMBDA-1; CRYL1	51084
MIM609878		17p11.2	MEDIATOR COMPLEX SUBUNIT 9; MED9	55090
MIM609879		4q34.1-q34.2	SPERMATOGENESIS-ASSOCIATED PROTEIN 4; SPATA4	132851
MIM609880		17q21.32	HISTONE ACETYLTRANSFERASE MYST2; MYST2	11143
MIM609881		7q11.2	RNA POLYMERASE II POLYPEPTIDE J-RELATED GENE	246721
MIM609882		1p22.1	METAL-REGULATORY TRANSCRIPTION FACTOR 2; MTF2	22823
MIM609883		17q23	MKS1 GENE; MKS1	54903
MIM609884		8q21.13-q22.1	TRANSMEMBRANE PROTEIN 67; TMEM67	91147
MIM609885		15q15.3	ELONGATION FACTOR, RNA POLYMERASE II, 3; ELL3	80237
MIM609886	C1835934	16p12.3	GLOMERULOCYSTIC KIDNEY DISEASE WITH HYPERURICEMIA AND ISOSTHENURIA	7369
MIM609887	C1835933	5q21.3-q22.1	GLAUCOMA 1, OPEN ANGLE, G; GLC1G	134430
MIM609888	C1835932	10p13	LEPROSY, SUSCEPTIBILITY TO, 1; LPRS1	81861
MIM609889	C1835931	11p13	ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY	5896
MIM609890		1p36.13	RETINOBLASTOMA-ASSOCIATED FACTOR 600	23352
MIM609891		6q26	CHROMOSOME 6 OPEN READING FRAME 59; C6ORF59	134701
MIM609892		21q22.2	DOWN SYNDROME CRITICAL REGION GENE 6; DSCR6	53820
MIM609893	C2940785	15q25.3-q26.1	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 3; CHNG3	780915
MIM609894		19p13.3	UNC13, C. ELEGANS, HOMOLOG OF, A; UNC13A	23025
MIM609895		1p36.22	CASTOR ZINC FINGER PROTEIN 1; CASZ1	54897
MIM609896		3p14	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E FAMILY, MEMBER 3; EIF4E3	317649
MIM609897		6p21.32	EPIDERMAL GROWTH FACTOR-LIKE 8; EGFL8	80864
MIM609898		22q12.1	KRINGLE DOMAIN-CONTAINING TRANSMEMBRANE PROTEIN 1; KREMEN1	83999
MIM609899		16p13.3	KRINGLE DOMAIN-CONTAINING TRANSMEMBRANE PROTEIN 2; KREMEN2	79412
MIM609900		 	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3D; APOBEC3D	140564
MIM609901		16p12.2	ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 4B; ANKS4B	257629
MIM609903	C1835929	13q32	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 5; SLEB5	100188798
MIM609904		6p22.2	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER A; HIST1H2BA	255626
MIM609905		20q11.23	MYOSIN LIGHT CHAIN 9, REGULATORY; MYL9	10398
MIM609906		14q11.2-q12	EMBRYONAL FYN-ASSOCIATED SUBSTRATE; EFS	10278
MIM609907		 	SEMAPHORIN 3D; SEMA3D	223117
MIM609908		1q25.3	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 4; APOBEC4	403314
MIM609909	C1835928	6q22.1	CARDIOMYOPATHY, DILATED, 1P; CMD1P	5350
MIM609910		3q13.3-q21.1	AMY1-ASSOCIATED PROTEIN EXPRESSED IN TESTIS 1	89876
MIM609911		14q32.31	HEPATOCELLULAR CARCINOMA-DOWNREGULATED MITOCHONDRIAL CARRIER PROTEIN	283600
MIM609912		16p11.2	HISTONE ACETYLTRANSFERASE MYST1; MYST1	84148
MIM609913	C1835927	1p21.3-p13.3	RETINITIS PIGMENTOSA 32; RP32	641433
MIM609914		11q14	AQUAPORIN 11; AQP11	282679
MIM609915	C1835926	7q22.3-q31.1	CARDIOMYOPATHY, DILATED, 1Q; CMD1Q	664728
MIM609916		3p24.1	5-@AZACYTIDINE-INDUCED GENE 2, MOUSE, HOMOLOG OF; AZI2	64343
MIM609917		1p32	PRION PROTEIN-INTERACTING PROTEIN; PRNPIP	79033
MIM609918	C1835925	1p36.21	GALLBLADDER DISEASE 2; GBD2	100048905
MIM609919	C1835924	1p34.3	GALLBLADDER DISEASE 3; GBD3	100048906
MIM609920		20q13.1	CADHERIN 22; CDH22	64405
MIM609921		14q11.2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 10; LRP10	26020
MIM609922		2p15	EH DOMAIN-BINDING PROTEIN 1; EHBP1	23301
MIM609923	C1835923	9p21	RETINITIS PIGMENTOSA 31; RP31	10210
MIM609924	C1835922	3p21.1	AMINOACYLASE 1 DEFICIENCY	95
MIM609925		16q22.1	DIPEPTIDASE 2; DPEP2	64174
MIM609926		16q22.1	DIPEPTIDASE 3; DPEP3	64180
MIM609927		8p23-p21	VACUOLAR PROTEIN SORTING 37, YEAST, HOMOLOG OF, A; VPS37A	137492
MIM609928		20q11.22	MYOSIN, HEAVY CHAIN 7B, CARDIAC MUSCLE, BETA; MYH7B	57644
MIM609929		3q13.13	MYOSIN, HEAVY CHAIN 15; MYH15	22989
MIM609930		12q13.13	MYOSIN, LIGHT CHAIN 6B, ALKALI, SMOOTH MUSCLE AND NONMUSCLE, SLOW; MYL6B	140465
MIM609931		12q13.2	MYOSIN LIGHT CHAIN 6, ALKALI, SMOOTH MUSCLE AND NONMUSCLE; MYL6	4637
MIM609932		19q13.33	SPERM ACROSOME-ASSOCIATED PROTEIN 4; SPACA4	171169
MIM609933		2p12	REGENERATING ISLET-DERIVED 3-GAMMA; REG3G	130120
MIM609934		8p21.2	EARLY B-CELL FACTOR 2; EBF2	64641
MIM609935		20p13	EARLY B-CELL FACTOR 4; EBF4	57593
MIM609936		9q22.1-q22.3	SPINDLIN; SPIN	10927
MIM609937		2q31	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 7; CDCA7	83879
MIM609938		3p12	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 4D; IGSF4D	253559
MIM609939	C1835919	16p11.2	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	3684
MIM609941	C1864968	11p13-p12	DEAFNESS, AUTOSOMAL RECESSIVE 51; DFNB51	448963
MIM609942	C1860991	12p12.1	NOONAN SYNDROME 3; NS3	3845
MIM609946	C1864964	2p25.1-p24.3	DEAFNESS, AUTOSOMAL RECESSIVE 47; DFNB47	449489
MIM609947		14q13	KIAA0391 GENE; KIAA0391	9692
MIM609948		7p22	RING FINGER PROTEIN 216; RNF216	54476
MIM609949		19q13.4	G PROTEIN-COUPLED RECEPTOR 77; GPR77	27202
MIM609950		19p13.2	RAVER1, MOUSE, HOMOLOG OF	125950
MIM609951		12p12	ZINC FINGER PROTEIN 384; ZNF384	171017
MIM609952	C1864962	4q12-q13.2	DEAFNESS, AUTOSOMAL RECESSIVE 55; DFNB55	494148
MIM609953		1p31.3	RAVER2, MOUSE, HOMOLOG OF	55225
MIM609954	C1864961	3p24-p21	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 4	100188800
MIM609955	C1864960	2p23.3-p22.3	FIBROMATOSIS, GINGIVAL, 3; GINGF3	780916
MIM609956		17q25.1	RAS-ASSOCIATED PROTEIN RAB37; RAB37	326624
MIM609957		1p13.2	PROTEIN PHOSPHATASE, MAGNESIUM-DEPENDENT, 1J; PPM1J	333926
MIM609958	C1864959	2p16	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 3	100188801
MIM609959		19q13.33-q13.4	MYELOID-ASSOCIATED DIFFERENTIATION MARKER; MYADM	91663
MIM609960		9p24.2	KIAA0020 GENE; KIAA0020	9933
MIM609961		5q32	MINOR HISTOCOMPATIBILITY ANTIGEN HB-1	57824
MIM609962		12p13	C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER E; CLEC4E	26253
MIM609963		5q31	CHONDROITIN SULFATE SYNTHASE 3; CHSY3	337876
MIM609964		12p13	C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER D; CLEC4D	338339
MIM609965	C1864957	14q11.2-q12	DEAFNESS, AUTOSOMAL DOMINANT 53; DFNA53	353347
MIM609966		19q13.2	GAMETOGENETIN, MOUSE, HOMOLOG OF; GGN	199720
MIM609967		19p13.11	B-CELL NOVEL PROTEIN 1	199786
MIM609968	C1864952	19p13.2	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	3643
MIM609969		19q13.1	SUPRABASIN	374897
MIM609970		1p36.31	HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 2; HES2	54626
MIM609971		1p36.31	HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 3; HES3	390992
MIM609972		14q24.3	ACYL-CoA THIOESTERASE 2; ACOT2	10965
MIM609973		1q22	HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 3; HCN3	57657
MIM609974		5p14	CADHERIN 9; CDH9	1007
MIM609975	C1864948	4q22-q26	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	3033
MIM609976		19q13.2	HYPOXIA-INDUCIBLE FACTOR 3, ALPHA SUBUNIT; HIF3A	64344
MIM609977		1p34.3	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 8; CDCA8	55143
MIM609978		7q31.3	CALCIUM-DEPENDENT ACTIVATOR PROTEIN FOR SECRETION 2; CADPS2	93664
MIM609979		6q21	VESTIGIAL-LIKE 2; VGLL2	245806
MIM609980		3p12.1	VESTIGIAL-LIKE 3; VGLL3	389136
MIM609981	C1864947	8p11.23-q11.21	NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT; NKGCD	780917
MIM609982		16q22	VACUOLAR PROTEIN SORTING 4, YEAST, HOMOLOG OF, A; VPS4A	27183
MIM609983		18q21.3	VACUOLAR PROTEIN SORTING 4, S. CEREVISIAE, HOMOLOG OF, B; VPS4B	9525
MIM609984		15q22.3	ZWILCH, DROSOPHILA, HOMOLOG OF; ZWILCH	55055
MIM609985	C1864946	4q31-q34	PANIC DISORDER 3	677663
MIM609986		5p13.1-p12	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 6; CARD6	84674
MIM609987		7q31	STIMULATED BY RETINOIC ACID 8, MOUSE, HOMOLOG OF; STRA8	346673
MIM609988		4q25	PYROPHOSPHATASE, INORGANIC, 2; PPA2	27068
MIM609991		6q25	FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 1; FNDC1	84624
MIM609992		12q24.31	PROCESSING OF PRECURSOR 5, S. CEREVISIAE, HOMOLOG OF; POP5	51367
MIM609994	C1864941	4q22-q27	MYOPIA 11, AUTOSOMAL DOMINANT; MYP11	594832
MIM609995	C1864940	2q37.1	MYOPIA 12, AUTOSOMAL DOMINANT; MYP12	664780
MIM609996		7p21.3	COLLAGEN, TYPE XXVIII, ALPHA-1; COL28A1	340267
MIM609997		9p11.2	HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 2; HINT2	84681
MIM609998		6q22.33	HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 3; HINT3	135114
MIM609999		14q24.3	SYNAPSE DIFFERENTIATION-INDUCED GENE 1-LIKE; SYNDIG1L	646658
MIM610000		10q23.33	CENTROSOMAL PROTEIN, 55-KD; CEP55	55165
MIM610002		6p12.3-p11.2	COLLAGEN, TYPE XXI, ALPHA-1; COL21A1	81578
MIM610003	C1864923	8p23	CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	2055
MIM610004		4q25	COLLAGEN, TYPE XXV, ALPHA-1; COL25A1	84570
MIM610005		3q26.2-q26.3	TRAF2- AND NCK-INTERACTING KINASE; TNIK	23043
MIM610006	C1864912	10q25-q26	2-@METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	36
MIM610007		12q13.12	LIMB REGION 1 HOMOLOG-LIKE; LMBR1L	55716
MIM610008		17q24.2	ARYLSULFATASE G; ARSG	22901
MIM610009		5q32	ARYLSULFATASE I; ARSI	340075
MIM610010		4q26	ARYLSULFATASE J; ARSJ	79642
MIM610011		5q15	ARYLSULFATASE K; ARSK	153642
MIM610012		8q13.3	SULFATASE 1; SULF1	23213
MIM610013		20q13.12	SULFATASE 2; SULF2	55959
MIM610014		15q26.3	TM2 DOMAIN-CONTAINING PROTEIN 3; TM2D3	80213
MIM610015	C1864910	1q31	GLUTAMINE DEFICIENCY, CONGENITAL	2752
MIM610016		17p13.3	MICRO RNA 132; MIR132	406921
MIM610017	C1832708	 	MULTIPLE SYNOSTOSES SYNDROME 2; SYNS2	8200
MIM610018		14q11.2	SOLO GENE	55701
MIM610019	C1864908	3p22-p21	CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 2; CATC2	79443
MIM610020		22q12.1-qter	TBC1 DOMAIN FAMILY, MEMBER 10A; TBC1D10A	83874
MIM610021	C1864902	1p13.2-p12	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	6566
MIM610022		15q21	MYOSIN VC; MYO5C	55930
MIM610024	C1864900	12p13	RETINAL CONE DYSTROPHY 3A; RCD3A	5149
MIM610025		1p22.3	COLLAGEN, TYPE XXIV, ALPHA-1; COL24A1	255631
MIM610026		8q24.2	COLLAGEN, TYPE XXII, ALPHA-1; COL22A1	169044
MIM610027		11q25	VACUOLAR PROTEIN SORTING 26, YEAST, HOMOLOG OF, B; VPS26B	112936
MIM610028		3q21.1	POLY(ADP-RIBOSE) POLYMERASE 14; PARP14	54625
MIM610029		8p11.2	VOLTAGE-DEPENDENT ANION CHANNEL 3; VDAC3	7419
MIM610030		1q25.3	VOLTAGE-DEPENDENT ANION CHANNEL 4; VDAC4	7418
MIM610031	C2750247	6p25.2	POLYMICROGYRIA, SYMMETRIC OR ASYMMETRIC; PMGYSA	347733
MIM610032		7q32.1	TRANSPORTIN 3; TNPO3	23534
MIM610033		1p34	PENTA-EF-HAND DOMAIN-CONTAINING PROTEIN 1; PEF1	553115
MIM610034		12q24.31	VACUOLAR PROTEIN SORTING 33, YEAST, HOMOLOG OF, A; VPS33A	65082
MIM610035		1q21-q22	VACUOLAR PROTEIN SORTING 45, YEAST, HOMOLOG OF, A; VPS45A	11311
MIM610036		1p34.2	CLAUDIN 19; CLDN19	149461
MIM610037		12q24.31	VACUOLAR PROTEIN SORTING 37, YEAST, HOMOLOG OF, B; VPS37B	79720
MIM610038		11q12.2	VACUOLAR PROTEIN SORTING 37, YEAST, HOMOLOG OF, C; VPS37C	55048
MIM610039		7q11.23	VACUOLAR PROTEIN SORTING 37, YEAST, HOMOLOG OF, D; VPS37D	155382
MIM610040		2q31.1-q31.2	MYOSIN IIIB; MYO3B	140469
MIM610041		13q22.2	NEDD4 FAMILY-INTERACTING PROTEIN 2; NDFIP2	54602
MIM610042	C1864887	7q35-q36	CORTICAL DYSPLASIA-FOCAL EPILEPSY SYNDROME	26047
MIM610043		5q35	COLLAGEN, TYPE XXIII, ALPHA-1; COL23A1	91522
MIM610044		1q31.3	POTASSIUM CHANNEL, SUBFAMILY T, MEMBER 2; KCNT2	343450
MIM610045		6p22	ALDEHYDE DEHYDROGENASE 5 FAMILY, MEMBER A1; ALDH5A1	7915
MIM610046		5q23.1	LAEVERIN	206338
MIM610047		7q22.1	CANOPY 4, ZEBRAFISH, HOMOLOG OF; CNPY4	245812
MIM610048	C1864738	12q21.3	CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD	1634
MIM610049		12q13	SAP DOMAIN-CONTAINING RIBONUCLEOPROTEIN; SARNP	84324
MIM610050		11q23	TRANSMEMBRANE PROTEIN, SERINE 13; TMPRSS13	84000
MIM610051		14q12	CHMP FAMILY, MEMBER 4A; CHMP4A	29082
MIM610052		2p24	VACUOLAR PROTEIN SORTING 24, YEAST, HOMOLOG OF; VPS24	51652
MIM610053		 	TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 6; TUBGCP6	85378
MIM610054		 	H2A HISTONE FAMILY, MEMBER Y; H2AFY	9555
MIM610055		19p13.12	COILED-COIL AND C2 DOMAINS-CONTAINING PROTEIN 1A; CC2D1A	54862
MIM610056		 	SPERM-ASSOCIATED ANTIGEN 7; SPAG7	9552
MIM610057		 	TRANS-2,3-ENOYL-CoA REDUCTASE; TECR	9524
MIM610058		 	TUBULIN-SPECIFIC CHAPERONE A; TBCA	6902
MIM610059		 	MITOCHONDRIAL RIBOSOMAL PROTEIN L33; MRPL33	9553
MIM610060		6p22.3	POLYMERASE I, RNA, SUBUNIT C; POLR1C	9533
MIM610061		 	DYNEIN, AXONEMAL, HEAVY CHAIN 7; DNAH7	56171
MIM610062		14q24.3	DYNEIN, AXONEMAL, LIGHT CHAIN 1; DNAL1	83544
MIM610063		 	DYNEIN, AXONEMAL, HEAVY CHAIN 17; DNAH17	8632
MIM610064	C1864733	18q21, Chr.17	OPIOID DEPENDENCE, SUSCEPTIBILITY TO, 1	100188802, 4200
MIM610065	C1864732	20p12	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 7; SLEB7	100188803
MIM610066	C1864731	20q13	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 8; SLEB8	100188804
MIM610067		17q11.2	MYOSIN XVIIIA; MYO18A	399687
MIM610068		3p21.3	SOLUTE CARRIER FAMILY 26 (ANION TRANSPORTER), MEMBER 6: SLC26A6	65010
MIM610069	C1864730	10q22.3	POLYPOSIS SYNDROME, HEREDITARY MIXED, 2; HMPS2	657
MIM610070		4q32	ASTER-ASSOCIATED PROTEIN	79884
MIM610071	C1864729	2p14-p13.3	HYPERPARATHYROIDISM 3; HRPT3	780919
MIM610072		 	ERMIN	57471
MIM610073		2q32.2	ORM1-LIKE PROTEIN 1; ORMDL1	94101
MIM610074		12q13.2	ORM1-LIKE PROTEIN 2; ORMDL2	29095
MIM610075		17q21.1	ORM1-LIKE PROTEIN 3; ORMDL3	94103
MIM610076		9q22.1	CELL CYCLE-RELATED KINASE; CCRK	23552
MIM610077		13q12-q14	RESPONSE GENE TO COMPLEMENT 32	28984
MIM610078		 	MORC FAMILY CW-TYPE ZINC FINGER 3; MORC3	23515
MIM610079		11q24	SIALIC ACID ACETYLESTERASE; SIAE	54414
MIM610080		 	TM2 DOMAIN-CONTAINING PROTEIN 1; TM2D1	83941
MIM610081		 	TM2 DOMAIN-CONTAINING PROTEIN 2; TM2D2	83877
MIM610082		6p23-p22.3	MYOSIN REGULATORY LIGHT CHAIN-INTERACTING PROTEIN; MYLIP	29116
MIM610083		 	ODZ, DROSOPHILA, HOMOLOG OF, 3; ODZ3	55714
MIM610084		 	ODZ, DROSOPHILA, HOMOLOG OF, 4; ODZ4	26011
MIM610085		8p23-p22	FAMILY WITH SEQUENCE SIMILARITY 167, MEMBER A; FAM167A	83648
MIM610086		 	PROTEIN ARGININE N-METHYLTRANSFERASE 8; PRMT8	56341
MIM610087		 	PROTEIN ARGININE N-METHYLTRANSFERASE 7; PRMT7	54496
MIM610088		 	OLFACTOMEDIN-LIKE 3; OLFML3	56944
MIM610089		 	RAD50-INTERACTING PROTEIN 1; RINT1	60561
MIM610090	C1864723	17q21.32	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	55163
MIM610091		 	WD REPEAT- AND SOCS BOX-CONTAINING PROTEIN 1; WSB1	26118
MIM610092	C1864721	14q24.3	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3; MCOPCB3	338917
MIM610093	C1864720	14q24.3	MICROPHTHALMIA, ISOLATED 2; MCOP2	338917
MIM610094		 	DEF6, MOUSE, HOMOLOG OF; DEF6	50619
MIM610095		 	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, LONG CYTOPLASMIC TAIL, 3; KIR3DL3	115653
MIM610096		 	T-CELL IMMUNOGLOBULIN AND MUCIN DOMAINS-CONTAINING PROTEIN 4; TIMD4	91937
MIM610097		17p13.1	OUTER DENSE FIBER OF SPERM TAILS 4; ODF4	146852
MIM610098		 	MINICHROMOSOME MAINTENANCE DEFICIENT DOMAIN CONTAINING 1; MCMDC1	254394
MIM610099	C1864706	8p22-q11	MYOPATHY, DISTAL, 3; MPD3	780920
MIM610101		10q24	CUTC COPPER TRANSPORTER, E. COLI, HOMOLOG OF; CUTC	51076
MIM610102	C1864694	5p13	COMPLEMENT COMPONENT 7 DEFICIENCY; C7D	730
MIM610103		5q13.3	S100 CALCIUM-BINDING PROTEIN, ZETA; S100Z	170591
MIM610104		11q24.1	MICRO RNA 125B1; MIR125B1	406911
MIM610105		21q21.1	MICRO RNA 125B2; MIR125B2	406912
MIM610106		 	DREBRIN-LIKE; DBNL	28988
MIM610107		14q11.2-q12	O-SIALOGLYCOPROTEIN ENDOPEPTIDASE; OSGEP	55644
MIM610108		11q13	ANOCTAMIN 1, CALCIUM-ACTIVATED CHLORIDE CHANNEL; ANO1	55107
MIM610109		12p13	ANOCTAMIN 2; ANO2	57101
MIM610110		11p14	ANOCTAMIN 3; ANO3	63982
MIM610111		12q23	ANOCTAMIN 4; ANO4	121601
MIM610112		16q24	C-MAF-INDUCING PROTEIN	80790
MIM610113		1q21	ADAMTS-LIKE 4; ADAMTSL4	54507
MIM610114	C1864691	9q22	STATURE QUANTITATIVE TRAIT LOCUS 8; STQTL8	100037266
MIM610115		1p32.3	TRANSMEMBRANE PROTEIN 48; TMEM48	55706
MIM610116		 	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 14; P2RY14	9934
MIM610117		 	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 11; SLC26A11	284129
MIM610118		 	G PROTEIN-COUPLED RECEPTOR 33; GPR33	2856
MIM610119		 	ODZ, DROSOPHILA, HOMOLOG OF, 2; ODZ2	57451
MIM610120		 	TETRASPANIN 33; TSPAN33	340348
MIM610121		3q27	5-@HYDROXYTRYPTAMINE RECEPTOR 3C; HTR3C	170572
MIM610122		3q27	5-@HYDROXYTRYPTAMINE RECEPTOR 3, SUBUNIT D; HTR3D	200909
MIM610123		3q27	5-@HYDROXYTRYPTAMINE RECEPTOR 3, SUBUNIT E; HTR3E	285242
MIM610124		 	CARBOHYDRATE SULFOTRANSFERASE 13; CHST13	166012
MIM610125	C1864690	14q21-q22	MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	5015
MIM610127	C1864669	11p15.5	CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10	1509
MIM610128		 	CARBOHYDRATE SULFOTRANSFERASE 11; CHST11	50515
MIM610129		 	CARBOHYDRATE SULFOTRANSFERASE 12; CHST12	55501
MIM610130		 	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 1; SLC26A1	10861
MIM610131	C1864668	17q23-q24	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 4; PEOA4	11232
MIM610132		1p13	VANG-LIKE 1; VANGL1	81839
MIM610133		 	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 3; ST6GALNAC3	256435
MIM610134		1p31.1	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 5; ST6GALNAC5	81849
MIM610135		 	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 6; ST6GALNAC6	30815
MIM610137		 	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 2; ST6GALNAC2	10610
MIM610138		 	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 1; ST6GALNAC1	55808
MIM610139		 	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 6; ST8SIA6	338596
MIM610140	C1857829	 	HEART-HAND SYNDROME, SLOVENIAN TYPE	4000
MIM610141	C1857828	1q23.3	QT INTERVAL, VARIATION IN	100379215
MIM610142		12q21.3	CENTROSOMAL PROTEIN, 290-KD; CEP290	80184
MIM610143	C1857820	12p13.2-p11.23	DEAFNESS, AUTOSOMAL RECESSIVE 62; DFNB62	692220
MIM610144		17q12	TBC1 DOMAIN FAMILY, MEMBER 3B; TBC1D3B	414059
MIM610145		 	ENDOTHELIN-CONVERTING ENZYME 2; ECE2	9718
MIM610146		 	INSULIN-LIKE GROWTH FACTOR II, ANTISENSE; IGF2AS	51214
MIM610147		2q35	G PROTEIN-COUPLED BILE ACID RECEPTOR 1; GPBAR1	151306
MIM610148		12q21.2	BBS10 GENE; BBS10	79738
MIM610149	C1857813	10q25.3-q26.2	MACULAR DEGENERATION, AGE-RELATED, 7; ARMD7	5654
MIM610150		5p15.2	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 5; CCT5	22948
MIM610151		 	METHIONYL AMINOPEPTIDASE 1; METAP1	23173
MIM610152		22q13.31	CENTROMERIC PROTEIN M; CENPM	79019
MIM610153	C1857811	5q13.1	DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49	153562
MIM610154	C1857809	7p14.1-q11.22	DEAFNESS, AUTOSOMAL RECESSIVE 44; DFNB44	449484
MIM610155	C1857808	2q24.3	DIABETES MELLITUS, INSULIN-DEPENDENT, 19; IDDM19	 
MIM610156	C1857802	9q34.3	MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS	56623
MIM610158	C1857800	13pter-q12.13	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2; FECD2	100188278
MIM610159		 	ZINC FINGER PROTEIN 366; ZNF366	167465
MIM610160		 	ZINC FINGER PROTEIN 367; ZNF367	195828
MIM610161		6p21.1-p12.1	TRANSCRIPTION FACTOR AP2-DELTA; TFAP2D	83741
MIM610162		 	COILED-COIL DOMAIN-CONTAINING PROTEIN 28B; CCDC28B	79140
MIM610163	C1857798	1q22-q23	IMMUNODEFICIENCY DUE TO DEFECT IN CD3-ZETA	919
MIM610164		14q32.31	MICRO RNA 134; MIRN134	406924
MIM610165		2q22	GLYCOSYLTRANSFERASE-LIKE DOMAIN-CONTAINING PROTEIN 1; GTDC1	79712
MIM610166		 	IQ MOTIF- AND SEC7 DOMAIN-CONTAINING PROTEIN 1; IQSEC1	9922
MIM610167		9q34.3	PHOSPHOHISTIDINE PHOSPHATASE 1; PHPT1	29085
MIM610168	C2674876	3p22	LOEYS-DIETZ SYNDROME, TYPE 1B; LDS1B	7048
MIM610169		15q15.1	INO80 COMPLEX HOMOLOG 1; INOC1	54617
MIM610170	C1857795	5p13	KYPHOSCOLIOSIS 1; KYPSC1	780921
MIM610171		1p36.33	CALMODULIN-LIKE 6; CALML6	163688
MIM610172		 	KPL2 GENE	79925
MIM610173		 	MICRO RNA 10A; MIRN10A	406902
MIM610174		5q35	UBIQUITIN DOMAIN-CONTAINING PROTEIN 2; UBTD2	92181
MIM610175		11q12	MICRO RNA 130A; MIR130A	406919
MIM610176		 	SECRETOGLOBIN, FAMILY 1C, MEMBER 1; SCGB1C1	147199
MIM610177		15q26.1	INTERFERON-STIMULATED EXONUCLEASE GENE 20-KD-LIKE 1; ISG20L1	64782
MIM610178		 	KIAA0586 GENE; KIAA0586	9786
MIM610179		2p23.2	PHOSPHOLIPASE B1; PLB1	151056
MIM610180		9q13-q21	OSTEOCLAST-STIMULATING FACTOR 1; OSTF1	26578
MIM610181	C3489724	13q14.1	AICARDI-GOUTIERES SYNDROME 2; AGS2	79621
MIM610182		 	PALMDELPHIN; PALMD	54873
MIM610183		15q25.1	ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 6; ZFAND6	54469
MIM610184		 	MONOACYLGLYCEROL O-ACYLTRANSFERASE 3; MOGAT3	346606
MIM610185	C2750234	17p	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 2; CAMRQ2	124997, 780925
MIM610186		 	DEUBIQUITINATING ENZYME 3	377630
MIM610187	C1857781	8q23	DIAPHRAGMATIC HERNIA 3	23414
MIM610188	C1857780	12q21.3	JOUBERT SYNDROME 5; JBTS5	80184
MIM610189	C1857779	12q21.3	SENIOR-LOKEN SYNDROME 6; SLSN6	80184
MIM610190		19q13.1	CARBOHYDRATE SULFOTRANSFERASE 8; CHST8	64377
MIM610191		 	CARBOHYDRATE SULFOTRANSFERASE 9; CHST9	83539
MIM610192		9p24.3-p23	GLIS FAMILY ZINC FINGER PROTEIN 3; GLIS3	169792
MIM610193	C1857777	18q12.1-q12.2	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10; ARVD10	1829
MIM610194		 	BETA-1,3-N-ACETYLGALACTOSAMINYLTRANSFERASE 2; B3GALNT2	148789
MIM610195		 	PROSTATE TUMOR OVEREXPRESSED GENE 1; PTOV1	53635
MIM610196		4q31.1	ELMO DOMAIN-CONTAINING PROTEIN 2; ELMOD2	255520
MIM610197		19q13.3	MEDIATOR COMPLEX SUBUNIT 25; MED25	81857
MIM610198	C1857776	3q26.3	3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5	131118
MIM610199	C1857775	9p24.3-p23	DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM	169792
MIM610200		 	MITOCHONDRIAL RIBOSOMAL PROTEIN L13; MRPL13	28998
MIM610201		 	KIAA1009 GENE; KIAA1009	22832
MIM610202	C1857768	 	CATARACT, PULVERULENT, JUVENILE-ONSET	4094
MIM610203		 	CYSTEINE-RICH INHIBITOR OF PAK1	285464
MIM610205	C1857761	1p13-p11	ALAGILLE SYNDROME 2; ALGS2	4853
MIM610206		20p13-p12	SOLUTE CARRIER FAMILY 4 (SODIUM BORATE COTRANSPORTER), MEMBER 11; SLC4A11	83959
MIM610207		 	SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 9; SLC4A9	83697
MIM610210		8q24.3	MAF1, S. CEREVISIAE, HOMOLOG OF; MAF1	84232
MIM610211		14q24.3	SRA STEM LOOP-INTERACTING RNA-BINDING PROTEIN	81892
MIM610212	C1857750	6p22.3-p21.2	DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	606719
MIM610213	C1857749	5p15.2-p14.3	ANEURYSM, INTRACRANIAL BERRY, 4; ANIB4	724058
MIM610214		 	ENDOPLASMIC RETICULUM DEGRADATION-ENHANCING ALPHA-MANNOSIDASE-LIKE PROTEIN 3; EDEM3	80267
MIM610215		 	RAC- AND CDC42-SPECIFIC GUANINE NUCLEOTIDE EXCHANGE FACTOR	115557
MIM610216		19p13.11	ANOCTAMIN 8; ANO8	57719
MIM610217	C1857747	22q13.1	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	8398
MIM610218		17q25.1	SAP30-BINDING PROTEIN; SAP30BP	29115
MIM610219		2q31.1-q31.3	DFNB59 GENE	494513
MIM610220	C1857744	2q31.1-q31.3	DEAFNESS, AUTOSOMAL RECESSIVE 59; DFNB59	494513
MIM610221		 	AKT1 SUBSTRATE 1, PROLINE-RICH; AKT1S1	84335
MIM610222		20p11.22	RAS AND RAB INTERACTOR 2; RIN2	54453
MIM610223		 	RAS AND RAB INTERACTOR 3; RIN3	79890
MIM610224		 	SPERMATOGENESIS- AND OOGENESIS-SPECIFIC BASIC HELIX-LOOP-HELIX PROTEIN 1; SOHLH1	402381
MIM610225		22q13.1	RIBOSOMAL PROTEIN S19 BINDING PROTEIN 1; RPS19BP1	91582
MIM610226		17q25.3	ZINC FINGER PROTEIN 750; ZNF750	79755
MIM610227	C1853258	17q25.3	SEBORRHEA-LIKE DERMATITIS WITH PSORIASIFORM ELEMENTS	79755
MIM610228		 	CALPAIN 13; CAPN13	92291
MIM610229		 	CALPAIN 14; CAPN14	440854
MIM610230		22q13	tRNA 5-METHYLAMINOMETHYL-2-THIOURIDYLATE METHYLTRANSFERASE; TRMU	55687
MIM610231		 	POLYCOMB GROUP RING FINGER PROTEIN 1; PCGF1	84759
MIM610232		 	ATPase, TYPE 13A3; ATP13A3	79572
MIM610234	C1853255	14q11.2-q12	SYNPOLYDACTYLY 3; SPD3	780922
MIM610235		 	MITOCHONDRIAL PROTEIN, 18-KD	51537
MIM610236		2q31	LUNAPARK	80856
MIM610237		8q24.11	MEDIATOR COMPLEX SUBUNIT 30; MED30	90390
MIM610238		 	SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 11; SLC5A11	115584
MIM610239	C1853253	4q32.3	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 4	100188806
MIM610240		 	LHFP-LIKE PROTEIN 4; LHFPL4	375323
MIM610241		 	RING FINGER PROTEIN 32; RNF32	140545
MIM610242		 	CHROMOSOME 7 OPEN READING FRAME 13; C7ORF13	129790
MIM610243		10q24.2	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 27; ZFYVE27	118813
MIM610244	C1853251	10q24.2	SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT; SPG33	118813
MIM610245	C1853250	20p13	SPINOCEREBELLAR ATAXIA 23; SCA23	5173
MIM610246	C1853249	18p11	SPINOCEREBELLAR ATAXIA 28; SCA28	10939
MIM610247	C0341106	17q11.2	ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	100302511
MIM610248	C1853248	20q13.2-q13.3	DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	692219
MIM610249		 	PROTEIN O-FUCOSYLTRANSFERASE 2; POFUT2	23275
MIM610250	C1853247	2p11.2	SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31	65055
MIM610251	C2674838	12q24.2	ALCOHOL SENSITIVITY, ACUTE	217
MIM610252		 	MICRO RNA 1-2; MIRN1-2	406905
MIM610253	C0795833	9q34.3	KLEEFSTRA SYNDROME	79813
MIM610254		 	MICRO RNA 133A1; MIRN133A1	406922
MIM610255		 	MICRO RNA 133A2; MIRN133A2	406923
MIM610256	C1853230	1p32	APHAKIA, CONGENITAL PRIMARY	2301
MIM610257		 	SEC31, YEAST, HOMOLOG OF, A; SEC31A	22872
MIM610258		 	SEC31, YEAST, HOMOLOG OF, B; SEC31B	25956
MIM610259		21q22.3	NONCODING RNA 163; NCRNA00163	727699
MIM610260	C1853228	16p13-p12	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 2; IHPS2	780923
MIM610261	C1853227	20q11-q13	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 5	100188807
MIM610262	C1853226	5p13-q12	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 6	100188808
MIM610263		 	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 13; DNAJB13	374407
MIM610264		 	TESTIS-PROSTATE-PLACENTA-EXPRESSED PROTEIN	374739
MIM610265	C1853223	6p21.3	DEAFNESS, AUTOSOMAL RECESSIVE 67; DFNB67	222662
MIM610266		17q11.2	TAO KINASE 1; TAOK1	57551
MIM610267		 	METHIONINE AMINOPEPTIDASE 1D	254042
MIM610268		 	MONOACYLGLYCEROL O-ACYLTRANSFERASE 1; MOGAT1	116255
MIM610269	C1853220	 	BULIMIA NERVOSA, SUSCEPTIBILITY TO, 2; BULN2	627
MIM610270		 	MONOACYLGLYCEROL O-ACYLTRANSFERASE 2; MOGAT2	80168
MIM610271		 	PHOSPHATIDYLINOSITOL GLYCAN, CLASS S; PIGS	94005
MIM610272		 	PHOSPHATIDYLINOSITOL GLYCAN, CLASS T; PIGT	51604
MIM610273		1q23.2	PHOSPHATIDYLINOSITOL GLYCAN, CLASS M; PIGM	93183
MIM610274		1p36.11	PHOSPHATIDYLINOSITOL GLYCAN, CLASS V; PIGV	55650
MIM610275		17q12	PHOSPHATIDYLINOSITOL GLYCAN, CLASS W; PIGW	284098
MIM610276		3q29	PHOSPHATIDYLINOSITOL GLYCAN, CLASS X; PIGX	54965
MIM610277		12q24	ORAI CALCIUM RELEASE-ACTIVATED CALCIUM MODULATOR 1; ORAI1	84876
MIM610278		 	PLATELET ENDOTHELIAL AGGREGATION RECEPTOR 1	375033
MIM610280		 	OSTEOCRIN; OSTN	344901
MIM610281		5q35.3	ZINC FINGER PROTEIN 62; ZFP62	643836
MIM610282	C1853214	1q22	RETINITIS PIGMENTOSA 35; RP35	64218
MIM610283	C1846529	1q22	CONE-ROD DYSTROPHY 10; CORD10	64218
MIM610284		2q11.2	LIPOYLTRANSFERASE 1; LIPT1	51601
MIM610285		4p16.2	DOWNSTREAM OF TYROSINE KINASE 7; DOK7	285489
MIM610286		16p12.3-p12.1	LEUCINE CARBOXYL METHYLTRANSFERASE 1; LCMT1	51451
MIM610287		 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 15; FBXL15	79176
MIM610288		15q22	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 6; GOLGA6	342096
MIM610289		 	3-@OXOACID CoA TRANSFERASE 2; OXCT2	64064
MIM610290		9q22	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 12; GALNT12	79695
MIM610291		 	SYNAPTIC VESICLE GLYCOPROTEIN 2C; SV2C	22987
MIM610292		4q22-q24	B-CELL SCAFFOLD PROTEIN WITH ANKYRIN REPEATS 1; BANK1	55024
MIM610293	C1853205	1q23.2	GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	93183
MIM610294	C1853204	6p25.3-p22.3	INTELLIGENCE QUANTITATIVE TRAIT LOCUS 2	100462722
MIM610295	C1853203	2q24.1-q31.1	INTELLIGENCE QUANTITATIVE TRAIT LOCUS 3	100462723
MIM610296		 	NUDC DOMAIN-CONTAINING PROTEIN 3; NUDCD3	23386
MIM610297	C1853202	2p12	PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK13	27429
MIM610298		 	PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY B, MEMBER 2; PHLDB2	90102
MIM610299		 	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 17; SLC6A17	388662
MIM610300		5p15.33	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 18; SLC6A18	348932
MIM610301		 	TRANSMEMBRANE PROTEIN 57; TMEM57	55219
MIM610302		 	ENDOPLASMIC RETICULUM DEGRADATION-ENHANCING ALPHA-MANNOSIDASE-LIKE PROTEIN 2; EDEM2	55741
MIM610303		8q24	V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE HOMOLOG A; MAFA	389692
MIM610304		 	DER1-LIKE DOMAIN FAMILY, MEMBER 2; DERL2	51009
MIM610305		 	DER1-LIKE DOMAIN FAMILY, MEMBER 3; DERL3	91319
MIM610306		 	NEPHRONECTIN; NPNT	255743
MIM610307		 	CERAMIDE KINASE; CERK	64781
MIM610308		13q12.3	UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE-LIKE; B3GALTL	145173
MIM610309		19q13.42	UBIQUITIN-CONJUGATING ENZYME E2S; UBE2S	27338
MIM610310		4q31.1	LOC152586 GENE	152586
MIM610311		 	MEDIATOR COMPLEX SUBUNIT 28; MED28	80306
MIM610312		8p21.3	PIWI-LIKE 2: PIWIL2	55124
MIM610313	C1853198	11q13.3	COLD-INDUCED SWEATING SYNDROME 2; CISS2	23529
MIM610314		 	PIWI-LIKE 3: PIWIL3	440822
MIM610315		 	PIWI-LIKE 4; PIWIL4	143689
MIM610316		 	POLYRIBONUCLEOTIDE NUCLEOTIDYLTRANSFERASE 1; PNPT1	87178
MIM610317		 	CORDON-BLEU, MOUSE, HOMOLOG OF; COBL	23242
MIM610318		 	COBL-LIKE PROTEIN 1: COBLL1	22837
MIM610320	C1853196	 	MYOPIA 14; MYP14	100359407
MIM610321	C1853195	15q12	PROSTATE CANCER, HEREDITARY, 7; HPC7	100188809
MIM610322		 	TRANSCRIPTIONAL REGULATING FACTOR 1; TRERF1	55809
MIM610323		8q22-q23	METADHERIN; MTDH	92140
MIM610324		3p24.2	3-@OXOACYL-ACP SYNTHASE, MITOCHONDRIAL; OXSM	54995
MIM610325		 	NUCLEAR DISTRIBUTION GENE C, A. NIDULANS, HOMOLOG OF; NUDC	10726
MIM610326		13q14.1	RIBONUCLEASE H2, SUBUNIT B; RNASEH2B	79621
MIM610327		 	RUN AND FYVE DOMAINS-CONTAINING PROTEIN 1; RUFY1	80230
MIM610328		 	RUN AND FYVE DOMAINS-CONTAINING PROTEIN 2; RUFY2	55680
MIM610329	C1835916	11q13.2	AICARDI-GOUTIERES SYNDROME 3; AGS3	84153
MIM610330		11q13.2	RIBONUCLEASE H2, SUBUNIT C; RNASEH2C	84153
MIM610331		2q37.3	HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 6; HES6	55502
MIM610333	C1835912	19p13.13	AICARDI-GOUTIERES SYNDROME 4; AGS4	10535
MIM610334		 	HEPATOCELLULAR CARCINOMA-ASSOCIATED ANTIGEN 112	55365
MIM610335		 	PHD FINGER PROTEIN 20; PHF20	51230
MIM610336		19p13.3	C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 4C; C2CD4C	126567
MIM610337		7p13	UPREGULATOR OF CELL PROLIFERATION; URGCP	55665
MIM610339		1p34	LEUCINE- AND PROLINE-ENRICHED PROTEOGLYCAN 1; LEPRE1	64175
MIM610340		9q31-q32	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 4B; EPB41L4B	54566
MIM610341		 	LEPRECAN-LIKE 1; LEPREL1	55214
MIM610342		 	LEPRECAN-LIKE 2; LEPREL2	10536
MIM610343		15q21.3	C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 4A; C2CD4A	145741
MIM610344		15q21.3	C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 4B; C2CD4B	388125
MIM610345		7q34	ACYLGLYCEROL KINASE; AGK	55750
MIM610346		 	CDC37-LIKE 1; CDC37L1	55664
MIM610347		 	REGULATION OF NUCLEAR PRE-mRNA DOMAIN-CONTAINING PROTEIN 1A; RPRD1A	55197
MIM610348		10q24	FAMILY WITH SEQUENCE SIMILARITY 178, MEMBER A; FAM178A	55719
MIM610349		 	MEF2-ACTIVATING SAP TRANSCRIPTIONAL REGULATOR	284358
MIM610350		 	LINES, DROSOPHILA, HOMOLOG OF, 1; LINS1	55180
MIM610351		 	SUPPRESSOR OF MEK1, DICTYOSTELIUM, HOMOLOG OF, 1; SMEK1	55671
MIM610352		 	SUPPRESSOR OF MEK1, DICTYOSTELIUM, HOMOLOG OF, 2; SMEK2	57223
MIM610353	C1835905	8p21	EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 4	1135
MIM610354		 	CONNEXIN 43-INTERACTING PROTEIN, 150-KD; CIP150	57589
MIM610355		16p12	PARTNER AND LOCALIZER OF BRCA2; PALB2	79728
MIM610356	C1835897	9p24.2	RETINAL CONE DYSTROPHY 3B; RCD3B	169522
MIM610357	C1835896	 	SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE; SPG30	547
MIM610358		 	SIGNAL PEPTIDASE COMPLEX, SUBUNIT 1, S. CEREVISIAE, HOMOLOG OF; SPCS1	28972
MIM610359	C1835895	2q11.2	RETINITIS PIGMENTOSA 33; RP33	23020
MIM610360		 	MUCIN 20, CELL SURFACE-ASSOCIATED; MUC20	200958
MIM610361	C1835894	13q33.1-q34	OROFACIAL CLEFT 9; OFC9	100462724
MIM610362		19p13.3	RETINA AND ANTERIOR NEURAL FOLD HOMEOBOX-LIKE 1; RAXL1	84839
MIM610363		 	PEPTIDYLARGININE DEIMINASE, TYPE VI; PADI6	353238
MIM610364		 	TRANSMEMBRANE BAX INHIBITOR MOTIF-CONTAINING PROTEIN 1; TMBIM1	64114
MIM610365		 	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 1; C1QTNF1	114897
MIM610366		 	ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-1 SUBUNIT; AP3M1	26985
MIM610367		 	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 11; SLC2A11	66035
MIM610368		13q14	LEUCINE-RICH REPEATS AND CALPONIN HOMOLOGY DOMAIN-CONTAINING 1; LRCH1	23143
MIM610369		10p12.3	HEAT-SHOCK 70-KD PROTEIN 14; HSPA14	51182
MIM610370	C1835888	10q21.3	DIARRHEA 4, MALABSORPTIVE, CONGENITAL; DIAR4	50674
MIM610371		1p36.2	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 7; SLC2A7	155184
MIM610372		 	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 12; SLC2A12	154091
MIM610373		 	DEAD/H BOX 50; DDX50	79009
MIM610374	C1835887	11p15.1	DIABETES MELLITUS, TRANSIENT NEONATAL, 2	6833
MIM610375		 	C1q DOMAIN-CONTAINING PROTEIN 1; C1QDC1	65981
MIM610376		2q37	CHEMOKINE, CXC MOTIF, RECEPTOR 7; CXCR7	57007
MIM610377	C1959626	12q24	MEVALONIC ACIDURIA; MEVA	4598
MIM610378		 	GLIS FAMILY ZINC FINGER PROTEIN 1; GLIS1	148979
MIM610379	C1835867	3p21	WEST NILE VIRUS, SUSCEPTIBILITY TO	1234
MIM610380		3p22	LOEYS-DIETZ SYNDROME, TYPE 2B; LDS2B	7048
MIM610381	C1835865	19p13.3	CONE-ROD DYSTROPHY 11; CORD11	84839
MIM610383		 	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 9; RASSF9	9182
MIM610384		 	HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 1; HECW1	23072
MIM610385		 	LR8 PROTEIN; LR8	28959
MIM610386		14q32.1	BTB/POZ DOMAIN-CONTAINING PROTEIN 7; BTBD7	55727
MIM610387		 	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL IRON CARRIER), MEMBER 37; SLC25A37	51312
MIM610388		 	RAS (RAD AND GEM)-LIKE GTP-BINDING 1; REM1	28954
MIM610389		1q22	MAPBP-INTERACTING PROTEIN	28956
MIM610390		 	MACROPHAGE EXPRESSED GENE 1	219972
MIM610391		 	PLASTICITY-RELATED GENE 2	79948
MIM610392		 	MYC-BINDING PROTEIN 2; MYCBP2	23077
MIM610393		 	GON4-LIKE PROTEIN; GON4L	54856
MIM610394		 	GLIPR1-LIKE PROTEIN 2; GLIPR1L2	144321
MIM610395		 	GLIPR1-LIKE PROTEIN 1; GLIPR1L1	256710
MIM610396		 	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 6A; TRAPPC6A	79090
MIM610397		 	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 6B; TRAPPC6B	122553
MIM610398		 	SAP30-LIKE PROTEIN; SAP30L	79685
MIM610399		 	TRANSMEMBRANE PROTEASE, SERINE 11E; TMPRSS11E	28983
MIM610400		 	MACRO DOMAIN-CONTAINING 1; MACROD1	28992
MIM610401		12q22-q23	NETRIN 4; NTN4	59277
MIM610403		 	CULLIN-ASSOCIATED NEDDYLATION-DISSOCIATED 2; CAND2	23066
MIM610404		9q21.32	RECQ-MEDIATED GENOME INSTABILITY 1, S. CEREVISIAE, HOMOLOG OF; RMI1	80010
MIM610405		2q36.1	CHONDROITIN POLYMERIZING FACTOR; CHPF	79586
MIM610406		17p13.1	TRANSFER RNA ARGININE 1; TRNAR1	7230
MIM610407		17p13.1	TRANSFER RNA GLYCINE 2; TRNAG2	7196
MIM610408		 	SOLUTE CARRIER FAMILY 15 (OLIGOPEPTIDE TRANSPORTER), MEMBER 3; SLC15A3	51296
MIM610409		 	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 8; SLC16A8	23539
MIM610410		 	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 1; DHRS1	115817
MIM610411		 	IMPORTIN 13; IPO13	9670
MIM610412		 	SERINE PALMITOYLTRANSFERASE, SMALL SUBUNIT, B; SPTSSB	165679
MIM610413		 	INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-LIKE 1; IGFBPL1	347252
MIM610414		1q21.1	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 15; NBPF15	284565
MIM610415		 	SYNTAXIN-BINDING PROTEIN 4; STXBP4	252983
MIM610416		 	SCAN DOMAIN-CONTAINING 1; SCAND1	51282
MIM610417		 	SCAN DOMAIN-CONTAINING 2; SCAND2	54581
MIM610418		 	WD REPEAT- AND FYVE DOMAIN-CONTAINING PROTEIN 2; WDFY2	115825
MIM610419	C1835854	 	DEAFNESS, AUTOSOMAL RECESSIVE 68; DFNB68	751609
MIM610421		8q24.2	KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 3; KHDRBS3	10656
MIM610422	C1835852	3q26.2-q26.31	ALOPECIA-MENTAL RETARDATION SYNDROME 2; APMR2	100049544
MIM610423		 	PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 2; PACS2	23241
MIM610424	C1864880	6q23-q24, 21q22.1, 21q22.1	HEPATITIS B VIRUS, SUSCEPTIBILITY TO	3455, 3459, 3588
MIM610425	C1864879	22q11.2-q13.1	CATARACT, LAMELLAR 2	1413
MIM610426		22q11.2-q13.1	MICROPHTHALMIA, ISOLATED, WITH CATARACT 4; MCOPCT4	1413
MIM610427	C1864877	11q13.1	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B; CSNB2B	57010
MIM610428		 	CYTOCHROME c OXIDASE ASSEMBLY PROTEIN COX18; COX18	285521
MIM610429		 	CYTOCHROME c OXIDASE ASSEMBLY PROTEIN COX19; COX19	90639
MIM610430	C1864876	4q	MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 2; WM2	100188811
MIM610431		 	RING FINGER PROTEIN 167; RNF167	26001
MIM610432		 	RING FINGER PROTEIN 125; RNF125	54941
MIM610433		 	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G5B; LY6G5B	58496
MIM610434		 	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G5C; LY6G5C	80741
MIM610435		 	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G6C; LY6G6C	80740
MIM610436		 	ROTATIN; RTTN	25914
MIM610437		 	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G6E; LY6G6E	79136
MIM610438	C1864875	9p24-p22	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 3; RLS3	100188812
MIM610439	C1864874	2q33	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 4; RLS4	100188813
MIM610440		 	SMALL G PROTEIN SIGNALING MODULATOR 3; SGSM3	27352
MIM610441	C1864873	4p15.31-p15.2	TESTICULAR MICROLITHIASIS	10568
MIM610443	C1864871	17q21.31	KOOLEN-DE VRIES SYNDROME; KDVS	284058, 791085
MIM610444	C1864870	3p21	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3	2779
MIM610445	C1864869	3q21-q24	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1; CSNBAD1	6010
MIM610446	C1864868	2q35	BURULI ULCER, SUSCEPTIBILITY TO	6556
MIM610447		10q26.3	SHADOW OF PRION PROTEIN; SPRN	503542
MIM610448	C3277619	3p21, 3p21.3-p21.2	CHILBLAIN LUPUS 1; CHBL1	11277
MIM610449		 	MITOCHONDRIAL CARRIER HOMOLOG 1; MTCH1	23787
MIM610450		 	LY6/PLAUR DOMAIN-CONTAINING PROTEIN 1; LYPD1	116372
MIM610451		 	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 35; LRRC35	219899
MIM610453		8p11.1	HEPARAN-ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE; HGSNAT	138050
MIM610454		 	LEUCINE ZIPPER, PUTATIVE TUMOR SUPPRESSOR 2; LZTS2	84445
MIM610455	C1864861	7q21	TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL; NFTC	54809
MIM610456		7q21	STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 9; SAMD9	54809
MIM610457		 	SPHINGOMYELIN PHOSPHODIESTERASE 4, NEUTRAL MEMBRANE; SMPD4	55627
MIM610458		 	LEUCINE ZIPPER AND CTNNBIP1 DOMAINS-CONTAINING PROTEIN; LZIC	84328
MIM610459		 	PROLINE-RICH PROTEIN 13; PRR13	54458
MIM610460	C0342801	6p22.3	THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	7172
MIM610461		 	RETICULON 4 RECEPTOR-LIKE 1; RTN4RL1	146760
MIM610462		 	RETICULON 4 RECEPTOR-LIKE 2; RTN4RL2	349667
MIM610463		6q22.31	NUCLEAR UNDECAPRENYL PYROPHOSPHATE SYNTHASE 1, S. CEREVISIAE, HOMOLOG OF; NUS1	116150
MIM610464		3q13-q22	G PROTEIN-COUPLED RECEPTOR 156; GPR156	165829
MIM610465		17q21.33	ACYL-CoA SYNTHETASE FAMILY, MEMBER 2; ACSF2	80221
MIM610466		 	LIMB EXPRESSION 1, MOUSE, HOMOLOG OF; LIX1	167410
MIM610467		10p14-p13	PROTEIN TYROSINE PHOSPHATASE-LIKE (PROLINE INSTEAD OF CATALYTIC ARGININE), MEMBER A; PTPLA	9200
MIM610468		1p31.1	INTERFERON-INDUCED PROTEIN 44; IFI44	10561
MIM610469		 	ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-2 SUBUNIT; AP3M2	10947
MIM610470		11q13	TRANSFER RNA PHOSPHOTRANSFERASE 1; TRPT1	83707
MIM610471		 	VASOHIBIN 2; VASH2	79805
MIM610472		 	ACYLTRANSFERASE-LIKE 2; AYTL2	79888
MIM610473		 	LYSOPHOSPHATIDYLGLYCEROL ACYLTRANSFERASE 1; LPGAT1	9926
MIM610474	C1864852	4p16.3	CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	2261
MIM610475	C1864851	2q31.2	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2	50940
MIM610476	C1864850	18q12.1	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11; ARVD11	1824
MIM610477		 	TRANSMEMBRANE PROTEASE, SERINE 9; TMPRSS9	360200
MIM610478	C1864849	12p13.3	RETINAL CONE DYSTROPHY 4; RCD4	93589
MIM610479		5q23.1	SERUM RESPONSE FACTOR BINDING PROTEIN 1; SRFBP1	153443
MIM610480		 	LEM DOMAIN-CONTAINING PROTEIN 1; LEMD1	93273
MIM610481		 	SH2 DOMAIN-CONTAINING PROTEIN D; SHD	56961
MIM610482		 	SH2 DOMAIN-CONTAINING PROTEIN E; SHE	126669
MIM610484		 	PROLINE-RICH SYNAPSE-ASSOCIATED PROTEIN-INTERACTING PROTEIN 1	9762
MIM610485		 	LOSS OF HETEROZYGOSITY, CHROMOSOME 3, REGION 2, GENE A; LOH3CR2A	29931
MIM610486		 	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 4; LRRC4	64101
MIM610487		 	KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 2; KHDRBS2	202559
MIM610488		 	TETRATRICOPEPTIDE REPEAT DOMAIN 9; TTC9	23508
MIM610489	C1864846	17q23-q24	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1	5573
MIM610490		 	PURPLE ACID PHOSPHATASE, LONG FORM	390928
MIM610491		 	SLAIN MOTIF FAMILY, MEMBER 1; SLAIN1	122060
MIM610492		 	SLAIN MOTIF FAMILY, MEMBER 2; SLAIN2	57606
MIM610493		 	DIX DOMAIN-CONTAINING PROTEIN 1; DIXDC1	85458
MIM610494		 	DDB1- AND CUL4-ASSOCIATED FACTOR 6; DCAF6	55827
MIM610495		 	HOM-TES-103 GENE	25900
MIM610496		1p22.1	RHO GTPase-ACTIVATING PROTEIN 29; ARHGAP29	9411
MIM610497		 	BRAIN AND REPRODUCTIVE ORGAN-EXPRESSED PROTEIN; BRE	9577
MIM610498	C1864843	10q22.1	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	51021
MIM610499		5q31.1	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; RAPGEF6	51735
MIM610500		5q31.3	ANKYRIN REPEAT AND KH DOMAIN-CONTAINING PROTEIN 1; ANKHD1	54882
MIM610501		1p36.2	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 1; NBPF1	55672
MIM610502		6q21	RETICULON 4-INTERACTING PROTEIN 1; RTN4IP1	84816
MIM610503		16p13.3	CHROMOSOME 16 OPEN READING FRAME 5; C16ORF5	29965
MIM610504	C0729264	11q13.5	PRETERM PREMATURE RUPTURE OF THE MEMBRANES; PPROM	871
MIM610505	C1864840	12q13-q14	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3	10102
MIM610506		19q13.2	PAF1 RNA POLYMERASE II-ASSOCIATED FACTOR, S. CEREVISIAE, HOMOLOG OF; PAF1	54623
MIM610507		15q15.3	LEO1 RNA POLYMERASE II ASSOCIATED FACTOR, S. CEREVISIAE, HOMOLOG OF; LEO1	123169
MIM610508	C1864839	2p25	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7; MODY7	8462
MIM610509		 	RESISTANCE TO INHIBITORS OF CHOLINESTERASE 3, C. ELEGANS, HOMOLOG OF; RIC3	79608
MIM610510		 	AURORA BOREALIS; BORA	79866
MIM610511		14q21.1	SEC23, S. CEREVISIAE, HOMOLOG OF, A; SEC23A	10484
MIM610512		20p11.2	SEC23, S. CEREVISIAE, HOMOLOG OF, B; SEC23B	10483
MIM610513		1p36	ATPase, TYPE 13A2; ATP13A2	23400
MIM610514		 	PHD FINGER PROTEIN 17; PHF17	79960
MIM610515		 	PHD FINGER PROTEIN 15; PHF15	23338
MIM610516		3p21	GLYCERATE KINASE; GLYCTK	132158
MIM610517		 	CONTACTIN-ASSOCIATED PROTEIN-LIKE 3; CNTNAP3	79937
MIM610518		 	CONTACTIN-ASSOCIATED PROTEIN-LIKE 4; CNTNAP4	85445
MIM610519		 	CONTACTIN-ASSOCIATED PROTEIN-LIKE 5; CNTNAP5	129684
MIM610520		 	CD300 ANTIGEN-LIKE FAMILY, MEMBER G; CD300LG	146894
MIM610521		 	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 12; KCTD12	115207
MIM610522		 	COORDINATED EXPRESSION TO IRXA2	153571
MIM610523		 	CENTROSOMAL PROTEIN, 41-KD; CEP41	95681
MIM610524		 	HUMAN ENDOGENOUS RETROVIRUS FRD ENVELOPE PROTEIN	405754
MIM610525		 	5-PRIME-@NUCLEOTIDASE, CYTOSOLIC, IA; NT5C1A	84618
MIM610526		 	5-PRIME-@NUCLEOTIDASE, CYTOSOLIC, IB; NT5C1B	93034
MIM610527		14q22.1	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 1; TXNDC1	81542
MIM610528		14q11.2	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 8; CHD8	57680
MIM610529		9p21	TUMOR SUPPRESSOR CANDIDATE 1; TUSC1	286319
MIM610530		5q35.3	TRIPARTITE MOTIF-CONTAINING 41; TRIM41	90933
MIM610531		7p15.3	FAMILY WITH SEQUENCE SIMILARITY 126, MEMBER A; FAM126A	84668
MIM610532	C2674508	7p15.3	LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	84668
MIM610533		5q34-q35.2	WW, C2, AND COILED-COIL DOMAIN-CONTAINING 1; WWC1	23286
MIM610534		 	DECAPPING ENZYME, SCAVENGER; DCPS	28960
MIM610535	C1864653	5q22.1-q32	GLAUCOMA 1, OPEN ANGLE, M; GLC1M	777643
MIM610536	C1864652	 	MANDIBULOFACIAL DYSOSTOSIS WITH MICROCEPHALY; MFDM	9343
MIM610537		 	DIPEPTIDYL PEPTIDASE VII; DPP7	29952
MIM610538		1q31	UBIQUITIN-CONJUGATING ENZYME E2T; UBE2T	29089
MIM610539	C1864651	10q22.1	GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	5660
MIM610540		20q13.2	GNAS COMPLEX LOCUS, ANTISENSE TRANSCRIPT 1; GNASAS1	149775
MIM610541		 	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3B; PPP1R3B	79660
MIM610542	C1864649	 	MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 1; CMSTA1	2673
MIM610543	C1864648	16p13.3	CHROMOSOME 16p13.3 DELETION SYNDROME, PROXIMAL	100188814
MIM610544		19p13.3	IGF-LIKE FAMILY MEMBER 1; IGFL1	374918
MIM610545		19p13.3	IGF-LIKE FAMILY MEMBER 2; IGFL2	147920
MIM610546		19p13.3	IGF-LIKE FAMILY MEMBER 3; IGFL3	388555
MIM610547		19p13.3	IGF-LIKE FAMILY MEMBER 4; IGFL4	444882
MIM610548		 	AQUARIUS, MOUSE, HOMOLOG OF; AQR	9716
MIM610549	C0271690	19p13.2	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS	3643
MIM610550		10q22	METHIONINE ADENOSYLTRANSFERASE I, ALPHA; MAT1A	4143
MIM610551	C2750180	11q13	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 1	81622
MIM610552		3q22	UBIQUITIN-ACTIVATING ENZYME E1 DOMAIN-CONTAINING 1; UBE1DC1	79876
MIM610553		 	UBIQUITIN-FOLD MODIFIER 1; UFM1	51569
MIM610554		 	UBIQUITIN-FOLD MODIFIER-CONJUGATING ENZYME 1; UFC1	51506
MIM610555		7p14-p13	CORE 1 SYNTHASE, GLYCOPROTEIN-N-ACETYLGALACTOSAMINE 3-BETA-GALACTOSYLTRANSFERASE, 1; C1GALT1	56913
MIM610556		20q13.33	HIGHLY ACCELERATED REGION GENE 1A; HAR1A	768096
MIM610557		20q13.33	HIGHLY ACCELERATED REGION GENE 1B; HAR1B	768097
MIM610558		 	MITOGEN-ACTIVATED PROTEIN KINASE-ASSOCIATED PROTEIN 1; MAPKAP1	79109
MIM610559		 	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 4; RASSF4	83937
MIM610560		 	PROTEASE, SERINE, 36; PRSS36	146547
MIM610561		 	POLYSERASE 3	339105
MIM610562		 	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12A; ZC3H12A	80149
MIM610563		 	KARYOPHERIN ALPHA-6; KPNA6	23633
MIM610564		6q21	PRENYL DIPHOSPHATE SYNTHASE, SUBUNIT 2; PDSS2	57107
MIM610565		 	DYNEIN, AXONEMAL, LIGHT CHAIN 4; DNAL4	10126
MIM610566		5q33.3	MICRO RNA 146A; MIR146A	406938
MIM610567		 	MICRO RNA 146B; MIRN146B	574447
MIM610568		1q21.2	ZINC FINGER PROTEIN 687; ZNF687	57592
MIM610569		1p32.3	UBIQUITIN-SPECIFIC PROTEASE 24; USP24	23358
MIM610570		 	UBIQUITIN-SPECIFIC PROTEASE 40; USP40	55230
MIM610571		 	FK506-BINDING PROTEIN 11; FKBP11	51303
MIM610572		5q13.1	MARVEL DOMAIN-CONTAINING PROTEIN 2; MARVELD2	153562
MIM610573		20p13	R-SPONDIN FAMILY, MEMBER 4; RSPO4	343637
MIM610574		 	R-SPONDIN FAMILY, MEMBER 3; RSPO3	84870
MIM610575		8q23.1	R-SPONDIN FAMILY, MEMBER 2; RSPO2	340419
MIM610576		12q14	RHO GTPase-ACTIVATING PROTEIN 9; ARHGAP9	64333
MIM610577		10p12	RHO GTPase-ACTIVATING PROTEIN 12; ARHGAP12	94134
MIM610578		 	RHO GTPase-ACTIVATING PROTEIN 15; ARHGAP15	55843
MIM610579		 	RCSD DOMAIN-CONTAINING PROTEIN 1; RCSD1	92241
MIM610580		 	ONCOGENE PIM3; PIM3	415116
MIM610581		 	COATOMER PROTEIN COMPLEX, SUBUNIT GAMMA-2, INTRONIC TRANSCRIPT 1; COPG2IT1	53844
MIM610582	C1864623	11p15.1	DIABETES MELLITUS, TRANSIENT NEONATAL, 3	3767
MIM610583		6q14-q16	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 6; ANKRD6	22881
MIM610584		 	TRIPARTITE MOTIF-CONTAINING PROTEIN 67; TRIM67	440730
MIM610585		 	RHO GTPase-ACTIVATING PROTEIN 22; ARHGAP22	58504
MIM610586		4q21	RHO GTPase-ACTIVATING PROTEIN 24; ARHGAP24	83478
MIM610587		2p13	RHO GTPase-ACTIVATING PROTEIN 25; ARHGAP25	9938
MIM610588		12q13.1	DENDRIN; DDN	23109
MIM610589		15q13.2	RHO GTPase-ACTIVATING PROTEIN 11A; ARHGAP11A	9824
MIM610590		17q12	RHO GTPase-ACTIVATING PROTEIN 23; ARHGAP23	57636
MIM610591		17q21	RHO GTPase-ACTIVATING PROTEIN 27; ARHGAP27	201176
MIM610592		18p11.31	RHO GTPase-ACTIVATING PROTEIN 28; ARHGAP28	79822
MIM610593		3q27	MAP6 DOMAIN-CONTAINING PROTEIN 1; MAP6D1	79929
MIM610594		5q23.3	FOLLICULIN-INTERACTING PROTEIN 1; FNIP1	96459
MIM610595		1q21.3	FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE, S. CEREVISIAE, HOMOLOG OF; FLAD1	80308
MIM610596		8q24	BLOCK OF PROLIFERATION 1; BOP1	23246
MIM610597		19q13.3	GLUTAMATE-RICH WD REPEAT-CONTAINING PROTEIN 1; GRWD1	83743
MIM610598		17q22	PRCD, DOG, HOMOLOG OF; PRCD	768206
MIM610599	C1864621	17q22	RETINITIS PIGMENTOSA 36; RP36	768206
MIM610600	C3463917	8q21	CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY	1585
MIM610601		19q13.4	KALLIKREIN-RELATED PEPTIDASE 15; KLK15	55554
MIM610602		12q23.3	AlkB, E. COLI, HOMOLOG OF, 2; ALKBH2	121642
MIM610603		11p11.12	AlkB, E. COLI, HOMOLOG OF, 3; ALKBH3	221120
MIM610604		19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, PSEUDOGENE 1; KIR3DP1	548594
MIM610605		4q32-q33	CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 2; CPEB2	132864
MIM610606		10q23.3	CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 3; CPEB3	22849
MIM610607		5q21	CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 4; CPEB4	80315
MIM610608		20p11.21	GINS COMPLEX SUBUNIT 1; GINS1	9837
MIM610609		16q24.1	GINS COMPLEX SUBUNIT 2; GINS2	51659
MIM610610		16q21	GINS COMPLEX SUBUNIT 3; GINS3	64785
MIM610611		8p11.21	GINS COMPLEX SUBUNIT 4; GINS4	84296
MIM610612	C1857743	1q32.3	LEBER CONGENITAL AMAUROSIS 12; LCA12	343035
MIM610613		8q21	CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 1; CYP11B1	1584
MIM610614		11q24.2	TRANSFORMING GROWTH FACTOR-BETA REGULATOR 1; TBRG1	84897
MIM610615		9q34.3	PARTNER OF ARF	55684
MIM610616		18p11.22	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 12; ANKRD12	23253
MIM610617		1q32.1-q32.2	DENTICLELESS, DROSOPHILA, HOMOLOG OF; DTL	51514
MIM610618	C1857728	5q33-qter	ANGIOEDEMA, HEREDITARY, TYPE III; HAE3	2161
MIM610619		5q33-qter	COAGULATION FACTOR XII; F12	2161
MIM610620		13q31	ADP-RIBOSYLHYDROLASE-LIKE 1; ADPRHL1	113622
MIM610621		4q28	INTURNED, DROSOPHILA, HOMOLOG OF; INTU	27152
MIM610622		19q13	FUZZY, DROSOPHILA, HOMOLOG OF; FUZ	80199
MIM610623	C1864567	10q25	CATARACT, POSTERIOR POLAR, 4; CTPP4	5309
MIM610624		1p35.3-p34.1	ADP-RIBOSYLHYDROLASE-LIKE 2; ADPRHL2	54936
MIM610625		11p15	ADP-RIBOSYLTRANSFERASE 5; ART5	116969
MIM610626		8p12	PPAP2 DOMAIN-CONTAINING PROTEIN 1B; PPAPDC1B	84513
MIM610627		12p13.31	ALPHA-2-MACROGLOBULIN-LIKE 1; A2ML1	144568
MIM610628	C1857720	3p21.1	HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	60675
MIM610629	C1857719	10q22-q23	DIAMOND-BLACKFAN ANEMIA 3; DBA3	6229
MIM610630		 	PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 20A; PTPN20A	653129
MIM610631		 	PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 20B; PTPN20B	26095
MIM610632		 	EF-HAND DOMAIN FAMILY, MEMBER A1; EFHA1	221154
MIM610633		 	EF-HAND DOMAIN FAMILY, MEMBER A2; EFHA2	286097
MIM610634	C1855179	14q22-q23	CATARACT, POSTERIOR POLAR, 5; CTPP5	791086
MIM610635		8q22.3	COLLAGEN TRIPLE-HELIX REPEAT-CONTAINING PROTEIN 1; CTHRC1	115908
MIM610636		9q22.32	MICRO RNA 27B; MIRN27B	407019
MIM610637		10q23.3	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 5; MARCH5	54708
MIM610638		21q22.2	JUNCTIONAL ADHESION MOLECULE 4	150084
MIM610639		 	GRID2-INTERACTING PROTEIN 1; GRID2IP1	392862
MIM610640		1p35	YTH DOMAIN FAMILY MEMBER 2; YTHDF2	51441
MIM610641		 	TERMINAL URIDYLYL TRANSFERASE 1, U6 snRNA-SPECIFIC; TUT1	64852
MIM610642		 	ENDOPLASMIC RETICULUM PROTEIN, 27-KD; ERP27	121506
MIM610643		3q13.13	KIAA1524 GENE; KIAA1524	57650
MIM610644	C3149931	1p34.3	PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	284654
MIM610645		 	CALCIUM- AND INTEGRIN-BINDING PROTEIN 3; CIB3	117286
MIM610646		 	CALCIUM- AND INTEGRIN-BINDING PROTEIN 4	130106
MIM610647		 	N-ACETYLTRANSFERASE 8-LIKE; NAT8L	339983
MIM610648		 	CUT-LIKE 2; CUTL2	23316
MIM610649	C1857711	8q24	BONE SIZE QUANTITATIVE TRAIT LOCUS 3	100188815
MIM610650		 	ADHESION-REGULATING MOLECULE 1; ADRM1	11047
MIM610651	C1970808	2q21	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B; XPB	2071
MIM610652		 	PHOSPHODIESTERASE 10A; PDE10A	10846
MIM610653		 	RIBOSOMAL RNA-PROCESSING 1, S. CEREVISIAE, HOMOLOG OF; RRP1	8568
MIM610654		 	RIBOSOMAL RNA-PROCESSING PROTEIN 1, S. CEREVISIAE, HOMOLOG OF, B; RRP1B	23076
MIM610655	C1857688	7p14	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	791087
MIM610656		1p22.2	CYSTEINE CONJUGATE BETA-LYASE 2; CCBL2	56267
MIM610657		8q24.13	KIAA0196 GENE; KIAA0196	9897
MIM610658		 	TRIPARTITE MOTIF-CONTAINING PROTEIN 29; TRIM29	23650
MIM610659		10q22	GLUTAMATE RECEPTOR, IONOTROPIC, DELTA 1; GRID1	2894
MIM610660		16p13.3	NUCLEAR PROTEIN, 60-KD	84656
MIM610661		3p24	N-GLYCANASE 1; NGLY1	55768
MIM610662		 	PHOSPHATIDYLINOSITOL GLYCAN, CLASS Y; PIGY	84992
MIM610663		1q41	SET AND MYND DOMAIN-CONTAINING PROTEIN 2; SMYD2	56950
MIM610664		 	BREAST CANCER-OVEREXPRESSED GENE 1	9703
MIM610665		1q23	Fc FRAGMENT OF IgG, LOW AFFINITY IIIb, RECEPTOR FOR; FCGR3B	2215
MIM610666		20p13	NEURENSIN 2; NRSN2	80023
MIM610667		1q32	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE L5; UCHL5	51377
MIM610668		11p15.2	INSCUTEABLE, DROSOPHILA, HOMOLOG OF; INSC	387755
MIM610669		4p16.3	TNFAIP3-INTERACTING PROTEIN 2; TNIP2	79155
MIM610670		4q25	CYTOCHROME P450, FAMILY 2, SUBFAMILY U, POLYPEPTIDE 1; CYP2U1	113612
MIM610671		19q13.4	ZINC FINGER PROTEIN 628; ZNF628	89887
MIM610672		 	BTB/POZ DOMAIN-CONTAINING PROTEIN 14B; BTBD14B	112939
MIM610673		9q34.11	CHROMOSOME 9 OPEN READING FRAME 90; C9ORF90	203245
MIM610674		20p13	CHROMOSOME 20 OPEN READING FRAME 28; C20ORF28	25876
MIM610675		 	HEMATOPOIETIC STEM/PROGENITOR CELL PROTEIN MDS032	55850
MIM610676	C1970807	17q21	AUTISM, SUSCEPTIBILITY TO, 7; AUTS7	100188816
MIM610677		 	LSM14A PROTEIN; LSM14A	26065
MIM610678	C1857682	16p11.2	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	7284
MIM610679		7q21.13	PFTAIRE PROTEIN KINASE 1; PFTK1	5218
MIM610681		12q13.3	PHOSPHOFRUCTOKINASE, MUSCLE TYPE; PFKM	5213
MIM610682	C1853162	3p22, 3p24.1-p22	OSTEOGENESIS IMPERFECTA, TYPE VII	10491
MIM610683		4q27	BBS12 GENE; BBS12	166379
MIM610684		 	C-TERMINAL DOMAIN NUCLEAR ENVELOPE PHOSPHATASE 1; CTDNEP1	23399
MIM610685	C1853156	6q14.1	SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 2; SHFLD2	791123
MIM610686		8q12.1	LOC137886 GENE	137886
MIM610687	C1853154	14q12	NEMALINE MYOPATHY 7; NEM7	1073
MIM610688	C1853153	8q21.13-q22.1	JOUBERT SYNDROME 6; JBTS6	91147
MIM610689		9q33.1	DIPLA1, ANTISENSE	493913
MIM610690		2q32.2	3-@HYDROXYISOBUTYRYL-CoA HYDROLASE; HIBCH	26275
MIM610691		9p13	PRUNE, DROSOPHILA, HOMOLOG OF, 2; PRUNE2	158471
MIM610692		1p36.23-p34.3	HEAT-SHOCK 27-KD PROTEIN 7; HSPB7	27129
MIM610693		11q24.2	HYLS1 GENE; HYLS1	219844
MIM610694		19p13.11	PYROGLUTAMYL PEPTIDASE I; PGPEP1	54858
MIM610695		19q13.13	HEAT-SHOCK 27-KD PROTEIN 6; HSPB6	126393
MIM610696		15q22.1	PCNA-ASSOCIATED FACTOR, 15-KD	9768
MIM610697		5p13.2	PDZ DOMAIN-CONTAINING 2; PDZD2	23037
MIM610698	C1853147	17q21.2, 1q32	MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4	3075, 60681
MIM610699		7p22.3	ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 2A; ZFAND2A	90637
MIM610700		8p11.23	HTRA SERINE PEPTIDASE 4; HTRA4	203100
MIM610701		10q26.12	HEAT-SHOCK 70-KD PROTEIN 12A; HSPA12A	259217
MIM610702		20p13	HEAT-SHOCK 70-KD PROTEIN 12B; HSPA12B	116835
MIM610703		13q12.3	HEAT-SHOCK 105/110-KD PROTEIN 1; HSPH1	10808
MIM610704		12p13	PROHIBITIN 2; PHB2	11331
MIM610705		17q25.1	CD300 ANTIGEN-LIKE FAMILY, MEMBER B; CD300LB	124599
MIM610706	C1853144	11q13	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA	2248
MIM610707	C1853143	16q	PSORIASIS SUSCEPTIBILITY 8; PSORS8	140454
MIM610708	C1853139	22q12.1-q13.1	OPTIC ATROPHY 5; OPA5	692222
MIM610709		5q22.2	TESTIS-SPECIFIC SERINE/THREONINE KINASE 1; TSSK1	83942
MIM610710		22q11.21	TESTIS-SPECIFIC SERINE/THREONINE KINASE 2; TSSK2	23617
MIM610711		14q11.2	TESTIS-SPECIFIC SERINE/THREONINE KINASE 4; TSSK4	283629
MIM610712		19p13.11	TESTIS-SPECIFIC SERINE/THREONINE KINASE 6; TSSK6	83983
MIM610713	C1853137	2q31-q32	BRACHYDACTYLY-SYNDACTYLY SYNDROME	3239
MIM610714		9q34.11	PROTEIN KINASE N3; PKN3	29941
MIM610715		9q22	HEMOGEN; HEMGN	55363
MIM610716		15q22.3	TIMELESS-INTERACTING PROTEIN; TIPIN	54962
MIM610717	C1853136	11p15.5	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	57104
MIM610718		17p13.1	MICRO RNA 195; MIR195	406971
MIM610719		19p13.2	MICRO RNA 199A1; MIRN199A1	406976
MIM610720		1q24.3	MICRO RNA 199A2; MIR199A2	406977
MIM610721		1q24.3	MICRO RNA 214; MIR214	406996
MIM610723		9q22.32	MICRO RNA 23B; MIRN23B	407011
MIM610724		19p13.12	MICRO RNA 24-2; MIRN24-2	407013
MIM610725	C1853124	10q23	NEPHROTIC SYNDROME, TYPE 3; NPHS3	51196
MIM610726		10q25.3	TRUB PSEUDOURIDINE SYNTHASE, E. COLI, HOMOLOG OF, 1; TRUB1	142940
MIM610727		9q34.11	TRUB PSEUDOURIDINE SYNTHASE, E. COLI, HOMOLOG OF, 2; TRUB2	26995
MIM610728		6q22.31	SPHINGOMYELIN PHOSPHODIESTERASE, ACID-LIKE, 3A; SMPDL3A	10924
MIM610729		2q14	WD REPEAT-CONTAINING PROTEIN 92; WDR92	116143
MIM610730		17q12	CHAPERONIN-CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 6B; CCT6B	10693
MIM610731		7q31.3	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 7; ANKRD7	56311
MIM610732		11q23.2	TETRATRICOPEPTIDE REPEAT DOMAIN 12; TTC12	54970
MIM610733	C1853120	2p22-p21	NOONAN SYNDROME 4; NS4	6654
MIM610734		10q23.31-q23.32	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 2; ANKRD2	26287
MIM610735		5q31	MYOZENIN 3; MYOZ3	91977
MIM610736		2p11.2-q11.1	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 23; ANKRD23	200539
MIM610737		12q24.2	KINASE SUPPRESSOR OF RAS 2; KSR2	283455
MIM610738	CN032247	1q21.3	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	10456
MIM610739		16p12	TRINUCLEOTIDE REPEAT-CONTAINING GENE 6A; TNRC6A	27327
MIM610740		22q13.1	TRINUCLEOTIDE REPEAT-CONTAINING GENE 6B; TNRC6B	23112
MIM610741		17q25.3	TRINUCLEOTIDE REPEAT-CONTAINING GENE 6C; TNRC6C	57690
MIM610742		1p13.2	MOLONEY LEUKEMIA VIRUS 10, MOUSE, HOMOLOG OF; MOV10	4343
MIM610743	C1853116	6q25	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	23345
MIM610745		15q24.1	STIMULATED BY RETINOIC ACID 6, MOUSE, HOMOLOG OF; STRA6	64220
MIM610746		9q34.11	DOLICHOL KINASE; DOLK	22845
MIM610747		14q22.2	STERILE ALPHA MOTIF DOMAIN-CONTAINING 4A; SAMD4A	23034
MIM610748		11q23	UBIQUITIN-SPECIFIC PROTEASE 28; USP28	57646
MIM610749		6p12	KELCH-LIKE 31; KLHL31	401265
MIM610750		12q12	ZINC FINGER CCHC DOMAIN- AND RNA-BINDING MOTIF-CONTAINING PROTEIN 1; ZCRB1	85437
MIM610751		10p12.1	PHOSPHORIBOSYL TRANSFERASE DOMAIN-CONTAINING PROTEIN 1; PRTFDC1	56952
MIM610752		6q25.1	URONYL 2-SULFOTRANSFERASE; UST	10090
MIM610753	C1853104	16q11-q22	ALOPECIA AREATA 2	100034703
MIM610754		10q23.2	WINGS APART-LIKE PROTEIN, DROSOPHILA, HOMOLOG OF; WAPAL	23063
MIM610755	C1970712	12p13	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	1027
MIM610756	C1853102	19q13.2-q13.3	CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	2068
MIM610757		17q12	CHEMOKINE, CC MOTIF, LIGAND 4-LIKE 2; CCL4L2	388372
MIM610758	C1853100	19q13.2-q13.3	CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	2067
MIM610759	C1853099	10q25	CORNELIA DE LANGE SYNDROME 3; CDLS3	9126
MIM610760	C1853098	2p24-p22	CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2	100188817
MIM610761	C1853097	3q24-q26	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 5	100188818
MIM610762	C1853096	12q24.31	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6	100188819, 949
MIM610763		20p11	N-ACETYLNEURAMINIC ACID PHOSPHATASE; NANP	140838
MIM610764		17q23.2	BENZODIAZAPINE RECEPTOR (PERIPHERAL)-ASSOCIATED PROTEIN 1; BZRAP1	9256
MIM610765		11q24-q25	ICHTHYOSIS WITH HYPOTRICHOSIS, AUTOSOMAL RECESSIVE	6768
MIM610766		15q21.3	MEIOSIS-SPECIFIC NUCLEAR STRUCTURAL PROTEIN 1; MNS1	55329
MIM610767		2q37.1	AUTOPHAGY 16-LIKE 1; ATG16L1	55054
MIM610768	C1835849	9q34.11	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M	22845
MIM610769		10q24	NUCLEOLAR COMPLEX-ASSOCIATED PROTEIN 3, S. CEREVISIAE, HOMOLOG OF; NOC3L	64318
MIM610770		1p36.33	NUCLEOLAR COMPLEX-ASSOCIATED PROTEIN 2, S. CEREVISIAE, HOMOLOG OF; NOC2L	26155
MIM610771		1p36	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 5; CHD5	26038
MIM610772		8p11.2	NK6 HOMEOBOX 3; NKX6-3	157848
MIM610773	C1835845	12q23	MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY	5250
MIM610774		6pter-p12	CANOPY 3, ZEBRAFISH, HOMOLOG OF; CNPY3	10695
MIM610775		12p13.3	TP53-INDUCED GLYCOLYSIS AND APOPTOSIS REGULATOR	57103
MIM610776		12q23.2	DAMAGE-REGULATED AUTOPHAGY MODULATOR 1; DRAM1	55332
MIM610777		14q11.2	NEUROGUIDIN; NGDN	25983
MIM610778		22q11.2	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-1-LIKE; GNB1L	54584
MIM610779		16p13.3	NUCLEOTIDE-BINDING PROTEIN 2; NUBP2	10101
MIM610780		3q29	LARGE SUBUNIT GTPase 1, S. CEREVISIAE, HOMOLOG OF; LSG1	55341
MIM610781		14q11-q21	GUANOSINE MONOPHOSPHATE REDUCTASE 2; GMPR2	51292
MIM610782		7q32.3	MICRO RNA 29A; MIR29A	407021
MIM610783		7q32.3	MICRO RNA 29B1; MIR29B1	407024
MIM610784		1q32.2	MICRO RNA 29C; MIR29C	407026
MIM610785		1p35.3	PDLIM1-INTERACTING KINASE 1-LIKE; PDIK1L	149420
MIM610786		17q12	SNAP25-INTERACTING PROTEIN	80725
MIM610787		17q21.3	HOXB CLUSTER ANTISENSE RNA 5; HOXBAS5	360205
MIM610788		6p12.1-p11.2	SOLUTE CARRIER FAMILY 35 (3-PRIME-PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE TRANSPORTER), MEMBER B2; SLC35B2	347734
MIM610789		20q11	p53 AND DNA DAMAGE-REGULATED 1; PDRG1	81572
MIM610790		17q21.33	SOLUTE CARRIER FAMILY 35, MEMBER B1; SLC35B1	10237
MIM610791		17p13.3	SOLUTE CARRIER FAMILY 43 (L-TYPE AMINO ACID TRANSPORTER), MEMBER 2; SLC43A2	124935
MIM610792		11q12.3	SOLUTE CARRIER FAMILY 22, MEMBER 25; SLC22A25	387601
MIM610793		13q14.11	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, KIDNEY), MEMBER 30; SLC25A30	253512
MIM610794		6p22.3-p22.1	ZINC FINGER PROTEIN 323; ZNF323	64288
MIM610795		8p21.3	SORBIN AND SH3 DOMAINS-CONTAINING 3; SORBS3	10174
MIM610796		4q28.1	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER 31; SLC25A31	83447
MIM610798	C1835829	1q22	IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	28956
MIM610799	C1835828	12q12, 11q23-q24	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 1; IPD1	114609, 51135
MIM610800		5q14.2	AUTOPHAGY 10, S. CEREVISIAE, HOMOLOG OF; ATG10	83734
MIM610801		1q31-q32	SOLUTE CARRIER FAMILY 41, MEMBER 1; SLC41A1	254428
MIM610802		12q23.3	SOLUTE CARRIER FAMILY 41, MEMBER 2; SLC41A2	84102
MIM610803		3q21.2	SOLUTE CARRIER FAMILY 41, MEMBER 3; SLC41A3	54946
MIM610804		1p32-p31	SOLUTE CARRIER FAMILY 35 (UDP-GLUCURONIC ACID/UDP-N-ACETYLGALACTOSAMINE DUAL TRANSPORTER), MEMBER D1; SLC35D1	23169
MIM610805	C1835826	1p33-p32	RENAL HYPODYSPLASIA, NONSYNDROMIC, 1; RHDNS1	100034704
MIM610806		17q12	TBC1 DOMAIN FAMILY, MEMBER 3C; TBC1D3C	414060
MIM610808		17q12	TBC1 DOMAIN FAMILY, MEMBER 3E; TBC1D3E	100302591
MIM610809		17q12	TBC1 DOMAIN FAMILY, MEMBER 3F; TBC1D3F	84218
MIM610810		17q12	TBC1 DOMAIN FAMILY, MEMBER 3G; TBC1D3G	654341
MIM610811		17q12	TBC1 DOMAIN FAMILY, MEMBER 3H; TBC1D3H	729877
MIM610812		16q22.2	HYDROCEPHALUS-INDUCING, MOUSE, HOMOLOG OF; HYDIN	54768
MIM610813		1q21.1	HYDROCEPHALUS-INDUCING, MOUSE, HOMOLOG OF, 2; HYDIN2	100288805
MIM610815		8q21.2	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, FOLATE), MEMBER 32; SLC25A32	81034
MIM610816		1p36.22	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 33; SLC25A33	84275
MIM610817		1p36.21	SOLUTE CARRIER FAMILY 25, MEMBER 34; SLC25A34	284723
MIM610818		17p13.1	SOLUTE CARRIER FAMILY 25, MEMBER 35; SLC25A35	399512
MIM610819		3p22.1	SOLUTE CARRIER FAMILY 25, MEMBER 38; SLC25A38	54977
MIM610820		17q12	SOLUTE CARRIER FAMILY 25, MEMBER 39; SLC25A39	51629
MIM610821		7q21.12	SOLUTE CARRIER FAMILY 25, MEMBER 40; SLC25A40	55972
MIM610822		19p13.3	SOLUTE CARRIER FAMILY 25, MEMBER 41; SLC25A41	284427
MIM610823		19p13.11	SOLUTE CARRIER FAMILY 25, MEMBER 42; SLC25A42	284439
MIM610824		1q22	SOLUTE CARRIER FAMILY 25, MEMBER 44; SLC25A44	9673
MIM610825		11q13.1	SOLUTE CARRIER FAMILY 25, MEMBER 45; SLC25A45	283130
MIM610826		5q22.1	SOLUTE CARRIER FAMILY 25, MEMBER 46; SLC25A46	91137
MIM610827		20q11.2-q13.1	ZINC FINGER PROTEIN 335; ZNF335	63925
MIM610828	C1835820	9q22.3	HOLOPROSENCEPHALY 7; HPE7	5727
MIM610829	C1835819	2q14	HOLOPROSENCEPHALY 9; HPE9	2736
MIM610831		11q13.1	TBC1 DOMAIN FAMILY, MEMBER 10C; TBC1D10C	374403
MIM610832	C1835817	16p12	FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	79728
MIM610833		20p11.2	N-ACETYLTRANSFERASE 5; NAT5	51126
MIM610834		3q13.2	N-ACETYLTRANSFERASE 13; NAT13	80218
MIM610835		15q21.3	NMDA RECEPTOR-REGULATED 2; NARG2	79664
MIM610836	C1970512	1q41-q42	AUTISM, SUSCEPTIBILITY TO, 11; AUTS11	100188820
MIM610837		19q13.3	BCL2-LIKE 12; BCL2L12	83596
MIM610838	C1970511	21p13-q11	AUTISM, SUSCEPTIBILITY TO, 12; AUTS12	100188314
MIM610839	C1835815	2q33.3	OSTEOARTHRITIS SUSCEPTIBILITY 4; OS4	100188821
MIM610840	C1835814	13q31.3-q32.1	MITRAL VALVE PROLAPSE, MYXOMATOUS 3; MMVP3	100034705
MIM610841		4p15.1	STROMAL INTERACTION MOLECULE 2; STIM2	57620
MIM610842	C1835813	2p12	PSEUDOXANTHOMA ELASTICUM-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	2677
MIM610843		22cen-q12	UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX, 7.2-KD SUBUNIT	29796
MIM610844		15q21.1	SPG11 GENE; SPG11	80208
MIM610845		6p24.3	SOLUTE CARRIER FAMILY 35 (3-PRIME-PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE TRANSPORTER), MEMBER B3; SLC35B3	51000
MIM610846		12q15	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 10; LRRC10	376132
MIM610847		6p22.1	ZINC FINGER PROTEIN 322A; ZNF322A	79692
MIM610848		12p11.22	RAB15 EFFECTOR PROTEIN; REP15	387849
MIM610849		17q21.32	TUBULIN TYROSINE LIGASE-LIKE FAMILY, MEMBER 6; TTLL6	284076
MIM610850		19p13.2	XPA-BINDING PROTEIN 2; XAB2	56949
MIM610851		4q25	CHROMOSOME 4 OPEN READING FRAME 16; C4ORF16	55435
MIM610852	C1970506	7p14-p13	CILIARY DYSKINESIA, PRIMARY, 6; CILD6	51314
MIM610853		1q44	AT HOOK-CONTAINING TRANSCRIPTION FACTOR 1; AHCTF1	25909
MIM610855		10p12.1	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 26; ANKRD26	22852
MIM610856		10p11.21	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 30A; ANKRD30A	91074
MIM610857		12q13.2	SMALL BREAST EPITHELIAL MUCIN	118430
MIM610858		14q22.1	CHROMOSOME 14 OPEN READING FRAME 166; C14ORF166	51637
MIM610859		16q22	RGD-, LEUCINE-RICH REPEAT-, TROPOMODULIN DOMAIN-, AND PROLINE-RICH DOMAIN-CONTAINING PROTEIN	146206
MIM610860		1p21	AMYLO-1,6-GLUCOSIDASE, 4-ALPHA-GLUCANOTRANSFERASE; AGL	178
MIM610861		14q32.13	CHROMOSOME 14 OPEN READING FRAME 49; C14ORF49	161176
MIM610862		14q32.2	DEGENERATIVE SPERMATOCYTE, DROSOPHILA, HOMOLOG OF, 2; DEGS2	123099
MIM610863		3q26.3	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-4; GNB4	59345
MIM610864		1q31	LQK1 PROTEIN	642946
MIM610865		14q24.3	FELINE LEUKEMIA VIRUS SUBGROUP C RECEPTOR 2; FLVCR2	55640
MIM610866		20q13.33	URIDINE/CYTIDINE KINASE-LIKE 1; UCKL1	54963
MIM610867		2p12	LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 1: LRRTM1	347730
MIM610868		5q31.2	LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 2; LRRTM2	26045
MIM610869		10q21.3	LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 3; LRRTM3	347731
MIM610870		2p12	LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 4; LRRTM4	80059
MIM610872		1p35.1	IBR DOMAIN-CONTAINING PROTEIN 3; IBRDC3	127544
MIM610873	C1970484	22q13	MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 1; MENAQ1	100188822
MIM610874		8q24	SPERMATOGENESIS- AND CENTRIOLE-ASSOCIATED 1; SPATC1	375686
MIM610875		19q13.42	SAPS DOMAIN FAMILY, MEMBER 1; SAPS1	22870
MIM610876		6q21	HECT DOMAIN- AND ANKYRIN REPEAT-CONTAINING E3 UBIQUITIN PROTEIN LIGASE 1; HACE1	57531
MIM610877		22q13.33	SAPS DOMAIN FAMILY, MEMBER 2; SAPS2	9701
MIM610878	C1970483	3p12.3	VESICOURETERAL REFLUX 2; VUR2	6092
MIM610879		11q13	SAPS DOMAIN FAMILY, MEMBER 3; SAPS3	55291
MIM610880		11q13	CHROMOSOME 11 OPEN READING FRAME 24; C11ORF24	53838
MIM610881		11q13	SUPPRESSOR OF VARIEGATION 4-20, DROSOPHILA, HOMOLOG OF, 1; SUV420H1	51111
MIM610882		9q34.3	SJOGREN SYNDROME NUCLEAR AUTOANTIGEN 1; SSNA1	8636
MIM610883	C1970482	17p11.2	POTOCKI-LUPSKI SYNDROME; PTLS	100038247
MIM610884		19q13.11	CHROMOSOME 19 OPEN READING FRAME 40; C19ORF40	91442
MIM610885		17q21.3	ESSENTIAL MEIOTIC ENDONUCLEASE 1, S. POMBE, HOMOLOG OF, 1; EME1	146956
MIM610886		16p13.3	ESSENTIAL MEIOTIC ENDONUCLEASE 1, S. POMBE, HOMOLOG OF, 2; EME2	197342
MIM610887		4p16.2	POLYMERASE, DNA, NU; POLN	353497
MIM610888		11q14	GASTRIC CANCER-RELATED GENE 224	360219
MIM610889		5q12.1	IMPORTIN 11; IPO11	51194
MIM610890		5q12.3	REGULATOR OF G PROTEIN SIGNALING 7-BINDING PROTEIN; RGS7BP	401190
MIM610891		9q34.13	FAMILY WITH SEQUENCE SIMILARITY 102, MEMBER A; FAM102A	399665
MIM610892		4q13.2	SYNAPTOTAGAMIN 14-LIKE PROTEIN; SYT14L	401135
MIM610893		19q	CHMP FAMILY, MEMBER 2A; CHMP2A	27243
MIM610894		15q24.1	NEUREGULIN 4; NRG4	145957
MIM610895		17q21.3	WAP, FOLLISTATIN, IMMUNOGLOBULIN, KUNITZ, AND NTR DOMAINS-CONTAINING PROTEIN 2; WFIKKN2	124857
MIM610896	C1970479	19q13.3	BRANCHIOOTORENAL SYNDROME 2; BOR2	147912
MIM610897		20q11.21	CHMP FAMILY, MEMBER 4B; CHMP4B	128866
MIM610898	C1970476	11p12-p11	SUPRANUCLEAR PALSY, PROGRESSIVE, 3; PSNP3	100038248
MIM610899		 	CHMP FAMILY, MEMBER 4C; CHMP4C	92421
MIM610900		9p13.3	CHMP FAMILY, MEMBER 5; CHMP5	51510
MIM610901		17q25.3	CHMP FAMILY, MEMBER 6; CHMP6	79643
MIM610902		6q24.1	CHROMOSOME 6 OPEN READING FRAME 55; C6ORF55	51534
MIM610903		13q14.3	VACUOLAR PROTEIN SORTING 36, S. CEREVISIAE, HOMOLOG OF; VPS36	51028
MIM610904		17q21.32	SNF8, S. CEREVISIAE, HOMOLOG OF; SNF8	11267
MIM610906	C1970474	1p31	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 4	100188823
MIM610907		17q21.3	VACUOLAR PROTEIN SORTING 25, S. CEREVISIAE, HOMOLOG OF; VPS25	84313
MIM610908	C1970473	12q14.2	AUTISM, SUSCEPTIBILITY TO, 13; AUTS13	100188317
MIM610909		10q26.11	MINICHROMOSOME MAINTENANCE COMPLEX-BINDING PROTEIN; MCMBP	79892
MIM610911		3q13.3	RHO GTPase-ACTIVATING PROTEIN 31; ARHGAP31	57514
MIM610912		4q13.3	AMELOTIN; AMTN	401138
MIM610913	C1970470	8p21	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; SMDP2	6440
MIM610914		13q14.11	ECTO-NOX DISULFIDE-THIOL EXCHANGER 1; ENOX1	55068
MIM610915	C1970458	1p34	OSTEOGENESIS IMPERFECTA, TYPE VIII	64175
MIM610916		5p15.31	NOL1/NOP2/SUN DOMAIN FAMILY, MEMBER 2; NSUN2	54888
MIM610917		17q11.1	RAS-ASSOCIATED PROTEIN 34; RAB34	83871
MIM610918		22q12.2	SELENOPROTEIN M	140606
MIM610919		20q13.33	GTP-BINDING PROTEIN 5; GTPBP5	26164
MIM610920		7q21.13	GTP-BINDING PROTEIN 10; GTPBP10	85865
MIM610921	C1970456	16p13.3	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3	21
MIM610922		15q11-q13	NUCLEAR PORE ASSOCIATED PROTEIN 1; NPAP1	23742
MIM610923		7q33	SOLUTE CARRIER FAMILY 35 (UDP-XYLOSE/UDP-N-ACETYLGLUCOSAMINE TRANSPORTER), MEMBER B4; SLC35B4	84912
MIM610924		20p13	RANBP-TYPE AND C3HC4-TYPE ZINC FINGER-CONTAINING 1; RBCK1	10616
MIM610925		3p25.3-p24.1	INTERLEUKIN 17 RECEPTOR C; IL17RC	84818
MIM610926	C1858210	10q11.2-q21	TOOTH AGENESIS, SELECTIVE, 5; STHAG5	100188748
MIM610927	C1970455	1q32	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9; SLEB9	1380
MIM610928		8q12-q13	SRY-BOX 17; SOX17	64321
MIM610929		7q22.1	ORAI CALCIUM RELEASE-ACTIVATED CALCIUM MODULATOR 2; ORAI2	80228
MIM610930		16p11.2	ORAI CALCIUM RELEASE-ACTIVATED CALCIUM MODULATOR 3; ORAI3	93129
MIM610931		8q23-q24	ZINC FINGER GENE IN AUTOIMMUNE THYROID DISEASE 1; ZFAT1	57623
MIM610932		12q12	TWINFILIN, DROSOPHILA, HOMOLOG OF, 1; TWF1	5756
MIM610933		9q33.3-q34.11	LEUCINE-RICH REPEAT- AND STERILE ALPHA MOTIF-CONTAINING 1; LRSAM1	90678
MIM610934		7q35	NEWBORN OVARY HOMEOBOX, MOUSE, HOMOLOG OF; NOBOX	135935
MIM610935		17q25.3	LIGAND-GATED ION CHANNEL, ZINC-ACTIVATED, 1; LGICZ1	353174
MIM610936		9q21.31	PHOSPHOSERINE AMINOTRANSFERASE 1; PSAT1	29968
MIM610937		16q12.2	RPGRIP1-LIKE; RPGRIP1L	23322
MIM610938	C1970441	7q11.2	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7	948
MIM610939		11q13.1	MICRO RNA 192; MIRN192	406967
MIM610940		1q41	MICRO RNA 194-1; MIRN194-1	406969
MIM610941		11q13.1	MICRO RNA 194-2; MIRN194-2	406970
MIM610942		9q21.11	MICRO RNA 204; MIR204	406987
MIM610943		1q41	MICRO RNA 215; MIRN215	406997
MIM610944		2p16.1	MICRO RNA 216; MIRN216	406998
MIM610945		20q13.3	MICRO RNA 296; MIRN296	407022
MIM610946		6p12.2	MICRO RNA 133B; MIRN133B	442890
MIM610947	C1970440	12p13.3-p11.2	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	4040
MIM610948	C1970439	3p14.1-q12.3	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 7	100188825
MIM610949		1q32.2	SYNAPTOTAGMIN 14; SYT14	255928
MIM610950		14q23.1	SYNAPTOTAGMIN 16; SYT16	83851
MIM610951	C1838571	4q28.1-q28.2	CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	256471
MIM610952		20p11.2	CROOKED NECK PRE-mRNA SPLICING FACTOR-LIKE 1; CRNKL1	51340
MIM610953		15q22.31	PIF1, S. CEREVISIAE, HOMOLOG OF; PIF1	80119
MIM610954	C1970431	18q21.2	PITT-HOPKINS SYNDROME; PTHS	6925
MIM610955		1p34.3	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 3; TRAPPC3	27095
MIM610956		1q25.1	ASPARTYL-tRNA SYNTHETASE 2; DARS2	55157
MIM610957		12p11.21	TYROSYL-tRNA SYNTHETASE 2; YARS2	51067
MIM610958		4q21.23	1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 9; AGPAT9	84803
MIM610959		14q32.31	MICRO RNA 376A-1; MIRN376A-1	494325
MIM610960		14q32.31	MICRO RNA 376A-2; MIRN376A-2	664615
MIM610961		14q32.31	MICRO RNA 376-B; MIRN376B	574435
MIM610962		1q21.2	SMG5, C. ELEGANS, HOMOLOG OF; SMG5	23381
MIM610963		17p13.3	SMG6, C. ELEGANS, HOMOLOG OF; SMG6	23293
MIM610964		1q25	SMG7, C. ELEGANS, HOMOLOG OF; SMG7	9887
MIM610965	C1970416	16p13.3-p13.13	XFE PROGEROID SYNDROME	2072
MIM610966		16q12.2	FAT MASS- AND OBESITY-ASSOCIATED GENE; FTO	79068
MIM610967	C1970414	 	OSTEOGENESIS IMPERFECTA, TYPE V; OI5	387733
MIM610968	C3151218	 	OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	60681
MIM610969		17p13	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 1; TRAPPC1	58485
MIM610970		16q22.1-q22.2	TRAFFICKING PROTEIN PARTICLE COMPLEX 2-LIKE; TRAPPC2L	51693
MIM610971		11q23.3	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 4; TRAPPC4	51399
MIM610972		1p36.32	ADHERENS JUNCTION-ASSOCIATED PROTEIN 1; AJAP1	55966
MIM610973		10p12.1	MEMBRANE PROTEIN, PALMITOYLATED 7; MPP7	143098
MIM610974		18q11.2	ZINC FINGER PROTEIN 521; ZNF521	25925
MIM610975		17q11.2	SKIN-, EMBRYO-, BRAIN-, AND OOCYTE-SPECIFIC HOMEOBOX	645832
MIM610976		22q13.1	APOLIPOPROTEIN B mRNA EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3H; APOBEC3H	164668
MIM610977		4p16.3	TETRACYCLINE TRANSPORTER-LIKE PROTEIN	10227
MIM610978	C1970269	14q13	CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESS	7080
MIM610979		15q15.3	HISTIDINE ACID PHOSPHATASE DOMAIN-CONTAINING PROTEIN 2A; HISPPD2A	9677
MIM610980		11p15.5	KCNQ1 DOWNSTREAM NEIGHBOR; KCNQ1DN	55539
MIM610981		22q13.2	WWBP2 N-TERMINAL-LIKE PROTEIN; WBP2NL	164684
MIM610982		14q32.33	INVERTED FORMIN 2; INF2	64423
MIM610983		14q32.31	MICRO RNA 368; MIRN368	442913
MIM610984	C0001733	4q25	COMPLEMENT FACTOR I DEFICIENCY; CFID	3426
MIM610985		11p15.2-p15.1	UBIQUITIN E2 VARIANT AND LACTATE/MALATE DEHYDROGENASE DOMAINS-CONTAINING PROTEIN; UEVLD	55293
MIM610986		15q26.3	LEUCINE-RICH REPEAT KINASE 1; LRRK1	79705
MIM610987		10q11.23	N-ACYLSPHINGOSINE AMIDOHYDROLASE 2C; ASAH2C	653308
MIM610988	C1970254	6p21.3	LEPROSY, SUSCEPTIBILITY TO, 4; LPRS4	4049
MIM610989		7q21.3-q22.1	LEMUR TYROSINE KINASE 2; LMTK2	22853
MIM610990		6p21.3	KIAA1949 GENE; KIAA1949	170954
MIM610991		2q35	OBSCURIN-LIKE 1; OBSL1	23363
MIM610992	C1970253	9q21.31	PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	29968
MIM610993		12q22	UBIQUITIN-SPECIFIC PROTEASE 44; USP44	84101
MIM610994		 	KUA GENE	387521
MIM610995		2p13.3	PRENYLCYSTEINE OXIDASE 1; PCYOX1	51449
MIM610996		20p11	D-TYROSYL-tRNA DEACYLASE 1, S. CEREVISIAE, HOMOLOG OF; DTD1	92675
MIM610997	C1970250	17q21-q22	PROSTATE CANCER, HEREDITARY, 9	100188826
MIM610998		16p13.3	METEORIN; METRN	79006
MIM610999		10p11	ENHANCER OF POLYCOMB, DROSOPHILA, HOMOLOG OF, 1; EPC1	80314
MIM611000		2q23.1	ENHANCER OF POLYCOMB, DROSOPHILA, HOMOLOG OF, 2; EPC2	26122
MIM611001		1p35.3-p33	CHROMOSOME 1 OPEN READING FRAME 149; C1ORF149	64769
MIM611002		16p13.3	CHROMOSOME 16 OPEN READING FRAME 30; C16ORF30	79652
MIM611003	C1970249	10q22	SMOKING AS A QUANTITATIVE TRAIT LOCUS 1; SQTL1	100188827
MIM611004	C1970248	22q12	SMOKING AS A QUANTITATIVE TRAIT LOCUS 2; SQTL2	100188828
MIM611005		18q21.2	MEX3, C. ELEGANS, HOMOLOG OF, C; MEX3C	51320
MIM611006		9q21.2-q22.1	IRON-SULFUR CLUSTER ASSEMBLY 1, S. CEREVISIAE, HOMOLOG OF; ISCA1	81689
MIM611007		1q22	MEX3, C. ELEGANS, HOMOLOG OF, A; MEX3A	92312
MIM611008		15q25.2	MEX3, C. ELEGANS, HOMOLOG OF, B; MEX3B	84206
MIM611009		19p13.3	MEX3, C. ELEGANS, HOMOLOG OF, D; MEX3D	399664
MIM611010	C1970245	11p15	FIBROMATOSIS, GINGIVAL, 4; GINGF4	100124414
MIM611011		19p13.3	CHROMOSOME 19 OPEN READING FRAME 6; C19ORF6	91304
MIM611012		1q25	REGULATOR OF G PROTEIN SIGNALING-LIKE 1; RGSL1	353299
MIM611014	C1970244	18q21.2	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 8; HYT8	100188321
MIM611015	C1970243	7q31	AUTISM, SUSCEPTIBILITY TO, 9; AUTS9	4233
MIM611016	C1970242	7q36	AUTISM, SUSCEPTIBILITY TO, 10; AUTS10	2020
MIM611017		10q22.1	TRYPSIN DOMAIN-CONTAINING PROTEIN 1; TYSND1	219743
MIM611018		2p13.3	POLYADENYLATE-BINDING PROTEIN-INTERACTING PROTEIN 2B; PAIP2B	400961
MIM611019		7q36	ATPase, H+ TRANSPORTING, LYSOSOMAL, 9-KD, V0 SUBUNIT E2; ATP6V0E2	155066
MIM611020		17q23.2	MICRO RNA 21; MIR21	406991
MIM611021		3q26.1	NMD3, S. CEREVISIAE, HOMOLOG OF; NMD3	51068
MIM611022	C1970239	11q23	DEAFNESS, AUTOSOMAL RECESSIVE 24; DFNB24	5962
MIM611023		14q23.1	tRNA METHYLTRANSFERASE 5, S. CEREVISIAE, HOMOLOG OF; TRMT5	57570
MIM611024		19q13.4	ZINC FINGER PROTEIN 667; ZNF667	63934
MIM611025		10p12.1	CHROMOSOME 10 OPEN READING FRAME 63; C10ORF63	219670
MIM611026		16q23	FATTY ACID 2-HYDROXYLASE; FA2H	79152
MIM611027		16q11.2	SHC SH2 DOMAIN-BINDING PROTEIN 1; SHCBP1	79801
MIM611028		6q14.1	TRANSMEMBRANE PROTEIN 30A; TMEM30A	55754
MIM611029		14q23.1	TRANSMEMBRANE PROTEIN 30B; TMEM30B	161291
MIM611030		3q12	TRANSMEMBRANE PROTEIN 30C; TMEM30C	644444
MIM611031	C1970238	16q13-q22.1	EPISODIC KINESIGENIC DYSKINESIA 2; EKD2	100124415
MIM611032		1q41	SPERMATOGENESIS-ASSOCIATED PROTEIN 17; SPATA17	128153
MIM611033		11p15.5	CHROMOSOME 11 OPEN READING FRAME 21; C11ORF21	29125
MIM611034		6p21.3	SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 3; SLC17A3	10786
MIM611035		2p14	CHROMOSOME 2 OPEN READING FRAME 13; C2ORF13	200558
MIM611036		12q12	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 13; SLC2A13	114134
MIM611037		3p14.3	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 26; SLC25A26	115286
MIM611038	C1970237	18q21.3	MICROPHTHALMIA, ISOLATED 3; MCOP3	30062
MIM611039		12p13.3	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 14; SLC2A14	144195
MIM611040	C1970236	11q23	MICROPHTHALMIA, ISOLATED 5; MCOP5	83552
MIM611041		17q24-q25	TRIPARTITE MOTIF-CONTAINING PROTEIN 47; TRIM47	91107
MIM611042		1q21	LATE CORNIFIED ENVELOPE-LIKE PROLINE-RICH 1; LELP1	149018
MIM611043		1p36.11	LIN28, C. ELEGANS, HOMOLOG OF, A; LIN28A	79727
MIM611044		6q21	LIN28, C. ELEGANS, HOMOLOG OF, B; LIN28B	389421
MIM611045		17q21	GLUCOSE-6-PHOSPHATASE, CATALYTIC, 3; G6PC3	92579
MIM611046	C1970235	8q12-q13	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 2	100188829
MIM611047		6q24.2-q25.3	RETINOIC ACID EARLY TRANSCRIPT 1L; RAET1L	154064
MIM611048		19q13.2	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 15A; PPP1R15A	23645
MIM611049		6p21.3	SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 2; SLC17A2	10246
MIM611050		7q33	LEUCINE ZIPPER PROTEIN 6; LUZP6	767558
MIM611051		3q28	COILED-COIL DOMAIN-CONTAINING PROTEIN 50; CCDC50	152137
MIM611052		16p11.2	SET DOMAIN-CONTAINING PROTEIN 1A; SETD1A	9739
MIM611053		9p13.1	RUN AND SH3 DOMAIN-CONTAINING 2; RUSC2	9853
MIM611054		11q13.3	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN ALPHA-1; PPFIA1	8500
MIM611055		12q24.31	SET DOMAIN-CONTAINING PROTEIN 1B; SETD1B	23067
MIM611056		2q37.3	SELENOCYSTEINE LYASE; SCLY	51540
MIM611058		3q26.2-q27	PEROXISOME BIOGENESIS FACTOR 5-LIKE; PEX5L	51555
MIM611059		3p21.1	WD REPEAT-CONTAINING PROTEIN 82; WDR82	80335
MIM611060		18q21.1	SET-BINDING PROTEIN 1; SETBP1	26040
MIM611061		7p22	FAMILY WITH SEQUENCE SIMILARITY 20, MEMBER C; FAM20C	56975
MIM611062		17q24.2	FAMILY WITH SEQUENCE SIMILARITY 20, MEMBER A; FAM20A	54757
MIM611063		1q25	FAMILY WITH SEQUENCE SIMILARITY 20, MEMBER B; FAM20B	9917
MIM611064	C1970224	12q14.3	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5	11213
MIM611065		4q22.1	PROTEIN PHOSPHATASE, PP2C DOMAIN-CONTAINING, 1K; PPM1K	152926
MIM611066		16q22.3	PH DOMAIN AND LEUCINE-RICH REPEAT PROTEIN PHOSPHATASE-LIKE; PHLPPL	23035
MIM611067	C1970211	1p36	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4; DSMA4	57449
MIM611068		22q13	SMALL NUCLEOLAR RNA, C/D BOX, 43; SNORD43	26807
MIM611069		22q13	RNA, U86 SMALL NUCLEOLAR	116936
MIM611070		22q13	SMALL NUCLEOLAR RNA, C/D BOX, 83A; SNORD83A	116937
MIM611071		22q13	SMALL NUCLEOLAR RNA, C/D BOX, 83B; SNORD83B	116938
MIM611072		11p13	DPH4, S. CEREVISIAE, HOMOLOG OF; DPH4	120526
MIM611073	C1970209	8p12-q22	ALZHEIMER DISEASE 12	100188830
MIM611074		11q24.1	BRAIN-SPECIFIC HOMEOBOX, MOUSE, HOMOLOG OF; BSX	390259
MIM611075		1p21.2	DPH5, S. CEREVISIAE, HOMOLOG OF; DPH5	51611
MIM611076		12q22-q23.1	5-PRIME-@NUCLEOTIDASE DOMAIN-CONTAINING PROTEIN 3; NT5DC3	51559
MIM611077		3p25.1	COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 4; CHCHD4	131474
MIM611078		9p24.3	COBALAMIN SYNTHETASE W DOMAIN-CONTAINING PROTEIN 1; CBWD1	55871
MIM611079		2q13-q14.1	COBALAMIN SYNTHETASE W DOMAIN-CONTAINING PROTEIN 2; CBWD2	150472
MIM611080		9q13	COBALAMIN SYNTHETASE W DOMAIN-CONTAINING PROTEIN 3; CBWD3	445571
MIM611081	C1970207	2q37.1	INFLAMMATORY BOWEL DISEASE 10; IBD10	55054
MIM611082		22q12.1	MIAT GENE; MIAT	440823
MIM611083		8q13.1	ALCOHOL DEHYDROGENASE, IRON-CONTAINING, 1; ADHFE1	137872
MIM611084		2q13-q14.1	FORKHEAD BOX D4-LIKE 1; FOXD4L1	200350
MIM611085		9p11.2	FORKHEAD BOX D4-LIKE 2; FOXD4L2	100036519
MIM611086		9q13	FORKHEAD BOX D4-LIKE 3; FOXD4L3	286380
MIM611087	C1970203	17q23.3	POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	92335
MIM611088		12q13.12	COILED-COIL DOMAIN-CONTAINING PROTEIN 65; CCDC65	85478
MIM611089		3p25.3	MYOTUBULARIN-RELATED PROTEIN 14; MTMR14	64419
MIM611090	C1970200	1p34-p33	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12; MRT12	100101420, 6487
MIM611091	C1970199	5p15-p14	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5; MRT5	100188831, 54888
MIM611092	C1970198	6q21	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	2898
MIM611093	C1970197	8p12, 8p22	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7; MRT7	7991
MIM611094	C1970196	10q22	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 8; MRT8	100101423
MIM611095	C1970195	14q11.2-q12	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	100101424
MIM611096	C1970194	16p12-q12	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10; MRT10	100101425
MIM611097	C1970193	19q13.2-q13.3	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 11; MRT11	100101426
MIM611098		7q21	SIX-TRANSMEMBRANE EPITHELIAL ANTIGEN OF PROSTATE 4; STEAP4	79689
MIM611099		2p25-p24	PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 6; PDIA6	10130
MIM611100	C1970192	8q24	PROSTATE CANCER, HEREDITARY, 10; HPC10	100188834
MIM611101		1p36	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY G, MEMBER 5; PLEKHG5	57449
MIM611102	C1970187	15q15.3	DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	100240731, 117155, 161497
MIM611103		3q26	ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9; ACAD9	28976
MIM611104		12p11.2	FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 4; FGD4	121512
MIM611105	C1970180	1q25.1	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	55157
MIM611106		6q25.1	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12D; ZC3H12D	340152
MIM611107	C1970179	1p21.1-p13.3	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4; MRT4	100009675
MIM611108		7p12.2	VON WILLEBRAND FACTOR C DOMAIN-CONTAINING PROTEIN 2; VWC2	375567
MIM611109	C1970178	4q32.3	CINNAMON ODOR, PLEASANTNESS OF	100188835
MIM611110		21q21	CHROMOSOME 21 OPEN READING FRAME 7; C21ORF7	56911
MIM611111		6q13	DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 5; DPPA5	340168
MIM611112		19q13.3	DAPPER, ANTAGONIST OF BETA-CATENIN, 3; DACT3	147906
MIM611113		16p13.3	CEMENTUM PROTEIN 1; CEMP1	752014
MIM611114		19q13.33	MICRO RNA 150; MIR150	406942
MIM611115		11q11	VON WILLEBRAND FACTOR C AND EGF DOMAIN-CONTAINING PROTEIN; VWCE	220001
MIM611116		14q12	MICRO RNA 208A; MIR208A	406990
MIM611117		11q13.4	PROTEIN PHOSPHATASE METHYLESTERASE 1; PPME1	51400
MIM611118		16p13.3	NUCLEAR PRELAMIN A RECOGNITION FACTOR-LIKE; NARFL	64428
MIM611119		7p15.3	KELCH-LIKE 7; KLHL7	55975
MIM611120		20p12.3-p12.1	SERINE PALMITOYLTRANSFERASE, LONG-CHAIN BASE SUBUNIT 3; SPTLC3	55304
MIM611121		14q32.13	CALMIN; CLMN	79789
MIM611122		3p25.1	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 28; ANKRD28	23243
MIM611123		1p34.3	EPHRIN RECEPTOR EphA10; EPHA10	284656
MIM611124		4q28.1-q28.2	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 8; MFSD8	256471
MIM611125		18q21-q22	DERMATAN SULFATE EPIMERASE-LIKE; DSEL	92126
MIM611126	C1970173	3q26	ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9, DEFICIENCY OF	28976
MIM611127		1p13.3	UBIQUITIN-LIKE 4B; UBL4B	164153
MIM611128		14q21	MAM DOMAIN-CONTAINING GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR 2; MDGA2	161357
MIM611129		10q24.32	CHROMOSOME 10 OPEN READING FRAME 26; C10ORF26	54838
MIM611130		8p21.3	CHMP FAMILY, MEMBER 7; CHMP7	91782
MIM611131	C1970163	15q23	RETINITIS PIGMENTOSA 37; RP37	10002
MIM611132		2p23.2	RIBOKINASE; RBKS	64080
MIM611133		2q12-qter	SMALL NUCLEOLAR RNA, C/D BOX, 82; SNORD82	25826
MIM611134	C1970161	12q21.3	MECKEL SYNDROME, TYPE 4; MKS4	80184
MIM611135		4p14	KLOTHO, BETA; KLB	152831
MIM611136	C2749942	5q34-q35	EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 5; EJM5	2554
MIM611137		14q11.2	PROTEASOME SUBUNIT, BETA-TYPE, 11; PSMB11	122706
MIM611138		9q34	SPERMATID PERINUCLEAR RNA-BINDING PROTEIN; STRBP	55342
MIM611139	C1970158	9p21	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 8; CHDS8	100188836
MIM611140		16p13.3	TELOMERE MAINTENANCE 2, S. CEREVISIAE, HOMOLOG OF; TELO2	9894
MIM611141		 	MINDBOMB, DROSOPHILA, HOMOLOG OF, 2; MIB2	142678
MIM611142		11p11.2	CYTOSKELETON-ASSOCIATED PROTEIN 5; CKAP5	9793
MIM611143		4q21.2	COILED-COIL DOMAIN-CONTAINING PROTEIN 98; CCDC98	84142
MIM611144		10q26.13	FAMILY WITH SEQUENCE SIMILARITY 175, MEMBER B; FAM175B	23172
MIM611145		8q24.11	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 8; SLC30A8	169026
MIM611146		1q41	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 10; SLC30A10	55532
MIM611147	C1970149	2q31	PAROXYSMAL NONKINESIGENIC DYSKINESIA 2; PNKD2	100188328
MIM611148		2p22-p21	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 6; SLC30A6	55676
MIM611149		1p21.2	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 7; SLC30A7	148867
MIM611150		22q13	ATAXIN 10; ATXN10	25814
MIM611151		22q11.21	tRNA METHYLTRANSFERASE 2, S. CEREVISIAE, HOMOLOG OF, A; TRMT2A	27037
MIM611152	C1970147	1q21	ALZHEIMER DISEASE 13; AD13	100188837
MIM611153		9q22.3	XPA GENE; XPA	7507
MIM611154	C1970144	1q25	ALZHEIMER DISEASE 14; AD14	100188754
MIM611155	C1970143	3q22-q24	ALZHEIMER DISEASE 15; AD15	100188838
MIM611156		9p24	ENDOPLASMIC RETICULUM METALLOPEPTIDASE 1; ERMP1	79956
MIM611157		20q13.33	CHROMOSOME 20 OPEN READING FRAME 20; C20ORF20	55257
MIM611158		12q13.13	KERATIN 77; KRT77	374454
MIM611159		12q13.13	KERATIN 78; KRT78	196374
MIM611160		12q13.13	KERATIN 79; KRT79	338785
MIM611161		12q13.13	KERATIN 80; KRT80	144501
MIM611162	C1970028	17q21-q22, 17cen-q11.2, 1q23.2, 1q22, 11q23-q24, 7q11.2, 6p21.3, 4q28.2-q31.1, 3p21.3, 2q14-q21, 1q32, 19p13.3-p13.2	MALARIA, SUSCEPTIBILITY TO	114609, 1154, 1378, 2213, 2532, 2993, 2995, 3383, 4843, 6521, 7124, 948
MIM611163		 	TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 2; TOX2	84969
MIM611164		3q13.3	ARGININE-FIFTY HOMEOBOX; ARGFX	503582
MIM611165		 	DIVERGENT-PAIRED RELATED HOMEOBOX; DPRX	503834
MIM611166		 	TETRAPEPTIDE REPEAT HOMEOBOX 1; TPRX1	284355
MIM611167		 	TETRAPEPTIDE REPEAT HOMEOBOX-LIKE; TPRXL	348825
MIM611168		 	DOUBLE HOMEOBOX A; DUXA	503835
MIM611169		 	CATION CHANNEL, SPERM-ASSOCIATED, BETA; CATSPERB	79820
MIM611170		7q21.2	STERILE ALPHA MOTIF DOMAIN-CONTAINING 9-LIKE; SAMD9L	219285
MIM611171		 	KIAA1598 GENE; KIAA1598	57698
MIM611172		1p36	MICRO RNA 34A; MIR34A	407040
MIM611173		2q35	MICRO RNA 375; MIRN375	494324
MIM611174	C1970027	 	HAMAMY SYNDROME; HMMS	10265
MIM611175		 	OBG-LIKE ATPase 1; OLA1	29789
MIM611176		 	CHROMOSOME 14 OPEN READING FRAME 100; C14ORF100	51528
MIM611177		3q24-q26	INTRAFLAGELLAR TRANSPORT 80, CHLAMYDOMONAS, HOMOLOG OF; IFT80	57560
MIM611178		 	GALANIN-LIKE PEPTIDE; GALP	85569
MIM611179		 	SHROOM FAMILY MEMBER 1; SHROOM1	134549
MIM611180		9q34	COFACTOR OF BRCA1; COBRA1	25920
MIM611181		 	ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 10; ACAD10	80724
MIM611182	C1970021	16q22.1	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh; CDG2H	84342
MIM611183		 	C3ORF10 GENE; C3ORF10	55845
MIM611184		 	FAMILY WITH SEQUENCE SIMILARITY 38, MEMBER A; FAM38A	9780
MIM611185	C1970020	6p21	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 6; RLS6	100302512
MIM611186		1q22	MICRO RNA 9-1; MIRN9-1	407046
MIM611187		5q14.3	MICRO RNA 9-2; MIR9-2	407047
MIM611188		15q26.1	MICRO RNA 9-3; MIRN9-3	407051
MIM611189		 	MICRO RNA 197; MIRN197	406974
MIM611190		 	MICRO RNA 346; MIRN346	442911
MIM611191		19q13.33	MICRO RNA 125A; MIR125A	406910
MIM611192		16q24.3	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 11; ANKRD11	29123
MIM611193		 	RIBOSOMAL RNA-PROCESSING 15, S. CEREVISIAE, HOMOLOG OF; RRP15	51018
MIM611194		 	RUN AND FYVE DOMAINS-CONTAINING PROTEIN 3; RUFY3	22902
MIM611195		 	JANUS KINASE AND MICROTUBULE-INTERACTING PROTEIN 1; JAKMIP1	152789
MIM611196		 	ZING FINGER MIZ-DOMAIN CONTAINING 2; ZMIZ2	83637
MIM611197		 	JANUS KINASE AND MICROTUBULE-INTERACTING PROTEIN 2; JAKMIP2	9832
MIM611198		 	CHROMOSOME 10 OPEN READING FRAME 39; C10ORF39	282973
MIM611199		 	DNTT-INTERACTING PROTEIN 2; DNTTIP2	30836
MIM611200		 	TUDOR DOMAIN-CONTAINING PROTEIN 6; TDRD6	221400
MIM611201		 	KELCH-LIKE 9; KLHL9	55958
MIM611202		 	N-ACYLSPHINGOSINE AMIDOHYDROLASE 2; ASAH2	56624
MIM611203		 	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 5; DNAJC5	80331
MIM611204		 	COILED-COIL DOMAIN-CONTAINING PROTEIN 88C; CCDC88C	440193
MIM611205		 	COILED-COIL DOMAIN-CONTAINING PROTEIN 88B; CCDC88B	283234
MIM611206		10q22.2	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 9; DNAJC9	23234
MIM611207		 	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 1; DNAJC1	64215
MIM611208		 	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN L-LIKE; HNRNPLL	92906
MIM611209	C1970016	17q25.1	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	9382
MIM611210		 	PDZ-BINDING KINASE; PBK	55872
MIM611211		11q13.4	RECEPTOR EXPRESSED IN LYMPHOID TISSUES; RELT	84957
MIM611212		 	RELT-LIKE 1; RELL1	768211
MIM611213		 	RELT-LIKE 2; RELL2	285613
MIM611214		 	TSR1, 20S rRNA ACCUMULATION, S. CEREVISIAE, HOMOLOG OF; TSR1	55720
MIM611215		 	PRADER-WILLI REGION NONCODING RNA 1; PWRN1	791114
MIM611216		 	UBX DOMAIN-CONTAINING 2; UBXD2	23190
MIM611217		 	PRADER-WILLI REGION NONCODING RNA 2; PWRN2	791115
MIM611218		17q12	GASDERMIN A; GSDMA	284110
MIM611219		15q25-q26	UNC45, C. ELEGANS, HOMOLOG OF, A; UNC45A	55898
MIM611220		 	UNC45, C. ELEGANS, HOMOLOG OF, B; UNC45B	146862
MIM611221		17q21	GASDERMIN B; GSDMB	55876
MIM611223		1q44	V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 3; AKT3	10000
MIM611224		2p11.2	SUCCINATE-CoA LIGASE, ALPHA SUBUNIT; SUCLG1	8802
MIM611225	C2749936	8p12-p11.21	SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	11160, 140906
MIM611226		 	ARMADILLO REPEAT-CONTAINING PROTEIN 3; ARMC3	219681
MIM611227		 	HYDROGEN VOLTAGE-GATED CHANNEL 1; HVCN1	84329
MIM611228	C1970011	6q21	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J; CMT4J	9896
MIM611229		2p16.2	ENDOPLASMIC RETICULUM LECTIN 1; ERLEC1	27248
MIM611230		 	NON-SMC CONDENSIN II COMPLEX SUBUNIT H2; NCAPH2	29781
MIM611231		 	CLAUDIN 8; CLDN8	9073
MIM611232		 	CLAUDIN 12; CLDN12	9069
MIM611233		 	ARGININE-RICH PROTEIN MUTATED IN EARLY STAGE TUMORS-LIKE 1; ARMETL1	441549
MIM611234		 	FAMILY WITH SEQUENCE SIMILARITY 84, MEMBER A; FAM84A	151354
MIM611235		 	TRANSMEMBRANE PROTEIN 38A; TMEM38A	79041
MIM611236		 	TRANSMEMBRANE PROTEIN 38B; TMEM38B	55151
MIM611237		6p21	BTB/POZ DOMAIN-CONTAINING PROTEIN 9; BTBD9	114781
MIM611238		8q12	COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 7; CHCHD7	79145
MIM611239		 	G PROTEIN-REGULATED INDUCER OF NEURITE OUTGROWTH 1; GPRIN1	114787
MIM611240		 	G PROTEIN-REGULATED INDUCER OF NEURITE OUTGROWTH 2; GPRIN2	9721
MIM611241		 	G PROTEIN-REGULATED INDUCER OF NEURITE OUTGROWTH 3; GPRIN3	285513
MIM611242	C1970010	20p13	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 5; RLS5	100188839
MIM611243		 	tRNA-WYBUTOSINE-SYNTHESIZING PROTEIN 1, S. CEREVISIAE, HOMOLOG OF; TYW1	55253
MIM611244		 	tRNA METHYLTRANSFERASE 12, S. CEREVISIAE, HOMOLOG OF; TRMT12	55039
MIM611245		 	tRNA-WYBUTOSINE-SYNTHESIZING PROTEIN 3, S. CEREVISIAE, HOMOLOG OF; TYW3	127253
MIM611246		 	LEUCINE CARBOXYL METHYLTRANSFERASE 2; LCMT2	9836
MIM611247	C1970943	16p12	MAJOR AFFECTIVE DISORDER 4; MAFD4	100126593
MIM611248		 	KELCH DOMAIN-CONTAINING 3; KLHDC3	116138
MIM611249		22q13	MICRO RNA LET7B; MIRNLET7B	406884
MIM611250		 	MICRO RNA LET7E; MIRNLET7E	406887
MIM611251		1p36.22	PATCHED DOMAIN-CONTAINING PROTEIN 2; PTCHD2	57540
MIM611252	C1970009	14q12-q21	SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	724107
MIM611253		 	KINESIN FAMILY MEMBER 27; KIF27	55582
MIM611254		 	KINESIN FAMILY MEMBER 7; KIF7	374654
MIM611255		 	NADPH OXIDASE ACTIVATOR 1; NOXA1	10811
MIM611256		 	NADPH OXIDASE ORGANIZER 1; NOXO1	124056
MIM611257		 	TRANSMEMBRANE PROTEIN 132D; TMEM132D	121256
MIM611258		 	TUDOR DOMAIN-CONTAINING PROTEIN 7; TDRD7	23424
MIM611259		6p22.3	CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1-LIKE 1; CDKAL1	54901
MIM611260		 	THREONINE SYNTHASE-LIKE 1; THNSL1	79896
MIM611261		 	THREONINE SYNTHASE-LIKE 2; THNSL2	55258
MIM611262		 	DEOXYHYPUSINE HYDROXYLASE; DOHH	83475
MIM611263	C1970005	3q24-q26	ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	57560
MIM611264		 	CHROMOSOME 6 OPEN READING FRAME 173; C6ORF173	387103
MIM611265		 	PEROXISOMAL PROLIFERATOR-ACTIVATED RECEPTOR ALPHA-INTERACTING COFACTOR COMPLEX, 285-KD SUBUNIT	85441
MIM611266		 	POTE ANKYRIN DOMAIN FAMILY, MEMBER K, PSEUDOGENE; POTEKP	440915
MIM611267		 	OLFACTORY RECEPTOR, FAMILY 51, SUBFAMILY E, MEMBER 1; OR51E1	143503
MIM611268		 	OLFACTORY RECEPTOR, FAMILY 51, SUBFAMILY E, MEMBER 2; OR51E2	81285
MIM611269		 	NUCLEOLAR PROTEIN WITH MIF4G DOMAIN 1; NOM1	64434
MIM611270		 	N-ETHYLMALEIMIDE-SENSITIVE FACTOR ATTACHMENT PROTEIN, BETA; NAPB	63908
MIM611271		 	KINESIN FAMILY MEMBER 18A; KIF18A	81930
MIM611272		 	ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 5; ZKSCAN5	23660
MIM611273		15q23	LBX1 COREPRESSOR 1, MOUSE, HOMOLOG OF; LBXCOR1	390598
MIM611274	C1969812	 	GLAUCOMA 1, OPEN ANGLE, N; GLC1N	777645
MIM611275		 	BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 2-LIKE; BNIPL	149428
MIM611276	C1969811	 	GLAUCOMA 1, OPEN ANGLE, H; GLC1H	399564
MIM611277	C1969810	5q31.1-q33.1	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 3; GEFSP3	2566
MIM611278		 	KINESIN FAMILY MEMBER 12; KIF12	113220
MIM611279		1q31	KINESIN FAMILY MEMBER 14; KIF14	9928
MIM611280		 	KELCH DOMAIN-CONTAINING PROTEIN 2; KLHDC2	23588
MIM611281		 	KELCH DOMAIN-CONTAINING PROTEIN 1; KLHDC1	122773
MIM611282		 	DYNAMIN-BINDING PROTEIN; DNMBP	23268
MIM611283	C1969809	11q25	ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	27034
MIM611285		 	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 5; KCTD5	54442
MIM611286		 	RNA TERMINAL PHOSPHATE CYCLASE DOMAIN-CONTAINING PROTEIN 1; RTCD1	8634
MIM611287		 	CORNICHON, DROSOPHILA, HOMOLOG OF; CNIH	10175
MIM611288		 	CORNICHON, DROSOPHILA, HOMOLOG OF, 2; CNIH2	254263
MIM611289		 	LEUCINE-RICH ALPHA-2-GLYCOPROTEIN 1; LRG1	116844
MIM611290		2q35	NONHOMOLOGOUS END-JOINING FACTOR 1; NHEJ1	79840
MIM611291	C1969799	2q35	SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION	79840
MIM611292		 	RETINALDEHYDE-BINDING PROTEIN 1-LIKE 1; RLBP1L1	157807
MIM611293		 	COILED-COIL DOMAIN-CONTAINING PROTEIN 86; CCDC86	79080
MIM611294		 	ONE CUT HOMEOBOX 3; ONECUT3	390874
MIM611295		 	KELCH-LIKE 24; KLHL24	54800
MIM611296		 	CHROMOSOME 5 OPEN READING FRAME 39; C5ORF39	389289
MIM611297		8q23	ODD-SKIPPED-RELATED 2; OSR2	116039
MIM611298		 	KIAA1324	57535
MIM611299		 	KIAA1333	55632
MIM611300		 	La RIBONUCLEOPROTEIN DOMAIN FAMILY, MEMBER 6; LARP6	55323
MIM611301		 	CHROMOSOME 17 OPEN READING FRAME 70; C17ORF70	80233
MIM611302	C1969796	17p13	SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2	100126095
MIM611303		16p13.13	C-TYPE LECTIN DOMAIN FAMILY 16, MEMBER A; CLEC16A	23274
MIM611304		 	TRANSMEMBRANE PROTEIN 159; TMEM159	57146
MIM611305		 	ACTIN-BINDING LIM PROTEIN FAMILY, MEMBER 3; ABLIM3	22885
MIM611306		 	SCAVENGER RECEPTOR CLASS A, MEMBER 5; SCARA5	286133
MIM611307	C1969785	11p14.3	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L	203859
MIM611309		 	CHROMOSOME 10 OPEN READING FRAME; C10ORF10	11067
MIM611310		 	PHOSPHOSERYL-tRNA KINASE; PSTK	118672
MIM611312		 	CORNULIN; CRNN	49860
MIM611313		10q26.13	ARMS2 GENE; ARMS2	387715
MIM611314		 	CHROMOSOME 15 OPEN READING FRAME 21; C15ORF21	283651
MIM611315		 	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 20; ZSCAN20	7579
MIM611316		 	SOLUTE CARRIER FAMILY 12 (SODIUM/POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 8; SLC12A8	84561
MIM611317		 	PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 5; PIK3R5	23533
MIM611318		3q21-q25	MEDIATOR COMPLEX SUBUNIT 12-LIKE; MED12L	116931
MIM611319		 	FAMILY WITH SEQUENCE SIMILARITY 14, MEMBER A; FAM14A	83982
MIM611320		 	FAMILY WITH SEQUENCE SIMILARITY 14, MEMBER B; FAM14B	122509
MIM611321		 	CALSYNTENIN 1; CLSTN1	22883
MIM611322		16q12.1	DNAJ/HSP40 HOMOLOG, SUBFAMILY A, MEMBER 2; DNAJA2	10294
MIM611323		 	CALSYNTENIN 2; CLSTN2	64084
MIM611324		 	CALSYNTENIN 3; CLSTN3	9746
MIM611325		 	TRANSFORMING GROWTH FACTOR-BETA REGULATOR 4; TBRG4	9238
MIM611326		 	CELL CYCLE PROGRESSION 1; CCPG1	9236
MIM611327		 	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 4; DNAJB4	11080
MIM611328		 	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 5; DNAJB5	25822
MIM611329		 	SMALL CAJAL BODY-SPECIFIC RNA 18; SCARNA18	677765
MIM611330		 	SMALL NUCLEOLAR RNA, H/ACA BOX, 12; SNORA12	677800
MIM611331		 	SMALL NUCLEOLAR RNA, H/ACA BOX, 74B; SNORA74B	677841
MIM611332		 	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 6; DNAJB6	10049
MIM611333		 	SMALL NUCLEOLAR RNA, H/ACA BOX, 45; SNORA45	677826
MIM611334		 	SMALL NUCLEOLAR RNA, H/ACA BOX, 81; SNORA81	677847
MIM611335		 	SMALL NUCLEOLAR RNA, H/ACA BOX, 5C; SNORA5C	677796
MIM611336		 	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 7; DNAJB7	150353
MIM611337		 	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 8; DNAJB8	165721
MIM611338		 	AUTOPHAGY 4, S. CEREVISIAE, HOMOLOG OF, B; ATG4B	23192
MIM611339		 	AUTOPHAGY 4, S. CEREVISIAE, HOMOLOG OF, C; ATG4C	84938
MIM611340		 	AUTOPHAGY 4, S. CEREVISIAE, HOMOLOG OF, D; ATG4D	84971
MIM611341		 	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 11; DNAJB11	51726
MIM611342		 	CHROMOSOME 9 OPEN READING FRAME 64; C9ORF64	84267
MIM611343		 	CHROMOSOME 9 OPEN READING FRAME 103; C9ORF103	414328
MIM611344		 	RAS AND EF-HAND DOMAINS-CONTAINING PROTEIN; RASEF	158158
MIM611345		 	INTEGRATOR COMPLEX SUBUNIT 1; INTS1	26173
MIM611346		 	INTEGRATOR COMPLEX SUBUNIT 2; INTS2	57508
MIM611347		 	INTEGRATOR COMPLEX SUBUNIT 3; INTS3	65123
MIM611348		 	INTEGRATOR COMPLEX SUBUNIT 4; INTS4	92105
MIM611349		 	INTEGRATOR COMPLEX SUBUNIT 5; INTS5	80789
MIM611350		 	INTEGRATOR COMPLEX SUBUNIT 7; INTS7	25896
MIM611351		 	INTEGRATOR COMPLEX SUBUNIT 8; INTS8	55656
MIM611352		 	INTEGRATOR COMPLEX SUBUNIT 9; INTS9	55756
MIM611353		 	INTEGRATOR COMPLEX SUBUNIT 10; INTS10	55174
MIM611354		 	CLEAVAGE AND POLYADENYLATION-SPECIFIC FACTOR 3-LIKE; CPSF3L	54973
MIM611355		 	INTEGRATOR COMPLEX SUBUNIT 12; INTS12	57117
MIM611356		 	G KINASE-ANCHORING PROTEIN 1; GKAP1	80318
MIM611357		 	FAMILY WITH SEQUENCE SIMILARITY 46, MEMBER A; FAM46A	55603
MIM611358		17q11	RING FINGER PROTEIN 135; RNF135	84282
MIM611359		11p11.2	ACTIVATING MOLECULE IN BECLIN 1-REGULATED AUTOPHAGY; AMBRA1	55626
MIM611360		15q25-q26	FANCI GENE; FANCI	55215
MIM611361		 	UBIQUITIN-ACTIVATING ENZYME E1-LIKE 2; UBE1L2	55236
MIM611362		 	UBIQUITIN-CONJUGATING ENZYME E2Z; UBE2Z	65264
MIM611363	C1969657	7p15-p14	ATRIAL SEPTAL DEFECT 4; ASD4	57057
MIM611364	C1969656	5q12-q14	MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	100126594
MIM611365		 	TRANSMEMBRANE PROTEIN 183B; TMEM183B	653659
MIM611366		 	CHROMOSOME 12 OPEN READING FRAME 10; C12ORF10	60314
MIM611367		 	ASPARTYL AMINOPEPTIDASE; DNPEP	23549
MIM611368		1q24.1	MAELSTROM, DROSOPHILA, HOMOLOG OF; MAEL	84944
MIM611369	C1969655	19p13.3	LETHAL CONGENITAL CONTRACTURAL SYNDROME 3; LCCS3	23396
MIM611370		 	FLJ10986	55277
MIM611371		 	ZINC FINGER PROTEIN 653; ZNF653	115950
MIM611372		 	STROMAL MEMBRANE-ASSOCIATED PROTEIN 1; SMAP1	60682
MIM611373		 	LIVER-EXPRESSED ANTIMICROBIAL PEPTIDE 2; LEAP2	116842
MIM611374		 	MICRO RNA 34B; MIRN34B	407041
MIM611375		 	MICRO RNA 34C; MIRN34C	407042
MIM611376	C1969653	8q23-q24	MUNGAN SYNDROME; MGS	100126595
MIM611377	C1969652	17q22	BRACHYDACTYLY, TYPE B2; BDB2	9241
MIM611378	C1969651	19p13.3-p13.2	MACULAR DEGENERATION, AGE-RELATED, 9; ARMD9	718
MIM611379		12q13.12	DISCO-INTERACTING PROTEIN 2, DROSOPHILA, HOMOLOG OF, B; DIP2B	57609
MIM611380		10p15.3	DISCO-INTERACTING PROTEIN 2, DROSOPHILA, HOMOLOG OF, C; DIP2C	22982
MIM611383	C1568249	9q32-q34	USHER SYNDROME, TYPE IID; USH2D	25861
MIM611386		 	ACTIVITY-DEPENDENT NEUROPROTECTOR HOMEOBOX; ADNP	23394
MIM611387		 	CXC CHEMOKINE LIGAND 17; CXCL17	284340
MIM611388		 	DEOXYNUCLEOTIDYLTRANSFERASE, TERMINAL, INTERACTING PROTEIN 1; DNTTIP1	116092
MIM611389		 	CHROMOSOME 6, OPEN READING FRAME 49; C6ORF49	29964
MIM611390	C1969645	2q33-q34	SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3	100379201
MIM611391	C1969644	20p12.1-p11.23	CATARACT, CORTICAL, JUVENILE-ONSET	631
MIM611392		 	CHROMOSOME 10 OPEN READING FRAME 22; C10ORF22	84890
MIM611393		 	FAMILY WITH SEQUENCE SIMILARITY 110, MEMBER A; FAM110A	83541
MIM611394		 	FAMILY WITH SEQUENCE SIMILARITY 110, MEMBER B; FAM110B	90362
MIM611395		 	FAMILY WITH SEQUENCE SIMILARITY 110, MEMBER C; FAM110C	642273
MIM611396		 	ADIPOGENIN; ADIG	149685
MIM611397		 	TETRATRICOPEPTIDE REPEAT, ANKYRIN REPEAT, AND COILED-COIL-CONTAINING PROTEIN 1; TANC1	85461
MIM611398		 	GROWTH ARREST-SPECIFIC 2-LIKE 2; GAS2L2	246176
MIM611399		 	SODIUM CHANNEL AND CLATHRIN LINKER 1; SCLT1	132320
MIM611400		12q13.13	HOX TRANSCRIPT ANTISENSE RNA; HOTAIR	100124700
MIM611401		 	CHROMOSOME 6 OPEN READING FRAME 15; C6ORF15	29113
MIM611402		 	DOCKING PROTEIN 6; DOK6	220164
MIM611403	C1969640	17q21	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 6	100188840
MIM611404		 	CHROMOSOME 6 OPEN READING FRAME 21; C6ORF21	259215
MIM611405		 	RNA TERMINAL PHOSPHATE CYCLASE-LIKE 1; RCL1	10171
MIM611406		 	DYNEIN, CYTOPLASMIC 1, LIGHT INTERMEDIATE CHAIN 2; DYNC1LI2	1783
MIM611407	C1969639	10q22.1-q23	CARDIOMYOPATHY, DILATED, 1W; CMD1W	7414
MIM611408		6q14.1	LCA5 GENE; LCA5	167691
MIM611409		15q11.2-q12	OCA2 GENE	4948
MIM611410		6p22.3-p21.32	FAMILY WITH SEQUENCE SIMILARITY 65, MEMBER B; FAM65B	9750
MIM611411		 	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1, ALPHA; CAMKK1	84254
MIM611412		1q25	N-ACETYLNEURAMINATE PYRUVATE LYASE; NPL	80896
MIM611413		 	DISCS LARGE-ASSOCIATED PROTEIN 3; DLGAP3	58512
MIM611414		19p13.12	CALRETICULIN 3; CALR3	125972
MIM611415		 	POLYMERASE (DNA-DIRECTED), DELTA 3, ACCESSORY SUBUNIT; POLD3	10714
MIM611416		 	TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 3; TOX3	27324
MIM611417		 	SMALL G PROTEIN SIGNALING MODULATOR 1; SGSM1	129049
MIM611418		 	SMALL G PROTEIN SIGNALING MODULATOR 2; SGSM2	9905
MIM611419		6p21.3	CHROMOSOME 6 OPEN READING FRAME 1; C6ORF1	221491
MIM611420		 	CDKN1A-INTERACTING ZINC FINGER PROTEIN 1; CIZ1	25792
MIM611421		16p11.2	SNF2-RELATED CBP ACTIVATOR PROTEIN; SRCAP	10847
MIM611422		 	MEIOTIC NUCLEAR DIVISION 1, S. CEREVISIAE. HOMOLOG OF; MND1	84057
MIM611423		 	CENTROSOMAL PROTEIN, 135-KD; CEP135	9662
MIM611424		9q34.3	ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 19; ZMYND19	116225
MIM611425		 	CENTROSOMAL BRCA2-INTERACTING PROTEIN; CNTROB	116840
MIM611427		 	METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1-LIKE, NADP(+)-DEPENDENT; MTHFD1L	25902
MIM611428		 	DOWNSTREAM NEIGHBOR OF SON; DONSON	29980
MIM611429		 	CHROMOSOME 3 OPEN READING FRAME 35; C3ORF35	339883
MIM611430		 	TETRATRICOPEPTIDE REPEAT DOMAIN 21A; TTC21A	199223
MIM611431	C1969623	15q13.2	LEGIUS SYNDROME	161742
MIM611432		9p24	DEDICATOR OF CYTOKINESIS 8; DOCK8	81704
MIM611433		 	SERINE/THREONINE/TYROSINE KINASE 1; STYK1	55359
MIM611434		 	CYTOKINE-DEPENDENT HEMATOPOIETIC CELL LINKER; CLNK	116449
MIM611435		5q35.3	DOCKING PROTEIN 3; DOK3	79930
MIM611436		 	CARBONIC ANHYDRASE XIII; CA13	377677
MIM611437		 	DUAL-SPECIFICITY PHOSPHATASE 19; DUSP19	142679
MIM611438		 	TAXILIN, BETA; TXLNB	167838
MIM611439		 	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 22; ZBTB22	9278
MIM611440		 	WD REPEAT-CONTAINING PROTEIN 46; WDR46	9277
MIM611441		 	DOUBLE HOMEOBOX PROTEIN 1; DUX1	26584
MIM611442		 	DOUBLE HOMEOBOX PROTEIN 2; DUX2	26583
MIM611443		 	DOUBLE HOMEOBOX PROTEIN 3; DUX3	26582
MIM611444		 	DOUBLE HOMEOBOX PROTEIN 5; DUX5	26581
MIM611445		 	DYNAMIN 3; DNM3	26052
MIM611446		 	DUAL-SPECIFICITY PHOSPHATASE 18; DUSP18	150290
MIM611447		 	Y BOX-BINDING PROTEIN 2; YBX2	51087
MIM611448		 	BMS1, RIBOSOME ASSEMBLY PROTEIN, S. CEREVISIAE, HOMOLOG OF; BMS1	9790
MIM611449		 	EXPORTIN 4; XPO4	64328
MIM611450		3p14.3	PXK DOMAIN-CONTAINING SERINE/THREONINE KINASE; PXK	54899
MIM611451	C1969621	11q13.3-q13.4	DEAFNESS, AUTOSOMAL RECESSIVE 63; DFNB63	220074
MIM611453		20q12	DYSBINDIN DOMAIN-CONTAINING 2; DBNDD2	55861
MIM611455		1p33	KINOCILIN; KNCN	148930
MIM611456	C1969617	 	TREMOR, HEREDITARY ESSENTIAL, 3; ETM3	101027378
MIM611457		1p34.1	FORKHEAD BOX O6	100132074
MIM611458		3p21.33	GALACTOSIDASE, BETA-1; GLB1	2720
MIM611459		 	SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 7; SLC10A7	84068
MIM611460		 	FAMILY WITH SEQUENCE SIMILARITY 79, MEMBER A; FAM79A	127262
MIM611461		14q11.2	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 17; SLC22A17	51310
MIM611462		 	CHROMOSOME 17 OPEN READING FRAME 38; C17ORF38	146850
MIM611463		17p13.1	SPERMIDINE/SPERMINE N(1)-ACETYLTRANSFERASE 2; SAT2	112483
MIM611464		 	MON1, S. CEREVISIAE, HOMOLOG OF, A; MON1A	84315
MIM611465	C1969115	2p21	GALLBLADDER DISEASE 4; GBD4	64241
MIM611466		17q21.3	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY M, MEMBER 1; PLEKHM1	9842
MIM611467		1p22.2	GUANYLATE-BINDING PROTEIN 5: GBP5	115362
MIM611468		 	BRAIN-DERIVED NEUROTROPHIC FACTOR, OPPOSITE STRAND; BDNFOS	497258
MIM611469	C1969113	8q24	COLORECTAL CANCER, SUSCEPTIBILITY TO, 2; CRCS2	100188841
MIM611470		 	GLUTAMATE-AMMONIA LIGASE (GLUTAMINE SYNTHETASE) DOMAIN-CONTAINING 1; GLULD1	51557
MIM611471		 	ACID PHOSPHATASE 6, LYSOPHOSPHATIDE; ACP6	51205
MIM611472		2q23.1	METHYL-CpG-BINDING DOMAIN PROTEIN 5; MBD5	55777
MIM611473		 	EMBRYONIC STEM CELL-RELATED PROTEIN	790952
MIM611474		 	HRAS-LIKE SUPPRESSOR FAMILY, MEMBER 5; HRASLS5	117245
MIM611475		15q15.1	RNA POLYMERASE II-ASSOCIATED PROTEIN 1; RPAP1	26015
MIM611476		1p22.1	RNA POLYMERASE II-ASSOCIATED PROTEIN 2; RPAP2	79871
MIM611477		12q13.11	RNA POLYMERASE II-ASSOCIATED PROTEIN 3; RPAP3	79657
MIM611478		7q22	METHYLPHOSPHATE CAPPING ENZYME; MEPCE	56257
MIM611479		2p23.3	XPA-BINDING PROTEIN 1; XAB1	11321
MIM611480		19q13.33	PIH1 DOMAIN-CONTAINING PROTEIN 1; PIH1D1	55011
MIM611481		7q22.1	UFM1-SPECIFIC PEPTIDASE 1; UFSP1	402682
MIM611482		4q35.1	UFM1-SPECIFIC PEPTIDASE 2; UFSP2	55325
MIM611483		5q32	YIP1 DOMAIN FAMILY, MEMBER 5; YIPF5	81555
MIM611484		11q13	YIP1-INTERACTING FACTOR, S. CEREVISIAE, HOMOLOG OF, A; YIF1A	10897
MIM611485		19p13.1	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 12; CYP4F12	66002
MIM611486		10q26.3	SYNAPTONEMAL COMPLEX CENTRAL ELEMENT PROTEIN 1; SYCE1	93426
MIM611487		19p13.13	SYNAPTONEMAL COMPLEX CENTRAL ELEMENT PROTEIN 2; SYCE2	256126
MIM611488	C1969108	9q32-q33	MACULAR DEGENERATION, AGE-RELATED, 10; ARMD10	7099
MIM611489	C1852529	14q32.1	CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	866
MIM611490	C1969106	16p13	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 4; OPTB4	1186
MIM611491		7p22.1	RAS ASSOCIATION AND DILUTE DOMAINS PROTEIN; RADIL	55698
MIM611492		8q22	CARBONIC ANHYDRASE II; CA2	760
MIM611493	C1862394	21q22.1	ATRIAL FIBRILLATION, FAMILIAL, 4; ATFB4	9992
MIM611494	C1969099	4q25	ATRIAL FIBRILLATION, FAMILIAL, 5; ATFB5	100188842
MIM611495		19p13.12	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 22; CYP4F22	126410
MIM611496		20q13.2-q13.3	GATA-BINDING PROTEIN 5; GATA5	140628
MIM611497	C1969093	17q21.3	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6; OPTB6	9842
MIM611498	C1969092	16p13.3	NEPHRONOPHTHISIS 7; NPHP7	84662
MIM611499		7q21.11	BETA-GLUCURONIDASE; GUSB	2990
MIM611500		6p21.32	MICRO RNA 219-1; MIRN219-1	407002
MIM611501		1p36	CALMODULIN-BINDING TRANSCRIPTION ACTIVATOR 1; CAMTA1	23261
MIM611502		5p15.2-q12.3	CENTROMERIC PROTEIN K; CENPK	64105
MIM611503		1q25.1	CENTROMERIC PROTEIN L; CENPL	91687
MIM611504		2p23.3	CENTROMERIC PROTEIN O; CENPO	79172
MIM611505		9q22.31	CENTROMERIC PROTEIN P; CENPP	401541
MIM611506		6p12.3	CENTROMERIC PROTEIN Q; CENPQ	55166
MIM611507		4q22-q24	CDGSH IRON SULFUR DOMAIN PROTEIN 2; CISD2	493856
MIM611508		17p13.2	CALMODULIN-BINDING TRANSCRIPTION ACTIVATOR 2; CAMTA2	23125
MIM611509		16q23.2	CENTROMERIC PROTEIN N; CENPN	55839
MIM611510		16q22.1	CENTROMERIC PROTEIN T; CENPT	80152
MIM611511		4q35.1	MLF1-INTERACTING PROTEIN; MLF1IP	79682
MIM611512		2p11.2	LYSINE-SPECIFIC DEMETHYLASE 3A; KDM3A	55818
MIM611513		7p15-p14	NEUROGENIC DIFFERENTIATION 6; NEUROD6	63974
MIM611514		1p31.3	G PROTEIN-COUPLED RECEPTOR 177; GPR177	79971
MIM611515	C1969087	21q22	FEBRILE SEIZURES, FAMILIAL, 7; FEB7	100049160
MIM611516		3p21	NICOLIN 1; NICN1	84276
MIM611517		19p13.1	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 11; CYP4F11	57834
MIM611518		2q36.2	DEDICATOR OF CYTOKINESIS 10; DOCK10	55619
MIM611519		17q11.2	POLYMERASE DELTA-INTERACTING PROTEIN 2; POLDIP2	26073
MIM611520		22q13.2	POLYMERASE DELTA-INTERACTING PROTEIN 3; POLDIP3	84271
MIM611521	C1969086	19p13.2	TYROSINE KINASE 2 DEFICIENCY	7297
MIM611523	C1969084	6q16.1	PONTOCEREBELLAR HYPOPLASIA, TYPE 6; PCH6	57038
MIM611524		6q16.1	ARGINYL-tRNA SYNTHETASE 2; RARS2	57038
MIM611525		11q13	POLYMERASE (DNA-DIRECTED), DELTA 4; POLD4	57804
MIM611526		4p16.3	NOP14, S. CEREVISIAE, HOMOLOG OF; NOP14	8602
MIM611527		4q24	Na+/H+ EXCHANGER DOMAIN-CONTAINING PROTEIN 1; NHEDC1	150159
MIM611528	C1969081	17q21	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 12; ARVD12	3728
MIM611529		19q13.2	CYTOCHROME P450, FAMILY 2, SUBFAMILY S, POLYPEPTIDE 1; CYP2S1	29785
MIM611530		5q12.3	NEUROLYSIN; NLN	57486
MIM611531		12p13	ESSENTIAL FOR MITOTIC GROWTH 1, S. CEREVISIAE, HOMOLOG OF; EMG1	10436
MIM611532		9p13	NUCLEOLAR PROTEIN 6; NOL6	65083
MIM611533		6p23	NUCLEOLAR PROTEIN 7; NOL7	51406
MIM611534		9q22.32	NUCLEOLAR PROTEIN 8; NOL8	55035
MIM611535	C1970944	2q22-q24	MAJOR AFFECTIVE DISORDER 5; MAFD5	100188843
MIM611536	C1970945	6q23-q24	MAJOR AFFECTIVE DISORDER 6; MAFD6	100188844
MIM611537		20q11.2-q12	CATENIN, BETA-LIKE, 1; CTNNBL1	56259
MIM611538		19p13.2	OLFACTORY RECEPTOR, FAMILY 7, SUBFAMILY D, MEMBER 4; OR7D4	125958
MIM611539		1p31	FORKHEAD BOX D3; FOXD3	27022
MIM611540		1p31.3	SH3-DOMAIN GRB2-LIKE (ENDOPHILIN)-INTERACTING PROTEIN 1; SGIP1	84251
MIM611541		1q21.3	SORTING NEXIN 27; SNX27	81609
MIM611542		5q11-q13	ARYLSULFATASE B; ARSB	411
MIM611543	C1969063	12q	CAVITARY OPTIC DISC ANOMALIES	100188845
MIM611544	C1969062	22q11.2-q12.1	CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 3; CATCN3	1414
MIM611545		19p13.1	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 8; CYP4F8	11283
MIM611546		4q25	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 6; ELOVL6	79071
MIM611547	C1969061	12q14.3	STATURE QUANTITATIVE TRAIT LOCUS 9; STQTL9	 
MIM611548	C1969060	7q35	PREMATURE OVARIAN FAILURE 5; POF5	135935
MIM611549		13q32.3	SODIUM LEAK CHANNEL, NONSELECTIVE; NALCN	259232
MIM611550		6p21.3	NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NCR3	259197
MIM611551		2q13	FIBULIN 7; FBLN7	129804
MIM611552		8q24.3	NICOTINATE PHOSPHORIBOSYLTRANSFERASE DOMAIN-CONTAINING 1; NAPRT1	93100
MIM611553	C1969057	3p25	NOONAN SYNDROME 5; NS5	5894
MIM611554	C1969056	3p25	LEOPARD SYNDROME 2	5894
MIM611556	C1969054	19q13.3	GLYCOGEN STORAGE DISEASE 0, MUSCLE	2997
MIM611557		19q13.1	UROPLAKIN 1A; UPK1A	11045
MIM611558		11q23.3	UROPLAKIN 2; UPK2	7379
MIM611559		22q13.31	UROPLAKIN 3A; UPK3A	7380
MIM611560	C1969053	16q12.2	JOUBERT SYNDROME 7; JBTS7	23322
MIM611561	C1969052	16q12.2	MECKEL SYNDROME, TYPE 5; MKS5	23322
MIM611562		16p13.3	SEPTIN 12; SEPT12	124404
MIM611563		7p13	SEPTIN 13; SEPT13	641977
MIM611564		16q24	BTG3-ASSOCIATED NUCLEAR PROTEIN; BANP	54971
MIM611565		4q27	KIAA1109 GENE; KIAA1109	84162
MIM611566		7p21.2	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE 1-LIKE 1; PRPS1L1	221823
MIM611567		20p12	MACRO DOMAIN-CONTAINING 2; MACROD2	140733
MIM611568		8q23	GOLGI-LOCALIZED SYNTAPHILIN-RELATED PROTEIN	55638
MIM611569		13q14	CYTOSKELETON-ASSOCIATED PROTEIN 2; CKAP2	26586
MIM611570		9q22.2-q22.3	FRUCTOSE-1,6-BISPHOSPHATASE 1; FBP1	2203
MIM611571	C1969046	16q22.1-q23.1	OTOSCLEROSIS 4; OTSC4	286751
MIM611572	C1969044	6q13-q16.1	OTOSCLEROSIS 7; OTSC7	399516
MIM611573		10q11.2	SPHINGOMYELIN SYNTHASE 1; SGMS1	259230
MIM611574		4q25	SPHINGOMYELIN SYNTHASE 2; SGMS2	166929
MIM611575		10q22.2	STERILE ALPHA MOTIF DOMAIN-CONTAINING 8; SAMD8	142891
MIM611576		2q31	MICRO RNA 10B; MIR10B	406903
MIM611577		17p13.1	LYSINE-SPECIFIC DEMETHYLASE 6B; KDM6B	23135
MIM611578		1p21.2	FERRIC CHELATE REDUCTASE 1; FRRS1	391059
MIM611579		16p13.3	TRANSMEMBRANE PROTEIN 114; TMEM114	283953
MIM611580		14q11.2	FAMILY WITH SEQUENCE SIMILARITY 12, MEMBER A; FAM12A	10876
MIM611582		14q11.2	FAMILY WITH SEQUENCE SIMILARITY 12, MEMBER B; FAM12B	64184
MIM611583		2q11.2	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 5A; ARID5A	10865
MIM611584	C2700405	22q13	WAARDENBURG SYNDROME, TYPE 2E; WS2E	6663
MIM611585		12q24.2	TESCALCIN, MOUSE, HOMOLOG OF; TESC	54997
MIM611586		17q21	COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 1; C1QL1	10882
MIM611587		10q24.1	RHO GTPase-ACTIVATING PROTEIN 19; ARHGAP19	84986
MIM611588	C1969040	9q31	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	2218
MIM611589		22q13.31	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 5; PNPLA5	150379
MIM611590	C1969038	17q21-q22	RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	6521
MIM611591		4q13.3	PRO-PLATELET BASIC PROTEIN-LIKE 2; PPBPL2	10895
MIM611592		6p25.1	PHENYLALANYL-tRNA SYNTHETASE 2, MITOCHONDRIAL; FARS2	10667
MIM611593		4q13.3	SUBMAXILLARY GLAND ANDROGEN-REGULATED PROTEIN 3, MOUSE, HOMOLOG OF, B; SMR3B	10879
MIM611594		2p11.2	UBIQUITIN-SPECIFIC PROTEASE 39; USP39	10713
MIM611595		18q23	THIOREDOXIN-LIKE 4A; TXNL4A	10907
MIM611596		14q11.2	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 4; DHRS4	10901
MIM611597	C1969032	3q21-q25	CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	8419
MIM611598	C1969030	4q27	CELIAC DISEASE, SUSCEPTIBILITY TO, 6; CELIAC6	100188846
MIM611599		6p12.2	MICRO RNA 206; MIR206	406989
MIM611600		1p34.1	PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 3; RIMS3	9783
MIM611601		20q13.3	PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 4; RIMS4	140730
MIM611602		12q24.33	RIMS-BINDING PROTEIN 2; RIMBP2	23504
MIM611603	C1969029	12q12-q14	LISSENCEPHALY 3; LIS3	7846
MIM611604		10q21-q22	ENDOPLASMIC RETICULUM LIPID RAFT-ASSOCIATED PROTEIN 1; ERLIN1	10613
MIM611605		8p11.2	ENDOPLASMIC RETICULUM LIPID RAFT-ASSOCIATED PROTEIN 2; ERLIN2	11160
MIM611606		7q32.2	MICRO RNA 96; MIR96	407053
MIM611607		7q32.2	MICRO RNA 182; MIR182	406958
MIM611608		7q32.2	MICRO RNA 183; MIR183	406959
MIM611609		1q42.2	SIPA1-LIKE PROTEIN 2; SIPA1L2	57568
MIM611610		11q13.4	PHOSPHOGLUCOMUTASE 2-LIKE 1; PGM2L1	283209
MIM611611		15q24	S-PHASE CYCLIN A-ASSOCIATED PROTEIN IN THE ENDOPLASMIC RETICULUM; SCAPER	49855
MIM611612		14q11.2	THIAMINE TRIPHOSPHATASE; THTPA	79178
MIM611613		13q33	KDEL MOTIF-CONTAINING 1; KDELC1	79070
MIM611614		4q21	UTP3, S. CEREVISIAE, HOMOLOG OF; UTP3	57050
MIM611615	C1969024	9q31	CARDIOMYOPATHY, DILATED, 1X; CMD1X	2218
MIM611616		1p36.33-p36.21	NAD KINASE; NADK	65220
MIM611617		2q37.1	EF-HAND DOMAIN FAMILY, MEMBER D1; EFHD1	80303
MIM611619		6p21.33	MICRO RNA 877; MIRN877	100126314
MIM611620		3q27.1	MICRO RNA 1224; MIRN1224	100187716
MIM611621		16p13.3	MICRO RNA 1225; MIRN1225	100188847
MIM611622		3q25	IQ MOTIF-CONTAINING PROTEIN J; IQCJ	654502
MIM611623		12p13.31	NECAP ENDOCYTOSIS-ASSOCIATED PROTEIN 1; NECAP1	25977
MIM611624		1p36.13	NECAP ENDOCYTOSIS-ASSOCIATED PROTEIN 2; NECAP2	55707
MIM611625		20q13.33	CHROMOSOME 20 OPEN READING FRAME 11; C20ORF11	54994
MIM611626		13q12.11	M-PHASE PHOSPHOPROTEIN 8; MPHOSPH8	54737
MIM611627		17p13.3	FAMILY WITH SEQUENCE SIMILARITY 57, MEMBER A; FAM57A	79850
MIM611628		1q31	NEURON NAVIGATOR 1; NAV1	89796
MIM611629		12q21.1	NEURON NAVIGATOR 3; NAV3	89795
MIM611630	C1968848	4q13.2-q21.3	EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	100188848
MIM611631	C1968847	9q21-q22	EPILEPSY, FAMILIAL TEMPORAL LOBE, 4; ETL4	100144434
MIM611632		1p36.3	UbiA PRENYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 1; UBIAD1	29914
MIM611633		15q15.1	RTF1, S. CEREVISIAE, HOMOLOG OF; RTF1	23168
MIM611634	C1968846	3p24.2-p23	FEBRILE SEIZURES, FAMILIAL, 9; FEB9	100188849
MIM611635		12q13	NEUROGENIC DIFFERENTIATION 4; NEUROD4	58158
MIM611636		11q14.3-q21	N-ACETYLATED ALPHA-LINKED ACIDIC DIPEPTIDASE 2; NAALAD2	10003
MIM611637	C1968845	4p16	PRIMARY LATERAL SCLEROSIS, ADULT, 1; PLSA1	100240702
MIM611638	C1968843	7q36	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5; MCOPCB5	6469
MIM611639		19p13.2	ZINC FINGER GATA-LIKE PROTEIN 1; ZGLP1	100125288
MIM611640		10q26.2	FIBRONECTIN TYPE III AND ANKYRIN REPEAT DOMAINS 1; FANK1	92565
MIM611641		11q24.2	CANCER SUSCEPTIBILITY GENE HEPN1; HEPN1	641654
MIM611642		11q24	HEPATOCYTE CELL ADHESION MOLECULE; HEPACAM	220296
MIM611643		6p21.33-p21.31	ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 4; ZKSCAN4	387032
MIM611644	C1968840	4q31.3-q32.3	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 9; HSCR9	100188850
MIM611645		4q22-q24	CXXC FINGER PROTEIN 4; CXXC4	80319
MIM611646		2q36	SPHK1-INTERACTING PROTEIN; SPHKAP	80309
MIM611647		1q42.2	ARV1, S. CEREVISIAE, HOMOLOG OF; ARV1	64801
MIM611648		5q21.1	HISTIDINE ACID PHOSPHATASE DOMAIN-CONTAINING PROTEIN 1; HISPPD1	23262
MIM611649		10p13	CHROMOSOME 10 OPEN READING FRAME 97; C10ORF97	80013
MIM611651		22q11.2-q13.2	PHOSPHOLIPASE A2, GROUP III; PLA2G3	50487
MIM611652		4q25	PHOSPHOLIPASE A2, GROUP XIIA; PLA2G12A	81579
MIM611653		10q22.1	PHOSPHOLIPASE A2, GROUP XIIB; PLA2G12B	84647
MIM611654		8q13.2	CENTROSOME SPINDLE POLE-ASSOCIATED PROTEIN 1; CSPP1	79848
MIM611655		2q33.1	GPI DEACYLASE	80055
MIM611656		1p13.2	SUPPRESSOR OF IKK-EPSILON	80143
MIM611657		1p36.22	SPRY DOMAIN- AND SOCS BOX-CONTAINING 1; SPSB1	80176
MIM611658		12p13.31	SPRY DOMAIN- AND SOCS BOX-CONTAINING 2; SPSB2	84727
MIM611659		16p13.3	SPRY DOMAIN- AND SOCS BOX-CONTAINING 3; SPSB3	90864
MIM611660		3q23	SPRY DOMAIN- AND SOCS BOX-CONTAINING 4; SPSB4	92369
MIM611661		17q21	DBF4, S. CEREVISIAE, HOMOLOG OF, B; DBF4B	80174
MIM611662		3p26.2	EOSINOPHIL GRANULE ONTOGENY	100126791
MIM611663		20p13	TBC1 DOMAIN FAMILY, MEMBER 20; TBC1D20	128637
MIM611664	C2674081	12q22	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 7; SHEP7	4254
MIM611665		12q22-q23	DEAD/H BOX 54; DDX54	79039
MIM611666		9p24.1	PPAP2 DOMAIN-CONTAINING PROTEIN 2; PPAPDC2	403313
MIM611667		12q13.2	SPERMATOGENESIS-ASSOCIATED SERINE-RICH PROTEIN 2; SPATS2	65244
MIM611668		16p13.3	CORONIN 7; CORO7	79585
MIM611669		19p13.3	tRNA METHYLTRANSFERASE 1, S. CEREVISIAE, HOMOLOG OF; TRMT1	55621
MIM611670		19p13.1	INOSITOL-3-PHOSPHATE SYNTHASE 1; ISYNA1	51477
MIM611671		3q29	PHOSPHATIDYLINOSITOL GLYCAN, CLASS Z; PIGZ	80235
MIM611672		17q11.1	SOLUTE CARRIER FAMILY 46 (FOLATE TRANSPORTER), MEMBER 1; SLC46A1	113235
MIM611673		1q25	CHROMOSOME 1 OPEN READING FRAME 25; C1ORF25	81627
MIM611674		22q11.1	X KELL BLOOD GROUP PRECURSOR-RELATED FAMILY, MEMBER 3; XKR3	150165
MIM611675		16q24.1	KIAA0513 GENE; KIAA0513	9764
MIM611676		4q11	PHOSDUCIN-LIKE 2; PDCL2	132954
MIM611677		1q44	OLFACTORY RECEPTOR, FAMILY 13, SUBFAMILY G, MEMBER 1; OR13G1	441933
MIM611678		2q11.2	PHOSDUCIN-LIKE 3; PDCL3	79031
MIM611679		17p12	F-BOX AND WD40 DOMAIN PROTEIN 10; FBXW10	10517
MIM611680		1q32.2	SPECIFICALLY ANDROGEN-REGULATED GENE	79098
MIM611681		12q11	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 20; ADAMTS20	80070
MIM611682		6q26-q27	LIPOPROTEIN(a)-LIKE 2; LPAL2	80350
MIM611683		17q25	FRUCTOSAMINE 3-KINASE-RELATED PROTEIN	79672
MIM611684		12q24.1	SQUAMOUS CELL CARCINOMA ANTIGEN RECOGNIZED BY T CELLS 3; SART3	9733
MIM611685		6p21.3	RING FINGER PROTEIN 8; RNF8	9025
MIM611686		7q21	CAS1 DOMAIN-CONTAINING PROTEIN 1; CASD1	64921
MIM611687		6q13	CHROMOSOME 6 OPEN READING FRAME 221; C6ORF221	154288
MIM611688		6q13	KH HOMOLOGY DOMAIN-CONTAINING PROTEIN 1; KHDC1	80759
MIM611689		6q13	OOCYTE-EXPRESSED PROTEIN, DOG, HOMOLOG OF; OOEP	441161
MIM611690		11p13	PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 4; PRRG4	79056
MIM611691		9q32	SUSHI, VON WILLEBRAND FACTOR TYPE A, EGF, AND PENTRAXIN DOMAINS-CONTAINING 1; SVEP1	79987
MIM611692		9q33.3	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 34; ZBTB34	403341
MIM611693		11q24.1	ADIPOCYTE-SPECIFIC ADHESION MOLECULE	79827
MIM611695		15q15.2	TAU TUBULIN KINASE 2; TTBK2	146057
MIM611696		11q13.1	SOLUTE CARRIER FAMILY 22, MEMBER 20; SLC22A20	440044
MIM611697		6p25.2	CHROMOSOME 6 OPEN READING FRAME 85; C6ORF85	63027
MIM611698		11q12.3	SOLUTE CARRIER FAMILY 22, MEMBER 24; SLC22A24	283238
MIM611699		12q24.1	SV2-RELATED PROTEIN; SVOP	55530
MIM611700		7q34	SV2-RELATED PROTEIN-LIKE; SVOPL	136306
MIM611701		17p13.2	SPINSTER, DROSOPHILA, HOMOLOG OF, 3; SPNS3	201305
MIM611703		1p36	ZINC FINGER PROTEIN 436; ZNF436	80818
MIM611704		4q13.2	TRANSMEMBRANE PROTEASE, SERINE 11A; TMPRSS11A	339967
MIM611705	C2673677	2q31	MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY	7273
MIM611706	C2673676	10q22-q23	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	100188851
MIM611707		11q23.3	MYELIN PROTEIN ZERO-LIKE 3; MPZL3	196264
MIM611708		14q32.31	MICRO RNA 431; MIRN431	574038
MIM611709		14q32.31	MICRO RNA 127; MIRN127	406914
MIM611710		14q32.31	MICRO RNA 136; MIRN136	406927
MIM611711		14q32.31	MICRO RNA 433; MIRN433	574034
MIM611712		19q13.2	HOMEODOMAIN-INTERACTING PROTEIN KINASE 4; HIPK4	147746
MIM611713		1p34.1	TCTEX1 DOMAIN-CONTAINING 4; TCTEX1D4	343521
MIM611714		9q33.3	GTPase-ACTIVATING PROTEIN AND VPS9 DOMAINS 1; GAPVD1	26130
MIM611715		4q12	STEROID 5-ALPHA-REDUCTASE 3; SRD5A3	79644
MIM611716		12q24.3	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A2; ATP6V0A2	23545
MIM611718	C2673648	4q25	HYPOMAGNESEMIA 4, RENAL; HOMG4	1950
MIM611719	C2673642	3q23	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	56945
MIM611720		14q24.3	CHROMOSOME 14 OPEN READING FRAME 4; C14ORF4	64207
MIM611721	C2673635	10q22.1	COMBINED SAPOSIN DEFICIENCY	5660
MIM611722	C2673266	10q22.1	KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY	5660
MIM611723		21q22.2-q22.3	CHROMOSOME 21 OPEN READING FRAME 24; C21ORF24	400866
MIM611724	C2673265	6p25.3	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 8; SHEP8	100188852
MIM611725		7q11.21	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 7; KCTD7	154881
MIM611726	C2673257	7q11.21	EPILEPSY, PROGRESSIVE MYOCLONIC 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS; EPM3	154881
MIM611727		1q24.3	CHROMOSOME 1 OPEN READING FRAME 76; C1ORF76	148753
MIM611728		11p13-p12	PROTEIN OBSERVED WITH RICTOR 2	79899
MIM611729		11q12-q13	KINESIN LIGHT CHAIN 2; KLC2	64837
MIM611730		2q14	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 5; EPB41L5	57669
MIM611731		5q21-q22	APC GENE; APC	324
MIM611732		6p23	MEMBRANE-BOUND O-ACETYLTRANSFERASE DOMAIN-CONTAINING 1; MBOAT1	154141
MIM611734		1p13.2	WD REPEAT-CONTAINING PROTEIN 77; WDR77	79084
MIM611735		3p23-p21	CUB DOMAIN-CONTAINING PROTEIN 1; CDCP1	64866
MIM611736		2p25.1	GREB1 PROTEIN	9687
MIM611737		2q13	SEPTIN 10; SEPT10	151011
MIM611738	C2673201	20p12.3	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 7; BMND7	100188853
MIM611739	C2678504	11p12	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 8; BMND8	100188854
MIM611740		11q22.3-q23.1	BETA-CAROTENE DIOXYGENASE 2; BCDO2	83875
MIM611741		7q35	CATION CHANNEL, AMILORIDE-SENSITIVE, NEURONAL 3; ACCN3	9311
MIM611742	C2673200	20q11.2	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 9; SHEP9	434
MIM611743		12p13.31	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY G, MEMBER 6; PLEKHG6	55200
MIM611744		4q31.2	OTU DOMAIN-CONTAINING PROTEIN 4; OTUD4	54726
MIM611745		8q13	VCP/p47 COMPLEX-INTERACTING PROTEIN 1; VCPIP1	80124
MIM611746		22q13	SIGNAL PEPTIDE-, CUB DOMAIN-, AND EGF-LIKE DOMAINS-CONTAINING PROTEIN 1; SCUBE1	80274
MIM611747		11p15.5	SIGNAL PEPTIDE-, CUB DOMAIN-, AND EGF-LIKE DOMAINS-CONTAINING PROTEIN 2; SCUBE2	57758
MIM611748		1q21.2	OTU DOMAIN-CONTAINING PROTEIN 7B; OTUD7B	56957
MIM611749		10q26.13	ZINC FINGER- AND RAN-BINDING DOMAIN-CONTAINING PROTEIN 1; ZRANB1	54764
MIM611750		1p34.3-p34.1	SYNCOILIN 1; SYNC1	81493
MIM611751		2p22-p21	THUMP DOMAIN-CONTAINING 2; THUMPD2	80745
MIM611752		2q14.1-q14.3	CHROMOSOME 2 OPEN READING FRAME 40; C2ORF40	84417
MIM611753		17q23.1	TRANSMEMBRANE PROTEIN 49; TMEM49	81671
MIM611754		4q32.2	ALPHA-AMINOADIPATE AMINOTRANSFERASE; AADAT	51166
MIM611755	C1857821	12q21.3	LEBER CONGENITAL AMAUROSIS 10; LCA10	80184
MIM611756		5p15.2	ROPN1-LIKE PROTEIN; ROPN1L	83853
MIM611757		3q21.1	RHOPHILIN-ASSOCIATED TAIL PROTEIN 1; ROPN1	54763
MIM611758		1p36.13	OTU DOMAIN-CONTAINING PROTEIN 3; OTUD3	23252
MIM611759		7p14-p13	STARD3 N-TERMINAL-LIKE; STARD3NL	83930
MIM611760		13q21.1	PROTOCADHERIN 17; PCDH17	27253
MIM611761		16p13.3	LIPASE MATURATION FACTOR 1; LMF1	64788
MIM611762	C2673198	19q13.4	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	91662
MIM611763		2p23.1	LIMB BUD AND HEART DEVELOPMENT, MOUSE, HOMOLOG OF; LBH	81606
MIM611764		19q13	CORNIFELIN; CNFN	84518
MIM611765		2p13.1	ASPARTIC PEPTIDASE, RETROVIRAL-LIKE 1; ASPRV1	151516
MIM611766		15q22.31	MITOCHONDRIAL METHIONYL-tRNA FORMYLTRANSFERASE; MTFMT	123263
MIM611767		9q34.3	MICRO RNA 126; MIR126	406913
MIM611768		 	MICRO RNA 335; MIRN335	442904
MIM611769		3p22	MICRO RNA 128-2; MIRN128-2	406916
MIM611770		8p21	NK2, DROSOPHILA, HOMOLOG OF, 6; NKX2-6	137814
MIM611771	C2673196	19q13.2	LIPOPROTEIN GLOMERULOPATHY; LPG	348
MIM611772		1q23	NUF2, S. CEREVISIAE, HOMOLOG OF; NUF2	83540
MIM611773	C2673195	13q34	ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS; HANAC	1282
MIM611774		2q21	MICRO RNA 128-1; MIR128-1	406915
MIM611775	C0026691	19q13.2	KAWASAKI DISEASE	80271
MIM611776		6q16.1	NADH DEHYDROGENASE 1 ALPHA SUBCOMPLEX, ASSEMBLY FACTOR 4; NDUFAF4	29078
MIM611777	C2673193	3p22.3	BRUGADA SYNDROME 2; BRGDA2	23171, 781
MIM611778		3p22.3	GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1-LIKE; GPD1L	23171
MIM611779		14q21.3	FIBROUS SHEATH CABYR-BINDING PROTEIN	84075
MIM611780		11p15.5	KIAA1542 GENE	57661
MIM611781		8q13.3	PR DOMAIN-CONTAINING PROTEIN 14; PRDM14	63978
MIM611782		11q23	DOWN SYNDROME CELL ADHESION MOLECULE-LIKE 1; DSCAML1	57453
MIM611783	C2673187	2p21-p16	ERYTHROCYTOSIS, FAMILIAL, 4; ECYT4	2034
MIM611784		6q21	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 6; GTF3C6	112495
MIM611785		7p15.3	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 5; ABCB5	340273
MIM611786		2p22-p21	MEDIATOR OF CELL MOTILITY 1; MEMO1	51072
MIM611787		2p25.2	CYTIDINE MONOPHOSPHATE (UMP-CMP) KINASE 2, MITOCHONDRIAL; CMPK2	129607
MIM611788	C2673186	10q22-q24	AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6	59
MIM611789		4q24	NA+/H+ EXCHANGER DOMAIN-CONTAINING PROTEIN 2; NHEDC2	133308
MIM611790		3p21.33-p21.32	MYOSIN VIIA- AND RAB-INTERACTING PROTEIN; MYRIP	25924
MIM611791		10p12.1	PATCHED DOMAIN-CONTAINING PROTEIN 3; PTCHD3	374308
MIM611792		4p15.2	ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 4; ZCCHC4	29063
MIM611793		17q21.31	LSM12, S. CEREVISIAE, HOMOLOG OF; LSM12	124801
MIM611794		14q32.31	MICRO RNA 369; MIR369	442914
MIM611795		5q33.1	MICRO RNA 145; MIR145	406937
MIM611796		15q21.3	SECRETOGRANIN III; SCG3	29106
MIM611797		20q11.22	UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CHAPERONE; UQCC	55245
MIM611798		8q24.2	EFR3, S. CEREVISIAE, HOMOLOG OF, A; EFR3A	23167
MIM611799		4p15.3	LIGAND-DEPENDENT NUCLEAR RECEPTOR COREPRESSOR-LIKE PROTEIN; LCORL	254251
MIM611800		2p21	THYROID ADENOMA-ASSOCIATED GENE; THADA	63892
MIM611801		17q12	PER1-LIKE DOMAIN-CONTAINING PROTEIN 1; PERLD1	93210
MIM611802		17q12	CHROMOSOME 17 OPEN READING FRAME 37; C17ORF37	84299
MIM611803		16q12.1	INTEGRIN-ALPHA FG-GAP REPEAT-CONTAINING PROTEIN 1; ITFG1	81533
MIM611804	C2678497	1p36.2-p34	ELLIPTOCYTOSIS 1; EL1	2035
MIM611805		6p12	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 5; ELOVL5	60481
MIM611806		10q24	ARSENIC (+3 OXIDATION STATE) METHYLTRANSFERASE; AS3MT	57412
MIM611807		1q23.2	TIP41-LIKE PROTEIN; TIPRL	261726
MIM611809	C3888198	11q13	BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB	7439
MIM611810		19p13.1	USH1C-BINDING PROTEIN 1; USHBP1	83878
MIM611811		19p13.1	ZINC FINGER PROTEIN 333; ZNF333	84449
MIM611812	C2678492	1p35	46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	54361
MIM611813		1p34.2	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 1; ELOVL1	64834
MIM611814		6p24.2	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 2; ELOVL2	54898
MIM611815		10q24.32	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 3; ELOVL3	83401
MIM611817		12p13.2-p12.3	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY K, MEMBER 1; KLRK1	22914
MIM611818	C2678485	3p25	LONG QT SYNDROME 9; LQT9	859
MIM611819	C2678484	11q23	LONG QT SYNDROME 10; LQT10	6330
MIM611820	C2678483	7q21-q22	LONG QT SYNDROME 11; LQT11	10142
MIM611821		4q21.1	MITOCHONDRIAL RIBOSOMAL PROTEIN L1; MRPL1	65008
MIM611822		6p21.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L2; MRPL2	51069
MIM611823		19p13.2	MITOCHONDRIAL RIBOSOMAL PROTEIN L4; MRPL4	51073
MIM611824		1q21	MITOCHONDRIAL RIBOSOMAL PROTEIN L9; MRPL9	65005
MIM611825		17q21.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L10; MRPL10	124995
MIM611826		11q13.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L11; MRPL11	65003
MIM611827		6p21.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L14; MRPL14	64928
MIM611828		8q11.2-q13	MITOCHONDRIAL RIBOSOMAL PROTEIN L15; MRPL15	29088
MIM611829		11q12-q13.1	MITOCHONDRIAL RIBOSOMAL PROTEIN L16; MRPL16	54948
MIM611830		11p15.5-p15.4	MITOCHONDRIAL RIBOSOMAL PROTEIN L17; MRPL17	63875
MIM611831		6q25.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L18; MRPL18	29074
MIM611832		2p11.2-q11.2	MITOCHONDRIAL RIBOSOMAL PROTEIN L19; MRPL19	9801
MIM611833		1p36.3-p35.2	MITOCHONDRIAL RIBOSOMAL PROTEIN L20; MRPL20	55052
MIM611834		11q13.2	MITOCHONDRIAL RIBOSOMAL PROTEIN L21; MRPL21	219927
MIM611835		5q33	MITOCHONDRIAL RIBOSOMAL PROTEIN L22; MRPL22	29093
MIM611836		1q21-q22	MITOCHONDRIAL RIBOSOMAL PROTEIN L24; MRPL24	79590
MIM611837		17q21.3-q22	MITOCHONDRIAL RIBOSOMAL PROTEIN L27; MRPL27	51264
MIM611838		2q11.2	MITOCHONDRIAL RIBOSOMAL PROTEIN L30; MRPL30	51263
MIM611839		7p14	MITOCHONDRIAL RIBOSOMAL PROTEIN L32; MRPL32	64983
MIM611840		19p13.1	MITOCHONDRIAL RIBOSOMAL PROTEIN L34; MRPL34	64981
MIM611841		2p11.2	MITOCHONDRIAL RIBOSOMAL PROTEIN L35; MRPL35	51318
MIM611842		5p15.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L36; MRPL36	64979
MIM611843		1p32.1	MITOCHONDRIAL RIBOSOMAL PROTEIN L37; MRPL37	51253
MIM611844		17q23-q25	MITOCHONDRIAL RIBOSOMAL PROTEIN L38; MRPL38	64978
MIM611845		21q11.2-q21	MITOCHONDRIAL RIBOSOMAL PROTEIN L39; MRPL39	54148
MIM611846		9q34.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L41; MRPL41	64975
MIM611847		12q22	MITOCHONDRIAL RIBOSOMAL PROTEIN L42; MRPL42	28977
MIM611848		10q24	MITOCHONDRIAL RIBOSOMAL PROTEIN L43; MRPL43	84545
MIM611849		2q36	MITOCHONDRIAL RIBOSOMAL PROTEIN L44; MRPL44	65080
MIM611850		17q21.31	MITOCHONDRIAL RIBOSOMAL PROTEIN L45; MRPL45	84311
MIM611851		15q24-q25	MITOCHONDRIAL RIBOSOMAL PROTEIN L46; MRPL46	26589
MIM611852		3q26.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L47; MRPL47	57129
MIM611853		11q13.2	MITOCHONDRIAL RIBOSOMAL PROTEIN L48; MRPL48	51642
MIM611854		9q31.1	MITOCHONDRIAL RIBOSOMAL PROTEIN L50; MRPL50	54534
MIM611855		12p13.3-p13.1	MITOCHONDRIAL RIBOSOMAL PROTEIN L51; MRPL51	51258
MIM611856		14q11.2	MITOCHONDRIAL RIBOSOMAL PROTEIN L52; MRPL52	122704
MIM611857		2p12	MITOCHONDRIAL RIBOSOMAL PROTEIN L53; MRPL53	116540
MIM611858		19p13.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L54; MRPL54	116541
MIM611859		1q42.13	MITOCHONDRIAL RIBOSOMAL PROTEIN L55; MRPL55	128308
MIM611861		15q24.1	ADP-DEPENDENT GLUCOKINASE; ADPGK	83440
MIM611862	C2676078	1q23.2	WHITE BLOOD CELL COUNT QUANTITATIVE TRAIT LOCUS 1; WBCQ1	2532
MIM611863	C2678482	4p16-p15	MICROTIA WITH NASOLACRIMAL DUCT IMPERFORATION AND EYE COLOBOMA	100188855
MIM611864		7q11.2	ARMADILLO REPEAT-CONTAINING 10; ARMC10	83787
MIM611865		22q13.3	L3MBT-LIKE 2; L3MBTL2	83746
MIM611866		12p13.31	RETINOL-BINDING PROTEIN 5; RBP5	83758
MIM611867	C2678480	22q11.2	CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	100188856
MIM611868	C2678479	2p15	PROSTATE CANCER, HEREDITARY, 12; HPC12	23301
MIM611869		16p11.	RAB GTPase-BINDING EFFECTOR PROTEIN 2; RABEP2	79874
MIM611870		9p22.2	CENTLEIN; CNTLN	54875
MIM611871		8q21.3	FAMILY WITH SEQUENCE SIMILARITY 82, MEMBER B; FAM82B	51115
MIM611872		2p22.2	FAMILY WITH SEQUENCE SIMILARITY 82, MEMBER A1; FAM82A1	151393
MIM611873		15q15.1	FAMILY WITH SEQUENCE SIMILARITY 82, MEMBER A2; FAM82A2	55177
MIM611874		1q32.3	NEURON-DERIVED NEUROTROPHIC FACTOR; NENF	29937
MIM611875	C2678478	12p13.3	BRUGADA SYNDROME 3; BRGDA3	775
MIM611876	C2678477	10p12	BRUGADA SYNDROME 4; BRGDA4	783
MIM611877		7q21.3-q22.1	BAI1-ASSOCIATED PROTEIN 2-LIKE 1; BAIAP2L1	55971
MIM611878	C2678476	15q22.1	CARDIOMYOPATHY, DILATED, 1Y; CMD1Y	7168
MIM611879	C2678475	3p21.3-p14.3	CARDIOMYOPATHY, DILATED, 1Z; CMD1Z	7134
MIM611880	C2678474	19q13.4	CARDIOMYOPATHY, DILATED, 2A; CMD2A	7137
MIM611881	C0272066	16p11.2	GLYCOGEN STORAGE DISEASE XII; GSD12	226
MIM611882		1p36.11	PROLINE-RICH NUCLEAR RECEPTOR COACTIVATOR 2; PNRC2	55629
MIM611883		10q25.3-q26.2	BRCA2- AND CDKN1A-INTERACTING PROTEIN; BCCIP	56647
MIM611884	C2678473	7p21	CILIARY DYSKINESIA, PRIMARY, 7; CILD7	8701
MIM611885		8q24.3	SHANK-ASSOCIATED RH DOMAIN INTERACTOR; SHARPIN	81858
MIM611887		7q11.23	UROPLAKIN 3B; UPK3B	80761
MIM611888		19q13.1	ETS2 REPRESSOR FACTOR; ERF	2077
MIM611889		1p34.3	S100P-BINDING PROTEIN; S100PBP	64766
MIM611890	C2678471	9q34	LETHAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; LAAHD	2733
MIM611891	C2678470	9p21	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 3; AAA3	100188857
MIM611892	C2678469	9p21	ANEURYSM, INTRACRANIAL BERRY, 6; ANIB6	100188858
MIM611893		19q13.1	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY G, MEMBER 2; PLEKHG2	64857
MIM611894		16q22.1	MICRO RNA 140; MIRN140	406932
MIM611895	C2678468	14q11.2	AMYOTROPHIC LATERAL SCLEROSIS 9; ALS9	283
MIM611896		14q32.2	RETROTRANSPOSON-LIKE GENE 1; RTL1	388015
MIM611897	C2678467	2q11-q14	NANOPHTHALMOS 3; NNO3	100187717
MIM611898		17q25.3	ENDO-BETA-N-ACETYLGLUCOSAMINIDASE	64772
MIM611899		14q32.33	MICRO RNA 203; MIRN203	406986
MIM611900		18p11.2	METALLOPHOSPHOESTERASE 1; MPPE1	65258
MIM611901		1p36.3	VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 1; VWA1	64856
MIM611902		7q31-q32	COILED-COIL DOMAIN-CONTAINING PROTEIN 136; CCDC136	64753
MIM611903		19q13.41	ZINC FINGER PROTEIN 649; ZNF649	65251
MIM611904		11q23.2	CHROMOSOME 11 OPEN READING FRAME 34; C11ORF34	349633
MIM611905		2p23.3	FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 4; FNDC4	64838
MIM611906		1p35.1	FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 5; FNDC5	252995
MIM611907	C2677843	19q13	EPISODIC ATAXIA, TYPE 7; EA7	100188859
MIM611908		3p21.1	RFT1, S. CEREVISIAE, HOMOLOG OF; RFT1	91869
MIM611909		3q26	FIBRONECTIN DOMAIN III-CONTAINING PROTEIN 3B; FNDC3B	64778
MIM611910		10q23.3	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 12; SLC16A12	387700
MIM611911		12q24.1	IRON-SULFUR CLUSTER SCAFFOLD, E. COLI, HOMOLOG OF; ISCU	23479
MIM611912		1q32.1	NUCLEAR CASEIN KINASE AND CYCLIN-DEPENDENT KINASE SUBSTRATE 1; NUCKS1	64710
MIM611913	C3150154	16p11.2	CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	100187724
MIM611914		7p21-p15	TSC22 DOMAIN FAMILY, MEMBER 4; TSC22D4	81628
MIM611915		7p11.2	EGFR-COAMPLIFIED AND OVEREXPRESSED PROTEIN	81552
MIM611916		3q21	COLLAGEN, TYPE XXIX, ALPHA-1; COL29A1	256076
MIM611917		16p12.1	JUMONJI DOMAIN-CONTAINING PROTEIN 5; JMJD5	79831
MIM611919		14q24.3	MYC-ASSOCIATED PROTEIN WITH JMJC DOMAIN	79697
MIM611920	C2677836	10q23-q24	C-REACTIVE PROTEIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; CRPQTL1	100188860
MIM611921		6q15	GAP JUNCTION PROTEIN, BETA-7; GJB7	375519
MIM611922		10p11.21	GAP JUNCTION PROTEIN, DELTA-4; GJD4	219770
MIM611923		1p34.3	GAP JUNCTION PROTEIN, ALPHA-9; GJA9	81025
MIM611924		6q15	GAP JUNCTION PROTEIN, ALPHA-10; GJA10	84694
MIM611925		7q22.1	GAP JUNCTION PROTEIN, GAMMA-3; GJC3	349149
MIM611927		8q24.3	FAMILY WITH SEQUENCE SIMILARITY, MEMBER H; FAM83H	286077
MIM611928	C2677821	10q11.2	PROSTATE CANCER, HEREDITARY, 13; HPC13	4477
MIM611930		1q23.1	INTERFERON-STIMULATED EXONUCLEASE GENE 20-KD-LIKE 2; ISG20L2	81875
MIM611931		3q26.1	PROTEIN PHOSPHATASE 1-LIKE; PPM1L	151742
MIM611932		10q21.1	CDGSH IRON SULFUR DOMAIN PROTEIN 1; CISD1	55847
MIM611933		17q12	CDGSH IRON SULFUR DOMAIN PROTEIN 3; CISD3	284106
MIM611934	C2677808	10p11.22	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 5; EIG5	100188861
MIM611935		2q23.2	MMADHC GENE; MMADHC	27249
MIM611936	C2749873	3q29	CHROMOSOME 3q29 DUPLICATION SYNDROME	100188862
MIM611937		14q32.33	IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY GENE 3-3; IGHD3-3	28501
MIM611938	C2677794	1p13.3-p11	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	845
MIM611939		14q32.33	IMMUNOGLOBULIN HEAVY CHAIN VARIABLE GENE 3-23; IGHV3-23	28442
MIM611940		8p12	MEMBRANE-BOUND O-ACETYLTRANSFERASE DOMAIN-CONTAINING 4; MBOAT4	619373
MIM611941		8q24.13	ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 2; ATAD2	29028
MIM611942	C2749872	16p13.3	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6; ECA6	8912
MIM611943	C2677792	3q29	RIDDLE SYNDROME	165918
MIM611944	C2677787	6q16.2-q22.1	LYMPHEDEMA, HEREDITARY, IB	100188865
MIM611945	C2936880	8p21.1-q13.3	SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37	100049159
MIM611946		19p13	UBX DOMAIN-CONTAINING GENE 1; UBXD1	80700
MIM611947		11q23.3	NLR FAMILY MEMBER X1; NLRX1	79671
MIM611949		2p25.1	MEMBRANE-BOUND O-ACYLTRANSFERASE DOMAIN-CONTAINING 2; MBOAT2	129642
MIM611950		12p13	MEMBRANE-BOUND O-ACYLTRANSFERASE DOMAIN-CONTAINING 5; MBOAT5	10162
MIM611951		19q13.2	B9 DOMAIN-CONTAINING PROTEIN 2; B9D2	80776
MIM611952		8q24.3	VACUOLAR PROTEIN SORTING 28, YEAST, HOMOLOG OF; VPS28	51160
MIM611953	C2677774	20p11.2	MACULAR DEGENERATION, AGE-RELATED, 11; ARMD11	1471
MIM611954		19q13.41	MICRO RNA 373; MIRN373	442918
MIM611955	C2677773	17q12	PROSTATE CANCER, HEREDITARY, 11; HPC11	 
MIM611956		3q13.2	CHROMOSOME 3 OPEN READING FRAME 52; C3ORF52	79669
MIM611957		5q33.1	MICRO RNA 378; MIRN378	494327
MIM611958	C2677772	11q13	PROSTATE CANCER, HEREDITARY, 14; HPC14	100188867
MIM611959	C2677771	19q13.4	PROSTATE CANCER, HEREDITARY, 15; HPC15	100188868
MIM611960	C2677770	1q32.1	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7	1116
MIM611963		4p14-p11	ACYL-CoA THIOESTERASE 7-LIKE	344967
MIM611964		16q22.1	CYTOCHROME b5, TYPE B (OUTER MITOCHONDRIAL MEMBRANE); CYB5B	80777
MIM611965		3p14.1	THO COMPLEX, SUBUNIT 7; THOC7	80145
MIM611966		8q24.3	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 9; TRAPPC9	83696
MIM611967		4q22.1	KELCH-LIKE 8; KLHL8	57563
MIM611968		10q22-q23	CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 2, 64-KD, TAU VARIANT; CSTF2T	23283
MIM611969		11p15.5	HCCA2 GENE; HCCA2	81532
MIM611970		2q14.2	MKI67-INTERACTING NUCLEOLAR PHOSPHOPROTEIN; MKI67IP	84365
MIM611971		9q34	MITOCHONDRIAL RIBOSOMAL PROTEIN S2; MRPS2	51116
MIM611972		2p11.2-q11.2	MITOCHONDRIAL RIBOSOMAL PROTEIN S5; MRPS5	64969
MIM611973		21q21.3-q22.1	MITOCHONDRIAL RIBOSOMAL PROTEIN S6; MRPS6	64968
MIM611974		17q23-q25	MITOCHONDRIAL RIBOSOMAL PROTEIN S7; MRPS7	51081
MIM611975		2q12.1	MITOCHONDRIAL RIBOSOMAL PROTEIN S9; MRPS9	64965
MIM611976		6p21.1-p12.1	MITOCHONDRIAL RIBOSOMAL PROTEIN S10; MRPS10	55173
MIM611977		15q25	MITOCHONDRIAL RIBOSOMAL PROTEIN S11; MRPS11	64963
MIM611978		1q23-q25	MITOCHONDRIAL RIBOSOMAL PROTEIN S14; MRPS14	63931
MIM611979		1p35-p34.1	MITOCHONDRIAL RIBOSOMAL PROTEIN S15; MRPS15	64960
MIM611980		7p11-q11.21	MITOCHONDRIAL RIBOSOMAL PROTEIN S17; MRPS17	51373
MIM611981		6p21.3	MITOCHONDRIAL RIBOSOMAL PROTEIN S18A; MRPS18A	55168
MIM611982		6p21.3	MITOCHONDRIAL RIBOSOMAL PROTEIN S18B; MRPS18B	28973
MIM611983		4q21.23	MITOCHONDRIAL RIBOSOMAL PROTEIN S18C; MRPS18C	51023
MIM611984		1q21	MITOCHONDRIAL RIBOSOMAL PROTEIN S21; MRPS21	54460
MIM611985		17q22-q23	MITOCHONDRIAL RIBOSOMAL PROTEIN S23; MRPS23	51649
MIM611986		7p14	MITOCHONDRIAL RIBOSOMAL PROTEIN S24; MRPS24	64951
MIM611987		3p25	MITOCHONDRIAL RIBOSOMAL PROTEIN S25; MRPS25	64432
MIM611988		20p13	MITOCHONDRIAL RIBOSOMAL PROTEIN S26; MRPS26	64949
MIM611989		5q13.2	MITOCHONDRIAL RIBOSOMAL PROTEIN S27; MRPS27	23107
MIM611990		8q21.1-q21.3	MITOCHONDRIAL RIBOSOMAL PROTEIN S28; MRPS28	28957
MIM611991		5p12-q11	MITOCHONDRIAL RIBOSOMAL PROTEIN S30; MRPS30	10884
MIM611992		13q13.3	MITOCHONDRIAL RIBOSOMAL PROTEIN S31; MRPS31	10240
MIM611993		7q32-q34	MITOCHONDRIAL RIBOSOMAL PROTEIN S33; MRPS33	51650
MIM611994		16q13-q21	MITOCHONDRIAL RIBOSOMAL PROTEIN S34; MRPS34	65993
MIM611995		12q21.1-q21.3	MITOCHONDRIAL RIBOSOMAL PROTEIN S35; MRPS35	60488
MIM611996		5q12.1	MITOCHONDRIAL RIBOSOMAL PROTEIN S36; MRPS36	92259
MIM611997		13q12.11	MITOCHONDRIAL RIBOSOMAL PROTEIN 63; MRP63	78988
MIM611998		19p13.3	cAMP RESPONSIVE ELEMENT-BINDING PROTEIN 3-LIKE 3; CREB3L3	84699
MIM611999		17q11.2	RAB11 FAMILY-INTERACTING PROTEIN 4; RAB11FIP4	84440
MIM612000		11p15.4	TRIPARTITE MOTIF-CONTAINING PROTEIN 66; TRIM66	9866
MIM612001	C2677613	15q13.3	CHROMOSOME 15q13.3 DELETION SYNDROME	100188869
MIM612002		1p31.2	DEP DOMAIN-CONTAINING PROTEIN 1; DEPDC1	55635
MIM612003		2q37.1	GRB10-INTERACTING GYF PROTEIN 2; GIGYF2	26058
MIM612004	C2677608	7p15.2	THROMBOCYTOPENIA 4; THC4	54205
MIM612005	C2677607	1q31	CELIAC DISEASE, SUSCEPTIBILITY TO, 7; CELIAC7	100301522
MIM612006	C2677606	2q11-q12	CELIAC DISEASE, SUSCEPTIBILITY TO, 8; CELIAC8	100188870
MIM612007	C2677605	3p21	CELIAC DISEASE, SUSCEPTIBILITY TO, 9; CELIAC9	100188871
MIM612008	C2677604	3q25-q26	CELIAC DISEASE, SUSCEPTIBILITY TO, 10; CELIAC10	100188872
MIM612009	C2677603	3q28	CELIAC DISEASE, SUSCEPTIBILITY TO, 11; CELIAC11	100188873
MIM612010	C2677602	6q25.3	CELIAC DISEASE, SUSCEPTIBILITY TO, 12; CELIAC12	100188874
MIM612011	C2677601	12q24	CELIAC DISEASE, SUSCEPTIBILITY TO, 13; CELIAC13	100188875
MIM612012		14q24.1	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 26; ZFYVE26	23503
MIM612013		4p15.3	COILED-COIL AND C2 DOMAINS-CONTAINING PROTEIN 2A; CC2D2A	57545
MIM612014		2q24.3	TETRATRICOPEPTIDE REPEAT DOMAIN 21B; TTC21B	79809
MIM612015	C2677590	3p21.1	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In; CDG1N	91869
MIM612016	C2677589	1q42.2	COENZYME Q10 DEFICIENCY, PRIMARY, 4; COQ10D4	56997
MIM612017	C2677588	11q14-q22	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 3; IHPS3	100188876
MIM612018	C2677587	10q23.3	CATARACT, JUVENILE, WITH MICROCORNEA AND GLUCOSURIA	387700
MIM612019		22q12.3	INTESTINE-SPECIFIC HOMEOBOX; ISX	91464
MIM612020	C2677586	19p13.3	SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39	10908
MIM612021		8q21.3	OTU DOMAIN-CONTAINING PROTEIN 6B; OTUD6B	51633
MIM612022		10p12.2	OTU DOMAIN-CONTAINING PROTEIN 1; OTUD1	220213
MIM612023		1q32.1	YOD1 OTU DEUBIQUITINATING ENZYME 1, S. CEREVISIAE, HOMOLOG OF; YOD1	55432
MIM612024		15q13.3	OTU DOMAIN-CONTAINING PROTEIN 7A; OTUD7A	161725
MIM612025		6q24-q25	IODOTYROSINE DEIODINASE; IYD	389434
MIM612026		4q25	La RIBONUCLEOPROTEIN DOMAIN FAMILY, MEMBER 7; LARP7	51574
MIM612027		12q13.13	GRP1-ASSOCIATED SCAFFOLD PROTEIN; GRASP	160622
MIM612028		14q12	FAT-INDUCING TRANSCRIPT 1	161247
MIM612029		20q13.12	FAT-INDUCING TRANSCRIPT 2	128486
MIM612030	C2677580	8p22	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 9; CHDS9	100188877
MIM612031		12q13.3	INHIBIN, BETA E; INHBE	83729
MIM612032		2p22.3	DPY30, C. ELEGANS, HOMOLOG OF: DPY30	84661
MIM612033		16p11.2	CHROMOSOME 16 OPEN READING FRAME 53; C16ORF53	79447
MIM612034		19p13.3	APC2 GENE; APC2	10297
MIM612035		6p21.1	ALANYL-tRNA SYNTHETASE 2; AARS2	57505
MIM612036		1p32.2	PROLYL-tRNA SYNTHETASE 2; PARS2	25973
MIM612037		1p36.12	MITOCHONDRIAL UBIQUITIN LIGASE ACTIVATOR OF NFKB 1; MUL1	79594
MIM612038		7p22.2	TRANSMEMBRANE EMP24 PROTEIN TRANSPORT DOMAIN-CONTAINING PROTEIN 4; TMED4	222068
MIM612039		15q14	1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 7; AGPAT7	254531
MIM612040		16q12.2	LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 2; LPCAT2	54947
MIM612041		4p16.3	RING FINGER PROTEIN 212; RNF212	285498
MIM612042	C2677576	4p16.3	RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1; RRQTL1	285498
MIM612043		19q13.41	MICRO RNA 371; MIRN371	442916
MIM612044		19q13.41	MICRO RNA 372; MIRN372	442917
MIM612045		5p13	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 3; C1QTNF3	114899
MIM612046		12q21.3	E2F TRANSCRIPTION FACTOR 7; E2F7	144455
MIM612047		11p15.1	E2F TRANSCRIPTION FACTOR 8; E2F8	79733
MIM612048		3p25	TRANSMEMBRANE PROTEIN 43; TMEM43	79188
MIM612049		3q12.1	MYC-INDUCED NUCLEAR ANTIGEN; MINA	84864
MIM612050		5q31.3	NEDD4 FAMILY-INTERACTING PROTEIN 1; NDFIP1	80762
MIM612051		16q21	BRAIN-EXPRESSED, ASSOCIATED WITH NEDD4; BEAN	146227
MIM612052	C3150168	15q25.1, 15q25.1	SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3	1136, 1138
MIM612053		2p21	ZINC FINGER PROTEIN 36-LIKE 2; ZFP36L2	678
MIM612054		2q35	REQUIRED FOR CELL DIFFERENTIATION 1, S. POMBE, HOMOLOG OF; RQCD1	9125
MIM612055		15q22.2	RIBOSOMAL PROTEIN S27-LIKE; RPS27L	51065
MIM612056		7p22.3	GOLGI TO ER TRAFFIC PROTEIN 4, S. CEREVISIAE, HOMOLOG OF; GET4	51608
MIM612057		9q34.3	CHROMOSOME 9 OPEN READING FRAME 140; C9ORF140	89958
MIM612058		22q13.31	SORTING AND ASSEMBLY MACHINERY COMPONENT 50, S. CEREVISIAE, HOMOLOG OF; SAMM50	25813
MIM612059		5q33.2	La RIBONUCLEOPROTEIN DOMAIN FAMILY, MEMBER 1; LARP1	23367
MIM612060		16q23.1	ZINC FINGER AND RING FINGER PROTEIN 1; ZNRF1	84937
MIM612061		7p15.1	ZINC FINGER AND RING FINGER PROTEIN 2; ZNRF2	223082
MIM612062		22q12.1	ZINC FINGER AND RING FINGER PROTEIN 3; ZNRF3	84133
MIM612063		19p13.3	ZINC FINGER AND RING FINGER PROTEIN 4; ZNRF4	148066
MIM612064		7q22.1	GRB10-INTERACTING GYF PROTEIN 1; GIGYF1	64599
MIM612065		3q21	POLY(ADP-RIBOSE) POLYMERASE 9; PARP9	83666
MIM612066		3q21	POLY(ADP-RIBOSE) POLYMERASE 15; PARP15	165631
MIM612067	C2677567	2q31.3	DYSTONIA 16; DYT16	8575
MIM612068		17p13.1	PHOSPHOINOSITIDE-INTERACTING REGULATOR OF TRANSIENT RECEPTOR POTENTIAL CHANNELS	644139
MIM612069	C2677565	1p36.2	AMYOTROPHIC LATERAL SCLEROSIS 10, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	23435
MIM612070		17q11.2	MICRO RNA 144; MIRN144	406936
MIM612071		17q11.2	MICRO RNA 451; MIRN451	574411
MIM612072		17q25.1	MIF4G DOMAIN-CONTAINING PROTEIN; MIF4GD	57409
MIM612073	C2749864	13q12.2-q13	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH METHYLMALONIC ACIDURIA); MTDPS5	8803
MIM612074		7q32.1	RNA-BINDING MOTIF PROTEIN 28; RBM28	55131
MIM612075	C2749861	8q23.1	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY); MTDPS8A	50484
MIM612076	C2677549	4p16-p15.3	HYPOURICEMIA, RENAL, 2; RHUC2	56606
MIM612077		17p13.3	MICRO RNA 22; MIRN22	407004
MIM612078		16q24	ZINC FINGER PROTEIN 469; ZNF469	84627
MIM612079	C2677535	7q32.1	ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME	55131
MIM612080		5q31.1	UBIQUINOL-CYTOCHROME c REDUCTASE, COMPLEX III SUBUNIT VII, 9.5-KD; UQCRQ	27089
MIM612081		16q22.1	INTERLEUKIN 34; IL34	146433
MIM612082		19q13.2	CAPICUA, DROSOPHILA, HOMOLOG OF; CIC	23152
MIM612083	C2677532	14q24.3	MUSCLE STRENGTH QUANTITATIVE TRAIT LOCUS 1	100192311
MIM612084		3q29	ORGANIC SOLUTE TRANSPORTER, ALPHA	200931
MIM612085		15q21	ORGANIC SOLUTE TRANSPORTER, BETA	123264
MIM612086		18q21.3	MINOR HISTOCOMPATIBILITY ANTIGEN, SERPIN DOMAIN-CONTAINING; HMSD	284293
MIM612087		12p13.31	C-TYPE LECTIN DOMAIN FAMILY 2, MEMBER A; CLEC2A	387836
MIM612088		12p13	C-TYPE LECTIN DOMAIN FAMILY 12, MEMBER A; CLEC12A	160364
MIM612089	C2677524	13q13.1	HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	100188880
MIM612090		1p36.33	MICRO RNA 200A; MIR200A	406983
MIM612091		1p36.33	MICRO RNA 200B; MIRN200B	406984
MIM612092		12p13.31	MICRO RNA 200C; MIR200C	406985
MIM612093		12p13.31	MICRO RNA 141; MIR141	406933
MIM612094		1p36.33	MICRO RNA 429; MIRN429	554210
MIM612095	C2677516	4p15.3	RETINITIS PIGMENTOSA 41; RP41	8842
MIM612096	C2677515	9p13.1-q21.11	OTOSCLEROSIS 8; OTSC8	100151644
MIM612098	C2677506	15q14	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11	70
MIM612099	C2677505	9p21	TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 2	100188881
MIM612100	C2677504	7q35-q36	AUTISM, SUSCEPTIBILITY TO, 15; AUTS15	26047
MIM612101		4p15.2	PHOSPHATIDYLINOSITOL 4-KINASE, TYPE 2, BETA; PI4K2B	55300
MIM612102		3p21.1	MICRO RNA LET7G; MIRNLET7G	406890
MIM612103		2q32.3	OLIGONUCLEOTIDE/OLIGOSACCHARIDE-BINDING FOLD-CONTAINING PROTEIN 2A; OBFC2A	64859
MIM612104		12q13.3	OLIGONUCLEOTIDE/OLIGOSACCHARIDE-BINDING FOLD-CONTAINING PROTEIN 2B; OBFC2B	79035
MIM612105		10q23	KILLIN; KLLN	100144748
MIM612106		1p36	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 40; ZBTB40	9923
MIM612107		20q13.3	SOLUTE CARRIER FAMILY 17, MEMBER 9	63910
MIM612108	C2677501	2q24-q32	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 1; FGQTL1	100499165
MIM612109	C2677500	4p16.1	OCULOAURICULAR SYNDROME	3166
MIM612110	C2677499	13q14	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 9; BMND9	100188882
MIM612111		5q23.1	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8; TNFAIP8	25816
MIM612112		1q21.2-q21.3	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8-LIKE 2; TNFAIP8L2	79626
MIM612113	C2677498	8q24	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 10; BMND10	100188883
MIM612114	C2677497	6q25	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 11; BMND11	100188884
MIM612115		3p21-p13	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 3; ARHGEF3	50650
MIM612116		17p11.2	UBIQUITIN-SPECIFIC PROTEASE 22; USP22	23326
MIM612117		5q33.1	MICRO RNA 143; MIR143	406935
MIM612118		12p13.33	IQ MOTIF- AND SEC7 DOMAIN-CONTAINING PROTEIN 3; IQSEC3	440073
MIM612119	C0268187	11q23	TREHALASE DEFICIENCY	11181
MIM612120		3p25	CELL DEATH-INDUCING DFFA-LIKE EFFECTOR C; CIDEC	63924
MIM612121		6p21.31	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 1; PNPLA1	285848
MIM612122		9q34.3	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 7; PNPLA7	375775
MIM612123		7q31	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 8; PNPLA8	50640
MIM612124	C2677491	11p15.1	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12; CMH12	8048
MIM612125		19q13.1	SERTA DOMAIN-CONTAINING 3; SERTAD3	29946
MIM612126	C1842534	1p35-p31.3	GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	6513
MIM612127		4q22.1	17-@BETA-HYDROXYSTEROID DEHYDROGENASE XIII; HSD17B13	345275
MIM612128		17q12	RAS-LIKE, FAMILY 10, MEMBER B; RASL10B	91608
MIM612129		8p12	INDOLEAMINE 2,3-DIOXYGENASE 2; IDO2	169355
MIM612130		7q22.1	GENE AMPLIFIED IN ESOPHAGEAL CANCER 1; GAEC1	100126794
MIM612131		2q31.1	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 9; DHRS9	10170
MIM612132	C2677481	14q13	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT	4792
MIM612133		7q22.1	TRANSCRIPTION FACTOR NFE4; NFE4	58160
MIM612134		15q23	GLUCURONIC ACID EPIMERASE; GLCE	26035
MIM612135		18q12.2	CALCIUM-BINDING TYROSINE PHOSPHORYLATION-REGULATED PROTEIN; CABYR	26256
MIM612136		6q22.33	ENOYL COENZYME A HYDRATASE DOMAIN-CONTAINING PROTEIN 1; ECHDC1	55862
MIM612137		6q22.1-q22.33	RING FINGER PROTEIN 146; RNF146	81847
MIM612138	C2677349	8q24	EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	5339
MIM612139		8q13.1-q13.2	PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE-DEPENDENT RAC EXCHANGER 2; PREX2	80243
MIM612140		7p11.2	SEPTIN 14; SEPT14	346288
MIM612141		5q22	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 4A; EPB41L4A	64097
MIM612142		11q24.1	MICRO RNA LET7A2; MIRLET7A2	406882
MIM612143		22q13.31	MICRO RNA LET7A3; MIRNLET7A3	406883
MIM612144		21q21.1	MICRO RNA LET7C; MIRLET7C	406885
MIM612145		9q22.32	MICRO RNA LET7D; MIRNLET7D	406886
MIM612146		9q22.32	MICRO RNA LET7F1; MIRNLET7F1	406888
MIM612147		16q11.2	MYOSIN LIGHT CHAIN KINASE 3; MYLK3	91807
MIM612148		12q14.1	MICRO RNA LET7I; MIRNLET7I	406891
MIM612149		22q13.1	RNA-BINDING MOTIF PROTEIN 9; RBM9	23543
MIM612150		7q22.1	MICRO RNA 25; MIR25	407014
MIM612151		3p22.2	MICRO RNA 26A1; MIR26A1	407015
MIM612152		2q35	MICRO RNA 26B; MIR26B	407017
MIM612153		19p13.12	MICRO RNA 27A; MIRN27A	407018
MIM612154		3q28	MICRO RNA 28; MIRN28	407020
MIM612155		9p21.3	MICRO RNA 31; MIRN31	407035
MIM612156		22q13.2	MICRO RNA 33A; MIR33A	407039
MIM612157		12q13.1	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 1; SENP1	29843
MIM612158	C2677338	1q42-q43	CARDIOMYOPATHY, DILATED, 1AA; CMD1AA	88
MIM612159		12q24.1	RABPHILIN 3A; RPH3A	22895
MIM612160	C1266127	2q32.3-q34	HISTIOCYTOMA, ANGIOMATOID FIBROUS	1385
MIM612161	C2677337	11q24-q25	ANEURYSM, INTRACRANIAL BERRY, 7; ANIB7	100188885
MIM612162	C2677336	14q23	ANEURYSM, INTRACRANIAL BERRY, 8; ANIB8	100188886
MIM612163		11q13.2	TWO-PORE SEGMENT CHANNEL 2; TPCN2	219931
MIM612164	C2677326	9q34.1	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4; EIEE4	6709, 6812, 9863
MIM612165	C2677325	4q32-q34	RETINITIS PIGMENTOSA 29; RP29	54110
MIM612166		14q11.2	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 2; SLC39A2	29986
MIM612167		3p21.33	WD REPEAT-CONTAINING PROTEIN 48; WDR48	57599
MIM612168		19p13.3	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 3; SLC39A3	29985
MIM612169		1q23	Fc FRAGMENT OF IgG, LOW AFFINITY IIc, RECEPTOR FOR; FCGR2C	9103
MIM612170		12q12	MUCIN 19, OLIGOMERIC; MUC19	283463
MIM612171		2q23	REPRIMO; RPRM	56475
MIM612172		12q13.12	DEAD BOX POLYPEPTIDE 23; DDX23	9416
MIM612173		2q34	SPERM-ASSOCIATED ANTIGEN 16; SPAG16	79582
MIM612174		2q37.1	CALCIUM-BINDING PROTEIN 39; CAB39	51719
MIM612175		13q14.2	CALCIUM-BINDING PROTEIN 39-LIKE PROTEIN; CAB39L	81617
MIM612176		1p32.1	MYB-LIKE, SWIRM, AND MPN DOMAINS-CONTAINING PROTEIN 1; MYSM1	114803
MIM612177		14q22.1	RNA, 7SL, CYTOPLASMIC 1; RN7SL1	6029
MIM612178		1p13.3	CHROMOSOME 1 OPEN READING FRAME 59; C1ORF59	113802
MIM612179		14q22.1	RNA, 7SL, CYTOPLASMIC 2; RN7SL2	378706
MIM612180		14q22.1	RNA, 7SL, CYTOPLASMIC 3; RN7SL3	378707
MIM612181		3q13.3	MUCIN 13, CELL SURFACE-ASSOCIATED; MUC13	56667
MIM612182		8p23.1-p21.3	N-ACETYLTRANSFERASE 2; NAT2	10
MIM612183		15q14-q15	G PROTEIN-COUPLED RECEPTOR 176; GPR176	11245
MIM612184		16p13.3	CASK-INTERACTING PROTEIN 1; CASKIN1	57524
MIM612185		17q25.1	CASK-INTERACTING PROTEIN 2; CASKIN2	57513
MIM612186		15q21.2	DMX-LIKE 2; DMXL2	23312
MIM612187		12q13	HEME-RESPONSIVE GENE 1	55652
MIM612188		15q15.1	VACUOLAR PROTEIN SORTING 39, YEAST, HOMOLOG OF; VPS39	23339
MIM612189		10q21.1	PHENAZINE BIOSYNTHESIS-LIKE PROTEIN DOMAIN-CONTAINING PROTEIN; PBLD	64081
MIM612190		16p13.3	MTOR-ASSOCIATED PROTEIN LST8; MLST8	64223
MIM612191		9p13.3	PC3 PROSTATE CANCER CELL-SECRETED MICROPROTEIN	692094
MIM612192		6p22.1	ZINC FINGER PROTEIN 57, MOUSE, HOMOLOG OF; ZFP57	346171
MIM612193		5q12-q13	CARDIOMYOPATHY-ASSOCIATED PROTEIN 5; CMYA5	202333
MIM612194		9p22.1	RAS-RELATED GTP-BINDING PROTEIN A; RRAGA	10670
MIM612195		2p23.3	ABHYDROLASE DOMAIN-CONTAINING 1; ABHD1	84696
MIM612196		15q26.1	ABHYDROLASE DOMAIN-CONTAINING 2; ABHD2	11057
MIM612197		18q11.1	ABHYDROLASE DOMAIN-CONTAINING 3; ABHD3	171586
MIM612199	C2677299	 	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC	80169
MIM612200		3q24	CHROMOSOME 3 OPEN READING FRAME 58; C3ORF58	205428
MIM612201	C2677294	1p36.2	ATRIAL FIBRILLATION, FAMILIAL, 6; ATFB6	4878
MIM612202		8p22	SRY-BOX 7; SOX7	83595
MIM612203		4q21-q22	NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 5; NAP1L5	266812
MIM612204		2q35	AUTOPHAGY 9, S. CEREVISIAE, HOMOLOG OF, A; ATG9A	79065
MIM612205		7q35-36	AUTOPHAGY 9, S. CEREVISIAE, HOMOLOG OF, B; ATG9B	285973
MIM612206		11p13	FOUR-JOINTED BOX, DROSOPHILA, HOMOLOG OF, 1; FJX1	24147
MIM612207		5p13.3	GOLGI PHOSPHOPROTEIN 3; GOLPH3	64083
MIM612208		1q21.2	GOLGI PHOSPHOPROTEIN 3-LIKE; GOLPH3L	55204
MIM612209		2p24.2	MESOGENIN 1; MSGN1	343930
MIM612210		6p24.3	HIGHLY UPREGULATED IN LIVER CANCER; HULC	728655
MIM612211		17p13.3	TUMOR SUPPRESSOR CANDIDATE 5; TUSC5	286753
MIM612212		2q12.2	PLASMINOGEN-LIKE A; PLGLA	285189
MIM612213		19q13.32	SEMINAL PLASMA PROTEIN, BOVINE, HOMOLOG OF, 1; BSPH1	100131137
MIM612214		22q11.2	RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 4; RGL4	266747
MIM612215		8q13	SMALL NUCLEOLAR RNA HOST GENE 6; SNHG6	641638
MIM612216		8q13	SMALL NUCLEOLAR RNA, C/D BOX, 87; SNORD87	641648
MIM612217		6p21.31	CHROMOSOME 6 OPEN READING FRAME 106; C6ORF106	64771
MIM612218		3q23	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 38; ZBTB38	253461
MIM612219	C0553580	22q12	EWING SARCOMA; ES	2130
MIM612220		12p13.3	BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE 3; B4GALNT3	283358
MIM612221	C2677152	3q23	STATURE QUANTITATIVE TRAIT LOCUS 10; STQTL10	100270794
MIM612222		16q24.3	GALACTOSAMINE-6-SULFATE SULFATASE; GALNS	2588
MIM612223	C2677134	7q21	STATURE QUANTITATIVE TRAIT LOCUS 11; STQTL11	100270795
MIM612224	C2677133	4q31	STATURE QUANTITATIVE TRAIT LOCUS 12; STQTL12	100301523
MIM612225	C2677132	7q32	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9; MODY9	5078
MIM612226	C2677131	4p15.3	STATURE QUANTITATIVE TRAIT LOCUS 13; STQTL13	100270796
MIM612227	C0743110	7q32	DIABETES MELLITUS, KETOSIS-PRONE; KPD	5078
MIM612228	C2677124	20q11.22	STATURE QUANTITATIVE TRAIT LOCUS 14; STQTL14	100270797
MIM612229	C2677123	18q21.1	COLORECTAL CANCER, SUSCEPTIBILITY TO, 3; CRCS3	4092
MIM612230	C2677122	10p14	COLORECTAL CANCER, SUSCEPTIBILITY TO, 5; CRCS5	100188887
MIM612231	C2677121	8q23	COLORECTAL CANCER, SUSCEPTIBILITY TO, 6; CRCS6	100187710
MIM612232	C2677120	11q23	COLORECTAL CANCER, SUSCEPTIBILITY TO, 7; CRCS7	100187711
MIM612233	C2677109	2q33.1	LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4	3329
MIM612234		10q24.33	CALCIUM HOMEOSTASIS MODULATOR 1; CALHM1	255022
MIM612235		10q24.33	CALCIUM HOMEOSTASIS MODULATOR 2; CALHM2	51063
MIM612236		12p11.22	ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT PROTEIN 2; ERGIC2	51290
MIM612237	C1275278	17q11.1-q11.2, 9q22, 3q11-q12	CHONDROSARCOMA, EXTRASKELETAL MYXOID	10342, 8013, 8148
MIM612238	C2677108	9q31.2-q34.2	SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 4; IS4	100190785
MIM612239	C2677107	17q25.3	SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 5; IS5	100190985
MIM612240	C2677106	12p13	ATRIAL FIBRILLATION, FAMILIAL, 7; ATFB7	3741
MIM612241	C2677105	3p21.3	INFLAMMATORY BOWEL DISEASE 12; IBD12	100188952
MIM612242	C2677102	10q23	CHROMOSOME 10q23 DELETION SYNDROME	 
MIM612243		6q24.1	G PROTEIN-COUPLED RECEPTOR 126; GPR126	57211
MIM612244	C2677101	7q21.1	INFLAMMATORY BOWEL DISEASE 13; IBD13	5243
MIM612245	C2677100	7q32	INFLAMMATORY BOWEL DISEASE 14; IBD14	3663
MIM612246		2q24	CD302 ANTIGEN; CD302	9936
MIM612247	C2677099	4p16.3	CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS; CAN	2261
MIM612248		19p13.2	ZINC FINGER PROTEIN 627; ZNF627	199692
MIM612249		7p21.3	THROMBOSPONDIN TYPE-1 DOMAIN-CONTAINING PROTEIN 7A; THSD7A	221981
MIM612250		1q24.2	G PROTEIN-COUPLED RECEPTOR 161: GPR161	23432
MIM612251	C2677097	7q32	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10; SLEB10	3663
MIM612252		12p13.31	C-TYPE LECTIN DOMAIN FAMILY 9, MEMBER A; CLEC9A	283420
MIM612253	C2677096	2q32.2-q32.3	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11; SLEB11	6775
MIM612254	C2677095	8p23.1	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 12; SLEB12	100190928
MIM612255	C2677094	10q21	INFLAMMATORY BOWEL DISEASE 15; IBD15	100190929
MIM612256		19p13.2	MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 1; MAST1	22983
MIM612257		1p34.1	MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 2; MAST2	23139
MIM612258		19p13.11	MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 3; MAST3	23031
MIM612259	C2677093	9q32	INFLAMMATORY BOWEL DISEASE 16; IBD16	100190930
MIM612260	C2677092	3p22-p21.3	MYD88 DEFICIENCY; MYD88D	4615
MIM612261	C2677091	1p31.3	INFLAMMATORY BOWEL DISEASE 17; IBD17	149233
MIM612262	C2677090	5p13.1	INFLAMMATORY BOWEL DISEASE 18; IBD18	100190931
MIM612263	C2677089	20q11.2	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 7; CMM7	100190932
MIM612264		17q23.2	MANNOSE RECEPTOR, C-TYPE, 2; MRC2	9902
MIM612265		9q22.31	FAMILY WITH SEQUENCE SIMILARITY 120, MEMBER A; FAM120A	23196
MIM612266		6q26-q27	FAMILY WITH SEQUENCE SIMILARITY 120, MEMBER B; FAM120B	84498
MIM612267	C2677088	11q13.2	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10; SHEP10	219931
MIM612268		14q24.3	TUBULIN TYROSINE LIGASE-LIKE FAMILY, MEMBER 5; TTLL5	23093
MIM612269	C2677087	15q11.2-q12	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	2562
MIM612270		14q32.33	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 4; CDCA4	55038
MIM612271	C2677086	9p23	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 11; SHEP11	100190933, 7306
MIM612274	C2677085	15q24-q25	CILIARY DYSKINESIA, PRIMARY, 8; CILD8	100190786
MIM612275		17q12-q21.1	GAMETOGENETIN-BINDING PROTEIN 2; GGNBP2	79893
MIM612276		1p34.2	YRDC DOMAIN-CONTAINING PROTEIN; YRDC	79693
MIM612277		9q34.2	ADAMTS-LIKE PROTEIN 2; ADAMTSL2	9719
MIM612278	C2677079	5q33.1	INFLAMMATORY BOWEL DISEASE 19; IBD19	100190926, 345611
MIM612279	C2677078	8p23-p21	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 6; GEFSP6	100190787
MIM612280		1p34	FUCOSIDASE, ALPHA-L, 1; FUCA1	2517
MIM612281	C2677065	5q33	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE, NIPAL4-RELATED	348938
MIM612282		2q32.1	ZINC FINGER PROTEIN 804A; ZNF804A	91752
MIM612283		2q13-q14	PROTEIN C; PROC	5624
MIM612284	C2676790	4p15.3	MECKEL SYNDROME, TYPE 6; MKS6	57545
MIM612285	C2676788	4p15.3	JOUBERT SYNDROME 9; JBTS9	57545
MIM612286	C2676786	5q35	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1; NPHLOP1	6569
MIM612287	C2676782	17q25.1	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2; NPHLOP2	9368
MIM612288	C2676781	10q23-q24	INFLAMMATORY BOWEL DISEASE 20; IBD20	100190788
MIM612290	C2676772	7p15-p14	MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATE	3199
MIM612291	C2676771	3q11.2	JOUBERT SYNDROME 8; JBTS8	200894
MIM612292	C2676770	8q24.1-q24.3	BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME	51305
MIM612293	C2676769	1p31.3-p31.1	POROKERATOSIS 5; POROK5	100190982
MIM612294		11p13	DEP DOMAIN-CONTAINING PROTEIN 7; DEPDC7	91614
MIM612295		11p14.1-p13	CHROMOSOME 11 OPEN READING FRAME 46; C11ORF46	120534
MIM612296		11p14.1-p13	LOC283267 GENE	283267
MIM612297		11p13	CHROMOSOME 11 OPEN READING FRAME 41; C11ORF41	25758
MIM612298		11p13	TRIPARTITE MOTIF-CONTAINING PROTEIN 44; TRIM44	54765
MIM612299		11p13	COMM DOMAIN-CONTAINING PROTEIN 9; COMMD9	29099
MIM612300	C2676767	11p13	CD59 DEFICIENCY	966
MIM612301	C2676766	18q22.1	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	8792
MIM612302		10q26.3	G PROTEIN-COUPLED RECEPTOR 123; GPR123	84435
MIM612303		4p15.2	G PROTEIN-COUPLED RECEPTOR 125; GPR125	166647
MIM612304	C2676759	2q13-q14	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	5624
MIM612305		19p13.3	EMR4, MOUSE, HOMOLOG OF; EMR4	326342
MIM612306	C2676758	5q13	THYROID-STIMULATING HORMONE LEVEL QUANTITATIVE TRAIT LOCUS 1; TSHQTL1	100190789
MIM612307		3q12.2	G PROTEIN-COUPLED RECEPTOR 128; GPR128	84873
MIM612308		17p13.1	ZINC FINGER AND BTB DOMAIN-CONTAINING 4; ZBTB4	57659
MIM612309		1q23	COAGULATION FACTOR V; F5	2153
MIM612310	C2676742	2p12	PREMATURE OVARIAN FAILURE 6; POF6	344018
MIM612311	C2676741	2q21.1	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 5	100190790
MIM612312	C2676740	13q12.11	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 6	100190791
MIM612313	C2676739	2q32-q33	CHROMOSOME 2q32-q33 DELETION SYNDROME	100190983
MIM612314		10q24-q25	GLUTATHIONE S-TRANSFERASE, OMEGA-2; GSTO2	119391
MIM612315		12q13.13	KERATIN 6C; KRT6C	286887
MIM612316		1p36.33	ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 3A; ATAD3A	55210
MIM612317		1p36.33	ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 3B; ATAD3B	83858
MIM612318	C0549150	12q13	PSEUDOFOLLICULITIS BARBAE	9119
MIM612319	C3668943	16q21-q23.1	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE; SPG35	79152
MIM612320		1p32	CUB DOMAIN-CONTAINING PROTEIN 2; CDCP2	200008
MIM612321		11p14.1	DOUBLECORTIN DOMAIN-CONTAINING PROTEIN 5; DCDC5	100506627
MIM612322		2q33.3	FAST KINASE DOMAIN-CONTAINING PROTEIN 2; FASTKD2	22868
MIM612323		11p13	INNER MITOCHONDRIAL MEMBRANE PEPTIDASE, SUBUNIT 1, S. CEREVISIAE, HOMOLOG OF; IMMP1L	196294
MIM612324		11p14.1	COILED-COIL DOMAIN-CONTAINING PROTEIN 34; CCDC34	91057
MIM612325		6p12.3	INTESTINAL CELL KINASE; ICK	22858
MIM612326		16q24.3	TRANSCRIPTION FACTOR 25; TCF25	22980
MIM612327		6q16	MANNOSIDASE, ENDO-ALPHA; MANEA	79694
MIM612328		11p13	COILED-COIL DOMAIN-CONTAINING PROTEIN 73: CCDC73	493860
MIM612329		6q13	MICRO RNA 30A; MIR30A	407029
MIM612330		11p14.1	MICRO RNA 610; MIRN610	693195
MIM612331		19q13.33	LIN7, C. ELEGANS, HOMOLOG OF, B; LIN7B	64130
MIM612332		11p14.1	LIN7, C. ELEGANS, HOMOLOG OF, C; LIN7C	55327
MIM612333		10q24.2-q25.1	PROGRAMMED CELL DEATH 11; PDCD11	22984
MIM612334		7q22.1	N-ACYL PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D; NAPEPLD	222236
MIM612335	C2676732	4p16-p15	SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38	100049707
MIM612336	C2676728	3q11.2	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT; THPH5	5627
MIM612337	C2676727	1q42-q44	CHROMOSOME 1q43-q44 DELETION SYNDROME	100190984
MIM612338		20p11.1	GAMMA-GLUTAMYLTRANSFERASE, LIGHT CHAIN 1; GGTLC1	92086
MIM612339		22q11.2	GAMMA-GLUTAMYLTRANSFERASE, LIGHT CHAIN 2; GGTLC2	91227
MIM612340		22q11.2	GAMMA-GLUTAMYLTRANSFERASE, LIGHT CHAIN 3; GGTLC3	728226
MIM612341		17p13.2	GAMMA-GLUTAMYLTRANSFERASE 6; GGT6	124975
MIM612342		20q11.2	GAMMA-GLUTAMYLTRANSFERASE 7; GGT7	2686
MIM612343	C2676725	4q22	MUSICAL APTITUDE QUANTITATIVE TRAIT LOCUS	100192307
MIM612344		2q31.2-q31.3	ZINC FINGER PROTEIN 385B; ZNF385B	151126
MIM612345	C2676724	2q31.2	CHROMOSOME 2q31.2 DELETION SYNDROME	100192308
MIM612346		22q11.2	GAMMA-GLUTAMYLTRANSFERASE 1; GGT1	2678
MIM612347	C2676723	21q22.1-q22.2	JERVELL AND LANGE-NIELSEN SYNDROME 2; JLNS2	3753
MIM612348	C2676721	8p12	THROMBOPHILIA, FAMILIAL, DUE TO DECREASED RELEASE OF TISSUE PLASMINOGEN ACTIVATOR; THPH9	5327
MIM612349		12q24.1	PHENYLALANINE HYDROXYLASE; PAH	5053
MIM612350	C2676510	11p11.2	SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	91252
MIM612351		2p11.2	FORKHEAD BOX I3; FOXI3	344167
MIM612352		10q23	STAM-BINDING PROTEIN-LIKE 1; STAMBPL1	57559
MIM612353	C2676508	18p11.3	POROKERATOSIS 6; POROK6	100196911
MIM612354	C2676507	18p11	INFLAMMATORY BOWEL DISEASE 21; IBD21	100192312
MIM612355		11p15.3	MICAL C TERMINUS-LIKE PROTEIN; MICALCL	84953
MIM612356	C0398626	22q11	HEPARIN COFACTOR II DEFICIENCY	3053
MIM612357	C2700439	10q21	MAJOR AFFECTIVE DISORDER 8; MAFD8	100196912
MIM612358		3q27	KININOGEN 1; KNG1	3827
MIM612359	C3552552	11q23, 1p36.1-p35	COWDEN-LIKE SYNDROME	5728, 6390, 6392
MIM612360		20p12.1	CHROMOSOME 20 OPEN READING FRAME 7; C20ORF7	79133
MIM612361	C2677614	2q32.1	SCHIZOPHRENIA 14	100196913
MIM612362	C2676498	5q15-q21	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12; BMIQ12	5122
MIM612365	C2676495	 	GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1	 
MIM612366	C2676494	 	GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2	 
MIM612367	C2676493	1p36	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2	100196914
MIM612368	C2676492	6p22	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 3	100196915
MIM612369	C2676491	10q21	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 4	100196916
MIM612370	C2675302	8q12.1	HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA; HH5	55636
MIM612371	C2700438	22q12	MAJOR AFFECTIVE DISORDER 7; MAFD7	7494
MIM612372	C2700440	12p13.3	MAJOR AFFECTIVE DISORDER 9; MAFD9	100196917
MIM612373		10q22.1	SOLUTE CARRIER FAMILY 29 (NUCLEOSIDE TRANSPORTER), MEMBER 3: SLC29A3	55315
MIM612374		5q31.2	TRANSMEMBRANE PROTEIN 173; TMEM173	340061
MIM612375		1q41	AXIN INTERACTOR, DORSALIZATION-ASSOCIATED; AIDA	64853
MIM612376	C0023487	17q21.1	ACUTE PROMYELOCYTIC LEUKEMIA; APL	5914
MIM612377		13q22	COMM DOMAIN-CONTAINING PROTEIN 6; COMMD6	170622
MIM612378	C2676487	6q23	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 13; SLEB13	100196918
MIM612379	C3150191	4q12	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq; CDG1Q	79644
MIM612380	C2676485	17q21.2	INFLAMMATORY BOWEL DISEASE 22; IBD22	100240732
MIM612381	C2676484	1q32.1	INFLAMMATORY BOWEL DISEASE 23; IBD23	100240733
MIM612382		5p15.31	MEDIATOR COMPLEX SUBUNIT 10; MED10	84246
MIM612383		17p13.2	MEDIATOR COMPLEX SUBUNIT 11; MED11	400569
MIM612384		1p35.3	MEDIATOR COMPLEX SUBUNIT 18; MED18	54797
MIM612385		11q12.1	MEDIATOR COMPLEX SUBUNIT 19; MED19	219541
MIM612386		18q21.3	FERROCHELATASE; FECH	2235
MIM612387	C2676468	6p21.3	SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	56244
MIM612388	C2676467	10q22.3	SARCOIDOSIS, SUSCEPTIBILITY TO, 3; SS3	100196919
MIM612389	C2676466	3p25.1	PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	80746
MIM612390	C2676465	19q13.4	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	79042
MIM612392		8q22.1	CHROMOSOME 8 OPEN READING FRAME 38; C8ORF38	137682
MIM612393		15q25.2	WAS PROTEIN HOMOLOGY REGION 2 DOMAIN-CONTAINING PROTEIN 1; WHDC1	123720
MIM612394	C2676285	7q22	BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	8985
MIM612395		22q13	CHOLINE KINASE, BETA; CHKB	1120
MIM612396		2p25	ALLANTOICASE; ALLC	55821
MIM612397		3p24.3	DUAL INTRACELLULAR VON WILLEBRAND FACTOR DOMAIN A-CONTAINING PROTEIN	344875
MIM612398		12q21.1	RAB-ASSOCIATED PROTEIN RAB21; RAB21	23011
MIM612399		19p13.3	TRANSDUCIN-LIKE ENHANCER OF SPLIT 6; TLE6	79816
MIM612400	C0029410	 	OSTEOARTHRITIS SUSCEPTIBILITY 5; OS5	8200
MIM612401	C0409959	3p24.3	OSTEOARTHRITIS SUSCEPTIBILITY 6; OS6	100286836
MIM612402		3p21.31	ALS2 C-TERMINAL-LIKE PROTEIN; ALS2CL	259173
MIM612403		13q12.2	RAS-LIKE, FAMILY 11, MEMBER A; RASL11A	387496
MIM612404		4q12	RAS-LIKE, FAMILY 11, MEMBER B; RASL11B	65997
MIM612405		4q12	ADP-RIBOSYLATION FACTOR-LIKE 9; ARL9	132946
MIM612406	C2676281	20p11.2-q13.12	DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17	100216344
MIM612407		1q31.2	REGULATOR OF G PROTEIN SIGNALING 21; RGS21	431704
MIM612408		13q12.11	PARASPECKLE COMPONENT 1; PSPC1	55269
MIM612409		11q13	RNA-BINDING MOTIF PROTEIN 14; RBM14	10432
MIM612410	C1538742	18p11.23	PSORIASIS SUSCEPTIBILITY 10; PSORS10	503613
MIM612411		4q28.1	FAT TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 4; FAT4	79633
MIM612412		21q22.3	CHROMOSOME 21 OPEN READING FRAME 56; C21ORF56	84221
MIM612413		11q23.1-q23.2	RNA-BINDING MOTIF PROTEIN 7; RBM7	10179
MIM612414		11q13.3-q13.4	LEUCINE-RICH TRANSMEMBRANE O-METHYLTRANSFERASE; LRTOMT	220074
MIM612415		5q35.3	RAS-ASSOCIATED PROTEIN 24; RAB24	53917
MIM612416	C0015523	4q35	FACTOR XI DEFICIENCY	2160
MIM612417	C2676275	22q13	NARCOLEPSY 4, SUSCEPTIBILITY TO; NRCLP4	100216484
MIM612418		8q21.11	TRANSMEMBRANE PROTEIN 70; TMEM70	54968
MIM612419		19p13.11	CARTILAGE INTERMEDIATE LAYER PROTEIN 2; CILP2	148113
MIM612420		10q25.3	ACTIN FILAMENT-ASSOCIATED PROTEIN 1-LIKE PROTEIN 2; AFAP1L2	84632
MIM612421	C2676272	20p11.22	ALOPECIA, ANDROGENETIC, 3; AGA3	100217387
MIM612422	C2676271	1q32	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3; RCM3	7139
MIM612423	C0272339	4q35	PREKALLIKREIN DEFICIENCY	3818
MIM612424		6q12	EYES SHUT, DROSOPHILA, HOMOLOG OF; EYS	346007
MIM612425		2q33.1	SHUGOSHIN-LIKE 2; SGOL2	151246
MIM612426		16p13.13	CHROMOSOME 16 OPEN READING FRAME 75; C16ORF75	116028
MIM612427		14q24.2	RNA-BINDING MOTIF PROTEIN 25; RBM25	58517
MIM612428		20q13.31	RNA-BINDING MOTIF PROTEIN 38; RBM38	55544
MIM612429		5q33.1	ZINC FINGER PROTEIN 300; ZNF300	91975
MIM612430		5q33.1	RNA-BINDING MOTIF PROTEIN 22; RBM22	55696
MIM612431	CN029720	4q12-q13.1	DEAFNESS, AUTOSOMAL DOMINANT 27; DFNA27	23722
MIM612432		7p15.1	WAS/WASL-INTERACTING PROTEIN FAMILY, MEMBER 3; WIPF3	644150
MIM612433	C1539278	1q43-q44	DEAFNESS, AUTOSOMAL RECESSIVE 45; DFNB45	449483
MIM612434		16q24.1	CYSTEINE-RICH SECRETORY PROTEIN, LCCL DOMAIN-CONTAINING, 2; CRISPLD2	83716
MIM612435		15q26	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 3A1; SLCO3A1	28232
MIM612436		20q13.33	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 4A1; SLCO4A1	28231
MIM612437	C2676254	12q12	EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	144165
MIM612439		22q13.2	ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 3; ARFGAP3	26286
MIM612441		17q25.3	ALPHA-1,6-@MANNOSYL-GLYCOPROTEIN BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, ISOZYME B; MGAT5B	146664
MIM612442		3q21.1	SECRETION DEFICIENT 22, S. CEREVISIAE, HOMOLOG OF, A; SEC22A	26984
MIM612444	C2676235	17q25	CILIARY DYSKINESIA, PRIMARY, 9; CILD9	64446
MIM612446	C2676232	5p13	COMPLEMENT COMPONENT 6 DEFICIENCY; C6D	729
MIM612447	C2676231	11q23.1	SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	7704
MIM612448	C2676230	8q24.13-q24.22	AGE-RELATED HEARING IMPAIRMENT 1; ARHI1	100233147
MIM612449		2p24.2	GEN1, DROSOPHILA, HOMOLOG OF; GEN1	348654
MIM612450		6q24	HBS1-LIKE PROTEIN; HBS1L	10767
MIM612451		20q13	RING FINGER PROTEIN 114; RNF114	55905
MIM612452		17q21.31	KAT8 REGULATORY NSL COMPLEX SUBUNIT 1; KANSL1	284058
MIM612453		5q23.2	MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 10; MEGF10	84466
MIM612454		15q22.31	MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 11; MEGF11	84465
MIM612455		11p14.2	SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 12; SLC5A12	159963
MIM612456		12p13.2	APOLIPOPROTEIN L DOMAIN-CONTAINING 1; APOLD1	81575
MIM612457		15q24	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 3B; ARID3B	10620
MIM612458		7q22	ACTIN-LIKE 6B; ACTL6B	51412
MIM612459	C2675915	2q14.1	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 13; BMIQ13	100233157
MIM612460	C2675914	16q12.2	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 14; BMIQ14	100233158
MIM612461		8q24	ACTIVITY-REGULATED CYTOSKELETON-ASSOCIATED PROTEIN; ARC	23237
MIM612462	C2675910	20q13.2	PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C	2778
MIM612463	C0033835	 	PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP	2778
MIM612464		5q14.3	ARRESTIN DOMAIN-CONTAINING 3; ARRDC3	57561
MIM612465		13q22.2	TBC1 DOMAIN FAMILY, MEMBER 4; TBC1D4	9882
MIM612466		1p22.2	GUANYLATE-BINDING PROTEIN 4; GBP4	115361
MIM612467		1p22.2	GUANYLATE-BINDING PROTEIN 6; GBP6	163351
MIM612468		1p22.2	GUANYLATE-BINDING PROTEIN 7; GBP7	388646
MIM612469	C2675904	11p13-p12	WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, MENTAL RETARDATION, AND OBESITY SYNDROME; WAGRO	100233159
MIM612470		1p32.3	BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR, ATF-LIKE, 3; BATF3	55509
MIM612471		5p13	ALANINE-GLYOXYLATE AMINOTRANSFERASE 2; AGXT2	64902
MIM612472		14q11.1	METHYLTRANSFERASE-LIKE 3; METTL3	56339
MIM612473		8p21.2	PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN 4	157310
MIM612474	C2675897	1q21.1	CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	100217370
MIM612475	C2675891	1q21.1	CHROMOSOME 1q21.1 DUPLICATION SYNDROME	100217371
MIM612476		14q24	BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR, ATF-LIKE; BATF	10538
MIM612477		3q29	IQ MOTIF-CONTAINING PROTEIN G; IQCG	84223
MIM612478		20q11.22	N-TERMINAL EF-HAND CALCIUM-BINDING PROTEIN 3; NECAB3	63941
MIM612480		3q25.31	TCDD-INDUCIBLE POLY(ADP-RIBOSE) POLYMERASE; TIPARP	25976
MIM612481		7q34	POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 12; PARP12	64761
MIM612482		17q23.2	RING FINGER PROTEIN 43; RNF43	54894
MIM612483		11q14.3-q21	FAT TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 3; FAT3	120114
MIM612484		14q11.2	RIBONUCLEASE A FAMILY 7; RNASE7	84659
MIM612485		14q11.2	RIBONUCLEASE A FAMILY, 8; RNASE8	122665
MIM612486		4q31.3	DACHSOUS, DROSOPHILA, HOMOLOG OF, 2; DCHS2	54798
MIM612487		14q11.2	RING FINGER PROTEIN 31; RNF31	55072
MIM612488		9p13	RING FINGER PROTEIN 38; RNF38	152006
MIM612489		20p13-p12.1	RING FINGER PROTEIN 24; RNF24	11237
MIM612490		2p11.2	RING FINGER PROTEIN 181; RNF181	51255
MIM612491		11p13	APAF1-INTERACTING PROTEIN; APIP	51074
MIM612492		12q23-q24	UBIQUITIN-SPECIFIC PROTEASE 30; USP30	84749
MIM612493		7q36.3	CANOPY 1, ZEBRAFISH, HOMOLOG OF; CNPY1	285888
MIM612494		1p36.13	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 10-LIKE PROTEIN; ARHGEF10L	55160
MIM612495		6q14.1	UBIQUITIN-CONJUGATING ENZYME E2C-BINDING PROTEIN; UBE2CBP	90025
MIM612496		1p36.13	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 19; ARHGEF19	128272
MIM612497		5q13.3	TRANSFORMING GROWTH FACTOR-BETA-INDUCIBLE NUCLEAR PROTEIN 1	10412
MIM612498		14q32.33	ADENYLOSUCCINATE SYNTHASE-LIKE 1; ADSSL1	122622
MIM612499		5q12.1	DIMETHYLADENOSINE TRANSFERASE 1-LIKE; DIMT1L	27292
MIM612500		17q21.1	DEAD BOX POLYPEPTIDE 52; DDX52	11056
MIM612501		15q23	UBIQUITIN-CONJUGATING ENZYME E2Q 2; UBE2Q2	92912
MIM612502		2p25.3	COLLECTIN 11; COLEC11	78989
MIM612503		17q24.2	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 5; ABCA5	23461
MIM612504		17q24.2	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 6; ABCA6	23460
MIM612505		17q24.2	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 8; ABCA8	10351
MIM612506		9p22.1	UBIQUITIN-CONJUGATING ENZYME E2R 2; UBE2R2	54926
MIM612507		17q24.2	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 9; ABCA9	10350
MIM612508		17q24.2	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 10; ABCA10	10349
MIM612509		6p21.1	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 10; ABCC10	89845
MIM612510		7q36	ATP-BINDING CASSETTE, SUBFAMILY F, MEMBER 2; ABCF2	10061
MIM612511		1p31.3	MICRO RNA 101-1; MIRN101-1	406893
MIM612512		9p24.1	MICRO RNA 101-2; MIRN101-2	406894
MIM612513	C2675875	2p16.1-p15	CHROMOSOME 2p16.1-p15 DELETION SYNDROME	100240740
MIM612514	C2675874	7q35-q36	SPECIFIC LANGUAGE IMPAIRMENT 4; SLI4	100233227
MIM612515		2q22.3-q35	DDB1- AND CUL4-ASSOCIATED FACTOR 17; DCAF17	80067
MIM612516		15q24	UVEAL AUTOANTIGEN WITH COILED-COIL DOMAINS AND ANKYRIN REPEATS; UACA	55075
MIM612517		14q21.3	KINTOUN, MEDAKA, HOMOLOG OF; KTU	55172
MIM612518	C2675867	14q21.3	CILIARY DYSKINESIA, PRIMARY, 10; CILD10	55172
MIM612519		6q23.3	SOLUTE CARRIER FAMILY 35, MEMBER D3; SLC35D3	340146
MIM612520	C2675866	12q24.2	DIABETES MELLITUS, INSULIN-DEPENDENT, 20; IDDM20	6927
MIM612521	C2675865	6q25	DIABETES MELLITUS, INSULIN-DEPENDENT, 21; IDDM21	 
MIM612522	C2675864	3p21	DIABETES MELLITUS, INSULIN-DEPENDENT, 22; IDDM22	1234
MIM612523		15q22.31	IQ MOTIF-CONTAINING PROTEIN H: IQCH	64799
MIM612524		6p21	RIBONUCLEASE P/MRP, 21-KD SUBUNIT; RPP21	79897
MIM612525	C2675862	16q24.3	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 5; IHPS5	100270639
MIM612526	C2675861	7q31.1	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	857
MIM612527	C2675860	15q	DIAMOND-BLACKFAN ANEMIA 4; DBA4	6218
MIM612528	C2675859	3q29-qter	DIAMOND-BLACKFAN ANEMIA 5; DBA5	6165
MIM612529	C2675858	11q22.3-q23	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA2; AI2A2	9313
MIM612530	C2675857	1q41-q42	CHROMOSOME 1q41-q42 DELETION SYNDROME	100529242
MIM612531		12q21.1	THAP DOMAIN-CONTAINING PROTEIN 2; THAP2	83591
MIM612532		1p36.31	THAP DOMAIN-CONTAINING PROTEIN 3; THAP3	90326
MIM612533		2q37.3	THAP DOMAIN-CONTAINING PROTEIN 4; THAP4	51078
MIM612534		7q31.1	THAP DOMAIN-CONTAINING PROTEIN 5; THAP5	168451
MIM612535		4q21.1	THAP DOMAIN-CONTAINING PROTEIN 6; THAP6	152815
MIM612536		19q13.12	THAP DOMAIN-CONTAINING PROTEIN 8; THAP8	199745
MIM612537		4q21.22	THAP DOMAIN-CONTAINING PROTEIN 9; THAP9	79725
MIM612538		15q23	THAP DOMAIN-CONTAINING PROTEIN 10; THAP10	56906
MIM612539	C2675528	3q25.31	SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42	9197
MIM612540	C2675527	12q11-q12	MYOPATHY, CONGENITAL, COMPTON-NORTH	1272
MIM612541	C2675526	17q21	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	92579
MIM612542	C2674252	19q13.3	VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; B12QTL1	2524
MIM612543		17q25.3	UBIQUITIN-SPECIFIC PROTEASE 36; USP36	57602
MIM612544		4p16	ACTIN-BINDING LIM PROTEIN FAMILY, MEMBER 2; ABLIM2	84448
MIM612545		7q11.23	WILLIAMS-BEUREN SYNDROME CHROMOSOME REGION 26; WBSCR26	171022
MIM612546		7q11.23	WILLIAMS-BEUREN SYNDROME CHROMOSOME REGION 27; WBSCR27	155368
MIM612547		7q11.23	WILLIAMS-BEUREN SYNDROME CHROMOSOME REGION 28; WBSCR28	135886
MIM612548		7q11.23	TRIPARTITE MOTIF-CONTAINING PROTEIN 50; TRIM50	135892
MIM612549		7q11.23	TRIPARTITE MOTIF-CONTAINING PROTEIN 73; TRIM73	375593
MIM612550		7q11.23	TRIPARTITE MOTIF-CONTAINING PROTEIN 74; TRIM74	378108
MIM612551	C2675525	22q12.3	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO; FSGS4	8542
MIM612552		22q13.33	ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 4; ZBED4	9889
MIM612553		14q32.31	MICRO RNA 370; MIR370	442915
MIM612554	C2675523	5p15.33-p15.2	MYOPIA 16, AUTOSOMAL DOMINANT; MYP16	100270641
MIM612555	C2675520	13q12.3	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2	675
MIM612556	C2675517	3q27	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; ADIPQTL1	9370
MIM612557	C2675516	9q34.1	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 3	100270642
MIM612558	C2675515	6p25	LEUKEMIA, CHRONIC LYMPHOCYTIC SUSCEPTIBILITY TO, 4	100270643
MIM612559	C2675514	11q24.1	LEUKEMIA, CHRONIC LYMPHOCYTIC SUSCEPTIBILITY TO, 5	100270644
MIM612560	C2675513	14q13.3	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12	254170
MIM612561	C0265265	1p22.1	DIAMOND-BLACKFAN ANEMIA 6; DBA6	6125
MIM612562	C2675512	1p36.1-p35	DIAMOND-BLACKFAN ANEMIA 7; DBA7	6135
MIM612563	C2675511	2p25	DIAMOND-BLACKFAN ANEMIA 8; DBA8	6201
MIM612564		2q11.2	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 9; TXNDC9	10190
MIM612565		11q13.1	RAS-ASSOCIATED PROTEIN RAB1B; RAB1B	81876
MIM612566	C2675509	20q13	INFLAMMATORY BOWEL DISEASE 24; IBD24	100270798
MIM612567	C2675508	21q22.1	INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE; IBD25	100270799, 3588
MIM612568		12q22	SPIC TRANSCRIPTION FACTOR; SPIC	121599
MIM612569		10q21.3	CELL DIVISION CYCLE AND APOPTOSIS REGULATOR 1; CCAR1	55749
MIM612570		5q23-q31	FIBRILLIN 2; FBN2	2201
MIM612571	C2675497	5p15.33	LUNG CANCER SUSCEPTIBILITY 3; LNCR3	100271687
MIM612572	C2675496	 	RETINITIS PIGMENTOSA 46; RP46	3420
MIM612573	C2675495	12q24.31	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 1; MPVQTL1	100271867
MIM612574	C2675494	3p21-p13	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 2; MPVQTL2	100271868
MIM612575	C2675493	17q11.2	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 3; MPVQTL3	100271869
MIM612576	C2675492	17p13.3-p13.1	SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 3; SHFLD3	100270800
MIM612577	C2675491	6q21	AMYOTROPHIC LATERAL SCLEROSIS 11; ALS11	9896
MIM612578	C2675490	8q21.13	STATURE QUANTITATIVE TRAIT LOCUS 15; STQTL15	100270801
MIM612579	C2675489	15q22.32	STATURE QUANTITATIVE TRAIT LOCUS 16; STQTL16	100270802
MIM612580	C2675488	16q24.3	MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	1013
MIM612581	C2675487	11q24.2	MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	84623
MIM612582	C2675486	6pter-p24	CHROMOSOME 6pter-p24 DELETION SYNDROME	100270803
MIM612583		16p11.2	SPINSTER, DROSOPHILA, HOMOLOG OF, 1; SPNS1	83985
MIM612584		17p13.2	SPINSTER, DROSOPHILA, HOMOLOG OF, 2; SPNS2	124976
MIM612585		5p15.33	CLPTM1-LIKE PROTEIN; CLPTM1L	81037
MIM612586	C2675485	2q33.1	ANEURYSM, INTRACRANIAL BERRY, 9; ANIB9	100271688
MIM612587	C2675484	8q12.1	ANEURYSM, INTRACRANIAL BERRY, 10; ANIB10	100271689
MIM612588		6q22-q23	BCL2-ASSOCIATED TRANSCRIPTION FACTOR 1; BCLAF1	9774
MIM612589	C2675483	14q22.2	COLORECTAL CANCER, SUSCEPTIBILITY TO, 8; CRCS8	100271690
MIM612590	C2675482	16q22.1	COLORECTAL CANCER, SUSCEPTIBILITY TO, 9; CRCS9	100329169
MIM612591	C2675481	19q13.1	COLORECTAL CANCER, SUSCEPTIBILITY TO, 10; CRCS10	100271691
MIM612592	C2675480	20p12.3	COLORECTAL CANCER, SUSCEPTIBILITY TO, 11; CRCS11	100271692
MIM612593	C2675479	6p21.33	LUNG CANCER SUSCEPTIBILITY 4; LNCR4	100271693
MIM612594	C2675478	10p15.1	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 2; MS2	100271694
MIM612595	C2675477	5p13.2	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 3; MS3	100271695
MIM612596	C2675476	1p36	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 4; MS4	100271696
MIM612597		11q22-q23	CYTOTOXIC AND REGULATORY T-CELL MOLECULE; CRTAM	56253
MIM612598		1p32-p31	RING FINGER PROTEIN 11; RNF11	26994
MIM612599	C2675475	5q31.1-q33.1	PSORIASIS SUSCEPTIBILITY 11; PSORS11	100271719
MIM612600		17p13.3	RNA METHYLTRANSFERASE-LIKE 1; RNMTL1	55178
MIM612601		19q13.4	RET FINGER PROTEIN-LIKE 4A; RFPL4A	342931
MIM612602		3p21.1	RNA-BINDING MOTIF PROTEIN 15B; RBM15B	29890
MIM612603		1q21	LATE CORNIFIED ENVELOPE PROTEIN 1A; LCE1A	353131
MIM612604		1q21	LATE CORNIFIED ENVELOPE PROTEIN 1B; LCE1B	353132
MIM612605		1q21	LATE CORNIFIED ENVELOPE 1C; LCE1C	353133
MIM612606		1q21	LATE CORNIFIED ENVELOPE PROTEIN 1D; LCE1D	353134
MIM612607		1q21	LATE CORNIFIED ENVELOPE PROTEIN 1E; LCE1E	353135
MIM612608		1q21	LATE CORNIFIED ENVELOPE PROTEIN 1F; LCE1F	353137
MIM612609		1q21	LATE CORNIFIED ENVELOPE PROTEIN 2A; LCE2A	353139
MIM612610		1q21	LATE CORNIFIED ENVELOPE PROTEIN 2B; LCE2B	26239
MIM612611		1q21	LATE CORNIFIED ENVELOPE PROTEIN 2C; LCE2C	353140
MIM612612		1q21	LATE CORNIFIED ENVELOPE PROTEIN 2D; LCE2D	353141
MIM612613		1q21	LATE CORNIFIED ENVELOPE PROTEIN 3A; LCE3A	353142
MIM612614		1q21	LATE CORNIFIED ENVELOPE PROTEIN 3B; LCE3B	353143
MIM612615		1q21	LATE CORNIFIED ENVELOPE PROTEIN 3C; LCE3C	353144
MIM612616		1q21	LATE CORNIFIED ENVELOPE PROTEIN 3D; LCE3D	84648
MIM612617		1q21	LATE CORNIFIED ENVELOPE PROTEIN 3E; LCE3E	353145
MIM612618		1q21	LATE CORNIFIED ENVELOPE PROTEIN 4A; LCE4A	199834
MIM612619		1q21	LATE CORNIFIED ENVELOPE PROTEIN 5A; LCE5A	254910
MIM612620		4q13.3	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 6; RASSF6	166824
MIM612621	C2675473	6p21.3	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5; MRD5	8831
MIM612622	C2675472	4q27	DIABETES MELLITUS, INSULIN-DEPENDENT, 23; IDDM23	100271697
MIM612623	C2675471	7q21	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2; MVCD2	2056
MIM612624	C2675470	17q23	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3; MVCD3	1636
MIM612625		6q13	LMBR1 DOMAIN-CONTAINING PROTEIN 1: LMBRD1	55788
MIM612626	C2675463	15q26-qter	CHROMOSOME 15q26-qter DELETION SYNDROME	100271921
MIM612627	C2675462	1p36.12-p35.1	SEIZURES, BENIGN FAMILIAL INFANTILE, 4; BFIS4	100271922
MIM612628	C2675112	2q14.2	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4; MVCD4	3557
MIM612629	C2675461	11q23-q24	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 4; ADIPQTL4	100271698
MIM612630	C2675460	2q11-q13	HAIR MORPHOLOGY 1; HRM1	10913
MIM612631	C2675459	9q34.1	ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	203
MIM612632	C2675458	15q22-q23	USHER SYNDROME, TYPE IH; USH1H	100271837
MIM612633	C2674665	7q21.3	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5; MVCD5	5444
MIM612634	C2675128	6q25.3	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6	6648
MIM612635	C2673520	6p21.3	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7; MVCD7	3077
MIM612636		2q35	CHROMOSOME 2 OPEN READING FRAME 21; C2ORF21	285175
MIM612637	C2675251	3q26.2-q26.33	FEBRILE SEIZURES, FAMILIAL, 10	100271923
MIM612638		19p13.3	NADH DEHYDROGENASE 1 ALPHA SUBCOMPLEX, 11; NDUFA11	126328
MIM612639	C2675249	12q15	INFLAMMATORY BOWEL DISEASE 26; IBD26	100271838
MIM612640		10q22.1	CHROMOSOME 10 OPEN READING FRAME 27; C10ORF27	219793
MIM612641		8p11.2	ANKYRIN 1; ANK1	286
MIM612642	C2675238	11p14.2-q12.3	DEAFNESS, AUTOSOMAL DOMINANT 59; DFNA59	100271924
MIM612643	C2675237	13q12	DEAFNESS, AUTOSOMAL DOMINANT 3B; DFNA3B	10804
MIM612644	C2675236	1p35.1	DEAFNESS, AUTOSOMAL DOMINANT 2B; DFNA2B	2707
MIM612645	C2675235	13q12	DEAFNESS, AUTOSOMAL RECESSIVE 1B; DFNB1B	10804
MIM612646		7p21.1	METASTASIS-ASSOCIATED GENE IN COLON CANCER 1; MACC1	346389
MIM612647		6q22.1	RADIAL SPOKE HEAD 4, CHLAMYDOMONAS, HOMOLOG OF, A; RSPH4A	345895
MIM612648		6p21.1	RADIAL SPOKE HEAD 9, CHLAMYDOMONAS, HOMOLOG OF; RSPH9	221421
MIM612649	C2675229	6q22.1	CILIARY DYSKINESIA, PRIMARY, 11; CILD11	345895
MIM612650	C2675228	6p21.1	CILIARY DYSKINESIA, PRIMARY, 12; CILD12	221421
MIM612651	C2675227	6p12.3	ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	22858
MIM612653	C2675212	17q21-q22	SPHEROCYTOSIS, TYPE 4; SPH4	6521
MIM612654		12q24.1	TRICHOPLEIN; TCHP	84260
MIM612655		6p24.1	TBC1 DOMAIN FAMILY, MEMBER 7; TBC1D7	51256
MIM612656	C2675211	5p13	EPISODIC ATAXIA, TYPE 6; EA6	6507
MIM612657	C2675210	4p15.3	CONE-ROD DYSTROPHY 12; CORD12	8842
MIM612658		6p21.1	TIGHT JUNCTION-ASSOCIATED PROTEIN 1; TJAP1	93643
MIM612659		6q22.2	REGULATORY FACTOR X, 6; RFX6	222546
MIM612660		15q21.3	REGULATORY FACTOR X, 7; RFX7	64864
MIM612661		17p13	WD REPEAT-CONTAINING PROTEIN ANTISENSE TO TP53; WRAP53	55135
MIM612662		12q21.1	TBC1 DOMAIN FAMILY, MEMBER 15; TBC1D15	64786
MIM612663		5q31.2	TRAF-INTERACTING PROTEIN WITH FORKHEAD-ASSOCIATED DOMAIN, FAMILY MEMBER B; TIFAB	497189
MIM612664		12p12	RAS-LIKE AND ESTROGEN-REGULATED GROWTH INHIBITOR; RERG	85004
MIM612665		19q13.31	TESTIS-EXPRESSED GENE 101; TEX101	83639
MIM612666		1q32.1	DUAL SERINE/THREONINE AND TYROSINE PROTEIN KINASE; DSTYK	25778
MIM612667		2q37.1	HOLLIDAY JUNCTION RECOGNITION PROTEIN; HJURP	55355
MIM612668		12p13.2	TASTE RECEPTOR, TYPE 2, MEMBER 43; TAS2R43	259289
MIM612669		12p13.2	TASTE RECEPTOR, TYPE 2, MEMBER 31; TAS2R31	259290
MIM612671	C2675207	6p21	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4	100272225, 10786
MIM612672		2p23.3	RAS-ASSOCIATED PROTEIN RAB10; RAB10	10890
MIM612673		9q33.2	RAS-ASSOCIATED PROTEIN RAB14; RAB14	51552
MIM612674	C2675204	20p11.21	POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT; PHARC	26090
MIM612675		15q25.2	SMALL CAJAL BODY-SPECIFIC RNA 15; SCARNA15	677778
MIM612676		4p15.31	QUINOID DIHYDROPTERIDINE REDUCTASE; QDPR	5860
MIM612677		1q21-q23	PYRIN AND HIN DOMAIN FAMILY, MEMBER 1; PYHIN1	149628
MIM612678		1q21	TRINUCLEOTIDE REPEAT-CONTAINING GENE 4; TNRC4	11189
MIM612679		18q12	BRUNO-LIKE 4; BRUNOL4	56853
MIM612680		19p13	BRUNO-LIKE 5; BRUNOL5	60680
MIM612681		15q24	BRUNO-LIKE 6; BRUNOL6	60677
MIM612682		1p36.22	DORSAL REPULSIVE AXON GUIDANCE PROTEIN	374946
MIM612683		17p12	TEKTIN 3; TEKT3	64518
MIM612684		14q24.3	ISTHMIN 2, ZEBRAFISH, HOMOLOG OF; ISM2	145501
MIM612685		19p13.2	KIAA1543 GENE; KIAA1543	57662
MIM612686		11p15.1	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 7; PLEKHA7	144100
MIM612687		5q21.1	RGM DOMAIN FAMILY, MEMBER B; RGMB	285704
MIM612688		3q29	RING FINGER PROTEIN 168; RNF168	165918
MIM612689		19p13.3	TIGHT JUNCTION PROTEIN 3; TJP3	27134
MIM612690	C2675192	15q15	SPHEROCYTOSIS, TYPE 5; SPH5	2038
MIM612691	C2675191	6q16.3-q22.1	POLYMICROGYRIA, BILATERAL OCCIPITAL	100294715
MIM612692	C3150207	17q23	AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE; AGM6	974
MIM612693		9q34.11	UBIQUITIN-RELATED MODIFIER 1, S. CEREVISIAE, HOMOLOG OF; URM1	81605
MIM612694		19q13.33	ATP-BINDING DOMAIN PROTEIN 3; ATPBD3	90353
MIM612695		5q31	VAULT RNA 1-1; VTRNA1-1	56664
MIM612696		5q31	VAULT RNA 1-2; VTRNA1-2	56663
MIM612697		5q31	VAULT RNA 1-3; VTRNA1-3	56662
MIM612698		18q12.2	MICRO RNA 187; MIR187	406963
MIM612699		22q11.21	RIMS-BINDING PROTEIN 3; RIMBP3	85376
MIM612700		22q11.21	RIMS-BINDING PROTEIN 3B; RIMBP3B	440804
MIM612701		22q11.21	RIMS-BINDING PROTEIN 3C; RIMBP3C	150221
MIM612702	C2675188	10q24	HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	2253
MIM612703	C2675187	1p32	MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE; MCPH7	6491
MIM612704		2p11.2	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 1; RGPD1	400966
MIM612705		2p11.2	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 2; RGPD2	729857
MIM612706		2q12.3-q13	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 3; RGPD3	653489
MIM612707		2q12.3-q13	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 4; RGPD4	285190
MIM612708		2q12.3-q13	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 5; RGPD5	84220
MIM612709		2q12.3-q13	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 6; RGPD6	729540
MIM612711		2q12.3	GRIP AND COILED-COIL DOMAIN-CONTAINING PROTEIN 2; GCC2	9648
MIM612712	C2675186	14q23.3	LEBER CONGENITAL AMAUROSIS 13; LCA13	145226
MIM612713	C2675185	4p12-q12	KAHRIZI SYNDROME; KHRZ	79644
MIM612714	C2675184	20q11.21	EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL HYPEROSTOSIS	84701
MIM612715	C2675183	12q21-q23	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 2; DUH2	100301525
MIM612716	C0268468	2p14-p12	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	6697
MIM612717	C2675180	10q21.1	MYOPIA 15, AUTOSOMAL DOMINANT; MYP15	100294716
MIM612718	C2675179	15q15.3	ARGININE:GLYCINE AMIDINOTRANSFERASE DEFICIENCY	2628
MIM612719		11q22.3-q23.3	6-@PYRUVOYL-TETRAHYDROPTERIN SYNTHASE; PTS	5805
MIM612720		5q11.2	DEAH BOX POLYPEPTIDE 29; DHX29	54505
MIM612721		2q35	REGULATED ENDOCRINE-SPECIFIC PROTEIN 18	389075
MIM612722		8p21.1	ELONGATION PROTEIN 3, S. CEREVISIAE, HOMOLOG OF; ELP3	55140
MIM612723		2p21	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY H, MEMBER 2; PLEKHH2	130271
MIM612724		9q22.3	ALDOLASE B, FRUCTOSE-BISPHOSPHATE; ALDOB	229
MIM612725		9q33.3	PROTEIN PHOSPHATASE 6, CATALYTIC SUBUNIT; PPP6C	5537
MIM612727	C2674801	16q23	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 13; BMND13	100294717
MIM612728	C2674800	1p33-p32	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 14; BMND14	100294718
MIM612729	C2674799	8q23	LEAN BODY MASS QUANTITATIVE TRAIT LOCUS 1; LBMQTL1	100294719
MIM612730		20q13.13	SOLUTE CARRIER FAMILY 9 (SODIUM/HYDROGEN EXCHANGER), MEMBER 8; SLC9A8	23315
MIM612732		3q12	COPROPORPHYRINOGEN OXIDASE; CPOX	1371
MIM612733		22q12	THO COMPLEX, SUBUNIT 5; THOC5	8563
MIM612734		10q24	TLX1 DIVERGENT GENE	100038246
MIM612735		6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-3; HLA-DRB3	3125
MIM612736	C0574080	19p13.3	GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	2593
MIM612737	C2674783	7p15	STATURE QUANTITATIVE TRAIT LOCUS 17; STQTL17	100301526
MIM612738		3q13.2	SOLUTE CARRIER FAMILY 9, MEMBER 10; SLC9A10	285335
MIM612739		6q15-q16.2	SPERM ACROSOME-ASSOCIATED PROTEIN 1; SPACA1	81833
MIM612740	C0268328	9q34	PORPHYRIA, ACUTE HEPATIC	210
MIM612741		16q24.3	SNAIL, DROSOPHILA, HOMOLOG OF, 3; SNAI3	333929
MIM612742		1q31.3	MICRO RNA 181A1; MIR181A1	406995
MIM612743		9q33.3	MICRO RNA 181A2; MIR181A2	406954
MIM612744		1q31.3	MICRO RNA 181B1; MIR181B1	406955
MIM612745		9q33.3	MICRO RNA 181B2; MIR181B2	406956
MIM612746		19p13.3	MICRO RNA 181C; MIR181C	406957
MIM612747		22q12.1	TUFTELIN-INTERACTING PROTEIN 11; TFIP11	24144
MIM612748		10p11.23	LYSOZYME-LIKE 2; LYZL2	119180
MIM612749		17q12	SPERM ACROSOME-ASSOCIATED PROTEIN 3; SPACA3	124912
MIM612750		3p21.33	LYSOZYME-LIKE 4; LYZL4	131375
MIM612751		17q11.2	LYSOZYME-LIKE 6; LYZL6	57151
MIM612752		5q31.3	CXXC FINGER PROTEIN 5; CXXC5	51523
MIM612753		18q21.32	COLLAGEN AND CALCIUM-BINDING EGF DOMAIN-CONTAINING PROTEIN 1; CCBE1	147372
MIM612754		10q26.3	GLUTAREDOXIN 3; GLRX3	10539
MIM612755		12q24.13	MITOCHONDRIAL DISTRIBUTION AND MORPHOLOGY 20, YEAST, HOMOLOG OF	80018
MIM612756		17q23.3	TESTICULAR CELL ADHESION MOLECULE 1; TCAM1	146771
MIM612757		8q24.3	GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED HIGH DENSITY LIPOPROTEIN-BINDING PROTEIN 1; GPIHBP1	338328
MIM612758		4p15.32	TRANSMEMBRANE ANTERIOR POSTERIOR TRANSFORMATION 1; TAPT1	202018
MIM612759	C0233778	2q24.1	SYNESTHESIA	100301527
MIM612760		3p21	SNF-RELATED KINASE; SNRK	54861
MIM612761		4q22-q23	SWI/SNF-RELATED, MATRIX-ASSOCIATED ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, DEAD/H BOX-CONTAINING, 1; SMARCAD1	56916
MIM612762		2p25	SUPPRESSOR OF TY 7-LIKE; SUPT7L	9913
MIM612763		1q24-q25	TRANSCRIPTIONAL ADAPTOR 1-LIKE; TADA1L	117143
MIM612764		3q21.3	ISY1 SPLICING FACTOR, S. CEREVISIAE, HOMOLOG OF; ISY1	57461
MIM612765		22q12.2	SFI1, YEAST, HOMOLOG OF; SFI1	9814
MIM612766		19p13.11	CHROMOSOME 19 OPEN READING FRAME 62; C19ORF62	29086
MIM612767		3q25.2	DEAH BOX POLYPEPTIDE 36; DHX36	170506
MIM612768		4q32.1	FOLLICULIN-INTERACTING PROTEIN 2; FNIP2	57600
MIM612769		11q13.1	NONCODING RNA 84; NCRNA00084	283131
MIM612770		22q12	PHOSPHATIDYLSERINE DECARBOXYLASE; PISD	23761
MIM612771		15q15	DUAL OXIDASE MATURATION FACTOR 1; DUOXA1	90527
MIM612772		15q15	DUAL OXIDASE MATURATION FACTOR 2; DUOXA2	405753
MIM612773		19q13.2	BASAL CELL ADHESION MOLECULE; BCAM	4059
MIM612774		12p13.2	TASTE RECEPTOR, TYPE 2, MEMBER 46; TAS2R46	259292
MIM612775	C1423873	8p11, 8p11.23	CONE-ROD DYSTROPHY 9; CORD9	8754
MIM612778		3p21.3-p21.2	SET DOMAIN-CONTAINING PROTEIN 2; SETD2	29072
MIM612779		1p22	DIHYDROPYRIMIDINE DEHYDROGENASE; DPYD	1806
MIM612780	C2748572	1q23.2	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE; SESAMES	3766
MIM612781	C2748571	7p15-p14, 17q22-q24	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B	2688, 2692
MIM612782	C2748568	12q24	IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 1	84876
MIM612783	C2748557	11p15.5	IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 2	6786
MIM612784		15q15.3	HUNTINGTIN-INTERACTING PROTEIN K	25764
MIM612786		10p11.2	CYCLIN Y; CCNY	219771
MIM612787		2p16.1	PSEUDOURIDYLATE SYNTHASE 10; PUS10	150962
MIM612788		6p25	FORKHEAD BOX Q1; FOXQ1	94234
MIM612789	C2748554	8p22-p21.3	DEAFNESS, AUTOSOMAL RECESSIVE 71; DFNB71	100302513
MIM612790		5q13.2	RGNEF, MOUSE, HOMOLOG OF	64283
MIM612791		6p22.1	ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 3; ZKSCAN3	80317
MIM612792		8q22	PHOSPHATIDYLSERINE SYNTHASE 1; PTDSS1	9791
MIM612793		8q22	PHOSPHATIDYLSERINE SYNTHASE 2; PTDSS2	81490
MIM612794	C2748552	15q14	ATRIAL SEPTAL DEFECT 5; ASD5	70
MIM612795	C2748551	11q12-q13.1	POLYUNSATURATED FATTY ACIDS PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; PUFAQTL1	100302559
MIM612796	C2748550	13q13.3	INFLAMMATORY BOWEL DISEASE 27; IBD27	100302059
MIM612797	C2675071	15q21-q23	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12	3990
MIM612799		16p13.1-p11.2	GLUTAMYL-tRNA SYNTHETASE 2; EARS2	124454
MIM612800		13q34	CYSTEINYL-tRNA SYNTHETASE 2; CARS2	79587
MIM612801		1q41	ISOLEUCYL-tRNA SYNTHETASE 2; IARS2	55699
MIM612802		6p21.3	VALYL-tRNA SYNTHETASE 2; VARS2	57176
MIM612803		11q14.1	ASPARAGINYL-tRNA SYNTHETASE 2; NARS2	79731
MIM612804		19q13.2	SERYL-tRNA SYNTHETASE 2; SARS2	54938
MIM612805		1q21.2	THREONYL-tRNA SYNTHETASE 2; TARS2	80222
MIM612806		1q21.1	G PROTEIN-COUPLED RECEPTOR 89B; GPR89B	51463
MIM612807		19q13.2	LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 1; LRFN1	57622
MIM612808		6p21.2	LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 2; LRFN2	57497
MIM612809		19q13.2	LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 3; LRFN3	79414
MIM612810		11q13.1	LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 4; LRFN4	78999
MIM612811		14q21.2	LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 5; LRFN5	145581
MIM612812		5q35.2	PROFILIN 3; PFN3	345456
MIM612813	C2748544	15q26.1	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	176
MIM612814		4q11-q12	SPERMATOGENESIS-ASSOCIATED PROTEIN 18; SPATA18	132671
MIM612815		11p15.1	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 13; ZDHHC13	54503
MIM612816		17q21.33	UTP18, S. CEREVISIAE, HOMOLOG OF; UTP18	51096
MIM612817		12q21.2	KRR1, YEAST, HOMOLOG OF; KRR1	11103
MIM612818		15q15.1	NUCLEOLAR AND SPINDLE-ASSOCIATED PROTEIN 1; NUSAP1	51203
MIM612819		12q24.33	NUCLEOLAR COMPLEX-ASSOCIATED PROTEIN 4, S. CEREVISIAE, HOMOLOG OF; NOC4L	79050
MIM612820		15q22	NEUROPLASTIN; NPTN	27020
MIM612821		1q21.1	G PROTEIN-COUPLED RECEPTOR 89A; GPR89A	653519
MIM612822		12q23.2-q23.3	UTP20, S. CEREVISIAE, HOMOLOG OF; UTP20	27340
MIM612823		11q21	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1D; TAF1D	79101
MIM612824		22q12	SEC14-LIKE 3; SEC14L3	266629
MIM612825		22q12	SEC14-LIKE 4; SEC14L4	284904
MIM612826		14q22.1	SPHINGOSINE-1-PHOSPHATE PHOSPHATASE 1; SGPP1	81537
MIM612827		2q36.1	SPHINGOSINE-1-PHOSPHATE PHOSPHATASE 2; SGPP2	130367
MIM612828		2p22.2	CCAAT/ENHANCER-BINDING PROTEIN, ZETA; CEBPZ	10153
MIM612829		5q13	RAS-ASSOCIATED PROTEIN RAB3C; RAB3C	115827
MIM612830		1p36.1	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 3; DHRS3	9249
MIM612831		4q21	17-@BETA-HYDROXYSTEROID DEHYDROGENASE XI; HSD17B11	51170
MIM612832		19q13.33	17-@BETA-HYDROXYSTEROID DEHYDROGENASE XIV; HSD17B14	51171
MIM612833		14q23.1	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 7; DHRS7	51635
MIM612834		11q23.3	PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY B, MEMBER 1; PHLDB1	23187
MIM612835		3q25.31	PHOSPHOLIPASE C, ETA-1; PLCH1	23007
MIM612836		1p36.32	PHOSPHOLIPASE C, ETA-2; PLCH2	9651
MIM612837		16q13	COQ9, S. CEREVISIAE, HOMOLOG OF; COQ9	57017
MIM612838	C2748541	19q13.1	BRUGADA SYNDROME 5; BRGDA5	6324
MIM612839		4q24	TET ONCOGENE FAMILY, MEMBER 2; TET2	54790
MIM612840	C2748536	11q12	LEUKOCYTE ADHESION DEFICIENCY, TYPE III; LAD3	83706
MIM612841	C2748535	1p21.1-q21.3	HYPOTRICHOSIS 5; HYPT5	100302560
MIM612842		22q12.3	RASD FAMILY, MEMBER 2; RASD2	23551
MIM612844		17p13.1	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 3; SENP3	26168
MIM612845		3q29	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 5; SENP5	205564
MIM612846		3q12.3	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 7; SENP7	57337
MIM612847	C2748515	10q22-q24	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, PAKISTANI TYPE	9060
MIM612848		19q12-q13.2	SUCCINATE DEHYDROGENASE COMPLEX ASSEMBLY FACTOR 1; SDHAF1	644096
MIM612849		4q12	UBIQUITIN-SPECIFIC PEPTIDASE 46; USP46	64854
MIM612850		6p25.2	TUBULIN, BETA-2B; TUBB2B	347733
MIM612851	C2748508	14q11.2	NARCOLEPSY 5, SUSCEPTIBILITY TO; NRCLP5	100302514
MIM612852	C2748507	2q14.2	OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	3557
MIM612853	C2748506	2p14-p13	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 7	100302561
MIM612854		9q34.3	SEC16, S. CEREVISIAE, HOMOLOG OF, A; SEC16A	9919
MIM612855		1q25.2	SEC16, S. CEREVISIAE, HOMOLOG OF, B; SEC16B	89866
MIM612856		9q33.1	ASTROTACTIN 2; ASTN2	23245
MIM612857		10q22.3	PLACENTA-SPECIFIC GENE 9; PLAC9	219348
MIM612858	C2748505	8q24.31	OROFACIAL CLEFT 12; OFC12	100302515
MIM612859		3q13.3	T-CELL IMMUNORECEPTOR WITH IMMUNOGLOBULIN AND ITIM DOMAINS; TIGIT	201633
MIM612860		9q34.3	QUIESCIN Q6 SULFHYDRYL OXIDASE 2; QSOX2	169714
MIM612861		5q35.2	NOP16, S. CEREVISIAE, HOMOLOG OF; NOP16	51491
MIM612862	C2748504	6p21.3	PULMONARY HYPERTENSION, CHRONIC THROMBOEMBOLIC, WITHOUT DEEP VEIN THROMBOSIS, SUSCEPTIBILITY TO	100302516
MIM612863	C3150215	6q25, 6q24-q25	CHROMOSOME 6q24-q25 DELETION SYNDROME	100505391, 23118
MIM612864		15q15	PHOSPHOLIPASE A2, GROUP IVD; PLA2G4D	283748
MIM612865		9q34.11	PHOSPHATIDYLINOSITOL 4-PHOSPHATE-5-KINASE-LIKE 1; PIP5KL1	138429
MIM612866		1p21.3	ALG14, S. CEREVISIAE, HOMOLOG OF; ALG14	199857
MIM612869		10q26	ATTRACTIN-LIKE 1; ATRNL1	26033
MIM612870		6q14	PLECKSTRIN HOMOLOGY DOMAIN-INTERACTING PROTEIN; PHIP	55023
MIM612871		1p35.2	Na+/K+ TRANSPORTING ATPase-INTERACTING 1; NKAIN1	79570
MIM612872		8q12.13	Na+/K+ TRANSPORTING ATPase-INTERACTING 3; NKAIN3	286183
MIM612873		20q13.33	Na+/K+ TRANSPORTING ATPase-INTERACTING 4; NKAIN4	128414
MIM612874	C2752073	11pter-p13	ERYTHROCYTE AMP DEAMINASE DEFICIENCY	272
MIM612875		1q12-q21.3	GONADOTROPIN-RELEASING HORMONE RECEPTOR 2; GNRHR2	114814
MIM612876	C1421994	 	SPINOCEREBELLAR ATAXIA 9; SCA9	140451
MIM612877	C2752072	18q12.1-q12.2	CARDIOMYOPATHY, DILATED, 1BB; CMD1BB	1829
MIM612878		11q22.3	EXOPHILIN 5; EXPH5	23086
MIM612879		9q21.11	MAM DOMAIN-CONTAINING 2; MAMDC2	256691
MIM612880		11q14	SYNAPTOTAGMIN-LIKE 2; SYTL2	54843
MIM612881	C2752071	5q14.3-q15	HETEROTOPIA, PERIVENTRICULAR, ASSOCIATED WITH CHROMOSOME 5q DELETION	100302682
MIM612882	C2752070	6q21	MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 2; MENAQ2	100302562
MIM612883	C2752069	9q31.2	MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 3; MENAQ3	100302563
MIM612884	C2752068	19q13.4	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 2; MENOQ2	100302517
MIM612885	C2752067	20p12.3	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 3; MENOQ3	100302518
MIM612886	C2752066	5q35.2	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 4; MENOQ4	100302519
MIM612887		4q21.1	SEPTIN 11; SEPT11	55752
MIM612888		1p22.2	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8B; LRRC8B	23507
MIM612889		1p22.2	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8C; LRRC8C	84230
MIM612890		1p22.2	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8D; LRRC8D	55144
MIM612891		19p13.2	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8E; LRRC8E	80131
MIM612892	C2752065	6p22.1	STATURE QUANTITATIVE TRAIT LOCUS 18; STQTL18	100302683
MIM612893	C2752064	6p21.31	STATURE QUANTITATIVE TRAIT LOCUS 19; STQTL19	100302684
MIM612894	C2752063	13q14.3	STATURE QUANTITATIVE TRAIT LOCUS 20; STQTL20	100302685
MIM612895		17p13.3	NUCLEOREDOXIN; NXN	64359
MIM612896		17q11.2	RAD52 MOTIF-CONTAINING PROTEIN 1; RDM1	201299
MIM612897		16p11.2	SEPTIN 1; SEPT1	1731
MIM612898		9q34.13	COENZYME Q4, S. CEREVISIAE, HOMOLOG OF; COQ4	51117
MIM612899	C2752062	3q13.3-q21	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 8; EIG8	846
MIM612900	C2752061	9p24.3	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2; CPSQ2	23189
MIM612901		20q13.3	TUBULIN, BETA-1; TUBB1	81027
MIM612902		9q34	LIPOCALIN 8; LCN8	138307
MIM612903		9q34	LIPOCALIN 9; LCN9	392399
MIM612904		9q34	LIPOCALIN 10; LCN10	414332
MIM612905		9q34	LIPOCALIN 12; LCN12	286256
MIM612906		6q24.3	RAS-ASSOCIATED PROTEIN RAB32; RAB32	10981
MIM612907		3p25.1	tRNA NUCLEOTIDYLTRANSFERASE, CCA-ADDING, 1; TRNT1	51095
MIM612908	C1852127	6p24	KERATOSIS PALMOPLANTARIS STRIATA II; PPKS2	1832
MIM612909		2q21.1	RAS-ASSOCIATED PROTEIN RAB6C; RAB6C	84084
MIM612910		17p13	PHD FINGER PROTEIN 23; PHF23	79142
MIM612911		3p21.31	NADH DEHYDROGENASE 1 ALPHA SUBCOMPLEX, ASSEMBLY FACTOR 3; NDUFAF3	25915
MIM612912		17q11.2	TRANSMEMBRANE PROTEIN 97; TMEM97	27346
MIM612914		19q13.2	MEDIATOR COMPLEX SUBUNIT 29; MED29	55588
MIM612915		6p21.1	MEDIATOR COMPLEX SUBUNIT 20; MED20	9477
MIM612918	C2752042	 	CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	5290
MIM612919		7p11.2	LanC-LIKE 2; LANCL2	55915
MIM612920		21q22.3	THROMBOSPONDIN-TYPE LAMININ G DOMAIN AND EAR REPEATS; TSPEAR	54084
MIM612921	C2752041	2q35	THREE M SYNDROME 2; 3M2	23363
MIM612922	C2752040	1q32	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2	4179
MIM612923	C2752039	4q25	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3	3426
MIM612924	C2752038	6p21.3	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4	629
MIM612925	C2752037	19p13.3-p13.2	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5	718
MIM612926	C2752036	20p11.2	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6	7056
MIM612927		7p14.3	AVL9, S. CEREVISIAE, HOMOLOG OF; AVL9	23080
MIM612928		19q13.42	ISOCHORISMATASE DOMAIN-CONTAINING 2; ISOC2	79763
MIM612929	C2752035	19q13.31-q33	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 3	100302686
MIM612930		2q36.3	PHOSPHOTYROSINE INTERACTION DOMAIN-CONTAINING 1; PID1	55022
MIM612931		7p13-p12.3	PHOSPHOGLYCERATE MUTASE 2; PGAM2	5224
MIM612932	C2752027	17pter-p12	GLYCOGEN STORAGE DISEASE XIII; GSD13	2027
MIM612933	C2752022	11p15.4	GLYCOGEN STORAGE DISEASE XI; GSD11	3939
MIM612934		1p31	GLYCOGEN STORAGE DISEASE XIV; GSD14	5236
MIM612935		17p11.2	MYOSIN PHOSPHATASE RHO-INTERACTING PROTEIN; MPRIP	23164
MIM612936	C2752008	7q22.1	SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50	9179
MIM612937	C2752007	1q12-q21	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Io; CDG1O	54344
MIM612938	C2752001	16q12.2	GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLY DEATH; GDFD	79068
MIM612939		19q13.42	HEAT-SHOCK 70-KD PROTEIN-BINDING PROTEIN 1; HSPBP1	23640
MIM612940	C2751987	17q25.3	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	5831
MIM612941		2q23.3	PRECURSOR mRNA-PROCESSING FACTOR 40, S. CEREVISIAE, HOMOLOG OF, A; PRPF40A	55660
MIM612942		1q22	RAS-ASSOCIATED PROTEIN RAB25; RAB25	57111
MIM612943	C2751986	7p15.3	RETINITIS PIGMENTOSA 42; RP42	55975
MIM612944		6q27	RIBONUCLEASE T2; RNASET2	8635
MIM612945		19q13.2-q13.3	RAS-ASSOCIATED PROTEIN RAB4B; RAB4B	53916
MIM612949	C2751855	2q24	HYPOMYELINATION, GLOBAL CEREBRAL	8604
MIM612950	C2751854	20q13	PSORIASIS SUSCEPTIBILITY 12; PSORS12	 
MIM612951	C2751843	6q27	LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	8635
MIM612952	C2749659	20q11.2	AICARDI-GOUTIERES SYNDROME 5; AGS5	25939
MIM612953	C2751842	22q13.1	PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	8398
MIM612954	C2751831	10q25.2-q26.2	MYOPATHY, MYOFIBRILLAR 6, MFM6	9531
MIM612955	C2751830	20q11.2	LONG QT SYNDROME 12; LQT12	6640
MIM612956	C2751829	7q36.2	VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2; VF2	1804
MIM612957	C2751828	1p36.12	VITAMIN B6 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; B6QTL1	100302718
MIM612958		17q22-q24.2	TRANSLATIONAL ACTIVATOR OF MITOCHONDRIALLY ENCODED CYTOCHROME c OXIDASE SUBUNIT I; TACO1	51204
MIM612959		8q22.1	EPITHELIAL SPLICING REGULATORY PROTEIN 1; ESRP1	54845
MIM612960		16q22.1	EPITHELIAL SPLICING REGULATORY PROTEIN 2; ESRP2	80004
MIM612961	C2751826	13q11-q12	MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3	2254
MIM612962		16p12.2	DYNACTIN 5; DCTN5	84516
MIM612963		8p12-p11	DYNACTIN 6; DCTN6	10671
MIM612964	C2751825	9q33	PREMATURE OVARIAN FAILURE 7; POF7	2516
MIM612965	C2751824	9q33	46,XY SEX REVERSAL 3; SRXY3	2516
MIM612966		20q13.3	RAS-ASSOCIATED PROTEIN RAB22A; RAB22A	57403
MIM612967	C2751823	17q23.2-q25.1	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 15; BMIQ15	100302719
MIM612968	C2751822	1p34.3-p32.2	CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 3; CATC3	100302720
MIM612969		16p13	TIGGER TRANSPOSABLE ELEMENT-DERIVED GENE 7; TIGD7	91151
MIM612970		1q21.1	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 23; NBPF23	100302292
MIM612971		10q24.3	PDZ DOMAIN-CONTAINING 7; PDZD7	79955
MIM612972		2q37.1	TIGGER TRANSPOSABLE ELEMENT-DERIVED GENE 1; TIGD1	200765
MIM612973		4q22.1	TIGGER TRANSPOSABLE ELEMENT-DERIVED GENE 2; TIGD2	166815
MIM612974		8q24.12	DEP DOMAIN-CONTAINING PROTEIN 6; DEPDC6	64798
MIM612975	C0751509	12p12.1-p11.23	SHORT SLEEPER	79365
MIM612976	C2751814	3p26.1-p25.1	AGE-RELATED HEARING IMPAIRMENT 2; ARHI2	100302721
MIM612977		4q12	DCN1 DOMAIN-CONTAINING PROTEIN 4; DCUN1D4	23142
MIM612978		14q12	PRECEREBELLIN 3; CBLN3	643866
MIM612979		20q13.12	SYS1 GOLGI-LOCALIZED INTEGRAL MEMBRANE PROTEIN, S. CEREVISIAE, HOMOLOG OF; SYS1	90196
MIM612980		15q24	IMP3, S. CEREVISIAE, HOMOLOG OF; IMP3	55272
MIM612981		2q21.1	IMP4, S. CEREVISIAE, HOMOLOG OF; IMP4	92856
MIM612982		11p15.5	MICRO RNA 210; MIR210	406992
MIM612983		7q22	MICRO RNA 106B; MIR106B	406900
MIM612984		7q22	MICRO RNA 93; MIR93	407050
MIM612985		16q12.2	IROQUOIS HOMEOBOX PROTEIN 3; IRX3	79191
MIM612986		12q23-q24.1	E1A-LIKE INHIBITOR OF DIFFERENTIATION 3; EID3	493861
MIM612987		10q26.13	NON-SMC ELEMENT 4, S. CEREVISIAE, HOMOLOG OF, A; NSMCE4A	54780
MIM612988		11q14.1-q21	TRANSMEMBRANE PROTEIN 126A; TMEM126A	84233
MIM612989	C2751812	11q14.1-q21	OPTIC ATROPHY 7; OPA7	84233
MIM612990		20q11.21	ADDITIONAL SEX COMBS-LIKE 1; ASXL1	171023
MIM612991		2p23.3	ADDITIONAL SEX COMBS-LIKE 2; ASXL2	55252
MIM612992		1p36	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 3; NBPF3	84224
MIM612993		3q12.1	FILAMIN A-INTERACTING PROTEIN 1-LIKE; FILIP1L	11259
MIM612994		4p15.33	RAS-ASSOCIATED PROTEIN 28; RAB28	9364
MIM612995		 	TRANSFER RNA VALINE 2; TRNAV2	7240
MIM612996		 	TRANSFER RNA LYSINE 2; TRNAK2	790966
MIM612997	C2751811	11q13.1	SPERMATOGENIC FAILURE 7; SPGF7	117144, 117155, 161497
MIM612998	C2751807	6q25	EMERY-DREIFUSS MUSCULAR DYSTROPHY 4, AUTOSOMAL DOMINANT; EDMD4	23345
MIM612999	C2751805	14q23	EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT; EDMD5	23224
MIM613000	C2751804	17q12-q21	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL; FNEPPK	3868
MIM613002	C2751803	4q35	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 2	7098
MIM613003	C2751802	12q21.1	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 7	121278
MIM613004		4p16.3	HUNTINGTIN; HTT	3064
MIM613006	C2751697	10q23.31	DIABETES MELLITUS, INSULIN-DEPENDENT, 24; IDDM24	100303715
MIM613007	C2751696	6p21.3	BILIARY CIRRHOSIS, PRIMARY, 2; PBC2	100303716
MIM613008	C2751695	1p31.2	BILIARY CIRRHOSIS, PRIMARY, 3; PBC3	100303717
MIM613009		4p15.2	O-PHOSPHOSERINE tRNA-SELENOCYSTEINE tRNA SYNTHASE; SEPSECS	51091
MIM613010		9q21.1	RIBOFLAVIN KINASE; RFK	55312
MIM613011	C2751686	5q32	LYMPHOPROLIFERATIVE SYNDROME, EBV-ASSOCIATED, AUTOSOMAL, 1	3702
MIM613012		3q21.3	UROCANASE DOMAIN-CONTAINING PROTEIN 1; UROC1	131669
MIM613013	C2751682	4p12	NEUROBLASTOMA, SUSCEPTIBILITY TO, 2; NBLST2	8929
MIM613014	C2751681	2p23	NEUROBLASTOMA, SUSCEPTIBILITY TO, 3; NBLST3	238
MIM613015	C2751680	6p22	NEUROBLASTOMA, SUSCEPTIBILITY TO, 4; NBLST4	100306937
MIM613016	C2751679	2q35	NEUROBLASTOMA, SUSCEPTIBILITY TO, 5; NBLST5	100306938
MIM613017	C2751678	1q21.1	NEUROBLASTOMA, SUSCEPTIBILITY TO, 6; NBLST6	100306939
MIM613018		16q22.1-q22.3	TYROSINE AMINOTRANSFERASE; TAT	6898
MIM613019		11q13.1	SUCCINATE DEHYDROGENASE COMPLEX ASSEMBLY FACTOR 2; SDHAF2	54949
MIM613020		1p36.1	CATARACT, AGE-RELATED CORTICAL, 2; ARCC2	1969
MIM613021	C2751666	12p13	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2	6337
MIM613022		7p14-p13	OXOGLUTARATE DEHYDROGENASE; OGDH	4967
MIM613023		1q44	CENTROSOMAL PROTEIN, 170-KD; CEP170	9859
MIM613024	C2751665	6p21.33	FOLLICULAR LYMPHOMA, SUSCEPTIBILITY TO, 1; FL1	100306940, 8915
MIM613025	C2751663	15q13	SCHIZOPHRENIA 13; SCZD13	100329170
MIM613026	C2751651	19q13.11	CHROMOSOME 19q13.11 DELETION SYNDROME	100306978
MIM613027	C2751643	16p12.1-p11.2	GLYCOGEN STORAGE DISEASE IXc; GSD9C	5261
MIM613028	C2751642	10q23.31	GLIOMA SUSCEPTIBILITY 2; GLM2	5728
MIM613029	C2751641	13q12.3	GLIOMA SUSCEPTIBILITY 3; GLM3	675
MIM613030	C2751640	9p21.3	GLIOMA SUSCEPTIBILITY 5; GLM5	100415894
MIM613031	C2751639	20q13.33	GLIOMA SUSCEPTIBILITY 6; GLM6	100415895
MIM613033	C2751637	5p15.33	GLIOMA SUSCEPTIBILITY 8; GLM8	100316847
MIM613036		9q34.3	PEPTIDASE, MITOCHONDRIAL PROCESSING, ALPHA; PMPCA	23203
MIM613037		9q34.3	INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 72-KD; INPP5E	56623
MIM613038	C2751608	3p11	PITUITARY HORMONE DEFICIENCY, COMBINED, 1; CPHD1	5449
MIM613039		1q21	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 1-LIKE; CHD1L	9557
MIM613040		8q24.21	COILED-COIL DOMAIN-CONTAINING PROTEIN 26; CCDC26	137196
MIM613041		12p13.31	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A1; FAM90A1	55138
MIM613042		8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A3; FAM90A3	389611
MIM613043		8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A5; FAM90A5	441315
MIM613044		8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A7; FAM90A7	441317
MIM613045		8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A8; FAM90A8	441324
MIM613046		8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A9; FAM90A9	441327
MIM613047		8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A10; FAM90A10	441328
MIM613048		8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A12; FAM90A12	645879
MIM613049		8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A13; FAM90A13	441314
MIM613050		8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A14; FAM90A14	645651
MIM613051		8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A15; FAM90A15	389630
MIM613052		8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A18; FAM90A18	441326
MIM613053		8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A19; FAM90A19	728753
MIM613054		8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A20; FAM90A20	728430
MIM613055	C2751607	16q22	ATRIAL FIBRILLATION, FAMILIAL, 8; ATFB8	100306979
MIM613056		7q34	LUC7, S. CEREVISIAE, HOMOLOG OF, 2; LUC7L2	51631
MIM613057		12q14.1	MICRO RNA 26A2; MIR26A2	407016
MIM613058	C2751606	1q42	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 2; BCC2	100307119
MIM613059	C2751605	5p15.33	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 3; BCC3	100307120
MIM613060	C2751603	1p36.3	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10	2563
MIM613061	C2751602	12q13	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 4; BCC4	100307121
MIM613062	C2751601	9p21	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 5; BCC5	100307122
MIM613063	C2751600	7q32	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 6; BCC6	100307123
MIM613064	C2751599	11q13.5	DERMATITIS, ATOPIC, 7; ATOD7	100310755
MIM613065	C0023449	10q21, 22q11.21	LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL	100310785, 613
MIM613066		11q24-q25	PBX/KNOTTED 1 HOMEOBOX 2; PKNOX2	63876
MIM613067	C2751593	7p12.2	LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 2	100310786
MIM613068	C2751584	11q13.3-q13.5	NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	2348
MIM613069		6q26	PHD FINGER PROTEIN 10; PHF10	55274
MIM613070	C2751567	22q13	LIVER FAILURE, INFANTILE, TRANSIENT; LFIT	55687
MIM613071	C2751324	16p13-p12	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3	6340
MIM613072		18q12-q21	LIPOXYGENASE HOMOLOGY DOMAIN-CONTAINING 1; LOXHD1	125336
MIM613073	C2751322	20q11.2-q13.1	METAPHYSEAL ANADYSPLASIA 2; MANDP2	4318
MIM613074	CN035509	7q32.2	DEAFNESS, AUTOSOMAL DOMINANT 50; DFNA50	407053
MIM613075	C2751321	20p11.22	MACROCEPHALY, ALOPECIA, CUTIS LAXA, AND SCOLIOSIS	54453
MIM613076	C2751320	16p13.3-p13.12	MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARING LOSS, AND DEVELOPMENTAL DELAY	2671
MIM613077	C2751319	8q23.1	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 5; PEOA5	50484
MIM613078	C2751318	5q31	NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD	10111
MIM613079	C2746083	18q12-q21	DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	125336
MIM613080	C2751317	17q25	46,XY SEX REVERSAL 5; SRXY5	84733
MIM613081		6p22.3	LYSINE-SPECIFIC DEMETHYLASE 1B; KDM1B	221656
MIM613082		16q24.1	ATPase, Ca(2+)-TRANSPORTING, TYPE 2C, MEMBER 2; ATP2C2	9914
MIM613083		21q22.11	LISTERIN E3 UBIQUITIN PROTEIN LIGASE 1; LTN1	26046
MIM613084		2p24	MYELIN TRANSCRIPTION FACTOR 1-LIKE; MYT1L	23040
MIM613085	C1428921	14q24.3	GLAUCOMA 3, PRIMARY CONGENITAL, C; GLC3C	399565
MIM613086	C2751316	14q24	GLAUCOMA 3, PRIMARY CONGENITAL, D; GLC3D	4053
MIM613087	C2751315	4q32-q33	ATRIAL SEPTAL DEFECT 6; ASD6	7092
MIM613088	C2751314	9q21	PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO, 2	100312955
MIM613090	C2751312	1p36	BARTTER SYNDROME, TYPE 4B	1187, 1188
MIM613091	C2751311	11q13.5	ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	79659
MIM613092	C2751310	1q32	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 2; HNFJ2	5972
MIM613093	C2751308	10q24	CONE DYSTROPHY 4; COD4	5146
MIM613094	C2751307	8q22.1	MICROPHTHALMIA, ISOLATED 4; MCOP4	392255
MIM613095	C2751306	4q21-q23	POLYCYSTIC KIDNEY DISEASE 2; PKD2	5311
MIM613096	C2936879	12q23-q24	SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	791228
MIM613097	C2751297	11q12	TOOTH AGENESIS, SELECTIVE, 6; STHAG6	4054
MIM613098	C2751296	16q24.3	INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC	4157
MIM613099	C2751295	16q24.3	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5; CMM5	4157
MIM613100	C2751294	19q13.3	GLAUCOMA 1, OPEN ANGLE, O; GLC1O	4909
MIM613101	C2751293	 	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5	6813
MIM613102	C2751292	18q12.1	HYPOTRICHOSIS AND RECURRENT SKIN VESICLES	1825
MIM613103		12q24.23	SERINE/ARGININE REPETITIVE MATRIX PROTEIN 4; SRRM4	84530
MIM613104		9q34.2	CHROMOSOME 9 OPEN READING FRAME 7; C9ORF7	11094
MIM613105	C2751290	6p21.1-cen	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2	5961
MIM613106	C2751289	22q12	VERTIGO, BENIGN RECURRENT, 2; BRV2	100313948
MIM613107	C2751288	1p22	NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT; SCN2	2672
MIM613108	C0341024	12p13.2-p12.3	CANDIDIASIS, FAMILIAL, 4; CANDF4	64581
MIM613109		5q31.3-q33.1	GM2 ACTIVATOR; GM2A	2760
MIM613110		20q11.2-q12	BLADDER CANCER-ASSOCIATED PROTEIN; BLCAP	10904
MIM613111		20q13.1	CATHEPSIN A; CTSA	5476
MIM613112	C2751259	20q13.3	MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED	81027
MIM613113		17q11.2	NEUROFIBROMIN 1; NF1	4763
MIM613114		5p15.1	FAMILY WITH SEQUENCE SIMILARITY 134, MEMBER B; FAM134B	54463
MIM613115	C2751092	5p15.1	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B	54463
MIM613116	C2751090	3q27	THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY; THPH11	3273
MIM613117		6q15	SMALL NUCLEOLAR RNA, C/D BOX, 50A; SNORD50A	26799
MIM613118	C0272375	1q23-q25	ANTITHROMBIN III DEFICIENCY; AT3D	462
MIM613119	C2751089	11q13-q14	BRUGADA SYNDROME 6; BRGDA6	10008
MIM613120	C2751088	11q23.3	BRUGADA SYNDROME 7; BRGDA7	55800
MIM613121		1p32-p31	NEXILIN, RAT, HOMOLOG OF; NEXN	91624
MIM613122	C2751084	1p32-p31	CARDIOMYOPATHY, DILATED, 1CC; CMD1CC	91624
MIM613123	C2751083	15q24-q25	BRUGADA SYNDROME 8; BRGDA8	10021
MIM613125		11p15.3	NUCLEAR RECEPTOR-INTERACTING PROTEIN 3; NRIP3	56675
MIM613126		1p13.1	PROLINE/SERINE-RICH COILED-COIL PROTEIN 1; PSRC1	84722
MIM613127		11q13.4	CHORDIN-LIKE 2; CHRDL2	25884
MIM613128		10q24.33	OLIGONUCLEOTIDE/OLIGOSACCHARIDE-BINDING FOLD-CONTAINING PROTEIN 1; OBFC1	79991
MIM613129		17p13.1	CONSERVED TELOMERE MAINTENANCE COMPONENT 1; CTC1	80169
MIM613130		17q25.1	CHROMOSOME 17 OPEN READING FRAME 106; C17ORF106	100134934
MIM613131		5q11.2	MICRO RNA 449A; MIR449A	554213
MIM613132		5q11.2	MICRO RNA 449B; MIR449B	693123
MIM613133		1p13.2	TETRASPANIN 2; TSPAN2	10100
MIM613134		15q24.3	TETRASPANIN 3; TSPAN3	10099
MIM613135	C2751067	5p15.3	PARKINSONISM-DYSTONIA, INFANTILE; PKDYS	6531
MIM613136		4q23	TETRASPANIN 5; TSPAN5	10098
MIM613137		12p13.32	TETRASPANIN 9; TSPAN9	10867
MIM613138		7q31	TETRASPANIN 12; TSPAN12	23554
MIM613139		7p21.1	TETRASPANIN 13; TSPAN13	27075
MIM613140		10q22.1	TETRASPANIN 15; TSPAN15	23555
MIM613141		7q11.23	DELTEX, DROSOPHILA, HOMOLOG OF, 2; DTX2	113878
MIM613142		12q13.3	DELTEX, DROSOPHILA, HOMOLOG OF, 3; DTX3	196403
MIM613143		3q21	DTX3-LIKE; DTX3L	151636
MIM613144	C2751055	 	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 3; CACD3	100653393
MIM613145	C2751054	1q21-q23	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 14; SLEB14	100322878
MIM613146		15q25.1	MICRO RNA 184; MIR184	406960
MIM613147		1q32.2	MICRO RNA 205; MIR205	406988
MIM613148	C2751053	11q23.3	INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE; IBD28	3587
MIM613149		9p21	CDKN2B ANTISENSE RNA; CDKN2BAS	100048912
MIM613150	C3150411	14q24.3	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2; MDDGA2	29954
MIM613151	C3150412	1p34-p33	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 3; MDDGB3	55624
MIM613152	C2751052	9q31	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4; MDDGB4	2218
MIM613153	C3150413	19q13.3	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	79147
MIM613154	C3150414	22q12.3-q13.1	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6; MDDGA6	9215
MIM613155	C3150415	9q34.1	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	10585
MIM613156	C3150416	14q24.3	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2; MDDGB2	29954
MIM613157	C3150417	1p34-p33	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3	55624
MIM613158	C3150418	14q24.3	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2	29954
MIM613159	C3150419	22q13.31-q13.33	NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1; NPHPL1	63929
MIM613160		12p13.3	VON WILLEBRAND FACTOR; VWF	7450
MIM613161	C1291512	22q11.2	BETA-UREIDOPROPIONASE DEFICIENCY	51733
MIM613162	C2680447	10q24.3-q25.1	SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	100322879
MIM613163	C0342708	16p13.3	GABA-TRANSAMINASE DEFICIENCY	18
MIM613164	C2751012	1q32	PARKINSON DISEASE 16; PARK16	100359403
MIM613165		17q25.3	CALCIUM-ACTIVATED NUCLEOTIDASE 1; CANT1	124583
MIM613166		4q31.23	DOUBLECORTIN-LIKE KINASE 2; DCLK2	166614
MIM613167		3p22.3	DOUBLECORTIN-LIKE KINASE 3; DCLK3	85443
MIM613168		17pter-p12	SERPIN PEPTIDASE INHIBITOR, CLADE F, MEMBER 2; SERPINF2	5345
MIM613169		3p21.31	KELCH DOMAIN-CONTAINING PROTEIN 8B; KLHDC8B	200942
MIM613170		1p34.1	TETRASPANIN 1; TSPAN1	10103
MIM613171		10q25.2	RNA-BINDING MOTIF PROTEIN 20; RBM20	282996
MIM613172	C2750995	10q25.2	CARDIOMYOPATHY, DILATED, 1DD; CMD1DD	282996
MIM613173		1p31.1	NEURONAL GROWTH REGULATOR 1; NEGR1	257194
MIM613174	C2750805	5p13	CHROMOSOME 5p13 DUPLICATION SYNDROME	100379202
MIM613175		17q22	CHROMOSOME 17 OPEN READING FRAME 71; C17ORF71	55181
MIM613176		19q13.31	CHROMOSOME 19 OPEN READING FRAME 61; C19ORF61	56006
MIM613177	C2750804	19q13.1-q13.2	CUTIS LAXA WITH SEVERE PULMONARY, GASTROINTESTINAL, AND URINARY ABNORMALITIES	8425
MIM613178		18q21.1	KIAA0427 GENE; KIAA0427	9811
MIM613179	C0268125	14q13.1	PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	4860
MIM613180	C2750798	22q11	POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	51807
MIM613181		1q21.2	BolA, E. COLI, HOMOLOG OF, 1; BOLA1	51027
MIM613182		16p11.2	BolA, E. COLI, HOMOLOG OF, 2; BOLA2	552900
MIM613183		2p13.1	BolA, E. COLI, HOMOLOG OF, 3; BOLA3	388962
MIM613184		11p15.4	TRIPARTITE MOTIF-CONTAINING PROTEIN 68; TRIM68	55128
MIM613185		Chr.4	MICRO RNA 95; MIR95	407052
MIM613186		11q24.1	MICRO RNA 100; MIR100	406892
MIM613187		5q34	MICRO RNA 103-1; MIR103-1	406895
MIM613188		20p13	MICRO RNA 103-2; MIR103-2	406896
MIM613189		10q23.31	MICRO RNA 107; MIR107	406901
MIM613190		16q24.1	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 50; LRRC50	123872
MIM613191		10q22.2	DUAL-SPECIFICITY PHOSPHATASE 13; DUSP13	51207
MIM613192	C2750791	8q24.3	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	83696
MIM613193	C2750790	16q24.1	CILIARY DYSKINESIA, PRIMARY, 13; CILD13	123872
MIM613194	C2750788	11q13	RETINITIS PIGMENTOSA 50; RP50	7439
MIM613195	C2750787	15q24	WEILL-MARCHESANI-LIKE SYNDROME	170691
MIM613196		2p15-p13	EWING TUMOR-ASSOCIATED ANTIGEN 1; ETAA1	54465
MIM613197		12q24.13	TRAF-TYPE ZINC FINGER DOMAIN-CONTAINING 1; TRAFD1	10906
MIM613198		19q13.42	SUPPRESSOR OF VARIEGATION 4-20, DROSOPHILA, HOMOLOG OF, 2; SUV420H2	84787
MIM613199		16p13.1-p12	TAO KINASE 2; TAOK2	9344
MIM613200		 	PDS5, REGULATOR OF COHESION MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, A; PDS5A	23244
MIM613201		16.13.3	CHROMOSOME TRANSMISSION FIDELITY FACTOR 18, S. CEREVISIAE, HOMOLOG OF; CHTF18	63922
MIM613202		 	CHROMOSOME TRANSMISSION FIDELITY FACTOR 8, S. CEREVISIAE, HOMOLOG OF; CHTF8	54921
MIM613203		8q24.12	DEFECTIVE IN SISTER CHROMATID COHESION 1, S. CEREVISIAE, HOMOLOG OF; DSCC1	79075
MIM613204	C2750786	12q13	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	3679
MIM613205	C2750785	 	MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED	4000
MIM613206	C2750784	1q41-q42	SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	57165
MIM613207	C2750782	9q33	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 8; ASRT8	100415896
MIM613208		3p25	XPC GENE	7508
MIM613209		6q25.3	TRANSMEMBRANE PROTEIN 181; TMEM181	57583
MIM613210		9q34.3	WD REPEAT-CONTAINING PROTEIN 85; WDR85	92715
MIM613211	C2750771	15q21.3	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3; AI2A3	256764
MIM613212		17q21.31	ALANYL-tRNA SYNTHETASE DOMAIN-CONTAINING 1; AARSD1	80755
MIM613213		22q13.31-qter	CYTOCHROME b5 REDUCTASE 3; CYB5R3	1727
MIM613214		15q21.3	WD REPEAT-CONTAINING PROTEIN 72; WDR72	256764
MIM613215	C2750748	17p13.3	CHROMOSOME 17p13.3 DUPLICATION SYNDROME	100379203
MIM613216	C2750747	15q13-q14	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C	4308
MIM613217	C2750737	2p21	DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL; DIAR5	4072
MIM613218		18q23	CYTOCHROME b5, TYPE A (MICROSOMAL); CYB5A	1528
MIM613219	C2750735	7p15-p13	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 2; FGQTL2	100379216
MIM613220		2p25.3	TRANSMEMBRANE PROTEIN 18; TMEM18	129787
MIM613221		11q12.1	MITOCHONDRIAL CARRIER HOMOLOG 2; MTCH2	23788
MIM613222		4p13	GLUCOSAMINE-6-PHOSPHATE DEAMINASE 2; GNPDA2	132789
MIM613223	C2750733	4p14	LEPROSY, SUSCEPTIBILITY TO, 5; LPRS5	7096
MIM613224	C2750732	1p13.2	NOONAN SYNDROME 6; NS6	4893
MIM613225	C2750514	6p25-p24	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	2162
MIM613226		19q13.32	ZINC FINGER PROTEIN 296; ZNF296	162979
MIM613227	C2750509	8q11-q12	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 3; CAMRQ3	767
MIM613228		4q32-q33	ASPARTYLGLUCOSAMINIDASE; AGA	175
MIM613229	C0040953	13q31	TRICHOTILLOMANIA; TTM	114798
MIM613230		19cen-q13.11	PEPTIDASE D; PEPD	5184
MIM613231		14q32.33	KINESIN FAMILY MEMBER 26A; KIF26A	26153
MIM613232		19q13.12	RNA-BINDING MOTIF PROTEIN 42; RBM42	79171
MIM613233	C2750485	11q21-q22	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 3; FGQTL3	100379217
MIM613234		3q26.3	NEUTRAL CHOLESTEROL ESTER HYDROLASE 1; NCEH1	57552
MIM613235	C2750481	1q31-q32.1	FACTOR XIII, B SUBUNIT, DEFICIENCY OF	2165
MIM613236		17p11.2	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 18; KCNJ18	100134444
MIM613237	C2750475	14q32.33	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5; FSGS5	64423
MIM613238	C2750474	2q36.1-q36.3	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 3; SPDA3	100379218
MIM613239	C2750473	17p11.2	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	100134444
MIM613240		2q32.1	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 1C; PPP1R1C	151242
MIM613242		6q24.3-q25.3	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14C; PPP1R14C	81706
MIM613243	C2750472	3p21.3-p14.3	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13; CMH13	7134
MIM613244	C2750471	2p21	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 8; HNPCC8	4072
MIM613245		19q13.3-q13.4	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 12C; PPP1R12C	54776
MIM613246		12q13.2	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 1A; PPP1R1A	5502
MIM613247		19p13.3	PERILIPIN 4; PLIN4	729359
MIM613248		19p13.3	PERILIPIN 5; PLIN5	440503
MIM613249		10p12.3	ENDOGENOUS BORNA-LIKE N ELEMENT-CONTAINING PROTEIN 1; EBLN1	340900
MIM613250		3p14-p13	ENDOGENOUS BORNA-LIKE N ELEMENT-CONTAINING PROTEIN 2; EBLN2	55096
MIM613251	C2750467	14q12	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14; CMH14	4624
MIM613252	C2750466	14q12	CARDIOMYOPATHY, DILATED, 1EE; CMD1EE	4624
MIM613254	C1860707	12q14	TUBEROUS SCLEROSIS 2; TSC2	3458
MIM613255	C2750459	10q22.1-q23	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15; CMH15	7414
MIM613256		15q15.1	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14D; PPP1R14D	54866
MIM613257		1q32.1	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 15B; PPP1R15B	84919
MIM613258		18q21.	CHROMOSOME 18 OPEN READING FRAME 54; C18ORF54	162681
MIM613259		1q21	REPETIN; RPTN	126638
MIM613260		1q21	KERATINOCYTE PROLINE-RICH PROTEIN; KPRP	448834
MIM613261		15q21.3	PROTOGENIN, CHICKEN, HOMOLOG OF; PRTG	283659
MIM613262		15q21.3	RIBOSOMAL PROTEIN L24 DOMAIN-CONTAINING PROTEIN 1; RSL24D1	51187
MIM613263		6q15	SMALL NUCLEOLAR RNA HOST GENE 5; SNHG5	387066
MIM613264		6q15	SMALL NUCLEOLAR RNA, C/D BOX; SNORD50B	692088
MIM613265	C2750457	20q13.2-q13.3	WAARDENBURG SYNDROME, TYPE 4B; WS4B	1908
MIM613266	C2750452	22q13	WAARDENBURG SYNDROME, TYPE 4C; WS4C	6663
MIM613267	C2750451	18q21.2-q21.3	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3	100380873
MIM613268	C2750450	20p13-p12	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD4	83959
MIM613269	C2750449	5q33.1-q35.2	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 5; FECD5	100380874
MIM613270	C2750448	10p11.2	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6; FECD6	6935
MIM613271	C2750447	9p24.1-p22.1	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 7; FECD7	100380875
MIM613272		1q41	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 3; KCTD3	51133
MIM613273		9q32	CHROMOSOME 9 OPEN READING FRAME 80; C9ORF80	58493
MIM613274		18q12.2	MOLYBDENUM COFACTOR SULFURASE; MOCOS	55034
MIM613275		20q11.22-q12	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 16B; PPP1R16B	26051
MIM613276		16q13	CHROMOSOME 16 OPEN READING FRAME 57; C16ORF57	79650
MIM613277		11q13	TRANSMEMBRANE PROTEIN 216; TMEM216	51259
MIM613278		16p13.3	SLX4, S. CEREVISIAE, HOMOLOG OF; SLX4	84464
MIM613279		14q31.3	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 14: ZC3H14	79882
MIM613280	C2750442	 	HYPERMANGANESEMIA WITH DYSTONIA, POLYCYTHEMIA, AND CIRRHOSIS; HMDPC	55532
MIM613281		16q12.1	SORTING NEXIN 20; SNX20	124460
MIM613282	C2750440	22q13	FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1; NAFLD1	100380876
MIM613283		4p13	GLUTAREDOXIN, CYSTEINE-RICH, 1; GRXCR1	389207
MIM613284	C2750092	22q12-q13	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HCHGQ3	100381206
MIM613285	C1414017	4p13	DEAFNESS, AUTOSOMAL RECESSIVE 25; DFNB25	389207
MIM613286	C2750091	19q13.4	CARDIOMYOPATHY, DILATED, 1FF; CMD1FF	7137
MIM613287	C2750090	16q22	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N; CMT2N	16
MIM613288		16p11.2	TRIPARTITE MOTIF-CONTAINING PROTEIN 72; TRIM72	493829
MIM613289		13q21	ATAXIN 8; ATXN8	724066
MIM613290	C2750088	6p22.3	HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO; CIHL	100381207
MIM613291	C2750087	13q33	BILE ACID MALABSORPTION, PRIMARY; PBAM	6555
MIM613292		1q31.3	DENN/MADD DOMAIN-CONTAINING PROTEIN 1B; DENND1B	163486
MIM613293		5q35.1	SH3 AND PX DOMAINS-CONTAINING PROTEIN 2B; SH3PXD2B	285590
MIM613294		19q13.32	SUMO1-ACTIVATING ENZYME, SUBUNIT 1; SAE1	10055
MIM613295		19q12	UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 2; UBA2	10054
MIM613296		8q22.1	LYSOSOME-ASSOCIATED PROTEIN, TRANSMEMBRANE 4, BETA; LAPTM4B	55353
MIM613297		5p15.2	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 6; MARCH6	10299
MIM613298		15q26.1	CHROMOSOME 15 OPEN READING FRAME 42; C15ORF42	90381
MIM613299		4q22.1	FAMILY WITH SEQUENCE SIMILARITY 13, MEMBER A; FAM13A	10144
MIM613300		4q22.1	FAM13A OPPOSITE STRAND; FAM13AOS	285512
MIM613301		7q31.32	FEZ FAMILY ZINC FINGER PROTEIN 1; FEZF1	389549
MIM613302		7q22.1	AlkB, E. COLI, HOMOLOG OF, 4; ALKBH4	54784
MIM613303		17p11.2	AlkB, E. COLI, HOMOLOG OF, 5; ALKBH5	54890
MIM613304		19q13.12	AlkB, E. COLI, HOMOLOG OF, 6; ALKBH6	84964
MIM613305		19p13.3	AlkB, E. COLI, HOMOLOG OF, 7; ALKBH7	84266
MIM613306		11q22.3	AlkB, E. COLI, HOMOLOG OF, 8; ALKBH8	91801
MIM613307	C2750082	9q34.3, 9q34.3	DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	286262
MIM613308	C2750081	6p	DIAMOND-BLACKFAN ANEMIA 9; DBA9	6204
MIM613309	C2750080	12q	DIAMOND-BLACKFAN ANEMIA 10; DBA10	6231
MIM613310	C2750079	7q31	EXUDATIVE VITREORETINOPATHY 5; EVR5	23554
MIM613311		6p25.1	LYR MOTIF-CONTAINING PROTEIN 4; LYRM4	57128
MIM613312	C2750078	6q22-q23	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	5167
MIM613313	C1865616	19q13	HEMOCHROMATOSIS, TYPE 2B; HFE2B	57817
MIM613314		2q35	RIBOSOMAL PROTEIN L37A; RPL37A	6168
MIM613315		12q13.2	RIBOSOMAL PROTEIN L41; RPL41	6171
MIM613316		10q11.22-q11.23	WD REPEAT- AND FYVE DOMAIN-CONTAINING PROTEIN 4; WDFY4	57705
MIM613317		14q11.2	DDB1- AND CUL4-ASSOCIATED FACTOR 11; DCAF11	80344
MIM613318	C2750077	8q22.3	MIYOSHI MUSCULAR DYSTROPHY 2; MMD2	100505381
MIM613319	C2750076	11p14.3	MIYOSHI MUSCULAR DYSTROPHY 3; MMD3	203859
MIM613321		12q12	GLUCOSIDE XYLOSYLTRANSFERASE 1; GXYLT1	283464
MIM613322		3p13	GLUCOSIDE XYLOSYLTRANSFERASE 2; GXYLT2	727936
MIM613323		10q11.22	FERM AND PDZ DOMAINS-CONTAINING PROTEIN 2; FRMPD2	143162
MIM613324		13q12.12	SPERMATOGENESIS-ASSOCIATED PROTEIN 13; SPATA13	221178
MIM613325	C2750074	19p13.2	RHABDOID TUMOR PREDISPOSITION SYNDROME 2; RTPS2	6597
MIM613326		8q22	DIHYDROPYRIMIDINASE; DPYS	1807
MIM613327	C2750069	17q21	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	284119
MIM613328	C2750068	15q11-q21.1	ROIFMAN-CHITAYAT SYNDROME	100462676
MIM613329	C2750067	7q21.3-q22	PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY	5054
MIM613330	C2750066	4p16.1	SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	579
MIM613331		4q32.2-q32.3	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 1; MARCH1	55016
MIM613332		19p13.2	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 2; MARCH2	51257
MIM613333		5q23.2	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 3; MARCH3	115123
MIM613334		2q24.2	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 7; MARCH7	64844
MIM613335		10q11.21	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 8; MARCH8	220972
MIM613336		12q14.1	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 9; MARCH9	92979
MIM613337		17q23.2	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 10; MARCH10	162333
MIM613338		5p15.1	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 11; MARCH11	441061
MIM613339	C0393729	10q21.3-q22.3	EPILEPSY, HOT WATER, 1; HWE1	100415903
MIM613340	C3150536	4q24-q28	EPILEPSY, HOT WATER, 2; HWE2	100415904
MIM613341	C2750063	4q31	LEBER CONGENITAL AMAUROSIS 14; LCA14	9227
MIM613344		7q34	KIAA1549 GENE; KIAA1549	57670
MIM613345	C2750061	17q23.1-q25.3	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2	6329
MIM613346		16p13.12	SHISA, XENOPUS, HOMOLOG OF, 9; SHISA9	729993
MIM613347	C3150546	13q12.3	PANCREATIC CANCER, SUSCEPTIBILITY TO, 2	675
MIM613348	C3150547	16p12	PANCREATIC CANCER, SUSCEPTIBILITY TO, 3	79728
MIM613349		10q26	ORNITHINE AMINOTRANSFERASE; OAT	4942
MIM613350		20p13	SOLUTE CARRIER FAMILY 52 (RIBOFLAVIN TRANSPORTER), MEMBER 3; SLC52A3	113278
MIM613351		6q22-q24	RHO GTPase-ACTIVATING PROTEIN 18; ARHGAP18	93663
MIM613352		3q25.32	ARGININE/SERINE-RICH COILED-COIL PROTEIN 1; RSRC1	51319
MIM613353	C3150596	5q32	MONONEUROPATHY OF THE MEDIAN NERVE, MILD; MNMN	79628
MIM613354		9q34.3	TAPERIN; TPRN	286262
MIM613355	C3150607	17q23.1-q23.2	CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	100415941
MIM613356		7p14.3	TLR4 INTERACTOR WITH LEUCINE-RICH REPEATS	9865
MIM613357		9q34.1	FIBRINOGEN C DOMAIN-CONTAINING PROTEIN 1; FIBCD1	84929
MIM613358		19q13.33	ALDEHYDE DEHYDROGENASE 16 FAMILY, MEMBER A1; ALDH16A1	126133
MIM613359		2q23.1-q23.2	LY6/PLAUR DOMAIN-CONTAINING PROTEIN 6; LYPD6	130574
MIM613360		1p13.3	DAMAGE-REGULATED AUTOPHAGY MODULATOR 2; DRAM2	128338
MIM613361		6q22.3	CHROMOSOME 6 OPEN READING FRAME 192; C6ORF192	116843
MIM613362		14q32.31	CDK2-INTERACTING PROTEIN; CINP	51550
MIM613363		9q34.11	WD REPEAT-CONTAINING PROTEIN 34; WDR34	89891
MIM613364	C2680445	11p14.1-p11.2	SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41	100359402
MIM613365		5q21.1	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 6A1; SLCO6A1	133482
MIM613366		4q21.3	SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 6; SLC10A6	345274
MIM613367		4q21.22	LIN54, C. ELEGANS, HOMOLOG OF; LIN54	132660
MIM613368		11q13	CARNOSINE SYNTHASE 1; CARNS1	57571
MIM613369		17q23.3	DEAD BOX POLYPEPTIDE 42; DDX42	11325
MIM613370	C3150617	11p15.5	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10	3630
MIM613371	C2936793	4q34.3-q35.1	SPINOCEREBELLAR ATAXIA 30; SCA30	100359393
MIM613372		6q16.1	KIAA0776 GENE; KIAA0776	23376
MIM613373		3q27.1	YEATS DOMAIN-CONTAINING PROTEIN 2; YEATS2	55689
MIM613374		16p11.2	COILED-COIL DOMAIN-CONTAINING PROTEIN 101; CCDC101	112869
MIM613375	C3150618	8p23-p22	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11; MODY11	640
MIM613376	C3150619	5q11.2	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C	8988
MIM613377		5q32	SH3 DOMAIN-CONTAINING RING FINGER PROTEIN 2; SH3RF2	153769
MIM613378		13q32.3	AIG2-LIKE DOMAIN-CONTAINING PROTEIN 1; A2LD1	87769
MIM613379		5p15.2	CARBOXYMETHYLENEBUTENOLIDASE-LIKE PROTEIN; CMBL	134147
MIM613380		10q26.13	H6 FAMILY HOMEOBOX 3; HMX3	340784
MIM613381		21q22.3	CYSTATHIONINE BETA-SYNTHASE; CBS	875
MIM613382	C3150644	12p12.1-p11.2	BRACHYDACTYLY, TYPE E2; BDE2	5744
MIM613383		22q13.1	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 54; ANKRD54	129138
MIM613384		3q25.31	CYCLIN L1; CCNL1	57018
MIM613385	C3150649	20q11.22-q11.23	AUTOIMMUNE DISEASE, SYNDROMIC MULTISYSTEM	83737
MIM613386		13q12.3	PROTEASOME MATURATION PROTEIN; POMP	51371
MIM613387	C3150651	11q23	FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2; NAFLD2	100462725
MIM613388	C3150652	5q35	FANCONI RENOTUBULAR SYNDROME 2; FRTS2	6569
MIM613389		12p12	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1C1; SLCO1C1	53919
MIM613390	C3150653	17q22	FANCONI ANEMIA, COMPLEMENTATION GROUP O; FANCO	5889
MIM613391	C3150654	12q21.2	DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	374462
MIM613392	C3160740	17p12-q11.2	DEAFNESS, AUTOSOMAL RECESSIVE 85; DFNB85	100359399
MIM613393	C3150657	2p13	BIRBECK GRANULE DEFICIENCY	50489
MIM613394		3p21.32	MICRO RNA 138-1; MIR138-1	406929
MIM613395		16q13	MICRO RNA 138-2; MIR138-2	406930
MIM613396		21q22.2	DOWN SYNDROME CRITICAL REGION GENE 8; DSCR8	84677
MIM613397		12q14	ADVILLIN; AVIL	10677
MIM613398	C3150658	12p11	WARSAW BREAKAGE SYNDROME	1663
MIM613399	C3150659	17q22	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3; BROVCA3	5889
MIM613400		2p25.3	ACIREDUCTONE DIOXYGENASE 1; ADI1	55256
MIM613401		14q24.3	VPS33B-INTERACTING PROTEIN, APICAL-BASOLATERAL POLARITY REGULATOR; VIPAR	63894
MIM613402	C3150667	19q13.4	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 10; EIEE10	11284
MIM613403		2q11	TRANSMEMBRANE PROTEIN 127; TMEM127	55654
MIM613404	C3150672	14q24.3	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2; ARCS2	63894
MIM613405		9q34.11	MICRO RNA 2861; MIR2861	100422910
MIM613406	C3150674	15q24	CHROMOSOME 15q24 DELETION SYNDROME	100502567
MIM613407	C3150676	13q14.11	LEPROSY, SUSCEPTIBILITY TO, 6; LPRS6	100499166
MIM613408		13q14.11	COILED-COIL DOMAIN-CONTAINING PROTEIN 122; CCDC122	160857
MIM613409		13q14.11	CHROMOSOME 13 OPEN READING FRAME 31; C13ORF31	144811
MIM613410	C3150677	3q24	AUTISM, SUSCEPTIBILITY TO, 16; AUTS16	285195
MIM613411	C3150678	13q34	OGUCHI DISEASE 2	6011
MIM613412	C3150679	5q22	ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	100499167
MIM613413		7p21.3	TRANSMEMBRANE PROTEIN 106B; TMEM106B	54664
MIM613414		 	INTERLEUKIN 17 RECEPTOR E-LIKE; IL17REL	400935
MIM613415		15q15	CREATINE KINASE, MITOCHONDRIAL 1A; CKMT1A	548596
MIM613416		7p21.3	SCINDERIN; SCIN	85477
MIM613417		13q13.3	FAMILY WITH SEQUENCE SIMILARITY 48, MEMBER A; FAM48A	55578
MIM613418	C2677169	9q34.11	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15; BMND15	100422910
MIM613419		19q13.43	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 4; ZSCAN4	201516
MIM613420		18q11.2	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING 1; KCTD1	284252
MIM613421		12q24.11	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING 10; KCTD10	83892
MIM613422		17q25.1	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING 2; KCTD2	23510
MIM613423		5q31.3	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING 16; KCTD16	57528
MIM613424	C3150681	15q14	CARDIOMYOPATHY, DILATED, 1R; CMD1R	70
MIM613425		2p24.1-p23.1	CHROMOSOME 2 OPEN READING FRAME 71; C2ORF71	388939
MIM613426	C1834481	14q12	CARDIOMYOPATHY, DILATED, 1S; CMD1S	4625
MIM613427		10q22.1	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 16; ANAPC16	119504
MIM613428	C3150691	2p24.1-p23.1	RETINITIS PIGMENTOSA 54; RP54	388939
MIM613429		15q15.2	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 2; HAUS2	55142
MIM613430		4p16.3	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 3; HAUS3	79441
MIM613431		14q11.2	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 4; HAUS4	54930
MIM613432		19q13.12	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 5; HAUS5	23354
MIM613433		9p22.1	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 6; HAUS6	54801
MIM613434		19p13.11	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 8; HAUS8	93323
MIM613435	C3150692	10p15-p14	AMYOTROPHIC LATERAL SCLEROSIS 12; ALS12	10133
MIM613436	C3150693	11q13.3-q13.4	AUTISM, SUSCEPTIBILITY TO, 17; AUTS17	22941
MIM613437		19p13.11	FCH DOMAIN ONLY PROTEIN 1; FCHO1	23149
MIM613438		5q13.2	FCH DOMAIN ONLY PROTEIN 2; FCHO2	115548
MIM613439		1q44	CONSORTIN; CNST	163882
MIM613440	C3150694	2q37.1	STATURE QUANTITATIVE TRAIT LOCUS 21; STQTL21	100502568
MIM613441		22q11.2-qter	TRANSCOBALAMIN II; TCN2	6948
MIM613442		16p13.3	PENTRAXIN 4, LONG; PTX4	390667
MIM613443	C3150700	5q14	MENTAL RETARDATION, STEREOTYPIC MOVEMENTS, EPILEPSY, AND/OR CEREBRAL MALFORMATIONS	4208
MIM613444	C3150701	 	CHROMOSOME 16p11.2 DELETION SYNDROME, 220-KB	100859928
MIM613445		7p13-p12	MYOSIN IG; MYO1G	64005
MIM613446		5q23.2	CENTROSOMAL PROTEIN, 120-KD; CEP120	153241
MIM613447		3q13.2	SPINDLE- AND CENTRIOLE-ASSOCIATED PROTEIN 1; SPICE1	152185
MIM613448		13q21.33-q22.1	CHROMOSOME 13 OPEN READING FRAME 37; C13ORF37	440145
MIM613449		2q21.1	FAMILY WITH SEQUENCE SIMILARITY 128, MEMBER A; FAM128A	653784
MIM613450		2q21.1	FAMILY WITH SEQUENCE SIMILARITY 128, MEMBER B; FAM128B	80097
MIM613451	C3150703	11p11.2	FRONTONASAL DYSPLASIA 2; FND2	60529
MIM613452		19q13.1	CATION CHANNEL, SPERM-ASSOCIATED, GAMMA; CATSPERG	57828
MIM613453	C3150704	6p25	DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91	5269
MIM613454	C3150705	14q13	RETT SYNDROME, CONGENITAL VARIANT	2290
MIM613455		1q42	MELANOMA INHIBITORY ACTIVITY FAMILY, MEMBER 3; MIA3	375056
MIM613456	C3150706	12q21.3-q22	FRONTONASAL DYSPLASIA 3; FND3	8092
MIM613457	C3150707	14q11-q22	CHROMOSOME 14q11-q22 DELETION SYNDROME	100505392
MIM613458	C3150708	16p13.3	CHROMOSOME 16p13.3 DUPLICATION SYNDROME	100505393
MIM613459	C3150709	3q25.3	BIRTH WEIGHT QUANTITATIVE TRAIT LOCUS 2; BWQTL2	100502569
MIM613460	C3150710	3q21	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 6; FGQTL6	100499168
MIM613461		1p31	LEPTIN RECEPTOR OVERLAPPING TRANSCRIPT; LEPROT	54741
MIM613462	C3150713	7p21.2	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 4; FGQTL4	100499169
MIM613463	C3150714	2p23.3-p23.2, 2p23.3-p23.2	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5; FGQTL5	2646
MIM613464	C3150715	14q32.1	RETINITIS PIGMENTOSA 51; RP51	123016
MIM613465		1q24	NONMETASTATIC CELLS 7, PROTEIN EXPRESSED IN; NME7	29922
MIM613466		1q23.3	PREFOLDIN 2; PFDN2	5202
MIM613468		8p22-p21.3	N-ACYLSPHINGOSINE AMIDOHYDROLASE 1; ASAH1	427
MIM613470	C3150730	19q13.1	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	2821
MIM613471	C0748397	1q42.1	REYNOLDS SYNDROME	3930
MIM613472		15q24.1	UNC51-LIKE KINASE 3; ULK3	25989
MIM613473		18q21.3	WD REPEAT-CONTAINING PROTEIN 7; WDR7	23335
MIM613474		2q35	ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 2B; ZFAND2B	130617
MIM613475		6p21.1	RIBOSOMAL RNA-PROCESSING FACTOR, 36-KD, S. CEREVISIAE, HOMOLOG OF; RRP36	88745
MIM613476		2q32.2	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 6; MFSD6	54842
MIM613477	C3150731	9q33-q34	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5; EIEE5	6709, 6812, 9863
MIM613478		19q13.42	COILED-COIL DOMAIN-CONTAINING PROTEIN 106; CCDC106	29903
MIM613479		17q25.3	5-@AZACYTIDINE-INDUCED GENE 1, MOUSE, HOMOLOG OF; AZI1	22994
MIM613480	C3150732	1q41-q42	LYMPHEDEMA, HEREDITARY, IC	57165
MIM613481		12q24.31	COILED-COIL DOMAIN-CONTAINING PROTEIN 62: CCDC62	84660
MIM613482		1p36.33	CYCLIN L2; CCNL2	81669
MIM613483		8q13	BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E22; BHLHE22	27319
MIM613484		1p36.13	SPEN, DROSOPHILA, HOMOLOG OF; SPEN	23013
MIM613485	C3150733	11q24	LONG QT SYNDROME 13; LQT13	3762
MIM613486		17p11.2	MICRO RNA 33B; MIR33B	693120
MIM613487		17p13.3	MICRO RNA 212; MIR212	406994
MIM613488	C0206634	12q13.1-q13.2	MYXOID LIPOSARCOMA	1649
MIM613489	C3150736	16q22.1	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	25839
MIM613490	C0221757	14q32.1	ALPHA-1-ANTITRYPSIN DEFICIENCY	5265
MIM613491		19p13.3	ALKALINE CERAMIDASE 1; ACER1	125981
MIM613492		9p22.1	ALKALINE CERAMIDASE 2; ACER2	340485
MIM613493	C3150738	16p11.2	IMMUNODEFICIENCY, COMMON VARIABLE, 3; CVID3	930
MIM613494	C3150739	22q13.1-q13.31	IMMUNODEFICIENCY, COMMON VARIABLE, 4; CVID4	115650
MIM613495	C3150740	11q13	IMMUNODEFICIENCY, COMMON VARIABLE, 5; CVID5	931
MIM613496	C3150741	11p	IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	975
MIM613497		10q23.31	LIPASE A, LYSOSOMAL ACID; LIPA	3988
MIM613498	C3150748	17p13	SEX HORMONE-BINDING GLOBULIN CIRCULATING LEVEL QUANTITATIVE TRAIT LOCUS; SXGQTL1	100528025
MIM613499		6p22.2	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER A; HIST1H2AA	221613
MIM613500	C3150750	22q11.21	AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE; AGM2	3543
MIM613501	C3150751	19q13.2	AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE; AGM3	973
MIM613502	C3150752	10q23.2	AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE; AGM4	29760
MIM613503		6p21.32	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ ALPHA-2; HLA-DQA2	3118
MIM613504		14q32.33	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 21; ZFYVE21	79038
MIM613505		9q34.3	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 26; LRRC26	389816
MIM613506	C3150753	9q34.13	AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5	56262
MIM613507	C3150754	3q24-q25.1	GLYCOGEN STORAGE DISEASE XV; GSD15	2992
MIM613508	C3150755	12q24.1	SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1; SSQTL1	59341
MIM613509	C3150756	4q21	CHROMOSOME 4q21 DELETION SYNDROME	100528026
MIM613510		11q13.4	CHROMOSOME 11 OPEN READING FRAME 59; C11ORF59	55004
MIM613511		5q33.1	SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 9; SPINK9	643394
MIM613512		1q32.1	ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 6; ZBED6	100381270
MIM613513		1q32.1	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 11A; ZC3H11A	9877
MIM613514		1q43	ZONA PELLUCIDA GLYCOPROTEIN 4; ZP4	57829
MIM613515		 	AUTOPHAGY 14, S. CEREVISIAE, HOMOLOG OF; ATG14	22863
MIM613516		 	KIAA0226 GENE; KIAA0226	9711
MIM613517	C3150757	2q37.1	MICROPHTHALMIA, ISOLATED 6; MCOP6	646960
MIM613520		 	FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 6; FGD6	55785
MIM613521		1p34	UROPORPHYRINOGEN DECARBOXYLASE; UROD	7389
MIM613522		7q31.3-q32	OPSIN 1, SHORT-WAVE-SENSITIVE; OPN1SW	611
MIM613523	C3150773	8p11	CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME	100529119
MIM613524		1q43-q44	SEROLOGICALLY DEFINED COLON CANCER ANTIGEN 8; SDCCAG8	10806
MIM613525		 	SEEK1 GENE	170679
MIM613526		 	SPR1 GENE	170680
MIM613527		2p23.3	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 27; DNAJC27	51277
MIM613528		11p15.4	SYNAPTOTAGMIN 9; SYT9	143425
MIM613529		15q21.1	CENTROSOMAL PROTEIN, 152-KD; CEP152	22995
MIM613530	C3150786	3p25.1-p23	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H	100529230
MIM613531		 	PHOSPHATASE AND TENSIN HOMOLOG PSEUDOGENE; PTENP1	11191
MIM613532		 	RAS-ASSOCIATED PROTEIN RAB8B; RAB8B	51762
MIM613533	C3150787	17q21.31	CHROMOSOME 17q21.31 DUPLICATION SYNDROME	100529226
MIM613534		 	FANCD2/FANCI-ASSOCIATED NUCLEASE 1; FAN1	22909
MIM613535		 	KIAA0319-LIKE; KIAA0319L	79932
MIM613536		 	LEUCINE-, GLUTAMATE-, AND LYSINE-RICH PROTEIN 1; LEKR1	389170
MIM613537		 	NLR FAMILY, CASPASE RECRUITMENT DOMAIN-CONTAINING 5; NLRC5	84166
MIM613538		 	FEM1, C. ELEGANS, HOMOLOG OF, A; FEM1A	55527
MIM613539		 	FEM1, C. ELEGANS, HOMOLOG OF, B; FEM1B	10116
MIM613540		14q13.1	SERINE PALMITOYLTRANSFERASE, SMALL SUBUNIT, A; SPTSSA	171546
MIM613541		12q24.31	CHROMOSOME 12 OPEN READING FRAME 65; C12ORF65	91574
MIM613542		 	MITOCHONDRIAL TRANSLATIONAL RELEASE FACTOR 1-LIKE; MTRF1L	54516
MIM613543		 	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 5A1; SLCO5A1	81796
MIM613544	C3150790	6q11-q14	CHROMOSOME 6q11-q14 DELETION SYNDROME	100529221
MIM613545	C3150792	1p34-p32	MACROSTOMIA, ISOLATED	100529231
MIM613546	C0878680	15q21.1	AROMATASE DEFICIENCY	1588
MIM613547	C3150793	16q24	STATURE QUANTITATIVE TRAIT LOCUS 22; STQTL22	100529227
MIM613548	C3150794	1p32	STATURE QUANTITATIVE TRAIT LOCUS 23; STQTL23	100529222
MIM613549	C3150795	2p16	STATURE QUANTITATIVE TRAIT LOCUS 24; STQTL24	100529223
MIM613550	C3150796	8q21.13-q22.1	NEPHRONOPHTHISIS 11; NPHP11	91147
MIM613551	C3150797	11q24	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6; AIS6	54414
MIM613552		7q11.23	PIGEON, DROSOPHILA, HOMOLOG OF; PION	54103
MIM613553		22q13.31-q13.33	X-PROLYL AMINOPEPTIDASE 3; XPNPEP3	63929
MIM613554	C1264040	12p13.3	VON WILLEBRAND DISEASE, TYPE 2; VWD2	7450
MIM613555		 	TET ONCOGENE FAMILY, MEMBER 3; TET3	200424
MIM613556		 	MICRO RNA 659; MIR659	724029
MIM613558	C3160736	9q21.11	DEAFNESS, AUTOSOMAL DOMINANT 51; DFNA51	 
MIM613559	C3150801	12q24.31	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	91574
MIM613560		 	METHYLTRANSFERASE-LIKE 11A; METTL11A	28989
MIM613561	C3150802	12p11.21	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	51067
MIM613562		 	Fc RECEPTOR-LIKE PROTEIN 6; FCRL6	343413
MIM613563	C3150803	11q23.3	NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA; NSLL	867
MIM613564	C3150804	2p12-p11.2	CHROMOSOME 2p12-p11.2 DELETION SYNDROME	100529243
MIM613565		1p36.3	UBIQUITINATION FACTOR E4B; UBE4B	10277
MIM613566	C3150805	19p13.13-p13.12	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6; HBFQTL6	10661
MIM613567		 	ZINC FINGER, MYM-TYPE 6; ZMYM6	9204
MIM613568		 	ZINC FINGER, MYM-TYPE 4; ZMYM4	9202
MIM613569		 	SAD1 AND UNC84 DOMAIN-CONTAINING PROTEIN 2; SUN2	25777
MIM613570		 	CHROMOSOME 2 OPEN READING FRAME 43; C2ORF43	60526
MIM613571	C2673964	7q11.2	DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	5447
MIM613572		 	G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 6, MEMBER A; GPRC6A	222545
MIM613573	C3150807	1q23.3	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1; EDSS1	81607
MIM613574		9p22.3	TETRATRICOPEPTIDE REPEAT DOMAIN 39B; TTC39B	158219
MIM613575	C3150808	3p12-q13	RETINITIS PIGMENTOSA 55; RP55	84100
MIM613576	C3150809	7p21.2-p14.3	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	100505394
MIM613577		16p13.3	TBC1 DOMAIN FAMILY, MEMBER 24; TBC1D24	57465
MIM613578		9p13	PROTEASE, SERINE, 3; PRSS3	5646
MIM613579		12p13.31-p31.2	C-TYPE LECTIN DOMAIN FAMILY 6, MEMBER A; CLEC6A	93978
MIM613580		2p15	CHROMOSOME 2 OPEN READING FRAME 86; C2ORF86	51057
MIM613581	C3150819	3q11.2	RETINITIS PIGMENTOSA 56; RP56	50939
MIM613582	C3150821	17q25	RETINITIS PIGMENTOSA 57; RP57	5148
MIM613583		19q13.12	WD REPEAT-CONTAINING PROTEIN 62; WDR62	284403
MIM613584		 	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER L2; ALDH1L2	160428
MIM613585		 	TRANSMEMBRANE PROTEIN 147; TMEM147	10430
MIM613586		 	NIN1/RPN12-BINDING PROTEIN 1, S. CEREVISIAE, HOMOLOG OF; NOB1	28987
MIM613587	C3150833	8p23	OCCULT MACULAR DYSTROPHY; OCMD	94137
MIM613588		 	C-TYPE LECTIN DOMAIN FAMILY 3, MEMBER A; CLEC3A	10143
MIM613589	C3150834	1p21.3-p13.1	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; LDLCQ6	6272
MIM613590		6p22.1	BUTYROPHILIN, SUBFAMILY 2, MEMBER A1; BTN2A1	11120
MIM613591		6p22.1	BUTYROPHILIN, SUBFAMILY 2, MEMBER A2; BTN2A2	10385
MIM613592		6p22.1	BUTYROPHILIN, SUBFAMILY 2, MEMBER A3; BTN2A3	54718
MIM613593		6p22.1	BUTYROPHILIN, SUBFAMILY 3, MEMBER A1; BTN3A1	11119
MIM613594		6p22.1	BUTYROPHILIN, SUBFAMILY 3, MEMBER A2; BTN3A2	11118
MIM613595		6p22.1	BUTYROPHILIN, SUBFAMILY 3, MEMBER A3; BTN3A3	10384
MIM613596		2p15	FAMILY WITH SEQUENCE SIMILARITY 161, MEMBER A; FAM161A	84140
MIM613597		10q24.2	DIHYDRODIPICOLINATE SYNTHASE-LIKE, MITOCHONDRIAL; DHDPSL	112817
MIM613598		2p24.1-p22.3	ZINC FINGER PROTEIN 513; ZNF513	130557
MIM613599		20p11.21	ABHYDROLASE DOMAIN-CONTAINING PROTEIN 12; ABHD12	26090
MIM613602		2p24.1	WD REPEAT-CONTAINING PROTEIN 35; WDR35	57539
MIM613603	C3150857	4q32.1-q32.2	CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	100529228
MIM613604	C3150858	16q12.2-p11.2	CHROMOSOME 16p12.2-p11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	100526742
MIM613605		10q25.2	NONCODING RNA 81; NCRNA00081	92482
MIM613606	C3150859	1p33-p31.1	FORSYTHE-WAKELING SYNDROME; FWS	100529224
MIM613607		6q22.33	THYMOCYTE-EXPRESSED MOLECULE INVOLVED IN SELECTION; THEMIS	387357
MIM613608	C3150860	5p15.31-p15.1	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3	100529229
MIM613609		6p21.3	HFE GENE; HFE	3077
MIM613610	C3150874	2p24.1	CRANIOECTODERMAL DYSPLASIA 2; CED2	57539
MIM613611	C3150875	1q32	CHOANAL ATRESIA AND LYMPHEDEMA	5784
MIM613612	C3150876	7q31	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I	10466
MIM613613		14q11.2	MICRO RNA 208B; MIR208B	100126336
MIM613614		20q11.22	MICRO RNA 499; MIR499	574501
MIM613615	C3150877	 	SENIOR-LOKEN SYNDROME 7; SLSN7	10806
MIM613616	C3150878	10q24.2	HYPEROXALURIA, PRIMARY, TYPE III; HP3	112817
MIM613617	C3150879	2p24.1-p22.3	RETINITIS PIGMENTOSA 58; RP58	130557
MIM613618	C3150880	17q23.1-q23.2	CHROMOSOME 17q23.1-q23.2 DUPLICATION SYNDROME	100526743
MIM613619		22q11	SCAVENGER RECEPTOR CLASS F, MEMBER 2; SCARF2	91179
MIM613620		16p11.2	TBC1 DOMAIN FAMILY, MEMBER 10B; TBC1D10B	26000
MIM613621		14q12	NUCLEOTIDE-BINDING PROTEIN-LIKE PROTEIN; NUBPL	80224
MIM613622		11q24.2	FAD-DEPENDENT OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 1; FOXRED1	55572
MIM613624		15q25.3	ZINC FINGER PROTEIN 592; ZNF592	9640
MIM613625	C3150889	2p21-p16.3	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2; F5F8D2	90411
MIM613629		18p11.22, 18p11.22	FAMILY WITH SEQUENCE SIMILARITY 38, MEMBER B; FAM38B	63895
MIM613630	C3150891	10q24	COCOON SYNDROME	1147
MIM613631		10q11.22	FAMILY WITH SEQUENCE SIMILARITY 21, MEMBER C; FAM21C	253725
MIM613632		9p24.3	WAS PROTEIN FAMILY HOMOLOG 1; WASH1	100287171
MIM613633		9q33.2	DENN/MADD DOMAIN-CONTAINING PROTEIN 1A; DENND1A	57706
MIM613634		19p13.3	DENN/MADD DOMAIN-CONTAINING PROTEIN 1C; DENND1C	79958
MIM613635		7p22.1	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 1; EIF2AK1	27102
MIM613636	C3150892	11p14	TUBERCULIN SKIN TEST REACTIVITY, ABSENCE OF	100526790
MIM613637	C3150893	5p15	TUBERCULIN SKIN TEST REACTIVITY QUANTITATIVE TRAIT LOCUS	100526823
MIM613638	C3150894	19p13.13	CHROMOSOME 19p13.13 DELETION SYNDROME	100526791
MIM613639		12q24.33	G PROTEIN-COUPLED RECEPTOR 133; GPR133	283383
MIM613640	C3150896	14q24.3-q31	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	9517
MIM613641	C3150897	16q22.2-q22.3	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB	3735
MIM613642	C3150898	5p15	CARDIOMYOPATHY, DILATED, 1GG; CMD1GG	6389
MIM613643	C3150899	4p14	PARKINSON DISEASE 5, AUTOSOMAL DOMINANT; PARK5	7345
MIM613644		12p13.1	ACTIVATING TRANSCRIPTION FACTOR 7-INTERACTING PROTEIN; ATF7IP	55729
MIM613645		16p13.13	ACTIVATING TRANSCRIPTION FACTOR 7-INTERACTING PROTEIN 2; ATF7IP2	80063
MIM613646	C3150900	19p13.2	METHYLMALONIC ACIDURIA DUE TO TRANSCOBALAMIN RECEPTOR DEFECT	51293
MIM613647	C3150901	7p22.1	SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	9907
MIM613648		14q32	MATERNALLY EXPRESSED GENE 8; MEG8	79104
MIM613649		14q32	SMALL NUCLEOLAR RNA, C/D BOX, 112; SNORD112	692215
MIM613650		14q32	SMALL NUCLEOLAR RNA, C/D BOX, 113-1; SNORD113-1	767561
MIM613651		 	SMALL NUCLEOLAR RNA, C/D BOX, 114-1; SNORD114-1	767577
MIM613652	C3150902	 	C1q DEFICIENCY; C1QD	712, 713, 714
MIM613653		7p22.1	ADAPTOR-RELATED PROTEIN COMPLEX 5, ZETA-1 SUBUNIT; AP5Z1	9907
MIM613654		14q32	MICRO RNA 380; MIR380	494329
MIM613655		10q25.3	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 18; KCNK18	338567
MIM613656	C3150908	10q25.3	MIGRAINE, WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13; MGR13	338567
MIM613657	C3150909	15q26.1	D-2-@HYDROXYGLUTARIC ACIDURIA 2	3418
MIM613658	C3150910	2q36.2	RAJAB SYNDROME	100528027
MIM613659	C0038356	5q21-q22	GASTRIC CANCER	324
MIM613660	C3150912	10q23.1	CONE-ROD DYSTROPHY 15; CORD15	92211
MIM613661	C3150913	13q14.3	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	440138
MIM613662	C3150914	15q25	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	5428
MIM613663		3p13	SHQ1, S. CEREVISIAE, HOMOLOG OF; SHQ1	55164
MIM613664		11q12.1	SMOOTHELIN-LIKE 1; SMTNL1	219537
MIM613665		1q23.2	DUFFY ANTIGEN RECEPTOR FOR CHEMOKINES; DARC	2532
MIM613666		13q14.3	ALG11, S. CEREVISIAE, HOMOLOG OF; ALG11	440138
MIM613667		6q21	SINE OCULIS-BINDING PROTEIN, DROSOPHILA, HOMOLOG OF; SOBP	55084
MIM613668	C3150921	11q21	MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	9440
MIM613669		10p11.23	MITOCHONDRIAL POLY(A) POLYMERASE; MTPAP	55149
MIM613670	C3150923	3p14.1	MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND AUTISTIC FEATURES	27086
MIM613671	C3150924	6q21	MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	55084
MIM613672	C3150925	10p11.23	SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	55149
MIM613673	C3150926	19p13.13-p13.12	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV; CDAN4	10661
MIM613674	C3150927	8q12-q13	VESICOURETERAL REFLUX 3; VUR3	64321
MIM613675	C3150928	17q11.2	CHROMOSOME 17q11.2 DELETION SYNDROME, 1.4-MB	100852404
MIM613676	CN074082	13q12.2	SECKEL SYNDROME 4; SCKL4	55835
MIM613677	C3150933	 	HYPERALDOSTERONISM, FAMILIAL, TYPE III	3762
MIM613679	C0020640	11p11-q12	PROTHROMBIN DEFICIENCY, CONGENITAL	2147
MIM613680	C3150939	16p13.3	MICROCEPHALY, MENTAL RETARDATION, AND DISTINCTIVE FACIES, WITH CARDIAC AND GENITOURINARY MALFORMATIONS	100529147
MIM613681	C3150940	2q31.1	CHROMOSOME 2q31.1 DUPLICATION SYNDROME	100529099
MIM613682		22q11.21-q11.22	MICRO RNA 130B; MIR130B	406920
MIM613683		1q22	SOLUTE CARRIER FAMILY 50 (SUGAR TRANSPORTER), MEMBER 1; SLC50A1	55974
MIM613684	C3150941	22q13	RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	2033
MIM613685	C2829263	9p23-p21.2	DEAFNESS, AUTOSOMAL RECESSIVE 83; DFNB83	100359400
MIM613686	C3150942	17p13.2	SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	84667
MIM613687		12q23	CHROMOSOME 12 OPEN READING FRAME 48; C12ORF48	55010
MIM613688	C3150943	7q35-q36	LONG QT SYNDROME 2; LQT2	3757, 84920
MIM613689	C3150946	22q12.3-q13.1	MAMMARY-DIGITAL-NAIL SYNDROME; MDNS	100529148
MIM613690	C1860752	19q13.4	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7	7137
MIM613691		22q13.31	GRAM DOMAIN-CONTAINING PROTEIN 4; GRAMD4	23151
MIM613692		1q23.3	ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 11; ZCCHC11	23318
MIM613693	C3150953	21q22.1	LONG QT SYNDROME 6; LQT6	9992
MIM613694	C3160720	14q24.3	CARDIOMYOPATHY, DILATED, 1U; CMD1U	5663
MIM613695	C1867904	21q22.1-q22.2	LONG QT SYNDROME 5; LQT5	3753
MIM613696		11q14.3	UPSTREAM BINDING TRANSCRIPTION FACTOR (RNA POLYMERASE I)-LIKE 1; UBTFL1	642623
MIM613697	C3150958	1q31-q42	CARDIOMYOPATHY, DILATED, 1V; CMD1V	5664
MIM613698		3p21.31	SOLUTE CARRIER FAMILY 25 (CARNITINE/ACYLCARNITINE TRANSLOCASE), MEMBER 20; SLC25A20	788
MIM613699		9q34.3	GLYCOSYLTRANSFERASE 6 DOMAIN-CONTAINING 1; GLT6D1	360203
MIM613700	C3150966	22q11.2	SUPERNUMERARY DER(22)t(8;22) SYNDROME	100529149
MIM613701		16q22.1	MICRO RNA 328; MIR328	442901
MIM613702	C3150967	12p13.1	KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT; KFS3	9573
MIM613703	C3150968	12p13.1, 8q22.1	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6; MCOPCB6	392255, 9573
MIM613704	C3150969	12p13.1	MICROPHTHALMIA, ISOLATED 7; MCOP7	9573
MIM613705	C1866070	2q32.2-q33	OROFACIAL CLEFT 10; OFC10	7341
MIM613706	C3150970	7q34	NOONAN SYNDROME 7; NS7	673
MIM613707	C3150971	7q34	LEOPARD SYNDROME 3	673
MIM613708	C3150972	 	NEUROPATHY, HEREDITARY SENSORY, TYPE ID; HSN1D	51062
MIM613709		1q32.1	EUKARYOTIC TRANSLATION INITIATION FACTOR 2D; EIF2D	1939
MIM613710	C3150973	 	THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4	60386
MIM613711	C2931739	5p13.1-p12	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3; HSCR3	2668
MIM613712	C3150975	20q13.2-q13.3	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4; HSCR4	1908
MIM613713		13q34	PCI DOMAIN-CONTAINING PROTEIN 2; PCID2	55795
MIM613714		11p15.1	B7 HOMOLOG 6	374383
MIM613715		13q12.2	POLYMERASE I, RNA, SUBUNIT D; POLR1D	51082
MIM613716		8q24.3	MICRO RNA 661; MIR661	724031
MIM613717	C3150983	13q12.2	TREACHER COLLINS SYNDROME 2; TCS2	51082
MIM613718	C2239351	12q14.3	DEAFNESS, AUTOSOMAL RECESSIVE 74; DFNB74	253827
MIM613719		12q14.3	METHIONINE SULFOXIDE REDUCTASE B3; MSRB3	253827
MIM613720	C3150986	20q13.3	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7; EIEE7	3785
MIM613721	C3150987	2q23-q24.3	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	6326
MIM613722	C3150988	20p12	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	23236
MIM613723	C3150989	8q24	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Q; LGMD2Q	5339
MIM613724	C3150990	1p32	LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	6342
MIM613725		6p12.3	SOLUTE CARRIER FAMILY 25, MEMBER 17; SLC25A27	9481
MIM613726		4q12-q13, 3p22.1	ANOCTAMIN 10; ANO10	55129
MIM613727		15q22.31	KELCH REPEAT AND BTB/POZ DOMAINS-CONTAINING PROTEIN 13: KBTBD13	390594
MIM613728	C3150998	 	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10	55129
MIM613729	C3150999	 	CHROMOSOME 7q11.23 DELETION SYNDROME, DISTAL, 1.2-MB	100653380
MIM613730	C3151000	11q25	HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS	83700
MIM613731	C3151001	3q21-q24	RETINITIS PIGMENTOSA 4; RP4	6010
MIM613733		11q13	MEN1 GENE; MEN1	4221
MIM613734		2q21.2	COILED-COIL DOMAIN-CONTAINING PROTEIN 115; CCDC115	84317
MIM613735	C3151036	1p32-p31	CHROMOSOME 1p32-p31 DELETION SYNDROME	100532738
MIM613736	C3151037	19q13.1	ACNE INVERSA, FAMILIAL, 2; ACNINV2	55851
MIM613737	C3151038	14q24.3	ACNE INVERSA, FAMILIAL, 3; ACNINV3	5663
MIM613738		7q21.2	ALKYLGLYCEROL MONOOXYGENASE; AGMO	392636
MIM613739		11q25	THYMOCYTE NUCLEAR PROTEIN 1; THYN1	29087
MIM613740	C3151039	12q22	CARDIOMYOPATHY, DILATED, 1T; CMD1T	7112
MIM613741		 	GLYCOGEN PHOSPHORYLASE, LIVER; PYGL	5836
MIM613742		 	GLUCOSE-6-PHOSPHATASE, CATALYTIC; G6PC	2538
MIM613743	C3151055	 	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE	1583
MIM613744	C3151056	 	SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51	23431
MIM613745		 	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 10; ANAPC10	10393
MIM613746		 	BREAST CANCER ANTIESTROGEN RESISTANCE 4; BCAR4	400500
MIM613747		 	KINESIN FAMILY MEMBER 24; KIF24	347240
MIM613748		 	COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 3; CHCHD3	54927
MIM613749		 	ZINC FINGER PROTEIN 260; ZNF260	339324
MIM613750	C1834329	 	RETINITIS PIGMENTOSA 27; RP27	4901
MIM613751	C3151057	 	HETEROTAXY, VISCERAL, 4, AUTOSOMAL; HTX4	93
MIM613752	C3151058	 	HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	191
MIM613753		 	MICRO RNA 211; MIR211	406993
MIM613754		 	RING FINGER PROTEIN 187; RNF187	149603
MIM613755		 	MICRO RNA 326; MIR326	442900
MIM613756	C3151059	 	RETINITIS PIGMENTOSA 49; RP49	1259
MIM613757	C3151060	 	MACULAR DEGENERATION, AGE-RELATED, 6; ARMD6	84839
MIM613758	C3151061	 	RETINITIS PIGMENTOSA 47; RP47	6295
MIM613759	C3151062	 	INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	8772
MIM613760		 	SOLUTE CARRIER FAMILY 36, MEMBER 4; SLC36A4	120103
MIM613761	C3151063	 	MACULAR DEGENERATION, AGE-RELATED, 5; ARMD5	2074
MIM613762	C3151064	 	46,XY SEX REVERSAL 6; SRXY6	4214
MIM613763	C3151065	 	CATARACT, POSTERIOR POLAR, 2; CTPP2	1410
MIM613764		 	SECRETORY CARRIER MEMBRANE PROTEIN 4; SCAMP4	113178
MIM613765	C1861065	 	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9; CMH9	7273
MIM613766		 	SECRETORY CARRIER MEMBRANE PROTEIN 5; SCAMP5	192683
MIM613767	C3151066	 	RETINITIS PIGMENTOSA 45; RP45	1258
MIM613768		 	RING FINGER PROTEIN 213; RNF213	57674
MIM613769	C3151068	 	RETINITIS PIGMENTOSA 44; RP44	5995
MIM613770		 	PLACENTA-SPECIFIC GENE 4; PLAC4	191585
MIM613771		 	TRANSMEMBRANE PROTEIN 205; TMEM205	374882
MIM613772		 	KELCH-LIKE 14; KLHL14	57565
MIM613773		 	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 9B; IGSF9B	22997
MIM613774		 	CALMODULIN-REGULATED SPECTRIN-ASSOCIATED PROTEIN 1; CAMSAP1	157922
MIM613775		 	CALMODULIN-REGULATED SPECTRIN-ASSOCIATED PROTEIN 1-LIKE 1; CAMSAP1L1	23271
MIM613776	C3151069	 	CHROMOSOME 17p13.1 DELETION SYNDROME	100653374
MIM613777		 	FAD-DEPENDENT OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 2; FOXRED2	80020
MIM613778	C3151070	 	MACULAR DEGENERATION, AGE-RELATED, 8; ARMD8	387715
MIM613779	C3151071	 	COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D	718
MIM613780	C3151077	 	AORTIC ANEURYSM, FAMILIAL THORACIC 7; AAT7	4638
MIM613781		 	COILED-COIL DOMAIN-CONTAINING PROTEIN 125; CCDC125	202243
MIM613782		 	METHIONINE SULFOXIDE REDUCTASE B2; MSRB2	22921
MIM613783	C3151078	 	COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD	716
MIM613784	C3151079	 	MACULAR DEGENERATION, AGE-RELATED, 12; ARMD12	1524
MIM613785		 	COMPLEMENT COMPONENT 1, r SUBCOMPONENT; C1R	715
MIM613786		 	MICRO RNA 148A; MIR148A	406940
MIM613787		 	MICRO RNA 148B; MIR148B	442892
MIM613788		 	MICRO RNA 152; MIR152	406943
MIM613789	C3151080	 	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II; C8D2	732
MIM613790	C3151081	 	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I; C8D1	731
MIM613791	C3151085	 	MASP2 DEFICIENCY	10747
MIM613792	C2931337	 	CHROMOSOME 3pter-p25 DELETION SYNDROME	100653385
MIM613793	C1292305	 	BLOOD GROUP, CROMER SYSTEM; CROM	1604
MIM613794	C3151086	 	RETINITIS PIGMENTOSA 20; RP20	6121
MIM613795	C3151087	 	LOEYS-DIETZ SYNDROME, TYPE 3; LDS3	4088
MIM613796	C3151088	 	MYCOBACTERIAL AND VIRAL INFECTIONS, SUSCEPTIBILITY TO, AUTOSOMAL RECESSIVE	6772
MIM613797		 	PROTEASE, SERINE, 33; PRSS33	260429
MIM613798		 	COILED-COIL DOMAIN-CONTAINING PROTEIN 39; CCDC39	339829
MIM613799		 	COILED-COIL DOMAIN-CONTAINING PROTEIN 40; CCDC40	55036
MIM613800	C3151097	 	MEIER-GORLIN SYNDROME 2; MGORS2	5000
MIM613801	C3151107	 	RETINITIS PIGMENTOSA 40; RP40	5158
MIM613802		 	MALECTIN; MLEC	9761
MIM613803	C3151113	 	MEIER-GORLIN SYNDROME 3; MGORS3	23594
MIM613804	C3151120	 	MEIER-GORLIN SYNDROME 4; MGORS4	81620
MIM613805	C3151126	 	MEIER-GORLIN SYNDROME 5; MGORS5	990
MIM613806	C0566602	 	CHOLANGITIS, PRIMARY SCLEROSING; PSC	100653366
MIM613807	C3151136	 	CILIARY DYSKINESIA, PRIMARY, 14; CILD14	339829
MIM613808	C3151137	 	CILIARY DYSKINESIA, PRIMARY, 15; CILD15	55036
MIM613809	C3151138	 	RETINITIS PIGMENTOSA 39; RP39	7399
MIM613810	C3151139	 	RETINITIS PIGMENTOSA 43; RP43	5145
MIM613811	C3151140	 	PONTOCEREBELLAR HYPOPLASIA, TYPE 2D; PCH2D	51091
MIM613812	C3151147	 	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3	9420
MIM613813		 	MOUSE DOUBLE MINUTE 1 HOMOLOG; MDM1	56890
MIM613814		 	TETRATRICOPEPTIDE REPEAT DOMAIN 19; TTC19	54902
MIM613815		 	CYTOCHROME P450, FAMILY 21, SUBFAMILY A, POLYPEPTIDE 2; CYP21A2	1589
MIM613816		 	UBIQUITIN PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 7; UBR7	55148
MIM613817		 	SPERMATOGENESIS-ASSOCIATED SERINE-RICH PROTEIN 2-LIKE; SPATS2L	26010
MIM613818	C3151184	 	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7	1605
MIM613819	C3151185	 	ASPHYXIATING THORACIC DYSTROPHY 4; ATD4	79809
MIM613820	C3151186	 	NEPHRONOPHTHISIS 12; NPHP12	79809
MIM613821		 	PROTEIN PHOSPHATASE 3, REGULATORY SUBUNIT B, BETA; PPP3R2	5535
MIM613822		 	PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 2; PPP4R2	151987
MIM613823	C3151187	 	SECKEL SYNDROME 5; SCKL5	22995
MIM613824	C3151188	 	NEPHRONOPHTHISIS 9; NPHP9	284086
MIM613825	C3151189	 	COMPLEMENT COMPONENT 9 DEFICIENCY; C9D	735
MIM613826	C1854260	 	LEBER CONGENITAL AMAUROSIS 6; LCA6	57096
MIM613827	C3151190	 	RETINITIS PIGMENTOSA 48; RP48	2979
MIM613828	C3151191	 	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 8; GEFSP8	100653381
MIM613829	C3151192	 	LEBER CONGENITAL AMAUROSIS 7; LCA7	1406
MIM613830	C3151193	 	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D	9187
MIM613831		 	UBIQUITIN PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 3; UBR3	130507
MIM613832	CN226157	 	EPILEPSY, PROGRESSIVE MYOCLONIC 5; EPM5	166336
MIM613833		 	KAT8 REGULATORY NSL COMPLEX SUBUNIT 1-LIKE PROTEIN; KANSL1L	151050
MIM613834	C3151201	 	MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	59
MIM613835	C3151202	 	LEBER CONGENITAL AMAUROSIS 8; LCA8	23418
MIM613836	C3151203	 	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 5; ADIPQTL5	100653375
MIM613837	C1840284	 	LEBER CONGENITAL AMAUROSIS 11; LCA11	3614
MIM613838	C3151204	 	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16; CMH16	51778
MIM613839	C3151205	 	MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	1719
MIM613840		 	ZINC FINGER PROTEIN 304; ZNF304	57343
MIM613841		 	UBINUCLEIN 2; UBN2	254048
MIM613842		 	GDNF-INDUCIBLE ZINC FINGER PROTEIN 1; GZF1	64412
MIM613843	C3151206	 	LEBER CONGENITAL AMAUROSIS 15; LCA15	7287
MIM613844		 	UBIQUINOL-CYTOCHROME C REDUCTASE HINGE PROTEIN; UQCRH	7388
MIM613845	C3151209	 	HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS	54938
MIM613846		 	TECTONIC FAMILY, MEMBER 2; TCTN2	79867
MIM613847		 	TECTONIC FAMILY, MEMBER 3; TCTN3	26123
MIM613848	C3151211	 	OSTEOGENESIS IMPERFECTA, TYPE X	871
MIM613849	C3151433	 	OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	121340
MIM613850	C1840173	 	INOSINE TRIPHOSPHATASE DEFICIENCY	3704
MIM613851		 	PROLINE-RICH MEMBRANE ANCHOR 1; PRIMA1	145270
MIM613852	C3151219	 	FUCOSYLTRANSFERASE 6 DEFICIENCY	2528
MIM613853	C3151220	 	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 2; DTGA2	55997
MIM613854	C3151221	 	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 3; DTGA3	2657
MIM613855	C1866039	 	EPISODIC ATAXIA, TYPE 5; EA5	785
MIM613856	C1841721	 	ACHROMATOPSIA 4; ACHM4	2780
MIM613857	C3151222	 	OROFACIAL CLEFT 13; OFC13	100653367
MIM613858		 	PROTEASE, SERINE, 56; PRSS56	646960
MIM613859		 	UROMODULIN-LIKE 1; UMODL1	89766
MIM613860	C3151226	 	IMMUNODEFICIENCY DUE TO FICOLIN 3 DEFICIENCY	8547
MIM613861	C3151227	 	RETINITIS PIGMENTOSA 59; RP59	79947
MIM613862	C3151228	 	RETINITIS PIGMENTOSA 38; RP38	10461
MIM613863	C2751777	 	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7	6335
MIM613864		 	ZINC FINGER PROTEIN 317; ZNF317	57693
MIM613865	C3151230	 	DEAFNESS, AUTOSOMAL RECESSIVE 61; DFNB61	375611
MIM613866		 	HRAS-LIKE SUPPRESSOR 2; HRASLS2	54979
MIM613867		 	PHOSPHOLIPASE A2, GROUP XVI; PLA2G16	11145
MIM613868		 	SOLUTE CARRIER FAMILY 14 (UREA TRANSPORTER), MEMBER 1; SLC14A1	6563
MIM613869	C3151236	 	MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED	1410
MIM613870	C3151237	 	HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	1889
MIM613871		 	FUMARYLACETOACETATE HYDROLASE; FAH	2184
MIM613872		 	COAGULATION FACTOR X; F10	2159
MIM613873	C3151264	 	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17; CMH17	57158
MIM613874	C3151265	 	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18; CMH18	5350
MIM613875	C3151266	 	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 19; CMH19	125972
MIM613876	C3151267	 	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20; CMH20	91624
MIM613877	C3151268	 	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4	5346
MIM613878		 	COAGULATION FACTOR VII; F7	2155
MIM613879		 	THYROTROPIN-RELEASING HORMONE; TRH	7200
MIM613880		 	BROMO-ADJACENT HOMOLOGY DOMAIN-CONTAINING PROTEIN 1; BAHD1	22893
MIM613881	C3151293	 	CARDIOMYOPATHY, DILATED, 1HH; CMD1HH	9531
MIM613882	C3151295	 	HYPOMAGNESEMIA 6, RENAL; HOMG6	54805
MIM613883		 	KELL BLOOD GROUP METALLOENDOPEPTIDASE; KEL	3792
MIM613884	C0265451	 	CHROMOSOME 13q14 DELETION SYNDROME	100653382
MIM613885	CN077711	 	MECKEL SYNDROME, TYPE 8; MKS8	79867
MIM613886	C3151303	 	OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY	4915
MIM613887	C3151304	 	CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 4; CATC4	23424
MIM613888		 	RAS HOMOLOG GENE FAMILY, MEMBER T1; RHOT1	55288
MIM613889		 	RAS HOMOLOG GENE FAMILY, MEMBER T2; RHOT2	89941
MIM613890		 	3-@BETA-HYDROXYSTEROID DEHYDROGENASE 2; HSD3B2	3284
MIM613891		 	URIDINE MONOPHOSPHATE SYNTHETASE; UMPS	7372
MIM613892		 	DPY19-LIKE 1; DPY19L1	23333
MIM613893		 	DPY19-LIKE 2; DPY19L2	283417
MIM613894		 	DPY19-LIKE 3; DPY19L3	147991
MIM613895		 	DPY19-LIKE 4; DPY19L4	286148
MIM613896		 	BISPHOSPHOGLYCERATE MUTASE; BPGM	669
MIM613897		 	FANCF GENE; FANCF	2188
MIM613898		 	3-@HYDROXY-3-METHYLGLUTARYL-CoA LYASE; HMGCL	3155
MIM613899		 	FANCC GENE; FANCC	2176
MIM613900		 	TRANSGLUTAMINASE 6; TGM6	343641
MIM613901		 	CHROMOSOME 22 OPEN READING FRAME 28; C22ORF28	51493
MIM613902		 	ZINC FINGER PROTEIN 503; ZNF503	84858
MIM613903		 	ZINC FINGER PROTEIN 540; ZNF540	163255
MIM613904		 	ZINC FINGER PROTEIN 569; ZNF569	148266
MIM613905		 	ZINC FINGER PROTEIN 606; ZNF606	80095
MIM613906		 	ZINC FINGER PROTEIN 641; ZNF641	121274
MIM613907		 	ZINC FINGER PROTEIN 652; ZNF652	22834
MIM613908	CN077707	 	SPINOCEREBELLAR ATAXIA 35; SCA35	343641
MIM613909	C3151343	 	SPINOCEREBELLAR ATAXIA 32; SCA32	100653368
MIM613910		 	ZINC FINGER PROTEIN 480; ZNF480	147657
MIM613911		 	ZINC FINGER PROTEIN 496; ZNF496	84838
MIM613912	C1851396	 	COMPLEMENT FACTOR D DEFICIENCY; CFDD	1675
MIM613914		 	ZINC FINGER PROTEIN 746; ZNF746	155061
MIM613915		 	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 42: ZBTB42	100128927
MIM613916	C3151351	 	DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	100653376
MIM613917		 	MUCIN 22; MUC22	100507679
MIM613918		 	HLA COMPLEX GROUP 22; HCG22	285834
MIM613919		 	KINESIN FAMILY MEMBER 6; KIF6	221458
MIM613920		 	CHROMOSOME 2 OPEN READING FRAME 64; C2ORF64	493753
MIM613921		 	LIPASE FAMILY, MEMBER J; LIPJ	142910
MIM613922		 	LIPASE FAMILY, MEMBER K; LIPK	643414
MIM613923		 	LIPASE FAMILY, MEMBER M; LIPM	340654
MIM613924		 	LIPASE FAMILY, MEMBER N; LIPN	643418
MIM613925	C3151355	 	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	220296
MIM613926	C3151356	 	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	220296
MIM613927		 	COMPLEMENT COMPONENT 2; C2	717
MIM613928		 	DIFFUSE PANBRONCHIOLITIS CRITICAL REGION GENE 1; DPCR1	135656
MIM613929		 	SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 4; SPINK4	27290
MIM613930	C3151362	 	ALOPECIA-MENTAL RETARDATION SYNDROME 3; APMR3	100653369
MIM613931		 	TARGET OF EGR1; TOE1	114034
MIM613932		 	TNNI3-INTERACTING KINASE; TNNI3K	51086
MIM613933	C0268603	 	ACETYL-CoA CARBOXYLASE DEFICIENCY; ACACAD	31
MIM613934		 	TRANSMEMBRANE PROTEIN 25; TMEM25	84866
MIM613935		 	TRANSMEMBRANE PROTEIN 74; TMEM74	157753
MIM613936		 	TRANSMEMBRANE PROTEIN 102; TMEM102	284114
MIM613937		 	TRANSMEMBRANE PROTEIN 184C; TMEM184C	55751
MIM613938	C3151363	 	PARASOMNIA, SLEEPWALKING TYPE; PSMNSW	100653383
MIM613939		 	SPERMATOGENESIS-ASSOCIATED PROTEIN 20; SPATA20	64847
MIM613940		 	SPERMATOGENESIS-ASSOCIATED PROTEIN 5; SPATA5	166378
MIM613941		 	SERINE PROTEASE INHIBITOR, KUNITZ-TYPE, 3; SPINT3	10816
MIM613942		 	SAD1 AND UNC84 DOMAIN-CONTAINING PROTEIN 5; SUN5	140732
MIM613943	C3151377	 	ICHTHYOSIS, LAMELLAR, 4; LI4	643418
MIM613944	C3151378	 	IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	100653384
MIM613945		 	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 5, BETA; DNAJC5B	85479
MIM613946		 	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 5, GAMMA; DNAJC5G	285126
MIM613947		 	SPERMATOGENESIS-ASSOCIATED PROTEIN 6; SPATA6	54558
MIM613948		 	SPERMATOGENESIS-ASSOCIATED PROTEIN 8; SPATA8	145946
MIM613949	C3151379	 	OKT4 EPITOPE DEFICIENCY	920
MIM613950	C3151380	 	SCHIZOPHRENIA 15; SCZD15	85358
MIM613951	CN077628	 	FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	84464
MIM613952		 	FAMILY WITH SEQUENCE SIMILARITY 46, MEMBER C; FAM46C	54855
MIM613953	C3151402	 	CANDIDIASIS, FAMILIAL, 5; CANDF5	23765
MIM613954	C3151403	 	AMYOTROPHIC LATERAL SCLEROSIS 14, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS14	7415
MIM613955	C3151404	 	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 2; PLCA2	133396
MIM613956	C3151405	 	CANDIDIASIS, FAMILIAL, 6; CANDF6	112744
MIM613957	C3151406	 	SPERMATOGENIC FAILURE 8; SPGF8	2516
MIM613958	C3151407	 	SPERMATOGENIC FAILURE 9; SPGF9	283417
MIM613959	C3151408	 	SCHIZOPHRENIA 16; SCZD16	 
MIM613960	C3151409	 	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE III	4689
MIM613961		 	TASTE RECEPTOR, TYPE 2, MEMBER 19; TAS2R19	259294
MIM613962		 	TASTE RECEPTOR, TYPE 2, MEMBER 20; TAS2R20	259295
MIM613963		 	TASTE RECEPTOR, TYPE 2, MEMBER 30; TAS2R30	259293
MIM613964		 	TASTE RECEPTOR, TYPE 2, MEMBER 40; TAS2R40	259286
MIM613965		 	TASTE RECEPTOR, TYPE 2, MEMBER 41; TAS2R41	259287
MIM613966		 	TASTE RECEPTOR, TYPE 2, MEMBER 42; TAS2R42	353164
MIM613967		 	TASTE RECEPTOR, TYPE 2, MEMBER 45; TAS2R45	259291
MIM613968		 	TASTE RECEPTOR, TYPE 2, MEMBER 60; TAS2R60	338398
MIM613969	C3151410	 	MYOPIA 19, AUTOSOMAL DOMINANT; MYP19	100653370
MIM613970	C3151411	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6; MRD6	2904
MIM613971		 	EPILEPSY WITH NEURODEVELOPMENTAL DEFECTS; EPND	2903
MIM613972	C3151417	 	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6; CMM6	7517
MIM613973		 	MAB21 DOMAIN-CONTAINING PROTEIN 1; MB21D1	115004
MIM613974		 	DEAD BOX POLYPEPTIDE 60; DDX60	55601
MIM613975		 	INTERFERON-INDUCED PROTEIN 44-LIKE; IFI44L	10964
MIM613976		 	FANCE GENE; FANCE	2178
MIM613977	C3151421	 	CYANOSIS, TRANSIENT NEONATAL; TNCY	3048
MIM613978	C3161174	 	HEMOGLOBIN H DISEASE; HBH	3039, 3040
MIM613979		 	PRECURSOR mRNA-PROCESSING FACTOR 6, S. CEREVISIAE, HOMOLOG OF; PRPF6	24148
MIM613980	C3151431	 	ATRIAL FIBRILLATION, FAMILIAL, 9; ATFB9	3759
MIM613981	C3151432	 	HYPOTRICHOSIS 3; HYPT3	121391
MIM613982	C3279564	 	OSTEOGENESIS IMPERFECTA, TYPE VI; OI6	5176
MIM613983	C3151434	 	RETINITIS PIGMENTOSA 60; RP60	24148
MIM613984		 	FANCD2 GENE; FANCD2	2177
MIM613985	C0005283	 	BETA-THALASSEMIA	3043
MIM613986	C3151440	 	PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6	5015
MIM613987	C3151441	 	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2; DKCB2	55651
MIM613988	C3151442	 	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 3; DKCB3	55135
MIM613989	C3151443	 	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 2; DKCA2	7015
MIM613990	C3151445	 	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 3; DKCA3	26277
MIM613991		 	CDC42-BINDING PROTEIN KINASE, GAMMA; CDC42BPG	55561
MIM613992		 	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, DELTA; PPP2R2D	55844
MIM613993		 	MYOSIN, LIGHT CHAIN 7, REGULATORY; MYL7	58498
MIM613994		 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 4; NBPF4	148545
MIM613995		 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 5; NBPF5	100507044
MIM613996		 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 6; NBPF6	653149
MIM613997		 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 7; NBPF7	343505
MIM613998		 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 8; NBPF8	728841
MIM613999		 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 9; NBPF9	400818
MIM614000		 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 10; NBPF10	100132406
MIM614001		 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 11; NBPF11	200030
MIM614003		 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 14; NBPF14	25832
MIM614005		 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 16; NBPF16	728936
MIM614006		 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 19; NBPF19	641589
MIM614007		 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 20; NBPF20	641590
MIM614008	C3151446	 	NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	8815
MIM614009	C3279614	 	BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13	6915
MIM614010		 	INOSITOL MONOPHOSPHATASE DOMAIN-CONTAINING PROTEIN 1; IMPAD1	54928
MIM614011		 	ENDOGENOUS RETROVIRUS GROUP K, MEMBER 4; ERVK-4	60359
MIM614012		 	ENDOGENOUS RETROVIRUS GROUP K, MEMBER 5; ERVK-5	60358
MIM614013		 	ENDOGENOUS RETROVIRUS GROUP K, MEMBER 7; ERVK-7	449619
MIM614014		 	RIBONUCLEASE A FAMILY, 9; RNASE9	390443
MIM614015		 	DIACYLGLYCEROL LIPASE, ALPHA; DAGLA	747
MIM614016		 	DIACYLGLYCEROL LIPASE, BETA; DAGLB	221955
MIM614017	C3151460	 	CILIARY DYSKINESIA, PRIMARY, 16; CILD16	83544
MIM614018	C3279627	 	EPILEPSY, PROGRESSIVE MYOCLONIC 6; EPM6	9570
MIM614019	C3151461	 	LISSENCEPHALY 4; LIS4	54820
MIM614020	C3151462	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14; MRT14	9524
MIM614021	C3151463	 	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 3; CPVT3	100653371
MIM614022	C3151464	 	ATRIAL FIBRILLATION, FAMILIAL, 10; ATFB10	6331
MIM614023	C1291463	 	PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	5723
MIM614024	C3151465	 	PROTEIN Z DEFICIENCY	8858
MIM614025	C3151466	 	HEPATIC LIPASE DEFICIENCY	3990
MIM614026		 	KINESIN FAMILY MEMBER 26B; KIF26B	55083
MIM614027		 	INSULINOMA-ASSOCIATED 2; INSM2	84684
MIM614028	C3151467	 	HYPERALPHALIPOPROTEINEMIA 2; HALP2	345
MIM614029		 	SPEEDY, XENOPUS, HOMOLOG OF, A; SPDYA	245711
MIM614030		 	SPEEDY, XENOPUS, HOMOLOG OF, C; SPDYC	387778
MIM614031		 	RAN-BINDING PROTEIN 10; RANBP10	57610
MIM614032		 	TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 4; TOX4	9878
MIM614033	C1841858	 	HYDROXYACYL GLUTATHIONE HYDROLASE DEFICIENCY	3029
MIM614034	C1841651	 	HEME OXYGENASE 1 DEFICIENCY; HMOX1D	3162
MIM614035	C3279660	 	DEAFNESS, AUTOSOMAL RECESSIVE 29; DFNB29	23562
MIM614036	C1863095	 	ALPHA-2-MACROGLOBULIN DEFICIENCY; A2MD	2
MIM614037	C1855503	 	LEUKOTRIENE C4 SYNTHASE DEFICIENCY	4056
MIM614038	C3279664	 	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	2624
MIM614039	C3279670	 	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS; CDCBM	10381
MIM614040		 	ZINC FINGER PROTEIN 467; ZNF467	168544
MIM614041		 	RB1 GENE; RB1	5925
MIM614042	C3279690	 	MOYAMOYA DISEASE 5; MYMY5	59
MIM614043		 	LEUCINE-RICH REPEAT IN FLII-INTERACTING PROTEIN 2; LRRFIP2	9209
MIM614044	C0268417	 	TRYPSINOGEN DEFICIENCY	5644
MIM614045		 	FAMILY WITH SEQUENCE SIMILARITY 129, MEMBER B; FAM129B	64855
MIM614046		 	ARGININE- AND GLUTAMATE-RICH PROTEIN 1; ARGLU1	55082
MIM614047		 	METHYLENETETRAHYDROFOLATE DEHYDROGENASE 2-LIKE, NADP(+)-DEPENDENT; MTHFD2L	441024
MIM614048		 	KIAA1324-LIKE; KIAA1324L	222223
MIM614049	C3279693	 	ATRIAL FIBRILLATION, FAMILIAL, 11; ATFB11	2702
MIM614050	C3279695	 	ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12	10060
MIM614052	C3279699	 	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	54968
MIM614053	C3279708	 	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3; MC5DN3	514
MIM614054		 	RIBOSOMAL MODIFICATION PROTEIN RimK-LIKE FAMILY, MEMBER B; RIMKLB	57494
MIM614056		 	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 26; PPP1R26	9858
MIM614057		 	MICRO RNA 409; MIR409	574413
MIM614058		 	KETOHEXOKINASE; KHK	3795
MIM614059		 	MICRO RNA 338; MIR338	442906
MIM614060		 	HOXA DISTAL TRANSCRIPT ANTISENSE RNA; HOTTIP	100316868
MIM614061		 	OLFACTOMEDIN 4; OLFM4	10562
MIM614062		 	CDC42-BINDING PROTEIN KINASE, BETA; CDC42BPB	9578
MIM614063	C3279716	 	N-ACETYLASPARTATE DEFICIENCY; NACED	339983
MIM614064		 	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 24; ZBTB24	9841
MIM614065	C3279722	 	MYOPATHY, DISTAL, 4; MPD4	2318
MIM614066	C3279738	 	SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	10717
MIM614067	C3279743	 	SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE; SPG52	11154
MIM614068		 	INTRAFLAGELLAR TRANSPORT 43, CHLAMYDOMONAS, HOMOLOG OF; IFT43	112752
MIM614069	C3279748	 	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2; ICF2	9841
MIM614070	C3279754	 	PSORIASIS SUSCEPTIBILITY 13; PSORS13	10758
MIM614071		 	MYOCARDIAL ZONULA ADHERENS PROTEIN; MYZAP	100820829
MIM614072	CN068829	 	HERMANSKY-PUDLAK SYNDROME 3; HPS3	84343
MIM614073	C3484357	 	HERMANSKY-PUDLAK SYNDROME 4; HPS4	89781
MIM614074	CN068618	 	HERMANSKY-PUDLAK SYNDROME 5; HPS5	11234
MIM614075	CN068617	 	HERMANSKY-PUDLAK SYNDROME 6; HPS6	79803
MIM614076	C3279756	 	HERMANSKY-PUDLAK SYNDROME 7; HPS7	84062
MIM614077	CN068492	 	HERMANSKY-PUDLAK SYNDROME 8; HPS8	388552
MIM614078	C3279757	 	CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	54928
MIM614079	C3279774	 	ASPERGILLOSIS, SUSCEPTIBILITY TO	64581
MIM614080	C3279775	 	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	23556
MIM614081	C3279786	 	ANHAPTOGLOBINEMIA; AHP	3240
MIM614082	CN069000	 	FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	2189
MIM614083	CN068553	 	FANCONI ANEMIA, COMPLEMENTATION GROUP L; FANCL	55120
MIM614084		 	WEE1, S. POMBE, HOMOLOG OF, 2; WEE2	494551
MIM614085		 	CHROMOSOME 12 OPEN READING FRAME 32; C12ORF32	83695
MIM614086		 	IDAS	345643
MIM614087	CN068499	 	FANCONI ANEMIA, COMPLEMENTATION GROUP M; FANCM	57697
MIM614088		 	INTRACELLULAR ADHESION MOLECULE 4; ICAM4	3386
MIM614089	C1834527	 	ATRIAL SEPTAL DEFECT 3; ASD3	4624
MIM614090	C3279791	 	SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO; SSS3	4624
MIM614091	C3279792	 	SHORT RIB-POLYDACTYLY SYNDROME, TYPE V; SRPS5	57539
MIM614092		 	RAB-INTERACTING LYSOSOMAL PROTEIN-LIKE 1; RILPL1	353116
MIM614093		 	RAB-INTERACTING LYSOSOMAL PROTEIN-LIKE 2; RILPL2	196383
MIM614094		 	MARVEL DOMAIN-CONTAINING PROTEIN 3; MARVELD3	91862
MIM614095		 	PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL; PCK2	5106
MIM614096	C3279793	 	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8	57505
MIM614097	C0268419	 	ACATALASEMIA	847
MIM614099	C3279807	 	CRANIOECTODERMAL DYSPLASIA 3; CED3	112752
MIM614101	C2675436	 	PLASMA FIBRONECTIN DEFICIENCY	2335
MIM614102	C3279824	 	IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY; IGKCD	3514
MIM614104	C3279839	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 7; MRD7	1859
MIM614105	C1864150	 	METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; MMSDHD	4329
MIM614106		 	MUSCULAR LMNA-INTERACTING PROTEIN; MLIP	90523
MIM614107		 	KARYOPHERIN ALPHA-7; KPNA7	402569
MIM614108		 	BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 2; BPIFB2	80341
MIM614109		 	BPI FOLD-CONTAINING PROTEIN, FAMILY C; BPIFC	254240
MIM614110		 	BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 6; BPIFB6	128859
MIM614111	C1867399	 	PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD	5162
MIM614112		 	MICRO RNA 320A; MIR320A	407037
MIM614113	C3279842	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 2; MRD2	81704
MIM614114	C3279843	 	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	9702
MIM614115	C3279875	 	CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	10319
MIM614116	C3279885	 	NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	1786
MIM614117		 	EXOCYST COMPLEX COMPONENT 3-LIKE 1; EXOC3L1	283849
MIM614118		 	TEASHIRT ZINC FINGER HOMEOBOX 2; TSHZ2	128553
MIM614119		 	TEASHIRT ZINC FINGER HOMEOBOX 3; TSHZ3	57616
MIM614120	C3279899	 	HYDROLETHALUS SYNDROME 2; HLS2	374654
MIM614121		 	POLY(A) POLYMERASE-ASSOCIATED DOMAIN-CONTAINING PROTEIN 4; PAPD4	167153
MIM614122	C3279902	 	CHITOTRIOSIDASE DEFICIENCY; CHITD	1118
MIM614123		 	TRANSMEMBRANE AND COILED-COIL DOMAINS PROTEIN 1; TMCO1	54499
MIM614124		 	GLYCEROPHOSPHOCHOLINE PHOSPHODIESTERASE GDE1, S. CEREVISIAE, HOMOLOG OF; GPCPD1	56261
MIM614125		 	DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 4; DPPA4	55211
MIM614126		 	MOLYBDENUM COFACTOR SULFURASE C-TERMINAL DOMAIN-CONTAINING PROTEIN 1; MOSC1	64757
MIM614127		 	MOLYBDENUM COFACTOR SULFURASE C-TERMINAL DOMAIN-CONTAINING PROTEIN 2; MOSC2	54996
MIM614128	C1835592	 	LACTATE DEHYDROGENASE B DEFICIENCY; LDHBD	3945
MIM614129	C2681413	 	DEAFNESS, AUTOSOMAL RECESSIVE 81; DFNB81	100653390
MIM614130		 	ADENOSINE DEAMINASE DOMAIN-CONTAINING PROTEIN 1, TESTIS-SPECIFIC; ADAD1	132612
MIM614131	C3279905	 	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6; FSGS6	4643
MIM614132	C1859252	 	CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME; CFSMR	54499
MIM614133		 	HEPACAM FAMILY MEMBER 2; HEPACAM2	253012
MIM614134	C1852831	 	STICKLER SYNDROME, TYPE IV; STL4	1297
MIM614135	C2675767	 	EPIPHYSEAL DYSPLASIA, MULTIPLE, 6; EDM6	1297
MIM614136		 	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 8; TRAPPC8	22878
MIM614137		 	BET3, S. CEREVISIAE, HOMOLOG-LIKE; BET3L	100128327
MIM614138		 	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 11; TRAPPC11	60684
MIM614139		 	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 12; TRAPPC12	51112
MIM614140		 	SPERM ANTIGEN WITH CALPONIN HOMOLOGY AND COILED-COIL DOMAINS 1-LIKE; SPECC1L	23384
MIM614141		 	TRIPARTITE MOTIF-CONTAINING PROTEIN 2; TRIM2	23321
MIM614142		 	CUE DOMAIN-CONTAINING PROTEIN 2; CUEDC2	79004
MIM614143		 	IGF-LIKE FAMILY RECEPTOR 1; IGFLR1	79713
MIM614144		 	B9 DOMAIN-CONTAINING PROTEIN 1; B9D1	27077
MIM614145		 	COILED-COIL DOMAIN-CONTAINING PROTEIN 8; CCDC8	83987
MIM614146		 	CHROMOSOME 20 OPEN READING FRAME 194; C20ORF194	25943
MIM614147		 	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 8; C1QTNF8	390664
MIM614148		 	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 9B; C1QTNF9B	387911
MIM614149	C3279947	 	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 9; NDNC9	100682325
MIM614150		 	PROTEIN KINASE DOMAIN-CONTAINING PROTEIN, CYTOPLASMIC, MOUSE, HOMOLOG OF; PKDCC	91461
MIM614151		 	RING FINGER AND WD REPEAT DOMAINS-CONTAINING PROTEIN 3; RFWD3	55159
MIM614152	C3279948	 	DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	56616
MIM614153	C3472711	 	SPINOCEREBELLAR ATAXIA 36; SCA36	10528
MIM614154		 	NOP56, S. CEREVISIAE, HOMOLOG OF; NOP56	10528
MIM614155		 	MICRO RNA 1292; MIR1292	100302138
MIM614156	C3279964	 	HYPERBILIVERDINEMIA; HBLVD	57171, 644
MIM614157	C3279974	 	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 10; NDNC10	8323
MIM614158	C0398635	 	BLEEDING DISORDER, PLATELET-TYPE, 14; BDPLT14	6916
MIM614159		 	ZINC FINGER PROTEIN 644; ZNF644	84146
MIM614160	C0236033	 	MUSCLE HYPERTROPHY; MSLHP	2660
MIM614161		 	PR DOMAIN-CONTAINING PROTEIN 5; PRDM5	11107
MIM614162	C3279990	 	CANDIDIASIS, FAMILIAL, 7; CANDF7	6772
MIM614163	C0393770	 	DELAYED SLEEP PHASE SYNDROME, SUSCEPTIBILITY TO; DSPS	15
MIM614164	C0398747	 	GLUTATHIONE PEROXIDASE DEFICIENCY; GPXD	2876
MIM614165	C3279992	 	PARAGANGLIOMAS 5; PGL5	6389
MIM614166	C3279996	 	MYOPIA 20, AUTOSOMAL DOMINANT; MYP20	100682326
MIM614167	C3279997	 	MYOPIA 21, AUTOSOMAL DOMINANT; MYP21	84146
MIM614168		 	PHOSPHOENOLPYRUVATE CARBOXYKINASE 1, SOLUBLE; PCK1	5105
MIM614169		 	NEUROBEACHIN-LIKE 2; NBEAL2	23218
MIM614170	C3280011	 	BRITTLE CORNEA SYNDROME 2; BCS2	11107
MIM614171	C3280026	 	HERMANSKY-PUDLAK SYNDROME 9; HPS9	26258
MIM614172	C3280030	 	DENDRITIC CELL, MONOCYTE, B LYMPHOCYTE, AND NATURAL KILLER LYMPHOCYTE DEFICIENCY; DCML	2624
MIM614173	C3280031	 	JOUBERT SYNDROME 13; JBTS13	79600
MIM614174		 	MEIOSIS-EXPRESSED GENE 1, MOUSE, HOMOLOG OF; MEIG1	644890
MIM614175	C3280036	 	MECKEL SYNDROME, TYPE 10; MKS10	80776
MIM614176		 	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 28; ZFYVE28	57732
MIM614177		 	EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 4A; EFCAB4A	283229
MIM614178		 	EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 4B; EFCAB4B	84766
MIM614179		 	IMMUNOGLOBULIN SUPERFAMILY CONTAINING LEUCINE-RICH REPEAT 2; ISLR2	57611
MIM614180	C3280041	 	RETINITIS PIGMENTOSA 61; RP61	7401
MIM614181	C3280042	 	RETINITIS PIGMENTOSA 62; RP62	4117
MIM614182		 	HEART OF GLASS, ZEBRAFISH, HOMOLOG OF, 1; HEG1	57493
MIM614183		 	DIS3 MITOTIC CONTROL, S. CEREVISIAE, HOMOLOG-LIKE; DIS3L	115752
MIM614184		 	DIS3 MITOTIC CONTROL, S. CEREVISIAE, HOMOLOG-LIKE 2; DIS3L2	129563
MIM614185	C3280054	 	GELEOPHYSIC DYSPLASIA 2; GPHYSD2	2200
MIM614186	C3280062	 	LEBER CONGENITAL AMAUROSIS 16; LCA16	3769
MIM614187	C3280065	 	HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	100682260
MIM614188	C3280073	 	CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	3590
MIM614189		 	GOLGIN A7 FAMILY, MEMBER B; GOLGA7B	401647
MIM614190	C3280094	 	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3; PPNAD3	8622
MIM614191		 	DEP DOMAIN-CONTAINING PROTEIN 5; DEPDC5	9681
MIM614192	C3280095	 	MACROCEPHALY, MACROSOMIA, FACIAL DYSMORPHISM SYNDROME; MMFD	84282
MIM614193	C3280096	 	TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2; TFQTL2	3077
MIM614194		 	DEDICATOR OF CYTOKINESIS 6; DOCK6	57572
MIM614195	C1857964	 	CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS	30813
MIM614196	C3280100	 	NEPHROTIC SYNDROME, TYPE 6; NPHS6	5800
MIM614197		 	MITOCHONDRIAL CALCIUM UNIPORTER; MCU	90550
MIM614198	C3502630	 	MYASTHENIC SYNDROME, CONGENITAL, ACETAZOLAMIDE-RESPONSIVE	6329
MIM614199	C3280113	 	NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES; NPHS5	3913
MIM614201	C3280120	 	BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11	51206
MIM614202	C3280127	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	11253
MIM614203	C3280133	 	PARKINSON DISEASE 17; PARK17	55737
MIM614204	C0343055	 	PUSTULAR PSORIASIS, GENERALIZED; PSORP	26525
MIM614205	C3280146	 	THREE M SYNDROME 3; 3M3	83987
MIM614206		 	CHROMATIN TARGET OF PRMT1; CHTOP	26097
MIM614207	C3280153	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 17; MRT17	100689013
MIM614208	C3280154	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16; MRT16	100689014
MIM614209	C3280155	 	MECKEL SYNDROME, TYPE 9; MKS9	27077
MIM614210	C3280156	 	LUNG CANCER SUSCEPTIBILITY 5; LNCR5	100682395
MIM614211	C1414002	 	DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	29779
MIM614212	C3280160	 	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	1376
MIM614213	C3280168	 	NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	547
MIM614214		 	KELCH-LIKE 6; KLHL6	89857
MIM614215		 	ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 1; ASCC1	51008
MIM614216		 	ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 2; ASCC2	84164
MIM614217		 	ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 3; ASCC3	10973
MIM614218		 	WD REPEAT-CONTAINING PROTEIN 81; WDR81	124997
MIM614219	C3280182	 	ADAMS-OLIVER SYNDROME 2; AOS2	57572
MIM614220	C3280201	 	BILIARY CIRRHOSIS, PRIMARY, 4; PBC4	100689215
MIM614221	C3280202	 	BILIARY CIRRHOSIS, PRIMARY, 5; PBC5	100689212
MIM614222	C3280203	 	WARBURG MICRO SYNDROME 3; WARBM3	22931
MIM614223	C3280204	 	NARCOLEPSY 6, SUSCEPTIBILITY TO; NRCLP6	100689216
MIM614224	C3280205	 	RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVALVULAR PULMONIC STENOSIS; RAMSVPS	3490
MIM614225	C3280214	 	WARBURG MICRO SYNDROME 2; WARBM2	25782
MIM614226	C3280215	 	HOLOPROSENCEPHALY 11; HPE11	50937
MIM614227	C3280216	 	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 3; HNFJ3	100689490
MIM614228	C3280220	 	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	1778
MIM614229	C3280226	 	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	255928
MIM614230	C3280231	 	CHROMOSOME 8q21.11 DELETION SYNDROME	100689491
MIM614231	C3280240	 	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME; MEDS	51124
MIM614232		 	11-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II; HSD11B2	3291
MIM614233	C2681535	 	HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 1; FPH1	 
MIM614234		 	CHROMOSOME 1 OPEN READING FRAME 88; C1ORF88	128344
MIM614235		 	PDZ DOMAIN-CONTAINING PROTEIN 8; PDZD8	118987
MIM614236		 	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 7; SLC38A7	55238
MIM614237	C3280252	 	HYPOTRICHOSIS 9; HYPT9	100736250
MIM614238	C3280253	 	HYPOTRICHOSIS 10; HYPT10	100736251
MIM614239		 	FAMILY WITH SEQUENCE SIMILARITY 109, MEMBER A; FAM109A	144717
MIM614240		 	FAMILY WITH SEQUENCE SIMILARITY 109, MEMBER B; FAM109B	150368
MIM614241		 	LYSOCARDIOLIPIN ACYLTRANSFERASE 1; LCLAT1	253558
MIM614242		 	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 9; SLC16A9	220963
MIM614243		 	5-@OXOPROLINASE (ATP-HYDROLYZING); OPLAH	26873
MIM614244		 	PYRIDOXAL-DEPENDENT DECARBOXYLASE DOMAIN-CONTAINING PROTEIN 1; PDXDC1	23042
MIM614245		 	ACYL-CoA SYNTHETASE FAMILY, MEMBER 3; ACSF3	197322
MIM614246		 	N-ALPHA-ACETYLTRANSFERASE 60, NatF CATALYTIC SUBUNIT; NAA60	79903
MIM614247		 	MICRO RNA 519D; MIR519D	574480
MIM614248		 	PSEUDOPODIUM-ENRICHED ATYPICAL KINASE 1	79834
MIM614249	C3280265	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18; MRT18	9439
MIM614250	C3280266	 	NARCOLEPSY 7; NRCLP7	4340
MIM614251	C3280271	 	PARKINSON DISEASE 18; PARK18	1981
MIM614252	C3280275	 	ANEURYSM, INTRACRANIAL BERRY, 11; ANIB11	100750328
MIM614253		 	AMELOGENESIS IMPERFECTA AND GINGIVAL FIBROMATOSIS SYNDROME; AIGFS	54757
MIM614254	C3280282	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 8; MRD8	2902
MIM614255	C3280283	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	547
MIM614256	C3280284	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 10; MRD10	10369
MIM614257	C3280285	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 11; MRD11	2036
MIM614258		 	POLYMERASE III, RNA, SUBUNIT A; POLR3A	11128
MIM614259		 	WD REPEAT-CONTAINING PROTEIN 65; WDR65	149465
MIM614260		 	CHROMOSOME 9 OPEN READING FRAME 72; C9ORF72	203228
MIM614263		 	BACE1 ANTISENSE RNA: BACE1AS	100379571
MIM614264		 	RHO GTPase-ACTIVATING PROTEIN 30; ARHGAP30	257106
MIM614265	C3280314	 	COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	197322
MIM614266	C0004763	 	BARRETT ESOPHAGUS	115908, 4481, 51008
MIM614267		 	ACYL-CoA THIOESTERASE 6; ACOT6	641372
MIM614268		 	G PROTEIN-COUPLED RECEPTOR 115; GPR115	221393
MIM614269		 	G PROTEIN-COUPLED RECEPTOR 153; GPR153	387509
MIM614270		 	COILED-COIL DOMAIN-CONTAINING PROTEIN 108; CCDC108	255101
MIM614271		 	COILED-COIL DOMAIN-CONTAINING PROTEIN 137; CCDC137	339230
MIM614272		 	FAST KINASE DOMAIN-CONTAINING PROTEIN 5; FASTKD5	60493
MIM614273		 	OLFACTORY RECEPTOR, FAMILY 4, SUBFAMILY C, MEMBER 46; OR4C46	119749
MIM614274		 	STRAWBERRY NOTCH, DROSOPHILA, HOMOLOG OF, 1; SBNO1	55206
MIM614275		 	ZINC FINGER PROTEIN 565; ZNF565	147929
MIM614276		 	PHOSPHOLIPASE C-LIKE 2; PLCL2	23228
MIM614277		 	UBIQUITIN-CONJUGATING ENZYME 2W; UBE2W	55284
MIM614278	C1866472	 	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE DEFICIENCY; PAFAD	7941
MIM614279	C1839840	 	46,XY SEX REVERSAL 8; SRXY8	1109, 1646
MIM614280	C3280332	 	EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	100750238
MIM614281		 	ENDOTHELIAL CELL ADHESION MOLECULE; ESAM	90952
MIM614282		 	STROMAL CELL-DERIVED FACTOR 4; SDF4	51150
MIM614283		 	GLUCOCORTICOID-INDUCED TRANSCRIPT 1; GLCCI1	113263
MIM614284	C3280342	 	STICKLER SYNDROME, TYPE V; STL5	1298
MIM614285		 	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 9; C1QTNF9	338872
MIM614286	C0026986	 	MYELODYSPLASTIC SYNDROME; MDS	171023, 23451, 2624, 54790
MIM614287		 	OFC1 CANDIDATE GENE 1; OFCC1	266553
MIM614288		 	ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 11; ACAD11	84129
MIM614289		 	SUPPRESSOR OF LIN12-LIKE 2; SEL1L2	80343
MIM614290	C0795868	 	TETRASOMY 18p	100750329
MIM614291	C3280345	 	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4; BROVCA4	5892
MIM614292	C3280346	 	MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION; MCVD	55214
MIM614293	C0678213	 	HYDATIDIFORM MOLE, RECURRENT, 2; HYDM2	154288
MIM614294	C3280355	 	CHROMOSOME 15q25 DELETION SYNDROME	100820632
MIM614295		 	BICAUDAL C, DROSOPHILA, HOMOLOG OF, 1; BICC1	80114
MIM614296	C1857286	 	WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	54790, 7466
MIM614297		 	CHROMOSOME 19 OPEN READING FRAME 12; C19ORF12	83636
MIM614298	C3280371	 	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	83636
MIM614299	C3280378	 	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2; MMDS2	388962
MIM614300	C3280381	 	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	132
MIM614301		 	ATAXIN 1-LIKE; ATXN1L	342371
MIM614303	C3280392	 	EDICT SYNDROME; EDICT	406960
MIM614304		 	MICRO RNA 137; MIR137	406928
MIM614305	C3280402	 	SCLEROSTEOSIS 2; SOST2	4038
MIM614306	C3280415	 	COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	6334
MIM614307	C1858325	 	ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	23600
MIM614308		 	FORMIMINOTRANSFERASE N-TERMINAL SUBDOMAIN-CONTAINING GENE	348751
MIM614309		 	METHYLTRANSFERASE-LIKE 19; METTL19	152992
MIM614310		 	CENTROSOMAL PROTEIN, 70-KD; CEP70	80321
MIM614311		 	SYNAPSE DIFFERENTIATION-INDUCED GENE 1; SYNDIG1	79953
MIM614312		 	ZINC FINGER MYND-CONTAINING PROTEIN 15; ZMYND15	84225
MIM614313		 	ACYL-CoA THIOESTERASE 1; ACOT1	641371
MIM614314		 	ACYL-CoA THIOESTERASE 4; ACOT4	122970
MIM614315		 	ACYL-CoA THIOESTERASE 12; ACOT12	134526
MIM614316		 	VTI1, S. CEREVISIAE, HOMOLOG OF, A; VTI1A	143187
MIM614317	C3280439	 	VESICOURETERAL REFLUX 4; VUR4	100820757
MIM614318	C3280440	 	VESICOURETERAL REFLUX 5; VUR5	100820760
MIM614319	C3280441	 	VESICOURETERAL REFLUX 6; VUR6	100820763
MIM614320	C3280442	 	PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4	672
MIM614321	C3280443	 	MYOPATHY, DISTAL, TATEYAMA TYPE; MPDT	859
MIM614322	C3280452	 	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12	100820764
MIM614324	C3280471	 	OVARIAN DYSGENESIS 3; ODG3	29893
MIM614325	C3280479	 	PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	9378
MIM614326	C3280489	 	FEINGOLD SYNDROME 2; FGLDS2	407975
MIM614327	C3280492	 	TUMOR PREDISPOSITION SYNDROME; TPDS	8314
MIM614328	C3280501	 	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL; NISBD	6868
MIM614329	C3280523	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 31; MRT31	100852399
MIM614330		 	COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 2; C1QL2	165257
MIM614331	C1860896	 	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6; HNPCC6	7048
MIM614332	C3280524	 	SCHIZOPHRENIA 17; SCZD17	9378
MIM614333	C3280525	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29; MRT29	100852393
MIM614334		 	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 13; DNAJC13	23317
MIM614335	C3280526	 	ARTHROGRYPOSIS, DISTAL, TYPE 1B; DA1B	4604
MIM614336		 	PRESEQUENCE TRANSLOCASE-ASSOCIATED MOTOR 16, S. CEREVISIAE, HOMOLOG OF; PAM16	51025
MIM614337	C1838333	 	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4	5395
MIM614338	C3280527	 	PANCREATIC LIPASE DEFICIENCY; PNLIPD	5406
MIM614339	C3280537	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 32; MRT32	100852400
MIM614340	C3280538	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27; MRT27	100852397
MIM614341	C3280539	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33; MRT33	100852394
MIM614342	C3280540	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30; MRT30	100852401
MIM614343	C3280541	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19; MRT19	100852395
MIM614344	C3280542	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23; MRT23	100852398
MIM614345	C3280543	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24; MRT24	100852402
MIM614346	C3280544	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25; MRT25	100852403
MIM614347	C3280545	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28; MRT28	100852396
MIM614348		 	CHROMOSOME 6 OPEN READING FRAME 105; C6ORF105	84830
MIM614349		 	ZINC FINGER PROTEIN 638; ZNF638	27332
MIM614350	C1833477	 	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5; HNPCC5	2956
MIM614351		 	NUCLEOPORIN, 93-KD; NUP93	9688
MIM614352		 	NUCLEOPORIN, 205-KD; NUP205	23165
MIM614353		 	HAS2 ANTISENSE RNA 1; HAS2AS1	594842
MIM614354		 	PRO2268 GENE	55390
MIM614355		 	ACYL-CoA SYNTHETASE SHORT CHAIN FAMILY, MEMBER 1; ACSS1	84532
MIM614356		 	ACYL-CoA SYNTHETASE SHORT CHAIN FAMILY, MEMBER 3; ACSS3	79611
MIM614357		 	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 1; ACSM1	116285
MIM614358		 	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 2A; ACSM2A	123876
MIM614359		 	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 2B; ACSM2B	348158
MIM614360		 	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 4; ACSM4	341392
MIM614361		 	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 5; ACSM5	54988
MIM614362		 	ACYL-CoA SYNTHETASE, BUBBLEGUM FAMILY, MEMBER 1; ACSBG1	23205
MIM614363		 	ACYL-CoA SYNTHETASE, BUBBLEGUM FAMILY, MEMBER 2; ACSBG2	81616
MIM614364		 	ACETOACETYL-CoA SYNTHETASE; AACS	65985
MIM614365		 	AMINOADIPATE-SEMIALDEHYDE DEHYDROGENASE; AASDH	132949
MIM614366		 	POLYMERASE III, RNA, SUBUNIT B; POLR3B	55703
MIM614367		 	ADAPTOR-RELATED PROTEIN COMPLEX 5, BETA-1 SUBUNIT; AP5B1	91056
MIM614368		 	ADAPTOR-RELATED PROTEIN COMPLEX 5, MU-1 SUBUNIT; AP5M1	55745
MIM614369	C3280556	 	PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	79784
MIM614370	C3280574	 	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5; SMDP5	1439
MIM614371	C3280582	 	DENGUE VIRUS, SUSCEPTIBILITY TO	30835
MIM614372	C1835140	 	MANNOSE-BINDING PROTEIN DEFICIENCY	4153
MIM614373	C3280587	 	AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16	10280
MIM614374	CN119410	 	BLOOD GROUP, CHIDO/RODGERS SYSTEM	720
MIM614375	C3280597	 	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 4; AAA4	100859927
MIM614376	C3280598	 	ASPHYXIATING THORACIC DYSTROPHY 5; ATD5	57728
MIM614377	C3280612	 	NEPHRONOPHTHISIS 13; NPHP13	57728
MIM614378	C3280616	 	CRANIOECTODERMAL DYSPLASIA 4; CED4	57728
MIM614379	C3280641	 	COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD	721
MIM614380	C1852692	 	COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD	720
MIM614381	C3280644	 	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD8	55703
MIM614382	C3280645	 	BACTEREMIA, SUSCEPTIBILITY TO, 1; BACTS1	114609
MIM614383	C3280647	 	BACTEREMIA, SUSCEPTIBILITY TO, 2; BACTS2	1154
MIM614384		 	MICRO RNA 492; MIR492	574449
MIM614385	C1858380	 	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7; HNPCC7	27030
MIM614386		 	PROLINE-RICH TRANSMEMBRANE PROTEIN 2; PRRT2	112476
MIM614387		 	ZINC FINGER PROTEIN 526; ZNF526	116115
MIM614388	C3280660	 	ENCEPHALOPATHY, LETHAL, DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION; EMPF	10059
MIM614389	C0000809	 	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 1; RPRGL1	2153
MIM614390	C3280672	 	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 2; RPRGL2	2147
MIM614391	C3280674	 	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 3; RPRGL3	308
MIM614392		 	TUDOR DOMAIN-CONTAINING PROTEIN 3; TDRD3	81550
MIM614393		 	CHROMOSOME 6 OPEN READING FRAME 130; C6ORF130	221443
MIM614394		 	INTRAFLAGELLAR TRANSPORT 20, CHLAMYDOMONAS, HOMOLOG OF: IFT20	90410
MIM614395	C3280677	 	GRAFT-VERSUS-HOST DISEASE, SUSCEPTIBILITY TO; GVHDS	3586
MIM614396		 	G-PATCH DOMAIN-CONTAINING PROTEIN 8; GPATCH8	23131
MIM614397		 	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 2A; MFSD2A	84879
MIM614398		 	KIAA1462 GENE; KIAA1462	57608
MIM614399	C3280679	 	MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET; EMARDD	84466
MIM614400	C3280689	 	GLUCOCORTICOID THERAPY, RESPONSE TO; GCTR	113263
MIM614401	C3280690	 	ACCELERATED TUMOR FORMATION, SUSCEPTIBILITY TO; ACTFS	4193
MIM614402	C3553077	 	MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	11023
MIM614403		 	RHOMBOID 5, DROSOPHILA, HOMOLOG OF, 1; RHBDF1	64285
MIM614404		 	RHOMBOID 5, DROSOPHILA, HOMOLOG OF, 2; RHBDF2	79651
MIM614405		 	DEAH BOX POLYPEPTIDE 33; DHX33	56919
MIM614406		 	SLP ADAPTOR- AND CSK-INTERACTING MEMBRANE PROTEIN; SCIMP	388325
MIM614408	C3280703	 	MYOPATHY, CENTRONUCLEAR, 3; CNM3	4618
MIM614409	C2828721	 	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	100861438
MIM614410		 	ACTIN FILAMENT-ASSOCIATED PROTEIN 1-LIKE 1; AFAP1L1	134265
MIM614411	C1864340	 	GLYCEROL QUANTITATIVE TRAIT LOCUS; GLYCQTL	364
MIM614412		 	CHROMOSOME 3 OPEN READING FRAME 77; C3ORF77	375337
MIM614413		 	AMINOACYLASE 3; ACY3	91703
MIM614414	C3147085	 	DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	100861440
MIM614415	C3280721	 	CHILBLAIN LUPUS 2; CHBL2	25939
MIM614416	C3280729	 	RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES; RHFCA	56603
MIM614417	C3280730	 	EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5	57094
MIM614418	C3280734	 	FEBRILE SEIZURES, FAMILIAL, 11; FEB11	57094
MIM614419	C3280741	 	ASPARTATE AMINOTRANSFERASE, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1	2805
MIM614420	C3280742	 	SYSTEMIC LUPUS ERYTHEMATOSUS 16; SLEB16	1776
MIM614421		 	WEAVER SYNDROME 2; WVS2	2146
MIM614422	C3280758	 	CATARACT, CONGENITAL, CERULEAN TYPE, 5; CCA5	100861439
MIM614423		 	TRANSMEMBRANE PROTEIN 237; TMEM237	65062
MIM614424	C3280766	 	JOUBERT SYNDROME 14; JBTS14	65062
MIM614425		 	TELO2-INTERACTING PROTEIN 1; TTI1	9675
MIM614426		 	TELO2-INTERACTING PROTEIN 2; TTI2	80185
MIM614427		 	TEASHIRT ZINC FINGER HOMEOBOX 1; TSHZ1	10194
MIM614428		 	TRANSCRIPTION FACTOR AP2-EPSILON; TFAP2E	339488
MIM614429	C3280777	 	VENTRICULAR SEPTAL DEFECT 1; VSD1	2626
MIM614430	C3280781	 	ATRIOVENTRICULAR SEPTAL DEFECT 4; AVSD4	2626
MIM614431	C3280783	 	VENTRICULAR SEPTAL DEFECT 2; VSD2	10370
MIM614432	C3280785	 	VENTRICULAR SEPTAL DEFECT 3; VSD3	1482
MIM614433	C3280790	 	ATRIAL SEPTAL DEFECT 8; ASD8	10370
MIM614434	C3280794	 	CUTIS LAXA, AUTOSOMAL DOMINANT 2; ADCL2	10516
MIM614435	C3280795	 	HYPOPLASTIC LEFT HEART SYNDROME 2; HLHS2	1482
MIM614436	C3280797	 	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	90678
MIM614437	C3280798	 	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB; ARCL1B	30008
MIM614438	C3280799	 	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B	5831
MIM614439		 	ADP-RIBOSYLATION FACTOR-LIKE 14; ARL14	80117
MIM614440		 	PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN 3; PSD3	23362
MIM614441	C3280800	 	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2; PHOAR2	6578
MIM614442		 	PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN 4; PSD4	23550
MIM614443		 	EBNA1-BINDING PROTEIN 2; EBNA1BP2	10969
MIM614444		 	RAL GUANINE NUCLEOTIDE EXCHANGE FACTOR WITH PH DOMAIN AND SH3 DOMAIN-BINDING MOTIF 1; RALGPS1	9649
MIM614445		 	DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 2; DPPA2	151871
MIM614446		 	ATPase, CLASS II, TYPE 9B; ATP9B	374868
MIM614447		 	G0/G1 SWITCH GENE 2; G0S2	50486
MIM614448		 	GEMININ COILED-COIL DOMAIN-CONTAINING PROTEIN; GMNC	647309
MIM614449		 	PROTOCADHERIN 20; PCDH20	64881
MIM614450	C3280817	 	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	7067
MIM614451		 	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 7; ELOVL7	79993
MIM614452		 	ATPASE FAMILY, AAA DOMAIN-CONTAINING, MEMBER 1; ATAD1	84896
MIM614453		 	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 7; LRRC7	57554
MIM614454		 	UBIQUITIN PROTEIN LIGASE E3C; UBE3C	9690
MIM614455	C3280845	 	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE	64423
MIM614456	C3152204	 	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8; CMM8	 
MIM614457	C3280856	 	ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	6785
MIM614458	C3280866	 	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE); THMD5	27010
MIM614459		 	TRANSMEMBRANE PROTEIN 138; TMEM138	51524
MIM614460		 	UBIQUITIN-SPECIFIC PROTEASE 47; USP47	55031
MIM614461		 	CHROMOSOME 6 OPEN READING FRAME 125; C6ORF125	84300
MIM614462	C3280887	 	PYRUVATE DEHYDROGENASE LIPOIC ACID SYNTHETASE DEFICIENCY; PDHLD	11019
MIM614463		 	NMYC DOWNSTREAM-REGULATED GENE 4; NDRG4	65009
MIM614464	C3280897	 	JOUBERT SYNDROME 15; JBTS15	95681
MIM614465	C3280906	 	JOUBERT SYNDROME 16; JBTS16	51524
MIM614466	C3280913	 	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 6; CHDS6	 
MIM614468	C3280914	 	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	5336
MIM614469		 	SERRATE RNA EFFECTOR MOLECULE, ARABIDOPSIS, HOMOLOG OF; SRRT	51593
MIM614470	C2674723	 	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IV; ALPS4	4893
MIM614471		 	UBIQUITIN-SPECIFIC PROTEASE 19; USP19	10869
MIM614472		 	RING FINGER PROTEIN 123; RNF123	63891
MIM614473	C3276161	 	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2	368
MIM614474	C3280939	 	ATRIOVENTRICULAR SEPTAL DEFECT 5; AVSD5	2627
MIM614475	C3280943	 	ATRIAL SEPTAL DEFECT 9; ASD9	2627
MIM614476		 	THROMBOSPONDIN TYPE-1 DOMAIN-CONTAINING PROTEIN 4; THSD4	79875
MIM614477		 	CHROMOSOME 8 OPEN READING FRAME 37; C8ORF37	157657
MIM614478		 	CHROMOSOME 12 OPEN READING FRAME 62; C12ORF62	84987
MIM614479		 	MALONYL CoA:ACP ACYLTRANSFERASE, MITOCHONDRIAL; MCAT	27349
MIM614480	C3280953	 	HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	2819
MIM614481		 	ATXN7 ANTISENSE RNA 1; ATXN7AS1	100861563
MIM614482	C3280965	 	CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	9197
MIM614483	C3280970	 	PORENCEPHALY 2; POREN2	1284
MIM614484		 	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 13; ANAPC13	25847
MIM614485	C3280974	 	TRIGONOCEPHALY 2; TRIGNO2	158326
MIM614486	C1861173	 	THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT; THPH12	7056
MIM614487	C3280977	 	SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE; SPAX5	10939
MIM614488		 	MICRO RNA 1258; MIR1258	100302172
MIM614489		 	MICRO RNA 616; MIR616	693201
MIM614490	C3280986	 	BLOOD GROUP, JUNIOR SYSTEM; JR	9429
MIM614491	C1840390	 	PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B	65266
MIM614492	C1840391	 	PSEUDOHYPOALDOSTERONISM, TYPE IIC; PHA2C	65125
MIM614493	C3281001	 	WISKOTT-ALDRICH SYNDROME 2; WAS2	7456
MIM614494	C3281002	 	RETINITIS PIGMENTOSA 63; RP63	100862681
MIM614495	C3469605	 	PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D	26249
MIM614496	C3469606	 	PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	8452
MIM614497	C3281027	 	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7; MCOPCB7	 
MIM614498	C3281029	 	RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	221927
MIM614499	C3281044	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34; MRT34	8738
MIM614500	C3281045	 	CONE-ROD DYSTROPHY 16; CORD16	157657
MIM614501	C3281055	 	PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM; PMRED	79753
MIM614502		 	CHROMOSOME 9 OPEN READING FRAME 116; C9ORF116	138162
MIM614503		 	KELCH DOMAIN-CONTAINING PROTEIN 8A; KLHDC8A	55220
MIM614504	C3281066	 	USHER SYNDROME, TYPE IIIB; USH3B	3035
MIM614505		 	FK506-BINDING PROTEIN 14; FKBP14	55033
MIM614506		 	BRCA1-ASSOCIATED ATM ACTIVATOR 1; BRAT1	221927
MIM614507	C3281084	 	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir; CDG1R	1650
MIM614508	C3281089	 	MIRROR MOVEMENTS 2; MRMV2	5888
MIM614509		 	MICRO RNA 99A; MIR99A	407055
MIM614510		 	MICRO RNA 99B; MIR99B	407056
MIM614511		 	MYOD FAMILY INHIBITOR DOMAIN-CONTAINING PROTEIN; MDFIC	29969
MIM614512		 	TORSIN A-INTERACTING PROTEIN 1; TOR1AIP1	26092
MIM614513		 	TORSIN A-INTERACTING PROTEIN 2; TOR1AIP2	163590
MIM614514	C3281092	 	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6	5627
MIM614515		 	G PROTEIN-COUPLED RECEPTOR 179; GPR179	440435
MIM614517		 	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR-LIKE PROTEIN 2; ARNTL2	56938
MIM614518		 	GATA ZINC FINGER DOMAIN-CONTAINING PROTEIN 1; GATAD1	57798
MIM614519	C0019191	 	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH	1284, 1636
MIM614521	C3281125	 	THROMBOCYTHEMIA 3; THCYT3	3717
MIM614522		 	KELCH-LIKE 12; KLHL12	59349
MIM614523		 	MICRO RNA 489; MIR489	574442
MIM614524	C3281128	 	FIBROCHONDROGENESIS 2; FBCG2	1302
MIM614525		 	NFATC2-INTERACTING PROTEIN; NFATC2IP	84901
MIM614526	C3281137	 	CHROMOSOME 17q12 DUPLICATION SYNDROME	100884129
MIM614527	C3281138	 	CHROMOSOME 17q12 DELETION SYNDROME	100884130
MIM614528		 	HIF1A ANTISENSE RNA 1; HIF1AAS1	100750246
MIM614529		 	HIF1A ANTISENSE RNA 2; HIF1AAS2	100750247
MIM614530		 	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 12; NDUFA12	55967
MIM614531		 	RASGEF DOMAIN FAMILY, MEMBER 1A; RASGEF1A	221002
MIM614532		 	RASGEF DOMAIN FAMILY, MEMBER 1B; RASGEF1B	153020
MIM614533		 	CELL DIVISION CYCLE 26, S. CEREVISIAE, HOMOLOG OF; CDC26	246184
MIM614534		 	ANAPHASE-PROMOTING COMPLEX SUBUNIT 11; ANAPC11	51529
MIM614535		 	ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 7; ZSWIM7	125150
MIM614536		 	SWIM-TYPE ZINC FINGER DOMAIN-CONTAINING PROTEIN 7-ASSOCIATED PROTEIN 1; SWSAP1	126074
MIM614537		 	CHROMOSOME 10 OPEN READING FRAME 11; C10ORF11	83938
MIM614538		 	MICRO RNA 570; MIR570	693155
MIM614539		 	HELICASE, DNA, B; HELB	92797
MIM614540		 	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 3; IBGC3	6575
MIM614541	C3281152	 	CHROMOSOME 16q22 DELETION SYNDROME	100874527
MIM614542		 	FAMILY WITH SEQUENCE SIMILARITY 69, MEMBER A; FAM69A	388650
MIM614543		 	FAMILY WITH SEQUENCE SIMILARITY 69, MEMBER B; FAM69B	138311
MIM614544		 	FAMILY WITH SEQUENCE SIMILARITY 69, MEMBER C; FAM69C	125704
MIM614545		 	CHROMOSOME 19 OPEN READING FRAME 63; C19ORF63	284361
MIM614546	C3281153	 	EFAVIRENZ, POOR METABOLISM OF	1555
MIM614547		 	FAMILY WITH SEQUENCE SIMILARITY 103, MEMBER A1; FAM103A1	83640
MIM614548		 	SERINE INCORPORATOR 1; SERINC1	57515
MIM614549		 	SERINE INCORPORATOR 2; SERINC2	347735
MIM614550		 	SERINE INCORPORATOR 4; SERINC4	619189
MIM614551		 	SERINE INCORPORATOR 5; SERINC5	256987
MIM614552		 	XYLOSIDE XYLOSYLTRANSFERASE 1; XXYLT1	152002
MIM614553		 	N6 ADENINE-SPECIFIC DNA METHYLTRANSFERASE 1, PUTATIVE; N6AMT1	29104
MIM614554		 	FAMILY WITH SEQUENCE SIMILARITY 32, MEMBER A; FAM32A	26017
MIM614555		 	FERM DOMAIN-CONTAINING PROTEIN 6; FRMD6	122786
MIM614556		 	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 1B; ARID1B	57492
MIM614557	C3281160	 	EHLERS-DANLOS SYNDROME WITH PROGRESSIVE KYPHOSCOLIOSIS, MYOPATHY, AND HEARING LOSS; EDSKMH	55033
MIM614558	C3281191	 	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13; EIEE13	6334
MIM614559	C3281192	 	INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD	50
MIM614560		 	MAU2 CHROMATID COHESION FACTOR, C. ELEGANS, HOMOLOG OF; MAU2	23383
MIM614562	C3281201	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12; MRD12	57492
MIM614563	C3281202	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 13; MRD13	1778
MIM614564	C3281203	 	CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL; FCTCS	545
MIM614565	C3281215	 	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E; CSNB1E	440435
MIM614566		 	DYNEIN, AXONEMAL, ASSEMBLY FACTOR 3; DNAAF3	352909
MIM614567		 	DIAPHANOUS, DROSOPHILA, HOMOLOG OF, 3; DIAPH3	81624
MIM614568		 	UNC13, C. ELEGANS, HOMOLOG OF, C; UNC13C	440279
MIM614570		 	KINESIN FAMILY MEMBER 18B; KIF18B	146909
MIM614571		 	CHROMOSOME 5 OPEN READING FRAME 42; C5ORF42	65250
MIM614572		 	ZINC FINGER PROTEIN 42; ZFP42	132625
MIM614573		 	G PROTEIN-COUPLED RECEPTOR 158; GPR158	57512
MIM614574		 	ROGDI, DROSOPHILA, HOMOLOG OF; ROGDI	79641
MIM614576	C3553230	 	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	57511
MIM614577		 	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 3; PAQR3	152559
MIM614578		 	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 4; PAQR4	124222
MIM614579		 	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 6; PAQR6	79957
MIM614580		 	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 9; PAQR9	344838
MIM614581		 	MONOCYTE-TO-MACROPHAGE DIFFERENTIATION-ASSOCIATED PROTEIN 2; MMD2	221938
MIM614582	C3281234	 	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	11222
MIM614583	C3281235	 	BARAITSER-WINTER SYNDROME 2; BRWS2	71
MIM614584		 	PROLYL 4-HYDROXYLASE, TRANSMEMBRANE; P4HTM	54681
MIM614585		 	FERREDOXIN 1-LIKE PROTEIN; FDX1L	112812
MIM614586		 	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 5; ZDHHC5	25921
MIM614587		 	ChaC, E. COLI, HOMOLOG OF, 1; CHAC1	79094
MIM614588	C3281236	 	DYSTONIA 21; DYT21	100885773
MIM614589		 	TETRATRICOPEPTIDE REPEAT DOMAIN 37; TTC37	9652
MIM614590	C3281245	 	PODOCONIOSIS, SUSCEPTIBILITY TO; PDCOS	100885774
MIM614591		 	CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 16; CEACAM16	388551
MIM614592	C3281247	 	BENT BONE DYSPLASIA SYNDROME; BBDS	2263
MIM614593		 	KIAA0430 GENE; KIAA0430	9665
MIM614594	C2609071	 	PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES	162514
MIM614595	C3281288	 	PREECLAMPSIA/ECLAMPSIA 5; PEE5	10699
MIM614596		 	MICRO RNA 302A; MIR302A	407028
MIM614597		 	MICRO RNA 302B; MIR302B	442894
MIM614598		 	MICRO RNA 302C; MIR302C	442895
MIM614599		 	MICRO RNA 302D; MIR302D	442896
MIM614600		 	MICRO RNA 367; MIR367	442912
MIM614601		 	ZINC FINGER PROTEIN 326; ZNF326	284695
MIM614602	C3281289	 	TRICHOHEPATOENTERIC SYNDROME 2; THES2	6499
MIM614603		 	DDHD DOMAIN-CONTAINING PROTEIN 1; DDHD1	80821
MIM614604		 	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 7; ZDHHC7	55625
MIM614605		 	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 21; ZDHHC21	340481
MIM614606		 	FOCADHESIN; FOCAD	54914
MIM614607	C3553247	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 14; MRD14	8289
MIM614608	C3553248	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 15; MRD15	6598
MIM614609	C3553249	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 16; MRD16	6597
MIM614610		 	KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 2; KANK2	25959
MIM614611		 	KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 3; KANK3	256949
MIM614612		 	KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 4; KANK4	163782
MIM614613	C3553250	 	ACRODYSOSTOSIS 2, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS2	5144
MIM614614	C3281297	 	DEAFNESS, AUTOSOMAL DOMINANT 4B; DFNA4B	388551
MIM614615	C3553264	 	JOUBERT SYNDROME 17; JBTS17	65250
MIM614616	C3553270	 	DIARRHEA 6; DIAR6	2984
MIM614617	C2829265	 	DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	100887823
MIM614618	C3553288	 	HYPEREKPLEXIA 3; HKPX3	9152
MIM614619	C3553291	 	HYPEREKPLEXIA 2; HKPX2	2743
MIM614620		 	INTRAFLAGELLAR TRANSPORT 140, CHLAMYDOMONAS, HOMOLOG OF; IFT140	9742
MIM614621	C3553298	 	UV-SENSITIVE SYNDROME 2; UVSS2	1161
MIM614622	C3553302	 	KERATOCONUS 5; KTCN5	100885801
MIM614623	C3553306	 	KERATOCONUS 6; KTCN6	100885802
MIM614624		 	MITOCHONDRIAL ASSEMBLY OF RIBOSOMAL LARGE SUBUNIT 1; MALSU1	115416
MIM614625		 	DIFFERENTIATION-ANTAGONIZING NONCODING RNA; DANCR	57291
MIM614626		 	SMALL NUCLEOLAR RNA, H/ACA BOX, 26; SNORA26	677810
MIM614627		 	MICRO RNA 4449; MIR4449	100616436
MIM614628	C3553307	 	KERATOCONUS 8; KTCN8	100885803
MIM614629	C3553308	 	KERATOCONUS 7; KTCN7	100887822
MIM614630		 	ANDROGLOBIN; ADGB	79747
MIM614631		 	ISOPRENOID SYNTHASE DOMAIN-CONTAINING PROTEIN; ISPD	729920
MIM614632		 	UV-STIMULATED SCAFFOLD PROTEIN A; UVSSA	57654
MIM614633		 	VACUOLAR PROTEIN SORTING 54, S. CEREVISIAE, HOMOLOG OF; VPS54	51542
MIM614634		 	KIAA1377 GENE; KIAA1377	57562
MIM614635		 	LONG INTERGENIC NONCODING RNA 538; LINC00538	100861504
MIM614636		 	MYOSIN IH; MYO1H	283446
MIM614637		 	DESUMOYLATING ISOPEPTIDASE 1; DESI1	27351
MIM614638		 	DESUMOYLATING ISOPEPTIDASE 2; DESI2	51029
MIM614639		 	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 46; ZBTB46	140685
MIM614640	C3553328	 	UV-SENSITIVE SYNDROME 3; UVSS3	57654
MIM614641		 	LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 5; LAMP5	24141
MIM614642		 	START DOMAIN-CONTAINING PROTEIN 9; STARD9	57519
MIM614643	C3553330	 	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	729920
MIM614644	C3553339	 	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 4; MPVQTL4	100887753
MIM614645	C3553340	 	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 5; MPVQTL5	100887752
MIM614646	C3553341	 	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 6; MPVQTL6	100887751
MIM614647		 	COQ6, S. CEREVISIAE, HOMOLOG OF; COQ6	51004
MIM614648		 	RALY-LIKE PROTEIN; RALYL	138046
MIM614649		 	RING FINGER PROTEIN 170; RNF170	81790
MIM614650	C3553349	 	COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	51004
MIM614651	C3553354	 	COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2	23590
MIM614652	C3553358	 	COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	57107
MIM614653	C3539003	 	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6	667
MIM614654	C3553374	 	COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	57017
MIM614655	C3553381	 	STUTTERING, FAMILIAL PERSISTENT, 3; STUT3	100909386
MIM614656		 	KIAA1274 GENE; KIAA1274	27143
MIM614657		 	ANGIOMOTIN-LIKE 1; AMOTL1	154810
MIM614658		 	ANGIOMOTIN-LIKE 2; AMOTL2	51421
MIM614659		 	FAMILY WITH SEQUENCE SIMILARITY 123, MEMBER A; FAM123A	219287
MIM614660		 	PROTEIN ASSOCIATED WITH TOPOISOMERASE II, S. CEREVISIAE, HOMOLOG OF, 1; PATL1	219988
MIM614661		 	PROTEIN ASSOCIATED WITH TOPOISOMERASE II, S. CEREVISIAE, HOMOLOG OF, 2; PATL2	197135
MIM614662	C3553382	 	CORTISONE REDUCTASE DEFICIENCY 2; CORTRD2	3290
MIM614663		 	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN ASSOCIATED WITH LETHAL YELLOW, MOUSE, HOMOLOG OF; RALY	22913
MIM614664		 	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 4; TREML4	285852
MIM614665	C0270246	 	MECONIUM ILEUS	2984
MIM614666		 	COILED-COIL DOMAIN-CONTAINING PROTEIN 78; CCDC78	124093
MIM614667		 	MITOCHONDRIAL TRANSLATION OPTIMIZATION 1, S. CEREVISIAE, HOMOLOG OF; MTO1	25821
MIM614668	C3553403	 	STUTTERING, FAMILIAL PERSISTENT, 4; STUT4	100909385
MIM614669	C3553404	 	AURICULOCONDYLAR SYNDROME 2; ARCND2	5332
MIM614671	C3150155	 	CHROMOSOME 16p11.2 DUPLICATION SYNDROME	100909384
MIM614672	C3553409	 	CARDIOMYOPATHY, DILATED, 2B; CMD2B	57798
MIM614673	C3553414	 	MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8	9662
MIM614674	C3553418	 	PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	3350
MIM614675	C3808553	 	BONE MARROW FAILURE, FAMILIAL; BMFF	6731
MIM614676	C3553442	 	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 21; CMH21	100909387
MIM614677		 	COILED-COIL DOMAIN-CONTAINING PROTEIN 103; CCDC103	388389
MIM614678	C3553449	 	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B; PCH1B	51010
MIM614679	C3542550	 	CILIARY DYSKINESIA, PRIMARY, 17; CILD17	388389
MIM614680	C0021400	 	INFLUENZA, SEVERE, SUSCEPTIBILITY TO	 
MIM614681		 	AMINOGLYCOSIDE PHOSPHOTRANSFERASE DOMAIN-CONTAINING PROTEIN 1; AGPHD1	123688
MIM614682		 	ALANINE-GLYOXYLATE AMINOTRANSFERASE 2-LIKE 1; AGXT2L1	64850
MIM614683		 	ALANINE-GLYOXYLATE AMINOTRANSFERASE 2-LIKE 2; AGXT2L2	85007
MIM614685		 	ZINC FINGER PROTEIN 597; ZNF597	146434
MIM614686		 	FAMILY WITH SEQUENCE SIMILARITY 50, MEMBER B; FAM50B	26240
MIM614689	C3553493	 	SOLUBLE INTERLEUKIN-6 RECEPTOR, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS	 
MIM614690		 	CHROMOSOME 4 OPEN READING FRAME 48; C4ORF48	401115
MIM614691	C3553494	 	CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 5; CATC5	55750
MIM614693		 	ATM INTERACTOR; ATMIN	23300
MIM614694		 	REGULATION OF NUCLEAR PRE-mRNA DOMAIN-CONTAINING PROTEIN 1B; RPRD1B	58490
MIM614695		 	REGULATION OF NUCLEAR PRE-mRNA DOMAIN-CONTAINING 2; RPRD2	23248
MIM614696	C1836076	 	AMYOTROPHIC LATERAL SCLEROSIS 17; ALS17	25978
MIM614697		 	KATANIN, p60 SUBUNIT, A-LIKE PROTEIN 2; KATNAL2	83473
MIM614698		 	CYTOCHROME c OXIDASE 20, S. CEREVISIAE, HOMOLOG OF; COX20	116228
MIM614699	C3542922	 	IMMUNODEFICIENCY, COMMON VARIABLE, 7; CVID7	1380
MIM614700	C3553512	 	IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	987
MIM614701	C3553517	 	CORNELIA DE LANGE SYNDROME 4; CDLS4	5885
MIM614702	C3553529	 	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10; COXPD10	25821
MIM614703		 	SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2B; SRGAP2B	647135
MIM614704		 	SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2C; SRGAP2C	653464
MIM614706	C3539123	 	CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	2896
MIM614707	C3553538	 	BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	79581
MIM614708		 	SIGNAL PEPTIDE-, CUB DOMAIN-, AND EGF-LIKE DOMAINS-CONTAINING PROTEIN 3; SCUBE3	222663
MIM614709		 	LYR MOTIF-CONTAINING PROTEIN 1; LYRM1	57149
MIM614710		 	FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER A; FAM72A	729533
MIM614711		 	FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER B; FAM72B	653820
MIM614712		 	FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER D; FAM72D	728833
MIM614713		 	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 10; RASSF10	644943
MIM614715		 	TRANSMEMBRANE AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 2; TMIGD2	126259
MIM614716		 	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 16B; LRRC16B	90668
MIM614717		 	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 15; ANAPC15	25906
MIM614718		 	CHROMOSOME 15 OPEN READING FRAME 23; C15ORF23	90417
MIM614719		 	POTASSIUM CHANNEL MODULATORY FACTOR 1; KCMF1	56888
MIM614720		 	CYCLIN-DEPENDENT KINASE 19; CDK19	23097
MIM614721		 	TSPY-LIKE 5; TSPYL5	85453
MIM614722		 	MICRO RNA 3120; MIR3120	100422882
MIM614723	C0268120	 	ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY; APRTD	353
MIM614724		 	CENTROSOMAL PROTEIN, 63-KD; CEP63	80254
MIM614725		 	SERINE ACTIVE SITE-CONTAINING PROTEIN 1; SERAC1	84947
MIM614726		 	TRANSMEMBRANE PROTEIN 165; TMEM165	55858
MIM614727	C3553571	 	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk; CDG2K	55858
MIM614728	C3553582	 	SECKEL SYNDROME 6; SCKL6	80254
MIM614729		 	COP9, SUBUNIT 6; COPS6	10980
MIM614730		 	PHOSPHATIDYLINOSITOL GLYCAN, CLASS O; PIGO	84720
MIM614731	C3539120	 	PROSTATE CANCER, HEREDITARY, 2; HPC2	60528
MIM614732	C1846009	 	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES	1028
MIM614733		 	MICRO RNA 193A; MIR193A	406968
MIM614734		 	MICRO RNA 193B; MIR193B	574455
MIM614735		 	MICRO RNA 365A; MIR365A	100126355
MIM614736	C3553587	 	GLUCOCORTICOID DEFICIENCY 4; GCCD4	23530
MIM614737		 	BRAIN PROTEIN 44; BRP44	25874
MIM614738		 	BRAIN PROTEIN 44-LIKE; BRP44L	51660
MIM614739	C3553597	 	3-@METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	84947
MIM614740	C3553606	 	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7; BCC7	7157
MIM614741	C3553607	 	MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY; MPYCD	51660
MIM614742	C3553617	 	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	7015
MIM614743	C3553622	 	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	7012
MIM614744	C3553625	 	FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	3211
MIM614745	C3553633	 	BLOOD GROUP, JOHN MILTON HAGEN SYSTEM	8482
MIM614746	C3553634	 	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 5; UAQTL5	100996934
MIM614747	C3553635	 	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 6; UAQTL6	100996935
MIM614748	C3553636	 	INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL	3675
MIM614749	C3553637	 	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	84720
MIM614750	C3553645	 	MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 2; CMSTA2	1798
MIM614751	C3553656	 	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB; HMN5B	65055
MIM614752	C3540094	 	INTERLEUKIN 6, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS	3570
MIM614753	C3553660	 	SOTOS SYNDROME 2; SOTOS2	4784
MIM614754		 	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR 3; DMRT3	58524
MIM614755		 	MICRO RNA 520H; MIR520H	574493
MIM614756	C3553661	 	CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	23261
MIM614757		 	INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 5; IFITM5	387733
MIM614758		 	DYNACTIN 4; DCTN4	51164
MIM614759		 	COILED-COIL DOMAIN-CONTAINING PROTEIN 11; CCDC11	220136
MIM614760		 	PQ LOOP REPEAT-CONTAINING PROTEIN 2; PQLC2	54896
MIM614761		 	GLYCINE N-ACYLTRANSFERASE-LIKE 1; GLYATL1	92292
MIM614762		 	GLYCINE N-ACYLTRANSFERASE-LIKE 2; GLYATL2	219970
MIM614763		 	GLYCINE N-ACYLTRANSFERASE-LIKE 3; GLYATL3	389396
MIM614764		 	KATANIN p60 SUBUNIT A-LIKE 1; KATNAL1	84056
MIM614765		 	STRIATIN, CALMODULIN-BINDING PROTEIN; STRN	6801
MIM614766		 	STRIATIN, CALMODULIN-BINDING PROTEIN 3; STRN3	29966
MIM614767		 	STRIATIN, CALMODULIN-BINDING PROTEIN 4; STRN4	29888
MIM614768		 	TRANSMEMBRANE PROTEIN 66; TMEM66	51669
MIM614769		 	CYTOCHROME C OXIDASE ASSEMBLY FACTOR 1, S. CEREVISIAE, HOMOLOG OF; COA1	55744
MIM614770		 	PET100, S. CEREVISIAE, HOMOLOG OF; PET100	100131801
MIM614771		 	PET117, S. CEREVISIAE, HOMOLOG OF; PET117	100303755
MIM614772		 	CHROMOSOME 1 OPEN READING FRAME 31; C1ORF31	388753
MIM614773		 	MSS51 MITOCHONDRIAL TRANSLATIONAL ACTIVATOR, S. CEREVISIAE, HOMOLOG OF; MSS51	118490
MIM614774		 	PENTATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 1; PTCD1	26024
MIM614775		 	CYTOCHROME C OXIDASE ASSEMBLY FACTOR 3; COA3	28958
MIM614776		 	SIK FAMILY KINASE 3; SIK3	23387
MIM614777		 	MMS19 NUCLEOTIDE EXCISION REPAIR, S. CEREVISIAE, HOMOLOG OF; MMS19	64210
MIM614778		 	FAMILY WITH SEQUENCE SIMILARITY 96, MEMBER B; FAM96B	51647
MIM614779	C3553676	 	HETEROTAXY, VISCERAL, 6, AUTOSOMAL; HTX6	220136
MIM614780		 	SORTING NEXIN 10; SNX10	29887
MIM614781		 	TECTONIN BETA-PROPELLER REPEAT-CONTAINING 1; TECPR1	25851
MIM614782	C3539195	 	TREMOR, HEREDITARY ESSENTIAL, 4; ETM4	2521
MIM614783		 	POC1 CENTRIOLAR PROTEIN, CHLAMYDOMONAS, HOMOLOG OF, A; POC1A	25886
MIM614784		 	POC1 CENTRIOLAR PROTEIN, CHLAMYDOMONAS, HOMOLOG OF, B; POC1B	282809
MIM614785		 	MITOCHONDRIAL FISSION FACTOR; MFF	56947
MIM614786		 	TRANSMEMBRANE PROTEIN 207; TMEM207	131920
MIM614787		 	POGO TRANSPOSABLE ELEMENT WITH ZNF DOMAIN; POGZ	23126
MIM614788		 	FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 5; FGD5	152273
MIM614789		 	EGF DOMAIN-SPECIFIC O-LINKED N-ACETYLGLUCOSAMINE TRANSFERASE; EOGT	285203
MIM614790		 	WT1-INTERACTING PROTEIN; WTIP	126374
MIM614791		 	MICRO RNA 199B; MIR199B	406978
MIM614792		 	TRANSMEMBRANE AND UBIQUITIN-LIKE DOMAIN-CONTAINING PROTEIN 1; TMUB1	83590
MIM614793		 	MIXED-LINEAGE KINASE 4	84451
MIM614794		 	1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 3; AGPAT3	56894
MIM614795		 	1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 4; AGPAT4	56895
MIM614796		 	1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 5; AGPAT5	55326
MIM614797		 	PELLINO, DROSOPHILA, HOMOLOG OF, 1; PELI1	57162
MIM614798		 	PELLINO, DROSOPHILA, HOMOLOG OF, 2; PELI2	57161
MIM614799		 	CHROMOSOME 1 OPEN READING FRAME 109; C1ORF109	54955
MIM614800	C3541319	 	SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	51594
MIM614801		 	MALE-SPECIFIC LETHAL 1, DROSOPHILA, HOMOLOG OF; MSL1	339287
MIM614802		 	MALE-SPECIFIC LETHAL 2, DROSOPHILA, HOMOLOG OF; MSL2	55167
MIM614803		 	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR A1; DMRTA1	63951
MIM614804		 	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR A2; DMRTA2	63950
MIM614805		 	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR B1; DMRTB1	63948
MIM614806		 	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR C2; DMRTC2	63946
MIM614807	C3553709	 	MYOPATHY, CENTRONUCLEAR, 4; CNM4	124093
MIM614808	C3553719	 	AMYOTROPHIC LATERAL SCLEROSIS 18; ALS18	5216
MIM614809	C3553720	 	CFHR5 DEFICIENCY	81494
MIM614810	C3553728	 	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 5; MS5	7132
MIM614811		 	L-3-HYDROXYPROLINE DEHYDRATASE, TRANS; L3HYPDH	112849
MIM614812		 	NUCLEAR PROTEIN, TRANSCRIPTIONAL REGULATOR, 1; NUPR1	26471
MIM614813	C3542022	 	SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS; SOFT	25886
MIM614814	C3553748	 	ADAMS-OLIVER SYNDROME 3; AOS3	3516
MIM614815	C3553758	 	JOUBERT SYNDROME 18; JBTS18	26123
MIM614816	C3553762	 	LOEYS-DIETZ SYNDROME, TYPE 4; LDS4	7042
MIM614817	C3553774	 	INTERSTITIAL NEPHRITIS, KARYOMEGALIC; KMIN	22909
MIM614818		 	FURRY, DROSOPHILA, HOMOLOG OF; FRY	10129
MIM614819	C3553785	 	WEILL-MARCHESANI SYNDROME 3; WMS3	4053
MIM614820	C3553788	 	ALTERNATING HEMIPLEGIA OF CHILDHOOD 2; AHC2	478
MIM614821		 	PTCSC3 GENE; PTCSC3	100886964
MIM614822	C3553793	 	SPERMATOGENIC FAILURE 10; SPGF10	124404
MIM614823	C3542024	 	AORTIC VALVE DISEASE 2; AOVD2	4091
MIM614824		 	ADAPTOR-RELATED PROTEIN COMPLEX 5, SIGMA-1 SUBUNIT; AP5S1	55317
MIM614825		 	RALBP1-ASSOCIATED EPS DOMAIN-CONTAINING PROTEIN 1; REPS1	85021
MIM614826	C3553801	 	NYSTAGMUS 7, CONGENITAL, AUTOSOMAL DOMINANT; NYS7	101055624
MIM614827		 	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 11; DNAJC11	55735
MIM614828		 	GLYCOSYLTRANSFERASE-LIKE DOMAIN-CONTAINING PROTEIN 2; GTDC2	84892
MIM614829		 	CHROMOSOME 4 OPEN READING FRAME 26; C4ORF26	152816
MIM614830	C3553813	 	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8; MDDGA8	84892
MIM614831	C3553816	 	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13; SCAR13	2911
MIM614832	C3553830	 	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4; AI2A4	152816, 54959
MIM614833	C3553831	 	POLYMICROGYRIA WITH SEIZURES; PMGYS	25914
MIM614835		 	ACTIN, BETA-LIKE, 2; ACTBL2	345651
MIM614836	C3553840	 	HUMAN HERPESVIRUS 8, SUSCEPTIBILITY TO; HHV8S	101056702
MIM614837	C3553841	 	HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8	84634
MIM614838	C3553842	 	HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	26012
MIM614839	C3553843	 	HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA; HH10	6866
MIM614840	C3553844	 	HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA; HH11	6870
MIM614841	C1856897	 	HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA; HH12	2796
MIM614842	C3541462	 	HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA; HH13	3814
MIM614844	C3539071	 	NEPHRONOPHTHISIS 14; NPHP14	23090
MIM614845	C3541853	 	NEPHRONOPHTHISIS 15; NPHP15	22897
MIM614846	C3553858	 	TETRASOMY 15q26	101060869
MIM614847	C3553859	 	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12	6513
MIM614848		 	CENTROSOMAL PROTEIN, 164-KD; CEP164	22897
MIM614850	C3553869	 	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 4	148022
MIM614851	C3553870	 	SECKEL SYNDROME 7; SCKL7	51199
MIM614853		 	CYTOKINE RECEPTOR-LIKE FACTOR 3; CRLF3	51379
MIM614854		 	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 59; LRRC59	55379
MIM614855		 	TBC1 DOMAIN FAMILY, MEMBER 14; TBC1D14	57533
MIM614856	C3553887	 	OSTEOGENESIS IMPERFECTA, TYPE XIII; OI13	649
MIM614857	C3553915	 	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE; MAHCJ	5826
MIM614858	C3540450	 	HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA; HH14	55717
MIM614859	C3553929	 	PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	5193
MIM614861	C3553932	 	DEAFNESS, AUTOSOMAL RECESSIVE 98; DFNB98	54084
MIM614862	C3553936	 	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER); PBD4A	5190
MIM614863	C3553937	 	PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	5190
MIM614864		 	HEAT REPEAT-CONTAINING PROTEIN 2; HEATR2	54919
MIM614866	C3553940	 	PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER); PBD5A	5828
MIM614867	C3542026	 	PEROXISOME BIOGENESIS DISORDER 5B; PBD5B	5828
MIM614868	C3553943	 	T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITH OR WITHOUT CARDIAC MALFORMATIONS; TIIAC	6789
MIM614869	C3553944	 	USHER SYNDROME, TYPE IJ; USH1J	10518
MIM614870	C3553947	 	PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	5192
MIM614871	C3553948	 	PEROXISOME BIOGENESIS DISORDER 6B; PBD6B	5192
MIM614872	C3539168	 	PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	55670
MIM614873	C3553951	 	PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	55670
MIM614874	C3543825	 	CILIARY DYSKINESIA, PRIMARY, 18; CILD18	54919
MIM614876	C3553959	 	PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	9409
MIM614877	C3553960	 	PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	9409
MIM614878	C3553961	 	AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED; APLAID	5336
MIM614879	CN159238	 	PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	5191
MIM614880	C3553977	 	HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA; HH15	9394
MIM614881	C3553989	 	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5; DSMA5	3300
MIM614882	C3553999	 	PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	8504
MIM614883	C3554000	 	PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER); PBD11A	5194
MIM614885	C3554001	 	PEROXISOME BIOGENESIS DISORDER 11B; PBD11B	5194
MIM614886	C3554002	 	PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER); PBD12A	5824
MIM614887	C3554004	 	PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER); PBD13A	5195
MIM614895	C3540453	 	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F	 
MIM614896	C3554018	 	SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD	776
MIM614897	C3554021	 	HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16	10371
MIM614901		 	BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE KINASE; BCKDK	10295
MIM614902		 	RHO GTPase-ACTIVATING PROTEIN 33; ARHGAP33	115703
MIM614903		 	SORTING NEXIN 16; SNX16	64089
MIM614904		 	SORTING NEXIN 7; SNX7	51375
MIM614905		 	SORTING NEXIN 8; SNX8	29886
MIM614906		 	SORTING NEXIN 11; SNX11	29916
MIM614907		 	PRECURSOR mRNA-PROCESSING FACTOR 39, S. CEREVISIAE, HOMOLOG OF; PRPF39	55015
MIM614908		 	CHROMOSOME 11 OPEN READING FRAME 73; C11ORF73	51501
MIM614909		 	TRANSMEMBRANE PROTEIN 174; TMEM174	134288
MIM614910		 	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 6; C1QTNF6	114904
MIM614911		 	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 4; C1QTNF4	114900
MIM614912		 	TRAB DOMAIN-CONTAINING PROTEIN 2A; TRABD2A	129293
MIM614913		 	TRAB DOMAIN-CONTAINING PROTEIN 2B; TRABD2B	388630
MIM614914		 	MICRO RNA 298; MIR298	100126296
MIM614917		 	REQUIRED FOR MEIOTIC NUCLEAR DIVISION 1, S. CEREVISIAE, HOMOLOG OF; RMND1	55005
MIM614918		 	PENTATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 3; PTCD3	55037
MIM614919		 	NITRIC OXIDE-ASSOCIATED PROTEIN 1; NOA1	84273
MIM614925		 	OTOGELIN-LIKE PROTEIN; OTOGL	283310
